<SEC-DOCUMENT>0001398733-26-000030.txt : 20260513
<SEC-HEADER>0001398733-26-000030.hdr.sgml : 20260513
<ACCEPTANCE-DATETIME>20260513160839
ACCESSION NUMBER:		0001398733-26-000030
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		110
CONFORMED PERIOD OF REPORT:	20260331
FILED AS OF DATE:		20260513
DATE AS OF CHANGE:		20260513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aquestive Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001398733
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				208623253
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38599
		FILM NUMBER:		26973298

	BUSINESS ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059
		BUSINESS PHONE:		908-941-1900

	MAIL ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MonoSol Rx, Inc.
		DATE OF NAME CHANGE:	20070507
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>aqst-20260331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d4579-21a7-7c19-9fd0-51403d0078b6,g:613180f5-33da-4eff-b9e2-e98da0338ca1,d:65b3f6374bb0418bacd030f2ff357555-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:aqst="http://aquestive.com/20260331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>aqst-20260331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001398733</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-26">December 31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-29">False</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="f-98">http://fasb.org/us-gaap/2025#ManufacturedProductOtherMember</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="f-99">http://fasb.org/us-gaap/2025#ManufacturedProductOtherMember</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="aqst-20260331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>aqst:segment</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>aqst:lease</xbrli:measure></xbrli:unit><xbrli:unit id="payment"><xbrli:measure>aqst:payment</xbrli:measure></xbrli:unit><xbrli:unit id="instrument"><xbrli:measure>aqst:instrument</xbrli:measure></xbrli:unit><xbrli:unit id="pricing_period"><xbrli:measure>aqst:pricing_period</xbrli:measure></xbrli:unit><xbrli:unit id="pending_case"><xbrli:measure>aqst:pending_case</xbrli:measure></xbrli:unit><xbrli:unit id="renewal_option"><xbrli:measure>aqst:renewal_option</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-03</xbrli:startDate><xbrli:endDate>2024-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-23</xbrli:startDate><xbrli:endDate>2024-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-14</xbrli:startDate><xbrli:endDate>2025-08-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AnaphylmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AnaphylmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AQST108Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AQST108Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:PersonnelCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:PersonnelCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:ZevraAndCommaveTherapeuticsAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:ZevraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:AssertioHoldingsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:HyperaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:HyperaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-13</xbrli:startDate><xbrli:endDate>2025-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-13</xbrli:startDate><xbrli:endDate>2025-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-13</xbrli:startDate><xbrli:endDate>2025-08-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-03-03</xbrli:startDate><xbrli:endDate>2026-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-02</xbrli:startDate><xbrli:endDate>2023-03-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-23</xbrli:startDate><xbrli:endDate>2020-10-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-23</xbrli:startDate><xbrli:endDate>2020-10-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-23</xbrli:startDate><xbrli:endDate>2020-10-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:ZevraAndCommaveTherapeuticsAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-30</xbrli:startDate><xbrli:endDate>2026-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AtnahsPharmaUKLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-26</xbrli:startDate><xbrli:endDate>2022-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AtnahsPharmaUKLimitedAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-27</xbrli:startDate><xbrli:endDate>2023-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:AssertioHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-26</xbrli:startDate><xbrli:endDate>2022-10-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-12</xbrli:startDate><xbrli:endDate>2026-05-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-12</xbrli:startDate><xbrli:endDate>2026-05-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">aqst:MeasurementInputProbabilityOfSuccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyRightAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyRightAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-15</xbrli:startDate><xbrli:endDate>2019-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:A2020AdditionalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-15</xbrli:startDate><xbrli:endDate>2019-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-14</xbrli:startDate><xbrli:endDate>2023-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:ServiceBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:ServiceBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:ServiceBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeSixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeEightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwelveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:BlackScholesMertonModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA-BC</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:DebtInstrumentMilestoneTranchesAxis">aqst:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:DebtInstrumentMilestoneTranchesAxis">aqst:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:DebtInstrumentMilestoneTranchesAxis">aqst:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-12</xbrli:startDate><xbrli:endDate>2026-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i65b3f6374bb0418bacd030f2ff357555_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:34.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:472.75pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March&#160;31, 2026</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:34.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:472.75pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _____</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">to _____</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38599</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Aquestive Therapeutics, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">30 Technology Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Warren</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">NJ</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">07059</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-12">82-3827296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of Incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(&#160;<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">908</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">941-1900</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address, Zip Code and Telephone Number of Registrant&#8217;s Principal Executive Offices)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.822%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">AQST</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: &#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#9746; <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160; &#9744; No</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#9746; <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160; &#9744; No</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Securities Exchange Act of 1934.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160; &#9744; Yes&#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">&#9746;</ix:nonNumeric> No</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The number of outstanding shares of the registrant&#8217;s common stock, par value of $0.001 per share (the "Common Stock"), as of the close of business on May&#160;11, 2026 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">125,450,119</ix:nonFraction>.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_19">Condensed Balance Sheets as of March 31, 2026 and December 31, 2025</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_22">Condensed Statements of Operations and Comprehensive Loss for the three months ended March 31, 2026 and 2025</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_22">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_25">Condensed Statements of Changes in Stockholders&#8217; Deficit for the three months ended March 31, 2026 and 2025</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_25">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_31">Condensed Statements of Cash Flows for the three months ended March 31, 2026 and 2025</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_31">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_34">Notes to Unaudited Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_34">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_106">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_106">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_142">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_142">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_145">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_145">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PART II &#8211; OTHER INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_151">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_151">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_154">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_154">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_157">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_157">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_160">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_160">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_163">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_163">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_166">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_166">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_172">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_172">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_175">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i65b3f6374bb0418bacd030f2ff357555_175">49</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">GLOSSARY OF TERMS, ABBREVIATIONS AND ACRONYMS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following terms, abbreviations and acronyms are used to identify frequently used terms and phrases that may be used in this report (dollar amounts in thousands):</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:20.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TERM</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">DEFINITION</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.5% Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12.5% Senior Secured Notes redeemed on November 1, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.5% Notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13.5% Senior Secured Notes</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025 Underwritten Public Offering</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital raise of gross proceeds of $85,000</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ABL facility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Asset-based borrowing facility</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ADHD</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Attention deficit hyperactivity disorder </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AdrenaVerse&#8482; </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Epinephrine prodrug platform currently comprised of Anaphylm&#8482; and AQST-108</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ALS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amyotrophic lateral sclerosis</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amendment </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to the Purchase and Sale Agreement with RTW Investments LP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Anaphylm&#8482; </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Anaphylm&#8482;  (dibutepinephrine) sublingual film</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ANVISA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Brazilian Health Regulatory Agency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">API</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Active Pharmaceutical Ingredients</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive Therapeutics, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AQST</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nasdaq ticker symbol for Aquestive Therapeutics, Inc.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ASC</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assertio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assertio Holdings, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Assertio Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">License Agreement between Aquestive and Otter Pharmaceuticals, LLC, a subsidiary of Assertio Holdings, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ARS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acute Repetitive Seizures</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ASU</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Updates</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ATM facility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">At-The-Market facility for the purchase of AQST Common Stock, then in effect</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">CEO</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">CMC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, Manufacturing and Controls</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">CNS</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">CODM</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Decision Maker</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commave Therapeutics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commave Therapeutics SA</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock, par value $0.001 per share, of the Company </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued with private placement of up to $100,000 aggregate principal of 12.5% Notes originally due 2025</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Company</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive Therapeutics, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cosette</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cosette Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">CRL</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Complete Response Letter</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">CROs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contract Research Organizations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">DEA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Drug Enforcement Administration</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">EOP2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">End-of-phase 2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Act</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Securities Exchange Act of 1934</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Existing Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Purchase Warrants with the holder of the remaining 5,000,000 warrants</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">FDAAA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Food and Drug Administration Amendments Act of 2007</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">FDCA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The Federal Food, Drug, and Cosmetic Act</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:20.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">First amendment to the Sunovion License Agreement</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Generally Accepted Accounting Principles </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HCP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Provider</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">HF</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Human Factors</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Hypera</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Hypera Pharma, CosMed Industria De Cosmeticos E Medicamentos S.A</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IM</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intramuscular</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">IND</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Investigational New Drug</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Indenture Agreement</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agreement governing the 13.5% Senior Secured Notes</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Indivior</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Indivior Inc. (formerly, Reckitt Benckiser Pharmaceuticals Inc)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Indivior Amendment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 11 to the Indivior License Agreement</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Indivior License Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Exploitation Agreement with Reckitt Benckiser Pharmaceuticals, Inc. (with subsequent amendments collectively)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lenders</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oaktree Fund Administration, LLC and Oaktree Capital Management, L.P.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(diazepam) buccal film </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Marathon</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Marathon Asset Management</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MHRA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Medicines Healthcare products Regulatory Agency</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Multidistrict Litigation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Monetization Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase and Sale Agreement between Aquestive and Sunovion </span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Neurelis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Neurelis, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Not Meaningful, used in percentage changes</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Nasdaq</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">The Nasdaq Global Market</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">New Drug Application</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">New Warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase 2,750,000 shares of Common Stock </span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Orphan Drug Act</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21 U.S.C. &#167;&#167; 360aa&#8211;360ff (i.e., 21 U.S.C. &#167;&#8239;360aa et seq.)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">ODE</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Orphan Drug Exclusivity </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Offering</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$45,000 aggregate principal amount of 13.5% Senior Secured Notes due November 1, 2028</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PD</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacodynamics</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PDUFA</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Drug User Fee Act</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pharmanovia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Atnahs Pharma UK Limited, a company registered in England and Wales</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pharmanovia Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">License and Supply Agreement with Atnahs Pharma UK Limited</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pharmanovia Amendment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to the License and Supply Agreement with Atnahs Pharma UK Limited as of March 27, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pharmanovia Amendment No. 2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to the License and Supply Agreement with Atnahs Pharma UK Limited as of April 20, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PIP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pediatric Investigation Plan</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PK</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacokinetic</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-IND</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Pre-Investigational New Drug</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">PTO</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States Patent and Trademark Office</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase and Sale Agreement with funds managed by RTW Investments LP</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchaser</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">RTW Investments LP</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$75,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Obligations</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the Royalty Rights Agreements</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Rights Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Rights Agreements, component of 13.5% Senior Secured Notes</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Unit</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">RTW</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">RTW Investments, LP</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Securities Purchase Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Securities Purchase Agreements with certain purchasers entered into on June 6, 2022</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:20.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sunovion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sunovion Pharmaceuticals Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sunovion License Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">KYNMOBI Commercialization Agreement</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Territory</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certain countries of the European Union, the United Kingdom, Switzerland, Norway and the Middle East and North Africa under the Pharmanovia Agreement</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TGA</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Australian Government Department of Health&#8217;s Therapeutics Goods Administration</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant Issuance Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agreement with RTW Investments LP to issue a warrant to purchase up to 375,000 shares of the Company's Common Stock at an exercise price of $4.00 per share</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Zambon</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Zambon S.p.A.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Zevra</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Zevra Therapeutics, Inc. (formerly KemPharm, Inc.)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i65b3f6374bb0418bacd030f2ff357555_16"></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i65b3f6374bb0418bacd030f2ff357555_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">110,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">121,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-32">6,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">17,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-34">8,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-35">6,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">4,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">4,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">130,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">149,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-40">3,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-41">3,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-42">4,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-43">4,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-45">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-46">141,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-47">160,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">11,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-49">29,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">3,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">5,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-52">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-53">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">1,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">1,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loans payable, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LoansPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">13,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LoansPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">9,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">31,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">47,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-62">25,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-63">27,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:RoyaltyObligationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">26,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:RoyaltyObligationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">25,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">62,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">62,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">4,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">4,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">19,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">19,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">6,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">7,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-74">175,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-75">194,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Contingencies (Note 20)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-76"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-77"></ix:nonFraction></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; deficit:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-78"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-79">0.001</ix:nonFraction></ix:nonFraction> par value. Authorized <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-80"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-81">250,000,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-82"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-83">124,284,542</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-84"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-85">122,044,299</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2026 and December&#160;31, 2025, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-86">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-87">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-88">420,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-89">413,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-90">455,055</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-91">446,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-92">34,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-93">33,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; deficit</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-94">141,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-95">160,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share and per share data amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.239%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-96">14,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-97">8,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-98"><span style="-sec-ix-hidden:f-99">Manufacture and supply</span></span></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-100">3,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-101">3,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-102">4,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-103">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-104">10,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-105">19,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-106">18,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-107">28,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-108">4,204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-109">19,365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income/(expenses):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-110">2,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-111">2,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to royalty obligations</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RoyaltyExpense" scale="3" id="f-112">973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:num-dot-decimal" scale="3" id="f-113">1,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to the sale of future revenue</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:InterestExpenseSaleOfFutureRevenues" scale="3" id="f-114">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:InterestExpenseSaleOfFutureRevenues" scale="3" id="f-115">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income and other income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:InterestAndOtherIncomeNet" scale="3" id="f-116">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:InterestAndOtherIncomeNet" scale="3" id="f-117">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-118">8,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-119">22,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-120">8,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-121">22,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-122">8,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-123">22,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Loss per share attributable to common stockholders:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted (in dollars per share)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-124"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-125">0.07</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-126"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-127">0.24</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted (in shares)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-128"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-129">122,609,995</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-130"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-131">95,497,056</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Changes in Stockholders&#8217; Deficit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Three Months Ended March&#160;31, 2026</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.358%"/><td style="width:0.1%"/></tr><tr style="height:19pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deficit</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-132">122,044,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-133">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-134">413,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-135">446,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-136">33,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering-ATM</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-137">1,191,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-138">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-139">5,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-140">5,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering-ATM</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-141">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-142">303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued under the Purchase Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="aqst:ProceedsFromExerciseOfWarrantsNet" scale="3" id="f-143">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:ProceedsFromExerciseOfWarrantsNet" scale="3" id="f-144">916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-145">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-146">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-147">1,048,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-148">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-149">330</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-150">329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="f-151">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-152">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-153">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-154">8,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-155">8,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-156">124,284,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-157">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-158">420,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-159">455,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-160">34,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div id="i65b3f6374bb0418bacd030f2ff357555_28"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Changes in Stockholders&#8217; Deficit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Three Months Ended March&#160;31, 2025</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.358%"/><td style="width:0.1%"/></tr><tr style="height:19pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Deficit</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-161">91,413,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-162">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-163">302,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-164">363,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-165">60,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering-ATM</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-166">7,457,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-167">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-168">21,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-169">22,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering-ATM</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-170">729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-171">729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-172">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-173">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-174">445,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-175">702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-176">702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-177">22,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-178">22,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-179">99,317,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-180">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-181">325,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-182">386,144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-183">60,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-184">8,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-185">22,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used for operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation, amortization, and impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="f-186">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="f-187">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-188">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-189">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="f-190">916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:fixed-zero" scale="3" id="f-191">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-192">2,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-193">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-194">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-195">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-196">10,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-197">3,129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-198">1,896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-199">1,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-200">340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-201">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-202">17,973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-203">1,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-204">2,803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-205">2,776</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-206">272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-207">261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for operating activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-208">14,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-209">23,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-210">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-211">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-212">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-213">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issued under public equity offering-ATM, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-214">4,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-215">21,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-216">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-217">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of debt principal including lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfDebt" scale="3" id="f-218">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RepaymentsOfDebt" scale="3" id="f-219">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payments for royalty obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:PaymentsForRoyaltyObligations" format="ixt:fixed-zero" scale="3" id="f-220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:PaymentsForRoyaltyObligations" scale="3" id="f-221">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes on share-based compensation, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="f-222">329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="f-223">703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-224">4,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-225">20,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-226">10,435</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-227">2,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-228">121,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-229">71,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-230">110,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-231">68,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-232">1,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-233">1,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs associated with public offering-ATM in Accounts Payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" format="ixt:fixed-zero" scale="3" id="f-234">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" scale="3" id="f-235">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited, in thousands, except share and per share information)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_40"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="f-236" continuedAt="f-236-1" escape="true">Company Overview and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="f-236-1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A) Company Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. The worldwide leader in delivering trusted, quality medications on oral film, Aquestive operates as both a developer of its own proprietary products and a Contract Development and Manufacturing Organization (CDMO) for licensees, with its headquarters in New Jersey and U.S.-based manufacturing facilities in Indiana. The Company is the exclusive manufacturer of four commercialized products marketed by its licensees across six continents using proprietary, best-in-class technologies like PharmFilm&#174;. Aquestive's AdrenaVerse&#8482; platform contains a library of more than 20 epinephrine prodrugs enabling the pursuit of various potential allergy and dermatological indications. The Company is advancing Anaphylm&#8482; (dibutepinephrine) sublingual film for the treatment of severe allergic reactions, including anaphylaxis, and AQST-108 (epinephrine) topical gel for various potential dermatological conditions, including alopecia areata, atopic dermatitis, rosacea, and psoriasis. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)&#160;Equity Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Facility</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company established its first ATM facility in September 2019, and since inception to March&#160;31, 2026, the Company has sold <ix:nonFraction unitRef="shares" contextRef="c-32" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-237">28,506,216</ix:nonFraction> shares of Common Stock under its ATM facility which has generated net cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-238">86,563</ix:nonFraction>, net of commissions and estimated other transactions costs of $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-239">4,142</ix:nonFraction>. On April 3, 2024, the Company filed a new shelf registration statement on Form S-3, the 2024 Registration Statement, which was declared effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement are (i) a base prospectus registering the offer, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="aqst:SaleOfStockMaximumTransactionAmount" format="ixt:num-dot-decimal" scale="0" id="f-240">250,000</ix:nonFraction> worth of Common Stock, preferred stock, debt securities, warrants, rights and units and (ii) a $<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="aqst:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="3" id="f-241">100,000</ix:nonFraction> ATM facility prospectus. During the three months ended March 31, 2026, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-35" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-242">1,191,071</ix:nonFraction> shares of Common Stock pursuant to the ATM prospectus and the Amended Equity Distribution Agreement with Piper Sandler &amp; Co. (successor to Piper Jaffray &amp; Co.), which provided net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-243">4,810</ix:nonFraction> after deducting commissions and estimated other transaction costs of $<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" scale="3" id="f-244">252</ix:nonFraction>. For the three months ended March 31, 2025, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-36" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-245">7,457,627</ix:nonFraction> shares under the ATM facility which provided net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-246">21,306</ix:nonFraction> after deducting commissions and other transaction costs of $<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" scale="3" id="f-247">694</ix:nonFraction>. The remaining authorized balance of the ATM facility was approximately $<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="f-248">73,000</ix:nonFraction> as of March&#160;31, 2026.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Underwritten Public Offering</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2025, the Company completed the 2025 Underwritten Public Offering of <ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-249">21,250,000</ix:nonFraction> shares of its common stock at the public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-39" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-250">4.00</ix:nonFraction> per share. Net proceeds from the 2025 Underwritten Public Offering were $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-251">79,900</ix:nonFraction>, after deducting underwriting discounts of $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-252">5,100</ix:nonFraction>. In addition to the underwriting discounts related to this offering, the Company incurred professional fees and other costs totaling $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-253">440</ix:nonFraction>. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">C</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">) </span><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-254" continuedAt="f-254-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></ix:nonNumeric></div><ix:continuation id="f-254-1"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#8217;s audited financial statements and related notes for the fiscal year ended December&#160;31, 2025 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March&#160;4, 2026 (the &#8220;2025 Annual Report on Form 10-K&#8221;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2025 is derived from the audited financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying condensed financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-255" continuedAt="f-255-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-256" escape="true"><ix:continuation id="f-255-1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Adopted as of March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09&#8212;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The ASU modifies the effective tax rate reconciliation table and requires disaggregation of income taxes. The Company adopted ASU 2023-09 for the year ending December&#160;31, 2025 and added the required disclosures on a prospective basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Statements of Operations, and Comprehensive Loss as well as qualitatively describe the remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Company&#8217;s definition of selling expenses. These disclosure requirements will be effective for the Company for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact from the adoption of ASU 2024-03 on disclosures to its financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the FASB issued ASU 2025-06, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Internal-Use Software</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to provide clarification and improvements to the accounting for internal-use software costs under ASC 350-40, Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software. The guidance includes amendments related to capitalization of implementation costs, subsequent measurement, and related presentation and disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on its financial statements and related disclosures.</span></div></ix:continuation></ix:nonNumeric><div id="i65b3f6374bb0418bacd030f2ff357555_46"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="f-257" continuedAt="f-257-1" escape="true">Risks and Uncertainties</ix:nonNumeric></span></div><ix:continuation id="f-257-1" continuedAt="f-257-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company&#8217;s cash requirements for the remainder of 2026 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of March&#160;31, 2026, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-258">110,734</ix:nonFraction> of cash and cash equivalents.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a history of net losses. The Company&#8217;s accumulated deficits totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-259">455,055</ix:nonFraction> as of March&#160;31, 2026. The net losses and accumulated deficits were partially offset by gross margins from sales of commercialized licensed and proprietary products, license fees, milestone and royalty payments from commercial licensees and co-development parties. The Company&#8217;s funding requirements have been met by its cash and cash equivalents, as well as its equity and debt offerings, including the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-260">13.5</ix:nonFraction>% Notes as further discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the ATM facility and other equity offerings, including the 2025 Underwritten Public Offering as discussed in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company Overview and Basis of Presentation,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Part B, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Transactions.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-257-2">While the Company&#8217;s ability to execute its business objectives and achieve profitability over the longer term cannot be assured, the Company&#8217;s on-going business, existing cash and cash equivalents, expense management activities including, but not limited to, the ceasing of certain R&amp;D activities, as well as access to the equity capital markets through its ATM facility, provide near term liquidity for the Company to fund its operating needs for at least the next twelve months as it continues to execute its business strategy.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.         </span><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-261" continuedAt="f-261-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="f-261-1" continuedAt="f-261-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity for which separate discrete financial information is available for evaluation by the CODM in deciding how to allocate resources and in assessing performance. For the three months ended March 31, 2026 and 2025, the Company has identified <ix:nonFraction unitRef="segment" contextRef="c-5" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-262"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-263">one</ix:nonFraction></ix:nonFraction> operating and reportable segment. The Company defines its operating segment based on internally reported financial information that is regularly reviewed by the CODM to analyze financial performance, make decisions, and allocate resources. The Company's CEO is the CODM. The Company manages its operations as a single segment for purposes of assessing performance and making operating decisions. This segment encompasses the development and advancement of a product pipeline for the treatment of severe allergic reactions, including anaphylaxis, and the AdrenaVerse epinephrine prodrug pipeline platform. Additionally, the Company served as the exclusive manufacturer for its proprietary product, Libervant, while it had U.S. market access, and four licensed commercialized products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The CODM reviews the segment's profit or loss based on net loss reported on the Condensed Statements of Operations and Comprehensive Loss. The CODM also considers forecast-to-actual variances on a monthly basis for expenses deemed significant. Furthermore, the CODM reviews the segment's assets based on total assets reported on the Condensed Balance Sheets. All long-lived assets are held in the United States. While the Company generated $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-264">14,446</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-265">8,720</ix:nonFraction> in revenues for the three months ended March 31, 2026 and 2025, respectively, management expects the Company to continue to incur significant expenses and operating losses for the foreseeable future as it advances product candidates through all stages of development and clinical trials, ultimately seeking regulatory approval and commencing commercialization activities for Anaphylm, if approved by the FDA. The CODM uses cash forecast models to guide investment decisions and assess entity-wide operating results and performance. Net loss is used to monitor budget and rolling forecasts versus actual results. The CODM views specific categories within R&amp;D expenses, selling expenses, and general and administrative expenses as significant due to their direct correlation with cash burn and profitability.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-266" escape="true"><ix:continuation id="f-261-2"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles reported revenues to net loss under the significant expense principle for the three months ended March&#160;31, 2026 and 2025:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.970%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-267">14,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-268">8,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Manufacture and Supply Expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-269">3,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-270">3,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D Project expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Anaphylm project expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-271">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-272">2,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AQST-108 project expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-273">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-274">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D other expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-275">2,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-276">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-277">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-278">546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Research and Development Expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-279">4,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-280">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Selling expenses:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:SellingExpense" format="ixt:num-dot-decimal" scale="3" id="f-281">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:SellingExpense" scale="3" id="f-282">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:SellingExpense" scale="3" id="f-283">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:SellingExpense" format="ixt:num-dot-decimal" scale="3" id="f-284">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Selling expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:SellingExpense" format="ixt:num-dot-decimal" scale="3" id="f-285">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:SellingExpense" format="ixt:num-dot-decimal" scale="3" id="f-286">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">General &amp; Administrative expenses:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">5</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-287">5,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-288">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">6</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-289">3,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-290">11,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total General and Administrative Expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-291">9,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-292">16,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Selling, General and Administrative Expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-293">10,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-294">19,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-295">18,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-296">28,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-297">4,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-298">19,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income/(expenses), net</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-299">3,853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-300">3,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-301">8,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-302">22,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-303">8,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-304">22,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-305">8,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-306">22,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.952%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 - R&amp;D Personnel costs include payroll expenses,  share-based compensation expenses and severance</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2 - Other R&amp;D expenses include preclinical, consulting, maintenance, and testing fees</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 - Selling Personnel costs include payroll expenses, share-based compensation expenses and severance</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4 - Other Selling expenses include commercialization and other related expenses</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5 - G&amp;A Personnel costs include payroll expenses,  share-based compensation expenses and severance</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 - Other General and Administrative expenses include legal/patent fees, insurance fees, IT expenses, investor relations expenses, regulatory fees, facility and other costs</span></td></tr></table></div></ix:continuation></ix:nonNumeric><div id="i65b3f6374bb0418bacd030f2ff357555_52"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-307" continuedAt="f-307-1" escape="true">Revenues and Trade Receivables, Net</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-308" continuedAt="f-308-1" escape="true"><ix:continuation id="f-307-1" continuedAt="f-307-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age while Libervant had U.S. market access through April 2025. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a </span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-308-1" continuedAt="f-308-2"><ix:continuation id="f-307-2" continuedAt="f-307-3"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - a performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#8217;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and supply revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenu</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">e &#8211; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research Fees</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#8217;s R&amp;D projects may range from several months to approximately <ix:nonNumeric contextRef="c-51" name="aqst:ResearchAndDevelopmentProjectDuration" format="ixt-sec:durwordsen" id="f-309">three years</ix:nonNumeric>. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age while Libervant had U.S. market access through April 2025, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Once receivables are collected, allowances are reclassified and treated as accrued liabilities. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once related variable considerations are resolved and uncertainties as to incurred amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-307-3" continuedAt="f-307-4"><ix:continuation id="f-308-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of March&#160;31, 2026, and December&#160;31, 2025, such contract assets were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="f-310">445</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="f-311">627</ix:nonFraction>, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of March&#160;31, 2026 and December&#160;31, 2025, such contract liabilities were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-312">20,210</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-313">20,482</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain Contracts</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of March&#160;31, 2026 and December&#160;31, 2025, such costs to obtain contracts were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CapitalizedContractCostNet" scale="3" id="f-314">442</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CapitalizedContractCostNet" scale="3" id="f-315">449</ix:nonFraction>, respectively.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="f-316" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-317">8,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-318">7,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-319">5,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-320">790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-321">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-322">418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-324">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-325">14,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-326">8,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Zevra-related royalty revenue of $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-327">4,500</ix:nonFraction> recognized during the three months ended March&#160;31, 2026. For additional information, see Note 6, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-328" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated net revenue by geographic area: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-329">13,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-330">5,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ex-United States</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-331">1,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-332">3,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-333">14,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-334">8,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2026, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), Zevra (license and royalty revenue), and Assertio manufacture and supply revenue, license and royalty revenue and co-development and research fees). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Zambon (manufacture and supply revenue, license and royalty revenue, and co-development and research fees) for revenue markets outside of the United States.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and Assertio (manufacture and supply revenue, license and royalty revenue and co-development and research fees). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Hypera (manufacture and supply revenue, and license and royalty revenue) for revenue markets outside of the United States. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-307-4" continuedAt="f-307-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-335" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-336">5,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-337">8,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contract and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-338">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-339">9,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: sales-related allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:AccountsReceivableAllowanceForCreditLossPreReclassification" format="ixt:fixed-zero" scale="3" id="f-340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:AccountsReceivableAllowanceForCreditLossPreReclassification" scale="3" id="f-341">582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into Accrued distribution expenses and sales-related allowances</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" format="ixt:fixed-zero" scale="3" id="f-342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" scale="3" id="f-343">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-344">6,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-345">17,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Contract and other receivables totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-346">1,605</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherReceivablesGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="f-347">9,750</ix:nonFraction> as of March&#160;31, 2026 and December&#160;31, 2025, respectively, consisting primarily of contract assets and other receivables. Contract assets consist of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties. Other receivables include the current portion related to the Monetization royalty receivable and other receivables. As of December&#160;31, 2025, other receivables also include an insurance reimbursement. Sales-related allowances as of December&#160;31, 2025 were estimated in relation to revenues recognized for sales of Libervant for patients between two to five years of age while Libervant had U.S. market access.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an allowance for credit losses on accounts receivable, which is recorded as a reduction to accounts receivable. Changes in the allowance are classified as Selling, general and administrative expenses in the Statements of Operations and Comprehensive Loss. The Company assesses collectability by reviewing accounts receivable on a collective basis where similar characteristics exist and on an individual basis when it identifies specific customers with known disputes or collectability issues. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status. It also considers customer-specific information, current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss data. On an ongoing basis, management evaluates the adequacy of these reserves. The allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" id="f-348"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" id="f-349">0</ix:nonFraction></ix:nonFraction> as of March&#160;31, 2026 and December&#160;31, 2025.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_58"></div><ix:continuation id="f-307-5" continuedAt="f-307-6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Related Allowances</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, chargebacks, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on no less than a quarterly basis.</span></div><ix:nonNumeric contextRef="c-1" name="aqst:ScheduleOfAccountsReceivableAllowancesTableTextBlock" id="f-350" continuedAt="f-350-1" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provides a summary of activity with respect to sales-related allowances:</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="f-350-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:70.793%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-352">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="f-353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-354">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payments / credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="3" id="f-355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="3" id="f-356">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into Accrued distribution expenses and sales-related allowances</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="aqst:AccountsReceivableAllowanceForCreditLossReclassifications" format="ixt:fixed-zero" scale="3" id="f-357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" sign="-" name="aqst:AccountsReceivableAllowanceForCreditLossReclassifications" scale="3" id="f-358">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables as of December&#160;31, 2025 and accruals for wholesaler service fees, co-pay support redemptions and other rebates are reflected as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and accrued expenses were $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-361">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-362">902</ix:nonFraction>, respectively, as of March&#160;31, 2026, and $<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-363">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-364">906</ix:nonFraction>, respectively, as of December&#160;31, 2025. See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Expenses</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Customers are considered major customers when net revenue exceeds 10% of total revenue for the period or outstanding receivable balances exceed 10% of total receivables. For the three months ended March 31, 2026, Indivior and Zevra, represented approximately <ix:nonFraction unitRef="number" contextRef="c-76" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-365">57</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-77" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-366">32</ix:nonFraction>%, of total revenue, respectively. As of March&#160;31, 2026, Indivior and Assertio </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-307-6"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">exceeded the 10% threshold for outstanding receivable balances and represented approximately <ix:nonFraction unitRef="number" contextRef="c-78" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-367">81</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-79" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-368">15</ix:nonFraction>% of total trade and other receivables, respectively. For the three months ended March&#160;31, 2025, Indivior and Hypera exceeded the 10% threshold for revenue and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">represented approximately </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-80" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-369">67</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-81" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-370">17</ix:nonFraction>% </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">of total revenue, including the one-time recognition of deferred revenue, respectively. As of December&#160;31, 2025,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Indivior and Hypera exceeded the 10% threshold for outstanding receivable balances and represented <ix:nonFraction unitRef="number" contextRef="c-82" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-371">69</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-83" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-372">25</ix:nonFraction>% of total trade and other receivables, respectively.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_61"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-373" continuedAt="f-373-1" escape="true">Material Agreements</ix:nonNumeric></span></div><ix:continuation id="f-373-1" continuedAt="f-373-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase and Sale Agreement with RTW Investments LP</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2025, the Company entered into the Purchase Agreement with funds managed by RTW Investments LP. Under the terms of the Purchase Agreement, in exchange for the Purchaser's payment to the Company of a purchase price of $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="aqst:ConsiderationReceivableFromSaleOfFutureRevenuesInterests" format="ixt:num-dot-decimal" scale="0" id="f-374">75,000</ix:nonFraction>, upon approval of Anaphylm by the FDA by a specified date, the refinancing of the Company&#8217;s existing <ix:nonFraction unitRef="number" contextRef="c-85" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-375">13.5</ix:nonFraction>% Notes and certain other customary conditions (the "Closing Conditions"), the Company agreed to a sale of assigned interests to the Purchaser, including a right for the Purchaser to tiered revenue share payments ranging from <ix:nonFraction unitRef="number" contextRef="c-86" decimals="3" name="aqst:CollaborativeArrangementRevenueSharingPercentage" scale="-2" id="f-376">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-87" decimals="3" name="aqst:CollaborativeArrangementRevenueSharingPercentage" scale="-2" id="f-377">7.5</ix:nonFraction>% of net sales (as defined in the Purchase Agreement) of Anaphylm (and <ix:nonFraction unitRef="number" contextRef="c-84" decimals="3" name="aqst:CollaborativeArrangementRevenueSharingPercentage" scale="-2" id="f-378">9.5</ix:nonFraction>% for the subsequent calendar year period if net sales do not achieve specified level in a calendar year period beginning in 2027) in the United States. Revenue share payments commence in the first fiscal quarter in which the first commercial sale of Anaphylm in the United States after the satisfaction of the Closing Conditions. Revenue share payments will cease upon the Purchaser's receipt of $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="aqst:CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" format="ixt:num-dot-decimal" scale="3" id="f-379">187,500</ix:nonFraction> by December 31, 2035 or $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="aqst:CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" format="ixt:num-dot-decimal" scale="0" id="f-380">225,000</ix:nonFraction> thereafter. The Purchase Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company&#8217;s ability to, among other things, incur indebtedness (which restrictions are eliminated after the achievement by the Purchaser of a specified return on its investment), and other provisions customary for transactions of this nature, in each case subject to certain exceptions set forth in the Purchase  Agreement. As this financing is contingent on events that have not occurred yet and are outside of the Company's control, the accounting consequences for this transaction as of March&#160;31, 2026 and December&#160;31, 2025 have been limited to capitalized legal fees of approximately $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="aqst:CapitalizedLegalFees" scale="3" id="f-381">750</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="aqst:CapitalizedLegalFees" scale="3" id="f-382">700</ix:nonFraction>, respectively, recorded within Other current assets on the Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, the Company entered into the Amendment No. 1 to the Purchase Agreement. The Amendment extends the Marketing Approval Deadline from its original date in the Purchase Agreement to June 30, 2027. Concurrently, the Company entered into a Warrant Issuance Agreement with funds managed by RTW, pursuant to which the Company agreed to issue a warrant to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-91" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-383">375,000</ix:nonFraction> shares of the Company's Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-92" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-384">4.00</ix:nonFraction> per share, expiring on March 3, 2029. For information regarding the RTW Warrants, see Note 14, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, the Company also entered into a Share Purchase Commitment Agreement with certain RTW-affiliated funds, pursuant to which such funds committed to purchase, in the aggregate, not less than $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="aqst:SaleOfStockSharesCommittedAggregateAmount" format="ixt:num-dot-decimal" scale="3" id="f-385">5,000</ix:nonFraction> of Common Stock during the <ix:nonNumeric contextRef="c-93" name="aqst:SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" format="ixt-sec:durwordsen" id="f-386">90-day</ix:nonNumeric> period following the effective date of the Amendment, at prices determined in accordance with Rule 415(a)(4) under the Securities Act.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Exploitation Agreement with Indivior</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In August 2008, the Company entered into the Indivior License Agreement (with subsequent amendments) with Reckitt Benckiser Pharmaceuticals, Inc. who was later succeeded to in interest by Indivior.&#160;Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#8217;s requirements for Suboxone</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a sublingual film formulation, both inside and outside the United States on an exclusive basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain API&#160;for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year. The Indivior License Agreement provides for payment by Indivior of an agreed upon purchase price per unit until January 1, 2025 and, thereafter, that is subject to annual adjustments based on changes in an agreed upon price index. In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) outside of the U.S., subject to annual maximum amounts and limited to the life of the related patents. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&#8217;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was <ix:nonNumeric contextRef="c-94" name="aqst:LicenseAgreementTerm" format="ixt-sec:durwordsen" id="f-387">seven years</ix:nonNumeric> from the commencement date. Thereafter, the Indivior License Agreement automatically renewed for successive <ix:nonNumeric contextRef="c-94" name="aqst:AutomaticRenewalPeriodOfAgreement" format="ixt-sec:durwordsen" id="f-388">one-year</ix:nonNumeric> periods.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-373-2" continuedAt="f-373-3"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of March 2, 2023, the Company and Indivior entered into the Indivior Amendment to the Indivior License Agreement. The Indivior Amendment was entered into for the primary purpose of amending the Agreement as follows: (i) extending the term of the Agreement until August 16, 2026 and thereafter providing for automatic renewal terms of successive <ix:nonNumeric contextRef="c-95" name="aqst:AutomaticRenewalPeriodOfAgreement" format="ixt-sec:durwordsen" id="f-389">one-year</ix:nonNumeric> periods unless Indivior delivers notice to the Company, at least twelve months prior to the expiration of the then current term, of Indivior&#8217;s intent not to renew, subject to the earlier termination rights of the parties under the Agreement, and providing that the Agreement will not automatically renew for any renewal term beginning after the expiration of the last to expire of the product patents covered under the Indivior License Agreement; and (ii) agreeing to transfer pricing and payment terms for supplied product under the Indivior License Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreement with Sunovion Pharmaceuticals, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&#8217;s disease patients. Sunovion used this intellectual property to develop its apomorphine product KYNMOBI</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#8217;s obligation to remit a payment of $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-390">4,000</ix:nonFraction>, due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of FDA approval of the product. This amount was received as of September 30, 2020 and was included in License and royalty revenues for the twelve months ended December 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 16, 2020, the Company entered into the First Amendment. The First Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the EU which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company from January 1, 2020 to April 1, 2020, and (iv) modifying the termination provision to reflect the Company&#8217;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI was not commercialized by January 1, 2020. This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the First Amendment. The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents unless earlier terminated under the termination provisions contained therein. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties' agreement with respect to certain provisions in the Sunovion License Agreement, specifically the date after which Sunovion has the right to terminate the Sunovion License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#8217;s patents covered under the Sunovion License Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-391">22,000</ix:nonFraction> to date. In addition to the upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-392">5,000</ix:nonFraction>, the Company has also earned an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-393">17,000</ix:nonFraction> in connection with specified regulatory and development milestones in the United States and Europe (the &#8220;Initial Milestone Payments&#8221;), all of which have been received to date. With the Monetization Agreement (defined below) entered into on November 3, 2020 relating to KYNMOBI as described in the paragraph below, the Company is no longer entitled to receive any payments under the Sunovion License Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase and Sale Agreement with an affiliate of Marathon</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold to Marathon all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI. In exchange for the sale of these rights, the Company received an upfront payment from Marathon of $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-394">40,000</ix:nonFraction> and an additional payment of $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="aqst:AdditionalProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-395">10,000</ix:nonFraction> through the achievement of the first milestone. The Company has received an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-396">50,000</ix:nonFraction> through March&#160;31, 2026 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="aqst:ContingentMonetizationAgreementMilestonePayment" format="ixt:num-dot-decimal" scale="3" id="f-397">75,000</ix:nonFraction> may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-398">125,000</ix:nonFraction>. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets; therefore, the Company likely will not receive any of the additional contingent payments under the Monetization Agreement. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on the accounting for the Monetization Agreement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-373-3"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement to Terminate CLA with Zevra Therapeutics, Inc. (formerly KemPharm)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In March 2012, the Company entered into an agreement with Zevra to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. In March 2026, Zevra sold Azstarys to Commave Therapeutics SA. In accordance with the Company's agreement with Zevra, the Company received a payment out of the proceeds of the Zevra Commave  agreement and recognized royalty revenues of $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-399">4,500</ix:nonFraction> during the three months ended March&#160;31, 2026 and will recognize additional $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-400">500</ix:nonFraction> royalty revenues as a result of a payment to the Company in April 2026 in accordance with the Company's agreement with Zevra.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Supply Agreement with Atnahs Pharma UK Limited (Pharmanovia)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into the Pharmanovia Agreement, effective as of September 26, 2022, pursuant to which the Company granted Pharmanovia an exclusive license to certain of the Company&#8217;s intellectual property to develop and commercialize Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:700;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (diazepam) buccal film for the treatment of prolonged or acute, convulsive seizures in all ages in the Territory during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and the Company will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. Pursuant to the Pharmanovia Agreement, the Company received $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-401">3,500</ix:nonFraction> upon agreement execution and, upon the occurrence of certain conditions set forth in the Pharmanovia Agreement, will receive additional milestone payments and profit shares, as well as manufacturing fees and royalty fees through the expiration of the Pharmanovia Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 27, 2023, the Company amended the Pharmanovia Agreement to expand the scope of territory for the license of Libervant to cover the rest of the world, excluding the U.S., Canada and China. Under the Pharmanovia Amendment, Pharmanovia will be responsible for seeking applicable regulatory approval in the expanded territories, which include Latin America, Africa and Asia Pacific. Pursuant to the terms of the Pharmanovia Amendment, the Company received a non-refundable payment of $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-402">2,000</ix:nonFraction> from Pharmanovia in connection with the execution of the Pharmanovia Amendment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2026, the Company entered into a second amendment to the Pharmanovia Agreement relating to the license and supply of Libervant (diazepam) buccal film in territories outside the United States. The Pharmanovia Amendment No. 2 modifies certain commercial and operational terms of the agreement, including subcontracting rights, delivery terms, and minimum volume commitments in certain territories. All other terms and conditions of the Pharmanovia Agreement remain in full force and effect.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with Assertio Holdings, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of October 26, 2022, the Company entered into the Assertio Agreement to license Sympazan</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox&#8208;Gastaut syndrome in patients aged two years of age and older. Under the terms of the Assertio Agreement, the Company granted to Assertio an exclusive, worldwide license of its intellectual property for Sympazan to Assertio during the term of the Assertio Agreement for an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="3" id="f-403">9,000</ix:nonFraction>. In addition, Aquestive received a $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-404">6,000</ix:nonFraction> milestone payment subsequent to Aquestive&#8217;s receipt of a notice of allowance from the PTO of the Company&#8217;s patent application U.S. Serial No. 16/561,573, and payment by the Company of the related allowance fee. The Company received the notice of allowance from the PTO and paid the related allowance fee on October 27, 2022. Further, under the Assertio Agreement, the Company will receive royalties from Assertio for the sale of the product through the expiration of the Assertio Agreement. The Company also entered into a long-term supply agreement with Assertio for Sympazan pursuant to which the Company is the exclusive sole worldwide manufacturer and supplier of the product and will receive manufacturing fees from Assertio for the product through the expiration of such supply agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 8, 2026, Assertio entered into an Asset Purchase Agreement with Cosette,  a United States-based, branded specialty pharmaceutical company, to divest a portfolio of products, including Sympazan, to Cosette. Under that Asset Purchase Agreement, Assertio assigned and transferred its rights and certain obligations arising post closing to Cosette. Cosette assumed the intellectual property license and rights to commercialize Sympazan and will continue to purchase product and pay royalties and milestones to Aquestive under the Assertio Agreement and the Company's long-term supply agreement with Assertio.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-405" continuedAt="f-405-1" escape="true">Financial Instruments &#8211; Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-405-1" continuedAt="f-405-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&#160;Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1 &#8212; Observable quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2 &#8212; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160;methodologies and similar techniques.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the Condensed Balance Sheets for Trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-107" decimals="0" name="aqst:SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" format="ixt:num-dot-decimal" scale="0" id="f-406">4,000,000</ix:nonFraction> shares of Common Stock and Common Stock Warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-107" decimals="0" name="aqst:SharesOfCommonStockToBePurchasedByCommonStockWarrants" format="ixt:num-dot-decimal" scale="0" id="f-407">8,850,000</ix:nonFraction> shares of Common Stock in connection with its Securities Purchase Agreements with certain purchasers. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of the remaining warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-408">5,000,000</ix:nonFraction> of the shares of Common Stock. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-108" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-409">0.96</ix:nonFraction> per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder new warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-410">2,750,000</ix:nonFraction> shares of new warrants at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-109" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-411">2.60</ix:nonFraction> per share. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, in connection with the issuance of the <ix:nonFraction unitRef="number" contextRef="c-110" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-412">13.5</ix:nonFraction>% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides the Note Holders:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-111" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-413">1.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-112" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-414">2.0</ix:nonFraction>% of annual worldwide net sales of Anaphylm&#8482; (dibutepinephrine) sublingual film for a period of <ix:nonNumeric contextRef="c-113" name="aqst:RoyaltyObligationTerm" format="ixt-sec:durwordsen" id="f-415">eight years</ix:nonNumeric> from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-111" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-416">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-112" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-417">2.0</ix:nonFraction>% of annual worldwide net sales of Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (diazepam) buccal film until the earlier of (1) the first sale of Anaphylm and (2) <ix:nonNumeric contextRef="c-113" name="aqst:RoyaltyObligationTerm" format="ixt-sec:durwordsen" id="f-418">eight years</ix:nonNumeric> from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Those Royalty Agreements were valued based on Level 3 inputs and their&#160;fair value was based primarily on internal management estimates developed based on third-party data and reflect management&#8217;s judgment, current market conditions, and forecasts. The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-405-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, in connection with Amendment No.1 to the Purchase and Sale Agreement and the Equity Commitment Agreement with RTW, the Company also entered into the Warrant Issuance Agreement with the RTW investors. Pursuant to this agreement, the Company issued to the RTW Investors the RTW Warrant to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-114" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-419">375,000</ix:nonFraction> shares of the Company's Common Stock. The RTW Warrant entitles the holders to purchase shares of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-115" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-420">4.00</ix:nonFraction> per share. Management estimated the fair value of the RTW Warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="f-421">916</ix:nonFraction>, and it is presented within Additional Paid-in Capital on the Condensed Balance Sheets as of March&#160;31, 2026, and within Interest income and other income, net on the Condensed Statements of Operations and Comprehensive Loss for the three months ended March&#160;31, 2026. The RTW Warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_67"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryDisclosureTextBlock" id="f-422" continuedAt="f-422-1" escape="true">Inventories, Net</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-423" escape="true"><ix:continuation id="f-422-1"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of Inventory are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Raw material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-424">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-425">3,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Packaging material</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:InventoryPackingMaterialGross" format="ixt:num-dot-decimal" scale="3" id="f-426">2,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:InventoryPackingMaterialGross" format="ixt:num-dot-decimal" scale="3" id="f-427">2,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="f-428">1,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryFinishedGoods" scale="3" id="f-429">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-430">8,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-431">6,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i65b3f6374bb0418bacd030f2ff357555_70"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-432" continuedAt="f-432-1" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="f-432-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-433" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Useful<br/>Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-116" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-434">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-117" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-435">15</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-436">20,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-437">20,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-120" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-438">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-121" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-439">15</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-440">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-441">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-442">21,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-443">21,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer, network equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-126" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-444">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-127" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-445">7</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-446">3,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-447">3,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-448">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-449">2,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-450">47,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-451">47,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-452">44,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-453">44,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-454">3,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-455">3,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2026 and 2025, total depreciation and amortization related to property and equipment was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-456">113</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-457">139</ix:nonFraction>, respectively.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_73"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-458" continuedAt="f-458-1" escape="true">Right-of-Use Assets and Lease Obligations</ix:nonNumeric></span></div><ix:continuation id="f-458-1" continuedAt="f-458-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all realty used at its production and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these <ix:nonFraction unitRef="lease" contextRef="c-3" decimals="INF" name="aqst:NumberOfOperatingLeases" format="ixt-sec:numwordsen" scale="0" id="f-459">three</ix:nonFraction> leases include the characteristics specified in ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which require classification as financing leases and, accordingly, these leases are accounted for as operating leases. These leases, as amended, provide remaining terms between <ix:nonNumeric contextRef="c-132" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-460">2.0</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-133" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-461">7.5</ix:nonNumeric> years, including renewal options expected to be exercised to extend the lease periods. Commitments under finance leases are not significant, and are included in Property and equipment, net, and Notes Payable, net on the Condensed Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize a right-to-use asset and lease liability for short-term leases, which have terms of 12 months or less on its Condensed Balance Sheets. For longer-term lease arrangements that are recognized on the Company&#8217;s Condensed Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#8217;s short-term leases, as well as variable costs relating to the Company&#8217;s lease arrangements, are not material to the Company&#8217;s financial results.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. Measurement of the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-458-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">operating lease liability reflects a range of an estimated discount rate of <ix:nonFraction unitRef="number" contextRef="c-132" decimals="3" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="f-462">14.8</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-133" decimals="3" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="f-463">15.6</ix:nonFraction>% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#8217;s collateralized debt refinancing. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease costs are recorded in manufacture and supply, R&amp;D and selling, general and administrative expenses in its Condensed Statements of Operations and Comprehensive Loss. For the three months ended March&#160;31, 2026, total operating lease expenses totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-464">447</ix:nonFraction>, including variable lease expenses such as common area maintenance and operating costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-465">114</ix:nonFraction>. For the three months ended March&#160;31, 2025, total operating lease expenses totaled $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-466">427</ix:nonFraction>, including variable lease expenses such as common area maintenance and operating costs of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-467">93</ix:nonFraction>.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-468" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="f-469">991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-470">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-471">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-472">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" format="ixt:num-dot-decimal" scale="3" id="f-473">2,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-474">7,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-475">2,611</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-476">4,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_79"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OtherAssetsDisclosureTextBlock" id="f-477" continuedAt="f-477-1" escape="true">Other Non-current Assets</ix:nonNumeric></span></div><ix:continuation id="f-477-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="f-478" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of other non-current assets:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:CumulativeRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-479">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:CumulativeRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-480">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="f-481">635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="f-482">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-483">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-484">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-485">8,000</ix:nonFraction> of royalty revenue and corresponding royalty receivable, related to the <ix:nonFraction unitRef="payment" contextRef="c-1" decimals="INF" name="aqst:NumberOfGuaranteedRoyaltyPayments" format="ixt-sec:numwordsen" scale="0" id="f-486">eight</ix:nonFraction> $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="aqst:MinimumAnnualRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-487">1,000</ix:nonFraction> annual minimum guaranteed royalty payments that are due to the Company. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to determine whether the existing receivable was transferred to Marathon and concluded it was not transferred. As of March&#160;31, 2026 and December&#160;31, 2025, Royalty receivable consists of <ix:nonFraction unitRef="payment" contextRef="c-135" decimals="INF" name="aqst:NumberOfAnnualRoyaltyPaymentsReceivable" format="ixt-sec:numwordsen" scale="0" id="f-488"><ix:nonFraction unitRef="payment" contextRef="c-136" decimals="INF" name="aqst:NumberOfAnnualRoyaltyPaymentsReceivable" format="ixt-sec:numwordsen" scale="0" id="f-489">three</ix:nonFraction></ix:nonFraction> annual minimum payments due from Sunovion, the last of which is due in March 2028. The current portion of the royalty receivable is included in Trade and other receivables, net. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on how this receivable relates to the Monetization Agreement transaction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Non-current portion of costs to obtain contracts capitalized under ASC 340, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is recorded within Other non-current assets on the  Condensed Balance Sheets as of March&#160;31, 2026 and December&#160;31, 2025.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_82"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-490" continuedAt="f-490-1" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="f-490-1" continuedAt="f-490-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-491" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-492">2,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-493">3,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and personal property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="f-494">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="f-495">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued distribution expenses and sales returns provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-496">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-497">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="f-498">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="f-499">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-500">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-501">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-502">3,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-503">5,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The reduction in Accrued compensation is mostly related to payments of accrued bonuses during the three months ended March 31, 2026, partially offset by the current year accrual of bonuses. Accrued distribution expenses and sales returns provision mostly represent estimated liabilities for returns, wholesaler service fees, co-pay support redemptions and other </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-490-2"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">rebates related to the proprietary product Libervant and returns and other expenses related to the proprietary product Sympazan (prior to outlicensing to Assertio in October 2022).</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_85"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-504" continuedAt="f-504-1" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="f-504-1" continuedAt="f-504-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-505">13.5</ix:nonFraction>% Senior Secured Notes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company entered into an Indenture Agreement with certain institutional investors (the &#8220;Note Holders&#8221;) and issued $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-506">45,000</ix:nonFraction> aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-507">13.5</ix:nonFraction>% Notes due 2028. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-508">4,326</ix:nonFraction> from this transaction after the repayment of the Company's <ix:nonFraction unitRef="number" contextRef="c-138" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-509">12.5</ix:nonFraction>% Notes and deduction of debt discount, and debt issuance costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-510">13.5</ix:nonFraction>% Notes are senior secured obligations of the Company and mature on November 1, 2028. The <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-511">13.5</ix:nonFraction>% Notes bear interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-512">13.5</ix:nonFraction>% per year, payable quarterly commencing on December 30, 2023. On each payment date commencing on June 30, 2026, the Company will pay an installment of principal of the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-513">13.5</ix:nonFraction>% Notes pursuant to a fixed amortization schedule, along with the applicable Exit Fee. The Exit Fee totals $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="aqst:DebtInstrumentExitFee" format="ixt:num-dot-decimal" scale="3" id="f-514">2,000</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, at its option, redeem the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-515">13.5</ix:nonFraction>% Notes in full or in part:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">if such redemption occurs prior to November 1, 2025, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="c-140" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-516">100</ix:nonFraction>% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee, plus an Applicable Premium which is the greater of </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-23.27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt"><ix:nonFraction unitRef="number" contextRef="c-140" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="f-517">1.0</ix:nonFraction>% of the principal redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">the amount, if any, by which the present value of the principal to be redeemed on November 1, 2025, plus all required interest due on such date, computed using a discount rate equal to the Treasury Rate, plus <ix:nonFraction unitRef="number" contextRef="c-141" decimals="4" name="aqst:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" scale="-4" id="f-518">100</ix:nonFraction> basis points, exceeds the amount of principal to be redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">if such redemption occurs after November 1, 2025, the redemption price is equal to <ix:nonFraction unitRef="number" contextRef="c-142" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-519">108.5</ix:nonFraction>% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Note Holders may require the Company to repurchase for cash all or any portion of the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-520">13.5</ix:nonFraction>% Notes at a change of control repurchase price equal at <ix:nonFraction unitRef="number" contextRef="c-137" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-521">108.5</ix:nonFraction>% plus the Exit Fee of the remaining principal, plus accrued interest at the election of the Note Holders. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Indenture permits the Company, upon the continuing satisfaction of certain conditions, including that the Company has at least $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="aqst:LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" format="ixt:num-dot-decimal" scale="0" id="f-522">100,000</ix:nonFraction> of net revenues for the most recently completed twelve calendar month period, to enter into an ABL facility not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="aqst:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="0" id="f-523">10,000</ix:nonFraction>. The ABL Facility may be collateralized only by assets of the Company constituting inventory, accounts receivable, and the proceeds thereof. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2026, the Company entered into a <ix:nonNumeric contextRef="c-145" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-524">five-year</ix:nonNumeric> term loan facility of up to $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-525">150,000</ix:nonFraction> with funds managed by Oaktree Capital Management, L.P, consisting of a term loan in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-526">55,000</ix:nonFraction> which was funded on May 12, 2026 and was used by the Company to repay the Company&#8217;s existing <ix:nonFraction unitRef="number" contextRef="c-147" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-527">13.5</ix:nonFraction>% Notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-528">45,000</ix:nonFraction> plus fees associated with the repayment. See Note 21, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-529">13.5</ix:nonFraction>% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides Note Holders:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-111" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-530">1.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-112" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-531">2.0</ix:nonFraction>% of annual worldwide net sales of Anaphylm&#8482; (dibutepinephrine) sublingual film for a period of <ix:nonNumeric contextRef="c-113" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm" format="ixt-sec:durwordsen" id="f-532">eight years</ix:nonNumeric> from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-111" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-533">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-112" decimals="3" name="aqst:RoyaltyObligationPercentOfNetSales" scale="-2" id="f-534">2.0</ix:nonFraction>% of annual worldwide net sales of Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (diazepam) buccal film until the earlier of (1) the first sale of Anaphylm and (2) <ix:nonNumeric contextRef="c-113" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm" format="ixt-sec:durwordsen" id="f-535">eight years</ix:nonNumeric> from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Both the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-536">13.5</ix:nonFraction>% Notes and Royalty Right Agreements, represent freestanding instruments which were issued in conjunction with each other. They are classified as debt within the scope of ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and are subsequently measured on an amortized cost basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. These inputs are derived using internal management estimates developed based on third-party data and reflect management&#8217;s judgment, current market conditions, and forecasts.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Royalty Right Agreements&#8217; fair value is estimated by applying probability-weighted cash flows for future sales, which are then discounted to present value. Changes to fair value of the Royalty Rights Agreements can result from changes to one or a number of the aforementioned inputs. A significant change in unobservable inputs could result in a material increase or decrease to the effective interest rate of the Royalty Right Agreements liability.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-504-2" continuedAt="f-504-3"><ix:nonNumeric contextRef="c-1" name="aqst:ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" id="f-537" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant unobservable inputs used in the fair value measurement of the Royalty Right Agreements:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Methodology</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Input</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (range, if applicable)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-149" decimals="2" name="aqst:RoyaltyAgreementMeasurementInput" scale="-2" id="f-538">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Right Agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighted<br/>income approach</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Success</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-150" decimals="2" name="aqst:RoyaltyAgreementMeasurementInput" scale="-2" id="f-539">95</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Projected Years of Payments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, there were no changes to the significant unobservable inputs used to recognize the Royalty Right Agreements liability. During the year ended December&#160;31, 2025, the Company updated the probability-weighted cash flows for future sales, which decreased the royalty obligation to $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:RoyaltyObligationsGross" format="ixt:num-dot-decimal" scale="3" id="f-540">51,886</ix:nonFraction> and decreased the unamortized discount to $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-541">25,945</ix:nonFraction>. The effective interest rate changed by <ix:nonFraction unitRef="number" contextRef="c-152" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-542">2.64</ix:nonFraction>%, and the Company updated the projected years of payments to 2035.  </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since the Royalty Right Agreements were issued in connection with the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-543">13.5</ix:nonFraction>% Notes, the Company allocated the proceeds to the <ix:nonFraction unitRef="instrument" contextRef="c-153" decimals="INF" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" format="ixt-sec:numwordsen" scale="0" id="f-544">two</ix:nonFraction> instruments based on their relative fair values. The Company allocated approximately $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-545">13,856</ix:nonFraction> to the Royalty Right Agreements. The Company determined the allocated fair value by calculating the present value of estimated future royalties to be paid to Note Holders over the life of the arrangement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The excess of future estimated royalty payments over the allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The allocated amounts of $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-546">13,856</ix:nonFraction> when combined with the Exit Fee of $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="aqst:DebtInstrumentExitFee" format="ixt:num-dot-decimal" scale="3" id="f-547">2,000</ix:nonFraction>, original issue discount of $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="f-548">1,125</ix:nonFraction> and debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-549">3,517</ix:nonFraction>, resulted in a debt discount of $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-550">20,498</ix:nonFraction>. The debt discount is being amortized over the term of <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-551">13.5</ix:nonFraction>% Notes using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from the discounts related to the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-552">13.5</ix:nonFraction>% Notes and the Royalty Right Agreements for the three months ended March&#160;31, 2026 was $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="f-553">1,254</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-554">973</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from the discounts related to the <ix:nonFraction unitRef="number" contextRef="c-158" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-555">13.5</ix:nonFraction>% Notes and the Royalty Right Agreements for the three months ended March&#160;31, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="f-556">1,254</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="f-557">1,437</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized discounts totaled $<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-558">6,376</ix:nonFraction> for the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-559">13.5</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-560">24,972</ix:nonFraction> for the Royalty obligations as of March&#160;31, 2026. Unamortized discounts totaled $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-561">7,630</ix:nonFraction> for the <ix:nonFraction unitRef="number" contextRef="c-152" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-562">13.5</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-563">25,945</ix:nonFraction> for the Royalty obligations as of December&#160;31, 2025, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-564" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-term notes and unamortized debt discount balances are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Outstanding notes</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-565">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-566">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount, including Exit Fee</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-567">6,376</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-568">7,630</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:NotesAndLoansPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-569">13,630</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:NotesAndLoansPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-570">9,964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, long-term</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-571">24,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-572">27,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-573">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-574">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-575">25,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-576">27,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Royalty obligations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-577">51,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-578">51,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-579">24,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-580">25,945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, long term</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-581">26,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-582">25,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-504-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-583" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments on the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-584">13.5</ix:nonFraction>% Notes as of March&#160;31, 2026 are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-585">9,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-586">14,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-587">20,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-588">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-589">13.5</ix:nonFraction>% Notes were redeemed on May 12, 2026. See Note 21, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_88"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="aqst:WarrantsDisclosureTextBlock" id="f-590" continuedAt="f-590-1" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="f-590-1" continuedAt="f-590-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued to RTW Investments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, in connection with the Amendment No.1 to the Purchase and Sale Agreement and the Equity Commitment Agreement with RTW, the Company also entered into the Warrant Issuance Agreement with the RTW investors. Pursuant to this agreement, the Company issued to the RTW Investors the RTW Warrant to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-114" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-591">375,000</ix:nonFraction> shares of the Company's Common Stock. The RTW Warrant entitles the holders to purchase shares of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-115" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-592">4.00</ix:nonFraction> per share. The Warrant is exercisable at any time from the issuance date through March 3, 2029. Management estimated the fair value of the RTW Warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="f-593">916</ix:nonFraction>, based on an assessment by an independent third-party appraiser. The fair value was estimated using the Black-Scholes pricing model, which utilized the Company's historical stock price to measure volatility and a holding period of <ix:nonNumeric contextRef="c-3" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-594">three years</ix:nonNumeric> based on the time period between the valuation date and the termination date as defined in the Warrant Issuance Agreement. The fair value of the RTW Warrants is presented within Additional Paid-in Capital on the Condensed Balance Sheets as of March&#160;31, 2026 and within Interest income and other income, net on the Condensed Statements of Operations and Comprehensive Loss for the three months ended March&#160;31, 2026.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no warrants exercised as it relates to the RTW Warrants during the three months ended March&#160;31, 2026. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued to <ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-595">12.5</ix:nonFraction>% Senior Secured Noteholders </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Warrants that were issued in conjunction with the Initial Notes (the &#8220;Initial Warrants&#8221;) and Additional Notes (the &#8220;Additional Warrants&#8221;) entitled the noteholders of the Company's <ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-596">12.5</ix:nonFraction>% Notes to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-597">2,143,000</ix:nonFraction> shares of Common Stock and included specified registration rights. Management estimated the fair value of the Initial Warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="aqst:AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" format="ixt:num-dot-decimal" scale="3" id="f-598">6,800</ix:nonFraction> and the Additional Warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="aqst:AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" scale="3" id="f-599">735</ix:nonFraction>, each based on an assessment by an independent third-party appraiser. The fair value of the respective warrants was treated as a debt discount, amortizable over the term of the respective warrants, with the unamortized <ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-600">12.5</ix:nonFraction>% Notes portion applied to reduce the aggregate principal amount of the <ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-601">12.5</ix:nonFraction>% Notes. The <ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-602">12.5</ix:nonFraction>% Notes were refinanced with the <ix:nonFraction unitRef="number" contextRef="c-40" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-603">13.5</ix:nonFraction>% Notes on November 1, 2023. Additionally, since the Initial Warrants and Additional Warrants issued do not provide warrant redemption or put rights within the control of the noteholders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the warrants, except in the case of a &#8220;cash change in control&#8221;, the fair value attributed to the warrants is presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets. The Initial Warrants and Additional Warrants expired on June 30, 2025.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-604">no</ix:nonFraction> warrants exercised as it relates to the Initial Warrants and the Additional Warrants during the three months ended March&#160;31, 2025.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued Under Securities Purchase Agreements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants and Common Stock warrants to certain purchasers in connection with the Securities Purchase Agreements. The pre-funded warrants entitled purchasers to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-166" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-605">4,000,000</ix:nonFraction> shares of Common Stock and were exercised in full during the year ended December 31, 2022. The Common Stock warrants expire on June 8, 2027 and entitled the purchasers to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-167" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-606">8,850,000</ix:nonFraction> shares of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-168" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-607">0.96</ix:nonFraction> per share. Management estimated the fair value of the pre-funded warrants and Common Stock warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-608">5,874</ix:nonFraction> based on an assessment by an independent third-party appraiser. The fair value of the pre-funded and Common Stock warrants is treated as equity and presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets. On June 14, 2023, <ix:nonFraction unitRef="shares" contextRef="c-170" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" format="ixt:num-dot-decimal" scale="0" id="f-609">3,689,452</ix:nonFraction> Common Stock warrants issued pursuant to the Securities Purchase Agreements were exercised with proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-610">3,542</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-611">5,000,000</ix:nonFraction> of the remaining Common Stock Warrants. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-108" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-612">0.96</ix:nonFraction> per share of Common Stock, the then current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-613">2,750,000</ix:nonFraction> shares of Common Stock. The New Warrants became exercisable after February 2, 2024, expire on February 2, 2029 and are issuable only for cash, subject to exception if the shares of Common </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-590-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case, the New Warrants may also be exercised, in whole or in part, at such time by means of a "cashless exercise". The New Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-109" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-614">2.60</ix:nonFraction> per share. Management estimated the fair value of the warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-615">4,671</ix:nonFraction> based on an assessment by an independent third-party appraiser. The fair value of the New Warrants is treated as equity and is presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="c-171" decimals="-3" name="aqst:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-616"><ix:nonFraction unitRef="shares" contextRef="c-172" decimals="-3" name="aqst:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-617">no</ix:nonFraction></ix:nonFraction> warrants issued or exercised as it relates to the Warrants issued under Securities Purchase Agreements during the three months ended March&#160;31, 2026 and 2025.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, in addition to the remaining New Warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-173" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-618">2,200,000</ix:nonFraction> shares of Common Stock with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-109" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-619">2.60</ix:nonFraction> per share and the RTW Warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-114" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-620">375,000</ix:nonFraction> shares with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-115" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-621">4.00</ix:nonFraction> per share described above, there remain outstanding warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-172" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" format="ixt:num-dot-decimal" scale="0" id="f-622">160,548</ix:nonFraction> shares of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-173" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-623">0.96</ix:nonFraction>.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_91"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="aqst:SaleOfFutureRevenueTextBlock" id="f-624" continuedAt="f-624-1" escape="true">Sale of Future Revenue</ix:nonNumeric></span></div><ix:continuation id="f-624-1" continuedAt="f-624-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, an apomorphine film therapy for the treatment of off episodes in Parkinson&#8217;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, the Company received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-625">40,000</ix:nonFraction> and an additional payment of $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-626">10,000</ix:nonFraction> through the achievement of the first milestone. The Company has received an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-627">50,000</ix:nonFraction> through March&#160;31, 2026 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="aqst:ContingentMonetizationAgreementMilestonePayment" format="ixt:num-dot-decimal" scale="3" id="f-628">75,000</ix:nonFraction> may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-629">125,000</ix:nonFraction>. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the upfront proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-630">40,000</ix:nonFraction> and subsequent first milestone of $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-631">10,000</ix:nonFraction>, reduced by $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-632">2,909</ix:nonFraction> of transaction costs, as a liability related to the sale of future revenue that will be amortized using the effective interest method over the life of the Monetization Agreement. As future contingent payments are received, they will increase the balance of the liability related to the sale of future revenue. Although the Company sold all of its rights to receive royalties and milestones, as a result of ongoing obligations related to the generation of these royalties, the Company will account for these royalties as revenue. Its ongoing obligations include the maintenance and defense of the intellectual property and to provide assistance to Marathon in executing a new license agreement for KYNMOBI in the event Sunovion terminates the Sunovion License Agreement in one or more jurisdictions of the licensed territory under the Sunovion License Agreement. The accounting liabilities, as adjusted over time, resulting from this transaction and any non-cash interest expenses associated with those liabilities do not and will not represent any obligation to pay or any potential future use of cash.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-633">8,000</ix:nonFraction> of royalty revenue and corresponding royalty receivable, related to the $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="aqst:MinimumAnnualRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-634">1,000</ix:nonFraction> annual minimum guaranteed royalty that is due. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As royalties are remitted to Marathon from Sunovion, the collection of the royalty receivable and balance of the liability related to the sale of future revenue will be effectively repaid over the life of the agreement. In order to determine the amortization of the liability related to the sale of future revenue, the Company is required to estimate the total amount of future royalty and milestone payments to Marathon over the life of the Monetization Agreement and contingent milestone payments from Marathon to the Company. The sum of future royalty payments less the $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-635">50,000</ix:nonFraction> in proceeds received and future contingent payments has been recorded as interest expense over the life of the Monetization Agreement. At execution, the estimate of this total interest expense resulted in an effective annual interest rate of approximately <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-636">24.9</ix:nonFraction>%. This estimate contained significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the life of the Monetization Agreement. The Company assesses the estimated royalty and milestone payments to Marathon from Sunovion and contingent milestone payments from Marathon to the Company. To the extent the amount or timing of such payments is materially different from the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. There are a number of factors that could materially affect the amount and timing of royalty and milestone payments to Marathon from Sunovion and, correspondingly, the amount of interest expense recorded by the Company, most of which are not under the Company&#8217;s control. Such factors include, but are not limited to, changing standards of care, the initiation of competing products, manufacturing or other delays, generic competition, intellectual property matters, adverse events that result in government health authority imposed restrictions on the use of products, significant changes in foreign exchange rates as the royalties remitted to Marathon are made in U.S. dollars (USD) while a portion of the underlying sales of KYNMOBI will be made in currencies other than USD, and other events or circumstances that are not </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-624-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">currently foreseen. Changes to any of these factors could result in increases or decreases to both royalty revenue and interest expense related to the sale of future revenue. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. Further, the Company discontinued recording interest expense related to the sale of future revenue during the fourth quarter of 2022.</span></div><ix:nonNumeric contextRef="c-1" name="aqst:RoyaltyObligationActivityTableTextBlock" id="f-637" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the activity of the liability related to the sale of future revenue:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-638">63,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-639">63,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalties related to the sale of future revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-641">938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-642">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-643">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at end of the period (includes current portion of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-644">1,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" format="ixt:num-dot-decimal" scale="3" id="f-645">1,000</ix:nonFraction>, respectively)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-646">63,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-647">63,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_1353"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 16.&#160;&#160;&#160;&#160;       <ix:nonNumeric contextRef="c-1" name="us-gaap:AssetRetirementObligationDisclosureTextBlock" id="f-648" continuedAt="f-648-1" escape="true">Other Non-Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="f-648-1"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other non-current liabilities at March&#160;31, 2026 and December&#160;31, 2025  consisted of a confidential legal settlement net liability and AROs of  $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="3" id="f-649">2,072</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="3" id="f-650">2,065</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">AROs consists of estimated future spending related to removing certain leasehold improvements at the Company&#8217;s facilities in Portage, Indiana and Warren, New Jersey, and returning all facilities to their original condition. Depreciation expense related to the ARO assets included in overall depreciation expense for the three months ended March&#160;31, 2026 and 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:AssetRetirementObligationsDepreciationExpense" scale="3" id="f-651">6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:AssetRetirementObligationsDepreciationExpense" scale="3" id="f-652">7</ix:nonFraction>, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock" id="f-653" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="3" id="f-654">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetRetirementObligationLiabilitiesIncurred" format="ixt:fixed-zero" scale="3" id="f-655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="f-656">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2025</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="3" id="f-657">2,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="3" id="f-658">2,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AssetRetirementObligationLiabilitiesIncurred" format="ixt:fixed-zero" scale="3" id="f-659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="f-660">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="3" id="f-661">2,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i65b3f6374bb0418bacd030f2ff357555_94"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-662" continuedAt="f-662-1" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="f-662-1" continuedAt="f-662-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss by the weighted-average number of Common Stock.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-663" continuedAt="f-663-1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#8217;s equity compensation plans, warrants and ESPP. As a result of the Company&#8217;s net loss incurred for the three months ended March&#160;31, 2026 and 2025, all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended March&#160;31, 2026 and 2025 as reflected below.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-664">8,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-665">22,930</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-666"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-667">122,609,995</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-668"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-669">95,497,056</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss per common share &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-670"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-671">0.07</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-672"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-673">0.24</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended March&#160;31, 2026 and 2025, outstanding stock options of <ix:nonFraction unitRef="shares" contextRef="c-181" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-674"><ix:nonFraction unitRef="shares" contextRef="c-181" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-675">7,501,729</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-182" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-676"><ix:nonFraction unitRef="shares" contextRef="c-182" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-677">6,977,367</ix:nonFraction></ix:nonFraction> to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-663-1"><ix:continuation id="f-662-2"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three months ended March&#160;31, 2026 and 2025, outstanding restricted stock units of <ix:nonFraction unitRef="shares" contextRef="c-183" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-678"><ix:nonFraction unitRef="shares" contextRef="c-183" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-679">4,566,190</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-184" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-680"><ix:nonFraction unitRef="shares" contextRef="c-184" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-681">5,167,351</ix:nonFraction></ix:nonFraction> to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended March&#160;31, 2026 and 2025, outstanding warrants of <ix:nonFraction unitRef="shares" contextRef="c-185" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-682"><ix:nonFraction unitRef="shares" contextRef="c-185" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-683">2,735,548</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-186" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-684"><ix:nonFraction unitRef="shares" contextRef="c-186" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-685">4,594,332</ix:nonFraction></ix:nonFraction> to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div></ix:continuation></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_97"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-686" continuedAt="f-686-1" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-686-1" continuedAt="f-686-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="f-687" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation in its Condensed Statements of Operations and Comprehensive Loss during the three months ended March&#160;31, 2026 and 2025 as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.823%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-688">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-689">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-690">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-691">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-692">2,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-693">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-694">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-695">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation from:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-696">1,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-697">1,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-698">663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-699">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-700">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-701">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Equity Awards</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the three month period ended March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-702" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s awards of service-based and market conditions vesting-based restricted stock units for the three month period ended March&#160;31, 2026:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Service-based:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-197" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-703">2,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-197" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-704">3.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-198" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-705">1,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-198" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-706">4.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-198" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-707">1,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-198" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-708">2.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-198" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-709">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-198" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-710">4.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-199" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-711">2,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-199" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-712">4.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-199" decimals="-3" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" format="ixt:num-dot-decimal" scale="3" id="f-713">2,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-199" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" scale="0" id="f-714">4.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, $<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="3" id="f-715">8,931</ix:nonFraction> of total unrecognized compensation expenses related to unvested service-based restricted stock units are expected to be recognized over a remaining weighted average period of <ix:nonNumeric contextRef="c-198" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-716">2.24</ix:nonNumeric> years. The service-based restricted stock units granted to employees are subject to a <ix:nonNumeric contextRef="c-198" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-717">three-year</ix:nonNumeric> graduated vesting schedule and are not subject to performance-based criteria other than continued employment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-686-2" continuedAt="f-686-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-718" continuedAt="f-718-1" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-200" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-719">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-200" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-720">2.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-201" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="f-721">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-201" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-201" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="3" id="f-723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-201" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-201" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="3" id="f-725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-201" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-202" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-727">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-202" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-728">2.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-202" decimals="-3" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" format="ixt:num-dot-decimal" scale="3" id="f-729">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-202" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" scale="0" id="f-730">2.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, $<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="3" id="f-731">1,090</ix:nonFraction> of unrecognized compensation expense related to unvested market condition vesting- based restricted stock units are expected to be recognized over a remaining weighted average period of <ix:nonNumeric contextRef="c-201" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-732">0.78</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 market conditions vesting-based restricted stock units vest based on a Performance Price measured as the <ix:nonNumeric contextRef="c-202" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" format="ixt-sec:durwordsen" id="f-733">30-day</ix:nonNumeric> average of the closing prices of the Common Stock as reported on the Nasdaq Global Market immediately prior to and including the last calendar day of the <ix:nonNumeric contextRef="c-201" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-734">three-year</ix:nonNumeric> performance period (which ends on the third anniversary of the grant date). To the extent the Performance Price is less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-203" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-735">1.75</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-204" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:fixed-zero" scale="-2" id="f-736">zero</ix:nonFraction>. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-205" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-737">1.75</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-206" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-738">50</ix:nonFraction>%. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-207" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-739">1.76</ix:nonFraction> or greater, but less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-208" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-740">2.50</ix:nonFraction>, the Vesting Percentage will be a prorated amount between <ix:nonFraction unitRef="number" contextRef="c-209" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-741">50.01</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-210" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-742">99.99</ix:nonFraction>%, based on straight-line interpolation. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-211" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-743">2.50</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-212" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-744">100</ix:nonFraction>%. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-213" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-745">2.51</ix:nonFraction> or greater, but less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-214" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-746">3.25</ix:nonFraction>, the Vesting Percentage will be a prorated amount between <ix:nonFraction unitRef="number" contextRef="c-215" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-747">100.01</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-216" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-748">149.99</ix:nonFraction>%, based on straight-line interpolation. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-217" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-749">3.25</ix:nonFraction> or greater, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-218" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-750">150</ix:nonFraction>%. In no event will the Vesting Percentage exceed <ix:nonFraction unitRef="number" contextRef="c-193" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-751">150</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 market conditions vesting-based restricted stock units were measured over a <ix:nonNumeric contextRef="c-219" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-752">three-year</ix:nonNumeric> performance period. The performance period is split into <ix:nonFraction unitRef="pricing_period" contextRef="c-219" decimals="INF" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" format="ixt-sec:numwordsen" scale="0" id="f-753">two</ix:nonFraction> pricing periods. The first pricing period commences on the grant date and ends on the calendar day immediately proceeding the second anniversary of the grant date. The second pricing period commences on the second anniversary of the grant date and ends on the third anniversary of the grant date, The performance price for the first pricing period is calculated based on the <ix:nonNumeric contextRef="c-220" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" format="ixt-sec:durwordsen" id="f-754">30-day</ix:nonNumeric> average price observed for the last <ix:nonNumeric contextRef="c-220" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" format="ixt-sec:durday" id="f-755">30</ix:nonNumeric> days of the first pricing period. The performance price for the second pricing period is calculated based on the highest <ix:nonNumeric contextRef="c-220" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" format="ixt-sec:durwordsen" id="f-756">30-day</ix:nonNumeric> average for any <ix:nonNumeric contextRef="c-220" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" format="ixt-sec:durwordsen" id="f-757">30-day</ix:nonNumeric> period throughout the second pricing period. To the extent the Performance Price is less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-221" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-758">6.00</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-222" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt:fixed-zero" scale="-2" id="f-759">zero</ix:nonFraction>. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-223" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-760">6.00</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-224" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-761">50</ix:nonFraction>%. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-225" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-762">6.01</ix:nonFraction> or greater, but less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-226" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-763">7.00</ix:nonFraction>, the Vesting Percentage will be a prorated amount between <ix:nonFraction unitRef="number" contextRef="c-227" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-764">50.01</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-228" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-765">99.99</ix:nonFraction>%, based on straight-line interpolation. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-229" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-766">7.00</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-230" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-767">100</ix:nonFraction>%. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-231" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-768">7.01</ix:nonFraction> or greater, but less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-232" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-769">8.00</ix:nonFraction>, the Vesting Percentage will be a prorated amount between <ix:nonFraction unitRef="number" contextRef="c-233" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-770">100.01</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-234" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-771">149.99</ix:nonFraction>%, based on straight-line interpolation. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-235" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-772">8.00</ix:nonFraction> or greater, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-236" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-773">150</ix:nonFraction>%. In no event will the Vesting Percentage exceed <ix:nonFraction unitRef="number" contextRef="c-237" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-774">150</ix:nonFraction>%.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-686-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-775" continuedAt="f-775-1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of the fair value of the 2025 market conditions vesting-based awards at their grant or valuation dates were based on a Monte Carlo simulation and considered various variables and the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.515%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-776">0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-777">91.5</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-196" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-778">3.9</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock price at grant date</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-238" decimals="2" name="us-gaap:SharePrice" scale="0" id="f-779">2.65</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><ix:continuation id="f-718-1"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Stock Option Awards:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-239" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-780">6,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-239" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-781">5.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-195" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-782">946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-783">4.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-195" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-784">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-785">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-195" decimals="-3" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" scale="3" id="f-786">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-787">3.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-240" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-788">7,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-240" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-789">5.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-240" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-790">7,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-240" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-791">5.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-240" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="f-792">5,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-240" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-793">5.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:continuation id="f-775-1"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.146%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-794">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-795">98</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-241" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-796">6.1</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-241" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-797">3.8</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of stock options granted during the three months ended March&#160;31, 2026 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-798">3.43</ix:nonFraction>. During the three months ended March&#160;31, 2026, stock options were granted with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-195" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-799">4.29</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, $<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-800">5,272</ix:nonFraction> of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a remaining weighted average period of <ix:nonNumeric contextRef="c-195" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-801">2.04</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2022 Inducement Equity Incentive Plan (number of units in thousands)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Nasdaq Listing Rule 5635(c)(4), the Company adopted the 2022 Equity Inducement Plan approved by the Compensation Committee of the Board of Directors of the Company effective as of July 29, 2022. There were <ix:nonFraction unitRef="shares" contextRef="c-242" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-802">75</ix:nonFraction>  service-based awards and <ix:nonFraction unitRef="shares" contextRef="c-243" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-803">50</ix:nonFraction> options granted under this Plan during the three months ended March&#160;31, 2026. The options and service-based awards granted under this Plan are included in the tables above. As of March&#160;31, 2026, <ix:nonFraction unitRef="shares" contextRef="c-244" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="f-804">775</ix:nonFraction> shares remained available for grant under this Plan.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_100"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-805" continuedAt="f-805-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-805-1" continuedAt="f-805-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and R&amp;D credits. Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three months ended March&#160;31, 2026 and 2025, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-806"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-807">0</ix:nonFraction></ix:nonFraction>%, and the Company recorded <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-808"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-809">no</ix:nonFraction></ix:nonFraction> income tax expense from its pretax losses of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-810">8,057</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-811">22,930</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The primary factors impacting the effective tax rate for the three months ended March&#160;31, 2026 is the anticipated full year pre-tax book loss and a full valuation allowance against any associated net deferred tax assets.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-805-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 4, 2025, the President signed H.R. 1, the Budget Reconciliation Bill, into law. The legislation includes several changes to federal tax law that generally allow for more favorable deductibility of certain business expenses beginning in 2025, including the restoration of immediate expensing of domestic R&amp;D expenditures, reinstatement of 100% bonus depreciation, and more favorable rules for determining the limitation on business interest expense.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These changes were reflected in the income tax provision for the three months ended March&#160;31, 2026. As the result of the Company maintaining a full valuation allowance against its U.S. federal and state deferred tax assets, the changes introduced by this legislation did not result in a material impact to the Company&#8217;s income tax provision or deferred tax balances for the current reporting period. The Company will continue to monitor the potential future impacts of the legislation, including any changes to its valuation allowance assessment, as further guidance becomes available and as facts and circumstances evolve.</span></div></ix:continuation><div id="i65b3f6374bb0418bacd030f2ff357555_103"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-812" continuedAt="f-812-1" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-812-1" continuedAt="f-812-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the course of its business, including product liability, intellectual property, securities, civil tort, and commercial litigation, and environmental or other regulatory matters.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California Litigation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis, Inc. v. Aquestive Therapeutics, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, Neurelis, Inc. ("Neurelis") filed a civil tort lawsuit against the Company in the Superior Court of California, County of San Diego. In December 2025, the parties reached a mutual out-of-court settlement agreement resolving all claims related to the matter, the terms of which settlement agreement are confidential. In the settlement agreement, the Company did not concede liability and settled the matter for business reasons. The Company does not consider this settlement material to its financial condition. The settlement of the matter was recorded within Selling, general, and administrative expenses on the Company's Statements of Operations and Comprehensive Loss for the year ended December 31, 2025. The current liability was recorded within Accounts payable and the non-current liability was recorded within Other non-current liabilities on the Company's Balance Sheets as of March&#160;31, 2026 and December 31, 2025. On April 3, 2026 the court signed the Order dismissing the case with prejudice.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neurelis FDA Lawsuit</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis, Inc. v. Califf, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">et al</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, U.S. District Court for the District of Columbia</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2024, Neurelis filed a complaint in the U.S. District Court for the District of Columbia against the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, and certain government officials. The complaint in this matter alleges that the defendants violated the Administrative Procedure Act by approving the Company's NDA for Libervant for ARS patients aged between two and five years, and asked the Court to vacate that approval and enjoin the defendants from approving Libervant for this pediatric patient population until January 10, 2027, the scheduled date for the expiration of the U.S. orphan drug market exclusivity (ODE) granted by the FDA to the Valtoco</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> nasal spray product of Neurelis (the "ODE Expiration"). The Company intervened in this litigation to defend the approval of Libervant for this ARS pediatric patient population. Following submission of briefs and filings of respective motions by the parties for summary judgment, on February 14, 2025, the Court entered a final appealable judgment in favor of Neurelis, and against the FDA's and the Company's cross-motions for summary judgment, and directed the FDA to vacate the approval of Libervant. On February 18, 2025, the Company filed an appeal of the District Court's decision with the U.S. Court of Appeals for the District of Columbia Circuit (the "DC Appellate Court") and, on the same day, filed an emergency motion with the District Court to stay its order pending a decision on the appeal with the DC Appellate Court. The District Court denied the motion for a stay. On March 27, 2025, the DC Appellate Court denied the Company's emergency motion for stay. The FDA filed an appeal of the District Court's decision to the DC Appellate Court and the Company withdrew its appeal. As a result of the District Court's ruling, the FDA converted the approval of Libervant to a "tentative approval" and the Company has ceased marketing activities in the United States for Libervant for these ARS pediatric patients. After a delay of the proceedings at the DC Appellate Court caused by the government shutdown beginning in October 2025, on November 21, 2025, the DC Appellate Court entered a schedule for briefing and oral arguments on the appeal. Subsequently, on February 3, 2026, Congress adopted and the President signed into law legislation that amended the Orphan Drug Act to provide that ODE applies only to the extent a subsequent applicant seeks approval for the same approved use or indication within the designated rare disease or condition to which the ODE applies. As applied, this legislation would confirm the FDA's long-standing interpretation of the Orphan Drug Act and its authority to approve another sponsor&#8217;s orphan drug for a different use or indication than that of an approved drug with ODE, such as the FDA's prior approval of Libervant for ARS patients aged between two and five years. On February 16, 2026, the Company filed a motion with the DC Appellate Court requesting that the DC Appellate Court order all parties to submit simultaneous briefs regarding appropriate next steps regarding this legislation and its intended application to this case, including the possibility of a summary disposition of the matter by the DC Appellate Court. On February 18, 2026, Neurelis </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><ix:continuation id="f-812-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">filed a brief opposing the Company's motion. On the DC Appellate Court's own motion filed on February 17, 2026, the DC Appellate Court suspended briefing by the parties in this case pending further order from the court. On March 2, 2026, the DC Appellate Court entered an order directing the parties to file motions by March 20, 2026 addressing, among other things, their positions on the effect on the appeal resulting from the recent amendment to the Orphan Drug Act. The court denied pending motioned and entered a briefing scheduling order.  The Company is not able to determine or predict the ultimate outcome of these proceedings or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter or whether the FDA will grant U.S. market access to Libervant for ARS patients aged between two and five years in advance of the ODE Expiration.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suboxone Product Liability Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company was named as a defendant in a multitude of product liability lawsuits, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#174; sublingual film, a prescription drug product for opioid use disorder, caused them dental injuries. On February 2, 2024, this litigation became a MDL consolidated in the U.S District Court for the Northern District of Ohio. <ix:nonFraction unitRef="pending_case" contextRef="c-245" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="f-813">One</ix:nonFraction> case alleging the same allegations as contained in the MDL has been filed in a state court in the State of New Jersey. The parties to the MDL have agreed to a tolling of unfiled claimants in several states. Indivior has agreed to defend the Company in these litigation matters. Discovery is underway and no trial date has been set in the MDL matter. The Company's motion to dismiss the MDL matter was granted as to all claims against Aquestive by plaintiffs except design defect claims and claims for punitive damages. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company was named as a defendant in <ix:nonFraction unitRef="pending_case" contextRef="c-246" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="f-814">three</ix:nonFraction> proposed class action lawsuits filed in Canada, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#174; products caused them dental injuries. <ix:nonFraction unitRef="pending_case" contextRef="c-247" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="f-815">Two</ix:nonFraction> of these cases have been filed in British Columbia, and the plaintiffs in those cases are seeking assignment of a case management judge. The anticipated next step in British Columbia will involve applications by the plaintiffs to determine which of the <ix:nonFraction unitRef="pending_case" contextRef="c-247" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="f-816">two</ix:nonFraction> cases will proceed towards a certification hearing and which will be stayed. The third case has been filed in Quebec and is proceeding towards an authorization hearing, the date of which has not yet been set. The authorization and certification hearings will determine whether the Courts will allow the cases to proceed as class actions. Pre-discovery and case management proceedings are underway and no trial date has yet been set. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this litigation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Federal Securities Class Action</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2026, a putative securities class action lawsuit was filed against the Company and Daniel Barber in the United States District Court for the District of New Jersey, captioned Modica v. Aquestive Therapeutics, Inc. and Daniel Barber. The complaint purports to seek relief on behalf of a class of investors who purchased or otherwise acquired the Company&#8217;s publicly traded securities between June 16, 2025 and January 8, 2026, and asserts violations of Section 10(b) of the Exchange Act against all defendants and Section 20(a) of the Exchange Act against the individual defendant. The complaint alleges, among other things, that during the proposed class period, defendants made misstatements and/or failed to disclose certain facts regarding the NDA for Anaphylm. The complaint seeks various forms of relief, including monetary damages in an unspecified amount. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Shareholder Derivative Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2026, a shareholder derivative lawsuit was filed by a purported shareholder on behalf of the Company against certain individual directors and officers of the Company, naming the Company as a nominal defendant, in the United States District Court for the District of New Jersey, captioned Wilson v. Brown, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et al</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The complaint asserts claims for violation of Section 14(a) of the Exchange Act against the director defendants, and breach of fiduciary duty, aiding and abetting breach of fiduciary duty, and waste of corporate assets against all individual defendants. The complaint alleges, among other things, that the individual defendants failed to exercise adequate oversight of, and misrepresented and/or failed to disclose certain facts regarding the NDA for Anaphylm. The derivative action has been designated as related to the securities class action described above. The complaint seeks various forms of relief, including monetary damages in an unspecified amount and corporate governance reforms. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_1328"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Note 21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-817" continuedAt="f-817-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-817-1" continuedAt="f-817-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2026, the Company entered into a second amendment to the Pharmanovia Agreement relating to the license and supply of Libervant (diazepam) buccal film in territories outside the United States. The Pharmanovia Amendment No. 2 modifies certain commercial and operational terms of the agreement, including subcontracting rights, delivery terms, and minimum volume commitments in certain territories. All other terms and conditions of the Pharmanovia Agreement remain in full force and effect.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 8, 2026, the Company entered into a lease agreement which will serve as the Company&#8217;s corporate headquarters. The lease has an initial term of <ix:nonNumeric contextRef="c-248" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-818">eleven years</ix:nonNumeric>, inclusive of an initial rent abatement period of approximately <ix:nonNumeric contextRef="c-248" name="aqst:LesseeOperatingLeaseInitialRentAbatementPeriod" format="ixt-sec:durwordsen" id="f-819">twelve months</ix:nonNumeric>, commencing on the earlier of the date the Company obtains a certificate of occupancy or September 1, 2026. The lease provides the Company with <ix:nonFraction unitRef="renewal_option" contextRef="c-248" decimals="INF" name="aqst:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="f-820">two</ix:nonFraction> successive <ix:nonNumeric contextRef="c-248" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-821">five-year</ix:nonNumeric> renewal options at fair market rental value and an option to expand into additional space. The Company expects to account for the lease as an operating lease in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-817-2">On May 12, 2026, the Company entered into a <ix:nonNumeric contextRef="c-145" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-822">five-year</ix:nonNumeric> term loan facility of up to $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-823">150,000</ix:nonFraction> with funds managed by Oaktree Capital Management, L.P. The <ix:nonNumeric contextRef="c-145" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-824">five year</ix:nonNumeric> term loan facility consisted of an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-825">55,000</ix:nonFraction>, which was funded on May 12, 2026 and was primarily used to repay the Company&#8217;s existing <ix:nonFraction unitRef="number" contextRef="c-147" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-826">13.5</ix:nonFraction>% Notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-827">45,000</ix:nonFraction> plus fees associated with the repayment. Upon FDA approval of Anaphylm and satisfaction of other customary conditions, an additional $<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" format="ixt:num-dot-decimal" scale="3" id="f-828">20,000</ix:nonFraction> will be available. A third tranche of $<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" format="ixt:num-dot-decimal" scale="3" id="f-829">25,000</ix:nonFraction> will be available upon the achievement of specified sales milestones, with the final tranche of up to $<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" format="ixt:num-dot-decimal" scale="3" id="f-830">50,000</ix:nonFraction> available with the mutual consent of the Lenders and the Company. The Company will pay only interest on the new <ix:nonNumeric contextRef="c-252" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-831">five-year</ix:nonNumeric> facility with all principal amounts outstanding due at maturity.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read this section in conjunction with our condensed interim financial statements and related notes included in Part I Item 1 of this Quarterly Report on Form 10-Q and our audited financial statements and related notes thereto and management</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s discussion and analysis of financial condition and results of operations for the years ended December&#160;31, 2025 and 2024 included in our 2025 Annual Report on Form 10-K. All dollar amounts are stated in thousands except for share data. </span></div><div id="i65b3f6374bb0418bacd030f2ff357555_109"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q and certain other communications made by us include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; or the negative of those terms, and similar expressions are intended to identify forward-looking statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements include, but are not limited to, statements regarding the advancement and related timing of our product candidate Anaphylm&#8482; (dibutepinephrine) sublingual film through clinical development and approval by the FDA, including our ability to address the concerns raised by the FDA in the Complete Response Letter (CRL) dated January 30, 2026 and Type A meeting with the FDA on March 26, 2026, and for the FDA to approve Anaphylm or whether the FDA may request further information from us, disagree with our protocols, study designs, or findings or otherwise undertake a lengthy review of our resubmission, and challenges regarding the following commercial launch of Anaphylm, if approved by the FDA; the advancement and related timing of potential international regulatory filings and marketing authorization of Anaphylm outside of the U.S.; Anaphylm&#8217;s potential to be the first and only oral administration of epinephrine and to be accepted as an alternative to existing standards of care, if approved by the FDA; the expected growth of the U.S. epinephrine market including in value and the opportunity such growth presents to the Company should Anaphylm be approved by the FDA; the advancement, growth and related timing of our AdrenaVerse&#8482; pipeline epinephrine prodrug product candidates, including AQST-108 (epinephrine) topical gel, through clinical development and FDA regulatory approval process, including design and timing of clinical studies including those necessary to support the targeted indication of alopecia areata for AQST-108 or other possible indications; the potential sale or outlicensing of Anaphylm, Libervant or other product candidates; the approval for U.S. market access of Libervant and overcoming the orphan drug market exclusivity of an FDA approved nasal spray product of another company extending to January 2027; the commercial opportunity of Libervant, Anaphylm, AQST-108 and our other product candidates, should these product candidates be approved by the FDA; the focus on continuing to manufacture Suboxone</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Emylif</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Sympazan</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Ondif</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and other licensed products; the potential benefits our products and product candidates could bring to patients; the achievement of clinical and commercial milestones, product orders and fulfillment; our cash requirements, cash funding and cash burn; short-term and longer term liquidity and the ability to fund our business operations; our growth and future financial and operating results and financial position, including with respect to our 2026 financial outlook; and business strategies, market opportunities, and other statements that are not historical facts.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such risks and uncertainties include, but are not limited to, risks associated with our development work, including any delays or changes to the timing, cost and success of our product development activities and clinical trials and plans, including those relating to Anaphylm, AQST-108, and our other product candidates; risk of delays in advancement of the regulatory approval process through the FDA of our product candidates, including the filing of the respective NDAs, for Anaphylm, AQST-108, Libervant and other product candidates, or failure to receive FDA approval at all of any of these product candidates; risk of FDA inspections of manufacturing and clinical study sites for any of our product candidates, including Anaphylm; risk of government shutdowns or actions to reduce government workforces on the ability of the FDA to act on the approval of our product candidates, including Anaphylm and Libervant; risk of the Company&#8217;s ability to generate sufficient clinical and other human factor data, including with respect to our submission of pharmacokinetics and pharmacodynamics (PK/PD) comparability data for FDA approval of Anaphylm; risks associated with our ability to address the FDA&#8217;s comments on and identified deficiencies in our NDA for Anaphylm, including the concerns raised by the FDA in the CRL and Type A Meeting; risks associated with the success of any competing products, including generics; risks and uncertainties inherent in commercializing a new product (including technology risks, financial risks, market risks and implementation risks and regulatory limitations); risk of development of a sales and marketing capability for commercialization of our product candidates, including Anaphylm, if approved by the FDA; risks associated with the potential impact on the value of the Company of the sale or outlicensing of our product and product candidates, including Libervant and Anaphylm and other product candidates; risk of insufficient capital and cash resources, including insufficient access to available debt and equity financing, including under our ATM facility and the RTW Funding Agreement, and revenues from operations, to satisfy all of our short-term and longer-term liquidity and cash requirements to support our growth strategy, and other cash needs, at the times and in the amounts needed, and to fund future clinical development and commercial activities for our product candidates, including Anaphylm, AQST-108 and Libervant  should these product candidates be approved by the FDA; risk of the impact of our obligations under the Company's Purchase Agreement and the Royalty Rights Agreement with third parties, each of which </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">agreements requires the Company to make payments to each counterparty thereof, respectively, of a portion of our revenues, on our ability to contribute to the funding of our operations and the payment of interest on our debt; risk that our manufacturing capabilities will be insufficient to support demand of our product candidates in the U.S. and abroad, including Anaphylm, if such product candidates should be approved by the FDA and other regulatory authorities, and our licensed products in the U.S. and abroad; risk of eroding market share for Suboxone</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> as a sunsetting product, which accounts for a substantial part of our current operating revenue; risk of default of our debt instruments; risks related to the outsourcing of certain sales, marketing and other operational and staff functions to third parties; risk of the rate and degree of market acceptance in the U.S. and abroad of Anaphylm, AQST-108, Libervant and our other product candidates, should these product candidates be approved by the FDA and other regulatory authorities, and for our licensed products in the U.S. and abroad; risk associated with the size and growth of our product markets; risk associated with our compliance with all FDA and other governmental and customer requirements for our manufacturing facilities; risks associated with intellectual property rights and infringement claims relating to our products; risk that our patent applications for our product candidates, including for Anaphylm, will not be timely issued, or issued at all, by the United States Patent and Trademark Office (PTO) or, if issued, will be sufficient to provide long-term commercial success of these product candidates; risk of unexpected patent developments; risk of legislation and regulatory actions and changes in laws or regulations affecting our business, including relating to our products and product candidates and product pricing, reimbursement or access therefor; risk of loss of significant customers; risks related to claims and legal proceedings against us including patent infringement, securities, business torts, investigative, product safety or efficacy and antitrust litigation matters; risk of product recalls and withdrawals; risks related to any disruptions in our information technology networks and systems, including the impact of cybersecurity attacks; risk of increased cybersecurity attacks and data accessibility disruptions due to remote working arrangements; risk of adverse developments affecting the financial services industry; risks related to inflation and changing interest rates; risks related to the impact of pandemic diseases on our business; risks and uncertainties related to general economic, political (including the Ukraine, Israel and Iran wars and other acts of war and terrorism), business, industry, regulatory, financial and market conditions and other unusual items; risks related to uncertainty about presidential administration initiatives and their impact on our business, including imposition of government tariffs and other trade restrictions; and other uncertainties affecting the Company including those described in the "Risk Factors" section and in other sections included in this Quarterly Report on Form 10-Q. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include the matters discussed and referenced in the risk factors of the Company&#8217;s 2025 Annual Report on Form 10&#8209;K and our other Quarterly Reports on Form 10&#8209;Q and in our Current Reports on Form 8-K and our other filings with the SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements, which speak only as the date made. All subsequent forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by this cautionary statement. We assume no obligation to update forward-looking statements, or outlook or guidance after the date of this Quarterly Report on Form 10-Q, whether as a result of new information, future events or otherwise, except as may be required by applicable law. Readers should not rely on the forward-looking statements included in this Quarterly Report on Form 10-Q as representing our views as of any date after the date of the filing of this Quarterly Report on Form&#160;10&#8209;Q.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to &#8220;Aquestive,&#8221; the "Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Aquestive Therapeutics, Inc.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_112"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. The worldwide leader in delivering trusted, quality medications on oral film, Aquestive operates as both a developer of its own proprietary products and a Contract Development and Manufacturing Organization (CDMO) for licensees, with its headquarters in New Jersey and U.S.-based manufacturing facilities in Indiana. The Company is the exclusive manufacturer of four commercialized products marketed by its licensees across six continents using proprietary, best-in-class technologies like PharmFilm</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">. Aquestive's AdrenaVerse&#8482; platform contains a library of more than 20 epinephrine prodrugs enabling the pursuit of various potential allergy and dermatological indications. The Company is advancing Anaphylm&#8482; (dibutepinephrine) sublingual film for the treatment of severe allergic reactions, including anaphylaxis, and AQST-108 (epinephrine) topical gel for various potential dermatological conditions, including alopecia areata, atopic dermatitis, rosacea, and psoriasis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture licensed products at our facilities and anticipate that our current manufacturing capacity is sufficient for commercial quantities of our licensed products and product candidates currently in development. Our facilities have been inspected by the FDA, TGA, and DEA, and are subject to inspection by all applicable health agencies, including ANVISA and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">EMA. Not all collaborative or licensed products of the Company that may be commercially launched in the future will necessarily be manufactured by us.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complex Molecule Portfolio</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have developed a proprietary pipeline of complex molecule-based product candidates as alternatives to invasively administered standard of care therapeutics addressing large market opportunities. The active programs in our complex molecule pipeline portfolio are:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Anaphylm&#8482;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (dibutepinephrine) sublingual film &#8211; the first and only non-device based, orally delivered epinephrine prodrug product candidate in development that has shown clinical results comparable to auto-injectors (such as EpiPen</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and Auvi-Q</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) for the emergency treatment of allergic reactions, including anaphylaxis. Epinephrine is the standard of care in the treatment of anaphylaxis and is typically administered via intramuscular injection, including manual auto-injectors such as EpiPen and Auvi-Q, which require patients or their caregivers to inject epinephrine into the patient&#8217;s thigh during an emergency allergic reaction. As a result of this route of administration, many patients and their caregivers are reluctant to use injectable products. In August 2024, a nasal spray device was approved by the FDA for the treatment of severe allergic reactions, including anaphylaxis. However, Anaphylm would, if approved by the FDA, allow a patient to simply place a dissolvable strip, approximately the size and weight of a postage stamp, under the tongue, providing an appropriate medication where it is needed and when it is needed.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Regulatory Updates</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We completed the Anaphylm NDA submission to the FDA in the first quarter of 2025. On June 13, 2025, the NDA submission was accepted by the FDA and a PDUFA target action date of January 31, 2026 was assigned. The Company was informed in September 2025 that the FDA would not hold an Advisory Committee meeting regarding the approval of Anaphylm. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On January 30, 2026, the Company received a CRL that focused on administration and labeling guidance. The FDA cited deficiencies in the Anaphylm HF validation study. These included instances of difficulty opening the pouch and incorrect film placement which, if unaddressed, the FDA believes could cause significant safety issues in the setting of anaphylaxis. To resolve the FDA&#8217;s concerns, the Company has modified the pouch opening, instructions for use, pouch and carton labeling, and plans to conduct a new HF validation study with these modifications. The Company also plans to further address potential tolerability issues in its resubmission of the NDA. Clinical trial results submitted as part of the NDA regarding comparability to approved auto-injectors (such as EpiPen and Auvi-Q), such as bracketing, repeat dose, and sustainability, were not questioned in the CRL. In addition, there were also no CMC issues noted in the CRL. Due to the requirements related to the Anaphylm HF study, the FDA's clinical pharmacology division requested a single PK study to understand the impact of any modifications to packaging and labeling.  No additional studies were requested in the CRL. The Company plans to closely work with the Agency to achieve approval for Anaphylm as expeditiously as possible. As an initial step, the Company requested a Type A meeting with the FDA to discuss the most efficient path forward for resubmission. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 30, 2026, the Company announced the receipt of preliminary comments and completion of an in-person Type A meeting with the FDA regarding the resubmission of the Company's NDA for Anaphylm.  The Company continues to plan for resubmission of the NDA in the third quarter of 2026, subject to completion of the HF and PK studies and expected typical response times from the FDA. The Company plans to request accelerated review of the resubmission by the FDA, but no expedited review by the FDA can be guaranteed. </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company is concurrently pursuing regulatory strategies outside the United States. Based on feedback from regulatory agencies, the Company remains expects to submit regulatory applications in Canada, the European Union and United Kingdom by utilizing its existing clinical data.  In addition, the Company submitted its initial Pediatric Investigational Plan (PIP) to the European Medicines Agency (EMA), an important step in preparing for full submission of the Company's Market Authorization Application for the European Union.  The Company expects to file its New Drug Submission in Canada in 2026. The Company believes that these markets represent important opportunities to expand access to the Company's non-invasive epinephrine therapy globally.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Development of Anaphylm</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the original Anaphylm NDA submission is supported by a comprehensive clinical development program consisting of eleven independent clinical studies with approximately 967 total administrations across 411 subjects, including 840 single-dose and 127 repeat-dose exposures of Anaphylm. As part of the clinical development program, Aquestive conducted a first-of-its-kind oral allergy syndrome study, which demonstrated Anaphylm's performance in a real-world, allergen-induced setting. The program demonstrated that Anaphylm delivers a PK profile comparable to the leading epinephrine auto-injectors. These studies showed that Anaphylm was generally well-tolerated and had a safety profile similar to that of epinephrine.   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2022, following a Phase 1 clinical study conducted by the Company outside of the U.S., the FDA cleared our IND for Anaphylm, allowing for clinical investigation of Anaphylm in the U.S. The FDA confirmed that the 505(b)(2) regulatory approval pathway is acceptable for the development of Anaphylm. The FDA granted Fast Track designation of Anaphylm in March 2022.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Throughout 2022 and 2023, we reported positive topline data from several clinical studies evaluating multiple oral film formulations and dosage strengths of Anaphylm in healthy adult subjects, including cross over studies comparing the PK and PD of epinephrine delivered via Anaphylm compared to current standards of care, EpiPen</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and IM injectors. These studies demonstrated that treatment with Anaphylm was well tolerated, with no serious adverse events, significant medical events, or treatment-related severe adverse events reported. The data from these clinical studies formed the basis for the EOP2 meeting with the FDA in December of 2022, which provided clarity as to the FDA&#8217;s expectations regarding key clinical program areas for design of revised dosing instructions expected for use in our pivotal clinical trial.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2023, we received comments from the FDA on the protocol for our pivotal clinical study for Anaphylm, which comments indicated that our proposed endpoints, sample size, and statistical analysis for the proposed pivotal clinical study were reasonable and provided clarity on PK sustainability with repeat-dose requirements. We incorporated the FDA&#8217;s feedback into the pivotal clinical study design, which study commenced in in the fourth quarter of 2023.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In January 2024, we completed a Type C meeting with the FDA in which the FDA found that we had adequately addressed the FDA&#8217;s previous concerns noted in the EOP2 meeting, including addressing (1) the impact of any product hold time, (2) the potential for emesis (vomiting), and (3) the impact of potential mouth conditions such as angioedema (swelling), by removing product hold time from the administration instructions and providing additional information on how to characterize emesis in our NDA submission with the FDA. Regarding mouth conditions, the FDA recommended administering Anaphylm after oral exposure to a known allergen and assessing PK performance thereunder. This study replaced our previously planned angioedema study. In those comments, the FDA did not outline any new clinical development requirements for the Anaphylm program. The FDA reserved judgment on the sufficiency of the Anaphylm clinical development program until completion of ongoing and planned studies, the results of which were presented at a pre-NDA interaction with the FDA on November 22, 2024.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, we released topline data from our pivotal clinical study for Anaphylm. The two-part, Phase 3, single-center, open-label, randomized study was designed to compare the PK and PD of single and repeat doses of Anaphylm versus single and repeat doses of the IM injection and epinephrine autoinjectors (EpiPen</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and Auvi-Q</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) in healthy adult subjects. The results of this study demonstrated that the primary endpoint, epinephrine PK biocomparability of the single administration of Anaphylm to the single administration of Adrenalin (epinephrine IM injection) and epinephrine autoinjectors in healthy adult subjects was met. The study also met its secondary endpoints, which included evaluating the PK sustainability of Anaphylm following repeat administration, as well as its safety and tolerability of Anaphylm following single and repeat administrations versus epinephrine IM injection and epinephrine autoinjectors.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">n June 2024, we reported positive topline PK data from the Company's temperature / pH study of Anaphylm. The single-dose, five-period, randomized crossover study was designed to compare the PK and PD of Anaphylm just after consuming normal water at different temperatures (hot, cold, and room temperature) as well as water of different pHs (acidic- lemon water, and basic- baking soda water). The most consumed beverages, such as soda, milk, coffee, and juice, have acidity between lemon water and normal water. The primary PK parameters were the maximum amount of epinephrine measured in plasma (Cmax) and exposure, or the area under the curve (AUC), at predefined time points after dosing, in 30 healthy adult subjects. Topline PK and PD data from the study showed no statistically significant difference in PK and PD results between the different groups based on temperature and pH variability in the mouth.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, we reported positive topline data from the self-administration PK study of Anaphylm. The single-dose, three-period, randomized crossover study was designed to compare the PK and PD of Anaphylm self-administered, Anaphylm HCP-administered, and Adrenalin IM injection HCP-administered. The primary PK parameters were the Cmax and the AUC exposures, at predefined time points after dosing in 36 healthy adult subjects. The median time to maximum concentration (Tmax) was 15 minutes for both the Anaphylm self-administered and HCP-administered arms, while the median Tmax for the Adrenalin IM injection HCP-administered arm was 50 minutes post-administration. Also, there was no statistical difference between the Anaphylm self-administered and HCP- administered arms of the study based on a comparison of epinephrine exposures across the first 60 minutes post-administration. Topline PD data from the study showed no difference in the median increase in systolic blood pressure, diastolic blood pressure, and heart rate whether Anaphylm was self-administered or HCP-administered.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, we reported positive topline data from an oral allergy syndrome challenge study (now referred to as the "OASIS" study), meeting both primary and secondary endpoints. The two-part study demonstrated that Anaphylm's PK and PD profile during allergen-induced oral physiological changes was consistent with its profile without an allergen challenge. In addition, following allergen exposure where 94% of subjects exhibited moderate to severe symptoms per the predefined oral severity score, rapid symptom resolution was observed beginning as early as 2 minutes post-administration. The median time to complete symptom resolution was 12 minutes compared to 74 minutes at screening baseline, with 50% of all symptoms across all subjects resolving by 5 minutes. The mean time of symptom resolution for edema, which affected approximately 25% of subjects, was 5 minutes after Anaphylm administration. The PK profile remained consistent, with median Tmax maintained at 12 minutes and comparable Cmax values between allergen-exposed and non-exposed cohorts. The safety profile was favorable, with all adverse events classified as mild to moderate and resolving without medical intervention. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Also in October 2024, at the American College of Allergy, Asthma and Immunology 2024 Annual Meeting, we presented results from a subsequent analysis of our pivotal study data demonstrating Anaphylm's consistent PK and PD profile regardless of variable placement or intraoral movement. The analysis showed that 87.5% of subjects maintained consistent film placement during disintegration. In the 12.5% of subjects where movement was noted, there were no significant differences in Cmax and Tmax. These findings further demonstrate that initial placement or subsequent movement of the sublingual film had no impact on epinephrine PK or PD comparability to epinephrine autoinjectors.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 22, 2024, we received positive pre-NDA written response feedback from the FDA prior to our planned NDA submission in the first quarter of 2025. The FDA did not indicate in those responses that any additional adult clinical trials would be necessary for submitting the NDA for Anaphylm. In addition, the FDA agreed with our planned NDA content and format for the submission, planned safety evaluation, and planned pediatric trial. The FDA also provided further guidance on additional data views to be included in the planned NDA submission and continued to emphasize its focus on PK sustainability for a single dose. In addition, the FDA requested minor modifications to the pediatric trial protocol, which requested modifications were incorporated in the final pediatric trial protocol. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The pediatric study in subjects from the ages of 7 to 17 (weight greater than or equal to 30 kgs) was completed with positive topline data reported on April 1, 2025. A total of thirty-two patients completed the study. The PK results were consistent with previous adult studies. Anaphylm was shown to be safe and well-tolerated with no serious adverse events reported in this pediatric study. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">AQST-108 </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(epinephrine) topical gel &#8211; Our product candidate, AQST&#8209;108, is generated from our AdrenaVerse&#8482;  platform which contains a library of over twenty epinephrine prodrugs intended to control absorption and conversion rates across a variety of possible dosage forms and delivery sites. Epinephrine plays a critical role in immune suppression but, until now, its role has been limited due to issues in the absorption and conversion of epinephrine in the human body. We believe that our AdrenaVerse epinephrine prodrug platform has demonstrated the ability to harness the therapeutic potential of epinephrine through highly differentiated prodrug formulations, which are designed to achieve absorption, provide sustained local exposure and avoid systemic exposure.  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">AQST&#8209;108 is a topically delivered adrenergic agonist prodrug, which we believe has the potential to support the re-establishment of immune privilege in the hair follicle and we are pursuing its development for the possible treatment of alopecia areata, which is an autoimmune disease leading to hair loss on the scalp, face and, in more severe cases, other body areas. We completed the first human clinical trial for AQST-108 in 2024. The two-part trial was designed to assess the safety and local tolerability of AQST-108. Part 1 was designed as a single ascending dose escalation study to assess the safety and PK of five different dose levels. The 1.0% dose of AQST-108 was chosen based on the down selection from the highest dose to move into the Part 2 study of the development program. In Part 2, three formulations based on excipient variations were evaluated in twelve healthy subjects. In Parts 1 and 2, no serious adverse events or topical adverse events were observed. In Part 2, the calculated percentage of AQST-108 observed in the skin remained consistent across all studied formulations and zero post-dose AQST-108 concentrations in plasma were observed. We opened an IND for this product candidate in the fourth quarter of 2025. </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company recently completed its second phase 1 clinical trial, which was designed to further characterize the safety, tolerability, and pharmacologic profile of the topical epinephrine prodrug gel. There were no drug related adverse events observed in the study and the data did not indicate signs of systemic absorption. In addition, Aquestive identified a biomarker signal through the suppression of the cytokine Thymic Stromal Lymphopoietin (TSLP) when compared to placebo. The TSLP signaling pathway involves the activation of Janus Kinase (JAK) 1 and JAK2. This signal will be explored further in upcoming studies. We continue to believe AQST-108 has potential application across a variety of  dermatological conditions, including alopecia areata, atopic dermatitis, rosacea, and psoriasis. We plan to further study AQST-108 by utilizing an atopic dermatitis study design in the upcoming months. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proprietary CNS Product</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We believe the application of our proprietary PharmFilm</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> technology is particularly valuable and relevant to patients suffering from certain CNS disorders to meet patients&#8217; unmet medical needs and to solve patients&#8217; therapeutic problems. Our most advanced asset within our proprietary CNS portfolio, focused in epilepsy, is as follows:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a buccally, or inside of the cheek, administered soluble film formulation of diazepam, Libervant was developed as an alternative to device-dependent rescue therapies currently available to patients with refractory epilepsy, which are a rectal gel and nasal sprays. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 26, 2024, the FDA approved Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (diazepam) buccal film for U.S. market access for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, seizure clusters, ARS) that are distinct from a patient&#8217;s usual seizure pattern in patients with epilepsy between two to five years of age. Libervant is the first and only orally administered rescue product for the treatment of seizure cluster in patients between ages two to five. The only other current FDA approved products for these ARS patients between two to five years of age is a diazepam rectal gel and a diazepam nasal spray. In October 2024, Libervant 5mg, 7.5mg, 10mg, 12.5mg and 15 mg for ARS patients between two and five years of age became available through multiple retail distribution channels.  In the fourth quarter of 2024, the FDA granted seven years of ODE to Libervant for ARS patients between two to five years of age. Libervant was originally granted Orphan Drug Designation on November 10, 2016. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2025, in a lawsuit brought by Neurelis, the owner of the FDA approved nasal spray Valtoco, against the FDA (Neurelis, Inc. v. Califf, for which the Company joined as a Defendant Intervenor) challenging the FDA's approval of Libervant for ARS patients aged between two and five years, the U.S. District for the District of Columbia issued a final appealable order entering a judgment in favor of Neurelis's motion for summary judgment and vacating the FDA&#8217;s approval of Libervant. The District Court's ruling was not based on grounds of safety or efficacy of Libervant, but rather on the grounds that the law granting ODE to the FDA approved nasal spray Valtoco for patients aged six years and older should be interpreted to extend to children aged two to five years, despite that Valtoco was not approved by the FDA to treat these younger patients at the time the FDA approved Libervant for this pediatric age group. The FDA is appealing this ruling. As a result of the District Court ruling, the FDA converted the approval of Libervant for patients aged between two and five years to a "tentative approval" and Aquestive has ceased marketing activities for Libervant in the United States.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2025, Aquestive filed a request with the FDA that the FDA also confirm approval of Libervant for ARS patients aged between two and five years on the FDA regulatory grounds of clinical superiority over the other currently existing FDA approved ARS drugs. FDA&#8217;s orphan drug regulations define a &#8220;clinically superior&#8221; drug as &#8220;a drug shown to provide a significant therapeutic advantage over and above that provided by an approved orphan drug (that is otherwise the same drug)&#8221; in one of three ways: the basis of greater efficacy or safety, or providing a major contribution to patient care.  The FDA has taken this request under advisement and has not yet provided a response to the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the FDA approval of Libervant for ARS patients between two to five years, the FDA granted tentative approval in August 2022 for Libervant for the same indication in patients with epilepsy 12 years of age and older, finding that Libervant had met all required quality, safety, and efficacy standards for approval. However, due to the existing FDA regulatory grant of ODE for Valtoco for use in ARS patients 6 years of age and older, the FDA determined that Libervant was not yet eligible for marketing in the United States for this patient population of 12 years of age and older. We expect to file for FDA approval for use of Libervant for these ARS patients aged between 6 and 11 years in Q2 2026. However, as a result of the ODE granted by the FDA to Valtoco and the District Court's ruling, the FDA cannot give final approval for U.S. market access for Libervant for any age group until the expiration of the ODE or a determination by the FDA of inapplicability of the ODE for Libervant, unless the District Court's ruling vacating the FDA approval of Libervant for ARS patients aged between two and five years is overturned on appeal.  In the event that the District Court's ruling is reversed without further right of appeal, and the tentative approval of Libervant for ARS patients aged between two and five is converted to a final approval by the FDA, the Company would only be able to market Libervant for ARS patients aged between two and five years and would continue to be restricted from market access of Libervant for older ARS patients until the expiration of the ODE for Valtoco. However, overcoming the orphan drug marketing exclusivity determination is difficult to establish, with limited precedent, and there can be no assurance that the FDA will agree with our position seeking to overcome such market exclusivity and approve Libervant for U.S. market access for any age group earlier than January 2027, the scheduled date for expiration of ODE for Valtoco. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensed Commercial Products, Product Candidates and Other Products &#8211; Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a discussion of the licensing arrangement for Libervant.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Licensed Commercial Products, Product Candidates and Other Products</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio also includes other products and product candidates that we have licensed, or will seek to license, or for which we have licensed our intellectual property for commercialization. In the three months ended March&#160;31, 2026 and 2025, our licensed product portfolio generated $14,446 and $8,720 in revenue to Aquestive, respectively. Those products include:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Suboxone</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a sublingual film formulation of buprenorphine and naloxone, respectively an opioid agonist and antagonist, that is marketed in the United States and internationally for the treatment of opioid dependence. Suboxone was launched by our licensee, Indivior, in 2010. Suboxone is the most prescribed branded product in its category and was the first sublingual film product for the treatment of opioid dependence. We are the sole and exclusive supplier and manufacturer of Suboxone and have produced over 3.0&#160;billion doses of Suboxone since its launch in 2010. As of March&#160;31, 2026, Suboxone branded products retain approximately 25% film market share as generic film-based products have penetrated this market.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Emylif</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; an oral film formulation of riluzole, has been developed by Aquestive for the treatment of ALS. We believe that Emylif can bring meaningful assistance to patients who are diagnosed with ALS and face difficulties swallowing traditional forms of medication. This product was originally approved and marketed in the U.S. under the name Exservan. Exservan was approved by the FDA on November 22, 2019. We submitted a request for voluntary withdrawal of the NDA as the product is no longer marketed in the U.S. and the NDA was officially withdrawn on February 14, 2025. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2019, we announced the grant of a license to Zambon for the development and commercialization of Exservan in the EU for the treatment of ALS which it markets as Emylif. Zambon is a multinational pharmaceutical company with a focus on the CNS therapeutic area. Under the terms of the license agreement with Zambon, an upfront payment was paid to Aquestive for the development and commercialization rights of Emylif in the EU, and Aquestive will be paid development and sales milestone payments and low double-digit royalties on net sales of the product in the EU. Zambon is responsible for the regulatory approval and marketing of Emylif in the countries where Zambon seeks to market the product and Aquestive is responsible for the development and manufacture of the product.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Ondif</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; an oral soluble film formulation of ondansetron, a 5-HT antagonist, was developed for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. Ondansetron is available as branded and generic products as intravenous injections, intramuscular injections, orally dissolving tablets, oral solution tablets, and film. We licensed commercial rights for this product to Hypera in Brazil (which Hypera markets as Ondif). Hypera received approval to market Ondif in Brazil from ANVISA on February 21, 2022. Aquestive manufactures and supplies Ondif to Hypera. This product was originally approved and marketed in the U.S. under the name Zuplenz&#174;. We submitted a request for voluntary withdrawal of the NDA for Zuplenz, as the product is no longer marketed in the U.S. In November 2024, the request for FDA withdrawal of the NDA for Zuplenz was completed.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We entered into the Pharmanovia Agreement with Pharmanovia, effective as of September 26, 2022, pursuant to which we granted Pharmanovia an exclusive license to certain of our intellectual property to develop and commercialize Libervant for the treatment of prolonged or acute, convulsive seizures in all ages in certain countries of the Territory, as defined in the Pharmanovia Agreement, during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and Aquestive will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. We received $3,500 upon agreement execution. Effective March 27, 2023, we amended the Pharmanovia Agreement to expand the scope of the licensed territory for Libervant to cover the rest of the world, excluding the U.S., Canada and China. Pharmanovia will be responsible for seeking appropriate regulatory approval in the expanded territories. Pursuant to the terms of the Pharmanovia Amendment No. 1, we received a non-refundable payment of $2,000 from Pharmanovia on execution of the Pharmanovia Amendment No. 1.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Sympazan</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut syndrome, or LGS, in patients aged two years of age or older, was approved by the FDA on November 1, 2018. We commercially launched Sympazan in December 2018. On October 26, 2022, we entered into a License Agreement with Otter Pharmaceuticals, LLC, a subsidiary of Assertio Holdings, Inc., pursuant to which we granted an exclusive, worldwide license of its intellectual property for Sympazan to Assertio during the term of that agreement for an upfront payment of $9,000. Additionally, we subsequently received from Assertio a $6,000 milestone payment upon its receipt of a notice of allowance from the United States Patent and Trademark Office of its patent application U.S. Serial No. 16/561,573, and payment of the related allowance fee. Aquestive is the exclusive sole manufacturer and supplier of Sympazan for Assertio and will receive manufacturing fees from Assertio for the product through the expiration of such License Agreement. On April 8, 2026 Assertio entered into an Asset Purchase Agreement with Cosette to divest a portfolio of products, including Sympazan, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to Cosette. Under the Asset Purchase Agreement, Assertio assigned and transferred its rights and certain obligations arising post closing relating to Sympazan to Cosette. Cosette assumed the intellectual property license and rights to commercialize Sympazan and will continue to purchase product and pay royalties and make milestone-related payments to Aquestive under the Assertio Agreement.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">KYNMOBI</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; a sublingual film formulation of apomorphine, which is a dopamine agonist, was developed to treat episodic off-periods in Parkinson&#8217;s disease. We licensed our intellectual property to Cynapsus Therapeutics, Inc., a company that was acquired by Sunovion for the commercialization of KYNMOBI under the Sunovion License Agreement. KYNMOBI was approved by the FDA on May 21, 2020 and commercially launched by Sunovion in September 2020. On November 3, 2020, we entered into the Monetization Agreement. Under the terms of the Monetization Agreement, we sold all of our contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Azstarys</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">an FDA-approved, once-daily product for the treatment of ADHD in patients age 6 years or older. AZSTARYS consists of serdexmethylphenidate, a prodrug of d-methylphenidate (d-MPH), co-formulated with immediate release d-MPH. In March 2012, we entered into an agreement with Zevra (formerly KemPharm, Inc.) to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, we have the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys. On March 2, 2021, Zevra announced FDA approval of Azstarys for the treatment of ADHD. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the March 2012 agreement with Zevra, we began to receive milestone and royalty revenues for Azstarys. In March 2026, Zevra sold Azstarys to Commave Therapeutics SA. See  Note 6, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to our Condensed Financial Statements for additional information.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_115"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">                                                                                                                                                                                                                                                                                                  Critical Accounting Policies and Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies and use of estimates as previously disclosed in our 2025 Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Smaller Reporting Company</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a &#8220;smaller reporting company&#8221;, meaning we are not an investment company, an asset-backed issuer, or a majority-owned subsidiary of a parent company that is not a "smaller reporting company" which allows us to take advantage of certain exemptions from disclosure requirements including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and certain reduced financial disclosures in our periodic reports. In addition, we are eligible to remain a smaller reporting company, for so long as we have a public float (based on our Common Stock equity) of less than $250,000 measured as of the last business day of our most recently completed second fiscal quarter or a public float (based on our Common Stock equity) of less than $700,000 as of such date and annual revenues of less than $100,000 during the most recently completed fiscal year. We cannot predict if investors will find our Common Stock less attractive because we may rely on these exemptions. If some investors find our Common Stock less attractive as a result of these disclosure exemptions, there may be a less active trading market for our Common Stock and our stock price may be more volatile.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_118"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations Overview</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues to date have been earned from our manufactured products made to order for licensees, as well as revenue from our self-developed, self-commercialized proprietary product, Libervant for ARS patients between two and five years of age which lost U.S. market access as a result of a court case challenging FDA's approval of Libervant in April 2025.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> R</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">evenues are also earned from our product development services provided under contracts with customers, and from the licensing of our intellectual property. We generate revenues in four primary categories: manufacture and supply revenue, license and royalty revenue, co-development and research fees, and proprietary product revenue, net.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and Supply Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture based on receipt of purchase orders from our licensees, and our licensees have an obligation to accept these orders once quality assurance validates the quality of the manufactured product with agreed upon technical specifications. In most cases, our licensees are responsible for all other aspects of commercialization of these products, and we have no role, either direct or indirect, in our customers&#8217; commercialization activities, including those related to marketing, pricing, sales, payor access and regulatory operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect future manufacture and supply revenue from licensed products to be based on volume demand for existing licensed products, and for manufacturing and supply rights under license and supply agreements for existing or new agreements for successful product development collaborations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We realize revenue from licenses of our intellectual property. For licenses that do not require further development or other ongoing activities by us, our licensee has acquired the right to use the licensed intellectual property for self-development of their product candidate, for manufacturing, commercialization or other specified purposes, upon the effective transfer of those rights, and related revenues are generally recorded at a point in time, subject to contingencies or constraints, if any. For licenses that may provide substantial value only in conjunction with other performance obligations to be provided by us, such as development services or the manufacture of specific products, revenues are generally recorded over the term of the license agreement. We also earn royalties based on our licensees&#8217; sales of products that use our intellectual property that are marketed and sold in the countries where we have patented technology rights.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research Fees</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of our R&amp;D projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones contained in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for ARS patients between two to five years of age while Libervant had U.S. market access through April 2025, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Once receivables are collected, allowances are reclassified and treated as accrued liabilities. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once related variable considerations are resolved and uncertainties as to incurred amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted as needed on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs and Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our costs and expenses are primarily the result of the following activities: generation of manufacture and supply revenues; development of our pipeline of proprietary product candidates; and selling, general and administrative expenses, including pre-launch and post-launch commercialization efforts, intellectual property procurement, protection, prosecution and litigation expenses, corporate management functions, medical and clinical affairs administration; public company costs, share-based compensation expenses and interest on our corporate borrowings. We primarily record our costs and expenses in the following categories:</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and Supply Costs and Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply costs and expenses are primarily incurred from the manufacture of our commercialized licensed pharmaceutical products, including raw materials, direct labor and overhead costs principally in our Portage, Indiana facilities. Our material costs include the costs of raw materials used in the production of our proprietary dissolving film and primary packaging materials. Direct labor costs consist of payroll costs (including taxes and benefits) of employees engaged in production activities. Overhead costs principally consist of indirect payroll, facilities rent, utilities and depreciation for leasehold improvements and production machinery and equipment. These costs can increase, or decrease, based on the costs of materials, purchased at market pricing, and the amount of direct labor required to produce a product, along with the allocation of fixed overhead, which is dependent on production volume.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacture and supply costs and expenses are impacted by our customers&#8217; supply requirements. Costs of production reflect the costs of raw materials that are purchased at market prices and production efficiency (measured by the cost of a salable unit). These costs can increase or decrease based on the amount of direct labor and materials required to produce a product and the allocation of fixed overhead, which is dependent on the levels of production.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our proprietary products coming online, we may add licensee products which may need additional resources to manufacture. If such growth should occur for higher volume product opportunities such as Suboxone</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and Ondif</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, we would incur increased costs associated with hiring additional personnel to support the increased manufacturing and supply costs arising from higher manufactured volumes from proprietary and licensed products.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have focused significant resources on our R&amp;D activities. R&amp;D expenses primarily consist of:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee-related expenses, including compensation, benefits, share-based compensation and travel expense;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">external R&amp;D expenses incurred under arrangements with third parties, such as CROs, investigational sites and consultants;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of acquiring, developing and manufacturing clinical study materials; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with preclinical and clinical activities and regulatory operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect our R&amp;D expenses to continue to be significant over the next several years as we continue to develop existing product candidates such as Anaphylm, AQST-108, and others, and as we identify and develop or acquire additional product candidates and technologies. We may hire or engage additional skilled colleagues or third parties to perform these activities, conduct clinical trials and ultimately seek regulatory approvals for any product candidate that successfully completes those clinical trials.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selling, General and Administrative expenses consist primarily of salaries, benefits, share-based compensation, other related costs for executive, finance, and operational personnel. Other costs include facility and related costs not otherwise included in R&amp;D expenses such as: professional fees for patent-related expenses and for other legal expenses, legal expenditures, regulatory fees, consulting, tax and accounting services, insurance, market research, advisory board and key opinion leaders, depreciation, and general corporate expenses, inclusive of IT systems related costs. In addition, these expenses also include warehousing, distribution, selling and business development, and other costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative costs include costs related to accounting, audit, legal, regulatory, and tax-related services required to maintain compliance with exchange listing and SEC regulations, director and officer insurance costs, and investor and public relations costs. We continue to incur significant costs in seeking to protect our intellectual property rights, including significant litigation costs in connection with seeking to enforce our rights concerning third parties&#8217; at-risk launch of generic products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to manage business costs to prepare for a potential future decline in Suboxone</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> revenue and other external factors affecting our business. We continue to focus on our core business as well as regulatory and pre-commercial launch activities for Anaphylm.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists of interest costs on the outstanding balances of our 13.5% Notes at a fixed rate of 13.5%, payable quarterly, amortization of the discount associated with the long-term portion of the legal settlement as well as amortization of issuance costs and debt discounts. The issuance of 13.5% Notes is discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, to our Condensed Financial Statements. See </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> below for further detail on our 13.5% Notes.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense related to Royalty Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 13.5% Notes, we entered into the Royalty Rights Agreements with each of the Note Holders granting the Note Holders a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm (dibutepinephrine) sublingual film for a period of eight years from the first sale of Anaphylm on a global basis. The Note Holders are also entitled to a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. These royalty agreements are classified as debt, and the value of the $45,000 13.5% Notes has been allocated between debt and the Royalty Obligations based on their relative fair market values. The excess of future estimated royalty payments over the allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method. The 13.5% Notes are discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to our Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense related to the Sale of Future Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, we entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, we sold to Marathon all of our contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, an apomorphine film </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">therapy for the treatment of off episodes in Parkinson&#8217;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, we received an upfront payment from Marathon of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. We have received an aggregate amount of $50,000 through March&#160;31, 2026 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to us upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. In June 2023, Sunovion announced that it has voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets, therefore, we likely will not receive any of the additional contingent payments under the Monetization agreement. We discontinued recording interest expense related to the sale of future revenue under the Monetization agreement in the fourth quarter of 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, we recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the $1,000 annual minimum guaranteed royalty that is due in each of the subsequent eight years. In connection with the Monetization Agreement, we performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Financial Statements for further detail.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income and other income, net</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest income and other income, net consists of earnings derived from interest-bearing accounts, money market Treasury mutual funds, and other miscellaneous income and expense items. These interest-bearing accounts have no minimum amounts to be maintained in the accounts for which interest and dividends are earned.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_121"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2026 and 2025</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our revenue data for the periods indicated.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.373%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.776%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<br/>Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except %)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2026</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Compared to Three Months Ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2025</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2026, total revenues increased 66%, or $5,726, compared to the same period in the prior year primarily due to increases in license and royalty revenue and increases in manufacture and supply revenue.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply revenue increased approximately 22%, or $1,600, for the three months ended March&#160;31, 2026 compared to the same period in the prior year. This increase was primarily due to higher Suboxone revenues of approximately $2,600, partially offset by lower Ondif revenues of approximately $1,500. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">License and royalty revenue increased 583%, or $4,605, for the three months ended March&#160;31, 2026 compared to the same period in the prior year. This increase was primarily due to the recognition of royalty revenue from Zevra.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Co-development and research fees decreased 38%, or $160, for the three months ended March&#160;31, 2026 compared to the same period in the prior year. This decrease was driven by the timing of the achievement of research and co-development performance obligations which are expected to fluctuate among reporting periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary product revenue, net decreased by $319 for the three months ended March&#160;31, 2026 compared to the same period in the prior year. This decrease was primarily due to the withdrawal of Libervant from the market as U.S. market access ended in April 2025.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expenses, Interest Income and Other Income:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our expenses and income for the periods indicated.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.666%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.922%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except %)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,095)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to royalty obligations</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to the sale of future revenue</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income and other income, net</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2026</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Compared to Three Months Ended </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2025</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply costs and expenses decreased 5%, or $183, for the three months ended March&#160;31, 2026 compared to the same period in the prior year. The decrease in manufacture and supply costs was due to changes in product mix.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased 22% or $1,157 for the three months ended March&#160;31, 2026 compared to the same period in the prior year. The decrease in Research and development expenses is primarily due to lower clinical trial costs associated with the Anaphylm program, partially offset by increases in R&amp;D personnel costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The tables below provide a breakdown of the major costs included in total R&amp;D expenses and project costs by type of expense for each of the main clinical development projects in which we are engaged for each period presented:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(876)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Development and Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Product Research Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(51</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Project Expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(55</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D personnel costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Consulting and outside services</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(70</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation/amortization</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">All other R&amp;D</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,204&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,157)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The details of the project expenses are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.755%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Anaphylm</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AQST-108</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Trials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(42%)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(65)%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">209%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Development and Manufacturing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(75)%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Product Research Expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(51%)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(51%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Project Expenses</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,683&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(39%)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(56%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">186%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Total project expenses for Anaphylm decreased 56%, or $1,403 over the comparable period in 2025. Anaphylm clinical trial expenses and product research expenses decreased by $1,251 and $291, respectively. Total project expenses for AQST-108 increased $363, over the comparable period in 2025. AQST-108 clinical trial expenses increased $375 over the comparable period in 2025 due to the second Phase 1 clinical trial in the current period.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses decreased 42%, or $8,095 for the three months ended March&#160;31, 2026 as compared to the same period in the prior year. The decrease primarily represents the one-time Anaphylm PDUFA fee of $4,310 in the prior year period, lower legal fees of approximately $3,400, lower commercial spending of approximately $2,000, and lower regulatory and licensing fees of approximately $500 related to the regulatory fee for Libervant, partially offset by higher severance costs of approximately $600 which includes the acceleration of share-based compensation, higher personnel costs of approximately $500 and higher share-based compensation expenses of approximately $500.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $2,903 and $2,782 for the three months ended March&#160;31, 2026 and 2025, respectively. These amounts represent interest incurred on the outstanding 13.5% Notes, amortization of the debt and legal settlement discounts and capitalized debt issuance costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to amortization of the discount on the royalty obligations was $973 and $1,437 for the three months ended March&#160;31, 2026 and 2025, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These amounts are due to the accounting associated with the royalty obligations as part of the 13.5% Notes issuance. The decrease from the comparable period is due to a lower effective interest rate as a result from the update to the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">probability-weighted cash flows for future sales as of December 31 2025.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the sale of future revenue was $60 and $59 for the three months ended March&#160;31, 2026 and 2025, respectively, and represents amortization of the issuance costs. These amounts are due to the accounting associated with the sale of future revenue related to KYNMOBI royalties sold to Marathon on November 3, 2020 and do not represent or imply a monetary obligation or cash outflow at any time during the life of the transaction. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. As a result, the Company discontinued recording interest expense related to the sale of future revenue in the fourth quarter of 2022. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Financial Statements for details. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interest income and other income, net decreased 88%, or $630 for the three months ended March&#160;31, 2026 as compared to the same period in the prior year. The decrease from the comparable period is primarily due to the expenses associated with the issuance of the RTW Warrants recognized within other expenses during the current period.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_133"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We had $110,734 in cash and cash equivalents as of March&#160;31, 2026. While our ability to execute our business objectives and achieve profitability over the longer term cannot be assured, our on-going business, existing cash and cash equivalents, expense management activities, potential asset sales or product outlicensing as well as access to the equity capital markets, including through the ATM facility, provide near term liquidity for us to fund our operating needs for at least the next twelve months as we continue to execute our business strategy.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We established our first ATM facility in September 2019, and since inception to March&#160;31, 2026, we have sold 28,506,216 shares of Common Stock which has generated net cash proceeds of approximately $86,563, net of commissions and estimated other transactions costs of $4,142. On April 3, 2024, we filed a new shelf registration statement on Form S-3 to register the offer and sale of up to $250,000 worth of shares of Common Stock, preferred stock, debt securities, warrants, rights and units ("Registration Statement No. 333-278498" or the "2024 Registration Statement"), that was effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement was a $100,000 ATM facility prospectus covering the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">offering, issuance and sale of Common Stock pursuant to the Amended Equity Distribution Agreement with Piper Sandler &amp; Co.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2026, the Company sold 1,191,071 shares of Common Stock under the ATM facility, which provided net proceeds of approximately $4,810 after deducting commissions and estimated other transaction costs of $252.  For the three months ended March 31, 2025, the Company sold 7,457,627 shares under the ATM facility which provided net proceeds of approximately $21,306 after deducting commissions and other transaction costs of $694. The remaining authorized balance of the ATM facility was approximately $73,000 as of March&#160;31, 2026.. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, we entered into the Letter Agreement with the Exercising Holder of 5,000,000 of the remaining Common Stock Warrants pursuant to the Securities Purchase Agreement dated June 6, 2022. Pursuant to the Letter Agreement, the Exercising Holder and Aquestive agreed that the Exercising Holder would exercise all of its Existing Warrants at the then current exercise price of the Existing Warrants. The Exercising Holder subsequently exercised the Existing Warrants, with Aquestive receiving gross proceeds of $4,800. We also issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock. The New Warrants are exercisable after February 2, 2024, expire on February 2, 2029 and are exercisable only for cash, unless the shares of Common Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case the New Warrants may also be exercised by means of a "cashless exercise". The New Warrants have an exercise price of $2.60 per share. During 2025, 550,000 shares were issued upon the exercise of the New Warrants with the Company receiving proceeds of $1,430.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, we issued $45,000 aggregate principal amount of its 13.5% Notes due November 1, 2028. A portion of the net proceeds from that offering was used to repay all of the outstanding 12.5% Notes and to pay expenses relating to that offering, with the balance of the proceeds to be used for general corporate purposes. Interest on the 13.5% Notes accrues at a rate of 13.5% per annum and is payable quarterly in arrears on March 30, June 30, September 30 and December 30 of each year commencing on December 30, 2023. The 13.5% Notes are interest-only until June 30, 2026, whereupon on such date and each payment date thereafter we will also pay an installment of principal of the 13.5% Notes pursuant to a fixed amortization schedule, along with a portion of an Exit Fee determined as of the applicable date of prepayment, payment, acceleration, repurchase or redemption, as the case may be. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2025, we entered into a purchase and sale agreement with funds managed by RTW Investments LP. Under the terms of the Purchase Agreement, in exchange for the Purchaser's payment to the Company of a purchase price of $75,000, upon approval of Anaphylm by the FDA by a specified date, the refinancing of the Company&#8217;s existing 13.5% Notes and certain other customary conditions, the Company agreed to a sale of assigned interests to the Purchaser, including a right for the Purchaser to tiered revenue share payments ranging from 1.0% to 7.5% of net sales (as defined in the Purchase Agreement) of Anaphylm (and 9.5% for the subsequent calendar year period if net sales do not achieve specified level in a calendar year period beginning in 2027) in the United States. Revenue share payments commence in the first fiscal quarter in which the first commercial sale of Anaphylm in the United States after the closing of the transaction. Revenue share payments will cease upon the Purchaser's receipt of $187,500 by December 31, 2035 or $225,000 thereafter. The Purchase Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company&#8217;s ability to, among other things, incur indebtedness (which restrictions are eliminated after the achievement by the Purchaser of a specified return on its investment), and other provisions customary for transactions of this nature, in each case subject to certain exceptions set forth in the Purchase Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2025, we completed the 2025 Underwritten Public Offering of 21,250,000 shares of our common stock at the public offering price of $4.00 per share. Net proceeds from the 2025 Underwritten Public Offering were $79,900, after deducting underwriting discounts of $5,100. In addition to the underwriting discounts related to this offering, we incurred professional fees and other costs totaling $440.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, in connection with the Amendment No.1 to the Purchase and Sale Agreement and the Equity Commitment Agreement with RTW, the Company also entered into the Warrant Issuance Agreement with the RTW investors. Pursuant to this agreement, the Company issued to the RTW Investors the RTW Warrant to purchase up to an aggregate of 375,000 shares of the Company's Common Stock at an exercise price of $4.00 per share. The Warrant is exercisable at any time from the issuance date through March 3, 2029. For additional information regarding the RTW Warrants. See Note 14, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to the accompanying Condensed Financial Statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2026, the Company entered into a five-year term loan facility of up to $150,000 with funds managed by Oaktree Capital Management, L.P, consisting of a term loan in an aggregate principal amount of $55,000 which was funded on May 12, 2026 and was used by the Company to repay the Company&#8217;s existing 13.5% Notes in the aggregate principal amount of $45,000 plus fees associated with the repayment. See Note 21, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to the accompanying Condensed Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2026 and 2025</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for operating activities</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,806)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(23,400)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(10,435)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,889)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net cash used for operating activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for operating activities for the three months ended March&#160;31, 2026 decreased by $8,594 compared to the same period in the prior year.&#160;The decrease in cash used for operating activities was primarily related to the decrease in net loss by $14,873, decreases in trade and other receivables by $14,025 due to timing of payments by customers and receipts related to the confidential legal settlement partially offset by decreases in payables by $19,878 mostly attributed to payments made under the confidential legal settlement and to vendors. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net cash used for investing activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities for the three months ended March&#160;31, 2026 decreased by $83 compared to the same period in the prior year. The use of cash was related to capital expenditures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by financing activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the three months ended March&#160;31, 2026 decreased by $16,223 compared to the same period in the prior year. The decrease was primarily related to lower ATM proceeds of $16,601 due to lower volumes of Common Stock sold.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our on-going business, existing cash and equivalents, expense management activities as well as access to the equity capital markets, including through our ATM facility, and potential asset sales or product outlicensing potentially provide near term funding opportunities for Aquestive, see &#8220;Liquidity and Capital Resources&#8221;. On November 1, 2023, we issued $45,000 in aggregate principal amount of the 13.5% Notes due November 1, 2028.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have used and intend to continue to use our existing cash and cash equivalents, primarily to advance the development and commercialization of our product pipeline and for working capital, capital expenditures and general corporate purposes. We can provide no assurance that any sources of funding, either individually or in combination, will be available on reasonable terms, if at all, or sufficient to fund our business objectives. In addition, we may be required to utilize available financial resources sooner than expected. We have based our expectation on assumptions that could change or prove to be inaccurate, due to unrelated factors including factors arising in the capital markets, asset monetization markets, regulatory approval process, and regulatory oversight and other factors. Key factors and assumptions inherent in our planned continued operations and anticipated growth include, without limitation, those related to the following:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued ability of our customers to pay, in a timely manner, for presently contracted and future anticipated orders for our manufactured products, including effects of generics and other competitive pressures as currently envisioned;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval of Anaphylm by the FDA;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued ability of our customers to pay, in a timely manner, for presently contracted and future anticipated orders for provided co-development and feasibility services, as well as regulatory support services for recently licensed products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">access to debt or equity markets if, and at the time, needed for any necessary future funding, including our ability to access funding through our ATM facility, should we choose to access this facility;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing review and appropriate adjustment of our cost structure consistent with our anticipated revenues and funding;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued growth and market penetration of Sympazan, including anticipated patient and physician acceptance and our licensee&#8217;s ability to obtain adequate reimbursement and payment support from government agencies and other private medical insurers;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">infrastructure and administrative costs at expected levels to support operations as an FDA and highly regulated public company;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a manageable level of costs for ongoing efforts to protect our intellectual property rights and litigation matters in which we are involved; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">absence of significant unforeseen cash requirements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to manage business costs to appropriately reflect the anticipated general decline in Suboxone revenue, and other external resources or factors affecting our business including, if available, future equity financing, other future access to the capital markets or other potential available sources of liquidity. In doing so, we plan to continue to focus on the core drivers of value for our stockholders, including, more importantly, continued investments in our ongoing product development activities in support of Anaphylm and AQST-108. Until profitability is achieved, if at all, additional capital and/or other financing or funding will be required, which could be material, to develop and commercialize our product pipeline, including AQST-108, and to fund additional development and commercial activities that are required by the FDA for Anaphylm under the CRL issued to the Company on January 30, 2026, and to meet our other cash requirements, including debt service. Even as such, we expect to incur losses and negative cash flows for the foreseeable future and, therefore, we expect to be dependent upon external financing and funding to achieve our operating plan.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The sufficiency of our short-term and longer-term liquidity is directly impacted by our level of operating revenues and our ability to achieve our operating plan for revenues, regulatory approval in the time period planned for our product candidates and licensed rights within planned timeframes, and there can be no assurance that we will be successful in any transaction. Our operating revenues have fluctuated in the past and can be expected to fluctuate in the future. We expect to incur significant operating losses and negative operating cash flows for the foreseeable future, and we have a significant level of debt, substantial ongoing interest payments, and royalty obligation payments projected to be made through 2035, which are further discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Financial Statements. A substantial portion of our current and past revenues has been dependent upon our licensing, manufacturing and sales with one customer, Indivior, which is expected to continue, and it could take significantly longer than planned to achieve anticipated levels of cash flows to help fund our operations and cash needs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are currently engaging in plans to commercialize Anaphylm through our own sales force in the United States, should Anaphylm be approved by the FDA. We will need to raise significant funding to support the continued commercialization of Anaphylm over the long-term, in addition to the funds we may receive under the Purchase Agreement and the funds we received in the 2025 Underwritten Public Offering. To the extent such additional financing through debt or debt-like instruments is required, we may have increased repayment obligations and potential limits on our flexibility to raise additional debt. To the extent that we raise additional funds by issuance of equity securities, our stockholders would experience further dilution, and the terms of these securities could include liquidation or other preferences (if and to the extent permitted under the Indenture Agreement) that would adversely affect our stockholders&#8217; rights. Our ability to secure additional equity financing could be significantly impacted by numerous factors including our operating performance and prospects, positive or negative developments in the regulatory approval process for our product candidates, our existing level of debt which is secured by substantially all of our assets under the Indenture Agreement, and general financial market conditions, and there can be no assurance that we will continue to be successful in raising capital or that any such needed financing will be available on favorable or acceptable terms, if at all.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If adequate funds are not available for our short-term or longer-term liquidity needs and cash requirements as and when needed, we would be required to engage in expense management activities such as reducing staff, delaying, significantly scaling back, or even discontinuing some or all of our current or planned launch activities, R&amp;D programs and clinical and other product development activities, and otherwise significantly reducing our other spending and adjusting our operating plan, and we would need to seek to take other steps intended to improve our liquidity. We also may seek outlicensing opportunities for our proprietary products and product candidate programs that we may self-commercialize, including for Libervant and Anaphylm, or explore other potential liquidity options or strategic opportunities. Such strategic opportunities could include asset sales, outlicensing or other monetization opportunities of our proprietary products and product candidates, including Libervant and Anaphylm, although we cannot assure that any of these actions or opportunities would be available or available on acceptable terms. While an outlicensing of our proprietary products and product candidates, if approved by the FDA, could limit our exposure to the costs of commercialization of the product and provide a potential source of royalty and milestone revenues, the benefit from the potential future value that could result from our independent commercialization of these products and product candidates, assuming a successful launch of our proprietary products and product candidates, if approved by the FDA, would likely be limited. In addition, in the event of any such asset sales or outlicensing transactions, the future growth of the Company would be dependent on continued successful development of our early stage product candidates and/or asset acquisitions or other strategic transactions for the Company. There is no assurance that any such outlicensing or other strategic opportunities will be available or available on reasonable terms. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the period presented, we did not have any material off-balance sheet arrangements, nor do we have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_142"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;smaller reporting company&#8221; as defined by Item 10 of Regulation S-K promulgated by the SEC under the U.S. Securities Act of 1933, as amended, we are not required to provide the information required by this Item 3.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_145"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Evaluation of our Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and (2) accumulated and communicated to our management, including to our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(b) and 13a-15(e) under the Exchange Act). Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.&#160;Our principal executive officer and principal financial officer have concluded based upon the evaluation described above that, as of March&#160;31, 2026, our disclosure controls and procedures were effective at a reasonable assurance level.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act), identified in connection with the evaluation of such internal control that occurred during our last fiscal quarter, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_151"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For more information on Legal Proceedings, see Part I Item I. Financial Statements (Unaudited), Note 20, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_154"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information set forth in this report, you should carefully review and consider the information regarding certain risks and uncertainties facing the Company that could have a material adverse effect on our business prospects, financial condition, results of operations, liquidity and available capital resources set forth in Part I, Item 1A of Aquestive&#8217;s 2025 Annual Report on Form 10-K.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to manufacture API for our licensed products and product candidates, and we intend to rely on third parties to manufacture the API for other approved products. The commercialization of any of our licensed products and product candidates, if approved, could be stopped, delayed or made less profitable if those third parties fail to provide us with sufficient quantities of API or fail to do so at acceptable quality levels or prices or fail to maintain or achieve satisfactory regulatory compliance.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely, and expect to continue to rely, on third parties to manufacture API for our licensed products and our product candidates, and control only certain aspects of their activities.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any of these third parties may terminate their engagements with us at any time. If we need to enter into alternative arrangements, it could delay our supply of licensed products, proprietary product candidate programs and commercialization activities. Our reliance on these third parties reduces our control over these activities but does not relieve us of our responsibility to ensure compliance with all required legal, regulatory and scientific standards and any applicable trial protocols or our obligations under our product supply commitments and obligations. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we will not be able to complete, or may be delayed in completing, clinical trials required to support future regulatory submissions and approval of our product candidates and we would likely be in default in our supply commitments and obligations for our licensed products, which could result in the termination of our supply agreements, our incurring potential default damages and our loss of significant revenues.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The facilities used by us, and by our third-party API manufacturers, to manufacture our licensed products and product candidates must maintain a compliance status acceptable to the FDA or other applicable regulatory authorities pursuant to inspections that will be conducted after we submit our NDA to the FDA. If we or any of our third-party API manufacturers cannot successfully manufacture material that conforms to our specifications and the applicable regulatory authorities&#8217; strict regulatory requirements, or pass regulatory inspection, we or they will not be able to secure or maintain regulatory approval for the manufacturing facilities. In addition, we have no control over the ability of third-party API manufacturers to maintain adequate quality control, quality assurance and qualified personnel. Further, as we scale up manufacturing of our product candidates and conduct required stability testing, product, packaging, equipment and process-related issues may require refinement or resolution in order for us to proceed with our planned clinical trials and obtain regulatory approval for commercialization of our product candidates. In the future, for example, we may identify impurities in the product manufactured by us or for us for commercial supply, which could result in increased scrutiny by the regulatory agencies, delays in our clinical program and regulatory approval, increases in our operating expenses, or failure to obtain or maintain approval for our licensed products and product candidates. If the FDA or any other applicable regulatory authority does not approve these facilities for the manufacture of our products or if they withdraw any such approval in the future, or if our suppliers or third-party manufacturers decide they no longer want to manufacture our products, we would need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidates and which could also result in default in our supply commitments and obligations for our licensed products, our incurring potential default damages and our loss of significant revenues.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">More generally, we and our API manufacturers of pharmaceutical products, may often encounter difficulties in production, particularly in scaling up and validating initial production. These problems include difficulties with production costs and yields, quality control, including stability of the product, quality assurance testing, shortages of qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. Additionally, we and our API manufacturers may experience manufacturing difficulties due to resource constraints or as a result of labor disputes or unstable political environments, such as recent events in Ukraine and Russia, the Israel and Gaza armed conflict, the war with Iran or other geopolitical uncertainty. If we or our manufacturers were to encounter any of these difficulties, or otherwise fail to comply with their contractual obligations, our ability to manufacture our products, or to make our product candidates available for clinical trials and development purposes or to further commercialize any of our licensed products and product candidates in the United States, would be jeopardized. Any delay or interruption in our ability to meet commercial demand may result in the loss of significant potential revenues and could adversely affect our ability to gain market acceptance for approved products as well as a potential default of our supply commitments or obligations. In addition, any delay or interruption in the supply of clinical trial supplies could delay the completion of clinical trials, increase the costs associated with maintaining clinical trial programs and, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">depending upon the period of delay, require us to commence new clinical trials at additional expense or terminate clinical trials completely. Additionally, if supply from one approved API manufacturer is interrupted, there could be a significant disruption in commercial supply. Regulatory agencies may also require additional studies if a new manufacturer is relied upon for commercial production. Switching manufacturers may involve substantial costs and would likely result in a delay in our desired clinical and commercial timelines and disrupt our supply commitment and obligations.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any of these factors could have a material adverse effect on our business, results of operations, financial condition and prospects.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_157"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_160"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_163"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_166"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-832"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-833"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-834"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-835">Other Information</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i65b3f6374bb0418bacd030f2ff357555_172"></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed below are filed or furnished as part of this report.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.773%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1398733/000139873326000016/formofaquestive2026warra.htm">4.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Form of Warrant (filed as Exhibit 4.1 to the Current Report on Form 8-K of the Company, as filed on March 4, 2026, and incorporated by reference herein).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1398733/000139873326000016/amdno1rtw-aqstxfeb2026ex.htm">10.1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to the Purchase and Sale Agreement, dated August 13, 2025, by and between the Company and funds managed by RTW Investments, LP, dated March 3, 2026 (filed as Exhibit 10.1 to the Current Report on Form 8-K of the Company, as filed on March 4, 2026, and incorporated by reference herein).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1398733/000139873326000016/warrantissuanceagreement.htm">10.2</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Warrant Issuance Agreement, by and between the Company and funds managed by RTW Investments, LP, dated March 3, 2026 (filed as Exhibit 10.2 to the Current Report on Form 8-K of the Company, as filed on March 4, 2026, and incorporated by reference herein).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1398733/000139873326000016/equitycommitmentagreemen.htm">10.3</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share Purchase Commitment Agreement, by and between the Company and the parties thereto, dated March 3, 2026 (filed as Exhibit 10.3 to the Current Report on Form 8-K of the Company, as filed on March 4, 2026, and incorporated by reference herein).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ljb_terminationxemployme.htm">10.4</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Termination of Executive Employment  Agreement dated as of March 16, 2026, by and between Aquestive Therapeutics, Inc. and Lori J. Braender. </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ljb_employmentxageementx.htm">10.5</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Executive Employment Agreement dated as of March 16, 2026, by and between Aquestive Therapeutics, Inc. and Lori J. Braender.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12026ex311.htm">31.1</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12026ex312.htm">31.2</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12026ex321.htm">32.1</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q12026ex322.htm">32.2</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL document and contained in exhibit 101)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">*    Filed herewith.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i65b3f6374bb0418bacd030f2ff357555_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i65b3f6374bb0418bacd030f2ff357555_7">Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the County of Somerset, State of New Jersey.</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.096%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive Therapeutics, Inc.<br/>(REGISTRANT)</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel Barber</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Barber</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ A. Ernest Toth, Jr.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">A. Ernest Toth, Jr.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>2
<FILENAME>ljb_terminationxemployme.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ljb_terminationxemployme</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ljb_terminationxemployme001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_terminationxemployme001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">TERMINATION OF EXECUTIVE EMPLOYMENT AGREEMENT    This Termination of Executive Employment Agreement (the &#8220;Agreement&#8221;) is made and entered  into as of this 16th day of March, 2026 (the &#8220;Effective Date&#8221;) by and between Aquestive Therapeutics, Inc.  (the &#8220;Company&#8221;) and Lori J. Braender (the &#8220;Executive&#8221;).    WITNESSETH:    WHEREAS, Executive has served the Company since September 10, 2018 and is the current Chief  Legal Officer, Chief Compliance Officer and Corporate Secretary of the Company; and     WHEREAS, the Company and Executive wish to terminate the current Executive Employment  Agreement dated as of September 10, 2018 between the Company and Executive (the &#8220;2018 Employment  Agreement&#8221;) on the terms and conditions set forth in this Agreement effective as of May 7, 2026 (the  &#8220;Termination Date&#8221;); and    WHEREAS, the Company wishes to engage Executive to serve, and Executive wishes to serve,  the Company, solely as the Corporate Secretary of the Company in accordance with the terms and  conditions of an agreement to be entered into between the Company and Executive effective as of the  Termination Date;    NOW, THEREFORE, in consideration of the premises and the mutual covenants herein set forth,  and for other good and valuable consideration (the receipt and sufficiency of which are hereby  acknowledged), the parties hereto, intending to be legally bound, hereby agree as follows:    1. Termination of 2018 Employment Agreement/Employment.     A. Termination of 2018 Employment Agreement. The Company and Executive agree to  terminate the 2018 Employment Agreement effective as of the Termination Date (the &#8220;Termination&#8221;) upon  the terms and conditions set forth in this Agreement.     B. Payment and Other Consideration. Upon the Termination, the Company shall pay or  provide to Executive, and Executive shall be entitled to, and shall, receive the payments and benefits  described in Section 6(D) of the 2018 Employment Agreement in accordance with the terms set forth therein  except that: (i) all outstanding stock options, stock appreciation rights, performance stock units, restricted  stock, restricted stock units, and other equity-based compensation awards that are or become vested under  Section 6(D) of the 2018 Employment Agreement upon the termination of the 2018 Employment  Agreement pursuant to the terms of this Agreement (the &#8220;Vested Awards&#8221;) shall be exercisable (if  applicable) for at least five (5) years year after the date of Executive&#8217;s termination of employment as  Corporate Secretary of the Company after the Effective Date or, if earlier, until the expiration of the stated  term of the applicable award; and (ii) the benefit continuation period described in Section 6(D)(v) of the  2018 Employment Agreement shall commence on and continue for at least twelve (12) months after the  date of Executive&#8217;s termination of employment as Corporate Secretary of the Company after the Effective  Date. For clarity, other than the exceptions set forth in this Section 1(B), all of the terms of Section 6(D) of  the 2018 Employment Agreement shall remain in full force and effect and be enforceable by the parties to  this Agreement after the Termination.    C. Severance Protection. In lieu of the payments and benefits described in Section 6(E) of the  2018 Employment Agreement in connection with a Change of Control (as defined in the 2018 Employment  Agreement) such payments and benefits shall be due and payable upon the termination of Executive&#8217;s  employment as Corporate Secretary of the Company after the Effective Date under Section 5(E) or Section  Docusign Envelope ID: 6CE029AB-0202-49AB-9957-A56246CE5403 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_terminationxemployme002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_terminationxemployme002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2    5(F), as applicable, in accordance with the terms and conditions set forth in Section 6(E) of the 2018  Employment Agreement; provided, however, that such payments shall be calculated at the rate of  Executive&#8217;s Base Salary and Target Annual Bonus in effect as of the Termination (in each case determined  without regard to any reduction prior to the Termination) and the benefit continuation period described in  Section 6(D)(v) of the 2018 Employment Agreement shall commence on the date of termination of  Executive's employment as the Corporate Secretary of the Company after the Effective Date and expire  twelve (12) months from such date of termination.    2. Executive&#8217;s Employment as Corporate Secretary. Notwithstanding anything to the contrary  contained in the 2018 Executive Employment Agreement or otherwise, the Company and Executive agree  that the Company and Executive shall have the right to enter into an agreement to employ Executive as the  Corporate Secretary of the Company after the Effective Date on terms and conditions mutually acceptable  to the Company and Executive and such employment or the terms and conditions of any agreement of such  employment between the Company and Executive shall have no effect on or amend or modify the respective  obligations and rights of the Company and Executive under, or the terms and conditions of, this Agreement  or the 2018 Employment Agreement except as the terms and conditions of the 2018 Employment  Agreement are expressly amended and modified as set forth in this Agreement.    3. Venue; Jurisdiction. The validity, construction, interpretation, and enforceability of this  Agreement shall be determined and governed by the laws (procedural and substantive) of the State of New  Jersey without giving effect to the principles of conflicts of law. For the purpose of litigating any dispute  that arises under this Agreement, the parties hereby consent to exclusive jurisdiction of, and agree that such  litigation shall be conducted in, any state or federal court located in the State of New Jersey.    4. Binding Effect; Assignment. Executive shall not, without the prior written consent of the  Company, assign, transfer, or otherwise convey this Agreement, or any right or interest herein. This  Agreement, and all rights and obligations of the Company or any of its successors, may be assigned or  otherwise transferred to any of its successors and shall be binding upon and inure to the benefit of its  successors. As used herein, the term &#8220;successor&#8221; shall mean any person, corporation or other entity that, by  merger, consolidation, purchase of stock, assets, liquidation, voluntary or involuntary assignment, or  otherwise, acquires all or a substantial part of the assets of the Company or succeeds to one or more lines  of business of the Company.    5. Entire Agreement. This Agreement constitutes the entire agreement between the parties  hereto with respect to the subject matter hereof and supersedes all prior agreements, understandings and  arrangements, both oral and written, between the parties hereto with respect to such subject matter, it being  understood that this Agreement shall expressly supersede any employment agreement between Executive  and the Company, and any amendments thereto. This Agreement may not be modified, amended, altered or  rescinded in any manner, except by written instrument signed by all of the parties hereto; provided, however,  that any waiver by either party with respect to any provision hereof, or the breach of any provision hereof  by the other party, need be signed only by the party waiving such provision or breach; and provided, further,  that the waiver by either party hereto of a breach or compliance with any provision of this Agreement shall  not operate nor be construed as a waiver of any subsequent breach or compliance.       Docusign Envelope ID: 6CE029AB-0202-49AB-9957-A56246CE5403 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_terminationxemployme003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_terminationxemployme003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3    6. Severability. In case any one or more of the provisions of this Agreement shall be held by  any court of competent jurisdiction to be illegal, invalid or unenforceable in any respect, the remainder of  this Agreement, or the application of such provision to persons or circumstances other than those to which  it is held to be illegal, invalid, or unenforceable, shall not be affected thereby.    7. Section Headings. The section headings contained in this Agreement are for reference  purposes only and shall not affect in any manner the meaning or interpretation of this Agreement.    8. Counterparts. This Agreement may be executed in any number of counterparts, each of  which shall be deemed an original, but all of which taken together shall constitute one and the same  instrument.    9. Survival. The provisions of Sections 1(B), 1(C),and 2 through and including 9 of this  Agreement shall survive any termination of this Agreement    IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of  the day and year first above written.    EXECUTIVE    ______________________________________  Lori J. Braender    AQUESTIVE THERAPEUTICS, INC.     By:  ___________________________________  Daniel Barber, President and CEO    Docusign Envelope ID: 6CE029AB-0202-49AB-9957-A56246CE5403 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>3
<FILENAME>ljb_employmentxageementx.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ljb_employmentxageementx</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ljb_employmentxageementx001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">EXECUTIVE EMPLOYMENT AGREEMENT    This Executive Employment Agreement (this &#8220;Agreement&#8221;) is made and entered into as of this 16th  day of March, 2026 (the &#8220;Effective Date&#8221;) by and between Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;)  and Lori J. Braender (&#8220;Executive&#8221;).    WITNESSETH:    WHEREAS, Executive has served the Company since September 10, 2018 as the Chief Legal  Officer, Chief Compliance Officer and Corporate Secretary of the Company; and     WHEREAS, the Company and Executive have agreed to terminate the current Executive  Employment Agreement dated as of September 10, 2018 between the Company and Executive (the &#8220;2018  Employment Agreement&#8221;) effective as of May 7, 2026 (the &#8220;Termination Date&#8221;); and    WHEREAS, the Company wishes to engage Executive to serve, and Executive wishes to serve,  the Company solely as the Corporate Secretary of the Company in accordance with the terms and conditions  of this Agreement effective as of the Termination Date;    NOW, THEREFORE, in consideration of the premises and the mutual covenants herein set forth,  and for other good and valuable consideration (the receipt and sufficiency of which are hereby  acknowledged), the parties hereto, intending to be legally bound, hereby agree as follows:    1. Employment of Executive as Corporate Secretary. During the Employment Term (as  hereinafter defined), Executive agrees to be employed by and to serve the Company as its Corporate  Secretary, and the Company agrees to employ and retain Executive in such capacity, in accordance with the  terms and conditions of this Agreement. During the Employment Term, Executive shall report directly to  the Chief Executive Officer of the Company (the &#8220;CEO&#8221;). The Company and Executive acknowledge that  the role of Executive under this Agreement in the capacity of Corporate Secretary of the Company shall be  a full time role until May 7, 2026 in order to assist the Company in the transition of Executive&#8217;s successor  in the role of Chief Legal Officer and Chief Compliance Offer. During the Employment Term after May 7,  2026, the Company and Executive acknowledge and agree that the role of Executive as Corporate Secretary  of the Company shall be a part time role. Executive agrees to devote a sufficient amount of time to provide  strategic and administrative support to the Board of Directors of the Company (the &#8220;Board&#8221;), its  committees, and senior leadership in its interactions with the Board, consistent with the Board calendar and  regulatory cycles of the Company. Executive shall (i) faithfully, loyally, and industriously perform all duties  incident to the position of Corporate Secretary, as well as any other duties consistent with the stature,  responsibility and time commitment of Executive's position as Corporate Secretary and as may from time  to time be assigned by the CEO consistent therewith, and (ii) comply with the Company&#8217;s policies in effect  from time to time. Notwithstanding any provision herein to the contrary, Executive shall not be precluded  from devoting reasonable periods of time required for serving as a member of one or more advisory boards  or boards of directors of companies or organizations or engaging in other business activities, so long as  such memberships or activities do not interfere with the performance of Executive's duties hereunder and  are not directly or indirectly competitive with, nor contrary to, the business or other interests of the  Company, subject to prior approval by the CEO.    2. Employment Term. The term of this Agreement shall begin effective as of April 2, 2026  and continue until December 31, 2026 unless earlier terminated in accordance with the terms of this  Agreement (the &#8220;Initial Employment Term&#8221;). The Company and Executive may mutually agree in writing  to renew the term of this Agreement for consecutive additional periods (the &#8220;Renewal Terms&#8221; and, along  Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2    with the Initial Employment Term, collectively referred to in this Agreement as the &#8220;Employment Term&#8221;),  on terms and conditions mutually acceptable to the Company and Executive.    3. Base Salary. On and after May 7, 2026, , the Company shall pay Executive a base salary  (the &#8220;Base Salary&#8221;) at a rate of $15,000.00 per month, payable in accordance with the standard payroll  practices of the Company. The Board will review Executive's Base Salary at least annually and, with  recommendations from the CEO, may increase but not decrease the then current base salary rate.    4. Additional Benefits.    A. Executive Benefits. During the Employment Term, Executive shall be eligible to  participate in such employee benefit plans as are generally available to other senior executives of the  Company.    B. Expense Reimbursement. The Company will pay or reimburse Executive for reasonable  expenses incurred by Executive in connection with the performance of Executive&#8217;s duties and  responsibilities under this Agreement, subject to presentation of vouchers and compliance with generally  applicable business expense reimbursement policies of the Company.    5. Termination.    A. Termination for Cause. The Company may terminate Executive's employment for &#8220;Cause&#8221;  if Executive:    &#8226; is convicted of or pleads nolo contendre to a felony (or its equivalent under applicable state  law);    &#8226; commits fraud or a material act or omission involving dishonesty with respect to the  Company or any of its respective employees, customers or affiliates;    &#8226; willfully and repeatedly fails or refuses to carry out the material responsibilities of  Executive's employment by the Company (except where due to physical or mental incapacity);    &#8226; engages in willful misconduct or a pattern of behavior which in either case has had or is  reasonably likely to have a significant adverse effect on the Company;    &#8226; willfully engages in any act or omission which is in material violation of the Company&#8217;s  policies, including but not limited to engaging in insider trading transactions or disseminating  inside information; or    &#8226; commits a material breach of Executive's material obligations under this Agreement,  including but not limited to Section 8 of this Agreement.    A decision to terminate Executive's employment for Cause shall be made, if at all, by the CEO,  after consultation with the Board, upon reasonable notice to Executive and an opportunity for Executive,  together with counsel, to be heard by the CEO, and the CEO finding that, in his good faith opinion,  Executive engaged in conduct set forth above and specifying the particulars thereof in reasonable detail. If  the act or omission giving rise to the termination for Cause is curable by Executive, the Company will  provide thirty (30) days&#8217; written notice to Executive of the Company&#8217;s intent to terminate Executive for  Cause, with an explanation of the reason(s) for the termination for Cause and, if Executive cures the act or  omission within the 30-day notice period, the Company will rescind the notice of termination and  Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3    Executive's employment will not be terminated for Cause at the end of the 30-day notice period. If  Executive has previously been afforded the opportunity to cure particular behavior and successfully cured  under this provision, the Company will have no obligation to provide Executive with notice and an  opportunity to cure a recurrence of that behavior prior to a termination for Cause. For purposes of this  Section 5(A), an action or inaction shall not be treated as &#8220;willful misconduct&#8221; if authorized by the CEO or  the Board, or taken by Executive in the good faith belief that it was in, or not opposed to, the best interests  of the Company.    B. Termination by Reason of Permanent Disability. In a manner consistent with the Americans  with Disabilities Act and the Family and Medical Leave Act, this Agreement may be terminated at the  Company&#8217;s option immediately upon notice to Executive if Executive shall suffer a Permanent Disability.  For purposes of this Agreement, the term &#8220;Permanent Disability&#8221; shall mean Executive's inability to  perform the essential functions of Executive&#8217;s job under this Agreement, with or without reasonable  accommodation, for a period of 120 consecutive days or for an aggregate of 150 days, whether or not  consecutive, in any twelve (12) month period, due to illness, accident or other physical or mental incapacity,  as determined by a duly licensed physician mutually agreed to by both Executive and the Company.    C. Termination by Reason of Death. In the event of Executive's death, Executive's  employment shall be deemed to have terminated on the date of Executive's death.    D. Voluntary Resignation. Executive may terminate this Agreement at any time, subject to  providing thirty (30) days' written notice to the Company. The Company may waive such notice and/or set  an earlier termination date, without pay in lieu of notice.    E. Termination without Cause. The Company may terminate Executive's employment under  this Agreement at any time without Cause upon thirty (30) days&#8217; prior written notice to Executive. The  Company, at its sole discretion, may relieve Executive of Executive&#8217;s active duties during the notice period.  Executive's termination without Cause will be effective upon the expiration of the 30-day notice period.  For purposes of this Agreement, a termination of employment by the Company that purports to be for Cause,  but is not in full compliance with all of the substantive and procedural requirements relating to a termination  for Cause under this Agreement, shall be treated as a termination of employment without Cause.    F. Termination for Good Reason. Executive may terminate Executive&#8217;s employment under  this Agreement at any time for Good Reason upon the occurrence (or within thirty (30) days following the  occurrence, provided that Executive furnishes the Company with written notice of Executive&#8217;s belief that  grounds for a Good Reason termination by Executive exists no later than ten (10) days after becoming  aware of the occurrence) of any one or more of the following acts or omissions which, if curable, is not  cured within thirty (30) days after notice of the occurrence is provided by Executive: (1) any action by the  Company which results in a material diminution in Executive's position, authority, duties or responsibilities  as Corporate Secretary of the Company (including status, offices, titles and reporting requirements  contemplated by this Agreement); (2) a material breach by the Company of its obligations under this  Agreement, including, without limitation, a reduction of Executive's Base Salary in violation of this  Agreement; or (3) the Company requiring Executive to be based at any office location that is more than  fifty (50) miles from its current headquarters in Warren, New Jersey, except for travel reasonably required  in connection with the performance of Executive's responsibilities hereunder. Notwithstanding the  foregoing, if a &#8220;Change in Control&#8221; (as hereinafter defined) occurs, Executive will not have &#8220;Good Reason&#8221;  to terminate Executive&#8217;s employment under this Agreement merely because Executive reports to a senior  executive officer of a company that acquires the Company.    6. Obligations of the Company Upon Termination.    Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4    A. Termination for Cause/Voluntary Resignation. In the event that Executive's employment  under this Agreement is terminated for Cause by the Company or Executive voluntarily resigns from her  employment under this Agreement, the Company shall have no obligation to pay the Base Salary or any  other compensation provided under this Agreement, to or for the benefit of Executive, for any period after  the effective date of such termination, or to pay any incentive compensation for the fiscal year in which  such termination occurs; provided, however, that the Company shall promptly provide: (i) all Base Salary  earned by Executive through the effective date of such termination, and any unpaid annual bonus earned  by Executive for the year preceding the year in which Executive&#8217;s employment terminates; and (ii) any  benefits under any plans of the Company in which Executive is a participant, consistent with Executive's  (or Executive&#8217;s beneficiaries&#8217;) rights under such plans.    B. Termination Without Cause or for Good Reason, Death or Permanent Disability. In the  event that Executive's employment under this Agreement is terminated by the Company without Cause  (pursuant to Section 5(E)) or due to Executive&#8217;s Permanent Disability, by Executive for Good Reason  (pursuant to Section 5(F)), or due to Executive&#8217;s death, the Company shall, within five (5) business days  following such termination, provide to Executive (or Executive&#8217;s estate or other beneficiaries, as the case  may be): (i) a cash payment consisting of the sum of any previously unpaid Base Salary earned by Executive  through the date on which Executive&#8217;s employment terminates; (ii) any benefits under any plans of the  Company in which Executive is a participant, to the full extent of Executive's (or Executive&#8217;s beneficiaries')  rights under such plans; and (iii) accelerated vesting of any outstanding stock options, restricted stock units  (RSUs), stock appreciation rights (SARs), performance stock units (PSUs), restricted stock and other  equity-based compensation awards to Executive during the Employment Term as if Executive's  employment had continued through the end of the year in which Executive&#8217;s employment terminates or, in  the case of any such award that is subject to &#8220;cliff vesting,&#8221; on a pro rata basis determined by a fraction the  numerator of which is the number of days during such vesting period, and the denominator of which is the  total number of days in the vesting period that have elapsed as of the date Executive&#8217;s employment  terminates. Notwithstanding the immediately preceding sentence, with respect to any unvested stock  options, RSUs, SARs, PSUs, restricted stock and other equity-based compensation that are unvested at the  time of termination of employment under this Section 6(B), and which are subject to a performance  condition or performance period that ends at or after the date of employment termination, such awards will  be assumed to have been achieved at &#8220;target&#8221;, and Executive will be entitled to receive a pro rata share of  such awards, determined by a fraction the numerator of which is the number of days during the performance  period in which Executive was employed, and the denominator of which is the total number of days in the  performance period. Stock options, SARs, RSUs, PSUs, restricted stock and other equity-based  compensation awards that are or become vested upon termination of Executive's employment due to death  or Permanent Disability will be exercisable (if applicable) for at least five (5) years after the date of such  termination or, if earlier, until the expiration of the stated term of the award.    C. 409A Compliance. The Company shall take all reasonable actions to ensure that none of  the amounts earned or payable under this Agreement or under any Company stock purchase, compensation  or other equity incentive plan will violate Section 409A of the Code. To the extent necessary to comply  with the restriction in Section 409A(a)(2)(B) of the Code concerning payments to &#8220;specified employees,&#8221;  any amounts payable on account of Executive's separation from service shall be paid (or commence to be  paid in the case of any payments to be made in installments) on the first business day of the seventh month  following Executive's date of termination (or death, if earlier) and the first such payment shall include the  cumulative amount of any payments that would have been made prior to such date if not for such restriction,  together with interest at an annual rate equal to the minimum rate required by the Code in order to avoid  the imputation of interest on short-term loans between employers and employees. The date of Executive&#8217;s  termination of employment shall be determined in accordance with Treasury Regulation Section 1.409A- 1(h). Except as otherwise provide herein, any payment required as a result of a termination of employment  will be made (or, with respect to any payments to be made in installments under this Agreement,  Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5    commenced) within 45 days following such event. Notwithstanding anything else herein to the contrary, to  the extent that any payments due under the terms of this Agreement are conditioned upon the delivery and  non-revocation of a release, and if any of those payments are determined to be nonqualified deferred  compensation that is subject to the requirements of Section 409A of the Code, and if the period for  consideration and revocation of such release spans two calendar years, then any such payment shall not be  made until the later of (i) the end of the revocation period following delivery of the release, or (ii) the first  business day of the second calendar year.    D. Value of Insurance Coverage During Severance Period. To the extent any medical or dental  plan covering any post-employment period is a &#8220;self-insured medical reimbursement plan&#8221; under Section  105(h) of the Code, and such coverage would be discriminatory thereunder, the value of the insurance  coverage during the post-termination coverage period (based upon premium value) shall be reported as  taxable income to Executive, and the Company shall pay Executive promptly no later than January 15th of  the year of coverage, such additional cash payments as are necessary for Executive to receive the same net  after-tax benefits (taking into account all federal, state and local income, excise and employment taxes) that  Executive would have received under such plans if Executive had continued to receive such plan benefits  while employed with the Company; provided that any such additional cash payment that would be so  immediately paid shall be subject to the provisions of Section 6(C) in connection with compliance with  Section 409A of the Code.    E. No Effect on Termination of 2018 Employment Agreement.  Nothing contained in this  Section 6 or otherwise shall effect, amend or modify any of the severance terms to which Executive is  entitled or the obligations of the Company upon termination of the 2018 Employment Agreement.    7. Section 280G.    A. Notwithstanding any other provision of this Agreement or any other plan, arrangement or  agreement to the contrary, if any of the payments or benefits provided or to be provided by the Company  or its affiliates or subsidiaries to Executive or for Executive's benefit pursuant to the terms of this Agreement  or otherwise, including, without limitation, payments in connection with a Change in Control or the vesting  of shares of restricted stock, RSUs, SARs, PSUs, stock options or other equity awards or other non-cash  benefits or property, whether pursuant to the terms of this Agreement or any other plan, arrangement, or  agreement with the Company or any affiliated company (the &#8220;Total Payments&#8221;) (&#8220;Covered Payments&#8221;)  constitute parachute payments (&#8220;Parachute Payments&#8221;) within the meaning of Section 280G of the Code  and would, but for this Section 7, be subject to the excise tax imposed under Section 4999 of the Code (or  any successor provision thereto) or any similar tax imposed by state or local law or any interest or penalties  with respect to such taxes (collectively, the &#8220;Excise Tax&#8221;), then prior to making the Covered Payments, a  calculation shall be made comparing (i) the Net Benefit (as defined below) to Executive of the Covered  Payments after payment of the Excise Tax to (ii) the Net Benefit to Executive if the Covered Payments are  limited to the extent necessary to avoid being subject to the Excise Tax. If the amount calculated under (i)  above is less than the amount under (ii) above, then the Covered Payments will be reduced or cut back by  the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise  Tax (that amount, the &#8220;Reduced Amount&#8221;). &#8220;Net Benefit&#8221; shall mean the present value of the Covered  Payments net of all federal, state, local, foreign income, employment and excise taxes.    B. Any such reduction shall be made in accordance with Section 409A of the Code and the  following:    (i) the Covered Payments which do not constitute nonqualified deferred  compensation subject to Section 409A of the Code shall be reduced first;  and  Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">6      (ii) all other Covered Payments shall then be reduced as follows: (A) cash payments  shall be reduced before non-cash payments; and (B) payments to be made on a later payment date  shall be reduced before payments to be made on an earlier payment date.    C. Any determination required under this Section 7 shall be made in writing in good faith by  an independent accounting firm selected by the Company (the &#8220;Accountants&#8221;). The Company and  Executive shall provide the Accountants with such information and documents as the Accountants may  reasonably request in order to make a determination under this Section 7. For purposes of making the  calculations and determinations required by this Section 7, the Accountants may rely on reasonable, good  faith assumptions and approximations concerning the application of Section 280G and Section 4999 of the  Code. The Accountants' determinations shall be final and binding on the Company and Executive. The  Company shall be responsible for all fees and expenses incurred by the Accountants in connection with the  calculations required by this Section 7.    D. It is possible that after the determinations and selections made pursuant to this Section 7  Executive will receive Covered Payments that are in the aggregate more than the amount provided for under  this Section 7 (&#8220;Overpayment&#8221;) or less than the amount provided for under this Section 7  (&#8220;Underpayment&#8221;).    (i) In the event that: (A) the Accountants determine, based upon the assertion of a  deficiency by the Internal Revenue Service against either the Company or Executive which the  Accountants believe has a high probability of success, that an Overpayment has been made or (B)  it is established pursuant to a final determination of a court or an Internal Revenue Service  proceeding that has been finally and conclusively resolved that an Overpayment has been made,  then Executive shall pay any such Overpayment to the Company.    (ii) In the event that: (A) the Accountants, based upon controlling precedent or  substantial authority, determine that an Underpayment has occurred or (B) a court of competent  jurisdiction determines that an Underpayment has occurred, any such Underpayment, together with  penalties accruing thereon, if any, plus interest at the applicable federal rate (as defined in Section  7872(f)(2)(A) of the Code) from the date the amount would have otherwise been paid to Executive  until the payment date, will be paid promptly by the Company to or for the benefit of Executive.    E. The Company shall have the right to control all proceedings with the Internal Revenue  Service that may arise in connection with the determination and assessment of any Excise Tax and, at its  sole option, the Company may pursue or forgo any and all administrative appeals, proceedings, hearings,  and conferences with any taxing authority in respect of such Excise Tax (including any interest or penalties  thereon). Executive shall cooperate with the Company in any proceedings relating to the determination and  assessment of any Excise Tax and shall not take any position or action that would materially increase the  amount of any Overpayment or Underpayment.    8. Covenants of Executive. In order to induce the Company to enter into this Agreement and  continue to employ Executive hereunder, Executive hereby covenants and agrees as follows. For all  purposes under this Section 8 herein, references to &#8220;Company&#8221; shall be deemed to include the Company&#8217;s  wholly-owned subsidiaries, if any, and the Company&#8217;s &#8220;business&#8221; shall mean film based delivery systems  to deliver drug actives, nutraceuticals, cosmaceuticals or flavors, and soluble film based packaging systems  and such other lines of business in which the Company or its wholly-owned subsidiaries, if any, is actively  engaged or actively pursuing and with respect to which Executive has oversight responsibility or is  otherwise substantively involved.    Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">7    A. Non-Competition. During the Employment Term, including any extensions thereof (the  &#8220;Restrictive Period&#8221;), except as provided herein, Executive shall not directly or indirectly: (a) engage in or  in any manner be connected or concerned, whether as an officer, director, stockholder, partner, owner,  employee, advisor, creditor, or otherwise with the development, operation, management, or conduct of any  business in the United States that competes with the business of the Company being conducted at the time  of such termination; (b) solicit or otherwise attempt to divert business from or interfere in the Company  relationship with any supplier of the Company or any customer served by the Company or and potential  customer identified by the Company during the period of Executive's employment hereunder; or (c) solicit,  hire or otherwise interfere with the Company relationship with any person then or previously employed by  the Company; provided, however, that, after the termination of Executive's employment, Executive shall  not be bound by the covenants set forth in this subparagraph following a material breach by the Company  of any of its obligations to Executive hereunder or in the event of the cessation or dissolution of the  Company business. As used herein, &#8220;cessation or dissolution&#8221; means total liquidation of the Company and  does not include a cessation of business due to any Change in Control. Nothing contained herein shall  prohibit Executive from owning up to 3% of the stock of a publicly traded company that competes with the  business of the Company or, following the termination of Executive&#8217;s employment with the Company,  prevent Executive from being employed by or otherwise affiliated with a line of business of another  company that engages in multiple lines of business so long as Executive is not employed by, does not  provide services with respect to and is not otherwise involved in the line or lines of business of such other  company that compete with the Company.    B. Confidentiality. During the Employment Term, and following the termination of this  Agreement for any reason for as long as the information remains confidential, Executive shall not make  any use, for Executive&#8217;s own benefit or for the benefit of a business or entity other than the Company, of  any verbal or written secret or confidential information. Such confidential information shall include, but  not be limited to, customer lists, trade secrets, sales, marketing or consignment information, vendor lists or  operational resource information, forms, processes or procedures, budget and financial statements or  information, files, records, documents, compilation of data, engineering drawings, computer print-outs, or  any other data of or pertaining to the Company, its business, customers and financial affairs, or its services  not generally known within the Company&#8217;s trade and which was acquired by Executive during Executive&#8217;s  affiliation with the Company. Executive shall not remove from the Company premises or retain without the  Company&#8217;s written consent any of the Company&#8217;s confidential information as defined herein, or copies  thereof or extracts therefrom. Executive shall hold in a fiduciary capacity for the benefit of the Company  all secret or confidential information, knowledge, or data of the Company or its business or production  operations obtained by Executive during Executive&#8217;s employment by the Company, which shall not be  generally known to the public or recognized as standard practice (whether or not developed by Executive)  and shall not, during Executive&#8217;s employment hereunder or after the termination of such employment,  communicate or divulge any such information, knowledge or data to any person, firm or corporation other  than the Company or persons, firms or corporations designated by the Company. Executive acknowledges  that this information is treated as confidential by the Company, that the Company takes meaningful steps  to protect the confidentiality of this information, and that the Company has at all times directed Executive  to maintain the confidentiality of this information. Immediately upon termination of this Agreement,  Executive shall return all of the Company&#8217;s property to it, including any and all copies of said property.  Notwithstanding this provision or any provision in this Agreement to the contrary, nothing contained in this  Agreement is intended to nor shall it limit or prohibit Executive, or waive any right on her part, to make  any good faith reports to, initiate or engage in communication with, respond to any inquiry from, otherwise  provide information to, participate in any investigation or proceeding that may be conducted by, or obtain  any monetary recovery from, any federal or state regulatory, self-regulatory, or enforcement agency or  authority, as provided for, protected under or warranted by applicable law, in all events without notice to or  consent of the Company.    Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">8    C. Ownership of Work Product. Executive agrees that the Company shall own all intellectual  property including trade secrets, patents, patentable inventions, discoveries and improvements that relate to  the Company&#8217;s business that Executive conceives, develops during the period of Executive&#8217;s employment  with the Company or delivers to the Company while performing services pursuant to this Agreement  (&#8220;Work Product&#8221;). Executive further agrees to deliver to the Company, and that the Company shall  thereafter own for all purposes, all Work Product conceived or developed by Executive relating to the  business of the Company which does not otherwise belong to Employee's former employer or to which the  former employer has no legal right or claim. Executive hereby irrevocably extinguishes for the benefit of  the Company and its assigns any moral right to the Work Product recognized by applicable law. All Work  Product shall be considered a work made for hire by Executive and owned by the Company. If any of the  Work Product may not, by operation of law, be considered work made for hire by Executive for the  Company, or if ownership of all right, title and interest of the intellectual property rights therein shall not  otherwise vest exclusively in the Company, Executive agrees to assign, and upon creation thereof  automatically assign, without further consideration, the ownership of all trade secrets, copyrights,  patentable inventions, and other intellectual property rights therein to the Company, its successors and  assigns. The Company, its successors, and assigns, shall have the right to obtain and hold in its or their own  name copyrights, patents, registrations and any other protection available in the foregoing. For purposes  hereof, a &#8220;trade secret&#8221; shall mean any information, including, but not limited to, technical or nontechnical  data, formulae, patterns, compilations, programs, devices, methods, techniques, drawings. processes,  financial data, financial plans, product plans or lists of actual or potential customers or suppliers that derive  economic value, actual or potential, from not being generally known to, and not being readily ascertainable  by proper means by, other persons who can obtain economic value from their disclosure or use and are the  subject of efforts that are reasonable under the circumstances to maintain their secrecy. Executive agrees to  perform, upon the reasonable request of the Company and at no cost to the Company (other than travel out  of pocket costs where applicable), during or after the period(s) that this Agreement remains in effect, such  further acts as may be necessary or desirable to transfer, perfect and defend the Company&#8217;s ownership of  Work Product, or to enforce the Company&#8217;s Work Product against third parties. When requested, Executive  shall promptly and at no cost to the Company (other than travel out of pocket costs, where applicable): (a)  execute, acknowledge and deliver any requested affidavits and documents of assignment and conveyance;  (b) obtain and aid in the enforcement of copyright and, if applicable, patents with respect to the Work  Product in any countries; (c) provide testimony in connection with any enforcement proceeding or any  proceeding affecting the right, title or interest of the Company in any Work Product; and (d) perform any  other acts deemed necessary or desirable to carry out the purposes of this Agreement.    D. Inventions. All discoveries, designs, improvements, ideas and inventions, whether  patentable or not, relating to (or suggested by or resulting from) products, services, or other technology of  the Company or relating to (or suggested by or resulting from) methods or processes used or usable in  connection with the business of the Company that have been, or may be, conceived, developed or made by  Executive during the Employment Term (hereinafter &#8220;Inventions&#8221;), either solely or jointly with others, shall  automatically become the sole property of the Company. Executive shall immediately disclose to the  Company all such Inventions and shall, without additional compensation, execute all assignments and other  documents deemed necessary by the Company to perfect the Company&#8217;s title thereto, or to the patents  issued thereon, or to otherwise secure and protect the Company&#8217;s property rights therein. These obligations  shall continue beyond the termination of Executive's employment with respect to Inventions conceived,  developed or made by Executive during employment with the Company. The Company acknowledges and  agrees that the provisions of this paragraph shall not apply to any invention for which no equipment,  supplies, facilities or trade secret (or proprietary) information of the Company is used by Executive and  which is developed entirely on Executive's own time, unless (a) such invention related to the business of  the Company or to the Company&#8217;s actual or demonstrably anticipated research or development; or (b) such  invention results from any work performed by Executive for the Company.    Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">9    E. Acknowledgment. Executive acknowledges that all of the restrictions set forth in this  Section entitled &#8220;Covenants of the Executive&#8221; are reasonable in scope, both individually and in the  aggregate, and essential to the preservation of the Company&#8217;s business and proprietary interests and that  the enforcement thereof will not in any manner preclude Executive, in the event of Executive's termination  of employment with the Company for any reason, from becoming gainfully employed in such manner and  to such extent as to provide a standard of living for himself, the members of Executive&#8217;s family, and those  dependent upon Executive of at least the sort and fashion to which Executive and they have become  accustomed and may expect. The Company and Executive further agree that if any particular provision or  portion of this Section 8 shall be adjudicated to be invalid or unenforceable, such adjudication shall apply  only with respect to the operation of such provision in the particular jurisdiction in which such adjudication  is made. The Company and Executive also agree that in the event that any restriction herein shall be found  to be void or unenforceable if some part or parts thereof were deleted or the period or area of application  reduced, such restriction shall apply with such modification as may be necessary to make it valid and  enforceable to the fullest extent possible consonant with applicable law. In addition, pursuant to the Defend  Trade Secrets Act of 2016, the parties acknowledge that (a) an individual may not be held criminally or  civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (i) is made  in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney  and solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a  complaint or other document that is filed under seal in a lawsuit or other proceeding; and (b) an individual  who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose  the employer&#8217;s trade secrets to the attorney and use the trade secret information in the court proceeding if  the individual: (i) files any document containing the trade secret under seal; and (ii) does not disclose the  trade secret, except pursuant to court order.    F. Representations and Warranties. Executive represents and warrants to the Company as  follows: (a) Executive is under no contractual or other restriction or obligation which may conflict with or  be inconsistent with the execution of this Agreement or with the performing of any duties for the Company,  or any other rights of the Company; and (b) neither the Company nor any of its affiliates nor any of their  respective officers, directors, employees, agents or employees has requested that Executive communicate  or otherwise make available to any such parties at any time any proprietary information, data, trade secrets,  or other confidential information belonging to Executive's former employers or others.    G. Severability. All of the covenants of Executive contained in this Section entitled  &#8220;Covenants of the Executive&#8221; shall each be construed as an agreement independent of any other provision  in this Agreement, and the existence of any claim or cause of action of Executive against the Company,  whether predicated on this Agreement or otherwise, shall not constitute a defense to the enforcement by the  Company of such covenants. Both parties hereby expressly agree that it is not the intention of either party  to violate any public policy, statutory or common law. If any sentence, paragraph, clause or combination of  the same of this Agreement is in violation of the law of any state where applicable, such sentence, paragraph,  clause or combination of the same shall be void in the jurisdictions where it is unlawful, and the remainder  of such paragraph and this Agreement shall remain binding on the parties to the extent that it may be  lawfully done under existing applicable laws. In the event that any part of any covenant of this Agreement  is determined by a court of law to be overly broad thereby making the covenant unenforceable, the parties  hereto agree, and it is their desire that such court shall substitute a judicially enforceable limitation in its  place, and that as so modified the covenant shall be binding upon the parties as if originally set forth herein.    H. Remedies. Executive agrees that irreparable harm would result from any breach by  Executive of the covenants of this Section 8 in particular, and this Agreement in general, and that monetary  damages alone would not provide the Company adequate relief for any such breach. Accordingly, if  Executive breaches any covenant in this Section 8, the parties acknowledge that equitable or injunctive  relief in favor of the Company is a proper remedy, and nothing in this Agreement shall be construed as  Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">10    precluding the Company from seeking such equitable or injunctive relief in a court of competent jurisdiction  for Executive's violations of Section 8. Any award of equitable or injunctive relief shall not preclude the  Company from seeking or recovering any lawful compensatory damages that may have resulted from a  breach of the covenants of this Agreement. Any waiver or failure to seek enforcement or remedy for any  breach or suspected breach of any covenant of Executive in this Agreement shall not be deemed a waiver  of such provision in the future. Furthermore, the existence of any claim of Executive against the Company,  whether based upon this Agreement or otherwise, shall not operate as a defense to the Company  enforcement of any provision of this Agreement. Proceedings seeking equitable and injunctive relief to  enforce the terms of this Section 8 may be brought in any court of competent jurisdiction.     9. Indemnification.  Subject to the Company by-laws, to the fullest extent allowed or  permitted under any provision of applicable law, the Company shall indemnify Executive against any  losses, claims, damages or liabilities, or expenses (including reasonable attorneys&#8217; fees) incurred by  Executive arising out of any claim based upon acts performed or omitted to be performed by Executive in  connection with Executive&#8217;s employment with the Company.    10. Attorneys' Fees. In any action brought by any party under this Agreement to enforce any  of its terms, or any appeal therefrom, each party shall bear its own costs and expenses, including its own  attorneys' fees; provided, however, that Executive (or Executive&#8217;s estate or other beneficiaries, as the case  may be) will be entitled to reimbursement for reasonable costs and expenses, including reasonable attorneys'  fees, with respect to such action if and to the extent that Executive (or Executive&#8217;s estate or other  beneficiaries, as the case may be) is the prevailing party.    11. Cooperation. Executive agrees that, after the termination of Executive&#8217;s employment,  Executive shall cooperate on a reasonable basis in the truthful and honest prosecution and/or defense of any  claim in which the Company, its affiliates and/or its subsidiaries may have an interest (subject to reasonable  limitations and Executive's other commitments concerning time and place), which may include, without  limitation, making himself available on a reasonable basis to participate in any proceeding involving the  Company, its affiliates and/or its subsidiaries, appearing for depositions and testimony without requiring a  subpoena, and producing and/or providing any documents or names of other persons with relevant  information. The Company agrees to reimburse Executive for all expenses reasonably incurred by her and  to pay reasonable compensation to Executive for and in connection with services provided by Executive  pursuant to this section.    12. Travel Restrictions. As is reasonable, Executive has the right to refuse travel to destinations  deemed politically unstable or otherwise hostile and/or those that may represent a danger to Executive's  health and well-being.    13. Notices. Any notices permitted or required under this Agreement shall be deemed given  upon the date of personal delivery or forty-eight (48) hours after deposit in the United States mail, postage  fully paid, certified mail, return receipt requested, addressed to the Company at its principal headquarters  address and to Executive at Executive&#8217;s last address on record with the Company. Either party may change  the address to which notices to such party shall be delivered personally or mailed by giving notice thereof  to the other party hereto in accordance with the terms of this Section 13.    14. Venue; Jurisdiction. The validity, construction, interpretation, and enforceability of this  Agreement shall be determined and governed by the laws (procedural and substantive) of the State of New  Jersey without giving effect to the principles of conflicts of law. For the purpose of litigating any dispute  that arises under this Agreement, the parties hereby consent to exclusive jurisdiction of, and agree that such  litigation shall be conducted in, any state or federal court located in the State of New Jersey.    Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ljb_employmentxageementx011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ljb_employmentxageementx011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">11    15. Binding Effect; Assignment. Executive shall not, without the prior written consent of the  Company, assign, transfer, or otherwise convey this Agreement, or any right or interest herein. This  Agreement, and all rights and obligations of the Company or any of its successors, may be assigned or  otherwise transferred to any of its successors and shall be binding upon and inure to the benefit of its  successors. As used herein, the term &#8220;successor&#8221; shall mean any person, corporation or other entity that, by  merger, consolidation, purchase of stock, assets, liquidation, voluntary or involuntary assignment, or  otherwise, acquires all or a substantial part of the assets of the Company or succeeds to one or more lines  of business of the Company.    16. Entire Agreement. This Agreement constitutes the entire agreement between the parties  hereto with respect to the subject matter hereof and supersedes all prior agreements, understandings and  arrangements, both oral and written, between the parties hereto with respect to such subject matter, it being  understood that this Agreement shall expressly supersede any employment agreement between Executive  and the Company, and any amendments thereto. This Agreement may not be modified, amended, altered or  rescinded in any manner, except by written instrument signed by all of the parties hereto; provided, however,  that any waiver by either party with respect to any provision hereof, or the breach of any provision hereof  by the other party, need be signed only by the party waiving such provision or breach; and provided, further,  that the waiver by either party hereto of a breach or compliance with any provision of this Agreement shall  not operate nor be construed as a waiver of any subsequent breach or compliance.    17. Severability. In case any one or more of the provisions of this Agreement shall be held by  any court of competent jurisdiction to be illegal, invalid or unenforceable in any respect, the remainder of  this Agreement, or the application of such provision to persons or circumstances other than those to which  it is held to be illegal, invalid, or unenforceable, shall not be affected thereby.    18. Section Headings. The section headings contained in this Agreement are for reference  purposes only and shall not affect in any manner the meaning or interpretation of this Agreement.    19. Counterparts. This Agreement may be executed in any number of counterparts, each of  which shall be deemed an original, but all of which taken together shall constitute one and the same  instrument.    20. Survival. The provisions of Sections 6-11 and 13-20 of this Agreement shall survive any  termination of this Agreement and the termination of Executive's employment by either party for any  reason.    IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of  the day and year first above written.    AQUESTIVE THERAPEUTICS, INC.  EXECUTIVE      By: ____________________________  ______________________________  Daniel Barber, President and CEO     Lori J. Braender   Date:  _______________________     Date:  _______________________  Docusign Envelope ID: 133B1AD5-BD0A-40B1-BA84-E36F1C49BBE9 03-16-202603-18-2026 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>q12026ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i807ab590c85f42e5ba0e6d3a774e2d2b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer of Aquestive Therapeutics, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel Barber, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Aquestive Therapeutics, Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, consolidated results of operations and consolidated cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;13, 2026</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>q12026ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i1aba58a817f644aeb8483517884b8b9a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial and Accounting Officer of Aquestive Therapeutics, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">I, A. Ernest Toth, Jr, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Aquestive Therapeutics, Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, consolidated results of operations and consolidated cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;13, 2026</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; A. ERNEST TOTH, JR.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.28pt">Ernest Toth, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>q12026ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ice866dd84a6244eba222c2ff5647feda_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350, as Adopted</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), I, Daniel Barber, President and Chief Executive Officer of Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;), hereby certify that, to the best of my knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company&#8217;s Quarterly Report on Form 10-Q for the period-ended March&#160;31, 2026, to which this Certification is attached as Exhibit 32.1 (the &#8220;Quarterly Report&#8221;), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Quarterly Report and the results of operations of the Company for the period covered by the Quarterly Report.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;13, 2026 </font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Aquestive Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Quarterly Report), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:10pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>q12026ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i4cccddb230ed4805be5b2932c308cacb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial and Accounting Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350, as Adopted</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), I, A. Ernest Toth, Jr., Chief Financial Officer of Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;), hereby certify that, to the best of my knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company&#8217;s Quarterly Report on Form 10-Q for the period-ended March&#160;31, 2026, to which this Certification is attached as Exhibit 32.2 (the &#8220;Quarterly Report&#8221;), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Quarterly Report and the results of operations of the Company for the period covered by the Quarterly Report.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;13, 2026 </font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; A. ERNEST TOTH, JR</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.28pt">Ernest Toth, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Aquestive Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Quarterly Report), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>aqst-20260331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d4579-21a7-7c19-9fd0-51403d0078b6,g:613180f5-33da-4eff-b9e2-e98da0338ca1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:aqst="http://aquestive.com/20260331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://aquestive.com/20260331">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20260331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20260331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20260331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20260331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://aquestive.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheets" roleURI="http://aquestive.com/role/CondensedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheetsParenthetical" roleURI="http://aquestive.com/role/CondensedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofOperationsandComprehensiveLoss" roleURI="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Condensed Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofChangesinStockholdersDeficit" roleURI="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit">
        <link:definition>9952154 - Statement - Condensed Statements of Changes in Stockholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofCashFlows" roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows">
        <link:definition>9952155 - Statement - Condensed Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOverviewandBasisofPresentation" roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentation">
        <link:definition>9952156 - Disclosure - Company Overview and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952157 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RisksandUncertainties" roleURI="http://aquestive.com/role/RisksandUncertainties">
        <link:definition>9952158 - Disclosure - Risks and Uncertainties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://aquestive.com/role/SegmentReporting">
        <link:definition>9952159 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNet" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNet">
        <link:definition>9952160 - Disclosure - Revenues and Trade Receivables, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MaterialAgreements" roleURI="http://aquestive.com/role/MaterialAgreements">
        <link:definition>9952161 - Disclosure - Material Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueMeasurements" roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements">
        <link:definition>9952162 - Disclosure - Financial Instruments &#8211; Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNet" roleURI="http://aquestive.com/role/InventoriesNet">
        <link:definition>9952163 - Disclosure - Inventories, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://aquestive.com/role/PropertyandEquipmentNet">
        <link:definition>9952164 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligations" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligations">
        <link:definition>9952165 - Disclosure - Right-of-Use Assets and Lease Obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssets" roleURI="http://aquestive.com/role/OtherNoncurrentAssets">
        <link:definition>9952166 - Disclosure - Other Non-current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://aquestive.com/role/AccruedExpenses">
        <link:definition>9952167 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://aquestive.com/role/LongTermDebt">
        <link:definition>9952168 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://aquestive.com/role/Warrants">
        <link:definition>9952169 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenue" roleURI="http://aquestive.com/role/SaleofFutureRevenue">
        <link:definition>9952170 - Disclosure - Sale of Future Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNonCurrentLiabilities" roleURI="http://aquestive.com/role/OtherNonCurrentLiabilities">
        <link:definition>9952171 - Disclosure - Other Non-Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://aquestive.com/role/NetLossPerShare">
        <link:definition>9952172 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://aquestive.com/role/ShareBasedCompensation">
        <link:definition>9952173 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://aquestive.com/role/IncomeTaxes">
        <link:definition>9952174 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://aquestive.com/role/Contingencies">
        <link:definition>9952175 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://aquestive.com/role/SubsequentEvents">
        <link:definition>9952176 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://aquestive.com/role/SegmentReportingTables">
        <link:definition>9955512 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetTables" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTables">
        <link:definition>9955513 - Disclosure - Revenues and Trade Receivables, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNetTables" roleURI="http://aquestive.com/role/InventoriesNetTables">
        <link:definition>9955514 - Disclosure - Inventories, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://aquestive.com/role/PropertyandEquipmentNetTables">
        <link:definition>9955515 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsTables" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables">
        <link:definition>9955516 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssetsTables" roleURI="http://aquestive.com/role/OtherNoncurrentAssetsTables">
        <link:definition>9955517 - Disclosure - Other Non-current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://aquestive.com/role/AccruedExpensesTables">
        <link:definition>9955518 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://aquestive.com/role/LongTermDebtTables">
        <link:definition>9955519 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenueTables" roleURI="http://aquestive.com/role/SaleofFutureRevenueTables">
        <link:definition>9955520 - Disclosure - Sale of Future Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNonCurrentLiabilitiesTables" roleURI="http://aquestive.com/role/OtherNonCurrentLiabilitiesTables">
        <link:definition>9955521 - Disclosure - Other Non-Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://aquestive.com/role/NetLossPerShareTables">
        <link:definition>9955522 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://aquestive.com/role/ShareBasedCompensationTables">
        <link:definition>9955523 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOverviewandBasisofPresentationDetails" roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails">
        <link:definition>9955524 - Disclosure - Company Overview and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RisksandUncertaintiesDetails" roleURI="http://aquestive.com/role/RisksandUncertaintiesDetails">
        <link:definition>9955525 - Disclosure - Risks and Uncertainties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://aquestive.com/role/SegmentReportingNarrativeDetails">
        <link:definition>9955526 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" roleURI="http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails">
        <link:definition>9955527 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetNarrativeDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails">
        <link:definition>9955528 - Disclosure - Revenues and Trade Receivables, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetScheduleofRevenueDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails">
        <link:definition>9955529 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails">
        <link:definition>9955530 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails">
        <link:definition>9955531 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Trade and Other Receivables, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails">
        <link:definition>9955532 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Sales-related Allowances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MaterialAgreementsDetails" roleURI="http://aquestive.com/role/MaterialAgreementsDetails">
        <link:definition>9955533 - Disclosure - Material Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueMeasurementsDetails" roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails">
        <link:definition>9955534 - Disclosure - Financial Instruments &#8211; Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNetDetails" roleURI="http://aquestive.com/role/InventoriesNetDetails">
        <link:definition>9955535 - Disclosure - Inventories, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" roleURI="http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails">
        <link:definition>9955536 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetNarrativeDetails" roleURI="http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails">
        <link:definition>9955537 - Disclosure - Property and Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsNarrativeDetails" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails">
        <link:definition>9955538 - Disclosure - Right-of-Use Assets and Lease Obligations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails">
        <link:definition>9955539 - Disclosure - Right-of-Use Assets and Lease Obligations - Schedule of Operating Lease Liabilities Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1">
        <link:definition>9955539 - Disclosure - Right-of-Use Assets and Lease Obligations - Schedule of Operating Lease Liabilities Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails" roleURI="http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails">
        <link:definition>9955540 - Disclosure - Other Non-current Assets - Schedule of Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssetsNarrativeDetails" roleURI="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails">
        <link:definition>9955541 - Disclosure - Other Non-current Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://aquestive.com/role/AccruedExpensesDetails">
        <link:definition>9955542 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://aquestive.com/role/LongTermDebtNarrativeDetails">
        <link:definition>9955543 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" roleURI="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails">
        <link:definition>9955544 - Disclosure - Long-Term Debt - Schedule Of Royalty Right Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails">
        <link:definition>9955545 - Disclosure - Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofDebtMaturitiesDetails" roleURI="http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails">
        <link:definition>9955546 - Disclosure - Long-Term Debt - Schedule of Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsDetails" roleURI="http://aquestive.com/role/WarrantsDetails">
        <link:definition>9955547 - Disclosure - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenueNarrativeDetails" roleURI="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails">
        <link:definition>9955548 - Disclosure - Sale of Future Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenueScheduleofRoyaltyObligationDetails" roleURI="http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails">
        <link:definition>9955549 - Disclosure - Sale of Future Revenue - Schedule of Royalty Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNonCurrentLiabilitiesNarrativeDetails" roleURI="http://aquestive.com/role/OtherNonCurrentLiabilitiesNarrativeDetails">
        <link:definition>9955550 - Disclosure - Other Non-Current Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails" roleURI="http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails">
        <link:definition>9955551 - Disclosure - Other Non-Current Liabilities - Schedule of Liability for Asset Retirement Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareDetails" roleURI="http://aquestive.com/role/NetLossPerShareDetails">
        <link:definition>9955552 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails">
        <link:definition>9955553 - Disclosure - Share-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails">
        <link:definition>9955554 - Disclosure - Share-Based Compensation - Schedule of Restricted Stock Units Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>9955555 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails">
        <link:definition>9955556 - Disclosure - Share-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofStockOptionActivityDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails">
        <link:definition>9955557 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://aquestive.com/role/IncomeTaxesDetails">
        <link:definition>9955558 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesDetails" roleURI="http://aquestive.com/role/ContingenciesDetails">
        <link:definition>9955559 - Disclosure - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://aquestive.com/role/SubsequentEventsDetails">
        <link:definition>9955560 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" abstract="false" name="TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_RoyaltyObligationLiabilityNoncurrent" abstract="false" name="RoyaltyObligationLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" abstract="false" name="TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_InterestExpenseSaleOfFutureRevenues" abstract="false" name="InterestExpenseSaleOfFutureRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_InterestAndOtherIncomeNet" abstract="false" name="InterestAndOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ProceedsFromExerciseOfWarrantsNet" abstract="false" name="ProceedsFromExerciseOfWarrantsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" abstract="false" name="ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_PaymentsForRoyaltyObligations" abstract="false" name="PaymentsForRoyaltyObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" abstract="false" name="CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_WarrantsDisclosureTextBlock" abstract="false" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="aqst_SaleOfFutureRevenueTextBlock" abstract="false" name="SaleOfFutureRevenueTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock" abstract="false" name="ScheduleOfAccountsReceivableAllowancesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" abstract="false" name="ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="aqst_RoyaltyObligationActivityTableTextBlock" abstract="false" name="RoyaltyObligationActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="aqst_EquityDistributionAgreementMember" abstract="true" name="EquityDistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AmendedEquityDistributionAgreementMember" abstract="true" name="AmendedEquityDistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_UnderwrittenPublicOfferingMember" abstract="true" name="UnderwrittenPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_SaleOfStockMaximumTransactionAmount" abstract="false" name="SaleOfStockMaximumTransactionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SaleOfStockAggregateOfferingPrice" abstract="false" name="SaleOfStockAggregateOfferingPrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" abstract="false" name="SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SeniorSecuredNotes13.5DueNovember12028Member" abstract="true" name="SeniorSecuredNotes13.5DueNovember12028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AnaphylmMember" abstract="true" name="AnaphylmMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AQST108Member" abstract="true" name="AQST108Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_PersonnelCostsMember" abstract="true" name="PersonnelCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_TradeAccountsReceivableDoubtfulAccountsMember" abstract="true" name="TradeAccountsReceivableDoubtfulAccountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_OtherReceivablesAndAccruedExpensesMember" abstract="true" name="OtherReceivablesAndAccruedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_IndiviorMember" abstract="true" name="IndiviorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ZevraMember" abstract="true" name="ZevraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AssertioHoldingsIncMember" abstract="true" name="AssertioHoldingsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_HyperaMember" abstract="true" name="HyperaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ResearchAndDevelopmentProjectDuration" abstract="false" name="ResearchAndDevelopmentProjectDuration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_ManufactureAndSupplyRevenueMember" abstract="true" name="ManufactureAndSupplyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_LicenseAndRoyaltyRevenueMember" abstract="true" name="LicenseAndRoyaltyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_CoDevelopmentAndResearchFeesMember" abstract="true" name="CoDevelopmentAndResearchFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ProprietaryProductRevenueMember" abstract="true" name="ProprietaryProductRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ZevraAndCommaveTherapeuticsAgreementMember" abstract="true" name="ZevraAndCommaveTherapeuticsAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AccountsReceivableAllowanceForCreditLossPreReclassification" abstract="false" name="AccountsReceivableAllowanceForCreditLossPreReclassification" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" abstract="false" name="AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_TradeAccountsReceivableSalesRelatedMember" abstract="true" name="TradeAccountsReceivableSalesRelatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AccountsReceivableAllowanceForCreditLossReclassifications" abstract="false" name="AccountsReceivableAllowanceForCreditLossReclassifications" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_RTWInvestmentsLPMember" abstract="true" name="RTWInvestmentsLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_CommercialExploitationAgreementWithIndiviorMember" abstract="true" name="CommercialExploitationAgreementWithIndiviorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" abstract="true" name="LicenseAgreementWithSunovionPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" abstract="true" name="LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" abstract="true" name="LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarathonPangolinRoyaltyLLCMember" abstract="true" name="MarathonPangolinRoyaltyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AtnahsPharmaUKLimitedMember" abstract="true" name="AtnahsPharmaUKLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" abstract="true" name="AtnahsPharmaUKLimitedAmendedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_PurchaseAndSaleAgreementMember" abstract="true" name="PurchaseAndSaleAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MonetizationAgreementMember" abstract="true" name="MonetizationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_LicenseSupplyAgreementMember" abstract="true" name="LicenseSupplyAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests" abstract="false" name="ConsiderationReceivableFromSaleOfFutureRevenuesInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_CollaborativeArrangementRevenueSharingPercentage" abstract="false" name="CollaborativeArrangementRevenueSharingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" abstract="false" name="CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" abstract="false" name="CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_CapitalizedLegalFees" abstract="false" name="CapitalizedLegalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SaleOfStockSharesCommittedAggregateAmount" abstract="false" name="SaleOfStockSharesCommittedAggregateAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" abstract="false" name="SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_LicenseAgreementTerm" abstract="false" name="LicenseAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_AutomaticRenewalPeriodOfAgreement" abstract="false" name="AutomaticRenewalPeriodOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_ProceedsFromSaleOfFutureRevenuesNet" abstract="false" name="ProceedsFromSaleOfFutureRevenuesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet" abstract="false" name="AdditionalProceedsFromSaleOfFutureRevenuesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ContingentMonetizationAgreementMilestonePayment" abstract="false" name="ContingentMonetizationAgreementMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SecuritiesPurchaseAgreementMember" abstract="true" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ExistingWarrantsMember" abstract="true" name="ExistingWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_NewWarrantsMember" abstract="true" name="NewWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" abstract="false" name="SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" abstract="false" name="SharesOfCommonStockToBePurchasedByCommonStockWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_RoyaltyObligationPercentOfNetSales" abstract="false" name="RoyaltyObligationPercentOfNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aqst_RoyaltyObligationTerm" abstract="false" name="RoyaltyObligationTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_InventoryPackingMaterialGross" abstract="false" name="InventoryPackingMaterialGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ComputerNetworkEquipmentAndSoftwareMember" abstract="true" name="ComputerNetworkEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_NumberOfOperatingLeases" abstract="false" name="NumberOfOperatingLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_CumulativeRoyaltyReceivable" abstract="false" name="CumulativeRoyaltyReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_NumberOfGuaranteedRoyaltyPayments" abstract="false" name="NumberOfGuaranteedRoyaltyPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_MinimumAnnualRoyaltyReceivable" abstract="false" name="MinimumAnnualRoyaltyReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_NumberOfAnnualRoyaltyPaymentsReceivable" abstract="false" name="NumberOfAnnualRoyaltyPaymentsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" abstract="true" name="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RoyaltyObligationsMember" abstract="true" name="RoyaltyObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ABLFacilityMember" abstract="true" name="ABLFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RoyaltyRightAgreementsMember" abstract="true" name="RoyaltyRightAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_DebtCovenantRedemptionScenarioAxis" abstract="true" name="DebtCovenantRedemptionScenarioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aqst_DebtCovenantRedemptionScenarioDomain" abstract="true" name="DebtCovenantRedemptionScenarioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RedemptionScenario1Member" abstract="true" name="RedemptionScenario1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RedemptionScenario2Member" abstract="true" name="RedemptionScenario2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_DebtInstrumentExitFee" abstract="false" name="DebtInstrumentExitFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" abstract="false" name="DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" abstract="false" name="LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" abstract="false" name="DebtInstrumentCovenantTieredRoyaltyPercentageTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_RoyaltyObligationsGross" abstract="false" name="RoyaltyObligationsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_MeasurementInputProbabilityOfSuccessMember" abstract="true" name="MeasurementInputProbabilityOfSuccessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RoyaltyAgreementMeasurementInput" abstract="false" name="RoyaltyAgreementMeasurementInput" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aqst_FirstAdditionalWarrantOfferingMember" abstract="true" name="FirstAdditionalWarrantOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_PreFundedWarrantsMember" abstract="true" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_A2020AdditionalNotesMember" abstract="true" name="A2020AdditionalNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ClassOfWarrantOrRightWarrantsExercised" abstract="false" name="ClassOfWarrantOrRightWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" abstract="false" name="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_SaleOfFutureRevenueRollForward" abstract="true" name="SaleOfFutureRevenueRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="aqst_LiabilitiesSaleOfFutureRoyalties" abstract="false" name="LiabilitiesSaleOfFutureRoyalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" abstract="false" name="LiabilitiesSaleOfFutureRoyaltiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_AssetRetirementObligationsDepreciationExpense" abstract="false" name="AssetRetirementObligationsDepreciationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ManufacturingAndSupplyMember" abstract="true" name="ManufacturingAndSupplyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ServiceBasedMember" abstract="true" name="ServiceBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketBasedMember" abstract="true" name="MarketBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="aqst_A2025MarketBasedMember" abstract="true" name="A2025MarketBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_A2022InducementEquityIncentivePlanMember" abstract="true" name="A2022InducementEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketConditionsAxis" abstract="true" name="MarketConditionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aqst_MarketConditionsDomain" abstract="true" name="MarketConditionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketConditionRangeOneMember" abstract="true" name="MarketConditionRangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketConditionRangeTwoMember" abstract="true" name="MarketConditionRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketConditionRangeThreeMember" abstract="true" name="MarketConditionRangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketConditionRangeFourMember" abstract="true" name="MarketConditionRangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketConditionRangeFiveMember" abstract="true" name="MarketConditionRangeFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MarketConditionRangeSixMember" abstract="true" name="MarketConditionRangeSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionAxis" abstract="true" name="VestingConditionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aqst_VestingConditionDomain" abstract="true" name="VestingConditionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeSevenMember" abstract="true" name="VestingConditionRangeSevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeEightMember" abstract="true" name="VestingConditionRangeEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeNineMember" abstract="true" name="VestingConditionRangeNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeTenMember" abstract="true" name="VestingConditionRangeTenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeElevenMember" abstract="true" name="VestingConditionRangeElevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeTwelveMember" abstract="true" name="VestingConditionRangeTwelveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="aqst_SuboxoneProduceLiabilityLitigationMember" abstract="true" name="SuboxoneProduceLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_DebtInstrumentMilestoneTranchesAxis" abstract="true" name="DebtInstrumentMilestoneTranchesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aqst_DebtInstrumentMilestoneTranchesDomain" abstract="true" name="DebtInstrumentMilestoneTranchesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_TrancheTwoMember" abstract="true" name="TrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_TrancheThreeMember" abstract="true" name="TrancheThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_TrancheFourMember" abstract="true" name="TrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_LesseeOperatingLeaseInitialRentAbatementPeriod" abstract="false" name="LesseeOperatingLeaseInitialRentAbatementPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" abstract="false" name="LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>aqst-20260331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d4579-21a7-7c19-9fd0-51403d0078b6,g:613180f5-33da-4eff-b9e2-e98da0338ca1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedBalanceSheets"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d4579-22d9-7f39-9837-cb44d9dfc53e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d4579-22d9-73cf-a5e5-59ee957a93db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d4579-22d9-7f39-9837-cb44d9dfc53e" xlink:to="loc_us-gaap_CommonStockValue_019d4579-22d9-73cf-a5e5-59ee957a93db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7ba6-8260-66a139d9ff91" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d4579-22d9-7f39-9837-cb44d9dfc53e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7ba6-8260-66a139d9ff91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019d4579-22d9-7638-96a6-23d81452f965" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d4579-22d9-7f39-9837-cb44d9dfc53e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019d4579-22d9-7638-96a6-23d81452f965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d4579-22d9-7624-bde6-c9c6a5848617" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d4579-22d9-7f4e-a788-87fb7cb559c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d4579-22d9-7624-bde6-c9c6a5848617" xlink:to="loc_us-gaap_StockholdersEquity_019d4579-22d9-7f4e-a788-87fb7cb559c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019d4579-22d9-7994-8c78-aa29ce2d7912" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d4579-22d9-7624-bde6-c9c6a5848617" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019d4579-22d9-7994-8c78-aa29ce2d7912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d4579-22d9-7ae7-b365-b06ceb8e36c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d4579-22d9-7624-bde6-c9c6a5848617" xlink:to="loc_us-gaap_Liabilities_019d4579-22d9-7ae7-b365-b06ceb8e36c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d4579-22d9-7059-b536-a3368bc452e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d4579-22d9-7059-b536-a3368bc452e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationLiabilityNoncurrent_019d4579-22d9-70cf-b5fb-d2af34021a52" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:to="loc_aqst_RoyaltyObligationLiabilityNoncurrent_019d4579-22d9-70cf-b5fb-d2af34021a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_019d4579-22d9-7fc5-a0a4-19fbf4a61f5f" xlink:href="aqst-20260331.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:to="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_019d4579-22d9-7fc5-a0a4-19fbf4a61f5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d4579-22d9-71c5-b772-2eab4f5b8434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d4579-22d9-71c5-b772-2eab4f5b8434" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-7fc0-bdf5-6da448efb7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-7fc0-bdf5-6da448efb7c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019d4579-22d9-7ad1-9ade-7a6763ece759" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019d4579-22d9-7ad1-9ade-7a6763ece759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-22d9-736d-8fd3-659b0dad7ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d4579-22d9-7602-ba2a-2499c2cbddee" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-22d9-736d-8fd3-659b0dad7ffa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d4579-22d9-703f-b473-03f9bd817c50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d4579-22d9-79a3-9d39-91b2a0ec959e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d4579-22d9-703f-b473-03f9bd817c50" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d4579-22d9-79a3-9d39-91b2a0ec959e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7359-a2a0-66ac4c4e519e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d4579-22d9-703f-b473-03f9bd817c50" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7359-a2a0-66ac4c4e519e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019d4579-22d9-7758-b506-31ca6b234686" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d4579-22d9-703f-b473-03f9bd817c50" xlink:to="loc_us-gaap_InventoryNet_019d4579-22d9-7758-b506-31ca6b234686" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_019d4579-22d9-7885-abbc-b0fa9e75613a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d4579-22d9-703f-b473-03f9bd817c50" xlink:to="loc_us-gaap_ReceivablesNetCurrent_019d4579-22d9-7885-abbc-b0fa9e75613a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d4579-22d9-7ae3-a8f2-ad76aded5cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-22d9-76dd-9add-128663052928" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d4579-22d9-7ae3-a8f2-ad76aded5cd6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-22d9-76dd-9add-128663052928" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d4579-22d9-70a6-94fd-fed539df7183" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d4579-22d9-7ae3-a8f2-ad76aded5cd6" xlink:to="loc_us-gaap_AssetsCurrent_019d4579-22d9-70a6-94fd-fed539df7183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d4579-22d9-774c-ba66-bb95c0928f55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d4579-22d9-7ae3-a8f2-ad76aded5cd6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d4579-22d9-774c-ba66-bb95c0928f55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d4579-22d9-76ab-9ba5-7444d2706fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d4579-22d9-7ae3-a8f2-ad76aded5cd6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d4579-22d9-76ab-9ba5-7444d2706fc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-703f-83c3-b7c9c08fbd54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019d4579-22d9-7d4f-bbdf-f7beb2c024a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-703f-83c3-b7c9c08fbd54" xlink:to="loc_us-gaap_AccountsPayableCurrent_019d4579-22d9-7d4f-bbdf-f7beb2c024a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-22d9-79f3-8e62-715d12bcd4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-703f-83c3-b7c9c08fbd54" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-22d9-79f3-8e62-715d12bcd4fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d4579-22d9-747e-8041-10e57b4c6e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-703f-83c3-b7c9c08fbd54" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d4579-22d9-747e-8041-10e57b4c6e0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019d4579-22d9-7948-b809-d4d50932b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-703f-83c3-b7c9c08fbd54" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019d4579-22d9-7948-b809-d4d50932b1b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent_019d4579-22d9-7a2b-bbf3-67e92570263a" xlink:href="aqst-20260331.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-703f-83c3-b7c9c08fbd54" xlink:to="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent_019d4579-22d9-7a2b-bbf3-67e92570263a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableCurrent_019de5f3-2aa7-7934-bd49-117ebc11be48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-703f-83c3-b7c9c08fbd54" xlink:to="loc_us-gaap_LoansPayableCurrent_019de5f3-2aa7-7934-bd49-117ebc11be48" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d4579-22d9-7e5a-b6b3-d1d3313b14bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019d4579-22d9-70bc-a42f-4f7239f4f382" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d4579-22d9-7e5a-b6b3-d1d3313b14bc" xlink:to="loc_us-gaap_CostsAndExpenses_019d4579-22d9-70bc-a42f-4f7239f4f382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-22d9-7e3d-9133-d60745782eca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d4579-22d9-7e5a-b6b3-d1d3313b14bc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-22d9-7e3d-9133-d60745782eca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d4579-22d9-7f3a-afa3-df8b0fa2d820" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7ac1-97d5-21fec6e4a68b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d4579-22d9-7f3a-afa3-df8b0fa2d820" xlink:to="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7ac1-97d5-21fec6e4a68b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019d4579-22d9-7ce4-b125-b4f7ca68a106" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d4579-22d9-7574-9833-1a9ed17bc6da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019d4579-22d9-7ce4-b125-b4f7ca68a106" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d4579-22d9-7574-9833-1a9ed17bc6da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d4579-22d9-7f0e-a3ad-50947b7e4d73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019d4579-22d9-7ce4-b125-b4f7ca68a106" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d4579-22d9-7f0e-a3ad-50947b7e4d73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019d4579-22d9-7015-9e66-40d7b18368cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019d4579-22d9-7ce4-b125-b4f7ca68a106" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019d4579-22d9-7015-9e66-40d7b18368cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7045-bb1c-f0d12bcdadad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet_019d4579-22d9-7dda-b002-dc5e3add2823" xlink:href="aqst-20260331.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7045-bb1c-f0d12bcdadad" xlink:to="loc_aqst_InterestAndOtherIncomeNet_019d4579-22d9-7dda-b002-dc5e3add2823" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_019d4579-22d9-74c8-804f-95374c4af9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7045-bb1c-f0d12bcdadad" xlink:to="loc_us-gaap_RoyaltyExpense_019d4579-22d9-74c8-804f-95374c4af9ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestExpenseSaleOfFutureRevenues_019d4579-22d9-7824-ac7c-8fce6af8861c" xlink:href="aqst-20260331.xsd#aqst_InterestExpenseSaleOfFutureRevenues"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7045-bb1c-f0d12bcdadad" xlink:to="loc_aqst_InterestExpenseSaleOfFutureRevenues_019d4579-22d9-7824-ac7c-8fce6af8861c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019d4579-22d9-7d3e-8571-0d9a50033dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7045-bb1c-f0d12bcdadad" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019d4579-22d9-7d3e-8571-0d9a50033dbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d4579-22d9-7027-ac68-b627eee22873" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7045-bb1c-f0d12bcdadad" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d4579-22d9-7027-ac68-b627eee22873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7706-b400-8cfcdda36828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7c37-a87e-3edebd4f7844" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7706-b400-8cfcdda36828" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7c37-a87e-3edebd4f7844" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d4579-22d9-77ad-b548-546ebac33195" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_NetIncomeLoss_019d4579-22d9-77ad-b548-546ebac33195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019d4579-22d9-76eb-9ef8-6eb618387611" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_DepreciationAndAmortization_019d4579-22d9-76eb-9ef8-6eb618387611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d4579-22d9-70bd-8b5e-cb7966363c03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_ShareBasedCompensation_019d4579-22d9-70bd-8b5e-cb7966363c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019d4579-22d9-742a-9f88-099dc732eb85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019d4579-22d9-742a-9f88-099dc732eb85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019d4579-22d9-7dfa-ba25-b23d37822029" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019d4579-22d9-7dfa-ba25-b23d37822029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019d4579-22d9-7d39-8fa0-b7abbc5484b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019d4579-22d9-7d39-8fa0-b7abbc5484b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_019d4579-22d9-7372-aebe-47dce1af35fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_019d4579-22d9-7372-aebe-47dce1af35fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_019d4579-22d9-744a-b210-91c6ee31e9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_019d4579-22d9-744a-b210-91c6ee31e9c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d4579-22d9-7336-9322-b0e56360425c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d4579-22d9-7336-9322-b0e56360425c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d4579-22d9-70d7-8e22-abc3ed0199c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d4579-22d9-70d7-8e22-abc3ed0199c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d4579-22d9-7fb4-96f5-2b87fe74a3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d4579-22d9-7fb4-96f5-2b87fe74a3ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_019dac51-2aea-7493-a361-c0ae1c4760e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-71d8-88a3-30d75b0c8da5" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_019dac51-2aea-7493-a361-c0ae1c4760e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-707c-93a5-783656b1f0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_019d4579-22d9-73b6-8af4-d220bfcc4d48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-707c-93a5-783656b1f0e4" xlink:to="loc_us-gaap_RepaymentsOfDebt_019d4579-22d9-73b6-8af4-d220bfcc4d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PaymentsForRoyaltyObligations_019d4579-22d9-732d-be46-4e90e2c7a08a" xlink:href="aqst-20260331.xsd#aqst_PaymentsForRoyaltyObligations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-707c-93a5-783656b1f0e4" xlink:to="loc_aqst_PaymentsForRoyaltyObligations_019d4579-22d9-732d-be46-4e90e2c7a08a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d4579-22d9-737f-ac54-b6ed157fe28a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-707c-93a5-783656b1f0e4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d4579-22d9-737f-ac54-b6ed157fe28a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_019d4579-22d9-72ea-81b7-7ef9c49d82ef" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-707c-93a5-783656b1f0e4" xlink:to="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_019d4579-22d9-72ea-81b7-7ef9c49d82ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019dfb6b-429e-7363-9dae-ce6b8ece5379" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-707c-93a5-783656b1f0e4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019dfb6b-429e-7363-9dae-ce6b8ece5379" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-7402-829a-0334c6b54b11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d4579-22d9-70bd-87d0-4047402e3924" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-7402-829a-0334c6b54b11" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d4579-22d9-70bd-87d0-4047402e3924" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-78b5-8cb1-b12112868874" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-7d25-bcc6-8ee836674959" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-78b5-8cb1-b12112868874" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-7d25-bcc6-8ee836674959" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-7bad-8a83-fafdd1dc9b93" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-78b5-8cb1-b12112868874" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-7bad-8a83-fafdd1dc9b93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-7b40-8a5e-9e5eaee99866" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-78b5-8cb1-b12112868874" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-7b40-8a5e-9e5eaee99866" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d7c21-71b8-7b5f-a0bc-59f23d528f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d7c21-71b8-70a4-ab01-7dabd0a8dca4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d7c21-71b8-7b5f-a0bc-59f23d528f2c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d7c21-71b8-70a4-ab01-7dabd0a8dca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingExpense_019d7c21-71b8-7103-8dd8-4bfa682f6a97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d7c21-71b8-7b5f-a0bc-59f23d528f2c" xlink:to="loc_us-gaap_SellingExpense_019d7c21-71b8-7103-8dd8-4bfa682f6a97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_019d7c66-012d-73f7-af29-a4204818cf85" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_019d7c66-012d-724b-a114-7760f38e221b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_019d7c66-012d-73f7-af29-a4204818cf85" xlink:to="loc_us-gaap_AccountsReceivableGross_019d7c66-012d-724b-a114-7760f38e221b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c66-012d-7370-bf74-372cdd07e8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_019d7c66-012d-73f7-af29-a4204818cf85" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c66-012d-7370-bf74-372cdd07e8c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification_019d7c66-012d-7aa7-a965-561b74d67e7f" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowanceForCreditLossPreReclassification"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_019d7c66-012d-73f7-af29-a4204818cf85" xlink:to="loc_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification_019d7c66-012d-7aa7-a965-561b74d67e7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_019d7c66-012d-7280-b650-d5397b4613e4" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_019d7c66-012d-73f7-af29-a4204818cf85" xlink:to="loc_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_019d7c66-012d-7280-b650-d5397b4613e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#InventoriesNetDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/InventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019d4579-22d9-7ab7-adda-e03a20d009ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_019d4579-22d9-7b15-9c92-c3f2c5487f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019d4579-22d9-7ab7-adda-e03a20d009ed" xlink:to="loc_us-gaap_InventoryRawMaterials_019d4579-22d9-7b15-9c92-c3f2c5487f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InventoryPackingMaterialGross_019d4579-22d9-7278-a478-f999f1996bd6" xlink:href="aqst-20260331.xsd#aqst_InventoryPackingMaterialGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019d4579-22d9-7ab7-adda-e03a20d009ed" xlink:to="loc_aqst_InventoryPackingMaterialGross_019d4579-22d9-7278-a478-f999f1996bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_019d4579-22d9-70fe-832f-394e6d86232f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019d4579-22d9-7ab7-adda-e03a20d009ed" xlink:to="loc_us-gaap_InventoryFinishedGoods_019d4579-22d9-70fe-832f-394e6d86232f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-237c-7777-9918-a9423b3c1ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019d4579-237c-78d5-bb40-b51f9afe0043" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-237c-7777-9918-a9423b3c1ac1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019d4579-237c-78d5-bb40-b51f9afe0043" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019d4579-237c-7101-bce8-399cf9458d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-237c-7777-9918-a9423b3c1ac1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019d4579-237c-7101-bce8-399cf9458d7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-7089-b29e-014cd9666cce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019d4579-237c-7984-a98e-65314283d5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-7089-b29e-014cd9666cce" xlink:to="loc_us-gaap_OperatingLeaseLiability_019d4579-237c-7984-a98e-65314283d5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d4579-237c-79bf-8b11-c27bed5d8a89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-7089-b29e-014cd9666cce" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d4579-237c-79bf-8b11-c27bed5d8a89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1" xlink:type="simple" xlink:href="aqst-20260331.xsd#RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79b7-8747-bcad3db98009" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019d4579-237c-72bb-bf0d-5e0e2a566261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79b7-8747-bcad3db98009" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019d4579-237c-72bb-bf0d-5e0e2a566261" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019d4579-237c-701c-9ff2-df71043e21e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79b7-8747-bcad3db98009" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019d4579-237c-701c-9ff2-df71043e21e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d4579-237c-7621-a771-713b845c21db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79b7-8747-bcad3db98009" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d4579-237c-7621-a771-713b845c21db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019d4579-237c-78ee-9d08-e5d52c3a8050" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79b7-8747-bcad3db98009" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019d4579-237c-78ee-9d08-e5d52c3a8050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_019d4579-237c-7631-9ba1-0611b5bc936b" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79b7-8747-bcad3db98009" xlink:to="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_019d4579-237c-7631-9ba1-0611b5bc936b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d4579-237c-70b5-b250-728820467b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d4579-237c-7024-81b2-6a849e19aff2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019d4579-237c-70b5-b250-728820467b2d" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d4579-237c-7024-81b2-6a849e19aff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CumulativeRoyaltyReceivable_019d4579-237c-7d63-abda-3da80fc8b3d3" xlink:href="aqst-20260331.xsd#aqst_CumulativeRoyaltyReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_019d4579-237c-70b5-b250-728820467b2d" xlink:to="loc_aqst_CumulativeRoyaltyReceivable_019d4579-237c-7d63-abda-3da80fc8b3d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-730b-9bc5-34b78756a2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-237c-713e-b8ff-71bf4811fb40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-730b-9bc5-34b78756a2b0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-237c-713e-b8ff-71bf4811fb40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d4579-237c-7c24-9a61-d03084e181ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-730b-9bc5-34b78756a2b0" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d4579-237c-7c24-9a61-d03084e181ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_019d4579-237c-7ecb-b5ad-b2845bd3dd06" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-730b-9bc5-34b78756a2b0" xlink:to="loc_us-gaap_TaxesPayableCurrent_019d4579-237c-7ecb-b5ad-b2845bd3dd06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019d4579-237c-72d1-bcfc-86c77eebb989" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-730b-9bc5-34b78756a2b0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019d4579-237c-72d1-bcfc-86c77eebb989" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_019d4579-237c-79e9-966a-4ec1dbad402e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-730b-9bc5-34b78756a2b0" xlink:to="loc_us-gaap_InterestPayableCurrent_019d4579-237c-79e9-966a-4ec1dbad402e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-72a3-a562-48520f46d616" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019d4579-237c-72c1-922c-c27e20bbf619" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-72a3-a562-48520f46d616" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019d4579-237c-72c1-922c-c27e20bbf619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019d4579-237c-7923-b34f-1953802306ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-72a3-a562-48520f46d616" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019d4579-237c-7923-b34f-1953802306ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtScheduleofDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019d4579-237c-76e2-ba5b-bea1df9a7310" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019d4579-237c-7f8d-8f55-15b11dd2c69f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019d4579-237c-76e2-ba5b-bea1df9a7310" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019d4579-237c-7f8d-8f55-15b11dd2c69f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019d4579-237c-7722-8e47-e41d9f34f96a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019d4579-237c-76e2-ba5b-bea1df9a7310" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019d4579-237c-7722-8e47-e41d9f34f96a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019d4579-237c-7cb8-aeb1-6ebfe2444ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019d4579-237c-76e2-ba5b-bea1df9a7310" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019d4579-237c-7cb8-aeb1-6ebfe2444ec5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>aqst-20260331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d4579-21a7-7c19-9fd0-51403d0078b6,g:613180f5-33da-4eff-b9e2-e98da0338ca1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedStatementsofChangesinStockholdersDeficit"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d4579-22d9-76ec-aad3-177d402ec243" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-76ec-aad3-177d402ec243" xlink:to="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d4579-22d9-765d-8c18-b2b9ef113c76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d4579-22d9-765d-8c18-b2b9ef113c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d4579-22d9-765d-8c18-b2b9ef113c76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d4579-22d9-765d-8c18-b2b9ef113c76" xlink:to="loc_us-gaap_EquityComponentDomain_019d4579-22d9-765d-8c18-b2b9ef113c76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d4579-22d9-765d-8c18-b2b9ef113c76" xlink:to="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d4579-22d9-786b-bd8f-d582ba8caf0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:to="loc_us-gaap_CommonStockMember_019d4579-22d9-786b-bd8f-d582ba8caf0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019d4579-22d9-74ac-9189-72bbd35c75ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019d4579-22d9-74ac-9189-72bbd35c75ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019d4579-22d9-7b9a-a357-d84afc9a0104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:to="loc_us-gaap_RetainedEarningsMember_019d4579-22d9-7b9a-a357-d84afc9a0104" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7adb-a3bb-6567ab2ed4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7adb-a3bb-6567ab2ed4c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7adb-a3bb-6567ab2ed4c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7adb-a3bb-6567ab2ed4c6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7adb-a3bb-6567ab2ed4c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-78a4-a059-c06c0d7cb547" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7adb-a3bb-6567ab2ed4c6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-78a4-a059-c06c0d7cb547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7bff-b92d-43f221d01a39" xlink:href="aqst-20260331.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-78a4-a059-c06c0d7cb547" xlink:to="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7bff-b92d-43f221d01a39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-76ec-aad3-177d402ec243" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019d4579-22d9-7b24-90a4-4d5c25ed1466" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_SharesOutstanding_019d4579-22d9-7b24-90a4-4d5c25ed1466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d4579-22d9-7e05-a101-b288ade4df68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockholdersEquity_019d4579-22d9-7e05-a101-b288ade4df68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6dba-05aa-7a40-baef-4b59d513d901" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6dba-05aa-7a40-baef-4b59d513d901" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6dba-05aa-7915-a48e-ab9a358771cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6dba-05aa-7915-a48e-ab9a358771cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6dba-05aa-7b44-a045-7dd0274f7896" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6dba-05aa-7b44-a045-7dd0274f7896" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromExerciseOfWarrantsNet_019dda8c-71d0-7ef8-bf97-807cde33d755" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromExerciseOfWarrantsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_aqst_ProceedsFromExerciseOfWarrantsNet_019dda8c-71d0-7ef8-bf97-807cde33d755" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6dba-05aa-7901-a2ce-fd244f81d825" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6dba-05aa-7901-a2ce-fd244f81d825" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019d6dba-05aa-731d-a44e-2dbde788a0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019d6dba-05aa-731d-a44e-2dbde788a0d7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019de649-1492-78ab-9282-65a192dd5f20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019de649-1492-78ab-9282-65a192dd5f20" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019daa62-5508-7c9c-8967-3ad682d3d122" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019daa62-5508-7c9c-8967-3ad682d3d122" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019daa62-5508-787d-afe8-a738817a3b79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019daa62-5508-787d-afe8-a738817a3b79" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6dba-05aa-77cf-a2e1-2a23c817034e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_NetIncomeLoss_019d6dba-05aa-77cf-a2e1-2a23c817034e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019d4579-22d9-7ca0-bfac-d236f44a6604" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d4579-22d9-76f7-90f9-3f1cb2d12d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d4579-22d9-7d47-825a-e09bfd05fd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_StatementTable_019d4579-22d9-7d47-825a-e09bfd05fd7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7bc3-9847-0b7e6dea8e03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-7d47-825a-e09bfd05fd7f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7bc3-9847-0b7e6dea8e03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7bc3-9847-0b7e6dea8e03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7bc3-9847-0b7e6dea8e03" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7bc3-9847-0b7e6dea8e03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7af7-a465-23f6f86ac9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7bc3-9847-0b7e6dea8e03" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7af7-a465-23f6f86ac9e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7b2a-b839-5935618fb26b" xlink:href="aqst-20260331.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7af7-a465-23f6f86ac9e3" xlink:to="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7b2a-b839-5935618fb26b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7d88-b688-3ae48c7f91da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:to="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7d88-b688-3ae48c7f91da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019d4579-22d9-7b2c-b073-8fb8ba0bfae4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_DepreciationAndAmortization_019d4579-22d9-7b2c-b073-8fb8ba0bfae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d4579-22d9-7710-87b0-c5e9efd57982" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_ShareBasedCompensation_019d4579-22d9-7710-87b0-c5e9efd57982" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019dd936-1c07-775a-91be-79b26b99c63a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019dd936-1c07-775a-91be-79b26b99c63a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019d4579-22d9-7dc4-9c67-f9a876317ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019d4579-22d9-7dc4-9c67-f9a876317ea2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019d4579-22d9-7ce1-990f-d583d5b92fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019d4579-22d9-7ce1-990f-d583d5b92fbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_019d4579-22d9-7b19-8360-53dd98963cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_019d4579-22d9-7b19-8360-53dd98963cc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_019d4579-22d9-70d2-9bc2-f7255dfc5560" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_019d4579-22d9-70d2-9bc2-f7255dfc5560" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d4579-22d9-777a-9ea6-34484feef0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d4579-22d9-777a-9ea6-34484feef0e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d4579-22d9-7db2-8931-5b61e9a86c34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d4579-22d9-7db2-8931-5b61e9a86c34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d4579-22d9-719c-ac2c-3d5f8626ca5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d4579-22d9-719c-ac2c-3d5f8626ca5a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_019d4579-22d9-7253-80fd-86c43e1f30a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_019d4579-22d9-7253-80fd-86c43e1f30a2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-7fac-8dd0-8f4393883647" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-7fac-8dd0-8f4393883647" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d4579-22d9-75ae-b68b-54e98e4c34d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d4579-22d9-75ae-b68b-54e98e4c34d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-738a-92ff-3b5fd49b70b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-738a-92ff-3b5fd49b70b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_019dd939-9516-7362-9d8e-41bdd0132c3c" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_019dd939-9516-7362-9d8e-41bdd0132c3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019dfb6b-099f-77f3-a365-8dd138c22b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019dfb6b-099f-77f3-a365-8dd138c22b6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_019d6dd5-9056-7774-a045-a23f612f78e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_RepaymentsOfDebt_019d6dd5-9056-7774-a045-a23f612f78e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PaymentsForRoyaltyObligations_019d6dd6-21cc-71e5-bd6f-fd7a651c4f72" xlink:href="aqst-20260331.xsd#aqst_PaymentsForRoyaltyObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_aqst_PaymentsForRoyaltyObligations_019d6dd6-21cc-71e5-bd6f-fd7a651c4f72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d4579-22d9-789d-bf6c-5d1f182204f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d4579-22d9-789d-bf6c-5d1f182204f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-76de-9681-bbe3adafbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-76de-9681-bbe3adafbbaa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-754d-a3dc-bb13088677f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-754d-a3dc-bb13088677f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-22d9-7622-b744-0f5dedae3a38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-22d9-7622-b744-0f5dedae3a38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-22d9-7aa3-b124-f80add989f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-22d9-7622-b744-0f5dedae3a38" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-22d9-7aa3-b124-f80add989f3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-22d9-7b67-ab5f-f20f182ba8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_019d4579-22d9-7762-af5b-8699dd91e515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:to="loc_us-gaap_InterestPaidNet_019d4579-22d9-7762-af5b-8699dd91e515" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable_019d4579-22d9-77b8-98ab-c1df5ba02a80" xlink:href="aqst-20260331.xsd#aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:to="loc_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable_019d4579-22d9-77b8-98ab-c1df5ba02a80" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#CompanyOverviewandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7b74-e45b-75b1-9e25-6a03879eebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7b74-e45b-75b1-9e25-6a03879eebd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-75b1-9e25-6a03879eebd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7b74-e45b-75b1-9e25-6a03879eebd6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-75b1-9e25-6a03879eebd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7b74-e45b-75b1-9e25-6a03879eebd6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_EquityDistributionAgreementMember_019d7b74-e45b-7184-b119-fafa1b6ff0e4" xlink:href="aqst-20260331.xsd#aqst_EquityDistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:to="loc_aqst_EquityDistributionAgreementMember_019d7b74-e45b-7184-b119-fafa1b6ff0e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AmendedEquityDistributionAgreementMember_019d7b74-e45b-7b6a-b499-1189a21dbe80" xlink:href="aqst-20260331.xsd#aqst_AmendedEquityDistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:to="loc_aqst_AmendedEquityDistributionAgreementMember_019d7b74-e45b-7b6a-b499-1189a21dbe80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_UnderwrittenPublicOfferingMember_019d7b74-e45b-7fe0-b93f-4c7a10ba6692" xlink:href="aqst-20260331.xsd#aqst_UnderwrittenPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:to="loc_aqst_UnderwrittenPublicOfferingMember_019d7b74-e45b-7fe0-b93f-4c7a10ba6692" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d7b74-e45b-7ed7-93e3-6746e3ab7454" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:to="loc_srt_RangeAxis_019d7b74-e45b-7ed7-93e3-6746e3ab7454" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7b74-e45b-7ed7-93e3-6746e3ab7454_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d7b74-e45b-7ed7-93e3-6746e3ab7454" xlink:to="loc_srt_RangeMember_019d7b74-e45b-7ed7-93e3-6746e3ab7454_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7b74-e45b-742f-9c9d-b6d9d1132d55" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d7b74-e45b-7ed7-93e3-6746e3ab7454" xlink:to="loc_srt_RangeMember_019d7b74-e45b-742f-9c9d-b6d9d1132d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d7b74-e45b-7828-80c2-f12535ac6327" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d7b74-e45b-742f-9c9d-b6d9d1132d55" xlink:to="loc_srt_MaximumMember_019d7b74-e45b-7828-80c2-f12535ac6327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d7b74-e45b-77ff-9da7-d0f487b3a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d7b74-e45b-77ff-9da7-d0f487b3a7e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d7b74-e45b-76b7-adc1-f3afcaf6f54c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d7b74-e45b-76b7-adc1-f3afcaf6f54c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d7b74-e45b-7668-b651-e6fdd35c0165" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d7b74-e45b-7668-b651-e6fdd35c0165" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockMaximumTransactionAmount_019d7b74-e45b-7cfa-9f1e-cae8271cee7f" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockMaximumTransactionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_aqst_SaleOfStockMaximumTransactionAmount_019d7b74-e45b-7cfa-9f1e-cae8271cee7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockAggregateOfferingPrice_019d7b74-e45b-733f-bf89-edfc1b4cc1a5" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockAggregateOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_aqst_SaleOfStockAggregateOfferingPrice_019d7b74-e45b-733f-bf89-edfc1b4cc1a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_019d7b74-e45b-769a-8787-26a5510314e0" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_019d7b74-e45b-769a-8787-26a5510314e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019d7b74-e45b-7709-b854-401f794e46e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019d7b74-e45b-7709-b854-401f794e46e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019d7b74-e45b-7a5b-bbf7-7236eb44e547" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019d7b74-e45b-7a5b-bbf7-7236eb44e547" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RisksandUncertaintiesDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:to="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019d4579-22d9-7c53-8410-e09aacff525a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:to="loc_us-gaap_DebtInstrumentAxis_019d4579-22d9-7c53-8410-e09aacff525a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-7c53-8410-e09aacff525a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d4579-22d9-7c53-8410-e09aacff525a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-7c53-8410-e09aacff525a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-79cc-b189-9e519dfecdca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d4579-22d9-7c53-8410-e09aacff525a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-79cc-b189-9e519dfecdca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-22d9-7cf2-b6c4-c0115bec2ff9" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-79cc-b189-9e519dfecdca" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-22d9-7cf2-b6c4-c0115bec2ff9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019d7b81-6975-7727-9df0-3cedb9118597" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019d7b81-6975-7727-9df0-3cedb9118597" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6975-7727-9df0-3cedb9118597_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d7b81-6975-7727-9df0-3cedb9118597" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6975-7727-9df0-3cedb9118597_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6976-7dcd-80a0-434b1e3252f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d7b81-6975-7727-9df0-3cedb9118597" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6976-7dcd-80a0-434b1e3252f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019d7b81-6976-7c59-95bb-55bc498ad119" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6976-7dcd-80a0-434b1e3252f4" xlink:to="loc_us-gaap_SeniorNotesMember_019d7b81-6976-7c59-95bb-55bc498ad119" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7e44-85c7-38ba41a9d8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7e44-85c7-38ba41a9d8e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7ec5-984d-8e0b110b4529" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7ec5-984d-8e0b110b4529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d4579-22d9-7c24-a138-189cd2055921" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d4579-22d9-7c24-a138-189cd2055921" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019d7c21-71b8-70e3-9504-4bcaf9c01854" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019d7c21-71b8-70e3-9504-4bcaf9c01854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019d7c21-71b8-70e3-9504-4bcaf9c01854_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019d7c21-71b8-70e3-9504-4bcaf9c01854" xlink:to="loc_us-gaap_SegmentDomain_019d7c21-71b8-70e3-9504-4bcaf9c01854_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019d7c21-71b8-7b7e-93dd-fefb2df48b04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019d7c21-71b8-70e3-9504-4bcaf9c01854" xlink:to="loc_us-gaap_SegmentDomain_019d7c21-71b8-7b7e-93dd-fefb2df48b04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ReportableSegmentMember_019d7c21-71b8-74b0-b999-22a428b7b1ce" xlink:href="aqst-20260331.xsd#aqst_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_019d7c21-71b8-7b7e-93dd-fefb2df48b04" xlink:to="loc_aqst_ReportableSegmentMember_019d7c21-71b8-74b0-b999-22a428b7b1ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d7c21-71b8-7d91-a52f-77e6b200d04b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:to="loc_srt_ProductOrServiceAxis_019d7c21-71b8-7d91-a52f-77e6b200d04b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7d91-a52f-77e6b200d04b_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019d7c21-71b8-7d91-a52f-77e6b200d04b" xlink:to="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7d91-a52f-77e6b200d04b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019d7c21-71b8-7d91-a52f-77e6b200d04b" xlink:to="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AnaphylmMember_019d7c21-71b8-7cc7-9a83-bb55b6e0f0aa" xlink:href="aqst-20260331.xsd#aqst_AnaphylmMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_AnaphylmMember_019d7c21-71b8-7cc7-9a83-bb55b6e0f0aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AQST108Member_019d7c21-71b8-73c8-b702-dc1df8643afa" xlink:href="aqst-20260331.xsd#aqst_AQST108Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_AQST108Member_019d7c21-71b8-73c8-b702-dc1df8643afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PersonnelCostsMember_019d7c21-71b8-72fe-ab91-846f47875140" xlink:href="aqst-20260331.xsd#aqst_PersonnelCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_PersonnelCostsMember_019d7c21-71b8-72fe-ab91-846f47875140" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherMember_019d7c21-71b8-7f0d-b096-0372778b36d0" xlink:href="aqst-20260331.xsd#aqst_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_OtherMember_019d7c21-71b8-7f0d-b096-0372778b36d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c21-71b8-7a67-84ad-b847d9469fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c21-71b8-7a67-84ad-b847d9469fd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019d7c21-71b8-79af-a690-a63cb2846045" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019d7c21-71b8-79af-a690-a63cb2846045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d7c21-71b8-7338-8609-e1c416bb8cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d7c21-71b8-7338-8609-e1c416bb8cc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-7590-b200-0e6b9d49c807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-7590-b200-0e6b9d49c807" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingExpense_019d7c21-71b8-7c1f-88fa-5844eebbf0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-7590-b200-0e6b9d49c807" xlink:to="loc_us-gaap_SellingExpense_019d7c21-71b8-7c1f-88fa-5844eebbf0f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-79a6-abba-2dfa54a4536d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-79a6-abba-2dfa54a4536d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d7c21-71b8-70a3-a0c5-c8002799ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-79a6-abba-2dfa54a4536d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d7c21-71b8-70a3-a0c5-c8002799ba9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d7c21-71b8-7484-a6d6-b774bc47f442" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d7c21-71b8-7484-a6d6-b774bc47f442" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019d7c21-71b8-74c3-b64d-a2c15547b943" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_CostsAndExpenses_019d7c21-71b8-74c3-b64d-a2c15547b943" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d7c21-71b8-73e2-bac2-a675ee74738c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d7c21-71b8-73e2-bac2-a675ee74738c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d7c21-71b8-77e0-b198-96673dd7046d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d7c21-71b8-77e0-b198-96673dd7046d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d7c21-71b8-719c-a251-587b10b74a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d7c21-71b8-719c-a251-587b10b74a6a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d7c21-71b8-7f8a-aeb0-96da7465d347" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_NetIncomeLoss_019d7c21-71b8-7f8a-aeb0-96da7465d347" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d7c21-71b8-7eb2-99ba-aae3df6637a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d7c21-71b8-7eb2-99ba-aae3df6637a0" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d4579-22d9-7262-a00b-a54e183a1273" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_srt_RangeAxis_019d4579-22d9-7262-a00b-a54e183a1273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-22d9-7262-a00b-a54e183a1273_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d4579-22d9-7262-a00b-a54e183a1273" xlink:to="loc_srt_RangeMember_019d4579-22d9-7262-a00b-a54e183a1273_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-22d9-7c72-b1ab-34455b22db5e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d4579-22d9-7262-a00b-a54e183a1273" xlink:to="loc_srt_RangeMember_019d4579-22d9-7c72-b1ab-34455b22db5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d4579-22d9-7235-a856-ec2e02da40c7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d4579-22d9-7c72-b1ab-34455b22db5e" xlink:to="loc_srt_MaximumMember_019d4579-22d9-7235-a856-ec2e02da40c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-22d9-70f7-a90b-d9b15c6c2b61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-22d9-70f7-a90b-d9b15c6c2b61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-70f7-a90b-d9b15c6c2b61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-22d9-70f7-a90b-d9b15c6c2b61" xlink:to="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-70f7-a90b-d9b15c6c2b61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-22d9-70f7-a90b-d9b15c6c2b61" xlink:to="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_019d4579-22d9-741b-8dc5-11f11e1faf7b" xlink:href="aqst-20260331.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:to="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_019d4579-22d9-741b-8dc5-11f11e1faf7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAccountsReceivableMember_019d4579-22d9-7860-9e2a-163e32853250" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:to="loc_us-gaap_TradeAccountsReceivableMember_019d4579-22d9-7860-9e2a-163e32853250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherReceivablesAndAccruedExpensesMember_019d4579-22d9-7dc5-8c4f-97dcc360a749" xlink:href="aqst-20260331.xsd#aqst_OtherReceivablesAndAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:to="loc_aqst_OtherReceivablesAndAccruedExpensesMember_019d4579-22d9-7dc5-8c4f-97dcc360a749" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_019d4579-22d9-7761-96fe-449c2dfca77f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_srt_MajorCustomersAxis_019d4579-22d9-7761-96fe-449c2dfca77f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7761-96fe-449c2dfca77f_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_019d4579-22d9-7761-96fe-449c2dfca77f" xlink:to="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7761-96fe-449c2dfca77f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_019d4579-22d9-7761-96fe-449c2dfca77f" xlink:to="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember_019d4579-22d9-773a-bfff-6a5e8132ef1f" xlink:href="aqst-20260331.xsd#aqst_IndiviorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_IndiviorMember_019d4579-22d9-773a-bfff-6a5e8132ef1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraMember_019daa6b-cc28-70a8-94da-22356b6c0aeb" xlink:href="aqst-20260331.xsd#aqst_ZevraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_ZevraMember_019daa6b-cc28-70a8-94da-22356b6c0aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember_019daa6d-a479-7e9f-a21b-2d01effea4d4" xlink:href="aqst-20260331.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_AssertioHoldingsIncMember_019daa6d-a479-7e9f-a21b-2d01effea4d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HyperaMember_019d4579-22d9-73b0-8919-48e6405abfac" xlink:href="aqst-20260331.xsd#aqst_HyperaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_HyperaMember_019d4579-22d9-73b0-8919-48e6405abfac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-22d9-7e91-954d-e66b9fb6700a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-22d9-7e91-954d-e66b9fb6700a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-7e91-954d-e66b9fb6700a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-22d9-7e91-954d-e66b9fb6700a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-7e91-954d-e66b9fb6700a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-22d9-7e91-954d-e66b9fb6700a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_019d4579-22d9-703c-94c0-828c4e77d13c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_019d4579-22d9-703c-94c0-828c4e77d13c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_019d4579-22d9-7d3d-a00d-3a4d86419f77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:to="loc_us-gaap_AccountsReceivableMember_019d4579-22d9-7d3d-a00d-3a4d86419f77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_019d4579-22d9-7570-9501-c179664d2574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_019d4579-22d9-7570-9501-c179664d2574" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-7570-9501-c179664d2574_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_019d4579-22d9-7570-9501-c179664d2574" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-7570-9501-c179664d2574_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-70de-aef7-3ab1a7b95e69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_019d4579-22d9-7570-9501-c179664d2574" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-70de-aef7-3ab1a7b95e69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_019d4579-22d9-791e-b469-364debc30e28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-70de-aef7-3ab1a7b95e69" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_019d4579-22d9-791e-b469-364debc30e28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ResearchAndDevelopmentProjectDuration_019d4579-22d9-7d1c-820a-6625bae81bf1" xlink:href="aqst-20260331.xsd#aqst_ResearchAndDevelopmentProjectDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_aqst_ResearchAndDevelopmentProjectDuration_019d4579-22d9-7d1c-820a-6625bae81bf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_019d4579-22d9-77ed-bf92-60d27a264f98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_019d4579-22d9-77ed-bf92-60d27a264f98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019d4579-22d9-7ecb-928f-4e5ecbb6c9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019d4579-22d9-7ecb-928f-4e5ecbb6c9c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_019d4579-22d9-7c16-9a95-89bf84bbfeec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_CapitalizedContractCostNet_019d4579-22d9-7c16-9a95-89bf84bbfeec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c61-77a2-799a-b899-5e5f9cd1adaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c61-77a2-799a-b899-5e5f9cd1adaa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-22d9-721d-8272-0d19e640ead6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-22d9-721d-8272-0d19e640ead6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_019d7e1d-a71f-7214-99d3-ae509fa9137e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_019d7e1d-a71f-7214-99d3-ae509fa9137e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofRevenueDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c62-e7fc-775f-a8ee-f7d75e0b79f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c62-e7fc-775f-a8ee-f7d75e0b79f5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d7c62-e7fc-7ae6-8948-911792614779" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:to="loc_srt_ProductOrServiceAxis_019d7c62-e7fc-7ae6-8948-911792614779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-7ae6-8948-911792614779_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019d7c62-e7fc-7ae6-8948-911792614779" xlink:to="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-7ae6-8948-911792614779_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019d7c62-e7fc-7ae6-8948-911792614779" xlink:to="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember_019d7c62-e7fc-79ae-a58f-e3aa510dbc8b" xlink:href="aqst-20260331.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_ManufactureAndSupplyRevenueMember_019d7c62-e7fc-79ae-a58f-e3aa510dbc8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_019d7c62-e7fc-7f9d-937c-a67a45dca6e7" xlink:href="aqst-20260331.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_019d7c62-e7fc-7f9d-937c-a67a45dca6e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CoDevelopmentAndResearchFeesMember_019d7c62-e7fc-75d6-b948-b5f10c8b5676" xlink:href="aqst-20260331.xsd#aqst_CoDevelopmentAndResearchFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_CoDevelopmentAndResearchFeesMember_019d7c62-e7fc-75d6-b948-b5f10c8b5676" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProprietaryProductRevenueMember_019d7c62-e7fc-7540-9036-a5e3989d75aa" xlink:href="aqst-20260331.xsd#aqst_ProprietaryProductRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_ProprietaryProductRevenueMember_019d7c62-e7fc-7540-9036-a5e3989d75aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019dac4b-d927-7fe1-8afa-eb879e5de1be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019dac4b-d927-7fe1-8afa-eb879e5de1be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-7fe1-8afa-eb879e5de1be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019dac4b-d927-7fe1-8afa-eb879e5de1be" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-7fe1-8afa-eb879e5de1be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-783c-b62e-adb95bdf2c77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019dac4b-d927-7fe1-8afa-eb879e5de1be" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-783c-b62e-adb95bdf2c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dac4b-d927-79d3-beed-225277448999" xlink:href="aqst-20260331.xsd#aqst_ZevraAndCommaveTherapeuticsAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-783c-b62e-adb95bdf2c77" xlink:to="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dac4b-d927-79d3-beed-225277448999" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c62-e7fc-7552-a3f3-2d461113ec0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c62-e7fc-775f-a8ee-f7d75e0b79f5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c62-e7fc-7552-a3f3-2d461113ec0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c64-802b-7129-821b-f38eda858260" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d7c64-802b-7a70-a7a6-4881e9f8dcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c64-802b-7129-821b-f38eda858260" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d7c64-802b-7a70-a7a6-4881e9f8dcf2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019d7c64-802b-75e7-9918-10a596127884" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c64-802b-7a70-a7a6-4881e9f8dcf2" xlink:to="loc_srt_StatementGeographicalAxis_019d7c64-802b-75e7-9918-10a596127884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019d7c64-802b-75e7-9918-10a596127884_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_019d7c64-802b-75e7-9918-10a596127884" xlink:to="loc_srt_SegmentGeographicalDomain_019d7c64-802b-75e7-9918-10a596127884_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_019d7c64-802b-75e7-9918-10a596127884" xlink:to="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019d7c64-802b-78ff-8fac-0013066c427b" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:to="loc_country_US_019d7c64-802b-78ff-8fac-0013066c427b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_019d7c64-802b-7428-805b-e89a531bdc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:to="loc_us-gaap_NonUsMember_019d7c64-802b-7428-805b-e89a531bdc2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c64-802b-7026-b478-00347e76fff6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c64-802b-7129-821b-f38eda858260" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c64-802b-7026-b478-00347e76fff6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_019d7c68-87fa-73ca-b85c-a4d52f01928f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d7c68-87fa-7c40-8b5c-b887cf69454d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_019d7c68-87fa-73ca-b85c-a4d52f01928f" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d7c68-87fa-7c40-8b5c-b887cf69454d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d7c68-87fa-758f-87cd-e6040ed20cab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d7c68-87fa-7c40-8b5c-b887cf69454d" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d7c68-87fa-758f-87cd-e6040ed20cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-758f-87cd-e6040ed20cab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d7c68-87fa-758f-87cd-e6040ed20cab" xlink:to="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-758f-87cd-e6040ed20cab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-729b-99a0-5d592359ef43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d7c68-87fa-758f-87cd-e6040ed20cab" xlink:to="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-729b-99a0-5d592359ef43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember_019d7c68-87fa-79ec-a0cc-7fdd4d5ec7a8" xlink:href="aqst-20260331.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-729b-99a0-5d592359ef43" xlink:to="loc_aqst_TradeAccountsReceivableSalesRelatedMember_019d7c68-87fa-79ec-a0cc-7fdd4d5ec7a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_019d7c68-87fa-73ca-b85c-a4d52f01928f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d7c68-87fa-75ad-b80e-4a7969768f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d7c68-87fa-75ad-b80e-4a7969768f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_019d7c68-87fa-7dbc-94c9-734524f379da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_019d7c68-87fa-7dbc-94c9-734524f379da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_019d7c68-87fa-7218-b72f-59185eddedc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_019d7c68-87fa-7218-b72f-59185eddedc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_019d7c68-87fa-7d47-a0c4-751a6e3520e0" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowanceForCreditLossReclassifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_019d7c68-87fa-7d47-a0c4-751a6e3520e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d7c68-87fa-7266-8709-2bf88bf6c017" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#MaterialAgreementsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d7c84-1953-7e17-baa0-843edb169035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d7c84-1953-7e17-baa0-843edb169035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-7e17-baa0-843edb169035_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d7c84-1953-7e17-baa0-843edb169035" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-7e17-baa0-843edb169035_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d7c84-1953-7e17-baa0-843edb169035" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RTWInvestmentsLPMember_019d7c84-1953-7b81-8e00-bbe17c812908" xlink:href="aqst-20260331.xsd#aqst_RTWInvestmentsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_RTWInvestmentsLPMember_019d7c84-1953-7b81-8e00-bbe17c812908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_019d7c84-3e6f-72f8-b5a2-3459102aa0fd" xlink:href="aqst-20260331.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_019d7c84-3e6f-72f8-b5a2-3459102aa0fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_019d7c84-6cc1-75ab-ad7a-5cf33b9af190" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_019d7c84-6cc1-75ab-ad7a-5cf33b9af190" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_019d7c84-5718-721d-a4d8-f6477b6343cc" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_019d7c84-5718-721d-a4d8-f6477b6343cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_019dda6d-2627-7586-820b-8235f23da6d4" xlink:href="aqst-20260331.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_019dda6d-2627-7586-820b-8235f23da6d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dda6d-5a36-7b5a-881f-5bc30509aa68" xlink:href="aqst-20260331.xsd#aqst_ZevraAndCommaveTherapeuticsAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dda6d-5a36-7b5a-881f-5bc30509aa68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember_019dda6d-5a36-76a4-ac12-87007e543453" xlink:href="aqst-20260331.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_AtnahsPharmaUKLimitedMember_019dda6d-5a36-76a4-ac12-87007e543453" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_019dda6d-754a-7eca-a976-e96aaf0d2c56" xlink:href="aqst-20260331.xsd#aqst_AtnahsPharmaUKLimitedAmendedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_019dda6d-754a-7eca-a976-e96aaf0d2c56" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019dda6c-57c6-78e0-9ca6-738999a75f49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_CreditFacilityAxis_019dda6c-57c6-78e0-9ca6-738999a75f49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-78e0-9ca6-738999a75f49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_019dda6c-57c6-78e0-9ca6-738999a75f49" xlink:to="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-78e0-9ca6-738999a75f49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_019dda6c-57c6-78e0-9ca6-738999a75f49" xlink:to="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PurchaseAndSaleAgreementMember_019dda6c-57c6-7011-8aa7-1b84cc9e1b45" xlink:href="aqst-20260331.xsd#aqst_PurchaseAndSaleAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:to="loc_aqst_PurchaseAndSaleAgreementMember_019dda6c-57c6-7011-8aa7-1b84cc9e1b45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_019dda6d-2627-7935-836c-3e34110aa8c1" xlink:href="aqst-20260331.xsd#aqst_MonetizationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:to="loc_aqst_MonetizationAgreementMember_019dda6d-2627-7935-836c-3e34110aa8c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember_019dda6d-5a36-7327-8e8e-5a4f85fb2ee7" xlink:href="aqst-20260331.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:to="loc_aqst_LicenseSupplyAgreementMember_019dda6d-5a36-7327-8e8e-5a4f85fb2ee7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda6c-57c6-74e6-95a1-0797f9e682cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda6c-57c6-74e6-95a1-0797f9e682cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-74e6-95a1-0797f9e682cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda6c-57c6-74e6-95a1-0797f9e682cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-74e6-95a1-0797f9e682cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-7ef4-b239-5708fc93e8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda6c-57c6-74e6-95a1-0797f9e682cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-7ef4-b239-5708fc93e8b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda6c-57c6-70a1-9259-342cfbe49387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-7ef4-b239-5708fc93e8b8" xlink:to="loc_us-gaap_SeniorNotesMember_019dda6c-57c6-70a1-9259-342cfbe49387" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda6c-57c6-7c54-96b8-31becf980f70" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_srt_RangeAxis_019dda6c-57c6-7c54-96b8-31becf980f70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda6c-57c6-7c54-96b8-31becf980f70_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019dda6c-57c6-7c54-96b8-31becf980f70" xlink:to="loc_srt_RangeMember_019dda6c-57c6-7c54-96b8-31becf980f70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019dda6c-57c6-7c54-96b8-31becf980f70" xlink:to="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda6c-57c6-750b-a158-831a7ace9bb8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:to="loc_srt_MinimumMember_019dda6c-57c6-750b-a158-831a7ace9bb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda6c-57c6-79ff-90e8-fb2d5769f82b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:to="loc_srt_MaximumMember_019dda6c-57c6-79ff-90e8-fb2d5769f82b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019dda6c-ed83-7779-95d7-be25947b4195" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_srt_ProductOrServiceAxis_019dda6c-ed83-7779-95d7-be25947b4195" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7779-95d7-be25947b4195_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019dda6c-ed83-7779-95d7-be25947b4195" xlink:to="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7779-95d7-be25947b4195_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7986-bc8d-278b05208d28" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019dda6c-ed83-7779-95d7-be25947b4195" xlink:to="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7986-bc8d-278b05208d28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_019dda6c-ed83-794e-b9f6-523c12382cdb" xlink:href="aqst-20260331.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7986-bc8d-278b05208d28" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_019dda6c-ed83-794e-b9f6-523c12382cdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019dda6d-5a36-70b4-ad97-511618a81d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019dda6d-5a36-70b4-ad97-511618a81d5f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-70b4-ad97-511618a81d5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019dda6d-5a36-70b4-ad97-511618a81d5f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-70b4-ad97-511618a81d5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-7179-994f-b1d0cebe9a05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019dda6d-5a36-70b4-ad97-511618a81d5f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-7179-994f-b1d0cebe9a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019dda6d-5a36-7aea-97b5-fd458bd70d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-7179-994f-b1d0cebe9a05" xlink:to="loc_us-gaap_SubsequentEventMember_019dda6d-5a36-7aea-97b5-fd458bd70d1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019dda6d-754a-78f0-947d-cac976d3554d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_srt_CounterpartyNameAxis_019dda6d-754a-78f0-947d-cac976d3554d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-78f0-947d-cac976d3554d_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_019dda6d-754a-78f0-947d-cac976d3554d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-78f0-947d-cac976d3554d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-7056-9d9f-47f6cf8fb311" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_019dda6d-754a-78f0-947d-cac976d3554d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-7056-9d9f-47f6cf8fb311" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember_019dda6d-754a-7b92-84f2-42bc033649ac" xlink:href="aqst-20260331.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-7056-9d9f-47f6cf8fb311" xlink:to="loc_aqst_AssertioHoldingsIncMember_019dda6d-754a-7b92-84f2-42bc033649ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests_019dda6c-57c6-7969-b54c-30e24d9f50a0" xlink:href="aqst-20260331.xsd#aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests_019dda6c-57c6-7969-b54c-30e24d9f50a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda6c-57c6-7fe2-b1f5-63fe18de78a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda6c-57c6-7fe2-b1f5-63fe18de78a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementRevenueSharingPercentage_019dda6c-57c6-7876-81a4-7832d2796c1a" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementRevenueSharingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CollaborativeArrangementRevenueSharingPercentage_019dda6c-57c6-7876-81a4-7832d2796c1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen_019dda6c-57c6-7b5f-b129-75f7046a7940" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen_019dda6c-57c6-7b5f-b129-75f7046a7940" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter_019dda6c-57c6-7164-b3ce-4375b5194be6" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter_019dda6c-57c6-7164-b3ce-4375b5194be6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CapitalizedLegalFees_019dda6c-57c6-7ac5-9969-124b7b525957" xlink:href="aqst-20260331.xsd#aqst_CapitalizedLegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CapitalizedLegalFees_019dda6c-57c6-7ac5-9969-124b7b525957" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda6c-971d-78a7-ad7b-8635eba91130" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda6c-971d-78a7-ad7b-8635eba91130" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda6c-971d-7754-a62e-5b339356f5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda6c-971d-7754-a62e-5b339356f5a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockSharesCommittedAggregateAmount_019dda6c-971d-7d23-ac69-c1d88cacfd67" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockSharesCommittedAggregateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_SaleOfStockSharesCommittedAggregateAmount_019dda6c-971d-7d23-ac69-c1d88cacfd67" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate_019dda6c-971d-7314-897b-b90a0558a3ad" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate_019dda6c-971d-7314-897b-b90a0558a3ad" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementTerm_019dda6c-c0cc-7909-a984-f8b82fc133bc" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_LicenseAgreementTerm_019dda6c-c0cc-7909-a984-f8b82fc133bc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AutomaticRenewalPeriodOfAgreement_019dda6c-c0cc-7483-b486-c7dff584b046" xlink:href="aqst-20260331.xsd#aqst_AutomaticRenewalPeriodOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_AutomaticRenewalPeriodOfAgreement_019dda6c-c0cc-7483-b486-c7dff584b046" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019dda6c-ed83-7eb5-8bc4-8464d631475c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019dda6c-ed83-7eb5-8bc4-8464d631475c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019dda6d-2627-7ec6-b785-68d7aa1627e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_Revenues_019dda6d-2627-7ec6-b785-68d7aa1627e3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e34-87f3-7900f24dfa0b" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e34-87f3-7900f24dfa0b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e99-8d44-d90a0e942994" xlink:href="aqst-20260331.xsd#aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e99-8d44-d90a0e942994" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019dda6d-2627-7550-8164-76551c00b760" xlink:href="aqst-20260331.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019dda6d-2627-7550-8164-76551c00b760" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_019dda6d-754a-7704-bac4-1a63c2905b30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_ProceedsFromCollaborators_019dda6d-754a-7704-bac4-1a63c2905b30" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#FinancialInstrumentsFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019dda7e-a484-7e22-8f9b-9600d887c9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019dda7e-a484-7e22-8f9b-9600d887c9b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-7e22-8f9b-9600d887c9b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dda7e-a484-7e22-8f9b-9600d887c9b5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-7e22-8f9b-9600d887c9b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-70fb-9077-90f83428b8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dda7e-a484-7e22-8f9b-9600d887c9b5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-70fb-9077-90f83428b8b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SecuritiesPurchaseAgreementMember_019dda7e-a484-7826-aa66-4efb55ad5b53" xlink:href="aqst-20260331.xsd#aqst_SecuritiesPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-70fb-9077-90f83428b8b8" xlink:to="loc_aqst_SecuritiesPurchaseAgreementMember_019dda7e-a484-7826-aa66-4efb55ad5b53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda7e-a484-777e-9334-8c52f3ede9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda7e-a484-777e-9334-8c52f3ede9a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-777e-9334-8c52f3ede9a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda7e-a484-777e-9334-8c52f3ede9a0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-777e-9334-8c52f3ede9a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda7e-a484-777e-9334-8c52f3ede9a0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_019dda7e-a484-7f3c-bbcb-cb862aa1acfa" xlink:href="aqst-20260331.xsd#aqst_ExistingWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:to="loc_aqst_ExistingWarrantsMember_019dda7e-a484-7f3c-bbcb-cb862aa1acfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_019dda7e-a484-7db5-992b-5a63c6b59b2d" xlink:href="aqst-20260331.xsd#aqst_NewWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:to="loc_aqst_NewWarrantsMember_019dda7e-a484-7db5-992b-5a63c6b59b2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember_019dda7e-a484-7d79-8ca8-9a769acd2a26" xlink:href="aqst-20260331.xsd#aqst_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:to="loc_aqst_CommonStockWarrantsMember_019dda7e-a484-7d79-8ca8-9a769acd2a26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dda7e-a484-7a6e-bfc9-66cffb4d7b40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dda7e-a484-7a6e-bfc9-66cffb4d7b40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7a6e-bfc9-66cffb4d7b40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda7e-a484-7a6e-bfc9-66cffb4d7b40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7a6e-bfc9-66cffb4d7b40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7984-a26c-a296febf96f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda7e-a484-7a6e-bfc9-66cffb4d7b40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7984-a26c-a296febf96f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda7e-a484-7015-8da6-23a4f1525c86" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7984-a26c-a296febf96f8" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda7e-a484-7015-8da6-23a4f1525c86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda7e-a484-770e-9cd9-0bb4da28845a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda7e-a484-770e-9cd9-0bb4da28845a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-770e-9cd9-0bb4da28845a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda7e-a484-770e-9cd9-0bb4da28845a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-770e-9cd9-0bb4da28845a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-71b5-a969-d45c10039177" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda7e-a484-770e-9cd9-0bb4da28845a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-71b5-a969-d45c10039177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda7e-a484-7457-857c-068d638abcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-71b5-a969-d45c10039177" xlink:to="loc_us-gaap_SeniorNotesMember_019dda7e-a484-7457-857c-068d638abcbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda7e-a484-7838-a4cc-c208758052b5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_srt_RangeAxis_019dda7e-a484-7838-a4cc-c208758052b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda7e-a484-7838-a4cc-c208758052b5_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019dda7e-a484-7838-a4cc-c208758052b5" xlink:to="loc_srt_RangeMember_019dda7e-a484-7838-a4cc-c208758052b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019dda7e-a484-7838-a4cc-c208758052b5" xlink:to="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda7e-a484-728d-8580-0b17177f481f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:to="loc_srt_MinimumMember_019dda7e-a484-728d-8580-0b17177f481f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda7e-a484-73eb-b388-72a7afc53426" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:to="loc_srt_MaximumMember_019dda7e-a484-73eb-b388-72a7afc53426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_019dda7e-a484-7a07-95b7-b55efaf47ebe" xlink:href="aqst-20260331.xsd#aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_019dda7e-a484-7a07-95b7-b55efaf47ebe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_019dda7e-a484-749f-829b-f46044276ea8" xlink:href="aqst-20260331.xsd#aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_019dda7e-a484-749f-829b-f46044276ea8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda7e-a484-76a6-aac7-8494cd61cc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda7e-a484-76a6-aac7-8494cd61cc5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda7e-a484-7215-9693-b9d6214ce58c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda7e-a484-7215-9693-b9d6214ce58c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda7e-a484-7742-8379-5af4e90a6f23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda7e-a484-7742-8379-5af4e90a6f23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda7e-a484-7a19-83ae-f986266ce1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda7e-a484-7a19-83ae-f986266ce1dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda7e-a484-7441-a795-887868b9a51b" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationPercentOfNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda7e-a484-7441-a795-887868b9a51b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationTerm_019dda7e-a484-73f5-836b-0b5162cce000" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_RoyaltyObligationTerm_019dda7e-a484-73f5-836b-0b5162cce000" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019dda7e-a484-7612-b93f-95d41393a51c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019dda7e-a484-7612-b93f-95d41393a51c" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-22d9-7bc6-80ae-6a5cb952c2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-22d9-7bc6-80ae-6a5cb952c2ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7bc6-80ae-6a5cb952c2ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-22d9-7bc6-80ae-6a5cb952c2ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7bc6-80ae-6a5cb952c2ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-22d9-7bc6-80ae-6a5cb952c2ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_019d4579-22d9-77e9-95a4-ad7491131f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_019d4579-22d9-77e9-95a4-ad7491131f4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_019d4579-22d9-751a-87f3-55ced9269af7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_019d4579-22d9-751a-87f3-55ced9269af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019d4579-22d9-713c-99d6-c647d779f373" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019d4579-22d9-713c-99d6-c647d779f373" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_019d4579-22d9-72ae-b8f8-5863fdfa1697" xlink:href="aqst-20260331.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_019d4579-22d9-72ae-b8f8-5863fdfa1697" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_019d4579-22d9-7497-931b-e11ea2127763" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_ConstructionInProgressMember_019d4579-22d9-7497-931b-e11ea2127763" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d4579-22d9-7189-b6ea-da64716ae832" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:to="loc_srt_RangeAxis_019d4579-22d9-7189-b6ea-da64716ae832" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-22d9-7189-b6ea-da64716ae832_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d4579-22d9-7189-b6ea-da64716ae832" xlink:to="loc_srt_RangeMember_019d4579-22d9-7189-b6ea-da64716ae832_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d4579-22d9-7189-b6ea-da64716ae832" xlink:to="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d4579-22d9-7419-9313-cbe529c09d03" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:to="loc_srt_MinimumMember_019d4579-22d9-7419-9313-cbe529c09d03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d4579-22d9-75da-a4e2-24cdd30b4bf5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:to="loc_srt_MaximumMember_019d4579-22d9-75da-a4e2-24cdd30b4bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019d4579-237c-7541-a855-5f78a6f91a23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019d4579-237c-7541-a855-5f78a6f91a23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019d4579-237c-7993-a433-710a17c0d8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019d4579-237c-7993-a433-710a17c0d8b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019d4579-237c-7e65-9857-2db279f0dc14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019d4579-237c-7e65-9857-2db279f0dc14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-237c-79d8-9b51-ca1edfa63090" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-237c-79d8-9b51-ca1edfa63090" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RightofUseAssetsandLeaseObligationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019d4579-237c-7325-93a0-541558c71178" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019d4579-237c-7325-93a0-541558c71178" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d4579-237c-7164-89e9-252cc4dcf807" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019d4579-237c-7325-93a0-541558c71178" xlink:to="loc_srt_RangeAxis_019d4579-237c-7164-89e9-252cc4dcf807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-237c-7164-89e9-252cc4dcf807_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d4579-237c-7164-89e9-252cc4dcf807" xlink:to="loc_srt_RangeMember_019d4579-237c-7164-89e9-252cc4dcf807_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d4579-237c-7164-89e9-252cc4dcf807" xlink:to="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d4579-237c-7fdf-8a4c-b106e1fdec0a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:to="loc_srt_MinimumMember_019d4579-237c-7fdf-8a4c-b106e1fdec0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d4579-237c-7e54-8245-b78978190aac" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:to="loc_srt_MaximumMember_019d4579-237c-7e54-8245-b78978190aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfOperatingLeases_019d4579-237c-798a-97a5-62e515ef60c0" xlink:href="aqst-20260331.xsd#aqst_NumberOfOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_aqst_NumberOfOperatingLeases_019d4579-237c-798a-97a5-62e515ef60c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019d4579-237c-7530-8660-e8e03bb8be2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019d4579-237c-7530-8660-e8e03bb8be2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_019d4579-237c-7139-b55f-b6fbc60d051b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_019d4579-237c-7139-b55f-b6fbc60d051b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_019d4579-237c-725a-b7f2-1bdc17b0dc50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_OperatingLeaseCost_019d4579-237c-725a-b7f2-1bdc17b0dc50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_019d4579-237c-7409-8b1a-78e8cdc2d3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_VariableLeaseCost_019d4579-237c-7409-8b1a-78e8cdc2d3b0" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNoncurrentAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d4579-237c-7c71-8547-47e4d278f1fa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:to="loc_srt_ProductOrServiceAxis_019d4579-237c-7c71-8547-47e4d278f1fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d4579-237c-7c71-8547-47e4d278f1fa_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019d4579-237c-7c71-8547-47e4d278f1fa" xlink:to="loc_srt_ProductsAndServicesDomain_019d4579-237c-7c71-8547-47e4d278f1fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d4579-237c-7a0c-9929-97a561f67a3d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019d4579-237c-7c71-8547-47e4d278f1fa" xlink:to="loc_srt_ProductsAndServicesDomain_019d4579-237c-7a0c-9929-97a561f67a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019d4579-237c-7ab9-a141-b0d804a833a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d4579-237c-7a0c-9929-97a561f67a3d" xlink:to="loc_us-gaap_RoyaltyMember_019d4579-237c-7ab9-a141-b0d804a833a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d4579-237c-7a26-aa33-42c1276b95ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d4579-237c-7a26-aa33-42c1276b95ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-7a26-aa33-42c1276b95ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d4579-237c-7a26-aa33-42c1276b95ac" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-7a26-aa33-42c1276b95ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-74c8-b963-65d416699da0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d4579-237c-7a26-aa33-42c1276b95ac" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-74c8-b963-65d416699da0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d4579-237c-7403-ba9a-d569b6719abb" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-74c8-b963-65d416699da0" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d4579-237c-7403-ba9a-d569b6719abb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-7598-9e34-d68738658c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-7598-9e34-d68738658c8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfGuaranteedRoyaltyPayments_019d4579-237c-73ff-8cfd-d492cbd6258c" xlink:href="aqst-20260331.xsd#aqst_NumberOfGuaranteedRoyaltyPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_aqst_NumberOfGuaranteedRoyaltyPayments_019d4579-237c-73ff-8cfd-d492cbd6258c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_019d4579-237c-7e6a-90bb-ab4ad44171b3" xlink:href="aqst-20260331.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_019d4579-237c-7e6a-90bb-ab4ad44171b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_019d4579-237c-7904-b09d-7953025257a5" xlink:href="aqst-20260331.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_019d4579-237c-7904-b09d-7953025257a5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dda83-d084-7b06-9498-1d34196cae7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dda83-d084-7b06-9498-1d34196cae7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7b06-9498-1d34196cae7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda83-d084-7b06-9498-1d34196cae7e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7b06-9498-1d34196cae7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda83-d084-7b06-9498-1d34196cae7e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda83-d084-7297-bad4-f3a2ca8c0794" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda83-d084-7297-bad4-f3a2ca8c0794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda83-d084-7fef-b521-846d78cb4a33" xlink:href="aqst-20260331.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda83-d084-7fef-b521-846d78cb4a33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_019dda84-4229-78e4-936c-a5eccd9c4e68" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_RoyaltyObligationsMember_019dda84-4229-78e4-936c-a5eccd9c4e68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ABLFacilityMember_019dda84-5b87-7502-9a8e-cf54eb13235b" xlink:href="aqst-20260331.xsd#aqst_ABLFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_ABLFacilityMember_019dda84-5b87-7502-9a8e-cf54eb13235b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TermLoanFacilityMember_019e1f23-9665-7485-924d-542f09259856" xlink:href="aqst-20260331.xsd#aqst_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_TermLoanFacilityMember_019e1f23-9665-7485-924d-542f09259856" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyRightAgreementsMember_019dda84-8d07-7821-8cc9-ea6d9f5ab77a" xlink:href="aqst-20260331.xsd#aqst_RoyaltyRightAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_RoyaltyRightAgreementsMember_019dda84-8d07-7821-8cc9-ea6d9f5ab77a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda83-d084-78c2-b1c9-52576d0c0de7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda83-d084-78c2-b1c9-52576d0c0de7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-78c2-b1c9-52576d0c0de7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda83-d084-78c2-b1c9-52576d0c0de7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-78c2-b1c9-52576d0c0de7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda83-d084-78c2-b1c9-52576d0c0de7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda83-d084-70df-857b-9e110d340bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:to="loc_us-gaap_SeniorNotesMember_019dda83-d084-70df-857b-9e110d340bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_019e1f23-9665-75f7-8d52-d86fdab77429" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:to="loc_us-gaap_LineOfCreditMember_019e1f23-9665-75f7-8d52-d86fdab77429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_019dda84-8d07-7322-8ea6-b44dc7f14853" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:to="loc_us-gaap_UnsecuredDebtMember_019dda84-8d07-7322-8ea6-b44dc7f14853" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioAxis_019dda84-4229-73ac-a1b6-b318c76759ca" xlink:href="aqst-20260331.xsd#aqst_DebtCovenantRedemptionScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioAxis_019dda84-4229-73ac-a1b6-b318c76759ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-73ac-a1b6-b318c76759ca_default" xlink:href="aqst-20260331.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis_019dda84-4229-73ac-a1b6-b318c76759ca" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-73ac-a1b6-b318c76759ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:href="aqst-20260331.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis_019dda84-4229-73ac-a1b6-b318c76759ca" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario1Member_019dda84-4229-7526-b994-07862ccf38d8" xlink:href="aqst-20260331.xsd#aqst_RedemptionScenario1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:to="loc_aqst_RedemptionScenario1Member_019dda84-4229-7526-b994-07862ccf38d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario2Member_019dda84-4229-7657-8644-6fc6ebc88b92" xlink:href="aqst-20260331.xsd#aqst_RedemptionScenario2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:to="loc_aqst_RedemptionScenario2Member_019dda84-4229-7657-8644-6fc6ebc88b92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda84-5b87-7f2e-bd60-73228c942109" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_srt_RangeAxis_019dda84-5b87-7f2e-bd60-73228c942109" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda84-5b87-7f2e-bd60-73228c942109_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019dda84-5b87-7f2e-bd60-73228c942109" xlink:to="loc_srt_RangeMember_019dda84-5b87-7f2e-bd60-73228c942109_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019dda84-5b87-7f2e-bd60-73228c942109" xlink:to="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda84-5b87-72cd-af05-eec3133ce30c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:to="loc_srt_MinimumMember_019dda84-5b87-72cd-af05-eec3133ce30c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda84-5b87-75d0-b82e-dade31499900" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:to="loc_srt_MaximumMember_019dda84-5b87-75d0-b82e-dade31499900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019e1f30-36cf-7e95-a0c3-507be640cebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019e1f30-36cf-7e95-a0c3-507be640cebf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7e95-a0c3-507be640cebf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019e1f30-36cf-7e95-a0c3-507be640cebf" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7e95-a0c3-507be640cebf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7c6b-8c16-a09044f70d40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019e1f30-36cf-7e95-a0c3-507be640cebf" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7c6b-8c16-a09044f70d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019e1f30-6540-714e-acaf-f4ac69b06fae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7c6b-8c16-a09044f70d40" xlink:to="loc_us-gaap_SubsequentEventMember_019e1f30-6540-714e-acaf-f4ac69b06fae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda83-d084-7c9e-aa4b-3b67cae3199a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda83-d084-7c9e-aa4b-3b67cae3199a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019dda83-d084-7fb9-ba58-5fc947c6f3be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019dda83-d084-7fb9-ba58-5fc947c6f3be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_019dda83-d084-7689-b93a-46b7e5dd7a08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_019dda83-d084-7689-b93a-46b7e5dd7a08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentExitFee_019dda84-4229-793c-9147-b2f44b6ce141" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentExitFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_DebtInstrumentExitFee_019dda84-4229-793c-9147-b2f44b6ce141" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019dda84-4229-7c68-9331-ba11790fb434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019dda84-4229-7c68-9331-ba11790fb434" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_019dda84-4229-7c06-ad8f-64e93c8f2470" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_019dda84-4229-7c06-ad8f-64e93c8f2470" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_019dda84-4229-7244-85bb-0c42a8d7ea20" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_019dda84-4229-7244-85bb-0c42a8d7ea20" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_019dda84-5b87-7942-991c-d4a7345bdfe5" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_019dda84-5b87-7942-991c-d4a7345bdfe5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_019dda84-5b87-7b36-be80-9e0db25a11f5" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_019dda84-5b87-7b36-be80-9e0db25a11f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_019e1f23-9665-78ed-995a-30cdcf905511" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentTerm_019e1f23-9665-78ed-995a-30cdcf905511" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f23-9665-759a-98bb-00f7bffa3009" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f23-9665-759a-98bb-00f7bffa3009" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_019e1f23-9665-76fc-b392-5253cfec1787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_RepaymentsOfDebt_019e1f23-9665-76fc-b392-5253cfec1787" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda84-5b87-78e4-829c-4d759c72f30a" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationPercentOfNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda84-5b87-78e4-829c-4d759c72f30a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_019dda84-5b87-76cc-aa85-ddcdd933e5b6" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_019dda84-5b87-76cc-aa85-ddcdd933e5b6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsGross_019dda84-8d07-7db9-8575-ecc216dd979e" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_RoyaltyObligationsGross_019dda84-8d07-7db9-8575-ecc216dd979e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019dda84-8d07-7728-8c58-405e03cbe737" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019dda84-8d07-7728-8c58-405e03cbe737" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019dda84-8d07-7378-80c7-4ad2e5ae2b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019dda84-8d07-7378-80c7-4ad2e5ae2b4d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_019dda84-8d07-794a-86ef-805592cc51db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_019dda84-8d07-794a-86ef-805592cc51db" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_019dda84-8d07-79ad-82db-54fa10468548" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_LongTermDebtFairValue_019dda84-8d07-79ad-82db-54fa10468548" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019dda84-8d07-7dd8-be62-9d13b00eb742" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019dda84-8d07-7dd8-be62-9d13b00eb742" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_019dda84-8d07-79a0-8225-909ce882101b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_019dda84-8d07-79a0-8225-909ce882101b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019dda84-8d07-798b-a3e2-789d306215b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019dda84-8d07-798b-a3e2-789d306215b4" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019dda84-8d07-7a01-85f1-871e8914c23f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019dda84-8d07-7a01-85f1-871e8914c23f" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_019d7d44-0ca5-7926-9748-666906c57623" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_019d7d44-0ca5-7281-9560-c6e639bcf177" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d7d44-0ca5-7926-9748-666906c57623" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_019d7d44-0ca5-7281-9560-c6e639bcf177" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019d7d44-0ca5-7124-b403-f68ae99fa29b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d7d44-0ca5-7281-9560-c6e639bcf177" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019d7d44-0ca5-7124-b403-f68ae99fa29b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7124-b403-f68ae99fa29b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019d7d44-0ca5-7124-b403-f68ae99fa29b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7124-b403-f68ae99fa29b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019d7d44-0ca5-7124-b403-f68ae99fa29b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_019d7d44-0ca5-73bb-b625-0d418dd248fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_019d7d44-0ca5-73bb-b625-0d418dd248fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MeasurementInputProbabilityOfSuccessMember_019d7d44-0ca5-7a12-8fa8-951a73f2268a" xlink:href="aqst-20260331.xsd#aqst_MeasurementInputProbabilityOfSuccessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:to="loc_aqst_MeasurementInputProbabilityOfSuccessMember_019d7d44-0ca5-7a12-8fa8-951a73f2268a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyAgreementMeasurementInput_019d7d44-0ca5-7277-87c2-7eaac573b559" xlink:href="aqst-20260331.xsd#aqst_RoyaltyAgreementMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d7d44-0ca5-7926-9748-666906c57623" xlink:to="loc_aqst_RoyaltyAgreementMeasurementInput_019d7d44-0ca5-7277-87c2-7eaac573b559" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019d4579-237c-74a1-9ac4-e8453bfce5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:to="loc_us-gaap_DebtInstrumentAxis_019d4579-237c-74a1-9ac4-e8453bfce5ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-74a1-9ac4-e8453bfce5ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d4579-237c-74a1-9ac4-e8453bfce5ea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-74a1-9ac4-e8453bfce5ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d4579-237c-74a1-9ac4-e8453bfce5ea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-237c-7c17-94ad-beebd43f7ebc" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-237c-7c17-94ad-beebd43f7ebc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_019d4579-237c-76f3-b109-6dcd076c1e9a" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:to="loc_aqst_RoyaltyObligationsMember_019d4579-237c-76f3-b109-6dcd076c1e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019d4579-237c-757b-b4ad-b38f22734a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019d4579-237c-757b-b4ad-b38f22734a4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-757b-b4ad-b38f22734a4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d4579-237c-757b-b4ad-b38f22734a4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-757b-b4ad-b38f22734a4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d4579-237c-757b-b4ad-b38f22734a4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019d4579-237c-729d-ab81-c5b3b7e6227d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:to="loc_us-gaap_SeniorNotesMember_019d4579-237c-729d-ab81-c5b3b7e6227d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_019d4579-237c-7cd6-b345-ba68fa0dde47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:to="loc_us-gaap_UnsecuredDebtMember_019d4579-237c-7cd6-b345-ba68fa0dde47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019d4579-237c-7925-ae9c-62b9f42c2c34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_019d4579-237c-7925-ae9c-62b9f42c2c34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019d4579-237c-7505-9e35-95750d4a65e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019d4579-237c-7505-9e35-95750d4a65e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansPayableCurrent_019d4579-237c-7b39-8b34-8d773fa5f528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesAndLoansPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_NotesAndLoansPayableCurrent_019d4579-237c-7b39-8b34-8d773fa5f528" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019d4579-237c-7150-a572-f0c925dab8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019d4579-237c-7150-a572-f0c925dab8d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019d4579-237c-71c9-bb76-a600c2663cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019d4579-237c-71c9-bb76-a600c2663cc6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-73e6-8d6b-28e78b571618" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-73e6-8d6b-28e78b571618" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#WarrantsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda8e-83ba-7d6b-a565-a1ddeec0d03a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda8e-83ba-7d6b-a565-a1ddeec0d03a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7d6b-a565-a1ddeec0d03a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda8e-83ba-7d6b-a565-a1ddeec0d03a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7d6b-a565-a1ddeec0d03a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda8e-83ba-7d6b-a565-a1ddeec0d03a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember_019dda8e-83ba-7bf6-9118-2754ec6ef26b" xlink:href="aqst-20260331.xsd#aqst_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_CommonStockWarrantsMember_019dda8e-83ba-7bf6-9118-2754ec6ef26b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_FirstAdditionalWarrantOfferingMember_019dda8e-83ba-78d9-8681-bf172e050a2d" xlink:href="aqst-20260331.xsd#aqst_FirstAdditionalWarrantOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_FirstAdditionalWarrantOfferingMember_019dda8e-83ba-78d9-8681-bf172e050a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PreFundedWarrantsMember_019dda8e-d868-75bc-9928-f45d14f2e74e" xlink:href="aqst-20260331.xsd#aqst_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_PreFundedWarrantsMember_019dda8e-d868-75bc-9928-f45d14f2e74e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_019dda8e-d868-7d71-be57-236c0c7a32c9" xlink:href="aqst-20260331.xsd#aqst_ExistingWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_ExistingWarrantsMember_019dda8e-d868-7d71-be57-236c0c7a32c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_019dda8e-d868-732f-8dcf-826a16bb0144" xlink:href="aqst-20260331.xsd#aqst_NewWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_NewWarrantsMember_019dda8e-d868-732f-8dcf-826a16bb0144" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda8e-83ba-729d-8da9-02a7803b10de" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_srt_RangeAxis_019dda8e-83ba-729d-8da9-02a7803b10de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda8e-83ba-729d-8da9-02a7803b10de_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019dda8e-83ba-729d-8da9-02a7803b10de" xlink:to="loc_srt_RangeMember_019dda8e-83ba-729d-8da9-02a7803b10de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019dda8e-83ba-729d-8da9-02a7803b10de" xlink:to="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda8e-83ba-7441-acb7-1dcdff5860f8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:to="loc_srt_MinimumMember_019dda8e-83ba-7441-acb7-1dcdff5860f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda8e-83ba-7a1b-89ad-351c3a3db5b5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:to="loc_srt_MaximumMember_019dda8e-83ba-7a1b-89ad-351c3a3db5b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dda8e-83ba-7412-b9dd-1588cd90abd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dda8e-83ba-7412-b9dd-1588cd90abd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-7412-b9dd-1588cd90abd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda8e-83ba-7412-b9dd-1588cd90abd9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-7412-b9dd-1588cd90abd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda8e-83ba-7412-b9dd-1588cd90abd9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda8e-83ba-7366-8be2-04d93cec4c22" xlink:href="aqst-20260331.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda8e-83ba-7366-8be2-04d93cec4c22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2020AdditionalNotesMember_019dda8e-83ba-728e-b093-ac8e8a449915" xlink:href="aqst-20260331.xsd#aqst_A2020AdditionalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:to="loc_aqst_A2020AdditionalNotesMember_019dda8e-83ba-728e-b093-ac8e8a449915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda8e-83ba-7279-9c5b-e9567142ed2a" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda8e-83ba-7279-9c5b-e9567142ed2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda8e-83ba-7095-b006-68717cde1665" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda8e-83ba-7095-b006-68717cde1665" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7095-b006-68717cde1665_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda8e-83ba-7095-b006-68717cde1665" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7095-b006-68717cde1665_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7eb0-8a96-eeb871a9f779" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda8e-83ba-7095-b006-68717cde1665" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7eb0-8a96-eeb871a9f779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda8e-83ba-703f-91f5-705b4ff1393b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7eb0-8a96-eeb871a9f779" xlink:to="loc_us-gaap_SeniorNotesMember_019dda8e-83ba-703f-91f5-705b4ff1393b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda8e-83bb-7fd8-8cea-23275efce008" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda8e-83bb-7fd8-8cea-23275efce008" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda8e-83bb-7d48-9ff8-2d4249866f99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda8e-83bb-7d48-9ff8-2d4249866f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019dda8e-d868-7da8-af5d-a4c86874d7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019dda8e-d868-7da8-af5d-a4c86874d7c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e1cc2-8e22-747b-8dd1-4b43ff491a02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e1cc2-8e22-747b-8dd1-4b43ff491a02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda8e-83bb-73e8-b482-966eac7a4c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda8e-83bb-73e8-b482-966eac7a4c6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued_019dda8e-83bb-735f-9875-4204b76353ee" xlink:href="aqst-20260331.xsd#aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued_019dda8e-83bb-735f-9875-4204b76353ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_019dda8e-83bb-77ea-b80f-c6e0516ab1b3" xlink:href="aqst-20260331.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_019dda8e-83bb-77ea-b80f-c6e0516ab1b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_019dda8e-d868-7ff8-ac77-bd85be1cb5c7" xlink:href="aqst-20260331.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_019dda8e-d868-7ff8-ac77-bd85be1cb5c7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_019dda8e-d868-72bb-bdf3-2855a881e443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_019dda8e-d868-72bb-bdf3-2855a881e443" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda8e-d868-7a6c-8761-9c9a39fd023f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda8e-d868-7a6c-8761-9c9a39fd023f" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SaleofFutureRevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_us-gaap_CreditFacilityAxis_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4" xlink:to="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7fe8-bc0e-bd00acf0d785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4" xlink:to="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7fe8-bc0e-bd00acf0d785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_019d7d93-20f2-7c51-8bd3-d8d3bc5efa45" xlink:href="aqst-20260331.xsd#aqst_MonetizationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7fe8-bc0e-bd00acf0d785" xlink:to="loc_aqst_MonetizationAgreementMember_019d7d93-20f2-7c51-8bd3-d8d3bc5efa45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d7d93-20f2-7dfa-811e-e25f223e5b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d7d93-20f2-7dfa-811e-e25f223e5b98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-7dfa-811e-e25f223e5b98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d7d93-20f2-7dfa-811e-e25f223e5b98" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-7dfa-811e-e25f223e5b98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d7d93-20f2-7dfa-811e-e25f223e5b98" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_019d7d93-20f2-791b-b21c-eb0cbcd6b62e" xlink:href="aqst-20260331.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_019d7d93-20f2-791b-b21c-eb0cbcd6b62e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7d93-769c-7860-9345-e06381c6d194" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7d93-769c-7860-9345-e06381c6d194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d7d93-20f2-7694-9cdd-9ba836fb33e9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_srt_RangeAxis_019d7d93-20f2-7694-9cdd-9ba836fb33e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7d93-20f2-7694-9cdd-9ba836fb33e9_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d7d93-20f2-7694-9cdd-9ba836fb33e9" xlink:to="loc_srt_RangeMember_019d7d93-20f2-7694-9cdd-9ba836fb33e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7d93-20f2-7357-85a7-fd554f8b3d2a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d7d93-20f2-7694-9cdd-9ba836fb33e9" xlink:to="loc_srt_RangeMember_019d7d93-20f2-7357-85a7-fd554f8b3d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d7d93-20f2-7a64-b556-c9a23e27c585" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d7d93-20f2-7357-85a7-fd554f8b3d2a" xlink:to="loc_srt_MaximumMember_019d7d93-20f2-7a64-b556-c9a23e27c585" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d7d93-769c-71ff-a85a-d9d1a40fe019" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_srt_ProductOrServiceAxis_019d7d93-769c-71ff-a85a-d9d1a40fe019" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7d93-769c-71ff-a85a-d9d1a40fe019_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019d7d93-769c-71ff-a85a-d9d1a40fe019" xlink:to="loc_srt_ProductsAndServicesDomain_019d7d93-769c-71ff-a85a-d9d1a40fe019_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7d93-769c-7c90-b3c1-0c8b53e47ffe" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019d7d93-769c-71ff-a85a-d9d1a40fe019" xlink:to="loc_srt_ProductsAndServicesDomain_019d7d93-769c-7c90-b3c1-0c8b53e47ffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019d7d93-769c-75e2-8b68-9c0bcf341837" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d7d93-769c-7c90-b3c1-0c8b53e47ffe" xlink:to="loc_us-gaap_RoyaltyMember_019d7d93-769c-75e2-8b68-9c0bcf341837" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019d7d93-20f2-7f03-9cfc-367642a8856e" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019d7d93-20f2-7f03-9cfc-367642a8856e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019d7d93-20f2-72e9-bfe2-04d9babf97fb" xlink:href="aqst-20260331.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019d7d93-20f2-72e9-bfe2-04d9babf97fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_019d7d93-20f2-73fb-bbbd-434cb5a26c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_019d7d93-20f2-73fb-bbbd-434cb5a26c6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7d93-769c-7e86-a83d-d4baf4e548e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7d93-769c-7e86-a83d-d4baf4e548e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_019d7d93-769c-7728-b946-d8f84d74b924" xlink:href="aqst-20260331.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_019d7d93-769c-7728-b946-d8f84d74b924" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019d7d93-769c-7e40-a756-8d90bcd8f213" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019d7d93-769c-7e40-a756-8d90bcd8f213" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SaleofFutureRevenueScheduleofRoyaltyObligationDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-7865-ac99-5352da344a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-7865-ac99-5352da344a0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d4579-237c-7ef5-8fe4-2bafa90557d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-7865-ac99-5352da344a0c" xlink:to="loc_srt_ProductOrServiceAxis_019d4579-237c-7ef5-8fe4-2bafa90557d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ef5-8fe4-2bafa90557d3_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019d4579-237c-7ef5-8fe4-2bafa90557d3" xlink:to="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ef5-8fe4-2bafa90557d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ab0-9185-05bd2b8b27b2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019d4579-237c-7ef5-8fe4-2bafa90557d3" xlink:to="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ab0-9185-05bd2b8b27b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019d4579-237c-7b79-874a-f0de156bfa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ab0-9185-05bd2b8b27b2" xlink:to="loc_us-gaap_RoyaltyMember_019d4579-237c-7b79-874a-f0de156bfa0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:href="aqst-20260331.xsd#aqst_SaleOfFutureRevenueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:to="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-237c-7065-a7a0-375c47d64c01" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-237c-7065-a7a0-375c47d64c01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-73cd-aa2a-25bb16bc3f58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-73cd-aa2a-25bb16bc3f58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019d4579-237c-7415-94f7-5ee19a3a7d30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019d4579-237c-7415-94f7-5ee19a3a7d30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-237c-75ca-8453-7b5b3d7fa924" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_019d4579-237c-7a23-a92d-ab29ffe2e767" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_019d4579-237c-7a23-a92d-ab29ffe2e767" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShareDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#NetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/NetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d7d9a-b8bf-7314-9137-d5e74535efde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d7d9a-b8bf-7314-9137-d5e74535efde" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d7d9a-b8bf-7314-9137-d5e74535efde" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d7d9a-b8bf-7c0c-baaa-2bb40e6bc886" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d7d9a-b8bf-7c0c-baaa-2bb40e6bc886" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7d9a-b8bf-7c44-975c-285cd33aba0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7d9a-b8bf-7c44-975c-285cd33aba0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019d7d9a-b8bf-714e-a166-b98917f68722" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:to="loc_us-gaap_WarrantMember_019d7d9a-b8bf-714e-a166-b98917f68722" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsAbstract_019d7d9a-b8bf-7afb-b865-6fad84316a65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UndistributedEarningsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:to="loc_us-gaap_UndistributedEarningsAbstract_019d7d9a-b8bf-7afb-b865-6fad84316a65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d7d9a-b8bf-727c-bb56-7b82b2c9d6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UndistributedEarningsAbstract_019d7d9a-b8bf-7afb-b865-6fad84316a65" xlink:to="loc_us-gaap_NetIncomeLoss_019d7d9a-b8bf-727c-bb56-7b82b2c9d6eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d7d9a-b8bf-7e77-b37b-e72c1b2af823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d7d9a-b8bf-7e77-b37b-e72c1b2af823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d7d9a-b8bf-7817-a5f4-4089fec4a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d7d9a-b8bf-7817-a5f4-4089fec4a7a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019d7d9a-b8bf-70ee-bf58-bbca48b44625" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_EarningsPerShareBasic_019d7d9a-b8bf-70ee-bf58-bbca48b44625" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019d7d9a-b8bf-71d0-9c8d-5021d4add85d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019d7d9a-b8bf-71d0-9c8d-5021d4add85d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d7d9a-b8bf-74b1-be1b-9f85001dccef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d7d9a-b8bf-74b1-be1b-9f85001dccef" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7726-a8f8-332a2cb62b46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7726-a8f8-332a2cb62b46" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019d4579-237c-7375-9809-1776bc13359d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019d4579-237c-7375-9809-1776bc13359d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7375-9809-1776bc13359d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019d4579-237c-7375-9809-1776bc13359d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7375-9809-1776bc13359d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019d4579-237c-7375-9809-1776bc13359d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufacturingAndSupplyMember_019d4579-237c-7fc2-9dca-42893754b994" xlink:href="aqst-20260331.xsd#aqst_ManufacturingAndSupplyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:to="loc_aqst_ManufacturingAndSupplyMember_019d4579-237c-7fc2-9dca-42893754b994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d4579-237c-709d-98c7-3cb9a40fa598" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d4579-237c-709d-98c7-3cb9a40fa598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d4579-237c-7d60-adbc-88c91e2e0520" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d4579-237c-7d60-adbc-88c91e2e0520" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-77d5-8ee1-1df8543d66de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-77d5-8ee1-1df8543d66de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-77d5-8ee1-1df8543d66de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-77d5-8ee1-1df8543d66de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-77d5-8ee1-1df8543d66de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-77d5-8ee1-1df8543d66de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-7b96-b3d1-da2444501cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-7b96-b3d1-da2444501cc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7028-9fcc-8e92f86a483f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7028-9fcc-8e92f86a483f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_019d4579-237c-7570-95e3-7ea00896c7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7726-a8f8-332a2cb62b46" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_019d4579-237c-7570-95e3-7ea00896c7b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d4579-237c-7a25-b120-424289770bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_019d4579-237c-7570-95e3-7ea00896c7b4" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d4579-237c-7a25-b120-424289770bd0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-7d23-9c7d-fc01c38cfac9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-7d23-9c7d-fc01c38cfac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7d23-9c7d-fc01c38cfac9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7d23-9c7d-fc01c38cfac9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7d23-9c7d-fc01c38cfac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7cf0-aae0-ec9be85230a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7d23-9c7d-fc01c38cfac9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7cf0-aae0-ec9be85230a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-762d-8ff5-d9d94f07e379" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7cf0-aae0-ec9be85230a1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-762d-8ff5-d9d94f07e379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d7dce-1d37-7291-bd92-0b90dc179a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:to="loc_us-gaap_PlanNameAxis_019d7dce-1d37-7291-bd92-0b90dc179a9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7291-bd92-0b90dc179a9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019d7dce-1d37-7291-bd92-0b90dc179a9d" xlink:to="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7291-bd92-0b90dc179a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019d7dce-1d37-7291-bd92-0b90dc179a9d" xlink:to="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ServiceBasedMember_019d7dce-8d64-7ce4-aea2-83266e0d2df2" xlink:href="aqst-20260331.xsd#aqst_ServiceBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:to="loc_aqst_ServiceBasedMember_019d7dce-8d64-7ce4-aea2-83266e0d2df2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember_019d7dcf-af62-712b-b6b4-a0fc9e177412" xlink:href="aqst-20260331.xsd#aqst_MarketBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:to="loc_aqst_MarketBasedMember_019d7dcf-af62-712b-b6b4-a0fc9e177412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-237c-7864-9290-f9280b3c8655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-237c-7864-9290-f9280b3c8655" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d4579-237c-7c4e-b6b3-f407f2db3d07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d4579-237c-7c4e-b6b3-f407f2db3d07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019d4579-237c-742b-b5e9-11883aafee46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019d4579-237c-742b-b5e9-11883aafee46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019d4579-237c-72a0-aa47-c50ab13a993e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019d4579-237c-72a0-aa47-c50ab13a993e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-237c-7651-8bd6-5844ccfa6659" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_019d4579-237c-7506-a526-54b5440cb580" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_019d4579-237c-7506-a526-54b5440cb580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-237c-758b-be26-f6e26ba94923" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-237c-758b-be26-f6e26ba94923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7402-b8de-10fd9fb3b7db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7402-b8de-10fd9fb3b7db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7dd5-9750-9511fbd4b895" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7dd5-9750-9511fbd4b895" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019d4579-237c-7146-8f90-00b6842b2653" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019d4579-237c-7146-8f90-00b6842b2653" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-237c-7f5d-b964-d02b95a89b88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_019d4579-237c-769e-a656-ce95a1b21d5c" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_019d4579-237c-769e-a656-ce95a1b21d5c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d7dee-30b5-7d01-9d72-e8c0d3b71781" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_us-gaap_AwardTypeAxis_019d7dee-30b5-7d01-9d72-e8c0d3b71781" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7d01-9d72-e8c0d3b71781_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d7dee-30b5-7d01-9d72-e8c0d3b71781" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7d01-9d72-e8c0d3b71781_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d7dee-30b5-7d01-9d72-e8c0d3b71781" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7dee-30b5-7ff5-b0a2-19d7383a79be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7dee-30b5-7ff5-b0a2-19d7383a79be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_019d7dee-5fb9-7afb-8f7f-6bc90605c372" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:to="loc_us-gaap_PerformanceSharesMember_019d7dee-5fb9-7afb-8f7f-6bc90605c372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d7dee-c7fb-7949-b7c3-97386d737333" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d7dee-c7fb-7949-b7c3-97386d737333" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_us-gaap_PlanNameAxis_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9" xlink:to="loc_us-gaap_PlanNameDomain_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9" xlink:to="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ServiceBasedMember_019d7dee-30b5-7afc-8f85-7877bd7b2485" xlink:href="aqst-20260331.xsd#aqst_ServiceBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_ServiceBasedMember_019d7dee-30b5-7afc-8f85-7877bd7b2485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember_019d7dee-5fb9-7183-ab68-b5828242cd27" xlink:href="aqst-20260331.xsd#aqst_MarketBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_MarketBasedMember_019d7dee-5fb9-7183-ab68-b5828242cd27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2025MarketBasedMember_019d7dee-5fb9-7c3e-9e74-6b15da20d122" xlink:href="aqst-20260331.xsd#aqst_A2025MarketBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_A2025MarketBasedMember_019d7dee-5fb9-7c3e-9e74-6b15da20d122" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2022InducementEquityIncentivePlanMember_019db30e-9cb0-75fa-9e1f-f48f95f836a9" xlink:href="aqst-20260331.xsd#aqst_A2022InducementEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_A2022InducementEquityIncentivePlanMember_019db30e-9cb0-75fa-9e1f-f48f95f836a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionsAxis_019d7dee-5fb9-7413-9c28-4fa56700e78f" xlink:href="aqst-20260331.xsd#aqst_MarketConditionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_aqst_MarketConditionsAxis_019d7dee-5fb9-7413-9c28-4fa56700e78f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-7413-9c28-4fa56700e78f_default" xlink:href="aqst-20260331.xsd#aqst_MarketConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aqst_MarketConditionsAxis_019d7dee-5fb9-7413-9c28-4fa56700e78f" xlink:to="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-7413-9c28-4fa56700e78f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:href="aqst-20260331.xsd#aqst_MarketConditionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aqst_MarketConditionsAxis_019d7dee-5fb9-7413-9c28-4fa56700e78f" xlink:to="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeOneMember_019d7dee-5fb9-7abe-9b44-398b57f42f77" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeOneMember_019d7dee-5fb9-7abe-9b44-398b57f42f77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeTwoMember_019d7dee-5fb9-72ff-a1cc-6a768df6fd81" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeTwoMember_019d7dee-5fb9-72ff-a1cc-6a768df6fd81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeThreeMember_019d7dee-5fb9-784d-9a4f-a1ff923f4caa" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeThreeMember_019d7dee-5fb9-784d-9a4f-a1ff923f4caa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeFourMember_019d7dee-5fb9-775e-ac7d-204ebcb5c390" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeFourMember_019d7dee-5fb9-775e-ac7d-204ebcb5c390" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeFiveMember_019d7dee-5fb9-7e6b-a38a-7790053f05a0" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeFiveMember_019d7dee-5fb9-7e6b-a38a-7790053f05a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeSixMember_019d7dee-5fb9-757a-ad22-f8e09537ab31" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeSixMember_019d7dee-5fb9-757a-ad22-f8e09537ab31" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d7dee-5fb9-7935-a3ff-93bc055a33ba" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_srt_RangeAxis_019d7dee-5fb9-7935-a3ff-93bc055a33ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7dee-5fb9-7935-a3ff-93bc055a33ba_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019d7dee-5fb9-7935-a3ff-93bc055a33ba" xlink:to="loc_srt_RangeMember_019d7dee-5fb9-7935-a3ff-93bc055a33ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019d7dee-5fb9-7935-a3ff-93bc055a33ba" xlink:to="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d7dee-5fb9-786d-ac16-20289b318b6d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:to="loc_srt_MinimumMember_019d7dee-5fb9-786d-ac16-20289b318b6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d7dee-5fb9-7e9f-8639-3f91e41a162f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:to="loc_srt_MaximumMember_019d7dee-5fb9-7e9f-8639-3f91e41a162f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionAxis_019d7dee-a321-7a90-9bf6-e495af895926" xlink:href="aqst-20260331.xsd#aqst_VestingConditionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_aqst_VestingConditionAxis_019d7dee-a321-7a90-9bf6-e495af895926" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain_019d7dee-a321-7a90-9bf6-e495af895926_default" xlink:href="aqst-20260331.xsd#aqst_VestingConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aqst_VestingConditionAxis_019d7dee-a321-7a90-9bf6-e495af895926" xlink:to="loc_aqst_VestingConditionDomain_019d7dee-a321-7a90-9bf6-e495af895926_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:href="aqst-20260331.xsd#aqst_VestingConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aqst_VestingConditionAxis_019d7dee-a321-7a90-9bf6-e495af895926" xlink:to="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeSevenMember_019d7dee-a321-7029-8d30-07539722352a" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeSevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeSevenMember_019d7dee-a321-7029-8d30-07539722352a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeEightMember_019d7dee-a321-7f10-9ddd-63abcacf0496" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeEightMember_019d7dee-a321-7f10-9ddd-63abcacf0496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeNineMember_019d7dee-a321-7fb5-9029-e09f27787330" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeNineMember_019d7dee-a321-7fb5-9029-e09f27787330" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTenMember_019d7dee-a321-7630-8692-22387f594e1f" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeTenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeTenMember_019d7dee-a321-7630-8692-22387f594e1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeElevenMember_019d7dee-a321-7ecc-8b2b-61974365dc10" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeElevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeElevenMember_019d7dee-a321-7ecc-8b2b-61974365dc10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTwelveMember_019d7dee-a321-77e9-acc7-b4b01ecc7663" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeTwelveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeTwelveMember_019d7dee-a321-77e9-acc7-b4b01ecc7663" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d7dee-30b5-7fb1-ab36-d4056b93a045" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d7dee-30b5-7fb1-ab36-d4056b93a045" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d7dee-30b5-72cd-b68c-21303f6b93ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d7dee-30b5-72cd-b68c-21303f6b93ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d7dee-30b5-77c5-baf3-7b559c7aac8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d7dee-30b5-77c5-baf3-7b559c7aac8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_019d7dee-5fb9-7e23-a2ef-0022f267572f" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_019d7dee-5fb9-7e23-a2ef-0022f267572f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_019d7dee-5fb9-7ce2-8da7-c5591392316f" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_019d7dee-5fb9-7ce2-8da7-c5591392316f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_019d7dee-5fb9-7389-9dd8-d6040219c592" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_019d7dee-5fb9-7389-9dd8-d6040219c592" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods_019d7dee-5fb9-7c72-950c-c490de40160c" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods_019d7dee-5fb9-7c72-950c-c490de40160c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod_019d7dee-5fb9-7e79-804b-d4e0ce4a33f1" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod_019d7dee-5fb9-7e79-804b-d4e0ce4a33f1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d7dee-c7fb-7a67-a23e-bf51f3e0036f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d7dee-c7fb-7a67-a23e-bf51f3e0036f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d7dee-c7fb-7dd9-b2f1-1688312537aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d7dee-c7fb-7dd9-b2f1-1688312537aa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d7dee-c7fb-7fdf-bfd7-de1840bb869d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d7dee-c7fb-7fdf-bfd7-de1840bb869d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019df338-96fe-7964-b5fb-7be1fd183778" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019df338-96fe-7964-b5fb-7be1fd183778" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019db30e-9cb0-73a8-b6e4-ac2258db81f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019db30e-9cb0-73a8-b6e4-ac2258db81f1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019db30e-9cb0-703d-8ff2-f5c30461e062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019db30e-9cb0-703d-8ff2-f5c30461e062" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-7af1-a087-ad52ac9f19c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-7af1-a087-ad52ac9f19c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7af1-a087-ad52ac9f19c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7af1-a087-ad52ac9f19c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7af1-a087-ad52ac9f19c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7403-81f9-1da070efa08a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7af1-a087-ad52ac9f19c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7403-81f9-1da070efa08a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7aed-9747-45dc0404a922" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7403-81f9-1da070efa08a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7aed-9747-45dc0404a922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7edc-bc4f-9a2fd85ff551" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7edc-bc4f-9a2fd85ff551" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7edc-bc4f-9a2fd85ff551_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7edc-bc4f-9a2fd85ff551" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7edc-bc4f-9a2fd85ff551_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7d3d-89c6-9b1ad40b4412" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7edc-bc4f-9a2fd85ff551" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7d3d-89c6-9b1ad40b4412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BlackScholesMertonModelMember_019dda94-6ebf-76a6-b078-8563a4c60528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BlackScholesMertonModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7d3d-89c6-9b1ad40b4412" xlink:to="loc_us-gaap_BlackScholesMertonModelMember_019dda94-6ebf-76a6-b078-8563a4c60528" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019d7df9-59f1-75fb-9e96-5b005af75eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019d7df9-59f1-75fb-9e96-5b005af75eaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019d7df9-59f1-757e-8c79-d5f611cbfe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019d7df9-59f1-757e-8c79-d5f611cbfe2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019d7df9-59f1-76b2-996d-d5648d890cee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019d7df9-59f1-76b2-996d-d5648d890cee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_019d7df9-59f1-71d2-9dcf-683493e76a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_SharePrice_019d7df9-59f1-71d2-9dcf-683493e76a0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019d7df9-93e7-7ea8-9d39-7d1704406611" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019d7df9-93e7-7ea8-9d39-7d1704406611" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7854-8dce-2085b40ee7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7854-8dce-2085b40ee7e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-7a8c-b4c1-780b4943c9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7854-8dce-2085b40ee7e5" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-7a8c-b4c1-780b4943c9bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7a8c-b4c1-780b4943c9bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7a8c-b4c1-780b4943c9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7a8c-b4c1-780b4943c9bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-75ec-813d-69949731669e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7a8c-b4c1-780b4943c9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-75ec-813d-69949731669e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7944-bb4b-92ded79190db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-75ec-813d-69949731669e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7944-bb4b-92ded79190db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-237c-705b-bb6f-fa5975b0b549" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-237c-705b-bb6f-fa5975b0b549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019d4579-237c-7719-83d7-b42b451d8112" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019d4579-237c-7719-83d7-b42b451d8112" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d4579-237c-790d-b171-eff66dcff941" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d4579-237c-790d-b171-eff66dcff941" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_019d4579-237c-72d6-a9c6-875e9fd80840" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_019d4579-237c-72d6-a9c6-875e9fd80840" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-237c-7544-8137-dd98298d6efc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019d4579-237c-764e-8b5e-49715a1b2417" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019d4579-237c-764e-8b5e-49715a1b2417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019d4579-237c-7b75-8761-6c5475a2bb77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019d4579-237c-7b75-8761-6c5475a2bb77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7796-a29d-23ed2fe142d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7796-a29d-23ed2fe142d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d4579-237c-7251-9463-aaa28f492c48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d4579-237c-7251-9463-aaa28f492c48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019d4579-237c-7149-a666-ac11ad028ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019d4579-237c-7149-a666-ac11ad028ce6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_019d4579-237c-7fbe-be53-a2214fb611a8" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_019d4579-237c-7fbe-be53-a2214fb611a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7cf7-b5e7-4db6b606e906" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019d4579-237c-7d56-a3f9-9de71c653b59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019d4579-237c-7d56-a3f9-9de71c653b59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019d4579-237c-77c4-80b8-3ef16d0fa161" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019d4579-237c-77c4-80b8-3ef16d0fa161" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ContingenciesDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_019dac34-999f-76a1-b348-30b77761f807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_019dac34-999f-76a1-b348-30b77761f807" xlink:to="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_019dac34-999f-7897-9001-9c5b97e31500" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:to="loc_srt_LitigationCaseAxis_019dac34-999f-7897-9001-9c5b97e31500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019dac34-999f-7897-9001-9c5b97e31500_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_019dac34-999f-7897-9001-9c5b97e31500" xlink:to="loc_srt_LitigationCaseTypeDomain_019dac34-999f-7897-9001-9c5b97e31500_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019dac34-999f-75ac-9494-3923845953b9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_019dac34-999f-7897-9001-9c5b97e31500" xlink:to="loc_srt_LitigationCaseTypeDomain_019dac34-999f-75ac-9494-3923845953b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SuboxoneProduceLiabilityLitigationMember_019dac34-999f-746e-87e1-7f3eadbe7d09" xlink:href="aqst-20260331.xsd#aqst_SuboxoneProduceLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_019dac34-999f-75ac-9494-3923845953b9" xlink:to="loc_aqst_SuboxoneProduceLiabilityLitigationMember_019dac34-999f-746e-87e1-7f3eadbe7d09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019dac34-999f-77f0-b795-9dae018caac1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:to="loc_srt_StatementGeographicalAxis_019dac34-999f-77f0-b795-9dae018caac1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019dac34-999f-77f0-b795-9dae018caac1_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_019dac34-999f-77f0-b795-9dae018caac1" xlink:to="loc_srt_SegmentGeographicalDomain_019dac34-999f-77f0-b795-9dae018caac1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019dac34-999f-7399-ae7f-a07a7b902d03" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_019dac34-999f-77f0-b795-9dae018caac1" xlink:to="loc_srt_SegmentGeographicalDomain_019dac34-999f-7399-ae7f-a07a7b902d03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA-BC_019dac34-999f-72cc-a8b9-78923281e606" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA-BC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_019dac34-999f-7399-ae7f-a07a7b902d03" xlink:to="loc_stpr_CA-BC_019dac34-999f-72cc-a8b9-78923281e606" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_019dac34-999f-7bce-94d3-2cea94fd3214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019dac34-999f-76a1-b348-30b77761f807" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_019dac34-999f-7bce-94d3-2cea94fd3214" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019d4579-237c-7a51-82a5-bec0b750e47e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019d4579-237c-7a51-82a5-bec0b750e47e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7a51-82a5-bec0b750e47e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019d4579-237c-7a51-82a5-bec0b750e47e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7a51-82a5-bec0b750e47e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7fbf-8eea-99a97948a797" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019d4579-237c-7a51-82a5-bec0b750e47e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7fbf-8eea-99a97948a797" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019d4579-237c-7a92-84f1-7eedf13fbd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7fbf-8eea-99a97948a797" xlink:to="loc_us-gaap_SubsequentEventMember_019d4579-237c-7a92-84f1-7eedf13fbd5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e1f1d-1adb-72de-bde7-cc878070e5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e1f1d-1adb-72de-bde7-cc878070e5d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-72de-bde7-cc878070e5d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e1f1d-1adb-72de-bde7-cc878070e5d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-72de-bde7-cc878070e5d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e1f1d-1adb-72de-bde7-cc878070e5d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TermLoanFacilityMember_019e1f1d-700f-73f7-91d6-628acd1fb314" xlink:href="aqst-20260331.xsd#aqst_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:to="loc_aqst_TermLoanFacilityMember_019e1f1d-700f-73f7-91d6-628acd1fb314" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019e1f1e-d456-74da-853d-de9374d920d0" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019e1f1e-d456-74da-853d-de9374d920d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019e1f1e-2973-7f12-94af-7c0d051d7b95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019e1f1e-2973-7f12-94af-7c0d051d7b95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7f12-94af-7c0d051d7b95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019e1f1e-2973-7f12-94af-7c0d051d7b95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7f12-94af-7c0d051d7b95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019e1f1e-2973-7f12-94af-7c0d051d7b95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_019e1f1e-4b74-76c1-b08c-1a993ad23fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:to="loc_us-gaap_LineOfCreditMember_019e1f1e-4b74-76c1-b08c-1a993ad23fe0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019e1f1e-d456-7704-917c-830e738a04f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:to="loc_us-gaap_SeniorNotesMember_019e1f1e-d456-7704-917c-830e738a04f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-7f5b-a764-e302082a9737" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentMilestoneTranchesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-7f5b-a764-e302082a9737" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7f5b-a764-e302082a9737_default" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentMilestoneTranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-7f5b-a764-e302082a9737" xlink:to="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7f5b-a764-e302082a9737_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentMilestoneTranchesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-7f5b-a764-e302082a9737" xlink:to="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheTwoMember_019e1f2b-b007-787c-aca5-136cbf2e6277" xlink:href="aqst-20260331.xsd#aqst_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:to="loc_aqst_TrancheTwoMember_019e1f2b-b007-787c-aca5-136cbf2e6277" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheThreeMember_019e1f2b-eda7-7d68-9bd1-97edda0821b6" xlink:href="aqst-20260331.xsd#aqst_TrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:to="loc_aqst_TrancheThreeMember_019e1f2b-eda7-7d68-9bd1-97edda0821b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheFourMember_019e1f2c-379c-71f8-8c15-49ba81c90f17" xlink:href="aqst-20260331.xsd#aqst_TrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:to="loc_aqst_TrancheFourMember_019e1f2c-379c-71f8-8c15-49ba81c90f17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019e19bb-9e82-7282-a749-174c1fea1b09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019e19bb-9e82-7282-a749-174c1fea1b09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod_019e19bb-9e82-7c26-a571-6f137ab984aa" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseInitialRentAbatementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod_019e19bb-9e82-7c26-a571-6f137ab984aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseNumberOfRenewalOptions_019e19bb-9e82-77dd-bd1c-d46ae6b81185" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_aqst_LesseeOperatingLeaseNumberOfRenewalOptions_019e19bb-9e82-77dd-bd1c-d46ae6b81185" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019e19bb-9e82-78f6-a694-904fe11c7cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019e19bb-9e82-78f6-a694-904fe11c7cbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_019e1f1c-cb8c-785d-abde-177194e8cd35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_DebtInstrumentTerm_019e1f1c-cb8c-785d-abde-177194e8cd35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f1d-1adb-7481-bb66-fc4795e47c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f1d-1adb-7481-bb66-fc4795e47c98" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019e1f1e-3cae-704d-9b7e-8b9965403dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019e1f1e-3cae-704d-9b7e-8b9965403dcc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019e1f1e-5041-7a4e-a231-4661987558ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019e1f1e-5041-7a4e-a231-4661987558ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_019e1f2c-8f95-7705-a1d8-4af53d83b2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_RepaymentsOfDebt_019e1f2c-8f95-7705-a1d8-4af53d83b2d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit_019e1f2b-5924-7dad-9a88-361a83f0876e" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit_019e1f2b-5924-7dad-9a88-361a83f0876e" xlink:type="arc" order="9"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>aqst-20260331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d4579-21a7-7c19-9fd0-51403d0078b6,g:613180f5-33da-4eff-b9e2-e98da0338ca1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_aqst_DebtInstrumentExitFee_019d4579-237c-7fa2-ad87-2a500fcef2a7_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentExitFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, exit fee</link:label>
    <link:label id="lab_aqst_DebtInstrumentExitFee_label_en-US" xlink:label="lab_aqst_DebtInstrumentExitFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Exit Fee</link:label>
    <link:label id="lab_aqst_DebtInstrumentExitFee_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentExitFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Exit Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentExitFee" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentExitFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentExitFee" xlink:to="lab_aqst_DebtInstrumentExitFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_019d4579-237c-7031-a0bd-28bd6597c27c_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_019d4579-237c-7549-8d11-9cb2ad4401e1_terseLabel_en-US" xlink:label="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock in connection with securities purchase agreements (in shares)</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_label_en-US" xlink:label="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Of Common Stock To Be Purchased By Common Stock Warrants</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_documentation_en-US" xlink:label="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares of Common Stock to be Purchased by Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:href="aqst-20260331.xsd#aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:to="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019d4579-2421-786c-8764-0d1d16032879_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter_019d4579-2421-7674-8991-0de2ce2acc2b_terseLabel_en-US" xlink:label="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue share payments thereafter</link:label>
    <link:label id="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter_label_en-US" xlink:label="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Estimated Revenue Share Payments upon Purchaser&#8217;s Receipt, Thereafter</link:label>
    <link:label id="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter_documentation_en-US" xlink:label="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Estimated Revenue Share Payments upon Purchaser&#8217;s Receipt, Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" xlink:to="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InterestAndOtherIncomeNet_019d4579-2421-7575-ac70-64a46ca84ea4_terseLabel_en-US" xlink:label="lab_aqst_InterestAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income and other income, net</link:label>
    <link:label id="lab_aqst_InterestAndOtherIncomeNet_label_en-US" xlink:label="lab_aqst_InterestAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest And Other Income, Net</link:label>
    <link:label id="lab_aqst_InterestAndOtherIncomeNet_documentation_en-US" xlink:label="lab_aqst_InterestAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest And Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet" xlink:href="aqst-20260331.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InterestAndOtherIncomeNet" xlink:to="lab_aqst_InterestAndOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019d4579-2421-71a2-bbe3-a16d41272def_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionDomain_019d4579-237c-7d93-8efc-67adae60b9c6_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition [Domain]</link:label>
    <link:label id="lab_aqst_VestingConditionDomain_label_en-US" xlink:label="lab_aqst_VestingConditionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition [Domain]</link:label>
    <link:label id="lab_aqst_VestingConditionDomain_documentation_en-US" xlink:label="lab_aqst_VestingConditionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Conditions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain" xlink:href="aqst-20260331.xsd#aqst_VestingConditionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionDomain" xlink:to="lab_aqst_VestingConditionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019d4579-2421-7dd1-b28b-ad7b3f8ef7ec_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019d4579-2421-7886-bed0-6deefd37dd55_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7efd-9152-286335d5ccd2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_019d4579-2421-78cd-be88-7ced19e9d3d0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for loan acquisition costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsExercised_019d4579-2421-74c1-98a5-b1a571ac6b15_terseLabel_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsExercised_label_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Warrants Exercised</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsExercised_documentation_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of class of warrant or right exercised.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:href="aqst-20260331.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:to="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_019d4579-2421-7e6f-98ab-6bdbcd5a8681_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CumulativeRoyaltyReceivable_019d4579-2421-77b9-a713-939e6cb4c61e_terseLabel_en-US" xlink:label="lab_aqst_CumulativeRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty receivable</link:label>
    <link:label id="lab_aqst_CumulativeRoyaltyReceivable_label_en-US" xlink:label="lab_aqst_CumulativeRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Royalty Receivable</link:label>
    <link:label id="lab_aqst_CumulativeRoyaltyReceivable_documentation_en-US" xlink:label="lab_aqst_CumulativeRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CumulativeRoyaltyReceivable" xlink:href="aqst-20260331.xsd#aqst_CumulativeRoyaltyReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CumulativeRoyaltyReceivable" xlink:to="lab_aqst_CumulativeRoyaltyReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NumberOfGuaranteedRoyaltyPayments_019d4579-2421-7435-8282-839ba72fedc4_terseLabel_en-US" xlink:label="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of guaranteed royalty payments</link:label>
    <link:label id="lab_aqst_NumberOfGuaranteedRoyaltyPayments_label_en-US" xlink:label="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Guaranteed Royalty Payments</link:label>
    <link:label id="lab_aqst_NumberOfGuaranteedRoyaltyPayments_documentation_en-US" xlink:label="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Guaranteed Royalty Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:href="aqst-20260331.xsd#aqst_NumberOfGuaranteedRoyaltyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:to="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-710d-b316-c5c3c6d4a4f7_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Asset, Acquired, Finite-Lived [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Acquired, Finite-Lived [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019d4579-2421-72c4-9c7e-8dbe500fb3ca_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_019d4579-237c-7618-bae4-ef4457ddc8ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_019d4579-2421-79d6-968a-9f3e82c157eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationActivityTableTextBlock_019d4579-2421-700d-a177-3bcea2e1e20d_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Royalty Obligation</link:label>
    <link:label id="lab_aqst_RoyaltyObligationActivityTableTextBlock_label_en-US" xlink:label="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligation Activity [Table Text Block]</link:label>
    <link:label id="lab_aqst_RoyaltyObligationActivityTableTextBlock_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligation Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationActivityTableTextBlock" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationActivityTableTextBlock" xlink:to="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_019d4579-2421-74d7-b95f-8d6334dd5996_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of warrant or right, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019d4579-2421-7e0e-898f-9fbc7727f92c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019d4579-2421-7c8f-9129-791db778bd29_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss per common share &#8211; basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionRangeTwoMember_019d7dda-6c80-7b42-b061-84c3e5c2fe29_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Two</link:label>
    <link:label id="lab_aqst_MarketConditionRangeTwoMember_label_en-US" xlink:label="lab_aqst_MarketConditionRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Condition Range Two [Member]</link:label>
    <link:label id="lab_aqst_MarketConditionRangeTwoMember_documentation_en-US" xlink:label="lab_aqst_MarketConditionRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Condition Range Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeTwoMember" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionRangeTwoMember" xlink:to="lab_aqst_MarketConditionRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_019d4579-2421-7d97-9792-adaaff865326_verboseLabel_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Public Equity Offering - ATM</link:label>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_019d4579-2421-758e-8fb4-bf6637994334_terseLabel_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-the-market offering</link:label>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At The Market Offering [Member]</link:label>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At The Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember" xlink:href="aqst-20260331.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AtTheMarketOfferingMember" xlink:to="lab_aqst_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_019d4579-2421-75b8-bd2f-a7131955dc50_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues and Trade Receivables, Net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember_019d4579-2421-7a24-bfde-368c90c2fcb8_terseLabel_en-US" xlink:label="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer, network equipment and software</link:label>
    <link:label id="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer, Network Equipment and Software [Member]</link:label>
    <link:label id="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets which are related to computer, network equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:href="aqst-20260331.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:to="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-2421-74e5-aa01-0ea9a7deed26_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_019d4579-2421-752b-93be-95ce2b986981_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019d4579-2421-715c-b30e-132f9781960a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_019d4579-2421-7f84-8ec9-7a394a523130_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019d4579-237c-7587-ae50-923314107ee2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested restricted stock units, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable_019d4579-2421-7e5b-9995-09bcd652c427_terseLabel_en-US" xlink:label="lab_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs associated with public offering-ATM in Accounts Payable</link:label>
    <link:label id="lab_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable_label_en-US" xlink:label="lab_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Associated with At-the-Market Public Equity Offering in Accounts Payable</link:label>
    <link:label id="lab_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable_documentation_en-US" xlink:label="lab_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Costs Associated with At-the-Market Public Equity Offering in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" xlink:href="aqst-20260331.xsd#aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" xlink:to="lab_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_019d4579-2421-7453-9a2f-792afc06a362_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d4579-2421-795b-8076-85314381995a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_019dd939-9516-7172-9cda-a266e12c606f_terseLabel_en-US" xlink:label="lab_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from common stock issued under public equity offering-ATM, net</link:label>
    <link:label id="lab_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_label_en-US" xlink:label="lab_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises</link:label>
    <link:label id="lab_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_documentation_en-US" xlink:label="lab_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" xlink:to="lab_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_019d4579-2421-7bad-a265-3f205b3a9608_terseLabel_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030 and thereafter</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_label_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_documentation_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:to="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_019d4579-237c-7c99-99a3-57f0abd4ee33_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019d4579-237c-7446-867b-614f2893cf35_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unamortized deferred debt issuance cost and deferred debt discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansPayableCurrent_019d4579-237c-70e7-b2ee-c340e8688ae4_negatedLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansPayableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Notes payable, current</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes and Loans Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesAndLoansPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansPayableCurrent" xlink:to="lab_us-gaap_NotesAndLoansPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019d4579-2421-7cf6-9b7a-93db75969b2b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PreFundedWarrantsMember_019d4579-2421-73d3-a85f-f8d3d4fbdc53_terseLabel_en-US" xlink:label="lab_aqst_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:label id="lab_aqst_PreFundedWarrantsMember_label_en-US" xlink:label="lab_aqst_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_aqst_PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_aqst_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PreFundedWarrantsMember" xlink:href="aqst-20260331.xsd#aqst_PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PreFundedWarrantsMember" xlink:to="lab_aqst_PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_UnderwrittenPublicOfferingMember_019d4579-2421-79d4-8e5b-0a0754f340fd_terseLabel_en-US" xlink:label="lab_aqst_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering</link:label>
    <link:label id="lab_aqst_UnderwrittenPublicOfferingMember_label_en-US" xlink:label="lab_aqst_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering [Member]</link:label>
    <link:label id="lab_aqst_UnderwrittenPublicOfferingMember_documentation_en-US" xlink:label="lab_aqst_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_UnderwrittenPublicOfferingMember" xlink:href="aqst-20260331.xsd#aqst_UnderwrittenPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_UnderwrittenPublicOfferingMember" xlink:to="lab_aqst_UnderwrittenPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019d4579-2421-742f-8c4f-618179d94426_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-237c-7ec2-959f-7a49f46562a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d4579-2421-7613-a343-191c95767605_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d4579-2421-7399-a458-219e3fbfbc68_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019d4579-237c-7c28-84aa-506e3e1ae2df_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019d4579-237c-7085-b3ad-547a029df6af_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019d4579-237c-7f5c-9f5a-eed7af78d537_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019d4579-2421-7c99-9405-1e48be45918b_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expenses</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionsDomain_019d7dda-6c80-70af-b598-f7ca766ce1a5_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Conditions [Domain]</link:label>
    <link:label id="lab_aqst_MarketConditionsDomain_label_en-US" xlink:label="lab_aqst_MarketConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Conditions [Domain]</link:label>
    <link:label id="lab_aqst_MarketConditionsDomain_documentation_en-US" xlink:label="lab_aqst_MarketConditionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Conditions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionsDomain" xlink:href="aqst-20260331.xsd#aqst_MarketConditionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionsDomain" xlink:to="lab_aqst_MarketConditionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_019d4579-2421-703d-b570-de2454bf2ea4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019d4579-2421-7e4f-8844-9a63e36b3671_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_IndiviorMember_019d4579-2421-77bc-a0e0-639c0aac3ee4_terseLabel_en-US" xlink:label="lab_aqst_IndiviorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indivior</link:label>
    <link:label id="lab_aqst_IndiviorMember_label_en-US" xlink:label="lab_aqst_IndiviorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indivior [Member]</link:label>
    <link:label id="lab_aqst_IndiviorMember_documentation_en-US" xlink:label="lab_aqst_IndiviorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indivior</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember" xlink:href="aqst-20260331.xsd#aqst_IndiviorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_IndiviorMember" xlink:to="lab_aqst_IndiviorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d4579-237c-73df-8f2d-34b6a77ff52f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock issued under public equity offering-ATM (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019d4579-237c-7966-88e7-3b439c94307f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019d4579-2421-73a8-af87-cd81fa621249_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d4579-2421-7caa-b70c-e3b8beda5508_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-2421-7447-a6d1-76e9e6d72fa1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-2421-75cc-9999-cfd83cd76217_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-2421-7b20-a5f6-7536bae104a0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_019d4579-2421-7644-a63c-3d1be1be3396_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BlackScholesMertonModelMember_019dda94-6ebf-78ea-b946-36a96a082144_terseLabel_en-US" xlink:label="lab_us-gaap_BlackScholesMertonModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Technique, Black-Scholes-Merton Model</link:label>
    <link:label id="lab_us-gaap_BlackScholesMertonModelMember_label_en-US" xlink:label="lab_us-gaap_BlackScholesMertonModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Technique, Black-Scholes-Merton Model [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BlackScholesMertonModelMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BlackScholesMertonModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BlackScholesMertonModelMember" xlink:to="lab_us-gaap_BlackScholesMertonModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-2421-7798-ba86-91729a8d40af_periodStartLabel_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, net at beginning of the period</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-2421-7d98-be52-c4cebfa5c22f_periodEndLabel_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively)</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_label_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_documentation_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:to="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioAxis_019d4579-2421-7278-8f6e-2e4b46d7e1c5_terseLabel_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Axis]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioAxis_label_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Axis]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioAxis_documentation_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioAxis" xlink:href="aqst-20260331.xsd#aqst_DebtCovenantRedemptionScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis" xlink:to="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019d4579-2421-7cea-86fd-6b790c958bf6_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_019d4579-2421-7a83-b19b-e75571d29ed3_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationPercentOfNetSales_019d7cad-d702-79da-85f0-869e9cdd459f_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationPercentOfNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty interest percent interest (as a percent)</link:label>
    <link:label id="lab_aqst_RoyaltyObligationPercentOfNetSales_label_en-US" xlink:label="lab_aqst_RoyaltyObligationPercentOfNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Percent Of Net Sales</link:label>
    <link:label id="lab_aqst_RoyaltyObligationPercentOfNetSales_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationPercentOfNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Percent Of Net Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationPercentOfNetSales" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationPercentOfNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationPercentOfNetSales" xlink:to="lab_aqst_RoyaltyObligationPercentOfNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_019d4579-2421-7728-b8b4-8f88d8a375a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019d4579-2421-7812-9f72-3d27197f967e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Lease Liabilities Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_019d4579-237c-79f0-bb93-72e2edd26acf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_019d4579-2421-77bf-9c61-de917aa2471e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-2421-7035-a2a2-c222cae3c6c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_019d4579-2421-778d-897d-ba921f54a0de_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_019d4579-237c-75a8-970e-7ad146027c5e_terseLabel_en-US" xlink:label="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of annual royalty payments receivable</link:label>
    <link:label id="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_label_en-US" xlink:label="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Annual Royalty Payments Receivable</link:label>
    <link:label id="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_documentation_en-US" xlink:label="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of annual royalty payments receivable by the entity for the use of its rights and property by another party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:href="aqst-20260331.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:to="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_019d4579-237c-7307-89c0-c6ee81d534e8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_019d4579-237c-7cfb-afd4-029078828ca1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_019d4579-237c-7ec9-af31-6d551812b497_terseLabel_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants issued to purchase common stock (in shares)</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_label_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right Warrants Issued During Period</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_documentation_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of warrants issued during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:href="aqst-20260331.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:to="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_019d4579-237c-7761-bb00-d4eb06d9b71f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation, amortization, and impairment</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-2421-77c9-8e14-7263a6409e19_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-2421-7999-8aa3-149f1ef99619_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss)/income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019d4579-237c-7430-bde8-43b9dc8f1890_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_019d4579-237c-734e-9378-bfd644c0511a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, redemption price, percentage of principal amount redeemed (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_019d4579-2421-755b-846e-9834a2adf4e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_019d4579-2421-797a-816c-403dc94bc931_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_019d4579-2421-7ce0-bdfd-553dba200bcb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_019d7d36-bf6c-7370-a6b8-b3a3d0bc17af_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ABLFacilityMember_019d4579-2421-7ba9-869f-34feb3e65a0f_terseLabel_en-US" xlink:label="lab_aqst_ABLFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ABL Facility</link:label>
    <link:label id="lab_aqst_ABLFacilityMember_label_en-US" xlink:label="lab_aqst_ABLFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ABL Facility [Member]</link:label>
    <link:label id="lab_aqst_ABLFacilityMember_documentation_en-US" xlink:label="lab_aqst_ABLFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ABL Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ABLFacilityMember" xlink:href="aqst-20260331.xsd#aqst_ABLFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ABLFacilityMember" xlink:to="lab_aqst_ABLFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AutomaticRenewalPeriodOfAgreement_019d4579-237c-74cd-8f4d-dde38288f9f9_terseLabel_en-US" xlink:label="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Automatic renewal period of agreement (in years)</link:label>
    <link:label id="lab_aqst_AutomaticRenewalPeriodOfAgreement_label_en-US" xlink:label="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Automatic Renewal Period of Agreement</link:label>
    <link:label id="lab_aqst_AutomaticRenewalPeriodOfAgreement_documentation_en-US" xlink:label="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Period for which the agreement is renewed automatically.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AutomaticRenewalPeriodOfAgreement" xlink:href="aqst-20260331.xsd#aqst_AutomaticRenewalPeriodOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AutomaticRenewalPeriodOfAgreement" xlink:to="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_019d4579-237c-7f13-b040-36824792b19d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019d4579-2421-7f1f-b976-02e1f7ec7b23_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionRangeFiveMember_019d7dda-6c80-77b9-bc06-f57061377a41_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Five</link:label>
    <link:label id="lab_aqst_MarketConditionRangeFiveMember_label_en-US" xlink:label="lab_aqst_MarketConditionRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Condition Range Five [Member]</link:label>
    <link:label id="lab_aqst_MarketConditionRangeFiveMember_documentation_en-US" xlink:label="lab_aqst_MarketConditionRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Condition Range Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeFiveMember" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionRangeFiveMember" xlink:to="lab_aqst_MarketConditionRangeFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_019d4579-2421-7ce9-a34d-1b59eb5cd778_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019d4579-2421-74df-97ff-2ce25fb7fc8b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_019d4579-237c-740d-a692-b37e97b0b1cc_verboseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected to vest at end of period (in dollars per share)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_019d4579-2421-7a7c-a45c-f4129f925121_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_019d4579-2421-74ff-9c9b-d1a2437758fe_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_019d4579-2421-7e7f-b711-3477fbfb3552_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued_019d7d69-c7bc-7662-b329-14d02448658f_terseLabel_en-US" xlink:label="lab_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of warrants issued</link:label>
    <link:label id="lab_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued_label_en-US" xlink:label="lab_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Fair Value of Warrants Issued</link:label>
    <link:label id="lab_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued_documentation_en-US" xlink:label="lab_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of increase in additional paid in capital (APIC) resulting from the issuance of fair value of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" xlink:href="aqst-20260331.xsd#aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" xlink:to="lab_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019d4579-237c-788c-80b8-545c59ce97fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019d4579-2421-7af9-ac65-c153ff925f98_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification_019d7c66-012d-74f7-a397-6e31ebae8b1c_negatedLabel_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: sales-related allowances</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification_label_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification_documentation_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowanceForCreditLossPreReclassification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification" xlink:to="lab_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_019d4579-2421-7bc8-a645-2c9c0d128624_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_019d4579-2421-7f06-848a-7cd2fc710c24_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_019d4579-2421-7db7-9987-2dd35caed101_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_019d4579-2421-7cdc-9381-ab310c1a9f5e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d4579-237c-7dbb-b6f9-e5acb0e367c6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_019d4579-2421-74fa-84fe-c0c78459503c_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019d4579-2421-715e-8f71-749c02b4f281_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019d4579-2421-77be-ae0d-9a8f054159bc_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_A2020AdditionalNotesMember_019d7d69-c7bc-7e3d-b716-0dac4e44c482_terseLabel_en-US" xlink:label="lab_aqst_A2020AdditionalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020 Additional Notes</link:label>
    <link:label id="lab_aqst_A2020AdditionalNotesMember_label_en-US" xlink:label="lab_aqst_A2020AdditionalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2020 Additional Notes [Member]</link:label>
    <link:label id="lab_aqst_A2020AdditionalNotesMember_documentation_en-US" xlink:label="lab_aqst_A2020AdditionalNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2020 Additional Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2020AdditionalNotesMember" xlink:href="aqst-20260331.xsd#aqst_A2020AdditionalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_A2020AdditionalNotesMember" xlink:to="lab_aqst_A2020AdditionalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019d4579-2421-72b8-906b-258c087697cf_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeEightMember_019d4579-2421-7840-b597-52abbce7a8e1_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Eight</link:label>
    <link:label id="lab_aqst_VestingConditionRangeEightMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Eight [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeEightMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Eight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeEightMember" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeEightMember" xlink:to="lab_aqst_VestingConditionRangeEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019d4579-2421-7b6a-ae6f-23818bc2e8be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyAgreementMeasurementInput_019d7d44-0ca5-7ae0-acd9-3cdc6ecd8e21_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyAgreementMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty rights agreement, measurement input (as a percent)</link:label>
    <link:label id="lab_aqst_RoyaltyAgreementMeasurementInput_label_en-US" xlink:label="lab_aqst_RoyaltyAgreementMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Agreement, Measurement Input</link:label>
    <link:label id="lab_aqst_RoyaltyAgreementMeasurementInput_documentation_en-US" xlink:label="lab_aqst_RoyaltyAgreementMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Agreement, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyAgreementMeasurementInput" xlink:href="aqst-20260331.xsd#aqst_RoyaltyAgreementMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyAgreementMeasurementInput" xlink:to="lab_aqst_RoyaltyAgreementMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CommercialExploitationAgreementWithIndiviorMember_019d4579-2421-78e0-a276-4eda12824a53_terseLabel_en-US" xlink:label="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial exploitation agreement with Indivior</link:label>
    <link:label id="lab_aqst_CommercialExploitationAgreementWithIndiviorMember_label_en-US" xlink:label="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Exploitation Agreement with Indivior [Member]</link:label>
    <link:label id="lab_aqst_CommercialExploitationAgreementWithIndiviorMember_documentation_en-US" xlink:label="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The commercial exploitation agreement with Indivior.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:href="aqst-20260331.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:to="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_019d4579-2421-72c3-a852-ce09408e2577_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AmendedEquityDistributionAgreementMember_019d4579-2421-7c3a-b5d0-3b2c19ab194d_terseLabel_en-US" xlink:label="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Equity Distribution Agreement</link:label>
    <link:label id="lab_aqst_AmendedEquityDistributionAgreementMember_label_en-US" xlink:label="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Equity Distribution Agreement [Member]</link:label>
    <link:label id="lab_aqst_AmendedEquityDistributionAgreementMember_documentation_en-US" xlink:label="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Equity Distribution Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AmendedEquityDistributionAgreementMember" xlink:href="aqst-20260331.xsd#aqst_AmendedEquityDistributionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AmendedEquityDistributionAgreementMember" xlink:to="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019d4579-2421-72ef-81d1-8bba0c7fe571_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-2421-7299-8eb4-aecb7f5e235f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-2421-714b-80ce-850d7b9019cb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019d4579-2421-7978-87e9-5ea7af84b29b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Overview and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_019ddc57-d0d2-7e90-8563-3239392e136c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward" xlink:to="lab_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_019d4579-2421-76a8-a4ed-7f5cc187372a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_019d4579-2421-71dc-bfe3-a765ffd6cc61_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories, Net</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_019d4579-237c-744f-aa42-195d5254af70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_019d4579-2421-7a6f-9bdf-9eb14fe2855c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LesseeOperatingLeaseNumberOfRenewalOptions_019e15cf-a639-7124-bca3-59cfd7d4f689_terseLabel_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_aqst_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019d4579-2421-7e3f-8201-f7c028e57aec_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_019d4579-2421-74aa-9704-6a04a8e0afe9_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants on common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019d4579-2421-7df9-8300-c21b773f9763_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_019d4579-237c-79f4-8275-b570c05f1bee_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized contract cost, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-2421-7d90-84f2-d97788c9a6f5_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-2421-712a-b32b-6cb380fdcfaf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_019d4579-2421-7a58-9546-d78020ad5406_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_019d7d37-392b-7c82-9bcb-8c89366adb24_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of equity instruments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019d4579-2421-7c21-8967-9d0e8d4d8d46_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_019d7c68-87fa-73c8-bf6b-010eef0abd73_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provision</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_019d4579-2421-79b9-817d-19e1849ce7c5_terseLabel_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, accordion feature, net revenue threshold</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_label_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Net Revenue Threshold</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_documentation_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Net Revenue Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:to="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_019d4579-2421-7b33-8da2-2657cfea75f7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ProprietaryProductRevenueMember_019d7c62-e7fc-797a-91a9-b8a20c8f294c_terseLabel_en-US" xlink:label="lab_aqst_ProprietaryProductRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proprietary product revenue, net</link:label>
    <link:label id="lab_aqst_ProprietaryProductRevenueMember_label_en-US" xlink:label="lab_aqst_ProprietaryProductRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proprietary Product Revenue [Member]</link:label>
    <link:label id="lab_aqst_ProprietaryProductRevenueMember_documentation_en-US" xlink:label="lab_aqst_ProprietaryProductRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate revenue generated from proprietary product sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProprietaryProductRevenueMember" xlink:href="aqst-20260331.xsd#aqst_ProprietaryProductRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ProprietaryProductRevenueMember" xlink:to="lab_aqst_ProprietaryProductRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_019d4579-2421-7cb2-a8b1-7830839f73f7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases pending</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_019d4579-2421-7b77-8bb8-17d98b3fbd54_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RedemptionScenario1Member_019d4579-237c-70f6-8c5a-a36cdc64328f_terseLabel_en-US" xlink:label="lab_aqst_RedemptionScenario1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption Scenario 1</link:label>
    <link:label id="lab_aqst_RedemptionScenario1Member_label_en-US" xlink:label="lab_aqst_RedemptionScenario1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redemption Scenario 1 [Member]</link:label>
    <link:label id="lab_aqst_RedemptionScenario1Member_documentation_en-US" xlink:label="lab_aqst_RedemptionScenario1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redemption Scenario 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario1Member" xlink:href="aqst-20260331.xsd#aqst_RedemptionScenario1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RedemptionScenario1Member" xlink:to="lab_aqst_RedemptionScenario1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_019d4579-2421-7efa-9528-8b876a42d7d3_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligation, term (in years)</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_label_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Tiered Royalty Percentage, Term</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Tiered Royalty Percentage, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:to="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_019d4579-2421-790d-adcc-54da02090a13_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-237c-7a78-a237-87dabbecf328_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAndRoyaltyRevenueMember_019d4579-2421-7983-8284-b7b990560c1b_terseLabel_en-US" xlink:label="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License and royalty revenue a</link:label>
    <link:label id="lab_aqst_LicenseAndRoyaltyRevenueMember_label_en-US" xlink:label="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License and Royalty Revenue [Member]</link:label>
    <link:label id="lab_aqst_LicenseAndRoyaltyRevenueMember_documentation_en-US" xlink:label="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate revenue generated from licensing and royalties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember" xlink:href="aqst-20260331.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAndRoyaltyRevenueMember" xlink:to="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019d4579-2421-7f0c-9af9-25bf16d5e07a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019d4579-2421-77fe-b817-b3d42b19374a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019d4579-2421-79e8-82d0-d9a0dd6f325c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_019d4579-237c-79af-9270-0715a155adb0_terseLabel_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, net</link:label>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_label_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent</link:label>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_documentation_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:href="aqst-20260331.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:to="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d4579-2421-763a-bb92-968597f88dd8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7049-8008-bd44fe053006_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019d4579-237c-7a0d-8148-10dff1b16707_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective annual interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019d7cc8-85c7-7b1c-9281-01a3e250cd1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019d4579-2421-7999-b45f-3b3b113abd50_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ManufactureAndSupplyRevenueMember_019d4579-237c-7ac0-9fb3-a8d2af759374_terseLabel_en-US" xlink:label="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manufacture and supply revenue</link:label>
    <link:label id="lab_aqst_ManufactureAndSupplyRevenueMember_label_en-US" xlink:label="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacture and Supply Revenue [Member]</link:label>
    <link:label id="lab_aqst_ManufactureAndSupplyRevenueMember_documentation_en-US" xlink:label="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate revenue generated from manufacture and supply.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember" xlink:href="aqst-20260331.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ManufactureAndSupplyRevenueMember" xlink:to="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-2421-7c43-a4d9-9712f97a5ae9_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-237c-7fe9-a533-df92654f13df_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-237c-75ff-841a-d28411e10d6d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_019d4579-2421-7f23-912c-8f026c56bc7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019d4579-2421-735a-a143-f02e38cde966_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-2421-708d-8b44-cf7496b93471_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_019d4579-2421-719b-b1b7-2ee463ac5734_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real estate and personal property taxes</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember_019d4579-237c-7510-99a4-ad380d6fc87e_terseLabel_en-US" xlink:label="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Doubtful Accounts</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember_label_en-US" xlink:label="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Doubtful Accounts [Member]</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember_documentation_en-US" xlink:label="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:href="aqst-20260331.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:to="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-74dd-a8c2-01731e665feb_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentMilestoneTranchesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Milestone Tranches [Axis]</link:label>
    <link:label id="lab_aqst_DebtInstrumentMilestoneTranchesAxis_label_en-US" xlink:label="lab_aqst_DebtInstrumentMilestoneTranchesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Milestone Tranches [Axis]</link:label>
    <link:label id="lab_aqst_DebtInstrumentMilestoneTranchesAxis_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentMilestoneTranchesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Milestone Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentMilestoneTranchesAxis" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentMilestoneTranchesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesAxis" xlink:to="lab_aqst_DebtInstrumentMilestoneTranchesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-237c-7b18-889c-8426b96198fe_terseLabel_en-US" xlink:label="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">13.5% Senior Secured Notes due November 1, 2028</link:label>
    <link:label id="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member_label_en-US" xlink:label="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Notes, 13.5% due November 1, 2028 [Member]</link:label>
    <link:label id="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member_documentation_en-US" xlink:label="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Notes, 13.5% due November 1, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:to="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_019d4579-2421-7156-be11-3b73bf84bbec_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_019d4579-2421-7487-937a-0fb70bebd3f8_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019d4579-2421-7cce-ac0e-775e0a8d8724_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_019d4579-2421-768b-9f53-c2829070ee99_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationDisclosureAbstract" xlink:to="lab_us-gaap_AssetRetirementObligationDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationLiabilitiesIncurred_019ddc57-d0d2-7543-876e-c5d7acaa43eb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:to="lab_us-gaap_AssetRetirementObligationLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-2421-7a69-ad2f-9f6e5b46dc92_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_019d4579-237c-72a6-a5b9-5274ba58658d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ResearchAndDevelopmentProjectDuration_019d4579-2421-7f5c-90b8-803e3127a61c_terseLabel_en-US" xlink:label="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development, project duration (in years)</link:label>
    <link:label id="lab_aqst_ResearchAndDevelopmentProjectDuration_label_en-US" xlink:label="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development, Project Duration</link:label>
    <link:label id="lab_aqst_ResearchAndDevelopmentProjectDuration_documentation_en-US" xlink:label="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and Development, Project Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ResearchAndDevelopmentProjectDuration" xlink:href="aqst-20260331.xsd#aqst_ResearchAndDevelopmentProjectDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ResearchAndDevelopmentProjectDuration" xlink:to="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019d4579-237c-7ac7-96c5-79743c02ce6a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_019d4579-2421-7b23-b270-ab40276f34e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from collaborators</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollaborators" xlink:to="lab_us-gaap_ProceedsFromCollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_019d4579-237c-7860-88fa-f9cda8ebb7a2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InterestExpenseSaleOfFutureRevenues_019d4579-2421-7d4c-a512-b575953b11a4_negatedTerseLabel_en-US" xlink:label="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense related to the sale of future revenue</link:label>
    <link:label id="lab_aqst_InterestExpenseSaleOfFutureRevenues_label_en-US" xlink:label="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Sale of Future Revenues</link:label>
    <link:label id="lab_aqst_InterestExpenseSaleOfFutureRevenues_documentation_en-US" xlink:label="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Sale of Future Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestExpenseSaleOfFutureRevenues" xlink:href="aqst-20260331.xsd#aqst_InterestExpenseSaleOfFutureRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InterestExpenseSaleOfFutureRevenues" xlink:to="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-7570-8662-7aa84e91ca6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-7cc4-88c3-efb4396488b8_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_019d4579-237c-79ad-8e0e-a60ca005b9e4_terseLabel_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification into Accrued distribution expenses and sales-related allowances</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_label_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Reclassifications</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_documentation_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Reclassifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowanceForCreditLossReclassifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:to="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MinimumAnnualRoyaltyReceivable_019d4579-2421-7080-9c0f-9d82cea0d584_terseLabel_en-US" xlink:label="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum annual royalty receivable</link:label>
    <link:label id="lab_aqst_MinimumAnnualRoyaltyReceivable_label_en-US" xlink:label="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum Annual Royalty Receivable</link:label>
    <link:label id="lab_aqst_MinimumAnnualRoyaltyReceivable_documentation_en-US" xlink:label="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable" xlink:href="aqst-20260331.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MinimumAnnualRoyaltyReceivable" xlink:to="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-2421-7c34-8d82-02a6656521f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested, at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-2421-7504-b797-12f0dad9d82d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested, at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d4579-237c-72fa-b6ae-2eefd9711f9f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_019d4579-2421-7920-9766-ac5daa700fee_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019d4579-2421-736b-abdf-351046fce0b1_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ReportableSegmentMember_019d4579-2421-7920-8913-99f1b8e812a5_terseLabel_en-US" xlink:label="lab_aqst_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_aqst_ReportableSegmentMember_label_en-US" xlink:label="lab_aqst_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_aqst_ReportableSegmentMember_documentation_en-US" xlink:label="lab_aqst_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ReportableSegmentMember" xlink:href="aqst-20260331.xsd#aqst_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ReportableSegmentMember" xlink:to="lab_aqst_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-2421-79db-92db-60fea04f4ffb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d4579-2421-7f0a-84d7-ac140b7f60f1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense related to non-vested stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-2421-7570-a8ce-46c6b3bf68a0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used for operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_019e1f1c-cb8c-7880-87e1-d4ae86ff4506_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, term (in years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_019d4579-2421-7e22-b81c-d6d3e2f3279d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_019d4579-237c-741f-9600-292882e44984_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019d7df2-9177-7f86-8208-f704ed4260be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeTenMember_019d4579-2421-7909-ab49-f4be8d06279c_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Ten</link:label>
    <link:label id="lab_aqst_VestingConditionRangeTenMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Ten [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeTenMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Ten</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTenMember" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeTenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeTenMember" xlink:to="lab_aqst_VestingConditionRangeTenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_019d4579-2421-7204-90c1-0e973228295d_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_019d4579-237c-72cf-96d2-c380dd496136_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019d4579-2421-7cc2-9cce-c50f84b5f9da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested or expected to vest at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseSupplyAgreementMember_019d4579-2421-75e7-8e0b-c07617739c96_terseLabel_en-US" xlink:label="lab_aqst_LicenseSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License &amp; Supply Agreement</link:label>
    <link:label id="lab_aqst_LicenseSupplyAgreementMember_label_en-US" xlink:label="lab_aqst_LicenseSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License &amp; Supply Agreement [Member]</link:label>
    <link:label id="lab_aqst_LicenseSupplyAgreementMember_documentation_en-US" xlink:label="lab_aqst_LicenseSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License &amp; Supply Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember" xlink:href="aqst-20260331.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseSupplyAgreementMember" xlink:to="lab_aqst_LicenseSupplyAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019d4579-237c-7c9e-908d-bc4cf699ac47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-2421-7587-b020-0991d9d96c07_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_019d4579-2421-7e93-a7ff-ac843777e085_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ex-United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_WarrantsDisclosureTextBlock_019d4579-237c-774e-af1e-aa8b6370f502_terseLabel_en-US" xlink:label="lab_aqst_WarrantsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_aqst_WarrantsDisclosureTextBlock_label_en-US" xlink:label="lab_aqst_WarrantsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Disclosure [Text Block]</link:label>
    <link:label id="lab_aqst_WarrantsDisclosureTextBlock_documentation_en-US" xlink:label="lab_aqst_WarrantsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_WarrantsDisclosureTextBlock" xlink:href="aqst-20260331.xsd#aqst_WarrantsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_WarrantsDisclosureTextBlock" xlink:to="lab_aqst_WarrantsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAccountsReceivableMember_019d4579-2421-767b-a4f9-8982d9925783_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_TradeAccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAccountsReceivableMember" xlink:to="lab_us-gaap_TradeAccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_019d4579-2421-75d9-a71c-ad6035de7e2a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_019d4579-2421-757e-98ce-a09fa405a25d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019d4579-2421-77ec-a8a0-70430ca9f557_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unamortized discount (premium), net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_019e219c-30fe-768f-bfef-eeda0e3d5a75_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-2421-7f3d-844f-d01b7c8072ea_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-78ad-8ee7-a7d01d04dc45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019d4579-2421-714a-bde9-725fe84e8937_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d4579-237c-7b4f-b48b-9bd8f271bcb4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019d4579-237c-70ba-8082-285f1d4f9b20_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_019d4579-2421-77fd-894f-955a179e078f_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average closing prices period (in days)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7457-a50e-306078ca59b3_terseLabel_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue [Roll Forward]</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueRollForward_label_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue [Roll Forward]</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueRollForward_documentation_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueRollForward" xlink:href="aqst-20260331.xsd#aqst_SaleOfFutureRevenueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward" xlink:to="lab_aqst_SaleOfFutureRevenueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock_019ddc57-d0d2-7a35-8fe0-2c256db99002_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Liability for Asset Retirement Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Asset Retirement Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementTerm_019d4579-2421-723b-a5c5-a5af9d90248b_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement term (in years)</link:label>
    <link:label id="lab_aqst_LicenseAgreementTerm_label_en-US" xlink:label="lab_aqst_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement Term</link:label>
    <link:label id="lab_aqst_LicenseAgreementTerm_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License agreement term period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementTerm" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementTerm" xlink:to="lab_aqst_LicenseAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_019d4579-237c-7200-bef6-7ebca0390f7d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod_019e15cf-a639-7e37-8371-2d160e071db8_terseLabel_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial rent abatement period</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod_label_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Initial Rent Abatement Period</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod_documentation_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Initial Rent Abatement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseInitialRentAbatementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod" xlink:to="lab_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-2421-7235-ba1b-2a2ec43d095c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_019d4579-237c-7708-975b-385f438c6211_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019d4579-2421-7ed2-8969-df3f286d3ffe_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019d4579-2421-7b71-80f0-6f42034b34a9_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_019d4579-2421-7ec2-b987-84d3d118b419_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019d4579-2421-7724-9eef-a000f1a6e7ce_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019d4579-237c-7101-9365-6ef4bf6a33ed_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationsMember_019d4579-2421-7164-849a-1542daec5aa7_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Obligations</link:label>
    <link:label id="lab_aqst_RoyaltyObligationsMember_label_en-US" xlink:label="lab_aqst_RoyaltyObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligations [Member]</link:label>
    <link:label id="lab_aqst_RoyaltyObligationsMember_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationsMember" xlink:to="lab_aqst_RoyaltyObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_019d4579-2421-7fd8-97aa-ab035084f108_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_019d4579-2421-715a-94d5-1ecf562d455c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d4579-2421-7dbe-ac13-77a58d79ab4c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost, recognition period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d4579-237c-794d-94d0-bf14bba5310c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercises, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d4579-237c-75d6-81d7-ee501bddf8a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_019d4579-2421-7365-a6dc-4279d1302f07_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition and Performance Obligations</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionRangeFourMember_019d7dda-6c80-78b4-aa9e-fc3e653a2f1e_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Four</link:label>
    <link:label id="lab_aqst_MarketConditionRangeFourMember_label_en-US" xlink:label="lab_aqst_MarketConditionRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Condition Range Four [Member]</link:label>
    <link:label id="lab_aqst_MarketConditionRangeFourMember_documentation_en-US" xlink:label="lab_aqst_MarketConditionRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Condition Range Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeFourMember" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionRangeFourMember" xlink:to="lab_aqst_MarketConditionRangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarathonPangolinRoyaltyLLCMember_019d4579-2421-702d-bcd1-59f872dd724f_terseLabel_en-US" xlink:label="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MAM Pangolin Royalty , LLC</link:label>
    <link:label id="lab_aqst_MarathonPangolinRoyaltyLLCMember_label_en-US" xlink:label="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marathon Pangolin Royalty LLC [Member]</link:label>
    <link:label id="lab_aqst_MarathonPangolinRoyaltyLLCMember_documentation_en-US" xlink:label="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Marathon Pangolin Royalty LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember" xlink:href="aqst-20260331.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarathonPangolinRoyaltyLLCMember" xlink:to="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_019d4579-237c-71de-b446-a5a358da13b0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeNineMember_019d4579-237c-700e-b8d1-a669b49e0663_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Nine</link:label>
    <link:label id="lab_aqst_VestingConditionRangeNineMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Nine [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeNineMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Nine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeNineMember" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeNineMember" xlink:to="lab_aqst_VestingConditionRangeNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_019d4579-2421-7429-a747-72f32ec347a4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7cb6-b957-46553867a572_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-237c-797a-b0b3-f409cec5f5ad_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7eed-9b28-a37fef1a3410_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-237c-746c-bf79-59e28f2e208c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RTWInvestmentsLPMember_019d4579-2421-7463-ac24-ac9d3ee5792f_terseLabel_en-US" xlink:label="lab_aqst_RTWInvestmentsLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RTW Investments LP</link:label>
    <link:label id="lab_aqst_RTWInvestmentsLPMember_label_en-US" xlink:label="lab_aqst_RTWInvestmentsLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">RTW Investments LP [Member]</link:label>
    <link:label id="lab_aqst_RTWInvestmentsLPMember_documentation_en-US" xlink:label="lab_aqst_RTWInvestmentsLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">RTW Investments LP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RTWInvestmentsLPMember" xlink:href="aqst-20260331.xsd#aqst_RTWInvestmentsLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RTWInvestmentsLPMember" xlink:to="lab_aqst_RTWInvestmentsLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_OtherReceivablesAndAccruedExpensesMember_019d4579-2421-738e-b9d4-e45dd18d3221_terseLabel_en-US" xlink:label="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Receivables And Accrued Expenses</link:label>
    <link:label id="lab_aqst_OtherReceivablesAndAccruedExpensesMember_label_en-US" xlink:label="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables And Accrued Expenses [Member]</link:label>
    <link:label id="lab_aqst_OtherReceivablesAndAccruedExpensesMember_documentation_en-US" xlink:label="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Receivables And Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:href="aqst-20260331.xsd#aqst_OtherReceivablesAndAccruedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:to="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_019d4579-2421-7e23-84db-41a839a59213_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited/expired (in dollars per share)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period Weighted Average Exercise Price</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average price of options that were either exercised, forfeited or expired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_019d4579-2421-7ac7-8e65-ec68db5b02a4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_019d4579-2421-76ab-b1e3-14257049ead3_totalLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_019d4579-237c-7d29-886d-24fdcb1d1b06_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_019d4579-237c-75fd-b300-6b1e0a332205_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_019d4579-2421-7409-a3cf-3ee8d3f682c1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_019d4579-237c-788e-a638-8be64ffda8f9_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019d4579-2421-79a7-9ce6-de75c5a5f96a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_019d4579-237c-71b7-825d-b0af960dce39_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement with Sunovion Pharmaceuticals, Inc. upfront</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_label_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member]</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The license agreement made with sunovion pharmaceuticals, inc. advance payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:to="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d4579-2421-79ca-93b0-16c8a9f399db_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Product and Service Sold [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligation_019ddc57-d0d2-78ab-ab1e-c15868d7b4a2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset retirement obligation</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_019ddc57-d0d2-7387-915d-2ef39081fd46_periodStartLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_019ddc57-d0d2-7d85-9125-b02c84e67be6_periodEndLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at ending of period</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligation" xlink:to="lab_us-gaap_AssetRetirementObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_019d4579-237c-71e6-a5d9-9d867e66b2ee_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate payment</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_019d4579-2421-7f41-892b-e6e283e0cd5d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt Maturities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d4579-2421-7fc9-88ed-019c120951cd_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consideration received on sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_019d4579-2421-7cb4-9d4b-3fd01517c221_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019d4579-2421-76bf-8fcc-06de506877cd_terseLabel_en-US" xlink:label="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior secured notes due 2025</link:label>
    <link:label id="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_label_en-US" xlink:label="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]</link:label>
    <link:label id="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_documentation_en-US" xlink:label="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:href="aqst-20260331.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d4579-2421-7856-b1a5-77bcd725afaa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_019d4579-237c-7b05-b70f-1f9c2dad65f3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NumberOfOperatingLeases_019d4579-2421-754e-8060-0cbbc6bc76c2_terseLabel_en-US" xlink:label="lab_aqst_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of leases</link:label>
    <link:label id="lab_aqst_NumberOfOperatingLeases_label_en-US" xlink:label="lab_aqst_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Leases</link:label>
    <link:label id="lab_aqst_NumberOfOperatingLeases_documentation_en-US" xlink:label="lab_aqst_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of operating leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfOperatingLeases" xlink:href="aqst-20260331.xsd#aqst_NumberOfOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NumberOfOperatingLeases" xlink:to="lab_aqst_NumberOfOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019d4579-2421-7084-9af7-3738fb2cce9d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_019d4579-237c-70a4-be0d-967ecce36dea_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d4579-2421-716b-bea1-072c817e9418_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7ea4-a1d8-26aa91f10bf9_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentMilestoneTranchesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Milestone Tranches [Domain]</link:label>
    <link:label id="lab_aqst_DebtInstrumentMilestoneTranchesDomain_label_en-US" xlink:label="lab_aqst_DebtInstrumentMilestoneTranchesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Milestone Tranches [Domain]</link:label>
    <link:label id="lab_aqst_DebtInstrumentMilestoneTranchesDomain_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentMilestoneTranchesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Milestone Tranches [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentMilestoneTranchesDomain" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentMilestoneTranchesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesDomain" xlink:to="lab_aqst_DebtInstrumentMilestoneTranchesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketBasedMember_019d4579-2421-7018-98d8-2bc8a0904a37_terseLabel_en-US" xlink:label="lab_aqst_MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Based</link:label>
    <link:label id="lab_aqst_MarketBasedMember_label_en-US" xlink:label="lab_aqst_MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Based [Member]</link:label>
    <link:label id="lab_aqst_MarketBasedMember_documentation_en-US" xlink:label="lab_aqst_MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember" xlink:href="aqst-20260331.xsd#aqst_MarketBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketBasedMember" xlink:to="lab_aqst_MarketBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019d4579-237c-70e6-bf7e-151d2b6d9fd7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019d4579-237c-74c1-b8d3-51b2e60907d6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d4579-2421-7199-a118-0564114886b7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation costs of RSU awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-2421-70a7-b1f7-70e4fea2f713_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_019d4579-2421-7908-9090-0563b94ff9a8_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock price at grant date</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_019d4579-2421-7674-b664-a3180a552895_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019d4579-2421-7f78-8862-977ca397e000_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019d4579-237c-7bcf-89e9-a8ac6930d5d7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_019d4579-237c-7127-80f2-ff9e66d3871e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, long-term</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_019d4579-2421-70fa-82b2-027ad1eb19bb_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_019d4579-2421-7357-b50f-424b7e4b46a6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-2421-7c6f-a799-63e374b9cfee_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionAxis_019d4579-2421-7b04-a397-105fe97a4440_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition [Axis]</link:label>
    <link:label id="lab_aqst_VestingConditionAxis_label_en-US" xlink:label="lab_aqst_VestingConditionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition [Axis]</link:label>
    <link:label id="lab_aqst_VestingConditionAxis_documentation_en-US" xlink:label="lab_aqst_VestingConditionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionAxis" xlink:href="aqst-20260331.xsd#aqst_VestingConditionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionAxis" xlink:to="lab_aqst_VestingConditionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_019d4579-237c-7eda-ba88-0ae084f38bee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019d4579-2421-77ed-ae7d-31f9ee62737a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_019d4579-2421-736d-8c3f-313e70e30c78_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments &#8211; Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_019d4579-2421-7486-94ec-970235168edb_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_019d4579-2421-7977-bc71-bbec2181f1de_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; deficit:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_019d4579-2421-7994-af89-24d4eb320953_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting rights (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019d4579-237c-79a7-9204-971dc1d041f0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TradeAccountsReceivableSalesRelatedMember_019d4579-2421-7a6d-88c1-e8d831b4fc0d_terseLabel_en-US" xlink:label="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Sales Related</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableSalesRelatedMember_label_en-US" xlink:label="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Sales Related [Member]</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableSalesRelatedMember_documentation_en-US" xlink:label="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Sales Related</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:href="aqst-20260331.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:to="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019d4579-2421-7c8d-b00e-08e1429050b8_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019d4579-2421-767a-b862-93be1578cd60_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d4579-2421-705e-a75f-2616421cfbc8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d4579-2421-7df7-80ea-9960ccc50d4b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_019d4579-2421-7d43-892d-49e5de8a1103_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019d4579-2421-723e-9509-2ced3c97e469_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioDomain_019d4579-237c-7a50-b547-f342d81d3ebe_terseLabel_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Domain]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioDomain_label_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Domain]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioDomain_documentation_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain" xlink:href="aqst-20260331.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain" xlink:to="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_019d4579-2421-7f07-90f8-b42483528420_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense related to royalty obligations</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeTwelveMember_019d4579-2421-737c-8917-3d47d41c9c1a_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeTwelveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Twelve</link:label>
    <link:label id="lab_aqst_VestingConditionRangeTwelveMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeTwelveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Twelve [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeTwelveMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeTwelveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Twelve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTwelveMember" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeTwelveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeTwelveMember" xlink:to="lab_aqst_VestingConditionRangeTwelveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfStockSharesCommittedAggregateAmount_019d7c84-1953-7515-b4aa-e9b58e4f22f3_terseLabel_en-US" xlink:label="lab_aqst_SaleOfStockSharesCommittedAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock, Shares Committed, Aggregate Amount</link:label>
    <link:label id="lab_aqst_SaleOfStockSharesCommittedAggregateAmount_label_en-US" xlink:label="lab_aqst_SaleOfStockSharesCommittedAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Shares Committed, Aggregate Amount</link:label>
    <link:label id="lab_aqst_SaleOfStockSharesCommittedAggregateAmount_documentation_en-US" xlink:label="lab_aqst_SaleOfStockSharesCommittedAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Shares Committed, Aggregate Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockSharesCommittedAggregateAmount" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockSharesCommittedAggregateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfStockSharesCommittedAggregateAmount" xlink:to="lab_aqst_SaleOfStockSharesCommittedAggregateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-237c-745a-bc58-fac989448d9f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019d4579-237c-7dd9-a1c7-317737d0c63e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationsGross_019d7d37-392b-750d-afda-1b1a719ef56d_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Obligations, Gross</link:label>
    <link:label id="lab_aqst_RoyaltyObligationsGross_label_en-US" xlink:label="lab_aqst_RoyaltyObligationsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligations, Gross</link:label>
    <link:label id="lab_aqst_RoyaltyObligationsGross_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligations, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsGross" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationsGross" xlink:to="lab_aqst_RoyaltyObligationsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_019d4579-2421-7c18-81f7-dbf7c5f051d9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from warrant exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_019d4579-2421-7b1c-a7ec-684037231820_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_019d4579-2421-7b24-8740-582f1dd2410b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Term Notes and Unamortized Debt Discount Balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen_019d4579-2421-7155-b209-1497abb3d9a7_terseLabel_en-US" xlink:label="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue share payments year ten</link:label>
    <link:label id="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen_label_en-US" xlink:label="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Estimated Revenue Share Payments Upon Purchaser&#8217;s Receipt, Year Ten</link:label>
    <link:label id="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen_documentation_en-US" xlink:label="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Estimated Revenue Share Payments Upon Purchaser&#8217;s Receipt, Year Ten</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" xlink:to="lab_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d4579-2421-71de-976a-68082f3fde7f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_019d4579-2421-7f89-b2fb-4148930aefc0_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019d4579-237c-7a8f-b8ce-42afb14d3684_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ManufacturingAndSupplyMember_019d4579-2421-70be-9539-645ea5a72ac7_verboseLabel_en-US" xlink:label="lab_aqst_ManufacturingAndSupplyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Manufacture and supply</link:label>
    <link:label id="lab_aqst_ManufacturingAndSupplyMember_label_en-US" xlink:label="lab_aqst_ManufacturingAndSupplyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing And Supply [Member]</link:label>
    <link:label id="lab_aqst_ManufacturingAndSupplyMember_documentation_en-US" xlink:label="lab_aqst_ManufacturingAndSupplyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing Manufacturing and supply expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufacturingAndSupplyMember" xlink:href="aqst-20260331.xsd#aqst_ManufacturingAndSupplyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ManufacturingAndSupplyMember" xlink:to="lab_aqst_ManufacturingAndSupplyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_019d4579-237c-7c80-a18a-4972df8dc2ec_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d4579-2421-71c9-8257-913338745481_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Costs of common stock issued under public equity offering-ATM</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_019d4579-2421-7bac-9553-bf655bbe28a0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_019d4579-2421-7af5-b008-32f474fee708_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling expenses:</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_019d4579-2421-72cd-b6ff-0ecc59685b01_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019d4579-2421-75ec-b991-fca06ae1c7a7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019d4579-2421-73dd-9b7e-74117993190c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_019d4579-2421-7990-9691-654f184d695f_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionRangeOneMember_019d7dda-6c80-7fc9-872e-fb738017e84e_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range One</link:label>
    <link:label id="lab_aqst_MarketConditionRangeOneMember_label_en-US" xlink:label="lab_aqst_MarketConditionRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Condition Range One [Member]</link:label>
    <link:label id="lab_aqst_MarketConditionRangeOneMember_documentation_en-US" xlink:label="lab_aqst_MarketConditionRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Condition Range One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeOneMember" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionRangeOneMember" xlink:to="lab_aqst_MarketConditionRangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_019d4579-237c-7e00-a72e-54fab246b7a1_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d4579-2421-7e9b-985e-42a481cec3dc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_019d4579-237c-7ef9-857b-8b78103a7b52_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_019d4579-2421-71a8-80df-8907019d6164_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate_019d7c84-1953-7599-a679-3c1eba4695d4_terseLabel_en-US" xlink:label="lab_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock, Share Commitment, Period following Effective Date (in days)</link:label>
    <link:label id="lab_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate_label_en-US" xlink:label="lab_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Share Commitment, Period following Effective Date</link:label>
    <link:label id="lab_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate_documentation_en-US" xlink:label="lab_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Share Commitment, Period following Effective Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" xlink:to="lab_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MeasurementInputProbabilityOfSuccessMember_019d4579-2421-7b7d-aadf-ed4a8ef6f6d1_terseLabel_en-US" xlink:label="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Success</link:label>
    <link:label id="lab_aqst_MeasurementInputProbabilityOfSuccessMember_label_en-US" xlink:label="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Success [Member]</link:label>
    <link:label id="lab_aqst_MeasurementInputProbabilityOfSuccessMember_documentation_en-US" xlink:label="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Success</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:href="aqst-20260331.xsd#aqst_MeasurementInputProbabilityOfSuccessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:to="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_019d4579-2421-756f-a1db-75b525ed2305_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_019d4579-2421-729a-a2ec-7dacb361ecfe_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfFutureRevenueTextBlock_019d4579-237c-73ba-a730-46bab2a90fdc_terseLabel_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueTextBlock_label_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue [Text Block]</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueTextBlock_documentation_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueTextBlock" xlink:href="aqst-20260331.xsd#aqst_SaleOfFutureRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfFutureRevenueTextBlock" xlink:to="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7f5f-8bf5-58e9ed9b1a53_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d4579-2421-7d3b-8d16-6a728c5c66d4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_019d4579-2421-7f14-8d3e-539cb103911b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_019d4579-2421-7835-9890-deefc641c27f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InventoryPackingMaterialGross_019d4579-2421-7797-bc86-deb9dde901d7_terseLabel_en-US" xlink:label="lab_aqst_InventoryPackingMaterialGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Packaging material</link:label>
    <link:label id="lab_aqst_InventoryPackingMaterialGross_label_en-US" xlink:label="lab_aqst_InventoryPackingMaterialGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Packing Material Gross</link:label>
    <link:label id="lab_aqst_InventoryPackingMaterialGross_documentation_en-US" xlink:label="lab_aqst_InventoryPackingMaterialGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of packaging materials expected to be sold within one year or operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InventoryPackingMaterialGross" xlink:href="aqst-20260331.xsd#aqst_InventoryPackingMaterialGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InventoryPackingMaterialGross" xlink:to="lab_aqst_InventoryPackingMaterialGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_019d4579-2421-7c38-99a4-e71819820dfb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_019d4579-2421-78c0-96e0-ff8f7b06995f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_019d4579-2421-70ee-acf5-9e43a4a8de37_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TrancheTwoMember_019e1f2b-b007-7252-8043-a18a130a90fa_terseLabel_en-US" xlink:label="lab_aqst_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche Two</link:label>
    <link:label id="lab_aqst_TrancheTwoMember_label_en-US" xlink:label="lab_aqst_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Two [Member]</link:label>
    <link:label id="lab_aqst_TrancheTwoMember_documentation_en-US" xlink:label="lab_aqst_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheTwoMember" xlink:href="aqst-20260331.xsd#aqst_TrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TrancheTwoMember" xlink:to="lab_aqst_TrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_019d4579-2421-7f29-8fd6-c2a8f3fd1873_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019d4579-237c-7a11-85af-227dc6468e30_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-2421-727f-bf09-1907217cd2e3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested, at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-2421-780a-b836-e4c3565b42a1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested, at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_019d4579-237c-7209-a752-074ada38e686_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Non-current Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ProceedsFromExerciseOfWarrantsNet_019d4579-2421-7663-aac2-d1b8fdad1f79_terseLabel_en-US" xlink:label="lab_aqst_ProceedsFromExerciseOfWarrantsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants issued under the Purchase Agreement</link:label>
    <link:label id="lab_aqst_ProceedsFromExerciseOfWarrantsNet_label_en-US" xlink:label="lab_aqst_ProceedsFromExerciseOfWarrantsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Exercise of Warrants, Net</link:label>
    <link:label id="lab_aqst_ProceedsFromExerciseOfWarrantsNet_documentation_en-US" xlink:label="lab_aqst_ProceedsFromExerciseOfWarrantsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from Exercise of Warrants, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromExerciseOfWarrantsNet" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromExerciseOfWarrantsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ProceedsFromExerciseOfWarrantsNet" xlink:to="lab_aqst_ProceedsFromExerciseOfWarrantsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7e89-97c7-508357019f6e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d4579-237c-7273-816d-177e8acedbcd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NewWarrantsMember_019d4579-2421-7a32-b43d-0f748b9de94a_terseLabel_en-US" xlink:label="lab_aqst_NewWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Warrants</link:label>
    <link:label id="lab_aqst_NewWarrantsMember_label_en-US" xlink:label="lab_aqst_NewWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Warrants [Member]</link:label>
    <link:label id="lab_aqst_NewWarrantsMember_documentation_en-US" xlink:label="lab_aqst_NewWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember" xlink:href="aqst-20260331.xsd#aqst_NewWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NewWarrantsMember" xlink:to="lab_aqst_NewWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-7a94-be3d-04d4114203e0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-7cdb-ba2b-c53a47de5b97_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Notes payable, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019d4579-2421-7473-92f0-1690c360a873_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_019d4579-2421-78cd-adf0-9634e969f9a0_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dac47-c263-7f50-bc8d-f6663b4eeac2_terseLabel_en-US" xlink:label="lab_aqst_ZevraAndCommaveTherapeuticsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zevra And Commave Therapeutics Agreement</link:label>
    <link:label id="lab_aqst_ZevraAndCommaveTherapeuticsAgreementMember_label_en-US" xlink:label="lab_aqst_ZevraAndCommaveTherapeuticsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zevra And Commave Therapeutics Agreement [Member]</link:label>
    <link:label id="lab_aqst_ZevraAndCommaveTherapeuticsAgreementMember_documentation_en-US" xlink:label="lab_aqst_ZevraAndCommaveTherapeuticsAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zevra And Commave Therapeutics Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember" xlink:href="aqst-20260331.xsd#aqst_ZevraAndCommaveTherapeuticsAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember" xlink:to="lab_aqst_ZevraAndCommaveTherapeuticsAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ServiceBasedMember_019d7dc1-64c9-7081-a162-50e49e485750_terseLabel_en-US" xlink:label="lab_aqst_ServiceBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service Based</link:label>
    <link:label id="lab_aqst_ServiceBasedMember_label_en-US" xlink:label="lab_aqst_ServiceBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Based [Member]</link:label>
    <link:label id="lab_aqst_ServiceBasedMember_documentation_en-US" xlink:label="lab_aqst_ServiceBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Service Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ServiceBasedMember" xlink:href="aqst-20260331.xsd#aqst_ServiceBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ServiceBasedMember" xlink:to="lab_aqst_ServiceBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_019d4579-2421-709f-9ed7-cb36dc352092_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_019d4579-2421-7858-84e8-8a4f6026bc8d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_019d4579-2421-782b-bd70-58f3c3ca45c3_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_019d4579-2421-7191-a5cd-4d098fe2d532_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_019d4579-2421-78ff-b8c4-3f7cb3673317_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_019d4579-2421-720c-8058-e03a602fd85b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_019d4579-2421-755e-86c1-6fdab9739e3a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019d4579-2421-78b4-9659-32604b8adc24_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableCurrent_019d4579-237c-7273-abbb-d1e8427c36f2_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loans payable, current</link:label>
    <link:label id="lab_us-gaap_LoansPayableCurrent_label_en-US" xlink:label="lab_us-gaap_LoansPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableCurrent" xlink:to="lab_us-gaap_LoansPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019d4579-2421-76dc-88b4-df8421d47ff9_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019d4579-2421-7a1f-9f71-e7fa84e3d231_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019d4579-2421-7245-b9d0-542340e8392f_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ZevraMember_019daa6b-cc28-79a7-b358-e15ef091903c_terseLabel_en-US" xlink:label="lab_aqst_ZevraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zevra</link:label>
    <link:label id="lab_aqst_ZevraMember_label_en-US" xlink:label="lab_aqst_ZevraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zevra [Member]</link:label>
    <link:label id="lab_aqst_ZevraMember_documentation_en-US" xlink:label="lab_aqst_ZevraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zevra</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraMember" xlink:href="aqst-20260331.xsd#aqst_ZevraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ZevraMember" xlink:to="lab_aqst_ZevraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_019ddc57-d0d2-76f5-bd59-5076b7a5ce25_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accretion</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation, Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_019d4579-237c-78c9-8314-bb65bc5130cb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract_019d4579-2421-7703-8569-567b86908325_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General &amp; Administrative expenses:</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsAbstract_019d7d9a-b8bf-7fc9-a1f3-e3557fb0997f_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsAbstract_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undistributed Earnings, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UndistributedEarningsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsAbstract" xlink:to="lab_us-gaap_UndistributedEarningsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests_019d4579-2421-7a97-8f54-c9a9d0703511_terseLabel_en-US" xlink:label="lab_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange for the Purchaser&#8217;s payment</link:label>
    <link:label id="lab_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests_label_en-US" xlink:label="lab_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration Receivable From Sale Of Future Revenues Interests</link:label>
    <link:label id="lab_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests_documentation_en-US" xlink:label="lab_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consideration Receivable From Sale Of Future Revenues Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests" xlink:href="aqst-20260331.xsd#aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests" xlink:to="lab_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_019d4579-2421-7106-8206-67acc7efbca9_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationDisclosureTextBlock_019ddc57-d0d2-7f86-ace1-76340dbfb5b9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Non-Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationDisclosureTextBlock" xlink:to="lab_us-gaap_AssetRetirementObligationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_019d4579-2421-74fe-a359-7589e78ef0ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019d4579-2421-7e6b-a7f9-0b7f3895271f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019d4579-2421-7d83-a558-9f3e69c52e9e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value. Authorized $250,000,000 shares; 124,284,542 and 122,044,299 shares issued and outstanding at March&#160;31, 2026 and December&#160;31, 2025, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019d4579-2421-79ca-8557-e3bd7dc24397_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PaymentsForRoyaltyObligations_019d6dd6-21cd-7b0c-b573-ee0af37814a0_negatedTerseLabel_en-US" xlink:label="lab_aqst_PaymentsForRoyaltyObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments for royalty obligations</link:label>
    <link:label id="lab_aqst_PaymentsForRoyaltyObligations_label_en-US" xlink:label="lab_aqst_PaymentsForRoyaltyObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Royalty Obligations</link:label>
    <link:label id="lab_aqst_PaymentsForRoyaltyObligations_documentation_en-US" xlink:label="lab_aqst_PaymentsForRoyaltyObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments for Royalty Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PaymentsForRoyaltyObligations" xlink:href="aqst-20260331.xsd#aqst_PaymentsForRoyaltyObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PaymentsForRoyaltyObligations" xlink:to="lab_aqst_PaymentsForRoyaltyObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d4579-2421-77aa-83dc-e1a654a4a192_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d4579-2421-7ea8-a2f3-7b2b0f403ec1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares &#8211; diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019d4579-2421-72ec-8c30-b975a9b23ce4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies (Note 20)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock_019d7ccc-7cda-715b-8579-846b46050821_terseLabel_en-US" xlink:label="lab_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Royalty Right Agreements</link:label>
    <link:label id="lab_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock_label_en-US" xlink:label="lab_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement [Table Text Block]</link:label>
    <link:label id="lab_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock_documentation_en-US" xlink:label="lab_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" xlink:href="aqst-20260331.xsd#aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" xlink:to="lab_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019d4579-2421-7e51-ad29-09a6093496f4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationTerm_019d7cad-d702-78a9-9752-9deec9de63c4_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty payment term (in years)</link:label>
    <link:label id="lab_aqst_RoyaltyObligationTerm_label_en-US" xlink:label="lab_aqst_RoyaltyObligationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Term</link:label>
    <link:label id="lab_aqst_RoyaltyObligationTerm_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationTerm" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationTerm" xlink:to="lab_aqst_RoyaltyObligationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_019d4579-2421-7e1f-9f2c-99685b596ac2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_019d4579-2421-7c1f-b364-2f0563e12aee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RedemptionScenario2Member_019d4579-2421-706c-817b-cb38ec140033_terseLabel_en-US" xlink:label="lab_aqst_RedemptionScenario2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption Scenario 2</link:label>
    <link:label id="lab_aqst_RedemptionScenario2Member_label_en-US" xlink:label="lab_aqst_RedemptionScenario2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redemption Scenario 2 [Member]</link:label>
    <link:label id="lab_aqst_RedemptionScenario2Member_documentation_en-US" xlink:label="lab_aqst_RedemptionScenario2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redemption Scenario 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario2Member" xlink:href="aqst-20260331.xsd#aqst_RedemptionScenario2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RedemptionScenario2Member" xlink:to="lab_aqst_RedemptionScenario2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019d4579-2421-763d-8d79-15719e46fcfc_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_019d4579-2421-76ea-812a-0536aaee2b27_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019d4579-2421-7e9b-bd46-05226c6a14b6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019d4579-2421-753f-a127-a80205be7769_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod_019d4579-2421-7877-9ee2-19c108fd0068_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average closing price, number of days utilized in pricing period (in days)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Days Utilized in Pricing Period</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Days Utilized in Pricing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_019d4579-2421-76a9-be79-8b0dd4199d07_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-2421-795b-808b-7342ce8ecdcd_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-2421-7bb5-b0fe-296fb824c24b_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-2421-724b-92a3-6d2a65aa1ebc_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-2421-7359-bdac-1e025e0008f6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued distribution expenses and sales returns provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_019d4579-2421-7642-b875-d56f01c3f4f3_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_019d4579-237c-7a42-8fe6-cfc279433ad6_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount (premium)</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d4579-237c-76e1-9e23-0bd244337a9c_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement with Sunovion Pharmaceuticals, Inc.</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_label_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement with Sunovion Pharmaceuticals, Inc. [Member]</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The license agreement made with sunovion pharmaceuticals, inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:to="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019d4579-2421-703f-8ecb-35b16fb49174_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_019d4579-237c-73f5-a43f-beff0aad206b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_019d4579-2421-79c7-827b-8d7f81f20b89_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_019d4579-237c-77b5-a57e-11cc29a3fadb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_019d4579-2421-77eb-89bf-28ab2ac1eab5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_019d4579-2421-7a1c-8bb1-5000a80a08cb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_019d4579-2421-7066-81ce-0057add124e3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-2421-73f3-bf16-d1a1902a7bd2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c64-006d-7e44-a186-f3e6924398cb_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7d94-2ec2-7323-bbec-bea3ef3f2a13_negatedNetLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Royalties related to the sale of future revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_019d4579-2421-7912-a88d-ef6c63aabff5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_019d4579-237c-77c3-84b1-d4f3c7e7637e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d4579-2421-7791-9591-13b24bbefc7a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019d4579-237c-7c16-a8ef-cd9cae6df81d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested or expected to vest at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019d4579-2421-77b7-a8ed-f624dd4481d6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019d4579-2421-7edd-9e25-c104be431df4_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ExistingWarrantsMember_019d4579-2421-798c-ba9f-788275e7d4cd_terseLabel_en-US" xlink:label="lab_aqst_ExistingWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Existing Warrants</link:label>
    <link:label id="lab_aqst_ExistingWarrantsMember_label_en-US" xlink:label="lab_aqst_ExistingWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Existing Warrants [Member]</link:label>
    <link:label id="lab_aqst_ExistingWarrantsMember_documentation_en-US" xlink:label="lab_aqst_ExistingWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Existing Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember" xlink:href="aqst-20260331.xsd#aqst_ExistingWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ExistingWarrantsMember" xlink:to="lab_aqst_ExistingWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TrancheThreeMember_019e1f2b-eda7-7cbc-b7a4-c9700b6ca57d_terseLabel_en-US" xlink:label="lab_aqst_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche Three</link:label>
    <link:label id="lab_aqst_TrancheThreeMember_label_en-US" xlink:label="lab_aqst_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Three [Member]</link:label>
    <link:label id="lab_aqst_TrancheThreeMember_documentation_en-US" xlink:label="lab_aqst_TrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheThreeMember" xlink:href="aqst-20260331.xsd#aqst_TrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TrancheThreeMember" xlink:to="lab_aqst_TrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d4579-237c-73a1-abcd-08f945c40748_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments for taxes on share-based compensation, net</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_019d4579-2421-7bc3-96da-52ec25fdf3e6_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, redemption price, basis points above treasury rate</link:label>
    <link:label id="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Basis Spread On Variable Rate</link:label>
    <link:label id="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Basis Spread On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:to="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionsAxis_019d7dda-6c80-77ae-8e34-f4f293f8b92f_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Conditions [Axis]</link:label>
    <link:label id="lab_aqst_MarketConditionsAxis_label_en-US" xlink:label="lab_aqst_MarketConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Conditions [Axis]</link:label>
    <link:label id="lab_aqst_MarketConditionsAxis_documentation_en-US" xlink:label="lab_aqst_MarketConditionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionsAxis" xlink:href="aqst-20260331.xsd#aqst_MarketConditionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionsAxis" xlink:to="lab_aqst_MarketConditionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019d4579-2421-7a4d-9bb2-c26e58809b77_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_019d4579-2421-7c1d-825d-6b5e14714f56_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_019d4579-2421-720c-8802-63af1ef78fb0_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-743a-8c4a-3322552ecf76_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CoDevelopmentAndResearchFeesMember_019d4579-2421-7719-892f-ff50fd6868a3_terseLabel_en-US" xlink:label="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-development and research fees</link:label>
    <link:label id="lab_aqst_CoDevelopmentAndResearchFeesMember_label_en-US" xlink:label="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Co-Development and Research Fees [Member]</link:label>
    <link:label id="lab_aqst_CoDevelopmentAndResearchFeesMember_documentation_en-US" xlink:label="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate revenue generated from Co-development and research fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CoDevelopmentAndResearchFeesMember" xlink:href="aqst-20260331.xsd#aqst_CoDevelopmentAndResearchFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CoDevelopmentAndResearchFeesMember" xlink:to="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_019d4579-2421-757c-af86-b1a60623f6ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_019d4579-2421-71bf-a612-c16173db130e_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AssertioHoldingsIncMember_019daa6d-cd14-79b7-9670-804a0c8c8fb2_verboseLabel_en-US" xlink:label="lab_aqst_AssertioHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assertio</link:label>
    <link:label id="lab_aqst_AssertioHoldingsIncMember_019d4579-237c-75e6-9650-ccf114841a3a_terseLabel_en-US" xlink:label="lab_aqst_AssertioHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assertio Holdings, Inc</link:label>
    <link:label id="lab_aqst_AssertioHoldingsIncMember_label_en-US" xlink:label="lab_aqst_AssertioHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assertio Holdings, Inc [Member]</link:label>
    <link:label id="lab_aqst_AssertioHoldingsIncMember_documentation_en-US" xlink:label="lab_aqst_AssertioHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assertio Holdings, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember" xlink:href="aqst-20260331.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AssertioHoldingsIncMember" xlink:to="lab_aqst_AssertioHoldingsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019d4579-2421-72b9-9bc2-fa0a33956d3f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019d4579-2421-7043-9065-3c4b03f56121_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss per common share &#8211; diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_019d4579-237c-7080-8d6f-71a5b87148f6_negatedTerseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited/expired (in shares)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised, Forfeitures And Expirations In Period</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-2421-76da-855c-fe19ca1132e0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019d4579-237c-71ae-8a3a-d5a6ab7e5d3e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_019d4579-2421-77a7-86c9-ce79ad9334be_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods_019d4579-237c-7777-b1e7-f158d78a5be9_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of pricing periods</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Pricing Periods</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Pricing Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA-BC_019d4579-2421-72f1-ae97-613a7ef2b7c4_terseLabel_en-US" xlink:label="lab_stpr_CA-BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BRITISH COLUMBIA</link:label>
    <link:label id="lab_stpr_CA-BC_label_en-US" xlink:label="lab_stpr_CA-BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BRITISH COLUMBIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA-BC" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA-BC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA-BC" xlink:to="lab_stpr_CA-BC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d4579-2421-7848-a88d-31596b971b54_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_019d4579-237c-7a98-9aab-cb0f2c39819b_terseLabel_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, accordion feature, increase limit</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_FirstAdditionalWarrantOfferingMember_019d4579-2421-7c84-ac7d-6d903fff4393_terseLabel_en-US" xlink:label="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Additional Warrant Offering</link:label>
    <link:label id="lab_aqst_FirstAdditionalWarrantOfferingMember_label_en-US" xlink:label="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Additional Warrant Offering [Member]</link:label>
    <link:label id="lab_aqst_FirstAdditionalWarrantOfferingMember_documentation_en-US" xlink:label="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First Additional Warrant Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_FirstAdditionalWarrantOfferingMember" xlink:href="aqst-20260331.xsd#aqst_FirstAdditionalWarrantOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_FirstAdditionalWarrantOfferingMember" xlink:to="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019d4579-2421-77cd-b7f0-b01f0c3103cc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss per share attributable to common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyRightAgreementsMember_019dda82-b498-738c-bd83-674f8b25f347_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyRightAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Right Agreements</link:label>
    <link:label id="lab_aqst_RoyaltyRightAgreementsMember_label_en-US" xlink:label="lab_aqst_RoyaltyRightAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Right Agreements [Member]</link:label>
    <link:label id="lab_aqst_RoyaltyRightAgreementsMember_documentation_en-US" xlink:label="lab_aqst_RoyaltyRightAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Right Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyRightAgreementsMember" xlink:href="aqst-20260331.xsd#aqst_RoyaltyRightAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyRightAgreementsMember" xlink:to="lab_aqst_RoyaltyRightAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_EquityDistributionAgreementMember_019d4579-2421-7972-bf63-0320d07d854b_terseLabel_en-US" xlink:label="lab_aqst_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity distribution agreement</link:label>
    <link:label id="lab_aqst_EquityDistributionAgreementMember_label_en-US" xlink:label="lab_aqst_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Distribution Agreement [Member]</link:label>
    <link:label id="lab_aqst_EquityDistributionAgreementMember_documentation_en-US" xlink:label="lab_aqst_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Distribution Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_EquityDistributionAgreementMember" xlink:href="aqst-20260331.xsd#aqst_EquityDistributionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_EquityDistributionAgreementMember" xlink:to="lab_aqst_EquityDistributionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_019d4579-2421-7636-8fc4-b246000f30b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AnaphylmMember_019d4579-2421-7369-882b-e163576a5234_terseLabel_en-US" xlink:label="lab_aqst_AnaphylmMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anaphylm project expenses</link:label>
    <link:label id="lab_aqst_AnaphylmMember_label_en-US" xlink:label="lab_aqst_AnaphylmMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Anaphylm [Member]</link:label>
    <link:label id="lab_aqst_AnaphylmMember_documentation_en-US" xlink:label="lab_aqst_AnaphylmMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Anaphylm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AnaphylmMember" xlink:href="aqst-20260331.xsd#aqst_AnaphylmMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AnaphylmMember" xlink:to="lab_aqst_AnaphylmMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d4579-2421-7371-856f-a664aaca9b3b_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfStockMaximumTransactionAmount_019d4579-237c-721b-b4e8-0bd66d46906e_terseLabel_en-US" xlink:label="lab_aqst_SaleOfStockMaximumTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, maximum transaction amount</link:label>
    <link:label id="lab_aqst_SaleOfStockMaximumTransactionAmount_label_en-US" xlink:label="lab_aqst_SaleOfStockMaximumTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Maximum Transaction Amount</link:label>
    <link:label id="lab_aqst_SaleOfStockMaximumTransactionAmount_documentation_en-US" xlink:label="lab_aqst_SaleOfStockMaximumTransactionAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Maximum Transaction Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockMaximumTransactionAmount" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockMaximumTransactionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfStockMaximumTransactionAmount" xlink:to="lab_aqst_SaleOfStockMaximumTransactionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationLiabilityNoncurrent_019d4579-237c-70a3-a7d6-60a8f9f57c93_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligations, net</link:label>
    <link:label id="lab_aqst_RoyaltyObligationLiabilityNoncurrent_label_en-US" xlink:label="lab_aqst_RoyaltyObligationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Liability, Noncurrent</link:label>
    <link:label id="lab_aqst_RoyaltyObligationLiabilityNoncurrent_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligation, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationLiabilityNoncurrent" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationLiabilityNoncurrent" xlink:to="lab_aqst_RoyaltyObligationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019d4579-237c-7f1a-8e17-f96d5d069bef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SuboxoneProduceLiabilityLitigationMember_019d4579-2421-742e-8b01-3270d133ef70_terseLabel_en-US" xlink:label="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Suboxone Produce Liability Litigation</link:label>
    <link:label id="lab_aqst_SuboxoneProduceLiabilityLitigationMember_label_en-US" xlink:label="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Suboxone Produce Liability Litigation [Member]</link:label>
    <link:label id="lab_aqst_SuboxoneProduceLiabilityLitigationMember_documentation_en-US" xlink:label="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Suboxone Produce Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:href="aqst-20260331.xsd#aqst_SuboxoneProduceLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:to="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_019d4579-237c-7f88-a2f2-463ceac6d3e4_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Stock Units Awards</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-2421-7f71-81f9-a4367332dafb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TrancheFourMember_019e1f2c-379c-7de3-84ac-1b3dd331cfc4_terseLabel_en-US" xlink:label="lab_aqst_TrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche Four</link:label>
    <link:label id="lab_aqst_TrancheFourMember_label_en-US" xlink:label="lab_aqst_TrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tranche Four [Member]</link:label>
    <link:label id="lab_aqst_TrancheFourMember_documentation_en-US" xlink:label="lab_aqst_TrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tranche Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheFourMember" xlink:href="aqst-20260331.xsd#aqst_TrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TrancheFourMember" xlink:to="lab_aqst_TrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_019d4579-2421-766b-9360-7509f56eb3a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_019d4579-2421-7219-ba12-64d98f12bf15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Outstanding notes/Total Royalty obligations</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d4579-2421-7c60-84e6-f4fd631d4d0d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_019d4579-2421-7ace-a374-530e97bf4fdd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_019d4579-2421-7b91-90ea-e2d883d3978d_terseLabel_en-US" xlink:label="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock (in shares)</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_label_en-US" xlink:label="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_documentation_en-US" xlink:label="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:href="aqst-20260331.xsd#aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:to="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_019d4579-2421-7dee-9663-b6c45c9ff9e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments / credits</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019d4579-2421-7b7c-857f-bd97caf88c57_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_019e15cf-a639-72e6-bbe7-8be08e847f29_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-2421-7350-bff6-e333da8bee08_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_019d4579-2421-7b7e-9622-86211268077d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019d4579-2421-788f-a24e-a89dddd4b617_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_019d4579-2421-7d7d-9189-1bb1a5439be6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PurchaseAndSaleAgreementMember_019d4579-2421-709c-bd0c-83a1a6982415_terseLabel_en-US" xlink:label="lab_aqst_PurchaseAndSaleAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase And Sale Agreement</link:label>
    <link:label id="lab_aqst_PurchaseAndSaleAgreementMember_label_en-US" xlink:label="lab_aqst_PurchaseAndSaleAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase And Sale Agreement [Member]</link:label>
    <link:label id="lab_aqst_PurchaseAndSaleAgreementMember_documentation_en-US" xlink:label="lab_aqst_PurchaseAndSaleAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase And Sale Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PurchaseAndSaleAgreementMember" xlink:href="aqst-20260331.xsd#aqst_PurchaseAndSaleAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PurchaseAndSaleAgreementMember" xlink:to="lab_aqst_PurchaseAndSaleAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_019d4579-2421-783d-bf91-a87f4cd0d034_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_019d4579-237c-7088-afb1-cda8df159d52_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d4579-2421-7435-b604-192239447ef6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CommonStockWarrantsMember_019d4579-2421-7ad8-a459-dee2aee7589c_terseLabel_en-US" xlink:label="lab_aqst_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:label id="lab_aqst_CommonStockWarrantsMember_label_en-US" xlink:label="lab_aqst_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:label id="lab_aqst_CommonStockWarrantsMember_documentation_en-US" xlink:label="lab_aqst_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember" xlink:href="aqst-20260331.xsd#aqst_CommonStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CommonStockWarrantsMember" xlink:to="lab_aqst_CommonStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d4579-2421-7deb-884c-7965e26a5752_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeElevenMember_019d4579-2421-705d-a3fe-18b057196318_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeElevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Eleven</link:label>
    <link:label id="lab_aqst_VestingConditionRangeElevenMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeElevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Eleven [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeElevenMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeElevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Eleven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeElevenMember" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeElevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeElevenMember" xlink:to="lab_aqst_VestingConditionRangeElevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019d4579-2421-7539-b744-8d17dc12c234_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019d4579-2421-7494-90e8-b4e95c7610e6_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_A2025MarketBasedMember_019d4579-2421-7591-81d4-11c7a4b54b03_terseLabel_en-US" xlink:label="lab_aqst_A2025MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025 Market Based</link:label>
    <link:label id="lab_aqst_A2025MarketBasedMember_label_en-US" xlink:label="lab_aqst_A2025MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2025 Market Based [Member]</link:label>
    <link:label id="lab_aqst_A2025MarketBasedMember_documentation_en-US" xlink:label="lab_aqst_A2025MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2025 Market Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2025MarketBasedMember" xlink:href="aqst-20260331.xsd#aqst_A2025MarketBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_A2025MarketBasedMember" xlink:to="lab_aqst_A2025MarketBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_019d4579-2421-7473-b911-be9a6f36edba_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionRangeSixMember_019d7dda-6c80-7927-8b3e-0d4f0539107f_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Six</link:label>
    <link:label id="lab_aqst_MarketConditionRangeSixMember_label_en-US" xlink:label="lab_aqst_MarketConditionRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Condition Range Six [Member]</link:label>
    <link:label id="lab_aqst_MarketConditionRangeSixMember_documentation_en-US" xlink:label="lab_aqst_MarketConditionRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Condition Range Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeSixMember" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionRangeSixMember" xlink:to="lab_aqst_MarketConditionRangeSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet_019d4579-2421-7a40-a5c0-7282e2d07df0_terseLabel_en-US" xlink:label="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of future revenue</link:label>
    <link:label id="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet_label_en-US" xlink:label="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Sale of Future Revenues, Net</link:label>
    <link:label id="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet_documentation_en-US" xlink:label="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Sale of Future Revenues, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:to="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_019d4579-2421-71b8-af81-f7aa77fb2e33_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current and non-current contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_HyperaMember_019d4579-2421-770d-8570-63b1fe07e41c_terseLabel_en-US" xlink:label="lab_aqst_HyperaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hypera</link:label>
    <link:label id="lab_aqst_HyperaMember_label_en-US" xlink:label="lab_aqst_HyperaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hypera [Member]</link:label>
    <link:label id="lab_aqst_HyperaMember_documentation_en-US" xlink:label="lab_aqst_HyperaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hypera</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HyperaMember" xlink:href="aqst-20260331.xsd#aqst_HyperaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_HyperaMember" xlink:to="lab_aqst_HyperaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019d4579-2421-777a-b3fd-2ca67e73fa0b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_019e15cf-a639-7983-85be-8d917c553f45_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_019d4579-2421-7a6b-87f1-82a9625b2d85_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019d4579-2421-7ec8-86e0-96823000eb5c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_019d4579-237c-7fc5-ada4-25c439658361_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-2421-759c-b820-e7da83e6decc_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-2421-7575-a906-73337c4a36b7_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_019d4579-2421-74c0-9ca6-ffc669a6f9f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeSevenMember_019d4579-237c-74e0-b2c5-53020db5ecc0_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Seven</link:label>
    <link:label id="lab_aqst_VestingConditionRangeSevenMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Seven [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeSevenMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Seven</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeSevenMember" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeSevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeSevenMember" xlink:to="lab_aqst_VestingConditionRangeSevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_019d4579-2421-797f-9fa1-99e1a8553c29_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_019d6dd5-9057-797f-a74b-b11875472d87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of debt principal including lease liabilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_019e1f23-9665-7427-a8fb-5ca2c8d309a1_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MonetizationAgreementMember_019d4579-2421-76f3-a137-af2b5f041df1_terseLabel_en-US" xlink:label="lab_aqst_MonetizationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monetization Agreement</link:label>
    <link:label id="lab_aqst_MonetizationAgreementMember_label_en-US" xlink:label="lab_aqst_MonetizationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Monetization Agreement [Member]</link:label>
    <link:label id="lab_aqst_MonetizationAgreementMember_documentation_en-US" xlink:label="lab_aqst_MonetizationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Monetization Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember" xlink:href="aqst-20260331.xsd#aqst_MonetizationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MonetizationAgreementMember" xlink:to="lab_aqst_MonetizationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019d4579-237c-7afe-b64e-774d278e7ff9_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_A2022InducementEquityIncentivePlanMember_019d7dda-6c80-76d6-ab97-3b1b7ada3ad0_terseLabel_en-US" xlink:label="lab_aqst_A2022InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Inducement Equity Incentive Plan</link:label>
    <link:label id="lab_aqst_A2022InducementEquityIncentivePlanMember_label_en-US" xlink:label="lab_aqst_A2022InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Inducement Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_aqst_A2022InducementEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_aqst_A2022InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Inducement Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2022InducementEquityIncentivePlanMember" xlink:href="aqst-20260331.xsd#aqst_A2022InducementEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_A2022InducementEquityIncentivePlanMember" xlink:to="lab_aqst_A2022InducementEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SecuritiesPurchaseAgreementMember_019d4579-237c-77f1-8dde-1303bb1111d2_terseLabel_en-US" xlink:label="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities purchase agreement</link:label>
    <link:label id="lab_aqst_SecuritiesPurchaseAgreementMember_label_en-US" xlink:label="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
    <link:label id="lab_aqst_SecuritiesPurchaseAgreementMember_documentation_en-US" xlink:label="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SecuritiesPurchaseAgreementMember" xlink:href="aqst-20260331.xsd#aqst_SecuritiesPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SecuritiesPurchaseAgreementMember" xlink:to="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019d4579-237c-7bc1-b723-1ba5c1ab3f86_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_019d4579-2421-7a4b-87ee-42cfd74d346e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_019d4579-237c-7642-a224-a7beae081316_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Trade and Other Receivables, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_019d4579-2421-7ade-adc2-9943c9bff983_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019d7dda-6c80-7c5c-9e02-d401aedb59d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-74e1-be35-c7e57a3ece75_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_019d4579-2421-7a1f-b97e-5f7e5e90d301_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income/(expenses), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019d4579-2421-73f5-a210-14af89bf8e40_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-2421-7ee1-ac54-a37210e80b67_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used for operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_019d4579-2421-7251-8248-9a1ff3bde062_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-2421-7110-b380-6cc95f2ba70a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d4579-2421-78dc-95df-0038188dcfca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_019d4579-2421-72da-8aa0-dd797c223ff4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_OtherMember_019d4579-2421-7e25-8b62-3619633a0b98_terseLabel_en-US" xlink:label="lab_aqst_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_aqst_OtherMember_label_en-US" xlink:label="lab_aqst_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_aqst_OtherMember_documentation_en-US" xlink:label="lab_aqst_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherMember" xlink:href="aqst-20260331.xsd#aqst_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_OtherMember" xlink:to="lab_aqst_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_019d4579-2421-7ed3-b8f3-be34cde14950_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement with Sunovion Pharmaceuticals, Inc milestones</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_label_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member]</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The license agreement made with sunovion pharmaceuticals, inc. milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:to="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketConditionRangeThreeMember_019d7dda-6c80-7a9b-a73f-f33f5b8ac2b5_terseLabel_en-US" xlink:label="lab_aqst_MarketConditionRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Three</link:label>
    <link:label id="lab_aqst_MarketConditionRangeThreeMember_label_en-US" xlink:label="lab_aqst_MarketConditionRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Condition Range Three [Member]</link:label>
    <link:label id="lab_aqst_MarketConditionRangeThreeMember_documentation_en-US" xlink:label="lab_aqst_MarketConditionRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Condition Range Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeThreeMember" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketConditionRangeThreeMember" xlink:to="lab_aqst_MarketConditionRangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_019d6d91-5eea-7547-bfc1-adf89c7cd618_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_019d7c66-012d-7101-8fac-c99f01d2b635_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_019d4579-2421-7aee-b30d-9d6a2810835b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_019d4579-237c-72e5-86fd-f924f32278eb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_019d7c66-012d-7487-bf98-ec057b01d6d4_verboseLabel_en-US" xlink:label="lab_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reclassification into Accrued distribution expenses and sales-related allowances</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_label_en-US" xlink:label="lab_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_documentation_en-US" xlink:label="lab_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:to="lab_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d4579-2421-702a-94e0-5882ef9d37d2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_019d7c61-77a2-772f-b030-d1930e080efc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesGrossCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables, Gross, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesGrossCurrent" xlink:to="lab_us-gaap_OtherReceivablesGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019d4579-2421-77c6-9e13-93e7d3865ff1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_019d4579-2421-7364-9412-9a7c34a5d4ca_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent_019d6d92-648c-7e28-ab4c-65bb317f9fcc_terseLabel_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, current</link:label>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent_label_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current</link:label>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent_documentation_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" xlink:href="aqst-20260331.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" xlink:to="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019d4579-237c-7dc5-b818-143c00864844_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_019d4579-2421-7ef9-a81a-2c6f33f884b7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-Use Assets and Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-2421-75a7-8816-8af0bd763237_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_019d4579-237c-7a56-aaba-63c5da17c88d_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7021-b57e-1e60b9ab22dd_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019d4579-237c-7b85-ae8e-6a179eec2199_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-2421-7567-99ca-943de208181b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingExpense_019d4579-2421-708c-9f9a-a26ada52c9b7_terseLabel_en-US" xlink:label="lab_us-gaap_SellingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Selling expenses</link:label>
    <link:label id="lab_us-gaap_SellingExpense_label_en-US" xlink:label="lab_us-gaap_SellingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingExpense" xlink:to="lab_us-gaap_SellingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019de649-1492-7327-978f-353507eadcfe_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested restricted stock units, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d4579-2421-7d09-910d-814d7cc9e92b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d4579-2421-75ed-b994-812043e0b97a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares &#8211; basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019d4579-237c-77ba-9e37-28d6eeb9bf1e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_019d4579-2421-7c7e-a7e2-47eded479bf2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manufacture and supply</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_019d4579-2421-7f22-be2a-c83c97155011_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total Manufacture and Supply Expenses</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Product and Service Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_019d4579-2421-76a4-b74e-777c8b752c31_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ContingentMonetizationAgreementMilestonePayment_019d4579-2421-7362-95d9-ff0a74eec715_terseLabel_en-US" xlink:label="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from debt, contingent on additional milestones</link:label>
    <link:label id="lab_aqst_ContingentMonetizationAgreementMilestonePayment_label_en-US" xlink:label="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Monetization Agreement, Milestone Payment</link:label>
    <link:label id="lab_aqst_ContingentMonetizationAgreementMilestonePayment_documentation_en-US" xlink:label="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Monetization Agreement, Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:href="aqst-20260331.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:to="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019d4579-2421-7d49-a3e0-2147edf3844b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019d4579-2421-79e2-a11e-633f5d62879e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_019d4579-2421-7348-be19-11e7f5f800cc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_019d4579-2421-7042-a260-9404a80e2645_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019d4579-2421-7856-a574-4bde215ec719_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_019d4579-237c-7da9-8175-c24d57510dc3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-237c-7f61-8559-db064db823b5_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income/(expenses):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedMember_019d4579-2421-7fb5-9268-de22a8b21d5f_terseLabel_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedMember_label_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited [Member]</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedMember_documentation_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember" xlink:href="aqst-20260331.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AtnahsPharmaUKLimitedMember" xlink:to="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019d4579-237c-724d-9a2a-0045de7604bf_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_019d4579-2421-7994-a9af-b46e0f19d730_terseLabel_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, current</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_label_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties, Current</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_documentation_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:to="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_019d4579-237c-7544-a18b-76a92012a05d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019de643-ff38-7baf-a912-a7fab23b63ea_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of warrants</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_019d4579-237c-7b52-a7fa-5e8d189d3660_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_019d4579-237c-72fd-968a-57f6a8dc3290_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unamortized discount, including Exit Fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7155-8b91-9999bfbce658_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-74f5-91ce-b79e367aa2f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_019d4579-2421-7f80-8839-195b44072713_terseLabel_en-US" xlink:label="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwriting discounts</link:label>
    <link:label id="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_label_en-US" xlink:label="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction, Underwriting Discounts</link:label>
    <link:label id="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_documentation_en-US" xlink:label="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction, Underwriting Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:to="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-2421-77e9-8e18-2b711ca7d1ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019d4579-237c-7133-a2ba-f25cbd639230_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019d4579-237c-7009-a850-c2ebb9b86926_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CapitalizedLegalFees_019d7c84-1953-728f-8839-cb1a3fd3af1b_terseLabel_en-US" xlink:label="lab_aqst_CapitalizedLegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized Legal Fees</link:label>
    <link:label id="lab_aqst_CapitalizedLegalFees_label_en-US" xlink:label="lab_aqst_CapitalizedLegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Legal Fees</link:label>
    <link:label id="lab_aqst_CapitalizedLegalFees_documentation_en-US" xlink:label="lab_aqst_CapitalizedLegalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CapitalizedLegalFees" xlink:href="aqst-20260331.xsd#aqst_CapitalizedLegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CapitalizedLegalFees" xlink:to="lab_aqst_CapitalizedLegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019d4579-237c-7e1a-abfc-91f5650ec1f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_019d4579-237c-7d42-a9ec-b5fe877bd8ba_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance price threshold (in dollars per share)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_019d4579-237c-7dd1-8385-74268d238659_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet_019d4579-2421-7aa4-b04f-d13f9e2e494f_terseLabel_en-US" xlink:label="lab_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional proceeds from sale of future revenue</link:label>
    <link:label id="lab_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet_label_en-US" xlink:label="lab_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Proceeds From Sale of Future Revenues, Net</link:label>
    <link:label id="lab_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet_documentation_en-US" xlink:label="lab_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional Proceeds From Sale of Future Revenues, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet" xlink:href="aqst-20260331.xsd#aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet" xlink:to="lab_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_019d4579-2421-70c5-9c06-63deea2feb68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Non-Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_019d4579-2421-7d6a-b0a8-955859c95f6b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_019d4579-237c-7312-b3b6-5a2d205dd353_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019d4579-2421-770a-8722-ffab6edfab97_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019d4579-2421-7acc-b9cd-34045bb0855b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_019d4579-2421-7c28-a585-55aedde6577c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw material</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_019d4579-2421-7f78-b280-9543c469fb6a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_019d4579-2421-75ab-a98a-d62e6050814d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019d4579-237c-72f9-adb6-7b35060e17d2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CollaborativeArrangementRevenueSharingPercentage_019d4579-237c-7d78-bd1c-18d9fe2d70e8_terseLabel_en-US" xlink:label="lab_aqst_CollaborativeArrangementRevenueSharingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue sharing percentage</link:label>
    <link:label id="lab_aqst_CollaborativeArrangementRevenueSharingPercentage_label_en-US" xlink:label="lab_aqst_CollaborativeArrangementRevenueSharingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Revenue Sharing Percentage</link:label>
    <link:label id="lab_aqst_CollaborativeArrangementRevenueSharingPercentage_documentation_en-US" xlink:label="lab_aqst_CollaborativeArrangementRevenueSharingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Revenue Sharing Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementRevenueSharingPercentage" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementRevenueSharingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CollaborativeArrangementRevenueSharingPercentage" xlink:to="lab_aqst_CollaborativeArrangementRevenueSharingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_019d4579-2421-7f7a-ad53-7bc9b3740041_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_019d4579-2421-7eb8-8807-85096d1cd1b1_verboseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected to vest at end of period (in shares)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, in Shares</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AQST108Member_019d4579-2421-7288-9756-1798ce524fd0_terseLabel_en-US" xlink:label="lab_aqst_AQST108Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AQST-108 project expenses</link:label>
    <link:label id="lab_aqst_AQST108Member_label_en-US" xlink:label="lab_aqst_AQST108Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AQST-108 [Member]</link:label>
    <link:label id="lab_aqst_AQST108Member_documentation_en-US" xlink:label="lab_aqst_AQST108Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AQST-108</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AQST108Member" xlink:href="aqst-20260331.xsd#aqst_AQST108Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AQST108Member" xlink:to="lab_aqst_AQST108Member" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock_019d7c3b-63f1-7a03-96e2-f1231d256dae_terseLabel_en-US" xlink:label="lab_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Sales-related Allowances</link:label>
    <link:label id="lab_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock_label_en-US" xlink:label="lab_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable Allowances [Table Text Block]</link:label>
    <link:label id="lab_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock_documentation_en-US" xlink:label="lab_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock" xlink:href="aqst-20260331.xsd#aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock" xlink:to="lab_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PersonnelCostsMember_019d4579-2421-74a1-88ff-4d2df4d21182_terseLabel_en-US" xlink:label="lab_aqst_PersonnelCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Personnel costs</link:label>
    <link:label id="lab_aqst_PersonnelCostsMember_label_en-US" xlink:label="lab_aqst_PersonnelCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Personnel Costs [Member]</link:label>
    <link:label id="lab_aqst_PersonnelCostsMember_documentation_en-US" xlink:label="lab_aqst_PersonnelCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Personnel Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PersonnelCostsMember" xlink:href="aqst-20260331.xsd#aqst_PersonnelCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PersonnelCostsMember" xlink:to="lab_aqst_PersonnelCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d4579-237c-754c-9345-c8293afc6b2c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock issued under public equity offering-ATM</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019d4579-237c-7792-8d97-e9247d181138_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfStockAggregateOfferingPrice_019d4579-237c-793c-be5b-805cf4ed4f87_terseLabel_en-US" xlink:label="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate offering price</link:label>
    <link:label id="lab_aqst_SaleOfStockAggregateOfferingPrice_label_en-US" xlink:label="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:label id="lab_aqst_SaleOfStockAggregateOfferingPrice_documentation_en-US" xlink:label="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockAggregateOfferingPrice" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockAggregateOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfStockAggregateOfferingPrice" xlink:to="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TermLoanFacilityMember_019e1f1c-cb8c-7ab8-b6d1-49787a470ea1_terseLabel_en-US" xlink:label="lab_aqst_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_aqst_TermLoanFacilityMember_label_en-US" xlink:label="lab_aqst_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_aqst_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_aqst_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TermLoanFacilityMember" xlink:href="aqst-20260331.xsd#aqst_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TermLoanFacilityMember" xlink:to="lab_aqst_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit_019e1f2b-5924-7538-94ad-ec7dcff14174_terseLabel_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential increase in available borrowing capacity upon pre determined achievement of milestones</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit_label_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Available Borrowing Capacity, Increase Limit</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit_documentation_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Available Borrowing Capacity, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" xlink:to="lab_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-237c-78f0-b3ef-f7cfba3cda61_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_019d4579-2421-7ca4-bb26-d06d6767d11d_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_019d4579-2421-70cf-beff-909428121e91_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019d4579-2421-77b1-9e35-1d7996432432_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019d4579-2421-75c3-9c64-0ba4657071f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019d4579-2421-7e99-bc72-eaa31728516d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AssetRetirementObligationsDepreciationExpense_019ddc57-d0d2-7b9d-a2d9-4284cf32d7d2_verboseLabel_en-US" xlink:label="lab_aqst_AssetRetirementObligationsDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense related to ARO</link:label>
    <link:label id="lab_aqst_AssetRetirementObligationsDepreciationExpense_label_en-US" xlink:label="lab_aqst_AssetRetirementObligationsDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligations Depreciation Expense</link:label>
    <link:label id="lab_aqst_AssetRetirementObligationsDepreciationExpense_documentation_en-US" xlink:label="lab_aqst_AssetRetirementObligationsDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Depreciation expense of asset retirement obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssetRetirementObligationsDepreciationExpense" xlink:href="aqst-20260331.xsd#aqst_AssetRetirementObligationsDepreciationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AssetRetirementObligationsDepreciationExpense" xlink:to="lab_aqst_AssetRetirementObligationsDepreciationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_019d4579-2421-747d-a85e-c3a2589d3cd9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_019d4579-2421-7ecb-abad-3760262b8619_terseLabel_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited, Amended Agreement</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_label_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited, Amended Agreement [Member]</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_documentation_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited, Amended Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:href="aqst-20260331.xsd#aqst_AtnahsPharmaUKLimitedAmendedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:to="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-2421-76a5-93da-43edd68deaf4_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManufacturedProductOtherMember_label_en-US" xlink:label="lab_us-gaap_ManufacturedProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufactured Product, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturedProductOtherMember" xlink:to="lab_us-gaap_ManufacturedProductOtherMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>aqst-20260331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d4579-21a7-7c19-9fd0-51403d0078b6,g:613180f5-33da-4eff-b9e2-e98da0338ca1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://aquestive.com/role/Cover" xlink:type="simple" xlink:href="aqst-20260331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019d4579-22d9-7621-a860-84f1e75b1fe0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_DocumentType_019d4579-22d9-7621-a860-84f1e75b1fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019d4579-22d9-7dc6-aac1-30791ebe2523" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_DocumentQuarterlyReport_019d4579-22d9-7dc6-aac1-30791ebe2523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019d4579-22d9-753c-82cc-913d434c21c0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_DocumentPeriodEndDate_019d4579-22d9-753c-82cc-913d434c21c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019d4579-22d9-705a-831a-3240aa79d898" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_DocumentTransitionReport_019d4579-22d9-705a-831a-3240aa79d898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019d4579-22d9-7159-b748-e7b1cf9d50d7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityFileNumber_019d4579-22d9-7159-b748-e7b1cf9d50d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019d4579-22d9-7c12-a741-9ae17afe7ec2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityRegistrantName_019d4579-22d9-7c12-a741-9ae17afe7ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019d4579-22d9-7e9a-b85d-4debf259754d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019d4579-22d9-7e9a-b85d-4debf259754d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019d4579-22d9-7872-a953-bf2f842e51ac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityAddressAddressLine1_019d4579-22d9-7872-a953-bf2f842e51ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019d4579-22d9-74cf-ba23-09e73d521db6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityAddressCityOrTown_019d4579-22d9-74cf-ba23-09e73d521db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019d4579-22d9-7428-86e1-0baa52ad1a46" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityAddressStateOrProvince_019d4579-22d9-7428-86e1-0baa52ad1a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019d4579-22d9-74f8-bbac-f2623fa0727e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityAddressPostalZipCode_019d4579-22d9-74f8-bbac-f2623fa0727e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019d4579-22d9-78f1-bada-eb7c99d07bac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityTaxIdentificationNumber_019d4579-22d9-78f1-bada-eb7c99d07bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019d4579-22d9-77f0-8851-be2405e539a9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_CityAreaCode_019d4579-22d9-77f0-8851-be2405e539a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019d4579-22d9-7a42-9147-2618d56a60b2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_LocalPhoneNumber_019d4579-22d9-7a42-9147-2618d56a60b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019d4579-22d9-760b-b41f-726e12018c90" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_Security12bTitle_019d4579-22d9-760b-b41f-726e12018c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019d4579-22d9-7909-838a-be10e4a735ac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_TradingSymbol_019d4579-22d9-7909-838a-be10e4a735ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019d4579-22d9-73b5-baa2-0682f4a6fad3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_SecurityExchangeName_019d4579-22d9-73b5-baa2-0682f4a6fad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019d4579-22d9-7349-942a-4688a491948f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityCurrentReportingStatus_019d4579-22d9-7349-942a-4688a491948f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019d4579-22d9-7f81-a724-88ffc7c6150e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityInteractiveDataCurrent_019d4579-22d9-7f81-a724-88ffc7c6150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019d4579-22d9-7395-be69-346159ce9937" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityFilerCategory_019d4579-22d9-7395-be69-346159ce9937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019d4579-22d9-78e5-a504-2b7fea35b4c5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntitySmallBusiness_019d4579-22d9-78e5-a504-2b7fea35b4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019d4579-22d9-7f56-9e3e-a3b2593c1897" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityEmergingGrowthCompany_019d4579-22d9-7f56-9e3e-a3b2593c1897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019d4579-22d9-7478-a6a2-df5f11e65836" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityShellCompany_019d4579-22d9-7478-a6a2-df5f11e65836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019d4579-22d9-7bc4-87fc-0577ce46212e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019d4579-22d9-7bc4-87fc-0577ce46212e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019d4579-22d9-740c-937d-4662d42610c8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_EntityCentralIndexKey_019d4579-22d9-740c-937d-4662d42610c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019d4579-22d9-7440-a19b-d9052fcc0765" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_CurrentFiscalYearEndDate_019d4579-22d9-7440-a19b-d9052fcc0765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019d4579-22d9-71a4-bdb9-45b22ea65ff5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_DocumentFiscalYearFocus_019d4579-22d9-71a4-bdb9-45b22ea65ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019d4579-22d9-7e5b-b9f7-161be8162af6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019d4579-22d9-7e5b-b9f7-161be8162af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019d4579-22d9-7818-8e4c-d4b14db23328" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019d4579-22d9-7802-82a4-c5e265eb1416" xlink:to="loc_dei_AmendmentFlag_019d4579-22d9-7818-8e4c-d4b14db23328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedBalanceSheets"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019d4579-22d9-7835-9f4c-3423d2f1d04e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019d4579-22d9-71a5-95ec-4f50346dcb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d4579-22d9-7835-9f4c-3423d2f1d04e" xlink:to="loc_us-gaap_AssetsAbstract_019d4579-22d9-71a5-95ec-4f50346dcb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019d4579-22d9-7681-aec7-dc7da6605535" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d4579-22d9-71a5-95ec-4f50346dcb8f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019d4579-22d9-7681-aec7-dc7da6605535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7660-af53-25c0a6b07987" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d4579-22d9-7681-aec7-dc7da6605535" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7660-af53-25c0a6b07987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_019d6d91-5eea-7b7f-b050-c06d6b20b1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d4579-22d9-7681-aec7-dc7da6605535" xlink:to="loc_us-gaap_ReceivablesNetCurrent_019d6d91-5eea-7b7f-b050-c06d6b20b1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019d4579-22d9-7cb9-aabd-d97654039f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d4579-22d9-7681-aec7-dc7da6605535" xlink:to="loc_us-gaap_InventoryNet_019d4579-22d9-7cb9-aabd-d97654039f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d4579-22d9-7803-b9b3-3342650790c0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d4579-22d9-7681-aec7-dc7da6605535" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019d4579-22d9-7803-b9b3-3342650790c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d4579-22d9-7436-acbb-ed82cdecd103" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019d4579-22d9-7681-aec7-dc7da6605535" xlink:to="loc_us-gaap_AssetsCurrent_019d4579-22d9-7436-acbb-ed82cdecd103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-22d9-7b54-9286-d911b84e585c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d4579-22d9-71a5-95ec-4f50346dcb8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-22d9-7b54-9286-d911b84e585c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d4579-22d9-7b18-b591-215ff2a0e464" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d4579-22d9-71a5-95ec-4f50346dcb8f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019d4579-22d9-7b18-b591-215ff2a0e464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d4579-22d9-72fd-ac50-abff16dfa4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d4579-22d9-71a5-95ec-4f50346dcb8f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d4579-22d9-72fd-ac50-abff16dfa4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d4579-22d9-7bf1-adac-cd490b7886df" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019d4579-22d9-71a5-95ec-4f50346dcb8f" xlink:to="loc_us-gaap_Assets_019d4579-22d9-7bf1-adac-cd490b7886df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d4579-22d9-7835-9f4c-3423d2f1d04e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019d4579-22d9-7f9a-ba8d-de0b502084f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:to="loc_us-gaap_AccountsPayableCurrent_019d4579-22d9-7f9a-ba8d-de0b502084f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-22d9-7806-bf46-e8461077ad8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-22d9-7806-bf46-e8461077ad8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d4579-22d9-7e5b-86a7-060f2c06785c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019d4579-22d9-7e5b-86a7-060f2c06785c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019d4579-22d9-7ba0-b10d-00d18d03e0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019d4579-22d9-7ba0-b10d-00d18d03e0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent_019d6d92-648b-714f-95cd-c37407a97567" xlink:href="aqst-20260331.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:to="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent_019d6d92-648b-714f-95cd-c37407a97567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableCurrent_019d4579-22d9-75ee-a2b7-31cf2bd006ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:to="loc_us-gaap_LoansPayableCurrent_019d4579-22d9-75ee-a2b7-31cf2bd006ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-7e3c-a9bb-3d9fe68bbcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019d4579-22d9-7850-bfeb-30bf1013d183" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d4579-22d9-7e3c-a9bb-3d9fe68bbcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d6d94-e39e-7420-a13c-b4225a9e86dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d6d94-e39e-7420-a13c-b4225a9e86dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationLiabilityNoncurrent_019d4579-22d9-7b57-9bc9-b98550fefd89" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_aqst_RoyaltyObligationLiabilityNoncurrent_019d4579-22d9-7b57-9bc9-b98550fefd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_019d4579-22d9-7002-b5d7-4f827934b443" xlink:href="aqst-20260331.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_019d4579-22d9-7002-b5d7-4f827934b443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d4579-22d9-7a39-9ac2-fbf48f699b99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019d4579-22d9-7a39-9ac2-fbf48f699b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d4579-22d9-7a4f-83c9-d69cedfbae76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d4579-22d9-7a4f-83c9-d69cedfbae76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019d4579-22d9-7824-b126-693317e9fefa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019d4579-22d9-7824-b126-693317e9fefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d4579-22d9-7f5f-97e3-da3a68bb8f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_Liabilities_019d4579-22d9-7f5f-97e3-da3a68bb8f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019d4579-22d9-71bb-b5dd-023fdbc98ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019d4579-22d9-71bb-b5dd-023fdbc98ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7998-a0c5-05e3f7b69896" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7998-a0c5-05e3f7b69896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d4579-22d9-7bc5-bdc8-edaf2f764690" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7998-a0c5-05e3f7b69896" xlink:to="loc_us-gaap_CommonStockValue_019d4579-22d9-7bc5-bdc8-edaf2f764690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019d4579-22d9-7eae-b25d-98f242ec38c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7998-a0c5-05e3f7b69896" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019d4579-22d9-7eae-b25d-98f242ec38c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7afb-8256-9e68817766e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7998-a0c5-05e3f7b69896" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7afb-8256-9e68817766e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d4579-22d9-732a-a159-0dc68992dee7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7998-a0c5-05e3f7b69896" xlink:to="loc_us-gaap_StockholdersEquity_019d4579-22d9-732a-a159-0dc68992dee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d4579-22d9-7cf8-b674-bd964b663fca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019d4579-22d9-731d-8a60-02668b7aecb0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019d4579-22d9-7cf8-b674-bd964b663fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019d4579-22d9-78df-834a-c30c3a896bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7188-b4b9-992c0e301939" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019d4579-22d9-78df-834a-c30c3a896bdd" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7188-b4b9-992c0e301939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019d4579-22d9-738f-a39d-25d09471124a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7188-b4b9-992c0e301939" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019d4579-22d9-738f-a39d-25d09471124a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019d4579-22d9-7e63-ac3b-8f0c63ba51fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7188-b4b9-992c0e301939" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019d4579-22d9-7e63-ac3b-8f0c63ba51fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019d4579-22d9-7ad9-bee4-415cee26ff0a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7188-b4b9-992c0e301939" xlink:to="loc_us-gaap_CommonStockSharesIssued_019d4579-22d9-7ad9-bee4-415cee26ff0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019d4579-22d9-79e4-b3e5-8284e4f123b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019d4579-22d9-7188-b4b9-992c0e301939" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019d4579-22d9-79e4-b3e5-8284e4f123b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-22d9-79c6-9659-ce50f84edde2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-22d9-79c6-9659-ce50f84edde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019d4579-22d9-71ae-aa0f-409410a8c90a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019d4579-22d9-71ae-aa0f-409410a8c90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019d4579-22d9-7053-b6e8-2f40c6932542" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019d4579-22d9-71ae-aa0f-409410a8c90a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019d4579-22d9-7053-b6e8-2f40c6932542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_019d4579-22d9-7d27-8999-251e2b50d792" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_019d4579-22d9-7053-b6e8-2f40c6932542" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_019d4579-22d9-7d27-8999-251e2b50d792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d4579-22d9-7a36-ac02-8171bb5087b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019d4579-22d9-71ae-aa0f-409410a8c90a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d4579-22d9-7a36-ac02-8171bb5087b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d4579-22d9-7c72-a2b6-c08fdfb49db7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019d4579-22d9-71ae-aa0f-409410a8c90a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d4579-22d9-7c72-a2b6-c08fdfb49db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019d4579-22d9-7e66-b8e6-e2bae6820c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019d4579-22d9-71ae-aa0f-409410a8c90a" xlink:to="loc_us-gaap_CostsAndExpenses_019d4579-22d9-7e66-b8e6-e2bae6820c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d4579-22d9-797f-b12e-d8021b635a25" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d4579-22d9-797f-b12e-d8021b635a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-22d9-70a0-8a2a-1daa599a5d20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-22d9-70a0-8a2a-1daa599a5d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019d4579-22d9-7987-be8c-b09fa8d37d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-22d9-70a0-8a2a-1daa599a5d20" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019d4579-22d9-7987-be8c-b09fa8d37d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_019d4579-22d9-7a7f-ab3a-1e0415a1a92f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-22d9-70a0-8a2a-1daa599a5d20" xlink:to="loc_us-gaap_RoyaltyExpense_019d4579-22d9-7a7f-ab3a-1e0415a1a92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestExpenseSaleOfFutureRevenues_019d4579-22d9-766b-ba69-46067d7ac051" xlink:href="aqst-20260331.xsd#aqst_InterestExpenseSaleOfFutureRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-22d9-70a0-8a2a-1daa599a5d20" xlink:to="loc_aqst_InterestExpenseSaleOfFutureRevenues_019d4579-22d9-766b-ba69-46067d7ac051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet_019d4579-22d9-7a3b-9249-26fc61d289c3" xlink:href="aqst-20260331.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-22d9-70a0-8a2a-1daa599a5d20" xlink:to="loc_aqst_InterestAndOtherIncomeNet_019d4579-22d9-7a3b-9249-26fc61d289c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7649-a663-1e6c936b2c34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019d4579-22d9-70a0-8a2a-1daa599a5d20" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-22d9-7649-a663-1e6c936b2c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d4579-22d9-79ba-afa1-b9ee1da80127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_NetIncomeLoss_019d4579-22d9-79ba-afa1-b9ee1da80127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d4579-22d9-766a-b299-ead87547763c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d4579-22d9-766a-b299-ead87547763c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019d4579-22d9-71b7-b737-d936a83d2b70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019d4579-22d9-71b7-b737-d936a83d2b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019d4579-22d9-7356-90ed-03e086c8177c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019d4579-22d9-71b7-b737-d936a83d2b70" xlink:to="loc_us-gaap_EarningsPerShareBasic_019d4579-22d9-7356-90ed-03e086c8177c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019d4579-22d9-763d-986c-0d82daaa73be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019d4579-22d9-71b7-b737-d936a83d2b70" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019d4579-22d9-763d-986c-0d82daaa73be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_019d4579-22d9-74f3-a738-03a570adf181" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019d4579-22d9-7911-9eb5-bae20408ff73" xlink:to="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_019d4579-22d9-74f3-a738-03a570adf181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d4579-22d9-7bd0-b400-28ebde029d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_019d4579-22d9-74f3-a738-03a570adf181" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d4579-22d9-7bd0-b400-28ebde029d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d4579-22d9-768b-a396-c0c27f03f5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_019d4579-22d9-74f3-a738-03a570adf181" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d4579-22d9-768b-a396-c0c27f03f5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedStatementsofChangesinStockholdersDeficit"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019d4579-22d9-772b-8876-fdab79edd404" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019d4579-22d9-772b-8876-fdab79edd404" xlink:to="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019d4579-22d9-765d-8c18-b2b9ef113c76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019d4579-22d9-765d-8c18-b2b9ef113c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019d4579-22d9-765d-8c18-b2b9ef113c76" xlink:to="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019d4579-22d9-786b-bd8f-d582ba8caf0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:to="loc_us-gaap_CommonStockMember_019d4579-22d9-786b-bd8f-d582ba8caf0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019d4579-22d9-74ac-9189-72bbd35c75ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019d4579-22d9-74ac-9189-72bbd35c75ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019d4579-22d9-7b9a-a357-d84afc9a0104" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019d4579-22d9-7d85-aace-3fbcddd53981" xlink:to="loc_us-gaap_RetainedEarningsMember_019d4579-22d9-7b9a-a357-d84afc9a0104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7adb-a3bb-6567ab2ed4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7adb-a3bb-6567ab2ed4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-78a4-a059-c06c0d7cb547" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7adb-a3bb-6567ab2ed4c6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-78a4-a059-c06c0d7cb547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7bff-b92d-43f221d01a39" xlink:href="aqst-20260331.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-78a4-a059-c06c0d7cb547" xlink:to="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7bff-b92d-43f221d01a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d4579-22d9-76ec-aad3-177d402ec243" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-72b0-ba89-f2149bb4006b" xlink:to="loc_us-gaap_StatementLineItems_019d4579-22d9-76ec-aad3-177d402ec243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-76ec-aad3-177d402ec243" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019d4579-22d9-7b24-90a4-4d5c25ed1466" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_SharesOutstanding_019d4579-22d9-7b24-90a4-4d5c25ed1466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d4579-22d9-7e05-a101-b288ade4df68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockholdersEquity_019d4579-22d9-7e05-a101-b288ade4df68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6dba-05aa-7a40-baef-4b59d513d901" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_019d6dba-05aa-7a40-baef-4b59d513d901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6dba-05aa-7915-a48e-ab9a358771cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_019d6dba-05aa-7915-a48e-ab9a358771cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6dba-05aa-7b44-a045-7dd0274f7896" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_019d6dba-05aa-7b44-a045-7dd0274f7896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromExerciseOfWarrantsNet_019dda8c-71d0-7ef8-bf97-807cde33d755" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromExerciseOfWarrantsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_aqst_ProceedsFromExerciseOfWarrantsNet_019dda8c-71d0-7ef8-bf97-807cde33d755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6dba-05aa-7901-a2ce-fd244f81d825" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019d6dba-05aa-7901-a2ce-fd244f81d825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019d6dba-05aa-731d-a44e-2dbde788a0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_019d6dba-05aa-731d-a44e-2dbde788a0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019de649-1492-78ab-9282-65a192dd5f20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_019de649-1492-78ab-9282-65a192dd5f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019daa62-5508-7c9c-8967-3ad682d3d122" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019daa62-5508-7c9c-8967-3ad682d3d122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019daa62-5508-787d-afe8-a738817a3b79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019daa62-5508-787d-afe8-a738817a3b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d6dba-05aa-77cf-a2e1-2a23c817034e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_NetIncomeLoss_019d6dba-05aa-77cf-a2e1-2a23c817034e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019d4579-22d9-7ca0-bfac-d236f44a6604" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_SharesOutstanding_019d4579-22d9-7ca0-bfac-d236f44a6604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d4579-22d9-76f7-90f9-3f1cb2d12d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019d4579-22d9-7907-b96f-ff83e4a0ceef" xlink:to="loc_us-gaap_StockholdersEquity_019d4579-22d9-76f7-90f9-3f1cb2d12d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="aqst-20260331.xsd#CondensedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019d4579-22d9-71a0-afb1-45e252227db8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019d4579-22d9-7d47-825a-e09bfd05fd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019d4579-22d9-71a0-afb1-45e252227db8" xlink:to="loc_us-gaap_StatementTable_019d4579-22d9-7d47-825a-e09bfd05fd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7bc3-9847-0b7e6dea8e03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-7d47-825a-e09bfd05fd7f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7bc3-9847-0b7e6dea8e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7af7-a465-23f6f86ac9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d4579-22d9-7bc3-9847-0b7e6dea8e03" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7af7-a465-23f6f86ac9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7b2a-b839-5935618fb26b" xlink:href="aqst-20260331.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d4579-22d9-7af7-a465-23f6f86ac9e3" xlink:to="loc_aqst_AtTheMarketOfferingMember_019d4579-22d9-7b2a-b839-5935618fb26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019d4579-22d9-7d47-825a-e09bfd05fd7f" xlink:to="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7d88-b688-3ae48c7f91da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:to="loc_us-gaap_NetIncomeLoss_019d4579-22d9-7d88-b688-3ae48c7f91da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019d4579-22d9-7b2c-b073-8fb8ba0bfae4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_DepreciationAndAmortization_019d4579-22d9-7b2c-b073-8fb8ba0bfae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019d4579-22d9-7710-87b0-c5e9efd57982" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_ShareBasedCompensation_019d4579-22d9-7710-87b0-c5e9efd57982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019dd936-1c07-775a-91be-79b26b99c63a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_019dd936-1c07-775a-91be-79b26b99c63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019d4579-22d9-7dc4-9c67-f9a876317ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_019d4579-22d9-7dc4-9c67-f9a876317ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019d4579-22d9-7ce1-990f-d583d5b92fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019d4579-22d9-7ce1-990f-d583d5b92fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-71f0-aefa-233d86288655" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_019d4579-22d9-7b19-8360-53dd98963cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_019d4579-22d9-7b19-8360-53dd98963cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_019d4579-22d9-70d2-9bc2-f7255dfc5560" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_019d4579-22d9-70d2-9bc2-f7255dfc5560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d4579-22d9-777a-9ea6-34484feef0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019d4579-22d9-777a-9ea6-34484feef0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d4579-22d9-7db2-8931-5b61e9a86c34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019d4579-22d9-7db2-8931-5b61e9a86c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d4579-22d9-719c-ac2c-3d5f8626ca5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019d4579-22d9-719c-ac2c-3d5f8626ca5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_019d4579-22d9-7253-80fd-86c43e1f30a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019d4579-22d9-7b1b-bce6-ca60c354bb9d" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_019d4579-22d9-7253-80fd-86c43e1f30a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-7fac-8dd0-8f4393883647" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019d4579-22d9-75bc-a803-40648871674b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019d4579-22d9-7fac-8dd0-8f4393883647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d4579-22d9-75ae-b68b-54e98e4c34d9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019d4579-22d9-75ae-b68b-54e98e4c34d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-738a-92ff-3b5fd49b70b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019d4579-22d9-72e1-8100-016abdf4bf80" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019d4579-22d9-738a-92ff-3b5fd49b70b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_019dd939-9516-7362-9d8e-41bdd0132c3c" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises_019dd939-9516-7362-9d8e-41bdd0132c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019dfb6b-099f-77f3-a365-8dd138c22b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019dfb6b-099f-77f3-a365-8dd138c22b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_019d6dd5-9056-7774-a045-a23f612f78e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_RepaymentsOfDebt_019d6dd5-9056-7774-a045-a23f612f78e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PaymentsForRoyaltyObligations_019d6dd6-21cc-71e5-bd6f-fd7a651c4f72" xlink:href="aqst-20260331.xsd#aqst_PaymentsForRoyaltyObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_aqst_PaymentsForRoyaltyObligations_019d6dd6-21cc-71e5-bd6f-fd7a651c4f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d4579-22d9-789d-bf6c-5d1f182204f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_019d4579-22d9-789d-bf6c-5d1f182204f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-76de-9681-bbe3adafbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019d4579-22d9-7764-ad31-d120285f46c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019d4579-22d9-76de-9681-bbe3adafbbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-754d-a3dc-bb13088677f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019d4579-22d9-754d-a3dc-bb13088677f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-22d9-7622-b744-0f5dedae3a38" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-22d9-7622-b744-0f5dedae3a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-22d9-7aa3-b124-f80add989f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-22d9-7622-b744-0f5dedae3a38" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-22d9-7aa3-b124-f80add989f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-22d9-7b67-ab5f-f20f182ba8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_019d4579-22d9-7622-b744-0f5dedae3a38" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019d4579-22d9-7b67-ab5f-f20f182ba8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019d4579-22d9-7415-9be8-aba3b1ed7247" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_019d4579-22d9-7762-af5b-8699dd91e515" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:to="loc_us-gaap_InterestPaidNet_019d4579-22d9-7762-af5b-8699dd91e515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable_019d4579-22d9-77b8-98ab-c1df5ba02a80" xlink:href="aqst-20260331.xsd#aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019d4579-22d9-77dc-bb2d-465978ba91eb" xlink:to="loc_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable_019d4579-22d9-77b8-98ab-c1df5ba02a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentation" xlink:type="simple" xlink:href="aqst-20260331.xsd#CompanyOverviewandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CompanyOverviewandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-7734-94fc-dadfb8e1793a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019d4579-22d9-7a75-91eb-df37fbb579eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-7734-94fc-dadfb8e1793a" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_019d4579-22d9-7a75-91eb-df37fbb579eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="aqst-20260331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d4579-22d9-78ff-b6cb-5ac34f7dc7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019d4579-22d9-7ef4-9bfb-ebef8e0e85b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d4579-22d9-78ff-b6cb-5ac34f7dc7c9" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019d4579-22d9-7ef4-9bfb-ebef8e0e85b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RisksandUncertainties" xlink:type="simple" xlink:href="aqst-20260331.xsd#RisksandUncertainties"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RisksandUncertainties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_019d4579-22d9-7282-a6dc-44798a6da020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_019d4579-22d9-7a83-b63e-7b99fe6b9359" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_019d4579-22d9-7282-a6dc-44798a6da020" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_019d4579-22d9-7a83-b63e-7b99fe6b9359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SegmentReporting" xlink:type="simple" xlink:href="aqst-20260331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019d4579-22d9-7535-bff4-7c822c4b37f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_019d4579-22d9-7827-a852-88e5e5b3c71a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d4579-22d9-7535-bff4-7c822c4b37f5" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_019d4579-22d9-7827-a852-88e5e5b3c71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNet" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNet"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-7a84-9b91-c88489fb8949" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019d4579-22d9-71ee-a4e7-f5c028bc9a17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-7a84-9b91-c88489fb8949" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019d4579-22d9-71ee-a4e7-f5c028bc9a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreements" xlink:type="simple" xlink:href="aqst-20260331.xsd#MaterialAgreements"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/MaterialAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-717c-bcdf-0e8acdb1e290" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_019d4579-22d9-7782-8ffd-df99c76de17e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-717c-bcdf-0e8acdb1e290" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_019d4579-22d9-7782-8ffd-df99c76de17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" xlink:type="simple" xlink:href="aqst-20260331.xsd#FinancialInstrumentsFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019d4579-22d9-7d80-b465-67715ba7b50d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_019d4579-22d9-76ac-b37c-44e31a70e3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019d4579-22d9-7d80-b465-67715ba7b50d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_019d4579-22d9-76ac-b37c-44e31a70e3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNet" xlink:type="simple" xlink:href="aqst-20260331.xsd#InventoriesNet"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/InventoriesNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-793a-9b17-6417308d93b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_019d4579-22d9-7940-a09b-3a044476ae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-793a-9b17-6417308d93b9" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_019d4579-22d9-7940-a09b-3a044476ae8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="aqst-20260331.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-22d9-7991-a55e-fc9dfc1ab00e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019d4579-22d9-7985-b22b-91ebde912a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-22d9-7991-a55e-fc9dfc1ab00e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_019d4579-22d9-7985-b22b-91ebde912a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligations" xlink:type="simple" xlink:href="aqst-20260331.xsd#RightofUseAssetsandLeaseObligations"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019d4579-237c-735b-bf2e-63a9c262a0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_019d4579-237c-7b07-8124-64a74475de26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-735b-bf2e-63a9c262a0ba" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_019d4579-237c-7b07-8124-64a74475de26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssets" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNoncurrentAssets"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-7c22-97c8-53bf63ec0030" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_019d4579-237c-7d34-94f2-05701cd20247" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-7c22-97c8-53bf63ec0030" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_019d4579-237c-7d34-94f2-05701cd20247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpenses" xlink:type="simple" xlink:href="aqst-20260331.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-7e0d-ab20-bba820982395" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_019d4579-237c-764d-a57b-b13996608b32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-7e0d-ab20-bba820982395" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_019d4579-237c-764d-a57b-b13996608b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebt" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-761c-88f8-8ebf905feef9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_019d4579-237c-70a6-8a0d-9be3467a44f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-761c-88f8-8ebf905feef9" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_019d4579-237c-70a6-8a0d-9be3467a44f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/Warrants" xlink:type="simple" xlink:href="aqst-20260331.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_019d4579-237c-76c0-8cdc-2c38175c3dee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_WarrantsDisclosureTextBlock_019d4579-237c-7847-b435-1f4011e16836" xlink:href="aqst-20260331.xsd#aqst_WarrantsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_019d4579-237c-76c0-8cdc-2c38175c3dee" xlink:to="loc_aqst_WarrantsDisclosureTextBlock_019d4579-237c-7847-b435-1f4011e16836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenue" xlink:type="simple" xlink:href="aqst-20260331.xsd#SaleofFutureRevenue"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-72c0-9cfb-f553859fbfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueTextBlock_019d4579-237c-73af-903d-a4c01ed0e531" xlink:href="aqst-20260331.xsd#aqst_SaleOfFutureRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-72c0-9cfb-f553859fbfe7" xlink:to="loc_aqst_SaleOfFutureRevenueTextBlock_019d4579-237c-73af-903d-a4c01ed0e531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNonCurrentLiabilities" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNonCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNonCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-7b6a-9889-70aee4d9c105" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationDisclosureTextBlock_019ddc57-d0d2-73db-82b9-814c1b0af0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-7b6a-9889-70aee4d9c105" xlink:to="loc_us-gaap_AssetRetirementObligationDisclosureTextBlock_019ddc57-d0d2-73db-82b9-814c1b0af0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShare" xlink:type="simple" xlink:href="aqst-20260331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019d4579-237c-7fc1-b3de-e28e118a492d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_019d4579-237c-72fc-a8b6-051532f7dbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019d4579-237c-7fc1-b3de-e28e118a492d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_019d4579-237c-72fc-a8b6-051532f7dbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-7a40-bfc3-b44a9a51471b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019d4579-237c-7f8c-a85b-d7b8099a8020" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-7a40-bfc3-b44a9a51471b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019d4579-237c-7f8c-a85b-d7b8099a8020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxes" xlink:type="simple" xlink:href="aqst-20260331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019d4579-237c-7d0e-98de-b99ecd4f1126" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_019d4579-237c-713d-b0bb-dfe3572826d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019d4579-237c-7d0e-98de-b99ecd4f1126" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_019d4579-237c-713d-b0bb-dfe3572826d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/Contingencies" xlink:type="simple" xlink:href="aqst-20260331.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d4579-237c-74bd-9389-a468a91f572a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019d4579-237c-7228-b2a6-0a5cdfc938de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d4579-237c-74bd-9389-a468a91f572a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019d4579-237c-7228-b2a6-0a5cdfc938de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEvents" xlink:type="simple" xlink:href="aqst-20260331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_019d4579-237c-7f4c-a053-a0788663daab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_019d4579-237c-73cc-855a-86571706a566" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_019d4579-237c-7f4c-a053-a0788663daab" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_019d4579-237c-73cc-855a-86571706a566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="aqst-20260331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019d4579-22d9-77f1-91ed-ca2f623a6bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019d4579-22d9-7a8c-ba1a-cfd702a229b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d4579-22d9-77f1-91ed-ca2f623a6bcd" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019d4579-22d9-7a8c-ba1a-cfd702a229b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019d4579-22d9-7250-8874-83ed06911b47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d4579-22d9-77f1-91ed-ca2f623a6bcd" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019d4579-22d9-7250-8874-83ed06911b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_019d4579-22d9-7918-80b4-d75c042f1701" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019d4579-22d9-77f1-91ed-ca2f623a6bcd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_019d4579-22d9-7918-80b4-d75c042f1701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019d4579-22d9-7a98-998d-80f0137bdb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019d4579-22d9-7b35-9eca-ce4239dfd150" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d4579-22d9-7a98-998d-80f0137bdb4c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019d4579-22d9-7b35-9eca-ce4239dfd150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-7361-86b4-1c58acd37cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_019d4579-22d9-7926-9886-dd8665e5063a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-7361-86b4-1c58acd37cd9" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_019d4579-22d9-7926-9886-dd8665e5063a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_019d4579-22d9-78d5-ae50-a8d5dd55b658" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-7361-86b4-1c58acd37cd9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_019d4579-22d9-78d5-ae50-a8d5dd55b658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_019d4579-22d9-73eb-acb1-e5631b16a26c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-7361-86b4-1c58acd37cd9" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_019d4579-22d9-73eb-acb1-e5631b16a26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock_019d7c3b-63f1-7763-92bd-f5b4004c6947" xlink:href="aqst-20260331.xsd#aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-7361-86b4-1c58acd37cd9" xlink:to="loc_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock_019d7c3b-63f1-7763-92bd-f5b4004c6947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#InventoriesNetTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/InventoriesNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-7b01-914f-deaf8d4e70f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_019d4579-22d9-7c25-be80-59a3d2e95df3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-7b01-914f-deaf8d4e70f0" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_019d4579-22d9-7c25-be80-59a3d2e95df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-22d9-734e-8323-8dcbcd1d88c2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019d4579-22d9-7359-b550-35debca970ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-22d9-734e-8323-8dcbcd1d88c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019d4579-22d9-7359-b550-35debca970ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#RightofUseAssetsandLeaseObligationsTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019d4579-237c-79d8-b1b8-f5a81e400f47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019d4579-237c-74b7-8355-aa049f432db6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-79d8-b1b8-f5a81e400f47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019d4579-237c-74b7-8355-aa049f432db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNoncurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-7f24-85dc-3d458e8648ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_019d4579-237c-788e-ad95-053b9d380ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-7f24-85dc-3d458e8648ba" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_019d4579-237c-788e-ad95-053b9d380ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-7292-b5dd-ff851cf3a3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019d7cc8-85c7-7974-9746-d81bd1a76564" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-7292-b5dd-ff851cf3a3fd" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019d7cc8-85c7-7974-9746-d81bd1a76564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-72ac-8257-836f53408ead" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock_019d7ccc-7cda-7fe4-beab-c0f94c513b70" xlink:href="aqst-20260331.xsd#aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-72ac-8257-836f53408ead" xlink:to="loc_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock_019d7ccc-7cda-7fe4-beab-c0f94c513b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_019d4579-237c-77a1-ad06-1d948074d254" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-72ac-8257-836f53408ead" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_019d4579-237c-77a1-ad06-1d948074d254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_019d4579-237c-7ac9-a079-b450dbcdc17a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-72ac-8257-836f53408ead" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_019d4579-237c-7ac9-a079-b450dbcdc17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#SaleofFutureRevenueTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-71a7-9cb9-c29538d0580a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationActivityTableTextBlock_019d4579-237c-7a93-bce2-2774bb4b6610" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-71a7-9cb9-c29538d0580a" xlink:to="loc_aqst_RoyaltyObligationActivityTableTextBlock_019d4579-237c-7a93-bce2-2774bb4b6610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNonCurrentLiabilitiesTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNonCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNonCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-7875-93f2-286b0f025a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock_019ddc57-d0d2-7ba7-9bd8-1a90454916f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-7875-93f2-286b0f025a9a" xlink:to="loc_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock_019ddc57-d0d2-7ba7-9bd8-1a90454916f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019d4579-237c-7e3c-b30e-4c3144f6cac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019d4579-237c-7099-86ce-1778f571bf52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019d4579-237c-7e3c-b30e-4c3144f6cac1" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019d4579-237c-7099-86ce-1778f571bf52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d7df2-9176-7966-9b53-6ee83bc3e49b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_019d7df2-9176-7d5f-855c-01d47d07afc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d7df2-9176-7966-9b53-6ee83bc3e49b" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_019d7df2-9176-7d5f-855c-01d47d07afc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_019d7df2-9176-73d4-a033-081552ce33e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d7df2-9176-7966-9b53-6ee83bc3e49b" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_019d7df2-9176-73d4-a033-081552ce33e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019d7df2-9176-7c76-9925-16bc4fdb8b81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d7df2-9176-7966-9b53-6ee83bc3e49b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_019d7df2-9176-7c76-9925-16bc4fdb8b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019d7df2-9177-768d-b03d-95f212509856" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d7df2-9176-7966-9b53-6ee83bc3e49b" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019d7df2-9177-768d-b03d-95f212509856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#CompanyOverviewandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-7d47-8ad2-8cc20e59741f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-7d47-8ad2-8cc20e59741f" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7b74-e45b-75b1-9e25-6a03879eebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7b74-e45b-75b1-9e25-6a03879eebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019d7b74-e45b-75b1-9e25-6a03879eebd6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_EquityDistributionAgreementMember_019d7b74-e45b-7184-b119-fafa1b6ff0e4" xlink:href="aqst-20260331.xsd#aqst_EquityDistributionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:to="loc_aqst_EquityDistributionAgreementMember_019d7b74-e45b-7184-b119-fafa1b6ff0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AmendedEquityDistributionAgreementMember_019d7b74-e45b-7b6a-b499-1189a21dbe80" xlink:href="aqst-20260331.xsd#aqst_AmendedEquityDistributionAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:to="loc_aqst_AmendedEquityDistributionAgreementMember_019d7b74-e45b-7b6a-b499-1189a21dbe80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_UnderwrittenPublicOfferingMember_019d7b74-e45b-7fe0-b93f-4c7a10ba6692" xlink:href="aqst-20260331.xsd#aqst_UnderwrittenPublicOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019d7b74-e45b-7fc1-b688-0c8b269dc394" xlink:to="loc_aqst_UnderwrittenPublicOfferingMember_019d7b74-e45b-7fe0-b93f-4c7a10ba6692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d7b74-e45b-7ed7-93e3-6746e3ab7454" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:to="loc_srt_RangeAxis_019d7b74-e45b-7ed7-93e3-6746e3ab7454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7b74-e45b-742f-9c9d-b6d9d1132d55" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d7b74-e45b-7ed7-93e3-6746e3ab7454" xlink:to="loc_srt_RangeMember_019d7b74-e45b-742f-9c9d-b6d9d1132d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d7b74-e45b-7828-80c2-f12535ac6327" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d7b74-e45b-742f-9c9d-b6d9d1132d55" xlink:to="loc_srt_MaximumMember_019d7b74-e45b-7828-80c2-f12535ac6327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019d4579-22d9-7007-82fe-a14acb0af6dc" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d7b74-e45b-77ff-9da7-d0f487b3a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019d7b74-e45b-77ff-9da7-d0f487b3a7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d7b74-e45b-76b7-adc1-f3afcaf6f54c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019d7b74-e45b-76b7-adc1-f3afcaf6f54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d7b74-e45b-7668-b651-e6fdd35c0165" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019d7b74-e45b-7668-b651-e6fdd35c0165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockMaximumTransactionAmount_019d7b74-e45b-7cfa-9f1e-cae8271cee7f" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockMaximumTransactionAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_aqst_SaleOfStockMaximumTransactionAmount_019d7b74-e45b-7cfa-9f1e-cae8271cee7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockAggregateOfferingPrice_019d7b74-e45b-733f-bf89-edfc1b4cc1a5" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockAggregateOfferingPrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_aqst_SaleOfStockAggregateOfferingPrice_019d7b74-e45b-733f-bf89-edfc1b4cc1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_019d7b74-e45b-769a-8787-26a5510314e0" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_019d7b74-e45b-769a-8787-26a5510314e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019d7b74-e45b-7709-b854-401f794e46e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019d7b74-e45b-7709-b854-401f794e46e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019d7b74-e45b-7a5b-bbf7-7236eb44e547" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019d7b74-e45b-7851-b600-f54a840a77ee" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019d7b74-e45b-7a5b-bbf7-7236eb44e547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RisksandUncertaintiesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_019d4579-22d9-75df-83f8-c7991b772a52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_019d4579-22d9-75df-83f8-c7991b772a52" xlink:to="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019d4579-22d9-7c53-8410-e09aacff525a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:to="loc_us-gaap_DebtInstrumentAxis_019d4579-22d9-7c53-8410-e09aacff525a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-79cc-b189-9e519dfecdca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d4579-22d9-7c53-8410-e09aacff525a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-79cc-b189-9e519dfecdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-22d9-7cf2-b6c4-c0115bec2ff9" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d4579-22d9-79cc-b189-9e519dfecdca" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-22d9-7cf2-b6c4-c0115bec2ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019d7b81-6975-7727-9df0-3cedb9118597" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019d7b81-6975-7727-9df0-3cedb9118597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6976-7dcd-80a0-434b1e3252f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d7b81-6975-7727-9df0-3cedb9118597" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6976-7dcd-80a0-434b1e3252f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019d7b81-6976-7c59-95bb-55bc498ad119" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d7b81-6976-7dcd-80a0-434b1e3252f4" xlink:to="loc_us-gaap_SeniorNotesMember_019d7b81-6976-7c59-95bb-55bc498ad119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-72b5-9b5f-0fa7b18f1196" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7e44-85c7-38ba41a9d8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d4579-22d9-7e44-85c7-38ba41a9d8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7ec5-984d-8e0b110b4529" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d4579-22d9-7ec5-984d-8e0b110b4529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d4579-22d9-7c24-a138-189cd2055921" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-7157-8484-27c164e9d33a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019d4579-22d9-7c24-a138-189cd2055921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019d7c20-5754-7c6c-afa5-efd858d7622d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019d7c20-5754-7531-b7c5-69c6b35315ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d7c20-5754-7c6c-afa5-efd858d7622d" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019d7c20-5754-7531-b7c5-69c6b35315ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019d7c20-5754-7bf6-8be0-acc89a576f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d7c20-5754-7c6c-afa5-efd858d7622d" xlink:to="loc_us-gaap_NumberOfReportableSegments_019d7c20-5754-7bf6-8be0-acc89a576f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c20-5754-7958-9fd4-5267f6e13218" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d7c20-5754-7c6c-afa5-efd858d7622d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c20-5754-7958-9fd4-5267f6e13218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019d7c21-71b8-77ff-8d78-3b6eab7259fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019d7c21-71b8-77ff-8d78-3b6eab7259fc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019d7c21-71b8-70e3-9504-4bcaf9c01854" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019d7c21-71b8-70e3-9504-4bcaf9c01854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019d7c21-71b8-7b7e-93dd-fefb2df48b04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019d7c21-71b8-70e3-9504-4bcaf9c01854" xlink:to="loc_us-gaap_SegmentDomain_019d7c21-71b8-7b7e-93dd-fefb2df48b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ReportableSegmentMember_019d7c21-71b8-74b0-b999-22a428b7b1ce" xlink:href="aqst-20260331.xsd#aqst_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_019d7c21-71b8-7b7e-93dd-fefb2df48b04" xlink:to="loc_aqst_ReportableSegmentMember_019d7c21-71b8-74b0-b999-22a428b7b1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d7c21-71b8-7d91-a52f-77e6b200d04b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:to="loc_srt_ProductOrServiceAxis_019d7c21-71b8-7d91-a52f-77e6b200d04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019d7c21-71b8-7d91-a52f-77e6b200d04b" xlink:to="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AnaphylmMember_019d7c21-71b8-7cc7-9a83-bb55b6e0f0aa" xlink:href="aqst-20260331.xsd#aqst_AnaphylmMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_AnaphylmMember_019d7c21-71b8-7cc7-9a83-bb55b6e0f0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AQST108Member_019d7c21-71b8-73c8-b702-dc1df8643afa" xlink:href="aqst-20260331.xsd#aqst_AQST108Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_AQST108Member_019d7c21-71b8-73c8-b702-dc1df8643afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PersonnelCostsMember_019d7c21-71b8-72fe-ab91-846f47875140" xlink:href="aqst-20260331.xsd#aqst_PersonnelCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_PersonnelCostsMember_019d7c21-71b8-72fe-ab91-846f47875140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherMember_019d7c21-71b8-7f0d-b096-0372778b36d0" xlink:href="aqst-20260331.xsd#aqst_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c21-71b8-7a9c-a5a9-1825e0f4da08" xlink:to="loc_aqst_OtherMember_019d7c21-71b8-7f0d-b096-0372778b36d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019d7c21-71b8-79e4-9fb9-024023b4f874" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c21-71b8-7a67-84ad-b847d9469fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c21-71b8-7a67-84ad-b847d9469fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSoldAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019d7c21-71b8-79af-a690-a63cb2846045" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019d7c21-71b8-79af-a690-a63cb2846045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d7c21-71b8-7338-8609-e1c416bb8cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAbstract_019d7c21-71b8-754e-b249-1ae3c46c9823" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d7c21-71b8-7338-8609-e1c416bb8cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-7590-b200-0e6b9d49c807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-7590-b200-0e6b9d49c807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingExpense_019d7c21-71b8-7c1f-88fa-5844eebbf0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-7590-b200-0e6b9d49c807" xlink:to="loc_us-gaap_SellingExpense_019d7c21-71b8-7c1f-88fa-5844eebbf0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-79a6-abba-2dfa54a4536d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-79a6-abba-2dfa54a4536d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d7c21-71b8-70a3-a0c5-c8002799ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseAbstract_019d7c21-71b8-79a6-abba-2dfa54a4536d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d7c21-71b8-70a3-a0c5-c8002799ba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d7c21-71b8-7484-a6d6-b774bc47f442" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019d7c21-71b8-7484-a6d6-b774bc47f442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019d7c21-71b8-74c3-b64d-a2c15547b943" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_CostsAndExpenses_019d7c21-71b8-74c3-b64d-a2c15547b943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d7c21-71b8-73e2-bac2-a675ee74738c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d7c21-71b8-73e2-bac2-a675ee74738c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d7c21-71b8-77e0-b198-96673dd7046d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d7c21-71b8-77e0-b198-96673dd7046d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d7c21-71b8-719c-a251-587b10b74a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d7c21-71b8-719c-a251-587b10b74a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d7c21-71b8-7f8a-aeb0-96da7465d347" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_NetIncomeLoss_019d7c21-71b8-7f8a-aeb0-96da7465d347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d7c21-71b8-7eb2-99ba-aae3df6637a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019d7c21-71b8-73c5-9a73-db83df9ad0e3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d7c21-71b8-7eb2-99ba-aae3df6637a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-77b1-996c-cb55abf8a677" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-22d9-77b1-996c-cb55abf8a677" xlink:to="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d4579-22d9-7262-a00b-a54e183a1273" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_srt_RangeAxis_019d4579-22d9-7262-a00b-a54e183a1273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-22d9-7c72-b1ab-34455b22db5e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d4579-22d9-7262-a00b-a54e183a1273" xlink:to="loc_srt_RangeMember_019d4579-22d9-7c72-b1ab-34455b22db5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d4579-22d9-7235-a856-ec2e02da40c7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d4579-22d9-7c72-b1ab-34455b22db5e" xlink:to="loc_srt_MaximumMember_019d4579-22d9-7235-a856-ec2e02da40c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-22d9-70f7-a90b-d9b15c6c2b61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-22d9-70f7-a90b-d9b15c6c2b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d4579-22d9-70f7-a90b-d9b15c6c2b61" xlink:to="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_019d4579-22d9-741b-8dc5-11f11e1faf7b" xlink:href="aqst-20260331.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:to="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_019d4579-22d9-741b-8dc5-11f11e1faf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAccountsReceivableMember_019d4579-22d9-7860-9e2a-163e32853250" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:to="loc_us-gaap_TradeAccountsReceivableMember_019d4579-22d9-7860-9e2a-163e32853250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherReceivablesAndAccruedExpensesMember_019d4579-22d9-7dc5-8c4f-97dcc360a749" xlink:href="aqst-20260331.xsd#aqst_OtherReceivablesAndAccruedExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d4579-22d9-76be-bde6-bc8fa0cbfc49" xlink:to="loc_aqst_OtherReceivablesAndAccruedExpensesMember_019d4579-22d9-7dc5-8c4f-97dcc360a749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_019d4579-22d9-7761-96fe-449c2dfca77f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_srt_MajorCustomersAxis_019d4579-22d9-7761-96fe-449c2dfca77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_019d4579-22d9-7761-96fe-449c2dfca77f" xlink:to="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember_019d4579-22d9-773a-bfff-6a5e8132ef1f" xlink:href="aqst-20260331.xsd#aqst_IndiviorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_IndiviorMember_019d4579-22d9-773a-bfff-6a5e8132ef1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraMember_019daa6b-cc28-70a8-94da-22356b6c0aeb" xlink:href="aqst-20260331.xsd#aqst_ZevraMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_ZevraMember_019daa6b-cc28-70a8-94da-22356b6c0aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember_019daa6d-a479-7e9f-a21b-2d01effea4d4" xlink:href="aqst-20260331.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_AssertioHoldingsIncMember_019daa6d-a479-7e9f-a21b-2d01effea4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HyperaMember_019d4579-22d9-73b0-8919-48e6405abfac" xlink:href="aqst-20260331.xsd#aqst_HyperaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_019d4579-22d9-7743-b1f4-43546185d509" xlink:to="loc_aqst_HyperaMember_019d4579-22d9-73b0-8919-48e6405abfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-22d9-7e91-954d-e66b9fb6700a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-22d9-7e91-954d-e66b9fb6700a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019d4579-22d9-7e91-954d-e66b9fb6700a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_019d4579-22d9-703c-94c0-828c4e77d13c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_019d4579-22d9-703c-94c0-828c4e77d13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_019d4579-22d9-7d3d-a00d-3a4d86419f77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019d4579-22d9-747c-b019-1782b7766107" xlink:to="loc_us-gaap_AccountsReceivableMember_019d4579-22d9-7d3d-a00d-3a4d86419f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_019d4579-22d9-7570-9501-c179664d2574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_019d4579-22d9-7570-9501-c179664d2574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-70de-aef7-3ab1a7b95e69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_019d4579-22d9-7570-9501-c179664d2574" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-70de-aef7-3ab1a7b95e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_019d4579-22d9-791e-b469-364debc30e28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_019d4579-22d9-70de-aef7-3ab1a7b95e69" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_019d4579-22d9-791e-b469-364debc30e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_019d4579-22d9-7c2d-ad22-8d80f5697eec" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ResearchAndDevelopmentProjectDuration_019d4579-22d9-7d1c-820a-6625bae81bf1" xlink:href="aqst-20260331.xsd#aqst_ResearchAndDevelopmentProjectDuration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_aqst_ResearchAndDevelopmentProjectDuration_019d4579-22d9-7d1c-820a-6625bae81bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_019d4579-22d9-77ed-bf92-60d27a264f98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_019d4579-22d9-77ed-bf92-60d27a264f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_019d4579-22d9-7ecb-928f-4e5ecbb6c9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_ContractWithCustomerLiability_019d4579-22d9-7ecb-928f-4e5ecbb6c9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_019d4579-22d9-7c16-9a95-89bf84bbfeec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_CapitalizedContractCostNet_019d4579-22d9-7c16-9a95-89bf84bbfeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c61-77a2-799a-b899-5e5f9cd1adaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c61-77a2-799a-b899-5e5f9cd1adaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-22d9-721d-8272-0d19e640ead6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-22d9-721d-8272-0d19e640ead6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_019d7e1d-a71f-7214-99d3-ae509fa9137e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_019d4579-22d9-75ec-8fbc-6f6fcc48a259" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_019d7e1d-a71f-7214-99d3-ae509fa9137e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofRevenueDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c62-e7fc-7f2a-8214-a5e077ddbb52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c62-e7fc-7f2a-8214-a5e077ddbb52" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d7c62-e7fc-7ae6-8948-911792614779" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:to="loc_srt_ProductOrServiceAxis_019d7c62-e7fc-7ae6-8948-911792614779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019d7c62-e7fc-7ae6-8948-911792614779" xlink:to="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember_019d7c62-e7fc-79ae-a58f-e3aa510dbc8b" xlink:href="aqst-20260331.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_ManufactureAndSupplyRevenueMember_019d7c62-e7fc-79ae-a58f-e3aa510dbc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_019d7c62-e7fc-7f9d-937c-a67a45dca6e7" xlink:href="aqst-20260331.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_019d7c62-e7fc-7f9d-937c-a67a45dca6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CoDevelopmentAndResearchFeesMember_019d7c62-e7fc-75d6-b948-b5f10c8b5676" xlink:href="aqst-20260331.xsd#aqst_CoDevelopmentAndResearchFeesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_CoDevelopmentAndResearchFeesMember_019d7c62-e7fc-75d6-b948-b5f10c8b5676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProprietaryProductRevenueMember_019d7c62-e7fc-7540-9036-a5e3989d75aa" xlink:href="aqst-20260331.xsd#aqst_ProprietaryProductRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7c62-e7fc-71bb-849a-4f3e99a90739" xlink:to="loc_aqst_ProprietaryProductRevenueMember_019d7c62-e7fc-7540-9036-a5e3989d75aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019dac4b-d927-7fe1-8afa-eb879e5de1be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019dac4b-d927-7fe1-8afa-eb879e5de1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-783c-b62e-adb95bdf2c77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019dac4b-d927-7fe1-8afa-eb879e5de1be" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-783c-b62e-adb95bdf2c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dac4b-d927-79d3-beed-225277448999" xlink:href="aqst-20260331.xsd#aqst_ZevraAndCommaveTherapeuticsAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019dac4b-d927-783c-b62e-adb95bdf2c77" xlink:to="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dac4b-d927-79d3-beed-225277448999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c62-e7fc-775f-a8ee-f7d75e0b79f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c62-e7fc-79a4-9c9f-74c78a6b83db" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c62-e7fc-775f-a8ee-f7d75e0b79f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c62-e7fc-7552-a3f3-2d461113ec0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c62-e7fc-775f-a8ee-f7d75e0b79f5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c62-e7fc-7552-a3f3-2d461113ec0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c64-802b-7fb7-9a80-b999e1e38bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d7c64-802b-7a70-a7a6-4881e9f8dcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c64-802b-7fb7-9a80-b999e1e38bd7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d7c64-802b-7a70-a7a6-4881e9f8dcf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019d7c64-802b-75e7-9918-10a596127884" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c64-802b-7a70-a7a6-4881e9f8dcf2" xlink:to="loc_srt_StatementGeographicalAxis_019d7c64-802b-75e7-9918-10a596127884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_019d7c64-802b-75e7-9918-10a596127884" xlink:to="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019d7c64-802b-78ff-8fac-0013066c427b" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:to="loc_country_US_019d7c64-802b-78ff-8fac-0013066c427b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_019d7c64-802b-7428-805b-e89a531bdc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019d7c64-802b-71a2-9e24-12e0220fcb07" xlink:to="loc_us-gaap_NonUsMember_019d7c64-802b-7428-805b-e89a531bdc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c64-802b-7129-821b-f38eda858260" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d7c64-802b-7a70-a7a6-4881e9f8dcf2" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c64-802b-7129-821b-f38eda858260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c64-802b-7026-b478-00347e76fff6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7c64-802b-7129-821b-f38eda858260" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7c64-802b-7026-b478-00347e76fff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c66-012d-780c-8c70-e79816c58a75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_019d7c66-012d-7a42-a1a9-37cb5634a85d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c66-012d-780c-8c70-e79816c58a75" xlink:to="loc_us-gaap_AccountsReceivableGross_019d7c66-012d-7a42-a1a9-37cb5634a85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c66-012d-7bbb-86f9-c043e6eae277" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherReceivablesGrossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c66-012d-780c-8c70-e79816c58a75" xlink:to="loc_us-gaap_OtherReceivablesGrossCurrent_019d7c66-012d-7bbb-86f9-c043e6eae277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification_019d7c66-012d-70bb-a723-5f66e8a9efb6" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowanceForCreditLossPreReclassification"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c66-012d-780c-8c70-e79816c58a75" xlink:to="loc_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification_019d7c66-012d-70bb-a723-5f66e8a9efb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_019d7c66-012d-7706-b203-b0b57d84f888" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c66-012d-780c-8c70-e79816c58a75" xlink:to="loc_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet_019d7c66-012d-7706-b203-b0b57d84f888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_019d7c66-012d-729e-a8ba-cf9bc674272f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c66-012d-780c-8c70-e79816c58a75" xlink:to="loc_us-gaap_ReceivablesNetCurrent_019d7c66-012d-729e-a8ba-cf9bc674272f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c68-87fa-7784-b85e-5086a26dc54f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d7c68-87fa-7c40-8b5c-b887cf69454d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d7c68-87fa-7784-b85e-5086a26dc54f" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d7c68-87fa-7c40-8b5c-b887cf69454d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d7c68-87fa-758f-87cd-e6040ed20cab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d7c68-87fa-7c40-8b5c-b887cf69454d" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d7c68-87fa-758f-87cd-e6040ed20cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-729b-99a0-5d592359ef43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_019d7c68-87fa-758f-87cd-e6040ed20cab" xlink:to="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-729b-99a0-5d592359ef43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember_019d7c68-87fa-79ec-a0cc-7fdd4d5ec7a8" xlink:href="aqst-20260331.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_019d7c68-87fa-729b-99a0-5d592359ef43" xlink:to="loc_aqst_TradeAccountsReceivableSalesRelatedMember_019d7c68-87fa-79ec-a0cc-7fdd4d5ec7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_019d7c68-87fa-73ca-b85c-a4d52f01928f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_019d7c68-87fa-7c40-8b5c-b887cf69454d" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_019d7c68-87fa-73ca-b85c-a4d52f01928f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_019d7c68-87fa-73ca-b85c-a4d52f01928f" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d7c68-87fa-75ad-b80e-4a7969768f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d7c68-87fa-75ad-b80e-4a7969768f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_019d7c68-87fa-7dbc-94c9-734524f379da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_019d7c68-87fa-7dbc-94c9-734524f379da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_019d7c68-87fa-7218-b72f-59185eddedc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_019d7c68-87fa-7218-b72f-59185eddedc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_019d7c68-87fa-7d47-a0c4-751a6e3520e0" xlink:href="aqst-20260331.xsd#aqst_AccountsReceivableAllowanceForCreditLossReclassifications"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_019d7c68-87fa-7d47-a0c4-751a6e3520e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d7c68-87fa-7266-8709-2bf88bf6c017" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_019d7c68-87fa-7bc2-b08a-a3a875b8c032" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d7c68-87fa-7266-8709-2bf88bf6c017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#MaterialAgreementsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-7e8e-b3c1-18c9f02989bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019d4579-22d9-7e8e-b3c1-18c9f02989bc" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d7c84-1953-7e17-baa0-843edb169035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d7c84-1953-7e17-baa0-843edb169035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d7c84-1953-7e17-baa0-843edb169035" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RTWInvestmentsLPMember_019d7c84-1953-7b81-8e00-bbe17c812908" xlink:href="aqst-20260331.xsd#aqst_RTWInvestmentsLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_RTWInvestmentsLPMember_019d7c84-1953-7b81-8e00-bbe17c812908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_019d7c84-3e6f-72f8-b5a2-3459102aa0fd" xlink:href="aqst-20260331.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_019d7c84-3e6f-72f8-b5a2-3459102aa0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_019d7c84-6cc1-75ab-ad7a-5cf33b9af190" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_019d7c84-6cc1-75ab-ad7a-5cf33b9af190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_019d7c84-5718-721d-a4d8-f6477b6343cc" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7c84-6cc1-7ff3-9df8-55bb69bc1042" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_019d7c84-5718-721d-a4d8-f6477b6343cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_019dda6d-2627-7586-820b-8235f23da6d4" xlink:href="aqst-20260331.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_019dda6d-2627-7586-820b-8235f23da6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dda6d-5a36-7b5a-881f-5bc30509aa68" xlink:href="aqst-20260331.xsd#aqst_ZevraAndCommaveTherapeuticsAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_ZevraAndCommaveTherapeuticsAgreementMember_019dda6d-5a36-7b5a-881f-5bc30509aa68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember_019dda6d-5a36-76a4-ac12-87007e543453" xlink:href="aqst-20260331.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_AtnahsPharmaUKLimitedMember_019dda6d-5a36-76a4-ac12-87007e543453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_019dda6d-754a-7eca-a976-e96aaf0d2c56" xlink:href="aqst-20260331.xsd#aqst_AtnahsPharmaUKLimitedAmendedAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7c84-1953-71c4-8fd5-5bd474440345" xlink:to="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_019dda6d-754a-7eca-a976-e96aaf0d2c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019dda6c-57c6-78e0-9ca6-738999a75f49" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_CreditFacilityAxis_019dda6c-57c6-78e0-9ca6-738999a75f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_019dda6c-57c6-78e0-9ca6-738999a75f49" xlink:to="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PurchaseAndSaleAgreementMember_019dda6c-57c6-7011-8aa7-1b84cc9e1b45" xlink:href="aqst-20260331.xsd#aqst_PurchaseAndSaleAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:to="loc_aqst_PurchaseAndSaleAgreementMember_019dda6c-57c6-7011-8aa7-1b84cc9e1b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_019dda6d-2627-7935-836c-3e34110aa8c1" xlink:href="aqst-20260331.xsd#aqst_MonetizationAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:to="loc_aqst_MonetizationAgreementMember_019dda6d-2627-7935-836c-3e34110aa8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember_019dda6d-5a36-7327-8e8e-5a4f85fb2ee7" xlink:href="aqst-20260331.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019dda6c-57c6-74e3-a580-345649996907" xlink:to="loc_aqst_LicenseSupplyAgreementMember_019dda6d-5a36-7327-8e8e-5a4f85fb2ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda6c-57c6-74e6-95a1-0797f9e682cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda6c-57c6-74e6-95a1-0797f9e682cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-7ef4-b239-5708fc93e8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda6c-57c6-74e6-95a1-0797f9e682cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-7ef4-b239-5708fc93e8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda6c-57c6-70a1-9259-342cfbe49387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda6c-57c6-7ef4-b239-5708fc93e8b8" xlink:to="loc_us-gaap_SeniorNotesMember_019dda6c-57c6-70a1-9259-342cfbe49387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda6c-57c6-7c54-96b8-31becf980f70" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_srt_RangeAxis_019dda6c-57c6-7c54-96b8-31becf980f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019dda6c-57c6-7c54-96b8-31becf980f70" xlink:to="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda6c-57c6-750b-a158-831a7ace9bb8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:to="loc_srt_MinimumMember_019dda6c-57c6-750b-a158-831a7ace9bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda6c-57c6-79ff-90e8-fb2d5769f82b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda6c-57c6-730b-886f-24434f65f59b" xlink:to="loc_srt_MaximumMember_019dda6c-57c6-79ff-90e8-fb2d5769f82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019dda6c-ed83-7779-95d7-be25947b4195" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_srt_ProductOrServiceAxis_019dda6c-ed83-7779-95d7-be25947b4195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7986-bc8d-278b05208d28" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019dda6c-ed83-7779-95d7-be25947b4195" xlink:to="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7986-bc8d-278b05208d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_019dda6c-ed83-794e-b9f6-523c12382cdb" xlink:href="aqst-20260331.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019dda6c-ed83-7986-bc8d-278b05208d28" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_019dda6c-ed83-794e-b9f6-523c12382cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019dda6d-5a36-70b4-ad97-511618a81d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019dda6d-5a36-70b4-ad97-511618a81d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-7179-994f-b1d0cebe9a05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019dda6d-5a36-70b4-ad97-511618a81d5f" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-7179-994f-b1d0cebe9a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019dda6d-5a36-7aea-97b5-fd458bd70d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019dda6d-5a36-7179-994f-b1d0cebe9a05" xlink:to="loc_us-gaap_SubsequentEventMember_019dda6d-5a36-7aea-97b5-fd458bd70d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_019dda6d-754a-78f0-947d-cac976d3554d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_srt_CounterpartyNameAxis_019dda6d-754a-78f0-947d-cac976d3554d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-7056-9d9f-47f6cf8fb311" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_019dda6d-754a-78f0-947d-cac976d3554d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-7056-9d9f-47f6cf8fb311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember_019dda6d-754a-7b92-84f2-42bc033649ac" xlink:href="aqst-20260331.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_019dda6d-754a-7056-9d9f-47f6cf8fb311" xlink:to="loc_aqst_AssertioHoldingsIncMember_019dda6d-754a-7b92-84f2-42bc033649ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_019d4579-22d9-7793-86fe-23428c059ac6" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests_019dda6c-57c6-7969-b54c-30e24d9f50a0" xlink:href="aqst-20260331.xsd#aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests_019dda6c-57c6-7969-b54c-30e24d9f50a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda6c-57c6-7fe2-b1f5-63fe18de78a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda6c-57c6-7fe2-b1f5-63fe18de78a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementRevenueSharingPercentage_019dda6c-57c6-7876-81a4-7832d2796c1a" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementRevenueSharingPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CollaborativeArrangementRevenueSharingPercentage_019dda6c-57c6-7876-81a4-7832d2796c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen_019dda6c-57c6-7b5f-b129-75f7046a7940" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen_019dda6c-57c6-7b5f-b129-75f7046a7940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter_019dda6c-57c6-7164-b3ce-4375b5194be6" xlink:href="aqst-20260331.xsd#aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter_019dda6c-57c6-7164-b3ce-4375b5194be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CapitalizedLegalFees_019dda6c-57c6-7ac5-9969-124b7b525957" xlink:href="aqst-20260331.xsd#aqst_CapitalizedLegalFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_CapitalizedLegalFees_019dda6c-57c6-7ac5-9969-124b7b525957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda6c-971d-78a7-ad7b-8635eba91130" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda6c-971d-78a7-ad7b-8635eba91130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda6c-971d-7754-a62e-5b339356f5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda6c-971d-7754-a62e-5b339356f5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockSharesCommittedAggregateAmount_019dda6c-971d-7d23-ac69-c1d88cacfd67" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockSharesCommittedAggregateAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_SaleOfStockSharesCommittedAggregateAmount_019dda6c-971d-7d23-ac69-c1d88cacfd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate_019dda6c-971d-7314-897b-b90a0558a3ad" xlink:href="aqst-20260331.xsd#aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate_019dda6c-971d-7314-897b-b90a0558a3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementTerm_019dda6c-c0cc-7909-a984-f8b82fc133bc" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_LicenseAgreementTerm_019dda6c-c0cc-7909-a984-f8b82fc133bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AutomaticRenewalPeriodOfAgreement_019dda6c-c0cc-7483-b486-c7dff584b046" xlink:href="aqst-20260331.xsd#aqst_AutomaticRenewalPeriodOfAgreement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_AutomaticRenewalPeriodOfAgreement_019dda6c-c0cc-7483-b486-c7dff584b046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019dda6c-ed83-7eb5-8bc4-8464d631475c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019dda6c-ed83-7eb5-8bc4-8464d631475c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019dda6d-2627-7ec6-b785-68d7aa1627e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_Revenues_019dda6d-2627-7ec6-b785-68d7aa1627e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e34-87f3-7900f24dfa0b" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e34-87f3-7900f24dfa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e99-8d44-d90a0e942994" xlink:href="aqst-20260331.xsd#aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet_019dda6d-2627-7e99-8d44-d90a0e942994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019dda6d-2627-7550-8164-76551c00b760" xlink:href="aqst-20260331.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019dda6d-2627-7550-8164-76551c00b760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_019dda6d-754a-7704-bac4-1a63c2905b30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_019dda6c-57c6-7681-a697-20feb94efc37" xlink:to="loc_us-gaap_ProceedsFromCollaborators_019dda6d-754a-7704-bac4-1a63c2905b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#FinancialInstrumentsFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019d4579-22d9-7ed4-be52-1599df69da51" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019d4579-22d9-7ed4-be52-1599df69da51" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019dda7e-a484-7e22-8f9b-9600d887c9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019dda7e-a484-7e22-8f9b-9600d887c9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-70fb-9077-90f83428b8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019dda7e-a484-7e22-8f9b-9600d887c9b5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-70fb-9077-90f83428b8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SecuritiesPurchaseAgreementMember_019dda7e-a484-7826-aa66-4efb55ad5b53" xlink:href="aqst-20260331.xsd#aqst_SecuritiesPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019dda7e-a484-70fb-9077-90f83428b8b8" xlink:to="loc_aqst_SecuritiesPurchaseAgreementMember_019dda7e-a484-7826-aa66-4efb55ad5b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda7e-a484-777e-9334-8c52f3ede9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda7e-a484-777e-9334-8c52f3ede9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda7e-a484-777e-9334-8c52f3ede9a0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_019dda7e-a484-7f3c-bbcb-cb862aa1acfa" xlink:href="aqst-20260331.xsd#aqst_ExistingWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:to="loc_aqst_ExistingWarrantsMember_019dda7e-a484-7f3c-bbcb-cb862aa1acfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_019dda7e-a484-7db5-992b-5a63c6b59b2d" xlink:href="aqst-20260331.xsd#aqst_NewWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:to="loc_aqst_NewWarrantsMember_019dda7e-a484-7db5-992b-5a63c6b59b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember_019dda7e-a484-7d79-8ca8-9a769acd2a26" xlink:href="aqst-20260331.xsd#aqst_CommonStockWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda7e-a484-74c2-9b7e-2a5d780de167" xlink:to="loc_aqst_CommonStockWarrantsMember_019dda7e-a484-7d79-8ca8-9a769acd2a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dda7e-a484-7a6e-bfc9-66cffb4d7b40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dda7e-a484-7a6e-bfc9-66cffb4d7b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7984-a26c-a296febf96f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda7e-a484-7a6e-bfc9-66cffb4d7b40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7984-a26c-a296febf96f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda7e-a484-7015-8da6-23a4f1525c86" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda7e-a484-7984-a26c-a296febf96f8" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda7e-a484-7015-8da6-23a4f1525c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda7e-a484-770e-9cd9-0bb4da28845a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda7e-a484-770e-9cd9-0bb4da28845a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-71b5-a969-d45c10039177" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda7e-a484-770e-9cd9-0bb4da28845a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-71b5-a969-d45c10039177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda7e-a484-7457-857c-068d638abcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda7e-a484-71b5-a969-d45c10039177" xlink:to="loc_us-gaap_SeniorNotesMember_019dda7e-a484-7457-857c-068d638abcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda7e-a484-7838-a4cc-c208758052b5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_srt_RangeAxis_019dda7e-a484-7838-a4cc-c208758052b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019dda7e-a484-7838-a4cc-c208758052b5" xlink:to="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda7e-a484-728d-8580-0b17177f481f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:to="loc_srt_MinimumMember_019dda7e-a484-728d-8580-0b17177f481f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda7e-a484-73eb-b388-72a7afc53426" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda7e-a484-7169-969a-2c1b1cc9793d" xlink:to="loc_srt_MaximumMember_019dda7e-a484-73eb-b388-72a7afc53426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-22d9-79dd-b771-5df35526f633" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_019dda7e-a484-7a07-95b7-b55efaf47ebe" xlink:href="aqst-20260331.xsd#aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_019dda7e-a484-7a07-95b7-b55efaf47ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_019dda7e-a484-749f-829b-f46044276ea8" xlink:href="aqst-20260331.xsd#aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_019dda7e-a484-749f-829b-f46044276ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda7e-a484-76a6-aac7-8494cd61cc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda7e-a484-76a6-aac7-8494cd61cc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda7e-a484-7215-9693-b9d6214ce58c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda7e-a484-7215-9693-b9d6214ce58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda7e-a484-7742-8379-5af4e90a6f23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda7e-a484-7742-8379-5af4e90a6f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda7e-a484-7a19-83ae-f986266ce1dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda7e-a484-7a19-83ae-f986266ce1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda7e-a484-7441-a795-887868b9a51b" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationPercentOfNetSales"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda7e-a484-7441-a795-887868b9a51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationTerm_019dda7e-a484-73f5-836b-0b5162cce000" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_aqst_RoyaltyObligationTerm_019dda7e-a484-73f5-836b-0b5162cce000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019dda7e-a484-7612-b93f-95d41393a51c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda7e-a484-77a0-94e6-7bbbd5d07cb4" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019dda7e-a484-7612-b93f-95d41393a51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesNetDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#InventoriesNetDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/InventoriesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-7b38-bbb0-0c636e225a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_019d4579-22d9-743f-a411-a310ebb52ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-7b38-bbb0-0c636e225a5a" xlink:to="loc_us-gaap_InventoryRawMaterials_019d4579-22d9-743f-a411-a310ebb52ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InventoryPackingMaterialGross_019d4579-22d9-797a-87e4-60ee18629fd8" xlink:href="aqst-20260331.xsd#aqst_InventoryPackingMaterialGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-7b38-bbb0-0c636e225a5a" xlink:to="loc_aqst_InventoryPackingMaterialGross_019d4579-22d9-797a-87e4-60ee18629fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_019d4579-22d9-7807-8b6d-120594b2b044" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-7b38-bbb0-0c636e225a5a" xlink:to="loc_us-gaap_InventoryFinishedGoods_019d4579-22d9-7807-8b6d-120594b2b044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019d4579-22d9-7e57-aea9-4bb8e77313aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_019d4579-22d9-7b38-bbb0-0c636e225a5a" xlink:to="loc_us-gaap_InventoryNet_019d4579-22d9-7e57-aea9-4bb8e77313aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-22d9-7cc5-afdd-49bc4e1b62b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-22d9-7cc5-afdd-49bc4e1b62b0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-22d9-7bc6-80ae-6a5cb952c2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-22d9-7bc6-80ae-6a5cb952c2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019d4579-22d9-7bc6-80ae-6a5cb952c2ff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_019d4579-22d9-77e9-95a4-ad7491131f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_019d4579-22d9-77e9-95a4-ad7491131f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_019d4579-22d9-751a-87f3-55ced9269af7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_019d4579-22d9-751a-87f3-55ced9269af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019d4579-22d9-713c-99d6-c647d779f373" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019d4579-22d9-713c-99d6-c647d779f373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_019d4579-22d9-72ae-b8f8-5863fdfa1697" xlink:href="aqst-20260331.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_019d4579-22d9-72ae-b8f8-5863fdfa1697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_019d4579-22d9-7497-931b-e11ea2127763" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019d4579-22d9-7795-b79a-799ef86bb8f8" xlink:to="loc_us-gaap_ConstructionInProgressMember_019d4579-22d9-7497-931b-e11ea2127763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d4579-22d9-7189-b6ea-da64716ae832" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:to="loc_srt_RangeAxis_019d4579-22d9-7189-b6ea-da64716ae832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d4579-22d9-7189-b6ea-da64716ae832" xlink:to="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d4579-22d9-7419-9313-cbe529c09d03" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:to="loc_srt_MinimumMember_019d4579-22d9-7419-9313-cbe529c09d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d4579-22d9-75da-a4e2-24cdd30b4bf5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d4579-22d9-727b-a7bd-cc2e42cd9de2" xlink:to="loc_srt_MaximumMember_019d4579-22d9-75da-a4e2-24cdd30b4bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019d4579-22d9-7362-8bf4-ce275d7fbcd1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019d4579-237c-7541-a855-5f78a6f91a23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_019d4579-237c-7541-a855-5f78a6f91a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019d4579-237c-7993-a433-710a17c0d8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019d4579-237c-7993-a433-710a17c0d8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019d4579-237c-7e65-9857-2db279f0dc14" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019d4579-237c-7e65-9857-2db279f0dc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-237c-79d8-9b51-ca1edfa63090" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019d4579-237c-732b-90f6-600a764dbb96" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019d4579-237c-79d8-9b51-ca1edfa63090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#PropertyandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-237c-72e2-a750-78e2ce4b2b95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019d4579-237c-7460-bd0a-304639be564f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_019d4579-237c-72e2-a750-78e2ce4b2b95" xlink:to="loc_us-gaap_Depreciation_019d4579-237c-7460-bd0a-304639be564f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RightofUseAssetsandLeaseObligationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019d4579-237c-7336-b6c2-fae0a69a8b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_019d4579-237c-7325-93a0-541558c71178" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7336-b6c2-fae0a69a8b2c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_019d4579-237c-7325-93a0-541558c71178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d4579-237c-7164-89e9-252cc4dcf807" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019d4579-237c-7325-93a0-541558c71178" xlink:to="loc_srt_RangeAxis_019d4579-237c-7164-89e9-252cc4dcf807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d4579-237c-7164-89e9-252cc4dcf807" xlink:to="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d4579-237c-7fdf-8a4c-b106e1fdec0a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:to="loc_srt_MinimumMember_019d4579-237c-7fdf-8a4c-b106e1fdec0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d4579-237c-7e54-8245-b78978190aac" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d4579-237c-7b1c-872f-bbf3ae23e79c" xlink:to="loc_srt_MaximumMember_019d4579-237c-7e54-8245-b78978190aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_019d4579-237c-7325-93a0-541558c71178" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfOperatingLeases_019d4579-237c-798a-97a5-62e515ef60c0" xlink:href="aqst-20260331.xsd#aqst_NumberOfOperatingLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_aqst_NumberOfOperatingLeases_019d4579-237c-798a-97a5-62e515ef60c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019d4579-237c-7530-8660-e8e03bb8be2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_019d4579-237c-7530-8660-e8e03bb8be2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_019d4579-237c-7139-b55f-b6fbc60d051b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_019d4579-237c-7139-b55f-b6fbc60d051b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_019d4579-237c-725a-b7f2-1bdc17b0dc50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_OperatingLeaseCost_019d4579-237c-725a-b7f2-1bdc17b0dc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_019d4579-237c-7409-8b1a-78e8cdc2d3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_019d4579-237c-7aa0-abfb-d69e23484b1a" xlink:to="loc_us-gaap_VariableLeaseCost_019d4579-237c-7409-8b1a-78e8cdc2d3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019d4579-237c-721e-9df5-24eaf6444dea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019d4579-237c-721e-9df5-24eaf6444dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d4579-237c-75d9-98da-1369b621fc75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d4579-237c-75d9-98da-1369b621fc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019d4579-237c-7cb2-bc3a-77d0f70522d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019d4579-237c-7cb2-bc3a-77d0f70522d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019d4579-237c-7557-b5db-92fdf0e3bf68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019d4579-237c-7557-b5db-92fdf0e3bf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_019d4579-237c-75a0-bd94-97f277b7132c" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_019d4579-237c-75a0-bd94-97f277b7132c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79f1-bead-98835ae6c325" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019d4579-237c-79f1-bead-98835ae6c325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d4579-237c-7b59-83c2-e503fa070100" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019d4579-237c-7b59-83c2-e503fa070100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019d4579-237c-74a2-af68-dcc9384eb45a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_019d4579-237c-7c7e-b7a1-025a8f20a6ad" xlink:to="loc_us-gaap_OperatingLeaseLiability_019d4579-237c-74a2-af68-dcc9384eb45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-730b-9393-ffe3057ba336" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CumulativeRoyaltyReceivable_019d4579-237c-713b-a790-f6300a20472f" xlink:href="aqst-20260331.xsd#aqst_CumulativeRoyaltyReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-730b-9393-ffe3057ba336" xlink:to="loc_aqst_CumulativeRoyaltyReceivable_019d4579-237c-713b-a790-f6300a20472f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d4579-237c-7337-8586-e9dc45ad55a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-730b-9393-ffe3057ba336" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_019d4579-237c-7337-8586-e9dc45ad55a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d4579-237c-7498-b9d1-a51f23d98f71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-730b-9393-ffe3057ba336" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d4579-237c-7498-b9d1-a51f23d98f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNoncurrentAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-73d7-a555-7c7a36a0a71e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_019d4579-237c-73d7-a555-7c7a36a0a71e" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d4579-237c-7c71-8547-47e4d278f1fa" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:to="loc_srt_ProductOrServiceAxis_019d4579-237c-7c71-8547-47e4d278f1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d4579-237c-7a0c-9929-97a561f67a3d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019d4579-237c-7c71-8547-47e4d278f1fa" xlink:to="loc_srt_ProductsAndServicesDomain_019d4579-237c-7a0c-9929-97a561f67a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019d4579-237c-7ab9-a141-b0d804a833a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d4579-237c-7a0c-9929-97a561f67a3d" xlink:to="loc_us-gaap_RoyaltyMember_019d4579-237c-7ab9-a141-b0d804a833a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d4579-237c-7a26-aa33-42c1276b95ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d4579-237c-7a26-aa33-42c1276b95ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-74c8-b963-65d416699da0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d4579-237c-7a26-aa33-42c1276b95ac" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-74c8-b963-65d416699da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d4579-237c-7403-ba9a-d569b6719abb" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d4579-237c-74c8-b963-65d416699da0" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d4579-237c-7403-ba9a-d569b6719abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_019d4579-237c-7016-8330-6d6e2013bde7" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-7598-9e34-d68738658c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-7598-9e34-d68738658c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfGuaranteedRoyaltyPayments_019d4579-237c-73ff-8cfd-d492cbd6258c" xlink:href="aqst-20260331.xsd#aqst_NumberOfGuaranteedRoyaltyPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_aqst_NumberOfGuaranteedRoyaltyPayments_019d4579-237c-73ff-8cfd-d492cbd6258c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_019d4579-237c-7e6a-90bb-ab4ad44171b3" xlink:href="aqst-20260331.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_019d4579-237c-7e6a-90bb-ab4ad44171b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_019d4579-237c-7904-b09d-7953025257a5" xlink:href="aqst-20260331.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_019d4579-237c-73d9-83d3-b3b6a2143a29" xlink:to="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_019d4579-237c-7904-b09d-7953025257a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-738c-83bc-8e4ba2809940" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019d4579-237c-7238-95d6-49f3f3f08b07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-738c-83bc-8e4ba2809940" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019d4579-237c-7238-95d6-49f3f3f08b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_019d4579-237c-72f0-8aa5-adc8ae976ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-738c-83bc-8e4ba2809940" xlink:to="loc_us-gaap_TaxesPayableCurrent_019d4579-237c-72f0-8aa5-adc8ae976ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-237c-7d8d-8e8b-27224745f644" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-738c-83bc-8e4ba2809940" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_019d4579-237c-7d8d-8e8b-27224745f644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_019d4579-237c-7257-bdb8-f2dd62675eed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-738c-83bc-8e4ba2809940" xlink:to="loc_us-gaap_InterestPayableCurrent_019d4579-237c-7257-bdb8-f2dd62675eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d4579-237c-7a09-8632-c54eb767616a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-738c-83bc-8e4ba2809940" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019d4579-237c-7a09-8632-c54eb767616a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-796a-8c72-2ef18027242d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019d4579-237c-738c-83bc-8e4ba2809940" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019d4579-237c-796a-8c72-2ef18027242d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-761a-b7e4-8f8931873131" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-761a-b7e4-8f8931873131" xlink:to="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dda83-d084-7b06-9498-1d34196cae7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dda83-d084-7b06-9498-1d34196cae7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda83-d084-7b06-9498-1d34196cae7e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda83-d084-7297-bad4-f3a2ca8c0794" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda83-d084-7297-bad4-f3a2ca8c0794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda83-d084-7fef-b521-846d78cb4a33" xlink:href="aqst-20260331.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda83-d084-7fef-b521-846d78cb4a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_019dda84-4229-78e4-936c-a5eccd9c4e68" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_RoyaltyObligationsMember_019dda84-4229-78e4-936c-a5eccd9c4e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ABLFacilityMember_019dda84-5b87-7502-9a8e-cf54eb13235b" xlink:href="aqst-20260331.xsd#aqst_ABLFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_ABLFacilityMember_019dda84-5b87-7502-9a8e-cf54eb13235b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TermLoanFacilityMember_019e1f23-9665-7485-924d-542f09259856" xlink:href="aqst-20260331.xsd#aqst_TermLoanFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_TermLoanFacilityMember_019e1f23-9665-7485-924d-542f09259856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyRightAgreementsMember_019dda84-8d07-7821-8cc9-ea6d9f5ab77a" xlink:href="aqst-20260331.xsd#aqst_RoyaltyRightAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda83-d084-7135-9247-137e0ac0ec95" xlink:to="loc_aqst_RoyaltyRightAgreementsMember_019dda84-8d07-7821-8cc9-ea6d9f5ab77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda83-d084-78c2-b1c9-52576d0c0de7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda83-d084-78c2-b1c9-52576d0c0de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda83-d084-78c2-b1c9-52576d0c0de7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda83-d084-70df-857b-9e110d340bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:to="loc_us-gaap_SeniorNotesMember_019dda83-d084-70df-857b-9e110d340bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_019e1f23-9665-75f7-8d52-d86fdab77429" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:to="loc_us-gaap_LineOfCreditMember_019e1f23-9665-75f7-8d52-d86fdab77429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_019dda84-8d07-7322-8ea6-b44dc7f14853" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda83-d084-721c-b1dc-94d1888ca65b" xlink:to="loc_us-gaap_UnsecuredDebtMember_019dda84-8d07-7322-8ea6-b44dc7f14853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioAxis_019dda84-4229-73ac-a1b6-b318c76759ca" xlink:href="aqst-20260331.xsd#aqst_DebtCovenantRedemptionScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioAxis_019dda84-4229-73ac-a1b6-b318c76759ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:href="aqst-20260331.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis_019dda84-4229-73ac-a1b6-b318c76759ca" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario1Member_019dda84-4229-7526-b994-07862ccf38d8" xlink:href="aqst-20260331.xsd#aqst_RedemptionScenario1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:to="loc_aqst_RedemptionScenario1Member_019dda84-4229-7526-b994-07862ccf38d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario2Member_019dda84-4229-7657-8644-6fc6ebc88b92" xlink:href="aqst-20260331.xsd#aqst_RedemptionScenario2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_019dda84-4229-7a75-8345-513255f3e9f1" xlink:to="loc_aqst_RedemptionScenario2Member_019dda84-4229-7657-8644-6fc6ebc88b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda84-5b87-7f2e-bd60-73228c942109" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_srt_RangeAxis_019dda84-5b87-7f2e-bd60-73228c942109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019dda84-5b87-7f2e-bd60-73228c942109" xlink:to="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda84-5b87-72cd-af05-eec3133ce30c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:to="loc_srt_MinimumMember_019dda84-5b87-72cd-af05-eec3133ce30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda84-5b87-75d0-b82e-dade31499900" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda84-5b87-749c-acaa-12764d882835" xlink:to="loc_srt_MaximumMember_019dda84-5b87-75d0-b82e-dade31499900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019e1f30-36cf-7e95-a0c3-507be640cebf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019e1f30-36cf-7e95-a0c3-507be640cebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7c6b-8c16-a09044f70d40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019e1f30-36cf-7e95-a0c3-507be640cebf" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7c6b-8c16-a09044f70d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019e1f30-6540-714e-acaf-f4ac69b06fae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019e1f30-36cf-7c6b-8c16-a09044f70d40" xlink:to="loc_us-gaap_SubsequentEventMember_019e1f30-6540-714e-acaf-f4ac69b06fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019d4579-237c-7d1c-8b0b-af5e051f1e05" xlink:to="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda83-d084-7c9e-aa4b-3b67cae3199a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda83-d084-7c9e-aa4b-3b67cae3199a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019dda83-d084-7fb9-ba58-5fc947c6f3be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019dda83-d084-7fb9-ba58-5fc947c6f3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_019dda83-d084-7689-b93a-46b7e5dd7a08" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_019dda83-d084-7689-b93a-46b7e5dd7a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentExitFee_019dda84-4229-793c-9147-b2f44b6ce141" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentExitFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_DebtInstrumentExitFee_019dda84-4229-793c-9147-b2f44b6ce141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019dda84-4229-7c68-9331-ba11790fb434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_019dda84-4229-7c68-9331-ba11790fb434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_019dda84-4229-7c06-ad8f-64e93c8f2470" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_019dda84-4229-7c06-ad8f-64e93c8f2470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_019dda84-4229-7244-85bb-0c42a8d7ea20" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_019dda84-4229-7244-85bb-0c42a8d7ea20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_019dda84-5b87-7942-991c-d4a7345bdfe5" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_019dda84-5b87-7942-991c-d4a7345bdfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_019dda84-5b87-7b36-be80-9e0db25a11f5" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_019dda84-5b87-7b36-be80-9e0db25a11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_019e1f23-9665-78ed-995a-30cdcf905511" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentTerm_019e1f23-9665-78ed-995a-30cdcf905511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f23-9665-759a-98bb-00f7bffa3009" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f23-9665-759a-98bb-00f7bffa3009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_019e1f23-9665-76fc-b392-5253cfec1787" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_RepaymentsOfDebt_019e1f23-9665-76fc-b392-5253cfec1787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda84-5b87-78e4-829c-4d759c72f30a" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationPercentOfNetSales"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_RoyaltyObligationPercentOfNetSales_019dda84-5b87-78e4-829c-4d759c72f30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_019dda84-5b87-76cc-aa85-ddcdd933e5b6" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_019dda84-5b87-76cc-aa85-ddcdd933e5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsGross_019dda84-8d07-7db9-8575-ecc216dd979e" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsGross"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_aqst_RoyaltyObligationsGross_019dda84-8d07-7db9-8575-ecc216dd979e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019dda84-8d07-7728-8c58-405e03cbe737" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019dda84-8d07-7728-8c58-405e03cbe737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019dda84-8d07-7378-80c7-4ad2e5ae2b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019dda84-8d07-7378-80c7-4ad2e5ae2b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_019dda84-8d07-794a-86ef-805592cc51db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_019dda84-8d07-794a-86ef-805592cc51db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_019dda84-8d07-79ad-82db-54fa10468548" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_LongTermDebtFairValue_019dda84-8d07-79ad-82db-54fa10468548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019dda84-8d07-7dd8-be62-9d13b00eb742" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_019dda84-8d07-7dd8-be62-9d13b00eb742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_019dda84-8d07-79a0-8225-909ce882101b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_019dda84-8d07-79a0-8225-909ce882101b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019dda84-8d07-798b-a3e2-789d306215b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019dda84-8d07-798b-a3e2-789d306215b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_019dda84-8d07-7a01-85f1-871e8914c23f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019dda83-d084-7bd3-913b-193d730971c4" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_019dda84-8d07-7a01-85f1-871e8914c23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019d7d44-0ca5-7b79-b7ac-d24eaf0a60da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_019d7d44-0ca5-7281-9560-c6e639bcf177" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d7d44-0ca5-7b79-b7ac-d24eaf0a60da" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_019d7d44-0ca5-7281-9560-c6e639bcf177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_019d7d44-0ca5-7124-b403-f68ae99fa29b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d7d44-0ca5-7281-9560-c6e639bcf177" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_019d7d44-0ca5-7124-b403-f68ae99fa29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_019d7d44-0ca5-7124-b403-f68ae99fa29b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_019d7d44-0ca5-73bb-b625-0d418dd248fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_019d7d44-0ca5-73bb-b625-0d418dd248fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MeasurementInputProbabilityOfSuccessMember_019d7d44-0ca5-7a12-8fa8-951a73f2268a" xlink:href="aqst-20260331.xsd#aqst_MeasurementInputProbabilityOfSuccessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_019d7d44-0ca5-7fcb-9547-c63a90b4f436" xlink:to="loc_aqst_MeasurementInputProbabilityOfSuccessMember_019d7d44-0ca5-7a12-8fa8-951a73f2268a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_019d7d44-0ca5-7926-9748-666906c57623" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d7d44-0ca5-7281-9560-c6e639bcf177" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_019d7d44-0ca5-7926-9748-666906c57623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyAgreementMeasurementInput_019d7d44-0ca5-7277-87c2-7eaac573b559" xlink:href="aqst-20260331.xsd#aqst_RoyaltyAgreementMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d7d44-0ca5-7926-9748-666906c57623" xlink:to="loc_aqst_RoyaltyAgreementMeasurementInput_019d7d44-0ca5-7277-87c2-7eaac573b559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-7a52-afa1-c4efaa257777" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-7a52-afa1-c4efaa257777" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019d4579-237c-74a1-9ac4-e8453bfce5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:to="loc_us-gaap_DebtInstrumentAxis_019d4579-237c-74a1-9ac4-e8453bfce5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019d4579-237c-74a1-9ac4-e8453bfce5ea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-237c-7c17-94ad-beebd43f7ebc" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019d4579-237c-7c17-94ad-beebd43f7ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_019d4579-237c-76f3-b109-6dcd076c1e9a" xlink:href="aqst-20260331.xsd#aqst_RoyaltyObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019d4579-237c-7338-839d-4973afbb0acb" xlink:to="loc_aqst_RoyaltyObligationsMember_019d4579-237c-76f3-b109-6dcd076c1e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019d4579-237c-757b-b4ad-b38f22734a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019d4579-237c-757b-b4ad-b38f22734a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019d4579-237c-757b-b4ad-b38f22734a4c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019d4579-237c-729d-ab81-c5b3b7e6227d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:to="loc_us-gaap_SeniorNotesMember_019d4579-237c-729d-ab81-c5b3b7e6227d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_019d4579-237c-7cd6-b345-ba68fa0dde47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019d4579-237c-7395-b2ab-a29be2207e37" xlink:to="loc_us-gaap_UnsecuredDebtMember_019d4579-237c-7cd6-b345-ba68fa0dde47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_019d4579-237c-7c48-8b82-bb559b2f5f33" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019d4579-237c-7925-ae9c-62b9f42c2c34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_019d4579-237c-7925-ae9c-62b9f42c2c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019d4579-237c-7505-9e35-95750d4a65e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_019d4579-237c-7505-9e35-95750d4a65e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansPayableCurrent_019d4579-237c-7b39-8b34-8d773fa5f528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesAndLoansPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_NotesAndLoansPayableCurrent_019d4579-237c-7b39-8b34-8d773fa5f528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019d4579-237c-7150-a572-f0c925dab8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019d4579-237c-7150-a572-f0c925dab8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019d4579-237c-71c9-bb76-a600c2663cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019d4579-237c-71c9-bb76-a600c2663cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-73e6-8d6b-28e78b571618" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_019d4579-237c-7061-96ab-23344eaa7ad1" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_019d4579-237c-73e6-8d6b-28e78b571618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#LongTermDebtScheduleofDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-71c0-a017-9efdba67b320" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019d4579-237c-7e75-8253-3013b3de57c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-71c0-a017-9efdba67b320" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_019d4579-237c-7e75-8253-3013b3de57c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019d4579-237c-7cc4-92aa-9919e67512fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-71c0-a017-9efdba67b320" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_019d4579-237c-7cc4-92aa-9919e67512fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019d4579-237c-7e99-a87c-0d3dd143c452" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-71c0-a017-9efdba67b320" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_019d4579-237c-7e99-a87c-0d3dd143c452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019d4579-237c-7b84-b3f0-be1a9e083c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019d4579-237c-71c0-a017-9efdba67b320" xlink:to="loc_us-gaap_LongTermDebt_019d4579-237c-7b84-b3f0-be1a9e083c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#WarrantsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_019d4579-237c-74f9-80d4-f8b71e52b86b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_019d4579-237c-74f9-80d4-f8b71e52b86b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda8e-83ba-7d6b-a565-a1ddeec0d03a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda8e-83ba-7d6b-a565-a1ddeec0d03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_019dda8e-83ba-7d6b-a565-a1ddeec0d03a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember_019dda8e-83ba-7bf6-9118-2754ec6ef26b" xlink:href="aqst-20260331.xsd#aqst_CommonStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_CommonStockWarrantsMember_019dda8e-83ba-7bf6-9118-2754ec6ef26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_FirstAdditionalWarrantOfferingMember_019dda8e-83ba-78d9-8681-bf172e050a2d" xlink:href="aqst-20260331.xsd#aqst_FirstAdditionalWarrantOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_FirstAdditionalWarrantOfferingMember_019dda8e-83ba-78d9-8681-bf172e050a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PreFundedWarrantsMember_019dda8e-d868-75bc-9928-f45d14f2e74e" xlink:href="aqst-20260331.xsd#aqst_PreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_PreFundedWarrantsMember_019dda8e-d868-75bc-9928-f45d14f2e74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_019dda8e-d868-7d71-be57-236c0c7a32c9" xlink:href="aqst-20260331.xsd#aqst_ExistingWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_ExistingWarrantsMember_019dda8e-d868-7d71-be57-236c0c7a32c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_019dda8e-d868-732f-8dcf-826a16bb0144" xlink:href="aqst-20260331.xsd#aqst_NewWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_019dda8e-83ba-7c34-9937-b5172588c130" xlink:to="loc_aqst_NewWarrantsMember_019dda8e-d868-732f-8dcf-826a16bb0144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019dda8e-83ba-729d-8da9-02a7803b10de" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_srt_RangeAxis_019dda8e-83ba-729d-8da9-02a7803b10de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019dda8e-83ba-729d-8da9-02a7803b10de" xlink:to="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019dda8e-83ba-7441-acb7-1dcdff5860f8" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:to="loc_srt_MinimumMember_019dda8e-83ba-7441-acb7-1dcdff5860f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019dda8e-83ba-7a1b-89ad-351c3a3db5b5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019dda8e-83ba-7091-831f-d76dae0cb930" xlink:to="loc_srt_MaximumMember_019dda8e-83ba-7a1b-89ad-351c3a3db5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019dda8e-83ba-7412-b9dd-1588cd90abd9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_us-gaap_DebtInstrumentAxis_019dda8e-83ba-7412-b9dd-1588cd90abd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019dda8e-83ba-7412-b9dd-1588cd90abd9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda8e-83ba-7366-8be2-04d93cec4c22" xlink:href="aqst-20260331.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_019dda8e-83ba-7366-8be2-04d93cec4c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2020AdditionalNotesMember_019dda8e-83ba-728e-b093-ac8e8a449915" xlink:href="aqst-20260331.xsd#aqst_A2020AdditionalNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:to="loc_aqst_A2020AdditionalNotesMember_019dda8e-83ba-728e-b093-ac8e8a449915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda8e-83ba-7279-9c5b-e9567142ed2a" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019dda8e-83ba-775c-866e-b1247d2990b6" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019dda8e-83ba-7279-9c5b-e9567142ed2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019dda8e-83ba-7095-b006-68717cde1665" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019dda8e-83ba-7095-b006-68717cde1665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7eb0-8a96-eeb871a9f779" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019dda8e-83ba-7095-b006-68717cde1665" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7eb0-8a96-eeb871a9f779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019dda8e-83ba-703f-91f5-705b4ff1393b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019dda8e-83ba-7eb0-8a96-eeb871a9f779" xlink:to="loc_us-gaap_SeniorNotesMember_019dda8e-83ba-703f-91f5-705b4ff1393b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_019d4579-237c-7d02-9ec5-44e61e3f0af2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda8e-83bb-7fd8-8cea-23275efce008" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_019dda8e-83bb-7fd8-8cea-23275efce008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda8e-83bb-7d48-9ff8-2d4249866f99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_019dda8e-83bb-7d48-9ff8-2d4249866f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_019dda8e-d868-7da8-af5d-a4c86874d7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_019dda8e-d868-7da8-af5d-a4c86874d7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e1cc2-8e22-747b-8dd1-4b43ff491a02" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_019e1cc2-8e22-747b-8dd1-4b43ff491a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda8e-83bb-73e8-b482-966eac7a4c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019dda8e-83bb-73e8-b482-966eac7a4c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued_019dda8e-83bb-735f-9875-4204b76353ee" xlink:href="aqst-20260331.xsd#aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued_019dda8e-83bb-735f-9875-4204b76353ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_019dda8e-83bb-77ea-b80f-c6e0516ab1b3" xlink:href="aqst-20260331.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_019dda8e-83bb-77ea-b80f-c6e0516ab1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_019dda8e-d868-7ff8-ac77-bd85be1cb5c7" xlink:href="aqst-20260331.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_019dda8e-d868-7ff8-ac77-bd85be1cb5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_019dda8e-d868-72bb-bdf3-2855a881e443" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_019dda8e-d868-72bb-bdf3-2855a881e443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda8e-d868-7a6c-8761-9c9a39fd023f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_019dda8e-83bb-7339-be72-3899c6b772ba" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_019dda8e-d868-7a6c-8761-9c9a39fd023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SaleofFutureRevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-7332-be03-68eaf1ad080c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-7332-be03-68eaf1ad080c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_us-gaap_CreditFacilityAxis_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7fe8-bc0e-bd00acf0d785" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_019d7d93-20f1-7d57-83b3-ce64ebe8f0c4" xlink:to="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7fe8-bc0e-bd00acf0d785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_019d7d93-20f2-7c51-8bd3-d8d3bc5efa45" xlink:href="aqst-20260331.xsd#aqst_MonetizationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019d7d93-20f1-7fe8-bc0e-bd00acf0d785" xlink:to="loc_aqst_MonetizationAgreementMember_019d7d93-20f2-7c51-8bd3-d8d3bc5efa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_019d7d93-20f2-7dfa-811e-e25f223e5b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_019d7d93-20f2-7dfa-811e-e25f223e5b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_019d7d93-20f2-7dfa-811e-e25f223e5b98" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_019d7d93-20f2-791b-b21c-eb0cbcd6b62e" xlink:href="aqst-20260331.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_019d7d93-20f2-791b-b21c-eb0cbcd6b62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7d93-769c-7860-9345-e06381c6d194" xlink:href="aqst-20260331.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_019d7d93-20f2-73b8-82d0-e4701fc97ef5" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_019d7d93-769c-7860-9345-e06381c6d194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d7d93-20f2-7694-9cdd-9ba836fb33e9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_srt_RangeAxis_019d7d93-20f2-7694-9cdd-9ba836fb33e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7d93-20f2-7357-85a7-fd554f8b3d2a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d7d93-20f2-7694-9cdd-9ba836fb33e9" xlink:to="loc_srt_RangeMember_019d7d93-20f2-7357-85a7-fd554f8b3d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d7d93-20f2-7a64-b556-c9a23e27c585" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d7d93-20f2-7357-85a7-fd554f8b3d2a" xlink:to="loc_srt_MaximumMember_019d7d93-20f2-7a64-b556-c9a23e27c585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d7d93-769c-71ff-a85a-d9d1a40fe019" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_srt_ProductOrServiceAxis_019d7d93-769c-71ff-a85a-d9d1a40fe019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d7d93-769c-7c90-b3c1-0c8b53e47ffe" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019d7d93-769c-71ff-a85a-d9d1a40fe019" xlink:to="loc_srt_ProductsAndServicesDomain_019d7d93-769c-7c90-b3c1-0c8b53e47ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019d7d93-769c-75e2-8b68-9c0bcf341837" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d7d93-769c-7c90-b3c1-0c8b53e47ffe" xlink:to="loc_us-gaap_RoyaltyMember_019d7d93-769c-75e2-8b68-9c0bcf341837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-76d4-b12d-2ef52b35756a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019d7d93-20f2-7f03-9cfc-367642a8856e" xlink:href="aqst-20260331.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_019d7d93-20f2-7f03-9cfc-367642a8856e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019d7d93-20f2-72e9-bfe2-04d9babf97fb" xlink:href="aqst-20260331.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_019d7d93-20f2-72e9-bfe2-04d9babf97fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_019d7d93-20f2-73fb-bbbd-434cb5a26c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_019d7d93-20f2-73fb-bbbd-434cb5a26c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7d93-769c-7e86-a83d-d4baf4e548e2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d7d93-769c-7e86-a83d-d4baf4e548e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_019d7d93-769c-7728-b946-d8f84d74b924" xlink:href="aqst-20260331.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_019d7d93-769c-7728-b946-d8f84d74b924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019d7d93-769c-7e40-a756-8d90bcd8f213" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d7d93-20f2-790b-aa2d-a555735fbcd1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_019d7d93-769c-7e40-a756-8d90bcd8f213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SaleofFutureRevenueScheduleofRoyaltyObligationDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-7f8c-b9aa-423de806b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-7865-ac99-5352da344a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019d4579-237c-7f8c-b9aa-423de806b93a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-7865-ac99-5352da344a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019d4579-237c-7ef5-8fe4-2bafa90557d3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-7865-ac99-5352da344a0c" xlink:to="loc_srt_ProductOrServiceAxis_019d4579-237c-7ef5-8fe4-2bafa90557d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ab0-9185-05bd2b8b27b2" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019d4579-237c-7ef5-8fe4-2bafa90557d3" xlink:to="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ab0-9185-05bd2b8b27b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_019d4579-237c-7b79-874a-f0de156bfa0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019d4579-237c-7ab0-9185-05bd2b8b27b2" xlink:to="loc_us-gaap_RoyaltyMember_019d4579-237c-7b79-874a-f0de156bfa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019d4579-237c-7865-ac99-5352da344a0c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:href="aqst-20260331.xsd#aqst_SaleOfFutureRevenueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:to="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-237c-7065-a7a0-375c47d64c01" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-237c-7065-a7a0-375c47d64c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-73cd-aa2a-25bb16bc3f58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d4579-237c-73cd-aa2a-25bb16bc3f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019d4579-237c-7415-94f7-5ee19a3a7d30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019d4579-237c-7415-94f7-5ee19a3a7d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-237c-75ca-8453-7b5b3d7fa924" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_019d4579-237c-7061-b86f-95b2f2e9cc61" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyalties_019d4579-237c-75ca-8453-7b5b3d7fa924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_019d4579-237c-7a23-a92d-ab29ffe2e767" xlink:href="aqst-20260331.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019d4579-237c-7ba8-89d8-0c87f5695718" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_019d4579-237c-7a23-a92d-ab29ffe2e767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNonCurrentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNonCurrentLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNonCurrentLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-7573-9102-6d7977712911" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_019ddc57-d0d2-75c8-a96b-e4b1c0487905" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-7573-9102-6d7977712911" xlink:to="loc_us-gaap_AssetRetirementObligation_019ddc57-d0d2-75c8-a96b-e4b1c0487905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssetRetirementObligationsDepreciationExpense_019ddc57-d0d2-7702-b70b-c3894149e913" xlink:href="aqst-20260331.xsd#aqst_AssetRetirementObligationsDepreciationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-7573-9102-6d7977712911" xlink:to="loc_aqst_AssetRetirementObligationsDepreciationExpense_019ddc57-d0d2-7702-b70b-c3894149e913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-77ae-a9af-3ca79961543f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_019ddc57-d0d2-7345-a6f8-a93715a295e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationDisclosureAbstract_019ddc57-d0d2-77ae-a9af-3ca79961543f" xlink:to="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_019ddc57-d0d2-7345-a6f8-a93715a295e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_019ddc57-d0d2-7448-86e3-9406e147b8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_019ddc57-d0d2-7345-a6f8-a93715a295e1" xlink:to="loc_us-gaap_AssetRetirementObligation_019ddc57-d0d2-7448-86e3-9406e147b8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationLiabilitiesIncurred_019ddc57-d0d2-7b81-91f4-f2adf13cb381" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_019ddc57-d0d2-7345-a6f8-a93715a295e1" xlink:to="loc_us-gaap_AssetRetirementObligationLiabilitiesIncurred_019ddc57-d0d2-7b81-91f4-f2adf13cb381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_019ddc57-d0d2-7c6f-9265-6d7fb2debb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_019ddc57-d0d2-7345-a6f8-a93715a295e1" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_019ddc57-d0d2-7c6f-9265-6d7fb2debb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_019ddc57-d0d2-7c53-ae15-7e695f19ea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward_019ddc57-d0d2-7345-a6f8-a93715a295e1" xlink:to="loc_us-gaap_AssetRetirementObligation_019ddc57-d0d2-7c53-ae15-7e695f19ea8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossPerShareDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#NetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/NetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019d7d9a-b8bf-77f9-99e3-42d7113b151b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d7d9a-b8bf-7314-9137-d5e74535efde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019d7d9a-b8bf-77f9-99e3-42d7113b151b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d7d9a-b8bf-7314-9137-d5e74535efde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d7d9a-b8bf-7314-9137-d5e74535efde" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019d7d9a-b8bf-759d-ae0e-04c3602a5ceb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d7d9a-b8bf-7c0c-baaa-2bb40e6bc886" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d7d9a-b8bf-7c0c-baaa-2bb40e6bc886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7d9a-b8bf-7c44-975c-285cd33aba0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7d9a-b8bf-7c44-975c-285cd33aba0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_019d7d9a-b8bf-714e-a166-b98917f68722" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019d7d9a-b8bf-7c52-9582-ddf647d21729" xlink:to="loc_us-gaap_WarrantMember_019d7d9a-b8bf-714e-a166-b98917f68722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019d7d9a-b8bf-7314-9137-d5e74535efde" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsAbstract_019d7d9a-b8bf-7afb-b865-6fad84316a65" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UndistributedEarningsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:to="loc_us-gaap_UndistributedEarningsAbstract_019d7d9a-b8bf-7afb-b865-6fad84316a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d7d9a-b8bf-727c-bb56-7b82b2c9d6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UndistributedEarningsAbstract_019d7d9a-b8bf-7afb-b865-6fad84316a65" xlink:to="loc_us-gaap_NetIncomeLoss_019d7d9a-b8bf-727c-bb56-7b82b2c9d6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d7d9a-b8bf-7e77-b37b-e72c1b2af823" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019d7d9a-b8bf-7e77-b37b-e72c1b2af823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d7d9a-b8bf-7817-a5f4-4089fec4a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019d7d9a-b8bf-7817-a5f4-4089fec4a7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019d7d9a-b8bf-70ee-bf58-bbca48b44625" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_EarningsPerShareBasic_019d7d9a-b8bf-70ee-bf58-bbca48b44625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019d7d9a-b8bf-71d0-9c8d-5021d4add85d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019d7d9a-b8bf-7842-8be2-6dd5def28099" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019d7d9a-b8bf-71d0-9c8d-5021d4add85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d7d9a-b8bf-74b1-be1b-9f85001dccef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019d7d9a-b8bf-7ce9-bbba-3c325f467de8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019d7d9a-b8bf-74b1-be1b-9f85001dccef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-7783-8f25-305fd42c62f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-7783-8f25-305fd42c62f6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_019d4579-237c-7375-9809-1776bc13359d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_019d4579-237c-7375-9809-1776bc13359d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_019d4579-237c-7375-9809-1776bc13359d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufacturingAndSupplyMember_019d4579-237c-7fc2-9dca-42893754b994" xlink:href="aqst-20260331.xsd#aqst_ManufacturingAndSupplyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:to="loc_aqst_ManufacturingAndSupplyMember_019d4579-237c-7fc2-9dca-42893754b994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d4579-237c-709d-98c7-3cb9a40fa598" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_019d4579-237c-709d-98c7-3cb9a40fa598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d4579-237c-7d60-adbc-88c91e2e0520" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_019d4579-237c-7012-9976-4e37f5c18801" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_019d4579-237c-7d60-adbc-88c91e2e0520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-77d5-8ee1-1df8543d66de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-77d5-8ee1-1df8543d66de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-77d5-8ee1-1df8543d66de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-7b96-b3d1-da2444501cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-7b96-b3d1-da2444501cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7028-9fcc-8e92f86a483f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-72cd-8925-bf70f003630a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7028-9fcc-8e92f86a483f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7726-a8f8-332a2cb62b46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a8b-ace6-ba754f107bf3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7726-a8f8-332a2cb62b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_019d4579-237c-7570-95e3-7ea00896c7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7726-a8f8-332a2cb62b46" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_019d4579-237c-7570-95e3-7ea00896c7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d4579-237c-7a25-b120-424289770bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_019d4579-237c-7570-95e3-7ea00896c7b4" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019d4579-237c-7a25-b120-424289770bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-740a-8e0e-3bbac5704f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-740a-8e0e-3bbac5704f8f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-7d23-9c7d-fc01c38cfac9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-7d23-9c7d-fc01c38cfac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7cf0-aae0-ec9be85230a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7d23-9c7d-fc01c38cfac9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7cf0-aae0-ec9be85230a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-762d-8ff5-d9d94f07e379" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7cf0-aae0-ec9be85230a1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d4579-237c-762d-8ff5-d9d94f07e379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d7dce-1d37-7291-bd92-0b90dc179a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:to="loc_us-gaap_PlanNameAxis_019d7dce-1d37-7291-bd92-0b90dc179a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019d7dce-1d37-7291-bd92-0b90dc179a9d" xlink:to="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ServiceBasedMember_019d7dce-8d64-7ce4-aea2-83266e0d2df2" xlink:href="aqst-20260331.xsd#aqst_ServiceBasedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:to="loc_aqst_ServiceBasedMember_019d7dce-8d64-7ce4-aea2-83266e0d2df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember_019d7dcf-af62-712b-b6b4-a0fc9e177412" xlink:href="aqst-20260331.xsd#aqst_MarketBasedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d7dce-1d37-7f3b-93e1-018b468cd4bd" xlink:to="loc_aqst_MarketBasedMember_019d7dcf-af62-712b-b6b4-a0fc9e177412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7a86-88d3-dec81147ee8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-237c-7864-9290-f9280b3c8655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-237c-7864-9290-f9280b3c8655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d4579-237c-7c4e-b6b3-f407f2db3d07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019d4579-237c-7c4e-b6b3-f407f2db3d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019d4579-237c-742b-b5e9-11883aafee46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_019d4579-237c-742b-b5e9-11883aafee46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019d4579-237c-72a0-aa47-c50ab13a993e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_019d4579-237c-72a0-aa47-c50ab13a993e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-237c-7651-8bd6-5844ccfa6659" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_019d4579-237c-7a47-a1de-eef7bfda8af8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_019d4579-237c-7651-8bd6-5844ccfa6659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_019d4579-237c-7506-a526-54b5440cb580" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_019d4579-237c-7506-a526-54b5440cb580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-237c-758b-be26-f6e26ba94923" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-237c-758b-be26-f6e26ba94923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7402-b8de-10fd9fb3b7db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7402-b8de-10fd9fb3b7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7dd5-9750-9511fbd4b895" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_019d4579-237c-7dd5-9750-9511fbd4b895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019d4579-237c-7146-8f90-00b6842b2653" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_019d4579-237c-7146-8f90-00b6842b2653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-237c-7f5d-b964-d02b95a89b88" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_019d4579-237c-7688-ae5f-2e5afd41ac81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_019d4579-237c-7f5d-b964-d02b95a89b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_019d4579-237c-769e-a656-ce95a1b21d5c" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-73d3-9825-0e1000f2d555" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_019d4579-237c-769e-a656-ce95a1b21d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d7dda-6c80-78c9-a0d7-e22a4434171c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d7dda-6c80-78c9-a0d7-e22a4434171c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d7dee-30b5-7d01-9d72-e8c0d3b71781" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_us-gaap_AwardTypeAxis_019d7dee-30b5-7d01-9d72-e8c0d3b71781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d7dee-30b5-7d01-9d72-e8c0d3b71781" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7dee-30b5-7ff5-b0a2-19d7383a79be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_019d7dee-30b5-7ff5-b0a2-19d7383a79be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_019d7dee-5fb9-7afb-8f7f-6bc90605c372" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:to="loc_us-gaap_PerformanceSharesMember_019d7dee-5fb9-7afb-8f7f-6bc90605c372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d7dee-c7fb-7949-b7c3-97386d737333" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d7dee-30b5-7f7d-a79c-f774433f13f9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d7dee-c7fb-7949-b7c3-97386d737333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_us-gaap_PlanNameAxis_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019d7dee-30b5-73a7-a9f2-1bd7a9a476f9" xlink:to="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ServiceBasedMember_019d7dee-30b5-7afc-8f85-7877bd7b2485" xlink:href="aqst-20260331.xsd#aqst_ServiceBasedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_ServiceBasedMember_019d7dee-30b5-7afc-8f85-7877bd7b2485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember_019d7dee-5fb9-7183-ab68-b5828242cd27" xlink:href="aqst-20260331.xsd#aqst_MarketBasedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_MarketBasedMember_019d7dee-5fb9-7183-ab68-b5828242cd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2025MarketBasedMember_019d7dee-5fb9-7c3e-9e74-6b15da20d122" xlink:href="aqst-20260331.xsd#aqst_A2025MarketBasedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_A2025MarketBasedMember_019d7dee-5fb9-7c3e-9e74-6b15da20d122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_A2022InducementEquityIncentivePlanMember_019db30e-9cb0-75fa-9e1f-f48f95f836a9" xlink:href="aqst-20260331.xsd#aqst_A2022InducementEquityIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019d7dee-30b5-70d0-909b-ecf648ec5d96" xlink:to="loc_aqst_A2022InducementEquityIncentivePlanMember_019db30e-9cb0-75fa-9e1f-f48f95f836a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionsAxis_019d7dee-5fb9-7413-9c28-4fa56700e78f" xlink:href="aqst-20260331.xsd#aqst_MarketConditionsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_aqst_MarketConditionsAxis_019d7dee-5fb9-7413-9c28-4fa56700e78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:href="aqst-20260331.xsd#aqst_MarketConditionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_MarketConditionsAxis_019d7dee-5fb9-7413-9c28-4fa56700e78f" xlink:to="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeOneMember_019d7dee-5fb9-7abe-9b44-398b57f42f77" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeOneMember_019d7dee-5fb9-7abe-9b44-398b57f42f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeTwoMember_019d7dee-5fb9-72ff-a1cc-6a768df6fd81" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeTwoMember_019d7dee-5fb9-72ff-a1cc-6a768df6fd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeThreeMember_019d7dee-5fb9-784d-9a4f-a1ff923f4caa" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeThreeMember_019d7dee-5fb9-784d-9a4f-a1ff923f4caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeFourMember_019d7dee-5fb9-775e-ac7d-204ebcb5c390" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeFourMember_019d7dee-5fb9-775e-ac7d-204ebcb5c390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeFiveMember_019d7dee-5fb9-7e6b-a38a-7790053f05a0" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeFiveMember_019d7dee-5fb9-7e6b-a38a-7790053f05a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketConditionRangeSixMember_019d7dee-5fb9-757a-ad22-f8e09537ab31" xlink:href="aqst-20260331.xsd#aqst_MarketConditionRangeSixMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_MarketConditionsDomain_019d7dee-5fb9-75b4-9d80-f2960e1aab97" xlink:to="loc_aqst_MarketConditionRangeSixMember_019d7dee-5fb9-757a-ad22-f8e09537ab31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019d7dee-5fb9-7935-a3ff-93bc055a33ba" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_srt_RangeAxis_019d7dee-5fb9-7935-a3ff-93bc055a33ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019d7dee-5fb9-7935-a3ff-93bc055a33ba" xlink:to="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019d7dee-5fb9-786d-ac16-20289b318b6d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:to="loc_srt_MinimumMember_019d7dee-5fb9-786d-ac16-20289b318b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019d7dee-5fb9-7e9f-8639-3f91e41a162f" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019d7dee-5fb9-7082-a411-c64761648e8c" xlink:to="loc_srt_MaximumMember_019d7dee-5fb9-7e9f-8639-3f91e41a162f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionAxis_019d7dee-a321-7a90-9bf6-e495af895926" xlink:href="aqst-20260331.xsd#aqst_VestingConditionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_aqst_VestingConditionAxis_019d7dee-a321-7a90-9bf6-e495af895926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:href="aqst-20260331.xsd#aqst_VestingConditionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionAxis_019d7dee-a321-7a90-9bf6-e495af895926" xlink:to="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeSevenMember_019d7dee-a321-7029-8d30-07539722352a" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeSevenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeSevenMember_019d7dee-a321-7029-8d30-07539722352a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeEightMember_019d7dee-a321-7f10-9ddd-63abcacf0496" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeEightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeEightMember_019d7dee-a321-7f10-9ddd-63abcacf0496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeNineMember_019d7dee-a321-7fb5-9029-e09f27787330" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeNineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeNineMember_019d7dee-a321-7fb5-9029-e09f27787330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTenMember_019d7dee-a321-7630-8692-22387f594e1f" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeTenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeTenMember_019d7dee-a321-7630-8692-22387f594e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeElevenMember_019d7dee-a321-7ecc-8b2b-61974365dc10" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeElevenMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeElevenMember_019d7dee-a321-7ecc-8b2b-61974365dc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTwelveMember_019d7dee-a321-77e9-acc7-b4b01ecc7663" xlink:href="aqst-20260331.xsd#aqst_VestingConditionRangeTwelveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_019d7dee-a321-751a-826f-21f919e149cd" xlink:to="loc_aqst_VestingConditionRangeTwelveMember_019d7dee-a321-77e9-acc7-b4b01ecc7663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d7dda-6c80-7b47-96d4-7cd47b9dadc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d7dee-30b5-7fb1-ab36-d4056b93a045" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_019d7dee-30b5-7fb1-ab36-d4056b93a045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d7dee-30b5-72cd-b68c-21303f6b93ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019d7dee-30b5-72cd-b68c-21303f6b93ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d7dee-30b5-77c5-baf3-7b559c7aac8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_019d7dee-30b5-77c5-baf3-7b559c7aac8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_019d7dee-5fb9-7e23-a2ef-0022f267572f" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_019d7dee-5fb9-7e23-a2ef-0022f267572f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_019d7dee-5fb9-7ce2-8da7-c5591392316f" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_019d7dee-5fb9-7ce2-8da7-c5591392316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_019d7dee-5fb9-7389-9dd8-d6040219c592" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_019d7dee-5fb9-7389-9dd8-d6040219c592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods_019d7dee-5fb9-7c72-950c-c490de40160c" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods_019d7dee-5fb9-7c72-950c-c490de40160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod_019d7dee-5fb9-7e79-804b-d4e0ce4a33f1" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod_019d7dee-5fb9-7e79-804b-d4e0ce4a33f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d7dee-c7fb-7a67-a23e-bf51f3e0036f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_019d7dee-c7fb-7a67-a23e-bf51f3e0036f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d7dee-c7fb-7dd9-b2f1-1688312537aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d7dee-c7fb-7dd9-b2f1-1688312537aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d7dee-c7fb-7fdf-bfd7-de1840bb869d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_019d7dee-c7fb-7fdf-bfd7-de1840bb869d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019df338-96fe-7964-b5fb-7be1fd183778" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_019df338-96fe-7964-b5fb-7be1fd183778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019db30e-9cb0-73a8-b6e4-ac2258db81f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019db30e-9cb0-73a8-b6e4-ac2258db81f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019db30e-9cb0-703d-8ff2-f5c30461e062" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d7dee-30b5-7b44-b05e-bcc58029d9e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019db30e-9cb0-703d-8ff2-f5c30461e062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-790c-a973-7c689b5edc50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-790c-a973-7c689b5edc50" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-7af1-a087-ad52ac9f19c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-7af1-a087-ad52ac9f19c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7403-81f9-1da070efa08a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7af1-a087-ad52ac9f19c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7403-81f9-1da070efa08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7aed-9747-45dc0404a922" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-7403-81f9-1da070efa08a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7aed-9747-45dc0404a922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7edc-bc4f-9a2fd85ff551" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:to="loc_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7edc-bc4f-9a2fd85ff551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7d3d-89c6-9b1ad40b4412" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_019dda94-3fdb-7edc-bc4f-9a2fd85ff551" xlink:to="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7d3d-89c6-9b1ad40b4412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BlackScholesMertonModelMember_019dda94-6ebf-76a6-b078-8563a4c60528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BlackScholesMertonModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_019dda94-3fdb-7d3d-89c6-9b1ad40b4412" xlink:to="loc_us-gaap_BlackScholesMertonModelMember_019dda94-6ebf-76a6-b078-8563a4c60528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-75ff-9a72-fcdde18e62be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019d7df9-59f1-75fb-9e96-5b005af75eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019d7df9-59f1-75fb-9e96-5b005af75eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019d7df9-59f1-757e-8c79-d5f611cbfe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_019d7df9-59f1-757e-8c79-d5f611cbfe2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019d7df9-59f1-76b2-996d-d5648d890cee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_019d7df9-59f1-76b2-996d-d5648d890cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_019d7df9-59f1-71d2-9dcf-683493e76a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_SharePrice_019d7df9-59f1-71d2-9dcf-683493e76a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019d7df9-93e7-7ea8-9d39-7d1704406611" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-797e-9ffc-ee76c5fb6b8b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019d7df9-93e7-7ea8-9d39-7d1704406611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ShareBasedCompensationScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-798c-a79e-e84d5ba7fd53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7854-8dce-2085b40ee7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019d4579-237c-798c-a79e-e84d5ba7fd53" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7854-8dce-2085b40ee7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019d4579-237c-7a8c-b4c1-780b4943c9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7854-8dce-2085b40ee7e5" xlink:to="loc_us-gaap_AwardTypeAxis_019d4579-237c-7a8c-b4c1-780b4943c9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-75ec-813d-69949731669e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019d4579-237c-7a8c-b4c1-780b4943c9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-75ec-813d-69949731669e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7944-bb4b-92ded79190db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019d4579-237c-75ec-813d-69949731669e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019d4579-237c-7944-bb4b-92ded79190db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019d4579-237c-7854-8dce-2085b40ee7e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-237c-705b-bb6f-fa5975b0b549" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-237c-705b-bb6f-fa5975b0b549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019d4579-237c-7719-83d7-b42b451d8112" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019d4579-237c-7719-83d7-b42b451d8112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d4579-237c-790d-b171-eff66dcff941" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019d4579-237c-790d-b171-eff66dcff941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_019d4579-237c-72d6-a9c6-875e9fd80840" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_019d4579-237c-72d6-a9c6-875e9fd80840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-237c-7544-8137-dd98298d6efc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019d4579-237c-7a32-88e4-acffca02df5f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019d4579-237c-7544-8137-dd98298d6efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019d4579-237c-764e-8b5e-49715a1b2417" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019d4579-237c-764e-8b5e-49715a1b2417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019d4579-237c-7b75-8761-6c5475a2bb77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_019d4579-237c-7b75-8761-6c5475a2bb77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7796-a29d-23ed2fe142d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7796-a29d-23ed2fe142d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d4579-237c-7251-9463-aaa28f492c48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019d4579-237c-7251-9463-aaa28f492c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019d4579-237c-7149-a666-ac11ad028ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019d4579-237c-7149-a666-ac11ad028ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_019d4579-237c-7fbe-be53-a2214fb611a8" xlink:href="aqst-20260331.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_019d4579-237c-7fbe-be53-a2214fb611a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7cf7-b5e7-4db6b606e906" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019d4579-237c-7f54-86f8-14d4d5d9143c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019d4579-237c-7cf7-b5e7-4db6b606e906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019d4579-237c-7d56-a3f9-9de71c653b59" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019d4579-237c-7d56-a3f9-9de71c653b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019d4579-237c-77c4-80b8-3ef16d0fa161" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019d4579-237c-7c9a-a98c-9dfc6b211144" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019d4579-237c-77c4-80b8-3ef16d0fa161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019d4579-237c-72b0-ac25-821d2917dcde" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019d4579-237c-78bb-b3a3-772eb3eec7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019d4579-237c-72b0-ac25-821d2917dcde" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019d4579-237c-78bb-b3a3-772eb3eec7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019d4579-237c-744a-9d18-21ac5aca6e03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019d4579-237c-72b0-ac25-821d2917dcde" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019d4579-237c-744a-9d18-21ac5aca6e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-237c-7879-8d1a-77ac0df8767f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019d4579-237c-72b0-ac25-821d2917dcde" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d4579-237c-7879-8d1a-77ac0df8767f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#ContingenciesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d4579-237c-700b-9131-5718fc99556d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019d4579-237c-700b-9131-5718fc99556d" xlink:to="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_019dac34-999f-7897-9001-9c5b97e31500" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:to="loc_srt_LitigationCaseAxis_019dac34-999f-7897-9001-9c5b97e31500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019dac34-999f-75ac-9494-3923845953b9" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_019dac34-999f-7897-9001-9c5b97e31500" xlink:to="loc_srt_LitigationCaseTypeDomain_019dac34-999f-75ac-9494-3923845953b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SuboxoneProduceLiabilityLitigationMember_019dac34-999f-746e-87e1-7f3eadbe7d09" xlink:href="aqst-20260331.xsd#aqst_SuboxoneProduceLiabilityLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_019dac34-999f-75ac-9494-3923845953b9" xlink:to="loc_aqst_SuboxoneProduceLiabilityLitigationMember_019dac34-999f-746e-87e1-7f3eadbe7d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_019dac34-999f-77f0-b795-9dae018caac1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:to="loc_srt_StatementGeographicalAxis_019dac34-999f-77f0-b795-9dae018caac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_019dac34-999f-7399-ae7f-a07a7b902d03" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_019dac34-999f-77f0-b795-9dae018caac1" xlink:to="loc_srt_SegmentGeographicalDomain_019dac34-999f-7399-ae7f-a07a7b902d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA-BC_019dac34-999f-72cc-a8b9-78923281e606" xlink:href="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd#stpr_CA-BC"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_019dac34-999f-7399-ae7f-a07a7b902d03" xlink:to="loc_stpr_CA-BC_019dac34-999f-72cc-a8b9-78923281e606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_019dac34-999f-76a1-b348-30b77761f807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019d4579-237c-723c-b79d-85bd22fdb8c8" xlink:to="loc_us-gaap_LossContingenciesLineItems_019dac34-999f-76a1-b348-30b77761f807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_019dac34-999f-7bce-94d3-2cea94fd3214" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019dac34-999f-76a1-b348-30b77761f807" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_019dac34-999f-7bce-94d3-2cea94fd3214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="aqst-20260331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_019d4579-237c-7258-a75c-532aa7ccf4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_019d4579-237c-7258-a75c-532aa7ccf4a2" xlink:to="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_019d4579-237c-7a51-82a5-bec0b750e47e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_019d4579-237c-7a51-82a5-bec0b750e47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7fbf-8eea-99a97948a797" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_019d4579-237c-7a51-82a5-bec0b750e47e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7fbf-8eea-99a97948a797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_019d4579-237c-7a92-84f1-7eedf13fbd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_019d4579-237c-7fbf-8eea-99a97948a797" xlink:to="loc_us-gaap_SubsequentEventMember_019d4579-237c-7a92-84f1-7eedf13fbd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e1f1d-1adb-72de-bde7-cc878070e5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e1f1d-1adb-72de-bde7-cc878070e5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e1f1d-1adb-72de-bde7-cc878070e5d7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TermLoanFacilityMember_019e1f1d-700f-73f7-91d6-628acd1fb314" xlink:href="aqst-20260331.xsd#aqst_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:to="loc_aqst_TermLoanFacilityMember_019e1f1d-700f-73f7-91d6-628acd1fb314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019e1f1e-d456-74da-853d-de9374d920d0" xlink:href="aqst-20260331.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e1f1d-1adb-7e14-bb2e-0897e5bc7fb4" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_019e1f1e-d456-74da-853d-de9374d920d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_019e1f1e-2973-7f12-94af-7c0d051d7b95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_019e1f1e-2973-7f12-94af-7c0d051d7b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_019e1f1e-2973-7f12-94af-7c0d051d7b95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_019e1f1e-4b74-76c1-b08c-1a993ad23fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:to="loc_us-gaap_LineOfCreditMember_019e1f1e-4b74-76c1-b08c-1a993ad23fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_019e1f1e-d456-7704-917c-830e738a04f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_019e1f1e-2973-7b98-a969-4a3274df6f09" xlink:to="loc_us-gaap_SeniorNotesMember_019e1f1e-d456-7704-917c-830e738a04f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-7f5b-a764-e302082a9737" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentMilestoneTranchesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-7f5b-a764-e302082a9737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:href="aqst-20260331.xsd#aqst_DebtInstrumentMilestoneTranchesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesAxis_019e21d9-4746-7f5b-a764-e302082a9737" xlink:to="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheTwoMember_019e1f2b-b007-787c-aca5-136cbf2e6277" xlink:href="aqst-20260331.xsd#aqst_TrancheTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:to="loc_aqst_TrancheTwoMember_019e1f2b-b007-787c-aca5-136cbf2e6277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheThreeMember_019e1f2b-eda7-7d68-9bd1-97edda0821b6" xlink:href="aqst-20260331.xsd#aqst_TrancheThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:to="loc_aqst_TrancheThreeMember_019e1f2b-eda7-7d68-9bd1-97edda0821b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TrancheFourMember_019e1f2c-379c-71f8-8c15-49ba81c90f17" xlink:href="aqst-20260331.xsd#aqst_TrancheFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtInstrumentMilestoneTranchesDomain_019e21d9-4746-7505-b913-131917a5c89a" xlink:to="loc_aqst_TrancheFourMember_019e1f2c-379c-71f8-8c15-49ba81c90f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_019d4579-237c-7648-a66f-5dd5673e86a9" xlink:to="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019e19bb-9e82-7282-a749-174c1fea1b09" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_019e19bb-9e82-7282-a749-174c1fea1b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod_019e19bb-9e82-7c26-a571-6f137ab984aa" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseInitialRentAbatementPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod_019e19bb-9e82-7c26-a571-6f137ab984aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseNumberOfRenewalOptions_019e19bb-9e82-77dd-bd1c-d46ae6b81185" xlink:href="aqst-20260331.xsd#aqst_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_aqst_LesseeOperatingLeaseNumberOfRenewalOptions_019e19bb-9e82-77dd-bd1c-d46ae6b81185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019e19bb-9e82-78f6-a694-904fe11c7cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_019e19bb-9e82-78f6-a694-904fe11c7cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_019e1f1c-cb8c-785d-abde-177194e8cd35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_DebtInstrumentTerm_019e1f1c-cb8c-785d-abde-177194e8cd35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f1d-1adb-7481-bb66-fc4795e47c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e1f1d-1adb-7481-bb66-fc4795e47c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019e1f1e-3cae-704d-9b7e-8b9965403dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_019e1f1e-3cae-704d-9b7e-8b9965403dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_019e1f1e-5041-7a4e-a231-4661987558ba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_019e1f1e-5041-7a4e-a231-4661987558ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_019e1f2c-8f95-7705-a1d8-4af53d83b2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_us-gaap_RepaymentsOfDebt_019e1f2c-8f95-7705-a1d8-4af53d83b2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit_019e1f2b-5924-7dad-9a88-361a83f0876e" xlink:href="aqst-20260331.xsd#aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_019d4579-237c-75f8-b881-c0ac7121d138" xlink:to="loc_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit_019e1f2b-5924-7dad-9a88-361a83f0876e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ljb_employmentxageementx001.jpg
<TEXT>
begin 644 ljb_employmentxageementx001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57OK*VU*PGL;R(36UQ
M&8Y8VZ,I&"*L44 <7_PJ7P)_T+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=
MI10!Q?\ PJ7P)_T+=K_WT_\ \51_PJ7P)_T+=K_WT_\ \57:44 <7_PJ7P)_
MT+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=I10!Q?\ PJ7P)_T+=K_WT_\
M\51_PJ7P)_T+=K_WT_\ \57:44 <7_PJ7P)_T+=K_P!]/_\ %4?\*E\"?]"W
M:_\ ?3__ !5=I10!Q?\ PJ7P)_T+=K_WT_\ \51_PJ7P)_T+=K_WT_\ \57:
M44 <7_PJ7P)_T+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=I10!Q?\ PJ7P
M)_T+=K_WT_\ \51_PJ7P)_T+=K_WT_\ \57:44 <7_PJ7P)_T+=K_P!]/_\
M%4?\*E\"?]"W:_\ ?3__ !5=I10!Q?\ PJ7P)_T+=K_WT_\ \51_PJ7P)_T+
M=K_WT_\ \57:44 <7_PJ7P)_T+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=
MI10!Q?\ PJ7P)_T+=K_WT_\ \51_PJ7P)_T+=K_WT_\ \57:44 <7_PJ7P)_
MT+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=I10!Q?\ PJ7P)_T+=K_WT_\
M\51_PJ7P)_T+=K_WT_\ \57:44 <7_PJ7P)_T+=K_P!]/_\ %4?\*E\"?]"W
M:_\ ?3__ !5=I10!Q?\ PJ7P)_T+=K_WT_\ \51_PJ7P)_T+=K_WT_\ \57:
M44 <7_PJ7P)_T+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=I10!Q?\ PJ7P
M)_T+=K_WT_\ \51_PJ7P)_T+=K_WT_\ \57:44 <7_PJ7P)_T+=K_P!]/_\
M%4?\*E\"?]"W:_\ ?3__ !5=I10!Q?\ PJ7P)_T+=K_WT_\ \51_PJ7P)_T+
M=K_WT_\ \57:44 <7_PJ7P)_T+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=
MI10!Q?\ PJ7P)_T+=K_WT_\ \51_PJ7P)_T+=K_WT_\ \57:44 <7_PJ7P)_
MT+=K_P!]/_\ %4?\*E\"?]"W:_\ ?3__ !5=I10!Q?\ PJ7P)_T+=K_WT_\
M\51_PJ7P)_T+=K_WT_\ \57:44 ( %4*!@ 8%+110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@CM6E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/J:V<8O;A!'--SND4<!6]1[55T?PGX?T">XFTG2+2SDN.)6BC +#KCV'L.*
M,/3M/TVZM=)U:TUB[87=@R&,7#,+TE V]N<[EP>1C&<>U<YIFHW,GA7X97+W
M]PUS<W<<<SF=MTR^5(6#<_-R%ZYYQ7H&D>%=!T"YGN-)TFULYI_]8\,8!(SG
M ]!GL.*AA\%>&8"ACT2R&R?[0@\L$+)SR >!]X\=!F@#BM)L8+;0/B/+;R7$
M$\>H7OEO'<R*RX@C8$$-USSGK^%6+^2?3?"_@SQ8;FY,-C%;#44\Y]DD$D84
MR,N<,49@V3[UV[^&]&DFOYFTVW\V_79=N%P9EP 0Q'4$  ^N.:G&D6 T<Z1]
MEC.GF(P?9VY7RR,;<'MCC% '$:WJ,MCIVFWQNVM;;7=819I97<I% 4?RA]X;
M VR/=@CEVKH/#.DS:/J>K0OK"W<,S13162QL%L\@@[2SL<,5SC@#!QUK:O\
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MT^M>R6=G;Z?:1VMK'Y<$:A40$D*!P ,] /2LR7PCX?FBNXGTFU,=Y+YURH3
ME?.<MCKSS]>>M &!96OV#XG7VE0W5Z;.[T9;F5)+J1SYOG,F]26RI(X^7'05
MA:))KE[\./"MU9[=5N$66:YL+FY*/>H"RY#GJRE@<-Q^(%>B_P!@Z;]O-_\
M9O\ 3##]G,_F-O\ +_NYSG'?'KSUJ"/PMHL%K:VT%BL,5HS-;B)V0PEOO;""
M"N?;U/K0!#X,O[74O"]K<V@NUC+RH8[PDRQLLC!D8DDDJ01G/:LQ?^2S2?\
M8O)_Z4-75VEI;V-LEM:PI#"GW408 YR?Q)R:K#1M/&KG5A;#[>4\HS[CNV9S
MMZ_=SSCIF@#SVSTVZO=;^(5XVJ7=AJ<,Z+"\3A1'$D(:)B".5.6R#P>>_-=3
MH%I#XF\,:7J^LV*?VA>6$!N,97./G' /]XDCTR:V+S1--O[@W%S:1R2M'Y3M
MR/,3.=C@??7)/#9')K0  & , 4 5[6RM[+SOL\>SSI#+)R3N<]3S]!5BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "H;JZM[*V>YNIDA@C&6DD; 'XU-7&_$07D5GHFH0V\US:6
M&K0W-[% A=_)4-\P4<MM8JV!Z9[4 &E>*&N_'.NVDFH1-I=E8PW #QB/R&)?
M=O)Y'"@\XX.:W$\3:+)#<RC4852UC$L^\E3'&>CD'G:<'YNG%>?:KJ*W.O\
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M;P+9O!9O.C!4*/ 0BG!)8D C!W&I;*.*V^)UG(; V=M!X<$*KY?R0,)0?+#
M;<A>P/2@#N+.\MM0LX;RSGCGMIE#QRQMN5E/0@TS43>BQD_LY8C=G"QF;[BD
MD#<0,$@#)P",XQQFN%\":Y:Z!X'\/6.H0W<,UU<RVR*;9\1L9FVA^/D!W+C/
MJ*[;6-5AT72I[^>*>5(ESY=O$TDCGL%4<DT <QIFL:[I/BVZT77[RUO[3^SF
MU&.]AM_),85PK(ZY([Y!SV/X5;?QCJ*:!HGBB[*#3]4NXXGM-@'V>&5BL3AN
MI8?(6SP<G &.9-(U/3_$4M_;>3J)U+4[9HYYI+":&."(*0J*TBKD L?<EB<
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M_@: /5;[7])TV<0WM_# Y*J=[8"EN%#'HN>V<9I\^MZ;:W8MIKN-)3(D6#G
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MT:)7*K-G^%0H&1@'D^_6@#TJQ\4Z#J>I-IMEJUI/>JGF&".4%MOKC^?I4O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV^DE?WDD);<&\]MH& 2>?8T >QT56TX6XTRT%F^^U$*>2V2<I@;3D\GC%6:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** &"*-96E6-!(X"LX'+ 9P"?;)_,T)%'$7,<:H7;<Y48W'&,GU. /RI]%
M%%=$TI+O[6NF62W.=WG"W4/GUW8SFEN]'TS4)!)>Z=:7,BC ::!7(_$BKM%
M%:XTZQN[=;>YL[>:!,;8Y(E95QTP",5*UO"UL;9H8S 4V&(J-I7&,8Z8QVJ2
MB@"E=Z-I=_*)+S3;.YD P&F@5R!]2*9!H.CVS.UOI5C$SH48QVZ*64]0<#D'
MTK0HH H)HFDQ78NX]+LDN0<B9;= X/3.[&:6ZT72KYR]WIEG<,QW%IH%<DX
MSR/0 ?0"KU% %.?2--NK>*WN-/M)H8AB..2%65![ C J&'P]HEO,DT.CZ?'+
M&0R.EL@93Z@@<5I44 5+S2]/U$J;ZPM;K;]WSX5?'TR*<VGV3V8LWL[=K4#
M@,0*8_W<8JS10!GKH6CI;-;+I5BL#D,T0MT"L1W(QBG?V+I7V%['^S++[)(<
MO!]G7RV.<\KC!YJ]10 BJ%4*H  & !VI:** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV\5WXG\265];VT=_I6PP1Q[B+A9%S&PR?XF^3'8CK1J7BG48KB^L+"VCGO\
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MNC,H20QG.!O4#J.#D\YQ5V.#5+/Q/9VMG+$-!BLO+:U^SD&)EX4B3//&!M]
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M:_O[A+>U@7=)(YX _P >V.]6J\_^+&]=-\.3/G^SXM?LWOO[HBW'EO;)7]*
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M*/#2RD9.!]YN@]S7F^DZKJ7]O^$@FI7ES;:K'=">ZD.U+O;'O62.(D^6 >G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ1RLKR*@#LJ[03CD@=A[5A>+[76;JTL!I""9$O$>]MO.\EIX,'*A^W.TD<9
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M;7$H,=Q#,7!0L,[6VOU/ (KN=";4Y;>2XU/3[?3G? 2TAE$I0#NS@ $G/0<
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MR*H W!R!@'&!SR<6-?T[Q)XJ\$ZE;7%A;6%Y*(FM[/[2)/FCD60[I  !NV@
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M,LOU#*N/3<34'B+2M;M?%EIXAT2PM=3C-G]BNK&:41':'+HZ,01D$L"#V_0
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M'. 1_#G@\\X%7=2\3Z_83>*;#?8G4+"&*ZTQ3;.1<QOE0I ?)8R#9QCDCUH
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MQ!!8$J?G;IU]CS73 Y ."/8TM ')0>#+BWT6/21K+3V8T]-/DCN;975D7(#
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M1K/'.66,,28W#J.3TRHS_2JNK>*+VPU*2TLO#.J:FL2J9)[<Q*BL1G;EW7)
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<5\6_^25>(/^N
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MJB%_LQ?*X;^]SCI[5V>@V6J2W<FL:];6=OJ#PK;I#:R&18XP2Q^<@$EB1D=
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M:16MK'G;%$N ,]3]?>@""?P[HMR+X3Z392?;]OVO= I\_;]W?Q\V.V>E<O\
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M=ODY^7CCCMQ0!YZM^_VSPSJEA>7$L%YK\L#7LTY#W,9\[*&,<"-2H"YY^4'
MS3]+LH;7PQ\1YK>2X@GBO[[RWBN9%9=L*,""&ZYYSUKMQX*\,ABW]AV.3<?:
M>8A_K.?F]NI]N:LOX:T626_E;3;?S-07;=L%P9A@ AL=00!GUQS0!QVFW\M_
MKGA/1;^20V$_A\78!<@7,X$8PQ_BVJ6;'OGL*Q;Z?4H]+O[#^T+X6^G^*K:T
MM+A;AM_DN\9:-CGYPN\CYL_I7IDOAW29K*TM'LD\FS(-K@D-!@8&Q@<KQQP>
MG%+/X=TBYL8;*6PB:VAD\Y(^0!)G._W;/.>N>: .=\.1'3?B)XBTN">Y>R%I
M:W*QSSO+MD8R!B"Y)&=HS]*C\>_\C)X'_P"PS_[2>NK@T;3[?4Y=2BM@M[*@
M22?<2SJ.@))Y [5'J?A_2M8F@EU&RCN7@.Z$R$GRSZKSP?<4 <=\5<7\?AS1
M;0[]6N-7@GMT7[T:1DEY?95'4^]9>LW[^=_:>G7EQ+L\3PVK7<LY1A^]6-X$
M0<&,#(.<9.3@]:](L=%TS39Y)[.Q@AGD&'F5!O<>A;J1^-4I_!GANYFNI9M$
MLI'NI!+,S1 [W!!W?7(!/KCF@#A)I&T._P#B=JNG!Q>6PBDA(=FP3;*Q;:3@
MXY//I70Z/I2G6-.U6V\0Q36%[:/&UI&CNMX",B0EI&PP[MCG.">E=,FA:5'J
M4NHII]LMY+&(I)A&-S(!@ _AQ].*KZ-X4T#P]///I&DVME+/_K'AC )&<X]A
M[#B@#36UMT>-D@C5HD\N,A0-B\<#T' X]A7!Z7!'=^+OB+IES/)!ISM:LSQR
MF,QL]N!(0W8X53FN_D+K&Q10S@?*I.,GZ]JP(_"ULVC:G:7<4%W-JDK37AE4
ME'8X &.NU550!D?=Z@G- &[!&D-M%&C,R(@569MQ( ZDGK]:\KL[]SJ7A'4;
M&\N);6_U.YC:\GG(DO(RLI^:,?*$!4;><C X6O3=,L(M*TFSTZ$LT5K"D*%N
MI"J ,_E68G@KPS$5*:'8@K/]H7]T/EDYY'IU/'3F@#S>]CGA\'>*=774=2-[
MIGB"1;-VO9"(U$\:[<;L,-I(^;/%=1YR^(?$_C'3]0DE TR**.UA65DV(\6\
MRC!'S%B1N[!0/7/2MX3T)[*YLFTV)K6ZE\^>$DE99,YW,,\G.#D^@]*=>^%M
M#U&\BN[S38)[F*/REE<$L4_NL?XA['- &;\-O^2:^'/^O"+_ -!KJ:JZ=IMC
MI%C'8Z=:Q6MK$,)%$H515J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=IW-[=A574/&'V5WMH+6W-_%9I=36]U=>3MWYVQ@[3EOE;L ./6@#J:*X?\
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MRJ,H7.YL8&.I]^*M77B9]/L]-%_:P6NHWY.RVENL)'M7<VZ3;V&!P#R0.G-
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M9?#>O7-IX468Z;YNCW*33!)7"L%B:/"DKR3N)YQZ>]=K2*RL,J01DC@]QUH
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M8QWK.M?!VJR>&M+\,:G-:2Z=IT\+"YC=O,GBA8-&A0KA3\J@G<> <=>.[HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2V?[Y'.1C/&<$5](\1ZY<Z:EEJ&IQ)>6>M3:;<3PPCSKU8T+*8DVE0QRN[C
M 8Y%3MH<]M\1-&AMI=4BL[+19+1;U(0PW;TVHS%"A^53V[#O6W-X'TR2.P\J
M>\MKFRN9+J.[AE E>23/F%B00=V3GCZ8H Y,>*?$3^'[61+[RKJ/Q0-)D>:"
M-FDB\_9APORYQP2N,]B.M:]K/XCGU7Q9X?AUMY+JT@MY["[E@B#(TBO\C +M
M*[D';.#UJ\OP]TM(6BCO-25#J0U0 SA\3AMP/S \;N>>3W)JU=6$7AV\U7Q-
M%%JFHW5S'$DUK;JCLZH<+L7 Z;F/7IGKQ0!G^'/$-UXDAT+R+J6.5('EU5"B
M;@ZGR_*;Y?E)D#D8QQ&?45;\7:GJ&F7WAO['<^5%>:M':W">6K;T978\GI]T
M=*L>%M(CLAJ6IFQ^QW.K71NI86QN08"J&P2,X&X@'AG:K6M:!;ZY+I\EQ<7$
M1L+E;J$0E0/,4$ G*G/#'CWH X'4M=\31:'XSU*+7"C:%?N+>,6L>)$6.-]C
MY!.WYCTP>>O:O0=9O)K?PU>WEM<6MK.ELTD<UV2(HVVY!<CL*RYO ^GSZ=K=
MC)>7Q@UF4S78W)DL0%.T[.!A5'X5J:GH5IK'AV?1+]I9K6>'R7;<%<CL<@ 9
MX!Z4 <//XSU+0K[6_.>ZO;6TT%=2A%Y"D3M('93@*%(0X'# $8/:MN]N]9T'
M3I=?EU:/4-/ATR6XGMI(U4O*J;U,151A2 P()/&/<U9C\"Z;_:!O;NZU"^FD
ML383_:I]RSQ$DX<  =STP.<XSS2Z+X'T[1K=K8W>H7]J(F@BM[ZX\V.&,C!1
M!@<8XR<G'&<$T 54N]9L=.M/$,VK1W>G_P!G27-Y:M$J[F\OS%\@J,@<,,,6
MXQWYK,E\1:U8^&_#/B9KXW,>I36JW=EY2"-4N,8\L@;@4+#&2<C.:W="\$:=
MH $<5WJ-U:QJR6]K>7'FQ6ZD8(1<>A(YR0"0.II^G^"]/T^*TM4N+N6PLIO/
MM+*9U:.!AG;@[=Q"Y. S$#CT& #FX-;UZ(^*M5NM99K'P_>S'[(EK&/M$2P*
M^PMC(Y;@CGKG/&(=2&H7-U\/=2O-2>X:ZU!)9(1&BQJSV\C#9@;L#)').>.]
M=E8>%[*Q;5P99[F/5I&ENHIRI1F90IP HP"H Q[5EVWP\T^VCTR'^T]7DM]+
MN!/90R7 VPX4J%!"ABN&QR21T!QF@#)N?$FL6NJ:9(FH_:HKG7C83+#$GV58
MF+A4#%0YD7:,D$@,&!]*H:EKWB:+0_&>I1:X4;0K]Q;QBUCQ(BQQML?()V_,
M>F#SU[5TH^'.DK#% M[JBV\%_P#;[>%;G"P2;BQ"\="6/7)&3@BK$O@;3Y].
MUJPDO+XP:S*9;L;TR6("G:=O'"J/PH KMJ>HZ_KNN:3IVH-ISZ=:P&-D1'+R
MRHS!FW*?D&%&!C/S<]*JOJNO:CJ=UH<-R8[ZQT^"2::Q$6UYY-X)Q*#\@*=
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M-X?U&6W3-K%_I:(R'$OR_P!U\?)MZ9YK:\3^)KS1]<EAO[J[TO398XA9:A'
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M&6!R5R!QTJQ?R?\ "-P^/;;2D^RZ=:7]A))#;I\L,+K&9RJCIE=V<8[T >P
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MZX!/09S0!=HJ@NN:2[!5U2R9B< "X0DG\Z?/JVFVTIBGU"TBD7JDDRJ1^!-
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M;1K=_P!C+;LZJ!O1D1B&]>5&/J?6CX@>$IO&WAA]$COX[)))$=Y6A,A^4Y
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M7D<'\$+G82%'0 ^8>/85U^D>";CPIK&J77AR[MTLM2?SI+&YC)6*7GYHV4C
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MC#,ARK8/4>WH:S;WPCJ.O^'KBRU_6$DO7,;P36=OY26[QMN5PI8[FR!G)Y'
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MTW4V PEM,KVR,,I(SE=C*>-V.F>"V*H/X]UV/P]-KKZ58_9+34VL;F)9V,C
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M*2XB6)&"A@$^9MV]<<CJ>>@.8GC^ZB73X-8M8M"N+EYXO/OXW$#O&5"A2=I
M<,6!;&-I&":%^'=SIEEI#Z!JZV6I:8TX1W@WP/%,^]H2F[(0'&WG(Q6O/X>U
M2ZMA#?7UEJ44T3K>6]W:GRI&.-I10QV!0,8YSG.<\T ;UC+<2Z9;3742I=/"
MKRQQMN57*@D ]QG(S7)6'C+4)-?TC3+RUM$GU**=FMXY"7LY(U#".1@2&)!Y
MP 0>QK?T;0ET;PK:Z''=S.+>V%N+C.'Z8R/3';TXKF=,\":O82>&G?6[1_[#
M66*,)8E?-C=-I+?.?GXR3TZ\&@""V\>:W)I&GZQ/IEBEC+JG]G3HD[-(,SF$
M,O & 0,YZ\]*L>)M:NM;\-^,(=.BM3::;!/:S&<$F:01;G"X^[M# 9(.3GH!
MDJO@*_7PK!HO]K6V8M3_ +1\[[*W/[\S;-N_U.,YZ4^X\$ZG%-XABTS5K:'3
M]=5WN()[8NT4SIL9XV##AN,@@XQ0!O>&O-_X0C1_)*"7^SH-A<$KGRUQG':O
M.9M0U/5_ACX>U34FAN;J77+61"H*G/VH\9.<#L,=!7J.B6$NE:%8:=-.L[VL
M"0F58]@?:  =N3CIZUR,7@#48?"UAH0UFW,-AJ$=W YM#G:DID"M\_)).">.
M!T[T 6/^$UN],G\1P:W:6XDTF&&XC^R.S"59=P5?F&0VY<9QWSBK^E:]JT_B
M/^SKO37:SDM_.2]CM9HDC<'!B;S!R<<AAC..@JIJ/@8ZOJ7B":^O4-MK%G%:
MF.*(J\)C+%7#%CDY;/3L*T/#VE>(;,K_ &[KL6HB%-D7DVWD[_\ ;D^8[FQV
M&!R>IQ@ BUK7]3LO%FEZ)96=K(-0MYY5FFE8;6CVYR .GSCUS[=:P'\>:[!X
M<O=8FTS3Q'I-^UE?JLSYD*RA"T7' PP/S>X]STVHZ!<WOB_2-;CNXDCT^&>+
MR&B),GF[<G=N&,;!V/>L.X\!7UQX5U[13JMNIU;4'O?.%JW[K<X<KMW\\J!G
M(H UAX@O&\3:WHXB@'V&RBNH93GYMY<;6&>VSJ/6N>C\4ZWK-YX#N+4VUM!J
M\4UQ-"0S?,L)."<C*C=T]0#VK<N_#.IOXFGU>RU.W@%[8I:7D;VY<_(6(:,[
M@ ?G(Y!'3K5&R\"W]AI_A2*'6(/M6@!XQ*UH2LL;IL(V[^& Z'./;M0 77C6
M_MO#WBS4/LMLTV@7+Q!<L%G58T?/^R?G]^E6/$GBO4=&M[RZCMK2.WMK#[7&
M;A\F[?#%HD"G(P%&6(/WAQ@9JIJO@34;V+Q/96NKP0:?KI\UU>U+RQR%%0X;
M<!M.T'IGJ,CK3[[P1JEW<ZJPUN 1:II:V$^ZS+-'M5ES&=_RJ=^2#GGOZ #+
MFY2^^(W@R_2/9]ITN\EP>H!$) )]LUTFMZT=-N=,L8$5[W4K@P0!SA5VHSN[
M>H"J>.YP..HR;3PG?P:MX<OIM3MY#I%G):LJVQ7S=X0$@[SMQL'KWJYXL\-2
M^((+&:ROC8:GIUP+FTN?+WJK8*E67(RK D'F@"I<>)M5TM%MM3TZ%;VYU);"
MPD23$5P&&[S2,ED  ;*GG*X!YX1O$FK1:SJ?A]K6UEU>"Q%_9,NY8KJ/)4J1
MDE&##'4]0?:DU#PCJ&LZ7;MJ.KH=9M;N.\MKF&W*PPNF<*(RQ)4@L#ELG/48
M &G8:'*GB";7M0EBDOWM5M$6%"J1QABQQDDDECDGV QU) *6C>)YM;TKP_>6
MP@W:A$TURI!_<H@^<#GJKE4Y]<]L50M/&NI7YTB^L=)ENM-U&8(52UF#P1MG
M9,TA785Z;@.F>"V*U_#_ (5M] O]7N(I6DCO[@S1Q,/E@5OF95]BY=OQ [5F
M>'O".M>'RFFQ>(%D\/V\F^VMS;8G1<[A$9=W* ^V2..!0!G-X]UQ-(NM7DTN
MP6SL=6;3[E!.[.RB81;D^4#@D'GKSP.]_P 5>,K_ ,-KJ5T]K:K;61B,44KY
MEO$;;O9,'Y N['(.2#TJ&7P%?R^%M4T8ZK;@W^IMJ!F^RM\F9A*4V[^>1C.>
ME-UGP#J>JIXC@76X([?6A&[;[0O)$Z*H"AM_^KRN<8R,GGO0!=O?$FO-XFU;
M1=.L-/+6=E%=QS3S/A@Q<8("]?DZ?CGM67_PE6K:SJ/@2XL#!;6NKPS7$L$@
M9CN6$G:2",J-W'N :W(/#6I1>(]0UA]1MI)+RPCM"GV9E"E"QW??Z9<\>F.>
M]9]EX$OK"P\*Q0:O"+G0!)&)6M25FC=-A^7?PV,8.2,]NU %O3O%TFJ>(KC3
M()+-)K6\>WN+&7*W"Q+G$RY.&5L*1@8 ;KGBH/B</^*>TYUC#R)K%B4!XY\]
M>,]JGNO"$^I:O87NH7%K(]A?M=V]S' 5N!'N8K"6S]WY@">X'0'FK_BO0+CQ
M%I]K:P7<=L8;R&Z+/$9-WEN'"X##&2.M &0?&MWI=SXB@UNTMP^E6\-U&;1V
M82I)N"I\P^]N7&>AST%+)XJURVNKR-](^T0)8/=17(@FMXTD3DQ.74YR.0PZ
MXQ@5)J/@<ZQJFNSW]ZAM=7L8[-HHHBKQ;"Q5PQ8Y.6ST["GV?A[Q*VDW-EJ_
MB*"\8VSV\#I9F/.X;?,E&_YVQV&!U/)Q@ I67C+6&TG2M0O["SC364MQ8I T
MDKAWC:1RZA<X"J2 N3T!(ZBOK'B_5;7PMXBN+_P_%.-.:/8]S#)%!>1OCYE1
MU)RIX*GVYYK0NO!-S<>#-&TB/5OL^I:-Y+V=_%#P'C78"R$G(*D@C/>EU7PI
MK6O>$=0TK4];MVO;Y41IHK4K%$BMG"Q[\DGN2WIQP* )]0\0:T/&;^'=.LK$
MDZ=]LCN)YFP#Y@3#*%_0=?4=*O\ A'77\2^%K'5I8!!+.&$D2MN"NKE&P?3*
MG%0?V!??\)FOB$WMOQIWV'R/(;KOW[]V[U'3'3O4OA#09O#/AN#29KJ.Z,+R
M,)4B,>0[L_0D]"Q'6@#.T?Q<^LZW+9PR62O;7<T%W9292Y@1-X63D_,&(0\#
M #]3BJUKXUU&_.DWUCI4MUINH3B,JEK,'@C;.V8N1L9>A('3/!.*M/X0GO=9
MTS4-1N+66?3KEYHKJ* I.\9# 0LV3\H##/KM' J'P]X0UGP^Z:=%X@5_#T$I
MDM[8VV)T7=N$7F[L% ?]G)''% $O@34=7U-=;DU.>"7R=5N;9/+5EV^6P0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%8'BRZ:WL[&-;^6U:>]BB\N!<RW(Y)B0Y&TD#[V1@
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MG2D_8)>=QFB!R5.5.<' ],YH ]!K/U/5X-,:UB='EN;N4Q6\$>-TC!2QZD
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MM9&FN[?[-<A+B1$F3! #JK ,1DX)&1^527GBG2K+Q)::#/=1)>W$32A6< *
M5 !SW);@=>#5N36]+BOELI-1M4NF<1B)I5#%R,A<?WL<XZT 4HO"&BP3Z;-'
M;2K+IL1AMW%Q)GRR0=K?-\XRH.&SR*1/!^AKI^I6#6;2VNI2M/=QS3/())#C
M+?,3M/ Z8Z#TI_BZ_O-*\'ZOJ5A)$EU:6DLZ&6/>N44MC&1Z?_KI-"\2:;JL
M<-HFJ6<^IK;I)<6\<RF1"5&<J#D<F@"6#PYI\*S9^T2RS0_9VFFN'>3R_P"Z
M')R!].O4U7C\&Z)%;:5;QP3K%I3[[)?M4O[HX(_O<\$CG/!J^NMZ6^HC3UU&
MU-X2P$ E&\E?O #N1W':LGQSJ^H:'X>6^TZ2))!=V\3^9'ORKRJAQSP<-UYH
M Z6L;7]&.IFPN[<JM_IUP+FV9N 3@JR$]@RLPSV.#@XQ5O4-:TS2MO\ :&H6
MUKN&1YTH3C.,\]L\9IUYJVG:>%-Y>V\ 9"X\R0#Y1U;Z#(R>@S0!5ET#3K[5
MH-:GMIH]02#R-RSLIV9W;6"MM;!)(SG!Y%4T\$:#'I=IIJ6]P+2TN?M<$?VN
M7Y)=VX-G=G[Q)P>,FM)M>TA;9+G^T[0PNY1'696#,!D@8/)QS@=JQ/$WB*>U
MMO#UYHUY:RVE_JMM;22*HD$D4C8.Q@<#IUP?PH L'P+X>.O2:R+)UNY7$DJI
M.ZQ2N.C/&#M8]\D=>>M='7*V_B&X@\;Z[8:E=VL6F65E;W,;LHC$>\R!M[$\
M_='/ K=&L:8UI;W8U&T-M<,$@F$R[)6/0*<X)/M0!%J^A:?KJVJW\<KBUG6X
MA\N9X]LB_=;Y2,D>]5-=\'Z+XBN+6YU"WE^U6H*Q7$$[PRJIZKN0@D'TJOXZ
MU?4-"\-_VAITL22)=6\;^9'ORKRHAQSP?FZ\UJZ=KFDZQ)/'INIVEX]NVV9;
M>97,9]#@\=Z ,_4_!.@ZK'8+/9O$U@NVVEMIWADC4\%0Z$'![\T:IX)T#6+2
MQMKFR*"P_P"/62"5XI(<]=KJ0W/?GGZUHV^N:5=W1MK?4;66<*7\M)5+%0<$
M@9Y /!/:FG7]&%F;PZM8_9A+Y)F^T)L\S.-N[.-V>,=: *S^$]&DCTU/L\BK
MILGFVH2>1=C\Y8X;YB<G);.<GUKG="\+O<ZKXI;6+&\AMM1O_-1#<8CN(?+1
M<,J,>ZMD$#(.#D<5T]YXFT'3VN%O-9L+=K<J)A)<*IC+9VALG@G!_(U:N-3L
M;6UCN9KR".&7 B=G&'R,C;Z\<\4 5KCP]IESK-KJSP,+VUB\F-TE9!LR&VLH
M(# $ @$'!K4KEO ^O77B"RU:>YN;>Y6WU2>V@EMUVHT2[=I')SUZY-6O&VI7
MVC>"]6U/3I(DNK2V>9#+'O'RC/3(_P ]J +.H^&M+U75+;4KJ&3[7;HT2213
MO'N1B"4;:1N4D X.15*R\"^']/&FBUM9HQIKO): 74N(BX(;C=SD$C!XQ5[2
MM>T[4G^R0ZC:SW\42O<01RJ7CR!U4'(YJ5-=TF2]:R34K0W*AF,0F7=A?O'&
M>W?T[T 9\G@G0)[+4K.:S>6#4IO/NEDGD;=)Q\X);Y6X'*XZ"I-.\)Z5IFJK
MJD(NY+X6XMO/GO)96:,$G!W,<\GO5BV\2Z%>3"&VUBPFD,;RA8[A&)1259N#
MT!!!/L:RO$?BB*/PCKM_H.I64M[IUJ\Y&1+MPI894$8SC@]/K0!U-8][X9TW
M4)[J2X6=A>*J7,0G<1S*!@!DSCIP?4<'(IFD^)M)U",6ZZM92W\-NLMU"DZ[
MX_E!)90> ,_A5N/7M'FTTZE%JMB]@#M-RMPAB!SC&[..M &?J'@K0]3O;VZN
M;>7?>P>1<I'<2)',H4J"R A20#@$C(X]!4C>$='9]+?R;@-I2E;(B[E'E KM
M/\7/''.>.*V9)HH8&GEE1(44NTC, JJ.22>PJK8ZOIVI&5;*^M[AH<>8L<@)
M3(R"1V!'3UH K6_AO3;74[_4H%N$N[\*+F07,GS[00O&[ P#QC%49/ ?AV7P
M[;:$UD_V"UD\VV'VB3? ^<@H^[<IY/0]ZT8_$>B2S)$FK6)D< HOGKEP> 5Y
MY'N*2W\2:'=W*6UMK%A-.ZNRQQW"L653AB #T!!S]#Z4 5I?!VBS:1#I<EO,
MUM%,MP/])DWM*I!#L^[<QR!R2>@]*BU7P/H&LZK'J=W:R_;%C$32PW$D1E0?
MPOM8;Q]<UJ66M:9J4LL=EJ%M<20@-(L4H8J#T) ['L>E%EK6EZC<26]EJ%M<
M31J'>.*4,P4]&P.WOTH KCPUIBZK-J:12QW<UN+5G2XD4>4,X4*#@ 9.,#O6
M?-X \.3:-8Z4;.5+?3V+V;)<R++ 3UV2;MP'MG%;E[J5EIR(U[=0P!R0GF.
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MM&\@[0/($N&&[).3C.?P[4 =)=^'=-O=5L=3FCE^UV*LMLR3N@C###84$#D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD].]=%\1^?ASX@09+R64B(HY+,5P !W)KH+NSBO8UCGW&(.'* X#D'(!]1D
MX[]^*L4 >:W01O&'AU=,>.*1M NH$>/A5<B,Q@D=.02![&JGA&XT/4[;0+.]
MM]477M%51):SB1%M'5-KN6QMV$ XY.<@5ZK10!X_I]@\WP<OFTRQ\W48;Z:5
MXHDQ,\7VO>RCC/S1*,#N,5;U Z)XG\/^(M4T"+5+[49-#GM'EE24$ C*P[6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3J[LP QSQDX-<[%X\OT\+Q:E>Q,D,6JSV-]>06K-Y,49<"4Q\E<E4!ZXR>*
M/1:*R_#U\VIZ)!>->VMZ)2Y2XM.(Y$WG:0,G!VXR,\'-:E !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%8OB;Q!_PCEE;71LWN5FNX;8[7"[/,<(&.>O)[4 ;5%%% !11534[B[M
M=.GGL;$WUTBYCMA*(_,.>FYN!^- %NB@=.>** "L?Q1H(\3^'[G1WNFMHKD
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MHTUMX,.@V<.IZ)<LAE-TZ(YB8L#M4DG=M7"#(^ZM=RH(4 DD@=3WI:* .?\
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MSS7HFG>#?#FD?:_[.T>UM?M:E9S"FTLIZKQT'L.*E'A?1%@LH%T^,16+;[5
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M15.@B9=:0 _<E<L/*Q_=\Q3*/0K0!VM]J%IIEC)>WLRPV\8&YV[9. ,=222
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M;R26VI:=&SM;/@##J <JP)!!&#C% &M#XDTFXN+&WCNCYM^)/LRM$Z^9LSO
MR.",'(/-+#XBTF>SN[I+Q?)M)S;3ED92DHQ\F" 2WS*  .20!7"YUR%O!>M:
MU83RO975XEVUG9L6*R*ZQRF)067=P2,<%N<=*SWM-;%CJVH6^BW[/:>*QJOV
M1HMKW-N$53L[,PY( [K0!TOC7Q4O_"%:U=:%J<EOJ&FO$)E,.R2/<R\,DBY
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MVS:DC_9'BN/,!D5=QC?*KM;'0C(.#SZ@'24A( ))P!U)KA;;XAW4VGV&IR:
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MF4L''RC"_*0>N""/K ?%FJ'6[71ET "^N---\ ]X B$,JE&.W/&[D@'GL>M
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MBQNC_)_$JGD9P3WJ]X0\,?\ ",KJ21+';VEU<B:"QAD9XK8;0&"E@/O,"V
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M<2;)WNY0I+.S@E/*[;O7MVJW9>']8M/$VIZI)):7"W6G06BEI65V>/?EF 3
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MZ\*^*M)#Z>LNLZ@]W$_G.5C5MG#?)R1L[>OM3O$'@_Q!K,WB("XTTPZK8K!
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M8CD5E5N<$@C'OFM_0X](FL(=5TFRMX(]0B2XWQP+&T@8!@6P.N#WK4H X-?
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M*[$CJ]U?7DU]<LGW?,D;)"Y[ 8&>^,]ZVJ 00"#D&B@ HHHH **** "BBB@
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MP&:278NWS),;C]< #]*P;+PA'IU[J%W9ZSJ<,NH3>?<$&%@SXQD QG'  XH
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M1$X!\Q.A/L<D$=P:J>(_"=CXD>SGFGO+.]LF+6UY93>7-'N&& .""#@9!!H
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M)*K#8X 8'*^BJ.,8Q]<@'-_VWXG;P3JE]!J4DUYH6JSPSLL$6Z\MHI/FR-N
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MBR"<*3N0HH&TKG(.3P/>I1X#TJ2[O+B\GOKUKVS%G=+<SY69!NP2 !@_,>F
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MKV59VM;G[$[^9;L"4;9GY201U[XKSQ8;K_A$?AB%OI'FEN[9EDF16\O-H_
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M?";7UF,0TY==_P")5OQA;;[5%@)G^'(DQC^'VKV2)88H%$(C2$#(" !0/PH
MY+P_XBUW7XM6D2+3(!I^H3V)WESO,9'S>P.>G:NDL[TM:VJWY@M[Z2)3) )
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MI:8CNI7*2!5W@GL>.?UKHM<BN?#GCQ;W38/E\2V_V%V1,B.[0$QR-[;"^?\
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M((KRJR6YE\+^"KC1M3L$U2#0QMLK\9@NXBD0D7.<JP*KR/4YXS7:>'M:L8_
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M_E\=/X_IWKEK#5_!>HZ/::KIRFXO+'2)E>"QD(F@A\O+HZ@C!RN!GG<<CN:
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M1KNW$<1 D8R#"9Y&3GCJ*J:EX@TS2K:TN+J\B$=W/';P$.#YC.P QSR!G)]
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MI+QSVNH)$)Q;W"@,\9.-ZD$@C/!P<CN!0!I+!"CETB17/\04 TYHHW8,Z*Q
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M1P>>G;.>* -NQLX=/L+>SMP1%!&L:9.3@#')[GWJ2:"&YB,<\22QGJKJ&!_
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M/08YZ*66.")I99%CC099W. !ZDU6MM6TV\0O:ZA:3J#C,4RL,X)QP?0$_@:
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M?ZE8Z7!Y^H7EO:P_WYY B_F: //K&6XTWQ]X=2>PN3+'X8:*:) K-&1)$#D
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MG>$-570Y[F2PT^73K^P26/S0CLK"1/FVGE!D$@UZS3)IHK>)I9I$CC7EG=@
M/J30!PNMP^(AJF@^*;;1FF:T-Q%<:7'*GG+#*%PP.=I<% 2 >^ 3C-,\266N
M:@=&\0+X>CN397$IET>5XS(T$B!2222GF C=@'H<9S7>0SPW,*S02I+$WW71
M@RGZ$4QKVU6Z%JUS"+@C(B,@WD?3K0!P][HD&K:3 MUX1ET^WFNO-"V+)%=6
MC!#MG)C;&[.1A=QP1G/(%5O#VHWVB:99^(8-3N9K>6Y:VU6TD5+RU&X"%FVG
MEF3.[ /(&1U->DT4 ><Z?I7B?3=7\.Z_J<3ZA/'83:?J"1;?,0-('23:#AC\
MJA@IZ\C-5=4\,:LUAJEY;Z=-)<:GKUK?BU5T!BAB:/);+ ;B$)P">H'K7I[N
ML:,[L%51DL3@ 53AU?3+F988-1M)96^ZB3JS'Z &@"XIW*#@C(S@]12T44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5SGCK5I-#\)W-^MC;7JQR1*\-R?EPTBKG&#D@D'''3K71U
MA>+] F\3^&[C2(;M+4S/&QE>(R8".K]-PZE0.M %"^\0:X?&5SX>TZRL-R:<
MM['/<3/CERF& 'JO0>N<]JT_">NGQ+X5T[6&@$#W46YX@V0K D$ ^F0:K#P_
M?+XRE\0_;K?Y].6Q\CR&X(<ONW;_ %8\8Z=ZF\(:#+X8\,6>C2W271M@RB98
MC'N!8GID^OK0!Q%_?ZMJ?A#XE+J4UO+#:M=01*B$; MLA4#)/')/U)/M6YI/
MB34-/U+1M+U.VM8[*\TMKBWEBD9GC\I4W!\C'(<'CIC'/6I+GP3>R6OBNRAU
M:%+37FDDVM:EGA=XUC8YWC<,+D# Y/4U9;PG<S:OH-[/?6[QZ79RVCQ"W(\\
M2*BL<[_E^X..>IH JV'C#5+^?1;J#2I9],U0C=LM95>U1EW([.1L8'C.,8SP
M6'-:/BW7[[0%TDV5G!<F^U"*R;S92FW?G!& ?3\/0U2\->$];T 0Z:_B$7.A
M6C?Z- ;;;.$!RL;2;N57CH 3C'3BM+Q/H%SKW]E?9[R*V^P7\5Z?,A,F\IG"
M\,,9SUYH HV>NZW=ZH^A/'IL6K6UM]INY$+R0J&=EC51\K$D*22>GH<\<[K.
MOKXFT'P[=R6HM[NV\4VUI<P[MWE31R[6 ;'([@^AKJ[OPY<IXL'B+2[N*&YE
MM1:W4,T9:.90<JPP05923ZY!QQUK/N/ KG2K"TM;^..:'5QJ]S-) 6\^;S#(
M1@,-H)..IP .O6@ U7Q?J"MJIT73S>MIDPA:#[/,[7+A59E5U&U" V!G.2#P
M!@GHM0UFWTOP[<:U=I+%!;VQN9(V7#@!=VW'][MCUKGW\)ZU9^(KZ_T/7X[*
MSU-UEO+:6U$NV0*%,D1W#:2 .H(R,X/2NBU'2+75="N='N@[VMQ;M;R9;+%2
M,9R>_OZT 8$GBG4=-N= DU2VMA9:U(MNI@+;K:9U+(K$\.#@C< N#VK-\/6M
MQJOC#QE;:M'97=H+NW22)XBPX@1D !)& 3GZY-:MIX4O7AT2UU?4(;RWT:59
MH"D)1YG12D;/EB. Q/'4X/'2K>B:!=Z5KVN:E->PS)JDR3>4D!0Q%4" 9W'/
M"CL* ,#69CK'Q@TGP_=C=IUIICZGY+?<FF\SRUW#OMZCWYKK[S1;*]U.PU&6
M%/M5BS&*0*,X9&0J3Z$-G'J!6;X@\+MJFIZ?K.GWGV'6+#<L,YC\Q)(V^]'(
MN1N4^Q!!Y%7[6WU9W634+NVRF2L=K&RJS8QEB6)(]N/QH \Z\+:[J7A[PM8S
M1V=H^ER:[/9RY=A*/,NW0,H P "1P>O/2NGE\5QZ9KWBLWMA;Q0Z18PW1GA.
M99T(D(#9 Z;< <]>M55\!7R^%H-%_M:WS%JG]H^=]D;D^=YVS;O]3C.>E7[C
MP8;_ %?Q#<7]W')9ZU91V<D$<15HU0. 0VXY/SGMV% !:>(-<FUN"Q?3-UO=
M6[NMTMK-&EK*HR$D+@;@>S#'(Z#-9WPXMI-1\/\ VO5(K2Y>/4[R:&0QDNDO
MGR L"<XXR!CM6MX>T/Q%IJ1PZKXACU"&U0I;;;7RF?C :4[CNP.PQSR<G&+'
MA'0+GPWH[Z?<7D5V#<2SJZ0F/'F.SD$%FZ%C0!AZHB'XUZ Q4%AI-U@XY^^G
M^)_.NG\0:U'H.D->O&96,L<$48S\\DCA%' )QEAG )QG@UDZKX9U.[\9V7B*
MSU.T@-I:R6RP36C2!@Y!))$B\\"DU7PIJ'B'3+^TUC5TS,L?V1[*W,7V5T;>
M'Y=BS;@O<<+@8R30!3N?&FHZ1%K<^HZ3-/:6%C]LANXK:6!)2#@Q$2#(8'!R
M"1@Y[8JW!XCU9?%EGHDUK97"7.GF^\^%V38%8*4"D,&Y9<$E0>:H:Q%KND>#
M-5N=>UU;J8VQM8Y;2QV)$'(4RNF6W8R"3P  <"LWPRTYO8[/3M:\-ZG;3Q&W
MEDTF!DGMX@C;6WB1PH!Z*<<GB@#8TWQA?3>(='TN_MK1)-3AG:2"%BSV4D8#
M>6[9*L<'G&,$=.:?\.5"V&OJH  U^_P!V_>FJVE^!=5L)O#4DNMVKC0DEA18
M[$IYL;J%)/SGY^ 2>GM6[X6T"X\/P:C'/>1W/VR_FO04A,>PR-N*\L<X]: .
M?TZ=M:^,FNQ7OSPZ':6ZV43<JK2KN>0#^]_#GTX[TGB*631/BIX6FL $_ME;
MBUO8UZ2A$#(Y'JI)YZX.*W[[PV__  DJ>(M+N$MM0,'V:X61"\5S%G(# $$,
M#T8>X((HM_#LLWB*/7M6N([B\MX6ALXHD*QVZM]\C))9FP 6XX& .N0#A$CU
M*\\,?$&:Z^P3FWU&ZE!DB9BDD4$>QDR>-H V]P16I:3G2M-\"W%QI.EW,]V;
M>QCN]F)8(S#O&W(//RGN.O2M:#P?J$.C>)]/.J6S?VY//-YGV5AY)E0(1C?\
MV /;FI+CPE?7&G>&;4ZE;@Z)/%,7^S']_P"7&4 QO^7(8GO0 Z3Q%K%]%J-U
MH.GP7D5A>FS-N[[9+@HP64JQ(5-N3C.<[>V15;5/&.HK_:<FBZ<U[_9MQ]G:
MW%M*SW+ *7".HVH1NP,YR0>G%.@\'ZMIVM:D^E:ZMMI&IW#75S;-;;Y8Y&^^
M8I-PV[L=P<=J4^$M9L?$%_=Z'KZ6>GZE*)KJUEM1*R28"L\3;AM+ #J",\X/
M2@!(/$OB#4?%.HZ38Z98I%8BTE=[F9U8Q2[BPP%X<!>!T&#R<UO:]J%WIUG#
M):01/OG6.6:9PL=O&<[I6R1D#'0$9)%4M+\.W&F^*]6U@WL<D%_#!$(/*.Y!
M$&"G>6.XG<<\4_Q1H-WKD>FO97T=K/87J7:B:$RQ2;01M90RD_>R#G@@4 <W
M+\0;]/#6HZA%8VMQ+8:NNFN0[(DJLT8$B@@GD2#@GMU-7W\:7.CZCKMMX@MK
M:./3K!-11[1V;=&2Z[#N ^;*8!X!SVJI/\/]2GL-7M#KD!74=4BU(L;,Y1U,
M;%>'Y!,0QZ G.3TOZKX(.MZQJMU?WD9M-1TM=.D@CA(9 &9@X8L><L>,=A0!
MDZE)JD_CSP%<ZA%:()GNG"0AMT1-LQV%C]_KU 7ITJ[\4]1NK/PYI]E:S/!_
M:VJ6^G2S1G#1QR$[B#VR%QGWIUOX1U]K[P[<ZAKMG.=$=]C)9,K3JT9C^?\
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M!M:#=ZQ>P/<:I;6<$4JI);"WD9VVE02'R  0?3(_JSQ@ W@G7@0"#IUQP?\
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MC%HVW<@D=EPRGIN &#V-9VF^/-:NM+\.ZO<Z;8QV.JWPL72.9C(C,[JK#C&
M5&1U/7CI6KX<\->(-%BALKOQ&E[IUFNVT3[+LE8 802N&^8*,= ,X&3VJG;^
M KZW\,:%HPU:W8Z3J"WPF-H?WNUV<+C?QRQ&<GZ4 6_"NHZQ?>)_%$5]/ ]O
M9WJP1(B,"B^4C #)_P!HY]3Z#BH/B3IEE'\/_%-XMM%]IFLV9Y2H+$A0HY]@
M/YUKZ3X?N=*\2:SJ"WT;V>I2K<&W\G#I((U0_/NP5PN<;<Y[^LOBS1)O$?AB
M_P!&ANDM3>1&)I7B,FU3UP,CG\: ,B2YL-"T_0+J"RC_ +2O8DLH72$L<%/,
M8L$&Y@!$3@=_3)(HW_C?7=,TK4;B;0PSVE[;P1SNDD$=S'*RJ&17&=P+8()P
M.N36MK/A.YU7P[IEHFI_9-4TR2.:UO8H?E61%*\H2<J02",]ZK:GX4US6_#K
MV6HZ[;M>R3P2M*EH1$@B<.JJF_.21R2>?; H ;/XB\467B#2M'NM.TGSM1-T
M8Y(KF0JJQA2N04!S\W.,YQVZC-F\>:_;>&]5U>73=.VZ)>O:WRK,_P"^"LH)
MB&./E8'YB><CWKIM1T"[O_%.AZR+R&-=,296A\DGS3*J@X;=\N-O'!K%NO 5
M[=>&/$FC-JUNO]M7LET91:G]SO*Y7&_YONCG(H [>5F2)W1#(RJ2$! +'TYK
MCM,\7W\_B#3-)O(;-9M0LY9VCA8L;.6/:3$YR0Y^?DC&".G(KJKJUEO-*GM)
M)S%+-"T9FA&TJ2,;EYXQG(YKD-+\$:K8WGANXFUJT?\ L6WEM52*Q*"6-@@S
M]\X;Y!D].> .M ')7D^K)X%\=:@YL))K35[F6.22$NT<J;%5TR>"H VGJ,"N
M]N_$-[;7L&CIY3:C]D^U22K:S31JI8J@VID\D'DGC'?-4_\ A!;F7PSXFT:Z
MU.)EUNXGN!+';E3"TF.,%CN Q[9I^H>$]<EU#3];T_7;>VUNWMS:W#M:%K>X
MB+;@ICWY&#R#NSU]: *8\:>(IY/#UJF@0VE]JJ7(>*]E=/*DB7.2-N=AX(/7
M!Q@=:[.+[1)I*"_CA6Y: >>D1+1A]OS $C)&<]16#+X7U"77- U.35DEDTSS
MS+YEN<SM*N&QAL(!V&#[YZUTERDLEM(D#HDK*0K.I8 ^X!&?SH \M^&MZGA"
M.7P_?S>7I\FG1ZU82.>%C9 9T_X"^6QZ-FI_"<-PGQ;U>]O(W^V7FC0W+Q-U
MCW2MMC]MJJBGU()[UT-QX#M]0L?#46H7 DGT-E"RPH4$Z!-I1ADX5L*2,G.,
M=ZF/A6\;QEJ.NG4XTCO+ 6/DQPE7C4$D.'W?>RQ[4 4K#QAJ,VO:3I=Y!9QS
MZE!.[0QL6:REC ;RY""0YP><;2".G-/T[Q;J-YHMWYUM:Q:W;ZE_9[6@+%0Y
M8 '/4J4/F9QTSZ56TWP1J>F2>&Y[C7+5H] CEB CL2GFQ,H4D_.?G^7)/3VJ
M30H-(\1^-I_%FD7#3V7V5(RZ@B*:X&X;P"!EDC8J3Z/CJ#0!U][90ZC82V5V
M@D@F79*G0.IZ@^QZ$>AKDK/PWH4'Q"A;2]&TZR&E69DDDMK5(R99B50$J!T1
M)./]L5VU9>G:6^GG5+AYU>YO;EYVDV\*-H1%QWPJK]3GUH U**Q_#']K_P!A
MQC7)TN+T.X\Y8/)\Q-QVL4_AR.WTZ'BMB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.K:K!I%G]
MHFCGF+,$CAMXS))*QZ*JCJ< GT !)P!5ZHKF6"V@:XN61(X07+OT7CK0!BZ)
MXPTS7(-0=1<64VG'%[;WT?E20#&X%ATP0"00<<5+IWB>RU&YM8!%<6YO83/9
MM.@47,8QDKR2.&4X8 X.<<''&^,-)N3X)\;:VL;17NJ68VPXPZ6T2X 8?WB&
M=CZ;@.U6_$.)=:^'2V/)^UET*_\ /$6[;OPP10!L#Q]I0U>UL9K;48(KR7R+
M6^FM2MM/)V57]^Q( /8FMG4-9M=.N+>U?S)KRYSY-M"NZ1P.IQT"CC+$@#(Y
MY%96LV4.OW]AIZA19:9=1WES(.%5X_FCB'OG#'T Q_$*Y:SM=5U+Q;XZU&VU
M62QU&T:*UM1Y4;A8UB#J"'4_(S,2=N#[T >F1L7C5F1HR1DHV,CV."12/+'&
M\:NZJTC;$!/WC@G _ $_@:R?"6L3>(/".E:O<0B&:[MDE=!T!(YQ['J/8US_
M (OM%N?'_@E6GN45Y[I2(IV0<6[D'@]>V>N.* .CTC7X-8OM5LXK>XAETV<0
M3><%&YBH8%<$\885K5Y'J<=W$/B7J5GJ=Y9SV$ZW$/V=PH+I:QL-W'S#C&.G
M)_#>DU+4O$>NWFD0S>0T.F6]Q'LO'MFWRA\R#:I+!2%&#QZ@YX .^K"M_%$&
MH>:^EV-[J%K$[1M=6ZH(RRG#!2S*7P<C*@C(QUJG>IK7_"L;^*2ZBN];339X
MS/:C DF",,K[Y'YT?#9[:3X:^'3:%3&+&)6V_P!\##_CNW9]Z -S2=4MM:TZ
M._M/,\EV=1YL91LJQ4Y4\CE3P>:NUR&K:D/^$QT+P[;RF"RO5N[B9X'V-*\9
M&4##D?,S,V"#Q]:Y35M8URRDUC28]5NU33=;T^*"YR"[PW!0F)V(RVW=USD@
MC.: /6J*\_AL;^;QSK/A]O$&K"Q.GP7BD3@2)(S2*=KXRJ_*#M&!GVX./I>L
M:WK=C\.C)K5W VJPW"7AA" R%(6(;E?O<?0'G&: /6**\NM]1U/39M?\/W>O
M7<D5GJ=G%:7+KYES.DP#FW##'S$9 ?L&SD8XJ:OK.MVOAGQU'%J%Y:2:7=P?
M929A+)$DB1L4+G)(^8]\C. <4 >N45P\4=[!\1+G1&UC4)K2]T9KIB\HW12B
M4)NCP!LX;H..!5/PYJ=]J$-IX9O+RY_MK3KV1=2E$K!GBC^97Z_=D#Q<>A;'
MW: /1**Y[Q7=&&/3($OIH'N+U4\BW7][=@*Q,2MD;.F2V1@*>>:X6;6=<7PI
MJ>W4[JWFLO$Z6,9\P2,(6DB&QG(RV-Y&<Y/<F@#UNL>\URUTS7]+T9K6;S=3
M\WRI45?+!1"S;N<YP/3O7$ZMK^I>#K_Q@([VZU".TTF&^MUNVW^7*[2(<8 ^
M7Y5)'3@XQ5J]L/LWCWP'.-0NKLRK=[WFF+K(WV<G> >%SD\+@>W% '6>(?$=
MKX:M(;J\@N9(I9D@4P*K8=SA0<D=3WI\.M,]]!:SZ7?VK3[A'),J%"0"<95V
MP< ]?2N:^+ <^%+(1LJO_:UGM+#(!\T=1D9_.NAAAU:+5-^IZA:2V3PF-$@A
M: B0L/5V))'3&,<^M &S17FVD75]!XZE\-ZAK%U+:+<275E=-*X:YPJ[K8MT
M/E[MQQR<#T85))<:]XG;Q =+OX[&[T[4&MX)&O'18!&%/SQ!"KAADY8]#QC%
M 'HM%<%9W%]XN/B2--:ETV]T^[6VMGMV.R$"-'\QDR!(');[W& ,8Y-$5_=R
M:_XSM?[0N'MX-.MKBWVR$"-V24EDYR 2H.,XH [IY8XWC1W56D;:@)Y8X)P/
MP!/X57M;U[F[O(&LKF!;9U1990 DV5!RF#R!G'..17FMCYVK:O\ #.\O+R[>
M>ZTB:69EG9=SB&([L XR2QSZUL62:KK%[XYTI-8NTF@N(TL9M^TP,T"N,8 &
M-S=,<B@#O:*X/P]K\NN:187JM<B;3+%WU"#S6RURN4\MN>?FCD///W>QJ+P^
M^O:M:>'/$<6J0)!<HCWRO>/)'<"08V+&4"QLK' VGM@YZT >@T5S?B6X;^UM
M'LDO+@&=I6-C;$I)<A4Z^8&78J$@DYYR!ST/):!XEU&\LO"VE:A>R@ZA>W\$
M]P'Q(ZP,X2/>,')P/F&"=OO0!W>MZ_!H3Z<+BWGD%_>1V<;1!2$=S@%LD''7
MIGI6M7F?C"WO-'TK3$>^FUAXO$UM+;PG'FHA)9(2Q/S'T9CG!&:ENM5FO?A9
MKGB6PU>\2^>UFFVJY'V.1!S"$;.TJ1@GJ3DC (  /1Z*\\%]J.B>*M*8ZC>W
MT5_HUQ<SV\S@J9(A&RE !\I.XCW[Y/-4GUK5(OA_H/C*WU">:^N)K9KJW\PF
M*99I C1*G1=NX $#/R\DY- 'J%1W$I@MY)1&\A12VQ,;FQV&2!G\:\VUFXU6
MTU+Q-X>AU*]_M"\BBN]#<3G<N[*,@S_"K@D]?E;V%;?A75QXHM[358);A+>"
MP6.:(RL0;AOOJX)Y9 ._]_V% '0:!K5OXBT&SUBT21+>[C\R-90 P'O@D?K6
ME7DWA75+J+PA\/\ 18&54U&TF9R;AH"YC (0.H)&=Q/&#\O7KG2^V:YI6IZ/
MX:U+55D74M3G GBF+2Q6Z1>8L+2$ [R<#=UV^_- '8Z;K\&IZUJVEQV]Q%/I
MC1K*90NUMZEE*X)R,>N.M:U>6'^TM&O_ (F/HLTDM]##:R6[7$F]E_<$_>;K
M@9QNST&:TX[K4HO$$NH:=<:I+H=MHS7,D5SNP]R#\J9D&[)7.54C! Z9Y /0
M**X'0/[=U&/P[X@CU2!;6YB5KU7O'E2Y$BC 6,H%C8-T"GV.:V?$<[-K6D6,
M=Y<9F$SM86K&.2X   8R!@41"<GGDD#GI0!T:11QYV(JYZ[1BG5Y-8:QKE_X
M<\$2R:S=Q3W>K3V5R\94F1$,X!)*\D"->>G<@U+<>(M3\/VWB73EU&XF$&L6
MEE;7=RPD>W2=8RQ)(YV[FQGOCJ* .^_M^#_A+!X>-O.+DV9O!*0OEL@=4P#G
M.<MZ=JUJX.WL%L/C+ J7%S*CZ!(=L\S2E2)X\D%B3SQQG%:'B*:6?Q#!I\-]
M=,YL99?L-JYA8'<H69Y01A1R O.2<X.. #K**\TTK7]6O]!\!W-_<3&SOX7_
M +1FARKM((\QYV?,%)#$D8Y SQ52^F\2V/@BYO9M7U*&5M;CALS,JAC:FX5$
M+ J&Y5N<G)P,]30!ZM17GWEZA_PE5[X7CU2]N5CLEO8WN=0:"8M)(ZDJT:9*
MIM4 =!NYSQB.TO->N-6LO"^HW\%U>0Z69YI[:\>U\^03-&6#(I.5"C(X&6.0
M<"@#T6L;6O$MIHEI;7,D4UQ%/>)9AH-I"2,_E_-DC@-P<9Z4GAVVU-/#45GK
M6H1WE\@>&:ZMF*[L$@<@## 8!(QR#7F%I;%?@WH+K<3F2;6;?+22&3:?MI&0
M&)^I]>] 'M-%><3:A>:+JOC&PD\0W$-M!IT%W#=W@\\VLC^8K%1@9&54A?7H
M.U0S7-^-6\0Z1)-J,-FWAT7B1SW3-*DFZ12P8,2F=H^4-V[9(H ]*BECGA2:
M%UDBD4,CJ<A@>A!K)\0^);3P[HEWJLT<US#:L$F6VVLRDD#G)']X?G5/P#;+
M#\/M!"R2MYFGV[DO(6()B7@9Z#V' KSJYM!#\(O&CB>XD;^U;F,>=,T@PMT
M#R>OJ>IH ]JHKSS4-4U'PQXKUA([Z[OX5\/3:F(;E@P$T;X&T #:"#R!QQ5S
M1(=;GO="UA-5A.GW4!^U1O>/,+HLFY&C4H%C8$$X7 QGCB@#MZ*XKQ8;^;QI
MX9TVVU>]LK6_2[2=;=E4G;$"""0<'GKSCMSS5;2OMFN7?B/2GU>_BET8Q6=K
M*)MLF?*#>?)C <LQS\P*X7IR<@'47^OP:?X@TG1Y;>=I=3,HAE4+Y:F-"[!N
M<YP/3O6HR(Q!95)'(R.E>8:;K-WXAO?AAJM\@2ZN1=M* , G[.PW =@<9_&K
M-C=:_P")-,_MNQU&"SFM]1E$AEO'\M(HY64Q/#LV_< ^;.[)SD=* /2**Y?Q
MIK%QIB:):P2-"-3U2&RDG7K&C;B<'L3MV@]MW'.*IV\EY;?$"\\-FZNYM+N=
M+%]&7F8R6\@DV%5D)W88<\DX(..* -:P\4PZE>VL=KI]])97?FB&_6,-"3&2
M#D@Y4'!P2 #3(_%L-QK6HZ1;:7J,]YI_EFX5!$ HD!*$$N,Y /3\:R?A+;+#
M\.-(D$DS&6(DAY"P7#M]T'I^%4M(CU&3XK^./L%U:P$1:?N\^V:7/[I\8PZX
M[^OX4 =QINH)J5J9U@G@*R-&T4ZA75E.#D D=L@YY&*N5Q?B*WU;_A!E>'6&
MAUVP2-G>%R$N)L+F)E'/SY  '(W#'OFGQ5+#\.;SQ-#=2"ZN;E(YHYI#MT\M
M,L;1X8':4#$DD<GG&,  'HU(RJZ[64,#V(S7G'B"[\0>$++5M774(5L6LT$5
MM)=/=/#*941IE9U!V!7R5Y&0/6M/Q!8W6DZ5K5_:>(+SR?['FDBMGE9W$\:E
MA,KEL@<@%0-O3Z4 =HJ*B[44*/0#%4[[41:Z;=7=O;S7S6^08+7#2.PZJ 2!
MG\:XY-1OGUOP$IO;C9J5A,;M1(<2E8$8,1Z@L3D5SEL;K2O@WXEU"PU*^@NX
M;N]*2^>7(VW#C^+.">Y')]: /8!\Z<KC(Y4_RI0,# Z5Q7B"_G\/^*M"U>YO
MIUT:[#6=U&TI\J*9ES%)CWVLI[9(/6J]WJ.H6UQX>TYI)5;6YKB=UGNGB95"
M[TA#@$J0&'3!)0\\T =[16#X6M-6L(+VUU6_BNRMRS6^)3(\,3 %4=R 6(YY
M/)&*X^\UB_BOM,OK/4[JZCG\1BSDN-Q2!HF9D,*QY(;;C!? R5R">: /3JIZ
MIJEEHVG2W^H7"P6T0!9VR>IP  .22<  <DUQ*ZS>6/C"*TUS[?;K<:DZV%_!
M*9+2Y0[@D#J#B-QTY&25ZTOQ-9H]0\&2SG&FIKD)N"?NAL'RRWMG/7VH Z.?
MQ0EG;)=7NDZG:VSNB++)$C<LP5<JK%EY(Y8#'?%;U17(@:VD%SL\@J=^_P"[
MCWKAHKV]\21^+Y5U&ZL;G2KN2ULEAD*B+RXU8.R]'W,2?F!&.!B@#OJ*\ML=
M1UCQ9JWAQ)M6O]-BU7P_)=3Q6C*FV0-$ R$@D?>SSGCCO36M];U"W\9[?%6J
M0RZ/=-]C960#*P(X#X7#+D].!R>IH ]4HKSOPYKUYXPU:.RU"6XLU31+2],=
MO*T+22S EGRI!PN  .F2<YXQE0ZUK]_8^'8)M6N89AX@GTF>>$*OVJ.,2@/T
M^]\@]L@G% 'K-,,L8F6$NHE=2ZIGD@$ G'H-P_,5YGXB>^TG3=?M[/7M4O[G
M2=*$L;&78UJX$C[Y7&!*S #"[3PO.-V3;M$:]^*6G7DTUR7?PV+DHDS!=WFI
MD!0<8/<=#WH ]$K/U;6+;1X86G6226XE$%O!$H+S2$$A5R0.@)R2  "2:XC0
M+G7_ !#I6@>);?4H+<33*]XKWCO')&S%6A$6S:K D $'.1R3FNC\8Z!;^(K*
MSM#J,VG:A'<";3[J'[T<RJQZ=QMW9'<4 7]/UV._U*;3GLKRTNX8EE>.X10-
MK$@$,I*MT/0G&.<5JUYK:>*_$.BSZQIGB6QM9]8L-(FO[2^M01'=Q)V9>JMN
MQD?7';,\,VO6UGI_B:'489;(V$DUS ]X\PO6,1=#&I0"-L@\+@8R,<4 >AT5
MQF@PW>IZ9X>U]/$4ZF[MM]Y&3O2Y:1,@(I.V,HW3 Z#!SS7+:?JFK6/P[A\4
MW&O7\UR\[V3">11#&CWGE^:PVGYE7.&Y ST(&* /6V8*I9B H&23T%-B:-X4
M>(J8V 92O0@^E>:^+-,UFT\.^*6N-2V:;+HTLD5H+Z6:5)D'+J[!3L((!7)&
M?8XK3VE&T#2X-0OI"^GO,UC#,RR/P@$K3;@5122,=RPP#B@#NJ*\FTS5M;UG
M2OAZ9=:O(7U)KB&[:$J#($BDPQ^7[WRCGUYQFM>XNYO GB6V.IZKJ-]H]Y8M
M%&]U-O9+F(;B., F1 <?[2D#K0!Z%16=H5K=6>BVT5]-)+=E-TS/(7PYY*@G
ML,X'L*T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *S-;T#3_ !%9I::E'-) D@D"Q7$D7S#H248$
MXZ_7FM.H[BXAM('GN9HX84&6DD8*JCW)H R-'\(Z+H4D\EE;R[YT\N0W%S+/
ME?3]XS8'KCK4MAX;TO398Y+:%PT41@@WS._D1G&4CR3L' Z>@'0#$\.MZ7<6
MT]S%J-JT-N=LSB48B/HW]WJ.M<WX0UW4/%4-CK=MJEH;*42?:M/V*S0C+"+:
MPY#8 SNR#SC% $\7PV\,0RK(MK>$B3S=KZC<,K-G<2RF0@Y/)R.>]:]YX=TV
M^O)KN6*19IXA#.T4SQ^<@SA7VD;L9.._)'0U1D\66-UJ>KZ+87MNNI6$"M^\
M^8%V#G:%R"VT)DX/&?8U7\&>+K76M"T9+W4[-M;N[)+B2V610YRN20F<X[_2
M@"]<>&[>7Q+I6K0KY!T^%HE\N5@K1E2/+\L?+CD'/7Y0*MZMH.G:V]H]_"[R
M6DIE@=)7C9&(*GE2#@@D$="*?)K>E0Z@EA)J-JEV[;%A:4!BV,[<>N.<=<54
M\5^(X/"OA^?5)HFG92L<,"'#32L<*@/;)/7L,T 1R>#M$EBU6)[>8IJW_'ZO
MVJ7$O&W^]QP .,<<5%J7@7P_JK6+W-K,)K*/R8)XKJ6.41_W"ZL&8?4FBXC\
M6Q:+-<PW>G2ZF(2RVGV9A%OQD(&W;NO&X\'T';4N]:T[3HHVU"]@M"R;\32!
M2!W)ST [GH* +5O;PVEM%;6\:Q0Q*$1%& JC@ 5C1>$-)MKJ>>S%W9B=S)-#
M:W<L43L>K;%8 $]R,9J]<Z]I%FZ)<ZI90N\1F57G4$Q@9+]?N^_2JZ^+/#K1
MV<BZYIQ2];;;'[2G[TYQA>>>>/KQ0!)?^'=+U&"TBFM]GV)Q):R0N8WA;&,J
MRD$9'!'0]\U7N/".C7=C]DGMY7C-RMVQ^T2!WF4@AV8-EB,#&3Q@>@J>^\3:
M#IC3+?:S86S0;1*LMPJE-V=N03QG!Q]#4\^LZ9:VT%Q-?VR0SC="YD&)!C.5
M]1CGCM0! /#FFKJ\^JA+@7L\ MY)1<R<QC) QNP,$DY'/)KE-3\(+9ZUX0L]
M'TV\&D:7+</(\5T<P!XRJX+/N/S'H,C'Y5U[^(-&C2V=]6L52Z0O QN%Q*H!
M8LO/( !.1V%1+XHT!]-74AK>G?86D\H7!N4$9?\ N[LXS[4 077A#1;W37L;
MBV=T>Y%VTHG<2F8=)/,!W!A@ '/ &.G%5IO 'AN>/4(Y+*5DU#9]J'VN8>:4
MQ@D[NORC)ZG'.:WFO[-;J&U:[@%Q.I>*(R#?(HZE1U(&1R*;>ZG8Z<%-[=PV
M^X$KYCA<@=3]!D9/;- &==Z):VM[)K]K9SW>KP6;00J;MQYB_>$?S-MY8#DC
MKS4?AZPN&N[W7=1TZ.QU"_6-&@#K(T<<8.T,R\%LLQX[%1VK.O?%1L?&UE#/
MJ-G'H,^DRWOFMA1D/&%;S"<$$/QC'7O70_VWI9TZ#4!J%L;.? AF$H*R$] I
M[G@\#TH CUG0-.U^.W34(I&-M,)X)(IGB>-P",JR$$<$CK6:? /APPW$7V*5
M8[BY6[D5;J5095QAN&X.5!]R 35?Q;XDEM/"D6L:#>VLL;7<$1D4"565YEC8
M @X!&3Z]*L+J^H#XEOHKRQ'3SI/VM$$>&#^:$Y;//&?3K0!>;PQI$FHW=_+;
M/+/=VXM;CS9G=9(N?E*D[<<GMW-4;+P'H-A/I\T,5V6TXL;/S+V9Q &&"J@M
MPN.,=,5'XFUZZT7Q)X<B^U6\&FWDTR79E4 A4A=P=Y.%&5';\:VK+7-*U'36
MU&RU*TN+)<[KB.961<=<MG Q0!%KGA[3?$=M%;ZI%++%%(LJ*D\D6'4Y!^1A
MR#TIB>&]/2[ANBU[++!N,1FOII A92I(#.1G!(SC(R:MV&JZ?J@E^PWL%SY+
M;)1$X8H>N&';CUIE_K6EZ6P6_P!0MK9MN_$L@7"YQN.>@SQGI0!2G\(:+<V6
MGVDMO,8M/G^T6Q%U*'23GYMX;<3\QZD]:@O? OA[4-;.KSV3?;'"K,4G=%G"
M]!(H(5\?[0/O70/-%% TTDJ)$J[C(S *!ZY]*S+?Q1H%W?065OK6GS74Z>9%
M#'<(S2+ZJ >1P: *E_X(T#4M:.KW%FWVMU5)C'.\:SJ.@D52%<#_ &@?3I4N
MH>$='U/4WU&Y@E^T20?9Y?+G=$FC&<!U4A7QDXR#UJZVN:4E^+%M1M1=,_E"
M(RC<7QG;C^]CG'7%5I_%?AZVE,4VN:>D@D,10W*9W@9*XSUQV^E $*^#-"2W
MTJ!;214TH$6>+F0&-2 "N=V64@ %3D''2KMAH6GZ9J%]?6L<BW%^X>Y9IG<.
MP& <,2!P .,<"HO#OB/3_$^E)J.G3))$Y;@,"RC<0"PZC(&<'UJM;^+]'O=3
MU73H=0MXYM. $KR2  ,02>"1D*,9/3G':@#3L-*LM,:[:SMTA-W.US/M_CD8
M %C]<"LG2O WA[1-3>_T^R:&1G:18Q,YBC9NK)&3M4G)Y [U/I^MV-MI.F_V
MAK^GW,]Q%E+E66);G )+(N3Q@$\$B@^,/#0LEO#K^FBV>4PK*;I-I<8RN<]1
MD?F* )M6\.:9K5U975[%*;BR9C!+#.\3IN ##*$$@@#(/!Q6=)\/O#,FD-I9
MTXK:FY-T@69PT4I).Z-MV4Y)X4@<GCFMJ_U;3]+B$M_>P6R,"0TKA<@=3]!W
M]*G2Y@DM5NDFC:W9/,$JN"A7&=V>F,=Z ,9O!NB/8V=FUO,8K2X6ZB/VJ7>9
MATD9MV7;W8FFR^"M!F&JJUK,$U8YO46ZE59CC!)4-@$C@D8S5RU\2Z%>S"*U
MUBPGD,33!8[A6/EJQ5GX/W001GIQ4UIJ^GZFTL6GZA;3S1J"51PY4'[K$ YP
M?7OZT 5E\,Z6NHV%_P"5.;FPB,-N[7,AV(<9&"V#G ZYZ"HK/PCHUC(AM[9U
MACG-Q%;&9S#'(23N6,G:.22,# /(P:I>#?$$^H>$!JFM7,"R+<W$3RX$:829
MT7@GC@ =:W[#4K'5(&GL+N&YB5RC-$X8*PZJ<="/2@!LVEV5QJEKJ<MNCWEJ
MDD<,IZHKXW8^NT?KZTRTT:PL+*XM+2#R(;B62:01L5)>1BS'(Y!)/;I5JY\W
M[-)Y#JDNT[69=P!]QD9_.N)\,ZYXF\1> [+7Q?:5!=7419(6LWV;]Q55W>;W
M( _&@#7G\!^'+CP];:%)8L;"T</;+Y\F^!AT*/NW+^=23^"M!N-%ATJ2T<P0
MRB>.3SW\Y91TD$N=^[WS[=*T7UO28[V6R?4[-;J&,RRP-.H=$'5BN<@>_2G2
M:OIL5C'?/?VPM9?]7,) 5DXS\I[\ ]* .8USP9;P:+J[:/8/>7VI+%'=I<WL
MA:XC4@, S,0'V;MK'H3Z5!X<\/20:M;W=M8:]I441;SXM1U7[0DRE2-H02R#
MJ0<G!&.^:ZT:SIC:=%J"ZA;-9RX\N=904<^BGN>#P*;%KVCSBU,6J63_ &LE
M;?;.O[XC.0O/)&#D#TH S='\#>']!U%KW3K)H7+,Z1^>[11,WWBD9.U2<GD#
MH2.E7=5\.:9K-[9WMY#(;FSW>3+%.\3 -C<I*$94X&0>*KZSXPT31=%U#4Y;
M^WE2Q^66.*4,PDQQ&0.C'T/UZ4^35;>YU;2A::]8+%*)6:U!5WN@%."AW9 4
M@DD ],<4 5K?P)X>M8[2."SEC2SN6NK=5NI0(Y&)R0-W3YFXZ<GCDU-+X.T*
MX354GLFF35B#>K+-(XE(  ."WRD #!&,8'I5V'7M'N;2XNX-5LI;:V)$\R7"
M,D1'4,P.%Q[T7FO:1IZQM>:G:0+(H96DF505/ ;.>A]>E %'3_!^D:;J4&HP
MK=R7L$!MTFGO)96$9.=IW,<C('!]*GU#PSI.J:K!J=U;N;N&(PAXYGCWQDY*
M.%(#KGG#9%:K.BQF1F4(!DL3P!ZU3L=9TS4Y7BL;^VN)$0.RQ2!B%/1L>A['
MH: .(UKP;!8MI%E8>'KR\T6RCEV+8ZBT5S#*Q7G<\BDIM&,;O3C@5I:;X,M[
MO39[75(]3&GR2QS0V5WJ4DLD3H<[BZN<<[3M#,!MSU) Z#_A(]$\]83JUD)'
M)"*9U&\@X.WGG!XX[\4V+Q-H,]TEK%K-A)/([HD:7"%F9!E@!GD@')]* *VM
M^#M%\0RVD^H6\IN;0%8;B&XDBE53U&]""0?<TS5/!'A_5[>QBN+(I]@&+62W
MF>&2(=" Z$'![\UIV6M:7J4TL5EJ%M<21 ,Z1RABJGH2/0]CTIMKKNDWTTL-
MKJ5I-)$GF.J2J2J?WO\ =]^E %FRLK?3K.*TM(A%!$NU$!SC\3R3W)/)-88\
M">'EL/L*VDRVHN1=+$MW, D@8N"N&^4!B2%'&3G%:]GJVG:C(\=G>P3R(H=E
MC<$A3G!(]#@X/?%4=2\4Z5I>NV&CW5U''=W@=E#N%"JHZDGU. !W_"@!EYX.
MT/4)]0FN[229]0@6VNM]Q(1)&OW1C=@8))!&"":;:^#-#M+X7J6TLER+8VC2
MS7,LI>(YX;<QW=3R<D#@5H3ZWI5M>+:3ZC:Q7#,$$;R@'<>B_4]AU-7Z ,_1
MM%L= TV/3].CDCMH^$5Y7D(&, 98DX   '0 5FS^!O#]S:ZC;2V<IM]1F,]S
M$MU*JLY.XD -\N2 3MQD@9Z50U'Q8#XT\-:9IFI6<UK>RSI<QH [D)$[ AL]
M-RXX'4=>U=$VMZ4NH+I[:C:B\8E5A,HW$@9( ]<<XZXH A_X1W3/[975FBE>
M]6V-KO>>1@8B<E2I;:02,\BJ>A^"- \.W;7&F6;Q,=VQ&GD>.+=UV(Q*IGV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<?\
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MULUE++S&R(C+)$&Z;@S$[>IW9Q7>44 >0>&=-ETO5O %KJ,962"WU%@DR_-
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MYRNO,6(9!\P/W?F*CGOBK5VEJ4^*N(XRUQ#B+"\RG[*%^7^]\_''\7O7JU%
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MM/\ !^D:DMO--8Z=XDN+B^ABC+,L+23;9-HY(7>K_D>U:WC.XTC5/AWXEO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7.)EVE$WYVG/).\8!QT/XZ,^A:L^J>-YUL@8]8LXH+0^:N2RQ,AW<\#+ ]^
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MRW6.<D,'G3 /R\<CK[]!TK<\4:1<W47B3Q)=6YM5C\.W%C!"[*SMD,[LVTD
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M+J2:&9$&61T=B#E0>1@Y[UH?$;1M0\1>"+_1],A62ZNM@4NX15VNK$DGV4]
M:B\1Z=K_ (KT=]$6WBTNSN@([RY>822^7_$L:J,9(XR2, ]#0 S3O$.FZOX@
MT.X_LZ[&H7FC->6\HD'E^4WEEDQNY;)7DCMUI;'XAVE[8OJ+:3J5OIR"97NI
MEC"K)')Y?E\,268XQCCG&>#AYT&YLO&NC7EE9?\ $JT[2Y+$8D7<,E"H )Y
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MH ADB+XV-][!0[@01GCMP:RK7PWK]M;^#]3-I!]NT*!K.>S6X!\^%HU1F5B
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MH%:&5 Q=93G"[=I[G/&,YK/@\.:CX>\46>JV*OJ5L=*BTVZC,BK-F(Y24;B
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M-2UC3]'CA?4+I(%GE6&+=GYW8X  'N15N65(8GED;:B*68^@'6O,O$>LC7/
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MPGS,2228??NZ@@<;>G>NM^)]S>VGP]U.>QNC;2@(K,%R2C.JL!Z9#=?_ -=
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MNYVYQZY!(*CP+!':ZEID-]+'HNHS--/9; 2"YRZH_P#"C=Q@]3@BKH\0S?\
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M4 <I;^!;/_A$]2\.7US+=V5_++,[;0CHTCER01Z-R..,=Z+7P==KK&CZG?\
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MG?#LW']^O'S*1C\.U:=[IFE-X>U;1-8U&:\ W3RS.1YT7F%MF"H'SY!"@#G
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M>AP>>E #/#]UI^7UB:>W@FUR?=:+(P1I8@H$84'!)*C?CK\Y]*J?% X\$O\
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MYTQ=,GTFQDL%.5MFMT,:GV7&!2R:%I,T-M#)IEFT5J"MNA@7$(/4)Q\O0=*
M*7@R]M=0\(Z=<6=M/;0%&403G+QE6*E2>^"" >XQ6[3(88K>%(8(TBB10J(B
MA54#H !T%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMV1+I3"BJ/F # E2,?XU2T*.]D\;:-J#:;JXADT26UDEN+4PI%+OC.S9P(U
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MY^0YZ=10!V=%1W$CQ6\DD<1E=5)5 0-Q],FN#L_B5<36.AZK<^'I;?1M6D2
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MI6T5_J%W;I-=7=P@>221E#$[CR "> .@QBIK>Z70)=.\*Z>GVV]%M),OGS%
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M%\YLN7B\OY/D[8SSCT]ZZ^B@#@[CP7J=[I'C2QFFM(O[=E:6W='9O+/EJ@#
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ML&'[S>"N!@YY'.,=>>E=)678:_::AKFIZ1%'.MSIPB,QD3:I\P,5VGO]T]J
M.03P5KB^$K;2=^GF>'61J1?SGVE?/,VW[F<\[?U]JVXM%U6+QGJ>MA;,PW5A
M%:QQ^>P8,A=LGY,8._'X5J+K]HWBAO#_ )<XO%M/M>XIB,IN"\'N<GT[5J4
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MG. ,DX. <56M?&%E>W%JMK:7\UM<S-;K=I!F-)5&2KC.Y<$$9*X!!&: */\
MPCNK+KGBJ^ LC'J]K#! IF<%#&CKEOD[[\\9QCWK+M_!_B71X/#U[H]UIO\
M:>G::NF74%RSF"XB7!#!@NY6!&>G?'U]#IKNL:,[L%11EF)P /6@"MIL5[%9
M(-0FCENV):0Q*50$_P *@\X'3GD]>]6Z0$, 0<@\@BEH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEY!$TJV[. -P4X9@%R0,_*<8)S76:;X8$5Q8ZG?75S-JUO:&U\XS9^0D$J>
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MVMRACE5'*EE/49'/-4E\,6*:G9:B)+G[596YMH',I.V,XR".AS@<GG@4 4?
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MJWM+3P/-K6IM::5-H(ABNV"-&MSA-RN75@I* @$XZ$=S0![&CK(BNC!E89#
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M=)8U:8DG]W'@8'&,8Y&<59O[+0[NY^*<CP64FRU22,LJG8QM,[E]"6QR.<T
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M,=JL6]Y;78<VUQ#,$.UC&X;:?0XZ5Y!KCO;O\25TI 0MW827,5L/F,.R,S8
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MNBF5(/M!WHA[ QYP!QS[UOV(\(ZU<W6KZ;K#:B[:2\$\8$0A2'JHE547# ]
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MP-1,&&C>#"^3NQQ]XG;[!O0U+\));-_AUI<5NT)GBC*7"IC<C[FX;'0^QYH
MTM-\2RR^*/$.FZBUG;V^G/;K!)N*E_-0MABQQG@#BNAN+JWM(O-N9XH8\XWR
MN%&?J:\WEL/#EYX[\;IXCALY(OL]HRBZ R$\HAF3/(.<#(YSBL?2;N;0W\+V
MWC&_FTZVET/RH9[A4*+-O):-S(K!6,7ECG'W2* /9%8,H92"I&00>"*A>]M(
MW"274*,S^6%:0 EL9V_7!'%9'@VQT_3?"UI::5<7-QIZ;_L\MP069"Q((( ^
M7GY>.F,<8KS5]&\.W7A_XC1W5K:&[@U*Y^S */,B<QH8_+'4$OP,?>/'- 'L
M4UW;6YQ-<11$ '#N%X)QGGW.*#>6RW2VK7$(N&&Y8BXWD>N.M>9:=H^GZA\1
MH++7K6SNKQO#%L;J*95;?.)"&8CNP]>N*I:9+HNKP2:7KVKW=OXBM-7DF-E&
M(EG>82EHVC)3<RE"O.<!>,@"@#UI[NVCN4MGN(EG<92)G 9A[#J:P=+\0W%Q
MXI\1:9?"UAMM,-OY,BD@L)%9CN).,\ <5R&DZAH%]%JVB^)F']NQZU)-]F+E
M+B9A)N@:+!#%=FP#'  YP*DOMEWJWQ4MH]LLK:;"HC&"2?LT@Z?7% 'I8N(#
M(L8FC,C#<J[ADCU ]*YSQAXFDT"S@>R>RDN6N[>&6&9\L$DD5"P4$'^+Z5Q]
MIK.F7>O_  W:TO;6:1;"XB++(" YMTPA/9L_P]?:L235=+N/A7IHU">V77;?
M6()+Y)V GCG^U#S&8'D?*3STQ@4 >V2WEM!-'#-<0QRRG$:.X!<^P/6JFMZF
MNF:9/,LULER(V:%)WVAV SCU/X5YK>7.A:CJWBK1/%6L2V4UQ=+);H!&#/;E
M$\HPLR%F((. ISG.!DFIX]0L4U7QKIWB*5$NFM(UM%OV4-+:^3P%SPQW[MVW
M^(T =]X7U2;6_"FDZK<)&DUY:13R+&"%#,H) R2<<UK5S'PZFBG^''AQHI%<
M+I\"$J<X8( 1]0:Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "FR11RKMD17'7##-.KF_'NMW/AW
MP3JNI62.;F*W;RG50PC;'#'/84 ;XM;=2I$$0*]"$'%$EM!+*DLD,;R1G*,R
M@E?H>U<5%KFF^&]5 FE\0RW&H6IECT^5)+C)B^\T><G<01D XXS@5M7'C'3H
M+>XN?)O)(+2-9+QXX"?LH90V''7(4@E0"0.H% &XT$+OO:)"_P#>*C--^R6V
M,?9XL=<;!6-<^,=*@U&WL(_M-S<7-J;N 6T#.)8QMY5AP?O#H>.^*IQ?$/0Y
M;.UO%6^%M/.+9YFM6"V\I?9LE/\ "=W'?&1G@B@#J@ H    X %1FV@*[3#&
M5R3@J,9/4TEW=V]C9S7=U*D-O"ADDD<X"J!DDUQ-WK<]U\2?"T4/]I6MM<V]
MW(\,V4CF4(I1MH/49/#8(R,@<4 =O]FM\D^1%D\$[!S2?9;? 'V>+ Z?(.*Q
MCXPTQ;JRB9;A8;^0PV=T8_W4\@!.U6SU.#@D -C@FEM/%NGWND7NI0QW1ALY
MVMYD:+$@D4@%0N<YR0,=^V: -HV\)G$YAC,RC:)"HW >F>M2$ @@C(/:L2^\
M465BUVIANI_L4:R7GD1[_LZD;ANYY..<+DXYQR,T;GQE$/$FB:;96LMU;:G;
M272W40#(R*%QMY_VP2?3U[ '226T$L'D201O#P/+9 5X]JD50BA5 "@8  X%
M<C'XIT32K7Q)JKW6J2PV5WB[6:.1_)<(ORQJ1E4Q@]ADDYK4L/%6G:CK3:5&
MEU%<^1]IC,\#1K-'D LA/4 D?F#TH V&BC9MS(I8KMR1SCT^E,^R6V,?9XL#
MG&P5@?\ "<Z.%L9<79MM0D:*SN([=I$N&&<A0N6[$@D $ D9K2U_7['PUI$F
MIZBTJVT94,T<9?!) &<=!DCDX% %[[-;DD^1%ENIV#FD>UMY(3"]O$T1.2C(
M"OY5D0>*K2Y#+#9ZB;CS7CCMGMC')*$"EG4/@;/F7YB0,D#J<5%;>-=(O;>R
M>R,]Q/>22Q16JIMEWQ?ZQ6#$!2O?)'48SD4 ;_E1ED;RUW("%..5!]/2E>-)
M5VR(KKUPPS6):^+--O["PNK(37!OFD2"!4"R%H\B0$,0!M*D')^F<BI?^$DL
MC!9LD=P]Q>%Q!:B/$K;"0^02 H&.22!R!U(% &NJ*BA54*HZ # IDMO!/#Y,
ML,<D7'R.H*_E7/3>.]#M]'DU*62X6**Z%G.GD-OAF+!=KC^'DCD\'(P3D5+!
MXRTF5]428W-FVF0"YN!=P-&?)()$@!Y*_*WOQTH W3%&T8C:-2@QA2.!CIQ3
MBH)!(!(.02.E<Q<^)+74[/4=/B^V65Z---[%N&QC$00KJRDXY'0X(]*R?!OC
MBR?1/#&G:B]^+R]LH52[N8'\JXF\L%E$IX9NOU]2: .\V+AAM'S?>XZ]N::+
M> 1M&(8PC=5VC!_"N-\,ZJ;.\\8R:C?3R6UGJH2,S.TA13%$0BCW9N%'4FM_
M3_$5G?ZO<Z28Y[;4+>)9FM[A &,;' =2"01D8X/!ZXH TC;0,Q8PQECU)49-
M->QM)$"26L#H#D*T8(!K&U3QCIFE:L^E20W\]^MO]I$%M:/(SINQ\N!@\^G
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M"5^A[4LT$-S'Y<\22IG.UU##/T-5)]5A@O([5X;@R20//^[CW[57 .=N3G+
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M.,[AZ<U<;3]<T>Z\8Z>ND7-_;:R9+FSNH'3"LT(0QR;F!&-HP1G(]^*]&HH
M\NF\-WMSH&BQRZ7JFGZSIVCPPVVH6,R;TF4$-$^'PR$JIYXY.2*[6ZTN_P!6
M\#3:3?S1QZC=Z<;>>6,?*LK1[6(]LDUN5!>7MKIUJUU>W,5M;H0&EF<(H)(
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MK(J;NN5/S9[],>]7=-\&W,.FZ'IFHW\-S8Z*\;VZQ0&-I6C7$9<EC]WK@=2
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M"N<_,-N!SZ5KMI4NO^._%FF3ZSJT%K%;V<D*6]Z\?E.ZR99<'CD9QT/<' P
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M)GB2964)&51GYYR>%]/QK9KS*XLX!K/PYU".\N;F2XF=I)9+AG$Q:U=M^"<
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M!AC,G(P17100);0)"AD*H, R2,[?BS$D_B:\[\+VE_=>*?'8LM3-DW]I* 1
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M>AZHFN:!I^JQQ-$E[;QW"QL<E0RAL$_C5^N<\ ?\DZ\-_P#8,M__ $6M='0
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MH RKCPWI-S('>TV$6XM<0R/&IA&<1D*0"O)X/'-:<<:11K'&BHB *JJ,  =
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M D)R6!)RK9).1@\FMVLGQ'XBL/#&D/J.H2A(PRHBYP7=C@ ?CW[#F@!C^$]
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M26,\BX2YB16:,YZ@,"#3-)TU=+LO(,\MS,S&2:XEQOF<]6.  .P  P  !TH
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M&5=VYM[ <9(! ]<\5UR:KI,/C75%EM[BWO+;38YI[J63]TUON?!4!B."'R<
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MK7-K<K)I*LMXL"\B.]E0JY!_ZY@-C_IKF@#4\<Z]=^&O"5WJ=G;>?,FQ%RP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*2(PR&4C!!'H15?2])T_1+".QTRSAM+6/.V*%=H!/4_7WJY10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.R#Y8HAEG;H%&>,DX'.!ZT 6**Y72O%E]+XF70=;T-M+NIH&N+5TN5GCF12
MPR -K#(X_7U;'XXA>TAU7[(!H4][]CCO?-^8G>8Q(4Q@1EQC.[/(.,4 =917
M(>(O&&I:"ES?1^&Y[O1[,_Z3=K<JCA1]YDC(RRKSDDCH<<<UKZEXCM+""Q,:
MO=7.HD+96T7WYCC<3ST4#DL> /? (!L45%;-<-"#=111R]UBD+J/Q('\JEH
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M&O8KZ2>+3[F2U3S+A(F:)#_$P!P/SJI_PCFA_94M?[&T[[.C^8L7V5-BM_>
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M>RMTM[6"*"",82.) JJ/0 <"LVX\*^';RXDN+G0=+GGD.YY);.-F8^I)&2:
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M-$DJ'*.H93C'!KD_%>NR1W0T?^Q]:N+.1,W4]C9O(&4_\LU88ZCJ1T' Y.5
M,RQ\8ZIJNC^"[=E6SU/Q '>:5%!$<42%W= V1EOEQG(&[OBK]EJFL7^IZ]X:
MAOECO=.FA*W[Q*S"WE3>#LP%+@AEZ8Z$@\@U[^">_P!0\*>*;;2KRV@TR:>&
M2SDAQ,D$B>7N\L9/!53M&3M.?:H8I+S1=4\3^+!I-_<MJ<MO;V5K%;N9"D2;
M=[+C*J6+'GG '&2!0!<T'5M6TK6?$.F:_J:W]EIEO%=IJ#0K&RHP<LCA0%)
M3.0.A]ZD\)^)T\3R1W<FK6T#W"F:VTF*2,R+#V:3JQ8C!(& N0.3S5".-O$W
MAK7M$@TO5K2ZO[24SWVHVI@$LS+M7 R21C P.BJ!3%TVXUE/!*1Z?<V5[H\R
M27;2PL@A18F1XU8C#!FV@;200,T >ADX!-8K^+=$33+C4GO2MI;W!M9I##)^
M[E!"E6&W(Y('(QDUM5X_J]MJ<?A3QGH::+J<UY<:P]W"8K9FCDB>:-PROT/
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M+;MJD9R1C.1P,FKEE8ZA8^*X+G1!J45K<ZG-_:&F7MLQ@C!+[KB&1AA=Q^;
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M'<N;60"%FCC4!CC@DJWY4 ;Z^//#+O&JZHK>9<_90PBDVK+NV[6;;A<G@;B
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ML@D#;"0#SM&<?AUXKGM%@UC0=(\(:LVBZC/#ILE]!>V<=LWGQK-(2DBQD L
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MD55M682JUV) 5('S#9DY'';KQ0!Z+9^*-&U"XO+>VO=TUF@DF5HW0A#G#KN
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M8S1K=DR!C.T2E<J 1D#J1G)X%:/_  FMQIEWK]OKUE!"VEV:7RFTE,@DC?<
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M-S#HLP8\R1.A"%O4JZJ1Z;F'<T =Q4$M[:0N4EN88W'57D -3UP/Q0T;3H_
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MIALH(H(P#!Y<87R6'*LN.F"/QZ5GS^)KZZ?6SHMG!<IH[^5*LLA4SRA [(F
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MP>-GP>/E(VXXS6:OB76=1\2^$5MTMHK/4],DOI(6=L[ML9() Y $G [GD]J
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M/"4120,KD;@5R<]CQ0!V%%>>OX_UB+2;W5I-&M%LM/U5K"Z NV9R!*L6Y/D
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MK*MO NI6_A;0-'^W6C/I6I+?&7RV E"R,X7&>/O$9R>G2N]HH Y)O"5U/?\
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M)+.34(4OHM8;6+*YCC)6.4R%]K*3\R_,5/(R#7<QQ1PQB.)%1%Z*HP!^%/H
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M\5!X>\&6NAZ3J6FO*T]M=R2JB'CRK=BQ6$>R[WQ_O&M^]O8-/MC/</M7<$4
M9+,3A5 [DD@ 4K72)&Q*MYJQ^885P7Q] ?7CTH YCPQX=\1Z*EMIU]KMO=Z1
M9 +;;+<I<2(!A%D?=C"C'09.!DXR#?\ %6A76O1:8EM/#";/4(;UC(I._P M
MLA1CIGU[>E7= UNU\1Z'::O9+*MM=*7C$J@-C)'(!/I6E0!RZ^'=03Q'KVJK
M/;%=3M(K=(R&S&8PX#$]\[SQQTK,TSP5K&E-X=:#5;1CI5@U@ZS6[.A!V_O4
M&X;7PN._!KMKJYALK66ZN'"0Q(7=CV ZU!_:,9F%NL4K7'DB9H@!N13D#/.
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MM9(8(K2:UUA70NN-[8(D3S(B7Q\P(R#QZ^K5%);032))+!&[I]UF0$K]#VH
MH^'KJ[O-#MYKV&"*<[E(M\^6P#$*R9Y"L & /8UIT44 %%%% !1110 4444
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M@1?R#M^=1:9;N?B]K[F[NBJ:?:.(S)E>3*,8].^/7)K=UW1GO;W2]5M0IO\
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M@_C[FMFLKP[97>GZ/';WD]Q,X9BOVF7S940G*JS_ ,1 [\^F3C)U: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ljb_employmentxageementx002.jpg
<TEXT>
begin 644 ljb_employmentxageementx002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !65KNOVWAZWM[B[AG>*:=+</$H(1W8*N[)& 20,]*U:R_$
M>C1>(?#FH:3*=HNH617_ +C=5;ZA@#^% $,7B6UEUC5-+\BX2XTV%9YC($56
M1L[2IW<@[3ST&.<5176M.O/$^D@QZI%?SV$L\$#92-H_D)WKG:7Y7'7&><5S
MR>$->NKO1-6NVC74;V)K77U#94P%5;:/IY83CO(QK?U'3]0E^)&BZE%92/86
MUE<0RSAT 5I"A7@MN/W#T'<4 <MK_BJ]USX9ZIJP@O=,DMM06*-TG"_*MTL1
M4E&))QG(/'/&>M=SIGB:TU/6;K21;WEM=V\2S[+J'9YL3$@.O/3((YP1Z5P]
MSX=\0_\ "OM8\/IHTCW#ZHT\#K<1;9HS=";<,L,#:,<X.>W>NGBL-1;XGMJ[
M:?*E@VCK:^<SQ\2"4OC 8GH>N.M $_B'Q+<:-KNA:=!IL]U_:4TB,\;(,!(V
M; W,/FR ?3&><X%<Y:>*$\.>(?&LEZNJ7EG:74+XC#3"VB,",Q^8\*"2<#GK
M@<5N^*]/U*;7/#.IZ?9&\73[N1IHED5&"O"Z;OF(& 2,]_0&L2\T/6Y[?XAH
MNDR[M9C"V7[Z+$A^SB+^_P ?,,\XX_*@#K;[Q%;6N1!;W-_(MN+IX[4*66(Y
MPQW,!S@X Y.#@<5<TG5+/6])MM3T^836ES&)(G QD'V['VK@'T;6M+UJTU0>
M&(]9MKK3;>TN;5Y(1+:RQ;L,"YVE3N.<'MFN_P!+ADM],@CEM[>V< DP6XPD
M>23M' SC.,X&>N!F@#B=#U9M.\1>.KB_N[^>RTJ6(Q1&1Y?+0PAVVKDYY)/M
M6[I_C?3=0O\ 3[5;:_A_M&V-Q:2S0;4F 4,RKSG< <],'L37/P:-K:W/Q D;
M1YPNL(/L7[Z'YR(/+P?G^7GGGM4MOH^L1W7@!VTJ;;I%L\=Z?-B_=L8!&/X_
MF^8=L\4 *_BZVTGPDVHZ-:ZC>I-JQM&^UOEHY'GV-]]LA020H^F<#)K=74K"
M7QM:VDBZC#J9TZ240NQ$ CWIG(!*EP2!D9QSS7)'PWKS>!+RT&E.+U=>.HQV
M[319EC^U"7 8-M!V^I'-;TUEK$_Q!L=733&CMTTB:V:1Y8RL<KNC*" V2!MY
M(!YZ9ZT 7M.\9Z9J=UIT,45TD>J)(UC.Z )<"/EL8)8<<C<!D53\ 2S20^(4
MFN)YQ#KEU%&9Y6D944J%7+$G KGM-T?Q/)K'A/5-0T2;[;8R3KJ,\MW$VXO&
M5#( Q CR>%&"/[O>NF\$Z?J&G#7A?V4EM]JU>XNX=[HV^-R-I^5C@\=#0!D^
M+KU+/XB>&K:ZU6XL]-O(+LW*B]>!&9%39R&&#DGIC-:=MK.C:3IVM:Y;:E>W
MVF6@"2JLSW01D4LY1F8GD.N><#;5?Q#8ZK)\0_#NK6ND7%U9:?!=),\<L*DF
M55"X#N"?N\T_Q#%K&L^'?$=C::!-;F[L)(HQ++#ON)W38#\KD*J@#))R<C X
MY +0\=:>;^WLS8ZFLMW;F>SS;<7(&,A.>HW#.<#'.<<TT_$#1DT>+4I8[V)&
MOO[/DB:W)DAGW;2K@9 P2.YSVS5)M,U5_$G@R[_LN80:=9SQ7;&2+]VSHB@8
MWY/*'IGM7,:O9:GI>A73W>FRQ/<>,8+RWC,D9,J/,FT9#$ \=\=: .HU#Q=9
MZUHGB73H%U+3M3L;"2?RYT:WEV["5D0@YQD>OL15[0]=CMO#'AN"03WFHWFG
M12)#&09) L:EW)8@  D9)/4CN:S-7T/4-6U;6M:CT^6-WT*32[:!WC$DSNQ8
ML?FP%!V@9/\ >]LU['0]:TF_\*ZTNGRS&TT@:5?V:R1^9'PA#I\VUOF3!YSC
M&,]* -N;QYI,.D?VD8KMHDO/L-P@C >VFW!=L@)&WDCGD<@YP16AJ?B.UTF6
MY2X@NF%M:&\F>*,.$0$CH#G/![=CZ&L73_"*WEGXI_M:$Q1^()V=K?<"8HQ&
MJ*21D;_E+<$XR/2J>B:=J]S\-M0FO"+_ %?4;)H4:,A?-01F.(@L0,,/WAR>
MLC4 :D?C[3))]/B^Q:FHU*#SK)S;'$^%#%%P<[L'/( X)SCFK=CXOTV^TRYO
M/+N8&MKK[%+;31XE6?( 3 )!)W+C!QSUZUS\.CZPDWP_9M*F TB%DO3YL7[H
MFW\K^_\ -\W/&>/RK-O?"VOW5KX@EATU!<G7H]5LX;J2,QW2(B*4;#';G:W7
MV_  Z:\^(.DZ=;:K)?07UO-I81KFV:(-(%?[CC:Q4J?7/'?%6X?%UK<:G=Z:
MEC?K>06INXXI8A&;F+.W='N([X'S;>HKE]<TO5]=\"ZQ;VGA"+2[NZB2&.V6
M2#S)&W DLRD*%&..<GG@5M2:?J4_Q(MM5_LZ9+'^QI+1I6DC^61I$< @-GHI
MY /- %_P;K\WB;PQ9ZM-9O;&Y3S%5BI!!)QC!)P!QS@^U<QXVL[K1X-(GAUC
M5/.OM?@@F*WDBKY,LC9C50<* , $<\=:WOA[8ZEI/@O3M*U2Q-K<640@.95?
MS,$_,-I/!XQGGKP.]?X@:9J>JV^AQZ;I\ET;75[:\FVR1H%CC8EOO,,GT% %
M^,IX>O)+:*;4=2ENE\V&S:;S9$"8#D-(P 7)7J>IX]J:_$71)(-,D@COIVU%
MY8X8X[8EA)&&+1L.S?*1CZ'IS53Q7I>J+XFTWQ#8Z'%K,"VKVEU82-&LB!F#
M*Z%_ER""",]#^4=QI6JR:WX3O8M 2VAM+J>>Y@MGB @62%HU!^8;FR03M&.N
M,XY -%/'UC+)/!%I6LM=P6L=U):FS*RA'S@88CD;3GGV&33[3QYI-[+I/DQ7
MOV752%M;QH-L+2%2P0DG.[ /;&01FH8K'4H/B!K6J'39FLY].@@AD62/YW1I
M"1@MD??&,X[US]EX>UVW\'>!=.?2)OM.DW\4UVHFBPB(K@D'?S]\=/>@#TZL
MK4=>@T^Y:U2WN+RZ2 W#P6P4LD8.-QW$#D@@#.3@X!P:9H>L7>J3:E#>:7)8
M26=R85#3+()4P"KY7ID$':>1D>M8.IVVO:+X\EUS3-*;5K'4+..VN(8ITCDA
MDC9BK#>0"I#D'G/>@#8@\6Z=>P6#Z<D]])?6QNH8(5"OY0P"S;RH7D@<GD],
MX-<[XLU^#5_"%CJ>DWES"4U>U@D57:)T;SU22.101[@@U;?3M;L?&]IXE:S^
MUQW&F_8;RWMI%W6["0R(R[RH=?F*GH>AQV&1?>$]63PW>BWL'EO-1\0IJKVZ
M2QCR8Q*C8)+ %ML8S@GD]QS0!LV5X;3XE>)1<WDHL8=,MK@K-,QCBYEW, 3A
M1A1G'I6I'XOT_P#M2WL+J*YL9+J![BV>Z5529$&6((8E2 02&"G':L#4O#>I
M:SXA\5JUK);6>K:-'8PW3.A D DSE0Q;'SCMV-0Z=I&K:SHL^DZGX5LM&N39
MRVTVH(T3B1FC9-T03YAG.XYQ@<<YX .CB\864UW96ZV=\&U"&2:P9HU"W010
MQ"_-\I(((W[<U@)XPM=9^'L6LZS:ZE8VUQ<(%:T?#?Z_" ,C9 R%5B<9R?6M
M+PC<^)Q96.F:OHBV1LHA%/=_:$D2XVKM!C"G(SP3N QR.>W-+X=\0K\)$\-G
M1I#?6]S&%"W$6)56Y$I<'=@#:.,X.>PZT =['X@MI/$\OA\P7"7D=N+K<RJ$
M>/.W*G.3SQTXJ-/$MO+!;M%:7<D]SYA@ME">9(J'#.,MM"Y(Y)&=PQU%9GB[
M0M2U&[T?5M%80:C;2-!*S$ BWF&V3ZE3M<#U7WJEXIT*^M-9T75M(T2#5[6R
MMI+&;3G9%81,4*O&7^7*E!UZ@T 5]=\10:U;^%M1TJZNX5;Q!%:7$6]HR"-^
M^.1 <'!4=<^W6NILO$MI?:CJU@L%S%<:7M-P)0J@A@2I4[N00"<]*YO5])U6
M[L?#SVWA^.V,&M17TUK;/$/(B56!W'(#/R#\N?3)QDR^+-"FN_%FDSV,RQG4
M8WT_4HSUEM /,)]B""F?^FM '6V&H)?Z5!J"0S1QS1"54D3YPI&1E1GG';K7
M/Z?\0-)U& W,5MJ26864M=26K"-61]A0G^^3C"]\XZ\5U)^1"54G X5<<^PK
MSBU\*ZU=?"J\T)[06>IB[DNH$N'1T<BY,Z [21@\ YH ZF/Q9;R:A=Z8;"]B
MU.WMQ="TD$8:6(G;O0ARI /!R01Z5S'@_4#>:+H7B2_DU;^T[R)D\A9P8[YG
M!?B,L0 H4D$[, >E;&A_VA+#/=3^#8='F2W:,QQO"TLSG'"LI "<'[Q&<CCC
MGFH?#'B"T\$^$6718[G4-")6XTRXEC*W",A1MK9*[AD$9H ZB3XAZ+#:M+/'
M>QR1WZZ=- 8-SPS,0 &VDC!R"""<]L]*;)\0K"*:.V?2-<6\EAEFCM38MYKK
M&P5L#/.<Y&.U96KZ7JVHZ-I\EIX72Q==7M+MK.%X0ZQQ.&9G8,%+'H ">G7G
M V+ZQU&7XD:1JD>GRM8P6$\$LWF1@(\C(1QNR?N'.!Z4 3ZAXUTW3;22]G@O
M/L,#I'=70C&RV9L<."=W&Y<[0<$X/0XJ^+O$$0\/^(+:R2^FFL[-VFN+)MOV
M9RA9?FW Y PQ"Y(&,]><:WT76-*UW5[-O"MEJUI?WDEW:ZC(\0$/F'+)*K?,
M0ISC;G(I&TC7]('C'2X=(DU"UUHS7-I=0RQJ$>2((8Y%9@0 5&" >* .Q\*R
M/-X/T265V>1["!F=CDL3&N23W-9.D^-5NO\ A(KC4K.6PL=)NGA,\A0@!$0D
M':Q)8EB0 #Q@9SQ6OX7M[FS\*:3:7L!@N;>SBAEC+!MK*@4\@D'I7%7_ (1U
MO4-)\:Z,MN(/[1O_ .T+*\:53'(0(BJ$ [AS&0<@#GC- '96WB6UEUB'2;FV
MNK&\N(C-;I<JH\Y5QNVE6(R,C*G!&<XJ'Q7?:?96^G#4'OD6;4((XC9EE/F%
MP%#D$?(3U!ZBLYM/U#Q#XD\.:K>:;-IPTE9I95ED1BTLD>S8NQCE1EB2<=%]
M3B?QUIVH:GIVF1:?9/=/#JEK<R!71=L<<@9C\S#L.!0 Z^\<Z?97VJV8LM3N
M;C3(TEN$@MB<(P8[@20" %/U[9K?LKZ#4=.M[^T;S;>XB6:)@,;E89!Y]C7'
MG3-6'B7QA>#2YC!J%A!#:L)(OWCHD@(QOXY<=<=#6YX-L[K3O!>BV%];M!=6
MME%!+&S*V&1 IY4D$<4 <1XC\57VM_#7Q+?+;WNER6-VT,4B3A"-DJH02CY)
M^]D=.>">M=M9^*K*\UBZTO[-?074%N+I5F@*^=%G;O0<D\\8(!Y'%<5?>'/$
M+>!O%6A1:.\D]WJ4UQ;2+<1!94DG$@(RPQ@9SG!SC&>W2M9ZD?B5%K/]F3_8
M1HS6I?S(LB4RJ^W&_/0$9Z9_.@!?#_B'24\-:0^G'4+J.^DECM([E]T\A5G+
M9+MVVMU/3 ]JZ+3KY-1LEN4AFA!9T,<RA74JQ4@@$]P:\\TSPM=/X"T;1-<\
M/7,A@FF>1H+F-9K5B[,DL;*_^UC@Y]O7K_"EMJ^G>&8X=8EFN[N)I=AD93,T
M6X^6'(.TOMVY.<9[]Z ,'Q_XBU31Y[6[TTDV>D21WFK*O)>%V,>P>N 7<^FU
M376:EK5CI6DG4[F;_1?DV,@W&0N0$"^I)( ^M8%AX:35M,O[C7K&]AN]0DE-
MS;"]8*4/RJN(Y-AQ&%7GK@YKF%L-:M_A0/#^LZ5*U];W$5M89NH@\ZB4&)D(
M8@2*HS@\?)SQF@#M#XRL([^_L9[2_ANK& 7$\1@WXC()# H2#G!'7J#46G^.
M=.U*UBN8;/4EAGCA>V>6VVK<&0$A(R3@L,'/0 #.<<U@VCWDEYJS7WAW5X=8
MU*Q:"*6YEMV60(IQ&IC;"\L6R>O//04VY\-ZV_PY\+00Z;%)JNA&WDDT^YD0
MI<;(C&Z;@2HR&)!/M0!TUOXQTV<W\3I<07MC/';S6<JCS=\G^K VDJ=V>"#C
MKG&#56[^(.D:?:ZK+>P7MO-I1C^U6S1!I%$GW&&TE2I]<\=\5B:MH>KZUH"W
MEEX8L=-O+6\@NXM.F:+-UY>X,LC)E0"'(7K@C)QGANNZ5J^N^!=7@M/",6F7
M=TD<<=JLD'FN0X9F9@0H4 <#.>O H Z-O&MFNK3:7_9VJF]6'[1##]FYN(\[
M2R<\ 'KNV]15BR\6Z=J.C66HVJSR?;9&A@MM@65I%W;T() !78V<G''7I6?+
M9ZD_Q)M-8&F3_84TF2V:3S(LB1I$<#&_/12,],_G7*0^%_$-KH.E7:Z''<WF
MF:I>3R:;<2Q8N()W<_*V2H8!E(SCD'\0#K6^(6BQ6PDECO8Y%U!=-E@\C<\,
MQ(P&VDC'((()SVS3;OQY;Q:/X@NH=-OC>:+#YL]G.BQN5*EE?EL;2 3Z\'C/
M%96K:5JVHZ5I<EKX82Q9-8M;M[2%X0Z11-EF<A@I8]@">@YYX74O#^KZAJ?C
MO98.D6KZ5%:VDKR1[7D6.52" Q(YD')'K0!V6BWLVHZ-:7=Q;O!++$K,C[>I
M .1M)&#]:RY_&FF07+QM%=-;QWZZ=)=*@\M+AL84\[NK*,A<9/6M#P[]K'A^
MQ2]LGLYXX4C:%W5V4JH!R5)'4'H3QCZ#@==T;Q3JGVT7&C275Q;ZU#=6DHNH
MUC-JDJLJQJ6X?:#N+ 9Y^8\"@#N#XDMC=R0Q6UU-'%=+9RSQJI2.5MO!^;=Q
MN7)QCFHO&>OR^&/"6H:Q#:-<R6\194!  /0%LD< XSCFN:O/#VIR^)4UC3+"
MZTG53?1_:9HKA#:WEL&&XR)NR6V9 .T-G';IT7CO2;O7? VL:98(KW=Q;E8D
M9@H9N#C)X&<=Z ,+5]6N+7X@>'9S%J2K<6%X7L$?>7=3'M^16*9^8\YZ'DBN
M@L?%VG:AI%OJ%NEP6N)WM8[5D"S><I8-&5)P"-C$Y.  3G%94MKJ][XV\.ZN
M^C3PV]M97,<^9HB8VDV;0</S]PYQD<CDUS?_  B_B&+2TO8]%CGN[+7[N_73
M[F6+;=03%Q@$$J& ?(ST(H ]"T7Q!9ZXU[% DT-S8S>1=6TZ@/$V,C."000<
M@@D&L>_/BX2^(%M;*&1?W3:=)]LV>:OR[X]N/W;8W_/ZL.P&-+PW'-]GEN)M
M#@T;S2-MLFPR<?Q.4^7// !. .O.!MT >;:K?M!\0M#M=7U&?3;2YTF2:YMQ
MJ4D<:SJR@ .&7.,D=L]<5M)K^C:#H>JZ_%J%]?Z3 P5MLCW.QEX;8S$G'(ZG
M (/-0:K9:LOQ.T[6H-'N;FPMM/EMGDBEA!+NRD8#.#CY:C\66FM:_P"$O$6G
M6>@2V[74 2%))80\\K?>8X<JJ@*O4Y.3QQR :K>-K)=6;3#I^J?:V@-Q;I]F
M_P"/E 0"4Y[$C.[;USTJ(_$#15TBPU)DO5CO;LV2Q_9F+QS!BI1P,X(*GCG/
M;-13V6IR^/\ 1=5&F3BSM]-G@F<R191W:,@8WY/W#R/:N0O++4]'T?2%O--E
MCG?QG]JBA\R,F1)'D=<$,0#@]"1S0!U-[XLL]>\.>)[2V&HZ=J6G6<CR0SJT
M$T?R%D=2#T..H/UJ[HFN1VWACPW!*)[O4;S3XI$AC(,D@6-2[DL0 !D9)(Y(
M[FLS4=!U#4=0\2ZTEA)'+=Z/_9EI;,Z!Y3\Y+M\VT#+@#)SA3[5!9:'K6E7W
MA36DT^65K/2/[+O[-9(_,C&$(=/FVM\R<\YQC&>E &T_CW25M(+CR;PB2^&G
M2)Y8#6]P2 $DRPVY)'/(Y'/(S<U?Q39:+_:!NH+MH["U%W/)%&' 0E@.ASGY
M&[8XZUAQ>#EO],\6'51]E779_-"%@3;*B*J.2#C<"N_@X''I5:+2]:U+X3:E
M]IB%WKVM6#;Q&0@+-$$3[Q&!M"D^Y;UH VAXZT_^T(+(V.IK+=6YGL\VW%R!
MC<$YZC<,YP,<YQS5BQ\7:;?Z3]OC2Y1OM361M9(P)A.#@QXSC/?KC'). :QV
MTS57\2^#;S^RYA!I]G/%=,9(OW;.D:@8WY/*'.,]JPIO"_B!]+O[B+2$>[M_
M$LNK6]G=2QE+N%E*E,@D*VUC][H<4 =3<?$'1[*UU"6[AO8)M.GB@NK9H0TD
M1DQY9.TE=K9&#FIO^$SM6DU6!-/U 7FGVPNOLTT0C:>(YPR;CC&5(YP1Z5SV
MMZ7JVL^#;V*T\)QZ=<7$]J5M(Y(1(1',KLSL"%Q@8 R3],\:-YI&IWOCG4;U
M;"2.SN=!^PI.\D>!+O=L$!B<88<XZT ;GA36)]?\+Z;JES:O;2W5M'*5)7#;
MD#97!/R\\9P?:N1\56-UH]WX6BCUG56>_P!72WNV^VR 2(RNQ4 -A1D#&.<#
MK73^![>_L?!FDV&I6+6=S9VL5LR-(C[BB!2P*DC!(XYSZXK.\;Z;J>HZGX8D
ML-.EN8[#5$N[AUDC4*@5E.-S D_,.E %^*9/#LMQ91OJ6JS2DW4=OY@EDABV
MJI&Z1AQN!(!.22<9P<4_^%C:')#IDEI'?WG]I02S6J6ULS,_E_?7''S \8[=
MZI>)=+U2W\90:_::!%KMG-9+9W%HSQK)"RNSJZ^9\I'SD$9]*>VDZI_PE?A6
M]718X+:SCNQ<K;/&(X/.V[5QD%B-OS$#KR* +;?$'3@NH!--UB273X8IKF$6
MA5XT="^2&(Z <CKZ9YJU:>-=,O-2TVTBBO!'J<9>RNG@*PSX3>5!/.=N3R #
MC@FLDZ7JRZ]XWN?[+F:'4K6&*T82Q?O62)D/&_CEAUQ52VT36HK3X>QMI4V[
M1U O?WL7[O%N8N/G^;YCGC/'Y4 7QX6UE=.\A/$&L>8FJBZ@DDN5+B+ RDIQ
M\R9WD(/51Q@XT;/5'L?&LWAV:1I(I[3[=9LYR5 ;9)'D]0"58?[Q'0"NDKB;
M^"YN?B<-1M+<W TC1I 45@OF32L"D>3P#M0GVW+ZT =M16;H&IRZSHMO?3V3
M64TFX26[.'\ME8J1N'##(X(ZC!K2H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK"\3ZZ^C)ID%N
MJ&[U*^CLH6D!*H6!)8@$9PJGC(R<4 ;M%<+J7BG6-'U+7-(E:UFN;;2'U6QN
M6A(5E4E6CD4,.<@8((X/3CDTOQ)KQUCPLFH26,MKKUD\GEPPLK0.D2R9W%CN
M!R>,#''6@#NJ*X_XCW.H6V@V36%X+8R:G:12'R]VY6F48ZC ]?4<<4S4->UR
M:_U/2](19;S38(RSBW#++,ZE@I!D&U,8Z$GD\C'(!V=%<"VO>,+[Q#;:/!'I
MNFW,^C"^=+F)I3!,)%1D)5\,.3@C'7OBJ=[XK\4Q:+XLU".?2P= O'0(;5R)
MXUC1]OW_ )3\QYY^@QR >E45Q\&NZU!XPT[3[UK.:TU2QFN88X8F1X&CV':6
M+'>"'ZX7D=!TJ+P?XMF\0WRP37<$=W%;L;_2Y8&BN+6;*X R?F3!89P>W/.*
M .UHK#\0:A>V,^GQV\MO!;SRLD\SC?(,*2JQ1CEV)],X /'IR</C;7KGP_X?
MO(EL1<7NLOI=P)(7 (5I ' W97_5\@YZ]10!Z15(ZOIXUA=(-U'_ &@T1G%N
M#EM@(!;VY(KBY/&NIZ-#XEM]3^RWEYIES;06TD,9A24W 78&4LV-I;DYZ#UJ
M3R;^'XOZ2+VZAN =&N2K)#Y9!\R+<.IXZ8[]<YH [VBL'5]8GB\0Z7H5FT<=
MQ>QS3O,Z[O+CCV@X&1EB7&.P /6LQM>UVSO='T+4%LDU34KFY5+B(%D^SQ+N
M\S;GAR"HVYP"2><8H [&BO-];\;:WH^F^++;%F^I:&D,\4[0MY<\,O3*AOE<
M$$'G!QTK4D\3ZGHOBB\L]9DM9K%='EU53;PLC0B)P&3)8[^&!S@<CH* .GO=
M7T_3KFTM[RZCBFO)1%;QL>9'] *H7UKH?BJ:73[AVN)-,N8WDCCEDC,4H ="
M2I&2,@CK7':S=:IJ4?@'5;R:W$-[J]O/]FCC.8B\,C* ^><*2#D<G!&.E3ZY
MXBUM]#^(,27,%O-HZ8MYH82&VF 2<Y8_-\V,_CB@#NIM2LK.^LM/FN ES=[Q
M;QG),FP9;GV'/-7*XN'5]6T_6?!^ER36DUMJ,$WFL(&5P8X@RX.\CN,\=O>J
M<_C+59?!EYXQL!;-86TTI6R>,[I8(I"C$OGASM9AQ@< @]: .MUKP_I?B*""
M#5;7[1%!*)D4NR@, 1SM(R,$\'BM)55$5$4*JC  & !7"R^(/$.H:_K.GZ9<
MZ?!;V^G07UM++:N[?O-YVL-XS]T<\8]#GBO)\0)5T7PYJ5\R:79:I8^=+?&W
M:6&*<A=L;8/RJ<L<GKC&1R: /0Z*IV,ES<:-;2O+;M=26ZLTD0WQ%RHR5P>5
MSTYZ=Z\]L_&7BB7PUX<UUVTMEU&_6QEM1 Z\O(Z!P^XXP0.,'C/- 'IU%<!<
M^)]?TZ/QE:W$]C/=:+8I?6\R6S(CADD;8R;R>#'C(;H:T3XBU,Z]X7LU-L(=
M8L9II<Q$E)$1&!!W=,OT]NM '745Y7I/B'7]+^'1UI[ZWNYFU=H&$UN<D->&
M)N0P['(P,#&.:ZFYU_58?%NL:3#':S);Z0M_;*^8R9"TB[7?.-OR#G QF@#J
M9)$AB:61U2- 69F.  .]9*^*M#;3K+4!J4)M;Z806LG/[YRVT!1C)YXK#\/^
M)[Z\\6IH]Q/!=0RZ4+X3Q0-&!('",$).'3Y@0PSTZFN1L?\ DC_@[_L-VO\
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M+07(M9#)$K.P )&#D @,,=CD5J8P,"BB@ HHHH **** "BBB@ HHHH ****
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M4M&^>,_,N<,..,&NGD\(VXU^UU2TNYK1(; :>UO$J[7A#;E&2,K@^G:NBHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ K%\0QZU):NVEZG:::L4;2--/!YN2.Q!("KQR>3],<[58'B&\
MT"X)T+7(6F2YBW^4UK(Z.,D8#*I&[V!S0!:\,W]_JGAC3;[4[46M]/;I)-"
M1M8CT/(]<'D=*U:X_P +F3PEX,TJSU,7LA>Z-M;KY;2R1QO(WDA\9QA-H)/
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MWN-/N[>8;"5PYA 4G& 2 V/I7&V>EZU;> ]=MM<C=Y-)T^ZTG32%+-<@J<2
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M5A ,Q+=1GY@N.FW)SG%)IOBW3=6U^WNYK+5C=EOL]G ^F3HL"L0&=G90H8@
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M7=]8Q3'"_-(QC#.0BCH,Y.!@5Q]M,W]O^,YB-2GCO=&@,%Q/9NGFE5F!P-@
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M8<<CKSQ6OJ^HKI&CWFI/!+.EK"TS1Q;=Q51DXW$#H/6@"C_PC%K_ ,_^L?\
M@SG_ /BJSY/ T,^IBYGUS7);50K)9M?OY:R Y#Y^]GOUQFDM/&=Q>6MI.OA[
M4(TOC MF[E2LOF(SDDJ2450IR2.XP.:S]6\>W \.O>:;8'[3#JZ:7<*\BD1O
MYJJQ4_Q9##'3KD],4 =K9VJ65LL"232*N?FFE:1CDYY9B2:GKE]7\:VVDFXA
M:!'N[6W6XN(&NHXV4$$A5R?F? )P..G(R*W-)U2VUK2+34[-F:VNHEEC+#!P
M1GD=C0!<HKF[WQ<EO%JMQ:6$U[::2Y2]DB900RJ&<(I^^54@GIZ#)R*Q?$>L
MOJ6O^$+:TM1?Z1J7G3E-Z[+I1 64$-V&X-@]P.XH [ZDW#<5R-P&2,\XJEI&
MDVFAZ9%I]BCI;1%BB/(7V@DG )).!G '85YGX;E5O%4^C>)GGL/$RE)(;IY6
M'VT+-(^8F!P4*%5*>F1CC@ ]:HKC?%'F1^._!;)/.JRW5PDD:RL(W MW(RF<
M$@]\9J/XAKJLT%I'!HM]J6DINEO5T^]^SS\8V[<$,X'S$J",G;0!VU%8GA&7
M2I_"MA-HDLTFGR1EHFGD9Y.2<ABQ)R#D')XQBN2CEE\2IXXOY9I(Y=-N);+3
MV5R#;&&(-O7T8NV2>X !XXH ](HKS/P[KTOCCQ#I4%^H:S30(K^:WZ))<2MM
MR1W"A6P.Q;/4"L^P\17VHRZ/X5FN)74Z_>Z?/.7.^:WM@7"LW4Y!0$]P#GJ:
M /7**X_P[>/:>.O$7AU2?L4$5O=VL>>(1("'0>B[ER!VW&H1(/$7Q(UC2KP,
M]AI5C %AW$ RS;F,G'<*H /;DCK0!VU%>2:'XDOO$$GA+0+Z=Y5>XOEOY"<&
MX6V)5 Q[AB5+>NWG@FNL\)7TJ>*/%7AXNS6VF7$$EMN.?+2:+?L'L&#8'8''
M0"@#KZQ]<T)];>V5M4O;2V3>L]O;LJK<HP *N2"0..Q!Y/X0Z_XG30;_ $RS
M.G7EW+J,CQ0^1LQO5"VTY8<G'7H.I(K.L_B!8R6FIG4;.XTV^TVXCM[BSG9"
MV^3'E[6!VD-GKD 8)/ S0!URJ%4*H 4#  Z"EKAKGXF6%G;:TTME)+/I,*W$
MD=K-'*LD3<!E?('!X(ZCT-=/I.I7.I+<-/I=S8K'(!$9V0^<A (8!2<=>AP:
M +=W:17L!@G!:%C\Z9P''H?4>H[]#Q4]<]?^*6M/$HT&#2;NZNVLFO(V1XU1
MP&5<9+<<MR3CVSFLN#XBQ3:98:F=%OH["XNA9SS.T8^SS&3R\$;LL _!(XY[
M\@ ':T5SU[XI$4FJ+8Z?-?KI0'VPQ.JD';O*(#]Y@I!(X'(&<\55;QU;37NE
MVVFZ?=W_ /:EF]Y:21%%1U7;D'<PVD;AG./Q/% '5T5P=_X]NIM"TB^TW376
M6[UA--N8IG4- PEVNO<$G:0#TYS[54_M"YTKXC^(KBVTNYO)CI-I,]O'*HVG
M=+N^9CCL!@=?3J0 >@7=I%>P&"<%HF/SIG <>A]1ZCOT/%3GD=<>]4M'U2WU
MS1;+5;3=]GO(4FC#C# ,,X/O2ZKJ"Z5I-WJ#P2SI;1-*T<6W<P49.-Q Z#UH
M FM;6&SA\J%2%+%F)))9B<DDGJ2:FKC;+X@1W%]HL=UHU_96>LHOV*\E*%'D
M*;MA .Y<C."0,XXXYJU'XTC:]TV.73KB"WU*ZEM+:60A7,D>[ED/*JVQL'GM
MD#- '445S-KXQCN--URYDT^>";1YFAFMG=?,=@H8;<'&&##;ZYIFL^,QHL&H
M7$^E7)@TR&*6\?<%P'[1YXD*CKR/;)XH ZFBO.KF_N--^*>JS:=I=UJ<DNBV
M\OD0R*O_ "UERV78 < # Y/IUPW6=;L_$MOX&UJQ$R)-KB1E),JR$)*'1ESC
M(9?TH ]'HKC]:^(FEZ+]KE=5FMK&<073).@D5L@$K&3EPN>>G0XSBNO5E= R
MD%6&01W% "UBZEX?.H>(])UC[8T;:9YOEQ",%7\Q0K;CUZ#C&/QK 'BO2]%T
M_P 6ZQ!HMXC:?>'[<@="TKB-/G&7P!M*]#^&:V+#Q3]J\2#1;C3+JSDEM3=V
MTDK(1-&&"MP"2I!9>#S@]NE '0T51UC4TT;2;C4)()[A85!\JW3<[DD  #ZD
M5CCQI:6\NMPZG UK+I$44TX1A(KK(#LVD8))((P0.<=<T ;U_;/>Z?<6T5U-
M:R2QE%GAQOC)'WER",BJ^CZ2ND61A^TSW<\C>9/<W!!DF? &XX '0   < "L
MR7Q8MA/>)K&G7-A#;61OC<']Y$4!P5++P)!Q\O.<\$T[_A*?LMW+'JNF75A
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MN[<F?Y51F0_,<<$;#T!ZBO1HH8X(Q'#&L:#)"J, 9YZ4^@#B9=-\5:1XLO\
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MS.@CD8C'S# ##'?(.!S79E02"0,CH?2EH XZU\)OX=UC3=0T:(7$=OI:Z7-
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M37%YMTXQM9W22!9X&C&$96 QD#CD<]Z ,GPQ!-;?$[Q='/=R71^RV!6215#
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M(T83:PW=?O\ 3IQ5#^T_%.K6^K1:-=.U]I=R+.-BD*PSR(B%VE!RPW%F^[C
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M6>O:Q#81QF)(T>$,JG.0'\O<.IYSFK=YX4L+^#4K>YDFD@O[9;4QD)MAC (
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M?+I*&5@RDCKE%ZYZ<T )-?ZG;?$'3-&_M!Y+*XTR>5MT2!S(C1@-D+C/S'@
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MK;AG(YJ<:E!>ZMH5CX@O;2.SN_#L$MNVH1B2*:8Y\WEB!OV[/?!..IR >KT
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MLB>7GL54@J><8]* /7:YJ_\ $&I2:IJ>FZ%8V]U=Z9%#+-'<2F,2F3<0BMC
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M5@(VSCD?45K>'-<TW5/"UGJ5M<Q"V$"[R6 \D@#<K?W2#P0?2N7\:LE[XO\
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MR_MI);E?,A5DD=8$?)QC 8#/ (![5Z%X+T^PTVROX=,U/[=:->/(OE@>3 S
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M.?QJ]10!6CTZQALVLXK.WCM6!#0+$H0@]<KC'-,ATC3+:S>S@TZTBM9/OPI
MJHWU4#!JY10!1_L72@(1_9EEB#_4_N%_=_[O''X5+;Z?96<LLMM9V\$DIS(\
M42J7^I YJS10!7FT^RN+A;B:TMY)U0QB1XP6"GJN2,X/I5?^PM'\E(?[*L?*
MC;>B?9TVJWJ!C@^]:%% %.32=-FU"/4)=/M'O8AB.Y:%3(@] V,BKE%% &<=
M T9K_P"WG2+ WI.[[0;9/,SZ[L9S4EWI&F:A()+W3K2Y=1@-- KD#ZD5=HH
MJ6>E:=ISL]E86MLSC#&"%4+#WP*CFT32;B[^US:7927.0?.>W0OD=#N(S5^B
M@#.U+1K75;FQEN8HG-G,)HRT8+A@01M8\J,@$XZX Z9!M7=E:7\/DWEK#<Q9
MSLFC#KGUP:GHH I_V3IOVCS_ .S[3SMGE^9Y*[MN,;<XSC'&*C_L+1_LZ6_]
ME6/DI)YJ1_9TVJ_]X#& ?>M"B@##U33M518X_#C:98+/*[WLDMN2QW#[Z!2
M7SS\W6M6RLX=/L;>SMUVPP1K$@]% P*GHH K3:=97%U'=3V=O+<1?ZN5XE9T
M^A(R*@_L+1_)>'^RK'RG;>R?9TVLWJ1CD^]:%% %*?1],NI[>>XTZTEEMO\
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M@U=HH JQZ;816+64=E;):."&@6)1&0>N5QCFIX88K>%(88TCB0!41% 50.@
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M** *B:7I\=TMTEC:K<(NQ95A4.%QC .,XJ2UL[6QB,5I;0V\98L4B0("QZG
M[FIZ* *=WI.FW\\<]YI]I<RQ\))-"KLOT)'%/N-/LKN:":YM+>:6W;="\D89
MHSZJ2.#]*LT4 9[Z#H\D4<3Z38M'$6,:&V0A"WWL#'&>_K4EYI.FZA:I:WNG
MVES;QD%(IH5=%QTP","KE% #418T5$4*BC"JHP /055M])TVTN#<6VGVD,[9
MS)'"JL<]>0,U<HH HQ:+I4!4PZ991E)3,I2!1B0\%Q@?>]^M)_8FD_9Y[?\
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M-($4?B>*FDD2*-I)'5$49+,< #ZT .HJE%K&F3R".'4;221N J3J2?P!J[0
M4444 %%%9C>(]#2]^QOK&GK=;Q'Y)N4#[B=H&W.<D\8]: -.BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *YGQ'JMI+<'0WOX+4/%YMX[S!&$1R
MBY/WG((XZ*&Z$K735FW_ (>T;4Y6FO=)L+F<KM\V>V1VQVY(S0!@?"J>*;X9
M:"(I4<QVJHX5@=K>A]#78URNA>%+GPSX6TK1](O+6&2VEC-W/]D'^DH/O\9X
M9A@;LG&*ZJ@ HHHH **** "N)^(;VFJV2^%Y]5@TX7T,DLLTDRQX5!\@!)[R
M%#[JCBNVKD-.U6*SU?5+R];4+A[IU$?E:%>+Y4:#"IG80PR6;/'+F@"+PMXV
M@O/AH/$6HR#S+"!UO]A#'S8AA\=CNQD?[PK-U2;4[OQEX!O+Z&TC6>>>0)%G
M?"3;.=A8_?X/4!>1TJJ--LGOO%"3SZD=(\0#,MG'H%XK0OLVEU?81D\$\=0*
M;;PWYN/#LE]JMW-_8<K&-U\-7H:=3&8_GXQNP>H[\\T )XUUFZ\2?#>ZU6UB
MM?[*>]BCB#@F5D2Z1/,!Z#++PN/NG.<\5U3ZO='QQJ6DQ6-E'/%I274-VV69
MP9'4*_ .T%2< ]^HKB9=$D3PS>^&+/4[Z/1I+@3VHE\.7CRP#SA*4W!0&4$'
M'&><5T<5S"/&DVOS2ZBZ2Z<EBT":!>*?E=GW!MI[L>,=,<T 9^G^)M47X9:#
MK&I6UEJ+WMS;!S+D;?,E WXP06!.1TQ@5T\FO7^H:KK%AHD5JTFE!%D-SNQ-
M*R[Q&,'Y1C;\QSRW3BN.CTSR_!.G^&SJ-^RV-S#)%-_PC=X,I%('4$8Y8D $
MYQZ#O6JLR:?XDU'6-(EU"+^U(X_M<,^@WCJ)47:LB80=N"IZX'(H EMO']YJ
M[^&#I&G0&+7(+AP;F9E,,D0^92 O0'(R.N.@ZU9L/%NJWFASS-86JWMIJCZ=
M=R"7$$*HWS3_ #$$J!CC.<GK6/:6&G:9>^&&L)-42UT.*=/+ET*\9YS* '8L
M$ !R">AY-4VTUA!*8=0OUG.NG64#>'+TQ$D$&-UVY8#@@Y'(% $GBGQ WB/X
M6>+UGCA,FG7)M?,B!V2X,;*Z@\C(<<9/U->I#H*\HNM)^U:+XFTU]3U#&N7(
MN"__  C=Y^Z;:@;C;R/W8P.V>2:[D>*;46P!AU/S]OWO[%O-N?IY><?C0!YC
MHTJI\'-6@;PQ<ZA'YUZ%D1(BBGS7P^-V\;>N0N1CBNRT;Q']B\,^%].M[]=3
MO+RQ+_;EADF4K$%#MM4;V.YE7G'<D@C!R=$BO=#\-3:+;:K<A99)G^T'PO>E
MT\QBQP.F1N.,_D:C?1-/TW2- A\-WFLV%]H8D6">?0KN59EDYD61?+&0QYXZ
M'I0!L'QMKT=OI8FT!(;B[U9M-83L\0?"LRRH&7.Q@O?D<C!J>+QO=6<.M0:M
M9P?;].OH+-%M6=DF,X0QXX+#[_. >AP#TK.O3+J T:6ZU#49+JQU 7\K?\(]
M>!'8(4"(NWY%PWJ3GGO56_TNSU.3Q(UQ=ZM&=6F@N('@T&\5[26%5","4.[[
M@)Z=Z -\>(-=F.LV;6)C\BS^T6NHFUFAB?KN0J_(<=1@D'/;&*YW2;EM.\#^
M [^[TG3+Z:9[*TBN)5/F6Z2[?F&0<MD9ZCG!YK4L]1U%]+NXM7U.^NKN6!H(
MFA\.7D<2 CEV7;EF/'< =!U-4&M%/A7P[HHN[_=HUQ;3";_A'KW]Z(<;1MV\
M9QR<F@#6M]<UJ+Q?XP\T1W5II=K!)#:Q*V]@8Y' 7G[Q/!./3TK5\*^(V\1Q
MFZ@N]/O+)H582VI(:.0YW1NI)((&.N,\\"L&1_+\0:YJ=C?:G;C5;5(F4^'[
MMGBE1&5'5M@&/F!(QGCJ*ET>RBE\2WNJVWF6FK7=B;;>FC7,$+N"6\Z3S% +
M9Q@$YQD9.> #O:*KV,=U%I]O'>SI/=+&JS2HFQ7<#E@O8$]JL4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYS@4 6Z*IS:OIMNCO/J-I$J;=Y>95"[ONYR>,X./7%2+?V;7GV-;N W6S?Y
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MS(OJ&B& ,<8VXZ5WW]A7W_0SZM_W[M?_ (Q2_P!AWV<_\)/J^?\ KG:__&*
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M"5/_ "S&PC_@6,>_2O0!H%ZK,P\3:J&;J1%:9/\ Y I?["OO^AGU;_OU:_\
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MISC&3D M5YS\0KBP'C;P1%>WB6\:W5PTC?:#"4'DD [@05YP,Y'I7HU(0#U
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M&\H'//W<8]L5UM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX "C' &3US0!K-XT":R-*.AZI]JFMS<68VQXN54@-@[_ ),;@?GV\>_%0_\
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M?;)T50J>9@C:"06P""<=,]SQ1?>,5M=;O=(M]&U*\O;6V6Z*PB,*\;$C(9G
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M"(>4\99@8PY_B!R0W&.F.H-<Y;^%_%$'AW1M$73;4KI.M)=_:&NP!/$)GDR
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M: /0:*Y_3=<?6M2L6TZXAETUK!;J=S&=S&3_ %04YXX5R1@XP/6N@H ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFV>XM(+F=[G$#2JBF(A2V <?-CK0!JV7B#4;?X@/X6OGM[R-[#[;%<0QE'B
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MVMPK^7(&&8RC8^8C(P>1G-7+WQ/H>G7$]O=ZK:1301B26-I!N13T)'7FO/\
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MR#CUKS&]?Q&=&GDN4?6K?2]7MKAKRPB,,M_;A/F(52,NA*\J<';Z@UV/A/\
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MXM-1#Q7>DP2Z5:3OQYN#Q,/8J(>>N0_K69X/.E:A!H.G7VBZNFOZ/L5X[@W
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M3E55^>1RK#MR =12,RHI9B H&22> *6LOQ'<QV?AG4[F:R%[#%:R/+;$@"5
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M^;@XYYVG\=_2]2EU)[TFW6.""Y:"*19-WF[>&.,#&&RO?E30!5_X1BU_Y_\
M6/\ P9S_ /Q5'_",6O\ S_ZQ_P"#.?\ ^*K;KS+4+?3%^-5RM[I:W<3Z$DAC
M6T\[]YY[#>5 /.!C- '9?\(Q:_\ /_K'_@SG_P#BJ/\ A&+7_G_UC_P9S_\
MQ59,5_'H?A"_UK0/#SLAGEFDT\'R'^0^6Q5-O!(CW;>._>KEGXPMKK1K[73&
M@T2V@\Y+Q)"QF 3<VU2HZ'*]>2",4 6O^$8M?^?_ %C_ ,&<_P#\51_PC%K_
M ,_^L?\ @SG_ /BJR?\ A/H;;4##J-K'%:_8Y+O[5:W'VA8Q&-S))A1M;'(Y
M(." :O1>(-6>XME?0&6"[M7N(IEG++&0 0DWR?(2#QC<,@CWH L?\(Q:_P#/
M_K'_ (,Y_P#XJD;PU:*I9M0U<*!DDZG/@?\ CU9EKXY%UI7A?41IQ6'7IEA
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MW,"WLEB7C(%S$0&B_P!H$@CCWJ/1]*32++R1<374SMYDUS.09)GP!N;  Z
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MAN/,5W0;FC8E5VMCD=0<'FL)/B-J3^%;CQ(OA=_[.@AG=W-\@.^*0IMQC."
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MUD<)#$#\[(Q4DR$$XR !QZ'.-_PCM]X9TKQ3;6IMAX=FM9IK6W\QC);.8SO
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M%?CY2JMM &1@ ?+CGT>FR2+%$TC!BJ@DA5+'\ .3]!0!P5UX.UJYT3QC8;[
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M2!DY*#Z5I0_#[2;?2K+3X;K48TLKUKVVD%QEXG8L2 2/NG>W;//7/-7U\*V
MU;4=0EDGG.HVRVMQ!*RM&T:@@+C&?XF[\YYH P;O6-8T9O"M])J+7UOJ]Q%9
MW4+1(%1Y4++)&5 ( (Z$MD>_-8<_B'Q-!X:UC7#K99M*UQ[18!:QA9XA<)'M
M<XST;@K@YZY[=MIWA&ST];",W=Y=0:<2;&&Y=66W.TJ""%!8A20-Q; -5I/
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M"]^S)< 1Q2[Q(2ORYY89P20,G&*GN_ NFW.N2ZM%>:G9RW**EY':W1C2["C
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M4SUQSC HFU'Q==Z;XOO+3Q D+Z'?S"WB^QQE942))-CDC..2,C!R>O0#IXO
MFGP:/H^EQWE\+;2+A;BU^=,AUSMR=G(&X_G6)X>T"34KSQ?#?-JEK9W^J.Y@
M,1B2Y@,:+G+)GG# [2#B@!]AJ#:O\0?#6I%/*:\\-2S[.NPN\+8_#--T_P 0
M:O/X;O9;C5X8IX=?EL?/:$;VA2;;LB15.Z0@8 P>M=4WART/B&VUE)IXI[:V
M:TBBCVB,1D@D8V^JKW[5F-X TUM.:T^VZ@I_M(ZI'.LJB2*X))+*0N,'<>""
M.: .7U#Q5XAMO"_BR6*]DBNM)U*&&"2XAB,GER>5\KA?EX\P\CGIGFM._P#$
M>K>%_$&N17EZVIVUOH;:K'&\21^6ZNRE%*C.P\?>R1ZFM*X^'>E7%OJL#WNI
M^7JDL<MR/M ;+IMP1D'&2BD_3 P.*TI?"UE<ZW)JMU-<7$LMB;"6*39Y<D).
M2" HZG)Z_IQ0!EM=:UIFG1>()=6CO;!=-DN;JV>-5WR"/>IA*J"!PPPQ/&.I
MYJ/2+GQ1=7FB:B)Q+IEW!OO4G,04;D#(T.P;NIQAB>#Z\U>T/P1IVA)Y*7>H
MWEJB-'!;7MQYL5NA&"J+CICCG) R <$TF@>!M/\ #LZ-:7NIRVT))MK.XNB\
M-MG(^1<>A(&2<9.* )?'%QJUCX4O-0T:X>*ZL@+AD5$;S8U.77Y@>=N[&.^*
MY_\ X3-X/&$RM?SW&BW6FF>QVQQ@&=55VC4[<L3&\;#/<D<XX]!95=2K ,K#
M!!'!%<];^"-#MM,T;3X[8^1I%P+FU!;)$@W<D]_O$_@/2@#.DO=;T[Q7X3TJ
MYU,S+>VMR;S]T@WR1HI!!"C RQX'H,YKB[]+H_"CQW)<:C=71&I740$^P_=G
M50<A0<X &,X] *]1O= M[[7].UF2XN%N-/61840KLPX ?(*Y.0!WXQQ67<^
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M** "BBB@ HHHH ***Y7QU<V,-EI,%\&;[3J<,<,9E$<3R?,P$I(/R?*3C')
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MR72O ?CZQLBPT*"_A6P4L2J',1E5,_PB0D8Z @CUH ]H) ZG%-D+B-C&JM(
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M*6KS3^'#(9IU7+RAH2IR>K#)QWYK9^*D<3>#XY)6*!-0L_G#E=H,Z G/T)H
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M(\_D_P (8*@/LWK7= @@$'(/0B@!:*** "BBB@ HHHH **** "BBB@ HHHH
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M)K:HH SK31;6'15TRYCCO(F!,_G1AA,[,6=F4\<L2<>]:(&!@=*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBHY[B&UA,UQ-'#$O5Y&"J/Q- $E%16]S!=Q"6VGCFC)P'C<,/S%2
MT %%%% !1110 4451DUK2HI&CDU.S1T)5E:=001U!&: +U%06UY:WJ,]K<PS
MJIP3%(& /X5/0 4444 %%00WMK<7%Q;PW,,D]N0LT:."T9(R P[9'/-3T %%
M%0W=W;6%K)=7EQ%;V\0W22RN%51ZDG@4 344@(8 @@@\@BEH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD?'6BZUK-O9
MC3+;2+Z"W=I9[#4T9DN#C"CC@$9;&<C)![5UU96H6^NOJ,,NFZA90VGEE98;
MBU:0[L\,K*Z_3!H J>"KZPO_  K:RZ?I::5$K2126"($%O*KE9%P !]X'GOU
MKH*Q5T>[L-.M;72;U(&6[^T74LT(D,X9R\HX(VLQ8\CIV%;5 !1110 4444
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M7R #C@]>"!7<1AQ&HD8,X W,!@$]SCM0 ZBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYIV^68P1C[2GSR#&5'/)Y''N* ->BJ%YK>E:=,(;W4;6WDPIVRRA2 QP"<]
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M$9L<*&4E<GJ1[5W=AJUIJ<U[%;,[/93FWFW1LN' !P,CD8(Y'%7:* "BBB@
MHHHH *X/XGRHMMX;7.637K.9@.2J*Q+,?11W/2N\K&;P\68M_;.KC)S@7(P/
MTH YGQ=J*:/XSTG5M1>\30Y+&6V^UV@9A!*SHP+;03M8*!GU K):QT6TUSP.
MEA:RQ:;]OO)U%T&)P\+X<A^4#2'@'':N[_X1T_\ 0:UC_P "1_A1_P (Z?\
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M371[V5&ML0,6 C)#LS'HH4(3DX].I%<W82V^@^,H-<$./#^N3R>0@R?LEP0
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M"^:7)C4$<9P<@>G/2O2J* /,_#%[X=UJ;1K@PZDNK:3 ZRQ72R1K89CVN&)
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M^UF)R0W(SG(!Y /0=*VZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC"WU7P]:ZO;6%YBXN?LJVS>6)E<.4.1NP,$$GG( )J"'3-3/Q'76IK15M#I
MLV=90<2^9O.!P2O;.,Y[8IND>%[G3?&6J7OFI_9$TGVVW@'5+J1=DK?DN?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;V^TVWGN85V)*R_,%_NGU7V/% &!\,69/A3H;(OF,MH2JY^\06XKECJ%[/\
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M1U*ZBNI$8KNP\S)'D= S ?7&.A->GV6AZ=IR.MI;"/>@C+;V+;!T4,3D 9.
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MKW!SS7I]]H>FZC<0W%U:(T\*E(Y5)1U4]5W*0=I[CH:;-H&E3M9,]C%_H/\
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MS;1.EL40!EW#& Q^@Z] *H^!?"B:%X8TFWO[)%U&QBV$B3>BOC!=!G"D@G)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>]LH=0MFMKC<T
M#\21@X$B_P!UO8]QWZ'@D4Z6U@F>%Y(]QA.Z,9. ?7'3([>G:IJ* "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2T %%%% !1110 4444 %%5-/U&+4H9)88YXUCF>$B:)HR2K$$@'J..#WJW0
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M*;K3O+^T*\3(!O!*X) SPIY'%:5 !1110 4444 %%%% !1110 4444 %%%%
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M&QMD.5_NDN.HY)'M70ZVQT7_ (1[QW:P-=,ELEGJ A&YYH)0NUAZE9-OX,:
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M=<^E>/!FO_A!)"Q"^+[>_.5R!<+??:,@CORI^FSV%=+K\5YX6\8+JFEVH?\
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M#GV/>N2\?Z@NE77AN\O\C0X]1_T]B,HF8V$3/_LB0J>>,@>U8/B?_A'ET/\
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M'2J]_I-KJ%@MC+&JVN1NB5!@K_=Z< ]..<5>HH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0D $DX
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M"#0 ZBJ+ZUI<=M<W+ZE:+!:R&*XE:90L3CJK'. 1D<'UJZK!U#*05(R".XH
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M\ATZVDFEUS^R)@961<B0IO4$9YQG!Z9[UT'B+0+W5M1T:_L+^*VFTV=Y1'/
M98I R%#E0RG< 20<\9-82?#_ %".U6W_ +;A=4UW^V5+V9R3O+[#AQU)Z_I0
M!,?'-SI2>)EURT@\[1A Z?9')683#$:_-T;<-I/3G-5[I=2'Q7\+MJ L\M87
MI5K=6&#^ZRIR3D#C#<9R>!5K5? )UJY\2F]U!1;ZW#;QA8H2KP-#DHP8L=W)
MSC Z5-;^&=>E\0Z+J^J:S932Z;#-"RPV3)YPDV DY<X/R9X&/:@#KZXF/Q7K
M<NM:W#]@T^*PT6Y47<SSN6,)B$A9 %Y8 ]#@=LGJ.VKF]/\ "\EOJ?B.>]NH
MKBVUME9X%A*&,",1XW;CG*CT'- %"R\5ZS=WNE-'I#366HQEB5MYH_LAV[DW
MNR[64]"0!@^HK(A^(>O#PYI?B>ZT>Q319[@070CG9IH@TIC$@&,%0<<=3[=M
MOPYX;UO0(H+.^\2+=Z/8C%NAM_+E* 859)-V"%&.@&<#)QP><\!:/+XD^&FD
MV5Q>6SZ6+EII$C0F1PEPSB,G. -P!)QDCC ZT ;FH^,]1"7USH^F27\=C=FV
M:V2VE:2?:P60HX&Q2#G .<[>HS1X@\9W^A-<W$MK;1V\%U!%';R-F>YB<HK2
MK@_( 7(PPYVGD9%21^$-8T_6]0ETCQ MKI.I3FYN+5[;?)'(WWS$^X;=W7D'
M!YQ5/4_ &I7T&O6D6N0I:ZI>1WJF6T,DL;H4(0OO&Y!Y8P, C/7U )8O$&HV
M?C/Q:^H7$)TG2;*"?RT0[E39*Y(YQN..?H!VJ:'Q?J45]9R7NFN=*N+:2>:X
MCM9D%EL3?AV<8<$9 88Y'3FK#^#Y9M<U:[N+]);+5[&.UOK?R,,Q177*MNPH
M(<\8/0<U#HWA+6;?3_[(UKQ NHZ3%"UO%&EMY4LB%2@$K[CNPI[ 9."30!AZ
M_J&H:S!X&U::"VBL[S6;6:*( ^;$K(Y3<V<'*GD #!XYZU;L9;ZS\3_$2?2+
M:&>\BDM9(H),@2D6JG;D="?YT^'P+KB:9HFER:_:R6FBWL5Q:NUD?-:.,,%1
MSY@!P#C( Z9K52UA\(ZEXC\3:OJD"6%^\,C_ +EE\C8JQ+D[CG/'8<F@"32O
M$TFM6_A^:Q\B1=1@:YN/E/[J-0-V.>H=@N#[GMBNFKD?!&C6EF=5U6S\S[+J
M-TTEHCY 2')/R@]%:1I''LRUUU '"7(O[CXOBUD-K):?V(Q,4B%@8VG4.,9Q
MN.T>V *72O%-S::OH.B2V%E:QWOG0"Q@/SV'EH616*DJ<JO0!<<=:V)/#UV_
MC=O$ OXEB.G_ &'[.(3N W[]P?=US[5AZ9X!U6P'AU7UVWD&B3RM&5LB&E1U
M96+G><O\WWNF>2#0!GZ]JC:Q\,O'OGZ?:VLEG/=6Q6#YA(513O)(&6.>N.PK
M;U/Q:VE7]IHZ2V=K<2Z>L]JU]E8[J3D>4KY 5A@9SD_.,"F2>!KR7PWXGTAM
M4@SKEU+<>:+4_N?,"@C&_P"; 48.15O6O"U[K6GRZ==W%A<64UDENT4]J6\J
M4;OWR?-P<,./]D?-0!U,98QJ7&&(&1Z&L;5M<>UUO3=$M%C-]?K+('E!*11Q
M@;F(!!8DLH R.I.>.=.PM%L-.MK-9'D6WB6(/(<LP4 9)]>*Q]=\.2:CK&E:
MU8W2VVI::SA#(A>.6-QAT8 @]@01T(Z&@#G]2\?ZAIND:]OTZWDU31+J""XC
M$A$<D<S+Y<B<=PWW2>,'DUV.E/JSP3'5X;.*7SF\H6LC.ICXV[BP'S=<]N*Y
MG5O LVJ:3K,7]H0Q:AK%Q!-<7'V<LBK"4V(J[@< )U)Y+$^@'9IO$:^85+X^
M8J, GVH P?&FO77AGPM=:O:6L5S) 4!CD<J,,X7(P.3\W3CZU1E\1:Q:Z@FE
M7MO9Q7]P);B%K9)KE([=-@!=54,6+/CC X)ST!T?%^@S>)_#-SI$-VEJ;@IF
M5XC)@*X;IN']T=ZJ>(O#.HZE?:;K&E:K'8:S8J\?F-!YD,T;XW(R9!QE01SQ
M0!S/B/6=<U7PII$MQ8_V;.VNVMM/#,C@2XN$VLN<'RVP#@C/;M706&HSV_BS
M6M)6ST^*Y6RBOWN88ROG2,63YQG)QY8YSTI^K>%M3U;2+"VFUF)KN"_AOYIW
MMB5=HV#!%0.-B\ =2?J233[SPUJ3^*FUJQU*"W^TV*V=W&]N7)"LS!HSN&T_
M.1R".G!H R8/B&)='\-7=VUII?\ ;-L\OVBY#- D@VXBSD8+;B021]T\'-:<
M_B:^$]KIB0Q1ZHVGI>7.();B.,M\H0"/D@LK_,3P!T.>*VF>#=0T[PSIVA2W
MMAJ%E;6K6T]O<V9\N;)!5L;C@K@CWSVJLGP_O](&CW'A[71;7UA9"PE:Z@\Z
M*YA!W %=P(VL21@\#B@!P\>W"PZ-'J=K%H%UJ$,K'^TU81B9&"B(-\N-W+ G
MMC@DUVEE)/+86\EU&L=P\2M*BG(5B.0#W -8%[X<O[VS^QW5Y::A:S0&.YAO
MK8LKR%B?,7#?*!G 7T Y&,UK:'I:Z'H-AI2323K9VZ0"63[S[0!D_E0!@^.-
M1U6PF\.QZ;/#$EYJT5M-O4DL"&<#((P,ISZ_GF4^(-3O[G6;?1H;2232-L<H
MFW8N)B@<HI!^0 $#<=W)Z<<W/%&@3Z]#IIM;R.UN=/OX[V)Y(C(C%0PVLH93
M@ACT-4XO#&H:;K>IZAI.HPQKJJHUS'/ 6"3*NWS4PPZC&5/<=10!J^'-<M_$
MOAVQUFU5DANXA($;JIZ%3]""/PIFN:T=,GTVR@17O=2N/L\ <X5<(SLS>H"J
M>.YP.,Y$^A:/:^']#LM(L@WV>TB$:%CDMCJ3[DY)^M9_BSPU)XAMK*2SOC8:
MEI]R+JTN0F\*X!!#+D94@D$9H KRZQXBM+2X^UZ7;*\=ZD*WGFA83;D F=E+
M9 7D%<Y)[XK%G^(-_#X9UG48;*UN9M+U-+%BKLB3*YC"NH.?^>HX)QQG-:6H
M^%M;U33[)[G7(#J=M?17F1:G[,0@($?E;\X^8MDMG(![ "A=_#[4KK3]=M#K
ML&-5OHKXL;(_NW3RR1C?R"8@!Z G))YH L7WB+Q98:UIFDR:9HYN=2:Y\ATN
MI"BK&@9=V4![\XST[9XLV'B?4H-?O=*\11V-F\.G+?1RP,S)(O27DXX1ACU(
M(/'2KVIZ!>:AXFT+6%O8(QI8FWQ& GS3(H4X.[Y<8XX-8NOQZ-XO\4:;IMM<
MM)?Z3=LUZ(@1Y<)0[XW.,%7.P8[\^AH ZS1Y[RZTBUN;^%(;J6,2/$@.$R,[
M>>X[^]5?$6NKH=M9[8Q+<WUW'96R,<*9'/5CZ !B?ICO6Q6'XI\.KXDTZ"%;
MDVMW:7,=Y:7 7=Y4R'*DKD;AR01GH: ,B]\6ZAI6HZMI-W#;/>VVF/J=K,BL
ML<\:9#(RDDJP..YX.?:IHO%=W+=^$8Q;0"/7K9Y7Y.866'S>#W'.*L/X6;4;
MZ]U#5IXGNKG3VTY1;H56*)B2Y&226)Q]-H'J3F:?X+UF"Y\,37>MVL@T%7BC
M6.S*B6,Q^6-V7/S8YR./:@"UX!U'5M4L=3GU2>"9DU*Y@4QH5QLD*8&2<+A1
M@?SKJYO-,+^04$NT["X)4'MD#M6'X9\/W/A]M2B:^2XM+F]FNX8Q#L:,RN78
M,VX[L$\8 _'MOT >/R:AJFK?#/PSJFHM#<W4VNVDB%05))NCQDYP.PQT%=7_
M ,)K=Z9-XC@UJTM_-TF*":/[([%95FW!%Y&0=RXSCOG%5X? &H0>%]-T,:U;
MM#IVH1W<#FS.2L<ID56^?DDG!/' Z=ZN:CX&.KZAXAEOKY3;:S:0VQCBB*O"
M8BQ5PVXY.6ST["@"WI6NZM/XC.G7>G.UF]MYR7T=K+"B.#@Q,)!R<<AAUQT%
M=*V=IV@$XX!.*P/#VE>(+,J==UV/4?)39%Y-MY.[_;D^8[FQZ8 R>O&-\YP<
M8SVS0!YT_CW78_#T^NMI=A]EL]4:QN85G8R,!.(<H< <$@\]>>!WV[?Q'K$7
MB34=&OM/MI9XM._M"U6SE)WC<R^62P'S9 P>!ST%4)/ 5])X1U#0CJUN#>:B
M;\S_ &1OES.)MNW?SR,9STJ[JOA"\U77+[46U5;=;O1VTO;#"0\>XEO,#;NH
M)Z8_&@"#3?%NHWFO+HL@L#=3:8UXKQ;F6WE5E5HGPQ#X+CD$=#P,UG^&/%NH
M_P#"%>';B_=+C4-99A$RPN^WAW=F5<DX"\!<=0.!R-'2O!VJ66M:1J5SJ]JY
ML=/?3WA@LC&KQDH05^<[3E!GJ/0#K5.+X>7]OX6TK38->6*_T:?S=-O([7 0
M?,-LBECOW*Q!P1VXZY "[\;Z]8:=))-H:^;'JD%DLL@D@2XCE8!9$5AD'D@@
MG@CJ:O-K&L6WBCP[IVL:9I9FO7N]MQ;R,YB"(6&W<H()&,\^M+J7A36M8T>"
M"_URW>]2\@NVD6T(B'E.&5%3?D9(Y)))S] -'5- NM1\3:%JZWD,:Z7YQ:$P
MEC*9$VG#;AMP/8T 9,_C*_L]8TZWO+6UC6]U-K V@?=/"I#^7*S E<-LSMP#
MANIP:?X254\;>. H 'VZWX _Z=HZHQ_#_58[6RM1K\!CL=7.I0.UD3(Y+.2)
M&W_,?G(!&.G.>W1:+H%QI6OZ[J4MY%,FJ31RB-82IB*1J@&=QSPH[#F@#<<N
M(V,:JSX.T,< GW.#C\JX#3/'6M3^'(?$%[IEC'8S,UO''%,[2M<&X\E!C;]P
M]SR>,@=J] ?=L;80'QP6&1FN,MO 3#X?/X5N]3W$2-+#>6\1C:)_-,JM@L>0
MQ]>0* &7/C+5M,75VO-(EFMK2U6YAO8K2:*-LMM9&5QG*YW<$Y4'IBFZEXVO
M++PE>:_9?V9JUK%)"L,UM*560.ZH<C+892P^4D?4=*TK31O%']GR"_\ $=O+
M?J$6"2*SV1 !U9BZ;_F+!<'!  )QU-<AXY\.P:!X+\3Z@)+6UFU2:R+0P)LB
M5DF3Y@">6.22>.@]"2 ;\OC74-#U^XL?$UC:V]LUA-?VT]G*TGR1<R1MN RP
M!!R.#4S^+=0L$\/WVHVMN-/UJ:*W B+>9:R2KF,,3PX/0D!<'UJU<^%EUZ]:
M\UN:&X0V$MC%';J54)+CS'R23E@J@>@SUS4%GX0O/L.BZ=JFHQ7=GH\R30%8
M2DDIC!$6\[B/ER"<#D@'CD$ R+GQYKMOH^LZL=+T\6NCZFUI<)Y[EY$5D4E/
ME S\^<GZ8[UKW_BZ2+Q1<Z%!)907D2Q-#;W>5:\5N6,39 ^7D8P22#TZU3N?
M 5]<^&?$6CG5K=3K-^]X91:G]UN*DKC?S]P<Y'7I5SQ#X0NO$L%S9ZA=6DEK
M-)')"_V<B:S90H8Q-NX)*DCIC<<[NE $&HZHUUK/BS2)M/M4%OI"RBX7YGE5
MQ( &X' VG YZ]:Q_#7B36=#\.^"4OM/M#HNH6UI8QRQ3,9HI&B&QF! &UB,8
M'3/6NH;PO-)XEUC5)+Z/R-2L4LC"L)#1A=^&W;L$_.>WI5;3?!]S'I^A:=J=
M]!<6>B&-K=882C2M&NV-GRQQ@<X'4@'@#% '->*M4;5?A[\08I]/M;9[&=X"
M8?F\TB.-@[$@9;Y@.G85UEYJTMOXUT/2_L-JZW5G<21W3',D90)E0,< [AWY
MQ6=>>!+R[T7Q5IQU6!1KUP9BXM3^XRJJ1C?\W"#GCO6M<>'KRY\4:+K+WT &
MG6\T+1" _O?,"Y(.[Y<;!@8/>@#E+;Q)K4/P\\3:SJ,-AJ1M;J[0P2!E1ECD
M*8P=WRX P/S-=)?^);A;\Z7IT2?:XK*.ZD9K:69!O+!$Q&,C.QN2>..#GBC)
MX%O6\,>(=!75X1:ZI//+$QM26A$SEF#?/\Q!.!C;[Y[3ZCX3U?\ MFTUO1=:
M@LM16T6SNUEM3+!<1J25.W<"K DX.>^* *A\>W&-*@O;6+0KV^M&F6/5%95:
M8-M\D-Q@\9R>S# -=M;/*]K"\Z!)60%T!X5L<C\ZYO4_"][J5C)875[:W]G/
M;>5-'?6Y?]Z2Q,JX88^]PO;:,$8K=TJP72M'LM.2625;6!(!)(<LX50,GW.*
M *&LZXUCJVE:/:K&;[4VD\MI,E(TC7<[$#D]5 &1DMU&*Y[4?$VHW.B>,=+9
M(;;5]'M6=I4W;)(GB9DD3G*MP1C)P1U-;OB'PX^K:AI.JV=TMMJ6ERN\#NF]
M'1UVR(PR#@C'(/! -59O"4UQ9^(G:[A74M<A\B:80DI$@C**JKNR<!F.2>23
MT'% $O@RP4>&]%O;FWM#>+IT,,<\4>'$)13L)//49QTKI*H:)83:7HEEI\\R
M3/:P)#YB(4#!5 S@DXZ>M7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD)$%T@W-$H]77[O?*D#K76Z387$&@06E]<S2W318GE\UBV\CYMK=0 3@?04
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M.%AD/'D!]Z@DEO[W'2@#O:*\Q\4:Q?VL.KZEI^IW4[V6JVT(DC8QP6ZEXD:
MIG$K?.23CC=U!7%6FL]6U[Q;XOTP>)-3LX;1;5[7R'5?+9XV;^[RN>W?N3Q0
M!Z)17E^D:]J/B/0]%EN;ZY:^GT:2>2SM&,!W[MHN7D!&%^4X7!R6)P<<3^&O
M$5[XA?PMIFHWDJ?:]"-_-)$YB>YE#*N-RX(P"S$+C.1V&* .^O;U[26T1+*Y
MN!<3")FA (A&"=[Y(PO&.,]15A98WE>)74R)C<H/*YZ9K@]1;5M%;PC:/X@G
MO7;6#:7,@54\Y"DCA7QDD@*HZ\XR1FH="T=[W7O'L$&I7]O.;Q$BF6Y<F-C;
MQD-@G!P3P/3CI0!Z(20"0,GT]:K6&H0:C%(\)8-%(8I8W&'B<=58>O(/H001
MD$&N,\*ZQ=>((M'L)9[B*_TKS!K"B9L^;'F,(WJ';,@]DQT-.19G^*GB#2H;
MB:WBO]$AG>6$X:*4.\8=<\!MN/\ OD>E '=T5!9V[6EC;VS3RW#11JAFF(+R
M$#&YB.YZFIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\81]P'S+@D ]<8KH+KPMHUVFFH]GL73/^/00R-%Y0*[2ORD94C@@\'O6Q10
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M=01B[F^24-N#9W9^\2>N,FNAHH YR\\"^'K_ %QM8GLF^V.%$Q2=T2<+T\Q
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M.X(R*X&\\.:S/9>/8$LANUP$69,RXY@6+YN>.1GOQ[UVNDQ2P:/9PSQ^7+'
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M.#@_F*\XU;PEJ.KZ7:QW&D+#JMI81QV&I65X$DM9P""&;@E/NG@-U;CH3Z%
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M(Q)\Q ^7/)%8[77BHC6K>Z@\JR%D9;6_D2,,K\[XV19#GCD-QCOFN/-M?_\
M"M_A[)]L@PUYIBQ_Z-R@)4C)W<X(!/3.!TQ0!ZII>LZ?K,4TEA<>;Y$IAF4H
MR/&XZJRL 0>1U%7ZX>]UG7IKO6[/0;=)+W3!&K,($VW-P8E?#[I%*J057C)'
M//&*G@US7=;N-2L+%+?3M0TZS@>6&<"7-S+&7$9(.-@X!(R3DXQCD [&BN$M
M[C7)OBA8V]W=PPJ-"\^6UC3>B.94$@5L@GE>&/0#IUK=\3:[)H_]EVMN$^UZ
MG>I9Q-("5CR"S,1D9PJG R.2* -ZBN#U3Q3K.C7WB#27>VFNK/2&U:QN7A.'
M1<ADD4,.0P&"".#TXY?IGB'75UWPS#J$UG-:ZY8R2^7#"4:!TC1\[BQW [CV
M&.* .YJC%K&GSZO-I,5TCWT$0EDA&<HA. 3VZUSGQ&N+^WT?3/L-Y]F\W5K.
M*3Y-V]6F48Z]/7UZ9ZUFW,.K/\4[V*PO+:&[_P"$>@W7$L!=<B>7H@8=3[\>
M] 'H=%<#I/C;4-<TSP['!;[+_4["2\G:%%;8$94.T.P'+/GDG '0YR.E\,7.
MMW6DL?$%DEK?1S/&-A7$R _+)@,VW([9X(- %J]UK3M/N$M[FZ1;AUW+ H+R
M%?7:N3CWQBI+'5+#4UD-C=PW B;;)Y3AMC=<'T/MUKB_A9*VHVWB+5[OYM1N
M=8GBF9OO(L>%2/V"CH/>MGQ)?P^&(Q>V<$8O]7O;:R4N/D,KG8'8#!.%]^=H
M''6@#IJ*XVZU_5]*\2S:'/+;SF?3I+VQN6A(VO&0'1U##(Y!!!'ISUK(L_%7
MBB73_!^HO/IK1Z\%A>#[.P\IVB9Q)NW<\J?EP.#C/\5 'I-%>;:EXP\0Z3H'
MB_?+8SW^A3Q".<V[*DL<B(P!3?PPWD9R1QTK3.N>(])\:6>E:F;"[MM6MYY+
M3R(VB,$L2ABC,2=RD'[V!SV'2@#MJ*X/2?%.K3^(-(TV>XM9SJ6GS32/% WE
M0SQ[,B-\XE3YR.#VZ]JS],\8>)9M#\-:W=RZ>T&HZF+">VBMV!PTKH'#EN,%
M1Q@]^: /3**XK_A)]2T[6/$>FZI) TUK;K=:8(H2IGC;*@<L<L),)CCJOK70
MVT6N+=V37-W9M;K;$72)"P9Y^,%#GA>O!R: -2BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *Q(?#YA\7W/B#[8Q>XM4M6@\L;0B,S*0
M>N<L?\*VZ* .0TWP*=)OY19Z[?IHLDYN/[)VH8PY;<0'QN"$\[00#WX)S7'P
MZ"6T%JFO7Z6UKJ?]I6L82(^4Y=G(R5);EVQGU[UV]% '-R>$_M5U:/?W[74%
MG?M?VZO$!(CEF(7?G[@W=,9X )QQ5:/P);PZ?=Z.E[(-!NK@SO8% =N6WM&K
M]HRV<C&>3@BNMHH YP^%F_M?6]12_96U6VCMG3R@1&J!@I7GKAVZU1LO 7]G
MS:5+:ZU=Q/8:>-,8K&A\Z $$ Y!VMD#YAUKL:* .-L/ "Z98:#%::O<_:=$\
MQ;66:)&4HXVLC* ,C '((.>]6-1\$6^H^']4TQ[V59M5F6:\N]@+NPVX '0
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MQJD@5F8'"J,?>/ _6K>C^&[+1-3U>^M=WF:G<">12?E0[0"%'NVYC[L:V**
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M+ER264[6+$DD#OVJOI7@,:4WATIJ\\PT..2* 2Q+\ZNH4@XQT &/?KFNQHH
MX^3P%'+I&I6+ZI,&O=2&J+,D:AH9@ZOP#D%<H.#[\UTEQIZWFCS:;<S2R)/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !6-=^+-!L?$%MH-UJD$6J7
M(!BMF)W-GIST!/8$\]JV:Y34_AUX>U;QG9^*KJ&8ZC:E"NV3",R?=9AW(X[C
MH,YH ZNBBB@ K#E\8:%#::C=27CK#ILGE7C&WD_<MUP?E],'/3D>M;E<'K7A
MN\N?&5U;P0L=&\060CU.13CRVB('YR(VSUPN>U '5S:U81/%%)-)&\T#7"$P
MN,1KC+'*X&-R\'GD<<UR.HZO<0^'?"%UI6OW%Y!=:K;6\MT\: W<3L0=PV@C
MIVQ^-7/!5GJMEH4LNO1N;NTC.GQ$*6:2&$L!( .<OU]P%KF;.QOX?AOX%M'T
MR_%S9:I:R7,/V20M$J.Q9F&.  1]>U '666J7D?Q"\06=S=S36%M86UQ%"(@
MQC+&3=M"KN;.T>IK&T+Q4=3MK'Q!>ZS>V,3WTUN]JUDYMY5,KQQ(&*<-D*=P
M/7(/7 U=/6:+XG:]>26EVMK)I]LD<WV9]CLAD+ '') 85RL&GZB?A!!;C2[_
M .V66J"[DM6MG65HQ>F7Y5(^8[#G _G0!Z+=:O:W$FI:9:WCQ:C;6_FL!'AH
MP<[6&Y=I&0?4<5Q5OK^L2>#?A_J)U*7S]1O;6&\^5,3JZL6SQD<J.F*MVL]S
M<^.];U,:5J4=E<:+#'#+):NN]E:4D;<;@?F'RD9]JRK>SOHO ?P]M7TV_%Q8
MZA:O=1?9)"T*HCABPQP 2/KVH ]#L]?TV_N[^UMIW>>P.VYC\EP8R1D#D<Y'
M(QG-6K&^M]2L(+VT<O;SH)(W*%=RGH<$ X-<7XITF^B\76=QI1"QZ[$=,U$!
MMI55!=9A_M*@E7/^TM=U'&D4:QQJ%1 %50,  =!0!E2>)]'BOH;22[*23S&W
MB=HG$3RC.4$F-A;@C&<Y!'453/CWPR"1_:BD+<_9781.5CER!AVVX7D@9. 3
MWXKC_#%F\5M:>&];\,ZI<:C876Y+J3>UFX5RRSJY;:" <XQG/'?BM?V-_+\/
M_&MK'I>H&YO-;DGMXOL<FZ5#+&P8#;TPI.?:@#TG4/$&F:7)+'=W!5X8?/E5
M(GD,4>2-[;0=HX/)]#Z&H?\ A*M%,%M-'>&=;I7> 6\3RM(JXW,%4$X&1SC'
M(]:XOQ!=&S\8:P]K:ZKY>I:7##<O!ICW8S^\"G"D&-@I/##G(X&.9K6YBCF\
M-6NEZ=J4FBPZ?):K=Q6C?:ED0JGD2,0&A!VDD_+D@<@"@#LU\1:3)865[%>+
M+!?$"U,2L[3'!.%4 D\ D\<8.<8J.T\4Z+?6UQ<6]^KQVSB.;*,&1R=H0J1G
M=GC;C.>,5YEID=YH_A7P/+-I6JPZGID]PAC6S,S!"KA\Q AF!RH##&#SSP#;
MD@-SX<NI=%MM3NM1M]:36=0L9K:2SEF5R01&K<@87C!/*'G- 'H4/BG1YX[M
MENV5[21(IXI(725'? 0>6RAOFR,8'/;-7;#4K74EF-LTA,$GE2K)$T;(^T-@
MA@#T8'\:X2>TTG6]*O+S_A&M=M8[EX(Y;ETE2]#*^5=5RSXC.#GZXSCG=\%)
MK,,&HV^JSR7D,5R!:7L]OY$UQ'L7EUP,D'Y=V!G;F@"_>W]I'XJTZT?6)(+@
MPS.+!5!6=0!EF..-OU'6JR>//#,CQ*FJ*WFW'V56$3[1+NV[6;;A23P,D9[5
M2UR*=OB5X7N4M;E[>WMKQ9ID@=D0N(]@+ 8YVM7)SV-\WPZUJT72]0^U3>(6
MN8XOL<FYHS>+(' V]-@)_3K0!ZV2%4LQ  Y)/:L>S\5Z+?W$4-O>9::%IX2T
M3HLT:XW,C, ' R/ND\$'I6C=R2?V;/);P">7R6:.%_EWG'"G/3/3FO,-'%^^
MO>"]1ET;5HQ;VMS#=H;(Q16KLB81(Q@*@VD XY '+&@#M;;QUX:O)+);?4UD
M^VRF"!Q$^QI 2NPMMPK$J< D$]LY%7[/Q!IE_<7\%M.[RZ>VVZ3R7!C.,XY'
M)QSQG->;6MC?1_#K0+1M+U 75OXA6YEB^QR;DC%V\F\C;TV$']*W_$VDWL?B
M^TGTO A\00_V=J2[MI54!<2C_:$?F)GU9: .UL;V#4;&&]M7+V\Z!XV*%=RG
MH<$ UGKXIT9KZ.T%Y^\EN&M8V\I_+:9<YC$F-I88/&<Y!'45KHBQHJ(H55&
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M!QMZC!'7O7(7EK=/<_$S;I]ZPO[5([4BUDQ.1;>60O'/S<?KTYJ:V@NCX@\
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MG:BYM'9XB[)ED9"&5BK A@"""".1VK)FU?3[;Q1=)-K;J]M8>;-8%/D1-_\
MKL[<YYVXS^%-\&'6/[!*ZT0]PEQ*D<_D>2UQ&&.V1H_X6;J1_C6-J<=P/B/?
MW8LKQ[8^'C;B9+9V1I?-9M@(&"<$4 ;EAXT\/ZG>65K9ZB)9;V,R6W[IPLH
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MV.K;3M;!S@^AIU<3IGBG3;+3M<O!I4>GO'K363QB1?\ 2+AM@WLV,#.X9/.
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M/]WGK7=T4 9FOV-SJ?AG4=.@:'[3=6LD"M(2J LI7)P"<<YQ7/\ _",:OO\
M!K9LO^)&,7'[Y_WG[DQ?)\GOGG'I[UV=% ' W/@[69_#_C'3MU@'UVYDFA?S
MGQ$'1$PWR=1LSQZUIRZ%JTGBG0]7VV0CT^QFMY(_/?+-)LY'R=!L_7VKJZ*
M//;?P3K,'@K2M+$UA]OTW51J"'S'\J4"9I-I.W*\.1T/3WJZ^@>*M,\37NIZ
M)=Z4]OJBQM>P7JR 13(@3S(]N<@@#*DCIUKM:* .-A\.:YH_BV[U?2[FSNX-
M2@ACODO&9'62)=JRIM4@Y'5>/J*T? ^AWOAOP=IVCW\MO)/:H4+P9VD9)[@'
MOZ5T-% '!7?@.]O[#Q5I4]Y;QV6KW?VZWFC#&6*7]V5W#I@-&#P3G/:M:/0]
M3U/6]&U36ULXY=*24QK:2LXEED4(6.Y5V@+NPO/+=>.>GHH YKQ=H.HZK_9M
M_HMW!;:MIEP9K<W )BD#*4='QR 0>HY&*H:OH/B76])LEO)M,%[%J-O=O'$[
MK"B1.&VJ2I9F8CDD#MQQSVE% ' Z]976C7'BWQ%>O81V5[IL=L@<F3:Z[U7>
MI4 J6E /.,#GVI^'H=3TF_TR.6WT&X#PBRAN++4IIYXH\9RB2*1L& 3@C@#K
M@"O2'1)8VCD571AAE89!'H152PT;2]++G3]-L[,R??-O L>[ZX S0!PVF>"_
M$=I-X;FN;G2FETFXFDGF'F,]T)(V0RL2!\_(X_\ 'NU8NGS7;VTVNV<?AJ_T
MY[^6_BCDOYH7+;SL/D@,@DQCMG=R?FKV"J$>AZ1%?F_CTNR2])R;A;=!(3_O
M8S0!@_V'JLGBO5-;5+18;W3([2.)YF#JREVRV$('W\<$]*S[3P?K-MH_@VR+
M6#-H,RO,PF?$H$;1_+\G7YL\^F*[VB@#R.!KF\GU35K+_A&;O39=2>Y\NZOY
MK<[HVVJ7B4,F_* Y(R3@D9QCU.VN)KG38;G[.8II85D\B5L%&(SM8X.,'@\5
M#_8>D?VA_:']EV7VW.?M/V=/,SZ[L9J_0!YY9>"M;M?"_A;2B^GM+HVI"\E<
M3.%D4&3A?DX/[SOZ>_'0:+HM_8>+?$.J7'V;[/J;0-$L<C%T\N/9\P*@<]>#
MQ71T4 <YJNBZA>>-=#UB#[-]ET^&XCD5Y&#L90HX 4CC9Z\YKGY?!6N2^#]3
MT??IXGO-7;4%?SGVJIN!-M/R9SQM_'/M7H=% '$:_P"$+WQ!J"W$\&GPW,%U
M%+9:G#*RW-N@VETP$&_)#@9;&&Z<5!J/@2_UB+Q?!<W-O;IK4T$]M)$[.T+Q
M*@7<"H!YC!X/?'O7?44 <0?#WB35?$&CZEK/]DQI:6ES:W*6TLC^:)0@++E1
MC[IX[>I[2>&-$\7:);6VCW=_IL^DV("6\Z!Q<RQK]Q'!&U>P)&>!TR<UV=%
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M6WN'$OWD7. !T&-QY'J:K#P5I0L-)L5:[6WTB19;)1.?W;*"%.?XL D<YZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!HUEB!VEU)Z@$CKCJ*C3QAIC7UG;.MU$+]&>RF>$[+D*-QV8R<XY (!(Z9H
MWZ*Y6S^(6B7RZ=)"MZ+?4)S;0W#VK+&)=S*$8GH25./UQ4^B>)WUCQ%K6F?8
M)X4TZ9(1(ZC#$H&)//&=PP/3\J .CHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K O?!7AW4?$UKXBN],CDU6VQY4Y9A@C[I*@X)'8
MD<?@*WZ@^VVOV_[!]IB^V>5YWD;QO\O.-VWKC/&: )Z*** "N!TE/$?AW5M:
MTI=#>^MK_4);VSOUE011B4[BLH)##:<] <CI7:P:A9W-U<6L%W!+<6^WSHDD
M#-%G.-P'3.#U]*LT <'9Z=JVA7GBNS.FS7]OJUP]Y:31,N"TD85HWR1MP5&#
MTP?7BH-$\,ZCH'B#PK%]FEN+73-%ELY[I&7;YK&,X )W8^1NWI7=7FH6>G1+
M+>W<%M&S!%::0("QZ 9ZD^E.6]M7OGL5N8C=QQB1X XWJA) 8KUP2#S[4 >9
M3Z#KDGP[UC3%T>Y^VW.MM=Q1;X^8C=K-NSOP/E!XSG-;\%GJ2>,_$VH-IES]
MEO-/MXK=\I^\=!)N&-V1]\=<#K7:T4 >96>B:U#X9^']F^DW'GZ3=1/>KOC_
M '2K$Z$YW<\L.F>*FO/#^L7UI\1;=-/DC;5U_P!!,CH!-BW6/LW'S+WQUKT*
MYNK>RMWN+J>*"",9>25PJJ/4D\"G0S17$$<\,BR12*'1U.0RD9!!]* . U;2
M)M<M-,>ZT?5M.O;:T_T:^LID%Q;2\ HP5\%6P#CD<<D9X['05U)/#^GIK#1M
MJ2VZ"Y,>-IDP-V,<=?3BM&B@#E?$*ZP_B;35BT^XN]&:"59A:RI&XF)7;O)9
M3Y> V0O4XR#P*3X<:?J&D^!K#3=3LFM+FVWHR,ZMGYV((VD\<_7VKJZ* .5^
M(%A?:GX=AMM/LY+J87UM,41E&%2978Y8@=%-1QVM^GQ,O=7.G7'V%]'BMDER
MGS2+([E<;L]&'.,9KKJ* /+M!T[Q+I7A[PGIMQHUX;6!)X]0AMYHEE5RV8_G
MWC]V<G.UL],\<&+3O#^OV/ACPW"^AS&;2=>EN98(YHBSQ.T^&3+ 8'FKU(/7
MBO25UC3'@NYTU"U:&S)%S()E*PD#)WG/RX'/-6HI8YX4FA=9(I%#(ZG(8'D$
M'N* /.?[+U+3/$FL17/@Z#6[35+C[5;W1,)$+,BJT<N_D*"N00#P>A/%;.A:
M=?V?C[6KJ;3VCLKBRM(89TV"-FB#[@%#$@?.,9%=A4"WMJU\]BMS$;M(Q*T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&H_8;-WC>**X7:7\X*WS !0V5]0!GG(KQ_#W4(/#.CV,&OK%J6B2;M/O8[7
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MH[69I)@C[)'20#8""&PISD+U!.!HWOAN_P!:N]*.LWEI)!IMVEX@M[=D>65
M=I)+': 3D@9SZ@53M_!^KZ;J]_\ V9X@^SZ+J%PUS-:-;;I8W<YD\J3<-H8\
M\@XSQZT 3R>(M8OXM2N= L+>[CT^]-H;:1MLERRE1(58D*F,G&0<[>V14&D:
MCKESX[\4VKS6LMO9+;+!"59  R,PYR<')Y.#G ]*6+P?JNGZWJ4NDZ\+72M3
MG-S<VK6V^1)& #F*3<-N['<'!Z5H6WAV[L?%>JZQ:ZA$(=1BB#V\EN6*O&A1
M2&W#Y<')&,Y'44 8VA>,FO?#WA5+:QM;6^UP2>3"@(A@2,,SM@8)P !@8R6Z
MBHM7\>ZCH^F^)XY+&UDU30TCF/SLL4\,GW7 Y((P05SU'WJFLOA]/I^@^';>
M'5(_[3T"1VM;O[.0CH^0Z.F[HP.,@]@?:I]8\#2ZSI>OI+?Q1:AK21PRSK 6
M2**/[JJNX$]6.2>2>G04 7+'7]4_X37^PM2M;1(Y[!KVW>!V9E"NJ,CY')^<
M'(QWJO\ $!;R*RTG4-.:*6]L=026"QE/%XQ5E\L>C88L#T&W)P!D7O\ A'[Q
MO&5GK\E] 1!8/9- MN1NW,K%@V_CE!Q@U9UO1&U.YTR]@N!!>:;<&>$NF]&W
M(R,K#(ZJQYSP<'V(!B^ +^WUE=9U=':*ZN[S_2K!E*M9NB*FQ@?XB%!)Z'/'
M2M*XUNZN_$EUH6E?9UN+.U2XGFN%9E!<L$0*"#SM))SQQP<\6=)T06&IZGJ<
MKHUYJ+1F7RTVJ B[5'4DGKD]_;%4[KPY<Q^+&\0Z5=Q07$]L+:[AGB+I*JG*
M,,$$,N2.X(...M ')>(O$MYXC\"65U;I'9RC6;>ROK=\OME2Y12H8$97(STY
M![5Z#%8M;6]S-!%9Q:C<#=+,D.%DD P&8 Y.  .N<=ZYN\\"/)X;M]*L]0CA
MD&HKJ5Q<26Y<S3>;YI^4,-H+<=3@8'O78J&\L!R"V.2HP,T >0G4-4U7X=>"
M]4OWANKNXUNSF0@%229&."3G'/H.!VKH[WQ;JEOIWC&WU#3=.N+G1+9;C8KM
MY,\3QLV"""<C8P(Z'VI;;P!J%OX:T711K<#1:1?174+FR.62-BRJW[SJ<\M[
M#CULZCX*O;^X\52#5((UU^TCM"OV4DP!%9<YW_,2'/IVH -0\9?8+K3+ R6-
MA)>V N()+Q6$,TG'[E6! 4].N>", UU]NTCVT33($E9 74= V.17,:AX6O=0
MTH:9<W5A=63V*6LD-Q:%E$B[AYJ_/P<$<?[(Y%:ATBZM?"D>CZ9J!@GAM%MH
MKN:/S67"A=Y&1EN,]>M 'G&N^([6S\8V'C!-7MS!!>MI4]F+A<BT8[3*5SGB
M4%O==M>A:[KLFFZGHNF01IY^JW#Q)-*"4B"1LY) (R3MP!D=?:DU'PXFH>"9
MO#A:!$DL_L@;RB40;=H(7=GC@CGJ*XWQ+%<:3IGAG1-6\164,L#-(-1OK(BW
MD,:!4#Y?B3YMP.X?=)] 0"Y=^/=:M/#GB#43I=D[Z/J L3B=P)CO0%PNWCB1
M>-W7//'.K+XBUFUU%-)O8+.*_G$MQ$]M%-<I';J4 W*H#%RSX[# SGH#B6^D
M:CXJ\*:CH,>IZ*;)VBDAU'3;-O*9O,WNNWS,,V54E@W\1SS70^(?#&H:EJ&F
MZQI6K)I^LV*/$9&@\R&:-\;D9-P.,J".>* *-KXTU">&PL[O2Y;#5KDS[E>V
MEE54B*CS%10'*MO3 .,9.3QS ?&NOQV^DB?0HX+B[U9M-?SV>(.-K,LJ KG8
MP7OR.1@U<U3P?JMX-,U&VU\P^(+!Y&%VUN&BE60 /&8L\)A5QSD8SDDYJ6]\
M*ZIJ"Z-)<ZU%)=6&H"_E<VIVR,$*!$4/\BX;U)SSW- &9)XM\3)'XEMQ8Z4;
MO00)9)#)((YHS%YBJHZAL9!). <<'/&B_C"2]:RM].B\NXN--CU%C);2W 19
M/N*1'SR0V3D8QT.>%D\(WKW7BJ8:E /[>B6(+]F/[C;'Y>?O_-QSVYJFW@?5
M;-M&O='UV*UU.PL$TZ9Y+3?#=0K]W*;\J0<G(;N: &P^,O$%S=>';0Z%%976
MK07+217DCJT+PXSD;<[3D$=R...M9VI>+==O/#$$L7V6SOH?$,>E790,R/MG
M524Y!"GC.><$CWKI'\+WTFO:%JDFK+*^F)<"026Y)G:;&X@A@$ VC P<#BLY
M_ 5X^C7]G_:\(N)]9&L0RBU.V.02"38R[_F'&.HH [:+S!"@F*&7:-Y0$*3W
MP#VI]9T%MJB:JLT^HQ2V7V4(;<6^TF;=DR;L\#'&W]:T: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "DVKNW;1NZ9QS2T4 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4C*&&& (/8BEHH  ,# HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBJ]]>0Z=87%[<-MAMXVD<@9. ,F@"Q17->"/$MQXET:
M>2_MA::G9W4MK>6P/^J=6X^H*E3GZUTC,J*68A5 R23@ 4 +17'MXK-S\0=)
MTK3]1L[C3[FSN)I4B 9PR;-IW9^Z=QQ@<X/)KH8M;TJ;4/[/BU&U>\^;$*R@
ML=OWL#OCOZ=Z +]%4!K>EMJ L!J-J;MBRB'S1N)'4 =R.XZBJNF:I ;;4;J?
M7+*\MH[ME62+:JVXPN(F()!8$]>"=PXH V:*PM4UNSET2:>Q\06%BRS+%]JE
M*NB/E24*DCYB#C&<C-:-_J^G:6 ;^^M[;*EAYL@7Y1U//8=ST% %RBJ%QK>D
MVI@%QJ=G$;A"\.^=1YBA2Q9>>0 "<],5)INJ6&L6@N]-O8+RW+%?-@D#KD=1
MD=Z +=%8NJ^*=*T;6--TN\NHHKB_+[ [A0BJI)8D\#) 4>I/L:MW.MZ59W0M
MKG4;6&<E5V22A3EON@YZ$]O7M0!?HHK#T?Q;H^N3:DEG>0M]@G:*0F0#(55+
M/C^Z"V,].* -RBLM/$FAR0W,RZO8^5:X,[F=0(@>A;)X!['O4:>*_#TDWDIK
MFG-+YBQ;!<INWL,JN,]3Z4 ;%%8A\8^&A927AU_3?LT<GDO+]J3:'Z[<YZXY
M^E2WM\G]JZ3%#K-G )V9OLK!6>\382-ASD8^]D \"@#6HK'?Q7X>C=5?7-.5
MFG^SJ#<IS+QE.O7YEX]Q5F^US2M,E\N^U&UMGVAB)90N%)P"<] 3QD]Z +]%
M8LGBK2H_%2>'FNHA?-;F<JS@8^955>>K').!S@>XJVNMZ4^HC3UU&U-XQ8+
M)1O)7[P [D=QVH OT56U%YX].N)+9T29(V9&=-P! SR,C/YUR'AW6/$NO>"+
M#7?M^EQ7%W"'6!K-MA8G 3=YO<X&?>@#N**SWUW2([JXM7U6Q6YMXS+/"UP@
M>)!U9AG*CW-/FU?3;>RCO);^V6VE&8Y?,!5^,_*>_'/% %VBJ)UG3!80W_\
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M#Q%>RM9,^GVIN;240-LF"HQ*LN[@Y7'!Z8/?%3Z==>(+O2M(OVU#3B;P02/
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MJ88*+W<&QUQY?.?[OM4OC.^2[T_QA:PVT]K,EW;2&"&V9VNU4PGSV?! 7 P
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M=CWQCFDT_P 37]YXQU_2FTN8VVG1P;&1XR6+*[9.6'WL* .V.<9K @\&ZN/
M$G@.XA1K02>5'J(D7:;;S=_*_>$@'RXQC.#FM^QTK5-,\<Z[J26L4VGZC#;E
M7$V'5HD9=NTCDDD<Y Q0!!X;\1:0OAG0X]%LKH+?I(;*SDDS($1CO9V9C@ D
M=S]X 9JY'XTLVLH))+6XMKN:XEMEM;G;$V^/.\[B=NT8^\"<Y&.3BN2TOPGX
MGT'2/"U[96EO-J>CQW%M=63W 5;B*5@V4DP0""%/(]?QVM<TKQ1=R:/X@MK:
MQDU2PEE+Z8\W[MH)%5602[?OC8K9(QDGL.0#>\->)K/Q/:7,UJKQR6EP]K<1
M.5)21>O*D@@@@@@\@U1'B2]/Q"GT%K!ELX+!+DS[TYW.5W')R%&PC Y]NE:^
MC'47LVFU.U@M)I&R+:!_,$2X'!? W'J3QCG'.,G"OM U"?QW<7ZPQ/IM]I*V
M$S^=M>(AW8D#!SD/Q[B@";_A.+(6^GW\EI<QZ3J$RP6]\=NPLQPA89W*K'H2
M.XSC-=++&DT;1N,JPP1G%>?6_A36+GP7IW@[48(Q#93PJ]^D@VRP12!UVK]X
M.0JJ01@<G)Z5Z#*[)$S)&TC <(I )_/B@#R3P5=Z5=?#ZT;6+O5I;Z>XEMC,
ML]SNRUPT:8<':, KSGM7<ZGXNM?#VJVNE:C;W2K-;N\-ZVSRI6C7+)G=G>1T
M&.>U8_@[3O$'AKP5!H]SH45S<0O,XQ=H(V+2M(O)&1C<.W:K?B#P]J7B>Q%E
M?YA-I EQ;7-NZ@F^ X<#JJJ>@/7)SC R :UUXFAL[6P:ZM9+>\O@3%:3R1HZ
MX&6W'=M&,C/)Y(%4=-\>:;JUM']DAF>^>\ELOL>5WB6,;GRP.W:%P=P.,$8Y
M.*R]1T[Q;=1^'M?6PLGUO35EAO+!YP(KE) NXH^#M.44C(]1SCEVK:1XHN9M
M%\16MG8KJFG3RL=+\_"-!(@5D\W:,O\ *&SC'..<<@&F/&\"+:?:-+U"!Y]4
M_LIE=%&R;G!SGYD(&0RYJOKWCAM/TWQ2;/3IGO="A5W61D"/O0LK @DD #)&
M >U1Z_IGB+6-(TV\:SMA?V6J0WZV"W''EID%/,( +'<3G&.W;)S[KPMX@U0>
M.//M[2W_ +<LHHK;%P6VNL17#?+TR>3^AZT :\^K6LNI^%%U33+U;ZZD<VLG
MF*$C<0L6+!7YRN<#!'/:K=KXOM[B/7B]A=P2Z*Q6XBE*;G^3>"N&.05Z$XS6
M;=:5K=[?^#[N73XXSIDKR72)<!MH,+1@ G&XY;)]NYJSJ/A:XN/'-KJ]M*B6
M,\ CU*(]96B</ 1[AB0?88[T 3:KXTM=*6=7M9)+BUMUN+F#SHE>-2"=O+ ,
M^ 3@9^O(SMZ7J5KK&E6NI64GF6MU$LL38QE6&1QV-<G?Z9XCTGQG?:MH^G6>
MJV.J1Q">&>X\AK>6,;0P.ULJ5QD8SD?GV-HDT=I$EPR-.%'F&-=J[N^!Z>E
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MFTMY+R-;#S8%-M>0_+N42;21*?G&,C^$ 5%_;OB;6;2;4M!BD8P:A) MM)Y
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MC/ !.>I_3%=+?>*M5\,:EXFAU"Y348['2H]2M_W(BVLS.AC..JY4')Y SR:
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M#"IZNYR<#\ 3] : .?N/!%O=Z9!:76KZI--%=1W;7;R1F622,Y3.4("@C[H
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M-V05).=H[]JR)OAWI<^D75A)>Z@3-J#:E'<B1%EM[AB27C95&.2>"#UKKZ*
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MIY;1 L<<*"#EFYSWI^C:_-J?B#7M+FM$@.ERQ1ATE+^:'C#@]!C@CCGZUNT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9!87WA/X>2W<=O< :W/"SR@-\A-Q\I)[<+Q["O7[S2--U&>WGO=/M;F:V;=
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MBMKH6R%H.,#''0>E 'FOA_3GUVR\+@2PO>VUW+)J.H1W:_Z;%\_3:V]M[;"
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M=U$)KHK*H4PR,8U8C!16X [;<=J]!F\.Z)<:8FF3:1826"$%+9K=#&I'<+C
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MAI*7+V]DEND9>94.#*[.K=3G &, <YK5M[VYT.&\;7]066)KQ8[*018>165
MJ;4'S/OW]!SUP!P.;\%I/X#M+GPUJ5C?-:0W,DEA>6UK)/'+$[;@&\L$JX)(
M(( ]":TO%5_J#Z987%OI$\D!U&+>ZVOG7%O%@YF2,@D-G '!(!SC/  -4^+M
M#6QDO6O"L$=R+25F@D!BF) "."N5.67J!U'K5E]>TR*_N[*6[6*XM+?[5.LB
MLH2+GY\D8*\'D'L:\QN=*U1_#?C.WAT?5"[ZQ;W\*RH6>:)3 QVDDEFPC<#.
M,8X/%:]VSZIXOUJ_DT#5)]+N?#?D;'MFC,Y#RDQ@'!5B#@ @'D<<@T =O#K^
MFSFY_?/%]FB6>;[1"\.R,[L-\X''RMS[4ECX@TW4=0EL()W%Y%&)6@FA>%]A
M. P#@$KGC(R,UYU/HGB.71-<TC3+F]U*P^QPRV,FI0M#<+(DH8VY=@I<%5/)
MZ;L9KI_"\MIJVJ)J:>&M4T^[BMS%+<:HKJZY(/EIO)+#.22..!W- &WXFO+:
MP\.7T]WJ;Z9"(B#>1KN:'_: P<G\*6YU[3M-A N;F5REN)W9('D(C_OL$4[0
M<'KCH?0UG_$*">[^'^N6MK;S7%Q/:/%%%#&79F(P  !7.>([&>XFAO\ 2VUC
M3]9@TJ/R9XK-Y8;H9?\ T>:,J1P1WP1YF: /1T=9$5U.589!]JR;WQ1HVG3M
M%=7GE[95A>3RW,<<C8VJ[@;5)R."1U'J*O:>URVF6K7D20W1A0S1QG*H^!N
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MI)1G*+)C86X(QG.01U%<AI^BWNC>(? =E+#<3KINE3VMS<QPNT:.RQ!1NQ@
ME&_+FJ7A:S>.VL?#FM>&-4GU+3KD%;N7>UFVUR5G5RVT';S@#.>/H >GSHTD
M#HDKQ,RD"1 "5/J,@C\Q7!^!/'VGWWAW0;75]75]:OHN2\9 DDR?EW ;-V,?
M+G/3BO0#T->3Z9HU[J'PX\/>%GTZ[M]2L[N!YWFMW1+81R[V<.1M8E1@;2<[
MO3. #T.T\2:5?)J#V]P[C3F*76874Q,!D@@KR<<\5H6MS%>6L5S 6,4JAT+*
M5)!Z'! (_&N&U[1KQ/'$:6 7[#XB@\C5$W8*B'!\P#_:C+1'ZK7? 8&!TH X
M6VU#4[OXB:]H\NO7-M96=O;S0*D< (,@;<"6C.1\HQ6NNO6>A:.MYJ^LM<VD
MLY6"\,&<@D!0WEH%!SD X /%<W%;VP^*'B*^U31;N>RFM;:*WF?2Y9E9D#;P
M,(?4<]ZU+K[-J'A>;0K?0[F.PNI#8P1S6DBJJ$9,K+@%$7)VYQDJ.@Y !TB:
MS8.U\//VBP.+EY$9$C.T-RQ !X(/!XS4%MXETBYNKFV%T8I[:'[1+'<Q/ RQ
M?W\.!E>/O#@5PBZ?KDG@+7/"*6=R^H:?)FTNWB>--002+(#O.!O."K<\GG/-
M)J5@WC'PYJC:7X:U.PU8V#0^=JH='SN5O(0NQW*Q!R?N]/7@ [8>+M$WSH;N
M1'AMOM;(]M*K&'./,4%<LONN<587Q%I3RZ;$MUEM3B,MGB-\3*$W\'&,[><'
MFN?BU&;Q;I5YL\-WMA>MI\L#RW]MY3([+CRD8\L"W.1\O [FN?TI[ZXF^'2C
M1-5C&E1/!>--:,@B?[-Y??&1N_BZ'/!/. #H1XTT[6/#>N737=YH]O:RS6YO
M&MG5H]IVEAN7&[.?EZCN!6];:]IKZI%HRW<DE^;87 5H6!>/@;\[0N,G\^*X
M"2SU!/A_XYT<Z5?F[GN[]X MNQ$PE<F/81][(/;ICG%;7B&PU,6GASQ!HEH\
MNJ6!2!X)%*&2&4!'5@1D;6V/STVDT =/_;^G?9_.$LA7SGMU402%WD7.Y57;
MN;&&S@'H?0U-I6KV&M69NM/N!-$':-OE*LCJ<,K*0"K ]00#7&>*-.N]%N?#
M5_;6-_J=AIRS07L=D6^T'S G[X*I!8[D)(']XU>L=6L/#UA'=1>'=3M+?5-0
M ;$!:0,X \Z<$Y0$C'//3CG% '8NP1&8YPHR< D_D.M><:YXXEU/X?WNM:1-
M=Z?);7R0[I+<KN3[2(CDNN.1DD Y7OBO2*\AN++45^%^JZ(VD:B;U-7+A%M6
M82*;T2[E('S#9SD<=NO% 'I&G^)='U2ZO+:TO TUFH>971H]J'.'&X#<IP?F
M&1[TMGXDTJ^U%;""Y873Q>=&DL+Q^;'_ 'D+ !QR.5SU%<7XETJ_UOQ7KT5C
M;W,:WOA@V<-P\#I&9B[ML+$8'##\_6KWA::'6+^PN;CPMJMEJ=E&RRSZB'VP
M$KM81,S'?N./N\8'.#@$ WO&/B2+PEX6O-8DB,S0@+%"#CS)&(55_,C/MFHT
MTKQ"VE&23Q ZZJT>[:((OLR28^Z%V[BH/^UGWJ#X@^&Y_%7@V\TVS=4O,I-;
M%_N^8C!@#['&/QJ?3?%)O+1%GT?5;?4=H$EH]G( '[@2X\LC/1MV* +1UN#3
MK6UBU*23[<;82RQ0PO,XP!N8K&"0,\9Z4R;Q;H$$.GS/JD'E:C_QZ.N6$O!/
M! ] >OIBL.,7VB?$74-2OK6YFL=3L($2:UA><021%MT9"@L =Y8'&#]:YZST
M'4-*@\*))8W1"Z]<7[Q1PLXM(9!+M#%00,;UR.Q)]* .Q;X@>&4LYKIM181P
M2&.=3;2[X2,9+IMW(.1\S #GK4^H>-?#NEW$EO=:F@F2$3F.-'D8H>A 4'/?
MIV!/05R=U:W3CXF!=/OC_:$(6T_T23]^?LHC^7Y>?GX_7IS4>B7::?X_TTW5
MM=JX\)V\;*+61G1A*P(90I8=#V[?2@#MT\4Z++86-[!?+/#?Y^R^0C2--@$G
M:J@MP <\<=\5$WC+P\EC8WCZI$MO?2&*W<JPWN,@J1C*D%2#G&,&N'TO3=2\
M/PZ+#)I%TEI=WU]<N]K;>;/9+(V8HA@$QA@?F8=,8R.M5--L=1AT'PU9RZ-J
M<<EEXHEN9@]L[[8B\YWDC.1\Z<]\\$X- 'H'_";^'AI-WJ;7[+:6<ODW+/;R
MJT+<8WJ5W*.1R1CFM1M4M$N;.W9Y!+>*6A7RG^8  G/'RXR.N.M<II.F"_\
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MEC[$*&;CG)0Y(XH ZRHK:ZM[R+S;6>*>/<5WQ.&&0<$9'<$$&I&+!&* %L<
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MY;1FU:VMK>Y$C );3&1"F?E.2JG./:KU !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<3\3V9= TOR
MY(XY#K-CL:094'SEY(R,BNVJEJKZ;;6,E[JOV9;6W4N\MPH*H.YYH P-0\+7
M>JSZK?W,UM'?7>F-ID"IN:.&-B2S$\%B20>@^Z!ZFF77@ZYN?#OA^W6]BBU7
M0VBDMK@(3&Y1=A#+G.UER#@Y'X5?E\66=GIIU"XL-1M]/5<K.]MP1V^0'>H_
MWE ]<5T% &'IVARQ^(+K7[]HFOY[:.T5(<[(HE9FP">6)9B2<#H!CC)A\,^%
MH_#4FIF&<R1W-PTEO&>%MXR2_ECVWO(?Q'I7144 < WP_OI-!DMO[2ABU"'6
M7UFRN$B)6.5G9MC*3ROS,.O>IKCP1J&M:GJEUK=]:>3J6E+I\L-I"P*$,[!E
M9F[%L\C^7/<T4 <WX=TOQ-9^6FO:U:WL5LNR(V]NT3S<8WRDL03CL !DYYXJ
MUXMT)_$OA>^TB.X%O)<*NR5EW!65@PR.XRHK:HH Y@:!JK>+;'7I[JSD>WL)
M+1XTC9 Q=U;<.3@#:!CFLBW\"ZG!I.DV7VZT8V&LMJI?RV&_+NWEXSQ_K#SS
MT'%=G-?&'4K6R^R74GVA7;STCS%%MQP[9X)SQQS@U3USQ'9:#IHO[A9IH#.E
MN3;J'VNSA!GD ?,<&@"MHVA7FG>*->U6:>!X=4>)UC12&B\N,(,D]<@9[8]Z
MR-/M=/\  WA+^QO$VK63:=*\MO;[XRAD1R[%6Y.YB&(XQT]Z[>FO'')MWHK;
M3N7<,X/J/>@#G? NB/H/A.TMIGF>X=1)(T_^L' "*WNJ*B?\!IGC+2IKQ-(U
M2VC:2?2+^.[,:#+/%@K(JCN=K$@=RH'>NGHH QYWUJYO(Y]+N],;3)(1@RQ.
MSA\GY@5;#+C'''3K6=)X+@ATK1H+";R[O2+C[3;S2+D.[;O,# =GWMG'0D'M
MBNI  Z#%% '/6.FQZ%<:QKVH2J][?LC2^4IPJHNV.)!U8]?=F8\#@4WP/HD^
MA>&8X;M0M[<S2W=RH.=LDKEROX9 _"NB(!QD=.E9GB+7K7PSH=SJ]['/);VX
M!<0)N;&<="0/UH RKSPWJ4/C)O$6BWMM$UU;+;7MO=1,ZN%)*.I4@AADC'0C
MTK'T[P'K6F6>@I%K%E))I=S<S%);5C$XF9CG ?.]=QP>.I^M>@@Y&:* . 6Q
MTSPGX8O]#\4:K;3P:K/=-!$L12242,69%&3N?Y^,8YQCFM?1M!U/3/ ]IIT-
MXHU4+')/<7"^8)'W*SAL'D$ I],5TS1QNR,Z*S(<J2,[3ZBB21(EW2.J*2%R
MQQR3@#\20* .>\,^%X_#][JUW%'!;+J,J2&SM<^3$57!(X'+=3@#MZ9/1U4^
MW?\ $W_L_P"R76/(\_[3Y?[G[VW9NS]_OC'2K= '+7/@FSO/$>JZC<2%[34;
M18);3'RF3:T9E_WO+8+],U5N/!-S)\,I/"B:@KW,\ BFO9E)+-QEL=3T '/0
M#TKLZ* .;\0:#?ZU#H>V>VBDTZ^BO9,JQ$A0$;1Z9W'GG'O48\+70\0>(;L7
MT0LM:A19(O))D1UB\KALXQC!Z9S745B:MXGMM*EN(5M+V^FM85GN(K.-7>*-
MB0K$$@G.UN%R?E/% '._\(/K<6B^'OLNM6L6M:"GDVTWV9O)EA**C)(N[)R%
M!R#P>@[U>U#PUK6IP:.]WJ5K)=V>I)J$I6)EC.U2HCC7)*C#$Y))SD]\#JQ/
M'B(E@OF\(&^4L<$XP><X!./8UG:3K]KK-YJ=K;Q3I)IUP+>;SDVY8J&R.>F&
M'7% %72-"N]/\4Z]JTT\+Q:HT)6- 0T?EILY)ZY'/;'O1XAT*[U?4]#NK>>&
M-=,O/M3+(I)D^1DVC'3AB<\UOT4 <+?> 9]3_P"$A^T7\<+ZE>0WUK+$A+6L
ML2JJ$@\,/D&>G4_6MB+0+J]UNWUC6)+<W-K:26T$=L&VJ9,;WRW.2%  [#/)
MSQT5% '!1^!M63P5I7AYM3LW.G74$L<H@90R0N&4$;C\QP,GH/2KDGA?7+'Q
M/?ZIH6K6EM;:KL:]M[FW,OER*H7S(B&') '#<9&>>E=C10!QMQX5URP\23ZK
MX=UFWA2^BBCO8;^!I@S1KM652&4[MH (/!Q76VT1@MHH6E>5D0*9)#\SD#J?
M<U+10!PUQ\/Y;W3_ !)IEQJ*"RU6\:^@:.$B6"8E&!)W8(5D'&!G)YK6@T*^
MO-:TS5M:FMGN-,BD2!;96"L\@"M(<].!@+SC)Y/&-DW\/]HBP7<]QL\QU49\
MM#D MZ9(('<X/8'$UQ-Y$#R^7))L&2D8RQ'L._TH S_$FFSZSX;U'2K>2.)[
MVVDMS)("0@=2I.!U/-9=EH_B*ST"QTA-0L(TMX(K=KA(7\PHH"DK\V Q .#S
M@^M=%:W4%]:175K*LL$JAT=3PP-4-4UV'3)UMEMKF]O&A>X6UM0ID,:$!F^9
M@.K*,9R2> >: ,3Q!X0O->CN;A[R&'5(KA)=+ND4_P"AA2#T[D_-N_O @'A1
M2:CX:\0?V]!X@T?5+&VU%[5;6^AG@:2WG522K !@RL"S8YZ'&?7J;&\CU"PM
M[R))4CGC615E0HX!&<,IY!]JL4 <9?>$];BURSU[1]9@&IK:FTO/ML!>*X3>
M7!VJP*E68X /0@9XYL:CX9U674M"U2SU.![_ $Y9XYGNH6*2K-C<0%8%<%1@
M9Z<9[UU,DB1*&D=44D+ECCDG 'XD@5F6VOVMUXCO-#2*=;JTA2=V=,(RN2!M
M.<GE3VH Y8> M2&A75G_ &M;M<MK?]L6\C6YVAO.\S:X#<Y]L8]ZVX]!OQXW
M@U^6ZMW1---B\:QE2Q+ARXY.!D8V\\=ZZ.B@#GK/PK%9^,]0UY)V\N[B3_1L
M?*LP&UI?J4"+^?K69;^%->TO6=0&DZW;PZ+J-RUU-#+;EIH'?F3RG# #<>>0
M<$]#W[)9$=G5'5BC;7 .=IP#@^G!!_&G4 17%O%=6LMM,N^&5#&ZD]5(P1^5
M<=9^";Q= L/#=]?0W&D6$\<D;A")I8XVW1QL.@P0H+#J!T&<UVU% '/:1H5[
MI_BO7-7FGMWAU0PD1("&B\M-@Y_BSU[8]ZF\6Z$_B7PO>Z3%<+;R3A"DK+N"
MLKJXR,CC*@5H7%\;?4+.T^R74OVHN/.BCS'#M7/[PY^7/0=<FK= ',+H.JGQ
M?9Z_/=6DC0Z?)9O&L;(&+NK[AR< %0,<\<YK$B^'^JVNBZ<MEJ\$&L:9>W%U
M:W'DEHG69F9XW3.<'=C(/8&O0J:9$$HB+KYC*6"YY(&,G'XC\Z *&CVVI06K
M-JUY%<WDAR_D1F.)!CA44DG'N3DD^F ,O7/#$UYK]EXBTF[CM-7M8FMR98R\
M5Q"3DQN 0>#R"#P>QK:T^^_M""24VEU:[)GBV7,>QFVL1N R?E.,@]Q5N@#*
MCL]0O49=7>V$+(R-;VV[:^X8.YC@D8)XP/QXQSMIX(O$\/67AF]OH;C1[*>.
M2-]A$TL4;AXXF'08(4%AU Z#.:[>J]]>VVFV%Q?7DJQ6UO&TLLC=%51DG\J
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MUW5(=3N5NH+Z)/*^T6=R\#O'G.QBA!*U<3P_I\<SND;A6M!9B/>2B1#^%5/
M]_7C.<"@#E]?EU*R?P?::?XANBE]=^1/<[8W,ZF%WW_=QG(!&/E]C7,>)KC5
M+3PY\0/#U]J$^HVUE:V]Q:W-P%\U5E)RC%0 <%>..AKH=;\)K8_\(EIFD6VH
M/I^G:AY[LDS,UO'Y;J,,QS@,P^7GCMCBNDN_"&DW^EW^GW:S2QZ@P>\D,I$D
MY& ,L,8    & ,?6@#"\7:A>1SZLMEJ5R9+/2#<1VUIA#;2?.1+*Q."#M "<
MYPW'>JMOJ&L:QXD\.6S:S=6UOJ.@-=SI J#$F8N5)4X)WGKG';'6NDO/!>C7
M]]+>7"W32SVHM+C;<NBSQC.!(%(#8R>3ZTMCX-TK3KJQN;8W2S6-J;2!FN7;
M;$<94Y)ST'7T&.!0!RVC:UJ-YX;T>&[U:>2X.J75HZ1(/M%\D32J%## 0@*I
M9N.%/(SSD7=[J.K>&]/2]OKL26OC!+$$2 ,8UN,*'(X8KQSZC/)KN1X!T-;>
MVB1;R,VMU)=P21W<BR1R29\S#@YPV3D9[T[_ (0+0!87-FL%PL5Q>"^)6ZD#
M),&W!T.[*G//% &;=ZM?:3X]N[<W=Q<V-OX>:\6V;;S(DF,Y R20.^>IK+DU
MO5K7P;X:\61:A+<7%[-:_;+8X,4J3D*41?X2I88(Y^7G.:[6/PYI\6N)K"B?
M[6EJ+,%IF9?*SG:03SSSD\Y[U7L?!^D:=Y,<$<WV6WF-Q;VC2EH89"2<JIZ8
M)) Z G( H X;5+_7ETGQW?)XAOD?1+MGM%58P,+#&^UOEY7DC''4YSV](N=1
M:U\/S:F8B[16K7!C7^(A-V!6;+X,TB:UU>VD%R8M7<O>KY[?O"0%/^[P .,<
M"MNWMTMK2.V4LT<:!!O.XD#CD]Z /.Y-;U:U\'>&?%D6H2W%Q>S6OVRV.#%*
MDY *(O\ "5+#!'/R\YS5_0[(CXL>*)/M=R=EM9-M+\-N$W!XZ#M6[8^#](T[
MR([>.;[+;S&>WM&E+0PR')RJGI@DD#H"> *LVOA^RL]=N]9B:?[9>*J3EI25
M=5SM&WH,9/3UH YSQ=;O/X_\%H+NZB1Y;H%8I-HR(&(./7DC/H3ZUS>H?;[9
M/B3JEAJES936%T+B)8 N'=;:-OGR#D<8QQU/7C'I&K^']/UN:RFO$E\VRD,L
M$D,S1LI*E6&5(.""015.3P9I,L&KPN+DQZP<WJ^>W[SY0O\ P'Y0!QC@4 8<
MVIZMXBUN_P!)LIQ;-;:=;SILNC"WF2ASOX1MP7"C'3KG.1CJM%746T"UCU6Y
M@EU)8O+N)[3E#(."RY'7(Z8ZYXK,U'P)HNIS65Q*+R*[LXO(CN;:[DAE,7]Q
MG4@L/K_6M^"UAM;-+2W3RH8T$:*G\( P,4 >66&L:W9^ 6\4W.OW4\ZW$MEY
M<PC6%0UYY0E;"=5&3GIT&,==S4%\1:(FKW4VO6ECIKZ>3"UQ,UU);W 8#>H*
M*2I# ;>?FQ@<XKH;3PEH]IX?N-"%N\VF7!<R03R-(#O)9N2<C))/UZ52M_A]
MH$.C76E21W=U;7,8B;[5=R2LB @A4)/R $ \8Y ]* ,.+4M?77/$6E:?)<)(
M-(BNK&/4)%9DF9I$SNR<!BHX).#V'(JC<>.9-/T#7+B$ZC9:G;K:PR:?J8WM
M:-)(4,RL<AT.[(.2,H.@.*Z[_A!-$-Q+</\ ;I+B:U%I+*][*7= 202=WWAD
MX/4=L5;;PMI<\=ZM]$]\;V!;:=[EMQ:)<D)VP 6)R.<G.<T 8MY/J&B^.-$T
MN&_NI['6(+A)!*P=H)(D#B521QG)!'W<XP*YK1]7UT>&_!FNSZY=SSWVJ+9W
M$+J@BDC=Y%.0%SN&T$'/&.F*]"LO#EG8R)*);J:>* V\,T\QD>*,XR%)Z9P,
MGJ<#).*I1^!]&ATK3M,C%TMIIUP+JU3[0V4D!)!SG)P23@Y'- &1X-N;J\A\
M:7ZN@OCK-U!&\OW4$2*D8/\ LC&?Q-.\':Y-=ZRVFZF=3LM8AL]US87IWI*=
MP!FB<<,N>,# &1@#FM>W\/K9ZEK$2QF33-:)EG56P8I2@1S]'55Z<@@^O%JW
MT2VTR87T:W5[=PP&WA,TN]UC)!V G'4@9)R3@9/% &'X"GD%]XLT_)-O::U+
MY/HHD59&4?\  F8_C5>YLR?C/#)]JNAC0Y)=J/QQ/'\N,=#Z5TGAS1?[%L9Q
M(RO=WES)>73KT,KG) ]@,*/913W\/V3^(UUXM.+]8/LX82G;Y6X,5V],9 /K
M0!P,GB75I/A?#X\M[V8WHD$[V>087B\[88=N.H7^+[VX=>U;%BFK:KX_\0V;
MZ_?0V>G2V4T,,:Q@$,A9HV.WE3T]??BMR'P=I%N\BQQRK:O<?:C9^:?(\W=N
MW;/]X;L?=SSC-6[/0+*PUJ_U: S?:[_8+@M*2K;!A?EZ# ..* .=^),3RVGA
MX+<SPAM=LT81/MW R#KZXQD>_-9]SI\]U\2-<MX-3N[0IH=K^^@*^8Q#S8RQ
M!^IP.?S![76M$LM?L5M+])#&DJ3(T4C1NDB'*LK*000:K1^%].BU*XU"-KI;
MFXMEM9'\]CF-<[1R>V3SUY/- '':+XGU;Q!:^%K!Y5$]_H[7MPXG-NTSJ47"
MLJMCJ6( ';L"#V/A>'6+;1C:ZY>V]W>PRNGG0MN)3JF_Y5^<*1GCG@]ZH7'P
M]T"XT?3M-,5S''IA)LIHKETFM\]0L@.['M_@*W].TZVTJQCL[16$29Y=R[,2
M<EF9B2Q)Y))S0!YCIFHW/A[PYXCO8;V=I7\2R6(EN9<K$KSI'YA)!P0IZD$<
M#@CBM'Q$OBG0M%\27JZND%JNFM<6D8N//GBF3[Q!>,?(01GJ0>F,UU!\%Z$\
M6K0RVC2V^JNTEU!),[1LS8+,JYPI) .1@Y JO;^ M%@T:[THF^GM[N/R96N+
MR21_*_YYAB<JOL,4 8&K)K>E_P#"-S1^)M0D.JZI!%.CI$516A<D)\F0,J"
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M'ID<XH YL7<\GC2S\*_;;I+9=):_>028DF8R! N\<@+R>,=1VZ\Y<>(/$/\
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MVFPC8$7HR-\? )#\D@CT.>.FI:^#=-L;B]GM9]0ADO9C/<%+R0>8Y&"V,\<
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M=6.]9-_ .=QR,F@#UFF/+'%M\R14W'"[CC)]!5;28E@T:QA5KAECMXU!N?\
M6D!0/G_VO7WS7&_$*VT^77_!K:A' 8FU-HG:4  JT,GRD^A...AH [F"YM[F
M'SK>>*6+GYXW#+QUY%,BO[.>W>XANX)(4SOD20%5QUR0<"O(=5L_[$E\83Z-
M"\?AU+S3Y+F*S0%%VL#<[%P5^[LW#&.H/<4_Q/%X7O\ PEXMUC2]7;5)+C3
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M<95T8$$>Q%/KF?!-GI%II]\^AWT][97%X\_G,R&(NP!;RMH V9].,YH^(?\
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M>1%@]M@J6B@!  JA5  '  [4,H92K $'J#2T4 )M&[=@;L8SCG%-6&)"2L:
MGJ0HYI]% $8MX!MQ#'\HPORC@>U)]FM\8\B/![;!4M% $7V>#.?)CSC&=HZ4
M](TC&$15'7"C%.HH :Z+(A1U#*>"&&0::8(2Q8Q1ECU)49J2B@")K:!X6A:"
M-HF^\A0%3]14BJJ*%4!5 P !@ 4M% #7C25&21%=&&"K#((I(HHX(Q'%&D:#
MHJ* !^%/HH 8L,22/(L:+(^-S!0"V.F3WI]%% $*VMNDAD2")7+;RP0 EL8S
M]<&G?9X<L?)CRS!B=HY(Z'ZU)10!AZ9I&I1ZK-?ZOJ<=ZRF1+-([?REAC9@2
M#R=S851GC@>YK<HHH 8\4<N/,C1\=-R@XH6&)&++&BL>I"@$T^B@".&W@MU*
MP0QQ!CDA%"Y/KQ0;> J%,,>T$D#:,#/6I** (VMX7DCD>*-GC^XQ4$K]#VHD
M@AF='EBC=HSE"R@E3ZCTJ2B@ KG?$?A^YUK4]$N8Y;=8M-N3</'*A;S<HR%?
M888^M=%10 R.*.&(111HD:C 15P /I3$M+:.+RDMXECSG8J #/KBIJ* (S!"
MRJIBC*KT!4<4DEM!+)'))#&[QG*,R@E3['M4M% $<L$,ZA9HDD"D, Z@X/KS
M56\TJVO1;I*BB*&83A%4<NK;@<XR/F&>,9[\9!O44 %-:-'969%8KG!(SC/6
MG44 1?9K?&/(BQZ;!2M;P.\;O#&SQ_<8J"5^GI4E% !2,H92K %2,$'H:6B@
M"*WM;>T0I;010J3DB- H)_"E^SP?:/M'DQ^=C;YFT;L>F>M244 1_9X"2?)C
M^;K\HYIKV\83,<,.]1\FY> ?_P!=344 <[X.\--X9T*"PN&MKBXA:3%S'%M+
M*\C/CG)X+8Z]JWC;PLSLT,9+XW$J/FQTSZU)10!&;> EB88R6ZG:.:QM0T6_
MO]4B7^T8HM#"J9;%+8;Y'5MW^LSPIXR,<@$=ZW:* "BBB@!OEH0047#')&.M
M(\4<N/,C5\=-PSBGT4 1FWA+%C#&2>IVCFG(B1KM154>BC%.HH :\:2#$B*X
M'9AFFR6\,T/DRPQO%_<905_*I** (I;6WG0)-!%(@Z*Z @?G2RP0SQ^7-%'(
M@(.UU!&1[&I** &-#$Y!>-&(Z$J#BF_9H.?W,?/7Y!S4M% $36T#^7O@C;RS
MN3* [3ZCTIZ(D:!$554# 51@"G44 (RJZE6 92,$$9!%,-O"3DPQY QG:.E2
M44 1&W@,31&&/RWX9-HP?J*>B)$BI&BHBC 51@ 4ZB@!&174JZAE/4$9%,%O
M ""(8\KT^4<5)10!']G@^T?:/)C\XC;YFT;L>F>M*8HV+%HT)888E1R/0T^B
M@")K:!X3"\,;1'JA0%3^%.>&*2$PO&C1$8*,H*D>F*?10 U$6-%1%"JHP%48
M %.HHH BBMH("YAACC+G+E% W'U..M.2&*,YCB13TRJ@4^B@ IGE1['7RTVO
MDL-HPV>N?6GT4 1+:VZQ+$L$0C7[J!!@?04I@B)4F)"5X4[1Q4E% $7V:#!'
MD1X/;8*/LT!.3#'TQ]T5+10!%]F@P!Y$>!T^04OV>$ECY,>6(9CM')'0GZ5)
M10 PQ1L6+1H2P 8E1R/>FM;P/"87AC:)NJ%05/X5+10!'Y$/EK'Y2;%^ZNT8
M'T%"P1*X=8D##H0HS4E% !48MX021#&"6WGY1RWK]?>I** (OLUOC'D1X/;8
M*&MH',9>&-C'RA* [/IZ5+10 U$6-%1%"JHP%48 %.HHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***H:MK6F:%:"ZU6_M[* MM#SR!03Z#/4T 7Z*AM+NVO[2
M*ZM)XKBWE7='+$P96'J".M34 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !5._-E; :A=(I:%&1&V[F^8C*J.Y8A1@<G@5<K'UOPY;:]);/<7>H0
M&V):/[)=/#AB,9.TC)QD?B?6@"#P=HC:!X>6T=%B>6>:Y,"'Y8/,D9_+7'&%
M# <<<&M^J&D:1!HUHUO!-=3;W,C275PTTC$@#EF)/0 5?H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ljb_employmentxageementx003.jpg
<TEXT>
begin 644 ljb_employmentxageementx003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\2ZT?#WA
MZ[U46WVDVX4B+?LW$L%ZX..OI6M7/>.-/O-5\&ZC96$!N+J14\N(,JEB'4XR
MQ ' /4T 1P>)=1M]6LK#7-%6P%\[16UQ#=B>-I I;8WRJ5)"L1P0<5IVGB'1
MK[4)-/M-4LY[R/.Z&.9688X/ /8]?2N>O+?6_%6IZ4MSHT^CV-A<&[>6XGB>
M21PC*BH(V8 9?))(Z8[UDV?A[6KG2?#>@OI;Z<^C9$NI>;&4?$+Q9BVL7.\N
M&.X+CG.30!V4?BKP_,UTL>M6#FU0O/BX4^6H."3ST!X)[&KEUJFGV32K=7MO
M 88O/D$D@79'G&XYZ#/&:\_GT/6M2\%+X='AN&UN+32)+,7<\D9#2;%4"$J2
M0KE<DL%XQWZ3ZGINL>(=0U&^G\-W,5O)ID5O';RWD<<KR+/YAVLC,%(ZJ2<$
MKS@4 =6GB33[N&VFTV[L[N*6Z6V9EN578Q!./=NGR\$YJ2'Q-H5QJ)TZ'5[*
M2]#F/R%G4N6&25 SR1@Y],5QEGH?B&XG@DN(+IK>/5K:XC>^^SB[\M8W5VD:
M([6 )4+U;K[5FZ/+*K> =(^Q0NME>2!;^*XC=;@+;S N@4EP"<%MP7#8'- '
MHMAXFT+5;L6FGZQ8W5P4\P1PSJQ*\<C!Y'(_.J6L>(-0L_$%IHVF:3%?7$]K
M)=%I;OR%54=%(^XV3F05BZ#X:U'3].\!Q262Q2:7'(+T!U_=%H&4]#SER.F?
M6E\8:%+?^+=-U"7PY/K5C#8SPM'#/%&4D:2,J?G=,C"MTSUH Z)=>%A8"X\2
M?8=(D:0JBF\$BL ,\,57GKQCM5NRUK2]1%N;+4+:X%PC20^5*&\Q5(#$8ZX)
M /H37*VFBRS7GAM[?PY-I=II]_-++!<31.5#6[J'&UVSEV ZY'7&.:IW?AS7
MK33KN_TFTC_MBWUBZNK.-I%"RPS94Y.< 88/@\Y04 ===>)]!L88YKK6+&&.
M5G1&>=0&*':^.?X2"#Z=ZC_X22T36;^SG:*&VL[*"\>[>4!"LC2#Z #R\YSS
MFN/N_".H:)JEK+IT>J75HFDQV'_$OE@63S$9F)?SN"K[\D@YR.0>*@_X0O5[
M>%!#8B1+6RTK;;O<JXF:WGED>'<<= RX) !./? !W<?B?09=.?4$UBQ-FCB-
MYO/4*C'HI.>#R.#3X_$>BRZ7+J::K9FQB;;)/YR[$;C@GL>1Q[BO/_$MMJ$M
M[-KTVBR01W-]I4$5A-)'YD[1SL2S;6* G>%&3_#S@5-JWAS6]7O;C78K&[L\
MZA:W"V*2PBX=(HW0ODEHP^9 0">D8Y!Q@ ]#T_4K+5;076GW<-U 25$D3AAD
M=1QW'I7,3^-KDF&&PTA+BZFU:XTQ(Y+KRUS$KL7+;#C(0\8[]:M>#M+N;+^U
M+NZ@O87O;D2 7L\;RN%15W,(QM4G&, G@#)SQ7/OHFN:?<VE]%I$UX;?Q'>7
MQAAFB5FADCE56!=P.KCC.?:@#I+#Q4?MEY8Z[9+I-U:V_P!K8M<"2%X,D%Q)
M@?=(P00,9'K6Y<7D%M8R7LK_ .CQQF1G52WR@9R ,D_A7+6MOK%YX@N_$E[H
MKV_D:<UI::>T\;RSEF#L6(8HN2J*!N/<G%==&28U)382!E3V]J .;T_Q=)JG
MAZZU.TT:\::*[:TCLV&V1F#A 6S]P<Y.?N@'Z4D/BJ]E@U"'^Q'DU6RN8[9[
M6"?S(R9 K*WF;1A0&RQ*Y&.AXS'I]KK>C:3JTEM81SW4FK37,=N\B@RPM)D[
M3G 8KG&['.,XK,TC3M7T?^U[S2O#YMM/N9H"FD2RH)" ")I%VN45F!7 +8.S
MG!- %R?QO=16;*NCH^IQZHFER6WVO]WYCH'#"79R,,/X00<C'%7].\3RR7>I
M6>L:?_9]SI]NEW)Y4WVA&B;?@@A0<_NV^7&>F,UQEYX2U"739A;^')5TMM8M
M[N+1?/B#K$J$2M]_8NYCG:&]^I-;_A#0KG3O$5]>V^B2:%I<ULB-9RW"2-+.
M&/[S",P7"_+UY].* -OPYXEB\0V%[>?99K.*VN9("MR-KX4 [F4_=Z]#R.]4
M-"\;1:WH>IZB+&2W>Q0S""1^983'YD<@.. Z_D01VJA=Z%K4GA[Q!IEO"T<F
MKZLX\U9$S':R% \G7KL#8'7..*@N_"&KZ7J33Z?>7>J0WNF3:=<I<>1'Y2JA
M,! 14! 8LO<_/Z"@"_;>,]2CLM.U+5M 6TTN^,(%S!>B8Q>;@(74HI )902,
MXS5F'Q7=WGB.YTRSTN"2"VN?L[SO?*CG"J798]N2%W$=>2#6(MEXAUKPKI?A
MB?P_/IT,:VJ7=W<W,+ )$49@BQNQ);9@9  SFEU+P_=WMY+:P^%K>TO&U5+M
M=:A,841B0.7)W>9YA4%"N,$GKB@#JO$NN2Z#I\$]O9K=SW%W#:QQ--Y0+2,%
M!+8.!D^E8]SXVNM-MM:&JZ*+>\TS3SJ BBNA*DT?S# ?:"IRA'*_G57Q7X6U
M&XT81BXU#Q IU"VG>RG:!,1))N=4("#D<?,>PK$F\(ZE-9>)!I'AV31K:^T:
M6U%E+=1LUS<G[C85V5<#<,EAG=[4 =;'XHU.TO;"+7-#2RM[Z58(;F"\$ZK*
MPRJN-JE=V, C(S@<9IMIXS>YNK25M,,>D7MV]G:WOG@LTBE@"T>/E5BC ')/
M3(&:JW,6N>)9M(LY]!GTJSL[R&[GGNKB%V?RCN5$6-VZL%R3C !ZU1M-%UF*
MRTC0'TJ40:5J!NS>^;'Y<T2,[QA!NW;V)4$$ ##<],@'0+XN@;QLWAW[,X0(
M5%WO^4SA1(8<8Z^6P;.?6NADD2&)Y9'5(T!9F8X"@=237FA\$:^OAQ-374KI
MM>2[_M?^SLP>3]I)R8]^S=C:3'G?C\*Z+5/"=_J]K<1MXCU!(KIU=K6XBADC
M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
M\] ,^U)=>-KNT@E@DT9/[7BOK>S:U^U_NSYWW'$FSE3SU4'(/%9$/A7Q';VV
MISSRK>SQZY#J-M"$2+[0J! Q!W$*64$ '&"H[&HM=\/:MK@OM4ET&9UN=0L6
M_LUYHA*UO!DL2=^P$EVP-W0"@#J].\33OJ%_I^L:<-/N;.V6[;RI_M$;1$L,
M@A0<@H>"/IFI_#7B-/$MO?3QV=Q:I;7;6P6X4J[@*K;BI&5SNZ'GUQT&#X2T
M&XT_Q/=WUMH4FA:7+:".2TEN$D:>8-D281F"X7(ZY.[IQ6CINAWXC\0Q/=7&
MG->:HUQ!<6QC9_+V1C(W!@,E6&",T /U'Q'JL7B:;1=*T6&]>&TCNI));WR<
M!W=0 -C9_P!6>XZTT^,HF\%Q>((;&5Y9G$$-DS@,\YD\H(&&1]_^+ICFN<UG
MPM,?%C75_P"';WQ-:G3(;9+@SVZ/YBR2EMP+QCHZ]!BC3O"/B"XAT/3KN:?3
M+'3GN+R-H)8YGA8N5@@RX8-LC9LL01TP>,T =++XPB/A?3-8M+1IY-2DBA@M
MVD"!97.-KM@[=I!!X/(Q@FI+#Q7!-H^I7VH0?8WTRX>VNHU?S1O4*<(P WYW
M*!P#DXQFN2G\)ZU9V]UI+6\^L:(FJ)J!C>2)'NXW5C+%@;5^6;$F"%5@<5:T
MWP;J<R%[>5M"L(=0:[LM,EB2<1_NU&6 ;:/GWN%!(!8'J. #K_#6M?\ "1>'
M[35?LKVOV@,3"[;BF&*X)'TK'M_$VO:C=ZBFF>'K6:WL[N2T\V;4O++LF,G;
MY1P.?6JOAGPMKEMX5L;*^UV]L+F"65F2T2$95GR%;<K@]SD8^]CM6*GAHPZM
MK4NH>!;S5'N=1EGBN8;J!5:-L;>&F4COU% '4ZWXJOM%6YN9-#=K"RCC>[N#
M/M^]U$2E?WFWOROH,GBB^\67$6JW5K8:2;V&RD2*X<7 20N55BL28/F%592>
M5ZX&369XLL]5UNSN+!_#+3N\2OI=VD\:&RF*_>D)?*LC<@H&R!CZY&J^#+[?
MK]N-%74+_59(Y;36 T:_9'\M%+'+!TVNI<; <Y H Z@^)=;NM:U6QTK0;:YB
MTZ=8'FFU#RBS-&DG"^6W&' Z]JL:AXKCT[6M)TE[*>2ZOI5CD9 ?*MR49AER
M,,3L. .<#/'?,LO!%G=^)/$.HZSIRRFXO(WM93(?FC6")2<*>/F5NO\ *MCQ
M%I]U?WGA^2VBWK::FMQ,=P&U!#*N>>O+*,#GF@""Y\1ZC<:K>V&@Z1%?FP*I
M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;C?GH0,],_G0!HVOBO3K_2=.O[%9KD:BI:V@10)'V_>R&("[<8)) SQG)&:
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M&LGE2QJA;=D(9 5SC.,'&>,T 7?!5[/=^*O&*2F]6.&\@6."[D+-#F%2P')
M&XDC!QSQ78W,S6]M)*D$D[*,B./&YOID@?K7+>%K/5(O%?BC4+[3)+.WU":W
MEMS)+&Q(6!$((5C@Y'T]S74W+NEM(T<3RN%.(T(!8^@R0/S- 'G?A'5%NM#T
M/Q1J<VJIJ-V#$L*S@QWSR%B%6/<0 H!(/R8 .>*Z6;QOI=K9:O/=17<$VD*'
MO+5HMTJ*1D, I(*D \@XX.<5R>F^&-?LO"/@R0:>XU+P]-NGLC-'^^C961]C
M!MNX!LC)'?I5OQ!X;U36!XJU6#3Y4N-0T<:9:6K21AV/SDNQW;0,N .<X!H
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M"J7RH^<8SZ5A:'H'B/P[_P (GJ8TB6Y>RTMM+O[*.:+S(P65A(A+!6&5 (W
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M1$Q;S-K%2, D#)(..E86N^$]2UV'QAJ$5L8+C5-,2QM+:5U#-L#'<Q!(&2P
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M3Q'XO-]X8T^\M+#3[S4UNEN4DC,GEM$N5==KX*D$';G/;=0!Z!17.>#=9O\
M5['48]2,+W>GZC-8O+"A190A&&VDG&0PXR:S?&'B/5M$&K36TMI&EEI_VNWB
M,;323LNXOO53E(P%4;N.6Z\8H ZR]U"VT^)9+F0J';:BJI=W."<*J@EC@$X
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M86H77D'VM!&?E)MVERAW<<C&#GB@#HO^$HT/[%?WO]IV_P!FT^0Q74N[Y8W
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M\OQE;^'C9N/.LY+M;DN-N$95*[>O\?7BCQ#X@_L!]+!LWG6_OXK+<KA1$7.
MQ[GOP/TH V5544*H 4#  ' %<O-X'L[JX\0+<W4\MAK>&N+,A0JOL5-P;&[.
M%!'H>:WK>XNY-1O()K$PVT03R+CS5;S\@EOE'*[3QSUS5N@#GK+PS(ESIDVI
MZB^H-I:LMH6B"')7;O<@G<^W(R,#D\9Z3>*/#4'B;3X8'N9K2YMIUN;6[@QO
MAE7.&&>",$@@]0:VZIR7X>WOC8H+NYM,H8%<*3)L#A,G@$AEY[9H PKSP=)J
M?AVXT_4=:NKF^F>*7[>8T4QO&P=-J ;0 1T[Y//I$?!4TE_J-_/KEQ+=7^G"
MPF)A0)C+?,% X^^<#/US74VLDLUI#)/!Y$SQJTD)8-Y;$<KD<'!XR*EH Y2\
M\$0WOA'3-#?4+B*;2_*:ROX0%EB>-=J-CD'C@CH<GI6OHNEW6FP.U_JD^IWD
MF ]Q+&L? SA51  !R?<DGGIC4HH X*X%Q-\9)&L[R.!AH:1%I(O,1F\YV*]1
M\P!!QGIVJ_\ \('#;RZ//IVIW5I<Z<T[--L1S.9R#*6##&XD9! X],<5U%K=
M07MLES;2K+"_*NO1N<9%34 <3;_#W[+9Z?:Q:U<-%8:HVIPB6%2=Y+G:<8R/
MWC9[].E;5SX=\[Q9;^((;Z:":.U-I+$JJ5E3?O .1D<^G4>E;E% '&2?#VWN
M-"OM-GU&??<:DVJ0W42A)+:X9M^Y>HP#T![$\U:N?!TFI^&[_2]8UJZOKF\1
M5:[,:1F/8VY-J*-HPPR>I/KC&.IHH YFS\*75OXC77KC7)[F^^P_8V#0(L;#
M<6!V@<#.. ?QJA:_#XV.FZ#;6NM7$4^BRRO;SB%"660$.K*<@GYC@]J[6JEO
M<7<NH7D,UB8;:$IY%QYJMY^5RWRCE=IXYZT <HOP\\NV^SIK=R4&L#5U\R%&
M(E#[\<8R"Q.?PQCOVHS@9()[XK&O_$'V'Q3I&B-9NW]HI,RW&\!4\M0Q&.IZ
MCTK:H Y*/P/&MG>:6^H22:->7;W4MJT0WL7?>R;Q_ 6[8SCC-+=^"YCXCN=7
MTG7[W2OMP07T$,<;I,5&T,N\'8V.,CTKK*YF#Q9-=^(=5T6VT:>2XTSRC,WG
M1A2)%+*5R<G@'M0 ^+PJ;?7+[4[>^V&ZLH[(1-%N$:)NVD'.2?F/7K6?I_@
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M96D-K;H$AAC6.-1_"H& /R%<Q<>"Y%\17FJZ7KM[IL>H;3?VT*(RS,HVAE+
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MZ98ZMI\MAJ%I#<VDHP\,J!E/IQ0!C>&=)FT?4-6@?6!>0RO'-%9K&P%GD$$
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MW/'6NIJIINF66CV*66GVZ6]K'G9$GW5^@["K= !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0W5U;V
M5N]Q=3)#"GWG=L =A^M35R'Q AO?LNB7]M#+<6VGZM!=7D,2EF,(W L%'+;2
M0V!Z9[4 ;B^(M&:UNKDZE;QPVAQ<M*_E^2<9&\-@KQZ]:BL_%GA^_P!0>PM-
M8LIKM(_-:)91N"8SG\!U].]<1XEM_P"T-0\5Z]8Y.F_\(K-:RRA2%FF^=AC/
MWBJY!/;=CU ?:VEOK7_"OFTJ+$^FA9KB58ROD0^00R-QP68J-O4\GH,T =>G
MC3PQ+=6MM'KVGO-=L5@59U/F$,5P/Q! ]2.*N7^O:5IDC)>WT,#*H9]QXC4G
M +GHH)SR<#BO)[:TM];^$]_H5G#OU>XU:?R%6,AED^UL1+G'W54<MT&",YXK
MIK20Z5JGC33]<@FD_M&8W%J_E,XNH6A5!$N <LNW&WKSG&* .MU'Q1H6D2&/
M4-6L[=Q$9RDDH!$8P-V/3D?7-4++QUH5]>ZG#'>((=/5#).V=A!7<2#C[H!'
MS=.:Y'0=*NM,\0>!K+58FEGM-$G@G<QEUBD;R]J%L8!P&7KSCWJ[]FN#K?Q$
MTY;2X\[4($:UQ"VR1?L@3A\;?O#&,YS0!V_]MZ9YUG#]N@\R\C,ML-X_?(%W
M%E]0!S]*IIXQ\-R36\,>MV+O<2F&$+,#O?., _4$#U/ KA-,U%;N_P#APT5K
M?[+&WEANG:SE40O]F"$-E>S<$]!ZU2DA8?#?58DM)Q</XE-PL8MVWLGVQ7#@
M8R1L&<^@H ]&;5[6WUO4FEUV!X+2U1Y;!$!:W.6RY(RQW# VX[<=:ATKQOH>
MIZ7IMZ;R*W_M# @BE;#,QY"CU;!' K(C5I_B9KSQ1R%)M%@BCDV$([AI25#8
MP2 R\>]9VCZ1-KWP;TRP@CGM=6TVWB>W:>%HC%=P\C[P'&1M)Z8)H ]#6^M7
MOY+%9E-U'&)7B_B5"2 WT)!_(^E9OB'Q-8>&UL?MK$/>W26T2@'JQY)/8 9/
MX8JOX.EN-2T@:_>6Y@NM5"3>43GRH@H")GTQEOJYJC\0ED6UT"Z6&:2*TUNV
MGG,,32%(QN!;"@G R.U &]>:_I6GJ&NKZ*(&,2DD_=C/1V_NK[G K01TEC62
M-E=& 964Y!!Z$&N#TZZ&E^,/%']MP3BUU18)[.1X&82QB+8T. #\P.?DZG=G
M%;'P]TN^T7P#H^GZB&%U#!AT8Y* L2J'_=!"_A0!K:CKNEZ22+^]B@PN]MY^
MXN<;F_NKGC)P*<NM::US/;K>Q-/!$)I8PV65#T;'H<=:XB74(M%\:>)K'Q!I
MMW<V6LB%K-XK1[A)T$0C:$[0<$$$X.!\Q/&:D$HT7XC>;/83P0W>@P6]M'!
MTBB1)')B!48! 9>N!CGI0!U,GBSP]#!:SR:S8K'=HTD#&9?WB*"69?4  \T2
M>*M!BLH;Q]4MA;31K*DN[*[&X#$_PJ3QDX%>:^'8V73/A@EQ9W*FT>?SQ+;.
M/*S$ZJS9' +%<'I6GJ#6.F>+O$&G>(=.U633M66(V3V2SM%*GDK&T!6+H<@]
M1T;J* /3E8,H92"I&01T-9T_B#2;:]^QS7\*3^:L)!/"R-RJ$] QR, G)R*G
MTJVCL](LK6*W-M'# D:P,Y<Q@* %+$G..F<UY3XHN9;JS\06Z:=>VLL&MV\I
MM;:R=EG198?](=PIW$A> I& HX.,T >PUC0>+/#]S?1V4&LV4MS)(\21I,&+
M.@W,!CT%:\;B2)9 & 8 X8$$?4'H:\QL--N-3\+_ !!M+&!DU"[U"\:U9XRA
MD#QJJE6('!^8 CU- '?V>O:5J%XUI:WT,MP(_-$8/+)G&]?[RY[C(ID7B31I
MK@P1ZA"THC:4*#]]%X9E_O =R,XK@4&G^+M+D;2M*U>#Q%!IUQ K7K7""R>2
M(J4S(=C$M@ #.!SQBMGPGJ^G:Y!HT/\ 8=S%JNFVYAE^TV;Q_83L"L%=EP=Q
M &%/(Y/2@#IT\0:1)#8S)J-NT5^VRT<.-LS<\*>A/!X]JJOXS\,QS^0^O:>L
MGFM#@SKPZKN9<YQD C->::7<.G@_P'IAL=0^UZ7K,2WJ"SD/DE5F!S\O/7/&
M>.:ZGPRL"7OC>::W92^I/-&[PD;T\E%#*2/F&=XX]3ZT =+:^+?#]\9!:ZQ9
MRF*%9WVRCY8VX5C['C\QZTI\5Z"EG/=R:M:Q0V\@BF,K[#&YZ*0<$$]ACFO/
M+>TNK?X/^%I[;3;J2339;:6^M($:.X:-"=X &&W D/CVS1XFCT;5?!/B+4M"
MTS4I)KZ.VBDGN$N"]PR2 A523D[1G+ 8]S@X /2K#7M)U2\N;2QU"WN+BVQY
MT<;@E,]_IP>:+77]*O;T6=M?PR7#(71 W^L4'!*]F /4C.*X?Q#:W&H>--0A
MTH.DESX5GM;>94*H)F?*+NQ@'!SCL*DTG4+;Q+H%I96FC7-MKUCI\EMON;1X
MO[/<Q;"%D90#E@H 4YQSQB@#LX-?TFZU!;"&_A>Z969(PW^L"_>*]FQWQG%:
M)( ))P!U)KS3PA)I&J_V%;W&BZO'KVD($>.Z-PL=FP38S!B?+(., #.<C@#)
M'7>-;"^U3P3K5AIA(O9[22.( XW$C[N>V>GXT 7;37M*O[H6MK?0R3,GF(@/
M,B?WD_O+[C(KE[7Q#>>)M=U2TTC68[,Z==Q1Q1F!9$N$V*\A;(W#[Q VD8QG
MFJDK#Q+<>"I--@F@NM/N1-=AXF0VL0A97B?(X)8JN.^,]!FM'P9(#XE\8$I(
MHFU)9(B\;*)$$,:EE)'(RI&10!N>)O$5GX6T274[TDHI"(B@Y=V.%'MR>O:L
M*Z\5_8O'D,-QJ<$>A2:/)=_,@7]XLT: [NIX8\>_>I_B9;SW/P_U%+>&6:16
M@DV1(68JLR,Q ')P 3^%4C<PW7Q7T[4!%,+8:',JRRP,H5S,A )(^4E0QP<'
M% '4#7]);3K:_2_ADM;H@6[QMO\ .."<(!RQP#P.>#Z5GZGXVT73K#3KP7:3
MPZA=):P-$<@L6VL21TV\YSW&.M<'H-T^FZ!X8AFT^XA"ZE?AKT63R2609Y2F
MU-IP9%< $@C&>/2"V2X@\,VQDLM0"V/C$W,^^U?<(C,YWX"_-PP)V@]: /8X
MY%EC61#N1@&4CN#7#Z+XWM;2]URU\2ZW9PR0ZP]I:>;MB_=B.,@8^KGD^O6N
MXBD$L22!64,H8!EP1GU!Z&O,#!"EE\0-*O+"62]U*]F:UMS;L6N5:%%C*G&"
M X/.<+@DXZT >A:CK>FZ2FZ_O(X!M+G=SA1U8XZ*/4\5SE[XI.G^/88+G5+=
M-"ET=[P$A<%Q+&H8/U;(8X ]>]<S''_PB^L_8O%,&J7%G=Z3:6L=W9"=T,D2
M,DD3"+G)+%AD?Q&M+2[.UTWXA:,D.GRV=C:Z!+%&DH9Q 3*C*A<YPVP'C)[B
M@#M1K^E'3[6_2_ADMKO MWC._P XX)P@'+' / ]#Z5$?$^B"UM+DZI;>3>2>
M5;OOXE?.-@]6SD8ZY!KS;0;I].T#PQ#-I]Q"!J-^&O19/)+9;GD*!4VG!D#
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M]SI&I?#JQU*WD::ST^]28M&7$#2;-B,V, XRO7L: .^TO5+;4=:O6M->MKV
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MVUHTKWQQ)^[+[2%52>G!.[.0*ZWP=)YG@S128Y8V6RA1EEC9&!" '(8 ]0:
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M2X 4OY">5* &(R %W*N>G% 'HFCQ7UKIS#4M22^8.SI<"(1DQ'E=P'&0.I
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M&0%!(&1G.X8]@#JZ*X;X:L[)XIWPR0,->G!BD?>4_=Q<9R<CTK1UKQI'HO\
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M=.N'L],\K[5/D+GS,?ZL'[^ 03R/09/%7!XC5M=U/2%LY#<6-JEUG>-LJ.6
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M HHHH **** "LS6EU8PVSZ.(&GCN%:2.>0HCQX(9<@$YY&.#SBM.D9@HRQ
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M\4:58:5=V::<VI:/J%W+% 9F$=S!.[%E)V_(V",=>G/I7J-)N&X+D;B,@=Z
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M4M_%?BC4C;Q-;ZE;016^)OFW1JX.X8X!W^_2NK+ $ D#)P,]ZCN;A+2TFN9
M[)$C2,$4LQ &3@#DGV% ' ?\(KKB?#_PSHBV]LUYIEU:RSDSX0K"X8[3C))Q
MQP*U;O2=;A\<2ZS86MM+;WVFQVDOG3E&MW1W;=@ [QA^@(Y'4=:ZBUNXKNTM
M[F/>J7$:R(LBE&P1G!4\@X[=JGH \XT[PEKUIX<\$V$L%H9M$NEFN=EP2"@1
MTPN5&6^?..G'6ND\=Z/>Z_X,U'2=/6-KFZ0(AE?:H^8$DG!]/2NCHH Y:72]
M3D\?V6N"UC%I#IDMHZ^<-^]W1^!C! V8Z]ZYZ#PCKT6A:79FVMC+:^(3JDF+
MC@Q&5Y, X^]\^,=..M>E44 <'J_A.\U3Q!'J<-E%8ZI!>1M%JMO/M+VP8%DE
M4??)4%0#D=.1R*?HVC^*O#]]J&EV:6,NCW5Y+=07KS$2VJR-N=/+VD.02<'(
M'//I77:;J,.JV2W<"3I&7=,3Q-&V58J?E8 XR.*MT <-!X=UG2?^$FT^RB@N
M;+69YKJ":27:;>25<.'7'*@\C&3SCCK3]*\*WFA^*-*FM8TETW3]#_LP.9,2
M.X9&#;>F/D]>IKMJ* /,;'P;XBTS3_#M[;Q6CZGHUY>2-;-.1'<0W#L6 ?;P
MP!&,C&0:FO\ P?K^L6?C>.>*RMFUQ86M0+@OM>.-5PWRC@E>OZ'K7I%% '!7
M'AW7=>\1M?ZG:6=G:76B3Z9/''=&1XS(P.X': W3IQ]3TJ_X3MO%ME:66EZQ
M%IZ6UA&(OMD$Q=KM5&U?D*C9V).3R.!SD==10!S/@31]3\/^&X])U%+<?99)
M!%)#*6\Q6D9MQ! V\,..>AKIJ16##*D$>HI: .8BTK48OB'?:V8(S92Z;':)
MB7YRZ.[Y(QP#OQU[4O@;2=1T30Y;+4H8DE-W/.IBDWJ5DE9P.@Y&[%=-10!Y
MOXL\)^(]=_X2:V$5A<Q7L2#3KB><@VRA1NC";2 2P)W C.>>@%:DND>((?%\
M^K6]I92)J&F1VLX:Y(^S2(SG(^7YQA_]GD=LUVE% 'G.F>$O$.G:7X((AL7N
M]"$L4\7VA@K*\13<&V=1G)&/QJ2\\+:W<:5XYM5@MP^NN3:DS\*#$L?S\<?=
MSQGK7H5% '%V6A:OHWB=M:M;>.XBOK"&VO+;S@K1RQ9".I(P5P2".#WYZ51B
M\%ZG8#P^;=()I+;5YM4OCYNT;I1("J9'.-XQG&=O;-=C>:Y8V.L:?I4[R"[U
M N+=1$Q5MBEFRV,#@=,YK09@JEF( '4GM0!S%SI6ICXAIKL%O#):1Z3)9@--
MM9I#(KCC!PORXSUYZ5G^'=$UVQ>[O-2L[:?5]3G4WMV+GY8X0<".,;<[53(
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M7L4RI<0%B2P#!<$')R"#71:5I<6DV7V>.:XN&+;Y)[F3?)*W3<Q]< #C
MH \[CM]=?5?'MSHNL+82VU\LJH;99!,RVT9VN6Z*<8XP><Y[5?T[Q7JOBM8X
M; 7%E-_9%K>L;80D^9,'//FYRB[!T&3GDCC/13>#[.6\U.=+V^@BU0@WMM$Z
MA)B%"=2I9<J #M85%JW@?3M2U"SO[:ZOM*O+6$6R3:;,(BT(Z1L"""H[<<4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOXP6W>4)=V-F3Z9QQQUK4\,:!<Z"=5^T7<5P+^_EO1Y<)3RR^,KRQSC'7B@
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MN.UE/<$8/XU<K&\+:!'X8T"'2HI-Z1O(XP,*F]R^U1DX4;L 9Z"MF@ HHHH
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M!WA( ))P!6/=>)+2UUK1M,\J:1M6\PV\\84Q?)&7.3G/0<8!ZU5\>Q^9\/\
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MS!-%:;YDE>0N0#("OW1M7&#R=QST&>FJK#J=A<SK!!?6TLS1B98TE5F*'HP
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MRABP? Y(RO H O:+X'\/Z LR6-F_ER1M%Y<\[S(D;=457)"J>X'7O45K\/\
MP_9FR\J&[V6$IFM(VOIBL!P1A 6P!R>.E:$6I-?W6DW-A?61TZ[@:8HX/FS
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MW4VFZU>>![K07MR82WVA4(Q%9>21(D@[#<$7#?Q5Z3@9S@9I%C1"Q5%!8Y;
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M5)[.WU-8C:81"EU;&)5VQL48[@^_@'.6R.>:]5VC&,"D9$8J6525.5)'3Z4
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M3@;96?"!BARQ)+<YZEJ];  S@=>M-"('+A5#'@MCDT <=\6! WPPUWSQ&?\
M1SY>_'W\C&,]ZI^(;W3V\>^!&:XMB'^UMDNN"#!\I^A/2N_(!ZBDVCT% %/6
M)HK?1;V6:1(XU@?+.P '![UYAX(G\+6_PWT"ZO\ 7!#<6D<<[1'4G.&1L[?)
MWX).,8V]3QS7KA&>M)M7T'Y4 >8>.A#-J3ZYIL0>?2[4#7(%E56FM'(8P-ZM
M@,W7H,?Q"I=;\2Z;#XFT#5Y=4:U\.76GR16U]"B-%',64[7W*P3*#'0'@CUK
MTK ]!S2-&CH49%93U!&10!Y/;76C^$=:\.7/GW \*-'=K;7=U_JH[AV5@_
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M=S;QVODW4*6L)+_9MT:D1.YR6DSUSCD=.YJ0Z7IM]\,6L[2&V_X2I=5E^S!
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M@D@GC66-QT96&0?R-34  # & ** "BBB@ HHHH **** "BBB@ HHHH ****
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M++[["3!J5G!#;$2IDM&KJ<C/ )<8^AH TQXMMKB/36TZSNKUM0LC?0J@" 1
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M(/#RI)H=K8S_ &RUE%K'<HY"Q2AW9GP!R!@ 9]2>> #3E\;;(M=C_L:]BO\
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M2]/N2HO9Y)@\IC!!*1JN1DXQN)X&>#0!)8Z]I6H^*[*7['=QWLVB?;(YV?\
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MD#?:([9]LA3O@[EQ^!JOX+T2\T&PO+2:6X-D;DM86]S-YLEO#M4;"V3GY@Q
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M0%LYG1KB6>6YFV'*AY'+E5]AG&>^,UO4 %%%% !1110 4444 %%%% !1110
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MGY<[ 22">3C%13^"94\07FI:7K]]IL&H,'OK2%4996  W*6!,;$  D<UUM%
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M(20F, )Y:E5P<YZ'G/7VK;IDSO' [QQ&5U4D(I +'TR>*R_#&NIXF\-6.LI
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M\B3QF ONVDX7:5X*@=:7PVEUXCT70O$A\1I:W8NE^V!8Y"TC%BKVSCS, 9(
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M"2RGSYL,B[A(3R2V>ISSD\U7T_PKH6E7:7=EI=O%<QQ>2LVW+A/3<>?\X[4
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ML/<4 >9W4EW:ZCXUL0\MC$F@I=Q06]XY\F7$OS!N-K':N<<''>I])CDL-?\
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M<>&Y;UX#(Q6"=691MY^4, <KT)4^]=POAG15L[RT_LZ!K>]<R7,3C<LKGJS
M]6X'/7@>E6+71]/LX9HH;9=LXVRF0EVD&, ,6R2,<8- &=X)@BM_!.BK%G#6
M,#MERW)C7U/'TK?JIIFEV&C6266FVD5K;)]V.)< 5;H **** "BBB@ HHHH
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M05C,WEG9O$S,5W8QG:<XZXH R+7Q5KL_@#PAJ[7B?:M0U.WM[L^2O[Q'F*D
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M:C<N\+Z9&<'!XJ77$M?*\(OI^E26=J->6Y\I;=D*QE)<RNH'R LV><=1G!X
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M#T2BJ.CZK;:YI4&HV?F>1,"0)$*,I!((93R""""/:KU !1110 4444 %%%%
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MM&5NU,BRMNV#:0 5)7&2PQZ8Y(!WC,%4LQ  &23VH5E=0RL&5AD$'((KD/\
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M&;L%8-GKWP#TK8E\?W$/AB\UB310'TZ_:RU"$761!M8 R!MGS* P)X!QGTH
M[BH+P;K.8><L.4(,K#(0>O-86N>+%T0W<CVR2VMI9I<S3+-C87<J@QMZ'!);
M/ !..F:6O:_CP;K5]J&C6U_I\-MYFR&Z$D-U$02<,5'3'H: -OPUHB>'/#UG
MH\5PUQ#:1B..1U 8J.F<<$UJ-(BNJ,ZAGX4$\GZ5A/KSB[BTK2K&*>\6R6[>
M)YO*CBC/RHN0K<DA@!C&%.<<9S&U^&\UOP@;[PY+#=W_ )[0O=$"2R=8F+C&
M,Y(&.W!_"@#LJ*Y*X\:R6FHV,-UI9MX+W4FT^'S9MLY(+ 2^45YC)7@ANA![
MU1O?B%>6MGKMXOAYGM]$NC#=L;M02@5&+(-IR</G:<#CKGB@#NZ1AE2,D9'4
M=13&E)MC+"GF$KN1<XW<<<GI7#6OQ%N[C2M"U8^'G6PU:<6J%;M3*DK%@@VD
M %25QDL,9Z8Y(!V]K:PV< A@3:@);DDDDDDDD\DDDDGWJ:N&O?']UIFG^(Y+
MW142[T,12S0I=[EDBD!*LK[!SP<@CMUK;N/$$\?BL:!%91O++I\E[#*TY525
M=5VL-IQRXY&?I0!O45Y]H'C?4V\(>'M6U.Q@E.KWT=MNBN""GFR, =I3H.F,
M] .:VY?%LD5]XCLQI,]Q-H\4,JQVS>8]SY@8J N!@_+SUZT =-3!-$41Q*FQ
MR K;AAL],>M<FWB!-8FU_P /7UG;":UL1,XBG\^-U<,,'*KA@5/!'H:Y.WAB
M/@GX53&-3*M[9JKXY ,$F1GTX'Y4 >MT5S5OXL8ZEX@L;ZSCLWTB)9]S7!83
M1,I(<?+PORD'K@@_CLVMW/)I$=Y=6;0SF'S7MD;S&4XSM!P,GM]: +E%<KIG
MC&2[U[3])O=-%G/?V37D:>?ODBV[<I*A4%&PX]>01VJFOQ >73]&U.WTDS6&
ML79M+5A< 2;LMM+*5P =C=SCC/7@ [:BN/B\:7DNK:I;+H16TTJY$5[=/=J!
M''Y8D\P+CYL \J*2V\>1RZCIT4MG&+/4(GD2XAN/-,&U=^)E"X3([@L,C'O0
M!V-5S;V\5VU[(0)641AW;A02/E'89./J<>@KEK3Q['<WVDJ+-&L=3SY4T-QY
MDD.5W*9D"_(".^XX/!K \7ZP_B'0-!U2#38CITFMV9MKEY?WNWSP ^S;PK8_
MO9P1D=< 'J%%8_BO4KO1O">JZG8QQ27%I:R3HLS$+\JD]@<].G?ID=:S;#Q)
M=BTT.PEMH9M8U"U\\)]H.P1JJ[I';9D9+ 8"GD^@)H ZJF[T+E-R[P,E<\X]
M:QO#WB)-;;4+:6W-K?Z=<?9[JW+[PIP&5E; W*P((. ?85R<D]]IGQ0\1R:+
MHJ7]S)IMI(\?GK "=TN26(.6/ '';DB@#T>BN+M/B E]%X<NH=.9+#696MC/
M--M-M.NX&-EVG))1E'/)':NDT_49+^]U&+[.J06DWDI,)-WFMM!;C Q@G;U/
M(/I0!>WH9"FY=X&2N>0/6G5YP\]_IGQ/\2R:+HJ7]S)IUG(\?GK "=TN26(.
M6/ '';DBMK3/'5MKEKI']EVK/>ZE%+*+>=_+\A8FVR;R 2,/A1@')]J .MIN
M]/,\O<N_&=N><>N*\^U;QWJ#VL,%A90V^HPZY;:;?0S3GY-[J048+\RNO\1
M(!/&:C:>^T[XG:W/I^D0W%X^BVTLL0G$2%@\N<OMR3Q@';S@9Q0!Z/16;H&L
M0^(?#]AJ\"-'%>0+,J-U7(Z'Z=*X&*WTE?BYXF2]T@7D?V.T=46R\\*Q#Y.
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M.5 Z#/XU!H&A>*K?3X]$UR^TV?2K>$P+/;*XGN(]NU0X/RKQC)!.<?6NSHH
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M$1SNZ=J[&B@#G9+'7[VT>"Z:QCCN;C$Z03/^[ML#*HVP%G8YR<+P>.<&L1/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:P:A/J$$492*ZG.6E0$[3D=1C&#W&#5_4GN8]+NWLUW72PN85QG+[3M'YXH
MM9&<9YHKRGPI#H6N0^&]536H#J:IY<]M#$HGG9DQ+'."2S $$DL.V:LZ'IZ6
M>KZCX"DM5-I%?#4HF:/*M9L=X7/<B4>7S_#]* /3<@$#/)HR!WKR.Y&EZ]>>
M)K#7=9M]-U&UU$F%FC47,42[3"T#$Y ( X4=2?[W+KW1--O]6^(XO;=9_)L;
M>51+SLD^SN=^.@;/.>W..M 'J$NI6D.I6^GO,HN[A'DCB[E5QN/TY _&K5>5
M62V-QXI\!7VI);/+/X?=WGN%4F20" @Y/4C)(^IKU6@ JKJ%_#IFEW6H3D^1
M:PO/(5Y.U5+''X"N6\;730Z[X4MKH#^QKJ_>.\W?<9_*;R5?U!?'!XR!7.:S
MI\=N?B+8PP1'18M)%RL)0&."[,4A.P=%) 5CCN0>] '<Z)J6L:A+#/=6%M'I
MUS9I<PS13$NCM@^6RD<\'.X<<=*W:Q?"5K;6OA/2EM8(84>TBD81(%#,47+'
M'4GUK:H Y/2O%&KZQJNLV-MH]BK:7<BW=Y-0<;R5# C$)[$5T6G7%S=6,<MY
M:BUN"6#Q+)O (8C(; R#C(.!P:\_\,:>-0\5^.U&I7EI_P 3%5_T:4*>85YY
M!YJUXETVTUCPUID>E31SZW8S(FF7*@$/-#C?GUC^5@W;CN<9 /0* 01D'->4
MW&M6D/PVM;ZU4VJG5(H]?WQY>%_,_?\ F@8R-V,CIM..G%0:U_9VAZ?J6IZ/
MK"7-A<W%DVJ0Z<JB"&#S '<!"=K,N0<=1S0!ZZ"#T.:"<#)KROQG8^&SX-\6
MW>@R0S23:>DLL=HZM!&4^ZX"\*Y&>>I"UI27&EWOQ7TQ%EM)X[C0ITE4,K"7
M,D6 WK\N>#VH ZPZK+J.B"_T 6UV7DVQF:0I&RB3:Y# 'L&(]>*UJ\0MH-.7
MX"V#P);K=)=6S2F/ 8-]L"_-COC<.?>NP\3A?"OC?3_$L%GYL>HPOIMPB+R9
MS\T!^K$&,GW7/2@#OR0!DG K'U#6IK/Q-HVDI9&6+4$N&DN-^/)\M5(XQSG=
MCJ,8KC-8CM=!USPYHNI3V=MI<]I<9EN(%,$MX60DL"0H)!<C/J0*W?#NF:;I
MGA2YCM-4>ZM+<W'DW@ /D(>66(C^%3D#&>F.U '79!Z&BO.O!BW&E>)+;2=2
MT^Q:Y.FL]IJVG<1WD"L@)D7J'Y4YR0=QQ7HM ",<*3QGW.!6%X4UZ?Q!87L]
MS;1VTEM?SV92.0N/W;E<Y(&<X]!6+JUW!-\5;#2=8$1TYM*>:TCG ,<MQY@#
M\'@L$ QZ!F]:XG3]1L],T6" 7-O!H?\ PE5[#=.0)(D0F3R0XSC86V\GC@4
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MZL2!U.*"0!DG%>;:[<:==>.KG1M:N[&VT^72XFT\7<2M"X+.)=A8@!ON=.<
M53TZ;2;;Q'8Z%KNHB^TC^Q1_9MQJ179<'S'$C9/REMGEX/7;R.IR >JU4O\
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MWJ!NX-7_ .S_ !!_T'K;_P %_P#]G6=#\1= GM].NE-Z+/4',4%RUHXC,F2
MA./O':<#\.O%64\5Z7J%AK2L=0M6TZ/_ $M&MW2>-&4E750">0"01Z>U $TF
MEZ[-&T<NMVCQN"K*VG A@>H(WU6M?#>H6-N]O:7^F6\#_?CATE45N,<@/@U'
M;>+=&T[3O#UMY^HW']I6@>S>2%Y9)E6/=EF Y<C&1UR>E68/&FD7&DG4 TZ
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MUO9KVWT^UANY_P#6SQPJKR?[S 9/XU9$48F,PC3S2H4OCYB!D@9].3^=>?\
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M@&<8&T G/0EJN266H2>+?"%X--N1;V5C<17+G;^Z=UC"@C.3RAZ9KMP !@#
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M'\7/S>F>*@6T\26-MK3VND76VZ\1BZ=4,8E>S*H&:++8#Y7O@@$D8/(]-HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNVBV@R!(Y<$G;][Y!STSSC-;%Q=3^!/$MHVIZOJ-[HMW9/$DEU+O9+F,%^<
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MZ+3'ECC:-7=5:1MJ G[QP3@?@"?P-9/AMIKC3Y-1EEF=;Z9IX4D<D1PD_NP
M>F5PQ'8L1V%<_P"+K07/Q!\%AI[F-7ENP1%.R#B!B#@'KVSZ<4 ==;WKSZA>
M6K6=S$MMLVSR*!'-N&?D.<G'0Y YJW7F&NZKJ]NGQ)$.KW:'3K:":T8%<PYA
M9R%XX!/?K[U<ECU*/QCH%D->U(P:QIT[W2F1>&C$9!CX^0_.02.<>_- 'H=%
M>6V7B/5+?2K?3)+UYR_B6XT@75Q-L<Q)O9%,@4D,=JKNQGGL>1V/ANSU?3[W
M5(-2OHI[9G26S@\]II8$((96=E!92RDKG)ZC/% '0T45YY;:Q>6OBZ&PUXZA
M;-<7\PL[R&8O9WD9#A(2 <1NH([ DQYR<T >AUDZ;K]OJ>MZMI4<%Q%/IAB$
MIE "MYBEE*X)R,#OCK7 MK6J+\/);X:C=?:K?Q ;5)3(=QB^V"/:?4;#CFK:
MZ/<:QX[\;16^LWVF.BV122T95^?R3@L2"2!Z< Y.>V #OKF]>WU"RM5LKF9;
MDN&GC4&.#:N?G.<C/08!YJW7F>B>(M9U2;X=7EU=RQG4HKG[9 @"I,4A8JY&
M,\D!L9QTXJ2QN_$'B33!KEAJ$%G-!J,HD\V\?RUBCE93$\.S:/D ^;.[)SD#
MB@#TBF++&TKQ*ZF1 "R@\KGIG\JX73+B]\4:;J&J)KDVFW5EJLT6 <Q0Q0R8
M,;QY ;<@R2>06XX %2>#K0)XV\:2>?<N4OXE DG9A@P1MT)[9X]!P* .VEEC
M@B:65U1%ZLQP!3ZXKXI0^;X2A/FS1[=1LQ^[D*9S.@.<=>O?O@]J=!<2:KXU
MU;P[+=WD%KIEC;M#Y4[))*\F_=(7!R=NU0 >,DY!XP =G17,> =6U#5_# DU
M-_-NK>YGM&G"A1/Y4C('P..<<X[YKIZ "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***K7FH66GB(W
MEW!;B5Q''YL@7>Y. HSU))Z4 6:*RK;Q-H5Y:W-U;:SI\UO:G;<2I<H5B/\
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MX.3@>^.376'5M.&GQZA]NM_L<H!CG$@*.#TP>AS[4 4U\,:6FHV=^$N/M5G
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MZCK-[+#=/;75U'&UNNU95C=E0+R?O8&.3UK=?5K/2+2WCUG4[2*Y$*F5Y'5
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MH9H-N)X^0."F2/=17?5BZIH4^J:I!+)JUS'IR*!-IZ(FR=@VX%F(W8Z @'!
MQW.0"7P]:S0:6)[I"EY>.;JX4]5=^0O_  %=J?117/>#%>S\2^-XKG/F_P!I
MK<YQDF)X4V$>OW2/P-=M5-]-B.J)J,9,=R(_*D*])8\DA6'?!)(/49/8D$ X
MF\CTOQ)XGT#7_#5U))J$=R%NI8V<*+7:V])5/"Y.W (!S^)%1(Y?#^E>.](E
MC=[W4;NYN]/C49-U]HC 4)ZD/D'TQD\<UZ;10!YMXET:?3? 'A#04.Z]AO\
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M>#.[ ;I K\@$C'09P3T.3SGA6>+P-K?B'2=;?[+;WVIR:C97LHQ#*DH&4W]
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M@-S#YN@XZ=Z]8HH I:3>P:AI5M<VS,T+QC:S(5SQZ$ U=HHH **** "BBB@
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M:6-W<^4L5K'<J^-L@=F>3 '.,  'WZ\ '7:5J,VI13O-IMW8&*8QJMR%!D4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** &LBL5+*"5.5)'0].*=11
M0 4444 %%%% !1110 51U/1[#68HHM0@\Z.*02HI=E <'(;@CD'D'M5ZB@!%
M 50!G &.3FH+ZQM=3L9[*]@2>VG0I+$XR&4]C5BB@"M8:?9Z78Q65A;16UK"
MNV.*)0JJ/859HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'FGZG:7\L:W^I11ZE<3L^;4O)B52-V8PK?)@$8!X/>N\MM!TNS:T-M911?9
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M+<QQF$YG9@#Y/S+RIW ;EX]#6A>>-?#UA+?17&HJ)+#;]J1(GD,0()R0JGC
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M/-(5?<H!:(IMX<9SUQ@$^U22^+EABM?-@MXI[V>9+427.U'CC)S(S;> >,
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M0SROO,R* <LI+  XP#U&<UV2:7I\=^]_'8VR7CC#7"PJ)&'H6QDU:9E498@
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MO(5+,SE 1]T #!ZDUSUKX&U^P\*Z!%97MA%KFASRR0NQ=[>=)"VY'X##(;J
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M.0,\'C/XU%X7TGQ=I4%MI>IW^F3Z;8J(X9X5<7$Z*,(K@_*O;)&<X]\UV%%
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MCV\!C^82JB C:0-N?XL8SS6IX,FO;7Q$FDWXT_4 FF![/6+ ;?-MPX"I*HR
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M(&9?*#!?E+'Y_? J/PG97*:@GA"[MV:U\-W!GCF9?EFB8?Z,/<@,^?0Q#UH
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M -$."N?NG('(]!2SZMIUQ#9V\TT$=]+X40M<73[Q.CCF.),X9RPY/)^Z,'L
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MO)=&N?#UIXTU"33XIM CBBFN5C,8F#-YD;F16 8IY><XSMQ0!["9$6,R%U"
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MW'%NB>4OL !SG&[C=C;QUH ;K?AJ34]=T.^@-K';Z;++(\#QY\[S(S&1QP,
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MG7;O1I(I;=(].O1=NDJ%O-PC)M]AASSS]*J>'O&T6L>';'4Y[*XAEOYWBMH
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MA\F.WB2(G.Q4 7\JD2-(UVQHJ+Z*,"N4_P"%BZ%]E2[(OA9FZ-I)<M:.(X9
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M+OCK_C:>XT*2\LM1AMHX8G= +I40K(H^;Y3SP3BN]JI>:IIVGLBWM_:VS/\
M=$TRH6^F3S0!S/@S2-0T;4-0MTFOVT'RXC9Q:BV^6&3YMZ*<DE -N,]\X]35
MDTW5!K_CBX&F7#0ZC90PVCAD_>LD;J0/FR.6'7%=Q'+',"8I$<#@E6!QQG^1
M!_&GT >;:'HVLZ%J/AK5I=.GEBCT"+2;VW0JTEO(A#!P,X9200<$GH:CN_"N
MK0Z7-?PV$DMQ/XGBUEK)'3>L*LHQR0N_"[B,XYQGBO3:* ,#Q;;WFI^!-8M+
M:S=[V\L)88[<,N=[H0 22!P3R<UB1:?J8\4^$KQM,N!;V.ES6]RY9/W<CB,
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M'5LG&8E;>A [D_/'[!\]J7P1H&H:!:74&H?O([)GM-.P<L;4,70_[Q#!2/\
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M(H@D.XI,&^8!3GH#D=!7I5% '.>+QJZ:19C2+5[C;=Q?:X[<JLOV<9W^5N(
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M]* //]-LO$6GZ)X.T^71[M[.VLC;ZA%;31I*LJJH3+;Q^[X;.T\\9XX-'3-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF1YBI&8U4CS.#AB2?7M0 Z7Q3KBB[L%M+5M7L+=9+A((9YXI)&W%8U*KE<J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI8:I8:I'+)I][;W212F&1H) X1QU4XZ$9'%6Z "BBB@ HHHH **** "BBB@
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M#RV;-"S+<P>0%54P#G:0V1VR3ZUV_P#PCG_49UC_ ,"O_K4?\(Y_U&=8_P#
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MN).>,YXIMU;^(;O0=>T'3=0BUR(Z,?L6I1ILG4;@/LTN."Q7..AX.1S7HO\
MPCG_ %&=8_\  K_ZU'_".?\ 49UC_P "O_K4 <Q<W%MXCUKP;?:-A'L9));K
M VFU@,1#1R#^$EMHVGT)[5S*+!'\-ALC59QXF$^ F'VB\W!\=<;.<^E>F_\
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M#)*N%5' )*J#D@?R./7Z* (+6*UCAW6D<*Q2?/F)0 W YXZ\ 5/110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7-^-?$%YX=TBWN;*T-Q)->06Q.Y1L#R*I/)Y/.![G)KI*YSQOI
M%]K/A](=.2.2Z@O+>Z6.1]@?RY5<KN[$@&@# GU"ZL?BG<RP:=?W4LN@1R_8
MDE4E6\YP>6;8O  X/..,U?N?$VBZO8^%-2DLKV6'4;V,V3JVSR9BK8\P!AG
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M0E7X)'!]N:T=9\-ZCK,^OZN+,PW5[HC:3:6SR+N&XNQ=R"5 W,. 3PI/4XH
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MBQ+8/ &.>*<'@W5_^$!?P'<0HUH)?+34A(NTVWF[^5^\),?+C&,\[J -R_\
M':6=WK=M%H>IW,FC(DESY?E >6RE]RDN,_*.GWCZ=:Z2SO8K_3;>_M=TD-Q"
MLT78LK#(Z^QKD)-"U7^U/&LRV68M6M(H+,^:N2R1-&=W/ RV>_ /?BNC\,6=
MQIWA72;&[C\NXM;2*"10P8;D0*2".W% 'G?B#Q%?>(?A;K&H75I/9O;ZB(XS
M'*,86Z6/;\IRW .<C!SQ7;0>,+7^T]1L=0L[K37LK3[<7N=A5[?)!<;6.,%3
MD'!Z<5RMSX4\0GP+K/AY+.W=YM2:XMY1<##HUR)LL"/EP!COS[<UIZWX7OM?
M\3:G+)"UO87^@-IGFEU+1R,[-G:#R!G'7J/3F@#3L?'%A=Z_9:0\,D,U_"\M
MHQDC<2; "RG:Q*L <X/;/.1BM34M:BL+VSL$B>XOKS>88$(&50 LQ). HR!]
M2, UC>%QXJQ;VVN:9I]J+1-LEW;S^8;L@8!5=HV#N<G/&,<\/U_1M0_X2S1O
M$FFQBX:SCEMKFU+A6DBDP<H3QN#*#@D CN* )8/&NG2V=R[Q7$5Y;7BV,EBP
M7S?/8C:HYVD,""&SC')(P<+_ ,)?;P?VA'?6%Y:W%G+##Y;(&%PTN!&(F!PQ
M)..HP>N!S7.:IX)U:\.I:[9&&#6I=4MM2M[:5\IB"/RUC=AW92Y)&0"0,\9J
M]K>E>)_$_A[S9+>TTO4[6Y@N[&U,_G+YD3;OWCA1PW3 Z8SGG  +NH^.8](L
M]7GO]'U",Z6D<DRJJ$/&_1D;<%;!&",Y'O6E-XCBA\2?V']CN7N6L7OHV39M
M=%95*C+ ALL.N![UAZSIOB3Q;X*UBPOK*UTRYN;;RX+87'G9<'.6<*  2  !
MGN3Z!MO8^(KCQM9^(+K28((8]*EM)(!=AY [2(XP<8/W/7&.<]J (Q\3K8^'
M#X@_X1_6/[*\@3"XVQ8.9-FW&_.<D=O7&:UF\81QN(+G3+JTNY))!!!=211F
M6- I,N=V OSJ/7)Z<''-_P#"*:Y_PI>/PM]DC_M146+'G+Y?$H?=N],#'3.?
M;FMCQ+IFN-K>D^(]$LX+JXMH9+:YT^YE$?F1.5;Y7Y 960>QH ;;_$G3;N#3
M9+>POYFOKN6R\M%0F*>,$LC?-C^'@C*X.20*O6?C6RFTO5+R\M;FQDTRX^S7
M-M*%9Q(=NP+M)#;MZ@8/4UGZAI6NZA?^&KV:P@1K._:[N(89E(A0Q-&$#$#>
MWS9)P!UQVK.O_!VL:G;>+HT"6D]_?P7VGRNX90\0CVAP.1DQ^_!_"@#I'\70
M6<U_%JEC=V'V.W6Y+R*&21&)4!64D;LC&WW&,TFE^,;+4O$,FAM$T%Z+;[5&
M/-CD62/=M.&1B P/4'UXR*S-1TWQ/XO\*W]CJ5K::-</$OD*EQY^Z975U<D*
M-JY0#')P3GH,ZGAV7Q'<L'UO2;'3/*3:1;S^<9WX^8?*-B]>,DG/;'( S7-3
M>7Q3H_AN%V07:2W5VRG#>3'@!0>VYV4$^@([U+>>)X;5]1BLM/N;U=+4&[^S
M[!Y?R[MB@D;F"X.!V([\50UFR>S^(V@:Z?\ CVDMYM-F;LC.5>,GZLI7ZE1W
MIEKI&L:!KWB&2RM$OK+6)!<Q'S50P3[ C!\]4.%.5R1R,4 377CZS2;38M/T
MZ^U,ZE9O>6;6P3$JJ%)'S,,'YAUQZ=>*V-3UDZ7X<FUB2PNI%A@\^2VC"^:J
M@988+ $@9XSVXS7*:1X/OM U;PC%;Q^?9:1I\]K<3[PI9Y=AW*I.<94_@1UK
MOF571D=0RL,$$9!% '/1>+[6;5]&T\6EP/[7M6NK6?='Y955#%?O9W ,#P#5
M+5->TZY.B27^EW^R76!;VDBR*%$REU#G:^2AP^.#G'(Z5@K\/-7M]"A2VO8U
MU32[X?V1,W(BM1(P"MZDQR,#CKM0=JZ#Q)H-U-;^&;72K7S(-+U&"X?,@7$4
M:,N!GJWS#\CS0!0N_$%[J\OC729K&:WM].M]D<L<R@@F$R;B5;<"<K@#. .>
MII?!OBE8])\):/=6%[$;[3(_LUW)MV3.D*LXQNW#C)!(&<'%22Z%K,.M>,9(
M;2&:UUF!#!()PK!Q!Y6TJ1ZC.<]/4\5!:>'M8A/@(/9C_B1PF.\/FKU,'E?+
MSSSSVX]^* )8?%ND:+H7B+68=*U%([35'BO8RZNYFP@+@%R OS*,*??%;>G>
M)TO?$4^B3:=>65REN+J(S[,31;MNX;6.,'LV#R.*Y*^\*Z[<^$O%VFI9(+C5
MM4:[MMTR[1&3&?F.>#^[/ SU'OCHUTW4'^)$.MFT*6/]DFS9FD7<)#('Z ],
M#&?7VYH ?XP\0WF@)I L[)KAK[48;5F#*-H9LD $C)(! [#KFN>75I](^(7B
M>XCTZ_O2--LYVMHY%)C_ -:6Y=@HZ#@'GL.M=#XSTF_U2STJ338HYI[#4X+T
MQ22;/,5"<@-@X//Z5132=77Q3X@U*2Q4Q7^G06T6R93^\0/GKCY<OP?;H* )
MKC7]'U+4/"%R;2[E.I%IM/G5MJ1DPLQW@-R=N1C!&:8OCM[B:_ALO#NJ7#6-
MS);3MF)41UC#@D[^ASC(SCOU .9I_AK6K6R\!0R6:[M#R+PB9<?ZEHOEYYY;
M/;BM;PYHVHVDGBA;RW$*:G?R7-N_F*WRM&B88#H?ES^/6@"II7CR;_A%_#VI
MZII5T#JSQ0^=&8O+1Y -I/SY"DG XSZ]1GJH-3$^LW>G);R_Z-&CO/E=A+YP
M@YSN &3QT(]:Y&ST%H_A0/#GB;[-9>18^1YJ3[\>6N1*#@8((# =L5O^#[*^
MM/#EM+JK[]5NU%Q>OC&9&4#&/]E0J_\  : *U_J37_CFU\-H2MO%9-J%W@_Z
MP%]D<9]B=S$=]H'0D' ^($5AIL]A?/K=Y8:O-?PK;W#7$H@C3>-RLH_=A=@8
M<CDXR:UIK)]/^*T&JOQ:ZEI9L@W831R;U4_[REL?[AJ37[/5?$^EZKX?NM(B
MM[6YS"EX;E9%,9/WPN-P<=0N,9 ^:@"O-<MKOQ*NM$N&D_L[3M-29HD<H))I
M6(#'!!.U5X]"2>N,9%AKNHO\.]0U?SGEU/P[<W,1E8_\?,<#G<K^NZ,8)_O?
M-UKHI]%N=,\8?V_IUN;E)[ 65Q;B0*V4;=&X+<$<LIYST(STK)N]"F\._"O5
M-+RMQJFI).K"/I)<W)(PN>P+XSZ+DXYH [*/5+231DU8RA+)K<7/F/P%C*[L
MG\*X76=6EU+Q5X&NDLKVVM[F\D>-Y) %=# Y 9 W!/!&1G'H>*Z:Z\,BY^'[
M^%Q/LW:;]A$P'3$>P-BN;CTKQ9>/X2%YI5G%)HMSFXE%X"LJB%H]Z +D9SG!
MY[>] &\OC2V-W9(]A=QVM[?2:?!<.% :9-W5<[@I*, <=N@S3K7QC;7%GKT\
MEA=V[Z*[)<02[-[80/E0&((((P3C-<H_AGQ5<OI<]Y865QJ-CK7VN6]DN^9X
M?W@4*-IV* Z_+_L].:U]2T5;WXBV5S972>1<6V[58%Y$@@D4PDXZ'>2.>J@C
MM0!KR^*E6XNK>+3;F:XLXHY;J%'C\R(.,@8W?-@#)QQZ9/%;L\CQ0/)'"\SJ
M,B-" 6]AD@?F:X;Q;X6O-<U"XN;6P-MJL.P:9K-M.(VB&!N649RR@[N,-D'&
M!U/=.SQPE@AE<#[JX!8_CQ0!YEX2U"VGT+1?$^JVMX-8GN)(89(Y5!O7E=QY
M9 ;E5 XWX"A<CI72WVO0:G8^(-&FAN++4K2R:5XB^"T;*=LB.IY7(([$$8(]
M>>L?!VN0>"_#< ABCU?0;W[4(FF!BN%+/N0,.A*OP2.#[<UM7&@WVH:QJ^OO
M:&&XGTC^S+6U:12YRS,S.02H^9@!@G@$]\4 <_$7/AWX53^;+O>6V1_WC88&
MU<G(S@\@<FNNOO&-M:0:E=16-U=V6ER&.]GAVGRRH!?"D@MM!RV/?&2"*PT\
M.ZRFA^!;3[$#+HDL+7>)EQA(6C.WGG);(Z<"I(/#NLZ5:^*-'MK:.ZM-8N)[
MFUN3*%$#3CYUE4\X4Y(*AL@]J -R/Q9;3ZZNE6]I<3/+8?VA;3J4\NXCR!\A
M+9S\PZ@=0:9I7C"WUC1M+U*UL;LIJ-PT$<3&,.A7=N+?-@ ;&SR3QTK-U3P7
M<+I?AFWT:Z\FYT8+:_:&X8VS1^5+C_:P%8>ZBI_#?A%] \1ZI+&T:Z0S^;86
MZC_4O(%\[\,H"/3<WK0!4B\6Z1HNA>)-:ATK45CL]4>*]C+J[F;$8+@%R OS
M*, ^^*UHO&-L-6OM/O[*[T]K6S-^)+@+MDMP<,XVL2,'L<'D<5R]]X5UVY\)
M>,--CLE%QJ^J-=6VZ9=HC/E_>.>#^[/ SU'OC1U^VN+?Q+=^(KRTA32H]!FM
M)3<R+MWLX?#!225XVG&3D\ T :4/C6&6^T6U;2[U?[9B,UDX,9!0 ,Q?YAM(
M5@V!GCW!%2^-]?N_#?A[[;9VAN)6N(8,[E 3S)%3=SU/S<#UZ\5ROA^WU?1Y
M]!;6?#4ICLXTL;:Y&IQSBV\S:F53:I(X49)8A0>V<]5XYT>]USPM-9Z>L;W2
MSP3HDC[0_ERHY7/;(4B@# N;^ZL_BKYT.G7UQ-+H&_[$DJDAO/ ZLVQ>!U!Y
M]S6Y;^.-,N]%TO4(%?=J:L8()66-ALX?<2<#:>#R>2,9S4$6GZL?B"FNS6 %
MM_9!M&$<RL1+YGF8&<9&.,\<]L<US=AX3\3:/H?ANZM+.UFU/1WNXYK&:<!+
MF&=]QVO@X887J.Q_$ [CPUXEL_$]A/<VBO&]M</:W$4A!,<J=1E201R""#@@
MULUGZ-_:#61EU*V@M9Y&W"V@?>(EP  7P-QX))QWQSC)T* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***P?$^NR:,FF06X3[5J=]'90M("5C+ DL0",X53@9&3B@#>HK@=6\;WGA
M34M9L=42.\%MI@U*SF1?++C?Y9C?J =Y7YAV/3BM+5-5UWPS;7VJZBUI>Z5;
M:<]P_E*8Y%G7HBCG*$=SR,=Z .LHKF#)XHAQ<-<:?+:/8O+(PC(,,X *A1GY
MD(R.3GC.>U95GXNU6XTWP+>M]F']N,J7:",X!,+290[N.5QSF@#O*QK_ ,)Z
M!J>H?;[S2K:6[("M-MPS@= Q'WA]<UR]CKGBV_BUZ[2\TF.'2+ZZMRAM')E6
M.,%3_K/EY(SR<Y/2DL?$_B-="T'4;R2RF?7DMDMH8("&A=HFD=B6<!LJO XP
M2!SCD [^&&*WA2&"-(HD4*B(H55 Z  =!3Z\[UCQ'XQT30]6NKBSMT6VN[5+
M.XN$7-Q%+(J,"J.=K*6^]T(QQ5__ (2?4M%U_7+/6I;>ZM[+21JL;VT)B*J"
MX:/!9L_<X/'6@#M:*Y2WU/7XK6QUJY>RETJ6R>ZO8T4J\'R!T\LY.\=0<X]1
MCI5;2M:\4W]SHE\NG"73+^/?=#$:_9E9=R,C>82XYP<C)ZC'2@#M***XS4M4
M\27'CBZ\/:9=:=;1#3$O8YYK9I&0F1DP1O ;[O7C&>AH [.BO,[/QOXBU&S\
M.K&FGVU[>:A<:;?*\3.J2Q+)ET^8?+\F=OX9'6MK3M5UW4]2U/1%OK..^TB"
M$7%RML2DT\BEA\I;A H7/.22<$8Y .RJIJ>IV>CZ=-J%_,(;6$ R2$$[03CH
M.>I%<-;^.=4NM'\-:\T=O;:?=WAL=4C,99H9-S1AE;( 4R*!R#PPJ]XG\1:Q
MI?A/7];L9;0I:3;+598"V55@CDX8<[]P';"C@YH [1Y$CC:1V"HHW%CT ]:J
MZ7JEEK6G1:AIUPMQ:2E@DJ@X;:Q4XS[@UC2:Q>:EXLOM"TZ>.V&GVL4T\SQ;
MRSR%MB@9' "$GN<@#'6N1\$:W=V7@WPSI%M'NO+YKZ1GC56V+'.V[:&8#)+K
MC)Z9X- 'J=8.D1>&F\0:O/I4-I_:RLJZA+$GSY(R S?AG _&L.#Q+XBBFTW1
M=4LXK35=0OYX(+A@I5[:)-YFV*YPY&%VYX)STXIW@^.YB\>^-DNIDFE$UG^\
M5-FX>1QD>N,9_ITH [BJ.F:QI^L)</I]TEPEO.UO*R9PLB@$K[XR.E<UXJFU
M,>.O"%K:7X@MYY;DO&8MP9E@;!/(SP2 /QYXQRT>K:QX>TCQGK6GRV@M[+Q!
M-)+!+"7:<'R@P#!ALX/!P>?2@#URBN%\9>)]6T*/6;BWEM56PM$N+: 1F9YN
MI<RX_P!6G  /'.>3TI\%WJ5S\5UB%\%LO[$2Y6W,60N^7##.>IV#G]* .NO]
M0M-+LWN[Z=+>VC&7ED.%4>I/8>]48O%.A3-"L>J6S&=E2+Y^'9N% /?.1BJ?
MQ _Y)UXE_P"P9<?^BVJCX>FU:71/#-M-I5L;!X(3),MP7*A8=Z$KL&/G5.<G
M!H [&BN%U/Q%K^F^,E\/R2V075%5M*N3%@(5.9EE&_+,%Y7&,_GB]J>MZK/K
M5]HVD(3<65I%,\HB1]TDF_:"&=<+\G.,DYZC'(!UE%<9IVOZ]K%XFCS00Z3J
ML.FI=WBL!,%E=F557#8V_(6)R>& ZY-/MM;U^+Q-H6D:HEE')?:?/-<I I8)
M+&4'R,3]T[\X(_&@#L*J?VG9_P!K_P!E>>/MWD?:?*P<^7NV[L].O%>;ZCXA
MUS5- T^3[;#;RKXJ33Y#%#Q(B7&U<@MQ]T$@'GIP*ZI=6U;_ (3U] >>V,']
MC_:TE6 AA+Y@0Y^;!'4X&.OXT =317$:%XDU?5-'CMKB2VCU^/4WL;I$A/EH
M$)9B%W9P8@"#GJRU'-XD\2ZC!=7_ (?T[[4EK?O;+:L(PLR1R>7(2[2 JW#$
M<8Z @YS0!W=94?B32)-5BTQ;Q3=S>8(E*,%E*??"-C:Q7!R 21@YZ5HSK*\#
MK!(L4I'RNR;@#],C/YUY3X6U35-'^'?A"[6:UG6[U.*U*R6Y+(DLSJY#;OO<
M]<?@: /6J*X75/%&L6=SXVB@:T/]BZ?%>6IDA8YW)(Q5L,,_< !&.O>JUWKO
MBZPL=#O9+K2I4U>]M(%B%LX,2R(2WS;^>0.<=STH [V[NH;&SGN[F01P01M+
M(Y!.U5&2>/84MM<PWEI#=6[[X9D62-P,;E(R#S[&N('B37K6W\:6L\]C/>Z'
M MS;SBV9$D5HC(%9-^>"I&=W<4FH>-)].L= N-0G&GV=_8++)J)MC)"EP0A5
M'P?D4Y8\]?48H Z_^V-/_MK^QQ=(=1\DW'D#.X1@@;CV')'YU>KSNX.I7?Q'
MT9K6[M([R7PY*7N AEC!,L1+*H(W#/3GH<\]#)I7C74M1T708FA0ZIJ,UU#(
M\"# %NS*S*K,!DX7@GC)ZXQ0!Z!5>^L;;4K*:SNX_,MYE*21[B ZGJ#@]#Z5
MQ-SXH\1Z+I'GZ_I\EM;IJ#0RW\$(E*VNPE9C&C-M.["MU ZXKJO#M^=3T."\
M-[:WPE9REQ:C$;IO;:<9.#MQD9ZYH G L-!TC!9;:QM(^KN2(T';)R<"IK&]
MM]2L+>^M)1+;7$:RQ2 $!D89!YYZ&N#BFU.?Q'X^BN+\2VUM;Q)'$8L;5:!G
M !SQ@L<]<^U5O"6KZQIFG_#^TEEM)--U6P2 0K"1)$4MMZMOW?-G:01@8SWQ
MD@'IE%<)9^)/$NKP:=J^D:=]HL+B[V20,(U MMY7>',F=XP#C;CJ,<9,WQ:U
M*\TKX8ZS<V+M',42+S$ZHKNJL1^#'F@#?/B?1 S@ZE!LC8J\V?W2,."#)]T'
MV)K3AFCN8(YX7#Q2*'1U/#*1D$55L-.LK31K?3;>&/[#' (4CP"I3&,8[Y%8
M,5]+_P )"?"6D2I:1:;IT4CS/'YC<DK&H!(& $))[Y &* .KHKS=/'&N7-AI
M/EQV,-XVNOHM^K1LR;U#Y>,[N =H.#GKC/&:EDUWQ6&\5V2W^F^?H:+<)<&S
M;]\K1>8$*;_EQ@C=D\8XH ]#HKS^#Q+XCUO6]-L-.FT^SCU#04U,22V[2-"[
M,@(QO ;[W'3KGG&":3XNUG4=(MQ>?8[.ZM]3GTW49D!8EHP<>1'R6+';QS@9
MX/8 ] HKS9/&NO3:!I5U$+(7$NOG29_-@=0ZB1E#@;OD.%&0<]3TJ_#K'BF6
M3Q7I,$]A<:KI2PS6DOV9D282(6$;)O.#E2,[NXH [JBN5T3Q)-X@70I;":(Q
M7%H;J]W1<KT4)U^5M^\=_N-5KQKJ.J:/X7N]4TD1--9@321R1E]\0/SXP1@A
M<D?2@#H*J3ZG9VVHVFGS3A+J\#F"/!^?8 6YZ# (ZUR7_"9M!XRGLI[N!])?
M2S>VLT<!R74!G0MG#$(R. !T:K#:QKMEXC\*Z9>O9M_:5O<-=A(2"DD:!L*=
MQ&,MCIVZ\T =%J^L:?H6FRZAJETEM:1??D?.!^ Y-7J\;U6;4KGX5^/Y=0OA
M=;+ZZA&8MI^215'.>F !C'XUW5EJ^L0>/CH>HRVDUO<:<U["882AA*R*A0DL
M=PPP.<#IT% '3RPQSQ-%-&LD;C#(XR"/<4Y0%4 = ,<FN;\9ZQJ&@:=::I:O
M"+.*[B34/,C+%8&8*SJ01@KD'OQGTK)7Q=?Q^(?$VE2S6[R6D$<FF;8"/.+'
M9M)W88B4JAQCK0!W=5+/4[/4)KN&UG$DEG-Y$X (V/@-CGKPPZ5R4^I>*Y?&
M,_AZTOM+3RM-AO//DM'.6,C*R[=_?:<'/&>AZUC^(O$6MW/@?QY_I<,$^EW+
MVT4MO"5)B\N,XY8X8[R,_EB@#U"BN$OY-9C^(/A>R.J1F&2SNI706^%9E\L9
MQNZX<CKQSZT1>)/$NJV]OJNBZ=]IM&O6B:W81J&@61HV<.9 0_REL;<=L'J0
M#NZ*\SU#Q;XHM]&\5ZG'/IH30+]HQ']F;_2(U2-MI._Y3ASSSD]ACGTC<TD&
MZ,A69<J6&0#CC(R,_G0!)17F>G^,/$LFA>']<NI=/,%[JHT^>VCMV!(:=X@X
M8MQC XP>_//&M)XCU?4]/\1ZCI$EM&NC7,UM'!-$6^T-"H+[CD;<DE1CIC)S
MG  .VJII^IV>JPR364XFCCF>!R 1AT.UASZ$5PVFZWJ&O^/M%N[2\\BPN_#I
MO4MI(MVS=+%N!((RW09[8X')-3:?XSU*71K?[0+7^T;O79M)B=8RL:!'?YRN
M[)^6,\9Y)'- '?45R&H:SKV@)+'>K;77VJ_AM--FC7#,'&6\Q,@97#8P1NXZ
M5>T"Z\0OJ>HVVKV16R38UG=ML5Y,CYE95=N0>AXR#0!HZCH6E:O<6D^HZ?;W
M4MFYDMVF0-Y;''(S]!^0J[--';PR332+'%&I=W<X"J.22>PK U#6KB3Q?:^&
MK*1()7LGOIIV3<50.J*JCIDL223T"].<CBO%>O:EJWPS\8V=T\,-]I,KVER\
M49V7"':5903\N589&3T/K0!Z%::OI&O2W5A%*)I;?8TT$L3(R@\HV& .#C(8
M>G!IK>*=#2[FM&U.W%S 0)8MWSQYY&X=1FKUG!)%$&N'BEN"-K2I%LW $X&,
MGIGUKA-(EOXOBQXX^PV<%P3%I^X2W!BQ^Z?&,*V>_I0!W=C?VFIVHN;*XCN(
M"S*'C;(R#@CZ@@BI6@B>9)FC5I(\[&(R5SUQZ5R>LWWB'3O!":SI]K:PW\48
MNK^SD3=N& 90IR,,!G!/!Q[TT>+KA/!LWB8-#/;W<L:Z=$JX*K)(L:>8=V"<
ML"1QCIU!- '945P>H^)O$?AU-3N]1T[SM,CMD>VN)/+B(N&D$8B8*[97Y@V[
M' !'/%7]7NO%&C66KWAN+">TMM,DNHI3"59;A 24* \QD#KG(]Z .MK%2S\/
M^#=.O]0BM;;3K4L;B[EBB^\?4X&3U_6LA/$FIOJO@^ &W$6M6<LLX,1RCK"K
M@J=W3+=#Z=:YRQU[7]+^%_B#71?V]S>6UW=E3<6Y(.R9E/1AV P.@QWH ]35
M@RAE.01D&EKEM0UO4=,\9:+:W$D T?4XY(E;RB'2Y5=RJ6SC#*&QQG*XJM)X
MDU(?V5;(!)/J\L\ENT<2Y2V094X9@"Q!0\D8W'@XY .EU75]/T2Q-[JEY#:6
MJL%,LK;5!)P!FK@(8 @@@\@BN9TRWU?7=$U'3O$]BL(\]HHY%"?Z1!P0Q4,P
M1NH//&,C';.D\52V_BU]!EN8M,F6YB2RM[F B.\M\)N,<F<%^6 'L!@]: .P
MO;VVTVRFO+R9(;:%2\DCGA0.].M+N"_LH+RVD$EO/&LL3@$;E89!Y]C6?XI_
MY%'6O^O"?_T6U<3HNL>(- TSP2]U)8W&C:G%;6/DQPLLMNS0Y1MY8A\[>>!C
MM0!Z960?%&B_8M2O!?QFWTQBEY(H8B)@ 2.!SP1TS7-V7B3Q+K$&F:OI.G?:
M+"YNMLL#"-0MMN*^8',F=XP"1MP>1CC-9+ZK>Z%IWQ*U73C +FTU#S5$\9=3
MBWBR, B@#T]'61%=3E6 (/J*JZI+81V#IJ2QO;3?NFB>/S/-W<;0F"6)] #7
M/7NOZG=:O)I&EHRSPV$5U)*L2/\ -(6"C#.O'R$GKU'2L'69O$-]<^ I=22'
M3+^2_83VNT2K'*(9OFR'P01T&>,]: .F\+Z7X3,"ZCX>L[4(&:,2(A#1D'#+
MAN4/8C K7O\ 6-/TN6TBO;I(9+R98+=6SF1ST Q3[F.2+3+@6TB0SF-F$@C!
M ?'WMO?GFO*DFU&Z^'7@"ZN+I+BZN-7LY5>1"/F(<_,<G=SSGB@#V"BN&A\1
M:_!_PEEA--IL][I)A>"YD4V\.R5-WS@L<;<-WYP.E9VH^*=6ET[QM9V]Z5;3
M-,2\M;PVICD^9)"1M..\?#8[]^M 'I5%97AE9U\,Z;]HF65S;1G<J;>-HP,9
M/YUJT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5D>(O#UMXCL(K>:66":WG2ZMKB+&^&5#E6&>#W!
M!Z@FM>B@#G)_!]IJ@U!]:D^VSW]F+&1U3RU2$$G"#)P=QW$Y/('H!4&G^"V3
M2YM.UK6KW6;1K=K6..Y5$V1L-IR5 +/CC<3GTQDYZJB@#F=!\)3Z1"EO>Z[?
M:I:P1F&UAN%11$A&WDJ 7;;QDGH3QS6?9?#QK2#1(&U^^DAT6?S+-?+C&U K
M*$/R_-PV,GL.,<FNVHH YO3_  H]A8:Y:KJ+/_:]Q+<.QB'[IY  VWGI@#&<
M_C4%QX&M[OP;IWAZ6_N5;3?*-E>Q826%XAA&'8D#@^H)KJZS/$6J2Z)X<U'5
M8;=+AK.W>?RFDV!@JEB,X/8>E &)>>"KC4] FT[4M?N[NXGEA>6[>&-3B)PZ
M*J* JC<,G@DY//3%V3PM'=>(KK5KRY\Y;K3_ .SIK;R\(T623SG.26/X?G6O
MIMV;_2[.\9 AG@24J#G&Y0<?K5J@#E-!\%MH\,=E<:Y>ZCIENACM+.X5 L2$
M%<,P 9\*2!DX /3IA/#_ (*E\/M';KK^H76DVQS:6$P3;#Z N!N<+V!.!QZ"
MK>J>(+V/5KG2=&L8KS4+:S6\>.:;RE8,S*J X/S':W)X''KQO0N\D$;R1F*1
ME!:,D':<<C(X.* ,CPO::G9:2T.JW\]])YSF*:X15D,9Z;@O&<Y^@(!YKG)T
MN9OC'.]G=B#&AQPEWA\Q&<32,5ZCY@"#C/0\@UWM% '*_P#"#V\0T06M[+$-
M*N7NP60,T\KAM[.>.N]CQCK5N?PR4\1W&N:9?-975W"L-VIC$B3!<[&P<8=0
M2 <XQU!K?K/UO6K+P]I$^IZA(4MX0,A1N9V)PJJ.[$D #WH H2^$-,D\%R^%
ME#K920-%O)RX8G=YF?[VX[OK1K7A6#5_![>&UN9+>U:)(C(H#/M4@]3W.!DG
M/>F7.LZ_:Z1-J3^'HF6.(R_98[W,^ ,XQLV[O8,?8FN@1@Z*Z]&&10!SEUX3
MD?Q''KUCJTUC?/;K;79CB5DN$!R"5;.&!)P?PYK+7X;0P:%IEE:ZW?P7VESR
MSV=^JIOC,A)==N,,ISR#GZXXKN:* .3OO!'VZTL9)-9O/[9LK@W46J;4W[RN
MU@4 "["H V@#IZY)NZ)X:?2-:U359=4N+N?4O*\Y7C1$!1-H( &>GO\ F>:<
MVOS)XYB\/-:((9-/>\6X$I+$JZ)M*XX^]G.35W7=1DT?0K[4H[=;C[) \[1&
M39N55+$ X//% %37/#JZQJ&E7Z7T]G<Z;*[QO$JMD.A1E(8$<@]>U9%QX!6Y
MT'7=(DU27RM9NVNYW$(W(S;<A><8^1>N>]-C\>R06OA^]U32?LUCKC11VT\-
MSYOER2KN19 54C/J,@5VE '&ZGX!&IS:XSZU=PQ:U;I%>0QQIM+JFP,I() Q
MU4'\:OP>%/(U^RU==5NS/!9"RF!5,7"!MXS\OR\D],<<5T=% &;X@TG^WM!O
M=)-P;>.\A:"215#,$8$'&> <'K6=#X:OHM+M=,.NS&S@2.)E6!%:2-<#:6[9
M P2,'D]*Z.B@#E]8\&QZW97T5U?2?:;BXCGANTC DM3&04$9[8YQ_O-G.:CU
M+P;<7FK6VLV6OW>G:LEN+:XN((HV6YC!R-T; KD$G![9KK*K7E_;6 @^TRK&
M9YE@B!ZN['@#]3] : .;O_ _F:E9:II6M7NFZE;P&VDN55)3<1EMQ$BN""=Q
M)SC@D^U6+WPAYUYI%[9ZK=6EYIRRQ^?M21IDEP9-VX8R2H.<<'MCBNEHH XU
M?A["FBR:>FKWF_\ M7^U89F5"8I?,\S &/F&3SG-:L7AQH_%B:\U_))*MB+$
MQO&,,F[?N)'\6[TXQQBMVB@#'M?#=E:>*;_Q!%O%U>PQQ2+GY1MZL!ZD! ?]
MP5DIX&-MK5[<V.NW]IINH3&XO--14,<DC?>*L060-WVD$\\CMT>F2WTVG12:
ME;16UX<^9%%+YBKR<8; SQ@].]6Z &2J[1,L3A'(PK%<@'Z5R,?@&.+P;9^'
M4U2<?8)TN;.[\M?,CD23>I(^ZW)QC XKK+FYAL[66YN)5B@B0O)(YP%4#))J
MK)>7<W]G3:?;Q36MPP:=Y)"C1QE20P&#N.<#''6@#GI/ C3OKLDVMW<DNM6:
MV=RS11XVA67<H X.';';UR>:N7OA1KW2]#LFU%U_LBXBN(Y!$,RM$,+N&>F#
MSC&>V*Z2B@#EY_!YGN?$<QU%U.NP+!,!$/W2JA0%>>NUCUSSCZ5*GAFYAL+:
MSBU3,$=BMC)%-;K(DJ 8#%<CYL<>AYR.F.CK"CU^9O',OAY[1%C33Q>I<"4D
MMF39M*X&.A[GM0!4T_P7#I.J:;>6-[(J:=IO]FPPR(&!CRIRQR"6RH]![50/
MPYA70[.QAU>[@O+"[EO+._B51)$\C,S@CHRG<1@]L5V]% '/P^'[^"&W<:]<
M37T<IDFN)XD*SY7;L*+M 4<$!<<C.22<W- T*V\/:<]I;<B2>2XD(4*-[L6;
M:HX5<G '8#OUJGXN\22^%].M[Q+%;M);F*V*F?RRK2,%4_=.1D\U;AO=8%];
MPW>E6Z02E@9K>[:7RR 2-P,:\'&,YZX]: *$WA(-K&LZA!J4\/\ :T*QSP[%
M9 RH8PPXS]T],XSS[5!!X+^SQ^&8UU)ROA\;;?,0S(/+,?S\_P!T]L<\UU=%
M '(:9X%.D7\JV>NWZ:+).;C^R=J&-7+;B ^-P3=SM! /?()STVH6%KJNGW%A
M?0K-:W$9CEC;HRD8(JS10!SFF>'-1TJTCT^+Q#<R:?$NR(2PH9T0=%\SN .,
ME2??O3[GPL@UVWUK3+IK*]BMOL;Y3S(YH0<@,I(.0>0P.>3G-:\]_:VUY:VD
MLJK<7180Q]VVKN8_0#O[CUIMK+?/>7B75M%%;HZBVD27<TJ[026&!MP<CO0!
M@3>"+<VVF0V][)$;'43J;2,@9KBX)8LS].#O;@8[8QBI6\),UYXBN1J+ ZY$
ML4J^4,1!4* KSUVD]<\\^U=+10!YK::7<:7\1])TZSU# L?#OV-9Y(-ROME7
M:C $?-M&[@@\9QCBMU_ D$;:7/9:G=6M[8W,]RUR%1S.\_\ K2P(QDYXXX[5
MUM% '%1_#U8;:*!-9NFCBU<ZL@DC1L2;BVW@#(RQSWZ8Q5V:U@\*ZCK?BBZN
M+F=+T0+-!!:F0IL^1"H7+'[QSU]>*ZBJEE+?2278O;:*%$G*VYCEW^9'@89N
M!M.<\<]* ,3P=HMOIL.HZA%:R6S:I=O=>3*"&C0D[1@_=SEGV]C(17221I-$
M\4BAT=2K*1D$'J*@O[^UTRT-S=RK%$&5-Q[LQ"J![DD#\:LT <E;_#W2+?2=
M#T\-,RZ1<BYBD9LNY (VL>ZX(&/10.E:>HZ!_:'B32-9^UM&VFB41PA 0_F
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M%=OV;R5\K'IMQC% 'F7B>T>PN/'.GZ?'MTI= %[Y*#Y+>Z_> %!T4E4#''<
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MW)XOM=/DD@T*.XT_>8B0+,2L!<"/'W1MVG ^[OR,9KU:XTRPNK 6-Q96\MF
M ('B4H .GRD8X[41:;8P63V45G;I:N"'A6,!&SUR.ASWH XBVM-*L?C'8G3H
M[:%)M E.V# 5OWT6#@<9([]\>U=-XR./ ^OD_P#0-N/_ $6U6+'PYH>F21R6
M&CV%J\8(1H;9$*@]<$#C-7;JSMK^W:WO+:&X@?[T<R!U/U!XH \AT^(V$7@*
M_P#$5Q)>>'#96OV4OM5+"]\L;&?:!N4@X4MG:>O7-;^NSV^H^/;_ $+6+JP@
MMGTV)[)+Z'>KY:02LAWJ X^3GDX QCG/<?V/I@TTZ;_9UI]A(P;;R%\H_P#
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MO3+=2+R2\LK;R\?,CQ/F7([;?+<GTQ74:P9$^+WA@P9R^GWJW&/^>8,97/\
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MR3!KBY0HK*UPPP&<G/&#@YY-5;C1]+_X0/XFR+I]KO@O[Q(V$2Y0+%&P XX
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MZK608H9&5E(<-MV%2 P;=QMQG)''-);^)=(N5O2EWL:Q95N8Y8WC>(L,KE&
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M?B7C3[TB_A5;7_19/WY^RB/"\<_-Q^O3FI(K>Z_M3X=,+&]"V=K*ERWV60"
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M:SO8D@+0EO)C:%&.?+7A06^\WXFK_BZ*ZC\3>$M3BLKFZM[.[G\_[-&9&3?
MZ*2!VW$#/0=ZYZ_M+R:Q^)J+IM\7U%-MH/LDG[\_9EC^7CGY@1^O3F@#OM1U
MW3M+3=<S.<1F8B&%YBL8_C(0$A?<\5<M+NWO[.&[M)DFMYD#QR(<JRGD$&O-
M&^U:1K\-]?Z+K5]IFHZ5:P!K%)?,MY8M^4DC4@X._.3W_&O0-!LXK#1+6V@L
M%T^%%^2U4Y\H$DA3C(SSS@D9S@F@#E[[6;K6_&.I>'+2_O\ 3?LMG&\-Q#:,
M?W[,_P S;EP4 08R0K9/)XQOVGB;299;.T-_YDUQE(9C"Z1W#*.?+<C:QX)P
M"?:N<ELKR]\<^*HXH;NW6^TB*TM[MK=Q'YH\W.&QCC>I_E6;'87VL^"_"WA]
MM-N[/4],NK3[09(&5(!;XW.LF-K9"\;2<[OK@ L/K.LKX9^(4PU6?[3I5S.+
M.;9'F-4MT<+C;C&2>V>>M==;:W;VVD:6U[,[W5S;+($CB:623"@LP5 3@9&3
MC'(]17%26MZWASXDP#3[[S;^>X:T3[+)F<-;HBE>.<L"/UZ5<M(K[2_%>AZW
M-9WDFFRZ$NGR".W=GM9E8/EHP-P#8QG'51GB@#J#XMT/[)870O@T%_-]GMW2
M-V#RYQL.!\K9!&#@\'T-31>(]+FN-1MTN',NFC-VI@D!B!&1U7G(Y&,Y%<6G
MA&]O/"/BD(CV]SJ&J2ZIIJ.NUHG4JT;$'[I9DR1UPW/.14::+KUSKUCJLEL\
M:>([;R=8@).+5$PZ#Z^7OC/^T^: .LCUG3[CQ+"L>LS!_P"SFN/[/,153'N7
M]Z<KD$9 QGOTIMKXZ\-7LEDEOJ:R?;9## XB?8T@)&PMMP&)4X!()[9R*H7,
M<R?%BTO/LET;2/19H&G6W=D#F5&"[@,9PIKE+2QOH_AYX9M6TO4%N;;Q#'<S
M1?8Y-R1B[:0N1MZ;"#^E 'HNH>*-&TMKD7EX(Q:[/M#B-V2'=]W>P!"YXZD<
M$'O6E;7,-Y;1W%NX>*095@.HKRK6_+&K>+M+-KK0T[5)8Q</:Z6]UEO*0.4=
M#\A*X&&!((SWQ7I^F7-K>:7:W%DQ:U>-3$6!!VX[@\@^H/- %)_%.C1WHM&O
M,2&Y%F&\IS'Y^,^7YF-N[VSG/'6EO_%&CZ7+(EY>>6(G2.63RW:.)FQM#N 5
M0G(^\1U'J*\ZU==4O2QDT+4HYK/Q+#<&"UM"L)@68'S@1_K68#)/)![**U=+
MGOM*OM>T+4_#5[?B_P!1EO+27[.)+:5)"&"R/RJ%",'/8#&>,@'26OC&PN-?
MUG372>!-*1&FGEA=4&59F)8C 4* 021GG&1S6I8ZQ9ZA<RV\#3":)%D=);>2
M(A6R%/SJ,@[6Z>E<;);30>)?'*7NBWMY::C:0L@BB.R=%@*.@8?Q$_*!UY!Z
M<U:\&VNJ:?K-U9_:[Z_T-;5&MI]1MVCN(7W']R6909 !SDCC.* .MOM1M=.2
M-KJ7:97\N-%4N\C8)PJJ"6. 3P.@)[5FR^,-!@TBXU2;4%CM+:7R9V>-PT4F
M<;60C<#R.".XK+\5V]];^+/#&NQ6\]S86+W$5W' AD=!*@59 @Y8 C!P"<-]
M:Y;Q1HE]=Z7XZU*UL+R1-8-G%:VRV[^9*8L;WV8R >G('W/<4 >E:5K6GZVE
MP^G7'GK;S&"0[&7#@ X&0,C!!R.#GK4>H>(--TN22.ZG??%'YTJQ0O*8DY^9
M]@.T<'DXZ'T-:$4BRQ)(@8*P! 92I'U!Y'XUQ=G]JT'QSXEFO[.[N++5!!/:
MSV]N\P^2/8T3!0=IXR,\')YH W;CQ=H-M<6\#ZC&TMS ;B!8E:0RQ\<KM!W=
M1@#DYXJK'X]\,RP6LZ:F#%<R")'\F3".6VA9#M_=G=QA\5Q_A;0=0\/ZOX,M
MKNTN3]CTV\2>1(6=(&ED1TC+@$< $=>WTJO=V-])\-_$]FFEZ@;FYUV2XAA%
MG)N>,W2R!@-O3:": /05U&S_ .$NN+;^V7\Z&Q#R:>5 CC7>?WI;'7MUQ@=*
MEB\2Z3,'87+1HEN;HO-"\:^4.K@LH!'(Y%<W>1RR?$:_O?[,N[BS?P[Y )MW
M5)7\QW,>['!*D?GCKQ63I^FW=E#?Z<D.JZOX7?290+._MG2YMV.T?9XW(#.&
M7/'.-@YZ9 .VN?$&FRV&H@WL]D;:W$DTLEN\;0JX8*X#KSRK=CTHM-;T^UT?
M2V?4)KTW-LLD,@A9YKE0H)DV(N><@G@ %ATS7(6-IK%GIWB*P6?4=4T@Z619
MS7EHZW2R$./)Y4-(!D')'&['K4>@V^H:+JWAC5;JQO6L3X=BTR94MG:2UG0J
MQW(!NPV,9 QE1VQ0!V4GC#P_#I]G?R:I"MK>3""&0YPTA.-IX^4@\'.,8.<4
MZS\5Z+?6]]/!>_+8,%N1)$\;1DC(RK $Y[8'/;-<!<Z'?VUFMR+&[9+WQA%J
MBP);NS10!ER[* =N=I;!Y^;IG(K0OK(7'B/QI]NTG4KC3[VWL8QY-O(IDV%@
MYC('+)N#<>G% '>6.JVFHR3Q6[2^9 5$B2PO&RY&1PP%1W>M6%CJEGIMQ,R7
M=[N^SQ^4Y\S:,M@@8X')YZ5@>"X=8M;O5+6^N[G4-.B\H6-[>VYBN'&&+(^0
M"^WC#$<[C[XG\=Z==W6B0ZCIL+3:GI-RE];1I]Z3:</&/]Y"XQ[B@#0A\4Z/
M<6-]>17,C06,IAN6^SR QN.JXVY)&1G XS7-6WC"+1_%?BJ+6]4F-C:&U:W5
MH"QA1XMSDA%R%!(RS#CC)J+3?#FL6/C%XY5,FFZHL>IWSYRL=W&>47V),1'J
M(C45U;73:E\2&&GWI6^LXH[9A:R$3L+=D(4XY^8@?KTH ZMM2LIO%5E;Q:R_
MG/9R2K8HH*3(2O[PMCMQCG^*I#XGT=KV&R%[MEN)&@A?RV$<DBYRJR$;"PP>
M,]01V-<=I-K>'Q#X09K*^B6#P_):S2M:R 0RD185B1P?D;\O>I/!-S>6VC:7
MX:U3PU>?VCI3A&N9;;-L I(\Y)3P25/ 'S9/IDT 3^%?&EO#!=6VNZL\EU_;
M-S90R21'&%E*1JQ1=J$XP,XS7?5Y%<6-^_P\UVU32]0-U/XB:ZBB^QR;FC-X
ML@<#;TV G].M>CVFOPW7B&ZT;['?0RP1+,LTT!2*=2!G8W?;N / P30!'XCO
MK6SM[);G5Y--,UY#'&\:!C*Q<8CP0>&Z$^_6L76==EN_&T7AB*YO[.-K"2=I
M[:V<OYI=$3!V$;1EB3TS@$]JE^(<,]QI&F);6MQ<.FK6DS+!"TA5$E5F8[0<
M  &FN)O^%MP7?V2[^R_V*UN;C[,_EB0S*P7=C'0$T =+ S:;I$;:G?)*UO"#
M<7;J(E;:/F<CHHX)]!6>WB_0T^U"2[DB>TM_M4R26TJ.L//[P*5R4X.6 (%5
M_'VF7^K^"-2L]+0/>E4DBC)P)"CJY3_@04C\:R[B\E\7^'M7^S>'+VRO)M*G
MMC)?VWDR;V4XB4GEER22?N].N> #I?\ A(-+^U6-L;K$M]"T]ME& E0+N)!Q
MC@$'&<\UG1>/_"TVXIJ\6U4ED9RCA0(SA\L1@$'MU/&,URMA/=W>L^ IUT;5
MHX=/M)X;IYK-T\IS"BX((SC(ZXP>Q/.%TV/4K+X7:Y'#H4MS??;;F1;.ZLV_
M>H\Y8,$8#?\ (=P'J * .A\0^)89O"WB)M(OYK;4M.L'N"&@,<D?R,R';(O(
M.T\X['O4GASQEH^J+8:7_::R:K):)(R,C+YAVC<58C:Y!SG:3CGTKD+BPU&_
MU3Q7]FT[6)EU/PX(;>>\BV&24"88.<!#EE&W"]<X YK6AL9=<?P6L-E=V[:,
MPFNI;BV>$QA82AB&X#<68C[N1A<YZ9 -'PCK<YT[7I]8U!IEL]9N;6.610#L
M5@J* H&3R  !DD^];^FZYI^K374-G.QGM6"SPR1/%)&2,C*. 0".0<8->;/I
MVKMX=UB>UTR^DEMO%$FIBT*/"]U;[\_NR<<D<C'<5T5CJUA86>H>);;PMKB'
MRXXY?-MW-Y/\V,!';)5<Y)/'7'2@#N*YZRUK38[S6YCK<ERD%Q'') T?%LY5
M56-,+EBQ(..22P K<MKB.[M8;F(DQ3(LB$C'!&17G$^GK=:AXV34-+U5K.]O
M[-XI+:"19,*D:^;&0,DHZ[N,_=[T >@V&IVNI"<VS2$P2^5*LD3QLC[5;!#
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M+2H)6&50L-Q'J!4E>>>#+(^()]5O-:T^TEFM->N)(+@3LTD<D;!%4?*/E"C
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MYBP8 R!PRX&#T(YQC.>>E=)33(@D$9=?,(+!<\D#&3C\1^= 'GO_  A6N?\
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MK6+O1=%TW4HX=5L9Q"8X) TL5JT9$RL,Y4&/&"?XMGJ*[Q$6-%1%"JHP !@
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M%CD53AMI(.3C &[TKN]-L8],TRVLHB66",)N;JQ'5C[DY)]S3VL;1[U+UK6
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MGME)0V\'/4X8DX/'- ',>(M=U.R:^OK+4Y[AK;6;>WS"H6WAC9XT:!@?OO\
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MX>T^&>_DDN;_ ,2RZ6;QU7<D0EDZ #:&(3:..^>U6]8U35]&UKQ!HUOJ-PT
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MV&MRW,DMS<Q^;=+YDGRF)OFWON ((Q@9YX%>U=* ()KVUMI$CGN88G?.U9)
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M.7"[RH8]6"\^G!YJ+0O&D6IV6J7EW:3V<%G>R6B^8F2Q5@@7@G+EN,#U YH
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MPS,C2PQNT9W(64$J?4>E8NJ>+M-TB.XGN5N#:VKK'=W,<>Z.W9L8#\Y_B7.
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MR8_W<TD>[<H.<C[C8R #CC-9,?C*WU7P]XFN-0M]2T^RL99[9YH%/FHJ* S
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M!<_2E^S6^0?(BR.AV#BLC5O%>GZ,EU+<)<R6]D5%Y/#'O2VR 1NYST()"@D
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M_M=L\MVA6R<S ^:"-Q\OG!R.21V% $5OK,\GB>ZT:73)X8HX!-#>%U*3C@,
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M<=^M=(B)'&L<:JJ* %51@ #L!45I>VM_$TMG<Q7$:NT;-$X8!E.&7([@C&*
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M*22;ML)\L?*?D.6/J, \X9!XNUV^U?2=.CT:&RFO]-DNV2\D</!(C(I5E '
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MTR/QU>0>&]0NKZS@^WV6K#26\ICY)=G15DR>0N) 2/;'>KD'@^\AG\)R?VG
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MC4]$U?\ LJ^CM'EN;&:ZLKB-&5&>$;GC=2Q/0@A@?PXYBO\ X?G59/$AO-2
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M;;AM^]SD'.!^##X*U"3PU#H5Y?V%]9+IT=DT=Q9'"L@8"5/GX."./5001TH
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MV 6/V7[.<[=^_=OW=<\=* -N&WBM+2.VM(HX8HD"11HN%0 8  '0"O(]6O\
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M>Z5KFH";5EGM;F-)8K'<\GV<C(+!G8D*WITR#CO6)XT+6WQ-\!WUT<::LMU
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M[1=HF(&"X'OUKRQKM_#FD>-;ZRFN(7/B);5YC.["&*06X=\$D;@&.&(R,CG
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MTR3M'L,"L7QK=22S>)197UW)<:?H_FF..X:".R;$C+("IR\C;1@8P O)&[D
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M8#>V">G;&!0!ZX]U<KJT5JMC(UJT+2-=AUVHX( 3;G.2"3GIQ5NN)N99]/\
MB;9V]O/=RV_]AW$GV9[AW5W22, X8GYL$C/7FN=.J:A)\+M*\96E]<R:TT\,
MDBB9C'.7G$;P&/.W;\Q  &05'?)H ]8HKRG5H+B>3XD,VK:JG]F1I/9+'>R(
M(7^RB3(P>1N_A/R^U>D:+<27F@Z?<S-NEFMHY'/3+%03_.@"EX@\2V^A:!J>
MJK"]X-.!\^*%E#*0H;!R1V8'OUZ5L0R>=!'*!@.H;'ID5X]+90V_P[^);QM-
MD7U]& \[N,;4.<$D9_VNOO711LVA>.+%1J=X+6[T2>XNOM$[2(KQF/$@4G"X
M#-PH QVH ]"J*WN8;J,R02+(@=HRRGC<K%6'X$$?A7FFBW-T/$?A)$N[Z2RU
M73KDRRSW3[[P!8V65DR1&?F)&TY ;'&,5L?">UBM_ L#QM*2]Q<@AYG< +<2
M@8!) ]\8SWS0!UMS=7,-]9PPV,D\,S,)IU=0( %)!()R<GCBK=<AXDFGA\>^
M#5BNKB.*>>Y2:%96$<@$#L-RYP<&LC0]0O;/Q1I]CKL=V)[J69[+4K>Z:2UO
MU*LP5DSB-@O(&,?*<'% 'HU%<M\2)9[?X=ZY<6US/;3PVK21RP2F-E(]P<UB
M3Z>\?C[1[$:GJGV;5-,G>\C^VR8D9#'M(Y_=GYC]S;Z>M 'HE%>2Z1K5\LNB
MZ!<7MTUA+K^H6+W#S,9#'#O,41DSNY.!G.2%QTS1XGNM2TNS\>Z;:W]ZMG96
M$-[:2BX?S+:1PP9 ^=VT[<@$\9]* /6J*\\U&.32->T/2DU*Z:'6FFFF:\NY
M"'E2--L:D$% V6;:, D8Z<5TGA2PO-+M+VRO-5_M QW;F+)9FMXV 98BS$EL
M9X).<$4 ;,EU%'<+;[@;AHVE2($;F52 2,^[*/QK-\,Z^GB71_[1CMI+8>?+
M"8I""P,;LASCCJM<[)90O\;%E+3AO["\SY;AU!(G  P#C'^ST/IFN2L(Y;#P
M=8:S;7M['<Q^)6B")<,L1C>]9'0Q@[6!!/)!/O0![/17E?BO4;F.VUS4]-U"
M[EDL=5MH?/,[1);'?$K0(@.)!\QW%@ =_?'%F^M)=0\3>.[>75-42"UL;:>W
MCAO9(Q%(8Y3E=I!'(!QT/<' P >ET5C>$;R?4?!>AWMU(9+BXT^"65SU9FC4
MD_F:V: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *IZCI5GJJ0I>Q-(L,BRQ@2,NUU.5;Y2.0>1Z5<
MK#\7^(H?"OA>_P!7D,1D@A9H8Y'"^;)@[5]_PYQF@"[J^BZ=KNGM8:G;"YM&
M(+1.QVM@Y&<'GG!YKC?$/A*2\U])9_#=OK&GQVJ06I%\T,UO@DL&)Y<'(Q\W
M&.G)SHZ??7S^(K'/B_2[K3[E2T=F(D,\S!&W!65ONJ1GH3P03WJAJ7C/[7JF
MNVNGZ_IVG_V0L+(TNV5+@E2\@8 [B ,+\F"#GKTH UM)\&6$-C;QWMLW^CW)
MN;6#[7+*+0X PCL03T)SVW$#BKVM>$= \17,%SJVEP74\ Q'(V0P']TD$9'L
M>*9I?C'0M4T[3;I=4LH7U!%:&"2Y02%BH.S&>6&X9%:Z7MI+>2V<=U"]U"H:
M2%9 70'H2O4 T 9>L>#_  ]K_P!E.IZ5!.;4;8#@H8U_N@J1\OMTJQ_PC^EB
M_M[Y;0)<6T/D0O&[+Y<?'R* < <#CV%1:GJ[1:Q8Z+:$?;;M7F9B,^3"F-SX
M[DEE4>YSS@@\YKOBZ[?Q>/#>B:SH=G?11J9(]21V:9VY"IM91D#!/4G</0T
M= ?"&A-ILNG&QS9RS?:)(3,^UI,[MQ^;KNY^O/6FZGX,\.ZSJ$%_J.DP7-U"
MH199,[BHZ!N?G'LV:K7.M7MQXLC\-V,T,4\5C]LN[EHMP&6V(JKGN0Q.3P!C
MOD4K;QE-+X2?Q!+$BC3IY(-4MT!.WRWV2.AZ\8W@'JO'7F@#H&T#3&U"XO\
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M@^*!,EAJ>H>)])^QWUB)'M&=%>&?:'8(P/W%7=D-DC .: -^ZT@ZCX@LK^Z
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M]NHF4F91R2@S\P]Q0!DP>!_#-OY)BT> -#$\$;')(1A@KDG)& ,9Z=L5>M-
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M/]V6%PZMVX(X-%U=VUC 9KJ>.&($#=(P R>@^OM0!FVOA71;&XMY[2R$$MO
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MT4\\$^E/37=)DT];]-2M6M&?RUF64%2^<;0?[V>,=: *L_A'0;@Z@9=-B/\
M:)S=X+#SNF<X/? SZX&<U*?#FE->07;VI>>"$P1N\KMB,]5Y/(/&0>N*G36M
M,DL!?1ZA;/:LVP2K("I;.-N?7/&.N:5=8TQ[#[<M_;&TW%/.$HV;@=NW/KGC
M'KQ0!FV?@GPU82V<MMI%NDEDQ:W;DF,GT)/3T'0=L5H:9HFFZ,;@Z=9QVWVB
M0RR[/XF))/TY).!QR?6F'Q!HRZ;)J+:K9+91L4>=IU"*PZJ3G@^W6GVFMZ5J
M%[<6=GJ-I<75M_KX8IE9H_\ > /% !>:-87]_:7US 7N;,EK>3>P,9(P2,''
M(X/J.*BLO#NE:?+%);6I4PEC"&E=UB+?>**Q(4G)Y '4^M.M];TW4I'MM.U.
MTENO++JJN'^7.-V 1N7/&0?QKGO!'C6UU?0=*35=6L!KEXKM]F$BH[X=@-J9
MST'Z4 =1J6F6>L6$MC?PB>UE&)(BQ <>AP>1[57_ .$?TS[=:WI@<W-K&8H)
M3,Y*(>H'/0X&?7 K&L/$<T7BKQ3;:Q?6D.G:8+5H9' B6-9%8G<Q//('/'T%
M=!_:VF^3:S?VA:>5=L%MG\Y<3$C("'/S'Z4 41X2T(6,ME]@4V\MQ]J92[$B
M;.?,!SE7SSN!!J67PUI$^FW&GS6GFVUT=UPKR.S3' 'SL3N;@ <D\ 5;O=2L
M=-2-[Z\@MED<1QF:0)O8G 49ZD^E5%\3:$]@+Y-7LGM2S()DG4J67[P!!YQW
MH 34_#6CZSI,>EZE8I=6<9!1)6)*D="&SN!]\U;TS2[+1[".QTZV2WMH\[8T
M]^23W)/J:;)J^FQ6,5Z]_;"UFQY4WF@K)D9&T_Q9'I4,?B/0YH(YH]8L&BDF
M$".+E,/*<80'/+<CCKS0 ^[T+3+[4[?4KFSCDO;=2D4W(95)SCCW (]#R.:I
MCPAH0T]; 6/^B+/]H$7G/M$F=V_[W7//UYZU=FU;3_\ 384U2SCGM4W3[I5)
MM\YPSC/ X[XSBJ5IKVG66D:<=3\0:?--/!O6YWI$MP NYI%7/W< GC@"@!EU
MX)\-WLMY+<Z1!*]X5:<MGYV&,-UX;@?,.?>K"^&-'CEO)([/8UY$L-P4E=?,
M11A5(!Z $@#L"1WITGB;0H;2"[DU>R2WG0212F=0K*3@-G/3/&>E3:CJME80
M@3ZA:VLDB%HVF88P.K8R,J,C)R![T 36%A;:78PV5G%Y5M"H2./<2$4= ,]A
MZ59KG/ >L7FO^"-,U6_='NKA&:1HUVJ3O8<#Z 5T= !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<C
M\4#GX;:Y$ 6DEMBD:*,L[$C  [FNNHH X76[BWG\<^!;B*1'C#71,B\A0T!4
M9/;+<#/?BJUFPN?$WQ$BA^=[B*%8 !_K2+;:=O\ >P>#CH:]#HH \UMK&37/
MA!HDNFAUU;1K6WGM3)&R8N(4&Y.0,@_,A[<GTKJ_";R7VEG7+B%H9]5(N?*?
M[T<6T"-3_P ! )'JS5-KFB7&M26Z+J]U9V:AUNK:!4Q<HP VEB"5Z'E<'D_6
MMA5"J%4 *!@ =!0!QCQ20_&N&>4$0W/A]XH6/0NDX9P/?#J:C\83Z'XJTG5?
M#ZQM<:O"&2WB\AUDBGQE'5B.%!P=X.,9YKK+_38;\P2,3'<6S^9!,OWHVP0?
MJ""01W!^AJY0!PRV[^'_ (C/JNHS 6=]I$=NUV_"B>)B2I/;<K9'K@BLRUL)
M=)^$7BNZU")X7U(:A?>3(,,@E#;%([$C;QZG%>F53O\ 3HM2$4=R2UNCB1H?
MX9&4@KN]0" <>H'TH I^'()-.\':1!?D)+;V$*3EST98P&S^(->76$-JOPQ\
M#P2P('CUR%YHVCY11*^XL,<#:1DGL17M-% 'F\LD"^*/B$25\N;3+<*<<2,L
M<JL!ZD94?B!533I45OA4&.#!:NLV1_JS]EV8;^Z=WR\]^*]3HH \DTQM-N8[
MCPOXCMM5DUF+4Y9X[91*$N"9FDCF1U&T+R,DD8P:OVTESI_BN$:3>KJ&GW.L
M3"YTJZC_ ']E(6??/&PY\O.3R,8;@\UZ910!C>+G5/!NM;CC=8S*H[LQ0@ >
MI)[5PSO:S6_PP$FQQ 4\X,,^41:E?F_NX?:.>]>I44 <#92P:!X_\1Q:ND=M
M87UO;'3W=,1-$B%7B7MD,2=G4[LXKGM#TV;2Y?AM::G&5D@EO7V3+DP1NCF%
M6S]T@% ,]QCM7K]% 'CU_';-X0^)Z1Q(9;F]E,(5/FES%'M*_P![YPV,=\UZ
MO831R:7;S>8K(858N3QC%6J* /&K-A#X+T"<QR"*T\6///MC8F.,S388@#(&
M&7GW%:VM3W%GXAOM0T.\^T/->6QO=!O8>;AML6V6$\,K!=N>H!0YQBO3Z* .
M8^(=K?WG@/58=-A:>Z,:L(4ZRH'4N@]=RAACOG%8]WJ.C^,=$UF\T/3YYM0D
MT6>T:=[9XV3<I*P?,!EMQ)P,XQ[C/?T4 >5:?J]I?:U\.I+<3O';6=Q%._V=
M]L3^0BE6..,$8/IWJ"QM[,_"'Q81;Q?:F?4PG[OYR9&?9CC/S#;C'7BO7**
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M-6#P;AG+[FSCJ??BO2J* .,^%/'PUT>,Q21M&CJ5DC9"/G8]"!D8(YKLZ**
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M#IZ<][0!@Z[XHAT+4M-L'T^]NIM1:18/LZJ061"VTY88)QUZ<Y) !JC8^/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]".K6.A6GE[Y8Q%)J#!RT;%2/]5CDKQS^5 &CJ?A*QU/PDOAIIKFWL5CCBS
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MO=26%N]["D-TT:F:*-]ZH^.0&P,@'O4] !1110 4444 %%%% !1110 4444
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M2&.=3:R^9"0 273;N5<$?,0!SUKC%T2_L[K3;DV-X8KGQ;+JGE);NQMX&C=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***J:CJ=GI-F;J^F$408*."
M2S$X"JHY9B>  "30!;HJ&UG:Y@$K6\L&>B2@!L>N 3C\>:FH **** "BBB@
MHHK*N]?M;?4CIL$<]Y?K&)7M[906C0]"Q)"KGG )!.#C.* -6BL1?%6G-IVI
M78$^_35)N[4Q$318&[E3ZCD$<$=#6CIFH1:MI-GJ-NKK#=P)/&' #!64,,XS
MS@T 6J*PK3Q5:W]AK%U:V5_*=*GDMY8%A'FR.BJQ"+GG(8 9QS6U$_FPI)L9
M-RAMKC!&>Q]Z 'T44V21(EW2.J+D#+' R3@#\R!0 ZBJAOL:NNG_ &2Z(,!F
M^T^7^Y&& V;L_?YSC'2K= !1110 4444 %%85[XIM;.\EMX[.^O!!/'!<R6D
M0D%N[@%=PSN/#*3M!P",UMM(B,BLZJSG"@GECC.!Z\ T .HK*T37[77UOS:Q
M3Q_8KM[.43)M.]0I.!GI\PZXK5H ***Q(?%%I>-*VGVUY?V\+E)+FVC!C# X
M(4D@O@\?(&YXZT ;=%4]+U.UUG3H[^R9FMY"P4LA0G:Q4\'D<@]:N4 %%%%
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M$[0?Z1'M\S;CYTY.4.>#0!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI)"2,'!$/0C@@Y![YJO<^&[V[LQ;3:':E?M:WKN-8D#R3J05=F\G)(VC Z#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M52U36-.T2T^U:G>P6D&=H>9PH)]!ZG@_E0!=HJ*VN8+VUBN;6:.>"50\<L;!
ME=3T((ZBI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JIJ$<_V
M:26SM[::]6-EA%PQ1<G'!8 D X&<#M5NL_4-*%_/;S"^OK9H-V!;3;%<'&0R
M\ANG'&1SB@#$^'+H/!5I:K9-9R6<DMK/ 6W!94D8/@C@@MDCZXKJZ@L[*WT^
MU2VMH]D2DG&2222222>22222>2234] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ljb_employmentxageementx004.jpg
<TEXT>
begin 644 ljb_employmentxageementx004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN[R;J+RY4]F7L:Y'PK>3>.)-4U>ZNKJ+3HKV2TL;:VG>$;(^#(Y0@LS'/!.
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M$M-NK*2_G@NYWAM$N6+W$TF]\K\Q_P!ECR0 HYQBII_'&E6EAJ]S=17<,ND
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M.0 =G6.WA+PV[%F\/Z46)R2;*/)/Y5SMIXG\13-IVD7^F_8]9FMY[BX\I5D
M2-U1612^!NW@\DXP1@YR(3XD\7P-X>MKZSLK.ZO[^:SF$D98.JQNZ2KM<[00
MHRI.>HR.M '3_P#"(^&?^A=TG_P"C_\ B:/^$1\,_P#0NZ3_ . 4?_Q-<A/X
ME\5PZ;XLQ=:6;CPZ[2&4VCXND\E90NW?\AP2,Y/;@8YUIO$^HZG>_8-(A,<R
MZ=#>N_E++AI=VQ<%UX&PY/?(Z4 ;/_"(^&?^A=TG_P  H_\ XFC_ (1'PS_T
M+ND_^ 4?_P 37-1>(?%MQJ^@:9<VUAIEUJ%A/-<1R1F4P2QL@R-KX93NR!D8
MSR3C%95[XBUW5/#>B.UY!;W:^)4TVZ:*$[)O+G*A@"V0#L!(SSTR!0!W7_"(
M^&?^A=TG_P  H_\ XFJFGZ'X-U2*66RT31YDBF>!RMC&-LB'#+RO8UT*"00J
M'=6E"X+!< GUQGI[9K@8O&>JQ^%+O4[J%'-MK$UE<2VELSB&!)"IE\O))Q@9
MY.,YYQB@#J/^$1\,_P#0NZ3_ . 4?_Q-'_"(^&?^A=TG_P  H_\ XFE\-:I_
M;&D_;4U"TOX'D;R;BU&%9.V1DX8="/7L.E8$U[J,7Q6N8I+]1IUOHJW7DF'.
MT&5@V#NZG8.?PQ0!O?\ "(^&?^A=TG_P"C_^)H_X1'PS_P!"[I/_ (!1_P#Q
M-<_IOB'Q1J@T/4K33A)IVHA7G1D5?LT;KN1PWF9?&1N&.>V*S8/$_B^?PAJW
MB(7&CK'IRWP,!M9"9&A9@I!\S@':1CGUR<X !V7_  B/AG_H7=)_\ H__B:J
M:CH?@W2;475_HFCP0F1(][6,9^9F"J.%[D@5C_V]XF77- LS<:88];LY)$_T
M9\VKHB-G[_[P$,>/EJI)XRUV#PK>73FQDO=/UQ=+FD\A@LR&5$WJN[Y6PX[D
M9% '7?\ "(^&?^A=TG_P"C_^)H_X1'PS_P!"[I/_ (!1_P#Q-8=[K'B.?Q;K
M.BV%SIT$=K817<,LMLSL"Q<;2-X!^YUXQZ'LVR\4ZGJVA^'+]7M;)-2LS-,P
M0S2>;M7"11#EARQ)YP%[=: -[_A$?#/_ $+ND_\ @%'_ /$T?\(CX9_Z%W2?
M_ */_P")KAXO$>M^(5^'U\EU#9MJ,T_GQ+"61G2&7G[P..#A<\$Y).!6O>>)
MO$=['J5QX=T\71L+UK5+9D7;<;&"R9<N-A^]CCL,YSP ;-[X>\(:;937E[HF
MBP6T*EY)'LX@% [GY:=:^&O"=[9P7=MH.D203QK)&XL8QN5AD'E?0US^LZU?
M^(- \8BPDAMK73(IK,K+%O:600[I,D'Y0-P48[@GD<5TWA#_ )$K0?\ L'6_
M_HM: ,S5;+P)H@)U'2=&@50K.QL$81JQP&<A2$4G(!; X-:0\(^&2 1X>T@@
M]"+*/_XFN.CO9]+\8>/M1U">&XLK*SMI9X/L_,D8BE8(,L0.^>#G/:M6;Q+K
M&E1^&K^]-K-9ZS/#:RQ11%3;R2KF,JV3N4'Y3D<YR,=* -W_ (1'PS_T+ND_
M^ 4?_P 33)?"OA:&)Y9=!T:.- 69WLX@% ZDG' K(\,:MXEUO4[Y[BXTU+'3
M]4N;*6..W</*J ;64ER%.2,YSGGIQ5/XDS/-JGA#1I?^0?J&K*+M3]V0(-RQ
MMZ@GMWQ0!H1P?#Z7R]MAH $K!8F:TC5923@!"5P^2>V:UO\ A$?#/_0NZ3_X
M!1__ !-7[_3[;4K0VMU$'BW*X&/NLI#*P]P0"/I7&>(/%NK:-<7,Q>T*0:E;
MVZVD<;2EH)&1=\C@XC<EV(![*.#G- '2?\(CX9_Z%W2?_ */_P")H_X1'PS_
M -"[I/\ X!1__$UB3>)=6CN/&T"M:YT2".:U8PGG="9"'&[GD8XQ5*^\<W-G
M;:+)?7$&F0ZCID=PE]+;L]N;E@#Y;G/R+SGD\YZC'(!U'_"(^&?^A=TG_P
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M92JR':REOO=#QQ0!Z)15#2H]5C@F&KW-K/*9F,36T31A8^, @L<D'//TJ_0
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MQJ^W.<9&<5+0!S@\,7#:YI6K3:L\]SI\$L(WP*!+YFW<3MQC[JXQTQSFL]_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=#L4,,WGQXB'R/SR/3J>.G-3?\(QHOV6]M?L$9@OG,EU&2<3L>I<9Y)[YZT
M7=,_Y!5G_P!<$_\ 017D>JVYC\-_$35X;J[AO+#6))K9H;AXPCK'"<X4@-GI
M\V>/QKV*WMXK6WC@A7;%&H5%R3@#H.:RV\*Z&]M>6SZ?&T%Z_F749+%9V]7&
M?F/3KZ#TH XCQM=F:+Q9+9W5Q)=:=I<<A)G,*6+[7=3%MY:1N">@P ,]JN:M
M?MX?UKP[XJNKF=M.N[?['?)YC&-)&0-'*$SC)*E"<?Q"NIN/"/A^[N&N+G2+
M6:9X/L[O(FXM'C&"3UX)&3S5T:/IPTV'3A90"RA*&.#8-BE&#*0/9@#]: .)
MU&2YT_4/#.CW=T+9-5:YFN//9W0SX5EAR''RC>P S@[!Q71^$]-GTBSO;&;6
M#J0CNW,>48&V5@&$.69BP7/!)S@@=JT=8T33-?L#8ZM8PWEL6#>7*N0".A'H
M?<5+IVFV6D6$5CIUK%;6L0PD42X4=S^M '':A8+J7Q6?3[BZOOL4NA^:]O'=
MR(A;S@N0%88XQTQG'.:P/#NM7MWI_@+3+^ZGDM+YKY)Y7D.Z9H2PBC9NIR 3
MC^+;WYKTM]%T^35&U-K<?;C%Y!G#L'\O^[D'IGG'KSUJNOA;0UTI-,738191
MR>='$,@1OG.Y.ZG))R,=3ZT 8WA-[NU\6^*=&\V673+.2WDM/-<N8C)&6>,$
M\X! ('8-1X@OI)/'OA[0[AG33KN"YE90Q43RH%VH2.H +-COQZ5U%E86NGPF
M*UA6-68NV.2['JS$\L?<\U'J.E6.K11QWULDPB<21DY#1N.C*PY4^X- 'D^L
M&\%Y>:&]S</IUEXITU+.9I"SQB0*[1ACD_*6&,YQD5N"SET/Q5XBTFRNKN;2
M9="-X\5Q<//Y$Y9E&&<DC<H8XS_#7;2^'])FTTZ=+I\$EHS^88W7.7SG?D\[
ML\[NN>]/BT33H;.XM4MAY5P,3Y8EI>,?,Q.YN..3TXH \\M7EA\*_"MXKB>/
MS)+2&1$E94D0VK'#*#@\J.HJ36H-9U.3Q?9P-=R:J+B%=)N+65E6W!1"%W*<
M1D$EFS@D,.O KN/^$9T;R+&#[ GE6#!K1-S8@(Z%.>,=!CI7&7?@B6^UW4+C
M5/"FC:G)<W#21ZA]L:!A'P$5U"$Y50!D$YQGO0 WQ2%7^V[2VN[NXN=-T/>R
MR7;JEHQ$C"57R7:4[>,] OWAG!9IL4>H>/?"E_=N[W$WAHS22>:PW.&A.3@^
MY..G-=;!X,T7R;0W]C;WUW!:BU-Q.FYG0#H<DDCKC))'K5M/"^A1C3]FDVB_
MV<"+3$8_<YZ[?Q /U&>M 'G4VLWVD>'/%3QWEUY:^*%M'N'F9WMK=O(#$,22
M,!B!Z9R*U/$D5QH_B;[%ID]U'8W^C7DMS%'<./)>(*4E4YRK$MM)!&>^:[2'
MP]I$$-["EA#Y5\Q:ZC8;EG8C!+ YR2.I/6DA\.:3;VLUM'9KY4T8ADW.S%HQ
MT3).=O)^7..3QS0!Y_HB2V=S\-KU+V]>?4[,QWGFW+NLJ_9-X!4G:,, 00 ?
M7.37:^.88[CP%X@20$K_ &=.V 2.1&2.GN*LIX:T=/L&VQ0?V?Q9X9OW'&/D
MY^7CCCMQTK3EBCGA>&9%DBD4JZ,,A@>"".XH \WL)Q%>>!M!9I$TV]TYYY%\
MUL3S+%&50G.< %FV]#QQQ6WX.DO(/$'BG1WEEFTZPNXOL;RN7*"2)7:/<>2%
M)&,] V*V1X6T-=,@TU=,MTM+=Q)"B+M,3CHRD<AO<'-7[.QMM/@\FUA6*,L6
M('5F/5B>I)[D\F@#C-?LO[1^)VF:=->7T=E<Z5<M-!#=R1JY5XP/ND8ZGE<$
M]#QD5A:/<3Q6XT&[U&^NE@\1SVFGQM+S=PQQEO+ED/.Q"3D\D[ ,'I75:OX?
MN-2^(.F:I):%K"ULIH#*L^QUD=D(9<$,  I!.0>>XK9N?#.B7EA;V-QIEM):
MVTGFPQE.$?GYA[G)R>^3F@#SVTL]5U?P3KZ6EW<?VCI&M7+64<=U(0RQL&\@
MG(+(1E0#ZCIBNN\+:E!XINI/$EJ\HL7@C@MD+D*3C=(Q7ID%@G3(,;>M376E
M7&AH6\):+I2S7<^Z[,KF%0,$;_E4YP<<<=_6M;2--BTC2;:PB(*PI@MMQO;J
MS8'0DDG\: .3\?V4%SK?@UI@Q)U@1Y61EX,,I/0^H'/6L/4=.AO-<^(TAGNH
MS;65M+"8+AX\.MNY5LJ0200.N1[5Z1J>D:=K-O'!J5G#=11R"5%E7<%<="/?
MD_F:KGPWHYDO9/L*!KY ET0S#SE P%;GD <8]..E '$6>I7/B#5=&TB_O8T%
MSX>@O$68/BXE?(D(VNN64!2.N,DBNS\*VT]EX;M;2YU<ZO-!OB:]9-IDVL1S
MR<D8VYR<XS3+_P '>'=4TZTL+[2+:XM;/BWCD7/E#T4]0.!QTX'I6Q;V\-I;
MQV]O$D,$2A(XXU"JJC@  =!0!P#V]S<_&S45MKY[1AH,.62-7S^^?^\#6!IE
M\NB#XBZ?J6H3+<V[QRW&NVB_O9#*N$4+G:KKD* "!SVZUZ7/X7T6YU&34)K"
M-[R1=KSEFWE?3.>GMTJ1/#NBQZ5/I<>EVB6-QGSH%B 60GJ6'<^YYH X1?[1
MB\2^)-)MKM=)\W0X98%:Y:1()F:1 Y/\+$!<[?3.3UJG=^)+O1]'UZ.XL+G1
M=7@CL_M"+,9K<0-,4:XA.<CAGST(*CN":[Y/!GAM,[=%L@3;FV)\H9,1SE2>
M_4_G5R'0]-@BGC%HCK<1B*;SB93(@R A+$DJ,GY>G)]: ,/0])DL/$K7<6NQ
M36EY9!ET^)'*,RL/WZLTC8R& ..O!ZBIO&&A:9XDCL=-O+J>SOO,:>PNK=]D
ML4J#DJ?H3QW /IFM#1/#.B>&XY4T;3+>R68YD\I<%L=,GK@9/';-6=0TC3M5
M\K[?9Q7!A):(NN3&Q_B4]5/N.: . L]=UO1'\0Z#XKU"-GL]*-Y#KEI%B0PY
M9063IY@.2!T.#]:G\-RW%K\0[6RS)#:S^'_M!A>Y,K2.)459'["0ACG!.?4U
MV<'A_2K>WNX%LHW2\7;<^;F1IEQC#LV2PP2,$]ZKVGA#P]82P2VFD6L,L$;1
M12(F'16Z@-U[=>HH X'PO/$? G@VP,TYFNKNY\NSC?8EUM:8D2-V1>&.,Y(
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MG;U<9^8].OH*IW.FZG?ZI'ITUI91^'K9X9HY/.9YI63#*A4C"@.%.<GA<=^
M#0\/V,VGZ-#'=,[74F9I]TA?;(YW,H)/W5)V@>@%:E%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS'''&A=G8D< #DU3NKI['XBZ;K=P)&T6YTAK..X"$K!/Y@<[^/E#  9/=<4
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M20X!7;DD\8P>/4 Z:BN&E^)MA!8ZK,]C/+-IEQ!#<I;2)*N)B!&ZL#\RDG'
MR".E7V\8RK<ZO8OHUQ!?V-D+Z*&:5,3Q$L =RDA>5((_G0!U5%< GB&._P#"
M7A"_U_29IY=0NK(Q/%(H5)W *R$!@<9)XP>G-=%;>)DF\0:MH\UJ]M-IT"7!
MDED4++&V<,OL-I!)Z&@#=HKF)_&<$,5JC6ZQWUQ:B[^RW-RD)2,G"@L3C<>0
M /0Y(Q6GX<U^S\3Z!::Q8B06]RI(60892"593[@@B@#4HKG-1\6"T749;/3+
MK4(=,D6.[-O@L&(4E47JY56!(XZ]2<@277B?%QJ$.G:?-?OIR*]TJ,$*EEW!
M%!^\^W!P<#D<YXH WZ*Y3_A/+.>XT2/3K&ZODUFWDN+22,HJL$ +*<L"",C.
M<#KU/%4F^(ZQZ-<ZG+H-^D%A=-:ZB2\?^C,KA3CYOGZ@_+V- '<45RNH^,IK
M;7+[1K+P_J%_>VENESMB:-5=&+#();_9(P>2>@[TVV^(&DWVDZ9>V;+OU&.2
M2*&YE6'8(R%<.3T(8A<#.2>.,D '645Q-M\2K&\@TM[;3+Z9[Z[ELMB&,^7-
M&K$H3NP<[>"/EP<DBK4/CNU_LV^GO;.6RN;*_33Y;>:1<"1RNP[P=NTAP<]N
M>/4 ZRBL*;Q#/;6_[[2;G[2UZEE'&AWJY90PDWCI'@G+$=L8SQ6!K/CVXC\*
MZC?:=8$7EEJ2Z;<*\BE8W+HNY3_$,2+C@=>>E '>45S$FH6;>.M+M;O2IX]4
M>PGDAN#("B(&3>G#<G.WDCZ&HY?'5I%IL&LM:2_V%-<" 7X887+[!(5ZB,MQ
MNZ\@XQ0!U=%<??\ CMK2YUZ"'0;^X;1522Y*O$H,90ON4EN?E' ZGT%=397D
M.H6%M>VY)AN(EEC)&"58 C]#0!/17G6HD:]X^UG2-:L/,TJVTR)AOF4"$,\F
MZ8'.0Q"KR.1MK9@\8VUO9Z-<2V5S%I.I/'!9WDCACEA^[,@/*A\<'GJ-V,T
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MD;RR#VRH)SQQB@#M**X'1I?#OA;6?$J6VD75C)8V27MV[2^8K1'S&"QKN(4
MA\  =>E;H\510:=<ZC?VQ@L8;9+E;B*43)*K$@*I'5N!Q_M#!- '0T5SLGBF
M2SGO(M0T6_@%O8F^#Q)YRN@."F5X\S_9YZ\$T6?B%-4U:?0;VQDMKHV*WFWS
M P,3$K@D8*L#U'OP30!T59&N:&^MFV3^U;ZSMT+">&V95%PC#!5B02![@@\G
MV(Q_A:S-\,M"9F+,8#DDY)^9JU/^$B5?& \.RV<L<CVINHKAF79*H(4A>^X$
MC(].: -E$6-%1%"HHPJ@8 'I6._A\MXQC\1?;&$B69LQ!Y8VF,L')SUW94<^
MG:J;^,K6.VMFDB2*:[DF6V2:X1%D2,X,FX\!3QCJ3N7CGB#3/'=OK-K;G3["
M>6ZEO);)XB1LADC4LQ>1<C;@#!&<[A[X .MHKCC\0K7^Q].U!-,O9/MFHG33
M'&4)CF#LI!.[D94X(XZ9Q72Z5>7-_IT=Q=Z?-83L6#6TS*S)AB.JD@YQGKWH
M N45Q8\1Z;I=UXRU"+1KQ;G3/+DO\.I:<"+<K*"^  @'H?;-7M.\8"\UJPTZ
M?2KJS&HVK7-G-*R$2A0I88!)4@.#SC/MTH Z:BLOQ%K/_"/Z#=ZL;.:[CM(S
M+)%"1OV#[Q&>#@<U3C\4Q2>);'1?LS WMD;V"X$BF-U&,J.Y/S ].G- '045
MYQK.IO=^+_!.JQ6%P7E>]6.!) 3*HA.UAR%P>H)QP?PJWJ7BW3-3\+2W&J:)
M=LEMJL=C<VOF+F&=94VDL&&5W,AXSUZ4 =Y16!J7B;[)+J,5CI\^H2:9$LMV
MD) 9<@L$0?Q/M&=O'4<\US+ZA-#\49KS3]-N[R2Y\.PS+;;A&V3,WWMY 4X
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MI*5"OE0I\Q3M! !'ID=:GL]%UCP_XDUJ\L8HK^TU;RYOWDHC:&=4V'=QRC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K \7ZAJ6EZ3#=:=;75PJW"_:EM$5YUAP=S1JV0QSMXP>,XYK?JCJ>F
M#4A;$7=S:R6TWG1R6Y4'.UEP0P(((8\8H XH>*KB:S\-WNEZZ;ZVOM;^QRLT
M"*QC*NVQUV@JZ[0.,>O>C4/%^I:3>>+8GN%E6RO+&VLS+&H$/VA4R6V@9"ER
M>?3&>];MSX'TVYTXVPN+N&?^T/[2^V1,JRBY_O\ W=O3C&W&.U1GP!H\R:TE
MW)>7B:RD:W:SS9R44!6& ,-P#['I@8% %#Q=::O:>%?%@NM46\TV31IC"LR*
MLR2!&W<HJ@H1M]\U%H]_J^F^(O#&GSZC]JLM4TN1_(,*(('B6(@H0-QR'(.X
MG\.E:T?@>U&B7FF7.K:M>K=P&V>XNKA9)5B(P44[<#/<XR>,G@8M)X4MEU+1
M[\WMZTNDP/!;@F/!5@H;=A.<A5].E &5\3C<+X4B:WO)[8_VA:(WE;?G5IT4
M@Y!XYS^'.1Q3;W4M8O=9U70]+NKM9]-M82)T6#<\L@8AG#C&WY1PH'\7M71:
M_H=KXBTB33;QYDB=TD$D+;71D8,K D'D%1VK)U+P+9:AJ5MJ<>I:K8ZA%"()
M+JTN=CW$><[9,@@\DG@#';H, &(;WQ??>)K'1)-6M],N)]$>YG-O;I,L<Z2H
MA*ENHY/![$CK@BK?:QXG&G>-YX]>\M] <O;[+2/#A8%EV-D'Y3DCCGW[5V,/
MA6SM]?M=7@N+I);:T-FD6Y2AB)#$'*EB2R@DDYS5>3P792P:]"U]?;-<S]K&
MZ/N@0[?DX^4 ?_7YH S+;5M:@\6^'8KC41<6NMV4\KVWD*JV[HJ,"A'S$?,0
M=Q/X5D77B?Q#%X(UN_344^VV.O-8I(;=<&(7"1 8Z=&)SUKL/^$4MO[0T:]-
M]>F72(GAM\F/!5@%;=\G.0H';I5.3P#I\NC7VEO?Z@;>]OOM\QW1[C+O$AP=
MG W ''M0!1_M;6M,\3ZYI4^K6]PJ:,-1MIKR-8H[>3=(A#%1_J\J#SD@9Y-5
M;#6]6N/$$ND/J5V]O/H)O4N7@CC<2JX4M&-@.T[NCKVXK?U'P5I^K7][=WUS
M>2M>Z?\ V=,FY IBR3QA00<L3G/Z<4VR\$V5GJMKJ3ZAJ=U=06C69:XG!$D1
M(.&  '! Z8SWS0!R.E:GJ^E?"WPA>V^J2M)=7-C%-YT:.2DKJK*#CW/)R>>M
M=)%J6I^(M9\266GZB^GG2G2W@V1(V^0QARS[E/RY(  QP#SR,2IX!T^/P_9:
M*NH:E]DLKB.>#,J%D,;;D7E<;5/MD]R:NS^%;9M8NM4M;V]L;F\B6*[-LR 3
MA1A2P93A@"0&7!Q0!R.F^+=<\23>#7M[Q=/BUJRNGN8U@5RDD6T;D+9[DD9R
M.F<UTO@?5+_4M*OX]2N!<W%AJ5S8_:-@0RK&^%8A< '&.@JPOA#3XM0T>ZM9
M)[9=(A>"T@B*^6J, &!RI)R%7G/:K.A:!!H"7JV]Q<S"\NI+N3SRIQ(YRQ&U
M1@$]J ,6+4]3\1:OXDL]/U%]/.E2);P;8D;?(8PY9]RGY<D  8X!.>1C-\-^
M,KWQC)H]HLC:;)<:2VH7#0JI8L)?*VIO# +D,>A/*\]<]+<>%K9]8N]4M+R\
ML+F]B6*[^S,@6<*,*2&4X8 X#+@XJIJ/@/2;Q=+-I+>:5/ID?DVL^GRB-UBP
M 4.00RG Z@T 4[74M;.LZ7X7U'4H5U V,UW=7EI&H,FV1415# @$ALMQVXP#
M49O_ !%I6O>$]-U'4X;E[RXNH;OR8E"RJD3R1D\95L!<XP/:M'4O NFZA%IQ
M2ZU"SO-/+F"^MI\3_/\ ?W,P.[<>3D&I;WP=97=IIT:WE_;W.GSFXAO8Y09]
M[ ARQ<,&W!B#D?3&* .3U3Q/K]KX9\67-OJ(^T:7K26EN[P(?W3& ;3@ ?\
M+1N<9K1US4];\*R02:KJ5_=:3(9GGO[*RC+VA.SRU=-K?NP/,^8 GIGWOR_#
MS2YM.U2Q-]J0AU.Z6ZN/WZL2Z[2,%E..44^O'I6U=:,US=PW2:G>P31PF!C'
MY9$BD@Y960C.1U '4^M $&FB^OX=$U"+7(Y[06F;@10*4O&95Q(&ZH <G '.
M?:J?Q"U34-$\#ZCJ>EW"P7=NJLKM&'ZL 1@\=_>EB\+_ -GZAH"Z5<WMK8:7
M$T36ZS_N98RI #)U9\X.>W/>J_Q.MKB]^'FJV=I;7%S<3HB1Q6\3.S'>IZ*/
M0'F@"G)?>)-(\<V.E7>K)>V>LVUPT1^RJAM)8@&^7'WD(;&&).>_KBZ;XG\1
MQ^"M$\07NL)/+K#V]BD)M45()))=OG9')PN?EZ9Q7<V^A0R7*:E+>WMQ=BW,
M$$TZHKP(V"VU=@ 8X7)8$\"JT/@C28_!R>%Y6N;C3XP!$9' DCPVY2K*!@@\
M@T 49;_5K'QK'X=?4I9K?4K"2>VNFBC\VVEC(#=%"LI# \C.?KQ!X9UW5-9T
MO3;*XO7368+N:'5"L:<>2</QMQABT6,<X?.>*Z2PT**TO_[0GNKF^O1!]G6>
MYV;ECSDJ BJ.2 2<9.!Z"G66@V&GZUJ6K6\16[U'R_M#9X.Q=HP.W'7UQ0!Q
MDWC+5-+T[Q7+<3QW$UGJ\=A9%H@J1^8L04L!U ,A/)R<8S2:DUQH?Q+MKVZO
MI[](/#UY-B5$5@4>,L!L4#!P.W%=#)X%TJXL];M+N2YN8-9E\ZY21E&' 4!D
M*J""-JX^@HM/!5M!JMKJ5UJFIZA<VUL]JINY4(:)B"58*HW=!R>3WS0!DV.J
M^)6BTG72[2:5-;&?4(Y?)"*K)N5H-GS<'C#$Y'O6+JUWJ&M^%_!NO7-^V+[6
MK"<VBHGEQJTF54'&[*C )).>>.F.MT/P'IV@3 6][J<UE&6-O87%SOMX,Y^Z
MN,]"<;B<9JK'\-M,ALX+&/4]633[6[2\M;03KLMW5MP"G;NVY[$GVH [.N%\
M10W%Q\4/#T5K=FUD;3;T><J!V4;H?NAN,_4$>U;^A:3=:;?ZM-+?7L]O=7'F
M0Q7<WFF+KG9_=0Y&%YP%SU) DNO#T%WXCM-<:ZNDN;2%X8D0ILVOC=D%23G:
MO?M0!QNE^,-5FL-%TRXN@=0O-8NM.DOA$H.R N2P7&T.P51TQR3CM5JZU+Q(
MNJ^(_#=G?M)?6]@FH:;=M#&6.XLOE2#;M/S+@$ '!]JUE\!:6NEFR-S>L5OV
MU&&X+H)8)RQ8LA"@<DG@@CG&,5L:=HT&GW5S>&66YO;D(LUS-MW,JYVKA0
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MOECG8"5P!ZD#)[G@5<N-%NVU_1[R'4M0$5DCI.C3*(IU*D#<@ R^=I!X  -
M&9\4VG3X=ZG);W<UNR^6&,1 +JTBJ5.0>"#VQ^616?=6-]+\51:V^K303?\
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MX[R6W-W8>6GEK'.P7$9 W;E++R2<X.1Z0ZCK'B4VGCF>'7/(.A2&2V"6L9#
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M?462.,86(Y8@;<;6#1 =_P!X#GBJ8\8ZK9:/KK7%Q'/=IXB&DV<C1!4B5_*
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MO]IS&6^:,-,2%&UCR5^4 8'3..<5?HHH **** "BBB@ HHHH **** "BBB@
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M&)&QN  .[OW'XUO @]#7%?$M(Y--T%)F*Q-KUD'(<K@&3GD<CZUE6_A'3?\
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MSC]\_7\*[:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-6H+>&U@6&WBCAB085(U"JOT KE?AWJMSK&AW]Q<WDUWMU2ZBBEF7:QC60A
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MC@@-RTYD@.80\6Q=^,XR>W4=\5V]% '$7&@7\7C^8VL6=$U>..XOSGA)H"
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MM*C*IQG!*J3[=#@\5VM% 'C]II>KZ?H.AZ@VB7UVFG:E?-=V"(4F:&>1RLB
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M^=20P./E(YSD>J5AZGX6M=2U5=42\U"QO?*$+2V=P4\Q 20K*<J<%C@XSR:
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M=\:EMP</NZC P,4 4M/\8ZA+KVE:7>6UF)]1MII3!%(=UG+&%/E2,,ACAN2
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M5 I]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!:0!A#!&L2!F+$*HP,D\G@=34U% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5Y]X]F2V\8>#_-N[J"UN+F>.Y6&XD19%$1*A@A&<-BO0:X_P 5
MZ7JM[XJ\,ZC86/GP:7/-+/F54+!XR@"Y/)YSSB@#-\/:L;CXFWNGZ+J%S=:+
M%8![N.YF>00W)?Y1&9#NY7J!\OXUZ%7%CP]J>J?$>P\375O%I]MI]I) D:RA
MYK@O_?P,!5Z@9/-=/I<^H7%HSZE91VDXE=1''-Y@*!B%;.!U&#CM0!=HHHH
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MAR>^1TJI%XA\6W&L:%I=Q;6&F76H:?/-<1R1F4P2QL@R-KX93NR!D8SR3C%
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MSEFSRHPW'7I4USXAUC2+CPY-?O:SVFLS):2"*(J;>9T+(5.X[EX(.>>ASVH
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M*31P[4BA;D[5W')).223T7C YT)M<M(8K&Z+*]A>E%BNT;*!GQLSZ!L@ ^I
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M[G3YK.2%PN)&5@X(!W*5)XZCZB@#G]#\#RZ#*+>VU^^?18I#+;:9(B%8FSN
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M8!N+B4R@'G&-Q/X<>]9ND6UUJ'CCQO%;:D+>.Y:V0L(0Q8"!59HR3P0<C)W
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MP<YPPSW7CK5_6M&6WTO1;>;5+G3=5CDEN%U2WCWQI<,"9/,!&-C%VX..@&:
M.UL[VVU"U2ZM)DF@?.V1#D'!(/Z@U/6!X-N-1NO#,$NJVT4%WYDH<PH427]X
MV)0IY ?[W/\ >K?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J&[M8+ZTEM;J)98)D*21L.&!ZBIJ
MY3XE7M]I_P /-:N=/*K*MLX,GF%&C4C!9< Y//M]: +":!'<>([#6(]6>9].
MADM0A"OE7*E@[#G=\J\^W.:Z%W2-2SLJJ.[' KC[)K;3-?2TT_1;*/7KNQ$M
MPL5RRQ+!&VU"S;.22V!A,\'G %8GBW6[;Q+X$EG:T\B]T_6K:UGADPS03+<1
MAL-W!#<$=0?PH ]+WIY@CW+O(R%SSCUQ3JX>3[-9_&2XNG$<2_\ ".^9-)C&
M0L_4_0#]*M?\)N8K+2-5N=-\K1M5ECCAN!-F2/S/]4TB;0%5N.C'&1GV .NH
MKBKWQY<6&F^);F72$\_0956:W^UX,D;*&$BG9T(/ [X(Z]=B76WFS'!90WD!
MT_[7(R3\$-G:H!7!#8;GCA3QTH VT=)45XV5T895E.01[4ZN$T[QA%9Z#X17
M3/#^RVUE/+M[>*956W_=LX7D<\+UX_'I5I/'JP:%K5[J6G-;76DW:V<UM',)
M [OL\LJ^!P?,7D@8YH [&BN=L_$EU+XOE\.W.F+%-':K=F:.XWH8V)4=5!SN
M4C&/0U8U_P 10Z'/IT$GD+)?S&&)[B;RH@0I;!?!Y., 8Y- &U17-GQ-=0:O
MH6G7FEB"357N(\B?=Y31*S=-HW!@H(/'7I5>#QLCV]^9;$I=6^K?V1#"LNX3
MRD*00Q P,-D\<!3UZ4 =4[I&A=V5449+,< "G5YK\1;VZU#P#XGM=3T8VSV/
MD/#,&\R*;<ZG=&Q53D<@C'&>IS74Z?XDN;CQ7/H-]IGV.46@O;=Q.)/,CW["
M&  VL#C@%ASUH Z&BN6\::UJFD'0TTV*W87VJ0VLK2RE2 <M@84\':03V'8Y
MXAUCQQ_9W]HBWM+>ZETT*+J'[7LD9R@<I$NT[R%8==N2<=<X .OHKC3XUO[G
M6I--TKP[+=NMI;WJM)<K#F*5B.01PPP>#UP>E5)OB)=PZ1?:LWA]OL6G:B]C
M=G[6N]=L@C+(NWYN3T)'L3V .]IJ2)*@>-U=3T*G(KG;+Q->2^)KC0[W2?LU
MP+/[;;%;D2>;'NV$-P C D<98<]:P],\8VVG^#M O--\.>3;:CJ#626D$RKY
M+-*XST .2K'L,GKWH ] JI8Z=#IPE2VW) [F00_PHQ)+;?0$G..F<XKG;?QC
M=E-?AN-"F_M'2#'FTM)?/\\2#*%3M!]<\<8/6JM_XWO(K/Q5#;V=G_:6B60N
M_ENC)$X*N>H4$,-C?*1SQR,\ ':2.J@*9%1G.U,GJ<=O6J4>D00V,UK%)+']
MH<O/,K8DD9OO$MV)'&1C   Q@8Y=]8;[+X,;6=(@NKB]N(UBN!,&\F4PLPDY
M4'<0&X XSUJ]>>,9([/5]0L--^V6&D2O%=.)]DC&, R^6NTAMN<<LN2"!VR
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MOB#5A/$LOA]EAGM'N8IEN"RH5P?+E.SY&(/&-PR".V: .DI&944LQ"J!DDG
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M,DD$HY1E)!P>XXR#W!%:] !1110 4444 %%%% !1110 4444 %%%% !1110
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M\:39OC!"R1LHSG!(P0,_RO1:#JR>-[+6I9K6>&'37LYF+,KL[NKE@NT@ %<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'87$=S MN54!T^YG*G@>E0_\(O;C4]5U!;V\6?5(4@GP4P%0$+M&W@@,WYT
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M=O,4,DP*D,A"C&"B<<CCZUL7.CVE_HDND7RO=VLT1BE\YLM(#U)/K],8[8H
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MQ!4X;'=2,]\UKZ?I,6EZ';Z5:3W"16\*PQ2,P:15 P.2".@]* /)-!7Q!/\
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M/G+O\O) 8@8P .!6>/ &C'1=2T>5[J73[Z=K@PLX @D+;MT6T I\W( X_,Y
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MR644ZAHY)?,Q*<'@N%V^X!/J:XYK5WTG2;:X>1[*#QH;73G,C _906 4-G)
M8, ?11Z4 >T9STHKA_!UI;:9XX\9:;81);V43V<J6\0VHC/$=Q"]!G )JU\1
M=-:Y\-_VI;0++?:-,FH0*1DN(R&=/HR@C'KCTH ZZL"#7[B3QS=^'Y;6)(8;
M".\2=9"6<,[)@C QC:?6N#AE)\47C6MFJZ?XTM@+)A%@H4PKN?3=$QE'3.WU
MS6O-H.DZA\4KO3+NRAEL8_#T"K;,/W8 FE ^7IQV].M '<WKWZ2V@LH;>2-I
M@+DRR%2D>#RN <MG'!Q5O(SC/)KQW2I#<^#?A9=32&2?^T(XM[-DE1%,,?\
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M!^RH0Z\\-D=?;%5[*[DNK[3-)\:7=M;M/X?MVB&I1!DDD^<3<L0!)CR\]^*
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M$/MEQ$TK8'6WDPI/N>@]:X?5VL;CP?X^6"6(I'KT+Q>4^ H)MQD8['+<^YH
M]MS6!K>OW&E:[H-A';120ZG<M;O*9"&C(C9QA<<YV]<_A7&:Q$WAKQ?XC_X1
MVW$-P_A=KORXAGS)UD<+(1_$^#U/)JN3X?\ M'PVU*PDM?,EN#ON P\R3-N^
MXN>I;?U)YR3ZT >M9&<9Y]*,CUKR'1_[-U^VCGU/6H;/Q#9:JYE1(U%X)1*P
M6,$G<R,I"XQC;QVK:\$:!I5QKWB.^EMEDNK'7Y_LSER?)S%&#@9[@G/T'H*
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M*2>S*MY:)EB&C0C!8\Y(SG ':K=GXGL+_2-.U.U6>6VU!PEOM3YFSG!(SD#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5RWCSPW=>(M%M3ISQKJ>FWL6H6?FG"-)&<A6/8$$C\JZFB@#"M-<U"]@5!H-
M]:7A&'6YV>7&>Y+JQW#_ '<D^W;'L;34_#WBOQ',^G7%_9:L\=S;R0;21((P
MC1."1M^Z"#TP>2*ZZ6]M8+FWMIKF&.>X+"&)W :0J,MM'4X')Q4] 'FFB>%=
M3\/WW@2U:VDN(M*M+M+RXC(*1O*%( R<D @C@= *K7^AZU<> _&FGQZ1<F[U
M+59I[6,E!YD;LA#9W8'"GK@UZ9'?6<MY+9QW4#W42AI(5D!= >A*]1FK% '
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M_DED1]/OSG:1:R#.X?[2,,CW:NQJO-?6EO=06TUU#'<7!(AB>0!I"!D[1U/
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MAX?_ +.DO!C9YN^-NA.<80]O2M;XCV%[JO@'5M-TZTDNKNZB\N*-"!SD=22
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MGC ?V1/<KJS1O9NA3RWQ L9#DGY<$'.1TZ9Z5W5% 'ED/AC4/!^H:8_]@_\
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ML.02.^#R,]P#VH Y_P"'FD7&A?#_ $33KM2MQ%; R(>J,Q+%3]-V/PKIJ**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *Y[QCK]YX<TJWO+.SBNFDO(+=DDD*8$CA,CCD\]R*Z&L'
MQ9H%QXCTN"SM[N*U,=U#<EY(C)DQN' P&'4B@#,?6-7MO$_AW3]8TO2S+?37
M02X@E9S$J1EAMW*,$C )SZ\54U'QW?6^DZMJ]G96\MMINJ?V:]O*S+)(=ZQE
M]PSCYG&%VG(&<\XK=U70+K4?$F@ZLMY#$NEM*S1&$L93(FPX.X;<#GH:\]@O
M_M.L:C?VOB#PVES)?O(NG:G9-]J5D.U!L60$MA1M(0GGN: -N235H/B5K<FF
MVMC]N.B6KR":1O+#!Y<C(&6R>,X'K[4[_A*M6UK4/ ES8&"VM=7BFGE@D#,=
MRPD[201E1N...H!K:L]!U.37KKQ!-/;P37^FQ6S6AB+>2R[FY;=\W+D=!T%4
M;+P)?:?I_A6*#5X1<Z )(Q*UJ2LT;IL/R[^&QT.2,]J +>G^+I-3\17.F026
M:36MX\%Q8RY6X6)<XF7)PRM\IX'1NN>*O^*=<N- MM/N(88I5N+^WM)%<D$"
M5PFX$=QGIWJA=^$)]3U:PO-0N+61["_:[M[F. K<"/<Q$);/W?F )[@8QGFM
M'Q7H,GB'1EM;>Y6VNH;B&Z@E=-ZB2-PXW+D9!QCKWH S-1\6W]CJ'BBU2SMY
MCH^GQWT1,C)Y@82$JW!QCR^W7/:HM.\7:K)J_A^'4;*SBM-;LWGA:&5B\3I&
MKG=D8P0QZ=,=339?!FK75WKUW<:Q:F76--6QD5;,A8R XW+\^<8<\$G/J.E6
M$\(78O/"TSW]NR:';O Z?9S^_#1B,G[WR\#/>@#FO%>L7?B/P9IFLPPVRZ9<
M:M:&%6!\X1BX4+)GI\V/NXX#=>,5OZKXQU!#JCZ+ISWQTV?R&MQ;3.URP"EP
MCJ"J$;L#.<D'H,$YZ_#S5X?#D?ARWUVV&E6MW'<69ELV::-4E$@C8AP& (QG
M /TK2_X1+6['7[Z\T77X[2QU.037EM):>84EVA6>([OE+ #[P8 ^O2@ A\3>
M(-0\4:AI-AI=BD=FMI,SW,[JQBEW%@0%X<!>G08/)K0\4>)XO#T^FQ3SP6<-
M[(\9O;I288F R%;!&"W8D@<&ETOP[<Z=XLU36#>1R07T$$(@,;;T$08*2Y8[
MB=QSQ5O6=.N]0>%8GM)+3RY([FSNX=\<X;;COP1@]CU/UH S%\1ZC#KOA[3K
MJWM?^)K%<,[1.6$9B4$%3_$K!AZ54M?&T\MO-%):P_;CKDFCVX5B$=E&?,;N
M!M#''L!GG-1P^ KG3+3PX-(U*&.YT5IPIN8&DC=)L[E"AP0!QM^;H #4#_#J
M[DTN]B_MP)?-K#:Q9726V#!,>S#=AU(R"..O>@"MX_GU:7P-KD.JV$*BVN[3
M[+<PL-MRIFB.0I)*$'*G)^E='I>O:E)XPO- U2UM8W6S2]@DMI&8;&=D*MN
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MV+PUX>N=5N$,ODA56-3M\R1F"JOMEF SVKG-$AT?Q+XXD\5:/<M/9I:I&\B
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M]JUONFB=^7$4FX!0QYY!QVYYJKJ7P]N-0U+6-275(H+ZZN8+JQN([<[[.2)
MG][YPR@@C@'- '9SW2V&FRW=[(H2WB:69T4@ *,D@9/85R;^,KZUTS0M<O+2
M :3JTL,>Q"?-M1-_JV8]&'(#  8SQNQ74FS>[TE[+4S%.9H3%.8T**X(P< D
MD9!]37,V7@JZ31]+T._U&*ZTO2YXY8?W)6618CF)'.<84A<D#YMHZ<T 9USX
MV\3?8/$%]9Z)ITD.A7DD5PC73[Y8T17.SY?O88GGCH #5FQ\0:IJOC^!+.:
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M=GG-:UK#J>M>/M>LY->U2TM;2.QN8H8&1=A;>67E3E3MP1W[G@4 =\
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MGH !A0.O>N;O;'6O ^FWFL>'IHM:\(2K)=7&DW)P\$;9:0PO_=Y)VGISU/-
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M;M!-8ZAJ;3-(21R"LC;!C(X;YMW(&!GJAKFE-?BP&HVINRY00^:-Q8#)4#U
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MK0!7E\,Z5-K4NKF!TOIH1!-)%,Z"5!G =00K8SU()I+3P_8:4T5Q;PW$\MK
M8;82SM(T:'&54N>,[5Y)SP.:V*R?%%]=:7X6U34K)HA<6=K+<()4+*Q1"V"
M0><>M &)<^!TOO#NH6=TV;W4KPWL\T<SQB.3C;M*X+! % !QG;GC/'8*,*!D
MG ZFN5TJ]\1:AH.C:F;_ $W?>QV\SVYM&7*N SJK>;U"[L'!Z=*VF\0:*K7:
MMJ]@&LP#<@W*9@!Z;^?E_&@#FHM NKKXCZWJ%S;7T%E<65O!#<17/EARI?>"
M%;=_$N"1GK@BM?5?!>@:OI]C97%CLCT_'V-K>1H7@XQ\C*01P!6E>ZQING6Z
M7%Y?VT$+KN5Y)  R]21ZC!'-%QK&FVEK%=3W]M'!*-T<C2#:XQG*GN,<\=J
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MQ4D?@O0X;/2[2.WG6#2Y!+9H+J7]TP! /WN>"1SG@FMUW2*-I)&5$4%F9C@
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M0#C-6-335I&MDTN:U@!<F>6XA,N%P<!5#+R3CG/0&N4\.:UXKUU-4E6ZTO\
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MO00K;P)"A<HBA07<L<>Y/)_&I*AM+RVO[9+FTN(KB!\[9(G#*V#@X(]P14U
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MN@WL)#2OB(+- >&4A0A.00-ASC&*]/HHH Y3XE@/\-]?CV[GDLW1% R68C@
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M^HCXBMKGV%_L1T@6G^L3?YGF&3IGICC.>OMS0!&/B%I[Z;H=]#I^HS)K#M%
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MH9E(AB1&7;N(&]R6ST [9XR<[6_!NLZQ<^+FA2.V:_FL[FPDD<%2]N%X<#D
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M0V&#*Q &5.0>1Z$\5G:[IOB/7_#'ER:1:V=R]Y:RK:1W"OY:12J[%I, $G&
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M=U4WFE8>ZM@8<K&5WAPV_:<@'@$G(/%2W&N:1?:WX2E-K=ROJ*R3Z=<JVV-
M82QWKN&24Z @CFJIT;51K?C*Z%D3%JMK##:GS4R62-D.[G@$L"/8'OQ56R\/
M:Q!_P@(>R'_$C@:.\(E7J8/*&WGGGGMQ[\4 6Y_B/:P6FH7C:+J@M--O39WL
MQ$>(2"H+??\ F&7'W<G R<<9T-:\8V^BG4F:PNYX=+A2>\EC"@*KYQMW$;R
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M:VU;; QQ$LS1-*GS<8P&(.>"?2NQT^^N;[6M1"R1-IUMLACPGS-+C<YW9P5
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MIP01@_-UP?I6-+XA\3:1XBO='U&73K@RZ9+J%C<16SHJ-&0&C==Y)'(P<C_
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MLB ("(I)P/F8\D\D^P'454GN+N/4;."&Q,MM*'\^Y\U5\C &WY3RVXY''3%
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M0KR*'&\GL!D#KBNT/A/0CI[V!TV(VCR^<T&3L,F<[B,]<\Y]>:M)HFG)J?\
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M#D+I+CQ5K/BO3)-933KJPE1;8G>)+:+RD99EQ(HY8L22.V"<8%=5J^I7>E^
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MB:"]?S+J,DE9F]7&?F/3KZ"I;GP]I5W)!)-9JTL$9BCE#,KA#U3<#DJ?0G%
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M<WHNY;G3@S2V<[*[!QM!)5>(^F,8S0!UUAJ%MJ5NT]J[,BNT;;HV0AE.""&
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M$^T.^]\E(XHFE=@.I"("Q R,G'<>M5_#EE;Z?H-K;6FG?V=;J&,=IG)C4L2
M>3@\Y(R<$D5R_BX7>F>,=-UJ33M3O]*:SDLYAIID,L#EU97VH0S*<8./0>U
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MK3^?+'=ND%VUOY#W,0 VR.G9NHZ<A0>] &Y>WUMIUL;B[E$4>X*"<DLQ. H
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M=1Z3>RQI!#=,&V1QQDJN8^>"S9]3C%:T/C!9O$>C:7]F@\G5K$WEO<K<YW8
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M^S-;.SR12P,X;RW1RC#(ZC*GF@#8HK"\5^(F\,:5%?"P>\5[F* HD@4CS'"
M\]>2./Y50?Q==P3BPO--M+/5"DDPAN-0 C\H-M5MX4G+'.!MXP<GID ZRBN,
MLOB!%J$>DQQ62VM[J,4SI!J$_D -&P4HK;3N8DY&!RO/M4MQXPU*/6+/2+?P
M[))?W6FF^"/=*BHP*!D8X.,%L9QU'3G@ ZZBN,T_XAVM]I<$DEH+/4I+R6QD
ML[F<*L,T0+.&D /R@8Y .=PX]'V/CM;N/R&T]DU)K\V$,(EW13-M+^8DFT9C
MV!B3MR,$8SC(!V%%<)XD\5Z_9:).\>D+9W46IV]FSRS$QR1R.@WQ-L^;.[!R
M!MYZXQ7<0F5H4,Z(DI'S*CEE!]B0,_D* 'T5RGB#6M7LO&?AS2[&&V:VOOM#
MR&29D9C''G;PIP/F![Y(QQW2\\:/%INJ:M9Z;]KTO2YGBN9%GVR-Y?\ K6C3
M:0P7GJPSM/MD ZRBHK6YAO;2&ZMW$D$\:R1N.C*PR#^1K%UWQ!<Z3/(D.G"6
M.*T>ZDN;B8PPC!P(P^ULN>>..* -^BN.'CJ2YF\.QV&CR3_V[9/=P%YUC";5
M5BK<'^^,D>^ :@?X@3Q>&6UB31@HM=1;3]1C-UQ:LLGEE]P3YD!(). <'I0!
MW%%9T>I22Z_-IR6Z&&&W262<2=&<L NW'HI/7TXYJ]*9%B<Q*KR ?*K-M!/N
M<''Y4 /HKCK7QW]JT+PUJPTW;#K=VEKL,_S0LV[!^[\P^0^G:JM[\0;VUM=>
MNT\/-)!H=R8KIFNU4E JL60;3EL-G:<#CKVH [NBN?\ ^$E=?&%MH<EFJ0W=
MFUU;79F_UNT@,@7;]X;@>O3GVJN_B\1PV0D@MHKF_:9K99;K;&T,9 \POMR
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M&B,[R.03M55!). 3P. ">@J+3==L-5N;FUMGE%Q:A#/#- \3QAL[<A@.NTT
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M[65G5&="A.UBIX/(Y4]: ,73[*3P[KOB77-7NK"VT_4)H9$D:<KY>U%C <L
M!G []3BJ_@+1+?3_ .T[RTN#-I\UU(FG#C;%;[BQ"?[)D:3![J$]JZRZM+:^
MMGMKNWBN('X>*9 ZMWY!X-2(BQHJ(H5%&%51@ >@H =7EV@:5J'B#PSXIT9/
MLL=E>ZW?127!D;S$0S'> FW!.,X.X=>G'/J! 8$$ @\$'O6)>76A^#[:.3[)
M'9Q7=RD/^BVN \KL%7=M&!R>IH JZ7H%[8>--3U0K:C3[JTM[:-%D8R((M^"
M1MQSO]>,=ZS_  SX>\4^'EBT7[?ITF@6TF;>?:_VH1;MPB(^[_L[L].V>G;4
M4 <3X<\-^)?#I;1H;[3V\/I</+!*0_VI(V<N8L?=ZDC=G.#TZ832/#OBG0KN
MYTVRO].;P_+<R3Q22*_VJW61B[1J/NGDG#$\9Z'I72:MK]AHL=K)>/(%N;E+
M6(QQLX\QVV@$@87GUQ6G0!YQ=^"?$,6B^)O#^GSZ;)I>KR3SP2W$CK+;M+RR
M%0I#+G.#D$9Z&MM-!U=?%VEZPYLFBM-,>RD42.&9V9&R!M/'R8Z]_P *ZRB@
M#SR+P5KD?@[3]'W:>9[75QJ#/YS[647!FVCY,YYV_K[5FWR7&K>(_$5Q9?\
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M'NL<8'_ O6L>?P3JUUX5\5:5)-91S:MJ#WUNZN[*F61@K_*#_P L^HSU]J]
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MM8D=D<!V+SEU("':  ""0&P#BN@T?PQ;:-JNH:FEW>W-W?B/[0]Q*"&*+M!
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M<TV-OF#/;R0I_P"VQ]* .\6]M'E2)+J%I) 61!("6 ZD#N*=!<P72%[>>.9
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M&[$&Z, A!M9CW&6(4X_'\0#>-O"P(,,9!;<05')]?K22VMO.B)+!%(B$%5=
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MOY-Q \!4M'(D81HW#$8S@$'IUR161HGA35- N_ ML;1YXM+@O/MDT;+LB>8
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M:U5%CV[68VRC:Q)&/J>*S;;PIJ?A"YT:4Z$GB.S328M/NHX_+,D,J,S!T$A
M*GS&'4= :]#L-!LM-U6_U*W\[[3?E6N2\K,'*C:IP>!@#'%:= '"+I5_'XM\
M*W46A):6=I!>+.EKY8CMS,5*+@$9/RG<5!&>:AU7PWJ6LZ_XQA^SR6UMJNDQ
M6=O=LR[3(HDSD [L?..W/-=S:7]G?B4V=U!<"&0Q2&*0/L< $J<=#@CCWI3>
MVHOEL3<Q"[:,RB#>-Y0'!;;UQD@9H XDZ9JGB&T\)VM[IDUA/I%Y%=7DCLI3
M,2,NV,@G<&8CZ+G.#Q7/RZ-XDM?AO?\ @[^PKJZNH+H-;W<<D7E7$9N1+NRS
M AL$@@CMG->NT4 9/B&TN-5\):K901E;F[L9HHXW(&':,@ D''4^M<E%8ZS/
M<> II-$NH5TO>+L,\1,8^SF,$X?G+'MGCGCI7H=1SSPVT#SW$J11(,O)(P55
M'J2>E 'FYL?$UC#K\EGI-SB[\0)=,J/$)9+0I&KF,EL!\IWP0#D8/2E>^&=<
MN=(\=6EOHL\7]HR6]Q9B6X1C)M2/*D[B=^4;))QGN>M>JV]Q#=VT5S;RI-!*
M@>.2-@RNI&001U!%24 4)8Y=7T*:&6&6RDNH'C*2%2\>X$<[21GG/!-<5X0L
M=0MH-/TW4O!5K;WFFJJ2:F%A:.0(,!XL?/O; Z@8R23V/HE-:1%=49U#.<*"
M>6[\4 >76^@ZY'X T73FT>Y^V6VNK>2Q;X_EB%TTN[.[!^5AQG.:EGTW7M.T
M[QQHJZ-<WJ:RUU=65U"\>W,T6WRWW,"I4@ <'(KTQ)$D!*.K $J2IS@C@BG4
M >8ZIX>O[RPL98M,U33M>LM)BBM+^SF3)E ;,$H#%63(4\\88\@UVVJ#6?\
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M6J5MH^HZ;K&KZ;=>#K75X;Z]ENK347$31HLK;BLP;YOE)/0'(Z"O2B0JEF(
M R2>U0V=[::A;BXLKF&YA+%1)"X=20<$9''!!% '->';&^M?&WBJ[N+&6&TO
M7MFMIB4VR".((W 8D<CN*=XSL;^XN?#E[8V4EY_9^J+/-%$R!]ACD3(W$ X+
M#O6Y+K.EPR-'+J5G'(IPRM.H(/N,U9M[JWNXO-MIXIH\XWQN&&?J* .#ETO5
MWU#Q[*=*GVZI9Q16A#H1*ZP,A ^;CYB.3CBLY-'U?2+K0]3F\+G6+<Z+;Z==
MV?[IIK:6+)#+N.T@[F!P>P->I44 9^BVYM=)@B-A;Z?]YOLMN $BR2<?+QGG
MDCC.:\R;1O$MK\-I_!QT*ZN;NTNT:&[CDB\JXB%TLN[+."&QG(([9KUVB@#R
MSQAI?B77;/Q/8MHEU,9A$VFE)XTAV (6##?EI<AAR".F"!R=F?2=4N_&.K3-
MITT5IK&C1VOV@21D6S@RY#C=G.'&-H(SW[UVUQ<0VEM+<W,R0P1*7DDD8*J*
M!DDD] *=%+'-$DL3J\;J&5U.0P/0@]Q0!Y_X.LM0B33M/U/P7:6=YIRA)=4V
MPM&X48#Q$?/N; Z@8R<GL=;Q7IFHMX@\.:_80-=KI<TRW%JC .\<J;"RY(!*
MX!QW&:ZRB@#@Y]$OIIO&6LI93"35K%+2UM25$C[(W&YN<#)? R> O.,UTGA2
M&XM?"6D6EW;O;W-M9PPRQN02&5 #R"01D5L44 >9Z!HVH:7+)H-]X/M;W9=2
M26^L.L+1-$TA<,X/S[USC ') Y YI+O1-9F\+>/[)-)N//U:[EDLEWQ_O5:*
M- <[N.5/7%=\^MZ5%:7%U)J=FEO;2-%/*TZA8G'56.< CT-3MJ%FM['9-=P"
M[D4ND!D&]E'4A>I'O0!RDECJ,OCCPS?C39UM;73YX;B1BG[MW\O (W9/W#TS
MVKE/#VGW/B;X1Z5H,5E,GF789[I]OEQQI=&0N#G).%*@=<GTYKU2^O+.TB47
MEY%:B9A%&SRA"S-P N>I)/%0:'H=EX=TN/3=.61+6,L4220OMR23R>>I)_&@
M#B=6\+:IKE]X]M1;R6T6KVEM%9W+LNQVC1@0<$D#) Y'3-:$ECJ7B6\\+2WF
MF3Z?)I4_VJ[:4KC>(V38A4G<"S9STP/7BNWI" RD'H1B@#AET*>+XDW$5O(G
M]CW2QZI=P=UN4)1..P<A7^L-+_9VIIXB\;W/]F7!AU"T@CM'#)^^9(W4@?-Q
MRPZXKI="\.Z9X<M&MM,@:-';<S22M([>F68DX'89P*U* /.+71]7BL?AW$VE
M7 ?2 HOANC_=8MVB_O<_,>V>*B\/Z-J&ER-H%]X/M;PQ73O;ZRZPM$T3.7#N
M#\^]<XP!R0.0.:]%EO;6&[@M);F)+BXW&&)G :3:,MM'4X!&<=*6[N[:PMGN
M;RXBMX(QEY97"*H]R>!0!YGJ.@ZW<^#?'FGQZ1<&YU74)9K-"\?[Q&6, YW8
M'W#UP>E=''::E%\2AJHTV9K*[TF*V,N]!Y+I*[$.-V>C#& >?SKK8W26-9(V
M#(P#*P.00>AIU '*^-+"_N9_#MY864EY_9^JI<311,@?R_+D0D;B <%AWK &
MEZEIGB36(;KP=!K=IJEQ]JM[HF$B%F10T<N_D*"N00#P> 3Q7H-I?V>H1O)9
MW4-PB.8W:&0.%8=5)'<9Z58H X_0]/O[+QYKMW-I[QV5Q9VD,,T801LT0?<%
M4-D#YAC(KG)-!UQOAS?Z6-'N?MLNM&[2+?'S$;L3;L[L?='3.<UZG10!R M;
M\?$R?5_[.N#8MHJ6RRY3F42L^W&[/0CG&,US>FZ#KEMX1\"V,ND7 N=+U)9[
MQ \9\M )1G.[!^^.F>]>IT4 >;W]CXFMK_QE>:9I<Q:]NK-[<[HMTL2(B2[,
MG ? ;&['8U4G\-ZS=CQU#;Z+<P1ZQID*6C7-RCLTBQR*5<[V.XEAW(QU/:O4
MZ@N[VUL(//O+F*WBW*F^5PJ[F. ,GN20* .,O+75K[4?!-V-&NHDL9G>Z5WC
MW0J8&C&<-S\S=!GC\JHPZ'K-CX8\4>%FTZ2Y;4)KIK*[#+Y3)<9.9"3E2A8Y
MXYQQFO2** //]+T+4=)UO7%%C<S6K:/:V5M/E/WSQ)(IXW9&=PZX[U:\,7NH
M^'M"\(Z%>Z)<JTELMK/.)$*P2HG (!.[.#R.@%=M49@B:99FC4RH"%<CE0>N
M#VH P?&.F0:OIMK:76F7%];M=*SM;2;);;"L5F0Y!R&VCCG#'@]*Y6;1_$L.
MA:+-<QW>JOI6N_:8U<I]JDM KHI;D O\V>H)'7G->F44 >8WGAO7=<C\>1?8
M'L'U4VTME)-(A5FCB3Y6VDD'*X/!'7DXK<.HZ_KOAS4([GPS<:?.;&6)HY98
MV:69EP%CPV-F<G<V.W'7'944 >>6>D:M')\.M^EW &DV[1WQW)^Y)MO*_O<_
M-Z9XK>\7_P!L;=+.FVD]U;"\'VY+5U2?RMK ;&8C'S8R00<9P172T4 >=:/X
M3O+SPWXOT/4-/DL8]0OYI[61I5?[ZH8V!!)RK*"<]QQFH5\*^(+N\T76+L(E
M_J,+6FO1ALJL!4,%'N-A7CO*QKTNB@#@?%=EKVHZGJ]BNESW6GW&E&*R:"9(
MXQ,0X;SLL&/5=HP1UXSR(M!TW6(O$7A:ZN='N8(;30FL;AF>,^7(3'@'#$_P
M'IGJ/?'H=,EEC@B>6:1(XT&6=V "CU)- 'F-UI7B"PT/QOX?71KF]&JR7=S8
MW<+Q[&$R_<?<P(93QTYJ76M U"]@AN;33=3TWQ!:Z=%'9WMK*F)' .8)AN*L
M@;!R1C#<'M7H]M=07MM'<VLT<\$JAHY8V#*X]01P14M $4*R-:1I=;&E,8$N
MT?*6QSC/;K7F!\%:_:Z)_HP1[SP_?;M!1GXD@W[B'/\ M1OY>.WE^]>J44 <
M5XGT.]&A^'K*PM9;U[/5+6YN'0JI*H^Z1SN(Y)R<#J35BUM+^'XDZMJCZ?/]
MAETV"".8%,.Z-(Q &[/1AU%=;10!RWPZT^^TGP+INGZE:/:W=N'62-V5L9=B
M.5)'0BNIJE%J^FSZ@]A#J%K)>("S6Z3*9% ."2N<]>*NT %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5Q7Q,##1M(>.)9)4UNQ**3C)\Y>,]LUVM8GBC07\0Z9#;Q72VT]O=0W<4C1
M[UWQN& 9<@D$CG!% &!)XYU#0]1U:Q\26%LDMK8?VA;/8R,R3Q[MFSY@"'#%
M1Z'.>*T],U[5YO$::?=Z:[V<MN95O(K6:)89 >8V\P<Y'(88SCH*COO!<>O?
MVE-K<ZR7%[8_8!]G4HL$6=Q*Y))8M@Y/]U1C@YL^'M(\0V)0:YK\>I) FR'R
MK;R2_;?(=QW-CL,#DGDXP 6M=U*\T][-;=((X)I&6>\N6'EVRA21E=P+%FPH
M />N9A^(@/AW3=1O5M[ 7-_-8SW4JLT$#1EU#'H0&* #)&,\GCG>\0:!>ZGK
M&C:G8:A%;2Z:\I\N> RQR!UVDX#*0P&<'/<^M9FD^#]4TBP>S75+2\M7NKB:
M2WN;3Y)DE8MM;#=03UQCMCF@!VH>,9-+31TU&?3[+^T#,!?/E[7*,/+7<",;
MU.X$G^$]:LIXBU&/Q!H&EW5O:JVIV4T\AC8MY4D80D ]&4[^O'2JUCX+ETO1
MK?2;>:RN-. N/M%C=6Y:%_-D#J%&[Y0G( .<@]CS447@6ZTR'PT=)U2)+C1(
MI8-UU TB2QRXW# <$8*C;STXYH KR^.]3CT8W:Z=:R2QZ^='D'FLH($PBW@8
M/)]">/>K*^(O$\FN:OH:6.E"]M+>.ZBF,LGE&-]P"D8R6RA&>!CGV-<> +\:
M5+9?VU"V_7/[8$CVA)SYOF;#AP#D@<@#OQ6TGAV]C\5ZEK:WUO\ Z99QVHA-
MNWR;"Q#9W\\N>,#M0!G67CHZMINA-:6_DW>J6+7K PR3K J[0?E09;+. .@P
M"?0$L?&.I7G]F:=/I9L=9O9IX]MPCB-8X>6F .&*ME<#CENO%4X/A[J6FZ3X
M?&EZ['!JVBPO;)<M:YBN(6P2DB;L]0#D'J/RT-0\(:G=7&DZM%K2?V]I\DC&
M>2WS!*D@"O'Y8;*KA5Q@Y!&>22: *W@%;A=>\9K=+"LPU5=WD@A#^XCP0#TR
M,''.,]3UJQ-JFJI\4FT]KFW73(=(^U%"C9YEVL2<\GY>/0$^M7_#GAZ]T?4]
M:O;O4(+DZG<+<%(K<QB-@BIP2QR/EZ?K2W?AR>?QE%KL-[&D36/V&YMI(-_F
M)OWC:VX;3DD'(/'YT 8\OCF[@\,V7BQ[6 Z'<S('C&?.AA=]B2DYP>2I*X&
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MQ<3J9ECMF1?LX S$HWD@MSELDD-C P, %.#QDK^&+[Q0R))HZ1[[,HI62<8
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M:H=8^%/C@S:?:VLEK=7-LRP<AV0K\Y.!ECGKBM[5%4?%+PFP4;CI]\"<=?\
M4TR;P)>3^%?$FBOJL .M7<MSYPM3^Y$A!*XW_-C'!R*UKCP]>7/BG1=:>^@
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MC6\U0V'V0/NGB0[O+F9@2,-MSM('#=3BDM? ]Y;:7X4LAJD##0)1('^RG]^
MC(!C?\O#'UYJLOP_U5+6TM1K\!BLM8.IP.]D3(Y+.Q$C;_F/SD C'09SV )H
M?&.M//KES-I^GQ:9H=W+'>2>>[2&)(1)E!MP6Y[X'/XU<T[Q+J]QK>FP2Z6\
MEC?Q,[316TR"S<+N"NS@!P>0&&.1TYJ73O"+0Q^);?4+N.ZM-<FDEDCCA,90
M/&(RN=QS\JCG YIOAKP]K^D"WM=2\0K?V%FNRV5;;RY7 &U?-;<=V!Z 9.":
M -'7]=_LF33;2%%DO=2NA;6ZN<*OREF=O8*I..YP.,Y&9'XBU%M6UCP_.EM'
MJEI:K>6\ZJWE30L2-VW.5(((QD]C[5?\3>'3KT=A-!<_9=0TZZ6ZM9RF]0P!
M!5ER,JP)!Y%1Q>'K@ZAJ.KW%Q =4N[1;-&6(^7#&I8XQNRQ+,23D=AQCD RO
MAI9_:/ WAV_O8;66YCLQ]GG\O,B!Q\V6/.3WQUKMJQO"FBS>'/#-AH\UTES]
MCB$*RI$8]P'3(R>?QK9H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKGO&$FK1:5!)I$#7,BW*M/
M:QS^3+/$ Q98WXPW0]1D*1WH Z&BO,AX@^TVGANZTS4-342^(?L5U!>%EEB4
MJ[-!(I)R5(7GDXQSUI-6\3:AHEUXTVWL@AMKW3X(7E;>+59U02.,YZ;R1GC.
M.W% '?:YJT6@Z)>:K/#--#:1--(D(!;:HR2,D#H/6K5G<K>64%T@*I-&LBAN
MH!&>?SKBO%VF3:=X8\5NNL3S6=QHDY2RN&,C(ZHVZ178DX(905Z \]Z@TI[W
M2O%7A2W&IW<]MJFE3&>"9@8U:)8BI10/E^\1[CKD\T >A45S7B.=FUK2+&.\
MN,S"9VL+5C')< * &,@8;$0G)YY) YZ5QUIK.KKX \/^)KK4+EQ8:@\6I 2'
M$ML)WBW-C&2OR-GN <]: /5J*\RL=:NVUO7="-Y>%]2>.71IFG8L(&8H[)[(
M5:0>JE<YIGC/5;[3['Q)>:9JEY--I?V<1&.0I%9D!"R/D_OF;.3D' 8#(- '
MJ%9/B/7X/#6DMJ5U;W$T"R)&WDA25+L$!.2.,L/SKF9H-1U7XDZII9U[4K6R
MAL+6Z2.V=5VN9'! .T_*0O(ZG/6N:UF\F\3?"*7Q)<7ER)Y[^,^0LI$4:"\5
M%C*=.  2<9SWQQ0![#17GNO:S>:1XFF;5_M\.DR7=N+34K*4M#;CY-T,\8/&
MYMWSD'B0=,5Z%0 R5S'$[K&TA4$A$QEO89(%9_A[7+?Q)H-IK%I'+';W2ED6
M4 , "1R 2.WK6%%>2Z_XYU[1Y;NYMH-*M[<1);RF-G>568R$CDXPH /'7(.:
MY'P9J=W_ ,(WX*T")@L=Y874S9N6MS*T<@ 0.JEAPS,0,=!SC((!ZW)+'%M\
MQU3<P1<G&2>@%/KRO4],U2*\\*6FLZL]U,FO21(]O<N&6(PR.BN1MS(!@;L9
MQ]36A)-KOB:7Q##I=^ME=Z;??9K:1KQT$(14(9X@A$@;+'+$\'C&* /1**\]
ML(=4UOQQK=G-XBU"&WM8;"YB6S= FY@Y8#*G*';T/4=3P*POMVMIX%&NC7]0
M:]M=<:V3<Z['C-YY1#KC#?*?PP,8H ]>)P"<$^PJKIMX^H:=!=R6=Q9O*NXV
M]R )$]F )&?QKE+#[=9_$#5-#_M:^GM9=)BO%:=U=XI3(Z$ID8 ( .,8SVKG
M;'5M:O/!WP^N3K-Y'/J-ZL%U(I4F52DK9.0>?E&.WL: /6**\NF\0:EX>C\3
MV']HS3Q6FK65M#<WDN6@CG$9<ER#P-S8)!QD=<8JQXAOO$'@W3]7U$ZA"MI/
M%"EM!+<O<O;2M*L;2AG4$H X.#D @=C0!V<VOP0>*+707M[C[1<V\EQ'+A?+
M*H5!&<YS\P[43:_!!XHM=!>WN/M%S;R7$<N%\LJA4,,YSGYAVKF)=.6P^+>@
M[+JZF5]*N\BXF:3!#198$],Y&0... *7Q-9/J'Q-\/VRWEQ:!]-O=TMLP63&
MZ'@$@X^HYH [RBO*A+XC/A?75BU.]N[GPWJK"*02;7O;9 CO$Y'5MK$;ASD#
MWKL] U&/Q#J-QK-E=22:688HK<!SLD8C>[XZ?Q*OL5:@#HJ*\\\:ZA>1_P#"
M2O8ZE=O/IVE">.&V<Q)9.%=]\C9_>%MHPF#PO.-V:[&V+:GX;MWGD=7N+9'=
MHF*')4$X(Z4 4].\4PZI>6J6NGWSV5VLC07XC!@;8<')!)7/;<!FMZO&]%^V
MV'PP\"R:?JM[:M>7]I!-MDW H[," &!P..@X]0:WM9CNM-^WZ=;:]JM_-9Z5
M).J&;9) Y9V6:65<;A@!53!X4Y'.: /1J8\L<;QH[JK2':@)Y8X)P/P!/X5P
M.BZW=>(]3TC2KZ\FA$OAVWU)_L\AA>>60[6;<N#A<=!QE^>@JM<:;<)XW\$6
M]]K-SJ%PEM?1S7,;M$)&CV ':IP#R0?7'- '?VMZ]S=WD#65S MM($664 ),
M"H.Y,$Y SCG'(JW7E^I^*-5T*Q\?7(O99VL+VWAMGF (MUE2+)   PID)Z=N
M:V[Y[W1/&V@6%I?7<UEJ\=Q#<)-*93&\<>]94+9VGJ"/N\CB@#M:9++'!$TL
MKJD:#+,QP *\ETG4=97PMX1UR77+^>YN=96SG21QY<D3SR(05 Y. "#VQQ@<
M5U'Q5A\WP.[>;,A2\M/]7(4SFXC4YP>1@GKWP>U &^-?@/BP^'C;W"W(LS>"
M4A?+9-X3 .<YR?3M6M7G][IGVGXK0627UY @\/.&EBE_>D?:%_C.2/KUXK-T
M/Q+JNH:/X0TZXN3+-J/VU99GN# TWD.55=ZJ2"1\QQ@G;UZY /4J:$16+*J@
MMU('6L/PM:ZM8V=Y:ZM?Q7CI=.8"LAD>*(@%4=B 689ZD<C%>?WU_K4'A3Q3
MK(U_43<Z1K<D=LN]0A19(QM< ?,,,1CI[9S0!Z]17 2W]Z-2^(5L+ZY$5C:0
MS6H\TYA8P.Y*GJ/F ..G;IQ56UO-4U#5?!$$FL7L<.I:))-=+&RKO=4A.[.,
MY.\\_ECK0!Z317D$]]K-KX&UG51KVHO<Z'K$EK;;I!B2-;A5Q+Q^\)5B.?0>
M^>BOKC5_$>N^)=)T^[%K/IOE1VKK>/"8F>(.)2BH1("Q(PQQA,8')H [VBO.
M(XM9U?QH-*N?$EY%$="MKMVTYU5#,9&#,A*_=.WOS@]<<5!+K%_'?Z)?6FIW
M5W#=^(&LY;HML@EB/FCRDBR1A-@&_ R5)!.: /2TECD>1$=6:-MK@'E3@'!_
M @_C3Z\C749_"_A_X@ZU:3W#W-OK#0QM-*TBIO6!=Y4D@E=V>>PQTKIK^2]T
M/QGX>LK._NYK+5TG@N$FE,I1DCWK,A;.T\$$?=Y'% ';45POPWBU#4-#L]<U
M#6]1NYF^TP&&1U\H@3L Q &=P"XSGH<=,5/!<S^)?%GB?2I+VZLTTL016PMI
M3&RM)'O,IQ][DX .5^7IR: .EU35;?28(I)]S-/,EO#&F-TDC' 49('J>3T!
MIND:HVJV\LDFGWEC)#,T+Q72!3D?Q*02&4YX8'!KS*>]N_$_A3P#J>IR3)>3
M:U'#*89&C5ROG+O ' )VYR/7CBNZ\96FHMX.O/['NKF*_M8O.@*2'=(4Y*$]
M]P!'U.: .CK)GU^"W\3VF@O;W'GW4$D\<N%\O:A4,,YSGYAVKAE\9(GBFVU2
M*>[FT'4].*VR&<[1>!!+L49ZLC!1_M*0,'-6;W2K@>.?">GSZC=>>-*O!/<I
M)^\=LP[L,<D9/X@=,4 =WJ-Z]A;+-'97-V3(D?EVX!8!F W<D<#.3["K=>4G
M6=83X?)+_:UV;BS\0"P,Y8;YHA=B,!SC)^4XR,9[UT'G77B?7O%6E1ZI<:?/
MIODPVA@<KY1>(.)F4$;\L<8;C">YH Z"'7X)O%-QX?\ L]PES!:K=&1@NQT9
MBHVD'/53U Z5K5YP]C)JOQ+GA.JW";O#5N6N;)A$TI\Z7Y@>=H)YP/;G'7HO
M &IW>L^ =&O[Z8R74UL/,EP,LP)&[ZG&: -JPO7O4G9[*YM?*G>$"< &0*<;
MUP3\I[=_:K=>;6%_XAN/#.L&TGFU&[MO$$\ B><12S6\;\QHXP%;:.V.AZ5T
MG@O5K;6-+NY;>6_S'=-'+;:@")[5PJYB;)).,Y!R>#0!=\0^([3P[H5_JTT<
MMS#8C]^EOM+KP#T)'8@_C6NIW*&]1FO&;NT6'X7_ !%?S[F0KJ-[$/-G9Q@.
MN#R>OOUKIKK4-0\.>,)T6_N[Z"30+B_:WG8%?.B9<;  -H(8C ]N] 'H-%<'
MH*ZY>MX>UV/58!9W,(:\1[QY5NMZ978A0+&P;LN.,@YJUXKEOQXR\)V=MJ=U
M:6][+<QSI"5 8+ S \@\Y'X=<9H [*BO)QJNJVEJ]N-5O)#9>+X=/CEDE)=[
M=S&2CG^+[Y&3S6GJ^HZE#J/Q!AM]2NH5LM)ANK;:^[R9#',Q*[@< E%_IB@#
MT6LGQ!K\'AVRAN[FWN)8Y;B.WS"%.UI&"J3DCC)'3-<5&=476?!B#7M2VZU8
MRB\4R CY85<% 1A6SD9'.#USS67J=Q>S^"-:L;B^GN/[/\4P6EO/.=\@C$T#
M+DG[Q!<\GVH ]?HKR_6M5UGP1K6KI;ZE>:I:MH<^HHEZ1(8)HV5000!A#N^[
M['&*UX[/7$N8=0@UI8].N;*19%^VM<--)LWI+%O0*AX.0/EQV&* .YHKC?AU
M!>W7AC2]<O\ 6+^\N+VPB,D4S@Q*>NY1C(;G!.>:I17M[XC@\83+J-S8W6E7
MDMK9"&0JL7EQJP=EZ/N8DG<",<#% '7ZGJ\&F/:0LCS7-Y(8K:"/&Z1@I<]2
M  %4DDG]2!3M(U(ZMIR79LKNR9F96@NX]DB%20<C)!''!!((P:\ZDFD\2ZG\
M--5O&N+>XOXYI)4AF9 I^RLV5 /&?Y<5U?C#5Y[";0=-@F: :KJ*VLDZG#(F
MUF(4]F;:%SUY..<4 :5EK\%]XBU+15M[B.XT^.*21Y NQQ)NVE<$G^ ]0*UJ
M\NEQHGBGQY)'K$MD%TRR:.[N,W!@)\T# )RW/0$DY./05H6!U*[\5ZUH'VO4
M;*WETF&Y@\VY,DT$I>1-X;)QG:#MR1Q[D4 >@T5P'A75[O78=(TR>XN(]2TI
MY%UC$S9,D?R!6/<2,1(.V%(IGAW6;R/Q-9Z9KWV^UU.7SFBE$IELM17!8&,Y
MPA"\[<#CUXH ]"K)T/7X-=;4EAMYX&T^\:SE68*"7558D8)X^<5E:UJ<LOCC
M1O#@FDM[:YMI[N9HW*-*4VA8PPY ^8L<$'Y1VSGB$DNM%T#Q5+9WUTLT/BV*
M,2F4EBCFV4JQ_B^5B.>>_6@#V*JFIWKZ?8/<QV5S>,I4""V +ME@,@$@<9R>
M>@-<=JE]?Q>,/$=E!J%S##'H"7<2JP/ER[Y 64,"!PHK$NVUBR^$UMXD7Q'J
MKWUU9Z<[AI%V*6:,-M&W()#G)SDXS0!ZO17#7D5_J7Q+OM'.M:A;V#:/'<".
MWD5"CF5URI R.%'O[XXK+TCQ!K%]X6\#7=[<3-:WKO'J4\.1(Y5'\O[OS %E
MRQ'IS@9H ],95=2K*&![$9K.U/5K71=*O[TQM*EC$9IHK<*7"@;CP2!T!/6L
MCP3'JWDZI+J=S>2P&_E2P6Z #"V!^0\@-D\\L22 #WYY1;18[3XIR>?<N4\Y
M0))V88-HIZ$X[\>@X'% 'I>GWB:CIMK?1*RQW,*3*K=0& (!]^:LUYKH\M]I
M&K^"434;R>#4]+D$]M(P,8,<,;H44#Y2,D>XZYJ3P_<:_P"(-+\/>);?4H(%
MGE1[U7O'>.6-CM:(1; J,"0 0<Y').<T >C45QOB^74/^$J\*V5IJMU9P7T]
MQ%.L.WY@('8'D'GCCL.N*YEM>UGPY=ZWH,NI37<$.J6-O;WUW)B2..X&65I-
MIZ8P&()&\'TH ]8JEJNJ6VCV8N;HMM:1(8T49:21V"HH]R2!Z>O%>>^+$\2>
M'_#'B:[36C;P_9TGLX8[IIYH&#!7_>.H;8<CW!Z$5-XVT)K73]):?5]3NVG\
M06;?O9\"/=(H(0*!@<9'H2<4 =QI.J/J8NA+IUY8RVTQB9+E -_ (9&!(92#
MU!]16C7%6<LNN>*_$6A27U[;PZ1#;16YAG97+2(7,K-G+G.  <CY3QS7-Z=K
M6O>(4\#BYU:ZM'U!KZVO#:[4$WE*X$@XX)VY]!G('2@#UFBO.(++4I?$OB+1
M)/$FL/;V6F6CPR><JR!R)06W*HY)4$^O?CBJ>F:IJYT[P!KDVKWDT^K31VUW
M"S 0NK0NV=@& V4!SUZ]N* /4Z*\QO=8OXK[3KZSU.ZNHYO$BV<EP&V0&)G9
M# L>2&VXP7P.1D$\U5U6YUC^R_'UXOB#4DDT:Y,EF$=5"[84?! 7E<DC;TY.
M<F@#UBBN(AO[CQ-XDU71Y+Z>Q^RZ=;2P"VD,;&24,6EX(+!2% 7IUSG(Q6%W
MJFI:[)X:.I"XEM-*AE-S'=-9M/*S.CRC8K9 *+\N=H+'(/& #T"BLOPXFHQ^
M'[2+5[R"\U")3'/<0#"2,I()Z#GCGWS6I0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5+4=+MM42
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M1LXKRRN(KFVE7='+$X96'L17*G6=<G^(E[X>@N;&*UAL([Q'>U9WRSE=I_>
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M)KZV$EJH>=3*N8E/0L,_*/K4=IK.F7T,\MK?VTL=N2)V60'RCC/S?W>.>>U
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M&NU3ME=1@>F * -"+P[ID&N?VQ% Z7OV<6VY9G""('(0)G;@'GI69_PK[PT
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M&G6]A#.@B7#([.X(8Y/.%![<$<5M1>(M%G,XBU:R;R$\V7$Z_(G]X\_=]^E
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)H%1?,MKC=MVN-W_ *#G/'K3H_&\C:E!IDGAO5H=0GMY9XX)/)^81N%(W"3
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M(YX)/EV/&Q(Q_%G!';KTK&@\-^)+23P==2R1ZC=:6MS%=///ABLH 4EL?,5
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MG;73U@>"-,OM%\%Z3IFHQQ1W5I;+"XBDWC@8ZX'^>];DL:S0O$V=KJ5./0T
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M=2>]=E7,^ -)U'0O!]IINJ10QW,+RDB*7>,-(SCG Y^;WKIJ "BBB@ HHHH
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MO%TNBW%W%I]ZEV5CLKJ J+FV'22*3.&8]2.W(QQF@#MB P((!!X(-"J%4*H
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M<VC?Z6BQK( 1O^3AL9&<^V.=2ZUOQ%?^+ET72[C3[6&?2%OTFFMVD:-B^W!
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MOI6K21K')>6D4[HO12R@D#VR:U* "BBB@ HHHH **** "BBB@ HHHH ****
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M?>:0NHZE8S7.TVUB_G00C^*7:5#-_N@G ]3GL*TI(TEC:.1%=&&&5AD$>XH
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MW9>1Q_9C]ED_?XMA&=G'S?,,<?7I0!U5IK%C;:%IDSW\]Z+BV1X91 SRW*[
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M$OD,F6&/E^8@<X]>G-:GAN*>/QYXPGDM;F.&YEMF@ED@94D"0JC;6(P<,"*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5%!;0VWF>4FTR.7=B22S=,DGD\ #Z #M4M% !1110 4444 %%%% !1
M110!%%;0PS2S(F)9<;W)))QT&3V&3@=.3ZU+110 4444 %%%% !1110 4444
M %(1E2 2"1U':EHH R= \/P>'K>Y@M[FYG6XN9+I_/*$AW8LV-JC@DUK444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2*V1G9(E"*7.3@=,GO6=IWAS3],?4C$)9%U*5IKI)GWK([ *3@\#( &!Q@4
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M07?:,*.   !V '4]R:BU+P_I^JZC87]RLPN;$OY+Q3-'P^-RMM(W*=HR#Z4
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M:\PU*PM=-TWXF2:4D4&B2Z8%58L+";KRG$FP#C."@.._'45;N]7L;+Q%H?\
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M85=UZP\,II-M<Z??_;K2Z\2V<SW$CQ^4'9P)/**A0!@#<1QGOD' !Z\ES!+
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M6 H-C2$?>)D(P3R>>N*Y?3=3TR+P'X$LWN[=;JRUZ)9XBXW6^))0=X_@_'%
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M]0#[T >G@A@"""#R"*6N3^&4_P!H^&?AYS)YA%DBDYSC QC\,8KK* "BBB@
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MC07*6,2-*4<R2!B$'"\*,G_&NFB\3:?=:?87ECYMX-0A\ZUBA7YY$ !)P2
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M;V-TCPT7F8RF3Z8Z\9]*R8O%MGK/@_1-5U,:EIPO[JW\K[+N&YV<;%+#^ Y
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M$N;:9=LD1(RI/4$$<@@D'UH J:GHE_J&H0Q)J$,&A[ +BR6V&^9@V?OYX4C
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M/E" ?+C/7+*3Z#]+%[XOTRPD1I_/%HUS]D-Z(\PI-NV[2<Y^]\N<;0>"<YH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=P6T60H>:0("3T&3WJS0!QL%MJ?_  L.^U>32;E+271XK=6WQG,JN[E>&]&
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MD#K@?B*(Y$E0/&ZNIS\RG(]* ,CQ;;7%[X.UJSM('GN;FQFABC4@%F9"HY)
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MGLK*WT^SBM+2(101+M1!V']3[GK0!F^+=/N-6\':UIUHH:YNK&:&)2< LR$
M9/3DUR\5CK-OK7AKQ%_95SY=OI[Z=>69=#-$#L(D #8/S)@@'.,''4#T&B@#
MF?"VC7%EJ?B#5KB)H#JUXLT=NQ!*(D:H"V"1N8@G'N.^:HZ_!K.D^.;3Q'I^
MES:K9R6!L+JWMW198R'WJZAR 1R01GWKK;N\M=/M7N;RYAMK>,9>69PBJ/<G
M@5*CI+&LD;!D8!E8'((/>@#B;NQUJ'Q9HOBAM.,D8M9K.[LX'5GMT=PZ,.<,
M05 ;!^F:R-7\+ZM-IFN7=OITSW&K:S:7:6BN@,<4+1Y9LL!N(1C@$]0.N:]/
MHH Y%+6_7XFW6KG3KC["VC1VRRY3F197<KC=GHPYQC-<=I]KJ&@VGPVM+_3I
MTO+:\NUDMU*,V#%*<C#8/!SUSQZUZ_69J.@V6J:E8:A<^=]HL'9[8I*RA&(*
MDX'!R"1S0!P^N>&M3O\ 2?'=]:Z?*;G78H;>UM2RJY$:;0[9.%R6/!.< 9YX
MK6\965X^A:3K&G(L.M:9<1-:I-_&9"(WA8C/#!L<=P*[6L.?2M ;Q4NIW#QG
M5HK?<J/<GY8QD;_++8XR1NQWZT :&E6"Z7I=M9*Y?RD :0]9&ZLQ]R22?<U<
MJ*WN8+RW2XMIHYX)!E)(G#*P]01P:EH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_&.MWGAS15U
M2VBAD@AFC%WY@),<+,%9Q@\[<YQZ9Y%=!5;4+&#4]-NK"Z3?;W,30R+ZJPP?
MT- ',_\ "7RP^*==TBZ:V6.PL1>0/&K,TBD98$9ZKE.!UWJ>*?\ VQJ,?B_1
MM+O=/L!<W6G33FX0EFC=2FY!D<+EASGG':H+?X?6\<'AOS;V66YTARTTY'S7
M8*C(;VWK&<<\)BM6\T"XNO&>FZ\MY$D5E;RV_P!G,))<2%23NW<8V#MZT >>
M:G?ZKJGPAUJ\U6:"XD&J;$\M"I!2^5<#).!@ #VZDUWFF:]J;^,;S0-4MK1&
M6R2^MY+9V8;"[(5;<!D@CJ,9STK(G\ 7TGA?4] 36H5M;J^-W"S69+1@S^<5
M;YQN.X8SQQG@]MR+P_=+XW/B*2]A96T];$VZP$'AR^[=N]3TQTH H^-]0U:Q
MO/#<.FW$,4=YJJ6\P="2PV.X&01QE.1W_/."UYJVF>,O'=YI<%E)-!:6<\OV
MAF56VQ2$@!><G!Y)X]ZZ_P 3Z!/KJ:6]K>):W.G7R7L3R0F5&*JRE2H93@AS
MWJ@?"5\=0\2W7]J0$ZU;1V^#:G,6Q&0,</\ -D,3C H C_X3)[\:?#IT7EW%
MUID>I,9+:6X$:R?<7;'SR0W.1C'0YXV_#>IWFL:!:WVH:;-IUW(");64$%&!
M([@'!QD>Q%<U_P (+JMB-$N]'UV*UU/3M/3399)+3?#=0KC;N3?D$'G(;N:[
M#3[::TLHX;BZ>ZG&3),PV[V)R<#L.>!V&* ..@\9:TS:Y>7%AI\6EZ'=SQ7C
M"9VD:-(0^4&W!;)'7 Y]LU9A\5:T-1MEDT::ZL[FUDF+V]K-&;:15W"-F<8<
M-R PQSVYJSI_A!H;;Q)::C=QW5IKD\LTB1PF,QB1 A7)8YX4<X'-0Z-X9\1V
M%C]AO?%'VJWMX6BLW2U\N494JK2-N._:#T &2 30!4L_&%[K/AF_U/2[S2YO
M*L'G.Q&WVLX&?+D0MGIGGC..@[UK/Q-K]AX;\%J8;.]GUA(H3+)(Z$$P;P6Z
MY/RDD_D*U4\%^?JUUJE[-;+>7.G2:?,]G 8O.WD9D<$G)&.!VR>3QB"'P7JB
M6'ABVDUFV<Z#*CHPLB!*JQ&(+CS.#M))///8#B@!]KKVH6_BV'3]<L--BF71
MI+V:ZM79R-LBJ5!900O.<<]!5G3=;U_5(-'U*VTZV?3-3C,A&[$EJC)NC=B6
MP^> 54#&>IQFK%UX:DNO&:ZY)=1&V_LY]/>T,)RRNP8G?N_V0,8Z51\,^%-8
M\/QP:;+X@^U:+9G_ $6#[-MFVC[J/)NY5?8#.!GC@@'.VWB;6K?X5ZQKVHQ6
M&IO%<W(,,JLJ$+.Z$$?-D# PO' ZUV$^N75WXCN-"TK[.EQ:6J7,\UPK,H+D
MA$"@@\[22<\<<'/&-+X!O7\&ZQX:768EMKZ>62%S:$M"LDAD8-\_S')P#QQV
M-:DOAJ\B\3+X@T^]@BO);1;6\BDA)BF"G*N &RK D]SD''O0!C)\0+^ZL]%D
MM=+MQ<7>IR:7=PRSD>1.@?(!"\K\F<]<'IFMWPQKM]J=[K6G:G!;QWFEW*PL
M]L6,<BO&LBD;N0<-@CVK//@5XH]'%KJ$:/9:F^J7#R6Y8W,S[]W1AM'[PXZX
MP.O?4T70+C2]?UW4Y;R*9=4FCE\I82AB*1A ,[CGA1V'- $-]J\T'C[3=*^P
M6KK<6-Q-'<LQ\Q2A0%>GR@[AZ]*YZ'QYKC:/;:Q/IM@EE_:QTZX197:3!G,(
M9. .#@\]>>E=-?:!<W7C'3M>CO8D2SMIK<0- 6+^85).[<,8V#MZUB?\(%??
M\(J=%_MBWS_:?]H^=]C/7S_.V;?,_O<9STH [+4+=[S3;JVBG:"2:%XUE7K&
M2" P]QUKR[2]4CTI=$\)>-]%73KFSGA73=3A3?;3O&PVE7_@=L8(/7)SC.*]
M/U"T>^TFZLQ+Y;SP/%Y@'W2RD9Q^-<]J/AC4]=T^UTO6=2M;BRBFBFEDCM2D
MLQC8,!]XA<D#)'49  S0!7U7Q?J*MJO]B6!O'TR80M;_ &:9VN7"JS*KJ-J$
M!@!G.2#P!@F=_$FK:F-5&@V,3S:8L8>WNLJ\TS1B0Q Y 0A64;CGDD8XR8Y?
M"6L6GB.^U#0M?6QL]2=9+RUEM1+MD"A3)$=PVL0!U!&1G!Z4C^#]4L?$=WJ6
M@ZZ+*#4%C%[!<6_GDLB[1(C%AABH .<@GD@]* &6FIZ[<?$FZL9'MX[2+2H;
M@6K Y1G=P06!(+93&<8QT'<P:7XS;_A'K*4:?:V]]?ZO-IT,$)(C#B1PSDX!
M/",QX&3QQG-;"^&KBW\7+K=IJ(6)K".RFAEB,C.$9F5@^X8/S'.0<^QYK)C^
M'TR^'X;%M53[=::H^J6=VEL5$<C.SE60N=R_.P(R.#0!)?\ C'4=(NM=TVZM
M+6;4-/TQM4MG1FCCN(1D-D?,58,,8R<Y'(IVF^*]7DUKP_;:A96:6NMV;SPF
M"1B\3HBN0V>""&[=,=3UJQ?>$;C5!J]U=WD"ZEJ&FG34DC@)C@B.XG"ELL26
MSU'11V.2/PG>)J'A>Z;4H"-#MW@*BV(\_<@0G._Y>%![T :?B'6XM'M8D^T6
M\-U=/Y5N;APJ!L9+-DCY5')]>!U(KRS^UHM#\(?$IM)U)9KI+K=',LP>1MT4
M*M+D>[$Y' ->PWVF:?J:HM_8VUVJ$E1/$L@4^V1Q7-V7P]T>V3Q%#);V[0:T
M[ I%;K&88C&JE 1VRN[MR>E &9K,8T'Q#X"CTX+'N,NGLJC >(PYP?4!D5O_
M -=<I=:E+9_"W3[.X@NH/%=EJD. \#AC=&XY??C!#JS<YP02*](L_#$_]I:3
M>:I?)=OI,+Q6FR(IEF4*9'Y.6VC&!@<L>XQ9ET%M1UBUU'59DF6R8R6EK&I$
M<<A&/,;/WW ) / &3QGF@#*\?266H647AJ[U*&PCU-)#/-)*L96)!S@D]2Y0
M8[C=Z54\(>,#<?#&?5;MTGO=&@FAO-K[@\D"G)R.NX -G_:KI;#3+NWUS4=1
MNKN&<7*QQQ(D)0PQIG"Y+'=RS'.!R?I6*G@J8:_XBNVU"+^S=>A$5S9+;D%2
M$*;P^_&2#S\O/% #=&N]0T_X>:7J,<4=S?WR0W-W-,X1$,V&DE8DC*H#T!Z*
M ,#I/H>KKXLCU_2;Z.&5+.<6QF@#*DR-&KJZ@DE3\WJ>@(-9UOX?O]3\$Z1H
M37JV6J:'-;EO,B,D<WD<(67(W(X ;@\'W4@:&GZ3=>&+_7=9N]0%[_:3QRBV
MBMMC&58U3:OS'.=O [=R>M '+Z%XGN_$B^#-(O7WO*]T^H-_SV-J2BY]F?:Y
M'MCI73^,O#^B7.AZO/>:9#>7EY%Y,6] TC2%=L:1D\K\W(QT))]36-IW@^X\
M-6OA/46'FW.F-/\ VB(QG*W.6D8>H1RI_P!T&MK4M#\27^MC4]/\1V$%L$ M
MH9--,PC!'+!O- )/KCIP.IR 9_B=+OPM\-+'46F,VIZ#%;.TV>9=I1)03W#+
MN'Y'J!5W0-1.N>.?$$S'=!I8AL[5>RED\R1OJ<J/HGN:;XGTF\U?PI%X6FNS
M=WM\T:W=R(P@6(.&D?:/NC *J,]2!S@FI].TUM!\::Q, %M-96&6)\?*DZ+L
M9#_O (1ZX84 <EX;N/(L_'D?_",W.L1'7[PM'$(2K_*GR$.X8_@IZ\9/%7?"
M-O\ ;O@A##'J8N[F"UE:*YC+9MYD+,@&X!@8SM'(_A]*VM%\+:YH7]L_9-:L
M"=3OY;XF33W)B=P 0/WPR!M'6F0>'D\(>!;K1M,DDO-0NQ-L>3 :>XEZN0.%
M4$@GT H W/"NL'Q!X4TK5V4*]W:QRNHZ!B/F ]LYKG+CQU=KX3?Q?;VT$NB1
MS,&AY\]H%D,9E#9QG@MLQT_BS74Z!I$>@^'M.TF)MR6=ND(;'WMH )_$\US4
M/@*2#0;OPRNH1GP]<3M((3"?.CC9][0AMV-I.<'&0"1SUH AG:]N_B[;Q"6U
MDLVT.1U1XV8&-IHPW?&XX'/3':KGCZXNO#W@&4Z$8+)86@@55CP$C:18\( 1
MMX;\*OGP]=#QQ'X@2]@6!+ V(M?LYSM+A]V_=UXQTJQXKT$^)O#5WI*W/V9Y
MBC)-LWA61U<9&1D94=Z .7OAJB?%:S^RK9OJ#>'Y@SR;EB'[^/G R3],]^M6
M=.\=RZAH>B2&V6'4=2>XC94CDG2+R&*R,%4;F&0,#C[W)XK33P[J/_"6V^OS
M:G;221:>]DT0M2H8LX<L#OX&5  YX[D\UBQ_#N^M=#TN&SUU8-6TJ[GN;6\6
MU^0B9V9XW0L<J=V.HZ"@#H_#&K:CJMI=?VGITEG/;W+0JQC=$N$&"LB!QN (
M/0]"#7.:)*==^+7B9[X;TT*.VM[&)N1&94+O(!_>. ,]<<5U^D6=]:6A_M._
M%[>2-NDD2/RXUXP%1,G ^I)))^@R;_PO<+XF/B/1+V.SOYH1!=Q31&2&Z1?N
ME@""&'9@>G&#0!8UH:5X>-]XON(=LMK8NL[1J-TJ A@#ZD$8'^\:HR^)M2TN
M_P!"75K>V^R:S(($:#=NMIF4LJ,23O!P1N 7D=.>-&\T*76]*O;'7+E9HKNW
M:W:.V4QHBMU(R22W3!/3' '.:-IX6O9%T6+6=0AO(M&<2P&. HTLBH41WRQ&
M0&/ ZGGCI0!ROC'6KOQ)\.VU>V2U&E2ZA L2L"93&MTBB3=G R5^[CH>N>*Z
M'5O%VH+)JRZ)8F[DTN01- ;:9S<OL5V170;4(#  G.3G@#DYK?#K4X_#5QX9
MM-=MX]&^TK/:K)9EY8 )A+Y>[> R@@XXSS6G)X2UJT\17FI:+X@CLH-2V/?6
M\EH)1YBJ%,D66^4D <'(]<]* .E?4HX=%;5+F.2")+?[1*DBX>-0NX@CU'I6
M'9:[K4R:7J4UA;?V/>V[7$[(^'LEV;T+$G]YD<':!@^HK?EL8;C3'T^8-)!)
M"8'WL264KM.3ZD=ZYGP]X3U;2;2+2M0UY;_1K5#%;P?9MDK1X*JLK[B&"@XX
M S@9]* *TGC>]M_#VE^*)K6#^Q;Z6)7C7/G6\4K;8Y"V<-R5RN!C/!..:^H^
M-/$$">*Y;;3M.\OP^X9_,F<F:/RA*0, 8;!ZG@>_47+/P-/%H-KX<NM12XT2
MTN$EC0PD3/&C[TB9MV" 0.0.0,8'6G7'@N\N(/%L1U2!1XA7:3]E/[@>4(O[
M_P WRC/;F@"V?$=YJE_/8:)' )[>QBO)&N02,R[O+C !')VDEL\<<'/%>3Q5
MJ4DL.G+8BRU86"7=S%)#)=+$SEE6/]U[HWS9X '!SQ#)X,U:TU6TU71M<@M+
MT64=C>B6T,D5PB?=<+O!5AD]SU_.34?!^J#5[/6=$U[[+J4=M]ENGNK?SH[I
M-Q8%E!7#!F8C&.N.!0!2'C+Q)=3Z#9P:#;V=]JMI<RF*_E=3!)%M!# +G:=P
M((R2".E-N/%_B=#XEB33=*6;0H(II<SR,LF8?,95^4'/! )QCWSQLMX7OF\1
M:'JSZLLITV*>.026Y+3F;:7.0P"@%1@8.!Q4,WA"\ENO%<PU. #7X5A"_9B?
M(VQF//W_ )N#GMS0 C>)'N/$/A2--.MC#J]G-<1S2-F6'$:L5'' .X G/..E
M9$GCS78M'O\ 5Y--T];/3M7;3[E!,[.ZB98MR< 9!;//7T'?8@\(WL5_X6N3
MJ<##0K5[<J+8CS]R*A.=_P O"#U[U2G\!7T_A?6-&.KVX.I:FVH&869_=EI1
M*4V^9SRH&<]* +NJ>*KR+4/$%K80VX;1+*.[D^T9_?EE=MJD$;1A,;N>3TXY
MV_#^HSZOX?L-2N+=+>2[@2<1(Y8*&&0"2!S@C/'6O.O$%U%=>,]26?Q!H6GS
M0PQ6IMM:LLB9<;R8\R+NC)?&/FY7V%>B:!<WMUHEO-J*0I<G<&\E&1&4,0K!
M6Y4,H#8/3- '&W/C?Q.-+U[5+;1M.>VT.]FAN8S<OOECC"EBGRXR 2<GZ8];
MFO>-[S3M,NM5M;>U2RBL([VV%PV7O00694"G*;5 RQ!&6]!63X:LI_$%MXWT
MRWU&V2RN]:NHIBB;I51E0-M.['(R 2.#D\]*UM3\ 7-U)KD-EJT=M8:MI\=D
M87M?,> (A10C;AA><D$'O@@G- &B/$EVGC#3M-N(8(].U.S:>TFYWM(H!:(\
MX!VG=GN ?2J-QXMUB%=!>.RLIH]8OI((6,C)B/:[1OC!^\J!O;=C!JGXAMM/
MUFUT[P;)J+3:_:2V\I>VC:-H4'WY.X53'O7J>6 ZFNBUOPY+J=[H4UK=0VL6
MDW/VA8C 7W_(R!00PVC#'L>U '/3>,/$T5EXE'V'2S=>'R9)V\R0)/'Y0E 0
M8R&VD@DG ..N>-2?Q=+=3Q6FEQ!;AM/BOV:6VEG51)G8A$8R,[6R2>,# .>&
MR^#KV7_A+1_:< 'B!-G_ !ZG]Q^Z$7]_YOE&>W-5Y?!6K6MUIFHZ-KL-IJ5M
M8II]R9+0R0W,2<J2F\%6!).=W?% #(/&/B"[OM LAH4-C<ZI9SS/'>R.&@DB
M*@@@+]WYLCN1CIUK.O\ Q;KM_P"'=+FA-K9W@\11Z7>A SHQ2?:=AR"%.WG/
M."1[UTA\+WI\1:-JS:JLK:?!/$XE@):9I2I9LA@% *C P<#BLT^ KS^QIK0:
MO +G^V_[9@F^R'8DGF^9L9=^6&<C@B@"Q=^+;B'Q)-H0FL(=0B2%HH+E63[:
M& +F)BP''(V_,<CMUKI-7FN;?1KV>S:-;B.%WC,JEE! SR 1G\ZYW7O!]UXC
MMKBRU&^M9[65XY(I&MB)K5E"AC$V[@DJ2/3<?O=*ZJY@6ZM)K=B0LL;(2.H!
M&* .'\.^)M1'AKPA:W$D-QJNMVZO%*ZMM5%A$CNXSECVP,9+#I6YH7B">]US
M5]"U"&-+_33&_F0Y\N>*0$JX!Y4\$$9.".IS61;> [RVTCP]&-7B.IZ VVRN
M1:E4,6S8T;IO).Y>I!'."!Z[^DZ&;+5=1U:ZE274+_RUD:-"J(D8(5%!)/=B
M3W)[<"@".^T"ZNO$+ZC%K$]O;2V1M)K1(U.X_,5=7/*D;STZX'I6$^LW'@U-
M'\/ZEK-JTLL,GEZG?6_E0R,K )#A"%0[3U)Z+T)-=U6'KNBW.KM)"9+*;3YH
M#%+9WEN9%+9.'!##!&>F.>.1B@#(N/$GB-O$=MH5IING+=3Z3]N,D\[[$<.B
ML"%'0%B!@G/'(JMIGQ!FO["UMYK(6VLO>W%C<1*CSI$\ R[ (-S#E<#C[W7B
MLVSL7T3XE:)HVGZA"\EEX::WS=?,T@$J =""#QGOP"/<:]U\/Y/L-K-INK-:
M:[;WTVH"^\D,DDLN?,5H\_<(PN,Y 4<GN /M/&&IN;?3[S2S;ZI=:@]G;/)&
M\<4T:H9#.%;#8VJ?EZYP,\Y#/$&OZWI/A;4[K4]%L9OLMY%%&7?]U<1,Z!9
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M>=@(Y$$@./E^[F,G/7'8FM__ (1^]_X3/_A(?MUO_P @[[#Y'V<_W]^[=O\
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MZ<5%X=M[V^'AOQ%#X@7R+B+%Q'YLD@O2Z9P5+;596!/R@8P1P!B@#O\  SG
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M>$>;OB&Y0#\I^;/'T/&00#U2BN;\<:I=>'O FIW]DS>?;0 +(1O9 2%+\]2
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MI<11R+*@8D%''1@1@@\GD>M7ZK7FHV6GB(WMW!;B5Q''YT@7>Y. HSU))Z4
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M:U+:RZC91W$EJQ>!VR"A(P<$=B.HZ'O3DUS29-,BU*/4K5[&4@1W"RJ4<DX
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M7M[+>3V0,\Z".<J[*)U'19%4@.!TPP/'%3-HFG/K$6K&W_TZ*/RDE#L-J=U
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MMW(M]Y7GWEQYBB=D! "JX'W1@$@8.<<D''544 <.#:K\8KR:;R@BZ%&AD<#
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M82K8(<,I^[SANA%;&F70;XD:?=75L+%F\,*)HG/$+^8K&(L>X&>.N!FO0Z*
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MJ(^(K:Y]B;[$=(%H/WB;_,$ADZ9Z8.,YZ^W- %6[\4:+K&B^&=3FL+Z6WO\
M484MMK;#!<;BH\S##(!# CY@<?2IK_QY'9W.N6\>AZG<OHRI)=>7Y0'ELA?>
MI+C(VC./O'TK"M/"NNV_@WPSI;V2&ZTW6%O9P)UVF,2N_P I[G#@8XY!]LZ4
MVA:N^H>.)EL@4UFVCAM#YJ\LL)C.[G@9.>_'OQ0!KW7BV"-8FLK*YO ^G_VC
MN0!%$/&.6(&XYX7VYQ6?)XTFN=<\,0:;82S6&L6LEX)=R*Q4(I"X)XQO!/TP
M,\UF#P]XD:+3+*>RMKG3XM%2S,$USM2"Z48,I4 [P0!M/48[9-&D^&O$-@G@
M>9K.T,NCV<ME<Q_:>@9(U#@[>?N'('J.: ->R\0Z)82^*K]K:ZLS972"^:9M
M_FR>6FW8H8CD%  ,9)Z5<?Q8EMJBZ;?:;=VUW-;O<6L9,;?: G+JI#8W@$$@
MGH>":YO4/!>J:Q:^,K9PEHVJ7<-W8S,X8!HECVAP.F6C]^#ZUJW6E:IKFL:1
MJ][IWV2328+@B$3*YFFE0)A2#@(!NY."<C@8H =IGQ M=2;0Y/[*U"WL]9^6
MUNI0@7S-I8(0&+#A3SC&1P2.:U?%VO#PQX4U'6/+$CVT68T/1Y"0J ^Q8@5R
M5EX8UNV\.>![![)3-HETDMT1,N"JQNGR\\GYP>W0UT/Q"T6Y\0>!-5T^S7==
M-&LL*_WGC8.%_$KC\: +'VV/P]:Z=8SM+>ZI?/L 4C?/*%W.Y)("J "?0#
MZ"L^]^(%CI^DZU=W-A>"XT9E6]LUV&1 PRC@[L%".A!SUXXINL6-SK=WX8\5
MZ*%G>P+N;9WV>;#,@5P"> XP" <<@@XK)\1>#]4UC3?%MU#;*E_K<,%M!;O*
MH\I(_P")V'&22W SP%]Z .VTK4IM26Y:73+NQ$4NQ/M(4>:N 0ZX)XYZ'!'<
M5Q7Q%UX7W@/Q,EA;7<L5FCP274,H0)*,9 ^8%@I.&[=>N#CT*%W>%&DC,3D9
M9"02I],CBO,KOPKXFM_#/BGPQ:V5O=VNI2W$]G>&Y";!*=Q1U(SD$G!'!]J
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M$/J$4$-Q(2Q@@;<L0[+NP-Q]3@<D]JO4 %%%% !1110 4444 %%%% !1110
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MN!91WFC'R4.\DE#&1CYCYA1?HX^M.L/&$MWX<MM=6>5[>STB2^U"+8H9I "
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M61*% 7(;."!R/>MO2-1U:#QYJ.@ZA?)>P_8(KZ%Q (S$6=T9..H^4$9R?<T
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M< 'CG( .^HKS'5_%_B#3=+\3V:7,)O\ 1+RT1+IH!^_AG9-N0. X#$$@8X'
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M9'4G.2&4\CL?<]:LW<M\EW9K:VT4L#R$7+O+M,2;205&#N.<#''6K= '+_\
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M=K*5P"".P[\UU%% ',W_ ((L-1TF^L9[N\#W]Q'<7=RA02RLA4H.5( &Q0
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M2._@.T1Y&<0W%U"A=BQ")/(JC)]% 'X5E6FB:=J7Q.\5?;TEECM4TZZB0SN
MD@$K;@ >Q'3IR1CFN\LM.L=,A,-A9V]K$3N*01+&I/K@#K38M+T^"^EOH;"U
MCO)>)+A(5$C_ %8#)H \HTF[L?[;\#W]E.B6M]+>!I9Y0US=1F*1MT[# ^\!
M\O.,#G/%16L]KH'@G5Y[1+>T4>)98+R2./F.U%UALA2#L (! (X->J0^'-#M
MV5H=&T^-EF^T*4MD&)?[XP/O<GGK4Z:3IL;7;)I]JIO.;DB%1Y_&/GX^;\:
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MH7B.P8GQ-]KMPTXXEFG:8)+$_<KRPVG@!1P,"O7(HHX(DBAC2.-!A410 H]
M!TJI%HNEPWSWT6FVB7;L7:=85#EB,$YQG..] 'GUKI-O-XH\<7H@ENKS3+F*
MYL(VF<A)A;*PP ><L>AR*S#_ &5=^%?AYK220RZA/JUH;F[+#S))2K>:'/4X
M?L>F!C%>KVVEZ?9W4UU:V%K!<3_ZV6*%5>3_ 'B!D_C50>%O#ZW#W T/31,\
M@E>3[*FYG_O$XZ\GF@#SI3:^(EUH:EKEKIVKV&K2XD\G_2X%23]R(R7Y5DV@
M +ALGJ3FMC0-"T^_^('BN6Z269[#4;::V#3OB)S;HQ(&><DG@Y%=I+H>D3ZI
M'JDNEV4FH1C"730*95^C8R*DMM+T^SNIKJUL+6"XG_ULL4*J\G^\0,G\: .3
M^*UM;3^"2]Q#%((KZS8-(H.S-Q&">>G!(^A-0VZ6.I?$74=#O[:WDTZ#3(6T
MZV*@Q%2SB9E7IN!VKD<C';)KM[NTMK^UDM;RWBN+>08>*9 ZL/0@\&JUSHFE
M7D5O%<Z99S1VXQ LD"D1#&,+D<#''% &#\.);V3PGLNYI)XX;RX@M9I6+-)
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MM4T"ZN9CKTET-]IYJF!YE821J>)&"Y8 9P5Y]#5O-,U*\3XA16VF:L_]IZ7
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M-4GU+3KD%;N7>UFVUR5G5RVT';S@#.>/7 !WZ>(M,DN4@2:5W=I$0K;R%'9
M2P5MNUB-K< GH:K>%?$]OXJTQ[ZW@N(4$TL8$T+ID+(R Y( ).W) SC.#7*Z
M)8ZAI_B6PDT<:E'IES<3/?Z7?VS>79L5<F2&5@, L<;03D.>!SC7^',5U8^'
M9=-O+&ZMI[:\N=QFC*JX>=W4H3]X;2#D<<T =#?ZU8Z;*(;B20S%#+Y4,+S/
ML'!8J@) SQG%4YO%_A^"WT^XDU2#R=0_X]9%)82\$\$#CH>OICK6,RW>B?$J
M_P!3N;:ZGTW4K"&**>W@>;R)(F;*,J D!MY(.,9XKG+70;_3(O# DL;HK_PD
M-QJ+11P,XM()!+L#;00OWUR.Q)]* /1M'UW3M>@FFTZX,JPRF&56C:-XW&"5
M96 (.".H[TW4-?TW2WE6[FD!AB$TOEP/)Y:'.&;:IVCY6Z^A]*P_"D4\?BWQ
M?+):W,45S>120/+ R+(HA1"5)&#\RFLKQE87;ZO>ZAHAU.TUJ*T18_+MFGM-
M17YB(9%P5!!)&21@/G/H 6Y/%(T7Q[KT&K:E,=.@L;:>&$0[S&6,F\A8UW$8
M4$DYQZUU$FO::EK9W(N?-CO5WVPA1I6F7&[*JH)(QSG'%<G"EV/&_B*[N;"Z
M59M'MX@Z6TC(TB^8756 ^;&X=.M8WAFRU31'\&:I=Z??-:0:,VF740MG:2UE
M)1@QC W$'9MR <<=J .ZD\8>'X=+BU*34XDM))_LX=E8$2[MNQAC*D'@@@8[
MXK.7X@Z1<ZWIVFV0NKC[69@95M)=J>5@,/NY)W$9[ <G&1GD]7T2^&F:S>1V
M%X\>I^(;6\AM4MG9Q%&T>^1D RN[8QP0#C'<XKJ/$"7*>/?"NIQ6-W<6L<-Y
M#(T,1;RVD$6S</X0=IY. .^* .LNKA+2UEN)!(4B4NPC0NQ ]% ))]A6'H?B
M^QUCPW::RRS6\=SCRXW@?<Q.2%48RYP,_+GH?2GPZ#J,&HSW<GB/4;J&02;;
M*5(1$N[. "J!N,\<_7->?65KJ]EX*\'7+:'JLO\ 8;F*_LHT:.=@T;(7C (+
M;20>.H/'? !Z WC;PZEFMU)J:1Q&Z^QGS(W1DFR!L92-RGD=0.N>E10^/?#5
MPZ)%J):5UD=(A;R[V"-M8!=N20>,8R>V:Y/6;.*ZTBSO-,\.:C;K/K=G<S++
M;2-/*L;@O)(O)  X&[DXZ=*W]129OBAHEXMI=-;1:=<QO.MNY1&=HRH)Q@$A
M6H O1^//#,L-I-'J:M%=2"*-Q#)M5RVT*YV_NSGC#XK?G5GMY%25HF*D"1 "
M5/J,@C\Q7D]S8WS_  T\06::7J!NI]>>XBA^QR;GC-VL@8#;TV G].M>KR2J
M+5IMKE=F[ 1BV,?W<9S[8S0!RO@OQ$TWP]T/4]:O&DNKN, OLR\TA+<*BC).
M 3@#H#Z5L)XGT9].NK_[<JP6DGE7'F(R/$^0 K(0&#'(P,9.1CK7G>A:;JVF
MZ#\/]1DTZ],>CF>&_M/L[^;'YJE1($QE@O? )PQQWJ[JMGJ45YXH\0V.DRW-
MO?26$2026I>1A$?WDZPL,EE!&T$=4S@C&0#LI/%^A0V>H7<]\88M/(%V)H71
MXLC(RA4-R.1QS4ECXIT74M2DT^UO0]RD/G[3&RAH\XW*Q # $X)4G%>;ZG9:
MA+!\04ATK691JFG6XM))K=F:9A&ZGZ')'RX&/05T-W',_C+0+I--O);>+1KF
M&7-K(%#-Y95&.W@G:U '6V.O:=J-Q'!:RR,\D)GCW02(LD8(&Y690&'S+T/<
M5@^+=;FT3Q5X79]1>WTZXFN$NHMJE7"PLR]MV=V, 'GCC-9W@ZQU#2]<MK:P
MDU&7P\UFY\C5+=EET]\IMB21@"RGD;><;!STSI>+H)T\2>%-36UN)[2QNYC<
M-!$TK1AX613M4%B-Q'0'% &MIWBO0]5TN;4K/4$DMH)/*E)5E9'R!L*, P8D
M@ 8R<C'6L[6/'ND:9H6K:A$9YYM-4":U^SR)(K,/DW*R@JI_O$8]ZY76O#^K
M3S:]XCT[3YW2;4;&ZCL>89;F.W&'('!5FR<9P?D![BI-<L4\0^"?$=SH_AK4
M[:\N;-8BU]&ZW$Y5@VP*Q+$  _4GC/- '=1^)=,DU"+3_,G6\E@:X2%[65&:
M-3@G!4=_YCU%-MO%&D7FE+J=O<R26;SBW61;>3F0MLVXVY^]\O3KQ6%XGAU"
M]MM"\2:+83MJ-C<@+;3H8W>&7]VZL.JCE7YZ;*K>&_#>I:/XIO-.E+S:+'(N
MJ0W#]7N9%*.OIC<'DQV++0!T]UXGT>RNDM[B[,9:86XD,3F(2GHADQL#>Q/7
MBB^\3Z/IT_E7=V8\2K"TOE.8DD;&%:0#:I.1P2.H]17!Z;9O"]]X9UOPQJE_
M,;^::WN/G:SG1Y3*CNV[:A4MR,9XXR:(+-X+W6O#VM^&-4U+[7J$UQ:S)O:S
MGCD?S%\QMVU"I/.1_"",F@#L;SQUX;L'O$N-2 :R<)<A(9'\HD9RVU3A<8^;
MH,C)KH$=9$5T8,C#*L#D$>M>:WEI=O\ \+-5=.O2;^W"6F+63]^?LOEX7CGY
M^/UZ<UVNBQ2R>$;" B6";[$D9$B%'C;8 <@\@@T (/%.C&_ALS>;99RRPL\3
MK'*5^\$D(VL1@\ GH:ICQ]X8*PN-47RI9S;B7RI-BR!MNUFVX3D$#<1GM7*>
M$(#]BT?1=7\*ZH-4T=HU-Q.)&M%,8P)HW+;22HX"C.3C&,FJ,UC?/\,=3LAI
M>H&ZEUTW"0_8Y-S1F\67=C;TV G].M 'H5OXNT*Y-\([\ V,8EN!)$\>U#G#
MC<!N4X.&7(J&Q\<^&M2U&TL+35(Y+B\B$MNIC=1*NW=\K$ $X/*YR.XK U=)
MG\<ZO>BUNA:/X9: 3M;NJ>8'=]NXC&=I!_3K67I-FWB'P=\.[6TM+A)=/>SO
M)IY+=D2...+YL.0 V\D  $YW9[4 =+X8UF=9?%CZOJ1>VT[5'C26?:HBB$4;
M8X & 6-;,/B72IIKB!9I5N+>'SW@DMI$D\O^^J,H9AGC(!YXKSV^T?5[_1_&
M<=E8W0N'UR*_MXI8FC%U'&(254L #DQMCZ#UKI6@D\0>.M UJUMKNWM]/M+D
M7#W-N\#,90@6/# $XPS'' P.>: -V'Q-I%SHUOJ\%RTEA<.L<,J0N=[,VU<#
M;GEN,XI+OQ/H]A<K!<W9C)F%OYAB<Q+(>B-(!L5N1P2.HKF- T6[L/&-[HV%
M.A6,W]J6F#]QY@P$6/[JMYK@?[25E6-F\,VI^&M;\,:IJ$DNH33VTXWM9SI)
M*959VW;4*EN01GCC)H [,^-O#BZBU@=33[2L_P!F91&Y"R;=V"<8''<G'O5^
MQUW3]1N%@MI)3(T7GJ'@DC#QY W*64 CD=/6N6T6&6/6?'<LVF73Q74RR0K)
M Z"Y06ZH54D<Y8$?CFH_!UCJ.EZZEI:SZC<^'?L1:-=4MF2:QDW+B)78 NI&
M>.<;!STR =C?ZM9:8T"74I62X8I#$D;2/(0"QVJH). "3QQ6>_C+P]'8V5Z^
MIQ);WLIA@=E8;G!(*D8RI!!SG&,&J'BV>[AUK0?+TZXFM&DF$]W:6WG36YV
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MT>.4D *R$!EZCJ.]9WC^VO\ R=&U.RLKF_33;[S[FTM6(EDB:-XR4P02PWY
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M1OZ;@RD;<Y/8&MBTCO+;QWH>H2:9??9Y="^QEEA)\J7S$;#_ -W@$\^F.O%
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M9&"-)& 7B;()'!!##KSP*QM,\?:K>:=X<U6YTBUAT_5[L69"W):6-V+A6QM
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M9YVCDD5!EA&NYL=R!U..N!SZ TZ">&ZMX[BWE26&50\<B'*LI&00>XH X9O
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MA=>)9/#<UM*]P+3[83)$#$R;PO!/4Y/IVK5BAB@C$<,:1H.BHH 'X"@#AW\
M7%WH^LV=S?Q1SWFK'5K2XA0DVTN5*@@GY@-OMD$]*U6T]K?5%\4>(;FTB.G6
M4D2^3N\N-6(:20EN>0H '89Y.>.FI&574JP#*1@@C((H XSPGIMA<^(]:\2:
M7.9K"\<?9L']T9"J^=(GJ&*Q@GU1JK2^!=2E\'ZGH9OK0/?:DU_YWEMA,SB;
M;MSSR,9SWKO%540(BA548  P *JV-]]N:Z'V2ZM_L\[0YN(]OFX ^=.>4.>#
M[&@#GM0\)3:OXDN[^]EA^Q7>CMI<T"9WX9BQ8-T[D8Q[^U'A[1/%.F016FI:
MY:7MK9H4MBENT<DW&U?.;<00!V Y."3QSUE% '!VG@;4;7PUX7T@7UJQT.]2
MZ,NQAYP4. N/X<[SSSTK<T+0+O1M;UNX^V0R6.HW1NUB\HB1)"B*06S@K\G'
M&>?:N@HH QM=TNYU1HHA'8W5@8Y([FRO$)67.W:P.#@KANQ^]VZUA:9X'NM*
MNO"[0WT4L&AP7$1616W2>;C@')VA<  '/'%=M10!P'_"#:NENWE:E:"7^W7U
M@(\+-$X?/[MQD$[200?4#BDNO 6JW/A_Q/I3:M:-_;5Y]K$GV9E\HD1[N-QR
M/W8 ';/)-=KJ=]_9MA)="TNKO85'DVL>^1LL!P,CIG)]@:L2R>5$\FUFV@G:
M@R3[ 4 8$^A7T_C/3=>::W6.ULY;9X0&)8R%26![8V#C%3^*]"?Q'H$FGQ7*
MV\OG13QR.F]0T<BN 1D<$KCKWJSH&MVOB/0[75[)95MKE2T8E4*V 2.0"?2M
M*@#E;WPA_P )!/>7.NO&9)]/DT]([;.V)'.78%N2Q(7L,;<<\FI/#>D>)K#R
M8=;UNVO;>U79"8+=HY)N,!I26(.!V Z\YXK1T37[77A?FUBGC^PW;V<HF3:=
MZA2<#/3YAUQ6K0!SWBWPY-K]O82V5XMIJ6G72W=K,Z;TW $%7&1E2"0<'-8U
MSX%O]8N]=FUC4;81ZO8PVSI:0L#$T98JZL6[%L].<=J[JB@#E;#0O$=QIES9
M>(M;M;E7MGMHVM+8QE]R[?,DRQRV.PP.3UXQFMX)UR+2?#SVFLVL6M:'&8()
M?LS>1+"45&1UW9.=BG(/!Z#O78VU]]HO[VU^R747V4H/.ECQ'-N7.8SGYL=#
MTP:MT <AJ'AK6]2CT:6ZU*UDN[+45U"8B)EC8JA01QKDE5PW4DG//?%7GT.]
M_P"$Z/B%)K<Q?V<;$0,"&SOW[MWUXQCWSVKH:* ."B\"ZE%X0TS0Q?6A>QU-
M;_SO+;#XG,P7;GCDXSGM6C+X8U!]:\1WZW-L%U>RCM40JV8BBN Q/?/F$XXZ
M"NLHH XRW\(:A G@Y?M=J1X>C\MCM;]^/),7']W@Y[\TF@^%->T"8Z9;ZY ?
M#J3-+#$;<_:8U+;O*#[L;<D\X)QP,<$=I10!YS<_#W6!X;U?PQ8ZM9IH]Y,T
MUN9K=FEM]T@=DX8 KG)!Z\X]QZ$@E6 !V1Y@O) *J6^F3@?B:DHH X*+P+J<
M7AG3M)^W6A>SU<:GYOEMA\3&;9C/'+8SGH.E;NG:'=VGC'5];EF@:&_@@B$2
M@[D\K=@Y[YWGTQBN@HH YS6-!U*\\4:9K%A?V\:VD,L+P7,)D4;RO[Q,,,.-
MN,^A-<Y:?#S6-+TS1'T_6K5=6T9YUADDMF\J:&5LLDBALYZ'((QCIWKT:B@#
MC=6\)ZS?KI>J0ZS"GB'3IGE29H#]G99%"O%LW9"$*O<G(SU-2ZIX4U'6-,LI
M+K5(AK=G>I?03QPD0HZC'EA"Q.PKD'YLY)/M75R2)#&TDCJB*,EF. *=0!R.
MH^$[O5O[9O;F:V34M0TPZ7'L#&."([B3G@L26SVZ >I+-1\(7UWHOA[[-?P0
M:QH3(UO.8RT4F$V,K+G(5E]#D5V-% ' 7W@;6]2_X226;6+2&;68;9,0V[;4
M,)S@DORK E2.X/;I4ESX+UJ[N=;N)-3L VK:4NGO'':LJQ$!P"OS'@"0\'J1
MV%=W10!R(\*7S:AX7N);BU:/1K62WE0*W[\.BH2/[O"YQSUQ[U'X8\*Z[X>C
MATDZW!-H-HY:V40$7.S.5C9]VW:/4#) QP*Z>QOOMS70^R75O]GG:'-Q'M\W
M !WISRASP?8U;H XOP_X4U[P_(-+@UR!O#L4QD@B-N?M*(6W>5OW8VYXS@G'
M'';M**RM)U^UUB]U.UMXYTDTZ<03>:FW+%0PV\],$=<4 <L?AG /#SZ9%J$L
M<J:@+JTN%&&M8ED8K$OL$>0?5S6YXA\/3ZJ^A"RD@MXM+OH[O8ZD[@BLH08Z
M<-U]NE=%10!R$_A/4/[1\436U_;"WUR)1Y<D+;HW$(BSN!P5P,XQG/&13;?P
MEJ$,_A!S=6Q'A^%HGPK?O\Q>5D?W>.>_I[UV-%  >G%<SX;\/7VBZOKU[<7%
MO,NJW7VD)&K Q$*%VY/48 YX^E=-10!QMIX(D?PMKVA:G=1O%JEU/<B6W4JT
M1E;?WZE6P0>_I2#PWXJU#P_>Z7K/B2!G>U>W@N+*W:)R6&/,D^;DX[+@<GOC
M'9T4 <-!X0UZ+5(M2&K:?!.FCOIJI;V;*D9R&1ER_8@$^W '>I/^$$6ZO-9N
MY_LME+JNF/I]PMBI"2LV<S,#CYN< <]\DYXZ#5M?M='O=,M;F.=GU&Y%M"T:
M94.06^8DC'"G\JTUD1V=5=69#M< Y*G .#Z<$'\: .*LO">O+J7AN^O-3T]F
MT:":#RXK=P)59$4');(/RY)Z#T-7-#MH_ ?A:X_MS4K5+6.YEG-S@HJ^;*6P
M<Y_B?&:ZNJ>K7MEIVE7-YJ+*MG"A>4LNX8^G<^@]: .<\":+:V$>IZC9N[6=
M]=.]DK=(X-Q8!!V4NTCCU#+6MXLT>X\0>%]0T>WFBA>]A:$RR D(&&"<#J:F
MTS6/[0N[RT?3KZRFM"FX7,8"N&!(*,I96'!S@Y'<"M.@#C[WP?>30:'>6=[!
M::[I*+$MR(RT<\6 'C=<@E6QG&>#T--N_#7B&#Q+-K>AZK96LE_%''J%O=6[
M2QED&%D3#*0P7C!X.*[!Y$C ,CJH+!1N.,D\ 4Z@#R[Q+*?^$NCLUU[2+:YL
M=.6-CK2M&9_,)+LCHZ%@0J[ARH].M:D>E:KK^D:+=VSZ5;7FC7N^U:WC<V=Q
M%Y93Y%R"JX<@8)&5XR"#7<36T%QM\Z&.7:<KO0-@^V:EH X.?P-JEQI/BRSE
MU6U=M??=O%NR^23&J$_>Y'R\#\R:M7GA/5[G5Q>QZG:HDNE?V=+') TGE<G+
MQ?,,%LC.?[HZXKLCTJIIE]_:6G0WAM+JT\T9\BZCV2ISC#+DX- ')Z?X+U2P
M_P"$4E75+4SZ):264A^S-MDB947*C=PP\L<G@Y/':DN? 4FI6?B>UO;U$36;
MI+N&2!3NMI$5 AY^]@QJ>W<5W%(S!5+,0% R2>@% '.1Z%J%YJ^G:MJTMH]W
MIL$J6R0!@C22 !I&SR.!@*,XR>3QC&M? NI6WA?PYHXOK1FT?4$O#+L8"4*S
M,%QGY<[R,Y/3I78W&HB"XL8DM;FX6[<J)H$W1Q *6W.<\*<8!YY(JY0!1UBS
MGU#1KNSM;G[+<31%(Y]N[RV/1L=\=<5AZCX=U+7[C25UB6Q\C3;R.]$EO&P>
M:1,[<!C^[&3D\MG&,BNJHH XNW\*:]I>LZ@-)UNWAT74;EKJ:&6W+30._,GE
M.& &X\\@X)Z'NL/A37-+UW4Y-&UFW@TK5)S<W$,UN7EAE( =HFW 9; /S @'
ML:[.LO5-=ATR=+9;:XO+QX7G6UM0ID,:8#-\S =648SDD\9H H6OA^^L/%^J
M:Q:WD#6VH00J\$L;%P\2LJX?/0[LG@GBL6Q\ 7ECH'AV&+4(!JN@SO);W'EG
MRY4?.]&7.0"&QD$XP#[5VMA>1ZCI]O>Q)*D<\:R*DT91U!&<,IY!]JL4 <3K
M/@FYUG3O$+2W-O%J.M01VK.%+1P1)G '0L<LQ)XZCCCG2_L"_?QAIVN23VP2
MUL9+-XE#9;>RL6![8*#CWZUTE% #9-_EMY84OCY0QP,^]<UX=\/ZIX>\&/H\
M-Y:M>Q^>UO<^4=@>1V<%EST!;UYQ6GXBUZU\,Z'<ZO>QSR6]N 7$";FQG'0D
M#]:U <C- &+<>%M'U1(I];T?2M0U 1*DEQ+9(Q8@<XW D#.<#/&:P=-^'-MI
MG@_2M*MWMXM0TVXCO$NXH HDF0GEP.2"I*GG.#["NXHH P=.T.>TU;4M<G,,
MVIWJ1Q!%)6.*-,[4#8)/+,2<<Y''%.L=!>'5[G7+R9+G598?(B.TK'!$#D1H
M.3@GEFZD^@  W** ,?0]*N+#3)8K]K>YNY9I)I940A9"[$\@Y( !"XYX45E^
M$?"4^@^'IM!U.2SO].$SO;Q&$D1QLVX1D-D, 3P:ZRD=UC1G=@JJ,EB< #UH
M KV6GV6FPF&PL[>UB+;BD$2HI/K@#KP*LT@(90RD$$9!'>EH **** "BBB@
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M4\-R\<T"XQM$@.<8 &#Z5<'A+2EN=+G19TDTO>;4B=C@N"'9LGYRV3DMD\T
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M*G).<;>I %7= U#0-0L[C1_$; ^([?6I)FMBY2XEF$I:)TP02NS8 1\H4<X
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MAB>65U2- 69V. H'4D]JX[P9>:@^M:S9:M;6+7\$=N7U"PR(KI"'V$K_  N
M#D9Z$=L5V$L:RQ.CH'5A@JPR#0!1TK7=.UG2EU.SN8WM&!(D+ #:"1D^@.,\
M]JN07$%U")K>:.:(]'C8,#^(KQC0;ZWM_ ?@%]T)TRWO435]N,1OM<1^;Z /
MM)ST.TGM7<:% 4^)GB";3F4Z5+:6[3^6?D-WELXQQN\L+NQZKF@#K;Z2:&QG
MEMPAF2-F029VY [XK'\(^(1K_AO2KVYDMH[Z\M$N'MXVQC/<*23BMB\!-C<
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MVY5=^&S\K J 3TY&>* /45970,K!E89!!R"*KZA?0Z;IUS?7!(BMXVD? R2
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MH5%5["^M=3L(+ZQG2>UG0/%*AR&4]ZL4 %%%% !1110 4444 %%%% !1110
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MNQZ9ZU)10!$UO&0Y5$5V!&[8,\_SJ+3M/@TRR2UM@1&K,W..69BS'CCDDG@
M<\5:HH *;Y:8 V+@'(&.AIU% #&BC=P[1HS#H2H)%(T$3%BT2$M@ME1SCIFI
M** (Q!"K!A%&&'0A1D5)110 Q(8HR2D:*3U*J!FFI;P1O(Z0QJTO^L(4 O\
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MA>PN]2TN]LF9\SSZ9NNF#$DY8OL+<GYMOX5VE% $%M9V]I%''!"JB- BG'.
M,=>M/$$*SM.(HQ,PVF0*-Q'IFI** (_L\/G^?Y4?G$;?,VC=CTSUQ2?9H,$>
M1'@]1L%2T4 1B"$,&$488="%&12+;0+))(L,8>08=@HRWU/>I:* (OLUOC'D
M18]-@HEMTECD4*JLZ;"VP'C\>O7H:EHH KV%E!IUE%:6ZXBC&!GJ23DD^Y))
M_&K%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 457LKZUU&T2[LKB.XMY
M,[)8VRK8)!P?J#5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MYCQ7KEI9SVVEWANH[:Y4O<20VLLN8P<>6"BG!;H?]D-W(-=/10!Q/PGO;:[^
M'UA';[_W#2(P:)D /F,1C(&1@CIQVKMJI:1I5IHFEPZ=9(RVT.[8&8L1EBQY
M/N35V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ljb_employmentxageementx005.jpg
<TEXT>
begin 644 ljb_employmentxageementx005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
M\] ,^U)=>-KNT@E@DT9/[7BOK>S:U^U_NSYWW'$FSE3SU4'(/%9$/A7Q';VV
MISSRK>SQZY#J-M"$2+[0J! Q!W$*64$ '&"H[&HM=\/:MK@OM4ET&9UN=0L6
M_LUYHA*UO!DL2=^P$EVP-W0"@#J].\33OJ%_I^L:<-/N;.V6[;RI_M$;1$L,
M@A0<@H>"/IFI_#7B-/$MO?3QV=Q:I;7;6P6X4J[@*K;BI&5SNZ'GUQT&#X2T
M&XT_Q/=WUMH4FA:7+:".2TEN$D:>8-D281F"X7(ZY.[IQ6CINAWXC\0Q/=7&
MG->:HUQ!<6QC9_+V1C(W!@,E6&",T /U'Q'JL7B:;1=*T6&]>&TCNI));WR<
M!W=0 -C9_P!6>XZTT^,HF\%Q>((;&5Y9G$$-DS@,\YD\H(&&1]_^+ICFN<UG
MPM,?%C75_P"';WQ-:G3(;9+@SVZ/YBR2EMP+QCHZ]!BC3O"/B"XAT/3KN:?3
M+'3GN+R-H)8YGA8N5@@RX8-LC9LL01TP>,T =++XPB/A?3-8M+1IY-2DBA@M
MVD"!97.-KM@[=I!!X/(Q@FI+#Q7!-H^I7VH0?8WTRX>VNHU?S1O4*<(P WYW
M*!P#DXQFN2G\)ZU9V]UI+6\^L:(FJ)J!C>2)'NXW5C+%@;5^6;$F"%5@<5:T
MWP;J<R%[>5M"L(=0:[LM,EB2<1_NU&6 ;:/GWN%!(!8'J. #K_#6M?\ "1>'
M[35?LKVOV@,3"[;BF&*X)'TK'M_$VO:C=ZBFF>'K6:WL[N2T\V;4O++LF,G;
MY1P.?6JOAGPMKEMX5L;*^UV]L+F"65F2T2$95GR%;<K@]SD8^]CM6*GAHPZM
MK4NH>!;S5'N=1EGBN8;J!5:-L;>&F4COU% '4ZWXJOM%6YN9-#=K"RCC>[N#
M/M^]U$2E?WFWOROH,GBB^\67$6JW5K8:2;V&RD2*X<7 20N55BL28/F%592>
M5ZX&369XLL]5UNSN+!_#+3N\2OI=VD\:&RF*_>D)?*LC<@H&R!CZY&J^#+[?
MK]N-%74+_59(Y;36 T:_9'\M%+'+!TVNI<; <Y H Z@^)=;NM:U6QTK0;:YB
MTZ=8'FFU#RBS-&DG"^6W&' Z]JL:AXKCT[6M)TE[*>2ZOI5CD9 ?*MR49AER
M,,3L. .<#/'?,LO!%G=^)/$.HZSIRRFXO(WM93(?FC6")2<*>/F5NO\ *MCQ
M%I]U?WGA^2VBWK::FMQ,=P&U!#*N>>O+*,#GF@""Y\1ZC<:K>V&@Z1%?FP*I
M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
MQTG=TV@MTJI$FK^&-:UEK;1+C5;'4KD7D36LL2O%*45&1Q(R_+\@(89ZD8XK
M/UCPMXFUO2GOKG4H(M3_ +.N(%L8X%>-6DW?*KLPPQ78A;V)& 30!M3^*;N6
M[M;+2M(^V74EBE_,KW(B6*-CA0&VG<Q(8 8 XY(JG'XVN]4O;6#0-'CO4GTZ
M/4-]Q>>055V9=N-C<@J<\UGWFA:I;PZ2\FGZA>W<6G_9I;C3+M+9R<@B*0%@
M/+_VE)(()&,UD)X'FTR\TN.]\+R:[;6^BQ6A-O/$@CF$CLX DD0X^;@T =./
M'%U=V^C?V9HHFNM2>YC,,]T(A$T!(<;@K!AD'!'6B7QQ<Q:;.S:+C4X-3ATV
M2T-T/+\R785(E"G*XD4_=R.>*YE_".J1V7A]+WP[)J5E9W%XPTZ.ZC+6L+_Z
MF/>[J&V^Q..G.*6;PAJAT*]A@\/2Q:=)JUI=0Z+]JC9UC0@S'<7VC=C.T-_.
M@#L9_$6K:5IE[J.MZ)#;6]O%N06M[Y[RN2 J %% R2!G-6M)UVYNM4ETK4]/
M6QOT@6Y5([CSD>,DKD-M7D$8(QW&":YRWT6*32M6LK;P)/8_:;4@K=7D6R<@
M\)NCE=E/.0V!C'6K/A70;N+Q-<:U=0:E HLELXQJ=RLT[_/N8G8S*JC"@<Y)
MW$^X!VU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52M](TRSO9;RVTZ
MT@NIO];/% JN_P#O,!D_C5VB@ HHHH **** "BBB@".6"*<*)HDD"L'4.H.&
M!R",]P>]2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&P.01VZ]JM>*]&\4ZY:>(K231I+IY)H9--D%U&L*Q*8R5"EO];D/EB.AX8#
M(!W5KXAMKOQ#?:(MO<QW=G$LS^8JA71LA2ISR#@_3&#@U7A\66MU':FVLKR:
M:YMVNHX%";_)! W\L!@DC&"2<]*QO&&DWMYJ6@ZAI\@LM2N&;3KA=V2UM*A:
M0 CJR;=X[9!]:?XL\-QZI-:Q1Z5>(;2V/V'4=-G6*:UDZ;!EAE2 O&"..?8
MZVWO%NM.BO88Y&26(2HA #$$9 P3@'\:\]T?55U.._U_69M5L3IVKS)&\<X"
M.BR>4EN8U8AL\ C;RW0UW6BIJ,'A^P35G6;4DMD%RT>,/(%&['0=?I7GX\*Z
M]=>$-1MEL6M=1CUY]7M(YI8RDP$_F*A*L<9''/0XH [>VUZTO]4FT2XANK*_
M\CSA#,0K/$3M+HR,1P>#@Y''M7GEK>WS_"CPM>-J%Z;EM8@227[0^Z53=E2'
M.?F!'&#FNO&GWFK>,=.\0SZ=<64>G64T:PRM&9)9)"O'RL1A0IY)&2WIS7-V
M_AS7HOAIH.D-I$WV^SU2*XFB$T7$:7!E)!WX/R]LYS0!V]_XEM;*>\ACMKN\
M>QC66[%JBMY*D$C.6&3@$[5R<8XY&8X_%VFW&H:7:6PFG&JV[W%G/&%\N55&
M2,D@@@$<$=_8XR;&QU;P_P"*_$%W'ILU_8ZN8[F$Q21AHI50(T;[F'!P"",C
MK5#_ (0G4M)\ >'K+3'ADUS1)X[B%F.$9F8^:F>NPK(X_ 4 =':>+[.^TJ;4
M(;2\*PWGV)HBJ"3S=X0KC=_>('/UZ<U33Q%H^GWWBJ]+:FSZ<(GOD=794 C)
M'E(>@VC)( !ZU4T7P?=Z-XPN'CEWZ+(D=Z=Q^9K[:8W8C_:7YS_M8/:JE]HN
MLS3_ !",>E3%=8M$AL3YL7[UA 8S_'\O)SSCC\J .@T[QEI^HZK9V"VU] ][
M;FYM);B'8DZ@*6"G.<@,.HQW!(J*;QWI4,%O=>5>265S=FR@NHHMZ2S!BNU0
M#NY96 .,$CKR,Y::7JHUOP1<OIDJ0Z99317CM+%^Z9HT4?Q\\J>F>,5S>G">
MTTVWEN_#6K3:!:7\FJ6QM+FWD@5=[.CJ"PD9 &W@>I],"@#U+4M4M]*LUN;C
M=AY$AC1<;G=V"JHR0,DD=2!ZUFW/BVULHT>[LKZ#=?QZ>0Z*2LK[=N<,<J=X
MY&>]2>*;%-4T,V<ND_VK;32()[8.$;9G)9267#*<$<@\5QL_ACQ%'X7FMH_M
M=_'9:Q;7NG6]Y.AN6@C9&9"^<9R'VY.< 9]* .S;Q3IL-_JUI<M);-I4"7%S
M)*!L$;;L,""<_</'6L[5/$<%Y:ZEI)AU"POCIDEY"7_=LT8&-RLC$J0<9!P>
M>E<[JOAK7O$=]XK+:>VGQZKIMM':R2S(Q66)G;:X4G&21G&1[FMZ*^\3:SH%
M[#?^'6L)_L<D;1_:8I#/*5P!'AL!.IRQ!Z<4 5O!GBV"31_"VEW<=_\ :[[3
M8VBNIHSY<\BQ!G 8G);&3DC!P<$UUNH:C!IL432AW>:010Q1@%Y7()VC.!T!
M/)  !)P!7#66AZU#'\/%?2I@=&C*7W[V+]V?LYBX^?YOF.>,\?E6QX[T?4=1
MM=+OM+LX+^YTR\%R;&=@JW*%&1ERW ;#Y!/'% "S_$#2K6SO;B>VOHWL+E+:
M\A*)OMV?&PM\V-K9&&!(YK9NM;M;&YEBN5DB2&U-U-.=NR)!G[QSG/![<X/I
M619:0NN:!J5IJ/A^#1[?4(?):V7RS(1@@LQ3Y<\\#)QC/? S+?PKK6I?#C4=
M,U>XC&MWEK]F,V<J/+&V/)]#C>?>1J -E_&=A;WSV5Y:WUI<?96NXDEB!,\:
M_>*!2>1D94X(]*BT[QWI>IW.DQ16U_&FK1&2SGF@VQR$)O*9S][;D],'!P36
M7I<.L7>G3BZ\%VNEWD=K)&\D3PL9Y"I7$14_*I)R2Q'ISU%2RT+6X-.^'L#Z
M3,'T8@7O[V+]WB!HLCY_FY(/';\J .D\*>);CQ$^JF739K1+2^EM4+LA^YA2
M#M8_-G)]/<UOSPK<0O$Y<*PP3&Y1A]"""/PKC=#@UWP[;>)]NAO=2/J5Q>V@
M6YC47*R,"J@D_*0,YW =!C.>.SWL(=YB8OMSY8(SGT]* /-_!OB74M,U&/0/
M$MQ)/!J#RMI&HR-DR8<@P.W]\8R#W!^@KHM*U*#2-)N;B\N;J9I=4GM84>5I
M7=O.9(XT#'T'MP"2>":@C\+IXA\#?V-K5E-:2[W>-MZ&2%][,DB,K$ C([^H
MK%'A7Q+'X5T1[AH[W6M(UA[^1 X47B&20'!/"LR/N&<8/!Q0!TEYXTMK6QUI
MA8W7]H:3;FYFL)-BR-'@D.#N*E>#R"<8(QGBFZ5XP6Y_L2TO=/NX+[5+7SXB
M53RW*H&?!#G'7@'G!^M9FI^'+_7M4UW5Q:O:/<Z ^DVT,[+N=F+,6;:2  2H
M'.?O>V6W>BZW>^!]"DM[ 6FOZ/);R6\,\JL"44)(K,I(VLI?H>F.AX !NVGB
M^SO=+N+^&TO"L%Y]A>(J@D\[>$*XW?WB!U]^E9TWB.PTZ?Q??6D&I75WID4<
MMW;2/M08C)7RPYPHVC)(Z]>34&C>#[O1_&,\B2^9HTJ1WK[C\SWP4QLQ'HRG
M>?\ :QZ5%-H.K7>H^/Q]A:*+6+-(;*5Y$VR,L#1G(#$CDCJ.E %6_P!=NY=4
M\!:G,E] ;LR^?:QN2LV;9F'[M6(/S'C/([XKI;3QGIMYILEVL5U%+'>_V>UI
M*@647&1A,9V\@@YSC'>L"+3=<FN/ DTNB3PC2MXNP9X28P;<Q \/S\QSQGCW
MXJ)/#UY-!XCMM4\-RWEEJ6M?:1%Y\8?R3&JB1"'&UE9 >H..E &SKOC.73;2
MS>#2+QIIM5AT]XY/+4QEF7/\>#E3\I!QGJ0*LZEXTT_2_MIGMKQAI\,<U\8T
M4_95?.-WS<G ).S=@"N7E\-^(X_#=O#B[U$6&O6][9PW4Z&Y-K&RDJSDA2V=
MV,GIC)SP#Q;I/BC7HO$EC)H[W$-U8HNF;;J-8HGV?.K@D$R;^C$$=.5Y- '5
M7OC&QM-8ETF.SU&[O8[478BMK<MOC)P"I) Z@^W&,YP*D@\7:9>:7I=]9^=<
M?VH,VD$:@228!+<$@#: <DD =,\C.1IUEJZ>.UU>XT>:.V_L..T)$T3$2K(S
ME<;O0@9Z9[XYKG=%\.>)-!LO!^H_V1)//I4=U:WM@L\7F%)6W"2,[MI(P,@D
M$T 2V6MV\6A^/+C69=:CL(-1,9597:X@7RH\JK!CM )/(.WGK@UV5YXLL=/U
MA-&%KJ%S>M:&ZCCA@+;T!5<!B0,_,.IQZFN.O] \0WWAOQY:KHLJ3:S<>99H
MT\66!CC7YCNP,;3GGZ9KH19:F?B'8ZN=+G%E'HTEJ[^9%E96D1PN-^>BD9Z9
MH T+?QEI5WHNG:G 9F749OL]M 4Q*TN6!0@G (V-G)P-IYJQH_B2SUJ\OK2"
M&ZBN+&3RKE)HMNQ^#C<,J>"#P3P:\^&E:KIWA30K"31YCK,.M3W<$,5S"LH3
M?+(70EBA&UPK!CCYO7%=5X.E\N_U.*ZT?4M/U*[<7D[WK1/YW 0;3$Q4!0H&
M./QY- &AJ_B^PT>:_CD@NI_[/MENKQH$4B")MV&.6&>%8X7)P/I3+KQEI]OJ
MPTN*VO[N[>S^VQI;VY821Y ^4G SSWX]\\5SWB_2O$6L7'B.P&F/>6-UIGE:
M:ZW*1Q1RE&#>8I();<5VG! P.5Y-6-'T[68?&&FZE<Z/-%;PZ +*0B:)MLN]
M6V_>]%Z],]^] &K'XZTJ:ST2\BANWM]8E\BWD\L ++DC8^2-IRK#\#C-0^+?
M&1\/Z-K5Q:Z?<7,^G1(2WR",,_W<DMDXX)&,XQZBL6P\,W/_  J&XTC6(VTV
M[MS<7,<SNC>0XF>:.0%2>F5)_$58U/P_K&K_  HU"U>)'U[5(1<SQY" RDJ=
MF3P-JJJ#/]T4 +JNK7%G\1M$E,.IA)]-NBVGH^\LZO&%.P,4!P3SGH>35RZ\
M5:)JVF:%>NVIQ1W6J)!"D0:-EN%<KY<V#C;D'*DD''>DEMM7O/'FB:R^C3PV
MT-A<139FB)C>1D*@X?GA#G&1SU-<_#X>U]-$TZW.C3^;#XH;4W7SH>(#,[Y^
M_P!<,.* .HOO'NFV-QJ\'V+4YY-)"M=B&V)V(5+;LDC@ 9]^V>:TI/$EB)K*
M"U66\N+VW-U!% !N:$8^<[B !\RCD\D_6N9GTC5VU'Q[*NES&/5;6.*R;S8O
MWK+"T9_C^7D]\<5F26^K:?=>%OL6C74NJZ=HWD7B6MS )8U.Q0K!SL*%D8@@
MYROH"* .\\/^(++Q+IHU#3Q/]G+% 9HC&20<$<^A!!]Q5/5/&6FZ1'-<7$=R
M;&WG6WN;V-5,4#D@8;G<0"P!(! )P>AQ'X(^SP:$=/@TV]T][.5DEAO"C2%V
M_>%RR$J=V_/'KT%<Y::+K&E:UJU@_A6RU2UOKZ6[M=3D:+;$)6W%95;YSM).
M-N<C XH T++5%TSQUXSGO;V?^S[.QM+DK)*SK$-LI<JI)QG'05T \1VR)=O>
M6UU9+:PI,[3*I#*Y8+M*,V3E2,=>1ZBN>?2M43Q-XNNSHGVJUOK""&W222/9
M<M&L@9"-V0#O Y '6L:3P/J[Z-K>DZ2UU:Z5-;P2V-EJ<RRB&YCE$FQ2&8B(
MA5!!)Y)QQ0!W-CXEM;S7)=%EM[FSU%(!<K#<!?WD1.W>I5F! /!&<CTK US4
M9=,^)VDE3?SQ2Z7<L;.!F<2.KQ[2$SM!P3R<>YJ]X76^GG^T7GA*VT%TB*.0
M\3O(Q(^Z8_X.#UY/''%)J%AJ#_$C2M4BL)9+&WT^X@DF5XP [LA P6!_@/;N
M* +MEXMT[4='M-1MDN'-W*T$-L4"S&52P=""< KL;.3CCK5&3XAZ+#:F6>.]
MCD2_73IH#!N>&9B  VTD8.0003GMFN33POXAMM'L;Q-$CN;O3]8O+IM-N98L
M7,$[/]ULE0P# C/<'\=75]+U;4='TZ2T\+I8NNKVEV]G"\(=8XG#,SL&"ECT
M !/3KSP ='%XKBG@!BTK5#=;7D:R:%8YE16*[B&8#!(^7G+=@<'%%/$^@ZUJ
M7A:YMKF^<W_G/9&'>D3%8VWB4< D '@Y((JCXCTO5+;QG%KUKX?BUVSN+);2
MXM6>-98&1V977S#M(.\@C/O4MUI&J-KW@^ZCT>.*"QFN9;I+5XU2W$D;*J@$
MC<06&2!SR: +$WQ&T>&"\N&M=2-M97AL[N;[*0L#94;FR0=N6'3)[XQS71:M
M?G2M'O-0%O)<_9HFE\J,J&8 9P"2!7GE_P"'=>N/!?C73H]'F^U:IJ<EQ:(9
MH?GC;R\$G?@?</!]J]!U*WEU'0+RV1#'-<6KQJLA'RLRD '&1U/:@#(TCQ8+
MKPYHE[>6DR7VIQ(8;5-A:9C&'8I\V H&3EB,8YY(SIZ/KUIK37<4(EBNK.7R
M;JVF4+)"V,C(!(((((()!'0UQ-GHFOVUIX)U,Z5(+G0K=K*ZL//C+R1M$B-(
MA#;<AD! )R1Z'BND\/Z/<0^)M?U^YA:W.IF!(X'8%E2)"NYMI(R2QXR> ._
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M!7[0\TMQ*J'*HTDC/M!]!G'X5T- !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<?\1[G4+;P_9M8
M78MC)J5I%(?+W%E:91CJ,#GGU''% '1QZOI\NL2Z3'=QO?Q1":2!3EE0G )]
M.:NUY]=0ZL_Q6FBL;RUBO#X=B#7$MN74'[0_1 PZG_:X]Z?I/CB_UK2?#BQ6
MX34-4M);F8PH'"")E1MJLPZLP(R3@ ]: .^HK%\,7>MW>ER'7[%;6\BG>-2F
M,31@_+(%#-MR.JD\$&N>NO$WB.^BO[OP]IWVH65\]JMJR*!.(WV29D,@VGAB
M.,<#.<\ '=T5PNK^)/$&E>+HM%<V(CU:,?V3.T1 212/,27Y_FPIR,8STZU+
M>S:M_P +5TFS748Q:_V5-,T7D<$B2(,?O=3G@]O0Y- ':T5P=GXG\2:O!INK
M:3IOVBPNKK;) R(NVWW%?,#F3)<8!(V^H[9.==>,?$]OH.O:R9=,,6BZL]J\
M(MGS<1*Z+P=_R'#$Y^;)]!0!Z;17&64^J2_%C5;9[]&LH-.MY$@,/W0SR @'
M=URH))SG@8&*7Q[<:E!-X:CL+U;=+G688)5,6[>-K,,\C@%!QW]: .EM=7T^
M]U&\T^VNXY;NRV?:(T.3'NSMSVR=IX]JL6]M#:1>7!&$4DL>Y)/4D]23ZFO.
M99-8M_&OC:?2[FTAN(-/LI7DG@:0.524[0H88!QUR<>AZC6/B?4[[2]%O87M
MK.+4-+^U\1F>5IBJ$(L8Y* ,26^G3K0!VM%>9P^(-9U_4/A[>QW4-HFIV\\\
MT A+)YBP]?O D?,<#/'4YKN?$-Y>6&A75U8_91<1@%6NY-D2#< 68Y' &3C(
MSC% &G17G5SXTU>"Q\9?9WMY9-$M(KNVFGM'C\Q71V*LF1W0X(QP1P>^A::Y
MKZ>)],TZ]GL7AU;3I;B'RH&!MY$V=26^<$/Z+T[4 =K17#:3XHUB]T=K.X>S
MC\1Q:J=/FC6%O+7!W%PI;)!A!<'/)XK;\9ZM>Z#X-U35K#R#<V=NTRB="RM@
M=, C^= &]17#Q^(/$>G>+=&LM5^P7%AK<<@@%O&R/;2HF_:S$G>" ><#GL*A
MT[Q9J\NOZ'I]S+9R-JD-SYP@B8QVTL:A@$DSMD Y#>X[=* .^HKAM-\4:S<:
M;?6%T]FOB.VU,6'EK PC*L0RR!2^2IBW/U_A/I4-YX@\3M>^+[:UN=-B&B1Q
M30N]J[>8#$9"K#?QTQN_2@#OZ*X6Q\3ZV^K>%);HV1L/$,#,+>.)@]NPA\T'
M>6^;."#\HQ3;3Q/XDU:#3M6TG3?M%A<W6R2 HB[;?<5\P.9,[Q@$C;CJ.V2
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MBGB+?:)(T5GW$,-H);:,=,9YZ52L_%VL:_K.C0:4]G:VFJZ,VH*T\#2/ X9
M0<, _P!XC^'UYQ@@'?U!>7EOI]G+=W<R0V\*EY)'. H'<UC>"M:N]?\ #$-Y
M?K$+M9IK>8P@A&:.1DW $G&=N<>]<RL^J3ZS\0XKJ_2:VM8$CCC\G&U6MBX
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MY\17VI6EJNRS@G1%\H8P-S*,N0.!DXYZ=,7/$?AXZZNGR0WKV5YI]T+FWG1
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MPUB:R_M2%8[^%(5=)65=H==V=C8X[Y^O-=7574KPZ?IEU>K TY@B:3RU(!;
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MN;ZVMA'=7)!GE#',I P-W/.!TSTH K>*[R'3_">JW5Q>S6,4=LY-S NZ2+C
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MFE#1Y5G!SN*],Y')QSWJ6^\(>'=3U.#4KW1K.>\@ $<KQ#( Z#WQVSTH XB
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MLV+[*)OM AR=OFYSOQG[V><^O-3'P_I9NKJZ-H/M%U&(KB3>VZ5!T5CGD>U
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M23/F*"&Y))!W9.20!B=+C_A)'\:P:G<2O-IL*PVZ*S1>6A@#^:%!X+,6.3V
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M'2@#>C#B-1(P9P/F8# )^E.KC-%\2:/9^'9[RTTZXM1+JLMJMHS!I)KII2I
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MCKB@#J**P)?$P=_(TZQEO+M;-;V2$.%\N-L[03S\S;6P/]DY(XSR]WJK7'Q
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MB$N64HQ?Y><J2.,#TJUI7A^#2=3U._AN;F234I1-.LI4J&"A1MPH(^4 =>U
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M9@I7<Y93GY21@8&.,<"K\WA^WF\3P:\US<BY@MVMEC!7R]C$%@1MSR5!Z]J
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M-(AC145S:N<IM (')&"3VYZY[R:Q34-(>PU-([A)X/*N%QA7R,-] >:YVS\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6#XIUZX\/V^G306L4ZW6H6]G(7D*E!(X7<  <]>F16]7%?$U4?0M+65BL9U
MJQ#L&*X'G+DY'(^M ':@@]#17DVL:!:Z5K/BRST6V$>F2^&Y9KJVCYC6Z^;R
MV [.5#'CT!JQ:WUA)XC^&KQW5NTK:=,KLK@D@VZ;0?QS@'OF@#U#(SC(S533
M9+^2SW:E#;PW'F.-L$A==NX[3D@<D8S[UYYX8633]?TBSO[2TU"WOX9SIVMV
MGRR3(5WLMPO7<1_$#U]R:Q(;>"3X9Z"I+ )XJ"*5D((!OF'!!STH ]JR#TI
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MD4 >S45XYI6G_P!I_"NRU*Q$-WJOA^^GN;=%YWQQW$G[K')"L@PH]EQTKO\
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MUL]-4VFE0:Q9+,EO\HMX)4B,Q4#[H.3G'3)H ]&_M^<>/4\/&VB^SOIKWJW
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %17%M!=V[V]S#'-"XP\<BAE8>A!X-2T4 5[2PL["W^SV=I!;PYS
MY<,81?R'%06VAZ39&,VNEV4'E,SQ^5;HNQFQN(P."<#/KBK]% %*VT?2[)F:
MUTVS@9U*L8H%4L#U!P.E,_L+1_($']E6/E*^\1_9TVAO7&.OO6A10!5CTVPA
MNGN8K*V2X<8>58E#L/0G&345OHFDV<$\%KI=E!%<',T<5NBK+_O #G\:OT4
M44T72H[22UCTRS6VEQYD*P*$?'3(Q@U/:V5I8Q&*SM8;>,G<4AC" GUP*GHH
M J7FE:=J,D,E]86MT\#;HFGA5S&?521P?I3#HNE&&"$Z99&*!_,A3R%VQM_>
M48X/N*O44 8.JZ7JH$5MX?DTW3[6=Y#?.T!\SYL?/'M(&_KRV><'MSLVUM#9
MVD-K;H(X846.-!T50, ?D*EHH J7NEZ?J1C-]86MT8R2GGPJ^W/7&1Q2W6FV
M%ZL:W=E;7 CYC$L2OL^F1Q5JB@!%544*JA5 P !@ 51_L+2/+CC_ +*L=D;E
MT7[.F%8\D@8X/O5^B@"K'IEA#+-+%8VR23C$KK$H,@_VCCG\:2PTO3]*A:'3
MK&VLXF;<R6\*Q@GU(4#FK=% %.XTG3;NY%S<Z?:33J !+)"K, .1R1FB\TG3
M=1EAEO=/M+F2 [HGGA5S&?521Q^%7** *E[I6G:D\+WUA:W30MNB:>%7,9]5
MR.#]*6]TRPU)46_L;:Z6,[D$\2N%/J,CBK5% %6;3-/N?)\^QMI?(_U6^)6\
MO_=R./PI$TO3HFG:.PM4:X!$Q6%09 >H;CG\:MT4 4+/1-)TYD:QTNRM60%5
M,%NB%0>2!@=ZL7EC::C:M;7UK!=6[_>BGC#HWU!XJ>B@"G+I&F36<-I+IUI)
M;0D&*%H%*1D="JXP,>U-DT;2Y4D233;-TDD\UU:!2&?^\>.3[]:O44 4KK1]
M,OG@>[TZSN&MSF%IH%<Q?[N1Q^%.?2]/DN7N7L+5KAUV-*T*EF7I@G&2*MT4
M 4'T/2)+#[!)I5BUD6W?9VMT,>?7;C&:/[$TDVTMM_9=E]GFP98OLZ;7QC&X
M8P<8'7TJ_10!0?1-)D5UDTNR<2!0X:W0[@HPN>.<#@>E7(HHX8EBBC6.-!A4
M08 'H!3Z* ,+3--UA]6DO]<N+&4P^9'91VD;*$1F!W/N)R^%4<8 YZYK1OM)
MTW4VB:_T^UNS"VZ(SPK)L/J,C@_2KE% %6?3+"YNENI[&VEN%0QK+)$K.%/5
M02,X.3Q3(]&TN&:&:+3;-)85"1.L"@HHZ!3C@?2KM% $-O:6UHLBVUO%")',
MCB- NYSU8XZD]S4U%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4455N-3L+.3R[F^MH'Q
MG;+*JG'T)H M45%!<P74?F6\\<R?WHW##\Q4M !1110 4444 %%%58=2L;BX
M,$-[;23#.8TE4L,=> <T 6J*@^W6AN_L@NH?M(Y\GS!OZ9^[UZ4EY?6FG6YG
MO;J&VA! \R:0(N3T&30!8HHHH **** "BJM]J5CI<'GZA>6]I#_STGE"+^9-
M$NIV$$44LM];1QRC=&[RJ X]0<\T 6J*:CI*BO&RNC#*LIR"*=0 4444 %%%
M% !1110 445!=7MK80^=>7,-O%G&^:0(N?J: )Z*@MKRUO$#VMS#.A&0T4@8
M$=,\5/0 4444 %%%% !1110 45'-/%;Q-+/*D4:_>=V"@?4FJ\&K:=<R".#4
M+65ST6.96)_ &@"Y1110 45!<7EK:/ MS<PPM/((H1(X4R.02%7/4X!X'I4]
M !1110 454EU73H+P6<U_:QW1&1"\RAR/7:3FK0(90RD$$9!'>@!:*** "BB
MB@ HHHH **** "BJ<VK:=;3&&?4+6*4=4>958?@35M65U#(P92,@@Y!% "T4
M5!->6MM/!!/<PQ2W#%(4=P&D8#)"@]3@$\4 3T44UW2-&>1E1%&69C@ >IH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK@_&T,4WCWP$)8T<?;+GAE!_Y8$_T%=Y7,^(O#=_K&OZ'JEK?VUO_9,LDJQR
MV[2>8738<D.N  30!SOCVWB\,Z]X9\1:1&MM>7&JPZ?=)"-HNH9,Y#@<,1C(
M)Z5Z17-/X6FU+7[+5M<OTNSI[%[.U@A\J&.0C'F,"S%V Z'( ],\UL6$.H0S
M7IOKR*XCDG+6RI#L,4>!A2<G<<YY]Z +M%%% !1110 5P&J1IX6^*FG:TJ*E
MEX@C_LZ[;& MROS0L?=@"OX"N_KB_%\VE>)_#MWI$BZQ!(Y#0W":/=DPRJ05
M<$1]B.QZ4 +)=SI?W7B"VM8&\^Y73ENIV"I;6T1;?*V2"09-XP",_(:Y_P 4
M:^WB3X6>(GGAB$MAJ26A>,';)LGB(=0>1D,..?J:TM9^R7-EH<.DRZG:'1YT
MEB2XT&\FCD"H4 =0BDD9R#GJ*R+C2?/T#Q!I1U/4"-6U 7OF'PW>9C.Y&88"
M\\Q@#I@$]: .X&N7;>-;SP^(X L>G)>Q38.<L[)M89Y^[G(/>L?3/'DNJ:+H
M,J6RPW^JP2W&U8I)TA2-@I.U!N;)91VZGGC!K7EP7\6PZ]8W-_ [V(L;I)/#
M]X^5#EPT?RC#99ASD>QK#MM%;3M#T"/3]6U.'6-%$J0W)\.W9BEBD.6CD3;R
M.!R".G2@#T/PQJU_K&F2RZEILMA<PW#P,KHRK*%/$B!@#M8$$9''([5@7'CF
MZ7PK+XNMK2&;1(IF5HLGSVA60QM*#TSD%MF.G\0/%:&E>(([6SQJ$NK7=V[;
MY9%T.[C0' &$7RSM4 #N>Y[UR\.F6D&@WOAE+C4_^$?N9F<1G0KSSHHW?>\2
MMLQ@G.&QD ]^M &K<27MY\6[6$/:RV3:'*ZI(K$&-IH@W'3<0![8J/XGV5K:
M^"=.M+>WBBMH=3LDCB1 %11*HP!V&.*D-S /'$.OQOJ"V\=@;$6O]@7F=I</
MNW;.OR@8Q2>,IH/%&E06-O+J5H([J*Y+R:#>29,;!@,!!U(H T;[Q!KA\8W/
MA[3K&P+)IZWL4]Q,^.7*88!?5>@^N>U9T/Q%CFT3PW?W)MM+76(Y"UQ=9:&*
M5,#RR01@L=V"2.%/4T+=JOC.3Q#YM_\ /IRV/D?V!>\$.7W;MOJQXQT[UFZ5
M;C2_#>G:(\EQ?V=O#-#<07/AR\\NX#L&4XV'!7YAWSGM0!T\?B+48_$&A:5=
MVULK:G933NT;%O*>,)D _P 2G?P>.E9$OCS4X]&6\CTVUEE&O'1W7SF4$";R
MPXX/)]">/>LR'3H=+B\--I-YJ27&BQ30;KK0+V1)(Y<;@ %!&"HVC/3@U"-*
MVZ6UD-2U!B=<_M@2/X<O,Y\WS-APH!R>X ^E '3WNO\ B/38"NH6NEVKK!+-
MYXE:2*5PWR0HORMN*\DX./0]H(_&NIW\WA:.PTVU UZP>[5IIV_<LJ(Q!PO(
M^?J.N.W6JFJN+[Q-_:UM>:E#'+IYL)H9/#UY(5!8L7C.T;6.<'((X'!Q5'2+
M+^S9O"TDE]?S#0K66U"CP[>+YJNJKUVG& @]<DGIT !N:=XWN;K3X(9[2!-8
MEU:;2=B.3%YD>XM)D\[=JDXZDX'&<U:N?$NJZ3%)%JNG(L\E^EG8S0Y9+D,I
M;?L7<Z[0K97G)7@\Y')2Z-$^G7"IJ.J0ZBNL2:Q9W4?A^\Q#(Y.492AW+@D=
M15[4XY-;T14U#5-6368;B.ZM;NU\/W:Q6\B9V[8RAR"&;.3SGT % '5>'=:U
M+4;[4K/4-.DA6U9/(NQ;R11W*,,_*KC(*D8(R>W-8'A>4Z]\1O%5]?#S&TF:
M.QL8WY$"[<NRCL6/?K@ =*O:'KLUM%)+K5UJ5Y=N N+?0+R*)%&>BE"<G/)S
MZ<#%9URT-IXGN/$&@RZC;7%ZB)?6UQH5X\5QLX5^$!5P.,\@CMWH W]=?2O"
M<6J>+GM]LJVH2<1@ SD-\@/^UEL9]_:H9_$.I:7K^E:9JD-KMU99$MYH-V(9
MU7=Y;@GY@1G##'3H,UG:K-8^(]"O],UMM6=+R'RMMMHMXB1<Y# &,Y8$ Y/H
M.!SF&VG2YOM(NM;EU"ZDTD,83#H-XGFR,NSS'RAP=I/ [G.>@H T-*\5ZAJ&
MDW8EM[6+6+?4SI[6H+%0VX?-GJ04/F9] ?2H=3\9:BBZC+H^FO?_ -G7/V=[
M=+:9GN67;OV.H*H1D@ YSCMQ4<1T>'QK<>(T7609[=$>W_L:[VF5<J)?]7][
M8=GTS6:$N;#7]0N=%U?5+33=3F\^ZMI?#MW(\<A #/$VP;2V!U! /.#TH V[
M?Q+X@U'Q5J6DV.F6*PV#6CR27$[AC%*&+<!>' '3H,=3FHQXROX-;TJSO;6V
MB_M"]EM&M%?=-; !VC=V!*G<$SMP,!NIP:ATJYM]-\5:QJ[2:G)#J,<""'^P
MKP-'Y2E0=Y0[L[CGBN?M=)FMK;2+<ZMJ#II6I/>PN?#5YOE#;]WF''S/^\/S
M# ]0: -_4?'=]!I.J:O9V5O+;:=JG]FM;RLRR.=ZQE]P!Q\S@A=IR!G/.*MZ
MGXMU*.34[?3+%9[S3(T\Z%8)IA-*4#F)'1<+P5PS#DGH,5YZOBJT;Q%>S6^M
MZ4+V>_:5+#4-#N7G1U.V,$(1\P"C!V[A]<UTC27RZX^NZ1?:CIDNIPQ?VE97
M'A^[N$615"[D(1<,!\OH< T =]]H.H>'#<RVTEN;BTWO;S+AXRR9*L/49P:X
MOP!X=TG7/@_HMIJ%A!-'-:\DH-P.3\P;J&'8CFMZ;7[3^R&LX!JYE\GREFGT
M:[<DXQN;$8R>_:N8T=+S2/"-KX<@U>_BA@B\G[5#X9O!-MR?ND@JK<]<'Z4
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M(0<CIACT(K/G^W6GBJ#PPFI7=Y'<6LU^7NKTP2,V]5"*\:9VKR=HQ][K@8H
M[*]O7M)K1%L[FX%Q-Y3-"H(A&"=[Y(PO&.,\D5;KSF>7Q#I \)6NH:W]HN&U
MDVER8&!$L1CD=1(=H)8 *#T!ZXJGJ4VK2V_Q"E&OZE&VC$S6?ENJ["+990#A
M>5SQCN#SDT >GRN8XG<(TA4$A$QEO89XK/\ #VN6WB30;75[2.6.WN0619@
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MON* /2:*YCX>:C>:KX%TZZOYVN+G][$\K?>?9*Z GWPHS73T %%%% !1110
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M>VTLL/\ K4CE5FC_ -X \?C0!F>,[2ZO_!6M6-E;O<75U92P11H5&69"HY)
M R:9X>T"WL['3+B>"X%Y;6HA1;F8R&#( 8+R0,XZCMQG%:BZOIKARFH6C!(_
M-<B93M3IN// ]ZEMKZTO+<W%K=03P@D&2*0,H(Z\CB@##L/ GA[3-6DU*SLW
MAE>1I?+6=_)60]76/.T-[@<=JMV?A?2M/TV]T^VCG2VO7>2=3<R,69_OD$MD
M9R<X(J_;:C97A(M;RWGP<'RI5;!QGL?2B'4;&YNI;6"]MY;B+_61)*K.G;D
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MO5JV\+Z5::M!J<,4XNX+;[)&YN9& BSG;@M@C(!YJY!JVG7,$L\&H6LL,/\
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M/:;H^A6E_*J7K2G3DNL[IE#%B5X "\Y7.,@C%=1?2B#3[F9HY)%CB9BD?WF
M!.![FF7-A#=W-M-,2PMVWHG&-W8GOQ^7?L,6J /&M#U729]>\!2PW-HMDUC=
MVXMH\NMN#'&1"[G)9_[V<=,X'4TK :1;_#KPY=Q?8X[A/$R'S5*AE47C]^H&
MP_3!KW$(HZ*!^%&U?0?E0!Y#?:M8IH_Q*TW7)H8]6F:YDMXYR TUOY/[@QY^
M\!@].AR>]>D^%IHY_"6CR1.'0V4."#Z(!6HT<;G+(I.",D=CVIU 'F'B&ZFT
MSQ'JEYI]U::G;-?6@U#1;@8G67$7ER0,#DG&P[2,95L50UV_LK%/BII]S/'%
M=W4'FP0-]^539@;E7J0"#DCI@YQ7KAC0N'**7'1L<B@QHQ)9%)(VDD=O2@#R
MZT\0:7IGB:!O$%Q''I=_H%O%87,W^IR-WG1[N@9LH2.X4>U3?9]$C\=^#["*
M"..QATJZ$%O=')5=T6S(<D\@$@'GCU%>ELBOC<H;!R,C.#2X!.<"@#BOA=+
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M9&0/7YS^=>@[5P!@8'3BC ST% 'ALT>C+\*M7F06:S1^(CY4B[0R#[<,;3U
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M!0!Y'KDOA;6?#GBC7=.U675)I-"EAEE<(L2D F(, BCS<DX_B STXKL- O\
MPQHUIHEK"]E;7NL6Z>48D :Z9$&26 Y(SW/>NK6-$7:J*HSG &.:KW-A#=SV
MTDN2+=_,1.,%NQ/&>/RSSV% %D@$$$ @]0:\1AO-./PAT6RDF@$T.MP1W,3$
M H1>$E6]"%YQV'/0U[?2;1Z#\J /(]<7R=<\=VGA]8Q/)HUJZV]IM!<J9 X4
M#^+9Q^(K?\+W7AK7_$-KK6D:K=W]['9&!U"(BP1$@A)0J+@[N@//7' -=[@
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MPL$5[U8Y(PT.5#$8+#<P4AB%SP>I/%4-;\&_8]*TN+PY:ES9:O#J#P3W;L9
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MA$Q4;F3(8[7QS@\>_%8'B'P5=>,+G6;NX4Z>USI0TZU5V5GR)/-+OM) &X(
M 2< ^M7FTO5M>O\ P]=:K8"T?2':XFVRJ_GS>64 CP?NY8G+;3P!CJ0 4KOX
MDN_AO4-6TWP[J<D=K#<L99A&D:/"Q4JQWY[9X!ST'.<;:^*5AL=/2XM9/[1N
MK<S"W>2)"54+ERV[: 2PP,YYZ<'&)I_A?5F^&6N^'KB!(+V[^V^26D#(?.9V
M7)'3[P!_K3+O2?$\%YHFOV>E6=S=6]D;&\TR6Y W(2I#)(1M#!E/X&@#9T_Q
MUIFKV.GS:?%/-<WTDL4=I\HD1H_]9O.< +QDY.<C&<BJ'PZFEFN/%GFI<QE=
M;D417$F]D_=1<9R>,YQ@U'?Z/XB37=$\36]C:RW-NDT%UIL4P4+%)M(V.0 6
M4J"<XSSC'%:/@_3-5T^^\0SZE:PP)J&HF[A"3^8=IC1<'@8^Y_GK0!L:IK":
M9-96XMIKBYO93%#'$!C(4L2S'A0 I_I67:^-;"\LK26*"9;BZO9;!+:0JK":
M/=O4G.W V'D$YXQUI?%5GK5U=Z0VGP)=Z?',YO[,S^5YRE<)DXY4-R5[\<&N
M9L/"%\FAW6CZSX=L[W3YM6N;GRH+@!D1V9D>,G;M*D@=0<$].A /0-.O3J%D
M+AK6:U;>Z&*;&Y2KE3T)&#C((/0BK=8/A#3-0TCP^EEJ-U-<.DLGDF>3S)$A
M+'RT=OXF"X!/\ZWJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M% ,Q0JR!5V,X&_\ >+DY['CG@ [*BL;PQ=ZU=Z2QU^Q6TO8YGC^0C;*@/RR
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M:*3>64X?[V%^][=.<@ [>BO/)O&^J1^!X/&Z"W;3&E5Y++RSO%LTFP,'S_K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;8IC?R]VP^HQO/ (SQ63%#8>!O#$&AW@O-4ANI)HXDBLVD:0R%G9&VY !+$
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MH3G:F3\J\#@8' I^GZ+IVDR7$EC:K UPYDF*L?WCGJS<\MQUZT <YJ%W'?\
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M6('4L3DL3U))Y)/)H \N-^_VOPYJNGWEQ+!=^(9(&O9IR'N8SYP9/+' C4J
M,\_*#@9I;>&XAT[QMK<5YJ,]]HNH7C6$;W<CHN+=2 5)^8<]#GH,=\]S_P (
M5X9W,QT.Q):X^TG,0_UG7=^I_.K]AHNG:9)<O96J0M=.9)R"3YC'JS9ZGWH
MY30=/,FI:'KMIXDC>UNK=D>W1'87V4W!F+2, ZD$YQGJ#4WCI)&U?PFD=W=P
M+/JH@E$$[1AT,,A((!QU4<]1V(K;TCPGX?T&\GN]*TBTL[B?B22&, D9S@>@
MSV'%6[[2+#4YK::\MEFDM7\R!F)S&W]Y<'@^] 'F=SJEQX;M_%=E;WL\6GVN
MM647G32O(;6&98C*=Q;<!\Q[C&XD$&K7B(7GA#3M5U.VU\&UNH[;?:V\;XMD
M,R)).C%VVY1CTQR,]C7>KX>TA6OC]@A;^T!B[#C<)^,?.#UXXY[5%IGA30-&
MT^XL-/TBT@M+G(GB6,$2@C&&SU&.QH Y;Q28O"^CZOJ^D:I<*9K*(_9ED,L<
M:>8JM<+U.[:_7/.W/.,TEQHUW";RZTOQ7;P+J.F-'!"@D,1DR-MQO,C$?>"E
MAUW ]<5U>E>%]"T.SGM--TJUMK>XXFC6,$2#&,-GJ,$\'CFH;#P7X:TRSN[2
MRT6S@M[P8N$6/B0>A]O;I0!QUO=ZA=V>N:2EJV@^(4CM3]GFN6>UE!E(!C<'
M($G*'&",COFFIK=N^EW]C=P:GHNI?VG:0S:>DX<.[[=L<4F<"*0*<D8Q\W'/
M/>'PYI#VT]O)9++'/L\WS69V;8<H"S$G"GD#/':FS^&-%NK":RN=/BN()W62
M439=G=<;6+$EB1@ '/&* /,-:N;ZW\-?$2U6ZFM?L%Q;O;1VUVY$&^.,LJMP
M=I).5QC)/%=)XHT+_A&;*'Q+I]SJ<W]GW@O+Z"2\ED$T! 67Y2V/E'S@= 5/
MK72/X,\-R)<HVBV>VZ5%G CP)%7[H;'4# X]AZ4S6[7698X=*TJWM!I]Q"\-
MS<S3-YD"D 91<'><$XR1SC/% #O#;+?_ &W6UD=H;^7=; N2HA4!590>!NP7
MR.H8>E86O:=;3_%CPTT@DS)97K-MF=>5\G&,'C\.O>NWMX(K6VBMX$$<,2!$
M1>BJ!@ ?A52?1-.NM4AU.:U5[V!2L4^XAD!Z@'/ /<=Z /-GOKK4_AIKWB5K
MNXM]?L;JZ=625@;=HI"$AVYQM*A05(YW$GDYK1MM/?7?B%?V^HW6HPQC2[*[
M-M%>R(L<Q=\XP>!\N,=/;.".S?PYI#W\EZUA%Y\KK)(1D+(Z_=9E^ZS# P2"
M1@5-'HVGQ:M)JJ6RK?R)Y;SY.YE'13ST'I0!S_Q1_P"28>(O^O-OZ5/86=W9
MV^DW]SKLTEG%$OF03)&H)9 JX**"3D@ '.<^N*W-2TNRUBR>SU"W6XMG^_$^
M=K?4=_QJG'X6T2*2!TTZ+-NRO#DDA&7H0"< CM0!PVK+_9'CEH)+^]_X1W4;
MB!+I_.<BSN1EDB5]V423Y=P'3(' 88OZ@)?$/C'7O#TFHI9FVLX39HP?<%96
M+3)MD7Y@W&><;1TR<];/X;T>YTV?3I["*6SGE,TL+Y*NY.22">>>?KS4&J>$
M/#VM_93JFD6MXUJ-L+3+N*CTR>2/8\4 <GI,G]L^(+SPYK&L27GV?2+=K2XC
M8P_:=V\27"@'ELA,')QU'4U8TPF'XA:79+JEU?6LGAV7=++*<7#)-$HD(Z%B
M,_,!R#UKI]6\*:!KQMCJFDVET;;B$R1CY!Z#V]NE2ZAX=T?59+1[[3;>=K3/
MD%D_U8. 0/8X''3B@#RN!%U3PEX*FNYYKE_^$HEA$KW#LVSS+@ ;LYZ*H!]!
M786\/F_$[5].:XNFLI-$MW$?VER%)DD4E>?E.%'(QTK>/A/P^=..GG2+3[(9
MOM!B\L8,N<[_ />R3S5J'1=.M]3;4H;1$O&C$1E7()0=%_W1V'04 <1X2DN+
MI8_"=[/<27VB7LAO)FE;?-$OS0L6SGYPZ'!X(1Q533EN_$^F3:N?$4>G:C8Z
MI*)F$;L\.R9E$#+Y@4JR;1MV\YSR>:]*CL[:&[GNXX46XG"B60#EPN=N3WQD
M_G6:WA+P^^O#76T>T.J Y^T^6-V>Q^OOUH QOBM!'/\ ##7A("0EL7&"1R",
M=.M5WDCD^(%AX:F,@TL:0]U%&96Q--YH4@G.6VKR 3QNSV&.TN[2WO[.:TNX
M4GMYD*212+E74\$$50?PUHSVEI:_V?$D5F2;;R\HT)/4JRX()[X//>@#&\!3
MWK0ZY8W4TMQ;Z?JLUK:33,6<Q *0I8\MM+%<GT]JR[;3/[2^(OBB.>[U%X[(
M6-S;P)>R*HDVR-C /0D?=Z<GBN\M;2WL;9+>UA2&%,X1!@<G)/U)))/?-5X-
M&T^UU.XU*"V5+VY $TP)W2 = >><=O3M0!Y_X92YU_1_#OB=?$<<%UYZ&\"Q
MN6G=OE>W<&3 ^8\?+\N 0 *L^%'@\1^&]'\176K7-MJBWQ-T8Y3\S[V0VS(>
M G*@+CL#UYKK+7PEX?LM<DUJVT>TBU*0DM<)& Q)ZGV)[D<G-+!X4T"VUR36
MH-(M(]2D)+7*Q@,2>I^IYR>IS0!PVCK=^)M*AUP^(H["_M-3?[1B-V="LK+]
MG9?, VE=H"[><@X).3H:=ITVLW_C[2#J%[&/M4:6THN9-]NS6Z,"ISD ,<XZ
M=JZ@>$O#XU_^W1H]H-4SG[3Y8W9Z;OK[]:MV>D6&GW=U=6MLL4]TP:>0$YE(
MZ%O4XXH XSPQJUSKFD6MP8I1>Z':217<'F-\UXN4V'GYL;&;!S_K$-5_#$$V
ML6'AGQ-%XEC623;]J5(W8W;NN'B<&0C(;)&%^7;P *]"M[.VM#,;>%(C/(9I
M=@QO<@ L??@?E6;8^$O#^F:Q-JUEH]I;W\V=\\<8#'/7'IGOCK0!@_$VUAN=
M-T(RACMUVQ PY7 ,J@]#Z=^U4KC1[34_B=J5E+)<"V70+=<0W#H3B64#+*0Q
MQ]?KFNYU+3+'6+)[+4;6*YMG()CD7(R#D'Z@BJZ>'=)CNWNH[)(YWA%N9(R5
M/E#HG!^Z.PZ"@#SC0-<O=6T_P1IVHWZK'J&E2R%[G<PNIT**%8AE).TL<$\G
MG!(%=YX2L)]*TF6PGU@ZH8+B15E92#&I.1&268MMSC)/MVIUQX.\.W>BQ:/<
M:1:R:="VZ*W9<K&?5?[O?IZFM2QL;33+**RL;>.WMH5VQQ1*%51["@#S\7EY
MI?BZ#^U[>6>SN]5=+'5K.X) 9BRK;3QYX"G*@C(RH/!R:SX[]_MOA?5+"\N)
M;>]UR:%KV:<B2ZC(FRIC'RB-2H"YY&T' KT:'P_I4%V;F.S19/.:XQN)42MG
M=(%SM#')^;&>35,>"O#*L6&AV.?M'VG_ %0XDY^8>G4\=.: /.=2AF'@WQ[J
M U'4OM6EZM.UE)]ME_<E4B(Q\W(YQ@YXZ=ZZ&X\_0O'UN;":[F:\T6ZN)H9I
MWD6:6-HRAVDX!^8CY0!@XQ75MX5T1K6\M6T^,V][)YMU&22LS]V<9^8].OH/
M2IUT+3%O[>^%J#=6\?E0S%F+(G=02>GM0!Q'ABWFU:R\,^)HO$L8:15%RJ([
M&\9U^>)P9"-RMD\+\NTX %:GC]9?M/A817=U;^=K44$GD3LF]&20D$ X/*CG
MJ.V*V[#PEX?TO5YM5L='M+>_FSOGCC 8YZX],]\=:MZAH]AJKV[WULLS6T@E
MA+$_NW'1A@\'WZT >9WVIW/AA/&EI:7EQ'8VE_IX$DTSRFVBF$?G,&+;L8+'
MKP3D8J?Q7H7V7PUXHG_MN.>SNM$DF33X5<('09$ZL9&ZY (Z-P><5Z"OA_25
MFOI?L,3/?KMNRXW"<8P X/!XXYZ#BH-,\)>']&L+JQT_2+2WMKL%;B-8^)00
M1AL]1@GCIR: )] @BMM"LHX<[1"A.YRQR5!ZDDUI56T_3K/2K*.RL+:.WMHQ
MA(XQ@"K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %5[R^M=/M_/NYTACW! 6/WF)P% [DG@ <FK%
M<KXZNS9V6E2_83.G]I1;[@0-,;,8;]\$ ))'0'& 6R0>A +&L^+].T_PEJ>N
M6L\5P+..4!,D?OD4GRV'53D<@\UB6'BT6>N:7!>ZZM[#JT&Y(C;A?L[JI9R'
M4#*D[0%.3SG/%<\?.7P?\2;0V^HO-=3S/!YUJZO/OMXU4@;1DD@\ <=P*W=0
MF,>O^ M1$%S):Q0W$4C10.Y1WA4*K #(R01SZ<T =?<:_I-I>I9W%_#'.\@B
M"LV!O(R$)Z!B.@)R<U#_ ,)9X?\ MZ6(UBR-T\_V98EF!8RXSL^N,<>]>?VD
M=@[ZKX7\2:1J]S?R:E-/;HC7 @NU>8R1N'0[$ R,DXQMK<\/6SW'B;QQY&;6
MXN+N)K:Z>WR.(%4.NX88*V[_ ": .D\2^([+POI7VZ])VM(D4:J#EG9@H^@Y
MY-/NO$FC62*]SJ$,:F+SB3GY8\XWM_=7/&3@5R7C#2];MO UW]OU.7672\M)
MAY5D(VC1)T9\*F2W )_"J/BN^:_N_$=K#I][;M<Z'BWEAL7:2_RLGR,Q4[%4
MD?*<-\W7M0!Z ^N:7'J46G-?0B\FC,L<&[YG0#)91W&.XJQ9WUMJ5DEW8SI-
M!*,QRIRK#U'J*\VU2PD\3^%-"M-.CDMM6TZP6Z2YN(I(MF(]ABSP?WG(/HO/
M]W/=>&-7BUOP_:7D5G-9$QA7M)HC&T+ 8*X(' ['H1B@#G/#7CBT'VRS\0ZW
M9I?C5KFSMU<K&61)"B\>^.IZFNIU'7M+T@XO[Z&WP S%SPBDX#,?X1GC)P*\
MUDL5N?!_C/P[)82/JM_JMXUM;M P+F23,4N2,;1PV[. !5B?[/I/B/6]*\4V
MFK75IJD4(MI[47#QW"B!8GB81'AMRD\_WLY% '=WOBO0-/EFBNM8LXI($$DB
M&4%E4]"0/6K;:MIZZ?#??:XFM9PIAD1MPER,C;C[V1SQ7%:5;V]A\19,V3VU
MK!X<M[9 X9UC*R.3'YASN(4KGDDUS>EFZTGP?X$U&\L=2?3[".>WU".W659K
M=GP$<JN&P,$'V:@#NO$WC:QTSPA+K&FW=O<%W6&%@=R[S(J'(]5W9(..F*;I
MMW<1^)]DWC*"\M)(7F@L'MXUF*\99F7'RJ0<?*/O<YQ7-^(K?31\.]2ET/3;
MZ./4-2@N0)$F>6Y831,\NQ\NHPIZ@9VYQR,[VHR++\4_#MQ&KO"NGW:-*J$H
MI9HRH+8P"=K8'M0!IZ-XRTC6M.N+Z&<)!#</!EP06(<H#C&<L1P.O([UL66H
M6FHQ/):3+*L;F-\ @JPQE2#R",CBO,]-MX9/!]WI.HC5+">'7)W%U! ZM;.9
MW>.0$KAEZ9QD8/.*ZWP1/JTUEJ":LT%Q)%=E(M0AB\H7J!$Q)MZ9_A)''R\4
M 68-?2[U352DHCT[2&\JXE"[C)-L#,H]E#+TY+''&.4TCQCI&K:!;:NMPL4%
MRP6-&R7+'.U0,9+$#.!G]*R/ <$MM_PE]E,"+@:[=2D'J5D570_0JP_*N:T2
M_>Q\$>"K6?3+N)K6;R+F[>PD=[&01N,JFWDDG;NP5&[O0!UGB?Q+(FD:3J&A
M:A"T,VK6UI,RH'W*TH1UY^Z1R#QD>U;MUK.GB/4(1J<%O+:(?/E<C%L2N06S
MP.H.#UKR>2.Y;PW?60BU**<^,%N%D>T;>(S,K>;RN#@?,>,#OUKJ=%U":'PI
MK>@:G;.NI6,,J/<)$Q2_#(2)5;!W,V1N&20V: .EM?$6E66FZ6E_K]G-/<VP
MDCG=EB^TJ$W-(%[ @$^@JW:^(-(O=)?5;?4;:2P0D/.' 52#@@GL<]C7GNG1
MG'PL66VES:6S+<!H6_<-]FV#?Q\IW\<XYJK>1*?#'C-G6ZB(\2)=VY2V=]WS
M0;7V@9=-RG.W)X.,G% 'IMKK^DWM\UC!J%N;U/O6K/MF7C.3&<,!@@]*AO+Z
M)/$EA:_VU! QBE=]/*J7G&!A\]5"X/L<US?A/5=(U7QCJ>HQWQ_M&\MHH_LA
MMIH0L<6?F!D12YR_8<#'UJSKQ/\ PL[PG*$D,<-O?++($)5"ZQ[0S8P,[6QG
MTH UE\8^&WF@B36[%GGE,$068'>^<;0?KQ[GBBT\5:=>^*+_ $"*0FZLTC9R
M00"S;R5''. F2??'8UYQ<0L?AQXACCM)_M$OB1KB-%MVWNGVQ7#@8R1L!.?0
M5NW<%[-XM\:6EHEQ'<ZMI,"Z?<")O++".49W@;5P67J>XH [2WU_2;J]2T@O
MX7GD#&-0W^M"_>V'HV.^,XJU>W]KIT(FNYTB1G"+NZLQZ*!U)/H.:\X5'U[P
MYX)T^SMI[?5-,O;1[F)XF1K185(EW9' (!4?WMPQFND\<7ALUT5S9-)$=07?
M=K;M.UG\C8D5 #R<[02"!NR0>E &Y#K>F7&G/?QWT!M8W*/(6P$8'!4YZ-GC
M!YS38->TJYM;FYCOX?*M6V7!=MIA;T<'!4\CKZUY3'_:-E:WU['I^IW,5AXM
M.HW,3VS"26V,8 <# W$$AMHZ8Y K=\1W,>I:6OB+0-%N9H8=3M+R]9;5HIKV
M.(D'", S;!L()'...E '<V^NZ5=0W4L=]#LM/^/G>VPP\9^<-@KQSSVI(-?T
MJX%R8[V,FV4/.AR&C4]&*D9 /KC%<-XEEC\1:!=:QX<TBXDVW5G<7;FU:*6^
MCAD#&,*P#/M ^AZ#/-:%Q!_PD/CJQU;22S6T.E7$%S/L*B0R%?+CY R00S$?
MP]\9% '5)KVE2"Q*:A;LM_\ \>C!QB?C/RGOP,U4;QEX:5U4ZY89:?[,,3 C
MS./ES^('U.*\YTB[9]"^'5F+'4//TR]2*]7['+^Y802(0?EYY/49 '7&11J4
M#2> ?B%%':3-<76L2R0(L#;YE)BVLHQEA\K$$>AH ]&3Q5ITGBR7PZLA^UPP
M+*Y((&6) 4<<G@D^E:%]JMCIOEB[N%C:7/EI@LSX&3A1DG Y/I7+6\IA^+%Q
M.T-PT%]H]ND$RPLR,5DD+ L!A<!@>2.M2>);TVWC'1HWM)XHWMYP-1M[5II%
M8E/W*X5@F[&22/X<#'6@"3Q%X@GB/A:[T>_A>QU+5(K>1D57$L3H[<-V^[V]
M:FT;5-0N/'?B73+FX62TLXK1[9!&%V>8)"V3U/W1U]*X+21-'X&\"6TEI>1S
M6>O!ITDMW!C4&;+'C[HW+\W3GK79:%D?$[Q8YCD6.6"R6-V0A7*+)N"MC!QN
M&<>M $_B?Q/'IFN:-HJW@M6OY)/.G !:)$C9AM# C)8*.0>,U;LM8ATF"#3]
M=URUN-0\SRC.(_*#,QRBL!\JN5*\<9[#FLSQ/(%^(/@Z39(8X'NS-(L;%8PT
M)5=Q PN3P,US426#3ZWX8\2Z1J]U=W&HS7%M'&UQY%Y&\GF1D,AV)MX!)QC;
M0!V/C3Q+%HOAS5Y+;4(8-1MK-YH]R;]K;24##H-Q&!GKVS5RW\06EIH&G7>J
MWB1R36B3.2.3\H+-@#@#/)Z#-<#=W4NGZ/\ $71=3M+LZA?-=W%FRVSR+<PO
M"%CVL 1\NT*0>F*='>)H^L6-WK=EJXTJ_P!%M;:*:WBN 8)8]^Z.1(_F&[?D
M9':@#OKSQ=X=L$5KK6K&-6@^TJ3.IS%Q\XQV.1@]\U(?$VBB>.'^TK<M(Z1J
M0V5WN 47=T#,"" 3DY'K7%66FV-CXU\)V]II4UII\&FWD<<4JO)Y/F.A169L
M[69=W!/&2*R/$MQ+<6>NV\>FWMK);ZY;R_9;:Q<K-&LL7^D,X4[BP7@*1@ <
M'&: .ZTW5-0E^(>MZ3/<*]E;V=M/!&(PI0NT@;)ZG[HKIZX6SO%MOB/XBU&2
M&Y%N-)MF#>0_S%#*S*O'+ ,/E'/-=9H^K6NN:3!J5GYGD3 X$J%'4@E2&4\@
M@@@_2@")?$.DM*T:WL98(\@P#\RI]XJ<?,!T.,\U2T;QEH^L:#%K"7"Q6\LA
M1 ^=Q)8A !U+,!G:,GFN4\(K>6&MZ5:Z;<S7VA30RM]FO8"MQI)VY"%\ E2?
ME ;GCC(%9NBWLFG?#[PK:7&E72R6E_Y-S<26,CM8M^\^=5V\GG:&P5&_G/2@
M#N]5\:Z+IFBKJ@NEGB>Y6U41YSYI8*5;CY<$\YZ?E6A>>(-)L+=)[J^BBB9/
M-#'/"?WCZ+[GBO*Y(KD>%O$Z?8]2=H_$\-\3+:N'>'S(&+@;1GA6) &1CD"M
MK4[^ULO&>H3ZY9:N^DZQ9P+:3VT=QCY0P:%TC^8$[MP!'\1Z<T >D"X@:V%R
M)HS 4\P2AAMVXSNSTQCG-9]OXDT:Z\WRM2M_W4(G?>VS$1Z2<XRA_O#CWK-N
M+>/2OAQ<V]CH;R0PZ?(L.ER.SLR[3B)B2221P1D^@S7'Z5=AO&=CJ#+?RVLO
MAR6 2-8/%$CB2-O+4;1M  .,Y],DT =]:>*] O[VWL[35[2:XN4\R&-) 3(N
M,\?ASCTYZ5A_$/Q8-"\*ZG+INI0P:G;!<9C$@5B1A3GY0Q!R >?:N5TJ%K?P
MC\-(C:S1S6E\C7">0P:$>5*K%QCY1N9<D^M5-1GN(?AKXK\-W]E>OKGVN>7:
MMK(_VD/-O216 ((P0.O&,>E 'K.N3W%MX?U"XM95BN(K9Y(W9-P#!2>G?I6?
MH.NJ_@S0M2U6Z47%[902,=O,LC1ACM51R>IP!5K7)EE\):C(JR8>RDVJ8V#D
ME#@;2,YYZ8S7!Z0;K3)/ .J7<,_]F0:*;&X)C;_1)RD?S.,94'85SCCOC- '
MHD6LZ9/IAU**^MVLER&G$@V@@X()['/&.N>*BC\1:1):W-R-0@$5JXCGWG:8
MF.,*RGD$Y&!CG(Q7FNHZ?J=I-JGB*RLKF?2?^$BMM0^R1QG?+"D06654ZG+D
M,/79GI@ULZWJ^G7>D3ZUI>@/-%<7MGY]]+82!OE?_7>65#OY0 P>F3W - &Y
MXD\1@>"=>U+0[^,7>G6\KDF/<8I$3=M9&Z'&.H[UN6%R7T>VNKF106MTDD=L
M #Y023V%>67/FM9?$V)8=2F:]M(VMI)[1U:?-L$& % R6XP #QTKT_1Y4_X1
M^QD)*JMLF[<"",*,Y!Z8H S=,\0:;:Z)8S7_ (EL[W[5,\4%Y\D2SMO("J <
M''W<CTS6AI_B#2-5M[FXL=1MIX;9BL[I(,1D#/S>@QSGTKRZRA;_ (5YX0MI
M;2??#XB66:)[=LQQBXE8LRXX7:RG)XY%6O$5GJ%[J/Q 33+66::6/3I8HPA
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M]W#Y=SICE5"0N^!P>  1N&ST%;'A2XT77+_1YQHVKQ:SIL3I(+PW"K9%DVN
M7.QLD  #/'/&* .VO]7L-,*"\N5C:0,R)@LS!?O$*,G R,GH,U7E\3:% +0R
MZO9*+N,RVY,R_O4"EBR\\C )STK!\17A@\:Z;"]I<0I)8S*NHV]JTTC,77]P
M"%(3.-Q)';@CK7'^%T<6OPSBN+*Z1K%[I;@36SKY1\IPI.1P-Q !Z9Z=* /4
MK37](OM*?5+;4;:2Q0L'G#@*A7@@D]"/>L'2_$<^H?$B_P!*BO%FT^+3([@1
M>3L:.5I&4ALC=]T*>>S5QETE]'::S=VUG=36UMXPCU&X@CA;=-:JL>71<?.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(R*=H7YE)7!.01GH1R;MQXUDM]-\473::I?P^Y$B"XXF41B3(.W@X;H1U[T
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MTOMX!RI  )^8>^ #IZ*Q?#'B#_A(M.GG:S>UFM[A[:6,MN4LO\2-@;T(((;
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MNX)XY&E,S^652<2C'R9R<8_7VKN["]AU+3K6_MR3!<PI-&6&"58 C(^AJQ0
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M)IX3O9+,Z8+HRR7,4C&66/SS-LV%<*2<*3N/&?PZNZURQL];L-(F:07E^)#
M!$VU@B[F^;&.!VSGFC7=<L?#FE2:EJ+2K;1E0S1Q,Y!)P.@XY(&3Q0!SD/A_
MQ3H^O:G_ &+?::=(U.X-TXNU<S6LC !R@'#@XR 2,']7MX9U8:GXMN%:S:/6
M+6*WM]TS;E*1LF7^3ONSQGI795FZ3KMCK3WRV32DV-R;6821-&1(%#$88 ]&
M'- '(0^$O$VD-H>H:-<Z8;^TTN+2[VWN6?R9XX^5=6"[@P)8]/XL5J:SH.N:
ME_PCSF:REGT_4!?7+.S1AOE==B *W #\$G^'GK76T4 <NGA_4&\9:MJLK6RV
ME]I\=FH21C(I4N=Q&T#G?Z]JSM/\*ZO#X1TK0-3M=%U*TM8?LT]O(SA9$4 (
MX8H</P>,<9Z]QW-% &)X2T27P[X;MM+EN#,86?;ERXC0N66,,>2%!"@GKCMT
MK;HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KFO'5YJFE^&I-5TNYDC:Q=)[B-(T8RP!AY@^8'!
M";B"/2NEIDT,=Q!)#*@>.12CJ>C C!% ' 'Q?<V_B[5K5KZ6XL)['S=)PD85
MYAM#QHVW+',D6,YZD'.*;-8ZC)\3K.T_M>2.['AMQ->I#&78^>F2JD;!SZJ>
M/?FNDM_!>BVUGH5LENQ31'WVA9LG=M*DL>^2=WU -69/#T$GB4:\+JZ2[%J;
M0*I38(RP;H5/.X YSV].* .+M?%6N7'@WPCJ+7JBYN]9CL+QEA7$Z><\9.,?
M*2$SQZG&*GO]6.@^-/&VK"+S39Z';3A/[Q7SR!^E;4?@/3H='T[2TO;\6^GW
MOVZ#YTW"7<7&3LY&YF./?Z5?_P"$7L7UG4=2FDGF;4;9;6Y@D*F)XQG"XVY_
MB;OWH S=+;Q,=;TZ=[CS])N(&^U"X,(*OMW(T/EC)!Y!#$\8/K6KXJUEO#WA
M74M72-9'M8&D16Z%N@S[9(S5/P]X*L?#CI]GO]3N8805MK>\NC)'; \808';
M@$Y(&0.IK=O;*VU*QN+*\B6:VN(VBEC;HRD8(H Y&1O%=M=33+>$Z<]C(2]U
MY)>.<#<K1A  5(!R&SZ^M8MEK7B5]/\  ^H-KF\ZXJ0W,+6L>Q2T#/YBX ;<
M"OKMYZ <5T^E>!;/2;22VCU35[B(PM! +JY\P6R$8(C!&!QQD@D#C-/C\%6,
M5GH=JEY?"+1&#68W)D$*4&[Y.?E)'X^M '):KXD\0Z3X=\:Q)JQGN]$NH1;W
M<L$>]DD2-MK!5"Y&\\XK<2^U_1?B%INF7^IKJ.GZQ!.R+]G6,VLL0#':5Y*$
M-CYB3[U2\=^%_)\)>*)=/&H7M]K)B+PHGF992H&T*N1A5Q^'K75V>B0?;(]3
MEN[RZNEMS#!+<JH:%&P6PH5<$D+DD$\"@#@O"NMSZ?X/\*Z7;2>3+JVJ7<!N
M-H)B199G; .1N. !D$<YQQ6S+?>(CKNO^%[74V-W'8)?Z;>O#&67<67RY!MV
MD;EX. <'VS6I'X#TJ+P_;Z.)KPQ6ER;NUG,BB6"7<7W*P7U9N"".2.E69K>+
MPU;7VLBVU'5[Z41K*8D1YY%4X554;5PNYC@8ZD\F@#'T;Q3/K=AI5W!<S*+>
MRDN=4BV)NWKE/*;Y?E)=9.F/]6?45#I.J>)]1MM!UZ*7-A=1K-?02F+REC=<
MCRMHW[E) PQ.>_-;OA?1H[&'4;YK$6EQJUT]W-"<$IG 4-@D9P-Q )&YFJMH
MO@+3-!N_,L[O4C9I(9(=.DN2UM Q.<JF/4D@$D \CF@#CM9O[_Q'X T3Q#-?
MNL=YJUI+]C5$\M(S<J%7.-VX8!)SR<\8P!ZU7&_\*UTE;)M/BO\ 5(M-^U+=
MQ64<ZB*"0/O^3Y=P&[G&2.>,&NQ4;5"@DX&.3DT >:ZMKOB*QB\5:5%J<SZS
M:R17&E8@B)FAD'";=N#@K(">V ?KN66MW&O6,FIZ5J,BV2:8DBDQQMF=UW_-
M\N=RKMR!Q\_3BMV;0K"?Q#:ZY)%F^MH'@C?/ 5B">/48./\ >;UJ'3O#6GZ3
MH<^D:>'M[:9Y7)0C<#(Q)QD8XS@<< #TH X07VIZW!\,KR?5;J*:^+/.85C
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M<,>OS>] #? O_(2\9?\ 8>D_]$PUH^*]9FTF'2X+=Q%+J6HQ6*S$ ^4&#$L
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MS#YIEW'(VXQMQCG/7M5K(YY''6O/[N>TL_B=K%ZTCB >&!<2/ V6($KY9??
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M@. #T'^U!?6>I?V0T-S=VCO %=\1F8*#M+#/&6 ..G/I5R!I3:Q-<*B3% 9
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MR)N1"#]U6W@>F/:KFJZ?9:<_Q.T^S@2WLUT>&Z6"/Y564Q39< ="=JY/? H
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MCT?_ (1_[5)#'\L<-YB3&T#A2556('7@GK4QT+2T\5>" MJ@_M'3KA+W!/\
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M2Q/A2]\Z&%X;?QOM!E4,(T^TH",GH,<'VKIY-(T?6?BC<V=Q:VUSI_\ PCT
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M*MT4 5H=.L;>ZDNH;.WCN)/ORI$H=OJ0,FK) (P>1110!$MM;HL*K!$%@XB
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M)RI4DYR.0.,]*]'HH X4Z+?:=XH\&)#:7%S9Z1I\UI/=C;C+)&JG!.3GRSG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K$UGQ-;:
M+J6GV$UI=S3Z@[);"%5(=E&XC)88XYYK;K@?'BSMXR\#"VDCCF-]/M>6,NH_
M<MU4%2?S% '666K_ &N^:SDL+RTE$?FC[0JX=<X."K$9'&1[BM*LK34U*"^N
M1JM[;3^:5^S"&(Q *!\PVEF.<\DY[CTK5H **** "BBB@ K#T_Q5IU_XAO-
M(FMM4M465K>=0"Z'HR$$AATZ'C-;E>?:_P"%I->US5;[3)A::_ITD,UA=>C>
M7S&_JC#@B@#L8]5276YM*%K<"6&))FD(79M8L%.=V>2C<8[5H5Y=9^.Y;BQ\
M5:XMBT&K:5I$*75E(#^YN$:X)!]5Y!SZ&M*[O+_1G\'ZC:ZC<WB:K<Q6E['+
M(7282QLWFJ.B%2N<+@8/2@#OF)"DA2Q Z#J:YS3_ !A#JOVS[#I.ISBSN7M)
M]J1C;*F-R\N,XR.1Q725Y?X1M]=N++QPNCW]G;.VOWZQ^=:L[!\+@AA(H';^
M$XZ\]* .ZF\0V<.E6%\4F_T]HX[: J%D=W&0N"0 < DY/&#64/',;)=(FA:P
M][9J9+FR$*>:B;BH8 MAP=K%=I.=IK.\>6T-YJG@]UN)@#K:PGR9BH!$4V<8
M/# @C/7J*I",:3\0/%M_')=S/9:/;W*1M<.=Y'G':>>1QTH ]&BD$L22 ,H=
M0P#*01GU!Z&GUYY83:]]ATCQ/%J,,EH]HTUY"UX\HO-T>Y=B% L;!NR]L@YJ
M[X>2[UG1?#OB+_A()D-W")+V+<6CG,B?ZM%SB,HYP"HSQSGK0!V<<L<RDQNK
MA6*DJ<X(."/J#3ZXCX5VPA\(-+YUQ(SWMV#YLS/TN)!GD]3W/?O5_P 7:O/9
M:AX>TR*1H(]5O_(FG4X*H$9MH/8L0!GKC..<$ '445YAXAU/5]&F\8Z3:ZE=
M^1;:)_:EG.7WR6[_ #J8][ D@E,C/(YP:T=/GU&P\9^&XGU6\NH=6TR:2XBG
M8% \8B*L@ ^7[Y'OWR>: .SU/4(]+L'NY(9I@K(@C@3<[%F"@ ?5A6$GC>WD
MU&]T]-'U=[NRC26XA6%"R*P)4\/SG!X&373D ]0#7#Z#_P E?\7_ /7G8_RD
MH [2UN([NTAN8L^7,BR+D8.",BI:\WL;G7_$>EG6=/U""REMM1E5_,O'$20Q
M2LIB>$)M^X!SG.3G('%3:+;:IJVL>)6F\2:K&FFZH\<"1-& 5,"':P*$$ MD
M#'!&: /0JANYVM;*>X6"6=HHV<0Q %Y"!G:H..3T%>4Z?>ZT_AGP'K!U_4#=
M:I<Q6ET&92C))'(2=I&-P*@ACGGVXK3-YJ=A;?$+3HM7O7&E6ZW%G/*X>6,M
M;F0C<1R-P_#- 'HEM,;BUAG:&2$R(KF*0 ,F1G:<=QT-2UYRUUJEYJW@2V&L
M7L,.I:9,]T(V4%V6*,ALD9R2QYY]L'FHM-U6].AO8W.LW;20>(YM/BP-US>1
M(S$1!\KAL=7R,!3S0!Z1++'!$TLKJD:C+,QP!5>2]=-5ALA9W+))$TAN54>4
MA! VL<YW'.1QV->3ZM<WVH>"M<@O;F['V#Q-#;0@W#%EB,L!",PY?&\]<]NN
M :[&YNKS3_B/IEBE[=2V+:1<RFV9]P9T>, YQDG#'J30!V5%>5OK^JM\,+'Q
MU;WT[ZB98YI;82$PR(\PC,&SH, X! W97KR:EU235I[SX@@:_J4*:3#'/9K$
MZKL;[.9,'"\KN[=^^>, 'I]%4-#NY;_P_IMY.09;BUBE<@8&YD!/ZFN:M[FX
M\3>)_%&F/?75FNEF&"V%O*8RA>/?YIQ][). &RN%Z<F@#IM4U6WTF&%Y]S//
M,MO#$F-TDC=%&2!V)Y/0&FZ1JC:K:R2O87EC)%,T+PW<85LKW!!(93V8$@UY
MG-?77BCPQ\/=5U)YH[RXUB.*7R9&16*K.N\ ="=N<CL:]:C01QJ@+$* ,L<D
M_4]Z .8O?'VDZ=J26UU;ZC':M/\ 9O[1-JWV42YV[2_^]QG&,]ZT]0\06UA?
M&Q6"XN[I8#<R0VRAFCBSC<<D=2" !DG!P#@U0\26$7B*%/#D:K]G,L4MZP'$
M4:.'"#_:8J!CLN3Z9S?#FX?%3QJTQ^_#I[0$]XO+<9'MNW4 =!>^)=,LO#3>
M(3,\VFB#[0);>-I,IC.< =,=SC'?%376MV=GH\6IS%Q#*(Q&H7+NTA 1 /[Q
M+ ?C7G&AK(/V<=2+@A6T_4&B!_YYEI2OX8QCVQ71>)8[*X^&UE:7BRE[I;2"
MU,+['6X9D$3!OX</@YYX!X/2@#I;+68;O4)M/>&:UO88UF:"?;DQL2 P*D@C
M*D=<C'/45)J^IQ:-I-UJ4\4LD%K&TLOE %@B@EC@D9P!]:X_P8VI67BK4M+\
M2 7.N"UCDBU-.$N;56( "_P$,22.Y;/3%=!XV_Y$+Q'_ -@NY_\ 134 -M_%
M4=S9V=ZNE:DMG=^5Y4Y1"N)" K$!R0/F&>..];]<5X5BUJ/PMX6N)=1L1ID5
ME#)<1BV:-O+^SG&7,A!P=I/RCIGBLB_?5+J^^($?]O:E$FEQQS68AD5/+8V_
MF8X'(W=N_?/% 'IE%><V5]JB:UX(NY-7NY3KMK)]LA8KY0/V?S5*)C"D,/Q'
M7-84UWXAC^'VH^*8O$FH-?:5J%P(X7*^5-&EP5V.H7YLKQVQQ@#N >FV&OV^
MH:_JFC)!/'<::L32M( %<2;BI7!)/W3UQ6M7F5_K-QH6O?$/6+>'?<6NEV4J
M(PR VR7&?8'D_2M"^N;[1KSPE=6NHW5Y#JTZV=Y'+*7$N^)G$J_W""I/RX&#
MTZ4 =[17G%KJ&H6EWJ_@^ZU&[?59;Q&L+EY3O:UD^;>#ZQA) >Q*C/WJ=,FH
MWOB;QCIYUW4H;:RLK:6V6*4*8F9)3PV,]5'N>Y- 'HM%>8:;J>K>7X UB;5[
MN:76=L5Y Q A8-;L^0@'!#*#GKU[<5/8W7B#Q)I@URPU""SF@U&42>;>/Y:P
MQRLIB>'9M'R ?-G=DYR.E 'I%,,L8F6$NHE92P3/) P"<>G(_.O)]4O-:3P_
MXZU%?$&HK-HNH.;,*RA0%CB;:P"\KR1MZ<GO6_!;B;XR/,T]R,Z#%/L$[;0Q
MF88QG&.!QZ\T =Y6;::[I]]K6H:1;SAKW3Q&;B/^[O!*_H/U%6-3OX]+TRYO
MI062",OM7JQ[*/<G 'N:\OF6\\*>)/#WB2[TRZM1<LUAK4\CQ%':9]ZO\CL0
M%D) )'"D"@#UJBN1UR]N4\9V=C=S7,.C2Z=-(KVI8,;@.H^8I\P 4\=B3W.*
MYHR>*;?PYX-.I:SJ$&H:AJJP7898U;RV60@$!1@X13@YP2<YZ4 >IT5YXJ:I
M=:QJGA:VU2ZE?3;.)H;BXOVAG9I-Y\UBB?O ORK@\<<@YI+>\UW5=6D\.75]
M!)>6FEPR/-:WCVWFRLTBM*I5"6"E%&. "3D'C !Z)17G$/\ ;[>)_#FD:EX@
MDD>;3;H7C6)"I))$Z+N!VY#<D'T.<8K(DO\ 6K;P-J&K_P!O:A)<Z-K36<&Y
MQMEB6Z6/$HQ\Y*MC)]!COD ]>HK@;RXUGQ)K/B;3--NQ:7.FO'#:N+QXC$S1
M*XD9%0B0%F(PQQA< #DF"%=7U;QC<Z7=>(+M(3H5M<L;!U1/-9G5FC.W(4[0
M1W]\<4 >A/+'&\:NZJTC;4!.-QP3@>^ 3^!I]>1Z?<7/B)_A??W]Y<FXN8[G
MSFCF:/<RV[_-A2!N/K[D5ZY0 5D>(_$5IX7TQM2U"&Y-E&0)9H4#B($@ L,Y
MQD]@:UZP_%T:3>'S%(BO&]W:JRL,A@;B/((H MWVMVMEH3ZRH>ZLDA\\O;8;
M,>,[AR,C'/%7HG,D2NT;1DC)1\9'UP2/UKR36_.^'6G:MH4OF2>%]4MYUTR4
MY;[%.R,?(;_88_=/KQ[UUYO9=;\>ZMH,US<VUK86,$L:V\IB:1Y"V7W+@D+M
M4 =,DY!XP =9)+'%M\QU7>P5<G&2>@%9FF:_;ZGK.K:7'!<13Z8\:3&4 !MZ
M[E*X)R,8ZXZUYJEW?Z\O@\ZI=7#7-OK]S8//%(8A.(TF4287 W';C/UQC-6]
M1MKDZU\2+FUU.\LY;.WMYXFMG"DNEJ64L<$D<=.AR<YXP >E27KIJL-D+.Y9
M)(FD-RJCRD((&UCG.XYR..QJW7!:?JVI7OB_PV)+^80:AH$ES+ NT()?W7S
M8Z_.>N:Y^TU#6H_">E:Z^NZA+<IK_P!D9'=?+DB-VT15E Y^7OVP,8H ]=HK
MSGQ!?ZT][XMMHIKZ*^MH(6T1;0,0Y*9Y ^5B9 00_1<'@<UW>F17,&EVT=Y,
M\UR(QYKN5R6[_= '7CI0!;HKB1-=^*-;\5:9%JMQIT^F-%!:&!B/*+1!Q*R@
MC?EB1AN,+[DTW3KVX\2>)]<TB?4KA(M,M;00RVDAA\UY8R[3<'D=  <J,'@Y
MH [BF2RQP1-+*ZI&@RS,< "O*]+UW7M;'@C[3JEQ;27D]]:W9MPJK/Y*2 2
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MWJ .+C\.ZA'<Z7<+H>GB72XC#9L==N3Y:$ $8\GG( '.>@JJ_@V>2W>$Z!8
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M1[@U-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*XZ5E64=E<Z)XHAGO9[ /XG>:"[@',+90QRX(P4W+R>F,\\9KU:B@#R*\O\
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MTD*XR-QSQWXSUJS<:5K=QXH\+ZE-9P[+$71NA#(NV/S5"JJ9P6VXY.!GJ!V
M _\ X3W<VI0Q^'=7:ZTZWAN+B B)659%9NI?&0%(QG)/0<&I[/QS:7E[HR+I
M]]'9ZPF;*]D5 DC;-^TKNW#Y0>2,''''-5ETC5(_$OBV^^Q%H-3M((;8B5,E
MHT=3D9X!+C'L#]*S[;PYK,.E> [9K(;]#=#=XF3&%A:+Y>>>6SVXH N+XJTG
M1K/Q9JT>EZB#I]W_ *>A=69W$:?,H+X"[2O3'TK0B\9V_P#:TUA=Z=?696R>
M_ADE12)XD(#%0K%@1D?*0#STKGM1\,:W=Z+XZLX[)1)K<^^T)F7&#&B?-SQ]
MPGOUJ[K&C^(+O7[34=-@6VEAT:YLTFED0^7/)L*'&3E04Y^O0T :MGXO2[OH
M['^R[N*ZN-/.H6T<C(/-CR!M)W?*V67(/'/6L"+Q9#K'P\TW6-?TB\,%W=0D
M"WE50&:8>6<JX;:&V@YY..E+H?AW7+?Q5H^K7&E6MNJ:;+:7CF\\V5I&:-O,
M9MN7)VG')]R.E58O"OB&/X8:?X;>Q@-W97,!#)<@JZ13"0MR!C(& /7KB@#L
MKSQ&L-]>V=E8W.H7%C$LMRD!0; P)51N(RY )QZ8R1D9SSX^TZ5M$^P6E[?)
MK,4DEH\"IABBY93N8%6[<X YR>#4=OI>JZ'XPUK5;2S^VV6L)#(8Q*J/;S1I
MLP=QP4(QR"2"#P:R]+\&ZAH=WX,BAB6X@TD7;WDJN%&^<$G8"<D!F/IQCJ>*
M .L\.^((?$5C/.EM/:S6US):W%O/MW1RH>1E20>H.0>]1WGB-8;V]L[*QN=0
MGL8EEN4@* IN!*J-Q&7(&<>F,D9&:G@_2[_2WUXWUOY(O=5FO(<.K9C<* #@
M\'Y>1[]35:#2M5T+QEK>IV=I]OLM86*0HLJH\$T:;.=Q&48 '(R1CH: ,_Q-
MXJ&HZ1X8N='BFNM.U;48$=HRB^;&0[&(AF!!)3!!XP"">U:]X(_!'@O5M0TR
MQF<0QRWHLY)LB([=Q49.%08)VKQUQ6'_ ,(;J.E^'?".E6<*W3:7J:WUW()
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M L,(V3@$@CC-6_#VBSZ=?Z[K5W'_ *;JUPLIA1@=D<:!(TST+8!)[9;&>,D
MSO ,E]<^!;C%W)->"[O8XIKES(<B:14W$\D# _*L+P=K#:MJNDZ? T]IK6F;
MQKT=Q.6,V$9..3YF9,,&'W0I'&0#T?A/1-3L/"%]I5V#97<L]T\<T;A]OFR.
MRL,'J-P_$53L_"EQ(_A1I;!+*]T(!);R.12)8Q&4*)CYBK,0QW 8Y[T 3_%:
M6:V^&NLW=M/-;W$$2O%+#*T;*=ZC@J0:?8G1)]5TZWL[C4EO0#<#?+<!&50
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L,^#?#9OY+W^QK3SY'WR$)A7;^\5^Z3[D5N44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 50L]&L+"_N[ZV@*7-V0;B3
MS&)D(& 3D]AP/0<5?HH **** ,_5="TK7!;C5-/M[P6\GFQ"9 P5O7%:%%%
M!5'4M&L-8%N+^#SA;RB:+YV79(.C#!'(['M5ZB@  P,4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)
M8EFB>)]VUA@[6*G'U'(I]% %/2]*LM%L(['3H!!:Q_<B5B57V&3P/:KE%% $
M<\$5U;RV\\:R0RH4D1AD,I&"#[8JMI6DZ?HEA'8:79PVEK'G;%$NT9/4^Y]Z
MNT4 %%%% !1110 4444 %847@SPW#?->1:-:),S^8=J84MUW;?NYSSG%;M%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_7-3&
MCZ%>ZB4WM!"SHG=WQ\JCW)P/QK0J"ZL[>]B6*YB$L:R)*%;IN1@RG\& /X4
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MLAPX!!(.,\^E/JG9Z796-Q=W-O;117%XXDN708,C@8R?P%7* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO-(N-2\2PSW]M8SZ5;P,L4<C%V\UB,N4*[> ,#GC+>N*W0RMG!!P<'!Z&EH
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M+%D95&,EFX(/7Z58D\$V4UA:6TVH:E*]O=QWOVF697EDE3[A8E2,# X  ]J
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M '  53D@ $MDX'7DYIV?@'3=-.DS)>ZM.VCAQ9J]SG"%<>7@  C  ]>@)(H
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MX^5.  .!SR>!S63XPL[F\\8>$&@2^6.VN)Y)KFU@+^2&A95).TKRQ P>Q]*
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MZH ,A> 3MY'49FIW&G3>$?&D,UW:S.GB*WGC9<)@.UOET&?E!^?!!Y&>3R:
M/9;B[N)+JR^P7-@;<SM'="1B7("GY8\'&X,!D'MFK;W=M'<I;/<0K<.,I$7
M9A[#J:X'Q!IFBZ/XO\$FPL[&S,NI3.?)14W;K=P3QZG;^E8D4NBZL-7T7Q%J
M]U::W%K$DJVL8B6>1A+N@:$E"S?)L48/ &.!0!ZP;VU6Y^S-<PB? /E&0;L'
MVZU5U77-/T8VBWUPD3W<ZP0J6 +L?KV Y)K@GGGT[Q,DL,EGK.D7>N[&B8;;
MRPNBVTD$?>08)P<$(?2M;XC_ &2*7PI=7ODI!'KD/F2S8"JICEZD\ 9QU]J
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M&'E PSXBVKSU/7 Z^E<T[Q7OPX\66FI8'B2&^N&V])S<;\VQ3OR/+"D=A@4
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MSM4R.%!/H,U*K*Z!T8,K#((.017D>F/>7'A7PG>:5JE@VIP:%A[#4N8;N$A
MXW9RK H 3[C/%;VN7=[>_!%[K1+*XM9I-,B:.U4DR1Q87<H/4G9NP>O2@#N(
M;RUN3((+F&4Q'$@1PVP^AQTKF;3Q)J6N:E=KHC::UO8:B+2>*<MYDL85"\B,
MIP,%\ %3G;U&>,NY-C?^,?!M]X<> Q-!.+@V^-IL_+^4.!V#[0 >AS[U/\.1
M8FY\5M;"WWKKUPH,8&0NV/CCMF@#H9?$-I+>ZEIEC<02:E8P+(\;MP"P<A3C
MG.$)(]"/6H?"/B'^W_#.DWUT]O'?7MJMPT$;8P#W ))Q7-VDNGV7Q+\8I<-;
MPSRV5I) 'PK,!'+O9?;U/YUS.A0Z;9^'_A=?0+;17DETL<DZX$C*8) RENI&
M=HQ]!0!ZU:3W?VG4/MLUD8(Y1Y'DD[DCV@GS<G ;.3QQC%6K>ZM[N/S+:>*9
M/[T;AA^8KRV&'3I(OB!:#48M,B;6+?;<1JI6)RL.TLO0J9.&SP1NS74>"KV^
MEO=<M=5LK./4+::+S[NQ)\BZW1C:P!Y5@H (^E %KQGXNA\'Z?;7<L#3"6X1
M) O_ "RAW 22GV4$?BPKI P90P(*D9!'>N(DLW\:7.LSVU_8-ISQ/I2K);F?
M*C_6L"LBXR_'0_ZI37.6&KG4?@YX@T*\U9(-2T2&;3[F=#DE8^$? YVLH S]
M: /58+NVN@QM[B*8*<,8W#8/H<41WEM*^R.XA=MN_:K@G;G&?ID8KSO1#X>\
M2>-H=:-SH+F#2?LGV.*YAG;=NRS@#HJKE0>I#'( Z\WI-G867P7TW6[.TC:6
M.5$U"XMHU>;[(+K,BYP<J HRIR,#IB@#VBWN[:[C,EM<13(#M+1.& /ID4D-
M]:7$3RP74$L<9(=TD#!2.N2.E>5:V^D2:1KFO>&M6NM4>6&V_M'[)Y;1^0DJ
ME@55 /,\O>,'/RYR.E&M1^%-4\/>*=9TO5SJ<LN@2QR[?*\E-JDQ%PJ+B7).
MW/. ?:@#U5;VT9W1;J$LB"1U$@RJGHQ]![TZ.Y@EMQ<1S1O 1N$BN"N/7/2O
M,#IVB_\ "4_#]5M[,B[T^X$PPO[\"*-EW_W_ )N><\UE"]ATS0=3:&0QZ-9^
M,9!>"V56$%MC(.W!&P2%3C':@#V*.^M);;[3'=0/;_\ /59 5_/I37U"RCBN
M)7NX!'; F=C(,18&3N]/QKR/Q7:^&9/"'B35-+U0Z@+JYL9)9MT9A642HN8R
MB@!]GWL<XQFMNXL]-M?B-J]C806T<=QX9#O!"J@2.)7P2HZG!Z]: .]TC5K3
M6]+M]1L9!);W$:R(>^",C(['!'%7:Y+X93V4_P .]#%G)"Y2RA2;RB#B0(-P
M;'\0[]ZZV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "D90RE6 *D8(/0TM4]2U.UTJU$]TY56D6*-
M5&YI'8X55 ZDG_.* )TM;>*#R(X(DA_YYJ@"_E3T1(UVHJJH[*,"L(^+],B3
M4_M*W-M/ID7GW5L\):18R"0X"Y#+P>5) P<XJ?0O$EGXA#O907BQ+%'*LL]N
MT:2*XR"C'AL8YQ0!J+;PINVQ1KN&&PH&?K39+.UE""2VA<1XV!D!VXZ8]*R=
M0\5Z=IWVUW2YF@L"!>SP1[TMN WS=SA2"=H. <G%5)/%BOXRL]"M[2::"YT]
MKP7<6"I!=%4J<_=PQ)/TQGF@#IF4,I5@"I&"#T-1BW@  $,8 78 %'W?3Z5Y
M[X3\80Z;IUQ#JT^H7&=;N;-;N1'E2+]^4C5W/3L/;(SC-=7JWBO3]&2ZEG2Y
MD@LMOVR:&/>MMD C=WZ$$A02 03@$4 :WV2VQC[/%CTV"E%M &#"&,%>AVCB
MN>N/'6D0ZE-I\45_=W,2PNRVMH\F4D)"N#CE>.6Z<T?\)UI/]D)J?EWGV9KW
M["28<,DV_9M89^7YN,GC]* .@^RVX4K]GBP>2-@YIWD0[E;RH\H"JG:. >H%
M87B'6["VTW6(+U]0MX;:S\VXN+56W1HP891ER0PVL?;&3QBI?[?L[6WMH84O
M+M_L:W15 'D$.,!VR1DGT&23GB@#9$,0" 1H!']SY1\O;CTI/L\/VC[1Y,?G
M;=OF;1NQZ9ZXK*O/$UG:P&1(;JY*VRW<D=O'N:.(YPS D=<' &2<' .*T-.U
M"UU;3K?4+&99K6XC$D4B]&4]* )$M;>.9ID@B65AAG5 &(^M.EBCGB:*:-)(
MVZJZ@@_@:Q/$=]86ESHL5[<W\#SZA&EO]EW!9),'"2$<;",D@GG'M52]\?Z-
M8R:I&T6H2MI97[9Y5FY\I2N[<>/N@<Y[CIF@#I3;P&-8S#&8U^ZNT8'T%/V*
M$V!1MQC;CC%95WXBLK<HD*S7DKV_VH16RAF\G^^<D  ]N<GG .#7-W>N+J?B
M[P1?:5?SOINHQW;F-'*I*%ARNY3CD$GKT- ':PVT%OO\B&.+><ML0+N/J<=:
M([6WA(,4$28)(VH!@GK^=84GC728M%O-5<7(M;*[-G<_NOFCD#!"".XW$#(S
MUJ76]<MX8[ZQB6[FN8;8S3_8URUNA!PQ.1R<' &6XX% &P+: 7!N!#&)B-ID
MVC<1Z9ZT&UMS<"X,$1F7I)L&X?CUK@?".LP7&E>!5U'4-3?5+JR>2,!G,=P?
M+RYE/1B!R 3D$YK7;XB:&L<TQ6_^SV]Y]BN)S:.$@DW!?G)'RC<P'K[8H ZE
M88DD+K$BN>K!0":9':6T1)CMXD)).50#D]?SK,U'Q-8Z=<7<#+//)9VXNKI8
M$W&&(YPS<\YVL<#)X/%7=*U2UUG38-0LFD:VG4/&\D31EE/0@, <'L>] $_V
M6W,;1^1%L;DKL&#^%*UO Y):&-BQR<J#DXQFJ&KZ[::))8K=K-B]N%M8F1,K
MYC?=!/;/K5>/Q3827&L0>7<+)I"A[L.@&T%2P(YYRH)S0!KFWA;;NAC.T87*
MCCZ4&WA:=9S#&9E&U9"HW >@/6N<BUJPD\379C.K-?Q:8DSV+*RQ^66."JM@
M>83D$Y[8)&*YC4/%MSK'A;PIKZ&\T];G6+821QL0)(F8Y4A3EQ@ >Y[<T >D
MBUMUN/M @B$V,>8$&['UZT]T21=KJK+G.&&16':>,-)N8-4EE:>S_LLC[6EW
M$8VC4KN5L=P1T[U)#XFM)=2739;>ZMKV2$SP03QA3.@ZE#G&1D94D$9Y% &K
M+;03/&\L,<CQG*,Z@E3ZCTJ1E5U*L RGJ",@US\7C/29]+TK4D,YM-4N1:V[
M^41^\+%0&'4<J>?:FZ'XG?6?$.M:;]@GA33IEA$CJ,,2@8D\\9W# ]/RH W?
ML=K_ ,^T/_? I_DQ;BWEIDC:3M'(]*Y-[FXB^+:V_P!JN#:-H4DQM]Y*!Q,B
M[@OKCCUING^+-"TSPZ-0%WJ<]G-J,EN)+F-W=96E*E3D950QP <8 Q0!UAMH
M#"T)@C\I_O)L&#]12F"$P>08HS#MV^7M&W'ICIBN<_X3G33<WMHMGJC7MHJR
M-:BR?S7C;.'4?W>#R<<\=2!3+SQ%HNH0>&KQ+Z_6'4+I&LFM@Z+,Q5L)*<8V
MXR2I[K[4 =,;>$V_V<PQF';M\LJ-N/3'3%*D,<>=D:+D ':H&0.!7*6'CNVE
M7Q%<ZA:SV5EH]RT+32)G(5$)S@D[B7. .V._%6;OQG:6MGK+FRO/MFE6PNIK
M-E4.T9!*L""5(^5N_&#D4 =!]F@PH\B/"#"C8./I4A52P) )'0XZ5R'_  D-
MI?6'A:YU%M2LKF^GB:%( R)+*8R=KD9!0Y)P3SCVK3U#Q9IVG"]D=;B6WL&"
MWMQ#'O2W. WS=S@$$[0< \XH V9;>&XV^=#')L;<N]0<'U&>]25S]WXRTJVU
M1=-1;NZNI+3[9$EM;M()8\@ J0,-U'0X]2*T=%UBSU_2+?5+!V>VG!*EE*L"
M"000>A!!!^E %J.VMX6D:*")#(<N50#<??UIT<,46?+C1,]=J@9K-UWQ%I_A
MR"VFU%Y4CN+A+=&2)G&]C@9(' ^M9MMX]T.=-5,[W5B^EQ>==17EN\4BQ8R'
M"D9(..W/MS0!T9MX6D\QH8R^<[BHS^=)]F@^T?:/)C\_&WS-HW8],]:Q!XOL
M0U]'+;7L5Q96RWDENT0,C0MG#J%)#?=/&<\=*L0^);&XTW2K^%)Y(-4*BVVI
MECN4N"1GCY5)]L<T :BP1+(9%B0.>K!1G\Z)((92#)$CD<990:Y=OB+H26K7
M96^%I'=FSFN#:.$@D#[/G)'RC<<>H[@9K0L?%>G7NIW>GE;FUN+: 7)%W"8@
M\.2/,7=_#D8.<8H UUMK=,[8(QD8.$'(]*#;P,%!AC(7[H*CCZ5BIXPTTZA;
M6<L=W"]Y"\]F9(#BY11EM@&3D @[2 <=JJV'Q T34CI;0"]$&IN8K:YDMF6)
MI.2$W'^(A3^6.O% '2FWA:=9S#&9E&T2%1N ],]:#!"TZSF*,S*-JR%1N ]
M:Y?3?&\-S-X@>\LY[2UTFY,'FN@^;"(>Q/)+\#TQWXK>L=36]N+BW-M<6\T
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M1P:/%E]86.F6YU"YO[:.2[@1)++<&+F0;59AT4G .<9!Q0!N!$5V<*H9L;F
MY./6HTM+:.-HTMXE1CN950 $^I'K6%?^-M+L=0O[ P:A/=V,2S3106CL=C9Y
M'&"/E//3MUXK6MM6LKS18M7@F#V,L N$DQU0KNSCZ4 6#;0%54P1E5Z H,"C
M[-;DD^1%D]3L'-<=X.EN_&6A)XCU*[NXDO7=K2TMYVA6WB#%5SL(+L<9)8D<
M\ 5L6]S+X>LS%JU_-?33WC1V9*CS9@PW*F  ,@!LG@84DXYH UWL;21 DEK
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M>N%&!3JHZ/K%GKVF0ZCI[R/:S#=&[Q/'N'8@, <>]7J "BBB@ HHHH ****
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MGR8H6D >3 ).U>IP : /-O%?AK5=8A\3ZI9Z;.9M1@M+2VM2R*[B*3>TC9;
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MEF@UEUA:)HBY8.V?G\P XP!R0.0.:[GQ%HL/B+P]?Z1.=J74)0/W1NJL/<$
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M>D26,UW'=%KF:X#I$8\>8Y<C!8]"QK=H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)U[7X/#\=E)
M<6]Q*EW=Q6BM$%(1Y&"J6R1QD]LUK5Q?Q+5GT32420QNVMV(5P 2I\Y>>>*
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M8.#0!ZE17F'B5?$N@>'-:E_MPQ*+NS>RBCN#/+ DDRQNKNZAF4DDCOU&>*]
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M#@=JO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML+2.U@W^7&, R2,['W+,22?<FLT>%=%%SJ<YL@YU,$7<;R,T<F0%)V$[02
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M;,VMC'(%9MSO+*TKN<8RSL23P .O%)>:!IM_J]IJMQ QO;162*1)73Y202K
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M:BD64)DA)Q@?-@,#U!]>":S=7T+7-6U2^UNP TV_CTF2QL!,RLWFNP8NVTD
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M'YN<L<Y/;/M6IJ/BWQ#I>A^-%>:QGO\ 03&\4_V9E21)(U< IOX(R1G)[<4
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MOIEMX:U2\:VGL]8G@MYX(XRIMVF7*%&S\P!P#GKG(QTH [=55%"JH55&  ,
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M9:A$B^8@D)+JRGY64YZ8[#WSU6DZ=)IMF8Y[V:]N';?-<S!0TC8 SA0%48
M ';UR:O54U*6^ALF?3K:*YN=Z 1RR^6I4L QW8/09/3M0!SC>!VBUV]OM.UZ
M_L++49/-OK"$(4E?&&96(+1E@.2O/N.,6-7\&PZW9:G;W=VQ>[:,P3+& ]H$
M(*",]L'+9ZY)ZC '344 <GJ/@RXO-1L-7MM>NK+6;:W^RRWD4,;?:(LYVNC
MKG/((Z$GCIBU/X4674=#O%OY@VDO)(OF*',[R*5=G/'4,3QC!/IQ7144 <W_
M ,(IY]Y82W]^UVFGW;W=KNB D5FW *7!Y0!NF >%R3BJNC>!3H=WY5KKM_\
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M+1K;7+RVT:]G\\6BQ1MY+%P[!&(R%)&<=C^(/=44 0O;+-9M;3LTJO&8W9L
ML",'. !^5<A8_#][1="23Q!>S)H<A-FOE1KA-A0*WR\_*<$GGCC')K8U_7YM
M&U+0[9;1)HM3O1:-(92IB)1FR%QSPA[BMV@#C9O (G\/:OH[ZK+Y6J7S7TL@
MA7<CLX<A><8RHZY.,_A8G\&O_;M[JMCJ\]E)J,*QZA%'$C),57:KJ&SL;''?
MC\ZZJB@#AQ\.5M].T1-.UV^L]1TB$V\%\J1L6B.,QNA&UEX&,]/4UI2>$6DO
M]%O6U6XDN-,DDF\R5%9KAY%*,7Q@ ;3@!0 ./2K.J:_-IWBK0M(%HCPZH9@9
M_-(:,QQE\;<<YXYSZ\4>,-?F\,>&;K5X;1+HP%-T;RE.&8+G.#G&1QQ]: -7
M4+1=0TVZLF<HMQ"\19>H# C(_.L&Y\*3ZC9VVG:IK$M[IL$D<AC>%1+,8V#*
M)''!&0"<*I..O6NFHH Y.Z\%2?\ "176K:7KU_I:W^TWUM J,DQ48W#<#L8@
M %EY_&DG\#[-?FU31]:O=)^UQQQ7L%NJ.LP0;5(W@[&"\;A76T4 8 \+QP^)
MH]:M+V>W*V263VX"LDB(Q9,DC<,%CT/-9R?#^V&@+ICZA.9(=0;4K6[5%62"
M<N7R.Q&688(Z$BNPHH YNZ\)"_BU22\O3)?ZC9?8'N4B"B*'YLJBY."2Q)))
MYQV %-C\)%+WP[<G46)T.%X8E\H8E5D"$MSUVJ.F.?RKIJ* $(!Z@'ZUD:;H
M*:3=ZQ=6LQ,VI7/VEO,3*QML5, #&1\H/6MBB@#+T_0X;+4+C4Y9'NM2N%"2
M7$@ *H.1&@'"H"2<=2>22>:8-"2?6(=4U&8W5Q;!A;)MVQ09&"RKD_,1QN)/
M'3&3FY8RWTCW8O;:*!4G*VYCEW^9%@89N!M.<\<].M6R0 23@#O0!D:GH2:U
M-&FI3&:PCD606:KM21@<CS#DEP" 0.!Z@UKD @@C(/:JUA?6VIV45Y9RB6WE
M&8Y%Z,,XR/:K- ')6O@2WM=,&B"]D?05N!<1V+(,KA_,$>_J8PW.,9[9QQ6C
M'X>=/&$WB+[<Q>6T6S,!C&T1JQ<8.<[LL>??I6Y10!C^(] 3Q#9VL)NI;6:U
MNXKN":-58K(AR,A@01R:SO\ A#F^T:_,=4E9M:MTMYB\2DH$0H"N,<[2<YXS
MV XKH)K^U@O;:RDE47-SN,4?=@HRQ^@X_,59H XR;P"RKI%QINNW>GZGIMFM
MBMW#&C>= ,861&!4],Y]23].JT^S%A91VPFEF*Y+2RD%Y&)R6.,#)))X  [
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M[-N-,LY;'.[[,\"M'G.<[2,9SS3H='TNW\_R=.M(_M"!)MD*CS%"A0K<<@*
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M8)1MDB2%0KCL",<B@#EOA?H]C#X-T;6$1VU"ZTZ))IWE9BZCD#!..,^E9?\
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M>L]$TK3Y7DLM-M+=WR&:&%4)R<GH.YYJ+_A'-#-L]M_8VG>0[^8\7V5-K/\
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M_@((7_@-<5&T^E^++::_M+?4M.O-7E2TU:U;;<6\K&1?)F4\LJ_,H(. %''
MKTRJ,6BZ5!=M=PZ;:1W#.TC2I"H8LWWFSCJ<G)ZF@#R>^C ^&GBG$LP,'B=T
MC82MD#[7&N,YY^4D<UT/_".Z6?BG=Z6;8FPNM%6YN+8R,4FE$Q4.XS\QP>I^
MO6NR/AS0S;R6YT;3O(DD\UXOLJ;6?^\1C!/O4W]C:7]J^U?V;9_:?+\KSO(7
M?LQC;G&<8[4 >564CR_#OP'+)/*SQ^((H%8R-RBW$BA3SS@*HY]*U-0O;6PU
MCXF7-[/=06Z6EF))+,@3*#"P^0G@-SP3TKNQX<T,6\5N-&TX01/YD<?V5-J/
M_> Q@'WJ7^Q=*\VYE_LRR\RZ79</Y"YF7T<X^8?6@#S15BMO%6N:>C6EK#-X
M:64VUE-A1(&?!)&-S[<?, ,C';D]3\.-&L;3PCH^J0QO]MO=+M1<3-*S%\1@
MC@G QDC@=..U;D?AO0HD5(]%TY42(PJHM4 $9.2G3[I/..E7;2SM;"V6VL[:
M&V@3[L4*!%7Z <4 >;8T?2O%GQ$O;E1:F*V@D\ZV51.FZW<NT9_O'!.?4<TW
MP^+2'Q]96>+**RN_#A:2V20.),21A&E/ =RK'G'<\GK7H\FE:=+>/>26%J]U
M)$87F:%2[1_W"V,E?;I5:+PUH,$<<<6BZ<B1HZ(JVJ *K_> XX![^M ' ^$(
M+72_%L.E7F]].;SKCPW-,!^\5FS*I;JS#@H3U0Y^F_\ %)1_PA$DNYU>.\M"
MI5RO6XC!SCKP3UKI9-%TJ86HETRR<6G_ ![AH%/D_P"YQ\O0=*EO=.L=3@$%
M_9V]W$"&$<\2R+GUP10!Q%QH]CJOQ7U6SOHFN+631()'@>1BA8S2#.,XZ ?E
MGK7+Z1;I'X.^'VM[Y6U-]4@M6NGE9G:$F1#'DG[N ..G&>M>M?V-I?VE[G^S
M;/[0Z>6TOD+N9.FTG&2/:HQX=T,6\-N-&T_R(7\R*/[*FV-O[RC& ?<4 >93
MZ!IFIVGQ#DOIIQ)87LDMM*;EP;9A;HP=>>#D?IBM/PY+<:YXECTSQ9 LL@\/
MVDT-O<+E6=@?/?:>-^[:">H]LUNZ%X1-OK>NW^KV&FS?;KT75NRGS'0!$4*=
MR#H4SP3R:Z.^TG3M3,1O["VNC$28S-$KE,]<9'&: /*]+BUZZTBQ>W%KK7V"
M6^BATW47YO+19@J2HYR-Z[=H9L\-UYYL6NL:?JVI:'IT[V]KHUQH,;V,.KQ>
M8KN&*N#\Z@R!0G/)P21C)KTJXT72[L0BYTVTE\A2D6^%3Y:]PO' X' IM_H6
MD:I:16FH:7975O#CRXIX%=4QP, C X]* //M*\B#Q-X=\-7^IMJND#3;E[2:
MY *W<ZRA0#G(?9'G;UXY]#6S\,H[:"R\1V]J5\F+7KM456R%7*X'TKJK[1-*
MU.TBM;[3;.ZMX2#'%- KJA' P","I++3;'35D6QLK>U$C;W$,2IN;U.!R: /
M-Y]!T?6_%'Q".KEA';M;2+()F3R"+1#Y@P0,C'4^GUJ(&\T;0O!_CG5HW-Q;
MVT=OK!=27,,@ $K#KO0[2>,X9A7I%QHFE7=Z+RYTRSFN@ !-) K/@<CDC/%4
M-6T_6=4U-+1I+!?#[*C3@JYN'96R4_N[#A0>^-P[Y !+X9L3:Z6;F6$0W5](
MUW.F,%6<Y"'_ '1A?P)[UQ=EYNF^*;#^TK*VU&QOM1N!8ZQ;'$H=Q+F&X4\L
M -Z@@X&Q>!BO3:HV^BZ7:71N;?3;2&<LS&2.%5;+=3D#J>Y[T >6:,-$T[P'
M-#)&(9+CQ!):B*V9(C*1=MLCD;!Q%@8;C[N0.N*H:\MNWAKXE:>_V-H[:6WF
MAMX,>7"QCCWE >F">2,<YX&<5Z_)H&C317<4FDV+QWCB2Y1K=")F'\3C'S'W
M-.30])C6=4TNR47$0AF MU DC P%;CE0.,'B@#A]6GTX^-;;09Y=*M](DTPO
M9Q74 >WDE\UA*% 95W@;?4C)QC)KJ?"MK_9WA*VM;;4I-6$"ND5U+UE 8X&<
MG('0'N #5RZ\.Z)>V$%A=:183V<&/)@DMT9(\?W5(P/PK0CC2*-8XT5(T 55
M48"@= !0!X^));OX2V/B2U)_X2N.[CS..)FN3<!'A;N5()78> ,<8 K?T?0M
M/U+XD^*VNTEF-E=6-Q;J9WQ')Y.[< #Z]CQU]37:IHNEQW[7Z:;:+>,VYIQ"
MH<MC&=V,YQQFGP:7I]K>37EO86L-U/\ ZV:.%5>3_>8#)_&@#F?')_XFW@S_
M +#B?^B9:Y_$.M:)X\GU8^7JFG7ER(9B=LEI&D8:!HSU48&[(ZDMUS7H]WIE
MA?R0R7EC;7+PMNB::)7,9]5)'!^E1W&BZ7=WJWEQIMI-=* !-)"K/@'(Y(SP
M>10!YWI=^FL:V-+\;&*.670+26"*Y(12[!OM#J#P'#;1Z@#CO2:L-(F\S3H+
MN2^-GX>++-J<P:-8BS!9E& 7E8K]X$#&TYYP?1=2T32M8\K^T]-L[WR6W1_:
M8%DV'U&0<4MQH^F7=W#=W.G6DUS I6*:2%6>,'J%)&0/I0!YYIEXU[=?"F>2
M?SIGM)C(Y;<Q?[&"<GUK>^*IQ\-=8SZ1?^C4KH8] T:+[+Y>DV"_9!BVVVR#
MR?\ <X^7\*LWMA9ZE;&WO[2"Z@)!,4\8=21T.",4 >;^.Y;&[N/%B*ZO=V.C
M!G:[<;+<D2,A@7KYC'&6R,$)UZ4M_<0:7<^&/%<T?VRVO['^S;\*/,,CO&&C
M..[%U*$_[8%=_+H.CSW"7$VE6,DR1&!9'MT++&1@H#C[N"1CIS4Z:?9QVD-I
M':0);0E3%"L8"(5(*X'08(!'IB@#SGP79RB8>#]1MT:71+UKN60*2LD;#=#\
MQZG+D9_Z8D'K6]XWO)(-5\+6D_RZ3>:CY5X3]UCY;&)&_P!EGQQWP!76K!$D
M[SK$@ED 5W"C<P&< GOC)_,TV[L[6_M7M;RWBN+>08>*9 ZM]0>#0!Y1XHMG
ML$\?Z?9%X](CT=+M8HV*I;W)#Y" =,A58KTZ''->A^&M%L-*L!/9Q,LMY''+
M<.TK.9&" ;N2<''IBKG]BZ5]@>P_LVS-FYW/ 8%*,?4KC!-6H+>&U@2"WACA
MA0;4CC4*JCT ' H \BU*]LWNK'5+"=5)\6)"US<2@W+_ +S9)&,8VQ <!3G(
MQD"F:MIEG<Z9\3;ES)(]E(9[1S.Q\IQ;(X=>>#N[_A7J+^'-#DEGE?1M/:2X
M<23,ULA,C Y#,<<D'G)IQT#1F%P#I%@1<G,X-LG[T_[7'S?C0!Q6N2IX<U+0
MO'$D;26\ENMGJ>Q=Q D ,<H [AP%)ZD.!VKL/#FFMINCQK+$D=U.S7%R%Z"5
MR68#V&=H]@*IW&D:G<ZG%9 :9!X:A\J188HV$S.AW!"/N!-P4\=@1WS714 >
M,ZM$J_#OXB*LLH\G7)-A\ULCB 8SG)')X-=(VE65E\3+NP@AS:WWA^26ZA=B
MZSNLRJ&8-G<<,1D^M=@?#NB-#-"VC:>8IW\R9#:IMD;^\PQR?<U,FD:9'>)>
M)IUHMTB>6DZP*'5?[H;&0/:@#R/1KVTTSP)X"B,EE:Z?>L%U"66,-$TGE-Y8
ME 9<@L.YQE1GI5O6M(M+'2[>&TU@W,$GB2R81VC&.&U+R+NCCPQP.C;<_+G(
MQFO31H.CC3IM.&E6(LIF+RVPMT\MV/))7&"?>F_\(]HGV&"Q.CV!M(#NA@-L
MA2,^JKC /TH X2]L]+TWQFOA>4V%GI,FG&>TAU!&EBDE:5_.V[G'S@;,=2 3
MC&35>?3KVSTS3SIUS;>*[?3[&1)[2^;9)-$9&Q+"_(W (5![@#GD5Z/J.BZ5
MK$$<&IZ;9WD49W(EQ"L@4^H!'%)<Z)I-XT;7.F6<S1Q^4A>!253^Z..%]NE
M' 2+HVH>,/ .H?9H_LUQI%PZ-=HN_:J0LFXGN 2?;)Q6[X\O9+6?PY!(2NF7
M>JI#>MG *E6V(W^RS[0>QZ'K73W&FV%V]L]S96TS6K;X#)$K&)O5<CY3]*DN
MK2VOK62VN[>*XMY!AXI4#*P]"#P: /+O$EJ^GW?CBPL-T6D#P]]L:*)BB077
M[P#:!]W<J!B!UP#WKMO"&BV&F:/!=VD;">]MH'N)&E9S(P0 'DX'7MBM-=%T
MI;&2Q&FV?V20Y>#R%V.?=<8/0=:LV]M!9VZ6]M#'!!&,)'$@55'H .!0!Y)-
MH.F:EIWQ#FO9IQ+I]]-+:RFY?-LPMXV5UYZY'Z8J:WNI=:U+^Q_%=W96UQ)H
M=I)$FH0YR[(WG/&=ZA7#XR>O ]#75Z!X2:VUG7+[5[#39C?7_P!K@=3YCH-J
M*%.Y!T*9X)Y-=!J6B:3K/E?VGIEG>^2=T?VF!9-A]L@XH \]L='M+KQSHMA=
M7L^JVK>')0TLTC 7(6:)59AG!!'/H>#S530+FUD\-^%=,NGDN)6U&_BM;>>4
M"!TB>50)B02P1<;5ZY"^F1Z@^DZ;)>"\DT^T:Z5/+$S0J7"_W=V,X]JKMX:T
M%K5+5M$TXVZ2>:L1M4V!_P"\!C&?>@#RN.Y63X:2VXN8YEMO%"11B-OE6,7H
MVA1DX7&<#/2NJL+'31\7_$#2V]NLSZ?:,C$!7+,958@]<D8&1STKK7\/Z++'
M)')I%@Z23&=U:V0AI#_&1CEO?K4SZ5ITEXEX]A:M<I&84F:%2ZH>JAL9 ]NE
M 'DVFZFVG^!/"Z7%S'#ID^M7<%W/<@R1X\R?RQ)\PRI<+G)QP,\9%:\NAM#9
MW-KH6N:?<R2ZE'<1:?)&19%_+<M;@!FVA@/,QDX(!QS7>KH6D)ITNG)I5BMC
M+S);+;H(W^JXP::OA_1DT^+3UTFQ%E"^^.W%NNQ&Y^8+C /)YZ\T 97@6]BO
M-$N573'TR>WO98;FS9PZQ2@@L$8<%/F!'Y=JZ>HK:UM[. 06L$<,2DD)&H4
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M$12O'.6!'Z]*=>?;-*US1]7N-(UB\TN?1XK*5;%)1-;3(Q;+1J0VTAL>Q44
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ML4D,VX8!'')I]>+RVMN/@G?*(8\0:V_E#:/W?^G@?+Z<<?2O9R 001D'J#0
MBNC[MC*VTX.#G!]*=7DVA>(KKPCHOB"Z@\/M<Z/::]??:98IU0PQ^<1E(\?,
M%'497VS75ZMXZAL_M_\ 9UO!?&PC62:-KGRWDW('"Q+M.YMA!P<9+ 9ZX .N
MHJO8WB:AIUM>Q)(L=Q$LJK(NU@&&0".QYZ5Q5Q\1+NWTC5-5/A\FSTK4'L[P
MF\7> K*I=%V_,?FS@D<=">P!WM%<U;>*+K_A)IM%O](:V?[$U];M'.)6EC5@
MK*R@#:^2. 6!SUJO8>-6FUFPT[4=/2QDO;%[U5-QND@"[25F0J-C88'J>01V
MH ZMW2, NRJ"0 2<9)X IU>8>*=5EU^S\'ZJFF1+83Z[9O:W#2YF"%^&*;?E
M# 9X8GID>FYJOC^*P6[GMK-+RVLKK[-.L<_^D$A@KF.(*=P4GN03M;VR =G5
M9;&!-0>]C!2:10DNT\2 =-P]1Z]>U2R31Q0//(X6)%+LQZ  9)KGK'Q/>7K:
M3<KHLG]E:FADCNDEW-"FW<C2IM 0,/\ :."0#0!TM%<=)X\6'1;3Q ^GX\/W
M,ZQ"Z$_[Q$9]B2M'MQL)QT8D @XZ@-O?&VH0W/B."TT#SVT,))*9+P1B1&C\
MS*_*?FQT'3KDCN =G17)6GC2:XU;1()-(:*RUN%Y+*<W +DK'YF'3&%RN<'<
M?<"LJ;XEWD&D3ZR_AF;^RK.\DM;V87:EX@DFPNJ8^< ]>1CWYP >A45R'B#Q
MN^@17]Y)IA;3[)H5,\L_EM<;\$F%2I#[0PSR.01VJ2[\6:DOBB\T*P\/M=S6
MT,,YD-VL8:-V*D\@\C:3COCM0!U*2)(6".K;3M;!S@^AIU< /&%OHWAWQ1K-
MKX=$3V&J/%=0QS*#/)B,&4G'4[AZ]*VK7Q5-_P )+=:/J>F?8C'8F_AE$XEW
MQ!MK;@ -K D< L.>M '2UGZSI(UFP%J;Z^LL2*_FV,YBDX/3=Z'N*YR'QW-.
M/#TR:/FVUXG[*XN1N3Y2XWJ5P,J">">1CWKI-<U2/1-!U#595W)9VTDY7^]M
M4G'XXH 46-A:Z4NGX6.TCC"%3(1\ON<Y.>^3SSG.:N($5=B;0$^7:O;VK@K^
M[BTSX5IJNLZ8FKO=QP7%]%(P =Y&4]P?E5F4 =@H]*U/%-^?#^LZ%J<7$=[?
MQZ;=H.CK("$8^ZN%Y]&84 =736=$V[V5=QP,G&3Z54UBZN+'1;V[M8HI9X(7
MD1)7*J2!GD@$_I7FU[>WVHZ+\.-9OK2*;49;Z!E:)P6D#VSL<DA=N3R1R!CJ
M: /5J*Y"W\<JEGJQU2Q6SO=.O([-X$N!(CO*$,9#D+P=XSD<8-7=#\4-JNMW
MNE36:1R6\2S)/;S&:"5"<8#[5PP/5<=P: .BHKC/B)H*ZWI^G)!-]CU'[;&+
M:^C7]Y"V&(P>N,@9'>LE=>'B3P^^E:_9PQ>(-,U"RBO;9E!!S<Q 2IGJCC^9
M'U /2:*Y'6?&L>E'48[&SAN_[+VK/#]H\N1CM#E8DVG>0K#C(R3@4S2O$>J:
MGX\N;%+>!=+33K>ZCW2,L@$I?YBI3[WR@;<C'J<X !V-%<U\0X8Y?AWXB\R-
M7V:=/(FX9VL(V((]"#WKSO6+K3[3P9X8;1[.72]9D-H$U,VK6L,9PI<RRD!6
M5ANX).[- 'M-%<SK7BY=.N[RSLX;>YN;.!9I8YKKR=V[)5$^5MS$*?0<KSSQ
M3@\<W6H:I9V&FZ#+))>:9_:$1N9Q#M^95*.,$K@MC(!Y'0@Y !V5%<A9>/;:
M]T/2;T6Z07>I-*BV]Q.$6-HB5DW. > 1@$#)R.!SC!\4^++_ %;X=:M-;60M
M9H+Q+*YW3MM93+&NZ)MGSHRMC/R\$^F* /1XKNVG;;#<12-SPC@].O2IJX>P
MCL+#XBS6\7AJRM=9NM*>Z>\BGRCA9$01_<! .5);:.G0U?\  &LZIK_A:+4=
M4C@626:;:8I"W F=<8*C    Y.0,G% &_!86]L+AEW;[@[II2V'8XQU'3 X&
M,8J:WAAMX$B@14B4?*%Z5S.K7[7WCS2_#0_X]Q:2:E=KVD565(T/MN8L1WVC
MMFH];\:R:&UQ-<:44L8+V*T\R6;RY)MY0%XD*X=07'\0Z-Z<@'745S?_  E3
M3Z]>Z58VL$\UC<0PW$;7.R8*X0F58]IRBA\YR,[6]L]!<3Q6MM+<3N(X8D+N
MYZ*H&2?RH <SHF-[*N2 ,G&2>U.KS+Q'J4^MS>!M4.EQ0VEQK,$EM.TN9@C(
MY4,NWY=PP<!CC S6U?\ Q AM!)<V]FEW90WAM)?*GS<##[&=8@IW*&S_ ! X
M!.,=0#K;B6../$EPL!<[%<L <GIC/&:SO#.B6GA[0XM-L;J:YM8F<HTS*Q&6
M+,,J!_$37)S07&O?$77]+U33;.]T^/38$$+W#?*CO*<J-G#MM7/(QM7YCBET
MGQ;:Z3X*T2ZTSPWY%K>:D;!;.&=1Y3&=DW9(&XD@GZGKWH ]"HKD8O' M_[>
MCUC3_L4^CB%G6*<2K*LN?+VL0N"2-N#P#WQ49\?V]G=W\6J6R16]K9&]%U:3
M&XB90<%"=JXDSC"\YSUH [!G165690S'"@GD]^*5F5$+NP55&22< "O/-1DO
M+CXF^"KF]TN"T>2*\*NDWF/CR0=C_*,$9[$CD\^NQ\388I_AIXA$L:.%LI'7
M<,X8#((]Q0!U@((!!R#T-%<98>+[FSU;2])U?1GL+>^MV-E=_:%D#F--S*Z@
M?(=H)')!]:6U\>QW=YI(2Q66PU5ML4L,_F219&4,L>WY%([[C@D T =@KH^[
M:RMM.&P<X/I3J\X\*:K:>&]&UYA"#YGB>YM+6WCPN^1Y J*.P'J>P!KH'\4W
MD.KW>BSZ4@U5+,WMI%'<EH[I <,H<H"K X&"O<<^@!T])D;@N1D\@5QMMX]6
MY'A6464*V_B $+(;KF!PNXH1LY/&WM\W''&;&MW5UJ/AG6+^WA2WN=-:9["=
M9-Q=XLY)&!@%E*$<Y&: .KHJAH>J1ZWH.GZK$NU+RVCG"_W=R@X_#-<II_C*
M]M1XNO\ 7(H$T_2;QH4\B4L_$<95 "HR6+=21R<8QS0!U.M:+:Z]I_V.Z:>-
M1(DJ202F-XW4Y5E([@BHM.T$6,J37&I7^HRQY\M[R13Y>1@D!549P2,D9P3S
MR:ICQ+/:>(-.TC5]/2T?4D<VDL5QYJET&YHVRJ[6QR.H.#S5GQ;#'-X/UE98
MU=193$!AG!"'!H V:*\O\)P:!<^#_"MO-X?<W=S;VX-Z+'9MD$>_S/-*^J]<
M\D^]='J7C*YTOQ')HLVD SRP>;IK"X.+UMP4H/D^5AG)SG YZ9( .MHKGM4\
M3_V?>QZ:D=F=1-M]I>.>[\J-5)*@!]A))(;'R]%.<< U-*\:G7(;"/3]-==0
MNK9[F2VO)#"($5]AW,%8G+<# Y )XH ZRBN5M/%]S-J&@6=WHD]E+JZW&4GD
MP\#Q#)!7'(/8YY!SBLC6O&^IGPUJ%UI]E!!<6>M)I<OF7!(P9(U+*0G??CD<
M=>>E '?F1!((RZ[R"P7/) ZG'XBG5RTFI(/'EC8W&BVXU-],FFCO!-N"@.@:
M,';G!)'.!TZ4FF^+Y]1T2YN_[,2*^M]0.GO9-<Y(D#A>6V>A#=#\O- '545Q
MNK^/4TY;Z6ULH[V/3YA#<1I<XG9N-_E1[3OV[NY7.#^/7K*CP+,#B,KORW'&
M,\^E #ZCEGA@4--*D:D[078 $^G-<E)X\6+1K/Q!)I^- NIUC%T)OWD:,^Q)
M6CVX"$XZ,2 1QU H7<-QK?Q/U#2-2L+.ZTT:/&/*EG8@(\KAG V??.U01D8V
MCYJ /0*:70.J%E#-G:I/)QUKE_'.HW?A;X>ZA=Z/'$)+.V"1>8Y_=KPH(X.X
MCC /XFL?63>0?$WP[=1Z;;OJ4FFWJM''/A#AHMNZ0J#@9_NDC/ - 'H59$7A
MZWC\03:Q)=WT\K\QP37!:"W.W:3&G121G)]STR:Q[/QY!<Z+:74UJEM?7%Y+
M8_9I9P$26(MOS)C[H"$YQSD#'-:7AKQ&=?\ M\<MF;:>RG\I]KF2*4$9#QO@
M;@1[#!!% &[2!E89!!'L:X37;I];^*&F^%)F/]F0Z<^IW4(.%N3O\M$;U4'Y
MBO0\9S70OX8TN+4[#4;6WBLI+-V<B!!&LBF-DPP& <;L@GICCJ: -NBN.D\>
M+#HMKXA?3_\ BG[B=8_M0G_>(C/L65H]N-A;'\60"#CJ!:M_%LC77B*UNK!+
M>?1E5ROGEO/1E+*P^3@'!'<Y!% '3T5RNH^,)+)Y[6.TM7U"VM4N+BWEO?+
M+ D1HVP[F^4]@.1SS5+_ (3Z\N[RSM-*\.3W,]YIAU"%)[A8",,JE&R#M(+8
MSZX['( .R@MH;8R&),&5][L226;IDD\G@ >P ':I"0JEF(  R2>U<7J'Q!CL
MX9KJ&Q2YMK:Z^S7"1W&;@$-L<I$%.\*V1]X$[2>F,U?&NLMK/@[Q?;6.G0W=
MI86TUO/-+-MQ*(]S;%VG.S(.21R"!TH [Y65U#*05(R"#P12UF^'?^19TK_K
MSA_] %:5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %<YXQ\/WFNV-E)IEU';:GIUVEY:/,I,;.H(*
MOCG:58@XYKHZR]?UZS\-:1+JFHB46<./->--^P$@ D#GJ1TH P-6T3Q7K.B1
MBYNM,2]6[AEDLXVD^RRQ(26C9B-QW9R3MQ\H&.I.?=>"M>N=/\86OGZ8!KRI
MY07>HB/E+&0>#P-O&.O^STKJ;+Q5IE[JRZ46GMM0>+SDM[J!HFD3NRY&&QWP
M216U0!Q-WX<\1VOB&TU[1)M-%R]BEE?6EV[^4X0DJZ.JYW DCD8(-6-1\/ZX
MVMZ%K-I<65S>644\-TMR6B1UE*DE-H8C:5X4]1W[UUU% 'G3>"-=/A*^T@W&
MG23W&LG45DW.BA/M FP?E/)QC';/4U+XB\':_K,_B14N=.:#5K-8+=[@NSVA
M"8:-0!C8S?,6&#SRIXKT"B@#D[?0-9M_%]KK?FV#*VEI8W2?."I60N"G'(.[
M'./7':LA? >J/H)A:YM(=2MM<?6;*1&9X]S.S;'RH.,,5)'U]J]#IOF()!'O
M7S""P7/) [X_$4 <C?\ AC4=5N]2U6Y6SBU"?27TRVA29GC0.26=G* GG;P%
M_A]^(K?PMJ\4_@MV-CMT&!HKC$SYDS#Y65^3\>?I[UVM% %+58KR;3)H[ P?
M:3C:+@'RV&1E6P#P1D=.]<'>_#F[;0O$UCI<=AIT>LI$J64<[M;P.I)>0?(,
M%L@;0H'R@Y].^U+4K;2;"2]O'V0QX' R2S$*J@=R20![FJVEZW%J5S=6K6EW
M9W-L^UH;I I88!W(5)5E^8<@G&<'% &)J7A[6K_Q2=6AGM;0-H\VGJZ2LTD4
MCLK"11L (4J.XS[=*S]'\(Z_9:MX>OIFTA/[-M)K6=(3(3*7V$R;B!EF*<YZ
M9SEJ[^B@#SQ_!6MO\/[SP]OT\7,^H&[63SGV!3<>=@_)G/\ #^OM7H*%BBEP
M ^/F"G(!]CQFG44 <*/!^K?V5K^A--9_V=K%[<7#72NWFQQS-ET$>W!."0&W
M=\XXP9&\-^(M%\2WE[X9N=,_L_4%B^T6U^),P.B",/'M^]E57*DCIUKMJ* (
MX(WBMHHY)6E=$"M(PP7('4X]:X"Z\%:W<^$/$^C[]/6;5]0DNXW\YRL:NRM@
M_)DD;?QSVKT.B@#DM1\/ZS?>+%U>&:UM5_LB:P#I*S21R.RL'4; "%*CN,^W
M2L>Q\#ZW]HT%KY]*2*RL[BSNQ 9"TPE5 T@8@9=MA)ST)SEJ]%HH \WB\&^*
MDT#1-#>XTF2WT:_MYX+HO('FBB;*JR;<*V,#AB#[5HVGAWQ3HVL:E%I5_IIT
M;4;I[LM<*_VBU>0YD\L#Y6!.2,D8)[]^U21)5W1NKKDC*G(R#@_K3J (;JVC
MN[*:UFR8IHVC?GD@C!KDO#&@>)]*L+?0M3OM.GT>S3R8IH0XN)X@,(C@_*N!
MC)!.0,<9S72:EJT&FO;0LDD]U=,R6]O%MWRE5+'&X@# !.20/Q(HTW5X-2TA
M-2\N>UB8,62[C,3Q[20VX'I@@\]._2@#C[;P/J0\'Q^#;N:TET>*9-MT';SW
MMUE$@C*;=H;@+NW=.<9JY)X9U9KWQE,/L6W7(4CMP9GS&5B\K+_)^/&?3WK?
M_M^T'BA?#WESB\:T:\#E,1E RJ?F[G+#H*U* .*A\+ZO'+X+8FQQH,31SXF?
M]YF'RLK\G_ N?I[UA>'M(U#Q%X/U_11]ECL+S6;V.6X\QO,6/[0V\!-N"2 0
M#N&,YQQSZBRAE*L 5(P0>]<S!K6AZ/K=QH-AI,L-ZL8NI(;2S #(25#Y7@Y(
M/O0!@^(/ ^NZI'XDM8+G36M]22-;2:XWF2W5 O[D # 3*YR#U)R#6]INBZM!
MXWO-;NS9&"ZL8;8K%(^Y61G;."N,'?CKV_"MK3=3BU-)VBBGB:"7RI$GB*,&
MVANAZC##FKM 'GE[X*UNZ\,^*]+#Z>LNM:@;N)S,Y6-3LX;Y.O[OMZ^W.IJ-
ME>6'BJ3Q9>&TBT^UT:6WF4.[NOS"0L!L&X#;C&03^E=?533;X:GIT=V;2ZM1
M)N'D7<>R1<$CE><9QGZ$4 >8^&H]2TJWT2Z:V\.7T"%5@^S:C*94\T@.8HB#
M&IY/"D #(! KTC7]+77/#VI:4S;!>6TD&[^[N4C/X9IUGHFDZ?</<66EV5M.
M_P!^2&W1&;ZD#)J_0!P=QI6H^)OA5#H4(@@U)(H+:Y6X<J(I(F0MT!)SMX]0
MP/2K_BJQEU[4?#NF*H#6]_'J5V5.Y8XX@2!G ^\Y4#ID!CV-23^.-(M9+9Y+
M345-[,+:"3[$P\]QG 4XY'#$=JV=)U*VU-;J2"WG@>*;RIEG@,3[]JG.#U&U
MEYH L7]M]MTZYM=VSSXFCW8SC<",_K7$V_A+7TT?PC93/IC-H-Q&[E)9 )$C
MB:,8RG4[L]L=.>M=]10!P%_X'U349?$LOVNVM)K^\MKZPFC9G,$L"H%W@J 0
M2G;UKI=!C\1D&7Q%+IRRA=B1:?O*'U=BX!SQP ..>3GC8$B&1HPZEU 8KGD
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M&%0%#@@GJ>,G-=2WB;3/MMMIU\EQ:37I*0)=V[*DQQ]T-C;G'\).3Z5N
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MYW/D$2/NQC!4?*..3STQVU97B#Q!9>&=+;4M1$PM$95>2--^TLP5<@<\D@4
M<[%H7BJ\UWPUJ.JOI"MI(F68P22,9]Z!-P!4;3QG'/UKH?$^CMX@\+ZGI"3"
M%[RV>%9&7(4L,9(HBUZ%[VVM9+*_@>Y8I&TMN0I8*6P3T'"GK6M0!R@\-WNK
M7>DS:XEI''ID4BI%:S-)YLCQ^66)95V@*6P,'ENO'-?PMH?BS0X+;1KO4--F
MT>RPD%Q&KBZDB7[B.#\JX& 2,Y QC)S79T4 >>MX#U.XT74();FT@OCKK:W8
M2QLSHDF_<JN"HXZ@X]<]L5T%IHEW<^*8O$&J);13V]FUK#!;RM(HW,&=BQ5?
M[J@#''///'14UI$0H'=5+G:H)QN."<#\ ?RH X"X^'$K:7K5O;WRI*]W]JT=
MB.+%MXFX],R[LX_A"UO:]#_9?@:YTVR5IKA[0V=JA^]+*RE5S^)W$^F2>E;$
M%_Y^HWEG]DNH_LP0^=)'B*7<"?D;^+&,'TR*LE$+JY52Z@@,1R >O\A0!0T#
M2ET/P[INE*V\6=M'!N_O;5 S^.,UREYX#O-1M_%NF7%U;IIVMSBZBE0,9HI0
ML8&1P,!HP>O/M7>54U.^_LW3I[S[+=77E+GR+6/?*_.,*O<T 8,>AZIJFJZ)
M?Z[]B1])#NHM9&<33,FS<=RKM !8XYY(YXYV->M+G4- O[*T$7GW-O)"IE<J
MHW*1DD GC/I2ZCJ\&G-;1-'+-=73,MO;1;=\A52S8W$ 8 /)('0=2*73=6@U
M+1X]3$<]K"P8LEW&8GCVDAMP/3!!]N_2@#G](TSQ1I7A/3]$BATE9;2UCMA=
M_:I&QM4+O">4.<#(!;K3/$GA;4_$"7,_GP07]HZ/HLRS-B!EP2[_ "\ENA'(
MV\<<D[W]OVG_  E \/\ ESB\-HUV&*8C*!E4_-W.6'05J4 <7J.A>*?[<L?$
M6E3:4FIFS%E?VEPTAMY5#%E9&"[@06;J.AQ]6ZAX;\2QZWI_B+2[[3Y=52V>
MTO8;H.D$L;/O 0J"5VG@9!R.OOVU95YX@L[;4O[,B2:[U#8)&MK9-S(AX#,2
M0J@]MQ&>V: ,75?#^NSWWA_5H+BQN-2TV69IHYR\43K*NTA2 Q&WC&1SCFLN
M3P/K<OAW7;)[O3S=7NL+JENP#A,B2-]K]2,^7VSC/>NQT[6[34[RZLXEGCNK
M14:>*:(H4W[MO7@_=/()'O6E0!S#:+JTWC?3==F-EY-O82VLJI(V[<[*V5!7
MD#9CDC.<\=*=!X5-OXZNM>2X M+B)':UQ_R\J&3S?^_9V^_Y5TM% '%1>'_%
M&CZ_J;:+?::=(U.X-TXNU<S6LK !R@'#@XS@D<_KV+0K);&"3+HR;&W'EAC!
MS4E% ' VW@?4O^$0B\'7DUI+H\,Z;;H.WG/ DHD5"FW:&X"[MW3G&:VH-%U*
M/X@W>NL+3[%-81V:J)6\P;'9MQ&W'.\C&>U:&M:_::#]A^UQSL+V[BLXS$FX
M!Y&"KN/89/\ ^NK>H7L>G6$][,DC10(9'\M<D*!DG'?B@#,\8Z'+XE\(:GHT
M$R0RW<)1'<':&R",X[<50?1=<N?%NC:W<C3Q]CM)X9HXY7Y:0J?ERO(&P<G&
M<]!4UCX[T._;30)+FW74P/L4ES;O&D^1D!6(QDCH"03VKI: /.5\#:_!IL<U
MG>6%OK-GJ]QJ5HQ9WA=9BVZ*3Y00,.1D9Z5VFC1ZP+=I=;DM#=.1^ZL]QBC
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MJRWB&6WG>)@KX#*2I&0<#\J /.-1O+_7?A)IMYJ%[.;I-7C@=E*C>%OA&I;
MP2 HY'?FM[[-):_%J4M?W\R0:"LP1I =Q\X@C&,<[1TZULCP#H:Z-_9*+=)9
M?:OM8B6Y?B3?O&#G@!N<#C/-:,OAVPFURVUF3SS?00^0)%F91(F[< Z@@-AN
M>10!R6AW/B?7-/\ #WB*WU&UBM[O9)>H]SN1HW&-B)Y>%=6( YY(P2<U:\"#
M5]4274[_ %Z\N!;7UY:BW*1B.15E*J6PH.X8[8'MUSIZ9X#T/1]2>\L4NHE:
M1I4M1<N;>.0]76(G:#SZ<=L5IZ)H-GX?MIK>Q,WE33/.PED+_.YRQ&>F2<T
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MG><ML7:18Y)"X0DY.W/09.<#B@#A'U"X\/:Y\2-92>YN7T^.&6*"1\H2;?<
M1C[H)[8XS6I=ZAJ>B3^$KZ/49[Z'5KF.SO(I<%7,D982I@?)@J>!Q@].]=(?
M#&E'6+[4VA=IKZ(17,;2L8I0%*@LF=I.TXSCI4>F^%--TLV8B-Q+'8@BSBGF
M+K; C'R9]B0"<D D# )H R/B!<2"7PO89(@O=<MTG]&50T@4_5D7\JLZU?WU
MK\0O"]I#>2+97B7?GV^%VL4C!4YQN_B/?'2M+Q)HG]N:;%'&ZQW=K<1W=I(W
M198VRN?8\J?9C1+HUMJFIZ;K-U'<0WUBKB%/-XCWC#@@<-D #^6* ,SP;>WM
M[=^)X+^[DNUM-7>WA,BJ-L?E1D+A0!CYCVJO\+[B6;P6MO(Q9;*[N;.)CWCC
ME94_(8'X5L6^C1Z$FI3Z5'+-=W\QG=9I<HTQ &XY^Z, 9QV' S4_AW1(?#N@
M6FEPN9!"I+R$8,CL2SL?JQ)_&@#RZ[MY$^&GQ'DDO+J<K?WD6)GW<*4 /3K@
M >F*Z6;5-2\.^+&CDU"XO[670I[]K>4* LL3)C9M (!#$8Y[<DUN7'@;1;F#
M5H'2Y$&K.9+N);EPC,V-Q SA=V!G'7%7/^$;L3K%MJCO<275O;M:HSR9'EM@
ME2.AR0.3SQ0!SNAMXEO6T#6UU*U-A=0A[Z.2Y++,'4%3&OE@(P8] >1P<GFM
MOQC;0WF@I:W,22P37UG')&XRK*;F,$$>F*BT3P+HGA^]^T:>ETB*S-#;/=.\
M$!;.3'&3M4G)YQW..M:VJ:5!JT$4-Q),J1RI,!$^WYT8,I./1@#B@#S&]GN?
M =M<>$M0>271+S_D"7CDDQG<";9SZC^$GJ./8='J-YK.N^(/$&CZ7="UETZ*
M%8&%QY9621"XD8>6V]<X&#Q\IXYXZO5-(L=9L/L6H0B>$,KC=U#J058'L016
M7K/@K1];U:+59OM=O?)'Y33V=T\#21YSL<H1D4 <YID.H2_%&R.HZBSW2^'E
MDG%K)F R"8*^T$?=)7/K^57/C#_R2K6\?W8?_1R5T+>&-+.KV6II#)%<6<'V
M:+R9613$""$90<, 0" :D\0:!8^)M*DTS4O-:SE(,D<<A3?@@C)'/4 T <)\
M06U*RNO#5_KKVUQHEKJL,DB62-',)^1&QW%MR DY P>:T+F[\0^)+OQ%;Z+>
M1V=SIMV+:U+7&P(1&C[G3RVWABQ')Z#@ Y)Z)_".EW%U:7%[]JOGM)!+;K=7
M+R)&XZ-L)VEAV)!(J#4O VB:GKC:O(MU#=RJJ7!MKJ2%;E1T60*1N&..>W%
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MDU"\L9-/\AU_<PM$PF+($^\[9XW 8QU]ZY&WO]5M?'\GAB]UN=K2>;[5:7?
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MB[D.9E((89/!RH)]2.<X%6]>\(:7XBDLY[S[3'>6>?(N[6=H9D!ZC<N.#Z4
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MB4X8J.5)4!"P Z8SFBYM?#=_;:MJ&C^*9/,OI+/S+X>4]M'.DBF+<JJJEB0
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MUYQD_G0!Z$EY;27+VR7$+3H,O$K@LOU'45*S*B%W8*JC)). !7DT36^H>"O
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M 'OFMKXFK"VB:0;G:+9=;LC.SG"JGFC)8]ACO0!V,%S!=*S6\\<RJQ5C&X8
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MLL&GQ&5W54B&YIV&X8'5CTSZUY/\.D\/'X8Z-<WVN&TDMYC<NK:DZH/+N&<
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M 6 8DCGA<G\*\LBET75O[8T7Q%J]W::U%K$DJVL8B6>4B7= T)*%F^38HP>
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M^*-Q###X4\V6-/\ BI+)OF8#@,<GZ"G78L'^-.GJXMC(VB3-@[22WG1[3]<
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MC\Q51<2 _=SSP?2NU\$:9I=IX9TZ\T^UMXY;NRMS/-$HW3$)P68?>(R>3ZT
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M4'!]^.0*J^(_$SZ'JFB6*6,]P=1N6B+QJ"%"HS$#D98[?RS[9 .BJ)K:!X#
MT$;0GK&4!4_A7GNE^+HM OO%KZM-J5S:VNJ ;]CS"UB,49RQZ*H+'@>_'6NP
MU/Q%::;YP\JXNF@A%Q,MJ@<QQ'.&/(Z[6P!DG!P* -5$6-%1%"JHP%48 %#1
MH[!F16*YP2,XSUJ"PO[75-/M[^RF6:UN(Q+%(O1E(R#7(>$+V?QU8W'B"ZN[
MJ+3Y;B2.PM;:9H0L2,5WL4(9F8@G!.!Q@=Z .R^R6V,?9XL=<;!2M;0/)'(T
M,;/']QBH)7Z'M6+!+)X;MKQ]6U*:[CFO%6RWJ#(0RHJQ *!D[@WX<D]30?%V
MGI'J8EBNH[G3(Q+=6K19E6,C(< $AEP#RI/0CKQ0!O,BNI5U#*>H(R#47V.U
M_P"?:'_O@50@U^TN;32KF%)GBU3!MR%'0H7!;G@;03^G4@55?QAI<=U91R"X
M2"^F,%K=F/\ <S2#/RJ1SDX."0 V.": -PPQ$L3&F7&&.T<CWIK6MN\+0M!$
MT3=4* J?PKG+3Q]HM[)*(EOA!"TZ37+VCK%"T7WP[$?*?0'G\QFY%XKTYM3E
MT^Z$]C<I;&["W:! \(ZN#DCCN#@CN* -AK>%U57BC8*,*"H./I2?9;?SQ/Y$
M7G 8$FP;@/KUKA=2\027OCGP8+0ZE;VEX]PV'RD5S&(&925SV.#A@#T.*T_B
M5=W6G?#[5[^QN9K:[MH?,BEB<J5.1^!_&@#J#;PM.LYAC,RC"R%1N ] :DKS
MJ/5K_3/'OAK2[#5)]2M=2M99+ZVF<2FW"H"LH;&5!8D8)P>W-=)9>,]+O[FQ
MB@%P4U#S193%!LN3'DL%.<C@$C<!D#B@#=6WA1]Z0QJW]X* :/L\()/DQY+;
MR=HY;U^OO6):^+M-O-$O=6B2Z^SV4SP3(T6) ZG#+MZY!/3OVS4-UXXTRUN=
M2M?LVHRW.FQI)<Q16C,RJP)R.Q "GGIZ9H Z#[/!LV>3'LSG;M&,^M.2&*-B
MR1HK$!20H!('0?J:P+3QMH][?:;;0FZ,>I)NL[EK=EAF.W?M#'OMR?P(ZC%/
MN_%^F6,L9G\\6CW7V/[:(\PK-NV[2<Y^\-N[&T'C.: -N2"&4@R1(Y'0LH-)
M]F@WA_)CW#&#L&1CI7,7/Q$T.VCOY72_,.GW/V>[D6S?; <*=S9'"_,.?KQC
MFK!\4G_A.CX>%C/Y:6(NFN,#:=S[01S]T8;)]?IR =&RJZE6 92,$$9!%1FV
M@)!,,9(& =HZ5FZ;XBM=4FMEMX+D175N;FVG9!Y<L8*C<""<9WJ0" <=JDUC
M7;30VLA=K-B\N4M8FC3<!(QPH8]L^IXH O?9H/*:+R(_+?ADV##?44^.-(HU
MCC1411A548 'L*QX_%%C)=ZQ:[+A9=)0/=!T PI4L"#GD$ G/M5:'5-/O/&%
MO;";4X;]],:<6KADA\HNGS$'@R D#C) R#0!OM;PNSLT,;,Z[6)4'</0^U(;
M: L6,,9)ZG8.:\INM0U)/A+K]TNJ7PNK75YHHKC[0WF!%N@@7=G.-O&*]6N8
M_-MI8][IN4C<C88?0]J $^RV^ /L\6!T^0<4K6T#SK.T,;3(,+(5!91[&O//
M GCNT7PMX:M=7EU!KJ^C6(7UQ"YBEF).$\T\%C_];.1BNJU'Q?IFE[I+GSQ9
MQW MIKU8\PQ2DA=K'.>I ) (!X)!S0!MO#%)(DCQ(SQYV,R@E<]<'M3?LMOA
M!Y$6$&%&P?*/0>E5M9U>UT'2+G5+XR"VMD,DACC+D =3@5FVOC#3[U28;:_W
M,ZI CVS(;DLF\&,M@,-H)+9P,=>E &V+:!0P$,8#C# *.1[U(    , = *P;
M?QEI%S8R7"O,LL=W]A>U:/$PN/\ GGM[GOG.,<YP":YK3?%']G^*/&]YJ+:D
MMAI\5I(UO-\QMP5D+E5!(P< _+G/X4 >@+!"DSS)%&LKXWN% +?4]Z%MX5.5
MAC'S%^%'WO7Z^]9__"060UBSTMO-6XO+=KF E/E=%QNY[$;AP?6JD/C#2YKV
MP@'GB/469+*Y:/\ =7#*"2%.<] 2"0 0.": -M((8\[(D7=UVJ!FB*WA@B\J
M&*../^XB@#\A6(?%^F+>6,+^>D%_,8+2[:/]S-)S\H;.><'!( ;'!-<YX_\
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MDE#J1EN,#.<X]L]O5** .#UO1-1UKQA+(MG/!977AZXT\W+%,1RR,I (#9X
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MMI7]P5.[+=3G  R,FM7X=:??:3X"TG3M2M'M;NUB\N2-V5N<GD%201S7444
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MC.>BGG%=710!Y9<:!KDOPRU_2ET>X^WW>JRW$,)DCRT;7(D!SNP/E]3G->H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[L>% ZFO,[*]>UTG5M,FU741'!XG%C:*LK233(1&XM_,9L@'+#<6R!GFLCQ
MUS/X-\=6-Y)+Y=AJ=MY$0NWD$080DJ&."5RQ.#P">.@H ]HHJ*W@2V@6&-I&
M1> 9)&D;\68DG\37F/CO4;B.T\6WNFZA>/<::D!#B=H8[)P%;:@4_O&;.6R
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M"4[99WDP1/'R-Q)&>_Y]<UU6O:A)IFCSSVZ"2[;$5M&3P\SD*@/MN(SZ#)H
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M/V29A@7"#^Z3@,!]?I-'>SW>J>'?#QG6&WFT);A$:5XO/D&U2 4()*KSC/\
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MN[\/^,M5TM[N[E37+59-)\ZYD=8IP?+DC7+< %TDXQ@;O2@#T.BO/[A;B_\
M%=YX5%_+&EII<#VWFW4JRREBX>7<K LP*H,DG!^IK/73KZ\\4:'HM_XCO[E)
M=&N5N9[.X>$3/')&H< 'AN>2.N/0D$ ]0JCK.I#1]%O=2:WDN%M87F:.(J&8
M*,G&2!T%>?1KJ7B.UUXP:]_9UYI.HO"D[S2%K:.(C:63<%8,H))8'.X^@P7E
MRWB;1/B ]]<W"3::9[6"&*9XQ%&D 8/M!YWL6))SD<=!0!Z)I=\NIZ39:@J&
M-;J!)@A.2H90V/UJW6/X3_Y$W0_^P?!_Z+6MB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D8!E*G
M.",<'!I:YGX@:YJ'AKP7J&LZ:;?[1:*K!)XRZL"P7'# ]Z -*P\.Z3ID=Y':
M6:I'>.TERA=F65F^\S!B02>Y[U3MO _AJS:U:WTF&-[0,('#-NC#=0#G/88]
M,<8K-_X235M*\;Z-X?U3['=PZO!*\%Q;0M$T3QKN8.I=LJ1T((YKH8=>TBYN
M3;PZG:23!6;8LRDD*<,1SR >#Z=Z (9O"^C3VMA;26>8=/8/:+YCCR6'0J0<
MY';TK7K.BU_1I]-?4H=6L)+",X>Y2Y0Q*?0L#@?G4-SXJ\/68F-SKFG1"!E2
M4O<H-C-G //!."<>U $6G:#'IW]I6 BCETF^DDF\IO\ EFTG^L3'=6)+?\"(
MZ8IT'A+0[8V!@L!&=/R;4K(X\HD8)'/<<<]N.E6HM>TB?4_[,AU2SDOMGF?9
MTF4R;<9SMSGH0?QI7UO2H]033WU&U6\=MBPF4!BV,[0/7'..N* *,W@WP_<6
M]S!-IRR1W-P+J4-(Y+3#I)G.0WN.:4>#O#HBOXQI%L$OT"72[?\ 6   9_(<
MCN >M2/XK\/(Z(VN:<&><VZC[2G,HQE!SU^9>/<4U?%.E-XID\/"ZB^W1PB5
ME+@<DX"CU;@G Z<>M &I:6D%C:QVUM&(X8QA5';_ !^M9-]X-\.ZG=WEU>:3
M!-->1B.X9L_O !@$C.,@<!NH]:O6NLZ;?7/V>UO[>:;89/+CD!)4$#<!W&2!
MGI3KS5M-TZ:**]O[6VDE#&-)I50L "20">0 "3Z8H JP>&M)MKQKNWM#%<-
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M=VCC45N/MJ&%=V]82X 8<  X' YQUYKD[P7C_#OXDR76HW%ULO+N$"4)T54
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M?7=Z^EHZ69N-F4#+M))506.WCG\<GFLR#X<64%K86BZOJOV73KT7EE#YD>V
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M5Y'!=7,XN[J2[<SE#B1SEL;5'&>U4-3\$V>IZIJ-Z;_4+<:G:"TO8()%"3*
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MT;3)*4V*47:NW"@CCCDFM>BB@#GX/!VEP>%AX>S.]HLC3)(SCS$D,IE# @
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MIP\=L""/EP 3@$@;B< UM:MI-CKFE7&F:E;K/:7"[9(V[^X/8@X((Z$5=HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:QMY;F(0SO&K21@YV,1R,]\&@":BBL#Q'KUSH5WI!%M%)8WMZEI/,SD& O\
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M -QO#-\H)(7  .<>N*OV'B+4K6[\*Z;>002_VM;R%IEE8LACB#Y.1SG//]:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$'Z9=\L<MQT& ,GKGC3O+_[)<V</V2ZG^TRF/?#'N6'Y2=SG/RKQC//)%6Z
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M."3V'K6G110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWNP1226EU) 9D'17V$;A1J7@C1-3U*#4&BN+6YBB$&^RN7M_,B'2-MA&5]J
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M2QQ".!60Y'RMM!.WKCGI7N]9UKH>GVAU(QVX(U*4S72N2PD8J$/![;5 QTH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M \.7>ES?%KQ(UA<6DGVC3[1\P.I$C R!CQU(&W/X5W] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !36BC9U=D4NF=K$<C/7%.HH B%M -N(8QMX7Y1Q]
M*7[/ $9/)CV.,,NT88>]244 1Q00P#$421C &$4#@=!4E%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !115>]OK33;.2\OKF*VMHAF2:9PJ*,XY)X'- %BBJFFZ
MI8:Q9B[TV\@O+8DJ)8) ZDCJ,CBK= !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5A>*-#O=>L8(;'5?[/F@F$RL;=)D<@$ .K<$<Y^H![5NUG:E
MI":E-;3&]OK9[<MC[+<&,.#C(8=&Z<9&1VQ0!1\'W]W?Z%B_M8+:]M;B6UG6
MW&(F=&(+)['K[9Q6_4-K:065LMO;ILC7) R222<DDGDDDDDGDDYJ:@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ljb_employmentxageementx006.jpg
<TEXT>
begin 644 ljb_employmentxageementx006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[C2]NPQ@@)^9PH)8_0 'K7+:OXGU-+.*[M9+6VADTG[=$IC,\LDV,[2BG(C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !16*GB#=XS?PZ;-U*V/VT7!<88;]
MF .O7/6MJ@ HK%\1>(/^$?336-F]PM[?P66Y7"B,R.%#'/)Z]!^E%MX@^T>+
MKW0#9O&UK:QW(F9P1(KLRC '3E3U_*@#:HK%U7Q!_9>OZ+I9LWD&J2R1"<.
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MR.IX6@#';P"&\(7'ATZK)Y,UX;LS"$;PQE\X@<XQO_3CWKL%#; '(9L?,0,
MGZ4ZF2RI!"\TK!8XU+,Q[ <DT <I;^ X+;2WT(7KMX?-QYZV+1C<HW^9Y0?/
M^KW<XQG'&<5;E\*G^W-7U.WU*:'^U($BG@\M63<JE%;/7HW3/4 ^U2:+XAN]
M8EM)ETB1-,O;075M>"8-P<$+(F 58@@C&X=>>*WZ .2M_!)M[7PU;KJ3%- .
M8"81F7Y#'\W/]TGICFFZ=X&?2M1G%GKU]'HLT[7#:5L0H'8[F <C<$)Y*CW]
M377T4 8F@>'VT*?59/MAN!J-XUXZF,+L=@H('/3"CK^=3^(/#]CXETE]/OPX
M0LLD<L3;9(9%.5=&[,#6I10!B6ND:H(E@U'6S>0+C.VV6)Y!Z.P)!'KM"Y^G
M%57\)&'4]5NM-U*2SCU8 WD(B#C?MV^9&2?D<CKD,. <5TM% '/ZGX0TS4?"
M<7AU0]M:0+$+=H6P\)C(*E3USQU]S1XC\*6^O6%E#!=3:;=:?*LME=6V-T#
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M2*6!%D#P<$HZOD-R,Y/<DUV%% %73K+[!9);M<2W$@RTD\Q&^1B<EC@ #GL
M .@X%9>G^&A9ZSKE_-=?:$U@H9H&B 5=J", '/3:.<_I6]10!R.@^")=$"6;
M:_?7FBP9^S:=.B;8QV5G W.HSP"<#CK@52C^'#PZ5;:/%XAO%TNRO([NSA\F
M-GAV/O";R#N /3(X]Z[NH;>Z@NUD:WE618Y&B8KV93AA^!XH Y74_ IO[G7V
MBUFYMK;7+?RKN!8D;+B+RPX8C(&W&1WQU%)<>!)%O=/U#2]?O;#4;:T6QEN!
M%')]HA4Y ="NW(/0@?G78U"MU ]Y):+*IN(D61XQU56+!2?J5;\J .8U+P09
M[ZQU+2M;O=,U2UA-NUTJI*;B,MN(D5A@G<2V>Q)]L.NO!9:_TW5+'5[FVU6S
MC>%[IT63[3&[;F61>!][D8QCL,8KJZQ?%7B#_A&- FU4V;W21.BLB.%QN<*#
MD^[#H#0 WPUX<_X1R/4%_M">\-[>27C&547:SG)QM _STQ5+5?!@U+6-2OH]
M6NK6/4[$65W#&B,'50P4@L"5^^V<=<]JZFB@#DQX-N!HPTEM9>>R?3TL)8[B
MV1P57< Z@8"MAL<@CY1D$UTME:1:?86UE "(;>)8H]QR=J@ 9/T%3T4 <C)X
M#M[NU\06FH7CW%OK<PN)E6,(T4@"A2AR<8V*><\BM&U\/S?VC::CJ5^+Z\LH
M'AM7\D1JF_&YV )RYV@9! QG &:W:* .-/@$'P>_AS^U9/(:\^U^=Y(W[O.\
M['7&-_Z<>]:,GAF2+Q#/KFG:A]DO+N!(;Q3#OCFV?=<+D%6 ) .2,=0:G\.>
M(/\ A($U)C9O:M8W\EDRNX8L4"Y;C@9W=.:VJ .=N/!FFS>##X8C::*U"C9,
MK?O%D#[_ #,_WM_S9]:EB\*:;;^)+;6X4,<MO9"R2(?<V@_*<>H!90?1C6[1
M0!S=[X3.IRHE]?\ GV<5^M_%&T(\R)U?>%63/"Y]LX)&0*U[*SN;:\OII]0E
MN8KB4/#"Z*!;J% VJ0,D$C//K5VB@#G/$FD2S:KHFO6T;27&DS.6B49,D,B;
M) /4CY6 [[<=ZO6VFR?V]-K#7OFQSVZ0QPF+ B0$M\ISG))YSUPO3%:C$JA(
M4L0,A1U/M6/X7U\>)=$74A:M:YFFA,3.&(,<C(>1Z[<T 5F\,F+QL_BB/46A
M9[5;6:W$0V2(I+ L<YW#)P?3C%)H6E2?\)%K/B&X1HWO_*AMXW&&2"($ D=B
MS,S8[#;GG(K=NKJ"RMVN+F58HE(!9NF20 /Q) _&IJ .=\2>%?[<O=/U*SU*
M?3-5L"X@NH45_D< ,C*W#*<#Z$5!<>#9);W2M0CUR\34+$R[[EDC<SB4*'RI
M&U3\JXP. ,8-=310!R>D>#KG0K6*"QUR9DCFN)/+N8%=&65MY5@-I."2<YS^
M'%-L_ =OI\VA/9WAB32)9YTC\H;9'FW;^_RK\YP!T]ZZZB@#%T#0#H<^JR_:
MS/\ VC>->.#'MV.RJI YZ84=>?>N=UCSI/BYI!M;I('32KA"SQ^8A9I(R$89
M') ) R#QZ5WE% '(R^!(L6$]IJ=Q;:A:WTM^UT$5O.EE4K)N4C&-IP/0 5%'
M:V'@6TO4O)]2U.+6+Z200K:><?,D!+*1&O\ %CO@?3FNSHH Y/2?!R6?PY_X
M1D2-;FXM7BG<GS&3S 0P!/7:#M!]%'TJ9?";B]\.W)U'+:'$\42^2,2AD"$M
MSUV@=._/M735";J 7@L_-7[08S*(^^T$#/TR: .3F^'T%UINJVEQJ,X>^U'^
MU([B%1'):W&% 9#D\#:.#[\\T^\\%7>J>&[K2]4\0W5Y/=&,27;0(I5$8,%1
M% 4<CDG)/Y8Z^L71_$']JZSK6FFS>W?2YHXF9G#>9O0." .G!'>@")O#;2^*
M3KDU[N=K V#PK%M4H6W$@Y)!S^GYU5TGPE=Z)I6G6-IKLSI8(T2"X@5D>(@
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MV/5K&&\MPP<)*N=K#H0>H/N*KS>%- GL;.RDTBT:VLFW6T?E@"(]\?7OZ]Z
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M9I+&:[N//\/W-W+!-</()9HF38<$X4_,1\N!@XQ75MX-\-LMPIT6S N8UBG
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M>3G_ $C2KI+@#^XKH5)_X$?U-)XUBDF\4^$+=;V\MXKJ[GBF6WN'C#KY#G!
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M-#&LRDH^P]5W*02I]#Q22Z#I<TUE,]E%OL1BT*Y7R!C'R <+QQQVXH Y_P
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M#$9@JX8?.2^W@XP:O:[%I-W\/O%M]H.G:ANU2W">;,LYDNY0I4;8Y/FX&!G
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M'QC)(ZXSC(![#&S10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4453U+5;'2+=9[ZX6)'<1H,%FD<]%5
M1DLQ] ": +E%947B/3I;ZVL6>>&ZN2PABN+:2(R84L<;E&< <^G'K6K0 444
M4 %%%% !11574M2L](T^:_OYT@M81NDD?HHSC^9% %JBCK10 4444 %%9U[K
MEC8:MIVF7#R+=:@SK;@1,58JI8Y;&!P#QG-:- !12!@20""0<'':EH ****
M"BJESJ,-I>V5I(D[27;,L;)$S*I52QW,!A>!QGK5N@ HHI-PW!<C<1D"@!:*
MJ:?J,.I1S/"DZ"&=X&\Z)HR64X)&1R/0C@U;H **** "BBB@ HHI&8(C,<X
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M7[BQU+#:?8I<06UM$K[" Q8W!=< '  "L"1D@5) UY=_%B)O[1N4B;04N%@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;1T&3SQ0!V])D9QD9I:\HTE[[2-0L8FL[34FO+>ZDTC6K3B24[&?9<*>I/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8XP<; 2/FQR.I)XKUFB@#R673M1;X>:E9+I=]]JE\0&Z2+[,^XQ&\$N[ITV
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M<,K3J"#[C- '*^1<R>.?"MVME=BW@TR>&:0V[A8W?RMJMD<?<;Z5B:5I#O\
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M4E02X&""IR?R%,N? LLEG L%_$ET=976;J5H"1+(K A57<-JX 7J>!ZTS6/
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M[X."-P"\CIS74SM*L#M"B/*%)178J"?<@''Y&N8M/"M[*FB0ZS?PW<.C2"6
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M'AY=N?LY_?CRC%_?^7@Y[\T 5HO&+6.C>)=1FTRVMCIVK_9)6@#.NT^4#.^
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M69Y#,_ERQM'YBJ!C.[@@D\=.M7KCQ5>S:;IM]:6]M:VMYIPO1<7;;E,C!2D
M4$,6().1G[O0T]O"EZ=1\470U"W UR!(54P']QMC* D[OFX)/:J=IX)U.RN-
M(EAUF#%GI TJ4/:%@4&/WD?S_(YP <Y' X.* ,/4O%5A/JGP^\57X2S@GM;N
M9]QSM+0KA0>_S' ]<UT7B76=5TGP1<:IJ.F:?<.)(MUH[$JJM(J@MU#,,J<#
M !'!/6L^T^'$XLO#EEJ.H6E[::1;S6TD+6A47$<B!,??., 9SSSZ58F\$ZO<
M^ Y?"]QKL4R[T$%U);,72)'#JC?/\Q&T#=QQVH NWWB#7#XQN?#VG6-@633U
MO(Y[B9\<N4PP"^J]!]<]JJZ7XYFUFU\+K!:QV]UKD,TI,F72'R@-X !!8DGC
MD<9/;%:BZ!?+XSE\0_;+?Y].6R\CR6X(<ONW;O5NF.G>N$U#33X9MO#7ANY\
M1:99O81SSQW>H6A2"5BV% ;S!MD 9^C=#TZ4 =WX0U^]\0V5Y->64%LUK=RV
M?[J9G#M&Q5FY48!(XY/Z53\7ZCJ]GKWA>UTZ>".&\OFCF$BDE\1.P!(/W>/S
MQ^,_@JXNY-/E@E;2I[2$@6UUI431P2 Y+  DY(/5@2#N]0:L^)- N-9N-(N[
M.\CM;K3;O[0AEA,J."C(P(#*>C9!SVH XUM1U31/$OQ#U#2[2SE^R"VN9EG=
ME#!;4,54*.I /)]NO;HY_%\MU-':Z5#_ *0VGQ7S&2WEF51)NV(1&,@G:V2>
MF!P<\,F\'7TLGBQCJ4'_ !4$*P\VYS!B+RL_>^;CGMS5=_!>L6=UIFHZ+K<%
MKJ%O81Z?=>=:F2&YC3[IV;@58$GOWQ0!TOA_4KG6-!L[^\TZ?3KF9,RVDX(>
M)@2".0..,@]P16G5>QMY;6RCAFN7N90"7F<8+L3DG'89/ [# JQ0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !117,^,-7ETTZ):1S&W34]3CLY9P<%%*LV >Q8J%SVW<<XH Z:LSQ
M!K<'AS0KO5[F">:"UC,DBP %MHZD9('ZUSNJQ7.B07$+>);CRKJ_MOLUL4,E
MPJ,<- CEMQ,A5L,2-HSSQD<WJM]?3>"?B387;S&*Q#+;I/+YKQ(\"/M+]3R3
MW.,XR: /5H9!-#'*H(#J& /N*?7%)>R:KXL/AR2[GM8(-'BND$$IC>1W9E+;
MA@X7:..F6YSQ4-M-J=CXS\.:7<ZU+?B73KM;N51L6:2)HU#;02%898'!ZT =
M+XAU^W\.:?'>W4$\L3SQP?N0#M9V"J3DCC)%:U>2:C>W5[\-=0-W<R7#0>)5
MMT:1MS"-+Y%49[X %:/CC5;ZU@\47.G:G=/<:;:Q21) WE1V+ %COYQ*SC!V
ME3@8Z9R0#T<RQB982Z^:RE@F>2!@$X].1^=5]/O7OH99'L[FT*3/$$N% +!3
MC>,$_*>H]JXRVMC<?%^25KFY4MH,,VU9FVAC*PX7IC@<=,\UEVOB75+?P_;0
MS7\\DM[XIDTIKM\;XX?-<<<8!(3:..-V10!ZB5### $9SR*6O.]7OM4T?7]<
MT>TU"[^QOH,NI02._F26LR-M(#/DE6X.#G!!QBHM(N]4MM4\!SRZO>W(UFQ<
M7<4S@QDBW$BLHQP<CKU.>: /2:*\]\.ZS>)XEL],U[[?:ZG+YS12>:9;/45P
M6#1D'"$+SMP./6NB\67306NGQ)?RVS7%[''Y4"YENAR3$AR-A.,ELC !Y% '
M04P0Q*Y<1H'/5@HS7D]WK6N1^$/$)34KJWGT_P 116D!,@D=87>#Y&<C+8\Q
MN<Y[9-:&JZ[J/@_6?%"I>W6HPV^B)J44=VP;9-OD0XP!A3M4D#CCC% ':ZAK
M]OIVNZ3I,L%PTNIO(D,J@;%*(7(8YST'8&M:O-[RS,7BWX?79U"ZNWG>=I'E
ME++(QM6.\#HO?A<#!Z<5T?CK6[C0] BDMI/)ENKR"S$^ ?($D@5GYXX&<9XS
MB@"^-?M_^$K_ .$>,%P+G[&;P2D#RV0.$P#G.<MZ=JUJ\SU5F\-?$._U"VDN
M+DV_A6XN$BN)6E^9)5. 22<' XS]*T=*M-;OIM&U,:N@TZ]MBMVOVYY#<EX]
MRO$-BB-@<GY2!C/I0!W$4L<R;XG5UW%<J<C()!'X$$4^O(_"VH7.F^ /!EM!
M/)NUBZ:":2:Y90,"5@JMABA9E R!GD]#R+WB!?$VA:-=AM=,8;5+/[(D4QFE
MBBEE5&1W=0S+G<1WZ@DXH ].HKS^\LM1T[QKX?T=/$>KRVE]%?23>;(A;Y?+
M*@,%&,;B!UQVQUK N;[6K3P/X@U-=?U%KC0=6EM[4M(,/&DR@"7C]YD,1SZ#
M\0#U3[:_]KBP^QW.SR/.^U;1Y6=V-F<YW=\8QCO5NN1>YOC\5'TT:A<+9R:&
MTZPC;MCD\X+N''7'KFN1T?4M97PQX,UV;7+Z>YO-56SN(Y''E21/)(IRH')X
M!![=N.* /7*C,\8:1%(>6-0S1J1NP<XX]\&O-=8UF_M[D7UEJ=U<A?$4-H\R
MML@2)I%C:W$>2'(R<O@<]#QBKNA63#QEX]:.]O$>.6 (WG%MNZW5NC9'!)QQ
MQVH [?3KMK_3K>[>TN+1I4#&"X4"2/V8 D _C5JO,=!\1:AJ&G^ --N[R?.L
M6DT]U<!RLDICC!"!AR,ELDC!PON:J>(=9US3-+\;:;!JETHTB2TEL[O(,@28
MC=$S$9..<'[V",F@#UFBN#:35M-\<:EI=MK$\RW&A/>1F^8%(;A9-@88 "KR
M,@<<5)X-UB2YUF;3=1CU2PU>&T5I["]E,J28;!FBDR0RDG!QC'' YH [BBN-
M\8R7_P#PDWA6SM-4NK."^N9H9U@*C<H@=L\C.>..PZXK+5-9U.^UWP]8ZK.;
MC2(H8+>ZFOFCE#-$'$SJB$298XP>,)TR2: /1J*X?1KV\\1:[J.DZCJ#*=,L
M[3<VGS-$LTLJ%FE##!*\ *.G7(/&,3PWKFK75M\.[BXU&XDDU%[I+S<_$P6.
M1ER.G! Z>E 'I.I7C:?IT]VEI<7C1+N%O;*#))[*"0,_C5E3E0<$9'0]J\LU
M75]6@\%_$&:#5;N*;3-0D2UD#@M&@CB;:"03C+'W]ZV-6CU'4_B)!HT>NZC9
M6=QHDD[+:LJE7$L:AE)4X//4Y[CO0!WE4-;U6+0M%O-5GAFEAM(6FD6$ MM4
M9) ) Z ]ZX6*X\0>(K#4K[3=2BL[K3]2E@66>\<1QI#)M*RPA-IW(-Q).<MD
M$  5!K%Y-XG\'_$"ZFO+F'^SFO+*""&4JJ+%%SN4<-O).=V>",8QF@#TBUNU
MO-.@O(T?9-$LJH<;L$9 ^M4O#VO6_B/2O[0MH9X8_.EA*3@!@T;E#G!(ZJ>]
M2>'_ /D6]+_Z](O_ $ 5Y/ FJ:7\.+_Q+INLWD%SI^I7<D=F"OD2C[4P9'7&
M6+9/.<CC% 'M-%<%?ZQ<>%O&-W]ON+JXL-5LC)IT+RGY+E/OP+[ON4K]"!77
MZ59SV>C6UI=74EQ<)$%FG9B2[X^8@GWSCTH J>(/$MGX>T:?5)HYKB""18I!
M;[6*LS!1G)'=AGZULUXK-:^5\&_$KB>XD<ZM*F9IFD^[>@ \GKZGJ:[6R-]9
M_$>\T4ZM>SVMSI O,S,K&*7S2A*?+A001QC&1TH ZK3+U]1TZ&[>SN;-I 2;
M>Y4+(G)'(!([9Z]ZMUY?I.K^(;GX=^&M35+O5V)EDU&&WN/+NIHP6 9"""=I
M*Y4$9X%=KX2U&VU7PU;7=I>7%W"[2 27*E900[ HX/\ $OW3]* &3>*[5)+W
MR+&_N[>Q<QW5Q;1JR1N!EEQN#,0",[5;'3KFM>SNH[ZQM[N'=Y4\:RIN&#AA
MD9_.O/=0TC7_  ]?:EXC\%WD5]8W$\LU]HUUPKRJ2LC1/U5LJ>#QGUX%3V_B
M4^(KS0=/TR,VUC>Z0;Y(3=-;,2&50@=%)^49X&,\'H* /0J9)+'%L\QU7>P5
M<G&2>PK@-/N]8AUW1O">N:LLSO!=327%M*5>?8R>7&7 4A@KEF(P3M'OFKK>
ME7,&K>#K*\URZOI$U>:,RK(8F"&&1U5MIY95VC<>2/J: /08;UY=3N;,V=S&
MD"(XN'4>7+NSPISDD8YX'45;KSK4O$6I:%K'CN=;B:[CTW2[>YM8)<%8V*RY
MX '&5!/? ZU+?76H:0_A&^M-3NKI-6N([.\623>)/,B9Q,H.0A4KG"@#!Z4
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M-'KNH65E/HTDY6U95*.)44%25.#SWSW'0U0BN?$'B+3]1O\ 3=2AL[JPU*:
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MXH HQW<1\/"[C#3Q"UW@0\EP%SA<=S7E6A:GI=UKW@![>>U%F]G=6RVD67$
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MB-%9F5%#-]X@<GZTN #G H Y+QG!X9UB>UT#Q+'$$N(WFM[B1_+,;J5'RO\
MPM\V1SS@]:XOS->M_"'B_2K;4KG7=.TY[;['>C#RRQ;@UQ#NY$A5 1WZX]A[
M R*X(90P(P01G(I5144*BA5'  & * /(]8ETO7M%UO6_">IWVK:HVD^1+Y05
M5$(=6*,$1?WA7> /O8S[5N/J'A7Q/IU_J.@(MU>C19;8M"& ABQE8G7H&W=!
MC/![5WZ(B A%503DX&.:%14!"*%R<G QDT >237VDS^"OAK/%/:L\.H6$9D!
M&5(B(<9]C@'WZUH17%F#X_TOQ(T2W-Q.\D:S$9FM3$JP^7G[V"&&!T8^IKTS
M:N,8&/I2-&C,K,BEE^Z2.1]* /)]%LXT\9>$X/$"V[ZDOAMQ="XVEC(&BQOS
MU8 -U]":Z3X5RP-X-:*WDC:.&_O$54((1?/<J!CH,$8]J[7 SG I0 .@Q0!P
M7B7QGX5NK^?P_J.MV<%M"P^WAWYDP<^2,=N/F/I\O4G;#XKMM,\8ZII>F:FQ
MM=)FL'O;2]XBD,Y("A6;[I"'<5ZGC/"D5Z%M'H/RI&177:ZAAZ$9H \JT_\
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MVO7\]Q*]M>M ;>)I"5C"1[6VCMD_G5K5=8@TD6R.CS7%W,(+:"+&^5\$G&2
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MZ"3.1G@?./R-8VD>&?$7A^;PQJEO8QW4UEI TF_L_/53M!5A)&QX/*\@XXH
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M[MJX'7GN!U.*HZ?X\TS4H,00SF^^VO8?8OD,GG*I9L$-M*A06W9QCWXK(O\
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M4<'VB98(@QY=V. H'U(KE-/\1^);LZ-J@TX/I-[%YMV-B+]EC9-RNK>82^.
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M#R6V21K.L62-V0V&SG/X5<O=:\23>)O$.DV%SIT$=A90W4$LEL[M\_F?*1O
M/W.O&/0YX .XHKS9-=U?7-8^']W#=Q6L6IV<UU+;^2742"%23]X$CYR!Z=>:
MN:CXMU;3M6MDD>T99=;CT]K:*-I D+G:K-(#A9.0VT]CC'>@#KM.T73]*FNI
M;* Q/=2>;.?,9O,?IN.2>>!S[5?KS?4O%/BB&U\87-O-IBIX?EW(K6SDSH(E
MD*GY_E."1NY^@[WX[[4[SXI621WJ)8OH?VH6[19QNE0,,[A\QP.>WIUH [FL
M/7[/P[->:3<:[;6TLZ70BL&G3<1,PR ON=N>?05B^%?%T^NZH+2XNH+>^B1_
MMVE30&*>!@1M*$GYTZY8 YR#QTK2\5:S?:/=: +3[.8;[5(K.<21DL%8,<J<
M@ _+CD'K0!TE%>>:EXE\3I+XS%I/ID:: JS1;[9V,R^3YI0_.,'MN_05V"ZQ
M&OA@:W,A6(6?VMT7DA=F\@4 :=%<G8:IK\UII6MS&Q;2KJU:YO(E4A[93'O3
M8<G?Z'(&>HQTK+E\9:M;>$M*\7R+;/IMW+"9[-8SOBAE<*K*^>7&Y<@C!YQB
M@#T"BO.=2\4>*(H_&4MM/IB)X>82(&MG8S((1*4/S_*<'&[GZ"M&37]=O_%M
MKI.GS6-M;W>C?;UDEMVD>)MZ+@@. WWO]GKWQ@@':T5P&E>-]1U+1?#Z&!/[
M3U)KI)6@3<JBW<H[*K,.2=N 3QD]<8J>U\2>(8Y[#1]4LHK74;Z_F@M[EE&V
M2WCC,GF[%<X<CY=N>O/3B@#N*J?VG9_VN-*\]?MQ@^T^3@Y\O=MW>G7BN&\5
M7/BFUTRPBNKRU@9O$-K!'+!&3Y\#2H5+C/RG/W@#SCL#6O-XBOM.\:3:;?/;
MO80:(VH.\<)63<KA6ZL1C&2![]Z .MHK@9?%^K6GAO0_%,XMGT_4)8!/:)&0
MT$4Q 1E?/S,I9<@C!YQBJFH^*_%$-CXONX)M+5/#]P=JM;.3/&(DDVGY_E.&
M/S<_08Y /2:*J/)<76E>;9-'%<2P[HC*I958C(R 1D?B*X"#Q]J?V#PK=W+V
MD?VVZ:SU:+[.VZWD5_+)!W851(47G/W@: ._U'4[/2;3[5?SK!!O2/>P)&YF
M"J./4D"I[BXAM+>2XN)5BAC4L[N<!0.YKC=?\1ZSIV@76KVSV;0?VG%;0+)
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M<#/6@#OZ*Q/#%WK=UIT_]O6*VUU%</'&RX GB'W)-H9MI(/*YZ@UMT %%%%
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MM[IKR-"QC$B,'7:P9>">/0BL[4/ ECJ6E7EO/=7"W]U=)>MJ$1"RI.@ 1D[
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M;ABD2'JY"ECC\ 345K<7<M[>13V)@@A=1!-YJMYX*@D[1RN#D<]<9H Y?3O
M4EA/H$S:_=S-HD;P6ZF&-08F55VG ]%7)ZG';K2R^ A-X5U707U1_)U*\>[D
ME$(W*SR>8P7G&-P&,]L_AV5% # )1!M+H9=N-^SC/KC/3VS7'K\/8&\)OH,^
MI7#*MTU[;7<2B.:"8R&3<I''#,<<=":Z;5M0.EZ;+=K:SW;K@);VZ@R2,3@
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M=2P@[BRQA?, (Y;!Z$9(X]*]%HH Y*^\!6>H:5<027EQ'J$U\-1_M"'"R1W
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M 23P!C%7?'EXQM_&%Q87=R]UIEI"QD:<Q+8OMWJ(@O+,V03G Z#)Z5W1\):
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M -#1]-.G:';V$TTD\BQ!996D8EW(^8Y)R.<X]*\E6S@M_@G?^261WU<I]\G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M25!.X%>P_'% '4T5Q]SX[$&AR^(H]/\ .T&&=HI+E9OWNQ9/+:41[<%0P/\
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M%% !1110 4444 %%%% !116?K6MZ?X>TR34=4F:"TBQYDHB>0+DXR=H) R:
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M*1L7Q9-J^8FP#AL-GDY&/HMEX.O+;7)-:CMM.L+N:QD@NXK.9Q%>2MMVNPV
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MD5@-.$1:0QLS,'&W9]X  =?QQ7-R:OKEGX\;PQ=:R?)OF2XLKSRX@T<:AC)
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MC2P7NH,VD6[6UL))%8;&"@@Y7T51QC&/K3)? >GS:'J6D27M^;74;IKNX^=
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MT:TU35-7-Y]NLK>58?LZ1B%BF6(*\G.1UZ$<8!P.9O\ Q+K=OX1\=7<>HO\
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MGF*22*DB2!0%P">"!G'TK<?X=Z++I.H:?/+?2I>WGVYI7N#YD4_&)(V &TC
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M/?H]I]AAMY%:<"X,TA4I%@Y*X!RV<<'%<--I.CZO\4Y+.:UMKG3_ /A'(@L
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MLQ:52<GG<1@$]:Y[2[HVG@GPQ#(<:1-XBN(+XDY789YMBO\ [!?9G/!X!ZT
M>R@@C(.11D'H:\G\36(LKSQU9V,8CTC_ (1PW4L,?RQQ7F)-I4#A254$@=>"
M:N:=I]GI?C/P/-91+#-J&E7"W4BGYK@+'$R[S_%@DXSTH ],JGJMW<V.FS3V
M=D]]=* (K97">8Q. "QX4<\GL*N44 <GI7B;7[GQ+!I&J^&H; 2V\EQYL>HB
M?:JE5Y4(.I88Y['TKK*YW0/]/US6]9/*-,+"W/\ TSAR&/\ W]:4?\!%=%0!
M5U+4;;2=-N-0O)/+M[="[MC/ ]!W/8#N:RO^$FA@UG3])OQ%:WM]"\\<+O\
M-@?PCC#-@$G' QWXSD_% R?\(W88S]G.KV7VGT\OSEZ^V=M=DT,3RQRO$C21
MYV.5!*YZX/:@#DX_B#IEUHNFWMCMO+G4Y_L]I:0R99I,9(<D?+M7ECSCMGC-
MN_\ $MUH,]F==L[>&RNYEMQ=6TYD6&1ONAPRKA2>-P[XR!UK \86:Z3X\\&:
M^8DBTJUFN;>Y=5 6%YTVH[>@+<$GU'K4WQ:A;5O"*>'K3#ZEJEU#';1KR1MD
M5V?V554DGM^- '>T$@#).!7G6KQ-X5\>/<6=LK)XEM?LJGR\A;U/NEO165B6
M]=A-0:I'IFF^+['PWJ$UE:Z.-(462WT*O#)*'82_>(7?MV'UY/J<@'IA('4T
M9 [UY(/#VDR:[X'TI[N75K![348?.G?_ (^(UV;0<'YE )P>XP:=#X4\.7OB
M#QUIM_ @LK**T\E6E;%LOV;[XR>",'GZ^IH ]8) ZG%+7C=I<QWVD:7::Z4?
M5U\,^;,=38&)(V; 8(<%I3M )R,#U/%6(2D'@?P9XY3;=7&D6L*Z@P^=GMVC
M"R$]RR9#COPWK0!ZY29&"<CBO+_$VG0MX7T[5)H/)NM2U^SNG(RC*KS*$4XZ
M$1A0??)[U-!X9T.3XA>(]*?3K<Z=)IEM</:8_=&4M*ID*=-V /FQGO0!Z62
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M_%<.OP\N_LXQ<K<6OV;;U$GVB/;BNVH *,C.,\U'.9%@D,*AI0I* ]"<<5Y
MN;SX3Z9KMF/^*LCO8AY^,3M=&X"21OW((+ J>-H'& * /8\C.,T5YWHF@:5J
M'Q)\6R75LLSV5[97%N&<_NI/(#;@,]<YKT2@#&\5ZS/X>\+:CJ]O;1W,EG T
MWE22% 0!D\@'\OU%:=M-YUG#.V%,B*Q'ID5SOQ(./AKXC_[!\O\ Z":YO4[R
MSF\76>E:W=6<&GSZ+&UF+Z)7ADDW,)0-Q W[?+]\=.IH ],R!U-)D>HYKRF?
M2Y[33-/.CW5KXEM]/T^19++5" ]Q;F1L21/R ?EV@XP5"\]*CUM_M&EC7+&S
MMM4T@:' ;S2[PA+JV@VLPEB?D!L$Y'<QC!X% 'K=%16TZW-K%.BLJRH' <8(
M!&>1V-2$!E*L 01@@]Z .7\2>,%TOPIJ.M:7'#??89O(D#2E5W!@K8(!R06Z
M<=#S74YKQ&X@TVV^$_C..WBM8;A=6N498U575!=@*#CD 9&!71WT6F^&_'^K
MM"DMI:2>&9;N\^RG$DC)+CS/>3:3\QYH ]*!!S@]*7(]:\E\/MI\?C;0X87L
M(K6\\/R(T,,H+.-T6SS7& [D$G.!U;KUK-T&PM+7P?\ #C5X8PNHR:K' UUN
M)=HV$P9,_P!TXZ=* /;*:[K&C.[!44$LS'  ]33JH:Y!%<Z#J$,T22QO;R H
MZA@?E/8T 8^I>+?(3PW<V$$5S8ZU=QVXF:0J55T9PP7'.0OJ.M=/G/2O'+2#
M39? ?PU@@$ $FHV?V@0$*6<VTF=Q7G=Z]Z9J,\?ANZ\56=F%L]$@UK3S<QQQ
MYC@ADB0R':/X2VW<.X)'>@#V8$$9!R**X_PEI^E6NM:G<Z1J\%W'=I$\MO9*
M@MXF&0& 4D!F'7UQGTKL*  D 9)P**X_QA<:?_;WAVRN]C3S23R0)<N!;?+'
MAFD4CYR WRKQSGD8K@;#[-=^$_"T!N$E,'BQK=?*D*[8C+-M4 '(7 &!GH!C
MI0![;D8SD4I( R3@5Y.?#>BOJ_Q!TXZ?!]AM[6"XAM0,112M Y9U3HK?*#N
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M*-)TU;@7"Z?:B8)Y8D$*[@N,;<XSC'&*N44 4(M#TB%(TBTNQC6(,(U6W0!
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M)M OC#936.G-,TT5PQ)D\Q-HPNTCCKS^G6NHHH IOI&F2V:6<FG6CVJ'*0M
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MUAT(ST/O4E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKY]V'79%*H7,9&<D\GGVKI)[2&Y:(S)O$3AU4GC<.A(Z$CJ,]#S4U !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 55;4(1J2V";I+C9YCJO_ "S0Y 9O3)!
M'4X/8'%JN*\"RR7]_P",KJ9V6X.MRVH88RL<<:*F,\="3^- &^FO1KI\5[>V
M5W8PO*T3?:54&+YBJLV"<*QQ@^A!.*UJX/PU+/K?PHO1JMS)=R2K?PR2S$$L
MHEE09[<  ?A6UX!OKC4O &@WEVQ:XELHB[-U8[<;C]<9_&@#HJ*** "BBB@!
MKL51F"%R!D*N,GVYXK)\/>([7Q+:SW-E!<QQ0S/;L9U"_.APP !/0]ZV*\:M
M+N]T_P"$>OWFGWLUI<Q:Y/MDBQDAKH*0<CIACTP: /9::[I'&TCL%102S,<
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MA &YNF>*Z*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:6\=M*KZ9&8K9A<29"'&58[OG7Y1PV1Q6CIVDVFEM>-:K(IO+AKF;?(SYD8
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MC P>[E<I$>J(2V44^BXSQZ59E\)://HUCI$D,YLK%XWMX_M4H*%,;/FW9.W
MQD]JY[Q!X^BF\&>(=2\-WUL;K2W9 7 DW;=H9@N1QDD G(X[YKKK'6M,U&ZG
ML[34;6XNK;'GPQ2JSQG_ &@#QS0! /#FFC5;G5 MP+RYA%O+(+F0909P,;L#
M&3R.>356+P5H4%EI=G';SK;Z7+YMF@NI?W3<C/WN>"1SGJ:T;?6]+NKYK&WU
M&UENE!8PI*"V <$X[X/!]*37=9M/#VA7NKWS$6UI$9'V]3CH![DX ^M %*3P
M?HLL6K1O!.4U8YO1]JE_>\;?[W'  XQQQ4&I>!- U5K&2YMIQ-8Q^3!/%=2Q
MRB/^X75@S#ZDTNG/XFU'28M1DN+&TN)XQ+'9&!G2,$9"N^X$MZD  'L>]VVU
M=;71+"XUR:"RNYH$,T;MM DV@N%!Z@'/X4 5F\+VJ^)-,U2V0VXL+<VZB.5@
MK1D$"/9]W )#9ZY45LW=K!?6<]I=1++;SQM'+&W1E88(/U!JL^MZ5'#:S/J=
MFL5V0MLYG7$Q/38<_-^%5#XP\-"R>].OZ9]ECE\EYOM2;0_]W.>N.: 'Z=X:
MTW37@>%)I&MXS% ;B=YO)0XRJ[B<< #/7 QG%9]M\/O#=I]C$-G,%LIC-:J;
MN4B$D$%5!;A3DY4<'N*UKK7M'L<?:]5LH-T1F'F3JN8QU;D_=]^E+'KNDS:6
MFIQ:E:/8N0$N%F4HQ)P #G!.>,>M %:T\+Z7926S)'-(MJ6-NDT[R+"6!#%0
MQ.."1[ D# -5M&\#>'] O6NM-LWB8EBD1G=HHBWWBB$E4SD]!T)'2M#_ (2#
M1OL:W?\ :MF+=I?)60SJ%,F<;.OWL\8ZTV+Q+H4\-Y-%K-@\5D<7,BW*;83_
M +9SA?QH RD^'?AN-$B2VN4MXKD7<-NMY,L4,H.0R(&PO)SQBNI P,53&KZ:
M;>VN!J%KY-TP6WD\Y=LQ/0(<X8GVJY0!S$_P_P##MR;H2VL[1W5R+IXA=2B,
M2[@Q=5#85B1DD8/7UK,T_P -37'C?Q1<WUI?06-ZEM'#*MUM$R)&5<$*^[KW
M(!Z\\FNKMM;TJ\N3;6VHVLTX4OY:2J25!P2!GD \9J.W\1Z)=WD=G;:O8S7,
MI<1Q1W"LS[?O8 /..] $=WX:TJ[:P?[.8);!2EK+;.8FB4C!4%<?+@#Y3QP*
MCN/"6C7-E:VDEM((;6Y%W'LGD5O.W;O,9@V6;))R2>:@\=:S?>'O!NI:QIQ@
M^T6<7FA9XRZMR.#@@]_6GPOKV+"9]0TZ19F0R0_9&1F4C+;6\P\@<]#TH NV
MF@V%EK%YJT"2B]O%19W:=V#A<[?E)P,9/0=Z?K&BV.O6'V+4(FDA$B2KLD:-
ME=3N5E92""".H-1CQ%H;1SR#6-/*6[B.9A<IB)R<!6YX)/&#4M_K6F:4JM?Z
MA;6H89!FE"\>O/;D<]* *L?A?2X=2EU"..X6ZEMEM7D%U)S$,X7&['&2<]<D
MFJ%Q\/\ PW<:+8Z2UE(MM8-NLV2YD$D!_P!B3=N ]LXK:O=8TW38UDO;^VMT
M=2ZM+*%!4=6^@R.>E*FK:;)<FV34+5IQ#YYB$REA'_?QG.WD<].: ':=IUKI
M-C'9V<9CACS@%BQ))R26))))Y))R:S]1\*:/JFJC4[NWD:Z\@VSLD[H)8LD[
M'52 XR3P0>M0ZCXTT'3H-.F;4K66/4+@06\D<RE&.2&;<#C"X.3ZC%3)JMNN
MLWKR:]8-9P6J.]KE0T')S([[N%(QC('2@""U\%Z-8V\,%FMW;QQ6_P!E CO)
M>8N?E/S<]>#U X!%2R^$M(D1HUAEBA>V2S>"&=TC>%00J%0<8P2/7!QFKR:S
MI<EG!>)J5HUM.P2&83J4D8\ *V<$GT%))K>EQ:@EA)J-JEV[;%A:4!BV,[0/
M7'..N* ,S5? _A_6-1@O[FS=+J&,0B2VG> M&/X&V$;E]C5V+PYID&MKK$4#
MI>);BU4K,X01 Y"!,[< \]*TW=(XVD=@J*"69C@ #N:S1XDT(VUO<C6M.,%R
M_EP2BZ3;*_3:IS@GV% %=O"&BL=5_P!'E4:KN^V*MQ(JON #$ -A2P !*X)Q
MS3I?"FDR6^FQ"*9&TQ=MG,D[B6%<8(#YR01P020<"LWQUXCFT;PUJ-QI-[:#
M4;,PM)$X$C*KR*O*Y^7()P2#TK937](NUODM-8L6DLP1<%9E;R#SRXSQT/7'
M0T 5[CPEHUU80V4MM(88KD78VSR*S3!MV]F#99L\Y)-6;;0=/M-:N=7B247U
MS&L4LC3NP95SM&TG'&3V[FH]/U*&#P]97=_J]I=!XU!O4Q''.Q'51DCGL 36
M/X@\3O;2^&[K2]0LY--O]1%M<2##@IL=B0^<#!3!X_*@#H=6TBQUS3WL=1@$
MUNQ#8R5*L#D,K#!4@\@@YJ*UT.RM/M#)Y[3W"+'+<23NTK*N<#?G( R>!CDD
M]2:FTW5M.UFV:YTR^MKR!7*&2WE#J&'49'>J6O>)],\.M8I?W"1O>W"P1!F"
M\GJQ)Z #)S^'>@"QHNB6'A[3(M.TR-XK2+(CC:5Y-HSG +$GJ:AU'PSI6J:K
M!J=U!(;N&(PAXYWCWQDY*.%(#KGG#9%8=MXPCL_%GB*VUK5;"WTRT2S:TD<B
M(?O5D)!8GYC\H_+I73WFJZ?I]NMQ=WL$,+C*N\@ 88SQZ\<T 1Z)HEAX>TN+
M3=,A:*UBSL1I&?'XL2:T*BM[B"[MX[BVFCF@D4,DD;!E8'H01P14M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7":OJ(T3XJ6E]JN^/2I]*-M;7!4F.
M.X\W<ZDC[I90G)Z[<5W=% 'BEG<R6&CVFI?9K\:58^);Z2[$$#J\<<AE5) ,
M9*KNYQTS6IXDCT:3X:>*[W0TNY$U,*QFF$F;J7@$HC $\ <@<X/I7J]% '#Z
M[<V\_P 0O!$\4B2(!>9D4Y #1 +D]LD8'J1BLCPMJ%@;!?"^O:=//K]GJ<D_
MDO;N1(YF9TN ^-NW#9W$]B.> ?3Z* /)=2BN[F/XC)I<+SSM>6DR0Q<-/&B1
M>8J^N0KKQWXJ:^NO#FO:%X@UK2QJ%S>'0KBTDGN5E4)N4E8<, &<L3P,XQUY
M&?5** /,(O)36OAV+0QQLNFW,;,JX",T* !L=,L#P>I![T_P3J.FW>BZ)H&I
MZ9<-XBTF7]Y!+ ^895)#3[\;<$$MG/);'4UZ90>GI0!YXNEW=AXUN_#D,!.B
M:O*-6+CI#M(\^/Z._E''H[UZ'6-H6ASZ5YLU_JMQJM[( AN9T1"L8)(4*@ '
MWCD]3^  V: /(Y;2QET#Q_H]W9K)JU]J-TUI:M%^^FWJODN@(R5#<[AP,$Y%
M;.O66J^&I- \06,7VS44MX])OD!_U^\ 1N3_ +,V.?1VKT.L4Z%/-XB.I76K
M7,]HA5[?3RB"*&0+MW9 W-U)P3@$Y[# !>TNP32]+MK)&+^2@5G/5VZLQ]R<
MD^YKE=3G2P^+6F75RLB6\VCS6Z2"-BID\Z-MI('' )Y["NVHH \7LO(B^'/A
MS"*DZ>)TFD&W#J!=N2Y'7&P@Y/8CM5Z672Y-0\1^&_%,6J/-?7[SVT$*R%+Z
M)MICV,HQE=JJ<D8VCG@X]:HH ;$I6)%.00H')S^O>O,;6YMSXF^)KLZ^7/!!
MY1/27;;%6V_WL-QQWKU"B@#RC2_L\$/PIV*D;00LLVU<&,M:%6W>F7P#GO[U
M7=KR/PIXAM[>UO);BR\2R7MS;11,'DMQ<B3Y3C!)7YACKBO7Z* /(O$+^']9
M\'>*-8T47UU<7.F_9I+F=90'8'*1A7 W..>@X_&MGQ+!IGVGP.T$%MY1U*.1
MRD8QL$#J&;CH#M&3TXKT2B@#R2_OK>RN/&TC6*W<#ZQ92 %&9(QMB#3E5P6"
M,N2!U*X--DN5;_A9@\VZG^UZ7&T$TMN4\[_1G3Y?E Y) '<\=>M>NT4 97AE
MU?PKI)4@C['$#[$( 1]<UP^OV%OK?Q=>RDO+FV27P[);"YM9FC*3&<$+N4C+
M8R=IZXZ5Z;10!Y?9R7S?#O7/!J6<=EXALK66W2."/RH[P%21+%T!+CKCD$G.
M*T/#-WX=\2ZM8:A:0:G)J5I;O%*ETLB"T5AAHWW *QR  .>F1TKT"B@#@?!V
MFWMEJ4_AVX@<:=H-R\MG,W26.49A4'OL#2*?<)6#H[:9=1-X9\10:J^NVVI2
M3I:J)0DS^<TB3JZC:%^8$DGCFO7** /&M3CMG\%?$Q4C1I[C4I#$ GS2C9%M
M*]V&X-C'<&NF;4K?3_B@;RX:3R;_ $*&.VD2-G$TBRR%E7 .6PRG'O7?T4 >
M):#?-H_AOP+J>H)J$.D0V5Q:W,L,3@VTK,A5V &2I"E<@$<^]>F^#[33+;29
MY-'@N8[.ZN9+A6N"^96;!9PK\J"<X&!ZC@UT%% '&^+HO#.M7CZ%XHM46W6W
M2X@O)<HL;LSJ0LO1&&U3C/.>^*Y!$UZV\$W7[_4-8TK3-;AEMI\$W%Q9(5+$
M?W]K<AN^W(XQ7L-% 'D'B<Z!JO@GQ1JVB"]NIKVTBADN9EE'G,K#:BJP&Y@,
MY(''\NL\8:3'/X435-"@A^VZ9+'J5IY*@>:8Q@KQUW1Y7\O2NSHH \[\7QO<
M?"77[R:%UN]4@:<0LN7!8 1IC^\$"@@=P33;K6[;0O'9O=861M(U+288+2Z2
M%I8U=6<O&=H."P93[X [5Z-10!Y;=W5EX:\2Z;<7=K?Z7X<GTH6MHT"/BWD$
MK-M=5!*[U*'![K@]*[CPG86&F>&K2UTNVGMK%=[017!;>%+$@D-R,YS@\@''
M'2MJB@#RWQO>)+>>,=.6VFM;F310$>*W:1]0^23 !P55$)(.!G+=1BHYM>L]
M$UW0=8DG*"?P_P#9F2[@F6/ =2"&5&(;.<@CD;3GIGU:N>OO#U])KDNJZ;KL
M]E)/$D4T+0I-&P0MM*AN5/S-T.#GI0!Q&FW.CZ-HW@RST^Z2\MXY+B+^V8X&
M?[-)L^9 @SM9MQ5=P. .AXK-AD5? =O;2+.)H/%@=A-"R,%^V%RV,#HO)QTS
MVKU_3[!;"&0>;)/-*_F332 !I'P%R0  .%4<#H!5N@#SAOL3>-_',LHA*R:3
M;QH[ 8;Y)=Z@]^J9 ]1619F1/#'AFZT_6UTO6K30HTV7D>ZVNE &Z%P>0P9>
MQW<]#V]>HH \YTZ[DC\<^&;V]TZ6P^U^'3 L C9A%*9(F\K@<8&>O0#FNK\8
MVM]?>"]:M--S]MFLI4A"G!+%3P#ZGI^-;=% 'GGAJ_\ #>O:GI^IP1ZE_:.G
MV[I,+H21K8J5PZ/N 4\@ #GID=#7/::WV?X9^!IGCD$=EKB/<XC8F%=\PRP
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M">V58\^N*9;Z7=W/B]_%%S9/;M%IWV*"U,B-(Q+[V8D':!PH'/J3B@#'^'D
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MVDMIY4CD5C;Q_9PSG+N!QDG:I/Y5U6H>+8+3=]FLKJ\"6']HNT8"J(><8+$
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MYAC4NKJ%PYP<G Y/?V/7KB0!D\"D8D*2%+$#@#O6/X8U\>)-(:_^RM:E;B:
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MT*SA6+*6P!CECD+C(XXKHZQ;KQ!]E\7:?H+6;G[;;RSK<;QM'E[<C'7^(>E
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M;V9=DDZLP=U[ G/0=AVJLGA+08X+>!--B6*WF-Q"BD@1RG^-1GAN3R.>3ZT
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M $J.)I<)+(>=BJ 3U)V@8-94X:^\,1PWLKR_8_&B6T(\]V$4?VA1M#9!( )
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M8DQ*>H7G@'ICVH X/PU%/K^C^'/$H\2)#<-(GVT(DA:X=N)(&'F8&&/&%^7
M( %8ZI/!X,;6AJ.HM?6?B0PPR/>2,!']M$90@G# J2#NR??@5Z9;>$?#UEK,
MVL6NCVD.HS9WW"1X8D]2/0GN1R:7_A$]"^PM8_V;%]D:;SVAR=IDSG?C/7/.
M?7F@#GO#EC;1_%+QC* PD LF'[QN2T3YXS@_T[5/\406\$LH8J3?60W#J/\
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M\YW9/?--U:Q/B?P[J5]H7AS5+?5%MXAOU42)+*$F27R%\QB2#M;)Z9(P3DX
M.X;Q?H<:W9DNWB-G"+B=);>1'2(Y_>;2H)3@_,!@8JTVOZ8MW:VIN3Y]W"T]
MNHC<^:B@$E3C!P"..O(KE[ZZ?QAX9ULV7AV]M+R?29[;S+ZU\B4NRG;$N>6&
M223]W.,9YQG6%Q<W_B3P+<1Z1JL<%G97,%Q)/9O&(G,<2X;< 0,@\]#V)P<
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MA$C>1HPV2"0H/&%.2.G?%<=)";/7]?TO6_#VLZG:ZI=&YM)+7S&@F1T4>7(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!2T %%(S*HRQ &0.3W/2LZSUVQOM:U#28&E-W8+&TZO$R@!]VW!(^;[IY'%
M&E112%E! ) +' R>IH 6BBB@ HJO'>02WDMK&V^2$#S=HX0GD GUP<XZXP>X
MRS^T[+^U_P"ROM"?;O(^T^3_ !>7NV[OIGB@"W15>6]@@NX;:5]DD^?*W#AR
M!DJ#TW8!..N 2.AQ8H **0LJD D L<#)ZFL[2-=L=<^V_8FE/V*Y:UF\R)HR
M)%"DC# 'HPYH TJ*** "BFRR)#$\LKA(T4LS,<  =2:@T^_MM4TZVO[*42VM
MS&LL4@_B5AD&@"S1110 4444 %%%(S*BEF("CDDG@4 +1110 44C,JC+$ 9
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MN(+;QBWG-( !"AN)#\V?NC!7KCM7030:-J?CKQ8+F.SN(%T2U,:R!651B;D
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MP8!>H!(XR#QQ7HW@JST>VM=0ET._FO;.YNVG,Q9#$9& W>5L &W/7'&<]\T
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ML8&-$/+ \$L2<#MBNITCQ587M_'I)%U'=_9!<HUQ"R+-&,!F1CUP2/SSR.:
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MQC* Q;6).3AN0, 8Y-3^#KOQ$+#3](U3P^]G)I\2PW%X\J-%*$7:#%M.XEL
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MQ=/;[H9%D #QF/=PF%7'.1C.2234NH>%M4U&/1WGUB%[JQU!=0E=K4[)&"E
MB*'^1<-ZDYY[F@ TO7=<D\3-H&JV^GQW8TP7OF6S.R!C*R!?FP2, 'MUQVS6
M9%XSN=0\.>$M5FTJS?\ M34DMG#L6\ABS@.@(Y.$/.1C/>MO4/#M_)XO@U_3
MM0AMV-G]BN(YK<R9CW[PR$,,,"3UR.>E9%IX!O[7PUX>TC^UX&.CZ@MZ)#:'
M]Y@L0F-_'WSS[#B@!-1\8:_#/XKCM--T[;H"I*3+.Y\U#%YI PO#$?@#Z]M0
M>*)K_5]+TS3XHX9;[3#J7FW +*JY0!  1DY?)YX [YJ"?P?>33>+7_M* #Q!
M$L0'V8_N,1>5G[_S<<]N:YC7U%AJVBZ1<>(=)T^;3-,")-JEJ5AN"V%)C;S%
M(8+'\PW'AAUR< ';>#-?NO$_AR'5;JSBM#*[JL<<ID^XQ0DDJ.ZG'7C'-<ZU
M_JU]J?CZSO9K>2RLK=8XX@A&U6@+C'.,_-R>^.U=%X/GNYM%*7(T]HH9/+MI
MM/B:*"6(*I#(I)P 21P2#MR*J3>$[W^U_$=W;:G#'!K4**\3VQ9HW6+R\[MP
MRN.<8SGOCJ 8OA#7]3L+#P-IES:6OV#5--2*%TD8RH\=N'RW&,$*>!TXYJ]#
MXUU&]&G7^G:7)>:=>77DM'':S>9'$6*B;S,;". 2O8'J<5-;>#;RW'A ?VG
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M -"#QEKVN:A>6OA_3-/8)86U_;R7=PX#I,&(# +PWR@8Z#DD]JSY=>C\4O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/B^9=1N;&YTJ\EM;(0R%5B\N-6#LO1]S$GY@1C@8H [MYHTD6,N/,<%E3/+
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M>#WK<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8SW,N\1Q1W"LS[?O8 /.._T-0ZIXITO2-:T_2;JZBCNK[>4#L%"JJD[B3ZG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ.@8NR8^]A2H)'4Y'4&O0=?T"36[K29EO%M_[-NQ=HIAW[W"LN#\PXPQK<H
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M4ENDLD5S$851HAY8/S ACC_:SWKU&B@#R^UO+'PSXEU/3=?L;J+3-2TZTAL
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K.U#7M*TJXAM[^_AMI9\^4DC8,F.NWUQ[5
MHUP/CQID\9>!FMHDEF%]/M1WV _N6ZG!Q^5 '7V6M:;J5P\%G>PS31J'>-6^
M8*3@''I5^LG3)-0N-1NI-2TZ&U:(*D#QR^9O1AEOFVCN,8QV]ZUJ "BBB@ H
MHHH *PY_&/ARVE>*;6K*-TF,#!I1Q(#@I_O9!&*W*X+XD016]AX92) BGQ+9
MM@>K2,2?Q))_&@#HO^$O\/;8R-6MF\RY2U4(VXF5\;4P.<G(_.MNN(^)$ 33
M])G@CC^T2:W8#<W 8B7Y<_G4$GC#5-#F\4V^J-;7KZ7';36TD,1A#^>2JHP+
M-P& YST- '?4=*YK2KOQ-_PD;6]_9%])>VWBZ98XVBF!Y3:LC94CD'J,8)-9
M/Q>O;BS\ 3)!*T*W5S#:SRJ<%(G<!N>V1Q^- '1GQ7H(1Y#JEN($)#3EOW61
MU'F?=S[9K75E=%=3E6&01W%5CIMDVEG3#;1?83#Y'D;?D\O&-N/3'%<_%J=Y
M?>(-2\.Z5<1VJZ/:P;YI8O-9Y)%8J,9'RA5&>Y+<$8Y .JHKSBS\<:UJL7A=
MK>.RMI=1O+BQO8Y(V<)+$DF60[AE<IG'7MD=:9<>)?%<&D>*Y!>::9_#DKL9
M#:-BZ01+*%*[_DX)&03GCICD ]*HKAY]>\0ZCXKM](TN>PM8;K1AJ"2S6[2-
M$Q=5Q@. W7VZ]\8-?2?%VLZCI%L+S['9W4&ISZ=J,J L2\8;'D1\ERQV\<X&
M>#V /0**\VC\:Z]-X?TFZB%D+B;7SI,_FP.H=1(RAP-WR'"C(.>IZ5?BUCQ5
M*_BO28)K"XU72EAEM)?LS(DPDC+"-DWG!RI .[N* .ZHKE=$\23>(%T*6PFB
M,-Q:&ZO=T7*]%"=?E;?O'?\ U;5K>(KZ\TSP_>WNGVCW5U#'N2%%W,W(SA<C
M<0,G&><8H FU;6-/T+3WOM3NDMK9" 9'SU/ &!R:O5Y7XIU^+Q!\+?$=S::K
M;ZA:JL*QE8S%+$WF+N253R&S[#CMW/20ZUKEKXQO=%NWLKH/I;:A;;(S"(V5
M]GELQ8Y'(^;COQ0!U[,J(SN0JJ,DGH!6-_PEN@_V/%JW]I1?8)9O(CFP<.^_
M9@#&3\PQ6#H/BG4;GQ3IVEW4\%U%>:8]T\D,)5$F1D#"-^DD?S\'GIUKE3_R
M1!_^PW_[DJ /8JHZ;K&GZO\ :3I]TEP+68V\Q3.%D !*Y[\$=*O5Y)_:NL:!
MI_CO6M-FM%BL-;DFEAFA+F<>7#E<AALX[X//ICD ];HKA_%_B;5=&CU>XMIK
M6-+*P%W;0B(S/,1N+^:!_JT^4 'CDGGC%6I/$6H6WBW18;I[=-'U:T=HCY9W
MI<*H?8SYQ@KN(XSE: .NHKC7\1ZGNTBS5=]UJWVBYB:.)0T=LFW;\K. 7(="
M<GCGCBM?PQ<Z[<6%PNOV2VUS%<O'$ZE<3Q#&R3:K-M)!P1GJ* -LD $DX [U
M2TS5[#68)9].N4N(HI6A=TS@.OWASZ5S.IS:F?BMH]I%?A+,Z;<3& Q9&1)$
M"<Y')!P#V].37+6.KZQX?T+Q!K%E+:?9+;Q-<+-;R0EGF5[E4;#[AMQNR.#T
M_"@#URBN*U+Q!K][<ZY!X=M1)-I<BPQHR(RSR^6LA5BTBE5(<*,#J"<GI776
M<LTUC;RW,!MYWC5I(2P;RV(R5R.#@\9% $]5--U.SU>R%Y83B:W+N@< CYE8
MJPY]""*Y73=4\4:KXHUJQBO-,AM=+OHXCFU=FEC:)7Q]_@C<.>_MWIV?C75&
M\#:7JEREN+J]U8Z?+,D9$4"&X>/S"I/HH')ZD9H [?4=2L](L)KZ_N$M[6%=
MTDC]%%3031W-O'/"VZ*10Z-CJ",@UYSKNJZM>:)\1-,NY+>6QTS3I8XID@*O
M(SVY?#-NVY7." HZ@\=*N:9JNNV>IZ!I,UU9FVU32I'@\NW.ZV>)(\9);YP0
M_H.10!WU%<A\,;B^O/ .F7E_=_:9;A&E+%,-DNQ.3GDD_2H_%DVIKXV\(6UG
M?B"">>YWQF+<&98'()Y&1@GCUYYXH [.BN!G\6ZM<^%-7\4Z:;;[+IT\^RSD
MC/[Z&%BKDOG*L=K$8&!QD&NVL;N/4-/MKV($17$2RH&'.& (S^= %BBN/76=
M>UN'5KG0&LPVGZ@UG';7"G$_ELHD+N.5ZMMP.P)SG 3^WM6U@^(GT:6WA_L>
M=K:*.:(O]HE1%=MQR,+E@HQSP3STH [&BO/K+QAK'B#4_#\>EO9VEKK&E27G
M[Z!I'@=2@(X8!AEB!T]>>E9MWXAUS5O#?AZ5KR&WNCXC73[HQ0_)-Y<S -@G
M(&8P2,\^N* /4Z*XG^U/$]WXSU/1;:]TV*"QAM+CS7M7+.KE]ZXW]2%//;IC
MG(HS>-M4'@5/','D/IPEWO8F/YC;>;LR'S_K,?-TQVQWH [:#6-/N=5N=+AN
MDDO;9%DFB7.45LXSV[&KU<;II#?%S6V'0Z1:'_R)-6[XBO;O3]$FN;)K5)E9
M 9+M]L<:E@&8],X!) SR<"@"YJ&H6FE6$U]?3I!:PJ7DD?HH%5CK^E"[TZU-
MXGVC4D,EI'@YE4+N) QP-HSSBN)U#7[O5/#7Q"TRY;S8].T]_)F:!H7=)+9F
MPRGN"#S@9&.*DE_Y#?PQ_P"N4W_I&: /1**@O&F2RG>W9%F5"4,BEE!QW (R
M/Q%>;V?C'Q3'H7ACQ+>MITNFZG-!;W-K# RR1>:=HD5RQS\V/EQTXR>M 'I]
M%>>P^*?$")XBU.\N-/\ [-T"]N(YHH[9A)/$D*N I+G:V2.><Y[8YN3>)-8T
MI/#.H7KVUQ9ZS/#:S0Q1%3;R2KE"C9^90>#GKG(QTH [:BN/TS6=>\0:?::W
MI+6?V26^:-K692#]F61HV;>/^6GR[@,8[<]:J6GB3Q+J]OI^KZ1IWVBQGNRD
MD#"-0+;>5+AS)G>,9QMQU&.Y .[JGJFJV.BZ=+J&I7*6UK",O(_0?ES7()XD
M\2ZK;1:KH>G?:;7[<\)MF$:AX$E:-FWF0$/\I;ICM@]3D^+]8O\ Q'\.?%][
M:SPPV-L;BT2)HMQE6,[78MG@D[MN.F!G.> #T7^UK'^TH=.\\?:YH#<1Q[3\
MT8(!;.,=6'YU<KDX]8U&/QKI^B*UL+.?1WNE)B)=9%:-1D[N5^;H /K7/6/C
M#Q*^@Z)KES+IQ@N=7_LZ>WCMV!96N&B#AB_RD8'&#TY// !Z;17 Z[XOU6V3
MQ;+9FW@DT%8FAMYHRWVD,@;)Y!PQ)5=O<=^@-<\7:AHUQ;6NHW4&F&XL5DM[
MZ6T;[,]T2V8I#N/E@ )U/.3SQ@@'?44U#N13D'(SD=*X/4_$VO6%QXJL!+:?
M;[&&*ZTM3;L1<1OE0I ;);S!LXQR0>] '?'@9JIIFI6>L:=#J%A,)K68;HY
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M0 4444 %%%% !1163XAUV+0-/BN'C\V6>XCM8(MP4/+(VU06/W1W)] >#TH
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M'S;1NP"#QGIQ6P_@2"-]+GLM3NK6]L;B>X:Y"HYG>?\ UI8$8R>W'':NMHH
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M@S-I%N]O&@B $BN%5BW/7"+T[YK:M+^UOI+I+:59#:S>1-MZ*X56(_ ,*LT
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M$9*D]\'C-6: .*E^'B2:-JVE_P!M7AAU*_%](SQH61]RN<8 ZL@SGMP *[1
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M!!_(T ,TZR_L^R2W\^6X<9+S3$%Y&)R6. !R>P  Z  "K5%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %87BVUT34='73-?16LKZ9;<$MMVR')0ANQR  ?4BMVH+NRM;^'R;RVAN
M(LYV2H'7.,=#]30!Y]I/_"1^$/%<'AN34FUS3KNRGFLI+@9N;8Q[?E=A]Y22
M ">_IBJ'A5+#7K#PWK+:];1:JCJMREO$5NKB4C$L4IWDD9R?NC &1@"O2K'1
M],TQY'L-/M;9I  [0Q*I8#H"0.@ID.@Z/;ZC-J$.E64=[.");A+=1)(#URV,
MG- 'GW@[P=I&O^%[^2\25[HW>H6L<[3.6A0S,!MYQD8!!ZYYK1\$2-KMMI]O
M?VRI<^'D>TN<+@?:@=F5/^XN_P#[:*>U=M8Z98:9&\=A96UHCMN98(EC#'U(
M Y-3);PQ&4QPQKYK;Y-J@;VP!D^IP /PH \AM]2_LKPG&)IG32W\73VU](SD
MA;?S9  S'^'<$!SV.#P:U?$DFE^'K"[N-'O@EA<ZE9G4E0[[:UB;Y20J8VAL
M+O&>0WOSWT>AZ3%9SV<>EV26MP29H5MT"29Z[EQ@_C2VVC:79Z:VFVVG6D-B
MP(:VCA58R#URH&#F@# \*Z;96.M:G-I^K6UQ%=1QR/9V486WA/(#J S!2PZ\
M\XS5#Q79Z=)\3/!\UY;VS!H;X.\RKR%1"N2?3)(].:[#3=*T[1[7[-IEA;64
M&XMY=O$L:Y/? '6GW>G65^T#7EG;W#0/YD)FB#F-_P"\N1P?<4 >/ZU86[^%
M_B-J9#?;+'5Y);64.0876.$AEP>#[_A6EXZN+*[C\7M'(K7MCI,3/)=R#%LY
M1W3[.HP0['!+9ZA<9QBO13X>T0Q3Q'1]/,=PV^9#;)B1O5ACD_6B3P]HLTPF
MDTBP>40FW#M;(2(B,%,X^[@D8Z<T <1I\>G77Q2TZ]G2UDFE\.I)YS!26E$R
MJ#GNPZ>O:M?XKJ#\,==;<ZLD&Y2KE3G(]/Y5THT?3%DM)%TZT#V:[;9A N8%
MQC"''RCZ5+>6-GJ-L;:^M8+J!CDQ3QAU/X'B@#@[K0=-7XIVEF(6-M?Z1/)=
MQ&5BMRR2QA3(,_,?F/6LC1;BT'AS1M)N&EF/]OWEO9VTDVV%UC>7:DI8'**O
M(7J2%'T]-_L72OM,=S_9EGY\:>6DOD+N5?[H.,@>U0MX:T%[3[(VB:<;8R>;
MY)M4V;_[V,8S[T >;:9I#>(/!/B"ULIH)K_2];N9M.6,_NUV.&6,+DXC;E=O
M3!]J['PC>V_BB9_%<=N8XIH([:V#KA@%YD_'>Q3_ +9\=:T-1T[4;- ?"]OH
M]K-<3[[R2XA8;EQC< F-SCCKV[BM+3;"+2]-M[&$EDA0)N;JQ[L?<G)/N: .
M<\72V3ZYX>T^X!EN)Y)WAMYG"VSA8_F:4$'=M#951W],9' 69CO?"?AB![QI
M!'XK:V'DS,H\DRS84 -PN%&/0#@U[#?Z5IVJ+$NH6%M=B)_,C%Q$LFQO49'!
M]ZKMX=T-_OZ-I[?OC/\ -;(?WIZOT^\?7K0!R:Z19:%\2_#=CIL;PVHTV]Q$
M97<#YXSQN)[LWYUCZ5/J&C7=M#-8V]]=7-E=2:3K5D?^/P[/, G0\[R #G)&
M?J:]-?3-/EOH[Z2QMGO(AMCN&B4R(/0-C(J.RT72].D\RQTVTMGP5!AA5" 3
MDC@=S0!Y[X3CTW5AX9UVWUZT6^\O;-%;18GNF9/WB3Y<EBI!;)'!&:Z/XGJ&
M^&FOMN=2EH[J5<J01TZ5O6FAZ18W\]_::79V]Y/_ *V>*!5>3ORP&35B\LK3
M4+9K:]M8;F!OO131AU/U!XH X.\TVTU+XG:5;W:O+;S:!*TD)D;8^)(@,KG!
M'/3O6G\,68^"(8B[.L%W=01[F+$(D[JHR?0 #\*Z(:)I*W$=P-,LA-''Y:2"
MW3<J?W0<9 ]JELM.L=-A,5A9V]K&S;BD$2H"?7 '6@#SYY-'UW6_&&F>)KQ+
M6YMID%L[RB-[>V\I"LD)/W3OWDL.^,]A5G34M?$'B_Q-IFN1F:.VM[7[$ESP
MR0-'EI%ST;?G+#!! '85V5WH>DW]]!?7FF6=Q=V_^IGE@5GC[_*Q&13KW1M,
MU*6.6^TZUN9(P51YH5<J#U )'3VH \JT6.ZUB3X<'6Y9YIKF"_24M*P\^)5/
MELP!YRFTD]\G.<U#<0)%X-U2RBDECM['Q>EO;(DK*(HS/%\HP>@W-@=LUZ[-
MI6G7%U!=3V%K+<6XQ#*\*L\8_P!DD9'X56/AO0C&\9T73BCR>:ZFU3#/_>(Q
MR?>@#SO6#-X9U;QQ'H*R0XT2"[$<;%B)"TJO(,G[VT9SW(%.OA;VNFWOB/PO
MK5G)>-H\YBM=-@VB8!=PED7>QWJ>YYR<'K7I4>E:=#>->16%JETZ[&G6%0Y7
MT+8SCVIFG:'I.D-,VFZ99V;3G=*;>!8]Y]\#F@#D=.LO">IV]C?Z=<I-)=::
M\;012*XN4*@EIUY+,",;FZ%L'DURUI!9Q?"#P;+:B..;[=IS2^2VTLQE4$N!
MU/!Z^E>KZ?HFDZ3)-)IVF6=F\YW2M;P+&9#[X'-1_P#".Z']E%K_ &-I_P!G
M$AF$7V5-@<]6QC&??K0!R=K%:^(?%WC#3M>16^RB%;59#CR;=H\^9&?X27W$
ML.<@<\"N=T6.ZUJY^'+:ZT\L]WIU[]H#R,//10GEEAGG*D$^N3G->IW>BZ5J
M$L<MYIMI<21KL1Y858JOH"1T]J?-I>GW%W#=S6%K)<PC$4SPJ70?[+$9'X4
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M/]FV?VAT\MY?(7<R_P!TG&2/:HW\.Z)+I?\ 9CZ/8-I^[=]E-LGE9]=N,9H
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MBLXO ^C"S2%0;*!I!$ ,N8E))QW/%:5MH6D63H]KI=E T</D(T5NJE8\YV#
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MRM&&(P^YB -I.1S6)<V-\_PZU^T32]0-U/XA:YBB^QR;GC-VL@<#;TV G]*
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MP6<\IM-7UBWM)97E:SCN1Y6YV+-@E2ZY))^5AUKH888[>".&%%2*-0B(HP%
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MT#9 .Q@OS A@0?EX.>HQ79:;I5GI;76IC3;:SO;B-1<BT8NKB/.W'RKDX/\
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MZT =C17%Z3XNN(_"_AU]26U.IZG:)+'ON2B,HC5F=VV?*<L!M ;EASC)$/\
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M\SB@#D=4T+Q%:>+9==\-W.G%;V"."]M;_>%)0G9(C("<@,1@\'^47B3PE?\
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MF619(X]FW@$;3P<\GMCO73T4 ><VO@?Q!IGAOPP-.O;!-;T%9(E\PNUO<1.
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M326G@S2[/44U&.6_:]2U^R^?)>2.S)G/.202,G&>E 'GVF?\DG^'7_86L?\
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MD>XNY)/,C.>&R>>I^F:8O@C2$TO3M.5KS[/ITZ7%L&NG8HZ#"<DGA1P%Z>U
M&!_:^IZWH'BO5[74IK.ZTF\N8+2),>6@@ X=2/FWD$G/0,,8QFF6.IZOXD\4
MZ? =5O-/L]0\.1Z@]O L8:*1G4':Q4D=>^3Z8KJ)_"&E3W=]-B>)-0Q]N@BE
M*QW/&,LOJ1P<8R.N:L'P[9?VZ-91IH[P6OV-2CX58LYVA>G7G/7\* ,_X?:G
M>:QX'TZ]U";S[IA)')*0 7V2,@) XR0HKFKK7=3@U'2[JVU.>[CN/$/V&69%
M"VQA9G7RE4\EEVC+@?>!Y/2NZT/1+/P]I::;8>:+6-F9%DD+E=Q+'D\]23^-
M8Q^'F@;0@2\6);S[=%&MY*J0R[BQ* -\N23T]30!R.IZEKZ:)XYU"/Q#>I)H
ME\QM%5(@"%BC?:_R\KR1@8ZG.>W3VVIW'B+QAJND_:Y[.#3;.VD"V[!6DDF#
M-OSCD*%  Z$DYSQ5^3P5I,MEJUFYNC!JSF2\7SC^\) !_P!W@ <8Z4ZX\':7
M/J5MJ(>\AO8(!;F>"Y:-I8AT1RI&X>_7WH S?A2"/AGHP9MS!9<G&,_O7KLJ
MS=!T*Q\-Z3%IFFK*MK$25625I""3D\L>.2>!Q6E0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3)98
MX(FEFD6.-1EG<X 'N:?7)>/;^QL;+1S?HFV35(5BEFD*0PR#<RO(1U48Z'J<
M<CJ #IEO+5[7[4MS"UMC/G"0%,>N>E)]OL_LIN?M<'V<=9?,&P?CT[BO)=-E
MM[R#Q'90Z_;6=Y_PDB7%K/Y8,)D,4;+N0G[CLK <\G!!)J_'/>ZGI\:&73]#
M\06FMR"-E'F65[<"$[L X.&5C[A@>] 'IIO+86INC<0BW R9=XV ?7I2-?6B
M6HNFNH!;$ B8R#8<^_2O*'U\00>&KO5(!HNEQW]]!>26^V2WCNMWRR LI&QF
M,N"1P3UXS5Q=-T^*VM6\*>(D6X?4Y[RS>^"26=S*8\21IL"@+AC@KT(?'>@#
MTJ2^M(H%GDNH$A8[5D:0!2?0'I3S=6ZJC&>(*X+*2XPP R2/48YKS""XN]2T
M[0[O2FT_2-9@%^JZ;=?/:72B51-M88(&[!5AT!(Y%16K:5J_B'X=32:7;VBS
MZ?>*;23:V%58PB_[2\$KGMS0!ZB-0LBD+B[MRLYQ"PD&)#Z+SS^%.N+RVM-G
MVFXAA\P[4\QPNX^@SU->)W]II$7PX\=3Q16BRV>M3K:NH7, $J,HC/\ ",DG
M QWKH-9O]'E\8^(=+\4:M]@M+ZTA%D\GE".>W*8=4=T/S!RQP"#R#VH ],FN
M[:WW>?<11;5WMO<+A>F3GM[U2U#7],TR:PANKN))+^3R[<;Q\_REB?H .ON/
M6N!TW2=$/Q)MK.>%;B)/#,7%^JM(^V4@-(".6VXY(R*Q-&FL%\*?#>ZO)+?[
M+#J,\+S3,-B+LG"J2> .@ ^E 'MF<C(J&.\MI;B2WCN(7FC^_&K@LOU'452U
M\WI\,:F=*!^WFSE^RX&#YFP[,?CBO/$:UU#PU\/Y]#9!JD-Y;JP3_6H@4BZ6
M3OCAMV>^.Y% '477B34;_6M4TKP\^FM=::(2R7A8BX9P69593\N% YPW)Z#%
M=3/<0VL)FN9HX8QU>1@JC\37$^%UL#\3?&@B6W\U&L]NT+E<PG=CT]ZM>,M2
ML+'7_#27;0PSR33M;W=W(5MX"(B"6&0&8AL*"1W.>,$ ZP7,!BCE$\9CD("/
MO&&)Z8/?-,6_LVA,RW<!B#;"XD&T-Z9]?:O$[1M+N?#7A^VFDMY6@\8R188!
M2B-+*=N/X01@[?<5U6FZ'I&J^)?B!X<\JW2PG6T!@A"@1LT)!=5' ;(!SZ@4
M >B_:8,QCSX\R_ZOYQ\_T]:R/%^LW'AWPKJ&L6T44KV<1F,4N0' ZC(Z?K6!
MX)DOM8E@.KVVRY\/H^GNQ7B2XSAI%]O+5""/^>K#M5WXHR)'\,O$.]U7=9NH
MW'&2>@H T+:]UZ2WL+IHM/>*X,9>-"ZNJMC)7/!(!SCT!K6^WV>UF^UP83AC
MY@X^M<=ITGAVRMM$OUUJ22X1$CCMO[1>?S7D0(%6-G(SDCD#@9Z#-8&O_P!F
M:7XKF\11)&_AI[J&WUP*R^6;A3^[EVXY",4#X/)QP=K4 >HSWEK:HCW%S#"C
MG"M(X4,?09ZU!-)>C6;6..6S%DT4AE1R?.9QC:4[;<9SGVKA;S6=%A\>:Y9^
M*+FVBL+_ $V%=/EN7"Q20D,)51NF2Q&0#D_+Z"G10Z;9_$GPE'9Q^2O]BW$2
M+,?WI13%L#9^8G /7GK[T =_'>VLL[P1W,+S(<-&L@++]1U%+'>6TMQ);QW$
M+SQ\O&K@LOU'45Y9HT^HV,EA964EGK-O<V%VVC:E#\MS =F[9,.A&=HW<?,!
MGDU+X/E\-ZW_ ,(S<1:O=OKFGH4-BHC26)RNV82@(&VYSDL>3CDDT >AZE+J
MRS6T6F06K!]QFDN68*@&, !>I)/Y US7AWQ-XBUZVENTL-.$-OJ;V,R+(^_:
MD@1W7C'3)P?2NU)"@DD #DDUYCX+U"SB^'OBZY??<01:AJ4DD=L_SLF2?E(Z
M$CH: /1X]0LIO-\J[@D\G_6;9 =GUYXI5O;5]FVYA.\[4Q(#N/H/6O*_#^J:
M6OCG0I!?Z:+.3P[)"J0.#&BJ\1$;.3\[*N2<XXR<"I?#)T[P]XMM89E1-!U,
MRS^'6D8;8'8@R(!CY=_#)GH"5X)(H ]6J"WO;2[5VMKJ&8(<.8Y VT^^.E9/
MC6ZMK+P3K5Q>P3W%JMI)YL4#E'92,$!ATZ]>PKSP7NF3^+-2C>^TRXMKGPKM
M"VV/);8[84$D[RH[_H.E 'K,=Y:S2K%%<PO(R"1560$E3_$!Z>]<_P"-_$TG
MAO09KNR>RDO8FB_<3OR4:14)"@@\;L_A7"Z+#IMG!\*;NW6VBNIH]DLJX#R
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MX([TZB@"(VMN2Q,$66Z_(.:1[2WEB6*2WB>-3E49 0#Z@5-10 4444 %%%%
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M(W9"&SNP/NG@X-;6L:/J&K^-5G6RN(;*;0KFP>Y)3]U)(R$9&[/ 4]!7<T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCG<6B0X98V9B2Q4'J3G&* 'S^(XO[9ETC3[6:_OH$5[E8BJI;AON[V8C!/4
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MP):$W,JR(&CSYP*L"Y#'!+$_= [G(!Z'5;4+B>UT^XN+6T>\GCC+1VZ.%,A
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M?ETK?L=#T^&,R?8F$DL'DNMQ(966/O'DLP"^P.*9)XK\/1,JOKFG*S3_ &<
MW*<R\93KU^9>/<59OM<TK3)/+OM1M;9]H8B64+A2< G/09XR>,T 9L'@7PS;
M?9?)TB%&M=P@8,VZ,-U .<XX&!V[8J=/"6AQVEC:I9;;>PD\VUC$K@0OV*\\
M'D_F?6I[WQ%HNG2RQ7NK65O)#'YLB2SJI1,@ D$\ D@#US5/4O&6B:9_91EO
M[=DU20+;R+*-A7:6+[NFW Z]R10!'IUIJNHZXNI:WIUI:?81+%9I%/YS.'(S
M(3M&WY5  YZMGM71U1DUK2XKI;634+99V945#(,EFY5?J000.N*O4 8D?A#P
M_#I+:7'I4"632"7RE!&UP<@J<Y4@],$8[8K0L=-M-.606T15I6#22.[.\A P
M"S,2S8  Y/2H[C7-*M+L6EQJ-K%<%E7RWE (9ON@^A/8=^U07GB?0=/:X6\U
MJP@:V*B827"J8RV=H;G@G:>/8T )KOA;1/$JP#6-.BNC Q:)F)5D)ZX8$$ ^
MF:>/#FDK=6-REFL<MA&8K4QLR"%",%5 . " ,^N*LW.IV-I;1SSWD$<4N!$[
M.,.2,C;_ 'N.>.U87@;7;KQ!I^J7%U<P7(@U2XMH9;==J-$A 4CD]1SG)ZT
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M  =A5>SU2PU%Y4L[N&=XL>8L;@E,YQD=LX./6K+ND4;22,J(H+,S'  '4DT
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M+@QDVK*V[TR^ <]Z9(X7X>?$+39(I1=_;-198VB8;O,8F/!Q@EL@C'6O6J*
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M>81RYDDC/5PQ_> \Y.><BF:U_9VJ:1?>(O#%KJ6HN);.2_=UE!N8HI0YB57
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MS8^(-)@U/3I&DM9L[2R%&!!(((/(((-<M\8/G^&&L6Z O-,L:QQ*,LY$J$@
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M1F6<FW?*;DF"\ 9()8 $<<U[+10!Q&C""?XF>+4= T5Q9V:89>),"0./?&X
MCMFH?!%A?VMQ)H=[%)]D\.3R16<S\B=7&8B#ZI$Q4_[P]*[VB@#R3PVVFWEI
M8^'=>MM5?Q#IU_YOV8B4(95D+"X#@;=A!+$D\Y(YR,^MT44 >3:FMO+!\53L
M1I+B(+"=N3+BU50%_O?.,<=Z>VJ6VE:_!/KSWZ:5J6C6L-O=6ZR.@D3?OB?8
M"03O!Z=J]6HH \QLM-TJT\<>%[*&Q:*QBTBZBBAN@79 [H45MV2"5W?*><9%
M4RVEF\\0^%_$]MJC37>H236MO DOEWD3$&+8R# *X53D@#:.< X]:HH \T5-
M,M?%/CJ'6;56^W);B"*2(L]T@ME4K'D9D.X$8&3FHY]'U/PQX(\*ZXT+SZOH
M$$<=U"ARTMNX"R1 ]RORD>Z>]>GUC7NA3W^MPW<VK7/]GQA&.FJB"-Y$;<KE
ML;N#@XSC*CZ4 6-"L9;#2(H[C!NY"TUR1T,KDL^/8$D#V K ^(CW5MI6EZA#
M;37-K8:I!=7L,*EF,"YR0HZ[6*MC_9SVKL** /,O$L]IK.C3:[X<T^:X@_M"
MQN=1F2W=6O8H7RRA6 +[0%/3';D@BM:)(M:^)=IK&ER)/8)I4D%Y/'S'(6=3
M'&3T+#YR1U'?&:[>B@#@?!VFWUEJ,_AZYAD&G:#<O)93-TE249A /?8K2*??
M9Z5A:,VFW4/_  C/B&WU5]=M=2>=+8"4),_G,Z3JZC:%^;))/K^/K=% 'C6I
MQP/X(^):QQ*T]QJ<AA"I\THVQ;2O=AN#8QW!JWXQU"*\7QA9002P33:,ACD@
MMVE;41Y;D?-@J$3)!P <D\BO6J* /-](GLY_B-IUXX 1?#*KYLT97:_F D98
M#!VY/TYZ5A:.XM/"'@*XDCE6&RUF<3[8F8PAO/"Y4#(!W+CCN/6O9:* /,;R
M:YL?$LMSHUX+N&ZU6(7NA7D7[P/N0>?"WW@  KG.5^4\C&*].HHH \<\:7JW
M-CXPM([6>TN([ZVD:WAMG=KI5:']^[X("X7 "XQLY)SBMI9+*;QGXUN71-DV
MD6RQO)'M+?)+O49&<\ID=>1FO2:* /(?#NHMHUYX)O\ 5?,32O\ A'18K,R$
MK;7>4+!_[A*KMR?3%=1\-I$:V\1!(I8U;7;N1-\+1@JS9!&0/_K5VU% '+^/
MKM++PTLTMB+J,7EON+(SK;_O%/G,J\L$(#8'7%<'?+%>6_Q)AFN-1:*YMK:=
M+G[&P:15B R %4%<C&.Z@]>M>R5FZ]HXUS2VL_M=Q:,)(Y4F@(W*Z,&4X(((
MR!D$8- '%:%KFAZSXV.KSZM9+?#3/LBVJ+(H8!C([YD1>G8 <#<<\\9&EV$W
M_"B+-M-L&DO[=8VG@B3;,Z)<"22/IG)4'COQZUZ+8:->QSPSZKJ\FHR0,6A'
MD)$J,5*[L*,DX9AUQSTK9H \GU4:;XFT36-8\+0:G?:F;!899)1*A:-95<P8
M< ,Y <<9QT_B&;+3>$_$UI?ZK$NM2N=.:TN[EEE1[>-F!\O###.#EL '&T^H
MSZ?10!Q7@NYU0ZOJ5G?7EKJ\$4$)@UB",(95)?\ =28^4NO)X[,,]:VO&,P@
M\&ZQ(=.;4E%I)FS&?WPVX*\<X^G-;=% 'D7VFSN_$]Y-=27MYI]UX5DB:2"S
M>-2 Y+)'\O&%)QDDY.,D\5T?@R?4H]>N=/N+^#6[&.S1K?5DC"R@;B!#+C@L
M!D]CUR.:[JB@!'=8T9W8*JC)8G  KQVT-T?AOIDUM%+-'8>(C>7]NB$R&V%U
M(^=G4CE'Z<@5['10!PJF&^^(DVOZ?.CZ9'HK075S&<QR2&3<BYZ%E&XGN,@=
MZYFS<1_#3X=Q/E9(-4M#,A!!C"EMQ8=@,C)/3(KV"B@#SBVGBL+WQQIGB!27
MU"=Y[;>I/VNW:%46./\ OE=I&T<Y/3FH&TO6?#OASP7K!MI+O5],B2QNX%.6
MDBF4)M)[[7\OGV)KTZB@#SOPIH^I:7X@NO#EVK2Z;93C5(KG;A7:4']V!T $
MOFOCMA:K:5)<V'BBRCTN]74M*N=2G,NG7,?^D:;(WF%Y58<^626'S#HXP3FO
M3:* *6EZM::Q;R3V;2&..9X&\R-D.Y#AN& XR.M97CUU7X?^($)^>73YXXU'
M5W:-@% [DGM7144 <CX(T/2H=$T35;: )>)IJ02,&/\ $J%PP/0AD'TKCA'+
M-\,-<\*WT;-XE^U7 6$@B2XE><R1S)ZK\RG<. %.<8KU^B@#@-'M;=_BAK*7
MB0W$O]EV<?F.@(>1&<O@GN#L)';BN_HHH \:U34([CRREK<69M/%D4L]E%:.
MVT";F:1MI)+_ 'AM(&#@ XS71V=Q$/%GQ D9MJ/:VVPL,;ML+!L>I!(!]"<5
MZ%10!S/P\./AWX?0Y#QV$,;J1@JP4 @CL0:Z:BB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;Q'
MXCM_#-I;7-S:W,\<]S';#[.H8JSL%!(R"1D]@3[5LUQ?Q-:1=!TQH4#RC6K$
MHA; 8^<N!GM0!(OQ MT?6+>\T?4;.]TNT-\]K-Y>^6W&?G0ARIZ8(SUXK1'B
MNV-_H=J+2Z)UFW>XMG&S "H'*M\V0<$>H]ZRM1\,WGB#5=7U*:+[$UQHLFDV
MT<C*S?O"69VVD@#.T  GH35"PT;Q,^I>#KJZTNU@CT:WF@N%^UAF;,2IN7"X
MYQD#\R* +@^),)TJ[U5?#VL-86@N//F"Q8C:%L,I^?D\$Y&1[YSB[9>.;>XU
MZSTJZTR_L#?Q-+8W%RJB.X"C<P&&)4@<X8 XKG;S2[_1_@]XMM=1MQ%(Z7]P
MNV0."LC.XZ=QNP:U1H=UXED\.37UJ;2UTVW=W/F*S2R/#Y8"8Z* S')P?N\=
M< %\^.+%;6RU%[6X71[V<00WYV[,L=J,PSN5&/ ;'<9P#5N/Q-'<7L\-K9S7
M$5O>"RFEC9?W<G&25SG:,@9_3'-<M;^$=8G\#6O@F_@C^SVTT2-J"2#;);QR
MAUPOWA(0H7!&!R<GI5F^\*WMWXHAU>UL?[-U2._4R:A;S@1W5H&Y25 <LQ3Y
M>1UP=PZ4 :%_\0M)T^19)%9K+[7]C>Y21#LDW;"2F[=M##:3CWP1S6A;>)H[
MV\>*ULYIH([Q[&2=&4B.1,[MRYR%R,9QR2.,'-<_HFD^*=!N;G18K#3[C2GN
MI9K;4WGQ)!'(Y<JT>TEV!8X.0.F:)/"M[-XLM]9M;'^R]02_+75Y;S@17EH&
M;"R(#EG*[1RO!YW=J .G\2:]#X9T&YUBYMYY[>V :18-NX G&1N(!Z^M1S^(
MXH/$AT/[%<O<FQ:]1DV;9$5E4J,L/FRPZX'O4?C71;CQ%X,U72;1D6XN8"L1
M<X7<"" 3VSC%8\%CXBN/&UIX@NM*M[>%-*EM'@%V'<.TBL,'&#]WZ8YSVH E
MTWXAVFHIHEP-*U""QUB3R;>ZE"!1+AB$(#;N0IYQC/>LKXCZ\+[P#XE6PMKN
M6&S#027<,H0+*N-V!N!8*3ANW7K@XCL?"VN6OA'P9ICV2FXT?4([BZVS+M**
M'!VG/).\<''0U!=^%/$UOX6\3^%K6RM[JUU"6>:RO&N0FT2MN*.I&=P)/(X/
MM0!U>J>,+/1DFB\IKF:SMEGN$26-"JD$@#>PW,0I.!^F1FHWQ#M)KB"#3-(U
M+4GN-.&HP?9U3]Y$6"\;F&",\@XZ8&<U3DTOQ1H_B>?5=/TNPU*WU."%;JVD
MN_+-M-&NW<KE#N0C&>,\?G?MM(U:/X@6VK3P1O;+I!LI98V"CS3('RJ]=G&/
M7^= %SQOKUUX;\%ZCJ]G:^=<00Y568 (3QN.>H&>@Z_K6!K%]<P?$;PY=+87
MK3S:?> V2RJ2Q4Q[?XM@X).<CKZ\5T7C?1KGQ#X*U;2;,H+FY@*1^8<*6R"
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MV.0#QG%/TG2_%7A_4]5TVSM;.XTN^O9;R"_>XVM:^:=SJT>T[R"21@@'N1V
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MS)M61D$4A4,S#8 3EAG<.#0!TY\7:*-/U6_-S(+;2I&BO&^SR9C95#'Y=N2
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MS+N /G1<XR,T =I17E=CXG\4R^%_"NNOJENSZE?I936YM!Y9#NZ!\@[LC .
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MK;7,D)CQ=(OW=ZLA&X=F4 UTM% &3X:\/V_A?0K?2+6XN)X(,[&G8%ADDD9
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MABWGU^WUB>]NY9X;1[/RW\ORY(W(+;ALSDE1T(K5O)I;>RGFAB662-"RHS[
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M\56&@:7%9W%M;:;81)/$8G3[,NQEY^5E&,KR>/>IM*TRWT?2[?3[50L,"[5
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M,);>Y'4J0I#'G+=>:]#P,8P,>E4;30])L/,^R:99V_F*5?RH%7<#R0<#I[4
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M'-#M#$;;1M/A,,AEC,=LB['(P6&!P2.]2V6BZ7IK[['3;2U;:5!AA5, G)'
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ME_:DN?[-L_M")Y:2^0N]5_N@XR![5"/#6A!$1=%T]51BZ!;9!M8]2,#@GN:
M*O@N]MM0\(V%Q9VLUK"0ZBWG.6B97967/< @@'N,5O4R&&*WA2&")(HD 5$1
M0JJ!V '04^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI&9;+]VV)E"[^#C'W><'FN5U'2;CQ#XEOM7LK::*$:#/IZO/"T+3R2'<%VN
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M -&_UNPTV7RKB60RB,RF.&%YG5!QN*H"0,]S52Y\8>'[2&PFEU2'R[]2UJR
MN)0%+<;0>P/U/'6L:,7>A?$?6+^[M;N?3M5M+<03V\#S>2\6X&-@@)&=^X'&
M.O>N<T[0;_1QX,BFL;HK%JUW>2QQP-(MI'*LNQ6*@@8+KGT)/IF@#TNRU6RU
M#28M4M9M]G+'YJ2%2N5]<$ C\JY>/QA8:1X=T.9+Z]UI-1NQ;0WGV9B7R[;B
M=BCH P  R<#&>379.XCC9V#$*,G:I8_@!R:\FL-/U&W^'/@\/I=_YNFZTD]U
M;BV?S4CWR_-LQDC#J>,]: /1YO$6F03>5)-*&$D<3$6\A5'DV[%<A<*3N7AL
M'YAGK4VKZQ8:#ISZAJ4Y@M(R \OELP7)P,[0<#/>N#UFSU%/$-WJOA^/5+74
MGN;<7%C/;-)9WZ[8_G+8*HRC@L&X\O\ &N^U;3;?6='O-,NEW07<+PR#V88S
M]: (DUW3GUK^QQ-)]O\ (^T>287'[O.-V2,8SQUZ\=:Y;5O%(A\6^&9H-2F7
M2+M+P3PF @.T:C;@%=Y.XD8'7C K!BTCQ>+30]>,3C7+-O[(DC).&MSF,SL.
M_P"\"R_[H%=%JE@;3QOX+2UL[I[+3X;J)Y4@=TB#1JJ;F QS@_UH Z"U\3Z/
M>:/_ &M!>JUGYABW%&5O,W;=FPC=OW<;<9SVJ&;7+74=,U:/3;V2&]LXF+JT
M126%MI*DI(O0XX)&#7GXTS5Q;7%_!IUZRV/B^34WMF@9'GMFR-Z @;B,E@!Z
M>N*Z&>RFO_%NK>(K>WNTL_["-B%>V='GE+L_$9 8[1@9Q_%@=#0!3TW7=7FM
M?AM/)J,K?VI'_IJ%4Q,?LS/DG&0=PSP0/:NQM/$VDWMMJ%Q;W+M%ISLEV3!(
MIB91E@05SD#D@5PFFVE[#8?#..33K]6T\%;L&UD_<'[,T?S<<?,0/UZ5IZSH
MMW'X\$%D%.F^(8/^)DF>4,!7+X[AT81'Z@T =U;SQW5O'/$6,<BAE+*5.#TX
M."/QK,O?$^CZ=)*MU>;%@=8YI1$[1PLV,!W *H>1]XCJ/45'J6AW]]J<=U;^
M(]1L85"@VL"0F-L'G)9"W/3K7'16=_8Z!XR\.WNFWES=7]S=RV<D<#/'<K./
MDRX&U""<'<1C&>E '</XATQ-3N--,\AO+>#[3)$L$A/E]-PPN&&>.,]#Z4VW
M\3:3=:=9:A!<M):WK^7;R+#)B0X)_NY P"<GC@URNH^']9TA?"EWI7^D:C:6
MPTF[DZ@Q/&!YK>H21%;'H3ZU+X/\/WVB:M>Z9/'(=&TN9Y=,D<EBXF 8CZIF
M1<]_,]J -B/QYX9E>!8]45O.N/LJ,(I-HEW;=K-MPI)X&2,]LU=U/Q+I.CF3
M[==-&L6WSI!"[I#NZ>8R@A/^!$5YS+8WQ^'6HVBZ7J'VJ3Q";E(OL<FXQ_;!
M)OQMZ;!G].M7I8GL?$>OV&L>'-8U2RU:<7-K+:*[12*T:(8I1N"H04QEN,=>
ME '9:]KUE965W$M[+%=+:F??;PF8Q+@[7;"L%&0>6&#@^AIG@>^N=3\"Z'?7
MLQFNKBRBDED8#+,5!)XKEK)+[P[XA\26MWI-Y);ZG!"UC+9V[S1C9"(S"2!\
MF"."V 0<Y%='\/H;BV^'^A6UW;36UQ!9QQ213)M9650#D&@#13Q%IDMRD$<T
MKO(SI&RV\A1V3)8*VW:Q&T]#VJ)/%>B2:?8WZ7N;6^G^S6\OE/AI=Y3:>/E.
MX$<XZ5R.A6.H:?XDL'T<:DFEW,\SWVEZA;-Y=DQ5SYD,K 8!8XV@G(<].<8D
M$&I0>#](T0Z)JC7>F^(4GN"MJVSR_M;R;U;HXVG.5SCOCB@#H;/QO::)XA\4
M6_B'67\BUO8DM]\.[RD:%&Y\M>%W-]YOSKK+OQ)I-DK-+<LR)$L[O#$\JI&V
M=K,4! !P<$^E<DD<]CK'C>&YTF]G_M1D>T5+9G2X'V=8RI< JOS @[B,=>E8
MLWAO4]$TJ"/2Y-2A\0:?ID%L1';-/9ZF%3_5.,;1@EEW$C .?H >A0WUK+XP
MN;1-7D>XBLU9].V#9&-Y_>[L=3TQGMTKG_$?BM6U7PQ'I&I3B.[U5()0L!\J
MXBVONVR,N&P5'W6[]Z@U*PU+4/'&L"&WN('NO#0LX[KRG$2W&^0X#XQQN!S_
M %K(2>^NM \#V!\/ZM#=Z1J-LMY&;-PL8CB="P?&UE/!R"1SSB@#M[37-+@N
M-?NY=>,T%G(OVA)5"I9X0?*#M&<]>IY-3_\ "5Z*(K^22\:$:>BR72SPR1O$
MC D,590<'!Y ['TKB[Q=3MW^(-Q:Z'->/<3VSVT,]FS).JQQH[*K !RN&('<
MJ*JW4%[)J7BV:/3=;FBU'P\L4$UQ;,6ED F&-N/E.64;<#&<X YH ZF^\9>'
M]1LREKXBDLRD]MF:*%LMYC H@W(00V"IQT[XK:U3Q'I>C"0WUPZ")!),R0O(
M(E/1G*@[!P>6P.#Z5Q^O6US-\+="M(-/O7N(WT_? MJY=/+>,OE<9& I_I45
M\DFG>,-<CU30-8U/3-9$4EM)8K(Z?ZI8WBE4, OW<Y;C!.30!VMSXDTJTW>9
M<LRJB2,\,+RJJM]TLR@@ ]LGIS6K7E^M:1>V<LMSX=MK_3=7M[6" 626[3V-
M^@0 1-D;1MR4W9&!S].ZM->CN?$%WHKV5Y!/;1+*)I8L0S @9\MOXMI8 ].:
M (]1OK6+Q+HUF^KR6US*93'9(@*W0"$G<<' 7!8<CGUKG?[7O?$OBG6]'LM2
MO]+;3S;BVE2R8J6*EW,@=<8(PH!(R.1US5WQ)%._CWP?/':W,D-M+=&>6.!F
M2(/"57<P&!ECBF^'%F3Q_P"+II+2[B@NGM3!+);NJ2;(=K88C'!XH Z#4=<T
M_2YDANIG\YXVE6**%Y7*+C<VU 3@9'/N*J2^,?#\(L"^IQ8U"(RVFU6;SE W
M9&!Z=NI/'7BLKQ#+>#QA9P_V9=M926,B_;+*#=(TA<?N6DZQ(0-V<KDXY&.>
M5\+V>H01_#>.YTG486TZ*YCNC):OB(M%M4GC@%N.?KTYH [S_A-?#_\ 94>I
M_;V^R/<?9=_V>3*RYQL9=NY6SQA@*U3J-J-2CT\N_P!JDB,RIY;8V X))Q@<
MD<$YKB=$T :UH_C32=0M;JWAU'59Y8GE@:,E65-DB[@,X9<CW%+H6LZAIGA.
M;Q1K]C=7=Z0EJ\=A'YK&.(E#(!QP6,DA/]UAZ4 =W-*D$#RROL1%)9O05A:-
MK6GQ^'-,F&KSZHER"(;DP,TMQC))V(N>,=<=AZUN?:(S:_:!N:,IO&U"21C/
M ')^E>6:-HKR?#_PK8WT&MZ7J-FDOEWEI;R>;:2@]'3:<HP)ZC!Q^0!ZA8WU
MOJ-G'=VKEX9,[6*E3P2#P0".0>M9\'BG1KB]@M(KS=)<2R0PMY3B.5TSO59"
M-K$;6X!['T-1^$'U5_#-JVMQHM_F3S"L7E^8-[;7*?PEEPQ'8D].E>?1#5;J
M3PS=3Z!J<%Q9ZU(US:P6GEV]LK+*!L P&!+ F3GDG)&<4 >C3^*-&MKQ+::\
MVN]P+57\M_+\X](_,QL#=L9SGCK67;^,K#5+?Q$ADN]/BTV22W:[>V==F(U)
M<;EP""_"GD@9Q@UB>%I;[3;1O"NJ>'+RYN[>_EEANWM]UK(K3-(LQD/ 8;LX
M^]D<<]%MH+VTM/B!8RZ;?%[NXN+BW=(&9)5>!$4*1]XD@C Z8YQ0!U%CXATN
M&+1+%]2EN;C4+97M)7@?-T @)?(7:#CYB.,9Z"KKZWI\9NP\S*;218I<Q/\
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MCXCL;ZU@@FTF))H0CEOM,;J2K 8'<%<#//X4 =74+W5O'<QVSW$2W$@)2(N
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M$<YDW/&Q5CRBX&1QR>O;%:.M7MUI^ER7%E9&\N R*L0<*/F8 L3V502Q]@:
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MVEB4-'PA?);/H#C&: . \)R76GW&DI9ZEX3U=55( EBTAN$B8C>R?.P4#[S
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M Y:]^'U]JTOB ZAJT"KK$%L,VUN4:":#)1ERQ^4'!QU/J*TTT#7]3T#4=/\
M$.KVLLEU926:&SMVC0!UP9&!8[FZ<# '/K75TV21(8GEE=4C0%F9C@*!U)-
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MT[@ P((*# STXS5=? >IIX6&C_VG:NPU;^T1*T## \_SMIP>23QGC'I7?T4
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M16T*2MG+J@!/XU-0!QFI>$]:;4=,US3-9@77+6*2"X>Y@)@N8W8,5VALJ%8
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M%@>V-@XYZUU-% !7(V/AW6M.\5Z]K<%UI[#5C!F%XW_=")"@Y!YSG/2NNHH
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MH Q_"VA+X:\.6NDK,95@WX/.%#.6VC))VKG ]@*V*** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ljb_employmentxageementx007.jpg
<TEXT>
begin 644 ljb_employmentxageementx007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY!7RY8L%T=0W*X8$$$'MSUH ZZJ@U.S.K-I0G7[<L N##@Y$98J&].H(KG/
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M:X;:P'&>>*FU3P>-4L+S2Y;]FTJ\B2*2WEB$C(%4+N1R>&. <D'GD<]>GHH
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M-'"\%@N<GW(]:VJ .1O/ -I<:?"L%[<6VIP7[:DFH(JE_M#?>)7&"I!V[?0
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MAN9M.N=/E66QNK;&Z!@-O /!4@X(/45>T;3+C3K9OMNI3:C>2$&2YE14SCH
MJ@!0.>/<FM*B@#F]6\)G6OM5O>W_ )NG7%S%<^0T(+Q%-O$;Y^4$ID\$_,V"
M,U!/X+-Q'XGC;4F"^(%VSXA&8AY8C^3G^Z.^>>?:NKHH XZ3P&7N)I%UJZB6
MYTU--NDCB3]ZB!@K L#M.&.<=<]JFM/!CVMQX;F_M664Z% \$7F0K^]5D"'=
MC&,*HQC\<UI:KKKV>HQ:78VBWFI2VTETD+R^4OEH5!RV#@DN ./7)&*QX_&>
MIWUA)=:5X8N+MH)Q:W%LURD<L4VQ6(P?E*J6"EMW'/! H U_#N@'0%U%?M9N
M!>WLEZV8]NQY#E@.>GIW]S33X?E'BV?Q!'? 2RV2V0B:'*JJL6!ZY)W,?P_.
MMBW>26VBDFA\F5D#/%N#;&(Y&1P<=,U)0!QEE\/XM.TW0HK74I$OM$,@M+LQ
M [HW^^DBYPRGVP>!C'>Q?>![>_L+Q9+V5-1N[R&^DO41<B6(KY8"G(V@(!@Y
M[\DG-=710!1O-*@U+1)]*OV:Y@N(&@F9L!G!&">, 'Z=*YJU\"W44FAFY\27
MEPFBREK7,$88KL*!7;!W':<9X_/FNSK%'B#_ (K3_A'39NI-@;T7)<;6 =4V
MA>O5NIQTH Q[KP%]KT;Q#ICZHXBURZ-S.RPC=&2%!"\],(O7/>KWB#PH^N#3
M;J/59[#5].+&WOK=%_B #JR-D%3@9!]*V=,N+N[T^*:^L38W+;M]N95DV8)
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M]MEDL19"(PY55#%PW7).XGVQ^=:\MU!#<0022JLLY(B0]6P,G'T%34 <=;^
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MZN1$"TDD94H .@4;% '/ ZY)-=910 BA@@#D%L<D# )^E+110 4444 %%%%
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M(I;71K1988VCB=EW%%/4 G) [>U6/#N@VOAS2$TZS1(X5=W"1@A$W,3A02<
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M=G<.F017I&F6]M86,>GVT[RK:*(CYDQD<<<;B3G./6JW_"-:+BP5=.A1=/\
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MF6K+8'-H#&,0\8^7TZ#\J3_A'-(%_)>BPB$\D@F?&0KR#HY7[I88'S$9XZT
M<C Z^*=5\6:?JE_/87=BT2P>5.8VM(C$KB5><9+E\MZ #I6'XAU:73/'%].&
MG?39=(LH[^^CXE@@:28&4+@<YQD_P@DX.*]&U+PIH&L:E!J.HZ1:7-Y  $FD
MC!( .0#Z@'L<U++X?TJ:\N;N2S1KBZB,$\A)S)'_ '#SRO)XZ4 <EXAL+27Q
M?X%M+>67[*YO-KQW#%F7[/G_ %F=W([YS[UA1:M>:7I,VF)=W(L!XP&F-*TS
M%X;5MK;=Y.X#<=N<Y ;K7HL/A;1+=K)H;"-#8Y^R;6;]QG@A.?E!'!QUIZ^&
MM%6TO;7^SH6M[YS)=1N"RS.>K,#U;@<]>!Z4 <THN-+^(-_I5H\ATJXT5KN2
M!G++!,)-@*Y^Z&&>!P2I/K6!X;U!CH_PUT.:1H["_L9))<,5\YXXU*1DCM\Q
M)'?:!TR*])M]$TZUMYX8K?"SJ%E8NS.Z@8 +$[B "0!GC-5I?">@SZ1#I4NE
MP-8P,'AA(.(F'0IW7\,4 >;O>'PW_P ):MM<M;6K^(K2">X=V;R(7CBW$MD$
M+SMX(P#P1@5<\7Z7=:)X6\57-OXADV2V*7$-I:&2,6[ X\Q6\QB P/*\ X)[
M&N]@\*Z!;0WD,6D6:QWHQ=+Y0/G#&,-GKTJ&V\%^&[/2)M)M]'M8["=MTT"K
M\LA[;O[WT- %G2--M-':6.*ZN))KMO/87-RTC$X )4,>!TX' SVXK2EC$T3Q
ML6"L""48J?P(Y'X5CS^&;&;7-*U,01K+IJLL,G)DVLK+LR3]WYB>_..G?9D9
MDC9EC,C 9"*0"?;GB@#Q:Q@OHOAOX;\56VJZG+K:WD,>)+MW6X5[CRVB*$[3
MD$G.,\=:U-;OY/,?4].O+B4Q^)H+9KN6<H5_>(CP(@X,8&0<XR<G!ZUTO@+P
MBNA^&=-MM3LD74+,N>)2\8<EOG09P&PV,X!ZUK3^#/#=S-=2SZ)92/=2"6=F
MB!WN"#N^N0"?7'- ',:7H\6L^//%45Y?:D\%E=VDEO$M]*JJ6@#,.&Y4DGCI
MSQBN9TVW%K\(_#<MG=75M-)J\$;M#<NORF[92-N<8QV(QQ7K5EHFFZ=>W%Y:
M6B0W%SCSI%)S)@8&?7 X'H.!5/\ X1#P\+=H%TFV6)I_M)1%VCS<Y#<=P22/
M3)Q0!PNJWUWX5O?'$>F7-WY4&FVMW&)9GG,+NTBR2+O)/W0&^JUHW6E/!#=Z
MI9^),VMUI,VVVM&E'G%5W+.KF5B&' +#KD GI7:)H>F)?SWPM$-S<1^5-(Q+
M&1.RMD\CKP:I:?X,\-Z5;W<&GZ/:VT=X-MP(EV^8O]TG^[[=* ,WP%8V]IX9
MT?4I;ZZEO=2TVU\S[3=,X=A&#\JL< X)Z#G'/<UU]<_>>$-*N8M(@CM(8H=+
MG2>VP"6AVD$*G/R@X /MP!SD=!0!Y*]_=ZE\+]8\3F[N(/$%G<W+AEE8>0\4
MQ"P[<XVE H*D<[LGDYK0UF6?2_$K"[:[$/B/3/*A@6X<>3?+CY$.?DW!QR.Z
M9KMF\.:0U_)>FPB\^5UED(R%D=?NNR_=9A@88C(P*NSV=O<RV\L\*2/;R>;"
MS#)1]I7(]\,P_&@#@O!4L^M6MEI=_)<?:] $MMJ#+/(IDG!*(2V<L&4,_L2I
MKGM)%Q#X/\':U_:.H27\FNK:O))=R,'B>XD1D*DX.1W(STYXKUV.QMH6NFBA
M6-KI]\[)\I=MH7)([[5 S[5G+X3T)+&WLETZ);6WE\^&$%@L<F<[E&>#G)R.
MY/K0!Q)6Z\4Q^(I#XACTJ^TS4Y$6;8Y>TCC8;#M\Q5*L@R<C#;CUQ5W2=-34
M/B!XG-YJ&H&'3KFRN($^V2*B,8=[9&[[I.?E/')XKJ+KPCX>O=:BUFZT>TEU
M&+&VX>,%LCH3ZD=B>F*DD\.Z7NU*5+&)IM1C,=T7)Q.,8P_J,''L.E &HCI+
M&LD;JZ,,JRG((]0:=6?H>D0:%HUOIMM@10 [0!@#)+$ <X )X&>!@5H4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5%<W4%G;M/<RI%$N,LYP.3@#ZDX%2UQ_Q#6[BT_2M0@M;J[M
MK#44N+R"T+"5H=CJ67:025+!L#TH V/^$JT$6;W;:M:I#'-Y#F1]I63^X0>0
MW(XQFHSXQ\. 71_MJR_T0@38E&5SG''?.#TST-<%XCAT?4/!NMZAH>FZ@[:C
M<6/F33I<,]T8YD)PDGS85 ?FQ@\]<5T0,(^+QO/+/D#01&)_+.P-YQ;;NQC.
MTYQZ4 =#)XGT**WM+B36+)(;Q"]N[3J!*H!8L.>0 "2>U8^O>*X+GX?ZUK?A
MG5;::2SMY'6:,"0*Z+G:0>A^OK7"::T5GX<^'JWT#QB#6KCS(Y86!CR)RI*D
M9 P5.>PYK3UK37DL_B1JEC!(;/4[&."W$<9/VF98G#,@ YR649'4@^E 'H:Z
MQ:VNFV4U_<JLL\*L%QEG.T%B%')QG)P.*1_$FBQP64[:I:^5?,$M7$@(F;T4
MCJ?85R-O/+IGCC2]6O%D&DW.A):1S[#M@G5]S*_'R;ACDXY7%06'A&ZU'P=X
M@@0/:RW.KSZEHY=2I@8,&B;!Y4%E)QZ/[T =\^IV,5U+;274230Q>?(K-C9'
MS\Q]!P>?8^E0VFNZ7?27$=O?0M);*'F0G:R*>0Q!P=IP>>E<-=QZQXA^&E_K
MB6#C5=16WN19H^&\B)T;RE(_O 2,/^NF*J:E#8>*M#U;4?#6EZJ^K?V=Y#R7
MK7$;;1(KFW D.&)PWW<X]>: /1;'7-,U*ZEMK.]BEGB4.T0.&V'HV#U4]B.*
MT*X#1]5\.WMT_B2VTK6A=V-E(+F6[2YWP)]XPA7.'8D9PN<8ZCC/9Z7J5MK&
MEV^H6A<P3IN7>A5AV((/((.01[4 0KX@TEK];$7\)N'D:%5SPTBC+(#T+ 9R
MN<C%<_\ $'Q6-"\*:M+IVI0P:G:Q;ES'Y@5CR%.> Q'0'KZ&N.GO);E=%E_L
MV_M&M/$WF3Z?!82>7;KNE^<L%R[-N#9!Q\W04S4;B>#P!XT\.ZA97C:U+<W,
MR 6KN+E'?<DBL 01C Z\;0* /5K?6;";4/[,6\B;4$B$KVX/SJI_B(]/>J-[
MK5G<3:8+77[>U,EZ8_+*JS76W<&B /((/4CD;<5A^)H=0M;_ $'Q1HEI)-=!
M?[/N(60H6BFQL+@X("2A2<] 6I/%=DM@/!=I"LLJVNL1/(X0L0HBD#2.0.,L
MPR3W- '6#6]--\ED+N/[0\C1(O.&< EE!Z%@ 21G(Q3'U_28KU;-[^%9VE\D
M MP9/[F[IO\ ]G.?:N&LEO-/\50'1KF6ZL+G59_M>DWD!WV;%I-]Q$^ 0A.3
MSD'?P<FLM+.\N?A-=^#[FWF_X21+AXPIC;,DAN/,6=6Q]WG<7SQ@]Z /1[CQ
M9X?M;UK*?6;)+E)4A:(S#<LCYVJ1V)P>*V*X32?*M_B+XLN;J"1U%I9E)3 Q
M\PQJY?:<<D';P.^*ZO1-9M-?TB#4[+S1!-NP)8RCJ58J05/((((H 2;7]*M[
MU+.:_A2=I!"%9N/,(R$)Z!B.BYR:@3Q9X?EOTL8]9LGNGF-NL2S DR ;BO'<
M BN+\.7D,%M<>%==T6ZNM6AU.:>(26CO%<;IFD2?S,%0!N&23D;<8)XJ33+"
M:_C^(EO:1&.^O+F4V<KQE-Q-LJ*RL1R V[D>_K0!VUKK^DWM]]BM[^&2Y*&1
M8PW+J#@LO]X ]QFN=\3>+/LVI:!;:3J4.;G5H[2X01AO,3YMX5CQD$ ''(SV
MK!TDV'B'3[..TTG5[?Q-IUG+$ANS<(EA*T10D,QV$$X  SQS@8XHQZC'/X4\
M"Z<-.OX[_2M3LTO;?[%*6A,:,KL<+@@GG(SD'/K0!W<OB.PTL>(-1NM<BN[.
MQVL]M#&I:TPG*$KRQ8@GGI]*OVOB+3KC1[347G2-+E5V)DLQ<KDJH RQ'/0=
MC7#W=M/=S?%*&WMIG>[M%6W B;]\1:;"$X^;YN..]207<L.M>#]<DANO['CT
MV2RE=X'7[-,RQD.RD9"G85W8Q[X- ';-XET1-.BU!]5M%M)9/*24R@!GSC:/
M]K/&.M3Z9J^GZS;/<:;>0W<*2-$TD+;@'7J,UY9K^F3?V+XJNX[:9[#4];LY
MK6W$+,9%1H?.D"8SABK'..0N>A%>DIKVG)XACT15E6ZF@^U(PA(B<9/1\8+<
M$X]* +]Y?6UA");J98E9@BYZLQZ*!U)]AS5)_$VAQZ6VI2:K:)9HYB:5Y  K
M@XV'/(;/\/6L+Q;]ILO%_A;67CDDTJU>XBNC&I;R6D0*DA [#!4GMNKDO%.G
M33:1X_U"U@FDLM4>S6UB2)B9Y(]OF.J@9(/ SCG83TYH ]2TW5].UA)WTZ]A
MNE@E,,IB<,$<8RI]^145SK^DVEU]FN+^".3>L9W-PKM]U6;H&.1@$Y.15VW$
M!A5[=4$;@,-JXSQ_@!7EHAG7P+XN\+ZC:32:S<7%V;=/*)^UF5BT4B'&" 2N
M3GY=O.,4 =M_PE-E>:]J?A^TN!'?V<",9&0D;V#G '? 3)[<X[&L[P/XSM=8
M\/Z''J.J6SZY>VHE:$%59CC)PHXZ<X].:S]$6?1/&NL0ZDMR[SZ38JMR(79)
M6B202'>!@')'!.3D5A:3"]OX,^&L)M9HY[744:X3R&#0CRY0Q<8^499<D^M
M'IL^OZ3;7R64]_#'<22")59L R$9"9Z;B.BYR:JR>,O#<5Q]G;6['S?-:'8)
M@3O5=Q7CN!7!Z='82"\\+^(](U>XU1=1FGA16N!!=!IFDCE#J=B@9&2<8QW/
M%=%X-BC/B;QA(]N0TNIK+$[Q$;T$*+N4D<@'<,CW]: .@7Q-HCQ64J:G;-'?
M-MM6#Y$Y]$_O?A5?7M:LHM-O8T\06VE7$#HCW$BJ_E,2"%VMP2PX ]\UP%WX
M>UN#3-5TJQ@D2+PW>G5-(<#B8DB5(E]0H:9"/]I/>MCQC;W$OPIU&62UF-_J
M4D5R]NJ%Y QE0A,#J4154X_N9H [:^UO3=-=DO+N.(JH=\YPBDD L1]T$@@9
MQG'%-U'7M*TEMM_?0V^ "Q<\("< L>B@GC)P*X;Q=]HCU74=3T&]E34?LL:R
MZ;<0&6VU6/!*HO&0_P Q'RGTR #FH+N6UM/$WB'3?%.F:M);ZPT<EJ;07$D<
MZ&%(VA/E' 8%3UQUSD4 >EW%U!:6LEU/*L<$:EWD)X5?4^U44\2:-(;$)J-N
MQU 9M,-_KQZI_>]>.W-6M/MH[?2;6U%OY,<<"1B!GW[ % VEC]['3/>O*9M$
MUVQT6YM[:WEQX/OFN=,(&3=QDB01@]3B%GCP.I(]* /0M:UJR6TFBB\06VF3
MQ7,4+RR*KD,64^7M;J64X]<,#43>*[.\UG5]"LK@1W]C C>8R$C>P<X [[0@
M)[<X[&L#QE:3Q_#H+)!(]_=7]M=31QH78,;A'8<9)"*,9]%%36\WV+X@>*WG
MAN!%?6%H]O*L#LCA$E#?,!@8) P3DY&* +G@GQC::QH.B0W^J6SZY>6:S/""
M%9CC)PHXZ<X].:V/$GB2R\+Z6+V])P\J0QJ <LS,%'T'/)KSK2H6M_"WPSB^
MS31S6EVIN%\E@T(\F16+C'RC<PR3ZUU_Q*AEE\&NT,,LWDWEI,ZQ(7;8DZ,Q
M ')P 3QZ4 07'BT6'CQX+W5((]#.CB\3<@7#F7;][J> >/TKISK.F_V=!J"W
MD3VMP 89$;<)<C(VXY8X!.!Z5RD=Q%/\6EOS%*MO_8&Q9I8&4!O.W;<D<-MY
MP><=JX_1WN-'\.>#=1O;'4CIEG]MMKU+9)5EMC))F.0HF&VX7'T;WH ]?T_4
M;/5;-+NPN8KFW<D"2-LC(."/8@\$=JYCX@^*QH7A35I=/U*&#4[6+<N8_,"L
M>0ISP">P/7T-:/A*VTR'3[JXTBQN;6UO+I[G=<F3?.S ;I"LGS+DCH<9QG'-
M><ZE<3P> O&WAW4+.\;69;FZFC"VKN+I'?<DBL 01C Z\;0* /4[S7=-TJW1
M]1O8H/W8D8M_"O=CCHN>YXJ2/6],FU)=.BOH'O&B$ZPJV6,9Z./]GWZ5Y]>7
MEK8^*]1.OV.L-I>L6=NMI+;17./E0J\+I'\P8DD@$?Q&K^M:5<:'9^&=;\/Z
M3*LVF[;(V'F%G-M-A0C,222K>6W4XP>: .R.MZ:+9[C[7&8UE,!(R29!U0#J
M6&#P.>#7.^)O$SKI&D:CH.HP/!/JUM:RLBA]R/*$=>?NGJ#QD>U9OBBWE\/7
M'AB^FAOKO2[/SX]0DLO,\Q9)0I$Y"'<1N#YQ_?-4-8MM-7P[9W.BZ;?0V]WX
MCM;US*LS238D0R3%7RRC [@=,]QD ]"O]=TO2W*WM[%"54.^X_<0G&YO[JY!
MY.!Q45]XET/3'"7NK6<#F(S!7F4$Q\?-CTY'/?-<M8SC2?%?BV+6X97M]2,<
M]I+Y3.MQ%Y00Q+@'+ @_+U.[('-<_HMF_AO5OAU::\0MQ;Z5>*[2#=Y))B*@
MGH-H.W/3M0!Z.GBK0)-/M;]-8LC:7<@BMY?.&)7)QM7U.>W:H#XU\,BWN9_[
M;LO+MG"2D2CY21D<=>0"<CL#Z5YY>:2]MI=W/':2BRO_ !;;WEO (6/[E7CW
MR;<<*2K'D=,'O730F%?B9XBNGB/DOI-O&LQB.UR#(64-C!."N0/:@#KI=8T^
M&RAO&NXC;S@-"Z'?YH(R-H&2W'/';FJI\5: (;28ZS8B.[#&!C.N) H)8CGM
M@Y],<UYAH\LVB:+X)U+5+/4SID&F2V-U]F699+.4LA#.J8?:0F.GI[5K36.F
MP:EX1?2]+NK>P;6)KQA.DK-AH7'FN'R8P7(P#CL>,T =9J7CK0K'PQ<:]%>1
MW=K$_DCR3G,N<!#Z')'7H#FN@M[B*Z@2:!P\;C*L.]>2ZS;W%QH'Q%CM[6X<
MRZG!<1(D+9D11!N9!CYON-TSTKT2/Q1ITFL66EA;M9[V SP-);.B,!G@D@8;
M"L<'G H T[N]MK"#SKJ9(H]P4%CU8] /4GL!R:HMXFT./3)M1DU6UCM(7,<L
MLD@41N/X6!Y#>QYK"\9K=6OB#PKK BEFTRPNY?MBQH7,?F1%$E*CG"DG)[!L
MUR'C2S>72?B%K=N&&FW=C;1HVTA9Y4^\ZYZ@ JN>^#Z4 >FV'B/1=5U&YT^P
MU2UN;RV_UT,4@+)SCI]>/K2Q^(]&EO/LBZE;^=L9PI? 95^\5)X8#OC..]<;
MK>F_\)!XITFZ\/#RGL],O(I;A4,:IYD86*(\##!B6V]5VG.,C-;PE-H^HQZ'
M!=Z-J\6N:,@$B71N%CLRJ;78,3Y94@8 &<Y' &2 #LH?&?AJX)\G7;!\0M.2
MLZX\M6VEL^F[BDOO%^BV.C:EJ;W8>/3ES<1JI\Q#C(!0C()'3(]^E<)I/^@?
M!@,=$^U7$5T_FP36K%D5KLMYA3 9@J[7P.NT5!=Q7-[)\1([>'4[MM0T6$VT
MLUHR&<K'*#CY5'4@ 8!/;/6@#OO[<MK^;0G@UNWM&NG+?9"JN]T-A)09Y&T\
MY [8[U?NM?TFRN3;W-_#%(&5&W-PC-]U6/12<C )&<UQE_=)>WGP_N(8;GRX
MKDM(SV[J47[.Z98$94;B!DXS5%8YH?"?C3PWJEK-)JEW<WCVR>46^UB89B9#
MC!P2 ?[NWG % '>WWBC0M,GF@O-6M(9H$$DL;2C<BGH2.O-:%K=6]]:17=I,
MD]O,@>.6-LJZGH0:X+1[:33_ (B6PU#=));>&(+:6Z9"5:59&+C=C&<<XZX-
M'P]UNVT?PCX8T6^ANX;RZ66-%>V<*C*Y.UR1\I((QGK0!V^H:KI^E1Q/J%Y!
M;++((HS*X7>Y. H]36<?&?AH0W4O]MV6RU8+,1*#M)!(X[Y )&/0^E97Q+C\
M[PU:Q"%YB=2M&*)&7.U9E9C@ \!0<U# T"_%K4[QXSY!T6&,3F([2PDD+*&Q
M@G:5.* .HDUS2XK2UN3>Q-#=C=;F,[S,,;LH%R6XYX[5"WB?0DM[2=M7LEBO
M 3;N9EQ* "21ST&#GTQ7FWABZET_P]X&MKFPNK=EM[B)[U;)Y)K9\C]T%VG8
M7&.2#PN!UR(-&C== \$VD]E=K)9>(+AYUFMG'EKNN"&.1C'SISTR>O% 'J5M
MXDT6\TR;4K?4[:2R@<QRS"0;488^4^AY''N/6I;;6M-NX;J6&\BV6A(N-YV&
M'C/SAL%>.>>U>;ZA</9W7C:8:4]W#+JME(N^V>1%0)$&F"@9?8RDX'<<U5O(
M4NT^(T=R-7DM[RQMY8KEK-E>4+$02!M4=<#;P2,_6@#TV#Q'HUS>I91ZE;"[
MD :.W=]DCJ1D,JM@L" >0,<4L?B+1Y+W[&NHV_GE6=5+8W*OWBI/#8[XSCO7
M":?J=CX@\0R7*:IY.N2:/)IUM#]DG@5G/SE]TJ+SE00HS@ \GLGA&32-0AT.
MUO=&U>+7=&51(ER;A8K1E3:SAB?+*D#@#.<CC&2 #M(_&/AN:2U2/6[%S=L4
M@VS B0@D8!Z=5('KCBK.FZ_I&L&Y_L[4;>Y^S$";RW!V9&03[$ X/0XKRR*W
M_P"+5Z5;/93><OB!9I(3;MO"?;&<L5QG&P@Y]*U/$EE>ZGXC\8V^EQR&:[T"
M&*%@I5)I%:0E W0G:P'7O0!W<?B?0Y6G5=4M08(O/DWN$ CZ;\G&5_VAQ[TV
MS\5:#?WD-G::M:37$\7G11I("73&<C\"#CKCFN.L[S0=>B?4[?2=834[6PFB
ME:^%R/LNY,&+YSM=B<#"YZ9XXS1TR(P:5\+D^S2H]H<7 \E@8<VSJV_CY<N0
M.>] '>>'_%.G>))+];%R1:7+P'((+;<9;!' R2/PSWK;KS[PYJ\?ANS\62:A
M:7X\C6KFX*QVDC%HY)%V%<##9SGCL"377:B9-8\+79TJ?;+>63_99NF"Z'8W
MMU!H 6'7])N+U+.*_@:>3=Y:AO\ 6;?O;#T;'?&<=ZAB\6>'Y[^.QAUFRDNI
M)F@2))@Q:15#,HQW (KA(XI-:\'>#M(MK6>VUC3+RS,\3Q,K6ODC$C$XP%(#
M 'HVX8SFMWP-%'_:_BQWMRKR:R\T3R1%=Z>4BAE)'(R'&1[^M '6WNH6FGHC
M74ZQ[SM1>2SG&<*HY)P">*@77=*?3H+^._@DM;@XADC;=YIYX4#ECP>!SP?2
MN6\37\OA_P ?:5KEY;7,VC-8S6;RP0M+]FE9T8,RJ"<,%VY [52G5=.\2^&=
M:M]*EL_#RB[B9%@*F!Y2"LSH!E Q##)'&X9QD@ '8MXET1--74'U6T6T:3RA
M*TH +YQL_P![/&.M2:=KVDZO/<P:=J%O=2VQ F6)PQ3/3/L<'GVKS'Q%ILSZ
M/XSO8;>9['5-3L7M(%A8F7RVB\V0+C."0W..0N>F*T?$]K>ZAXMU^+1UD$]S
MX6^SV\J*55I?,D(0-TW;6'?C- &SJOBT'Q=X8LM,U*)[6]GF2XC6/=YJ+$[!
ME8]0&4<K^=="?$FC"Q-\=2MA:B;R#,7^59,[=A/8YXP>]< NKV^J7WP_>UL+
MZ-K&=H[F(V,H-J?LS)M;Y>,-@>G?I69J<DD'@WQ5HILKY[__ (2%KD11VDC9
MB:[1U<$#!!7I@D^U 'JNH:[I>E,5O[Z& A0[;S]Q2<!F_NKGC)P*J1>*]-F\
M52>'XY<W44"S,><?,3A1Z\ FN374H-+\5>)M/U_2[VYM-::*:S9;*29;B/RE
M0PD ':00>&Q]XDXK0L0]C\49/-L9H(KG1+:*$11,T2LDDA9-X&T;0PZX[4 =
MA>7UM80B6ZF6)68(N>K,>B@=2?8<UEZAXITVU\,W^MP7,5Q#:QR$A6ZR("=A
M[ALC&#R*R?%OVFR\7^%M9:.632K1[B*Z,:EO):1 J2$#L,$$]MU8UW9R_9_B
M-JL"2_8-3M%BM$6,_OY5MV5F1<9.XE5R!R5[]: .D\*7.I:I#;:M)K*7=E<V
M:&2V\A5,-P0&.QA@[<$C#9/3FM4^(-)%^MD;^'[0TI@5<\&4#)CW=-^.=N<^
MU1>%G#>$](&&#)9PHRLI4JP0 @@\@CTKS2_NY;G[&_\ 9U]:/:>*DFGL;>PD
M*1IYK9F9@I+L^=V5./FX'&: /1I_&7AJV+B;7+!/+F\A_P!\,*_'!],9&?3(
MS5]=8TY]6?2EO(CJ")YC6X;YPG]XCT]Z\QU"+SM ^)ZK:2F:\E;[.OD-NF_<
M(HV\?-\P(XSS6YXD2\L+?0/%ND0?:+ZU1+.: G:;B&;:H4Y[K)L8?C0!V]G?
M6M_'(]K.DJQR-$Y7^%U.&4^X/!JQ5+2; :7I5O9[_,>-?WDA',CDY=S[LQ)_
M&KM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%<3\3,1Z3HUQMD9HM:LB%C)R?WRY&.^: .VHKCA
MX]$+ZQ;7^BWEE?Z;9F_-M*\;&:W&<NC*2I(Q@C/7O6DGBJ!]1T"T^RS :U;O
M/!)D83:@<AAZX8=,T 2ZUX?.L:EI-Y]L: Z9<&XC18PP=BI7YL]L,>F*VJY_
M2/% UJ.WN;.Q>6QN5D:*>.56P4_A<?PL>PSV.<'BL/3?%VE:3X1L;^PT2]BL
M[O5'LQ &5FCE:=D+-ECU;)PN?2@#O*R=<T6765MT75KZQBC8^:EJRKYZD8*L
M2"0/<8/XX(S8/&ULK:VFJ64^FR:1''-,DK(^^-P=A4J2,DJ1C/6JK?$?3+>\
MO;:]C\MK:Q>_#03).KQK]Y<J>'''!X]S0!U\44<$*11($C10JJHP% X %/KG
M;CQ6EAIMY?W]IY5M!%#(D\<RR13"5BJ[7X P<9)X (/2M/3K^>\>=)[,VYB*
M[7$@=)01G<C<9';D#D4 79$\R-DW,NX8RIP1]#3+>WBM+>.W@0)%&-JJ.PKG
M[F_L%^(-K9OID[:F--FEAN@X"&(.@9 -W4DKR0.G6L^T^(L5U9Z=?G1+^&PO
M+XV!N)&C_=2^:T:Y4-D@LO)' SU/- ':T5S_ (WUN[\.^#-4U:R@6:XMH&=
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M'AR^-]I062XMQ+%CRF4LKA]V"2 ?E&3D?C5R7QKIQM-.EMFC>34+07L*3SK
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MG' YKT%6#*"I!!Z$5GQ:Y8S:_/HB/)]N@@6X=&B91L)V@AB,'D'IGH: +-W
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M&-9+G[/$SF"-R0&;;R <-TYX)[5>TO2[#2+,6VFVT=M;9+"./A03R2!VR>:
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M/#'A_6+P7=_I%C=7*#9YLD*LV/0GJ1[&M6&&*WA2&&-(XD 5$10%4#H !T%
M'$Z#H_BKP]<7>C6R6,NC2W<MQ;WS3$2P1R.79/+VD,P);!R!SD^E,A\,ZSIM
MAXFT2UCMY[+5YIY[:Y>7!MS./G5UQDA221C.<X..M=G?7]MIMHUU=RB.)2JY
MP22S$*J@#DDD@ #J35?2=:M=8^U"W6>.6UF,,\4\11D? /?J"""",CF@#G=,
M\-7FC>+;2ZMH4DTRST*/2XB90)&9&W D8QC QG/7M6'IG@WQ'HUAX7O;>*TE
MU'17NHYK4SD)/#.Q8[7V\,/EZCL:]/HH \VO/!_B#4]*\90RQ6,$NKW$-S:@
M7#/AHUC^5OD& 3'C/OTJU>>&-<\0Z_>W>I6UI96=_H4FF2+'<F22)G<G(^4!
MNOM^-=_533-1AU73XKV!)TBDW86>)HW&"0<JP!'(H Y_PM%XMAMK6PUR'3XH
MK*,1-<V\YD:[PNU3M*C8.A/).1T KGK/P?XHT_PEH,-K_9Z:OX?N"]N&F9HK
MJ,AU<,=HV;E?CK@CWX],I"P498@#..: .&UO1?%&OZ=I^HO%8VFK:=?QWEO8
MB<O$P4,K(TFT'+!CR!@8'N:N:-IFM_\ "<W^N7]G:VUM=V$%N(TN3(Z,C.?[
MH!^_Z_G6[8ZY8ZCJNHZ;;/(;G3B@N%>)DVEP2N"0,\#.1Q6C0!RVNZ9K-WXH
MT^Y@AM+W24MW22UN9BBQS%@5E("D/@ @ ],Y&.M<[H_@_P 1Z7I/@T&&PDNM
M"EG22/[2P5XY(V0,&V=1NSC'XUZ76??ZW8:;<PVL\K-=3 M';PQM+(RCJVU0
M3M'KT]Z *WBS29]>\(:MI-NZ)/=VDD,;/PH8J0,^V:Q+;2-=?Q7HFKW5E;1Q
MV>G2VLT<5SO(9RA&,J,CY.>G7OC)Z.QUS3]1O)K.WE?[5"BR2PRQ/&Z*Q(!(
M8 \X/Y5HT >9P>#_ !+8Z99W=B+-=7T[5KJ]BADE)BGAG9MT98#*MANN,9%=
MUHSZO-;-/K$-O;3N1MM;>0RK$!ZN0-Q/T ' ]2=*B@#E[72=4L/'FL:K'#;R
MV&HVUNI8RE9$>(.-H7&#G<.<C'-<]9^$=>MO"'AC2VM[8W.EZLM[.1/\IC$C
MMA3CDX<<$#H>:])HH XT:'JR^(/%MZ+:$PZK:0PVW[[G=&CJ=PQP#OSQGI65
M:>&O%.@0^'-0TN&RN;VQTM-+OK*:X*)*BX*NDFTX((/4=#7H]% %331??8D;
M4C#]J<EG2$DI'GHH) )P.Y R<G Z"W110 4444 %%%% !1110 4444 %%%%
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M.H6\]\OB JERD7\'DS;"RC W[2,XP,UK_P#"MM(30])TV"\U*"3269K*^BG
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M;YB8 .[(/4E>>@'%=>?"]O*MX]S>W=Q=W=K]D>[D\L2+%S\J@(%&223\N3^
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MU?12P"7\D9MYC"+=H(Y6C8,?]8'PN[.<9[8KI;?PO9VOB&/68+BY26.S6Q2
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MKXB<<R*)B3QU(POZ5';:'9V<WP]U71E*ZE>B.*\=)"3<6QMRTA?GD*0N/3(
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M2>@5"NYLX)X'09Z5%;^*M&N;2>X2[(%O.+:6)XG65)3C">61N+'(P .<\9H
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M'IM% '!BWNG\7>"[E;*[$-KIUQ%<2&W<")W6(*&XXY1OI^-8#Z;JJ_!J_P!
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M:_?#S+N+59M.M]_/V>"(+A5_NY))..IKL-)M+ZULS_:5Z+R\D;?)(D?EQ@X
MVHN3A1CN2<Y/>L1/"]]I&OW^J>'[VWABU)Q+>65U$6C:7&#(C*058]Q@@^U
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M30+"06W.KE@V[CE1Q@_6CQ!H%]J>KZ-J5AJ$-O+ILDC>5<0&6.0.NTG 92&
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M*XW;<'J=N-IZ[OO'ZUAV'@!]#.AW6DWZK>Z9!):OYT9,<\+MO*8SE0K8*\G
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M<9S6^;^S4P W< ,_^I!D'[S_ '?7\*3^T;+9._VRWVV_^N/FKB/_ 'N>/QH
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MD >O..E &K&GEQ(FYFVJ!N8Y)]S6!<>"=!N8]4BEM9?*U1R]W&MS*JR,<;B
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MALC&?N]\XKK+&Y:\L+>Y>WFMFEC5S!, 'C)&=K8)&17)W.E:W<^(_"VI2V,
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M$-Q8V45_I^MJD@8W C:VE6/RR&!'*D '(R1Z4 4/#&HV2^'OAW#J%O>3WES
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M6>L:?#?Z?.MQ:3 F.5<X8 XR,^XJU7&_"G/_  K#0LXSY+9Q_OM794 %%%%
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M$@9TD0Y4KG@5O44 <SJWA6?6[.^L;[4Q+8W\:I/"UL#M( !:,Y^1CCONP0"
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ML<<IC#K*DC%G1T&,KN.0 1CM4FH>!X+_ ,/:AIAO9(Y=2NEN[RZ$8+.ZLK#
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MTJV:R6;SU@9<JLF2=P!Z')/3U/K3+KP=X;O9[J:YT6RDDND"3,T0^< 8&?<
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MEP"I.WAE!! SZY)->H7K%+"X83B B)B)2,B/@_-CVZU03PSHR+8JMA&%L/\
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M\>V3RBWVL39,3H<8."0#S\NWG %>@V7F:-X9MO[0DDFDL[-/M#QHTC.40;B
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M+E9#N7)R<'ZX&:W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP4<!N".!DY'H*A?Q9<6=_I5OJ>EBVCU4%;61+C?B7;N$<@*@*2 <$%AD$>Y
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MLT>WYG;9UW, /E)YZX% '<.Z1H7=E51R68X K(\4:)%XFT&YT.6[-LEVN'9
M"^T$$XS[XYYKB?&VMV_B+X;Z_'/9B"_TR\A@N('(?RI!+'AD; RI5L@X'!/
MK9NHX8?C+8S[41FT*X\R3 !($T6,GVH [.)76)5D<.X'S,%QD_2GUQS^.Q%I
M%CK\FG[=!NYEB6Z$W[R-7;:DC1[<!"<=&) 8<=0%O/&UQ9IXG#Z2AGT)%F:+
M[7CSXF4L'4[.. 1CU!'U .PIJ2)*@>-U=#T93D&L2UU^6_-A]CLXKB.[L?MC
M,EQP@.-@&5YW9."<?=;TKG-+\8V]CX1\+W.E^'?)M-6N?LL-K#,JB!B7(Z@
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M9&5B1\N"!MQU'7M7444 <#;>"-3_ .$1@\'WLUI+I$$Z8N@[>=) D@D5"FW
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MRVNGR1F,?8;QY&CN+*7G+J54Y&=IQN&<8/7CLJ* (X(VBMXXWD:1D4*7;JQ
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M0,K#W!X-/CC2*-8XT5$0!551@ #H * *NDSW=UH]E<7\*P7DD"/-$N<(Y )
MSSU]>:N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5ROCO4]4TK3-.FTJZ2WEFU.VMG+Q!PRR2!
M2.>G7MS[BNJKC?B1:W%]HFG6]M!=RO\ VI:RL;6)G:-$D!9N <8'- &1>ZOX
MFT+6-?TB?6/MH&B2:K97;VT:O Z':8R% ##.",C-2V^L:_:V/AU[G5GNYO$
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MNYP0^XN&W;LG.1^55CX T@Z3JFF^??F'4;L7DC&X)=)0RL&4D<'*+USG'.:
M&37VIVWQ"TW1O[1DDLI]+GE8-%&',B/&H?(7KACQC'M6?I&M:Q-'J.@7FI2'
M7;;5!;K,(HP3;M^\60+MV_ZH/U'WEQ71CPU;C7;+6#>7CW5I;M;)O=2&1B"V
M[*Y))4'KVXP*L#0=/7Q(^OB+_B8-:BT+YX,8;=T]<GKZ4 <G<:KXEUP:T?#\
MK17&G7QM($?R?)<H%+>;D;_FR?NXP-N.^>[A=I((W<*&902%.0#CL>]<U=^
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M,H5IX$E*CL64'%6J\LAT&QLM8\#WVBQ!;Z]CVWY1RPN+7R,LTF2=P#; ">[
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M&QM9+NT\$QZ@\D\0UN[M[:1Y&W2VH281Y.<D$ ?48]: /9P<]* 0>AS7D-Q
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MH6GW$ 8+_94&TON&#N<A25P?NXZX.>*O:AXNTO3"7N3.+1+@6TMXL>88I20
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M*CQ[)1*B!0/FR",'.0,8[UMBSU"3QWX>O_[.N%M;?2YK>>5MN(Y',9 (SG^
M\C(KM** .3\;V=[>/X=-E9377V76(+J;R]OR1J&!/)&?O#@<UF:Y87^G>.)]
M6_X1K^W],U"UBA9(Q$9;:6,MCB0@;6#\G/4?GW]% 'F^O>&YK@0R66DW6D:I
M:V'^@7>CLJHCEW/V9UR%9!\A)(VG<QR*DLKN\LOBA*;ZUEN+H^'+43FT0,!(
M)9,X&<X)S@]!WQ7HE8ITW2;/Q4FJ271CU6]B^S1I)/CS43+;50]<9)X&: .
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M]( %\,I^Z_T=H_[W/S$=,\5T7CO2-0U72+*72T$MWINH0:@EN6"^?Y;9*9/
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MQ311YV$@,I#KD\YYS^=^;PO>G7]'U>'5@9[.WEM[DSP;S.LC*S%<, ARO'!
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M@E74KR*ZE:=VC>.'RPL9/RJ1DY('&>] %VBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:\:2#$B*X'9AFG4
M4 (JA5"J  .@%+110 4@4+G  R<G%+10 4444 %%%% !1110 4444 %,2&*-
MBR1HI/4JH%/HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!CQ1
MRX\R-7QTW#.*>  ,#@444 %%%% "*H484 #T I:** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRXV_:4SE 2_?^$ Y],<U%_PEWAS[-;W/]O:;Y%Q(8X9/M*8D8'! .>2"1^=
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M".0%Y/8 C/6O::* /)_$$-U=ZUX_ATF,RSSZ=8E(XO\ EOL+^8B^IV?+C_:
MKH/"]WX>\0:]%K6EC4I[^*U:":6Z$J"!"0?*8, "V[G SC!.>F>XHH 1F5%+
M,0J@9))P *\D\,6WAJ\M/%L.MO'&;O6[UD9V9&:)B-K+Z@\X(KURB@#S[4+Z
MUU3Q_P""KX1%8C!?,IE3!4,$\MCG[N[:2 <'\:YC4$MS\./'ZPQIYTVM3/$J
M)\T@\Q&0J.I'#$$>AKVBB@#SE;G0U^*FO2:BUF89M(M=CS %74M+N )X.1CC
MJ<>U8^F6$^C:)\.[.\5XGBU2:;RY,[H866;8&],!T'/0G%>A6F@2VWBZ_P!>
M-XK_ &R".W:#R<;5C+%2&W=?F.>/RK<H \L5UBT#QWH.M1DZE=W5W+;PLN6O
M$D4>28O[Q&%7C[I49Q5S5['5O#>F^&/$<<+7NK:?;1:=J$2M\URD@5<9[D2[
M2/JU>CUBS:%/=>(%O[C5KF2QCV/'IVQ!$LB]'+8W'GG!.,@'L, '*ZGI\.F^
M*_ 5K.4EDAENI+B4KP9'B8ESZ;I"2/<\5@WT=JWA#XGJD<9EN+V4Q +\TN8H
M]I7^]\X;&.^:]BHH \MO=4L]/\57#^();Y-*U;3;:.TNK=7>-RH</$VP$Y)?
M('N:L:59Z;IWQ#T*&&V:VM+7P_-'"MR26A_>H45F;D-LW'!.0,BO2J* /&K!
MUM_!7A24HX@LO%,DDVV,GR8R]QM) &0/G7'^\*]C1Q)&K@, P! 8$'\0>E.H
MH XWXJG/PSUR%<M++!LC11EG;<. .I-4O%UX]OI/A?68Q<SZ59W*R7IL\LZ(
M87028')"LW/>N_HH \B\01:!<>');_2HKF:#4-8L99I[@28N"DB[V5' . @Y
M8#!Y]*Z+5XK&/XH>%6BB@6-;6]=F5 %#OY14DCC)PV/7FN[HH \6O4MQ\-/&
MJPQIYTFO2O$J)\SK]H1D*@<D8#$$=@:]4LO$6F:AK5WI-M<%[RT1))%V,%*L
M 058C##!'0G&16K5=+.)+V2[.YIG4(&8_=4<[1Z#/)[G\!@ DN',=M*XC:4J
MA(C7JW'0?6O(-%U&WFUCP%=1QS06T*W4+VD=JXBLBT6!$6*[BP(P23VS@"O8
MZ* /%XUMX_AM%L1%G'B83X"8? O-P?'7&SG/I6E<:E'8K\0M,UA7%[?^=/9,
M8F87-N;<+&$(!!VX.1VR3ZUZM10!B>#FW>"M#^5T*V$"LLB%2"$ (((SU%8W
MQ#FC0^& S<KKMM(PZ[4&[+'T49&3T%=I10!P%E>0:;XS\61:^RK;:DL,MG+(
M,QW$ BVM&I[D'=\HY._('-8FDV=YH]M\,;/5"ZW-M+<&59.L*-#($5O3&Y%Y
M[\5ZU10!Y%K5O?:C;?$NWTI&FN9;BV=(DZSQI%$)%7UR%=>._%=%/-!XC\;^
M%-4T2021VD5RUY(@QY<3Q@+$_HV_!VGD;2<<5W=% 'D5[H.LQV6LZ#I\+QQZ
M#>'6=+FV\/N_>1PK[;C,I]MH[UI^+@]Y\(-;U">W=+O5HQ<"!AEQDJ(TQ_>"
M*N0.^ZO2J* .$>6RE^+]I=,T+1KH#A9C@J&,JD#=T!V[CZXSVKDM/N8--\ ^
M$;Z65X7T_6K@B-HG:, O/PX52R?(<J=IY(XP<CVBL77-"N-4NK&]LM6N-/N[
M/?L9$62-PX (9&'/3@@@CGUH Q/ %QI%W/KMWI^IV]U<WMZ;J>&$,OD!E"J,
M, QSLR6P,G/I73ZW$\V@ZC%$I>1[6554#))*G J/3=+EM)'N;R]>]O'0(9FC
M5 J@D[551P,G/.3[\#&E0!Y'%<VMWX9^&<3*2+6ZMUG66(J$*6SJQ(8= Q S
MTS3-4^T^?XUET^&:XCAUFQO9(+;[\T*+$9=GJ<J>G=:]?HH X[PG+H&K:Q<Z
MYHIOKB66W6&XN[@2*IP<JF' RPR<D#CIWKJ;Y&DT^Y1 2S1, !W.#5BB@#QN
MRU$V7@SP)J$L>H#3=+4P:D8(G#V[F+8'(QDA3N!(SC=5G6;?06TS3;O3(;A[
M.]\2VMU-+<A_W^#^\D"N,A , M@ \_4^MT4 <)=16,'Q<TEDB@CC32;GYE4!
M5=I8V'/0,1O/J>:Y$I;1_"R_2*-%F_X2+S454PVT7H8,!UQLR<^GM7M-% '
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MU\=0L[&&6X8."LT67*^6I?&>&Z[36_IJ726$?VU84N3EG2'E$R<[0<#.!QG
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M2:X2%D#*K9QA206^Z2?TR>*Y8:O+H7Q \8SQV-_J*QV=G,889 =B@2EB/,8
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MJ5YIUM=)+=V80W$2YS'NSMSVYVG\JO5YK,VL0^.O&,NF75K#<0Z992-+- 9
MQ59C@*&&,^N3CT/4:5IXPO\ 6H=&@L8#%=7ND)J4S1HLGE[\ *H9E&-V[)YX
M ]<@ [BJ6G:QI^K_ &G^S[I+@6LQMYBF<+( "5SWX(Z56\-76L7FA02Z]8I9
M:D"RRQ(P93@D!A@G (P<9.,XK@+6X\1V*^.=1T.:P5;+5YIW@N86<W&V"(E0
MP8;.!P<')/;N >JT5PB>+M4\0)*N@6S))'I]O=C=&DF9)D+JC;G7"@ 9(Y.3
MTQR0Z[XKO/$EAH\D=CIDUSH[7DR21&9K>99$1AE7PXY..1UYSC! .[J.XN(;
M2WDN+B5(H8E+O(YPJ@=237":5XVU+4=%T"-H$_M349;J*1H$!4"W=D=E5F')
M(7@GC)ZXQ6;XPN?$UQ\-=7&KPQV<D-[%''($4_:H#-'M;"N=AY((R<X[9H [
M:S\7:'?ZR='@OLZD Q:U>)XY%  ))5@"!@@@GKVS6W7)SZEJ=AXXT;27DLI(
M]0M+F265;8HY>+;MYW'Y?GZ>W7FH?AS/J5UI>I3ZA?"Z;^T[J,$Q;6^25EZY
MQC &!CC% '95%<7$-I;27%Q*D4,:EG=S@*/4FL"YUFZO/%\WAVPFCMFM[);N
M:=H]YR[%451D#^$DGW &.M<9XCU_4?$'PVO6F:&VO+#6(M/O5CC+))(EU$-R
M9;(4Y!P<]<>] 'H^FZWI^KR745E<;Y;5Q'/$\;1O$Q&1N5@",CD<<UH5!;0O
M%'F9HWN& \R5(]F_'3C)_G7$MXLU:VUG2(;B2UD%[JDEC/;P1EDA7$A3$PX,
MF$4LO^T>!B@#L]1U*STBPFOK^X2WM85W22.>%%3PS1W$$<\3;HY%#HWJ",@U
M@>/O^2=^)?\ L%W/_HIJY^RUCQ%HU[X9MKZ6PGTO5XA;1B&%EDM91%N3)+'S
M 0ISPM 'H5%>>0>,]9D\%Z1K#?9/M%QK(L)U$+;6C-TT.5&[(.!GJ>:NOXMG
M'C"71+BZBTZZ%W&MK;W4!"WEO\NYHY,X+\MQ[8QGF@#J[/4[/4)KN&UG$DEG
M-Y$Z@$;'P&QSUX8=*MUYSJ/C#7;3PSXUOD:Q-UHEXT4!,#;&01QMR-^=WSGG
M./:M%_$NJZ-XHGM-7DM9[)M(FU)1;PE&A\IE#)DL=X(;K@<CH* .UHKB].UK
MQ7=76D7:Z8)]-O83)<C$:?9\IN0HWF$N,_*<C/?CI57P_P",KW6(;DQ2Q2ZI
M;6$DESHTL!@N(KD;=J#)YC/S#//4<\XH [ZBN2\'>)QXCEE*:E#/Y42_:+1[
M<P7%M-GYE="<[?3Z'DU>U[7);+6M$T6U*)=:K)*!+(NX1QQ)O<@9&6^Z!VYS
MSC! -^BO-];\::WH^G^+;3_1'U'1(8KF"X:$[)X9,XRH;AP01G.#P<5VVD)J
MZI.VK7%I,7DW0"WB9/+0@?*<D[B#GGC/H.@ -*BN&O?$?B._759O#E@+AM/O
M#:QV[JFVX*;?,#.9 5/)Q@<8!.<X$%YXA\42ZCXLMK2?3K9='MH;F'S+9G8[
MHW<HV'QG*XW#TX'- 'H%5+/4[._GNX;6<226<ODSJ 1L?:&QSUX(Z5PZ:OJN
MK^+O!MQ%=I;VVH:1+>M;>5N4-MB)YR"3AR >WH<U3\1>(M;N/!7C[_2H()]+
MG:WAE@A()C\I&[L<,=Y&?R H ]/HKD-0U?6-"UGP\EY<VLFDW\AM9Y1;E6CF
M()BYWD!6QMZ=<>O&UH=Y=:A%=W4SQM;/<NMH$3:?*4[<DY.<D$@C'&* --T5
MQAU##(.",\@Y%.KE_P"V=1UCQ#KFDZ5<06K:2D*EY8C)YDTB%P",C" ;<XY)
M)Y&.>7TOQ/JOBCQ%X/O(YULX;JTO6GM#'O59H76-SG()ZMCT'KF@#T/3=7T_
M6(YY-.NDN$MYFMY63.%D7&5]\9'2KM>20ZOK'A[1_&&M6$MH+>S\13/-!+"6
M:=2T2L P8;.#D<'FNIU77]<N]0UNR\/VX>XTL(BAHT99IFC$@5BSKM7#*,CG
M.3GC% '945P;:WXNOO$XT:W_ +.TZ5M(AU!EN(6E,,C2%7C)5\-]T_,,?0]:
MW_&EQ>6?@C7+NPN?LUU;V,TT<H7<5*H6X]^.O:@"_<:QI]IJEGID]TB7MYN^
MSPG.Y]H+-^0!ZU>KS&Z34/[0^&X6X@>[9)]DKQ':H-H>JALM@>XS[5IV'B;6
MY-$U,3S:>+O3M8_L^:[=3'&8LH3($).7VO@+GDXZ]* .[HKS2]\<:W;>&O$]
MU ;=[G1[^*")[BV=#+')Y9&Y,@JP\P\XQP.*Z'3=7UB+QW<:#J4UI/"^GB^A
M>"$QF+]X4*'+'=V.>._% '551M=8T^^U&\T^VNDEN[+9]IC7.8]V=N>W.T_E
M7-^/9]1AG\,QV-Z+=+G688)5,>X.-KN,\C@%!QW]:Q9I-8M_&GCB?2[JTAN+
M?3[*5I)X#('*QRG:%## ..N3CT/4 'IE%<1;^+K_ %E=*MK" Q7-WI$6IS-'
M&LA3S.%4!G48R&R>>@]<CH?#=UJ]YH-O+KUBEEJ?S+-"C!ER"0&&">",'&3C
M.* +%]K&GZ=-'#=72)/("8X1EI' ZD*,DCWQ3K'5;#4C(+*\AN#%CS!&X)0G
M. P['@\'FN,^&LK:EJ/B_5KSYK]M:FLR6ZQPQ!1&@] ,D_C6UXFO[?PM:7&L
M6UNAO[^6WLUW<*TC/L1FQZ;R3W(4"@#I:*Y&?6M6TOQ;;:#<S6\Z:E:336=S
MY!4QRQ8+*ZAN5PP(((/;GK6!8^+_ !1/H'A+6GDTUDUFX2TEMO(<;&=7(</N
M[%?NXZ<9[T >FT5YSJ'BWQ#I.F>-(Y)K"XO=!CBGAG^S,B2))'NVE-_!&",Y
M].*O)KWB/3?%VC6.J&PN;'6XY1 +>)D:VE1-^TL2=X(!YP.>PZ4 =Q17 Z9X
MKU>3Q!H5A<S6DIU2"Y,PAA8Q6\L8# 1R9Q(!DJ<$\CJ.E4;3QAXF;0=+URYE
MTXP2:Q_9\]O';L"Z&X:'>K%_E(P.,'IR><  ],HKCCXFOM+\2:[IVL20>3#9
M"^TYH82&ECY#@Y8[G5MHP,9W#UKI],%Z-,MO[2:)KXQJ9S"I5-^.0H)/&?>@
M"U2$A5))  Y)/:L#6M<FM_$6CZ#:,D=QJ(FD:9UW>7'&H)P.,L2R@9X')YZ5
MS&L:[JEYX;\>:+<R0I?:/:.QN8XB%FAD@9T.-WROP03DC(SCM0!V=AXBTK4[
MY[*TO%DN5B$_EE&4M$3@.N0-R'^\N1[UJ5B^%8)$\-:6]P\4LWV2(*Z1;"$V
M+A>I_P ]JVJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@W]YK,4.IS1V&LRF6\@\M2^YE",$?^$,J@'()ZX(-:&DZMJ%]=M'=:0UM;M
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M<I#(J@1-(Q9@"!D\D]>E:&GW%W<PR/>6)LY%F=$0RK)O0'"OD=-PYQU&:MT
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M;I)';QI+()'50&<+MW>^.U244 <E)X(DCU^]U#3=>O\ 3K74'$E]90JA25\
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MZT=)F_XDUU+;20><N7\L*2V>@'S>] %V3PHUMKUUK&BZB^GSWNTWD)B$L,[
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MFA]ZVQ7Y%;.<K_=.<G(QU-.M/"VA6+7+6^DVB-=1B*X8QAC*F,;6)ZC'KUH
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ML]LUDKQ3QB&59'9]T8SA,DYV<GY>G)XI5\.Z2D]E.+)/-L4*6K$DF%3P0O/
M(XQZ#% 'GNC7DJ^(/!-S:W=Q)::E]KWW-Q.?-O4\IG#R(/E4 @%>20./EZ5#
M>_\ )-OB=_V$[[_T!*[^W\%^&;1H&M]#L8S!*9HBL0^1^>1Z=3QTJ;_A%]$^
MQWEH=/B-M>R&2YB))69SU9AGDGN3UQ0!H6?_ !XV_P#US7^5>7:M+<QZ%\4
ME]>J;23?;N+J3=%_HZ-A6SD#)/'2O5((([:!((EVQH JKDG ].:S'\+Z+*E\
MCZ?$RWYS=J2<3G_;YY_&@#CG^T:%XPTV2PGNYY+S0[J::&:X>19I8_+*':3@
M'YB/E X.*N>%$L]5T7POXC&M7/VR6,?:-LVX7<KI\\;KS]U@2 /NA3T%=4N@
M:6E[;7@M%^TVL?E02EF+1IW4'/3VJ"P\)Z!I>ISZE8:1:6U[/GS)HXP&.>N/
M3/?'6@#SB266V\$:S<P32PRQ^+Y )(I"A"M>JK D'H02"#6IXEUN]T/Q/XON
M=/ED=[7P]'<QPERR)+OD&_;G . I/J!7;#PQH@TV[T[^S8#9WC%[B%@2LC$Y
M+$'N3SGKD46?AC0["X%Q:Z5:QS>3]G\SRP6\O).W)[$L<^N>: .*FL;*+Q7\
M.;VUGEF,YN"TS3,_GYM'.]LGD^_OBH= %UXDT?3/$)\0QV5]#?YNP$=G+>85
M:V=?,Q@Y  V^A SR>SM?!/AFRE@EM]$LT>W<R0GR\^4QZE0>GX5+'X2\/Q:\
MVN1Z/:+JC$DW(C&[)X)^OOUH UHYHIMWE2(^UBK;6!PPZ@^]<-XFT^'5/B;X
M?M+AYUA?3;W>(9FB9ANAXW*0P'T(_*NET/P_::'-J,MK%'";ZX-Q(D0(4,1U
M]R>I/^%6-0T73M4D@EO+5))K<DPS E9(\]=K#!&>^#S0!Y:DM_86D5F-0O);
M6P\8P65K<23L7:W)3=&S9^=0Q*\YZ8[5<\1$7,GQ1LWGEDMX=(@E2$S,5C<Q
M3,2!GC)"DCO@5Z)<Z!I-YHYTB?3[=]/X_P!'V848.01CH<\YZYJ*V\+Z%:-.
MT&DVB-/#Y$I\H$O'@C:<]1R<^N>: #PS!%;^&M.2'.W[-&QRY;DH#U)-:U5=
M.TVRTFRCLM/MH[:VC&$CC& *M4 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 50U;6]-T."*?4[N.VC
MEE6)&?/+,< <>YJ_7(?$:">YT"SBM[6XN7&IVDC)!"TA"),K,2%!X !H VM.
M\2Z/JK7JVEZK-98-P'5H_+!!(8[@/E(!(8<''6DM?$NDWETEK#<MY\D1FB1X
M70S(.K1[E&\<C[N>H]:X7Q/HVIZ[K?C&VT^WN8VO]$@@MYGA=(Y)%:1F3>0!
MR& Z]_K6I.D_BC5/"%S;V%Y9RZ=.US=FXMWB\D>45,0+ !B6('RY& 3TQD W
M_#'BBV\46EQ<VT-Q$D5Q)"!-"Z9".5SD@#/RGCJ.^#6 ?&,.A>-_$MOKFK.N
MGV\%I);1M%N,6\2E\!%W$<+DG..,FKGP]CN;+3=1T^[LKJWFAU*[<M+$51U>
M9F4HQ^\""#D9J"-GTCXA^([R\L+R2VO[.T6W>&U>993&) ZY4$ _,O#8S0!T
MLFO::EG;72W/GQ7*>9!]F1IFE3 .Y50$D<CD#N/6K&FZE9:QI\5_I]PEQ:S#
M*2(>#S@_0@@@@]*\JL=$U/P7'X;GO]-U*]L4L)K6YBTMY&DM)'F\U>(R"R@'
M8<9'R@^E>C^&;2VM-' L],?38)9&E6WESYGS'.YP2<,3SC.>>><T <UIVMS_
M -A^,7UC7I;:.RU.>VBOC&FZWC$<97 "X)!8]JZ*;Q1HVGRV]E<ZD&NI+?ST
M3RV9Y$&/F"J.IR. ,\\"N'FM+U_!GQ&METZ_,]]>W36L?V23,P>)%4J-O()4
MUKJD[>.O"UU]BO?(ATB>*64VL@6-V\K"L=O!^5NM &U'X[\,RQ6DJ:JC1W4@
MBC<1O@.6VA7.W]V<C&&QS1=:W8V7B"_:35IY&M-/$LVFQ0[]BAC^]&%W%C]W
M&>W2N$NK&^?X:>(K--+U W,^O/<10BSDWO&;M9 P&WIM!.:Z*\MKF[^(NIS0
MV=UY$_AT6T<S6[K&9?,=MFXC&<,* -S1_%ECJGANPUAUF@%XB%(6A<NS,N[:
MB[<OQGE01P3VJS#XFT>XTPZA%>JUN)OLY^1@XESCR]F-V_/\.,^U>=0IJ=IX
M7\$:@VBZQ+!H]N;/4+2%)(KA28E7S$4$,P5E(XZ@G&:M7UH]K<Z'XDTKP]J$
M>G0:I)<WELT;M<S;X3']H:,DL2I)X^]CG% '0>%=<N-5\9^*[5KR:>SLVM1;
MQS0^4T)9&++@JIZ^O.,5IR^*K6/QG'X;\FY,[6IN&D$#E1\ZJHR!C'+9;H,
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M8K:UN;B0:E:2%((6D(5)E9B0H/  )H TUU"T/BVXMO[98RPV(>33RHV1KO\
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M.#0!ZA117,Z_XHO-)UZPT>RT9KZXOX)Y8#]H6)2T04E22#C[PYH Z:BN*O\
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MTGD(Y(5G"\X.#TR<#.,4U_%FF0V&E7DRW<*:G.EO;K):NK>8YP P(^3\<>U
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M?N[PRD9&3@@ \XZ5'_PA^FQW.BS6SW%LNC*ZVD43+M&Y=K;MP)8D=23[]>:
M.<BF\33:YXAT9_$TBG3M/M9HKF.SA#F1EDW$@J1@E 2,?0CO!IOB+7WMO ^L
M7&IB2/6W2"YLE@18QNA9PZG&\-E/[V.>@KK_ /A&;<:OJ>II>7:W&I0I!-@I
MM"J"%V@KP1N;UZU4C\$6$-AH=DEY?"'19!):#<F00I4;CLYPK$?C0!S][XDU
MBTU.PDCU+[5%/KXL)5AB3[,D+,RA-Q4.9!@$E20&# ^E&BMJ,,WC^YCU>Z::
MVO)!%YJQLJD6\; XVCIT SC';/-:Y^'.D^6(5O=42".__M""%;G"P2[BQV#'
M0DGKG&3@BM >$;%+K5YX;J]B_M4?Z1&LHV!M@0NH(/S%0!SF@# TKQ-J.J#P
M?I;W;0W.IZ.-0N[I$3>Y")\J@@J,LY)XX XQGC,U3Q5XAL=+\062WZ_;M&U2
MT@2[:!#Y\,[1X##&-P#D$J!VZ5UO_"%:>MCHT$5Q=Q3Z,NRQNT9?-C3;M*G*
M[64J ""#G [\TMYX+TZ^TJXL)9[L?:;I+NYG5E$DTJE2I8[<<;%P  ,*!0!5
MT>^U6V\?ZCH5]J+7]O\ V?#?1,\*(8F:1T9!M ROR@C.3[FNMKG[OPO#+J5]
MJOVW4?MES8&Q8PR(C",;B-AVC:X+$@YZGTJ_H-C<Z9H=I97=U+<SPIM:65][
MGDX!; W$# S@9QF@#DO#]G='XB^--FJW09?L@&Y(B#F$XR-@^[GC!'OFLA]5
MO-<^'G@/4]0E$MW<ZU9/*X4+D^:>PX%=W:>&X;+6-4U2&^O!<ZEL\_)0J-B[
M5*C;Q@?GWS5&/P)IT6@Z5HT=W?+:Z7<)<VWSIN#H<KD[>0"3_7- &7=ZKXCU
MR;74\/RM!<:;=_9;=3Y7E.RHC'S0P+8.XCY<<8QS46H^*=0L/$"VNL7-QI-O
M/+;?8KJ.));.7(0R1.^TE7+;P"2!C:1WSLWO@33KO7IM7BO=3LIKE56\CL[H
MQ1W6T8'F #KCC((-6;OPE97INXIKF[-C=21R2V.4\DE @ 'R[E'[M<@,.GO0
M!OUQ.MW.O7/C^'0M.UHZ?;7&DRW(9;9)&CD62-0PW#G[W0\8)[X(V]%TFYT_
M5=7N9+V\FM[R8210W,WF>4>=VS^ZARH"]MN>^!++X?@E\3PZ^;FY6ZAMVME1
M2OE^6Q#$$;<\E0<Y[4 <D-7\4ZU9WUWH<V)[+4)+98Y3"MO(L4FQ_,R"X+ ,
MV01C*^Y-V#4-<\2PZY/I&J1V,^GZBUG!#)&KQ'R]N\RY4L=V6^Z1@;?<F[)X
M"TMM=NM3AN]2MEO'\R[LH+DI;W+]V=,=3WP1GOGFEG\":9+KMSJD5UJ-M]L(
M-Y:6]P4@NB!C+KC.<<'!&>^<F@"E#JNJ>(Y_$PT[4FL6TJ<VMLJ1HX=UC5R\
MFY22I+8P".!Z\C&M/$VO^*+KPP++4O[*CUG29[B54MTD,4J%!N7<#D98\'C'
MOS77S^$[.35+V_MKN\LI+^-8[Q+9U"S@# )W*2K8XW*0<?04]?"EA%J^F:A;
MR3VYTRW-K;01%1$L1QE<%<G[J]^U '':KJ&H^(?!?C=_[4DBCTN.ZL B11XF
M,4/[QWRI(W$L %(P,=Z-0\17VAZ3I8N)[W3])DT> 0ZE;6Z31P7!4@^>"K$+
MC9@@ ?>]L='>^ M-N[K5I8KW4;.+5XV2^M[:95BF)7:7P5)#8[@C..0:G/@Z
MU^R-:)J.HI;/9+8RQ>8C"2)=P&=RD@X<C((XQZ"@#H(9%EACD1U=74,'4Y#
MCJ*Y_P 3:U/9:EH6D6DGD3ZM=-$;C:"8D1&=BH.1N. HR".<X.*DM-!DLO%
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M?+S\O'_U^: .?TS6/%&OV&F:[I;[;>:Z)GMYFB$'V?>RD @>8'  Y)QD'C'
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M_:+3YT)#8(&X[.1AF_/Z4 84GB+Q#I6E^-[=)WU6\T62,VLTD*ARDD2.=RH
M&V;F/ YQ6GI.I:C>>.#:VFL-J&A)IZ7#S>7&P$S,5";T4=5^?'48]"*9XE\-
M&VTO7KJRCU&^GUB2$7D4,J*ZQKM0M%POS*@X&><<Y[L\-6=\-6@N+74O%$EH
MNX7,6MJBH5VG 4% ^[=M.1Q@'VH U?$.LW%OX@T#0;68V\FJR3,]P%#,D<2;
MB%# C<25&2#@9KA+^]U7P];?$R^LM3<WUI-;2)<R1(6(\A, C&W@'&<=J]&\
M0>&K+Q$MHUQ+<6UU92^=:W=JX26%L8."01@C@@@@UE3_  ]TRZMM9AN+_4Y?
M[9\O[8[3+E]BA1CY<#.T=![# XH 9>G6]-O[.WN/$1F6\GE?R8+5!<$!!B.(
M;2NP-DEGZ J"WKAVWBG73X+T+Q'<WS+##J36VJJ(HQOA\]H0YX.T@A"=N!C=
M[5V&H^%K;4[[3;Z6]OHKW3U=$N(90C2(X&Y7P,$':.@!&.,5%9^"]*LO#-]X
M?5KF73[SS@Z32[RHD)+!2>G+$@]?4F@#G;3Q-J;ZQXCT9M1F:Y9X_P"QY6BB
M&4=C$6 "_,$D5LD]5 /O6JNH:J/']]HO]HLUJFC1W,6Z%,I(9&0L< 9X7..G
M/2M=/#&E1ZCI5^EOMGTNW>VM2#]U&"@Y]>%P/J?6D?PY _B&?6Q=W:7<UH+,
MA2FU8P2PP"O4$DY]Z .'T7Q%XC;2/!&M7>KFX76+E;6ZM?L\:H0Z2,'! W!@
M4'0X]JFUCQ/KHMO$'V2\-OK%EJ:6UCIHB1O/A)C ;!!9MP9FR#@;?0'/1P^!
M=/M]+T;3H[R^%OH\XGM!O3(8 @9.SD ,P_&N6CL+V75=1:4^,],O[B\DD\FP
M9'MFYPC*[AEY55)R1@Y&  * -'Q#XCU#0M7:UU._N["Q>*)+35$MT>V:7^(3
MG:3&2<8Z#%>@5S3>$SJ.GRPZMJ%U+]NAC34((R@AF=456(!7*YQSM(_"K5CI
M%Q:^*=0U$7EX;2XB1!:S3;HE90!F-/X!@<^I)Z8&0"MJ>JW$OC&Q\.6]RUH)
M;*6\DF15+L%9$"+N! ^\23CL*S!JFMVNL:%X7O\ 4HGO;L7,L]];QJ&:./!1
M0"-H<AU+<8X.!R"-KQ#X3L?$<UE<RW%Y9WUDS-;WEE+Y<L8889<D$$'C((-,
MN/!^G3P:>%FNXKO3Y6FM[Y9=TX=AAR68$-N'!!!'3C@8 ..UKQ5X@TW2?%MD
ME^#>Z)<VODWK0(3+#.5PK+C;N )!( [<5L-)K_\ PGLWA_\ X2&46USIGVX2
MBUB\R!A+L*Q_+C:<C[X<\=><UK7W@O3M0TB^T^XGNS]OF2>[N RB69EV[<G;
M@ ;%   ''US:/AV$^(EUS[;=_;%M#9CE-OEDACQMZ[@#G^G% '#VWB?Q'>^'
M?"$R:E%'=7^J2Z?=2FV4B0(9@'QV/[H' QR?2H=7\1^)_#]CXPL)M7-U<Z5;
MP7ME?&WB5F20D%'4+MX*G! !J]KOA?\ LB+PKIFF-JLMO;:R;N2:.+S&@5EE
M+-E4QC>_0@]?2NKG\(Z;=Z?JUI>&:Y.JJ$NYY& D< 84#: %"CH .N3R2: ,
M?7-3U-?%\^E0ZA-#:RZ!<78$:)NCE1T4,K%2>C'KFLGP]JU_9>%/ ^EPW5S-
M/JUEYID/E;T6.%6*(67'4@Y;<<!OJ.GM?!-C#JD.I3W^I7MW':/9E[F<'S(V
M()#!0!V'3'3/7FJTGP[TB3P]9:.;K4@M@X>RNEN<3VQ P C 8  XQCZY/- &
M+J.H^,M*L].ANM0BBFGUZ*TCE,<;O):R9QY@4!0PP1\N,^U=UIEI>V>F);WN
MI-?W2[LW3PK&6R21E5P. 0..N*R)?!5E/965O+J&I.]K>)?"X>97EEF7[K.6
M4YP.,  >U=&3L0L<D*,G R3^ H \FF\0>+X? UYXK77$D.F7TZ261M(PES"D
MY0AFQD':."N.G.2<UT5K<^(=6\<Z[I\6NFTLM/:RFCC%I&Q*N&9XR2,X.,9Z
M],8YS4\%^&C>^'[JVU;^T8X&U2XN&L)XO+CD!G9T/S(&*GY20&QZCDBNML_#
M\%CK^HZQ%<W)N-06-9D8J4P@(3 VY& 3WYSSF@#AKGQ-XAC\#ZK?IJ:_;;/Q
M UBLIMTPT0N5B (QCHW7K[U?O+[6K76/$VBS:U/,BZ*-0MYUBCCDMW)D4JN%
MQM^48SDCUSS6N_@/3I-'N]+:]OS;W5]]OE.]-QEWB3(.S@;@#CV]*OOX7M)=
M;N=5FN+F6:YLA8RHS*$:+).,!00<LQSGO0!B>&]8C\/_  Y\.7%Z=3OA/8V^
MWR+1IV3,2G&(TSM'J<GW-2Q>(IM?\6+HUE/=:?;KIBWS.8 D[%Y"BKMD4[0-
MI)XSDCT.=_0=%@\/Z1!IEM/<S0P*$C-Q)O95  5>@&  !T_6H=1\.6M_J]MJ
M\=Q<6>HV\;0K<VQ7<T3')1@RLK+GGD<'IB@#B[?Q=KCPZ9'-<@7,'B<Z)=NL
M2A+J,*S;\$?*2 O0CG/X1>+-5U2;2/B/8G4ITBTZWB:V,:HK*'AW,N0O()X]
M<=ZZ^[\&:9=:-#IRR7,!AN_MR74,@$PN-Q8R9((+$LV<C'.,=*B'@32BNMK-
M/?7']M0K#>>;/G< FP$<<''/MVP.* ,/7M<U'PXMJEW?:E#I+V(VZK#;12B"
M<D_Z]0G" ;<$ =\^H[ZUD$UI#*LJ2AXU82(<J^1U'L:PCX0A,+Q?VMJA26T%
MG.&E1_.0%NNY#@_.PRN.*=:>'WL?$L-W:7-Y%I\-@+06;3Y@^4C843L0 <L3
MZ#UH C\1:U<6NO\ A[0[:4V[ZM-,'N H)1(HRY"@@C<3M'(/&:Y/Q#XHU_1K
M#QG81Z@6N=(MH;RSO6A0N4DS\CC&W(*G!QR*[O6] L]=CM?M#2Q7%I,)[:Y@
M8+)"XXR"01R"00001U%4KWP9I^HZ5J=C=7%W(VJ;1>7.Y!+*JC"KD+@ #L .
MI/4DD T-(M-1MDG;4-4-\9G$D8\A8Q",#*#'49R03SSU-:51P1&"WCB,KRE%
M"[WQN;W. !^E24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4R66.")I99%CC499W. ![FGUR7CV_L
M;&RT<WZ)MDU2%8I9I"D,,@W,KR$=5&.AZG'(Z@ Z=+RUDMA<I<PM >DH<%3V
MZ]*07MJ1*1<PD0MME/F#Y#Z'T/UKQ#4;C3IO"?C*&6ZM9I$\1V\\;* F [6^
M709^4'Y\$'D9Y/)KM+;3M'7XJ:II,-M:)9WGA^+S[:-5"2GSI!DJ.IVD<^AH
M [S[7;;$?[1%L<X1MXPQ]!ZU*2%!)( '))[5YWX/M;IKR'PO?P,T/A:9BDSK
MQ.I7%L1V)$;/GT9%K3^),\UMH6GS[2=.CU2V;4\#(^RA_GW#^[G;GVSGB@#J
M/[3L/L,M[]MMS:1 F282@H@'7)Z#%<W>^,&<^%;G2_L\MAK5RD3M)G>BM$T@
MP < X7G.>M8NJVJ7/C75IM*$<ME-X>D^W"'#1O+N_<DXX+[=V.^!]*Q89M(O
M?"7PPMTDM)8S=6R7"*RX+BT8,K>IR0"#ZX- 'KL-S!<P^=!-'+%R-Z.&''7D
M4R*_LY[=[B*[@DA3.^1) 57'7)Z"O(M0FCTN/QO%IZ[-.M=:LIKJ"T13LMRD
M1F(3!&.#D8P0#GO3O%$/A>^\)>+=8TO5CJ;W&F*)W!B,"NO^K)"J )>3CN!U
MQQ0!Z_%/#,7$4J2%&VN$8':>N#Z&L3QAK[>'O#>H7UM):&]M[:2>*&X?'F;
M2< $$].U6M!TS2["P673+6WA%TJ2220J/WIV@;B1]XX[UY?JFI6$WA+XD6.M
MR6Z:R+BZ*Q7! D:()_HY0'DJ !C'?)[T >KPZG;BPLY[RX@@>XC5@'<*&8@'
M R?>HYM=TZWUV#1I+F,7T\+3K%N&0BE5R?J6&/7!]*\QUS5M)N[75[:.:UCN
M6\,1CS9WW_:4*2$) F<<'.YAGG QQFK>CWFFOXP\&WEQ-;,MQX<:..9R#YLP
M>'@'^)QSTYZT >G+>VKW36JW,+7"C+1"0%P/<=:G) &2< 5XK;:UI4L_@^\M
M+BVM8%UR?-NS[KB'>)MWG.3D,S?PX'7&6QFNY^)<UQ;^%HID5FLH[^V;40HS
MFU$@,F0.HQC/MGM0!U4-[:7$+3074,L29#.D@95QUR17-:'XBU/Q%-#?:<=.
M;2C=3P30N6$Z(C,BR!@2#DIG:5'!Z\51$4$_Q1M[K2W@>QETAQJ1B(,3C>OD
M[L<%L%\?[(/:G?"C[(W@I9+80EC>789H\9Q]HD(SCV(Q[4 =E/=VULT:SW$,
M32'""1PI8^@SUI9KF"W&9YXXA@M\[A>!U//I7 6TMC-XE\<6'B<PKYBQM%]H
M( :R\K V9[!M^<=&/K7/:3IL=WJOP\M?$T$,]]-I%VEQ'=*"T@Q'Y:R _>(7
ML>X/>@#V/S$\OS-Z^7C=NSQCUS4<=W;33-#%<1/*JAF17!(!Z$CT-<[XZLK5
M/AEK]JMO$((-*G$4>P;4VQ';@=L8&/3%<E#I.GKJ_@2_\.16Z:@\+M=2P8_>
MVY@^9I2/O?/L +=S0!Z>+RV:Z:U6XA-PHW&(.-X'KCK5>\UG3-/MIKB[O[:&
M*%6>1FD'RA?O?E7E_A230=<L/#\.HZO=+XCTZZ#36 $2SBX&1+O&S<8SEBQ)
MP1U.:9I.BZ+=?#OQE=PV%G->6\^KI!(L:L\2G?M53_",8P!QS[T >I6^LV%Q
MI4&I?:HHK69%=7ED50-PR 3G&?:B_GNPED]A-9!'N$$S7!.&B.<B/!^^>,9X
MKSVWUG0@?!D<4]C%(=/D,5Y-)_HZ'RXQ(H4$!Y3D#D\?-UZ5A:5<6#^ _ ):
M6!I[7Q&L.YL!HQYLWR_[/&WCTQ[4 >SRWMI!N\ZYACVD*=\@&">@Y]>U07,E
MZNK620R6:V;K)YZ2Y\YB -OEXXQUSGVKR_4M/T6>^^*AFMK)VBM4=-RJ?+<V
MN2P]&W=QSFM""6UF\5_#>Y:2%[B?2;@22$@M(/)BQD]^=WZT >CF]M!(L9N8
M0[N453(,LPZ@#U]J6:[MK9T2>XBB:0X0.X4L?;/6O$I[72(/AWXBOH8K-+FV
M\3-]GG4+NB O4P$/\(VD\#C!-;WB:_TZ#Q1XKT^]U/3#_:VE00Q+?72PBW.V
M0 #=U0[MY*Y(/:@#U0D!2Q( ')-9VD:[IVNV3WFGW4<T"221EU8$?([*3]"5
M.#W'-1>&M/LK#PKIUC9R6UQ:QVR)YL"KY<W'S.,<'<<D_6O*K.[@M?AW9)%Y
M7DVOB(_VW&@&Z.V^URG]X!R%^X2#_#GMF@#V>WNK>[B\VVGBFCSC=$X89],B
MJ5YKNG6.K6>ESW,:WEV&:.(L =JCEC[9P/<GZUS=G$K?%B6ZTIT-C)I ^W&$
M@QM+YG[HG'&_;O\ ?;CVJ+Q0UC;?$[PC/>^1'&]O?1AY0,,^(MJ\]3UP.OI0
M!J^&?$DVJ'5H]3:SMY;359;"$1L1Y@54(^\>6.X]/RKH)[NVM2@N+B&$R':G
MF.%W'T&>IKQ;6(M-D\#_ !"U!EMGO(-<E:&<X+QD-"1M/4<YZ5N:Q?:--XO\
M2:5XHU;[!:WUK"+)Y!$(Y[<QX8([H?F#EC@'.2".E 'I]Q/%:VTMQ/(L<,2%
MY'8\*H&23^%<YHNM:QXDTU-7L(+2UL)LM:QW2LTL\>>&8@@1[NH&&X(/M3K_
M $9]1^&UQHEG+<%Y]+:VA>[/[TYCVKYGOTS^-4/ /B+3?^$+TVQNKJ&ROM-M
M8[2\M;AQ')"\:A3N4] <9!Z$&@#H=,U.:;1EO=5ACT^4/(LL;2Y6/:[+]XXR
M. <\9S5[[3!]G%QY\?D$ B3>-I!]^E<5KFI#_A._"MQ> IHTJ7*1O,-J"Y('
MEEL]"5#[<_WCWKCO$EI!#X>\:,GE#1AK5D^GG(VK*7A^T&,]AN+ X[AO>@#V
M,W]F%F8W< 6 XF)D&(S_ +7I^-2>?"$1S+'MD^XVX8;C/'KQ7GHTK0O^%O2V
MOV.P^SOH*RO!L78SB9@&*]"0I/)&<&N4TN/3+KPO\.3>"WD@&JW-LS2$$;/W
MX6,G^Z<*-O0\"@#VN*[MI[<W$5Q%) ,DR(X*\=>>E)%?6DULUS%=020+G=*D
M@*C'7)Z5Y)?0:7H%SXQ,=HO_  CLMYIZ+%%)Y5O'<EAYA)7A4'[LOCZ50UV[
ML+BP^)T4M[971DM+:XB,2A4=O*(WH,GOM&<GG'- 'M0O+4O*HN82T0!D <90
M'H3Z4?;+7R?.^TP^5G;O\P;<^F:X"&UTJT^)NAQVD5K&MYH=P)E0+^_^>(C=
M_>/WCDYSS4>@Z=+9:O+X%EMC_9>G77]IPRLOR-:EB\4>?[RS9_".@#TJLM]0
MDL;K4Y]2N["+3+>-)(V#$21C!WF7)QC(^7'H:FTC6=.U[3UO]*O(KNU9BHEB
M.1D'!%>>S0VKZ_\ %&WACA9WTZW<QH 2S^1+DX]<X_&@#T"TUO3[S2+;4UNH
MH[6X1'1I'"XW $ \]>>E7=_F0EX&1\KE#G*GTY':O+[5EN_#W@^?PYJ^F1:G
M!IS;+:Y4-;W7[N(2HQ!R''R\CD?,#WKMO!EY'J'@[2[F*P^P1M" MMNW", D
M84]UXR#W!% $'@WQ*^O^'K2[U!K6&^GEG001-C(CE=,J"<GA1FM[[9:['?[3
M#M0X9MXPI]#Z5XI!I&FWGPOC-E#;_P#"5)JLBVDD>/M,<PO&(&?O !,DCH%R
M?>MC6+RPL;WXI6=U-!%-=6:/!"Y :4?8\95>K?,#DCICF@#U*:]M+<1F>ZAB
M$GW"\@7=],]:@:6\_MJ*-9;/[ UNS,A)\\R!A@CG&S!.>^2*\QO9G.CV6HZ3
M?:;>&+PY +[2KTC9<6V'R8W'W7R'!X(^[GH*UHI-.NOBAIDTUO% +OPP[30W
M 7=M,D1"N#U(&1SZ&@#OTO;625(DN86D<%D02 E@."0.XI7O+:.Y2V>XA6X<
M92(N S#V'4UXKH,&F6O@;X;:A"MM'>-J\4;7 P)"I$H92W7'08Z=*T8I=%U;
M^U]%\1:O=6FM1:Q)*MK&(EGE(EW0-"2A9ODV*,'@#' H ]8-[:K<_9FN81/@
M'RC(-V#[=:!>VK7)MEN83<+UB$@W#C/3KTKSAYY].\3++#)9ZSI%WKNQX6&V
M\L+HMM)!'WD&"<'!"GTHTB>?3O$FEQI)9ZSH]WJ5S]DG4;;NQF82M(K@<.H^
M<$\$<9[4 >G5#/=VUJT:W%Q%$9#M02.%W'T&>M5])UK3==M'NM+O(KN!)&B9
MXCD!UZ@^_P#C7 W.I:%_PEGB_1O&$T,*WB0BU^T-M\ZU,8&V(]21)O.%YW'B
M@#T?[5;@R#SXLQ_?&\?+]?2FRWMI#"DTMU#'$Y 5WD 5B?0UY_%=:;I7Q&OD
MNV6TCNO#]JL,=RWSRX>0%>>7<94$<FL+PXT]QX+\&SZ)JVGIJMMIDRBROL-!
M=1Y3S$)!RK A>1ZG/&: /49_$&F6^K6>F/=Q?:KN-I8D#CE!CYNO0D@#U_ U
M=^UVPNA:_:(?M!&[RMXWX]<=:\OLK[39?$?@+4)K&'38)]'N(X8)\':P\D(B
MD_>.!\O<CI6<&:_^#\D+$+XOM[\Y7(%PM]]HR"._*GZ;/84 >P37MK;AS/<P
MQ!,;]\@7;GIG/3.#BG"YMS<?9Q/$9]N_RMXW;?7'7%>9/8:/<^+OB&MW;V4F
MVPMG8.JD!C%+N;!Z'ISUJCI::?;67PKOHA;I>3[5FG!'F29M&#!FZGD <^PH
M ]:-W;+=+:FXA%PPW"(N-Y'KCK1]KMO.$/VB+S2Q0)O&2P&2,>N.?I7DVE2Z
M+K$!TS7=7N[?Q%9ZN\QLHQ$L[3B5BC1DIN92I7G. O&0!5G0])\.7">/9[F*
MV3[)J5RRW$2J9+9#;J&>/^Z>7Z=2/:@#T^"\M;HL+>YAF*G#>7(&Q]<4MS=V
MUG&)+JXB@0G :5PH)],FN(\&W%];^(Y-+U%-/O9$TV-[?5[ ;5G@#859$Y"M
MR2,'!&<5+XFU#38O'&GV=R\%O=/ITY2YO&)C*,Z!HTCR TAP/H.QSB@#M&GA
M39NEC7?]S+ ;N,\>O'-)%<P3P">&:.2$@D2(P*D?4<5XKX:_LO4K7X6)<FVN
M'$=U;RAR&)"PMA&]0#C@U)+=PZ=H^L1P[%T6#QFHOXXA\D5H0A;('1-^,CIU
M'K0!Z+I_B66^\<WFC1M9RV$6GQW<4T#%F):1D()SCC;V]:M>)O$,>@060W1?
M:+V\BM(O,/RJ7."Y&02  3VSP,C.:YK2+W2)_C)J#Z?<V<GVC1(&+02*1(PE
M?/3J0NW\,58^)'V,/X5-SY&YM>ME_>8R5^?(Y[=* -O0[C7WO;Y-:FT=[=-K
M6K6.\.Z'/SNK,0H(Q@ GH>:UX[RUFE6**YA>1D$@57!)0]&QZ>]><2Q:8GB_
MQ_!LM%A?1K9I(\*%)"S<D?\ ?/Z5G:+#IMFGPINK=;:*YG@*32K@/(#9G(8]
M3\P P>A % 'K"WEJUTUJMS";A1EHA(-X'N.M#7MHCA&N859G\L*9 "7Z[?KR
M.*\<CUK299/"EY:7%M:P)XAFW6[ONN(M_G[C,Y.06/1<="!EL56U*STB/P!X
M_NXX;-;BVUV4V\JA=T)#Q$;#_#SGI0![;/=VUKL^T7$4.\[4\QPNX^@SUJN\
MEZ-;AC62S%B;=V9&SYYD##!7MLP3GODBN"NM5T(>,_%6E^++BWBMK^U@6Q>Y
M?:LUL8\.L;>OF%C@<DD8Z5-']@L?BEI+00M$1X:E'EOS,562+:K9Y+8!Z\\&
M@#OH[VUFGDMXKF&2>/[\:R LOU'45B^$M<O-<AU8WL<$<EEJ<]DOD@X*QX )
MR>IR:\YT+5M*DUOX?7%G=6D-H?M<:VZR;Y(=\1(260G+2,V.,#GIGK79_#J:
M*5?%'ER(^/$%WG:P/=: .MGO+6U>-+BYAA:0X19) I8^V>M8NO>(AIVK:7H\
M$UM%=Z@TN)9_F2%43<25#*3D[0!D=2>V#Q'CW4-.DN/&MD&@M[U=%02&Y8N]
MR-DC(L*$\!22689Y[#&:MW%QIM_XK^'<SR6LYGM+HEV*MYF(4Q]><T :6G>)
M_$>J37VGVXT,:IICQ)<1%W:.Y+#<?+;.4PA4\AN<CMFNTM[RVNPYM;F&;8<-
MY;AMI]#CI7E\EQH]G>?%"XFMEN(81%OBM6"R%#:J&"L.5YSD]N:DT.]TR;XC
MB-[W3)[:Y\.JFRVP86"RGY,DG?M7.2>W8=* /0],N;C^RK:35;BQ-V_RN]JQ
M$+-D\)N.?\FICJ5@JQ,U[;!903&3*N' ].>:\:T^/3+CX??#(7(MG!U58CO(
MY0K-N4^Q.T$=#QFMOQ/:1>'YM6ET--,GT^WLHTU'09D$9\D%V#P,/NL2[<8P
M6Z<XH ]4J.:>*WB:6>5(HUY9W8*!]2:I6FNZ;>ZG-ID5TG]HV\22SVI/[R)6
M (R/Q'YCUKF_$]TUK\0/"K7Q"Z0XN$#O_JUNBH\O<3P#MWA?<F@#L!<VYMQ<
M">+R",B3>-I'UZ4Z*:*<,894D"L58HP.".H..]>+>)K2"'P_XV9?*&B_VO9/
M8'("I*7B^T&,]OF)SCON]Z]@TW3-.TNW>/3+.WM897,K+;H%5F(&6X[D <T
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MG9&F*[-VS(PN!LD89/"X'7B@#HA;0+;_ &<0QB'&/+"C;CTQTH-O V<PQG(
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MS^S6[F.:;SUV1L "59LX!Y'!]: .=UC^V_+\-BWTR[ELAN748;>2-+A#Y>$
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MW?FR,D8:>WF+C<AW8W!7S@D=ZZ?PW!J3>.O$6J7.DW5I9W]O:"%YFCSF-7#
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MTRSDNKRZC5(XT95YWJ<DL0!P#5TWU[++8^5X>O%G#+&9YS$%@0XWDXD)/ Z
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M!@^#[?5[3P^D&M3R3W"2R".6;'FM#O/EF3;QOVXS^O.:WJ** "BBB@ HHHH
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M;;I8F<Y<12;AM#')Y!QGCGFM[Q)X?LO%&A7&E7V\12X*R1G#QN#E74]B" :
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M;R>[33]5>""2X?=((S'&X4MWP6/)JQXDN&.L:/9)>7 ,QF8V%J2DER%4?,9
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MRJ0[91P>=R_=_"MR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(["JDG@G09=,U#37MIVM-0G-Q=1F[E_>2$@DYW9&<#@<<5=/B30UMK>X.L6
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MHDEFUW'JUD]NLK0F1)E8;UY*\'J!SCTH AG\*Z5<O<&9+ATNMGVB)KF0I-M
M W*6P>  ?7'.:KZCX&\/ZKK7]KW5DWVQE"2M'.\:SJ.@D52 X]B#QQTJOXE\
M96.E:7IL]I?V;?VE=PP0S>:I41NX#2CG!"C//3.,T_3?$5E8"X@U?Q3I-TWG
MJ+>02)&_ER#]VK@'!8D-@@ $#..M &@?#&E'4+^^\J87%_$L-PZW,@WH,@
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M<BW*RH+-6'S1MN 4G(  &>F>U=]10!R/C:!)IM*:/6)-'U")Y)+2]*!X0VT
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MOX)$:/9<Q$X^0[NN?7'4>HINE>+K;6=(T?4;2RNFBU60QQ(2@:/ 8LS_ #<
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MQ3XHAL_&%U!<::B^'YLHIM6/GH(EDVGY_E."1GGZ#'(!Z32,RHA9B%51DD]
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M<FF/J%D;:.8:Y_97V&6 N57S-@8X8$OCY^H&W\Z]#0.(U$A4O@;BHP"?8=J
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M\E_J=W%:VD9 >65L*,D ?J17-3>)=13^S88PLLNKW4PM#'$,I;HI8-AF 9F
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MLY.\<D'/ID8Z5P_@S5]8T7P=X)D66T?3;Z[%@]MY)\P;S(0_F;NH*]-O0]:
M/6Z9--';PO-*X2- 69F/ %/KB?"?BV?7=36TN;J*WOXHG-]I,\!BF@?(VE"3
M\Z=?FYSD'(Z4 ;F@6^B3I)KFBXD74L2/<*[GS\< D,>V, ^GM6U7D?@G5]8T
M7P;X$<2VCZ;?S+8/;>2?,7<)&#^9NZY3IMZ'KWK>U'Q9JVG:K;*\EJZRZW'I
M[6T49=4@=MJLT@X67D-M/8XQWH ZM?$.DM-J,0OXM^FA3>=<0[@2,GIT!JW8
M7UMJ>GV]_92B:UN(Q)%( 0&4C(/-<59?\CG\0O\ KUM/_1#UK_#K_DF_AO\
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MG@@ULT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[,<X.);5H^8%0]0N F .&W'KDU<O9II]?CCUV.*\:X\/1YLS+&AMK@D[SAV
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MDUS0+N6.]U)I+=Y=(EE\R(HJY!"' R#0!V$6NVNDV^EVFK:D9;J^;R[>;R&
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M6%V9H@0"RX'S<D# R>:YV/QCI^N>$;+56U&ZT:.ZN8Q')Y!W-F3Y4&Y2#N&
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M8$ A\!^-K6]\-Z'!J^IF75[WS%WO$0)'#M\NX+L#;1G;D'':N\KR/3K&_A\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA5MH/?GCC!ZU3U#QO>1V/BN&WL[/^TM#LA=?+=&2)@4<]0@.X;&^4CGCD9X
M.V:1$*AW52YVJ"<9/7 _(TZN(?6&%OX-.L:1!=7%[.BQ7 FW>1(86;S.5!W$
M!N .,]:N7GC&2.RU?4;#3/MEAI$KQ73B?9(QC ,OEIM(;;DCEER5/MD ZNBN
M1;QI/=:Y%IFCZ2+W[1IBZE;7#W(BC=&8 9^4D=>N">G'4C7\,:ZGB7PY9ZO'
M UN+A3NA9LE&5BK#/?!4\T :SNL:,[L%51DL3@ 4H.1D=*Y#XI0Q3?#'Q )8
MU<+:,Z[AG##H1[UI:;K-Q?%A86<=Q8P1!?M7G[?,E&0R(-N#@C!;.,Y')!
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M6FHZ2*&1E93T*G(K!OM9:\U*_P!%L-/AOY+6W5[Q9YO+0>9G;']UMS$*3@X
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MQ%YI5E"C VYP<Y..0*WM=UN'0[2&61#+-<W$=K;1 X\R5SA1GL.I)[ 'KTH
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M@#F9=&U27QQ8Z]LLQ!!I\EH\?GMN+.R-D?)C V8_'\*PD\$ZW%X:M[9)-/\
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M5RY<(X*@XPQ4D>N?:M2\\-ZCJFH7FKW:6<5\VER:=;0QS,\:[SEG9R@/4*
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M5+J7@;1M4U=-5F-Y#>^6(II;6Z>$W"#HLFPC<*Z..*.*)8HT58U4*J*,  =
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M!;:C_P )!%'=W>I6MF\$2"8#S$X;9@X7+,HY/?O0!S/A_5]3O[:V\.7=_/\
MV]9:@\>H3# 9H8_G\P#&-KJT2CCC><=*WO'&N7&@>'/M-JPCFFN8+59B 1#Y
MD@4N0>. 21GC.*7P[8R3ZE>^([W2_P"SKZ^CBA$+LK2+&@.-Y4D;B6;H>@7N
M,#8U32[+6M,N-.U&W6XM+A=LD;=Q]1R"#@@CD$4 <K=W.I:1XXT_1XM0NI;'
M5K*X8&0J\EM+%M.]6(/#!L8((SC&.E'PW.JZEX:TS7M3UJZNY;RR&^W=4$2M
MN)WC"YSC@\X]AP!O6OAVUMG,QGNY[GR/LZ7$\N^2./.2JGMD@9/4X&2<"IM#
MT6S\/:1!I=@)!:0#;$DCERH],GG% '*WZZOJGQ%O]#B\07ME8_V3%=*+=(PZ
M.TKK\K%3Q\H)SD^X%9&@>*M=U:'0]&NYD:\E-\D]P)/(-R;:01C:0K8R&+'
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M1E)@27=NW!>WS?,%^Z#R!FK-KHEEI.I:GJ\/VEKF^VO<@N7#E5VKA>V ,<4
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M \L?:X_NXZ?+GIVS786%OI=C\6[^TM(K2"WFT&&26&,*J.PFD&X@<$[3U]*
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M_LJ :GI5VWS2P@,0\,@Y#'<P P02/7%>HR232Z:\ENA2=X2T:R#!5B. ?QH
M<MW;-=-:K<1&X4;FB#C>!ZD=:/MEM]J^R_:(?M&-WE;QOQZXZUYMX+U#PWJ^
MB>'(9F#^)]/9M]L7*W,=S@K,\B@@[22Q);@\=\"L=6;4/A!'$I"^+[>_ VG
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MHM$\2:;)8?\ "9:RR:9'J/E6EL+GY611GY3[F0R'/H%/:@#M9)$AB:65U2-
M69F. H'4DUR&I>-0VFZ'J.B-;7-IJ&J0V4C29)".Y7<H!ZX!(SZCBNODC66)
MD=5=6&"K#(->):=/IDOPI\#VWFVV]=8LH[I P!#"1LJWN!U!YQ0![5#=6]PC
MO#/%(B$JS(X(4CJ#CH:K2:SID6G7&H/?VWV.W4M+,)050#KDBO+]4FT;1[[X
MC0/:HVG"VL#):6K^2"6#*Q^7[H^[N('0=ZCN;JUN]9\<0K>V-XUUX<1XQ:*/
M+D95F&4&3NV\#.3SQQTH ]8TW4+?5=.M[ZU?=#/&LB\C(! .#COS6-J7BNV6
MQU\:5/;3W^D0L\D;ME=X0OM.#G@ 9],U)X*N+*X\&Z2]C)#)&+2)6:$@C>$7
M/3OZUQ3RZ?:7_P 3X)&MXKHQ&1$. ^PV:Y8#KMSWZ9]Z ._T#5UU;1M.N)9(
M!>7%G%<RPQMRN]0?NY) R>,U?%Y;&Z-J+B$W(&XP[QO ]<=:\MTJ'3K+5_AE
M-9K;13W6GS++(F TO^C*<,>K?,._>H/"TNB:U9:);:IJ]W'XFTZ_$DM@@B2<
M7(8B0D;-[1D$ECG&WJ>* /3M>UNR\.:'=ZOJ#E;6U3>^T9)[!0/4D@#W-9Z7
M?BA]*.H"QL!,8_,336=@_3(4S= W_ ,9XSWK-^*FC7NM^ ;V#3HFGNH7CN5@
M7K*$<,5'J< X'<@5L:?XMT+4M+BO[?4K=HY /DWCS%;^X4Z[\\;<9S0!>BU*
M%=,M;N]EBM?.C1B)7" ,1G'/>K3S11[-\B+O.%RP&X^@]:X>.[C_ .%GZG#K
MJ)';W&E0G3ENL;-@+>>O/&[)3</0#L*Y"RLHDL? \6HK&\)UVYCLO/P6-F5F
M\M>>2A&W Z$%: /8/[2L?(6?[;;^2S[%D\U=I;T!SU]JEFN;>W!,T\40"ESO
M<+A1U//;D<^]>17FFZ)Y'Q3B^RV)CMHR\";5VQ.;122@Z*2XY([@>E7+2VT?
M4O'?AI]4BM+A;KPN2WGA66=P\1&[/#$#<><],]J /4'N[:.U^TO<1+;X!\UG
M 3!Z'/2E%U;M#',L\1BD(".'&UB3@8/?)KR#2);'0[73;:8QQ6#^(KUM%N;J
M4K:V\(1L$\@,"2^P9&<@@^N>DFF7'A^VMYIK:4V_C@*,X4HC7!)P/X01DX]*
M /;!?6;1/*MU 8T;8SB085O0GU]J?]JM_P!W^_B_>_ZOYQ\_T]:\]TS1M'OO
M&GCGP_Y%NEA<VEF'MH@JJ"4D#,%' ;[O/L*L>"?MVI36]GJUN1-X8#632%,+
M-/C"R+_VQVG_ +;>U '7ZQK5AH-B+O4)UBC:1(DR0"[L0 H]3D_S-6)=0LH1
M$9;NWC$O^KW2 ;_ISS7)?%)81X/2:=4\N'4+-W=P,(OVA-Q)/08ZUS/C'5-&
MN6\66MK):0S?V" 'E;?]J39*R+;IG& >2PSU''&: .Y?7;R/X@QZ$Z6XL7TN
M2]$G/F!ED1,'G&,,>U;?VVU^SO<?:8?)3[TGF#:OU/05X]J6I7MSKNBW.AW$
M5U./"^^:-)<27$8FB,B(X/RN0&P?8XP>1L:MXAT,6O@[4["Z6T\*EY$>:WC3
M9;2% (MZE2%P=XY'!- 'I)OK1;07;74 MB,B8R#8?^!=*DCECFC$D4BR(>C*
M<@_C7F(TW3H[:W?PKXC5;B759;RSEO0DEG<3&,B2-0@4;2&;E>A#8YS77>!K
MTW_A>.1M.CL)$N)XY(86W1;Q*P=HSW0MDCZT ;DU[:VX<SW,,00 OOD"[0>F
M<],X-.%U;FX%N)XO/*[Q'O&[;ZXZX]Z\V:PT:Y\>>/$NK>RD4:=:NRR*I 8I
M+N8@]^G/7GWK*TI-/MM&^%M_$+=+V::-);@$>8X-LX8,W4C(48/H!0!ZZUY;
M+=+:M<0BX8;EB+C>1Z@=:0WMJ+L6IN81<D9$)D&\CUQUKR?3Y=%U>&XTG7]7
MN[;Q#:ZQ)-]CC$2SO*)2T31$IN92FT9S@+QD 55UC6-+D=9K>XMK,6_B^)[B
M&5]UP&$P5Y7)/[M". ,8VXYYQ0![%)>VD)(ENH4(8(0T@&&/0?4^E03R7JZQ
M:1QRV8LFCD,J29\YF&-NSMCKG/M7D^I6.B7%G\593;V;M$F^$E5_=L;53E?[
MI+CJ.21[5O)+:3>/_!<[/ \UQHEQYCD@M(-L6,GO_%^M 'H/VVT\Q(_M4.]V
M*HOF#+$=0!W(I9KNVMY(XYKB*-Y#A%=P"Q]@>M>)I;:1;_#J6_ACM$N;?Q/B
M&==NZ-1?<!3V&TG@<8)-;/B:\TU?$'C/2;W5=+#:M8P10F_NDA%LWEL /F^\
MH)$F5SR?7F@#NO$7B./2+G2[&.6!;K4;CR4>8Y6)0C.789!(^3'4<GK5K1[V
M\:P?^V)M/%W$[!VM)#Y93/RL0QRI([$G'J:XC6+/1[#4/AU:1/82P+<LBR(J
M!95^SR?,,<8+'/U:K-Q=Z?IGQ.UY+V6"W%WHMN(4D('GD/*"%'\1Y P,GD4
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M-[$\MD[PG;<JHW'9C)SCG! )'04 ;#V=K)$8GMH6C/5#&"/RJ95"*%4 *!@
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MGG% &NUI;.Z.]O$SQ\HQ0$K]/2IJ\TU#Q1=7^D>!M=+7ED+W4(1<01EMLJ/
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M;?4XI+BX:W@\RQD42E4WY4XY!'3')]*A?XB:-'8WET]MJ8%A(8[V/[&Q>VP
M2SCLN"#G)R,XZ' !U7DQ9'[M.%V#Y1]WT^E-^RV^S9Y$6S(;;L&,^M8^H^+-
M.T^5X@)[EX[/[?(MN@;9;Y(WG)&0<' &2<'BJ<OC*-O$VC:99VD]Q;:C9O>+
M<HORE!LVXR0?XP3D<<=>< '2M;PL"&AC.3N.5')]?K3U4*H50  , #M7,Z9K
MVC0Q>(+\7]\8;2]*77VS?B*38GR1J1D+RN !R3QUJ[#XGLGU&33YX;JUO4@^
MTK!+%EI(@<%DVYW8/4#D9&10!JK;0).\Z0QK,XPT@4!F^I[UD6.D:D-:FO\
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MY?[GSLE=F<Y^\",XVYXS7-_$KQ,(_ VOMI<NH)+9CRFO;,E5BER/E+ Y[X)
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M2Y3?&X!&1T.0>A!!!'M5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU9VC*?NMC$D9.XDXX&.<Y'7W>H6=B81=W<%N9Y!%$)9 ID<G 5<]221P*LT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KD_B%J&IZ;H5I)ID\4+RZA:P2,ZDDJ\JJ0,$8SGGVS]:ZRL3Q
M5H+^(]%^Q0W2VL\=Q#<Q2M'YBAXW#C*Y&0=N.HH JC6]1OM:O]%TXV8N]-MX
MI+J69&*-)(&*HJ@@@87);)QD<&K?A3Q"GB?P_!J:P-;R%GBF@9LF*1&*LN>X
MR#@^F*HCPS?V?B277=/U"!;J\MD@OXYK<F.5DSLD4!@5(!(QDY'?/-:OA_1(
M/#VC1:? [2;6>225A@R2.Q9V/IEB>.W2@"AXLU^]T!=)-G:07'VW48;)_-D*
M[=YQD8!]/P]#6/\ \)-XG:]\0:8EEI7VS28X[@2F23RWCD5F5=N,[LHPSG'0
MX[5N>)] N-?72Q!>1VWV&_BO3OA,F\QG(7AAC.>O-5AX8O4USQ#J2ZA;_P#$
MWMHK<1FV/[GRPX!SO^;[YXX[4 0)XJOK_2=%U"U@MK2WU&Q^U-<73;U20JI6
M$*"&9CN/([+T.:HP>,Y=3TSP7J1TNU*:S<B-O,8LUN^QSE./]EAG(Z]*ETWP
M/J6E3:#);:W"6TS3CISB2S+!X\J=Z#?\C_* 3R#Z=JCT_P  7UCHWAG3O[9A
MD70[O[2K&T(\T;64+]_CASSSSVH AU#QKX@M[?Q3<0:;IWE^'Y?W@>9R98Q&
MLA P!AL,>3P.!@]:NIJ^K7?Q-M+.&X@73'T;[8(6C.[YI4!)(.-W''89/K2W
M/@F\N+/Q9;'58%'B DEOLI_< QB/^_\ -PH].:M1^%;R+Q#INK1ZG&CV^G?V
M?<H+<_O4#!@R'=\AR.^[@_C0!2M?&6H#Q!HVG7UM:QOJ<L\4EM&VZ6S9$9UW
ML"58LJ],*1GO5*X\:7^G^%?%6KPZ38)<:7JCVS1I(0L@ C^<G:"S?/[=.M2Z
M;X U2Q3P^C:_!(NB7,DD1%EAI4=75MYWG+_.?FZ9Y(-277@&]NO#WB32CJ\"
M_P!M7YO#*+0_N<[,KCS/F_U8YXZF@#4T_7M4/C670-3M;1 ]C]NMWMW9BJB0
M(R/D#)Y!R,5T4_FF"00%%FVG87!*@]L@8R*PU\/W9\:P^(9+Z JFGFQ:W6 @
MG+ARP;?QR.F.E=!0!X^VH:IJWPV\)ZIJ#PW-U/KMG*A *DL;@\$G./08' KJ
MAXUO--D\20:S:6YFTA+>2,VC,5F$^0B\C(.X8)QWSCM4,'@#4(/#.E:(-;@:
M+3+^*[@<V9R5CD+JK?O.22<$^@''<V]0\"G5K_Q'+?7ZFVUJV@@,<4)5X#%N
M*.&W')RV>G84 6])US5KCQ&^G7>GN]FUMYT=]':2P(C@X,3"3J<<AAUYX%;N
MH7T.F:;=7]R2(+6%YI"!DA5!)_05D>']*U^R(;7=>34C$GEQ>3:^0&_VW^8[
MFX[8 R>#VV+ZS@U'3[FQN5W07,30R+G&58$$?D: .?MM<UK;I^HW=C;?V/=6
MKW-Q)&^'L0$#KNR?WF1D?*!@^U4'\:7UMHFC>([FU@_L?4Y85:-,^=;)-Q&[
M-G#=5W  8SP3CFQH'A/5M.L8]*U775U'2;:(P00BV\N1XRI4"5]QW *<< 9(
M!-1V7@BXBT73] O-1CN='L)XY85,)$SI&VZ.-VW8PI"Y('(4#B@"AJ'C;Q!;
MVGBB[ATW3O*T"X(D#S.3+&(U<A< 8;#'D\#@8/6IM?N-1N/B#X/^RS0+!-#=
MS1I(C'GRTY;!Y.&('IDU8N?!%Y<Z?XKM#JL"CQ Y8M]E/[@&-8R/O_-PH].:
MN3>&+^;7?#^I?VC;C^R()8C']E;]]YBJI.=_R_=&!S0!DVOB:T\.6WBS_B36
M5G#H]S'''%9 +]H>15*Y.  2SJ.G'O45_)?6OQ1\/W&JM9[$TN]D+VZ,NW'E
M%@<DY XP>,Y/ J]>^ /[4A\4P7VH@Q:Y+%,ODPE&MWC50A!+'=@HIZ#O4B>$
M]9O-<TK4]9U>RN396T]K)'%9,@G60*"3^\.#\O;CVH CL?%^KWT^CW%OI+SZ
M?J:Y(6VF1K0,NY&>0C:ZG@' &,\;A5"U\=ZY)H^GZS/IM@EE+JO]G3HDKF09
MG,(=>,<$#KUYZ5I^'/"FN:"D.G/XC%SHMI_QZ0-;;9@H^XCR!N57CH 3@#..
M*K+X!OE\*V^B_P!L6^8=3_M#SOL9Y/GF;9M\S^\<9STH FTG4M=N/&GBRWDE
MM9H+'R$@A(9  T1<<Y.#EN3@Y]J;H_B>\N_!_AW4+:RL;""^0M/*Q @LUP2H
M";E+%B H (ZY]JT[?PY>V?B;6-6M]1A$6IQQ;X'MR2LB1[ 0V[[N.<8SD=:Q
M['P'J.FZ?X7AM=;@,VA"5 TMF6CF5UVY*>8"' S@Y[GUH RM8UY_$W@G1=0G
M@2*=/$=M X7.-T=UL)&>0#C.#R,XK=U37KZ#Q+KMA;6EC%<6NC+>P7; NS#<
MX"L.. 5)QGOUJLGP_OTT)-+&MQ,L>L#4TD>SR>)C+L.'&22>3P,=!6M/X6GN
M?%%_JTU]'Y-YI@TYH$@(90"S;@V[KESQCTH PK'Q-K>E>"_">IWS6EQ:7JVL
M=Y<LK!H5D10LC<X/S'!/&-P-=A87]Q>:OJ46(OL=JZ1(X!W-)M#,.N,#<H^I
M([<\I>1:=X>\#6_A#Q#?I?375FUG9PPV[(]P$0*JJ,M\_P!WDGJ<\8KJO#FE
M-HGA^RT^29IIXH\SS,<F64\NY/NQ)_&@ \1ZY;^&O#M]K%RC/%:Q[]BG!=B<
M*H^I('XUES>(-2TKQ#I.F:M%:M'JP=()K<,/)F5=VQ@2=P(SAACD=!FM7Q#H
M=KXE\/WNC7NX6]W&49DZJ>H8>X(!_"LVW\.7UQ?:3=ZU?P7<NE*Y@,4!C\R1
MEV>8^6/.TG@<9)/I@ Q?!5K/J=]XH&K)97<4>NN=K0DD2HD6QEW$X  &.XQU
MKKM>N+JS\/ZA=631+<PV[R1M*I900I/(!&>E4/#7A^ZT*XU>2>^AN5U&^>]P
MD!C,;,%&W)8Y&%'I6Q?6BW^GW-F[%5GB:(L.H# C/ZT >817&JW,OPOO)3;W
M.H302NKOE0=UEG+GDD]2<=?:M2_\9Z@O@3Q#?7FEZ?<7FD7K6=Q"S-Y$H!0A
M@"">CKP?0\U>L/!6IVK>%3-K-M,/#Z-&@6R*^:AB\H#_ %AP=O.>>>P'%17?
M@*]N_#_B72CJ\"_VW>F[,@M#^YSLRN/,^;[@YXZF@"YKGBZ33_$,FBPRV5M=
MFU6:T6^#*MZY+ QH^0 1M7U)W#CBNNKE?$7A6[\26=[87MU92V5W"J!);4LU
MO( 098SNX/(('8CJ>17301""WCA#,PC4*&8Y)P,9)]: .>EU>=?B&NCK86AS
MI,EU%<ECYA(D1=A./E7)SQGH#6!I_CO6[C2= UBYTZPCL=1U'^SY4CE<R*S2
MO&KKQC *C(/7KQTKI9O#]T_C:/Q#'>PJD=@]D+=H"3\SA]V[<.ZCC'2L2#P%
M?0>%]&T8:Q;DZ;J2WXF-F?WFV5I NWS..6(SGI0!5DEF_P"%C>)CJC6<NEP:
M/ T\4D)8>1NF)&"<9P#GC!]*NCQ=>:?H^@:Q<65LFC:H\$(AB!$EHLH_=$G.
MUARH( &,\9Q6B/"TTGBC5M4NKN":TU*S2RDM! 5(1=_\>_G.\YXJI9>"KF/2
M=+T2_P!2CNM*TR>.6 >25ED6,YB1SNQA3MR0.=HZ<Y (K'Q+XFU/4-7BM=-T
MH0:7?/;2F6YD!=1$K@J0AYRPSD8P?;-4;3QSKTVE^%]5?3-/-KKDBVXB69PZ
M2NC,K$X(V_(01@G'/M70:1X<O=*FU^0ZA!*=5N6N5'V8KY+%%3!^<[AA1Z=Z
MS(/ M[;Z!X7TM=6@(T&Z2X$AM#^^V*R@8W_+PYYY[4 2VOBC6S'XDLY=-M;G
M5=(DB5%MY2D4JR*&4DO]W:"<_3BLW4/&FI/I/C&&RGLGN='L%NX+V&-O+D5D
M=N%+'D&,@'<1R/0BKFJ^ [S4G\2N-8CA.LO;2*%MB?*,.W ;+_.K!<$<=:?)
MX'OKRZ\037VLQ,-;TU;*=8;38$95=0RY<_+B0\')SWQQ0 AUB_L4\&P7EK97
M9U"58C<-NWQ'R68,H.>2 03GOTI]SXNU"72=;UG2[:VFLM(GEB>&3<)+@0_Z
MTJP.%Q\P (;.WMGB63PGJ=Q'X:\_5K9I=&F$S%;,@2XC,8 &_P"7AB<Y//H.
M*:/!EU;1:[86&I1Q:7K,LDTL;PEI(&E&)?+;=C#=1D?*3WZ4 1+XNU75/$$.
MG:+:6)@NM(34[>XN9'^Z[8 90/T!_'C!V_".NOXE\*V&KR0""2X0^9&K9"LK
M%6P?3*G%4[7PI)8>*(M5LKJ".U@TI=,AM# 3M56W*V[=SZ8QT[TSPWX:U7PY
MIFD:;'K$$MK9O,;D"TVFX5R64 ECMVLWOF@#J:\]C>2V^+GB6XMXHY)TT2W9
M5=MH8AGX) )'0=J]"KE#X5OQXMU774U.V OK);,0&U8^6%R0V[?R?F.>!0!D
M6GCC7IM/\+:D^FZ>;;72L*QK,X>.5HV=6)P1M^4@C!/?GI3[SQOK&FZ)XLDN
M+&QEU'0"I/ER.L4J/&'4\@G(!P1[=:LP>![V#1?"VG#58"- G28.;0_O]J,@
M&-_R\.?7FDU/P+>:BGBQ/[6@C7Q L:G_ $0DP!$"?W_FR![<T 2R>(_$,?B>
MUT<V6F_\3"SDN;63S7_=%"H82<?-PX(VXYX]ZBL?'4\^D6HN;6--5FU*?3"D
M*/+&'AWEW"@;BNU"<=<D#(&2-.3PY>R>)])UEM0M_P#0+22V,0MC^\W[<MG?
MQ]P<8/>L9OAY=G29(H];6'4H]6EU6SO(K; ADD+%D92QW*0Q'4<4 3+XTU*W
MCDMK[2V2]DU&*QL)6BDAANO,!(?#C<H4!MPY^[P>:I6CZA:_$KQ-)/'9SW$>
MBV[1[ T:2C?*?F!W$'J._0>N!I:EX.U36M(@_M#75.M6MU'>6MU#;;887CS@
M",L<@AFSDY.?0 5);^%]8_M[4-8NM6LVGO=.2R:.*S944J7(89D)_CZ=_:@"
M'3?$EY/X5\-WMO:6-C;W]L))IG_U-K\@*HJ;E+%B<  ]C61+XOUK6=(\(7UF
M;>S_ +0U9K2YC*LP8Q^:.#D$*3%G'7D#/!SIV?@;4M.M_#"VNM0>;H<#VV9;
M,M'*C*%W;=XVN O7)ZGZ5';?#^^M-$TRRBUN(SZ9JKZA;RR6F5(8R$HZAQD_
MO6Y!'0<4 3ZGXPU)1JAT>P^VR:9,('MQ:S.;EPJLX1U&U,;L#.<D<X&"887F
MF^*E]-:Q+%<2>'('1+A2,,9I,!P.?8U9/A'6;'Q!>WVB^(1:6>I,LEY;RV@E
M(E"A3)$<@*S #.01GG!Z5;?1_P"R/$]WXIN=1C6QBTM;62)XF+)'&6?>7W')
MY.?EH JZ/XLOM7T#3IEAMHM5N+YK.XM6#$0,A;S0><Y55)SWR!QFNQKC/"MC
MINH>)]6\5Z7([V-XJ+"<$1O)M'FRH"/X@L:Y]4:NSH XZX\67\*>,E$%L9/#
MZ++&<-B8&'S<$9X/;/XX[5"?%FNW>LZ=I>G:?I_F7VC_ -HK+/,X5&W("& 7
M./G[9)XZ5)JG@S4+N_\ $;V>K0V]IKUL(KB-[8NZ.(C&"K;@ ",9!!/'&,Y&
M/'!<Z9\3-!TR'4;.2[M?#LD#-)&5$H$L8 VALJ2!GJ>A_  OZ3X_N-1@LK"6
MQBM]>GU*?3)82Q:*-X5+R.#P67;@@<9+ 9[TFJ^.M1T>T\36\UE:RZGHMNEV
MA#LD5Q"P.& Y((((*Y_&K4G@%5@M+FVOQ'K5MJ,FI"\,64>63B12F?N%<+@'
M( ')[NU;P3-K%AKWGWT,>HZS;):/,L!*0PKG"JN[).68DD]QQQ0!/8^(M5_X
M2ZVT?4K2T2&]L7N[=X'9F0HRAE?(P?O@Y'TYZUU$F_RV\LJ),':6&1GMFN='
MAN\;Q3I6M27\!%C926C0K;D>9O*DL#OX^X.,'O724 >=>&O%FIP^"[&^U22*
MZO-1U&:UM_+A<X;SI<Y R2H5#@#L ,]ZEU+QOKVE:/K-U+HJR&PFMUAN'CEM
MX[J.5@N55QD,I.""<=#FI!\/+D>&!HZZX8Y+.^:^TRZBML-;N7=_G!8B3_6,
MIZ#':K.I^$M<USPQ=:;J>OP/>7+PDS1V9$4:QN' 6/?G)(Y)/X#% "7/B'Q1
M8:_I.E76GZ27U.:Y6)XKB0A$CCWKNRHY]<=<=L\9L_CCQ%;^']<U%].TTOH-
MW)#> 2OB=5"M^[&/E.UA]XGFNFU/P_=ZCXBT'5A?0Q_V696:+R"?-,B;#@[O
MEP.1P:R+CP+>W&A>*-,;5H ->N'G,@M#^YW*JD8W_-P@YXH T)=:E_X3VSTQ
M;"U99]+ENHKEF/F<.@V=/E4[AZ]!6%9^.]<ET?2M9N-.L$LKG5/[.G1)7,@S
M.T(=>,8! SGKSTK?_P"$;OO^$IT_6SJ%OFTL'LC"+8_/N*DMG?QR@XP>_-94
M?@&^C\*V6B#6+<FUU,:@)OL9^8B8S;-OF?WCC.>E $FO^,M0T.>XEFMK5((;
MV"W2V=MTT\4C(IF!4X0!G( 8<[3R,BI-)U'7+GX@>)[1IK62ULHK400E67&Y
M9&'.3@D]3@\ <<53U'P!J=[;ZW:IKL*6^HW\>H*7LR\B2*R-L+;QN0>6 !@$
M>N!@[=IX<OK'Q3J.LPZG$4OX(4FA>VR?,B5E5@P884[LD8SQU% &/H7C)KOP
M[X86WL;6UO\ 6WE2&! ?)@6/>SM@8)P%''&2W:F:MX[U'1['Q/#+8VLFIZ)"
MER"'9(KB%P<.!R00005SVZU)9_#Z>QT#0+6+58_[3T*=Y;2[^SD(ROG>CIN/
M#!B#@@\ U8U?P/-K.G:^LU_#'J&M0QVTDZP%DAB3.%5=V2<EB23R3TXH LV/
MB'5?^$RCT74K2T2*ZL6O+=X'9F38ZJROD8)^<'(]QSUKI9YH[>"2>5@L<:EW
M8]@!DFL'_A';QO%NG:Y)?P$6EB]HT*VY&_>58L&W\<H.,'O6_-%'/#)#*H:.
M12K*>A!&"* .*D\;WMOX>TOQ1/:P?V+?2Q*\:Y\ZWBE;;'(6SAN2N5 &-W!.
M.8K>&\O_ (J:[:7GV.>R_LNW1X9(BP,3/-\N"<9/?C!]*LV?@:>+0;7PY=:B
MEQHEI<)+&AA(F>-'WI$S;L$!@O('(&,#K6I:>'[NV\:7^OM?0O%=VT5O]G$!
M#((RQ!W[N3\Y[4 ;JQK# (H$1%1=J*!A5 ' P.U>0ZI?ZKJGPBUZ[U6:"X==
M4,:>6A4C9>JN!DG P !^I->PUPEQX OI?#&JZ"FM0K:WE\UW$S69+1!IA,5;
MYQN.X8!XXSP>P!I66OZN?%E]H-]:67G"Q6^M6AE?;M+E"CDCJ"!R!T/2L33_
M !['%X9\-74\=CH\.JI+^^>,FV@96PL?!7!;)()('RFNB_X1^^_X3)O$/V^W
MR=-%CY'V=NN\OOW;_4],=.]9VE>#;_2O#>FZ(;^QOK.VAE@G@N;,^7<!V#*2
M-YP5P?7.[M0!U.FS7%QIEM-=I$EP\:M(L3;D#$<[3W'H:R/&&H06NE1V,MY'
M:'4I1:^=)((PB$$R-N/0A V#_>*^M7/#>B1^'/#MEI$4S3):IL#L,9Y)X&3@
M<X R<#%(-,NV\3G5)KN%[9+8P06XA(:/+ LV_=@YVKV_A'O0!S'PLU-&T:]\
M.&[CNI="N#:I,CAQ+;GF%\CC[OR_\!I)?'>I/I-IJ]G8VLEO=:N=,2VE9DD0
M^:T0=F&?XER5V\ ]>*UYO#-W'X]_X2BUU"*&)K,6MS:?9BQG4,6#;@X^8=!\
MIXXK@-)U"5WDU'3==\.W-_+<RW2:9>6#?;5D8GY"%D!$@4A=P3@>HY(!V:>)
MO$%QXGU?38;'3([;2I+9KB:6=R3#(I9BN%^\ . <#CJ<\,L?&.IWTVC7<&ER
M3:9J9!<):S*]HC+N21G(V..F<8QG@L!FM33/#MQ:^(]<U6YNH98=72%6MA"0
M8_+0KC=N.[()SP*H>'/"6LZ"(=-?Q#]IT&U;_1K<VVV<(#E8VEW<J/H"<8Z<
M4 06GC34]0.D7UCI<EUINHS!"B6LRO!$V=LQD(V,O3<!TSP3BJ,_CS7H= U+
M6SIFG_9M,U1[*XB$SEY%641DH<  \YR>OH.^GX?\'ZQX?9-.A\0^9X?@D,EO
M:FVQ,B[MPC,N[E ?;)'&0*@G\!7L_A36M$.KVX.IZ@]\9A:']WND$A7;YG/(
M SF@"W_PEE]IGB'4;#7+>U2"#2WU5)+5V8K&C;71MP&3T((Q]*;9>)];N=3T
MZ-=),UI?PNY=;>:(6;A=RAW9<.IZ;E Y[59O?"<FI>)I-3O+N%[6;2GTR:U6
M @LCL&9@V[CIC&.E1>'?#?B#1HH;.[\2+>V-FFRT0VNR0@#"B5@WSA1V &2
M2: ,G2_'>M7>F>&M7NM.L8[#5[P6;I'*QE1V+A6&1C&4P1U[\=!I^$=0UB_\
M0^*$O[B"2WM-0\B)$1@4 BC8 9)X^8Y]22>.E5;;P%>VWAGP]HXU>W;^Q[];
MP2FT/[W:S$+CS./OGG)[<5>_X1W4]*N/$E[I^L1PKJ;?:(@;(RO!-Y:IGAOG
M'R@A=N<GJ>A .LHJEHYOCHUD=3V_;S"GVC:NT;\<\9..>V35V@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ&*J"3U('059L;H7VGVUVJE!/$LH4G.-P!Q^M>7W.HS'PSXQTS5+&^T[5X]
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MG'.: .]INQ-V[:N[UQS7E^BZOJU]X5\ W-W<7-Q:W#.FH>4S&:;$;B,D+\S
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M2 23GH".<X/ WU]JD?@_Q4G]H7=O+8>((8;<PW;N8D=H,H'."R_O&X(QSTH
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M9V\KS6US&6,,T:DM$Z@@@Y'Y<UT-SJ=II4$?]IW]O$Y4G<Y";L=2 3T'?TH
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MTT47L!N+JV-RA\P!2NY H![EM^0!S@?2KL>N:5+?"QCU&U:Z)91$)06)7[P
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M!%9NG^'M+TMX7M+8J8(S%#OE=Q$AQE4#$[0<#@8Z#TJ*SU&*35=58ZY97%M
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M=DUJ#2;>/49&+M,H(^8]6QG 8Y/(&>34\'B?0;JZMK6WUFPEGN@6@C2X5FE
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M:TD<K$/WJN2"Q/S'Y1^705O7=\O]M:5!%K-I )?,9K-@K27:["04.<@+C<2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMX;.2<K&?)D\PQC*ABQRPZJ#U'?BIKO2]4G\5^%]36Q/D:=;7$=P/-3<&D5
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MY%=/KT,]SH&H6UK%YL\]O)$B[@HRRD#)/0<T <%X6FTF^\'^'%N;O53JM[#
M//\ -N>9=NXL6)VD?*2>QZ=ZZ;4/&UMIFN7.D7.G7JW26_VBW_U>+P;@H6+Y
MN6R0,''6J6A6WB'2/!>F:.-%A>]L[6. 2R7*&(.H W^I ZXQFD\4>']7UUI+
MVW!M]1TIEDT:3>N'DXWM)_LL!M*_W<GDG  -K4O$T&G30VK0%KZ2 S_9VFCC
M**#CEF;&2>!@G.#V!-5-,\<:?KME82Z1#/=3WL4DR6_RHT:HVQRY)P,,0O&<
MGID9(S-3L/$T?B"P\3:?I5I=3R6(LK_3)KD)MPQ=7CDP0<%FZCD'IGHE_I/B
MBS\0:;XFL+2RN[O[*]G>Z<)_*41L^]?+<KR5/!) SZ#/ !JV/C6UO;K1(#IU
M_ ^K^>(A/&J&)X@2ZN"<CH<$ @^M9FM^/98?#>I7VFZ;/]HLM373)5E9!L<L
MBEQ\Q!'[P8]^N!4VL:7X@GU'PWK:VMM<WFGSSM/:)/L54EC* *Y'S;>,D@9Y
MP!TK'G\(^(I_#/B:U>WLQ=7NM)J5LBW!PZJ\3%2=O'$9P>^>0* .DEU*R;QM
MIUO/I=['JK:?-+"[2KL"!DWH0KD%L[>2/QI]AXQ@U#1+K4H].O$:VO#9/:N8
MQ+YH<)M^]CJP[]#FH)=-U6Y\>:/K,EFB6]O83P3[9@VUY&0C'0D#9@GCKQ20
M>%KBW\>W>J1RH-)NE2Z>#O\ ;%4Q[OH4()_VE![4 +K7C[3=%2\EEB>:&P=4
MNVCDCW1D@$X4L"^T,"<#Z9(('412I/"DL3!HW4,K#H0>0:X>'2_$^A>(M633
MM.T_4-,U.Y-W'/<7'EM:2, '#+M)=<C( QZ9%=!8ZEJ1\37>DW-E&+2&W22"
M[24%I#P#O0#Y,G./7:: +6JZQ!I1M(G1YKF\F\FV@CQND;!8]2  %4DD]AZX
M%8EWX\L["PUN:ZL+Q;K155[NT787V,,JZG< RD9YSG@Y&:E\5Z)?7NHZ%K.F
M!)+S2+EI/L\C[1-&Z%'4'H&P<C/'%8FO^$]3UJV\4W\=J([W5K"/3[:V>5<Q
MJNXEI""1DEN@)X ]> #K]'U:75EG=],O+*-&7RFN0H\Y2H(9<$D#GH<'V[50
ME\61Q:KK&G?V9>M<Z9;+=E1Y?^D1MG!C^;G[I'..>*VK 2"PMQ-$8I1&H="0
M<$#GD=:YWQ)X8N=5\0:5J%G*L2A9+/40>LMJXW%?KN4#VWDT 7-/\4V^I6.C
M7EM:7#1:I$9TP4)BC"@EG ;W XSR0*KZ?XSM[Z^TNV:PN[<:K!)/9/*%^=4
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M.^,5>U7Q_,GA*ZU*PTN=+NVU%=.N()V3,$AD52>"0WWUQ@XY&:CM+&[U"_\
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M5.HRI((Y!!!P0:V:SM&_M!K(RZE;06L\C;A;0/O$2X  +X&X\$DX[XYQDZ-
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%8OB:]NK&PMGMKN"U\RZCCEDD!9]A/(B4 [I#T P>]
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M+;1M(QC/.> #OK.ZAOK*"\MV+0SQK+&Q&,JPR./H:S+CQ1I-MJ,5E)._F2W
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M!YPMY1-%\[+LD'1A@CD=CVK)\#ZM?:MHMS_:4J3W5G?W-D\RH$\WRI"H;:.
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M)"7) 5N!M.,$FG7^J^))];\8V=KJ\-K%I5K!<6Q6T5F!:.1MIW$Y!*C)_+%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:941N7.U-JA1T&,>Q).?1:S9-3:ZTZ_ET98;RZMF>%8VDV(TJCE2V#CG@^]
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MC:IJ<5CJ-T+R2UBD0(DV]79E.W=R5Z$D<DXSC'3)J$$]S>6EM(DMS:A?-3.
MK,"5!/8XY^A%.TZ2\ETZWDU"WCM[QD!FBBDWJC=P&P,_E0!DKX4A75M2U(:E
M?_:-0MDM9LF+ 5 =I4;.#\S>O6JUOX&LK6'P_#'J.H;-")^R9,7.4*8?Y.?E
M)'&/SKJ** .5L/ EEIFJ37%IJ.I1V$UP;IM,$P^S>:3DD#&X#/.W=C/;'%5_
M^%<V A6!-6U5+>+4?[1MX5E3;!+O+G;\F2"2>&)QGC%=E10!SR^$+6.ZUJ:&
M_OXDU<?OX5="BN4"%URI.2JCJ2/:HAX(LHK+0XK>\O(KG1$\JRO 4,@CVA2C
M?+M92H .1V!Z\UTU% ',WW@BPO\ 2KJQEN[Q6N[I+RYN4*"2:1"I7.5( &Q
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M\EH'&7$G^L#E@<[CR2,'/((J"?P%8W&DZYILFI:B8-:N#<71#1;@Q"@A3Y?
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M<[L3DLQ[DDDU9HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME:'1M/C99OM *6R B7^_T^]R>>M/?0M(D%T'TJQ87;!KD-;H?.(Z%^/F/UH
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MVQN$4!M7$@F9/(Q:J?,&"!D8ZGT^M>HU0N=$TJ\O%O+G3+.:Y4 ":2!6? Y
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M//')<&)F401$K& I!;&3SC\>VHE]::I\1_"VL6RA8KW0KB=6( 8HQA89^@-
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M75\H<C!RF.<\&LK2H-'\2^/?^$ET:]%S9Q6JI.T)S%+<#<L9]V1&D!]-Z5W
MD0RM$'4R* S+GD YP<>^#^1HCCCB0)&BHH_A48% &-X>EUF0ZB-6E@F1;MA:
MRPQ&,&+ (&"3G'3=WQ^)YW7_  +JNKOXFBBU:V2UUN*, RV[/+"44 (&W ;,
MC/3^(]SFNXN;F&SM9KJXD6."%#)([=%4#))_"LS2_$,>J7IMET^_M\VZW,4T
M\0$<L;="K*2 ?]EL-[4 8>O^#K[Q)936.IS6$R.8W@NEA9)K)P%W-%R>I4D<
MC&>2W2E^*Y"?"_7,N%_=( 3Z^8M;VO>(++P]HM[JMT)9H+(9F6W4.Z\ ],C'
M!!YQU%7WAM[V!/.A25#A@LBAL?G0!AG1;V^URSUJ^DM6GL+>6.TCBW;"\FT-
M(Q//10 HSC)Y.>,B#P!+_P *ZL/#,^H(MWISI+:7L49^22-]R,5)_ C/3TKM
MT1(D5(T5$48"J, "JNIZI9:-8/>ZA<+!;I@%B"223@  <DD\ #DT 9EKH=U/
MXAM]=U9[<W5M:M;016X;8N\@N^6YR=J@#L,\G/#='\*Q:/XDU?58YV:.^D\V
M.WQ\L#L%\TC_ 'RB$_2I9/$]O;"W:]L-0M([F:."%Y8,AG=@J@[22G)'W]OY
MUN4 <+=^ 9]2L/$MK<W\<1U:]2^MY84.ZVD0(%X/WN8P>W4U-_PBFM:EKUIJ
M6MWVGNJ:?-83PVUNX\U9"N2"6X/R^AQ[]:[2B@#C= \+Z_IUG'HVIZY;WNB6
MT9BA5+<I<2QXPJ2/NQ@#T&3@9/4'-B\!Z_%H>EZ&-:L7LM)OX+FTFDMF,I2)
M]RHX# ''3(QD>E>B44 9^MV4^I:#?6$$D:2W-N\(D<':NY2N<#KC/2N<'@Z]
MBM_#-S!>6ZZKH$/V='*MY5S$4".K#JN=H(/.".]=G10!P^L>!KK5=*UY1=V\
M6I:U- \TNQC'$D.W8BC.6^Z>3C)8GC@5MS2ZXOBFP2.6V;3&MV^UPB)MR/SA
MP_3&=JA<9Y8]N-VB@#A_B(\BWO@\021)/_;L93S?NG]S+P<<^V?>G:SX)NM:
ML/$+2W-O%J&M01VI8*62WA3. .A8Y9B3QU'''/836=K<LK3VT,K+T+H&(_.I
MJ .9U?PW=ZA=:'JUO<PPZOI+-M+*3%*CKMD0]P" "#S@CO5'5/ TFKZ5XC$U
MW'%J6MB(-(B%HX1%CRU )RPR"2>,[CP.!7:44 <;J/AGQ"=;M?$&E:O8PZK]
MF%I>QS6S-;SH&+*0H;<"I8X.><TFH>$];76+#7=)UF :O#;-:W1O("T-S&S[
M\;58%=K$[<'IQGU[.B@#E;[PQJ5SJ&@:C'JL37NFO.9GF@)642KAMJAAMQQM
M&3QUSWJV7A37M)U2^ATS6X(]"OKE[EX9+<M/ SG<ZQ.&  ))()!QGI7:44 <
M%=^!M6CMO$^FZ9J=HFEZZ9IF2XA9I()95P^TA@"I///3WKL-.LI+71K:QN94
MF>*!8GD1"@; QD DX_.KM% 'GMCX#UNVTWPYI[ZO8F#0KU9H"MJVZ6-5=1O^
M;[V' XP.IYZ5-=^!]1NO#OBG2C>VJG7;Q[D2;&/DA@@*X_BX0<\=:[RB@#D1
MX9U>R\576MZ7?6<?]I011W]O/$SKOC7:LD9!!Z<8/YUD6?P_UK2='\/G3-;M
M8]9T>.2 2/;,8)X7(+1NN[/! (8$=.E>BT4 <E>^&M8OKC0KNXU*VEN=/O3>
M3'RF5')1DV(N3M4!NI).>>];^LZ5;ZYHM[I5V&^SW<+0R;3@@,,9'N.M7J*
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MJ[^' \,1WZ&ZD1//O)E+;W#AW? ]6!XSQGVKL:* .<GT#4&\9V_B&WN[=/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***H:KK>E:'"DVK:C:V,4C;$>YE6,,<9P"3UH OT52TO6
M-,UNV:YTJ_MKV!7*-);RAU#  XR.^"/SJ[0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %5+Z*P5#?7L4++;1NWF2*#Y:XRW7I]T?E5NJNHV$.J:
M=/8W.XP3KLD"G&Y3U'T(X/L: ,SPC:-;>'H9I8A%<7K->3)C&QI#NV_\!!5?
M^ UNT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ljb_employmentxageementx008.jpg
<TEXT>
begin 644 ljb_employmentxageementx008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!^O7+ 'GC@GKZ5M^#='ET73KYKH)'/J&H7%^\(8$1>8V0F1P2 !G'&<XH
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MZ7%8VD4[KEV28S$OM) !.U1SG[WM0!;O=8N9_B3X96.WU2VBFM+N1H)G"I.
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M.5RIQ@YZY XSG2^'/$/_  JC5O#(T=VO?M,OD$7$6V97N6E##+<#:1UP<]J
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MCG QR<=N19\6Z#XFUBR\2:=_9,EXKF(Z7*+J-(1&NPE=I;/FY#?,PZ'&0."
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M+!':WNMV,RVHB.Z.-I04^?/+8QGC'/&,<@'I$&IV=SJ-WI\,ZO=V@1IX@#E
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M[QBZM@CID'!SBM#3KGQ->_V3>A]/:ROK9I;A=C VS,@:/9S^\&3@YQGJ,=*
M+W_"(^&?^A=TG_P"C_\ B:/^$1\,_P#0NZ3_ . 4?_Q-<?I7C'Q))X4L?$5\
MVG/'?.+2*UA@8,)WN/*5BQ?!4#)V\'@?-S1XHU;Q=;>&O%'F1FWM8=/,]KJ'
ME(K[N0\94.W..0W;GOS0!V'_  B/AG_H7=)_\ H__B:/^$1\,_\ 0NZ3_P"
M4?\ \37/:MXGNO#BZ3;ZE>Q6EI<6Q/\ :;6;-"LWR[(WPWR#!)R3SCJ*[+3Y
M)9M-M99WB>9X49VA.4+$#)4^F>E &=_PB/AG_H7=)_\  */_ .)H_P"$1\,_
M]"[I/_@%'_\ $UG>)]9UFP\0^']-TMK()J<DT3M<1,Q0I$SAAAAD<=.^,9&<
MC)L_%7B&--?TN_.F?VEI%U;*UZ<Q0-;S8(DVEOO!=WRYY.!]0#I_^$1\,_\
M0NZ3_P" 4?\ \31_PB/AG_H7=)_\ H__ (FN"\1^*=8N?!OC:"*Z$4NEM'''
M<_9FBDDBD16(*L?E;YB-V.G0#K757VM:JNL_V#:L)+R*R%U-<16P(^9V5 $:
M08'R'/)[=,T :?\ PB/AG_H7=)_\ H__ (FC_A$?#/\ T+ND_P#@%'_\37,Q
M^(O%[ZCX9TZ[M+#3;S4[>Z-S')&9?)>+;AE*O@JP8';D$>M9>I>(M>U#PM '
MO((+RV\31Z9<2PP$+.%N%4'!;*@\$C//3(% '=?\(CX9_P"A=TG_ , H_P#X
MFC_A$?#/_0NZ3_X!1_\ Q-<_K'BR[TSQ ='NKVWT^9XHOL4]S;,(+US]]=^[
M"-G@*3QD'YLXKN: ,;_A$?#/_0NZ3_X!1_\ Q-'_  B/AG_H7=)_\ H__B:R
M-5U;Q#)XY_X1[2Y].@BDTMKQ9Y[=W:-A(J<@. W7VQG/.,&AI/B_6=1T>W^U
MK96=U!J<^G:E*H+?/&#CR(^KECMXYQSP: .F_P"$1\,_]"[I/_@%'_\ $U+;
M>&M!LKA+BUT338)T.4EBM45E/L0,BN O/$NMZSX>T.9;J*UF/B5=/G*VY E"
M3,%)4ME?N E<]>,@<5NZAX@\07,^LVNA6ZS76E%(@#"I2XF,:R$',BE%(8 8
MS@Y.3TH [:BN&&M^*;_Q+<:/";#3W&DP7P$T#2O#([,K1MAP&P5QN! ]C65%
MXBUGQ#/\.[Z*ZBLQJ0GDGA$)=#(MN_/W@2O7 SQG)S@4 >G52L=7T_4KB[@L
MKN.>6SD$=P$.?+8C."?7%<?K7BW5M)OBS/:,JZO!9_98XVD_<2,JAWD!PDA+
M$A3VQP>M9T9\11^*/'D_A^>PBD@N8)2EW"TGG$6L9V9#+L!]>>O04 >@RZOI
M\.K6^E274:W]PC/%!GYF5>I]A5VO.H=87Q#XL^'NL+$8OMFG7LQC)SM)2(D9
M[X-6K+Q/XDU>'3-6TK3?M&GW5UME@*(NVV+%?,$ADR7& 2-OJ.V2 =AJ.IV>
MDVHN;Z=8(3(D0=@3\SL%4<>I(%6ZYOQMK-_H.B0WMC]G+&\MX9%FC+96254.
M,$8(W9YS6;>ZSXDG\6:WHUA<Z=!'9V,5W#++;.[98N-I&\ _<Z\8]#V .VHK
M@8O&6JR:9X-UN1;6+3-7,<-^/*8M#)(OR%6W8"E\+R#C(J]>>)M0@NX8(5CE
M_M&_DMK+9%\RQQ(QD8@N QW(P'(&,'GH0#L**\\U#Q+XPTK32]U8VL;C5[>T
M@EG3'VF"5U7.%<[&!)!/(/4"EU#7_$-O%XRTR:]M?M6FZ8M]:W=O;%-H99"5
M*EVY!CX.>_2@#9U/0/"]KJT5W=K+:7>I7 B @NIH5N92I.&6-@K$A3RPYQ73
M0PQV\*0PQK'$BA41!@*!T %<+#K&KZ1HG@A//M9X]1F@M9BT#!PK0EA@[SS\
MF"2.<]JGD\2ZOJ.G>(]2TAK5(]&N9K>.WFB+?:&A4&3<P(VY.0N.F,G.<  [
M:BN"M?%6LZ]K^GVFE2V5K9ZCH8U.-Y[=I)(6+H,$!P&^][=>^,&O#X^O%\(:
M)K&I*+6"XFF@O[V"W:6.W:-F0-MR2JLR]3G'3OD 'HM%9^B74E]HUM=2W-K=
M-*I;S[3_ %4@R<,O)X(QW-4?$FN2Z7-I5A:B/[;JEV+:)I 2L8"EW<@$9PJG
M R.2* +JZ]I3W.HVZWL32Z:@DO%7)\E2&(S^"MQ[5:L[N#4+*"\M9!+;W$:R
MQ.!PRL,@\^QKSVSFU/3?&'C^Y^T6\UW;Z=9RPR/"0K!4F(#*&'/!'!%33>.K
MFUTOP[<ZC/#IL&I:7'<'4)+9GMQ<LJD1N0?D7DGD\^HQR >AT5R::UJNJZE=
MZ3IT]I#=6-A!/+,R>8LDTH8JJX(^3Y"2>2=PQC%);Z[J]]KD'A]_LMCJ,6F)
M>WSHIE579MH1,D<95B2<\8'O0!UM%><3>.-:7PQ+JICM(GTC5CI^L@0LZ^6K
MJK2Q?,".&5L'/&?2MW6?$MUI<6J7T?DS6D#V]I;ILY:XD95R6W8*#S$].=PS
MQ0!U55-0U.STJ&.:]G6&.69($9@3EW.U1QZDUQVIZ]XNTJSUZY>RA-I9Z8][
M;7=Q"%_>H"6B9%D)((&0W&.0<TV^UWQ3IFBZ=JES<:7)'?WMC$L26SAHTE95
M<;M^"03P<>O% '?45Q6I^(M>N[C6X?#MH)9M+E$"(\2LL\OEK(59BZ[1APHP
M.H)R>E07OC.]M]<33+UX=%N9HH&M([R(M%<LP!D3S00H=3E0/4 _,#B@#O*1
M@&4J<X(QP<&L_7KN\L="O+JP6V-U%&6C^U2;(AZECQ@ 9/4=.HKCI/&.JQ+X
MLB@EMYVTG34U"UGFM'C$F5D)5ER,C,?##'7O0!V.CZ'8:#;26^G121Q22M,R
MO,\F78Y8_,3C))-2:EJ^GZ0D#7]U';B>58(MYY=V. H'U-<G8^)=:@UOP]'J
MDMC)9:S82W&R&%E:W>-$<G<6.X$,>PQ@5A^(-5U'Q%X-T'73+!'97FL6<B6O
ME'<D7VA=AWY^]P">,<D=LD ],U#4+72M/GO[Z80VMNADED()"J.IXYJE<^']
M'U35K/6KBU6>[MDQ;RL[849W [<[2<\@D9!JMXVU6]T+P;JNJZ?Y'VFTMVE4
M3H74X'3 (K.O-:UQ_&&G:-9S6,4-YIDEUYLD#.T;JR#H' 8?/TX^IQ@@'845
MYFOC'Q-'X5379Y--*V6I_8+N%+=\W %QY)=6W_(>00,-TZ\X&E/JWBW4/$GB
M/2-(GTJ$Z;';R6[SV[L7\Q7;8V''4KC=VQ]WG@ [JBO-K/QKK^OCPM_9@L+0
MZW974C^?"[^1+#M!QAAN4L3QQ]3TK4MM>UW5;77&T^:R6XT9_LI5H&*W-PD:
MO)_%E4);:.I&,DGI0!VM%<):>-+V\NO"6HJL$6AZ]&48/&3)#<;-RIOW8(8A
M@/EZ@>M6I_$VH1C3XHPDLNK7<RV9CAY6W16;?@N Q8*".0,,#@XP0#L:*\]O
MO$OB_2].1[NQM8G.LV]G%+,F/M,$KJH;"N=C#)!SD=P*L)JOBN7Q#K>@K?:6
M);6VBO(;O[&^ K[QY93S/5/O;NG8YX .ZHK@]-\;7VMZ?X>2VM_+O=2TUK^<
MQ1A_+"E%(568=6?N3@#H<Y$3>)/&$#^'K6]L[&SN[^_FLY?-C+!U6-W250KG
M (490G.1C(ZT >@T5Y7XA\0Z_)X'\5V\M[ E[I5_':-<V\!431/Y9^Z6.TXD
M()R>GXUN>(_%5YH&I1:?>WUO8K-:;K;49[5OLTUR68>6YW?NP %/)YW'D8P0
M#N*I3:OI\&K6VERW<:WURK/#!GYF51DGZ"L3Q_=WMI\.M:N[&Z%O<Q63N)57
M<1\O.WG@^_:L'58]1_X2[P(D=S;&\-K?8F:$[%'EQ\[-V3@=MPS[4 >C45PN
MG^*-9N/#\SSR6"75GK,FFW5TP*)Y:.1YB(227(V@+D\GOTK$UGQ/K.H^"]8:
M.Z6WFL=<BT\RBV9&FB:2+&Y6.5.),'UQVS0!ZK169JMQ>Z?X;O+F.6![VWMG
ME#O$?+9E4GE0V<<>M<C9^*/$2Z/H5[>-92OKR6ZVL5O 0T+&%I9"VYP&X7@<
M8)[XY .TU75]/T/3WOM3NH[:V0@-(YXR>@]S5VO+_&5WKT_P[\6V^M67EPP^
M5]CNL*IG0NI.Y S893QG@'@@5O>+O$.JZ.VHO;2VL4=KIS7=NAC,TD\B[BP9
M5.4C 51N]6Z\8H [*BN M]4U74_B'H+I>)#9W.A->&V,6X EX=W.X9/. >WI
MR:DL?$_B35X=*U;2]-^T:==W(66$HB[+8L1Y@<R9+# )&WGD=LD [NBN/^)%
MSJ%KX=M6L+L6Q?4;2*0^7N+*TRKCJ,#GGU''%3QZOJ6I^(M3T*RNK>&;2[:!
MY[A[<MYDLH8J N[A0%R><G=@$8Y .IHK!\'>()/$OAR*_N+=;>Z622WN(E.5
M62-BC;3Z$C(^M;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<3\3SNT+3(DE,<AU>S<,HR4"RJ6?
M'HHY.>/6NVJ&ZNH+* SW,JQQ!E7<WJQ"@?B2!^- &!<^%O[2&I75U?+)>W]B
M; 3QP[4B@.20B[CR2Q)))Y [#%)<^#HKOP[I.FO>RK<Z0T3V=[&@#H\8VJ2.
M001P1T.3TJY%X@\SQE/X=:S=&BL5O!.7!#J7*8 'N#UK:H X+QGHHM?!_BG4
MKJ<76J7NF-:ATCV#:%;9'&F2>68GJ22?0 #5T?0UOXM&U*_O%O196VVU58@B
M@N@5F?D[FVY7C &6X].HK$N_$<::V=%T^V>^U%(A-,BL%2W0_=,CGH3@X !)
MQG&.: ,O0O!$V@.MM!X@OI=&@<R6NG2HA6(YR 7QO95/(7(Z#K5BQ\&Q6OA;
M5?#\][)/;:B;@NX0(Z><6+XZCJQQ_6M*PUF6YU:?3;G3I[6XAA6;>S*T<@)(
M^1@><8YR >1QS6K0!PVNP00^&1X*NFOM3OKZT,4$OV4A 1A59F4;4VG#<G/'
MJ1GL-.L8M,TVVL8,^5;QK&I8Y) &,D]R>YJS10!S\GAF1O$6HZPE_MDO;);,
MQF'*HJEB".>3EC[51M_ YM]/\-V::FQCT&020$PC,F$* -S_ '6/3%==10!R
M.G^!VTK4;C['K=Y'HUQ<-<OI81"F]CE@'QN"$\E1[]B:G;P9#._B875X\D/B
M!-DZ*@4QXC\L;3D_P@=<\_E73T4 <C:^"95U+2;^_P!<N;R73[:6U"F&-$EC
M<*"" /1>>YSU'2J47PX>'2[/28_$-XNF6%['=V<)AC+Q;'W*F\@[@#TR/SKI
M-9UM]'NM-C_LVYN8+RX6"2>';MMRQ"J6!.<%F X]ZUZ .8E\(O)?>(;G^TF!
MUNV2VE!A'[I55D!7GKAFSGC...U1_P#")O:_\([<+>O*?#T#I!&L(S.#'Y>&
M^;KM'&,<\].*T?$?B#_A'TTYS9O<+>7T-GN5PHC,C!0QSR>O0?I6U0!Y!H/]
MH +<:9KUW_:[[I'T^\T(&178[C')-L5L9."Y/;(["O2?$NA1>)?#]SI,T\D"
MS%&$L8!9&1U=3@\'E1Q6M10!S\/AJ:/Q1;Z[)J;S3161LV1X5 =68.22,8.X
M#&. .,=ZR)?AWOBE@37KV.W_ +5&JP1B*,^5+YGF'DC+#.<9Z9YS76:;<7=U
M9"6]L393[W!A,JR8 8A3E>.0 <=LXJW0!Q=U\/RZZ[;V6MW-I8:VLAN[;RD<
M>:Z[6D4G[N[C([]L4^Y\"2K>V.H:5XAO=/U"WM%LIKA8HY!<Q+RH="NW<,G!
M []Z[&B@"G%8+#I7V%9I6S&R&9VR[$YRQ/J22:PSX+@OKI+C6KA;^1+"73]X
MA$32Q28W>803N/R\8P!EN.:ZBH)+R%+D6H<-<F)I5A!^9E! )]N2!S0!S6C>
M"I=/M?L&HZ]>ZMIL<306]K<HBA$92N&90&<[20,G'/3IA?#_ (/NM!BBMO\
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MOJ]_8262S-(02K*0 S$_=!.<<T <V+2;0_$/@[4;/4;Z0ZFCQZC'/<O(DJ"
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M548@F1LJXS\IXX.!6E/9+9^.=8TE+B[DLKSP^;F:*:YDD#2B0KN&3\N0<$#
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MI#GS8Y,.K9]40[,_[1KF;>)H_ASI,?V6=;E/$RW#IY#!PHO&?>1C.-F#GTH
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M*A8E0,@*J]^F*GANFTCXDZO>:EO_ +.U.QMA976PM&OE[]\60."2^X#OVYH
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M"0["QY4!Q@'& ,5?U'QG)::XVD6F@ZA?78LEO56)HU#QE]O!9AR.>N#Z9ZT
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MC5%"28'&=IZ9ZBMK3M-UZ?Q\/$%]86EI;/I0LWC6[,CJXD+]D /7U_PKL**
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M73=0AU73H+Z!)DBF7<JS1-&X'NK<B@"/23J;V9EU9((;F1MWD0.76%< !=Y
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MC;E)10N0?0XK8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^!('%I:Z?I[6U^\XE9YG\M3M55V@+G/)W<>]>H:A9C4-/GLVFEA2=#&SQ8W
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MQ&FZ)V:13@[>1\@ZYJ.\^'&EW4.K6J7^I6VGZJYEN;*"51$9"069<J64DCD
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MI+FYE6*&)2SNQP *QG\9:'#]N%Q<RV[V, N9XYK:5'6+_GH%*Y9>#R <=\4
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M5]:V>M/JM_*ES91B>UN82J&8A6,B;@"!R1A?E/;I74T %%%% !1110 4444
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M>">9(69(S(J!,D#N5/T[US-NFL6%C>&/1[UHIO%$]S(ZVFZ:.W?)66)6'4G
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M=L#N<*>*ZFJZWUH]\]BMU"UVB>8T D!=5]2O4#WH Y-#<2_$^WU5M/O8K/\
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M9:1',TR6J; [#&>2>!DX S@#)P * .?/C*_MM9TNUO;6VB^WW\EFUHK[I[<
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M>> P2,SQLBHQ#Y&,$-VZ8ZGK61I5OJ&MZ;K&B0:IX?O+34+.5)-1TR!SY<C
M)^\/F,'8J3CY@1L&>"*W4\*7HU+PQ=MJ$&-$MI(&40']]O14)!W?+@*#WH ;
MX4\6R>)Y8Y(9+(Q['^U6HRMQ92 @".12>?XN< 9'&<UK:[J5WIYLQ;QP)#-*
M5GO+A@([90I(8C(+98!0 1R:RM/\(SIX@TW6]1N+634+*W>![FV@,;W>X 9D
MY/ QG'/)SQTJYXAT"]U74]&U"POXK:;39I'\NX@,L4@=-I)4,IW $X.>Y]:
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MC !Y%4? 5_?7<.O6]]+(_P!AU>:VA$LGF,D>Q&"ENK8+GDY^IH ZZD90RD,
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MI6M]/T=IDA,C%6G*;]KC/)0 9_WSW Q;T>VULZMI&IKJD+:9=6Y%Q%)>//\
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M"WNA+,[K+&,@*5)QQD]!W-5+'P-H>GW6GW,27C2Z<&6T,M],_DJP *@%ONX
M&.F*W;B^M+3'VFZ@AW L/,D"Y &2>?0<FN>TKQ)-=>*O$%E=3V?]G6$%K/;S
MQ_+E90Y)9BQ!^Z,$8% &YJNE6.MZ=+I^HVZSVTN-R$D<@Y!!'(((!!'(J.PT
M:TTZ>2XC\V6YD18VGGE:20HN<+EB<#DG [G/6KD,\5S"LL$J2Q-]UT8,#]"*
M;-=VULRK/<11,X)4.X4D 9.,^@Y- &=-X8T:XL]4M)+&,P:I(9;Q?^>K%57/
MM]T?CS4NJ:#I^LFR-['(WV*9;BW\N9XPD@! ;Y2,X!/7UJ0:SI9BMY1J5F8[
MEMD#B=<2MTPIS\Q]A4EUJ5A8NB7=[;6[R?<6654+=N,GF@#/?PGHLLVJR36C
M3'5E5+U997=90HPORDX&!TQBJ^G>!] TS3;K3XK-YK:YC\F5;J=YLQ_W 7)*
MK[#%;-]?6UC!ON;RWM=V51[APJ[L>Y&?I6%X0\22:OX,@UK5Y;2W=I)ED=3L
MB 29T'WB<<*.IH DL?!&B:?>6%W$EX\^GJZ6K37LTGE*V 5&YC\N% QTK4U;
M2+'6[ V6H0F6$NKC:[(RLIRK*RD$$$ @@U9M[F"[MTGMIHYH7&5DC8,K#V(X
M-9/BWQ'!X5\-W>JR^6SQ)^ZB=POF.2 !^9YQVS0 Z2P&AV5[?:;83:CJ+1CY
M9+C][/M^ZF]S@ 9)QTY/<FF>'=-D@:_U2[LX[34-3F6:>)&#% J!$4L.&( R
M?=CC(IMCJ=S;&YN=7U;1WTQROV.ZA;RLGG>K;F*\$<$'UR.*UWO+6..*1[F%
M4E($;,X <GI@]\T 0ZMI5EKFEW&FZC#YUI<+MD3<5SSD<C!!! .1Z53B\+:7
M#J4&HHES]K@MVMHY6NI6/EL<L#EN22 23DD\YK4MKF"\MTN+6>.>%_NR1.&5
MNW!'!KG)?$D]GX]GTF]FLX=+CTL7HF?Y&5C+LPS%L8X]!UH ?+X"\.3Z%_8T
MED[60G-R@-Q(7CE)+%T<MN4Y)/![FM?2='L]$L1:62.L>XLS22-([L?XF9B2
MQX R3T ':H[^ZFV:?)8WMC''+<)O:<Y$L1!^6,@CYSQ@\CVJP^I6$<X@>]ME
MF+B,1M*H;<>0N,YR<=* *FK>'-,UFXM[JZBD6[ML^1=02M%+&#U =2#@]P>#
MZ5-;:/:6T4J%9+@S)LD>YD:5G7^Z2Q/')X''-31ZC8S7CV<5[;O=1C+P+*I=
M1[KG(JPV[:=I ;'!(R,T 8VG>%=)TLVWV:*8I:!A:QRSO(MN",'8&)V\$@>@
M) P.*@?P1H4FE7NF/;SM9WUP;FXC-W+^\D+;BV=V1D@' ..*K^$/%)UC28GU
M6YL8M1DNKF%(8VV>8(Y60%58DGA?>N@CU"RFEEBBO+=Y(<^8BR@E,=<C/% &
M9>^'[);R368X+F;4DLVM8R+AR6C/.W:6VG) .3W[UC>!/"HT_P *:%%JMK<)
M?:?$,03S^8D4N""R@,5[G![9.,5V,%Q#=0K-;S1S1-T>-@RG\17,^(]>U33/
M$_A_2;+['LU:2:,R31,QB,<>_/##.<8[8]Z 'M\/O#;E\V<P5KL7JHMW*%CF
MW;MR -A"3UVXJP_@S1)+;5+9K><PZJVZ\3[5+B4X"_WN. !QC@58M[K4;2ZG
M_M:XT\V:1AA/$#%L;.,,&8\8Q@Y]:NQZE8S/$D5[;NTP)B"RJ2X'4KSST/3T
MH Y[4M.NM4N(?#CZ+_Q(X&@E-]/<+)Y@C8.$"'+9W*H)/8GGIG>&DV@ULZQM
MD^V&W%L6\QMOE[MV-N=N<]\9J0:C8F^^PB]MS>8S]G\U?,QZ[<YH;4;%;T63
M7MN+LC(@,J[R,9SMSGI0!5UW0-.\2:8^FZK$\UG(07B69XPV"",[2">0#4=U
MX:TV]O-/O+@7+W&G[C;2?:I 4+#!/#<DCC)S5S^U=.^S_:/M]KY._9YGG+MW
M>F<XS[547Q)I3^(I-"6\A-_'$)7CWC*Y/"_[W!./3GO0!;U33+/6M,N--U"
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MQ]46%1_P*MO69M0N_AI'K[VL@&H7UMJ&HVZ LPL]R97 Y(\M4W#_ 'O>O4,
M9P.O6D    & .U 'GFI_8M1\=1ZEI\]K/IQT6==3E1E:%URIA#'H3G>1GL#7
M+-;Z1;_ +3;V!+**]EBLHI+@*N]BMQ&Q5FZG&"<9XQ7M:1HB[4157K@# I=H
M]!0!Q/@?6(FOM1T?5'@'B6&3?<RJP_TR,C,<J?[.T@;1]W\:["\FBM[.:::1
M(XT0EG=@ ![DU-@9S@4N,]: /+OA?X?TG6_ASX;GO7DN_L9,J6[3DQ1RAVP2
M@.,CMG-2Z5I^FWOCKQV+6WL)M0ADMI;3<B-Y4H@&'7T._J1W'->F  =!BDP
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MK6M,F_L>:WFBLTM_%A::S)+30L7E#/,Q)*[CR%X&&QSCCI-2L;K2?&%YI5A
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M74+2W2%RB%+J+R0LBJS(QW"3>< @Y;(YKTW1X$M=$L+>,7 CBMXT47)S+@*
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MBB@ HHHH **** "BBB@ KD?B%K]YHFCV%MIL@BO]6U"'3H)BH;R3(>7P>"0
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M4 6/A=+)/\,]"EED>21[<EF<DL3N/4FA=?TNPU?Q;=IIVH?:M-BAEOOG#"5
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M@[4M$N_!L<4*W$6E?:WO)4<*-\X).P$Y(#$^G&._% '0'Q>CP7+V^DW\\EG
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M)Q\QYP!535=>U2[T#QUHMQ) E]H]FS_:8XCMFADA=E.W=\K_ "D$Y(R,X[4
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M20_>*L063=WV\^A'&.OHK(UG7X-*T?5K^*,W;Z9$TD\$; $83?@D\ [<'\:
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MO*%D\R168%R<9"C/;BK&B^!]-@L;B"[TJWM[6=XY!IT=P\T4;IDA\MCYCD=
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M<Q27#LLICBC9,*3M4@D@8 ZUW,_AG1+FXO;B;3+=IKZ,1W4FW!F7&,,1U&
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M\,5Q;Q>3"\8V^7'_ ' !P%]NE-G\,Z)<W%[<3:9;M-?(([I]N#,N,88CJ,
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M,I!P>XS@TR[\/Z3?65O97-A"]K;%6AAQA(ROW2 . 1V]* +T,*6\*0Q[MB#
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MQQHZC&?F!Z8;/'3%;-YJ5SX9U;1?%&IM<_8]3L!;WT&]BL%UL#HRIG +$,G
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M -\L 0"1D]!2UR/A7PWI\_A;3[K4[:+4-0O+9+BZN[E \CNZACACR ,X &
M!BK%O<KX>DT[PMIZF]O6AEF03S%0D"L/F=\,2<NJC@Y.3Q0!TU%<1)\1/+@B
M7^QY6O5U=-)NK<3+^YD8\,I(&]2#D'C/?%/_ .$RU@W6M6"^'(VU#2D29T^W
MCRGB=692'V9W':PV[<<=: .THKC7\>23/X>33M&ENFURS>ZM]TZQA=JJQ5NN
M,;QD_7 /2ETSQQ<:E83 :%<1ZM;:@-/NK/S-RP,>?,:0#_5[>=V/P[T =C17
M#2_$41>'M2U-=,$[Z=J2Z?,D%R&1BS( ZO@9'[Q>,#O]:OQ>*M1?5M4TF30P
MFHVMFM[;0B[#"XC9F7!;;\C94C'(]\<T ='%:10W$UPH)FFP'=CDD#.%]@,G
MCW)ZDU/7,Z9XL.K:-H-_:6<;/JK[3"9SF !6+Y.WDKM((P.<#-=-0 U)$DW;
M'5MIVM@YP?0TZO-=0\436/@KQ3J6AZ1;Z?=VNJO;3[I/OR$QJTWRK@L=PX/I
MG)Z5T-UXLN(=4N-)CL;635+>U6Y:U-X5:4,6XBRGSX"\\#D@4 =315#7-5BT
M+0[W59T9XK2%I65>I %8&I>,KG3?#6HZX=.M;JTM(([B.6UO=\<Z,2#M;9U&
M!QCN.: .NHK N?$Z67B==)N8%C@.G2:A]J\S.U8V4,"N/]K.<GI4-GXGO+F3
M3)WT:1-+U&%IDNUEW&!0F]3,NT!-P]&.#Q0!TM%<U8^*+R_.DW4.BROI6IY,
M5RDFYXDVED>1-N%5@/[QQD9Z\48?B!#<7&E206B3Z?J5P((Y8)]\T>[.QWB"
M_*AQUW<9&1V !V=%<SHOBPZXRS6EK#)9>;+%*\=QNE@9-V!)'M^4G;TSW'K3
M-&\9QZMIR:OY-NFD&SDNGNHKGS#!LVDQR+M&UL,21DXVD>] '4T5R8\9R0)H
MEW?:;]GTW69$BMYQ/O>-Y!F,2)M 7<.."V#P?6JL7CN^D&K7'_".2_8=(N+B
M&\F%TA91%%ORJ8^8GIC/&1R>< ';45C:%K4VLCSA!:FS>%)8;JUNO.CD))RN
M=JX(P/SK7D?RXG?:S;5)VJ,D^P'K0 ZBN2L/&<UQK.G:9=:5]FN-1LY+N&'[
M1F6/:%.R5"HV,0P[GD$=LU1L?B'<W=AHVI2Z"T&GZC??8#(;I6>.0R-&I"A?
MF4E>3D$9Z$#) .Z9@JEF(  R2>U"L&4,I!4C(([UY_XXUEM9\%>+X++3H;NT
ML+>>WGFEFVD2K'N8HNTYV9!R2.00.E=;H\GD^%K"78[[+*-MJ#+-A!P!W- &
MI17)6'C1YM9L]-O]-^R37E@]\D:S[Y8@NTE)4V@JV&'KR".U+IOC4:AHK:VE
MG%)I8L)+PRVMSYKH4 /E,NT8?!/&3RI% '5LRHI9B%4#)). !6+I.@C3]=U;
M6%O3.=5,;O'L 5=B!5VD=MO7.?PK+G\2F^\+:EJ$NEVM_I@TYKC-M=B6.==K
M;XR2HP0!SUZU/;>)(8H/#>G6%A&D^IV7GP6YDV1P1)&I(W!3TW*  /RQ0!U%
M%<+_ ,+$F_L1=1.@R\:HNER1BY4E9/,\MB#CD!NG3/M5H^.'LSXACU;2S:S:
M/;I=%8I_-$L3AMISM&""I!&#CU- &L?#Y/C%?$7VQO,6S-GY'EC;L+!\YZ[L
MCKTQVK:K*T?5)]3,CO!;?9MB207-K<^=%,&W9P=HY&/U%6]2OH],TN[U"5'>
M.UA>9U098A5)( ]>* +)(4$D@ <DFD!$B!D8%6&0RG/XBN&UW5CXB^'OB"1[
M2SEL)-'FGAN;>Y\^-F\MOEY4892 ?_U5+X;\27,$GAS1+S2S!#?::'M+@3AB
MYC1"P9 /EX;(Y/OB@#>T'03HR2O/J5YJ5W* K75V5+[%)*J-H  &X]LDD^V-
M4S1*KL94"Q\.2PPO?GTKE;3QK)+K.CZ?>:6;,ZMYWD))-^_BV L/-B*C;N53
MC!/I7!ZK9VR_#;XA1K;Q!(M?D:-0@PAS#R/3J?SH ]I)P,GI6)K.A?VU-87U
MIJMU8W5KO,$]L4=65P,AE8%6! '/4=C4GBF&*X\):Q%-&LD9LILJPR#\A-<M
MX.\27-IIO@S1[K2_*MM1TN-;6Z$X9B\<"L0R8^4%02#N/3D"@#K]-TMK)VGN
M;Z>^NV4(9YE12%'.U50  9]LGN3@8T:Y%/&LJZKI5I=Z4;5-4N)K>!99L3H4
MWX9XBHPK;#@@GJ/6I+/Q?-<6FO&734AOM)N?LWV7[3N,S$*8R#L& ^X!>/RH
M ZJBN2UCQK_9S:A';VEM<W&FQJUU ;O8[,4#[(AL)=MI!YVYR!ZXV+G5I'\+
M2:Q80!G:T^TQ17),?\.X!N"0?48H TV=$V[F5=QP,G&3Z4ZO*+V^OM2T/X<:
MS?6D4VHRW\#JT3@M('MG8Y)"[<GDCD#'4UU,'CE8[35CJMBMG>Z;>1V;PK<"
M1'>4(8R'(7@[QG(XP: .NHKG=#\4-JNMWNE36B1R6\2S)/;3&:"5"<$!]JX8
M'JN.X-5M6\5ZC:>)I-!T[0&O[H6/VU";M8E==X0C)!QW_3Z@ ZE9$=F574LA
MPP!Y4]>:=7%P>*--TQO&.H3:1]C;2Y%:\>,AGN3Y2LIX[[2H'-3R^(Y[G6X?
M#M_HT1^W6#76Y;@21^6,*RL"HR067ID'- '5HZ2('1E93T*G(-.KR_P!XDN=
M*\(>"[*XTO%AJ""TCN_/&X2[689CQ]T[2,YS[5TO@_6M7UB_\0KJ$-LD-GJ<
MEK%Y4S,5"QQX7!49');.>IQC% '5T5R7]OZHOQ&O-*ECM4TNUTU+HN9B& 9V
M!8C;U&S&,XQSGG :?'/E:;I>LSZ=Y>B:C,D<5R)LR1B0XC=X]N K<=&)&1QU
MP =?02 ,DX K,UW6H=#LX99$,LUS<1VMO"#@R2N<*,]AU)/8 ]>E<UXAUU;R
MR\0^&M6T^*&[&D2WD(63SHIHMI!()52&5L9!'<$4 =NK*Z*Z,&5AD$'((I:\
M\\-^++S3-+\):?J&B/!8:A:06UK??:%;,WE JKH!\H;!P<GW [6M!\5:Y<:-
MK%_=Z6MU+!JDMG#!9RLQRLHB ^YP@^\6YXR<#I0!W#,J(SNP55&22< "@$,
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MY[XH Z^BL[0-8A\0>'[#5X$:.*\@694;JN1G!^G2M&@ HHHH **** "BBB@
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M!YC;MIRHZ>M8<_@K7)O!^M:/NT\3ZAJS:@C^>^U%,ZR[3\F<_+C\<^U>B44
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MR@_\L^HSU]JG\2>$]3\4VDT&HVNDM,8U-G>1RNDUC+W9"%RP!P>JY(YQGCN
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M.8XVD(+$  [1QR1R<#F@#D6\!W2KX@EL+;3],;5M,>SDM+>=S TS9!F(V#!
M., <Y.<5>7PSJ_\ :7A.Y+62+H]I+;S%96)8O&J;D!3'&W/..N*[.B@#SG2_
M!?B2UF\-S7-QI3S:3<S23S R,]V)(V0RL2!\_P PX_\ 'NU/O/!6MW7A;Q3I
M0?3UEUG46O(G,SE8U8H<-\G7Y.WK[<^AT4 9^K6UU?\ A^\M(EA6ZN+9X@&D
M.Q692/O;<X&?2N8M?"FKP-X)W&Q(\/PF*?$S_O<P>3E?D_X%S]/>NWHH \WM
M/!7B6)=%\^ZTJ6?3M3>[ENF\PR7:LLB[WXX8!P-N2./O #%=%<^%3+XZAU^.
MX"6S6X2[ML?Z^2,YA8_[NY_Q"UTK,JC+$ 9 Y/<]*6@#C;C0?$VF^+-0U3P]
M=::UGJGEM=6]^'S#*BA-Z;.N5 RIQTZUTTUD\^C26,D[.\EN86F8<DE<%B!^
M=7*3<H8+D;B,@9Y(_P D4 <#;^$O$":+X1L9GTQFT&YBD<I+(!(D<31C&4ZG
M=GMC&.>M&H>!]4U&;Q++]KMK26_N[:]L)HV9S!+ J!=P*@$$IV]:[33]1BU*
M*:2*.=!%,\#":)HR2IP2 >J^AZ&K= &+H,?B0@R^(9-.60+L2'3]Y0GN[%^<
M\< #CGDYXK'1=0_X6(->'V7[#_9OV(KYC>9GS-^[&W&.V,^_M71T4 >>ZSI]
MUH.F^-]3U"73H[?5R@@,A,BHQC6!1(&4#!."3G SSP*AT1-6TS4[2-['0;IY
M[<VD4UMJD\TJ1A2PXD4XCR!G![CKQ7HLL4<T312HLD;C#(XR"/0BJMAH^F:4
M'&G:=:6>_P"_]G@6/=]=H&: .+L_!FM6OASPAIA>P:30KQ)Y7$SXE55=<+\G
M4[\\^GO6]X<T/4-%U?76EEM9+#4+YKV(KN\T,RHI5AC  V=B<Y[8KHZQ[KQ+
M865AJM[<K=Q6^F,5N'-L_.%#%EP/F7!ZCCK0!G7GAN\N/&MQJBR6S:=>Z8MA
M=1N6$B@.[97 P<AR.2,=>>E9EKX,U1_"^G^%=1FM)=,L9XB+I';S9H8G#HA3
M;A3\J@D,> <=>.WMKB.[M(;F+)CF19%R,'!&15*XURQMM>L]%D:47MW&\D*^
M4VUE0#=\V,<9'&<\T 4?%_AZ7Q#IEJMI<);W]C>17UI)("4\V,\!@.=I!(/U
MJE=>%[O6M1O-2U(V]M<R:5)IL$<#M*L8D.7<L57/.T 8Z \\\;>N:Y8^'=,;
M4-1:1;=75"T<3/@L0HS@<<D#)P.:TJ .-L?"^I3V7ARQU;[&EOH31R*;:5G-
MQ)'&40G*KL')8CGG SCK0E\&^(8]%UC3K2]L%2YU9]0A#%P)HWE$C0RX'RJ1
ME3C.0>W(/H-5+748KN]O+5(YU>T=4=I(F56+*&&UCPPP><=#0!Q;^#]=?_A+
M?GTI%UVQ2WCCC+J(&$1CQG;RH!SG'..BU>A\-ZNFM>%KUOL7EZ18RVTRB9\N
MSJBY7Y.@V9YQU]J[&D)"J68@ #))[4 <]X1T6^T2#5$OC;$W>I7%ZGD2,V!*
MV[:<J.1T]ZYJ[\%>)+CSQ]ITN5QK<>IQ7,QD\V6-) ZQ/Q\H4<#&1[#K7:S:
M[8P:]::+(T@O;N-Y8AY3;65,;CNQCN.,YYK2H X6X\):U/:^-8BUAN\0)LA;
MS7 C_<"++#9[;N,^GO3K7PQKVD>(+;6-.;3Y6FT^&RO[6>9U7,>=LD;A"3U(
MP0/K7<54U#4;;38HWN&.99!%$BC+2.>BJ.YX/X D\"@#(\$:'?\ AWPVFFZA
M+;RRI/-(&@W;2'D9^_\ O8K O/!>M77AKQAI8>P637;Q[B)_.?$2LJ+AODZC
M9GCU]J[+2-8M=;LC=6HF55D:)TFB,;HZG#*0?0U?H Y*'0=7TSQ5>:YIXLY1
MJ=M#'>VLT[($EB!"NCA#D;3@@@= ?:J/_"#WMGIOANSL9;60Z;J9U*ZDE9D\
MUV\S<% 5L<RG&3P ![UW=% 'FMWX&\0IX<\0^&;&?37TO4I99K:>>1UE@\QM
MS(5"D,,YPV0>>AKT)5N5T\*PB:Y$>" Q5"V/7!('X58JIJ&HQ:;#'+-'/(LD
MR0@0Q-(06. 2!T'/)[4 <1H_@O6M-M?!D,CZ>_\ 8#3&8K,_[T/&R#;\G;?G
MGTKH/#&BW^D7^O3WGV8IJ-^;N+R9&8J"B)M.5']S/'K7144 <K=>'+^Z\9W^
MJ,]LEE=:0-.&'8R*=[MNQMQCY\8SVJC9^%M6'A/2=!U6ST74K2UMOLUQ;R,X
M5PJJL;JQ0D-PW88W<'C-=Q2.P1&8YPHR< D_D.M &)X9T!]%\)V^BW<[7(C1
MT)+EL(S,0@8\D*I"@GL.U<[;>"-3_P"$1@\'WLUK+I$$Z8N@[>=) D@D5"FW
M ;@*6W=.<9K<@\<:%<VUQ<6\E]-#;N\<SQZ;<L$9/O XCX([UO031W-O'/"V
MZ*10Z-CJ",@T 8&AZ+J&G^*O$6I7/V7[-J<D,D0CD8NFR,)A@5 YQG@\=/>E
M\4Z)?ZK<Z)>:=);"?3;[[24N"P5U,;H1E03GYLCZ5T5% '$S>%]9DN/&4FZP
M/]NVZ0P'S7'EE83%EAL/KG@GT]ZKIX6\3:3=Z5J>BW&F&\BTV+3K^UNFD\F5
M8\['1E7<&!+<$=#7?44 <I>:!K%UKWAG49)[28Z8\\ERQ9D+F5"N$7:<!<\9
M.< #WJQX3T74-&DULWWV4K?ZE+>Q^1(S%0X4;3E1R-O7WKHZ* .8OM OX/&L
M?B72FMY&EL_L5W:W$C1AU#;D=6"MA@21@C!![56_X0A)?!VMZ3/*GVO5YY[R
M65,A8YW.Y2O?"%4P>IVYXSBNPHH XR+P/(FN:+JCWH:6"!DU/C'VQ]XE1O8+
M+EAZ# Z5;_L/5$\9ZKK*"S:"[T^.TB0S,&#(7.6^0@ [^V>E=110!A>#='NO
M#_A#3-(O6A>>SA$)>%B5;'?D UNT44 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RWCW4M3TG1;2Y
MTN[6WF;4+:!BT0<,LDJH1@^Q[<^XKJ:RM>T&W\0V<5K=3W$4<4\=P/)*@ET8
M,N<@]" : .6_M?6M-U?Q3IDVM6\OV738KVUNK^-(TMV?S 0^P#* H#T)]S44
M&O:RNN:KIJWUTT2Z&M_;S7=O&KK)N920H ^4X'#@$'VK>U+P/INK7.J37L]W
M+_:5HMI<)O4#8I)7&%R""2<TQ? UD+YKZ34]5ENWL38R327 )>,DGD;<9&3V
MQWQGF@#FK/6?$KVO@>];7"YUV)8KF)K6/8A-N9/,7 !W97N2O/W0.*E7Q5JV
MDP:[87-XU]/::Q;:?;74L<:.$G$9RP4*F5WM@X /&:Z2/P7916^A0)>7HCT0
M@V8W)QA"@W?+S\I(_P#K\TV?P-I-Y%K<-XUS<Q:RZR7*2,H =0 K(5 *D!5Q
M]* 'Z&OB*'7;R/49#+I;Q*]L;AH_/20'#K^[ !7D$'J.E+KNKSQ>)-#T*WG-
ML=2$\CSJ%+!8E!VKN!&26')!X!^HLZ#X<BT)&_XF&HZA,5""?4+CS75!_".
M /7C)XR3@4WQ'X7L?$T5J+F6YMKFTE\VVN[23RYH6Q@E6P>HX(((- &'<:IK
M>E:EHWAZ\U.*:YU34+A([V.-0\=M'&9%##&WS#PN<8QSC-8WB/Q1K^AVOC#3
MX[_?<:7:0WUG>O"A?8Y(*.  I(*G!QTZUU\_@W3KG3;:VEGO&N+:X%U%?M-N
MN%F QOW$$'CC!&W'&, 5B^./#QC\!^(ULXKS4-4U*%8V<1[Y92.%7"*  !GH
M .2>IH 26[\1Z5XWTK3KK6?M=EKD$ZJ%MHT:SEC3>&0X.5(XPVZF:)KVKWM@
MFAW6H.OB.WU-K6\E6*,?NE/F&0+MP%:+: <?><5T%MI4-OY6M2OJ&HW-M:LM
MNDZJ)$4@%E5=J_,VU1EN>.HYJMX=LTU#7+SQ7+I,^G7%W;Q6L<5TH6;8A+%G
M ) )) QUP@H S=#F\1:QXAUR)]?,5MIFI^2D2VD9\R,PJVTDC(P6R".>N<\8
MH6/BO66^'F@:I<W.9;O4OLU]?"-1Y$/G2+OQC:/NHN2,#=DUV.E^'H-)N]4N
M;>[NFDU*7SIO,*$*^T+N4;>. !W'%<KKGAO^Q/#ND:/81ZW<:;!>M/)<6,BF
MYM_O,"H &X%V.>&QZ=, &=KE]JM]X2^(*W%^UYI5K;2164QC0"7,09OF4#=M
M)*Y'\P:V+"[UBS\5Z5I,VK236FIZ3+*$$,:_9I(_+ ,9P21A^C;N1^%)IWAV
MXUBPO["ZU3Q%+HU[;F*1=4$:S%B1]SY RC&X'<.XQWKH5\,6XUC3M4:\NWN-
M/MVMH@Q3:4;&[< O).U?RH X;PW?ZWI_PNTO4K>34M2,EW(UXL*QR3I%YLN]
MHP5^9BVTD')QG&*[?PEJT.M:$+VWU0ZE$TL@69HQ&ZC=PCJ ,,HP#P/7O5>Q
M\%6>F6,%I8ZCJ4$=O=-<P;9E;RB=^4 92-O[QN"">G/ J*[\)>7%:IIE[?V\
MPU+[?/-'.$$S$C?YH PP*\!0 ,XH Z>57>)UC?RW((5\9VGUQ7D]IXD\6Q>"
MM \83:PES%+<117EA]E15DCDE\O(8#<'!(QCCVZY]8ED$432,&(49(12Q_ #
MDUP'P]\,,W@?0X-7_M!6LG\[[!=($5)5<E3@J&(!(89)&<>@P ,UGQ'K%A>B
M>'4?M"#78;)XK>)#;QPNZIY;LRAC+R2=I.#@''2J_P#:MWX?U;XBZN][<W0T
M[R6B@EV;#FW5E!PH(4,QZ$<9SD\UOS_#K2IUNH_MFIQPSWPU 0QW&$BGWARR
M#'=AG!R!GC%7_P#A#]+;4M3NY#<2)J<*Q7=L\I,4H">6"1USMXZ^_7F@#)=O
M%=O=O.EX6TY[*0N]SY)>.8+N1HP@Y4@'(;/8^M9.C:[X@,?@74+S5S<QZX@B
MNK;[/&B F!I ZD#<&RO/.#G@"NBTGP+9:1:R6T>J:O<1>4T,"W5UY@MD(P1&
M",#CC)R0. >M20^"K&"VT*W2\OA'HC;K,;DXPI0;OEY^4D?CZT <MH<VN6F@
M>++RPN;W4KV+6YXEA;RB[(LB*Q3*CY_+!"@_+D#Y>U=3X-UR#7;6^FAU*XNQ
M'<;##=P"&>U.Q<QR*%7G.XYQWZG%.7P;91'43;WNH6_VZ[%XPCF&(I=RN60$
M$<E!D'/<< FJVK>$&FM;EK'4=1AU.[N8II+V*98F)1=J[]J@% /X0.3U]: .
MK8$J0IP2.#C.*\OM/$?B*V\(WOB:\UD3K:W5Q9BU-K&J,?M'E1NS#!&WJ0"
M0/J:]08$J0"02.H[5@6?@W2[;P_?:'*9[NPO7D>:.X8'F0EFP5 QR2?8],4
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M3:Z[HUWI5ZK-;7<312!3@X/H?6@#B]9M+L^._!]M%J4RS&ROP;IXXVD Q%T
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M6L:B2Y8Q$E;@9+-M8 Y;^(_[7(!W/B37[C0Y]&2&VBFCO]1BLI&:0JT8?)W
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M?:=1COQIGFM:2!E@$9<?/@C!?)QD$X&10!HG1].7RGAT^R6:!<6[F!?W7IC
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MAOY;^+3[5+R4;9+A85$CCT+8R:Y&VUJ>7XL-;RR7]K:+H3W#VUTVV-2)D D
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M*WLM0>W:&"]2W4O"2N%(^GIGM7+Z?X'D9K5-1TCPU";9XW%W8VI\]BA!!!8
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M6CVL)!BA:%2B$="JXP,>U8<GC[1X[.:Z:.]$5M!'<7FZW*M:H^=ID4X.>"<
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MK8/@S2!?SWD)O[9KB0RSQ6U_-#%*YZL45@,GOQSWK=BBC@A2&&-8XHU"HBC
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M=%N);-HRUVZ-NFX(5-A.8\@Y8XZC /-0V$=UJ.FW+W/P]M[*\ALY4E658?\
M2'*$&*)E.=K=V.!CCG.1Z!10!Y_H-CJOAB34I-,MM5O-$CLU>UTV]D!FCGW'
M,4;,<[ N.I(ST)YKM-*OUU72+/4%B>%;F%)1')C<NX9P<<?E2BYL-0>YLEGM
M[AXL+<0JX8IGH'';.#P>M6@ JA5   P .U '*^.[*]O[+1TL;.6Z:#5[2ZD$
M>WY8XY S'DCL.E5HK2_C\=>(M0.G7)M+G3H(8) %_>.GF$@#.1]\=<5VE% '
MDEAH.MZ-I7A*_F\-MJ8L=.;3[_3F\MI8\LK"2/<=K<K@\]#^6W?:5?I/X8U.
MQ\-K;QVNHRSS6%IY221I)"Z!F^8(6R03@\9[XS7H%% 'G%WI6K3+\10NE7&=
M6@"67*XE/V81<<\?-ZXXYJ;2=.U71/$MEJ\FGW,UG=:-!97$<>UI+6:(DC*Y
MY4[CR,\^QS7H-% 'EB>%M;T.ZTKQ#!8R731:Q?7USIL3KYD<5R-HVY.TL@ )
M /4D ]ZLMI=[?7WC&74?"]W/I^JRV12!Y(U=T5$5R,/D,N-PYZKUSQ7I5-DD
M2*-I)'5$0%F9C@ #J2: . TZZUKP;I6H2S6^J:QI2748M/M#K]JB@V9D9R<%
ME4C !^8_3!KT&JT;6>IVL%S&T-U;MMFAD4AT;NK ]#Z@TMS?6EF\*7-U#"\[
MB.)9) ID8]%4'J?84 <WXALM0_X3?PSJMI82W=O:I=PS^6Z QF14VL=Q'R_(
M<XR?8US^CZ/?Z;<76@W_ (.M]0!O)9K75I$A>$QO(9 TNX[]R[B, '.!TZUZ
M910!P&A)XA\/WNJ:&VA27<-SJ$UW9ZB)$\A4E<N?-!8,"I)X .>V.M5[W2=6
MFB^(R)I=R3JT02Q^Y^^/V81?WN/F'?'%>CT4 <'I5CJ4'C/1[^73+E+:#P\;
M*60[3MFWQMMP#D\(>1QTK&MM$UJ+P3H-BVCW0NK7Q"+V:/*96$7+R[L[L'Y6
M' YS7JM% 'FMTFLZ#)XSM9-'N+NRU02WMO?1.@2/, 5DDRP(V[!C .13=)MM
M0MH_ &MVVFW%_;1:']EF6V*;XV>.$J2&91CY",YXKT2_LXM1L)[*<N(9T,<F
MQMI*D8(SVXIFF:=!I&F6VG6N_P"SVT:Q1!V+%4 P!D\G H \OC\/>(8-'M[T
MZ +FXT_7KN\?3Y9(R+J"8R E"3C< ^1N Z5N7FD6^L:,OVCP;)8VUS=HS1VW
MEQ7<&U'Q<$QMU#;0 "3@GKG%=_10!P^E:AKOAG1+6/5;:^U5)=2-O'<N4$T=
MLS!8WF&?F;)QQR<C//%=Q4<D$4KQM)&KM&=R%AG:?4>]24 <3Y&K:%\1=5U)
M=+N=1T[6+>W59+9DW6\D08;6#,/E(8G/K7/Z%HNN6>E> X;C1;I)-+O)Y+L;
MHSL1UD56X;G[XXZ]>*]6HH \T\::;XAU@^*M.&DW-S!/9*NF/!*B1$[#O\SY
M@6?=P 01TQCDUJ:SHNL7DOAS5M,A:TU"-&LKM79=T=O*GS,2"061E1@ 2,UV
M]% '%^$?#%WH.L:C;.H&C6DSOI*YR56;:\@Q_LL"![,U<]>Z)K4W@GQ78IH]
MT;J^UTW=M'E 7B,T;[L[L#A#P>>E>JTC,%4LQ 4#))/ % '$:A;3'QW>ZK=Z
M?(-(;P^UM+-*RHF[>SE6.<@;3UQ@5@^&Y);,^&1KF@^((5TM!;VDLD41AA:4
M",%V1RQP#L!VC@Y(SR/0;N\T+5-&*W5W8W&FWS&URTRF.9F)38#G!.01@<Y%
M0:=X3TW3)(VBDOYEB(,4=U?S3QQXZ;5=B..QQD=J .8TC0]0LO%%G?:3;7^F
M0SW$K:MI\SAK4@JW[V+D[79MIPO8G(&.>VTJ]N;^S,UUI\UA)YCIY,K*S8#$
M!LJ2,$#/XU=HH YSQ_\ \DZ\2?\ 8,N/_1;5BPV-SKT_@Z[%C<6\6D1FYFDE
M !+&'8(TP?FR6R2.,+UR:[#5M+MM:TNYTV\WFVN4,<JHY4LI&",CGD4W3)+"
M*(Z997D<[6*K&\8E#O$,?*&[@X'?TH X"#POK.H?"2_T+[*]GJ?VN6XACG9=
MK_Z29D!*DC!&![9K5U+2;SQAK6C7KV5SIB6-M="4S[0PDFB\L(N"<@9+$].!
MC.>.YHH X7PA)XACT6P\.:EH,MI+I\(MI=0,B-"Z(NU6BP=Q9@!P0 ,G)[&A
MX/TN_L+?3M"U/P9;"ZTQD4:N4A:%T3[LBG._S"!Z<$Y)[5Z35>*^M)[N:TAN
MH9+F  RPI("\8.<;AU&<'KZ4 >?Z-H>I:=K%O=:397MC9SQS/J>DW3![99"A
M*F'DX+.>BG&W.<=*K6GA#46@OM+TG[?IVC:AI5Q#/8W[ATL[AP @A.2=O+9
M)7CU(QZC4%W>VMA;FXO+F&WA#!3)*X1020 ,GU) _&@#A-"AOY[*..\\!6MI
MJ-E;.LL\B0E)F\LKMA*G=\YQG(  )&31X>TO4O#E_<RZ3::H=#73WD&DWDBL
MT-R""L4#$GY2-P/)7.,$]O0J;)&LL;1NH9&&&![B@"EHNIG6-&MK\VTEJTRY
M:&0@LC D$9'!Y!Y'7K5^FHB1QK'&JHB@!548  [ 4Z@ HHHH **** "BBB@
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MTW_"X]*2TN+99QHUP"DW.X&6/C@Y![]^A^HLW?@66;1!9PZA$EU+JRZM=3O
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MS2["BR/ECC )X'<YSVJUX3T"X\.:;<6=Q=Q77FW<URKQQ&/'F.7(P6.<$]:
M,K6U ^*OA9U5=YL;_GIG_58R:IV_C867A>XU.XL;73U369;&=XE9X8<2%3,^
M "02.3QRPSBN@U'0+F\\7Z3KD=W%''I\,T7D-$29/-VY.[<,8V#L>]4-+\+:
MKI.FS6T.IVLC3:G-?2![4[)$E+%HF&_IEN#[#@T 9_B#7M;_ +.T&6RNM/\
M+O=:AMO/MR72>(G<I4@\ [<,,GN,]S?G\6SCQ-/H226,5_ 8-MM<;D:[1PI=
MXF) (7+#;@G*G.*J#X>&WT=+;3[N"SGCUE=7B00%H(F''EJFX';CT(Y)/'2K
M>N^#[KQ$DUMJ%W:S6[31303&W(GM"@3=Y;9P-Q0G/&-Q^]0!L>(]=3P_ID=P
M8_-GGN(K2WB+;0\LC!5!/8<Y)] :ST\0:A;>*AX=OX[8W%U:/<V-U$K*CE2
MR,I)((R#D'D'M5WQ3X=C\3:*UBT[VTR2I<6]P@R894;<K8[\CIZ$U#;Z%=RZ
MY#K>ISVTM];6KVUNL,;+&F\@NYR223M48[#/7.: ,+X<6TFH^'4N]4BM+EX]
M2O)H9#&2Z2^?*K,">G!(&.U6/%7C*_\ #:ZE=/:VJVUD8C%%*^9;U&QO9,'Y
M N['(.2.U:WA#0+GPUHITZXO(KK]_+,LD<)C_P!9(SD$%CT+5A:WX"U'5?\
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M[3PZ[@#M88(R/;M6S5+2[6[M;,+?7GVN[<[Y90FQ<^BKD[5  P,GU)))J[0
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MZI/>VL,E@;>\O'!>V6XEV.&?;V )!(.,C@T >GW4YMK.>=89)VBC9Q%$ 7?
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M$O=1M;=BH?$LH7"DX#'/09XSTIEYXAT73I)8[W5K*WDAC\V1)9U4HF0-Q!/
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MUI]W?6MA$);NXB@0G:#(P&3Z#U/!XH 98:;;:9I<&FVBNEK!&(HE,C,54#
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M110 4444 %%%% !1110 4444 %<;\2H/.\/6+/ TUO#JMG+< 1EPL2R@NS
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M02 0N.G4"M6^M=*L+;P<NE6\\%D?$'VE/M&[=L:.7=(0W**68=<=1TS7J5%
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M8&\?3^'GT>]72+G3FNVLWN$*0222*C2( _R!0O&WD$L0.:W-?TK7=4TK1?\
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MC2+/2MJ;/*@G$QD;(RV0HVKQP.2<\XQR 6#X@B'B>30/LMP;I;(WJ/\ +L=
MP3 .[(.3W 'O6.GQ!L9=+T:_CTW46CU:Y>UA4(A99%+C# -W\ML$9'J13]3T
MW5X/'UIKNGV<-W ^G/82J\XB,1\P.'/!R."#CFN>TSPKX@L]"\*64]E"TFEZ
MM)>3F.=3F-C+C&<?-^]'&2..M '36WC>Q;3]5N+ZTNK";2YU@N+:8*TF]@IC
M"[&(;=O4#GJ:QDU"5?BZLM[!<6,2>'YI9!-,&CP)H_F&&(! !ST_'K576/!V
MMZI/XIF@CCMYKJ_M+_3VED!5F@1!M<#D9*'UZCZ5:N="UWQ%XD-[?Z9%I]I<
M:'<:;./M8D>-I&4Y 48/3U'X=* -2#Q]I\VJ6%C]FG#:E&\EDP>-O-*KN*D!
MLHQ'(#8]#@\58\,^+T\4I#/:Z1J,%E-"\B74ZH$W*^PIPQ.[OTQUYXK/\+Q>
M*[2VMK#5])T^-;"/8U[;SAVO JX7:A V$\$EC]!SQ?\  .E7^A^#;+2]2@6*
MYMS(&VN'4AG9@01[-0!&?$%Y/X_N/#AT^46:6"SF9)%!.]RN[[P( VD<<Y.<
M=*YKP'XI&E>$?#]K>65_)#>7LUH+]BK()6GDV*<MO.<8W8(SWZXZ6;2]4M_B
M*^MV]M%/8SZ8EJY\[:Z.DCOPI'.0V!R.>M<Y:^%M=@\%>'=*:Q4W6GZRM[.!
M,FWRUG:3Y3GDX8#''(/X@'0:Q\0-*T5;F>9'DL[.<074\;I^[8D D(6W,%)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;0 45SNKZS>V'C+PYIL1A-IJ1N%F#(=ZF./>"ISZ]<@US5YXSUZWT/5[J+[
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M(:WMC<1I^X5AM).T N^.-S'\.3765SND^);C69[*>TTIY-(O!+Y=\LP)382
M70@8#8."">V0* (+CP:+GX?KX1;47%N+9;4W B&\Q*  ,9QG '/Z58N_##SZ
MKI^LP7_D:O:0-;&<0Y2>(G)1TSTR 1@C!_*NAHH Y.[\#PSV,$$5])%*NIKJ
MLT_EAFFG#!AD= O &!V &?70N/#[S^*K37A>[9;:U>V6'RLJRN5+$\YSE1BM
MRL7Q5X@_X1C09=5-F]TD;QHR*X7&]P@.3[L* ,=_ /F>&;O0VU63R;J_-\\H
MA&\.91,0.<8W@=NG%:UG::M'XJO;F74)IM-D@11;O&JI'* .8_XB#\Q.>[ #
M.#C<HH P]?\ #K:S=Z9?6]_+8WVG2M)#,D:N"'4HZE6X.0?PKBO%_AH:#X4O
MXX=3N[B74M:M[P[U0LC>;'O90%[*F3V&.@KTNUNX+VV6XMI5EA?.UUZ'!QQ^
M534 <Z_A:UU2:[N]7E2_>[LC8_(GEQK QRP49)RQP2<]AC&*98^$V@72HK[4
MI+Z'23NLEDB"L&"E%:0C[[*I(! 7KDY.".EHH XV3P#YOAV_T9M5D\J]U Z@
M\@A&Y7,HE('.,;@.W3-=+J>FQZOHEYI=TY\N[MWMY6CX.&4J2,YQU]ZG:[@6
M\CLVE47$D;2I'W**5#'Z NOYU-0!RT7@^5+KP_<2:Q--)HH<1F2%1YFY/+.<
M8P-O3'?DYJK/\/;>[T[5+6XU&X#WNH_VI'<0J(Y+6X  #(>>!M'!]3SS79T4
M 9.AZ1=Z9&[ZAJ]QJEY( K3S1I& HS@*B  =22>I]> !%:^'VMO%M[KWVPLU
MW!';O!Y8"A4+%2#G.<L<TMOX@\_QA>>'VLWC:VM([H3EP0ZNS*  .G*GK6U0
M!R&D^!FT6]:.TUV^71//-PFE%4*(Q;=@/C>$W<[0?KD$YK1_#D16ME:)K]^M
MM8:B;^T3RXR8R2Y*DE<MS(W)]:[BB@#FV\)_:;RQEO[\W4=A>O>VP:$"1&.[
M"E\\H-W3 )P,DXJK!X#MX-,FT1;V0Z!+<>?]@,8RN7WF,/\ \\RW.,9Y(S77
M44 <T_A1FU+Q!>+J!#:U D$B^2"(E164%>>N&/7OCZ53MO 7V2?3I8-:NXC:
M:8NE2;(T_?0*<KU!VMZD=?:NQHH XZR\!_V;:: MKK$YNM$CDBMY9HD96C<*
M"K*,=E7!!!Z\FI]1\$6^H>'M0TLWLJ2:C<K<WEWL!>1U92,#H -BJ!V ]>:T
M-1\0?V?XGT;1C9NXU,3;;C> J&--Q&.ISQZ5?L[B[GGO$N;$VT<4NR"0RJ_G
MIM!WX'W>21@\\4 <_J?@Z>ZUY=;TW7;O2K^2%8+QK>)'2X5>A*.& 89.#S@5
MT<%J+2Q2V@<_(FU7DRY)_O-ZG/)]:L5F^(-6.@^'[_5OLSW*V<#SM$C!254$
MGD^PH Q;?P'9KX&D\*7=W-<6A9F290(Y8V,AD# CC(8Y'';O36\#-J.@WFF>
M(-=OM6,\0B29U2)H0&# J$'+;E4[CG[H]\]-8W7VW3K:["%?/A679G.-P!QG
M\:S?#?B#_A(;:^E^R/:M:7TUDR.X8EHS@GCCK0!RD=E=Z;\2O#<>H:Q/J<J6
M%W&\\L2(%+&+8"%  )VGKR<5=B^'(BL;*P77KT6-AJ OK.)8HP8B'9]I)!W<
ML>3V[=ZZ[4;PZ?927?D/-'$-TBQ\L$'4@?Q$=<=3VR< S6]Q#=6T5Q;R++#*
M@>.1#D,I&00?3% '*?\ "#/!K=[=Z?KU_96&H2^=>Z?&J%)7(PS*Q&Y-W?;S
MZ$<8MWOA/^TG6*]OC/9)?)?11-"-\3JP8*KYX7(YXS@D9 -=)6*?$&/&B>'3
M9N"]@]ZMR7&TA75-H7K_ !=3CI0 FD>'5T?6-5O8;Z=H=1G^TM:LJ[4D*JK,
M#C<>$'&<#FFZGX<%WK]IKME=&SU.WA:W+[-Z30L<E'7() (R"""#6[0>E '*
M:AX'M[WPO?:(M[+%_:%P;J[N0BF220N')'8<JHZ<  >]=1$)%B42NKN!RRKM
M!_#)JOIEQ=W6G0SWUB;&Y<$R6QE63RSGIN7@^OXU;H XJ+X?"#0+#1H]9N3;
M6%['>6^^)"5V.71.,9&3R3R>.E7+SP1:ZE?:[-J%RTT&LVT=M/ J;0BQ[MA4
MY)!!8GG/.*ZFB@#G_#_AV]T@J=0\07NKF)/+M_M"(OEK[[0"[< ;FR?IDYDU
M_P ,6^N7%E?)<S66IV#%K6\@QN3<,,I!!#*1U!_2MRB@#,M-.O!(DFI:C]K:
M/[B1PB),XQDC)).">^/;-8EKX$M[72_[#%[(^@+<"X2Q:,97#^8(]_>/=SC&
M>V<5UU8&J^(I[74+C3M,T[^T;^WM1=RP><(OD+%5"D@@L=K8!P..HS0!"WA-
MC>^(KD:B0=<B6*5?)&(@J% 5YZ[2>N>>?:HD\'^0OAHG4SM\/H5A)A'[P>68
M_GY_N>F.>?:NAT^^AU*QCNX"=CY&#C*L"0P..,@@CCCBK- 'F?A+16U[0]>L
M+F]8:=<ZU=R36WE8=XS,6 #9X1P/0D@G!';8U;X>QZH=?C76+RWM-:"-/;HB
M$+(JJH8,1G&%7Y<]O3BNTKG_ !)XJ@T'P[?ZO# ;];*01RQQR!=K9 ()/IN&
M<9H 9!X8GM]>NM7_ +5>6XN+)+-O,A7&%+$-QCG+'V]JPK_3;/2/!L/@ QWF
MHRW-FT%JXM6VCG 9W4;5VDAL\<#UQGT"B@"KIUC%IFFVUC!N\JWC6-2QR2 ,
M9)[D]2:Y75?AZFIC7H1K5Y!::S(L\T"(A"RJ%&X,1G'R+\N>WX5VE% '-Q>%
MIHM9U'4_[4>2:^M([1_,A7@)NPW&.?G;/;V%9\'P^6R@T-K#5Y[:_P!'@-K#
M=")6\V XRDB'@] <C&#S7:54U"XN[:.%K.Q-XSS(DBB58_+0G#/SUVCG'4T
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MA!=P*K_(X 9&5AAE.!UZ$5'=>#DN/[,NAJ5R-7T^5YH]0=59I&<;75U  *L
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MKL(]"TR+5#J:6B"^:,1-/DEV0# 4G/(]C5?2/"?A_0;N>ZTK2+2SGGXD>&,
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MTF:ZLKJ33K9I[%=MJ_EC,*\<+Z#@<=L4VQ\/Z5ILD<EI9I&8@PB&25B#?>V
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M#98[00"5 QCBM30_ VGPI<BXT2UT^TN8O*ET^&Z>:.7D'<^0%R,8  Z$Y)X
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MN4N8V@:)",AB' .W@\].*\_UG3-7O+[QM+I^GW;R&^T^\MT:-X1=K (RZHY
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M7)D6!V48=%49 Q@[CD]!@9/-1>%([*3[;J-EI%Y8+=LA>2^#K/.R@C<RN2P
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MKV"Q^,MT\T4[!M B :*!Y2/W\G&%!(S_ $KFK70]3\+VV@ZG-I6HSZ>DU_\
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M@XR-^ S/XY\1W[Z=?I;W&D6\<3M:2?.R^8648')^9>/\* .G'B;1VO=.M$O
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MN02SO-<\*^$-&_LZ\L]2TN\M'N?-@9%@$ P[!R-K!@,+M)SN]CBUK'A2\O\
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M]N K<=&)&1QUQ)8^+-2U+Q!?:;;>'V,5A>K;75PUVHV*T8<.%Q\W4?*#WZT
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MT)!7'?<.<^M 'H-16UM#:0^5 FU,ECR222<DDGDDGN:YBU\;+<6DI:QV7O\
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MX)SGMS0!TBNCE@K*Q4X;!S@^AIU<-\,5*6?B16M4M6&OW0,,9RJ'"< X&1^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYS@D8('^'7PVKG3A;7TBW+NA69BN%?/WL#L.3@<\=S5E65U#*05(R"#P12T
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MQ7A_3;"\\=:KKNEWR7.ENL<@6%@\/VQEVR2*1P3Y80'']\]ZZO58KR;3)H[
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MUC1;_1M9OY-)@M])TZ>"[6W$CE@=C-("0"S'82<],]6KT$LJ@%B!DXY/>EH
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M$KG.TD9.<YSUYJK=_#[3+F'2O*OM3L[O2X!;6][:3B.8P@ >6QVX9>!U']:
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M)K;^(D$]W\/M;M+6WFN+BXM7BBBAC+LS$<# 'ZU8TK0K<_8-0N9KR[G@MC%
M+Q0IA# !OE"J<G !+9.![G(!RTOB?6K;P5HGC+[:9DNI;=KJP\M/+$4SA=J$
M+N#+N7DL<X.1Z:5MJ&M^)+;5[S2M5CL9;'4Y+2*"6-6A*1, _F?*6RPW'@C
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MLS:_8@UO)J**K03 X9B44 I@CC!.>.G%67\$Z5/!KEO=M/=0:TXDNXY67&X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;:P.#[TR"]M;F)Y8+F&6-"0SQR!@I'7)'2O(-3U2(S>/[C3I?.A%]IUQ<+;
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MBEK#\5ZV^AZ5$UN%-[>W45E:!QE?-D;:"?8#+$?[- &NMK;I$D201+&GW4"
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M> LK&&,E< ':.,4W[);8(^SQ8/.-@K@AXG_L#QSXL6];5;VUBBLY8X((GG$
M*R%V"CA5Z9_KBKFIZPM_XH\"WNEZC,^GZA+<$K%(1',GV=V7<O<@COT(]J .
MR>VMY/+WP1-Y1S'N0'8?;TI6MX&<NT,98]25&36+?>+]+T]U:X\\6GVD6C7H
MCS"DQ;;M)SG[WRDXV@\$@@UO4 1BWA"A1#&%#;@ HQGU^M(+6W%Q]H$$0FQC
MS-@W8^O6L_7?$.G^'+:WN-1>5(YYTMT9(F<!V.!D@8 YZFLZU\>:'<#51,]U
M8R:7%Y]S%>VSQ.(L9$@4C)4X[<^U '35%%:V\$;1PP11HQ)940 '/7(%83>,
M;-5OT-G>K=V=F+XVK(H>2$YPR\XZJ1R01WQ3=%\5KJ'AK2-1N+2=+O4(4>.V
M11ND8QASLR<;0">20/S% '0QPQ19\N)$SUVJ!FAH8G?>T2,^TKN*@G![?2N:
M_P"%@:$+6WF9[I3+?'3S%]F<O%<#K&X .#QT[]LU7U/X@6EMX9UW4[6RO'NM
M(!$UI-%Y;JQ7<I8'^$@@Y]/?B@#JFL[9WC=[>%FCQL)0$K]/2E:UMWG6=H(F
MF7[LA0%A]#65_P )'"JP1FSNWNGMS<-;I&-Z1@@%B,],G@#)/85JVMQ'>6D-
MS%GRYHUD7<,'!&1G\Z *NJ:8-0TR\MH)FLY[B%XQ=0J/,C+#&X'UK"L_"U](
MUNFKRZ--#;21R(;/33#(S(0RDL78+R!D ?B*O2^++"*XUF!H;LRZ1&LUTHBR
M=C D,O/S#"D\>F.O%31>([.>VTZXBBN7CU"$SPE(MQ\L*&W$#)Z$?F!U.* -
M+[);8Q]GBP><;!1]EMQG]Q%R,?<%<3#XPM-+\,>&Y=*34]3MM3O!;17%T2\F
M"S$EBQ!)(5@!],]*AB\2G1?&WBUKQM3NK2&ULIX[:-&F\@%93(0HX4<#/T'6
M@#O/LEO@#[/%@=/D'%.-O"9UG,,9F4;1(5&X#TSUIEG=P:A8V][:R"2WN(UE
MB<=&5AD'\C6'J7C72],U>;2GAU">]AA2=HK:SDD.QFVAA@<@'J1P/KQ0!O?9
M;?G]Q%SU^0<TX0Q*4(C0;,[<*/ESUQZ5B77B_2[.:$3>>MK-=?8UO/+S#YV2
MNPG.?O KG&W/&:FB\26DUU'%%#<R127$MLEPD>Z,R1A]Z\'(P8V&2,$C S0!
MJR11S(4E170_PL,BD:W@<DM#&VXY.5!R<8S7)'XF>'5CCG8WRVC7)M7NVLY!
M%#(&V8D8CY<D=^G&<9K5U;Q7I^C)=2SI<R066W[9-#'O6VR 1NYST()"@D @
MG (H V%MX4<.L,:L/X@H!IL=I;1.7CMXD8L6RJ ')ZGZFLC4?%NF:=#<S?OK
MF*T@6YN9+9-ZP1,,AFYYX!.!DXYQBJMMXO6]\9#1+>SF>W-@EXMT%&UU=L*1
MSPORGG'7Z<@'3,H92K %2,$$<$4V*&*&(111)'&!@(B@ ?A575]1&DZ1=ZBT
M$LZVT32F*(#<P S@9XK(TGQ9%=^'=&OKJWFCO-2BC,5JB_-*YC#MLY^Z!DY)
M P.: -Z.TMX83#%;Q)$3DHJ *3]*/LMOQ^XBXZ?(.*IZ1KEEK0N5MBZ3VDIA
MN;>5=LD+XSAA[@@@C((Z&J'BOQ*_AR/3-EE-<O?7\-H"@!";FYSR.< X]Z .
M@VJ6#8&X @''('^0*9);PS.C2PQNT9W(64$J?4>E<$/$;Z1X]\0M<G5+FU33
MK6X2TC1I3%DR;R%'"\ 9^G?BNJ_X2.QEL[*XLQ+>F^@^TV\5NN7>+ .[D@ ?
M,O4CD@=: (IM(U*[\0?:;O4XWTB)TE@L4M]K"11U=\_, WS 8'('ISLO%'(5
M+HK%#N4L,[3ZBJ6BZU8^(-+BU'3I3);R$K\RE65E)#*P/(((((KF-?NKS1_B
M+X>FDO;G^Q]3\RSD@\TB-+G;NC;_ ($ 5QTR,XH [(VMN<9@B."2/D'4G)I5
M@A0L4B12W4A0,UP/A76S!XT\7:/J&I7,\-IMN;22>0X6WP1(!Z['!7=U]^*U
M]&U;^S].A@N!J%_J4T)OI;=3YDD$3L2JG<0!@?*!U8J>#S0!T\,$5O&(X8DC
MC'144 ?D*C:R@%I+;0QQPI(""$C7'/4XQ@_C6%-X[T&.UTJYCFGN(M4++:-!
M;N^]@"2O3AOE(V]<\8K$L?$8_P"$XU&^FGOXM-_L.&\%K=!D,;&613B-NC':
M!CO^- '<6-G#IUC#9VZ[885"J#U_'WJQ4%I<_:[5)_(FA#C(29=K >X[?0\U
M/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7'?$2TD>PT74E!,6E:Q;7MQ[1 E7;_ ("'W'V!KL:K
MW=U9VT/^FSP11/\ +^^<*K>W- '-ZW:7L/CO1=;BL9KJR@L[BVF,&TLC.8RI
MVD@D?(>F:J6UC+X?\,>+-6OH_*DU":XO?LP(8H#&$1#C(+G:,XSRV!FNKTV2
MP:U6+3IX98(OE BE#A1V&<G ]!VJ:>UAN6B,R;_*<.JD\;AT..A(ZC/0\T 9
M'@O2IM#\$Z+IESQ<6UI&DH]'QR/P.163:6FI^'_&GB&\.GW%_8ZOY,\#VY4M
M'(B;&C8,1@' (/3KDBNSJO<W]G9O"EU=00/.XCA620*9&/15!ZGV% 'G>E>%
M=3\+_P#"$L;22\CTN"\CO/LQ#&-IRK# )!9001QSP.*75?"VK2:7J^IPV+/=
MWNMVNHBQ1T#B*%HQC).W>0A8C..<9KTNB@#S;Q59>(];_P"$BLWT2YDM[O2M
MFG".>-$20HVX3?,"SAB,#YE],<FKUI8ZJ?%7A>_ETFXB@M-)FM[@EXSY<C>7
MM!PW/W#TR.17=T4 >6#0=<_X0!=._L>Y^V#7OMGE;X_]5]K\[=G=C[O;.<UZ
MD#E0<$9'0]JAL[VUU"U2ZLKF*YMWR%EA<.K8)!P1QP01^%3T >57.F^)[Y]+
MN+S0KN6_L=?%S,ZW$0A,&Z3:85WX PRDD@,3G.>TM_H6MW'A'Q[8II%P;G5K
M^26S3?'^\1HXU!SNXY0]<=J]0HH X2SAUG1/'.I:E_8]U>V&LVUM@PO'OM98
ME*E'#,/E.<Y!(S6C\.+"_P!*\!:7I^I6;VEW;HRO&[*W\1(/RD]C]:ZJB@#A
M_%%KKE]KEY:)ID]UI<^F-';M!,D:BX);/G$L&*X*X'(Z\$],_2])UF.7X=&;
M1[B(:39O#>$O&?*)MQ&,X;G+ ],\8SCI7I%% 'D5QHOB2V^'>L>#AH=S=W N
M7>UO(Y(_*N(WN/-R2S AN2",?CCFO6XV9XE=HVC9@"4;&5]C@D?D:=10!YY>
MZ3JTEW\0V32[AEU6SCBLFW)^^80-&?XN/F(ZXXJ:+3-4_MGP',=,N%BTVSFB
MO&+)^Y9HD0 _-SRIZ9KO:* (+Z%KC3[F!,;Y(F1<],D$5YO:Z5KO_"*>!K&3
M0[J.?1[ZW:Z4R1'"1Q.C.,/R,L,=^O'KZ?4%I>VNH6XN+.YBN(2S*)(G#+D$
M@C(]""/PH \XUGPSK>I7?C&2VL-KW-W8WEB+ED\NY-N$W(P!. 2A'('45TWA
M=7N;AKU_",6@L(O*<R+%YLC9!P#'GY!COC)(X&*ZBB@#E/'VDZAJ>D6,^F6D
M-]<Z=?1WGV*8@+<J%963)X!(<D9[@5@:YIE]K/@K4UT[P<--N;I[8);@0I/)
MLE5V9RK;0H XR<]>!D5Z53&EC658FD42."50GD@=<#\: .4%K?\ _"SFU?\
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M5+>*PFM8895,##R@C-AMVXYR7/;TJ+P5I%G;W.L:U8F0VFI71DM%?(58^K%
M>@>0NWN"IH Z/5M2M]&T>]U.Z+?9[2!YY-HR=J@DX]^*Q!KNLV8AO]2L;?\
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M!NH!EL[N>>6V=>-T$QW?*?[R,6!'LIZ&@#<L[G7SJT5O?Z?:O83VQD:>!_\
M429'[I@QRX(/W@!T/%9W@N^<7OB'07)*:1?>7;Y_A@D02(O_  ')4>P%6-!T
MO6](@0Z_X@AO8+./9$R6_D[@!C?*=QW-CTP.2>3C">$M*EMI]:UBYC:.?5[T
MW C889(54)&".Q*KN([;L=J %\3^(-1T;4=$L[&QM[DZE<M;[I9BFQA&SCHI
MX^7D]?0&N=O?B#K6E:3XF2^TJR_M?0_*D98YF\F:*7[KKD9R.00<=.M7?'\Q
M3Q#X+2*Y@AG_ +59E\[D8\F0<C(/.<9]2*EUGP+/K.EZ^DE_#%?ZT(HY9A 6
M2**/[J*NX$]R23R6/'04 6CK^M0ZS:Z+=VVGQ7]^\LEN8Y'D2*WC526<87+[
MF"X! /7/'.=>>-M6M])\1^7I]O)JWAZ13=0@MLFA9=XD3N#LR=ISRI&>];.L
M>'+C4-2T?6;:[B@U;3=X#F(F*9' #HRYR < @Y.".]6=)T!+&ZU6^NG2XO-4
MD5KDJF$VJ@14 )/  []22>.@ "/5KB]O8DTXVMQ;M8BY:1MRAB_^KP>>&PQZ
M'&T=<\<_H7C$WGAOPNMI86MK?:WYGDVZ#$,"(&9VP,9  ' QDL.E;7A;PR/"
MNA/IUM<M,WF.8Y)@3M3.(TQGHJ!5Z\X)[U@V_P /+RPT'PY!9ZQ$NJZ [FUN
MFMCY<B/D.CINS@@XR#VH H:7K$OA[Q!XXNKV**2Y:_L8(TMU8+(\D:(AQR1G
M<"0,D<XSWZK1-;U2[UV[TZ^T]_L\<*S07Z6TL,;Y.&C*R<AAP>"00>V*Q[CX
M?W>I#Q"VH:P@DU:2WGC>UMC&UM-"JA'4ESD94<?K70:#IVN6H,FO:Q%?SA/+
M06]OY" =V8;CEC@<\ =AR: ,[XA:CJ>F>'(IM,FCADDO;:&1G4D['E52!@C'
M7D^F?J$U+Q-J$5W>Z=80QS7]A;I++_HLTB22."5C&S.SA?O$G[PX/-:7BO07
M\1Z"]A#=+;3":&>*5H]ZAXY%<97(R#MQU'6LF]\*:XGB#^W-&UZ"TN[F!(-0
MCFL_,AGV9VNJ[P589(')XQGW *L_CNY\^ULVMX-*U&YT]+JWM=4#+Y\Q+ P*
MV0 RE1UR3O'%6H-1UJ7XGZAIWG6YL8--AFCA*L#EW<')SUR@YQT[=<R:YX1N
MM:TZYTRZO+:[L;BV6+_3+??)%+\V9E((&X[AP ,%1@@<5/;^%[FR\5)J]IJ(
M\DZ?%8S130EW?RRQ5@^X8)W<Y!_#L 8-KXUOXO#^EW=MHUA&U[KCZ;)#'*55
M#YKKN'R\DE22>.N<&K7_  E'B8W?B'3DL=*^V:1''<>:99/+DC=&95QC.[Y&
M&<XZ'VI(? 5_%I.GV/\ :]L39ZR=6W_9&^<F1GV8W\<N>?IQ6F/"]ZNM>(]0
M74+?&L6T4 C-N?W/EJZ@YW_-G>>..@H BL?&#ZW)HEIIT445YJ6EC5',^76"
M([0!@$%B6?'4< GV.9<?$"_ATV0KIEN=1M-9BTJ\B,Q"Y=U"R(<<A@P(SC'O
MBK=CX&NM*_X1^[LM1A_M'2;'^SG=X"([JWX^5ANRI!4,""><\4M[X%EN;!TC
MU"*.\N-6BU2ZG:W+*[QLI5%7<,* BCJ>Y[T /A\1^('OO$&E&PL'U33[>*ZM
MEBD<QS*X?"$D ALH1GIR.!5G2?%$NMV/AV>R$#-J4;37*E6'DH@^?'/4.53!
M[G/;%-FM(_#FOZOXNU75+>*PFM8895,+#R@C-AMVXYR7/;TJ/P5H]G;W.L:U
M8F0VFI71DM%?("Q]6* ]%>0NWN"IH Z749I+?3;J:&*.62.)F6.1MJM@="<'
M^5<5:>,-0_LGP6;'2;%5UR/;Y8D,:P$0M( H"GY?EZ_I7;7T$ES87$$3K')+
M&R*[+N"Y&,D9&?SKDK/P1>VEIX2@&J0,/#Q//V8CSQY9C_O_ "\,?7F@#4\*
MZ[>:Q_:MMJ,$$5YIMZUK(;<DQR#8KJPSR.'''M5G6=9:PO\ 3-,MD1KW4I72
M(R9V(J(7=SCDX  P,9)'(ZU#H&@7&C:EK=W->13KJ=W]J")"4,9V*F,ECGA1
MZ5'XK\-3Z[_9UYI]_P#8-5TV<S6MP8_,7E=K(RY&58'!YS0!4E\3:M8"WL=1
MTZ&+4KS4C963+)^ZFC"[_/P"2H"@_*3G( SSD9FO>/=2\/P^(+6>QM9M1TNT
M2^A8.R17$#$KNQR0RL,%<\^M:>H>$;_5;&RGO-74ZW97:WD%TD&V%& QY8CW
M9V$$@_-DDYST%5]<\#7'B"TUE[J_@BU#4[-+'S4@+)!"K%L*"P))9B221VXX
MY +=OXAUA?%K:)>6-D#<:>][:&.9N"KJI20E?]L'('KUK'TGQWK%YIWA?5KK
M3K*/3]:N1:%8Y6,L;L'*MR,;?DQCKSGV&]+X>U"3Q9::\+^V#V]A)9^5]G;#
M%V5BV=_'*#CZ\UDVO@*]M?#?AK2%U:!O[$O4NA*;4_OMN["XW_+]\\\]!0 ^
MZ\::B\4M]I.ER7UK#>M:M;QVLS2RJDGEO(C@;."&.WG('4$X%Q_$6L7\-_=Z
M%I\%Y#8WQLS;N^V2X*,%E96)"IM); .<[>V15>S\'ZQI>JWJ:;X@$.AWMP]S
M):-;;I8F<Y<12;AM#')Y!QGCGFEM_!^K:;K.I-I>NK;Z/J=PUU<6K6VZ6.1O
MOF*3<-N[KR#CM0 W2=3URX\9^++:22UF@L/(2"$AD #1%QSSSEN3@YP/2HM#
M\8&\T'PI%:65K:WNMQN\4*@B&WCC4LQP,$X^4 #&2W45K6_AR\LO$^LZM;:A
M"(=32(M!);EBDD<>P'=N'RXP2,9SWK)L_ $^GZ-X:BM]3C_M/P^6%O<F A)8
MW&UT=-V>1CD'@@'VH @U;Q]J&DZ7XE62PMI-4T(Q,X\QEBFBE^Y(O!(/4%2>
M"/O5M6&OZF?&LF@:E:6L:R6)OK=[>1F*J) C(^0,GY@<CCK5'6/ LVL:5K\<
ME_#%J&M^4LTX@+)%''C:BKN!/<Y)Y+'CH*U!H%VWC6#Q#)>P%8]/:R:!8""=
MSJY8-NXY4<8Z4 7O$%W?Z?H%[>Z9;QW-W;Q-*D$A($FT9*@CH3CCWKGK;QJU
MQK_ART#6K66M6)N8YE#;@X4,$(S@;AN()_N,,<9KLZX0_#.S_P"$>?2DO9D(
MU 7=M.O#6\8D+")/8([J/]\F@">]\17B1^&[BXT^QGAU/51!#(<[HD*N8Y%!
M!^8HN>HQNQS69/?ZMJ!^(EK?S6\MI9P-#%&J$;5-MO&,G'\7)[GTZ5T_B#P[
M-K$NB&VNH;6/2[Y+P(T)??M1E"C##:,.?7H*I3^$;UK_ ,3RV^J0QV^NQ -&
M]L6:)_*$6=V\97 SC .>^.H!E^%M?U.QB\&Z5=VEJ+'4],5;=XY&,J-'"K?/
MD8P1G@=/4UW&H7$]KIMU<6UJUU<11,\=NK!3*P!(4$\#)XS7-0>$+R&X\)R'
M4H"- A:(C[,1YX,7E9^_\O SWYK<\0Z4VN^'M0TI;J2U:[@>$3Q]4R,9]_I0
M!S=GXQOI=8N]+:.PNIX]+_M!'@=E17#;6B8_-G!Q\P_(5!I/C76+O_A%;J\L
M+**RU]-J^5(S212>49 2",;3M(QUZ'/:K$/@[6%U:+4I=9LO-&E-IK1Q6)2,
M+N!4J-_'/4?EBEMO!%[;:?X3M!JD##P^X8-]F/[\"-HP/O\ R\,?7F@!UKXM
MU VGB*&[M[6/5M+N%@AMTW;9O, \ELD])"V/8@]<5V$?F>4GFE3)@;BHP,]\
M>U</:1Z-XL\>6VOZ3<M/%86[PW3Q@B.24-^Z4Y'+)F1O;*^HKNJ .(OO&FH^
M7=W>D:7)?P6=ZUJ]M':S-+,$?9(R.!L!!W84YR%ZC.*@U'QEK\+^*_LFFZ=L
M\/A96,L[YEC\KS2!A>&QZ\ ^O:W!X/UC3M8U Z7X@%OHVHW#7,]J]MNEB=^9
M/*DW#;N//(..U/G\'7DQ\6_\3* #Q#&(_P#CV/[@"+RO[_S<<]N: ,_7K[4+
M_P 6>!9K-X$@NC/<1QRJQPWV9C\V#S@,<>YJ=/$$UKHFMZAX>TVQ73M'N9T>
MV"E&N&C.Z9E(X0Y+8R#N([9JZWA._-[X7N1J5L#H4;H5-LW[\M%Y>?O_ "\<
M]^:C'@V[M5UZRT_48XM,UJ62:6-X2TD#R#$IC.<8;J 1\I]>E %:3QCK.I:W
M!8>'K"PECN](35+::[G=059P,,%4XX/;/U[&[!XBUG5+7^TM'T^WNK);]K4P
ME]LKHDACDE#$A1A@Q"D'('4$X$UEX4;3O%=KJEK<PI8VVEKID=IY)+!%8,#O
MW=>,=*IZ;X/U71]1O(+#75CT&[N7NFM#;YFB9SETCDW852<_PDC)Q@\T 17W
MC34?+N[O2-+DOX+2]:U>VCMIFEF"/LD9' V @[L*<Y"]1G%1WWB_7UF\5QV>
MG:</[!"29FF<^:AB\W' &&(X] ?7M8@\(:QINL7YTOQ +?1M1N&N9[5[;=+$
M[\OY4FX;=QYY!QVJ:3PA>//XLD&I0 :_&L8'V8_N,1>5G[_S<<]N: ([/Q;J
M4NM^'XKFQM8]/UZ!Y+?9*S2Q%8Q)\_ !RN>G0]S4,'C74;X:9?Z?I<EWIM[<
MB(I';3"2*(D@3&3&PC@$J.@/4XJU'X1O$N?"DIU& C08FC(^S']_NB\O/W_E
MXY[\U#H7@_6- F_L^V\0 ^'DF,L-J;;]_&"V[RA+N^YGVSCC(H S9_'FNPZ/
MJNKMI=@+32M5:RN$$[L[H)%0E/E S\V>>O3'<ZUAJ.L3_$[5]/DG@.GVUE;R
M)$$;(#F3)SG[V5&3Z ?4U+CP%?7'AC7M&.K6ZG5M0:^\X6A_=;G5RN-_/W0,
MY'TK9A\/7<'C.;7DOXA'=6D5O<V_D$EFC+%2C;OE'SG((/3K0!;\3:K/H?AC
M4]6MX(YY+.V>?RY'*!@JDGD ^G_ZJYV#Q?KEOK6B0ZII=DECK<9%K)!.Q>*4
M1[PLF1C# '[N<>_6M3X@R)'\.O$9=U4'3;A06.,DQL *I:-HL^JV?AO4;V[M
MIH].MA+:K#&0'E:+8'8Y/12PP.YSGM0!FVOC[6!X;G\1W^F6,>FP// T<5PQ
ME>99O*C"Y7&TG@D\]\=JV;GQ/=Z'XAL=-UQ+;R-0@FDAN;8,!&\2[W1@2<C;
MDAAC.","JUOX"#^!+[PMJ5\)XKF6699X(C&T;/*90<%CDJY&/I5T>&;G4;ZP
MN_$%S;W;V$$L4:P0F,.TB['=LL>2N0 .FX\GC  W3M=UJ_BT?4TTZ!M(U&,R
MR;7Q):1E-R.Q)P^1@$ #!/4XJC9>,M2OWT:]M-*EN-,U.158):S![:-AE)6<
MC8R],@8QG@MBIO#7A/6-#@ATNXUY;O1+3Y;:'[-LF*?PI))NP57V S@9XX+?
M#GA'6?#YBTU?$(FT"V?=;6YML3JH.5C,N[E ?;)'' H BM_&FHWW]EW]AI<M
MWIM]<B)DCM9O,BB)($QD(V$< E1T!ZG%8?CC6KOQ'\--3U.TCM?[*^U+%&'!
M,LBI<*AD!S@?,IPN.G.03BN@T'P?K&@3#3[?Q &\/1S&6&U-M^_C4MN\H2[O
MN9]LXXXK.G^'6ICPYJ7AJRUNWBT:YG\^W66T+RV^91(4#!P"NX$C(SSCWH W
M3J]Q_P )_=:0FG69D32ENHKDN0[@R%0C';\JY!/&>N:Q-)\=ZQ>:?X7U:ZTZ
MRCT_6[@6I6.5C+&[!RK<C&WY,8Z\Y]AOKX?OU\8OX@^WVY9M-%CY/V9@,AR^
M_._U/3T[UD6G@*]M?#?AG2%U:!O[#O$NA*;4_OMNX!<;_E^^>>>@H 35O'5[
M::7X@U6SLX)+?1;X6<EO*6628_)N8,/N\R# P<X[9X[> S-;QFX1$F*C>L;%
ME![@$@$C\!7DC7JW7B+5KN#Q#X=@N7OCC3]6LF-R#%A$^42*6^[N7Y2>0>M>
MK:=-<W&F6DUY"(+J2%&FB!R$<@$K^!R* .;F\3ZA=Q:]<Z+;VTT.BS- \<Q8
M-<R(@=U4C[F-P )#9.> .:HGQOJNJZAIEMX>L+*1-3TEM0MY+N9EVD%!M<*O
M'WL<9Y]*OCPG>V-]KC:5J,4%GK+&6:*6$NT,S+M=T(89W  X/<9Z<4ZR\'?V
M9X@TB]L;J..QTS3FTY+9H2S,A*G=OW#GY!V]: .HB,AB0RA1)M&X*<@'O@^E
M<7'XRU"/7-(L;VUM8VU&YFMVM5?=+:E5=D+L"5.Y4SC (W=\5VU>?V/P_P!6
MLX-#A.OP.NCWLEQ"YLCOE5PX;S#OY?YS\PP.Y!H BE\>:[#H^HZN^F6"V>F:
MJUC<H)W9W42K&63@#(W9YZ],#J>@7Q'<VWC.[T74EMK>U%E]LM+CG]ZH.) <
MG *<9'<,#Q65/X"OI_"^MZ,=6MP=4U%K_P X6C?N]TBR%<;^>5 SD?2D\1QZ
M1XNUW3M%CNC)JFF70>\$ 8>5"T9\Q')_AD!5<9YR/0T =7HEU=WVC6MW>Q)%
M/.@D,: C8#R <]\8S[UH444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 445R/Q"N[^STK3)-/OYK.
M235;2!FC"G<KRJI!R.G/;% '745YAJ,NM>'];\0Z3#KNH7-J^@2ZG!-.RO+;
M3(Q7"G;C:W7&.,'&*=%=ZCI]AX3,NM:C.WB-[:.YDFD&V$"%G*QX&5+G )R3
MU(.>: /3:*\O\0^)=4\'ZAXDLH+F6>TBT^WO;:6X)E:T:2;R6!9LE@.7 ;/0
MCI6QXDEO/"6EZIK=EK,T\(TXF.SN6,W[T,/WX8DD !AE0-O2@#N**\[U>XU_
MPU97_B"WOH9+%=,E<6LMX]UYLRJ625"RC P#D#@CH!3KNXUO0K5O$L-_#/IJ
M:;--);27KW'VN01F1'CRBA#\IR%P,'IQ0!UFJZ_!I&HZ593V]P[:E<?9XI$"
M[%?:6^;)ST4] :MVEZ]U<WD365S +>41K)* %F&T'<F"<CG'..0:\[O8'ED^
M'6J2ZA<W4UW?1R3%Y28W9[>1MRKT7'( 7'!YS4>JZKK$'ASXC21ZQ>";3;@_
M9905W1KY,;;1Q@#+'I@^] 'J=%<-9RZAIWQ"TZS.J7=W!J&E2SRQ7#@HLB-'
MAD 'R\.1@?SYK(TRY\1:K:>''CO-2BU62]E360F?*2(;]V-P* !@@4KU![\T
M >H45G:]="R\/:C=&^2P\JVD87<B;UA.TX<K_%@\X[]*Y#0[J_/C<:1+/J"V
M-SH0N"MS.3(T@D">8.28R0Q^4'CC@&@#7OO'.G6<+W4MG>R:4DDT,M_%$'B1
MXLA@P!W 95E!Q@D8[C.MINKR7U[=VDVEWUD]N$8-<(NR56SC8RD@D8((SD?C
M7DDNFQCX#:S/]HN]PN;GY3</MXNW'W<X^OJ>:[:]FNYO%S>%[>>;RH=-6[4O
MJ$D,LC/(ZEMX5F;;M''3YN0>, '<4QY8XWC1W56D;:@)Y8X)P/P!/X5P.DWF
MJSZ_IWA77=66::+2Y+F:XLI&B-S()C&!N&""JCD#&2>>!56\TNXC\6^!K2^U
MJZU">,WT<ES'(8=Y6,D953C< =I/4X.?2@#T"VO7N+^\MFLKF%;8H%GD "3[
MESE"#DXZ'('-6Z\VU#4M5B7XE*FK7:G3;=);-@5S"?LQDPO&,;O;/O5C3KC4
M;'Q5X3#ZM>74>L:;,UU%.X*;T2-E91CY3\Q'OWR>: /0:*\OM[KQ'JEEI?EW
M>HPZVVLR0ZB(<F)+82.&V[@8P H3##DGCDDUZ-J,7G:7=1%Y%W1,-\;E&''4
M$<@^XH H:KXEM-*;2]T<T\>HWB6<4L.THKMG&XDCC@],]*V:\;M+4CX9_#OR
M[B=9)]4LF+LY<H2K_=#9 ^F,>U:=WX@U'PT/&5JNHSW$5C<V(@FO)-S0+<;5
M<EB#PN21D$#T- 'J-%<QHUAK-CXEF>XOHCI=Q:Y2S>[>YD656&75G4$*0P!'
M(SC'6JGC66_36_"UO9ZG=6<5Y?M;SK"5&Y?)D;N.ORC';VH Z<WKC5UL?L5R
M4,!F^U8'E A@-F<YW<YZ8P.M6ZXG3A?:9\2+317U>_O;-=">7;=.K%I!.B[R
M0!DX)&36)8W/B/5;'06CO-2AUE]3DBU<1Y\J.!6DW8W Q@#:@4CD^YS0!W>D
M:_;ZQ?ZK9Q6\\,NFSK!-YP4;F*AP5P3Q@BM,RQB982ZB5U+JF>2 0"<>@W#\
MQ7D^IQW<1^)>I6>IWEG/83+<P_9W"@NEK&PW<?,.,8Z<GVQM6T9OOBSI]U)-
M<!I/#HN"B3L$#><G 7.,'N._>@#OFBC<@O&K$="1F@2QF8PAU\T*'*9Y )(!
MQZ<'\J?7":99!_BUXE?[3=JRV%FRXG8A2WG#[IR,#J!C /..: .ML=2%U81W
M5Q;3V!>0QB&Z"J^=Q4="1S@$<]"*KVNOP77B6^T(6\Z7%G!'.SN%V.KE@-N"
M3_">H%>9PR76L>&_ MSJ&H7LUP_B":%Y?/92ZAK@#.W R B@'MVK<U+4)=#\
M9^,-1MT\V6R\.031JV3N*&<C/Y4 >C45Q>C6^M/J>C:JFJPMIMU;D7,<EZ\_
MVIF3<CQ@H A&"2%XQVXJWXMU>>SU+P[I<4CP1:K?F":=#@A%C9]@/8L0!D<X
MSCGD '4T5Y?XAU/5]&D\9:5:ZE=^1:Z,-3LYR^^2W<[P8][9)!*9&>1S@UVO
MAJPGM; 75QJE[?27D<4K"X<%8SL&0@ & >N,F@#0^VO_ &O]A^Q7/E^1YWVK
M \K.[&S.<[N_3&.]6ZXJ^NM0'Q(NM/34KF.U;0'N$C7;B.02A=RC'7'KFN>T
M34-7CTWX?:O-K5]<2ZK(MO=Q2N#$ZM"[9VX^\"H.[KU[<4 >II+'(\BHZLT;
M;' /W3@'!]\$'\13Z\ELKZ7PWX=\8ZG;W,_FKXA:U\R>X9EC1Y(4+G=D94,>
M2#T'4<5JZ];^(M&TOQ%?1ZQ]FM/['EGMX%O&N)DGC!.]7D3(0@@$=CC&,T >
MBT5YRT^HZ;)X=MCJUY=-KY!F^U7/E*A2#=LC95)3<2#W)V]<DFI+J'Q9I&GO
M%YPU5(]0\[[#!>L+K[(4;]V)6"EF5L,.A(!&: ._DECA"F1U3<P1=QQDGH![
MT^O*+NYM->B\%W%M?ZHZ'7)H76XD>*:([)F,;C/WDX7)YP.O)KTG5[QM*T*^
MOHXS,UI;23*F<ERJD@?CB@"Z0&!! (/4&L/5?$\.G3W5O!I][J,UG%'-<Q62
M*[QHY(4[206/RL<+DX'N,\E)JFI6?A?PEXFMM1N+FYU">T2]A:0M%.L^ P5.
MB%2PQMQTP<U?\.V")\4_%T@GN28X[)@#.Q!W))P1GD#L#T[4 =N\\<<:O(X1
M6*J-_'+' 'U)(%9MAK\&H>(-5T9+>XCN--6)I&D"[7$FXJ5P3_=/7%<]\1+8
M3W7A+,UQ'NUV&,B*9D!!20]CURHP>WXUD7=C-/XO\=>1J5[9M;Z;9NKV\FUR
MRQRE26QDXQT[]Z /3J*\XT[7]3\03:!ILD@WW7A^+49=MV]JTLCX!(9%)^7K
M@8'S<YQ77^%X=4MM!@MM9OX;Z_A9HY+B+HV&.,\#Y@, \=10 MQXBMH]5DTN
MTM[B_OHD5YX;4+^Y5ON[V9E4$]AG)'.,5+INM0:G=W=HD%S!<VFSSHYX]I4M
MDC!Y#=.JDCWZUR'PP9A=^,HKL_\ $R77YVF#?>\LA?+/^[@'%:OC;6#H\-@M
MK(L-SJ&H6EA-.N-\,3NWS<].C@$]"U '645P&HW6I:1XLO=&M;^[-C=:+->Q
ML\GFR6LT;!<JSY.U@PX.<$<8K)LKC5S8_#^]_M_43+K,20789U96#6Q?(4C
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M['MWYQGRY.N*KZWX>O\ 1[#QCXNDU0IJ\^G-Y)M$V+ D2$J!NR6)(!)X]L4
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M09-DY4F)F(RVW)YSNP1DT >LT5Y_JEEJ6E^+O#6GQ>)-6DM]2NKLSB61#@"
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M01ACG:&;D^O/<GITJ63P]ILFN'63#(M^T(@:1)G4,HSC*@[21N."1D9XHO\
MQ)H>ERR17^L6-M)$H>1)KA5**2 "03P"2*T9)8XH6FDD5(D4LSL<  <DD^E
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MU;3M- -[?6]N"I?,L@7Y1U;GH!Z]* ,F7P/H$UK>6LEM<-#>W0O+A?MDWSS
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M9#;#M"JN1U(51D]-Q;UK"E\2W.N>(]6T;0]9L;2ZT\0^0) LJW+L&9PPSG:
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M1S)>H;N7]ZQ !/WN. !QC@5O44 16]O':VT=O%N\N-0J[F+' ]2>3^-<_<^
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M[6&L6L"6<HMWF25%1E>'Y0>=S,<=]QKT2B@#RCQ!/!'_ &WI,&F3:6Y\.K%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP !C-9'P]UV77O!,)O"?[1LMUE>JP(82Q\$D'GD8;\:X[3O^26?#?_L*V/\
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M$N+UV2W0@G>54L1QTX!/-6ZYO7-9O]/\6^&M/A,'V/4IIXYPT9+C9"SC:V<
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M=",<4 >B450TJ+5(;>5=6NK:YF,K&-[>$Q*(^P(+-R.><U?H **** "BBB@
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MSJ=Y/J-Y:AA:B4*L5ONX)1% ^8CN23Z8K2L+*YM)KUY]0FNUGG,L22*H$"X
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M1;2_@2Q#N6$>3$TB*3_"KDC'8Y]Z]5;P]HK6,5D=(L?LL3;XX?LZ;$;KE1C
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M_63I"JR/]6 R?QH Y7XE0K+IVA9>5#_;EDF8Y&0X:4 ]#_\ JKEM:>Y\,O\
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MO VT@,H#,%+XY&><9JUXB?3[R\DLY"DES!X>\UUO''D0(Q($B+C)E)7&<C
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MG_7_ .C)^]_WN/F_&@#SEK*TT;3?!<J1NEIK4UK'JLS2LPF(@/E*V3@*7(!
MP#@ \<4WQ+:OI\GCW3['=%I":"+SRHF*I;W1$G" ?=RJ!B!QT/>O33I6G-IO
M]FFPM38;=OV;R5\K'IMQC%-&BZ6M@]B--M/LDAR\'DKL8^I7&#T% 'GK:+8)
MXN\&HL;A=3TVX6^ E;_20D<3*'Y^8 D\>G'3BM?P%'#%HGB33R<6-IJ]Y;Q1
MDY$40P=HST R>*ZH:)I(EMY1I=D)+8;8'%NF8AZ*<?*/I5:Z\/VITZZL=.M[
M;3X[[*W4EO$$<J1AB,#EB,C)Z9SSC% &-\+6GF^%OA_[46WFT"C)(.S)"_\
MCN*\_ET:WD^&VL:S;S7(UO3M6N183K<.7C<7)"1J,\[L@8/7(]J]K@MXK*SB
MMK6)(XH8Q'%&.%50, >PXKE_!_A'^QK>X;5+'3GO6OI[J.>']X0)'9ARR @@
M-C- &+9:)::I\1O%/VV)YY+:/3[F&(W#A5F"R,",'U'TY/J:Q1)+=_"6R\26
MI/\ PE<=W'F<<3-<FX"/"W<J02NP\ 8XX%>KQ:7I\%]+?0V%K'=R\27"0J)'
M^K 9-,31=+COVOTTVT6\9MS3B%0Y;&,[L9SCC- 'G%[+::YIWQ'&LK&]_8&>
M*W24_-!;B &)DS]W<VYLCJ?PJ?0'MX_%?A1W>-8;CPJP<D@+(5,/7L2%S^%=
MY>^'M%U&[%W?:38W-R$,8FFMU=]IZC)&<<FEGT#1KF*UBGTFQECM&W6R/;H1
M"?5!CY?PH \JT76(+?1O#$%[<(-#N-;OX;IF?]V2'E\A'/383C@\<#M6CXHT
M?0+?3].CLG2ZM?\ A*+1W60J\5N9'7?''QA4Q@E?]JO16T+2'L)K!M+LFLYF
M+RP&!=CL3DDKC!.><TIT32CI0THZ99G3@ !:&!?*&#G[F,=>>E 'GWB@G2[^
M_P!56SL]7\/Q"".=(&"W.F[54@Q=F3#*VT8ZGMFO2(+ZTNIIX;>Z@FEMV"3)
M'(&:)B,X8#H<=C4#:'I+W7VEM,LS/\O[PP+N^7[O..V!CTQ4=AH=II^K:AJ4
M,,*7%]L\TQ1!-P7=@MC[S?,<L?;TH Y/QQ#?#5)+ZVM+/6+:VT__ $S2IWV2
MI&6;]]"QR WRL/\ @ P<UDM?6'B+7;G3-0O+2ULI]'M9M-74H<L8G1BSH=ZA
M9 <9(YX'I7H]YHVEZA.)[S3K2XF">6))859MO7;DCI[=*;J.A:1J_D_VEI=E
M>>0<Q?:(%DV'VR.* /.H=!L=4\:Z1I=_>W.JV<GAN4/+),Z?:0LT05S@]QSD
M=>#5J>U'ASQCJ6A6T&+?Q+;JUD=NX12KA)EY[!&$N#QPWK7H#:5IS7Z7[6%J
M;Q%VK<&%?,4>@;&0*G>"&2:.5XD:2+/EN5!*Y&#@]LT </<VR:=\4=)AL4*J
MNA7*I#O.WY7B"C&<"J'@Z30];T+P[K%Q?LOB".8_:#'(%GEN#D212#[Q0<G;
MT"J#P!7H+Z9827Z7[V-LUX@VI<-$ID4>@;&0*B@T/2;74YM2M],LXK^;B6Y2
M!5D?ZL!DT >9^&S;>(=/TC5;O7+6TURVU#_25BAQ=M-O*M Y+Y*'.,;<!0,8
M J_H[SZ7XITM=1M+>^MKZ[G;3];M&Q(S,LC&*X4\G"[@"#@;!P,5WJ:'I$>K
M-JJ:79KJ+C#7:P*)2.G+8S2VVBZ797'GVNFVD$W)WQ0JIYZ\@=^_K0!/9WUI
MJ-N+BRNH+F DJ)() ZY!P1D<<&N&M8K7Q#XG\96&OJI:T,2VPD./(MS%D21G
M^$EMQ+#G('/ KK=#T.TT&TEM[.&&)9IC,Z01".,,0!\JC@# '\SR:EO-&TO4
M9TGO=.M+F9%VK)-"KL%],D=/:@#RK2[:?Q%/\/5\1&>66_TJ]%TC2NOG*!'L
M+ $<E6R>YS7HOB,W.B^!-2_L6-OM%GI[BU49<@JGRXSDDC'?KBM.72M.N+V&
M]FL+62ZAXBG>%2\?^ZQ&1^%6Z /,IX+:.U\":IH.TSW]S#!<LAR;NW>%FE,O
M]\C;NRV2#]:Y\6MA;_!?54MXH(9CJY1_* 5PJZB H..< =/2O7[/1=+T^=Y[
M+3;2WE?.YX850G)R>0.YY-1R>'M$E6=9-'T]UN)/.F#6R$2/_>;CD^YYH \^
MUE9O#?B?Q4GA]'BE?PU]M$:L6+7 >11)@YRV._?%6=*L=&U&XL-6T[7+0BXL
M98WMM/0QFY0IG=-^\9MRD?>.#DX)YKOH])TZ*]%['I]JEV$\OSUA4/M_N[L9
MQ[5!:^'=$L3<FTT>P@^U?\?'E6R+YO\ O8'/XT <O\+-'LHO!NC:RJ.VH7.G
MQQS3O*S%E!R!@G'!]J3Q39Z<_P 3_"4UY;VQW6U\&>55YVK&5R3Z98CTR:[2
MSL;/3K86UC:P6L"G(B@C"*/P'%)=:=97TD#W=G;W#V[^9"TL0<QM_>7(X/N*
M /+;,VWB*WO)M0UNUT_6[#5I=[+#_ID168^7&I+\HR;5"A<$'')YJ[I\NC:]
M%KHUZ]-MK%CK,@#I($N8520>2L6>=K*%& /F+-W-=^^AZ1)JRZJ^EV;:BHPM
MV8%,H'3[V,]*)-#TF;54U633+-]0082Z:!3*H]FQF@#S'7-,M+Z7XI7%PA>6
MTCCF@.\CRI%LU97&#]X$#G_$UHPV5OK?C_1EU'?<1W7AAI9XVE;9(WF0]5S@
MCGIWKO&T'1V-R6TFQ)NO^/C-LG[[_?X^;\:$T+1XIHYH]*L4ECC\I'6W0,J?
MW0<<#VH \NT&_E72?!&FW;L^C3ZG?VL_F,2K&-I1;Q,3U&1P#UVBKFK12V%I
M\3--M<KHT6E>;%$/N03/ Y=$'8$!6(' W>]>BC0='73WL%TJQ6SD;<]N+=!&
MQZY*XQGWIXTC3!8/8?V?:?8WR6MS"OEMGKE<8- '#VDRWGC'0-'U.-)=,D\/
M":VAE ,<MP&4/P>&94QCT#$UC^;?6OAR[MC=;M+LO%2P6\4TP!N;4.-T"LQP
M0&+#!.,(03@5Z=-HFE7%I#:3:;9R6\!!AB:%2L9'=1C _"LGQ-X>N-0TZPM=
M,M]+>UMIM\FG7L/^CSKM("G:#MP3N'RD9 XH PM-\(VVLS>*6E ATW4MD=G#
M%.&-O\@WR*J,54E_F&.>.V<4O@R:779+"UU"U6.Y\-(]M=?)A3=?<4K[;%+_
M /;1#VJW8^%;_2([G4=&TGP[I>K-#Y,=O;JXMW!=23(RJI8@*=N%&,GKGCI=
M&T^73[20W4D<M[<RM/<R1J55G.!@ \X"A5&><** .>\87;IXH\)6%R/^)1>W
M4R76[[CR"(F%&]06R<'J5%8<UDL,WQ!TI8D?0X+))X(&&8X)VA=G5!T'1&P.
MA;(QFO1[RQM-1MFMKVVAN8&QNBF0.IQTX-1#2=-%@U@-/M?L;YW0>2NQL]<K
MC!H R? EK;6O@70_LT$40EL+>1_+4#>QB7+''4GUKHJAM+.UL+=;>SMH;>%?
MNQPH$4?0#BIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *Q/%'B2#PQIT-U/#-*9KF*W18HF?YG<+
MDX!QC/X]!R:VZY/XB6MU<^&8FM+6:Y>WU"TN'B@0NY1)E9L*.20 3@4 4;CQ
M3_9GQ"N(KW4+@:4VC1W<=LUL2RN964X14WGY5S@@D<]*Z=?$&EOIMI?Q77G6
M]XH:W,$;2-*,9^55!8\=>..]<Y"\K_%*74VL+Y+1M"2$2M:OC>)F<ID \[2#
MC\.O%<AI%GJNBZ!X.U&YT75KBWL;>ZL[ZTMDD2XA\R165P@PS#Y #CL: /6-
M+U:QUJQ6]T^X6>!F*[@""K X*D'!4@]00"*P=>U^[_X2O3/"NER+#=W<+W5S
M<E0QMX%.,JIX+,W )R!R<&M#PO;6L.FS2VFE2Z;%=3M/Y4X(E<L!EW!)(8D'
M@G.,9P<BL+Q)IE]IGC[2_&-G9S7MNEH^GWT%NNZ5(BV]9$7JV&Z@<XZ T ;I
ML-8M=2T]X-6FNK+S6%Y'<QQ[MOEMM*LJKCY]N1S^&#F1O%&C)<QP->;3+.;9
M)3&_E-*"1L$F-F[((QG.01UI]OJXU,JEE;WBH0=\UQ;20",8XP)%!8Y[ <<Y
M/0'SF+1]3N_A2O@B>PNX]9BF2#SC"_E86</YXEQMQM&[KG/&,T =Q=>.O#=G
M]K\[4ABSD$5R4AD?RC@'+;5.%Y'S=.>M6;?Q5HEUJATZ&_5KGRFF4%&"2(OW
MBCD;7QGG:3BN+NK2[>Q^)D:Z??%M05A:#[))^_S:K&-OR\_,"/UZ5<$-RWB/
MP!*MC>B.TLIX[AS:R 0LT2*H8X^7)4CGTH VX_B%X5EFM(TUB(F[E,,+>6X0
MN&*[2V,*<@X!(SVJ]=^*=&LKJ2WN+S:T4J02N(G:.*1\;5=P-JDY7@D=1ZBO
M,].LSXA^$MQX>M;2X:]N=3G5)/(81IB\9C)YF-N% /?.1BK/BV+5=0LO$]G_
M &)J(G6_MY;>.SM2(KB)7B)F9Q_K7(5AMR<!5^7@F@#O+[QMX>TZXOK>YU#$
MUB%:YC2&21HPV2"0JGC@Y(X'?&:M#Q)I+:C9:>MWNN;Z'S[95C<K+'C.X,!M
MQ@COW'K7)(EPWB;QM=-IU^L5YIMLD!:U<^8RQR!E& 02"ZCC^E5;C3KRV^%G
MAO58+>2'6?#MM!.L,R&-VVH$FA.1GYEW#W.V@#T*UU"VO9[J&!V9[63RI@8V
M4*V <9(P>"#QGJ*;?:I9Z<T27$C>9,2(HHXVD=\#)PJ@D@=SCC(J+0K&6PTF
M*.YP;N0M-<D<@RN2SX]@20/8"N>UB&\TWXCZ9KS6]Q<Z8^GRV$OD1-*UNY=7
M#E5!.&V[<@<8&: -:3QAX?ATR#49-3B6TGG%NDA##]YNV[&&,J0>""!COBKV
ME:O8ZW9&[T^8RP"1HRQC9"&4X(PP!ZUYIJ>B7T>G:C=I87CQZCXGMK^*VCMW
M9EA1X]\C*!E=VQFP<'&._%>L*0RAAG!&>1@T 86H>-/#VEW\MC>:BL=S"$,D
M8C=BH<[5/ /&?R[U/+XGT>"^AM);LH\TYMXW,3^4TO/[L28V;L@C&<Y!'45C
M6D4P^+6I736ER+>32H($N# XC+K)(S*'QCHR]ZYSP[9O%#%X:UOPSJEU?V=V
MSQW3EVLI!YA99P^[:" <XQG/N: .AT+7I+:_\8/K.IEK+3;Y4CDF"KY49B1M
MOR@9Y;CN?>M*]\9Z39Z7JUZ&N)&TJ+S;FW%M(LJ J67*,H(! /S=.#SP:Y"Y
M&IVUOX[FMM#GNWN-0AE@BFLV<2QA(D9T5AARNUB!W*BJ\VG:C>77CE+?3M7D
M&JZ"D=K-=Q%3,X28$'.-I)91MP,9Z 4 =A_;]G?CP[*^IW&GS7D@9+7R&'VD
M^624.Y<A>^>,XZU)<^/?#-H;GSM44"UF\BX*Q.PB;C[Q"_*O(^8\<]:YV\-S
M>0^ I$TS45%I=H\X>T<&)1 Z$L,?*-S <X]>G-4-0LKV70?B5 FFWS2ZA,QM
M%^R29G!@1 5^7GYE/\Z /1+[7-/TZ40W$[>:8FG\N*)Y6$:]7(0$@<]:DTO5
MK#6K);S3;E+FV8X61.A^GYUY_J=]+I7BRQU&UL]4,TFAI!.8M->Z"C>2@:-2
MK(P(?D\$''8D=3X%33;;PC96&E-=&WLE^SL+N%HIE<<G>C $'G/3H1CB@"6;
MQ3;1>,XO#?D7)F:T-RTH@<J/G55&0,8Y;+=!@#-3MXHT9+F.!KS:9)S;)*8G
M\II0<;!)C9NR",9SD$=:Q;Z&[@^*=I?"SNGM9]'>S$\,198Y/.5OF/11MR<G
MKC YXKEHM'U.Z^%(\$3V%W'K,4RP><8'\H@3AQ.)<;<;?FZYSQC- 'K5<_HF
MN+K$-_K#3K#I4$TL,!8@*RQ$J\K$]MRL!V &>_'0#I7E&E:!J-_\"]0\,VO&
MJVSW-LR,<;G6X9]N?]M<?@U 'H-MXDTF[NQ:QW+).83.B30O$9(QU9=X&X#C
MD9ZBH-+\8Z!K5Y%:Z=J"W$TJ2.@6-P"$;:W)&,@]NO(/0UAW0F\3>(/"NIPV
M-[:?V8TUQ=FXMGC:,-$4\H9 WDL?X<C"^XS:^&L$]IX2^SW-I<6TZWET[)/"
MT9(>=V4_,!G*D4 =+>ZA;:>L1N'8&5_+C1$9V=L$X"J"3P">!T!-4X_$VD2R
M6,:W+![Z22*W#PR+O="P=>5X(V-P<'BLWQII]OJ-OI\4PU.%UN"\-]IJLTEI
M($;#D*#E2"5.1CYN?4<O*FOQV'A;4]7M+B[;3=8F,TEK9L)9(625$F:%1D$[
M@2 ,\YQ0!WB>(](>WU"<WJI'ISF.[:163RFP#@[@.Q'3KD4VV\2Z3=:HVF1W
M++?*N\V\L+QN%QG=A@..#S[&O.]0M9[G0_'_ -KTK4X4O+Z">U B"O(0L(0J
M#PQ#J/E')QCKQ6MI%]8:EXFN[W4X]4BU"ZT[[$B7&F2V<;1IN=@I<D%SEC][
M@#V)H ZA?&&@M-:Q_;P#>9^RL8G"SX/.QB,-^!/'/2I;CQ/H]I>1VT]V4:2<
M6RR&)_*\T_P>9C8&[8SG/'6O./#%Y:B/PG'JT.M6\6DKMM#+I,J(&=/+023#
M*D!6QD!03@\=*MZ/9O#Y_AG6_#.J7MTE]++!<G>UE,K2M(DK-NVJ1NR1C.1Q
MDG% 'H'_  D&F_;%M1-(9'F:!66"0H9%!+('"[<C:W&>H(ZBL_1/&5AK-MJ=
MSLGMH+&YD@9[B!X\["%)Y&,[LC;UZ<9KFX+'4++Q8EUH8U&*"YU60:CIEY;L
MUOMW-NN8I&&$)P&P"02V*SY=+UH^&O$5E;:7>->6_B%]3CB8&-;J(7"RA4?N
M2H.,=".QQ0!Z#;^)=(N6OE%WY3V*"2Z2YC:!HD(R&(< [< \].*Y\>(Y+OXF
M:7I]I>77V*;3IYY+::V,0W!D".-R!B#ENY'%8.MV#^)_#&IWFA>&]2MM0\F$
M,=35XYKA4E60P*'8DC"MSTR0!G)QK1W\VL_$3P_JD&D:K%:II]S%*]S9O%Y3
MLT9"MN _NGGH>Q/- &UX_O;W3? >LW^GW<EK=6UL\L<J*I(('3Y@13M+\9Z%
MJ%P=/AU 2WT5OYSQ")\NH'+)Q^\'^[FE\>6%UJG@/7+&RA::ZGLY$BC7JS$<
M 5D_97U_Q+X5O[:TNH(M(2:2>6YMGA(WQ>6(@' )R3DXX&WKR* -^W\4:/=Z
M&FM6]TTFGNXC2989#N8ML  VY/S<=.M; Y&:X'2]%N[/QU?:.@4Z"LJZT@!^
MY*Y9?*Q_=\Q6E'H17<W,;S6LT4<AC=T*JXZJ2.#0!FCQ1HQNH;?[9@SS&"&0
MQ.(I)!D%%DQL+9!& <Y!':H#XT\/#53IG]HJ;P7"VIB6-SB1AE02!@9]>GO7
M#1:3J.H?##3_  =+I]W;ZS:SP0M(8&$48BF5C,LN-I!121@Y).,5T_AB*:/Q
MUXQGDM+F**ZGMG@ED@=%E5(%1MK$8.&!'ZT =/?W]KI=A-?7LRPVT"%Y)&SA
M5'4\5EV?C+0-025K2_\ -$0B)"POEO,!*!1MRQ.#PN2,'/2I?%B22^$-9BBB
MEEEELIHTCB0NS,R$  #GJ17':E:ZC#X.\&:A;Z9?7(TCRC>6$*O%/M,#1,57
M@EE+=!UY[4 =C!XHT>YMGGANV;R[C[,\7DN)5EQG88R-^['.,=.>E*/$^D$V
M@-RZ?:[@VL.^"1=TPSE#E>#\IX..AKD+O3=+U73/M*:'KFFK=WL3B]C207L<
MJ1OMG*_,P4<)\P_B/&,$T[J'Q#_8.BW>IV]Q?MIGB)9FF@LRLT]L%=!,T*C.
M[+<@#.!G% '5>)-?C?PQXG.DW\D.I:3:22.1%AHG$9=<AUP00!^!J'3_ !C"
ME_H>C7,=U)=7>F+=R3B!V7.(QU QR7))Z#'.,USMQ%?W2_$N0:1J*#4K-%LP
MULV9C]EV  #G.2..W?!! NV45Y:>*/"=^VFWS6XT-[*0K;MF*7,1PX/W1\K<
MGTH V[+Q/HMAI%WJ%SX@:ZM/[0DA\^:/'E.6QY0PHX4D#//UK2T[Q+I&JW-W
M;V=X&ELP&F5T:/:ISAAN RIP?F&1QUKSBZL;^3P%XAM5TO4#/<>)&N8HOL<F
MYXC=))O V]-JD_\ UZW]1@^T>.]:N+BRO#IL_AP6[R^2T:L0\C,@=@ &VL.I
M[T =''XNT.6YM+=;[$EZNZUWQ.HG7CE"1AAR.1V(/0BMF1Q%&\C!BJ@L=JEC
MQZ <GZ"O*_#%[ UWX4.L1:Q;RZ7;_9;0SZ1+#'OD58P'EY4G "C[H).?0#U5
MF"J6.< 9X&3^5 'G%EXN6]BN->OM<N]+M;'5)H'A>S8PRP*YC5#E<[R0#D'(
M)(QC@==!XMT2ZB:2WO#+MN&M@B0R%WD50Q"J%RV%(.0",<YKSNYL[Z;X5>([
M :5J)N[C5II8H#9R;I$:Z$@(&WIMYKJ]=2[MO&WA_P 0QVUS<:8EM/:SK%"[
M/ 9-K+)Y8&[!V;3QD4 ;$GB_0(M)_M234HTM!-]G9V5@4ESMV,N-RMD@8(&,
MU"?&_AX2W4/VYS-; ,\(MI3(RG.&1=N77@\J".*XC7M$OI-)\5WUO8WC)JVJ
MV4MK:I;N7*1-%OD* 97.UCR < >M=,HD'Q7DU#[)>?9/[#6'S_LLFW>)F?;G
M;UVD''X=>* +NK^(XH/#$?BK3+D76G0H)Y509$L&?F8=PRC)'T(([CHXY$FB
M26-@T;J&5AT(/0UYA91SZ?\  '4+2[M+B"Z^QW< @FA9'+R.X0 $<YWKC'K7
MH.A6<NG>'M-L9CF6VM8H7.>K*@!_E0!F7'CSPU:K=-+J8VVDWD7#+#(PA;C[
MQ"G:/F'S'CGK5RS\3Z/?ZNVEVUX'O!&90GEL%= 0"R,1M< D9VDXKA+RSO)/
M#_Q*@73;XRZA-*;1?LDF9P8$0%?EY^93_.M*YM[FX\5>$)(K6]2.'3;J&6;[
M+(!"[I&%#''!RIZ^E '4?\)1H_VZ&S^UL)9RRP$PN$F9?O*CXVL1@\ D\&N/
MU_QQ+J7P_P!5U?1IKS3Y;.\$*N]N5W*)UC;)=<<_-P.1QG%0>#[<FST?0]7\
M+:H-5TAHU^T7!=K13'P)HW+;22O0 9R<8 R:HWEEJ0^&GB+13I&HM>'5I)$5
M;5F$JM=B0%"!\PV9.1QQCK0!Z1I_B32-5O;JSL[P/<6JAY4:-D^0YPX+ !E.
M#\RY'O3;7Q/I%Y>6]K#=GS;I2]L7B=%N .28V8!7XY^4GCGI7(>(M,OM:\8:
MM'90W42WOAB2RBNG@=(Q,SLP4L1P<'\/K0;:[\1:7X-LUTZ\LKW2[VWN+SSK
M=HU@$*,'4.1M8,<*-I.0<] : +GQ#\5KIWA;46TK4IX+ZVECB\V& N@<NH,;
M.5*@X/3((.*Z>[U_3;*X>">:3?&R)(4A=UC9\;0S*"%)R.I[CUKRVZAU:W^&
M6L^$[C1M3GU>.[=UDBM7DCNE:Y$HD60#;T/()SQTK;\06FH?V[>ZKX>34[;5
M6D@62SFMFDL]23:G+9&U&4$J6R"-G- 'I59#^*-&CN8X'O-OF3FV24Q/Y32Y
MQL$F-F[((QG.01UK68$J0#@D=?2O)HM&U.Y^%+>![BQNTUF.80"8P/Y1 G#B
M<2XVXV_-USD8QF@#O)O&GAZWU1],DU%?MB3QV[1+&[%7D^X#@8Y]>@R,]16I
MJ6I6>D:?-?W\ZP6L*EY)&SA0/I7,>'X9H_B+XLGDM+E(;A;00SR0.J2;(V#8
M8C!P2/Z5H>/?^2>>)/\ L%W/_HMJ '6/C7P[J.I_V=:ZG&]T8C,J%&4.@ZE2
M0 V.^"<8.>E-L_'/AJ_DV6^JQ-^[EE+E&5%6,X<EB !@^IZ<]*YV*U.N7'@>
MXM;2YB728S<7$TEL\>Q/(V>6N0-Q9B.%SPN?3.;!H>K:A\'=5TFTLYX-2-Y/
M.D%Q$T1E'VHRA?F SN0 ?C@T >A67B#3;^_-C#.ZW?E><(9H7B9H\XW*' W#
M/<9Q4<7BC1YK^WLDO/WUR76W)C<),4^\$<C:Q'L3T-<SJEI<>+_$&@W]C!>V
M/V*VNS/+<V[PM&TL6Q8_F W'<<G&0-G7D9C\'75W+HFD^'[_ ,-7EMJ>E1+;
MO<SVP\B+8NSS(Y#PQ8=-O/S<\<T =4/$^CG4(+'[61+<.T<#-$XCE=<Y59"-
MC$8/ .>#Z5);^(-,NKJ.WAG=FEW^6QA<(^S[VUR-IQ[&N!\(6K"STC0-8\+Z
MH=4TF6,?:9R[6@,? G1RVW.WH ,Y.,8R:DT2QU#3M5M!I4.I-HUPD\EYI.HV
MS8LGV,1Y,C*."QV[03D,3] #NK/Q!IM_.D-O,Y:2$W$;/"Z*\8(!=68 ,/F7
MD'N*BM_%&C7-\EFEYMFDB:>+S8GC66,=61F #@9!RI/!STK@K+0M7-I=Z-HT
M^HG1KW1[B*.'5+=DDTV5E 2-)& +*<D;><! <],W-%>+5+2V-[X.U9=4TZVD
M6;[=YGEH3&59879B&W\#Y1T//09 .XL==T_4;A8+:24R-%YZ!X)(P\>0-REE
M (Y'3UJ35M7L=#T^2_U&8PVL>-\FQF"YXR=H.![UQW@ZRU'3-=2TM9]0N?#W
MV(M&FJ6[)-8R;EQ$KL 74C/'.-@YZ9U_B)IUWJOP_P!:LK&%I[F2W/EQ+U<@
M@X'OQ0!L-K6GIJS:6]P$O%MS=&-U91Y0(!;<1@@$CO4=KX@TV\D*13NI$'VC
M,L+QJ8O[X+  CD<BN,FNI]4\<1:HF@ZH^GMX?N+<B>U:+>YD1O+(/*DA2.1S
MVSUK-'A_6YM*U70M'N=0N-(N='E2U758&CFLY3M"P"1@"R,,C'.W:.>F0#T.
MS\2:5?:A]@AN6%T8O/6.6%XC)'G&]-P&Y?<9KFM;\5B7Q'X4ATG49_L][?-'
M*H@(BN(Q&YRKLOS $+]UL<UF"!_%FC726_AK5=.UQ=/N(!<ZEY@6"1XRI6)V
M8[@S8Y'&!DX.!42W=YJ%OX%B&@:M!/I=XBWL;V;JL.V!T)#$;67)&""1C&<<
M"@#U(G R>E9%OXGT>ZN[:VBO/GN@QMF:)U2?')\MR K\<_*3QSTJ;7[&?4_#
MFIV%K+Y5Q=6DL,4F<;69" ?S-<*MG>Z[X;\'Z3_9UY9ZAI=Y:2W7FP,B0" 8
M<JY&U@V,#:3G=Z X .MM?&?AZ]U)-.MM166Z>=[8(L;_ .L1=S*3C X]3@X.
M,X-:.JZO8Z)9_:]1F,-ON5#)L9@"Q &< XR2!SZUSG@6*:&Z\4>=:7-O]HUF
M:XB,T#QB2-E0!@6 R,J:G^(UC=ZCX#U&WLK>2XN 8I5AC&6<)*CD =SA3Q0!
ML/KNFQZE<:?+=".ZM[?[5*DBLH6+.-^XC!&0>0>U1+XETDQW,CW+P);0"YE:
MXA>$+$<_-\ZC(X/3TKCKJ635/&>H:B= U2?3)O#3P;9;9HC,WF.QCP<%6(R
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MHH **** "BBB@ HHHH **** "BBLS6=8CTB.U'EF:YO+A;:VBW;=\C GD]@
MK$G!X'0G H TZ*Y>;Q;<6$=RFIZ1+;W*WD-E:JLFZ*[>7&S8Y4<#)W9'&#UI
M)O%\UEJ5_I=]I@34+>Q-_ D-QO2XB!PV&*KA@>H([@C- '4T5QFF>.;F]N?#
MHN=$-M:Z[;F2VE%T'97$7F%67:." <-GMR!59OB)=IIUQJ3^'V2PL]3.GW<A
MNUW(1*(MZJ%^;YB,C(]B>P!WE%<EK?C=--?4UL[6&\;3,"XB-SY<KL5#E8EV
MG>P5@>2,DX]:ED\7374=ZVB:4U^UE;1SS1O*8G)=/,6-%VME]N#@X'S 9ZX
M.HI@99HW$4H[KN0@[2.#[9%<C;^(=8NOB FFBRBCL?[)2]\N24K*"[X.X;2-
MPVD;<XY)SV$.D>*M/M=!EN+?1TLII]9EL([2-Q^^N3(5+%@,#)#,3S@ ]>E
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MRA1@;<X.><<@4 =A17&#X@0R3:?+;V:7&GWMT+99()]\T>20LC1!>$)'7=D
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MP#J[;L;>2> 1D8P,9K/\6AH/B-X.NK6S6>[*7R*-P0L/*& 6/11DGOWP">*
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M"<# QQQS+=^'-1U34;G5[M+.*^_LR2PMH(YV>-?,.6=G* ]E  7L?7C73Q#
MT]O&]EJ$(N'")));$)DC(R>V<=ZUZ .&MO">L6\/@I"; GP^FV8^<_[W]R8O
ME^3WSS]/>JL_@K6YO!^M:/OT\3ZAJS7Z/YS[44SK+M/R9S\N/QS[5Z'10!Q3
M:#XITOQ-J%_H5UI?V+562:Z@O?,)MY@@0O'M'S@A1D';TZBD/ASQ)I/BB\U/
M0KW3YK?4XX1>)J <,DL:!!*FP8;*@94XY'45VU->1(P"[JH)"C<<9)Z"@#F1
MX?U2W\;6^M07-O-"=,6QN//W"0E7+[UP,'.2#TQUYZ5B+X#U1]!>%[FTAU*W
MUQ]9LI$9GCWEV;8^5!QAF4D?7VKN(K_S-4N+'[)=)Y,:2?:&CQ$^[/RJW<C'
M([9%6Z ./OO#.HZK>:CJMRMG%J$VE/IEM"DS/&@<DL[.4!/.W@+_  ^_$-OX
M6U>*;P4S&Q*Z#"T4^)GS)F'RLK\GX\_3WKMJ* *FJ:=;ZQI-YIMTNZWNH7AD
M'^RPP?YUQD/P^N?*\.S76HB34+-BNIS@?\?D3( T?3D9CB'/\(/<UU5GK]I?
M:_J.C11SK<V"122ETVJ1)NV[3W^Z>U:E '.:CHM_=>.=&UF(VWV2QMYX75I&
M$C&79R!MQQL]><USUUX(UV3PAK?A^*?3C'>:@]U;RL[@A6G$QW_*>1C;@9SG
M.1C![Z[N/LEG/<>3+-Y4;/Y4*[G? SA1W)Z 4MK/]JM(;CRI8O-C5_+E7:Z9
M&<,.Q'<4 8$>BZD?B NOR"U6U.F?8FC65BX;S-^X?* 1VZ^_M2^(-#U"^\0Z
M!J^G2VH?37G$B7&[#)*@4D;1U& <<9]171T4 >>77@K6[GPEXDT@/IZS:MJ;
MWL;^<Y6-6=7VGY,Y&S'X^U7Y="\4:=XHOM5T*YTO[-JHC>\MKWS#Y,J($WQE
M1\P*@9!VYQU%=A)/'%N!.YPA?RUY8@>@ZFJ.@:Y:^(]$M]6LEE6VN-VP2KM;
MY6*G(R<<@T 6A;O_ &>+:29I'\KRVE8<L<8+$#\ZXW3/!VICP]H7A_4WL_L.
MDS12F6"1F>Y\HY0%2H"<X)Y;ICOD=U5#6=6MM"TFXU.\63[+;H9)FC7<44=3
MCJ1]* .(U?P1K]UI?BO1[.XTU;+6KEKN.:5G\Q&8(&0J%QCY,ALGTQW%[Q/X
M0U#Q.DL=U#IHF&QK'44D=+BR< ;BN%RPW D#<,YY]MR'Q1:S1VLOV/4$@NFC
M6.9K8[?G("DGL"2.3ZUN4 <;+X9U9M7\67:-9-'K%E%:P;I6#(41UR_R8Y\S
M/'I[\1VWA75X7\%%C8D:!"8I\3/^\S#Y65^3_@7/T]Z[:B@#B/#?AWQ3X>":
M*E_ITGA^"4M;S;7^UK%NW"(C[O\ L[L].WHL7@^\E\3:=KD\5A::A:O)]HO+
M.1@][&59521-H'=222?N\=>.BT[7[34]7U33(8YUGTUHUG\Q-H)==R[?48_G
M6I0!Q6D>$+NW\466O7$-A97J6[QW[V$C;;]R!AG0JH&""V>3DXK1\0>'[R[U
M_1]?TN2$7VG>9&T-PQ6.>*0 ,I8 E2" 0<'I7244 <7>^$;ZZTKQ8X:U75/$
M47D.#(WE0H(O*4;MN6(!+=!DG'&*Z?1[>XM-'L[:Z$0FAA2-O*<LI*@#() /
M;TJ[10!YWJ7@C7+C1/$^D6\^G&#5M0-[#)([JR;F1B& 4CC80,9SGMC!T]4\
M*7FM>)KJ\N_LR:?=Z))I<JQS,9%+MN+#* ''3K[^U=C3?,3S/+WKYF-VW/./
M7% '+^&-/\7626UGKE]IDUI9KL2:U5_-N0!M7S W"\<G&<D#ISFQXM\,-XA@
ML9[6Y%IJFFW NK*X9=RJXZJP[JPX-2ZMXKL-&:\^TP7K1V47G7$T5LSQQK@G
MEAQG SBI-+\36>K7,,$-O>QF>W-S$\]LR)(@*\ACQGYUXZ\T +:GQ#<!$OX-
M/LP"#)):W+S%\=@&C7;GUR<?K7.1^#-5M-#USPU;3VC:1J<LS1SN[":V2;/F
M)LVD-C+;3N'7GISW=% '*6?AR^T[QC+JELEI]A72HM/@B:9@X\MF8$_(1@[L
M=^F?:L>U\%:W;>$/#&C[]/:;1]1CNY'\YPLBHS-@?)G)W?ACO7H=% 'FVCVV
MJ7^H>/["Q6T6.YU%H3--(P:(M;Q@L%"D-@'(&1R*L7?@75(VN;+3[FRDTQ]%
M73+;[7O,EH51D)0 8.\$;CD'@=0,5LW&M>'O#L,M_;Z<$CFNTM9+BSME DE9
M]G+#&<,<$GOQR00.HH XG2/#&MV.N:)?W#:>ZZ?HYTZ18Y7!9B4.X97I\@'X
MY]JJQ:58:%X#O?#_ (LOK"*.^>[= D_S2!W:3"!@"77<,8SR!7H%03V-I=2P
M2W%K!-) V^%Y(PQC;U4GH?I0!E>$=,NM*\,V<.H2M-J,B"6\E?[SRL!G/TX7
MZ**K7.B:DOCV/7[.2T:W;3OL4T<Q8,,2%P5P"#G)'/3KSTK;U*^_LW3I[S[+
M<W7DKN\BUCWRO[*O<U9!RH.",]C0!YY%X*UN/P?INCE]/,]IJXU!G\Y]K*+@
MS;1\F<\[?U]J;JW@KQ'J$6MPBYTR3[9?PWEO<3F0RJB2(X@.!\JKL.",]>@)
M)KT:JNI:C:Z3IT]_>R>7;PKN=L9]@ .Y)P /4T 8FFZ'J=AXTU35FFLWL]2A
MM_- #"19(D9<*.FTY!R3D8QCO3M8T6_OO%_A_5K?[-]FTWS_ #5DD8._F(%^
M4!2.,9Y//M5_3=<CU"^NK%[.\LKJV(S'=(!O4C.Y&4E6'/.#P>#BM2@#SQ_!
MOB$6=XD4VG$SZ^VJ-;O*YBN(6&##(=F>H!Z$$@9%;'A[PS?6%QXB756L9[/5
MK@S^7"K#AHD1E(/0?+COG/;I75U3FU2T@DN4DDVBUA\ZX<CY8UY/)]< G'H/
M<9 .:TKP,;?P+>^&]1OFN&NH7MC< ?,L0&R(#_=0+QZY]:M>&[/Q=;B&#Q!>
MZ9+#;+M62S#^9<G& TF[A>.2!G)QR ,&Y?\ BBRTV_TVRN8+L7&I$K:H(L[V
M R0>?E('/.*VZ .<U_1;^\\0:%K.GFV>33&G#07#M&)%E0*2&"M@C&>AS[5C
MZEX%O[VWO-1@OH+;Q!-J,6I128+0QO$GEI&>A9=FX$X!)8G':N[HH XO4_#O
MB7Q#H)&HW]A9ZO!/%<V7V-7>"*2,Y!8MAFW9(/' ]><QZSH/BSQ)X-U+3=3G
MTB*]NXUAC2V:3R4&X%G+,NXDX  P /4YKN*1F5%+,P50,DDX % '+3Z/JQ\9
MP^(!]@2*'2I+,H\SDAV=7W?<'R@KCJ.#GVK4\-7>J7N@P3ZS';)?$NLAM=WE
M. Q 9-W." ",^M6KC4!!=6,"VUS.MVS*)H8]T<6%+9<Y^4'& ?4BKE '%1>%
M-6TY?$=AITMF^G:U-+<*\[L)+625<284*0ZY^8#*^GO4VF^%+G2/%FG7=I]G
M_LNRT<:6BM*WFD!E8-C;C^''7OGVKKZ* .>\;:)>^(O"USI5BUNDTSQ-OG<J
MJA)%?L"3]W'XU$=&U0^/5U_99_9QI9LO+\]M^\N'S]S&,C'Z^U7[SQ)86.NQ
M:/.MR+F:W:>-E@9D8*"2H8#!?"L=O7 ^E1Z3XJTW6;:SN(//BCO"Z0_:(C&3
M(I(:,@\AQM)P>H!(S@X .5L/!?B*PTK0;43:9,-.O+F>>VDDD,,XE9F5ON?>
M0L< C&><@XQ-;Z39^'_"NL:/XNU/35M=3N;N2/:^QI%D9G. Q^\,\ 9Q@<FN
M_J"XL;2[DADN;6"9X'WQ-)&&,;>JD]#[B@#'\&:7=:3X6LXM0F>?49466[ED
M'S-(5 Y]P J_\!J"^T;5(_&R>(=/%G.K:?\ 89(+B5HBN)"X<,%;/7&,#ZUM
MW%_]GU&SL_LEU)]IW_OHX\QQ;1GYV_AST'J:IZ]XCL?#VDR:E="66".58G^S
MKO*LS!1GG Y(Z^M '+S^!=5L(=.U'0[^U&N6MW<W4QNE807)N#F5#MR5&0NT
M\XVBM6[N/%5A9V$F[2I[V>]075N/,VK"< K#W+#[Q9N/O'  Q7544 8?B[P^
MWB;PW<:;%<FUN"R2V\X&?+E1@Z''<949K'O_  UK_BKPO?Z7XEN["WDGA"1?
MV<'9%D5@XD8O@GYE7Y1T&>3GCM** .671-6U/5M'U+65L5FTE)6C2VE=EFF=
M-FXDH-B@;N/FY;KQSBV_@K6X?!^BZ.7T\SZ?JRW[OYS[743M+M'R9S\V/PS[
M5Z'66VOVB^)X_#YCG^UR6K72ML_=[%95/S>N6'2@#G;+PYXFT;6=4CTJ^TX:
M/J=T]XS3AS/:R/\ ZS8 -K GD9(P3T/=8_#_ (HT?Q#J4FAWNFG2=3G^TRK>
MJYEMI2H5V0+PX. <$CG]>UK+T37K37X[U[2.=!9W;V<HF3:=Z8S@9Z<T 9UI
MH5_!X]N-;=X&LY-.BLAF1C+E'9MQ&W'._'7M1HWA4Z3XIU?4UN UG=OYUO;
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MN@CO")C\ZA=H _N_+D<8_.@#EM/U36%U?P/>S:K/.NO6[_:[9E01*?LWF@H
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MK> =".CW6DA+I;*ZN?M4L2W3\OOW\'.0-W.!WH R&LI8_B_91G4;Z1(]#DD
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MO$D>Y=I'G P'=R26(''/&.,8 J27PCI4\VLR3I-+_;,0AO5>4[9%"E5P/X<
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MF0S+:?:7-M'(>KK%G:#^'';%*UD/"-G=W&CZ7?:G+>WGGSP).NXN_P!Z3+D
M#@< X^G- $'A[7%\4WEGJ.GW,RZ=%8JTL>[(::3G8W^T@4Y]W'I39=1GU?Q[
M?>'_ +5/:6UEI\=Q^X;8\KR,PW;NN%"CCH2QSGBM7PUHR:+I!B\B*&>XFDN[
MA(ONB61BS >H&0H/HHIVH>'K*_U2#5-TUOJ$,9A6YMWV,8R<E&[,N><$<'D8
MH \_C\0^(;VQT.!]5E@N5\13:/=3Q11XN402?O,%>&^4=.,YX/2NWU""]TCP
M/?)'JUU+>6MG*Z7LBH92P!8$C;M/8=*=-X0TF:#3852:*/3I_M-N(Y2,2\Y=
MCU8G<V<YSN.:3Q3->-ID^FVFEW5VU];3PB6(H$B<IA=^Y@0"3U .,<T <[I>
MO7NJ7GA/19[J:,7FA#4;F=#M>=\1@*&[<LS''/ [9SE:KXBUZS\*>+;<:E,+
MK1-1BA@O0B;I8I#&0K_+C<%?!(P>A]<]E!X1M#H^@V]RSK?:/;I%!=V[E'0A
M C8/=6 Y!!!]*FN_".DWVAW&D3),;6YE\^X*RD/-)D-N9NN<@?D!T&* ,6^.
MJ7_Q)N=%37+VUL&T=+D) L89',K(=K%3V ZY/H17-6M[J'B&S^&U[?:C<BXN
M+F=)FA8('9891OQC&X[?U.,9KT4>';0:XVLB:Y^WM:BT,GF\>6#D#'3.23G&
M<U1C\"Z)%I6G::BW2P:=.9[1EN75XF.<@."&P=S9&>] &'96=Y?>)?B%;:?>
MR65ZTEKY%PF"4?[,N"0001GK[59\+Z[<>)8]%1;B>&XLX7;5HRPR)E)C\M^.
M[J[<8X3T-:\VFQ^'#JVMZ987FH7UX8VFMHYAF4KA!MW$ ;5^G [FI?#>E?8D
MOK^:S2TO=4N3=3Q*02G 55)'!.U03CC<6QF@#/\ &5[>Z-=:+K$5Y+'IL5ZD
M&HPC&QHI/D5R<9&URAXZ@FL#2M>U"XO]:T*34+LW5U=1R:3.Y7<;1R?G3C!"
MB.5LG.1MSUKT#5=,M-9TJZTV^B\VUN8S%*F<9!]^Q]ZB&AZ<-5M=36U1;JUM
MFM87 QLC8J2H'_ 1CTR?6@#B-0N]1ED^(NGR:I=M!8Z?%):D%5:'=#(Q *@=
M2!R>?>J;VDHM?AC#'>SJ\C9$S;6:,&S;A<C'';(/XUW:>&--6_U:\999)-6C
M$5XKR$K(H4J!CM@$CCUJK!X*TJW725C>\_XE3%K0O<NQ0E=G.2<C;\N#P!0!
M5\$WE[)+XATZ]O9KP:=J;6\$T^-YC,:. Q &<%CS63_:VIZYHOBS5+74IK.Z
MTF\N;>TC3&Q/(4'YU(^;><DYZ C&.M=?I>A6>D75_<VIF\R_F\^X\R0L&? &
M0.W  X]*J7'A#2I[R^G GB74 !>PQ2E8[G QEE]2."1C(X.: .3T6ZGUWXBZ
M-JDL]U ;KPREX;97^1&:6,E0".AXSW.!S6/ID^HZ3X2AU>SU2XB">))(6M55
M/*DCDO&1PV1DG#'G(Q@8[D^EW/AO3;G6+352DL5W:PF"-H96C!CR#M90<, 0
M" >.*H_\(-H_]C_V5F[^Q_:OMFSSVSYN_?NSU^]SCIF@#$GN_$?B6;Q FB7L
M5G<Z=>_9;8O<%50JJ,3(GEMO#9/4],8P025L#K6L>.-8LG\0W,%M:0V%RD=J
ML93+[RZ E<E#M[\GCGC%;5]X$T2_UM]6D6[BNI55+D6]T\27048 E52 _''/
M4<'BM"T\/V5EKMYK$)F%W=HD<V9"494SL&WH,9.,>M '*>&->O'\16NEZ[)?
MV6L-'*S128>UO@,$20..!M'\/!P>02,UZ!6%:>%=/LA:[7NIQ91/%:++,6,
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MX@TJ>&&2TO[>[\_'DK;RK(TF?0 _F>@')Q0!=EO+:":.&:XACEE.(T=P&?Z
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MR7=EA) 6!"N1G!P<\<9],UY'9:EIL'@#PA8R75NEU9>)(_/A+#=;XNI,[Q_
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MN]TD9##/*N% R.W!Z5I:L^D:'XWU\0VRK:-X5,T]O8D1O+MD?D;?XMI^]U%
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MF()ZG   Y))(  Y).*RE\7Z6D^H07K2V$UA MS.ERN"(CG#@@D$9!&!SGC%
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M;_:9K%E E:/!(93G:RG!Y!.,'-<S?^)+JY_X0/5W:]M%O9O])MX]VV8-;,^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWR1NK(P1FWC<@\L # (]<#! +@\0>)+[Q7J^C:=8Z8J:<]L6FN)G.Z.0,20
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M#+DD\A<@ =,DY/& "I8>,=1DU_2-,O+:S6;4H9V:WB<EK.2,!O+=P65C@X.
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M%#[LA4*EB.X;Z5N>'=2_X2W2QJ\<UY!%#IXMVC2YD7;<$9E!&>63"@,><EJ
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M[&"1]P,>XG)4[-P4D@?2NANI7?Q5IWAA+EH[5]+:YC6:ZF!GDWX8;PVXE5Y
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M7 YX% 'I=17-S#9VLMS<2+%!"ADD=C@*H&23^%<'H5E>:B/#^NQ>(?\ 1KJ
MK<1K/*_VTNF>A;".I!.5 Q@C@"N/N],:_P#@5=Z[?:IJEU>-:2H1+>R&,XN#
M@E,X)&.I]?I@ ]P  S@#GK2UPWB<-X6U71?$"7U]_9$,OV348I+V5XU23A)F
M#,1\KD D]F]A70>&DE?36OYY+@O?RM<K'-(S>5&Q^10&/R_+MR!W)H V:J:;
M=7-Y9B:[L9+*8NZF&1U<@!B <J2.0 ?QKBM$TQ]4\:>)UN=5U7RM.U&$V\27
MLBJH:!692,\J2QXZ#MCFLO3;_5S\,]+G2\NIR=;:*\<S,T\MO]K=2JG.XMC:
M,#G (% '>>*->7PQX<O=9DM);J.U3>T<3*#CUR3T_,^U:ZMN0-ZC->2^*["_
MB\*>/[R22_&DO;*NGPW,LF -JF4A'.0-_3(]<<8K?BM7L_B/%IHO;^6TU'19
M9;B.6Z=@9%DC4.O/R'#D83:/:@#M[>YANX?.MY%DC+,H93D$@D']0:EKR7PQ
M;:G%\*?#,NBJ;J8OYMQ827KQFZC D!1&)PA!(; P#MYKN/!>HVVJ>&P]O]O7
M9<31RQ7S,9X7\QBT;$DD[<X!R> * )/$GBFV\/>'M0U=8'O4L6"31PLH*MQU
M)/;<,XR>>E;U>*75E#;?"7QV8VFR-4NXP'G=P%%P,<,2,^_4]S72ZC<WGAKQ
MGJ@L;J\N5;PY/?F"XG>56N(W 5E!.%R#C"X'3B@#T:BO/]#L;N_.@:W%XA_T
M6[MREQ&L\K_;2\>1U;".I!.5 Q@C@"N<TRZN].^&>E^)9M9U%[FZDCL[F>XN
MW:.*%[K:SD9X8#C?U&X\]* /7+R:6WLIYH+=KF:.-F2!6"F1@,A03P,GC)IU
MO))+:Q22PM#(Z!GB8@E"1RI(X..G%<!JVF:CI&D^*+E==D6&729;BWM89Y2T
M$L:D^:DC,2 >,@<$CZU'(+B]UWP);/J.H)!?:5.UTD5TZ"4K%$03@Y!^9OF&
M#SUH ](JEJFH-IMJLJ6=Q>2/(L:06^W>Q)_VB  !DDD]!7._#ZXF_LC5+6XN
MIITL=8N[.![B4N_EK)A%+-RV,XYYKKZ .13QTTM[J]G%X;U>2XTD(;N-&MR5
MWIO7'[WYOE]*T](\1QZMKFKZ8MI-"^F^3N>1E(D$BE@0 3@8'?GGI6#X4_Y*
MA\0/^NEA_P"DXK%U.P%WX@^(\WVN\MWMK.VFB-K</"1(MNY5B5()P1T)QZ@T
M >IT5YK::K>^(=4TC2;JZ"?:/#UO?!3-)$9Y7)$A!0@DJ IQVW$U'=CQ!I.G
M6+7%S/XFM;*UEBO_ +#<-!<J?,8"90&^=@$*]<Y4D=30!Z=17FMMJ#>*-8.C
MVVI.+7^Q;6YLF>:6&282!]TWR,"6&$Z]#]377:8]]IW@U6GO%U>^M;9P9T3;
M]H=,CISR<8]S0!N5C:%X@77+C5H1:2VS:=>&T<2LI+$(K;AM)&,,.]<(=0OE
M^'_AKQ99:A=3:K<7%J;A?.9DN?.<))$4SM !8XP/EV\=ZB;2/MT7Q!O5U74+
M">RU&6:"2VN6B5'6VC;<P& W0 ALC'3&2: /0)O$"0^+K7P^UI+ON+62Y6X+
M+LPA4$8SG/S#J!^-7;"XGO;5GO-/>S<2NHBD=7)4,0&RI(Y'/XUPNGW-UJ7C
M/P;=7ZE+NY\.323@?*5=O(+?3DFJ5C?ZO_PKA)HKRZF9=>>&X8S,T\EN+LJR
M(Q.XL5P  <XX'.* /4@ HP  /04O09-><W*76FIXPU6?5-3TW11;HEA+(9&:
M%BF)&2)SG[Q4+G'.<8%4[C[4NL^)=(G^TPV4GAM;H6SWKRLK[I%W$Y^5B%&X
M*2#CJ<T >A3:D[6UA<Z=:M?P74D8+Q2*H2)AGS>3R ,<#GFM"O+4633_  /\
M.GM+R\B,]YIR3*+J0AU>+YE()^[\H^7H.PK0@FF\2'QI]JOKNTNM-NWM[3R;
MAX_LZ+$K))@$ [F+,2<Y''3B@#T*BO+-(NM0\2:[X5.IWE_ NH^'I+B[MX+E
MX5=PT6& 4C:3NSE<'G&<9HTNYU^X\&Z>;)WU62QU*\CELYKPQ37<$<DB*!)G
MEERIP>N.: /4Z*P/!FHVNI^&H;BU:]V"65&2^),T3B1MT;DDDE3\O4\ 5OT
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MT 43X0T)M/GL&L<VD\_VB6(S/M>3.[<?FY.<'Z@&G6?ARTL_$]YKD4:QW%Q
ML$A5V)E"XPSY/4!0!CW))SQ;EUO2H+]+"74;5+N1@BPM* Q8C(7'KCG'6KDH
MD:%Q"ZI(0=K,NX ^I&1G\Z *>HZ-I^K/;R7EOOEMF+P2H[1R1$C!VNI##(X.
M#S4%QX9T>ZL8+*6R4V\$OGQH'9<29W;R0<ELY.3SDYZUA^!_&MIK6@:0NIZK
M8_VY>0F1K82*CM\S=$SGH/TKH[G6]*L[R.SN=1M8;B1@BQO* Q8]!]3V'>@"
M\% 7;U&,<G-8L?A#P_%I)TN/2X$LC()1$N1M<'(93G*D'I@C';%7K?6-+NY+
MF.VU*SFDM3BX6*=6,)_VP#\O3O3)->TB.SAO&U.T^S3J6AE$RE9 .I4@\@>H
MH EL=-M-.606T15I6W2.[L[R'&,LS$LW  Y/05#?Z%IVI7<-W<P'[5"I2.>*
M1XI%4]5W(0=I],XITFN:3#%:RR:G9K'=_P#'NQG7$W?Y#GYN/2BPUO2]5M);
MO3]1M;JVB8K)+#,K*A')!(.!QS0!#<^&M%O+>RMY]-MVAL6W6R!<"(XQQCL0
M<$=#WJ-_"NBR1:A$]F6CU$[KM3*^)CC'S<\\<?3BLB'Q2U[\1K32;+4+2XTZ
M739;ADB +JZO&%);/0ACC 'XUM>)/$-CX7T.XU74) L40PJYY=CT4>Y/Y=:
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MPS<#CD^M:EE8VVG6_D6L0CCW,Y&22S,<LQ)Y)))))Y-0W^M:7I;!;_4+:V)
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MZ7;/&KMF1<8VELY*X)&,XY/K5A/#6DQW%A.MJPEL(S%:MYSYB0\%1ST( 'T
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M/L:M5%;6T-G;1V\";(HUVJN<\?4]3[U+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?J^KV^C6L<
MTX=WFF2""&, O+(QPJKD@9[\D  $G@5H5R_C;1-1U:UTN[TGRFO]*OX[V.&9
MMJ3A0RLA;L2&.#ZT 8=AJRZ?\1?%-[J23V=O:Z5;2RK++YBCYI"63!/!  P
M.1TK8C\=VKZI)IGV"X:]^R-=P0Q2Q2&=5/S*"KX#CT)^A-8NH^%==\2:GX@E
MNK6'3H-4TF&UB8W(D>*5'=AD*,$989YZ>O;H?#<GB>=D&NZ5I^G^0FUY+:?S
M3<OTRHVC8O4X))Z>^0";3O%5OJFCZ-J5I:7#QZJP6),IN0;68EOFP,!3G!)S
MQUJC/\0M)M[FTW*S6=U=_8H[I9$($A8J"4W;@A8$;L>_0@TOACPM<:'K6J.\
MJ-IOGR2:;$.L*S;7E!]MXX]!GUK.\,Z3XIT +X?:PT^;3()F,&JF?]X(2Q8*
M8MO+@'&<@=^<<@#= U2VT*]\=7E[-+]EM=37[S-(W,,6%7)R26; 'J:Z!?%"
M1ZRFDWFG75M>S6[7%K&S(PN%7[RJ0V-XR,@^N02*YB^\%ZKJUCXOMF"6DFI7
M\5]82LX90T8CVAP.1DQ^_!]:VQI5_K?B;0]9U&R^P?V3%/\ NS*LADEE4(<%
M?X  W)P22.!B@"E:?$VQN8-(O7TC4[?2]4E6"*_E1!&DC$A58!BPR1C=C&>]
M6]6^(6DZ.)YIE9[*VN1;7%PDB?NWW!2=A;<55C@D#CGKBN4\(:5>^)?A5X:T
ME[3R;598IYKDR*08XY2X"@'=N)4#D #).3QG;T[2?%.A:IJ6G6MAI]WI=Y>2
MW5O?RS[7M1*Q9U:/:=^&)(P1GN1V )/&^O+=^$?%-O86UU<+8VLL<]S!*$$4
MOE[L [@6V@J6QV..3D5T^@-_Q3.ELQ_Y<XB23_L"N)N/#?B.QLO&6C6=E!>V
M6N-<W-M<M<B,Q/,F&1U(['H1^..W::983#PO:Z=?JB2BT6"81/N ^7:<' _E
M0!EGQQ8K:V.HR6MRFD7LX@AOSMV98[49AG<J,> V.XSC-+!XR^U:_=:1;:)J
M<DEG=1V]S*!'LB#KN#D[^5P1TR?4#C.#;^$M8N/ ]IX*OX(_L]M-$K:@D@VR
M6\<H==J_>#D*%((P.3D]*WO#VF:A9>*_$U]=6PCMM1GAEMV$BL<)$L9# =.5
MR/;TH N^(/$</AYM.$]G=3B_NEM(S JD*[ D9R0>@/0'\*R6\>E1JT?_  CN
MJ&\TK#W5L##E8RN\.&W[3D \ DY!XJUXPTN_U23038VXE%EJL5Y-EPOR(&!
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M(BA44#A0!@#%>:67AGQ4;SPY?7]A92ZCIU]*]Y=M=Y>X5D=0P^7Y5&X83MT
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MMT.SUXS^-5IO$VL6NK:43?1W*7>M/83QP1 VR1GS-@60J&,@V#=@D [@<<4
M>@2Q+-$T3[MK#!VL5/YCD5BZ--H>EWS^%]+5H);2$3_9MCA4C8X!4MQ@D'@'
MUKC)];\8S:)XIU2UU>S1M"O[A4@-F"MQ'$BL48DY7@G&.<]_2:&6^UWXAM=:
M=>?V;)=^&;682&(2LFZ60@ -QWYR#_4 'I5-=$EC:-U#(P*LI&00>U87@C6K
MCQ%X*TC5KL(+FYMPTNP8!;H2!VSC-4?&/B&XT"ZL99S>6^C.DGVF^M(!,8)
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M>3:VTX^;;@D=,^U=#X+U34+^/6K34[E;J?3=3DM%N!&$,B!4=2P'&?GQQZ4
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M;Q%X1MOM$7V;5=/FGG3R>?,2-&!SGIE^@QTH [&**."%(88TCB10J(BX"@=
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M56NHTCNXSTDV9V./1@"1[C'H*FBT72X+Y[Z'3;2.[=BS3I"H<L1@G.,Y([T
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M$4<8))P7Y)8XS_NKZ9(!C>* T7Q#\"BW&&\V\1E7@>5Y&6_#(7\<5K>.T#^
M/$)+,I33KAU*L5((C8@Y'N*NII(DU_\ M>Z*O-%$UO:H.D2,06/^\VU<^@4
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MQ38:>#!I,GAM[N>&%BB17(+A&4#[I95.0,9VY->A1:)I4-G-9Q:991VL^3+
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M1K'3[6U:4EI#!"J%SZG YH Y'X@6=C<:WX-DO+>WD7^UO+9I4!&TPR';SV)
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MN)#$\LBNF[.0".P[\]>:]?M-%TK3XI(K/3;2WCD7:Z10JH9?0@#D<GCWJ/\
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M^W_U=O&$#'JQ Y8^Y/)^M9L.FZO=:\)M3?3QIEE*9+"*V5_,)*E09">!@,V
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M6\TZV$4\4)=,QF7<"1T/S#CJ<\"N7TRQOX?!'P_M9=,U!9['54ENHS:2;H4
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M=^_@?*.G7' (!V47B72I5E;[0\:16YNF::"2)?*'\8+* 1]*L66K6FH7$UO
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MW,3R(67='(K@, 0<';CK6Y534[XZ;I\EV+2ZN]A4>3:Q[Y&RP' R.F<GV!H
MQ(=!U./QB^OR75I(6TU;$QA&3+!R^_J<#+8QSQW-8-K\/]7TS1= _LS6+:'6
M-%$L4<SPEH;B*1LLCKG(Y Y![>_'HE% %'2K>^M[/_B97:7-Y(V^1HD*1J<
M;44DD*,=R<G)[U@VWAG4=!UO4;[P_<VOV/4IOM%S8W2L%68C#21NO3=@9!!Y
M'!%=910!S6O>%[CQ%H;VUWJ'E7PFCN;::*/Y+>6-MR$*3SSG.3DY[<80^'[Z
M]U5=8U"2T^W064EI;1PAO+0R$%W)/)SM4 =AGDYXZ:J5[J:6EHEQ%;W%ZK3+
M%MM$$C#+;2QY^ZIY)[ &@#D[?P5J-OH/A331>6K'0;A)C)L;]^$1D Q_#D.?
M7I61X\T2YTSPMX^U:>X@:+58(F2-008S&JH 2>N<9[?C7J%1S6\-R@2>&.5
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MB7B^(+SQ'+/;K -&DLFA .1R7+[NG7C&.G.>U==3)8HYHS'+&LB-U5AD'\*
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M"RU"6[T]D6Y1( ?+++N7G.#D<\5JZ=J$6IV2W4*2QJ6="DR%'5E8JP(/NIH
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M-:&7;#,T#B6)HV5UQD%6 (QFK] 'G-Q\/=87PSJGABRU:S31[F<S6QFMV:6
M-()"G# $9R0>O./<=IJ]A<ZEX=O=/66(7%S;/ 92A"@LI4MMR3WSC/XUI44
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M10,(LC;L8 QT&3@9/4&[:^%8K3QI?:^D[>7=1)FVQ\HF *F7ZE-J_GZUT-%
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M?A49 ,?P\,3WZ5W%% '%Z=X4U[1M0N[73];@3P_=7+W/DO;DW$&]BSI&X8
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MZL26;W);H.!3? ^B3Z#X7@MKL 7LTDEU<@'(625RY7/?&<?A70D XR.G2EH
MY >$+BZU_2]6OWL_MFG3.XO;="LT\95E6)_8!ADY.=O &366W@'61I T>+5[
M)+&#51J-LQMF:3_7^=M?Y@#@DCC&>.1T/H=% '&1>%==TS7M2GT;6K:#3=5E
M^T74,UL7DAE*@.\)W  M@?>! /8U/_PB]^FM>(KZ.YMRFK6<5K&CAB8O+5U#
M$_Q9WD]NG6NLHH RO#6ES:)X9TW29Y4E>RMDM_,0$!PBA0<'IG%:M%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQF=!T#XZD9.&X(SP:#X6TO[;I5U'$\+Z5&T5FD4A5(E8!6&T<'( '/I0!G>
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M86\=WIND?$J_LM4O8KJSN9WC?<K99;:-@2&4@GC'TK3%YJ=A<^&+.;6[V?\
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M7-<T%/%NEVFJ7(2TTZ'4;.Y.UI(=SE&B9F!R"5)!/S#UKT&^\-:7J.F1V%Q
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M(P3MP/8GO0!TP&% R3@=Z6J6F:5;Z3%/';-,RS3O<-YLK2'<YR<$G@>@J[0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4457N[VVL41[F98P[;$!ZNW7 '4G
M / ]* +%%0VMU;WMNL]M,DT39 =&R,@X(^H((_"IJ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KCO'"7AOM"ET:9!KL4\C6EO*/W4Z;#YH<_PC
M;C##D$CUKL:HZAI-OJ,UK<2&2.YM'+P3Q'#(2,,.<@@CJ"".G<"@#$\ W,5W
MX?FE\J>&^:\F.H0S !HKDMEU '&T9&,=L'KFNIJK8:?;Z=%(D .99&EE=CEI
M'/5B?7I[   8 JU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
1%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ljb_employmentxageementx009.jpg
<TEXT>
begin 644 ljb_employmentxageementx009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5P7CN]^P^*/":R:E<65E=W4T
M5WMNWA1D$189(88^8#D8KO:XSQ?I^J77BKPM?6.ESW=OIMS+-<-')$N T90
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MM"BF58B,B1<,59< \J3T(Z\5R$?A?7T@^WQZ<ZW=EXFGU6*U>:/_ $F"0L"
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M/I,8EN[5H@TJH02'&TD,I /(..#G%<A8^%M?MO#.@3C3V74=&U>>\:S::/\
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MOJUKX9L8-;G,^HHA$LAQD_,=N['!;;MR1WS6Q0 4444 %%%% !1110 4444
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MDGW/- &U9:-X*U)Y4LM)T*=X@#(L=K$3'G.-PQD'@\'TJY_PB/AG_H7=)_\
M */_ .)JGXFOK?PS&^K6T$9U'4IK;3T+?=9RY5"V.2%WL?<#'%5I-9U>Q\6Q
M^';B>VD-_927%C=^01LDC(#(ZAOF7# @@@]1[T :O_"(^&?^A=TG_P  H_\
MXFC_ (1'PS_T+ND_^ 4?_P 36)X>\3:IK6C::KM;1:PUY+;ZA$(25A\HD28&
M[(_@ .3]]>*@C\3^)-4MX-4T73?M-HU\T)MRB#= LAC9Q(9!A_E+8VX[8/6@
M#HO^$1\,_P#0NZ3_ . 4?_Q-'_"(^&?^A=TG_P  H_\ XFN-U#Q=XHM](\5Z
ME'+I@30+YHQ&;9\W$:I&VW._Y3ACSSD]ACG4\6>)]5TB+4[FUDM8H[33A>6T
M1C::2=@&+>8JG*( JC=QR>O&* -[_A$?#/\ T+ND_P#@%'_\31_PB/AG_H7=
M)_\  */_ .)K";7]>U#Q9:Z3836%M!=Z,-0626W:1HF+JN,!P&Z\?=Z]\8.)
M)XCUS7-%\$7HNH+26]U5[:Z1(2R.T?G#/W@=N8L[<]QSQ0!T"_"KP.NI&_'A
MVU\XMOV[G\K/_7/.S\,5L?\ "(>&?^A=TG_P"C_^)K!E\6W$?BZ30[F[@T^Z
M%S$MM#=6Y"7L!";VCDSC?RX"]L 8/6NWH QO^$1\,_\ 0NZ3_P" 4?\ \34-
MUX;\)65N9[G0M'CC!"Y-E'R2<  ;<DDD  <DG%5O[9U'6/$&MZ5I,]O;-I*1
M*7FB,GF32(7 (!&$ VYQR23R,<\GJNO7OBKPWX)U:!H[(W.MPQRP-&7VS(9%
M/.X94,AX[\<T =;I>D>"M:MY)]/T;1YDCE:&0?8$5HY%ZJRE05(XX([U?7PQ
MX;M6%PNA:5$T1WB06D:E".<YQQCUK3@A\F/D1^8V&D9$VAVP 6Q^'J:Y%I]4
M?XO?9!?H+)-'$ZP&'.-TVUN=W4[!S^&* .GTO5;'6K!+[3KE+BU=F594S@E6
M*G'X@BKE>2>&=7UC0O"6CW<$EF=.FUV6SEMVB8R,LMW(N\/N !!/3:>G7G Z
M*^\2^(KT:K+X=L!<MI]X;5+=T7;<%-OF!G+C8>3CCC )SG  .YK-OO$&D:;=
MQVE]J-M;W$@)CBE<*S@=<#OCVK0C8O&K,A1B 2IZ@^E<%XP>>/XG^!6MH4FE
M"ZAA'DV _ND[X/\ *@#LK'6--U.26.QO8+B2$*9%C<$H&SC([9P?R-7:P;<Z
MS=PZK+]DM=/U)7$-K))F9'0(K*6QM)&YW'&,<UD>#?%&I^((IYK[[-;?V:K6
MVI0*F7^U*3NVG<<1@8(R#G/M0!VM%<+IOB7Q+J::)JUKIOFZ9J!5[B,HB_9X
M'&5D5_,RQ7C(V\\X JUH^L>(-?TW2-<T_P"Q&POI29;:12&BMSNVN'SRXPI(
MQCDCC&: .PHKSR;QGK47@K5-7_T,W5AK+6&/);9)&+A8LXW9#8;/7KVJ]ILV
MKS_$[Q';G4(C;06=H8HF@)"AO.QC##OR3WZ<8% '5:;J=GK%BE[83K/;.659
M%! )5BIZ^X(JW7G"^,=?/PVL/%/^A QW3C456W8@6XN&C9HQOR"JC/.>AK=U
MGQ-<:7#JNH1>3/96H@MX4"\O<2LHY;."@$D?;N>>* .AU#4;/2;":^U"YCMK
M6$;I)9&PJC..3]34$&NZ5<ZBFGP:C;2W;VXNDA20%FB/1P.X]ZQ+.3Q#?:M=
MZ9JEB&TB:TWI>/#&K)+NP8RF]PPQ\P)'&,'-:UKX>T^SNK*>"%5-C:BUMQM'
MR)P.O4\ #KZ^M &K10>G'6N!T_Q9J[^(-!L+J2SD;4UN5G6")FCMI(UW )+G
M$F,%6'KZ=* .^HKS>S\8>(U\.7?B&^?37M+6XN+,VT4#JTD@G\J-MQ<[1DC(
MYXYSSQT>DWOB0^(Y+6_LM^E/;>8EV8TB:.8-@QE0[94CD'MC!S0!TM%-D#F-
MA&RJ^#M++D ^XR,_F*\VTOQCXFF\.Z7K5VVG.FI3FQBMH;=MPF,S*'R7P5V(
MWR\9('S<\ 'I=%<4VL^++2#5_M-G:QP0F%K._NRD*[&8"3S%#GE!DCD;N!UJ
MJGC+54A\4QQ6SWSZ0]L862T=)'BE +$Q$@L5&XC&-P ^M '3:KX6TC6;Z.^N
M[>5;R-/+6XM[B2"39G.TM&RDC)/!]:T+&PMM.MA;VL7EQYR<DL6/JS')8^Y)
M-<8OCI3HL=Y8ZC9:F+[4H-/L95C*>6TF ?.3.0R_,<?+D8'&<U8O?$6KZ3X@
MO-$G>UG=],DO[&Y,) #1G#QR*&YZ@@@CKB@#M*.E>?:/XI\02R^#+F_>P>T\
M008DAAA96B?R#*&#ECG.",8&,]3C)D;Q;JUKK.DPW#VCB]U22PGMX(V=8%Q(
M4/G X,F$4LO^UT&* .PTW5]/UB*>33KJ.YC@F:"1H^0KKC*Y[XR*%U?3VUEM
M'6ZC.H+#]H:W!RRQY W'TY(KS*SOO$>D:3XRUC1Y-/-OI^M7MQ-;7$3,\ZKM
M+@.& 3Y0<<')]*VUU2"3XE6^KE66!O"K7.,<A?.5OSQ0!W]%<3I6O>)]0GT.
M_CTT2Z9J"![E=J)]F1EW(ROYA+XR ?EYZ@#I7;4 5+;4[.[OKRR@G5[FR9%N
M(P#F,LNY<_4<U;K@[WQ5K5M'X[V&Q,F@Q)+:DP-AP8/-(<;\D]L@CZ5/IWB#
M7$\2Z!::C)92VNM6$LZI#"R- \:HWWBQW ASV'2@#M:**XFP\73W?BU]&N+J
M"RO(KN5#I]S 5::V ;9)"Y.')PK'&<#(P,9(!VU%<?I.M:]X@T[3-<TS[$;&
MZNB)+652&6V#,N\/GF3@'&,<X[9-&?QAJT_A'4O%NG"V:RL9IMMG)&=TT$+E
M7)?/RL=K,.,#@$'K0!WU%<'_ &_XEUKQ%J.F:+<Z9;PQV%M>VTUS;.[8EW_*
MP#CKM'/;T/:'1?'FH>(;'2((+0P:C=6L\UT(T$GEF*41$*&8<%LG))P!CG.0
M >A45C^&+O6;S1E?7K%;2_21T94(VR*#\K@!FVY&."3@YK8H I66KZ?J-W>6
MMG=QS3V;*EPB'/EL1D ^^*NUYHB^(3XT\=/X?GL(9XY+1\7<+2"4BW7"<,NT
M'^]S]*T="\:W'BR?3+2P$=E)<:2NI7#NGF%"S[ BC(_B#$D]@..<@ [JJ5OJ
M^GW>IW6FV]W')>6BJT\2G)C#9QGMS@UYSJ/B?6M6TW381/#9WMKXHCTJ^\N(
MM',RL&5ERV0I^4[<Y[9];<W]L1_$#Q0VFW5I#=1Z19NTLT#.K%?.. @88R>^
M3CT/4 'I%5+[4[/3/LWVR=8?M,ZVT.0?GD;[J\>N#57PQJSZ]X6TK5I(UCDO
M+6.=T7HK,H) ]LU0\6:S?Z-)H1L_LYCO-5@LYQ+&6;8Y.2I!&#QW!ZT =)2,
MP52S$!0,DD\ 5Y_J/B+Q.+WQC#9W&F1)H44<\+26SL908C)L8;Q@\8W?I6E9
M^)[K7=5L--L6CM'DTJ/4[B1D\PJ).$11D=PQ)/8 =\@ V(O%&B3VEM=Q:A$]
MO<W7V.&102'FR1L''J#STXK7KR?PUK&J:+X8TKRVM&-YXHGLKO,3='N),E/F
M^7H>N>M=0?$M_IWBO6M,U62 6\5B+[3VBA(>1,E7!RQW,K;1@8SN% '2SZG9
MVVHVFGS3JEW=AS!&0<N$ +8^@(INJ:OI^B6?VO4KJ.V@W! [GJQ. !ZG-<_)
MK&MV/B?POI5ZUDXU&WN&NS%"RE9(T4_*2Q^7+>F>.O-<KXLUB_\ $WPONM;A
MF@CTZ:]C6*W,1+-$ETJ!BV>&)7=TP <=>: /5Z*Y'_A(-4.N>+-/#VP72[2&
MXM7\DYRZR,0_S?,/D'3%5K?Q+J]]HOAZ[,MI:_VCI8NI'2)I9&G*H0D<0.2G
MS,2>< #D=: .JN]7T^PO;.SNKJ.*YO'*6\1/S2$ DX'T!HL]7T_4+V\L[2ZC
MFN+)E6X1#GRRPR ?? KS^36IO$=C\-M8N(DBGN]0$DB1YVAOL\N<9[9%7K+^
MTO\ A+_B"=(: :@/L;0"="R,XM^ 0"#@],YXH [^BN1T+Q-=:_9^'9+22$2W
M43S:@K0G]V$^5T W?*WF$+SG@-Z5UU !17!7/BW5K+6-.CF:T=;K63I\MM#&
MSK%&=^QC*#CS/E4E3V;H,9JAJ'B[Q1;Z/XJU..73-F@7[1^6;9\W$:I&VW._
MY#ACSSD]ACD ])EEC@B>65U2- 69F. !ZU!INI6>L:?#?Z?.MQ:S F.5<X8
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MMI!*JH500V,'=V)X- &9#J#F^\*ZG87EQ-;WVM3PM>S3D2749$V5,8^41J5
M7/(VC@57M[A?#GA;QG?V<CV[IXA>!YO,=O*A:6%7?&>H5B=W7WKT)?!7AE6W
M#0['/VC[2/W0XDY^8>G4\=.:N+X?T=+B^G73+7S+\$73&('S@1@AO7( SZT
M8FC:;_9/B&:__M^!["ZL@_V)%;RP58?OPS2-C(8 XP#P>U=8"&4,I!!&01WK
MGX?!/AZPT:^TS3M&L8;>]7$T90[9/3=W('89'X5K:5I\6DZ19Z="28K6%(4)
MZD* !_*@#S/Q1?N(-9U33KRXDEL];MH#=23E/(8/$K01(/O)ACNSC)8_>QFK
M%_8_VAK_ ,0(IK[4/)M;*WGMT2]E58G,4C;EPW'(SCI[5V=UX.\.7L]W-<Z+
M9RR7A!N&:,'S",$$^_ Y]JG'AK1E>[=;"-6O(Q%<;21YJ 8"M@\@#@#L..E
M'%Z'J\VO:[X;TO59G>"7PU%J)4N5%S.Q4,6Q][:,G'^UGL,:GPQA6WT+58$9
MV6/6[Y SN68@3$<D\D^YK<N/">@W5I96TVF0/%8_\>H.<PCIA3G(&.,#CBK>
MF:+IFBQ2QZ98V]HDTAED$*!=S$Y)- ')ZO-)J_CZX\.W%Y';Q#3(Y[:*0/\
MO69W$C+M=?F7:F.N,DC'-9%]%K6F:;9R-=/XKL[*Q>*]\B4V]ROSL!<1C<=S
M (5^]DE,@\FN[UOPQHGB185UC3+:]\DYC,J9*>N#UP?2G3^'-(N&C9[)%,<
MME\HF,>4/^6>%(RG^R>* .!U[4+A;,:W%%<:KX;DTN$O);3F*[T\;2WGA,@-
ME64GG/R\\"K=P\GB_P 0>)=*&KI9/;10FR)$@>*-X5<3IMD7G>S9.#]T ^E=
MG/X<TBXF:22QCR\:PNJDJLD:_=1E!PRCG@@CFHM6\)>']=NX+O5=(M+NX@&(
MY)8P2!UP?4>QXH XZUT\ZKXY;3K[5KZ]M7\.6TTC17$D*32&1U,@56^3(4'
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MD6EV;J"PBCD,IF 7.T2'JX7[H8Y.6 R<FI8M$TZ#59=4CM@M], LDX8[G4=
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MOCFZ3+8G/3YQGGCCF@#E=;OF\-:[HOBR[N+@Z7=V_P!DOT\QC'%(RAHY0F<
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M/G2SF&-4:65RS2$#EB3SDGFLH6>KZGX@635+6RBTW3YS-9F.4R23-M*JS J
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MWFM6,1$(N"&F7/ED@!OH=PQZYJ>?Q%H]M<QV\VHP))(ZQKEN-[#*KNZ!B",
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M="GE?6H='8E52\F56"'(XVMPQ(R,>]%]XGT/3+B:WO=5M(9X8_-DB:4;E4G
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M_81N5UB&7^$,Q.8?;$J^8/8>] '5WGB#2=/N%@N[^&%V94^=L!6;[H8]%)[
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M*J[W0V$E!GD;3SD#MCO7 W<5S>O\18[>'4[MM0T:$VTLUHR&<K'*#CY5&<D
M# )[9ZUMW]TE[?\ P_N88;GRXKEFD9[=UV+]G=,L",J-Q R<9H [*ZU_2;*Y
M-O<W\$4@=4;<W",WW58]%)R, D9S4=]XHT+3)YH+S5K2&:!!)+&THW(IZ9'7
MFN!6.:+PCXT\-ZG:S2:K=W-X]LGE%OM8FR8G0XP<$@'^[MYP!6CI%M)8?$6#
M[?ND>V\,P6TMTT9*M*LC%QNQC..<=<&@#O;6ZM[ZTBNK69)K>9 \<L;95U/(
M(/I4U<?\+DDA^'.D02Q212Q(Z/'*A1D.]N"#R."*["@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBL[6-8M]&MX9)E>22XG2VMX4QNED8\*,\#H22>@!- &C16!:^)C-JM]HTMB\
M6K6L*W"V_F K/$QP'1^,C((.0"#7._#FSCUK0])\37]HRZKLE8W@EP;@.S;@
MX!^8#C ;I@8Q0!Z#17):[X^T_1#?G8MPNG$"["SHL@R Q"(QRY"L">G7 ).0
M%?QQYVH7UEINC7E[+;6D5XI5XT66.0,002W'W>AYR>G>@#K**Y"S\?6]Z="G
M72[R/3=:98[:\D* "4H7"% =P^ZPSC&1Z8-5;KXD"WM=4NT\.:I+:Z3=O;WT
MBF+]T%"DN!N^;[V<+G &3B@#N:*X9)[>;XN6%[!+N@N/#DLH?<=I7SHL-@].
M*OGQS:I96&J26<R:+?3K!#?;AP6.U'=>JHQQ@\]1D"@#JJ*YZU\5Q3WVNV<]
MH]K+HZAY?.=<.A4LKKC^$@'D]P1VJL?&,QU:VTI= OC?7&GF^2,O& !N5=I.
M[@C=SGTXS0!U5%<5!\18IM,L-3.BWT=C/="SN)G:,?9YC)Y6"-V6 ?@D<<]^
M0+&N^/\ 3M$-^VQ;A-.8+=A9T60$@,0B$Y<A6!/3T&2"  =;17(3>.PU[J5K
MI^B7MZ]E:Q7>Y'C198I Q# EO1>AY)/3J:BF\9W-UK/A./2[(RV&M6\EUO9U
M5RJQA@N#TQO!/TP* .THK)\2ZX/#>@7.KO:374-L-\J0D;@G=N>PZGVS5>/Q
M-&_BN/03;%9);+[;%/YBF.1 0I [D@D=NG- &]17'3Z[8WVK>%)+O1KG[1>R
M3/83>:NV(B)B2<-SN0< @CGL:Y;Q+KM_XA^&/C&6^LS;?8[N:"+RY<A?+=4Q
MQR>Y.>.: /6J*Y_3O$WVKQ))H=SIMS9S_9?M<#RLA$T08*3A2=I!(X//-0>+
M/$&H:-?:#;65F)EU"_%O(Y< @;&?: >YV]>WXT =/17FD.L3>'_&7CJ\ATNZ
MO4ACL[B6..51Y:B%F<Y8]>N .M=-=^,[")+46IBEFNK-;V-)KA(!Y3?=R6/4
M\@#V.2* .EHK(T#Q%8^(O#=OKEGYBVLR,^V1<,A4D,"/4$$5S'@)%\9^'E\4
M:VGVJ74)96@@E.Z.UB5RBJB] ?ER6QDD]>E '?45S8>'PC"8&FN;Q]1O]EE#
M)*7DW,@^3<Q^ZNQCD]%'<]8+GQQ!8P:XMYIUPE]HUO\ :I[6-E;S(2"1)&Q(
M#+P0>A!'3ID ZNBN2'C=_P"TK"R;0;X-J5LT]B0\?[XJ%+*?F^3 8'+8X]^*
MB;XA6T6A'4IM*O5>/4AIEQ;IL=H9MX7D@_,/F!&W.<]* .RHKDK?QW$+[5;'
M4M'U#3[VPM#?"W8)*T\ XW)L)!.>,9ZFIH_&(6^O+&ZTR>.\M]/741#'(CEX
MB2,9)&'!'(/'H30!T]%<AIGCQ-0GT(-I%Y;6VMPE[2XD9-I<1^9L(!R. <''
M./3!JQ:>,H[G2=9O&T^>&;2KAK:6T=U\QW&,!<''S;AMYYR* .GHJ)I)5M3(
M("TVS/E!AUQTST_&O,O#%[:3:)IOB?6;&5M7?4)X;6>*4"2YDDFD01'!&54
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML%^UNK>4%0EI6'0$$9Z #BNP@\*6L<]B\]Y>726$S3VL4[(1$Y##((4,0 S
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MJ;0(I3R_++!CP5SG< <Y_2@#C%UWQ-<?#>^UJ"_9[_3KZY\P)!'^^@BF964
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M+LQ@6T>#PH(P., XQVSS7HWAZPNM+T&ULKR[FNIH@P,L\GF2%=Q*AFP-Q"D
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MBNICEI$#'&".J@< ]P!6Y0 4444 %%%% !1110 4444 %%%% !1110 4444
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M9%(9"LR@;B0P7 P.2"016A;:C;7EW=VT#.TMHXCF!B90K%0P )&#P0>">HH
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M5Y+!+=6EO/) V^%Y8PQC;U4D<'Z5PGAA_$.N-XB5O$UZ)--UB6TMPT%OL>-
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M/6+S5O"DU]JOC"YM[I;F> %4M1@+(R)\IBY/ X[UV!\0V.GZA9:+J%VPU2:
MR >0X678N7*MMV\=<9H M3:#H]S=274^DV$MQ* LDKVR,[@8(!)&3C _*KX
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MNBMK*P@. <OA?E7D?,>/>M)/$&FR:^=#6=SJ @^T^7Y+X,6<;@^-I&3C@]:
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MUQE#DC[P'44 ;JJJ($10JJ,  8 %+5#2M8LM:MI)[%Y&CCE:%O,A>,AEZ\,
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M_EKM!10 <!1C^= '$VVC:SH]EIWAZ?3;NXACT$0"YL5&9+C)S$\N051>"!D
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M>@""]_X\+C_KDW\C7E>@6<GB/X;^!].MK2X66UN+2[DF>%E2)(CN+!R,$L.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<]XO\07?AVPLKFTLHKHW%]!:LKRE"/,<+D<<GGN170UP_P 4
M91'H&E@3Q0R-K-EL>3D B93DC(R!U/- $4OCZ]T"_P!8L_%%A;0O9:?_ &E!
M)92LZ31;MA3Y@"'#$#T.<\5IS>(]2TK6-'M-5MK4Q:ONBB>!F'D3A=PC;.=P
M(! 8 <C[M-U#P7#XAEU*XUN5)'O;#^ST6W! ABW;R03G+%MIST^4#'4F2W\-
M7\\NCOK-_!=G2"7@,<)0S2["BR/ECC )X'<YSVH YRX\8>++[P;K.LVEEI=G
M%91WJ,[2O(X>%F *K@ CY3UQSSC'!U6UB]LAX-AO;.SNVU"41FX8DO$WDLP9
M00>2 03GN>*L6'@R:#P;K/AZZU".1=1-T1-% 4,?GEB>"QS@MZBB3PIJEPGA
MHW&J6K2Z-,)F*VK*LN(S& !O^7AB<Y//H.* ([GQ??R:3K6LZ7:V\]CI$\L3
MQ2$B2X$7^M*L.%Q\P (.=O;--7Q=JFI^((M-T6SLFAN=(CU.VN;F5QE7; W*
M%_0>O4=*>/!EW:PZ[I]AJ,46E:S+)-(CPEI+=I1B7RSG!!ZC(^4GOTJU:^%9
M=/\ %,6JV5S!':0:4NF0VIB)*JK;E;=N_#&.G>@"[X2UUO$OA:PU=X!!)<(=
M\0;(5E8JP!],@UF3^)]0NX=>N=&MK::'19G@>.8L&N9$0.ZJ1PF-V 2&R<]!
MS6CX0T&;PSX9MM(FNDNC;E\2I&8\AG+="3_>]:SU\)WMC>ZX=*U"&&SUES--
M%+"7:"9EVNZ$,,[@ <'H1G..* ,75=9NM=U_P!?Z7)"+*^::YB296SN^S.?F
M /8,1QWK<\8/+X:^'NLW.@QVUE-!;RSKMCPJL<LS #'S$DG/KZTV7P<\-[X7
M;3+J&WM- 5TCADB+M*&B,?+!AC@YZ'FMGQ%HZ^(/#>I:0TQA%[;O!Y@7.S<,
M9QWQZ4 <9JIU$>,? TBQVLNH-:WH#$LJ?ZN/ECR?\3Z=:DO/&=XW@74-1O-)
ML9[G3]3_ +/NH&<F(LLRH'4$$GEE(!Q]:UQX8U236?#VI7.IVLDFDQ31NB6K
M*)?,55./G.W 4=<Y.>G09]QX"O[CPUK6D'5;=3J>J'4?-^RM^[S(LFS&_GE
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M)+9XXX.>,2X\ ZE=:!XFTV76+;=KMS]H:1;-@(250$ >9S]P8]/4U>U#PMK
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MX8WGC6WOYX=3MYIIEM]Y\E4CF9?):/H<HO)QNR<YZ"@#U%W6.-G=@J*"68G
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M1N),Y7'W@5!SU_#BNS\::Q<:8NB6L$C0C4]4ALI)UZHC!F.#V)V[0>V>.<4
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M;:!D')5V:,_+RIQ@CJ?7@5EOK^JGX8Z?XYM[Z>34&EBFFM@Y,,J/,(S"$Z#
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MLKX%IYC)\P6++C/0G/0<<# %9+:QJT?@VYNSJEV]U;^*#9K,7P6B^UB/:0,
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MK9W75P1?+).["7*[>A/'R\<8IL/A'1X+G3;A([DS::K+:N]W*Q4,,-G+?-D
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MR"V[Y?J A)'8$5)I=W*-$2YU.^L)77?YMQ;';#@,0,9)Q@8!YZ@T )%X>TJ
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M+#0;1[73HY(X7E:4J\KR?.QRQRQ)Y))K1K \%:U<^(_!FEZQ>+$EQ=P^8ZQ
MA0<GH"2?UK?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KB/BW]F'P[OFN/*!6:W,9?&0WG)TSWQG
M\,UV]! /49H \Q\87<EGJFKZEI=]97R?9H5U'1+OK<1X)1H'!R&.X@#!!;WQ
M7;^(S!)X3U,W:((39R%EFQ@?*>N>.M:IC1F5BBEEZ$CD4[K0!XW:0:-_9GPK
M+)9;Y JS$[<L#:L&#>OS!00>^!3[C4-(TU/&T4D,$MD-<M"(TD*10DK#^]?;
MT0.,MZXQ7L&T>@H*J005!!Z\=: /$=6U&5SX_P#L-U]N,ITZXF-K'CSK; $S
M(!G*[01G)R.YK>O]6TS4_B#IUSX=O;.:>;P_=PV\L#J1OS&8UR.A')P>E>H8
M .0!2)''']Q%7Z#% 'EO@^Y\/ZY_PC7_ !,;]]=TI-AL-B(]L^S;*),(#LZ\
ML>3CJ37I&EZM8ZU8K>Z=<+<6S,R"100"58JPY]"#5H(BLS!5#-U(')I54*,*
M !Z"@#@?B3=VT&I>"TEGBC8:_ Y#. 0NQQGZ9(&?>IOB1)9LOA6*Z>$Q2:];
MEED889=KYSGJ.1GMS7<$ ]0#00#U H \>U>06UU\0X=(0,D4^G3RVUH%+-$
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M8SK-',LJQAP2C!@'4_>4XY&1]: .'TVZ\-^(O%FHZ\VI:%-)_9(MOLL5PDS
M*6+2,2!@88+TZ=<=*P["&SL/@]X9UJSMDQ"]K_:EQ:PJ\P@5B6W<$L%;:Q4Y
MZ=*]+T_0[W[;!>:Q=V5U/;EC#]DLO( )4J2<NY)P2.H'/0\8W<#&,<4 >1ZS
M+I4FE:IXB\/:A?:I%+<V4NJSP*C(T,<@W!5"!6<+RPP>/O=:ZOPFV@:EKU]K
M>BZK<:G+<P1QW,XVB+Y?N A54;\$^X'7&178(BQJ%10JCH ,"A$2-=J*JKZ
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M01D&EP ,8XH \X\1SW,W@63Q''!<B.\O+:\N8XXPTJV2NN!M(.?D&\J01\S
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M(9-+\.ZAX8U2$II^AS&7[5?6<*,JS-&JQ22$JP/ ==Q'&[K7I:QHB[5157T
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M]XTTZ[U?P9J^F6,0DN;NU>",%@H!88R2>U96I:5JMQJO@^ZBL"R:6SR70,J
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MX' (#<^I_&M75K#Q%XA\$:U9S:+:Z?=WEJ;>"UCN5D^8YR[O@#'3 &>A]<
MV+CQ);Z9%;V:Q-=7@M%N&A61$(3H#EV R2" /8]*R+?Q_P#VMK/AM-(L9KC3
MM6MIKCSLHK?NR%*X+#&TMS].,U%?:5XAT_Q%:Z[I>E6VHI/I\=E>V$]PL3QM
M&S%75\$'[[ CZ?A;N]'UP^)/#6KI;6DK6L5U#=1I+L6+S2A&TX^8+MQT!/7
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MP?<>4.%.5R1R,&@"GXG\2_;H_"ATN&:\TS5KU"[1,@$\?ER-Y9#,#U4$@X&
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M;PD',FP<D A1[9S@XQ6*WBN^6W\.75K?Z;J%KJFJ_8VF@C.UHBKLI'S?*XV
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M0-<;B!'(P(V#&#SC.>HQSG7*ZG<_%,"PN;6"Z?PVA:>2(RHO[\]%##//O^=
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MS[@U;KC?A3G_ (5CHF[&[RWSCI_K&KLJ "BBB@ HHHH **** "BBB@ HHHH
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M;B<]<8R<LTKP3):V#Z;JNO7VKZ<(&MX+:X1%V1LI4[F4!G.TD D]SQFNMHH
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M%4#))_"@!;>!+6VBMX]VR) B[B2< 8Y)ZGWK$F\+K<>)+[5Y;MBMY8#3W@"
M 1@L<AL_>RQ]O:N@!R,T4 97AS1G\/Z%:Z6U]+>+;1K%')*BJ0B@*JX4=@!S
MU-.\0Z);^(] O-)NF9([F/;O7[T;=58>X(!'TJEXE\50:!X<U/5X8#?#3CMF
MBC<+AN,@D^FX=,UT .0#0!SVL^%(M2TO2K.UO)K%]+N(KBUE10^&12H#!N&!
M#'^=9=Q\/1<:9XAL7UJ[:+6Y!).7BC)1MJAB, <G8/8#MWKM:P?%'B9?#%M:
M3R6,UTMU=1VB"%U!$CG"YW$#&>^: ";P[)<>)-+UJ6^!DL+>2 1"'"R"3;N)
MYR#\HQZ>]8)^&NS17T.WUZ[AT<727-O;"&-F@*R"3:'(Y7<. 1QZGI6Q<^+X
MM+O[.UUK3KO3EO)!#!=2%'@:0]$+*Q*D]MP /K724 (H*H 6+$#!8XR??BN(
M7X=;+:WM4U^^6VM-3_M*U011DQN79B"2N6Y=L$^O0UOZKKCV>HP:78VJW>I3
MV\MRD+R^4NQ"H.6P<$EU X]>F*T-.N9;W3K>YGM);266,,]O*06C)ZJ<<<4
M<Q/X%^T:3XBTY]3?R]=F::=A"-T9*JI"\^BCKGO4[>$)HM?&M6&L36=W-;I;
M7H2%62Y5/NMM;.UQD@'GZ5U-0WD[6MG-.D33-&A81J0"V!TR>* ,SPKX?7PM
MX=MM'CO)KI+?=MDE50>23C '3)/7/UK9K+\.:ROB'PYI^L)"8%O(%F$1;<5!
M'3/>M2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "N3\>:K+IMMHT?VE;6UO-2CMKF=\[40HY )!!
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M58&RY<1X #!.2%4D9XQGC(JVGAS2([Y[Q+")9GE\]L9VF7_GH5^[O_VL9]Z
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MO+<O)'+%Y!??L)PNPJ,;0!SBJ4>JRZ3X?U=UN1:P7'C&:WN;@YQ%$TG))!!
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MYSG"*,]>*[#XJV\,OPLUL$%DCMPR88]01COS^-;G_")Z =,733I5LUDDWGK
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MG[,R;?3<><>V:KZGX2\/ZUJ,&H:EH]I=7<&!'++&"P .0#ZCV.: .4%A#/\
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MUK%:VL8PD42A5%6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\4:?XGM[B>P<E(9Y(<,""=K%=V".,D&M*\U"UT]$:ZF6/>VU%ZL[8SA5').
M3@>E<K\.B\&G:II\]O<17$.J7;N)(61</,S*0Q&&R"#QFCQ UQIOQ"T+6+A)
M'T@6MQ:22*I9;:5RK!VQT#!=N[H.^,T :&O^+[#2_!E]X@L[B"Z2&&0P[6RK
MR*#A#CIR,$=1S4OAXW]P[7LFM+J%A/"A2-H%5HI1]_#*!E>G!!(]:X;5M.N$
M\(_$2Z@AF^RZO*QL+=8F+2MY2JSJN,_,X/;D#/0YKTW394GTRVDC)*F)>HP1
MQW!Z4 <KXONO%NFZ?J.NZ=>Z?#::=&TPL9K<N;B-!EBT@;Y2<'  ],GGBS)X
MBNM2\1Z;H5D392SZ;_:=U(RAGB0D*B 'C<6)R2.BGUR*/B+Q3I<VJ2:/?6^I
MFQMV5KCRM-GE6Y8'(0,J$% 0-W//3IG(V;;X@67BJ:&:'3M0T;[(YDC(:"02
M>8F\?P[E9A]1CJ10!I:%X@O-9\.ZDZ_9X]4TZYGLIB4)B,L1^\%R#AAM.,\9
MQGBC0/$XD^'%EXFUJ5(P;$75RZ+@#C)P/Y"J/A+3YM+\.Z_J%[&\#:IJ-U?K
M$ZD.B/\ *@*]02JJ<=><=:PTT2^UO]GR'1K:%Q?C3XE-O(I1B\;*QC(/0G;C
MGUH Z_PSJ]SKL7VZXN[>)F4.-.A96>!&^Z)3R=^.2!@#ISC)Z*N"^RVVI^-O
M#6L:+;-;PV=I<"^*PF/$;( D+C ^8/SMZC:>G&>JT'7;/Q'IBW]B)EB+,A2>
M(QNK#L5/(['Z$4 5KCQ3I\'BN+PX9<7LMLT^2#M7YE55]R=Q/7M[BL3PEXS@
MGL_LVNZO:_VE)J5S:P*VV,N$E9$  ]=N!ZGUJ34&:R^+.GWDL%P;:;1Y;9)8
MX6=?,\Y&P2!A?E!.3@<5Q[1,/AS>QI:SBY;Q*;@(+=MY3[8'WXQG&P9SZ4 >
MHW^OZ3I<GEWU_#;GY=Q=L!-QPNX]%R>!G&:T6940NS *!DDG@"O+;A["#7_$
M>C^)M-U>ZAU6Y$]FUJ+AHKN)HT41_NS@,NS'S8XQSBO3+.(06-O"(_*$<:J(
M]Y?;@8QN/)QZ]Z ,E/&OAB2YM;9->T]IKIBD"K.I\PABN!^(('J1Q5NZ\0:3
M979M;F_ACE#HC!CPC/\ <5CT4MV!(SVKRBVM;?6_A3J>A6<._5KC5K@0(L9#
M"3[42)<X^ZJCEN@P1GM5GQE//=V'BZR33[RWN$N[=UAMK)V%XBF(^>\@4@\*
M0%4C&WG)H ]'O/%WAZPNI+:ZUJRBGB=(Y(VF&49\[0?0G!K)_P"$TTO6?#&I
MWMIK46DK#)) M[<(#Y95BH?:^ <D' /-5=$\FY^)_B&Y>VD\N>QLQ#)-;LH8
MJ9"P!8=1E,CJ./2N:N$G'PF\8:0;.\^VB[O0(OLS_.7G9DV\?-D$'Y<\4 >G
MWNL:?I4"/?7B1@H7R022HZM@= ,C)Z#-,GU_2K:".>2_A\F2+SUD0[E,?]_(
MSA>?O'CWKB-5OH=*\9B^U>WU.31M1TR"&"YLA.1%(C.6C=8OF^8.",CM]:J:
MAI<.E06S^')+O0+RTTT_9[6ZB:>"[A,DC"!PV3OSS@'<-^ #B@#U*-UEC61&
M#(P#*1W!K/\ ^$@TG[>ME]OA^T-*8%7/!D R4#=-^.=N<^U3:3)/+HUC)<VH
MM;A[>-I;<'(B8J,I^!X_"O*;Z[EN?L+_ -FWUJ]IXI2:>QM[!RD:>:W[TL%)
M=FR&R#CYN!QF@#U&ZU_2;*[%M<W\,4I=8\,W"NWW5)Z GC /)[5A:3XBGBU[
MQ;%K%]$MCIEQ L3L@01J\2L<GORV,FL#2+V*UDUOPQK^B75W>SZI-=6T;VC2
M17:.^^-]^"J[> =Q&W:/3%9E\VHV'COQ#K\%O/>:?:W]M)-8>23]I3R43S8N
M/G>-AP.1UZ'!H ])N?%.A6<K17.JVL4JP^>8WD <1Y W%>O)(QZYXJPFMZ9)
MI<.IQWT#V4^/*F5LK(3P N.I)XP.:Y0W-O=?%;3M11'-L-#E43M"P5',J$*2
M1\K;0W!YZUR^AQWEAIOA'4I+6Y_L_3=5U#[;#Y+;H1,\HBE*8SM ;KC@-F@#
MTQ_$VB1Z;)J,FIVR6<4GE2RN^T1OTVMG[I]CCJ*L)K.G2:G_ &8MW&;[RO.^
MSY^?9_>QZ>]<?;^'8_$.N>,Y65AH^L6L%LK;2!+(J,&D7/7&4 ;N5]JPHH_%
MGE:'XG-I(-6M_P#B2SVY'^L0Y0SMWQYP5O\ =&>] '6ZKXBG/B/PLFEWT;Z=
MJ%W/!<*L8._9$[?>/3#+V]*W+C7])M+U+.XOX8YWD$05FP-Y&0A/0,1T!.37
M+Z_:)I_B'P+;0)*T%G<R!W"%MB_9W0,Y XRQ')[FL&SCL';4_"_B32-7N=0?
M4IIX$1K@07:M,98Y Z'8@&1DG&-OX4 =;XY\3QZ'X9U>2SU&&#4K6U:5-R;]
MK8)0-V!8C SU[9K5CUNTM=-LI+^Z19IK83$8RQ 4%FV@<*,C)Z#(KS>^N9K/
MPS\0M"U*TNSJ=W->7%L5MGD6YB=/W95@"/E "X[;15V]U>'0O$ND:HRW4;3:
M"+:5)[&=D&'!7A$+*P.[(8#(QS0!W\?B#1Y[$7MOJ=I<6Q?RQ)!*) SXSM&W
M.6QS@<U8T_4K+5;1;NPN8KB!B5#QMD9!P0?0@]1VKRR,V.C:-X/N]/EO]5T#
M2Q<6E[-:)*DT3N%(D,:X< '<,=E8=>_>^$;?2X[&[NM(L;FUMKVZ:X+7)EWS
MNP&Z3;)\RY(QSC.,XYH ?/XIT^/Q6GAOS=MZ]L9RQ4[5^954>Y.XGKQCWK%\
M'^,X+K388-<U>U_M2>^N;>)#MC+A)G1 %'3(7 ]<=ZDO':R^+=K=S07'V:?1
MFMTE2%G3S!.&() POR\\XXKCTB9?AS%&+6<7(\3"X*"W;?M^V;]^,9QLYSZ4
M >HR>(-)BOA927\*SF408)X\TC(C+= Y&#MSGGI573?%6G:IX@U+1[:0F>P*
M)(2"-S$$D#CH!CGW]J\YUR[DNXKQ4TZ]MFM?$L$[VMM8N5>-9D_TAG"G>6 R
M-IZ8X.,UUWAUW@^(?BM);:Y3[8]K/ [0,$9! JD[L8X8$8SG- &_XAUI-"TP
M7&P2W$TT=M;0YQYDTC!47/89.2>P!IUQJ]GHT,<>J:@GGF-I&.W!*C[S;1DA
M!D<GIQD]ZY[XAPR$^%KP FWM->M9)SV56W(&/T9U_.H/%%TR^+S:?8KF+SM)
M=8[VVM6EDG8N?]'#!2$ P&.?4<C'(!NZQKRZ3#8ZN)XYM(GDBAE=2"$$A"I*
MK#JNYE!]B",8.=ZO)-0CENOV=K/3E@G2\EMK.RCBEB9',QDC4  @'KW]J]7D
M+1VSLJ&5U0D*."QQT_&@"A;^(M'NKI;:'4('E979!NP) APQ4]& [XSCO5>/
MQCX<FGMH8M;L7DNI#%"%F!\QP2, _4$#U(XKSK1[MI=6\"WGV&^MXK=KJ*:T
MCL)(X;%FA($8RN3SU8DCC/RBF>2R_#>6);2<7!\2_:!&+=M^S[8'WXQG&SG/
MI0![$2%4LQ  &23VKG]/\0:;;:8]W>>);.\AEO7BAN/D1<E\+$N#ABN0,]37
M0!U*;P1MQG/M7CL\32?#W4K<VD[/)XH,PB-NQ9HC>!]VW&2NS)STQ0!ZEINO
M:3K#W*:=J%O=-;$"81.#LSTS['!P>AQ7.7WBSS?'/AC3],U**2ROC<?:(UCS
MYBI"S*RN>JY'5>..M8'BJSO]2\0^+H='27S[OP[%# Z*0LL@>0L@;H6VL!U[
MU,=8M=8\2^ KJSL;Y$M3<)<(;*5?LI-N5V-\O&&P/3H>E '5VGB'3;2QU"_O
M?$EI=6:7SQB?"HEOTQ"6'!(SU/)SBM>;5+&WECBFNHXI)(VE0.=N47&YN>PR
M,^F1ZUQ'AS2(-=T;QKI-Y%(D%_J]T07C*Y1U4+(N1R,C(([BM/P2^J7&EC4O
M$,+0WMK%]A._^+RB1)*/]]AGW"*: -32-5MHO#-M?7>N0:C$V5^WJBHLQ+D
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M4(GEM)EF1)&B9E[.IPP^H/!]ZX;Q$+VSBT#Q=HMJ\MY$B6$UO*IC::&8A5#
MX(VRE&Y[%J[72K!=+TNVLE<N8D >0]9'ZLQ]R22?<T 4[[Q7H&FRW$5YJ]G#
M+;*&F1I1N0'.,CKV/'H*NOJEA'817S7</V68*8I0V1)N^[MQ][/8#K7(#RU^
M*&NW,L+>4=&AB$IB.UF#R%E#8P3@KD"N=T>.^L/#7PXU*:VN39:7OCU"'RFW
MP,\1C5V3&<*2<G' ;- '>:KXRT?3/#-]KOVE9[>S#*Z1Y+>8/^69'56SCJ..
MIXK:M+J&]MDN('#QN.&%>6^)=(N]2LOB%J6FP2RVE_801PJB'_298U.]U'?
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M'RH5(!8LQ))+,3DDD]237FGQ%UEM?^'&MSVFG0SZ;!.(5N9)L.724*SHFTC
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MCO.UN,8&.O(JI<>-M2^WV%A9^&+F2]O=.:^C@N+A864J5!C?(.T_-C/KCCN
M#LZY^^\-7$VMRZKI^NWVGS3QI%/'&L<L;A,[<!U.TC<>G'/2LK4?B"EE!<7,
M5@ES%9W M[F&.YS<!@0K^7&%.\*21U&=K8[9LZ#KFK:CXU\16%Q#;"RL# D1
M29BP#1EP<%>2=PSR,8 YZD Z"SM(=-@*F=Y))9-TD\S#?*YP,G  S@    <
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M/HH/Y]*O(XDC5UZ, 10!S.KZ-K5WXGTO5+:2Q>V@MWBEM;IG*Q2L01,F!\S
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M>Y>5V1IGG5@Y4!3@ N2,GL![UW3#<I'J,55GU&*WU*TL6CG:2Z5V1TB9D78
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MK"*ZALHUO9UFN>6D=%VKDG.%'8#.!GG YJS110 4444 %%%% !1110 4444
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M"Q@PP+&[ H2 "7V C=GA^Y'._?>&-*O_  NWAR2VV:885A6*,X**N-NT]B"
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M5RRE%POF94#+$G@G@>]-DU#QC:77AG3[_48(;B[OY[:=XXD<R1")W1V&,*^
M,@<9]1Q6O+\.M)DTC2;"*[U&WDTG(LKVWG"3Q*>"NX+@@C ((-7CX/LC+I4O
MVR^,NFRM/'(TH=I)&4JS2%@2Q()'8 =,8% '">(-2UB;P+XNLKK5[B672]5B
MMDN52-'FA<PG:X50.DA' &<#MD'U3<;'3V>::6X\E"S2.%WMCGHH S] *P9_
M VFW5EK=I/<7DD6L2K/<Y=05D7;M9"%&"-B^HXKH+6W%M:QP&66;:,&29MS,
M>Y)_R/2@#SN7Q5K,/@'3?&ZWAD266*2XT[RT\OR9) FQ#MW!UW#DL<D'CG N
MP65S+\7]7"ZK>1_\2BW8;%B. 99<*,H>!U'?U)K8M/!&F64"6<<UT=+CN/M,
M6G,RF&-PV\8^7=M#?,%+$9[5<3PY#'XCN==2]NQ=W$"V[+E"@122H V]BQ/X
MT ><Z?>:KH7P;UG5]/U:=;J"[NV3S(HF52+IP2/EZG.><CT KM)]1OM8\4ZK
MH5EJ#Z>;"RAE62-$9I))=^"=ZD;5V#@#DMUIW_"!Z=_PBMWX<:]OVL+J1I),
MNF_+.7;!V="QS_*I-5\%66J:I;:H+_4K/488?L[75G.(GFCSG:_RX(SSP!CM
M0!1;4M=L_%GA+3;R_@D%Y:W/VY((@$>6)4Y4GD#+'CCI68OB36(=7T)CJ/VR
M*^U6:SN/)B3[+MQ*46-BH<LH1<D$KG<,]!75OX6LFU72=02:YC?2HWCMXU<%
M<. 'W9!+$X').>_6LJ#X<:3;PV4$=[J@@L;LW=I%]JPL!.[*K@?=.\]<D=B*
M $\&?\C+XU_["R_^D\5=C7,7/A&*.RUT6M[JBS:M()96@N%B=7&T HX7Y>%
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M(_%5MKESH=W8'2HYK>%[U%221W(!*@,?D"J<$]=_'0UUC*KH590RL,$$9!%
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M-&QG$AZMC:6);.&'K5WP!H.E2ZCKFHM;*]Y8Z_>I;2%R3"" I &<8P?Y>@H
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M7B@ATO5H%1FN&\K%L!@!FXQEBQSGH5]!786WDBUA^SE3!L'EE#D%<<8/<8H
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M6#ZA<8KG]6\4:+>^%Y;R6\U*TMTO5M96M5=)HIEE"^6Q .T%L*>Q!Z\U=O\
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M ._G  Y&,\GMFLIOB'X?,&G2P2W5R-1BDEM5@M9':3RQ\Z@8^\#P5ZCO@<T
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M%/;6^E6EPK&50'EDEV@(!GD*%8YZ9(QGG'.:/8^)-*\'>'+$Z/>;(;Z<ZC#
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M,)_"^K6H@U6+3III)?%/]K26<;IYD<)C:,=6"ENC$9[^U:#6&J'6_'%PVEW
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MMZ5>$N9"JLNW(88&'///:D@T"\A\8W^OB\@(NK*.U6#R3\FPLP8MNYY<\8%
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M69;8*9%:8)@N5P"V.N,],]LUP]GX"U/3]'\/6MOK-L9]&NI9U:6T9HIA)O\
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M !Q@'/?US[/P/>V=AX3M1JENP\/ONW?9B//'EM'C[_R\,?7F@",^.[NP\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"F2RQP1F25U1!@%F.!R<"GUQ/Q/@\[P[8?O9H\:M9 ^5*4R#.@YQU]O0X/:@
M#H(M?MY/%4WA_P BX2YBM%N_,8#RV0L5&#G.<@]0.E:U>?76EM>?%6:R2_O;
M9!X=B!E@EQ*?W[X^<Y/OZ_KG/T'Q-JNL:7X.L+B</-J5E<RS2-<-;M.\+*H4
M.BD@X)8XP3CKC((!ZC16'X5MM6LM-GM-8OXKV>*Y<1NCEV2(X9$=B!E@#UQR
M,&N9FGUWQ/<>(H=+ODLKO3KW[-;.;MT$.U$8,\00APQ+?>/3@8QF@#T*BO.5
M.J:MXE\3V4NO7L<,&G6EQ%]CD"*CNLI)0XSMRH/J>,YJIIFJ:N;+P!K<VKW<
MTVKR1V]W"Q40NK0.V0@'#!E!SUY/;B@#U&LD:_;GQ6?#Q@G6Y^QF\$I \MD#
MA, YSG)].U>=7#:]<^&O&&K1^)]1BN=$U&[-JH*",K$JMM<;?F!'&. .N.N=
M==3E/C^VU62W/G'PDURT Z[O-1BOY\4 >B45Y@^LZI#X#\/>,+?4)Y[VYFMF
MN[?>3%,LSA&C5.BE2P (P?EYSDU=NM4O?#WB36](N;NYN#J4"S:*993P[$1M
M"#_LNR-GKM;VH ]"HK@IGU*_\0:AX9M[V7=I^G0-'*U\\$KN^_,Q*J=^"JC!
M^4'/!R,41%X@OO%&DZ'?^)KE&FT6=KJ73F5%,T<L:;T)7AN>?Q P* .VFU^V
M@\2V^AR6]X)[B$RQS^2?(;&<IOZ;\*3CTK5JA=6GEVSW$<B_;(;9DBN+@Y"G
M'WCV'(!) [5R?@[6)Y=;_LK5X]3L-:BL]T]I=RF6&XPR@SPODC&>"!C&X<#!
MH [AY8XWC5W56D;:@)QN."<#WP"?P-/KAO%UH+GXA>"@9[E%>2[!$4[(.(&(
M. >O.,^G%5-.&H7>N>*9[OQ-?V]OH]_NB!*")4^SJQ$@V\H"V<#'3K0!Z)63
MK>OV^A/IRW$%Q(+^\CLXVB (1W. 6R1@=>F>E<-8Z[J.F:UI$AN+ZZM+C0[B
MZE-RY_TN2(1L)5C)/E!MQPO'!Y48JM>F;5/#7@/7KB_N)KJ]U>QGF7S3Y67)
M;:$Z+M/ QSQSG)H ]8HKSC[5X@\2VVKWNF:A#8W6GZG+ DDMXZQPI"^"LD(0
MJP90223GYL@@ "NWUO[<= O_ .S98H;\V[BWDD/R+(5.TG/;.* -"BO+)/&<
MNFZ-KDA34M-U:VBM4EL=2E,JVX>4QM/'(=P9/GZ\C*#BKFOW?B'PA8ZOK*7T
M)L?L&8K66Z>Z=)]ZKYREU!V!7R5Z9 Z9H ]'HKC]4L+S3K6_O[+Q)=B!]+D*
M0NPE9IE&X3(S9"\<%0-O((Q7/VU[JEAX?\)W<NLWES-XA%I!/]IG"1QDP,_R
M,%)5G(52>2?8\T >FRRQP1-+*ZI&HRS,< 4^O*/%VFZO:>&]1AU'4S);?VG8
M2V<,=W))+"CS(K*[D*77()7.<?@*T_%NH7VA7D[W1U,Z$+5(TU"QG9WL)?FW
M/,@.74@H<G. O3G- 'HE,BECF3?$ZNN2N5.1D'!'X$$4R01WEDP61O+FCX>)
MRIP1U##D?45Y1X6U&?3O G@>RBN;A!K5UY-Q.TI)10)&VJ3]TL0!D<\G'/-
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M0XW/(!T_B5/8HU0>()GF\1:?IT5[<DO;32-86CF)WY0"5I01M1<D8[EAP<4
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MN$B/$,KSR%^4< @=:T(;V]\2+XOD74;FQN-*NY+6R6&0J(MD:L'9>C[F)/S
MC  &.30!WU%>8Z5JVK^)M;\,F?4KRRAU/0)+JX@MRJ#>&B&Y3C(SN)SDD \8
MKI?A[?7E_P"%%-]<R7,UO=W-MY\G+NL<SHI8]S@#F@#>6]=M6>Q^QW(18%E%
MT5'E,22-@.<[AC/3H15NN-:YOV^)6J::-2N5M3HD=Q&@VXAD:6125&,=%'7-
M<SH>I:PFB^ -:FUJ^N)]4N4MKJ*5P8G1XY&^[C[P*@YZ_AQ0!ZK++'!"\TSK
M'%&I9W8X"@<DDUF2Z_;P^*+;0'@N/M%Q;27*2X'EE4*@C.<Y^8=JP?BQ'O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KC_B4&'A:"8([);ZE9S2E%+%46="S8'. .:["B@#@H[FRN?BY
M+>/L\G_A'T59)4V@'SG8CYNAVD$CK@UR&AWK:-X<\$:EJ ODTBWMKJTNI+=6
MW6DK.I1G4#(&%*].-WO7ME% '/\ @^UTNWTJXET>&YCL[JZDN0]QOS*S8+.
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M/\2RDGRWTZSV[D(W;?-+#&,Y 89'49KI]#N]/OM$M+K2HQ'821Y@00F(!?\
M<(&/RK0HH XKP?&]KXP\;PW'$C7T5P">\30J%/T^5A^!IGP^F@AT'77<A8DU
M>^E.>/W9D9@WT(Y!KK)--B;5(]1C)CN53RG9>DD><[6'?!R0>H)/8D%=1L(]
M3LVLYV86\GRS(O\ RT3NI/H>A]J .:^%=K/:?##0(KD,LAM_, ;J%9BR_P#C
MI%5M"N[9?B%XU>25%C=;0JS'"L%B(;!Z'!ZXZ5W"JJ*%4 *!@ #@"EH \;L7
M6+X5^ XWRKPZQ:&1""#&%F)8L.P P3GIFK]Y<:9'K_B;0O%2:GY>J7 FM! D
MCQWD+1(H1=@/S*5QV[5ZK10!Y7JOVC2-6NY]$NA+*)K2.]\/WHWFY(2(*\+_
M 'MP7;D\C*$GI7=^+91!X/UB1M/;45%G+NLU)!F&TY7CGD>G-;-% 'DMG?V\
MGC$7;7$MQ;3^&'B67[(T<(82 [%RO0#^\2<\9SQ4>DB"WT'X7!42.6"8>< N
M#'FW=6W>F6(!SWQ7KU% 'GEWI=W8^-KO0[: MHWB/_39B.D+1E1< CTD4QCZ
ML:[;6$NY-$OX]/;;>M;2+;MG&)"IV_KBJ6BZ%/IUQ-=7^K7.J73Y1)9T1/*C
MW9V*$ '7&3U.!Z"MJ@#QQ-7L;GPKX!LHX)TO]-U2TCO+8VSF2!TC=7+#&1DY
M.>_7UJX"%\)>-_#VKQLVKW-U=O;PLN7NQ(,P/&/XL?*./N[><8KU>B@#RZSO
MO^$8\27=EXP6:6+4M*L[>&Y$#S)*T<;++%\H)R69FQWW?2KBS6F@?$+1YYK2
M6PL)= -G:Q")FVNLJL(OE!^;;CC^=>BT4 >+:487\(^!(KB%E:'Q!*\J31$;
M4W7!W'(^[\R<].16Q<+:'4OB@Q2+,UK&L9VC]Y_HVU@OK\^ <=\=Z]1HH \C
MM]4BT:\\.W^L2WT.D7/A^WM4NK=798;A3ET<*"06!7KW3':K=MI^DZ?XJ\"6
MUA:26]A!#J#1)<[BT8?84+;N5W')4'!'3@C%>HT4 >-N57POJ4J(Q@MO&8NG
MV(3M@^TJV\ ?PXR<CBO6+EI;S1YFLG9)9H&\EF4J0Q7Y20>1SCK5RB@#S7P=
MJ6F:GH>A:1)ILZ^(]'B$3136S@VDJH4>4N1MPW)')W;A^&1'%-J'PGL_#05X
MO%5K=Q)Y##]]%.MP&:?_ '=NY]_0@GG)KV&B@#RN^6T>^^*;,D9::S1(R5&9
M/]%VD+Z_/@8'? ZU9TRX%OXJ\%W<PE,4OA][59%C9@9LPG8<#@\'KZ'TKTNB
M@#QF'4HKAO"L\=M<6:6VOR^;IT5HY%IN$WWVVDL[%L\''S<#C-2ZP8W\,_%"
M) &:>Y)A0#)D)AC7*CO\P(X[@U[#10!Y^9;&#XD:!+$T,=LNASQLZX"*-\3*
MI/0<!B![&N7TY;=OAY\/X)XU)AUQ&ECD3F-09LE@>@^9>O'(]:]HHH \FUF&
MVNG^*,#RRQ0RP6[AK>/>6VP ,0!][! #?D<5I^&]9T?7?'<.IOJEE_:0TW[%
M'9Q+(/,PWF,X,B*>,<* <#<<UVFNZ0-<TI[+[7<6C%TD2: C<K(P9>""",@9
M!&#5>PT:]2>&?5M7?47@8O"OV=(E5BI7<0O).&(ZXYZ=* ,CXCY31])N2CF&
MUUFRGF95+;(UE&YB!V%4(Y[*X^*&KW4H3R6T&%%>9-O\<A9>>AVLN1UY&:]
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M-NPC)ZG=D#DFO5J* /,O!\MS9:WI%E87J:MH<T$K0K/'BZTH8!V.1U4G"_,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC9\C;<;C(Q&-P!8==P[XJYX/U,KJVJ6.IZ;-I&IP6\,D\!N/-MFC!<"6)L\
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M1M.UJ!(=2LX;E$8.GF+RC?WE/53[BG6&E66FAOLL&QFP&=F+NP'0%F)) ^M
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M$2.L#1>9($//.&XQD[<XY% '=Z?XGT;Q!+>6.E:H&N[=<N%0JZ ]'4.N&'N
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M975G:MNN6^?]U+*1E O!"$KDELYZ4 =5<>,+"+Q)INC1I/,U];-<I/%"[Q[
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MK3XLS36.E03ZA-X>1I(A/Y<983MRTA7)X  .W/3H.@!Z)37=(T+NRJHY+,<
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M"D=2HR<>I&!K^O3:W>>")]*B@N-,U*Y,P6:8IYI$$C!7 1L '![_ # <<9H
M]"CD26-9(W5T89#*<@CZT%T$@C++O()"YY('4X_$?G7&^*G?P1X"NI?#MG;6
M^)ERGF,%C,LH#,@P>[\#@#KVP:%ZU[;_ !:M+BWTRWEU*7P_,'C6?:A(GBQN
MD*YP!QG:3ST[T >@O(D8!=U4$A1N.,D]!3JX.X\6V>K>&O#NJ76A"=+S5H;;
MR99%/V2<3&/?G'S;64XP!GVS6P/%37&O7NEV-K!/+8W,,%Q&USLF"N$)E6/:
M<H _7(SM;\0#I**@O;N'3[&XO+E]D$$;2R-Z*HR3^0KS_P )7^H:5X[O=-U>
MXW_V] -4ME+ B&4 ++ /7:H3\%H ]'HKG-1\4O;ZGJEA86*W4VF6:W=P'F\K
M(;<55?E.20C'G Z<\\9G_"?74T?AXV>@23/KL$DULK72KC;'O 8X.,@C/ISU
MZ$ [:BN*O?'LMI9W<@TR%[JP1/MMF;T>:)"BNT<0"D2%0P_N@G@5+J/CV&&&
M[DTZUBNFM($FEAFN/)E;>@D"(NTEGVD'!QR0,]< '845R">-+N]U@:;IFAO-
M+)ID>I0M<W A!5VP%8;25/!['GMW%6S^(4UW8:#J9T-XM-U6Y2S,K7(,D4S$
MJ/D ^9-P(W9![XQ0!W-%<;J_CZ+3UO9K6S2]@L;G[/.D=QBX8@@.8XMIW;2>
MY&=K>@RR]\<WT-QXABL_#YN/[$C2:5GNQ&)(VC,F1\I.[ X'UR1QD [6BN,/
MB?4KSQEH%K806YTS4-,>^_>2E7(S'U 4@8#\#/.>HQ6_KFMQ:+%: QF6YO+E
M+6VAW;=\C9/)[  $DX/ Z$\4 :E%<C=>-9-/EUJSO=,VZCIEB=06&*?<EQ ,
MY97*C!!4@@CKC&:TO#NLZCK=J;NYT?[#;2PQ36KM<K(90ZY(( RN..O7/U%
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MK[,;1YR&B8%MX8[>JA&)&.W7I0!U-%%% !1110 4444 %%%% !1110 4444
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MI9BQ894 XSCK[^U6?#-CXNM%M[77KW3);:T78DMHK^;<X&U3(&X7CDXSDXY
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M]%P..^>U;7]@ZII_C"[U_31:2KJ5M%%>VL\S(%DCR$='"-D8)!! ]?:NJHH
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M(=P+$)]W< 0",]<^E:\GA*QGU#5;R>>YE;5+06=S&S*%:,!@ ,*"#\S<Y[T
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M[BF"3V[L2S;7"]"6/!!Z^PKH=)TJ+2+/[/'/<7#,V^2>YD\R25L 98_0 <8
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MN'N"-SKV'R@!<=1M YYZ\U%;>&(8)(99M0OKNXMH&@MIKAD+0*V Q7" %B%
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MT.6;RKB\15,TC (#& 3E,9;)QR$QWP =) );/3D%U<-<RQ1?O92H!<@<G
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M ,.W>B22W26][*9KJ1'423N6#$LQ'<@= ,  # XK?AC:*)4:5Y6 P7?&6^N
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M8G (/\.<XXK.U^ZN)_!?B6'6=/L8[ZRU&Q>YO+/F"XS)#^\&>5(0 ,#TX]:
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M$#SQS/NN"Z2QJTQ)/[N/ P.,8QR,XH ]8M-=TZ]U>]TNWN8Y+JSV><JL#M+
MG;]0!D^F167XT\0WGAO3[.[M(8)O/O8;1DER,>8VT-D>GIC\:Q_#,NGI\3?%
MT8,"W$S6DL"X =D-N-S*.N,]3ZTWXN2P)X:TU)YEB5M8M,DR;#@2#)!R",#G
M(Z4 =1%/K,-]"MXM@UJP;S'B9E:/ R#AN".Q],BM 7UHR@K=0$,VT$2#D^GU
MKG;630+#7HGMM7>YN;N(P+;O?-<\#+E_F8[0 #D]#QWQGC],;2] \8VUTPC7
MPKJUW(^EL77RH;TJ S@8X5P'V'.!STW# !ZG)>6T,\<$MQ"DTO\ JXV<!G^@
M[T2W=M;RQQ37$4<DIQ&CN 7/L#UKRBYFT34K[Q1H7BG5[BQO7U$R10*(UEFB
M^4P-"2A8G   4YSGCFK,-_H,U_XMT#QE($NY[M&ACG;;+/;;$\D1%>6(8-PG
M\1/<T >G?:[;$A^T18B.)#O'R'W]*I76OZ9::G8Z=+=Q"ZO59X4WCE5&2WTZ
M#W)K@KJ\L-/\5>.H+V2*VDO=*M6AAF8;YL12J=H_C(. <9JCI%QIBS_"VZN)
M+7RCHTL)D<J09!#" F?[V00!USF@#TVWNKB.ZO\ [?<V"VZ2J+?RV(=5*CB3
M)QNSG&.V*N?:;?,8\^/,GW/G'S_3UKS[0M(TS6M2^(>BND)M;F]5'2,#Y=UN
MF6 ['=DY]14GA.35-6T8_:;?9J6@VTNG(67 >Z7*EUSVVK&01Q^\8=J .\2[
MMI+E[9+B%IT&7B5P64>XZBIB0!D\"O*/!\OAW6XO#$G]KW9U_3OE>Q41I-'+
MMVS"4! VS.22QYXY)-=1\2;F:S\*+<B.22RBO;=]02,$EK42*9!@=1CJ/3/:
M@#J;>[MKN,R6UQ%,@.TM&X8 ^F11;W=M=AC;7$4P0[6,;AMI]#BO,_%EUHUY
MX<UW6/"CB\DF2U_M*:QD+HT".-RX!QN\LMD#D+UQD9U+N.QO?B'H%WI#6LME
M+IUR-3,6TQ/;87R=^./O$[<]MW8&@#MUO;1Y8XENH6DD!*() 2P'7 [XH2]M
M9(9)DN86BC)#NL@*J1UR>V*\3TVST@?#;P%<F*U$SZS!$\W <H9)%92W7&W@
MCIBK'BN#2[:/XGV4,5I%"NGV<J0(%55EVN-P4=&X7I[4 >R?;;3=*OVJ'="-
MTH\P90=<MZ#ZTHO+5EB9;F$K-_JB'&'^GK^%>=W&FZ'_ ,++\.1I;612YTFY
M,JA5(FPT3*6'\?.XC.>>:Y^*2TM_"%M(KPI8Z;XVSN! 2WA%T<'T5?F^G- '
MLHN8#YF)XSY7^LPX^3Z^E)'=VTTK117$3R*H8HK@D ]#CT->1ZY>Z3?7/Q0*
M3VDT<NBP21'*D2,L4WS*?XL-MY'?%:=E!I=EXQ\"-9I:Q/=Z5<K.T>T&<;(B
M-Q_BYR><]Z /0-.FNV@N&U":R9DGD"M:D[5C!^4-D_? Z]LU8BO;6:V-S%<P
MR0+G,J2 J,=>>E>.P7L&F^#Y)T53HUMXPF.H+",JEMYKX) _@#>6<>@K>U[4
M/"":?>ZG8".[AO\ 4;(7%S%<D6@F# (SL"5 4*"X'7Y0>N0 =OJ7B+2M*T*X
MUFXO838P(6:1'#!B/X1SR2> /6KKWEK';&Y>YA6W'65G 7TZ]*\4UJXMKG0_
MB? MU;7;YMKI3 @"D>5'ND5<G ]\G/J:ZWQ+K6FV?B/PW=RZ@EKX<FAN8XKR
M!8V@2X)3:6+*RC*B0 ^[<]: /0XY$EC62-U=&&593D$>H-.KG/!-CI=AH<D>
MBW<]UI[W,DL4LA4H=QRWE;0!Y>[.,#&<XXKHZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9)%'*
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MQ; W$8)QSBN:N/'6D0ZE-I\45_=W,2PNRVMH\F4D)"N#CE>.6Z<T?\)UI/\
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M&/\ <R3<C8#G/)! )&#C@FK^JZO:Z/#!)<ERUQ.EO!&@RTLC?=4=NQZD#@T
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M0K"MO$L2_=0( H^@IRV\*N'6&,,.C!1D5EZMXDL])%R9(KFX%I$)[K[/'O\
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M+'F&*0D*%8YSU(!(! /!(.:T=6U6TT339=0OI"D$94$A2269@J@ =26('XT
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M2CR]K6\B@ET920=_RG Z=\],Z5[XSTJPENA,+@Q6<L4-W.L>4MWDV[5;G/\
M$N< @9&: -M+2VC@,"6\2PGDQJ@"_E2I;010>1'!&D."/+5 %YZ\=*P+OQMI
MEKK%SI2V^HW%[;&+S8[>S=\"0D*W3[O'+=.:EM/%^FWNA7.KPI=?9[:9H)$:
M+$@D5MI78><Y.,=?2@#:EMH)U59H8Y%4@J'4$ CH1FEE@AN HFBCD"L&4.H.
M#ZC/>J>M75O:Z!?7-X]S!;I;NTKVX8RQKM.2NW)!'7(Z8S6/%XMTC3K70;/?
MJ$[ZA9B2S+0O+),JQALLP'+D$9[Y.3QS0!TR(D:[4557).%&!2-%&[;GC5B
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M_AO^Q9S?I<N(P)8L3 W1EW*=W VXZX.>,5Z=->VMM/;P3W,44MPQ2%'<!I&
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M*IMS^XVQF/.=_P W!SVYJ.+P?>Q-X2/]I0$>'T*?\>Q_?YB,7]_Y>#GOS0!
M?&5_;ZUI5I>VMK%]OOI+-K17W36P <QN[ E3N"9VX! ;J<&J&GZ]K8\/^-M1
MOELK]=/N[M%MW#(A6*-?E_B^7:#QCDD\\U+;?#_5K>UTJV_M^!DTO4VOH7-D
M2\@;S-WF'?\ ,_[PX88Z<@]M#_A#;U+#Q381:K"+76Y)Y4#6Q+0M,@5LG?\
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MUY>)(?,#I(FUA]X8(P"#R/4&@#+N?&%_)HNLZ[IEK;SZ?I,\L;PN2)+A8?\
M6LK=%QAL @YV]1GCJ[&\AU+3K:^MR6@N8EFC)&,JP!'Z&N5'@JZMK;7-+LM1
MCCTG6)999(WA+2VYE&)1&V<8/)&1\I/?I750VJV6G16=DJ1)!$L4(8$JH48
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MB1)2HX(QMP#WSD>^!>N=;N;CQ+-H.E_9UN;:T6ZGFN%+*N]B$0*""2=K$G/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%%  0""",@]J155%"JH4#H
M ,4M% !1U&#110 BHJ+M10H] ,4M%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %,6*-&+)&JD]2!BGT4 %%%% "!0"2
M 3U]Z6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN?[7L1!;$+/(TZ@1$C(W9/&1TSUH U**RU\2Z&ZRE-7LG\J7R'"S*2LF,[,
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M16#;^+M'N]8U/2X[^!)]/5?.9Y  &().,]0H R>G/M4^F:E##X=M+N_UFTO
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M..&.?>%U.*W+_9R(@H4!1C>P.T%@0-IX-<I9*H\,Z,+JWN#;V'BZ:6[:XMF
MCC+SX=\J !\RY/09'2O3_P#A'/\ J,ZQ_P"!7_UJ/^$<_P"HSK'_ (%?_6H
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M5)IO]H7]QHXU&>2UA"2V[R28D9OF7:)B & !YX!W=>*=X?\ &EIXD-L+&QO
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M;D+YB2+)$3MW!D)'!X(..W6KE_K:VNHKIMM;27E^T!N##&RKMC!QN8L0!D\
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MO7,US*J'<(2X 0 ]RH53G^]FI+31M7C^']Y9WQ2ZUV]M'6X9& 5Y6CV#D]@
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M$ YZY4$GG/3M7+>#-7UC1/!O@N59;1M-O;W[ ]MY)\P;VDP_F;NH*]-O0]:
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M+"L%UY"1R+<(I^7*N" PR<-70V4YNK&WN"H4RQ*Y4=LC-3-D*=H!;' )P":
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M\;RH/(7..!G-+HG@;^PKCR;76[XZ(DQGATME39$Q;=@/C?L#<A<_7/.>MHH
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M+TKK+Q/<%HXR0R!1E<*.3L'L!GCO7;56O+^UL!!]IE6,SS+!$#U=V/ 'ZGZ
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M\BLK2"T-I%;0I;$$&)4 0@]>.G.3FFVFGV5A:_9;.SM[>WY_=0Q*B<]> ,4
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MFK<3JPPA/1@BE]H]N^ :Q-:@F@T3Q-8I+,-+LM?LDL"LK 1[WA,L:X/W5+D
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MIK/4]-;,5Y&I0&0KU$@RIYSG)YZ5T/ANUTBXUW3-:TK7+)O/M61K6PBVBX3
M.^8;V.Y3_$><G!/-=E9:3INFEC8V%M;;E"GR8E3@=!P.GM3-/T/2=)EFETW3
M+.SDG.96MX%C+GW('- ')>,+/3I?B)X-EO;>V93]L5WF52"!#N )/8')K%8Q
M:QX3\<7NI-Y>LZ=>7?E3YQ+:B-=T'EGJJX"D8X;+=<FO3;O3K+4/)^VV=O<^
M2XDB\Z(/Y;CHRY'!]Q44VBZ7<7POI]-M)+L8Q.\*E^.1SC/';TH Q-46?4/A
M9<G5X%:[DT<O<1N@P)?*R>/9OY5R"V>GRZ7\,K:!(EBEE4S"!MFYC9,3DKSD
M\9^M>KLH92K %2,$$<$5G)X=T2)+=(]&T]5MF+0*ML@$1/)*\?*?I0!Y?->G
MP[IGB6TM9/LVDVWB2WBEX9DM[=UB9^ 00FX\@$<,?6NT\+:=8V6NZC/I^KVM
MQ%=11R/9V,86WB(R X 9@I89^NW/:N@CT;2XA<B/3;-!=9^T;8%'G9Z[^/F_
M&G:;I.G:-;&VTRPMK* MN,=O$L:D^N .M ' ZS);:SXTU_0M9OK"U1;2$V0O
M8LD1LIWR1$NH5@^<D<\+Z5%8Z/9W_CZQL;VZGU2V;PRI=YW8"YQ,JAV7.#D8
M/OP>M>@:CH>DZN\+ZEIEG>/ <Q-<0+(4/MD<4]])TV2]-Z^GVC793RS.T*ER
MG]W=C./:@#R0PPWWP?\ "\EZB7#Q:O! CS#>PC%YLVY/;:H'T%=5:6UGJ7Q
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MN/8CT(K%\/37VEB^\+ZGX<O+R?\ M&:XMKIK??:S))*9%D:0\*5+<CKP,9-
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MT;1.,?*RL 0>1@8YR,9S6=XWGO+?3;![33Y+M1?P^>\-L)Y;:/G,L:8.6!P
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M"CR.(0LF_P R,,0KYP,!@,CV(KD+GXCWT&FZEJB^%YI-/TN]EM;Z07:;T5&
M9T7'S8ZD9''<\X /0*:70.J%E#L"0N>3CK7.P>*FNM7U73X+-'-E9Q7D4OGG
M;,DF['\.5/R'UZUR"ZU+JGC/PQXATO1UDN]0T&>00-,J<%XB \F.@R><'KTH
M ]1=TC7<[*J^K' H\Q/,\O>OF8W;<\X]<5Y?XFUZ+Q1X%^T3Z<;._P!/URUM
MKBWE(=H)EN(P=K#J"K#D=0:ZJ75["V\?75O<Z;'#<0:/]I;4F8%C ).4P!G
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M)O%W@*RJ71=OS'+9P2..A/;3_P"$MO8=<N]*O-%,,R6#ZA;;+I7,L:L%96X
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M.#RN"6R >0!@=>I@\/>*;#_A&/#2:5I,=K)JP<66GK)M2-4#,Y+!>  .P/+
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MR&628.&V@*< &0XR>@ ]ZZCQ'HL7B/PYJ&CS2-&EY T7F*,E">C>^#@UJ44
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M<G&<D#D#K+K_ (?O+OQ!H^OZ7)"+W3O,C:&X8K'/#( &4L 2I! (.#[UTE%
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M"@D.U?G //'/![URF@>([Q=26QUZYN]-UA+.:21;K#V=WC!\Z)QQM4 G:",
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MA=6SM494%0V,<<UT.EVGB&V\10W$VH02:1/;E7ADNC*[3=0\9\M0 1G(!QW
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M1H[1XKIT=8V !0LI!*G Z^E '#)>ZCKN@^!;F^U&Z%RVNRVTC1L%WA//56(
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M*I F<9SU89[<<9H ],-S )&C,T?F(NYEW#('J1Z4U[VTCMOM+W,*P?\ /4R
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M[O[?;&VMP6FE$JE8P.3DYXJBFL/JNE:7J.C7%D+>ZDA>0W1.3$PR57!XDY7
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M<$#H1C)'YURVB:M!I_A?P1/>WSVVB1W%]!+<H%=()?,80;MRL -H< XXR.E
M'M44L<\2RPR))&PRKHP((]B*C-[:BZ^RFYA^T=?*\P;_ ,NM8'@FSTBTTZ];
M0[V:\L;B\DG$K,AB+M@MY6T ;,^G&=U<O%//IOBB!HI+/6=(NM=F15QMN]/N
MB7#]/OH,-UP0I'84 >CK>VK736JW,)N%&3$)!O ^G6A[ZTC8*]U K&3R@&D
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M5:18HU4;FD=CA54#J2?\XH G%M L*PB",1+]U @VCZ"E^SP[E;R8\JI53M'
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M!$57.!L&!7GWA+QA#IVF20:M/J%P6UJYLUNY$>1(LSLD:O(>G8#TR,XS7HU
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M=+U.ULYM-\^\:ZCDD2&) )%6-@LFX,1@JS $=<G@&@#9:SMG:-FMX6:,Y0E
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MVP1]GBP>HV"E>UMY!&'@B81G*;D!VGU'I61/XLTU/LHMA->R75F;Z*.V0%C
M,?O.2!CYEXZG/ K.N/',#:EX;ATZUGN[76HY)TN$3CRUC+8 )!W9*YST&>]
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M"T?[]D@:,_Q<<D=<5U?A2WN+/PAHUI=P/!<V]E##+&Y!*LJ!2,@D'D>M;%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;0QEI #N,KY.W.<<+M;_ (&*R=;\0:S:>++'0M,L;*1KVTFG2:XF8!"A0'<
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M_:.,G&06QC/-;_B2XA3X13:KHNM:A/YGDS)>&\DWL6E4,.ORCYF!08 Z8XH
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MN0R+:2<OM<ME?+V2 '/4KZT >CT5YS.M_P")M7\4:3#JIL+G3I(XK5OM$JO
MAB1EEPK -EBV2V<@8-1PVD^K^+]4L;S6=0EM_P"P[6XS;74D*-*QD!D0*<J#
MM!P#CUS0!Z3@$@X&1TI:\RT'4KC7=&\'Q7-]=75_/I3SRVBS&%90-B^=+(IW
M#!.  "26SCC(SM'O=1U72?ARUQJU^)+R:Y@N6CN64S*L<N-WJ?E'S=>^0>:
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M?DM+'(\;/'UV,5(W+['(K.\*>*++6-(TB*?4[2369].ANI[9)%$F6C5B=@Y
MR?U%:IUO2EU%=/.HVHO')583*-Q8#) 'KCG'6@".\\/Z5?BR6XM 5L65[54=
MD6%E& 5"D $#@'M5Z:WCN+9[>4,8W78PW$$CZCFL>VUNRMDU6\OO$6G2V<-S
MM#!D1;4;1^[=MQ!;.3S@\]*TK'5=/U-KA;&]M[DV\GE3"&0/Y;_W6QT/M0!F
MMX-\//;6%NVF1&+3R?LJEF_= C!4'/W2.J]/:K-IX;T:PTVZTZUTZ"&SNRYG
MA4?*^_.X'V.3Q[U'X@UNVTG3KG.H6EK=B!I(A.01QT)7(XSQG(YJIX>\1QR^
M"-%U?6;R"&:\LXI9'8A SE S8'YGB@#8&F60N+6<6L8EM(VBMV"_ZI&P"%]
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M:'9:J+V".&ZC5E4RJ2K%0Q0X_B /([4 :EO;PVEM%;6T2101($CC1<*B@8
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M"347PM8KX0>V=)TE@O[L.)HBAYG=AU '0@\=,UVM(1D$ X]QVH XXJ/^%SY
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M.2>><<YP!7LM% 'CDFGVMYX'\5Z UHK:[=:M=M;6S1[9BS3$Q2CC.T AM_0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM$M)RX.V2 LP+ <@%B/7@&M*YT34O$^H:)<ZO9BP&FI,TH297\V5XS'\A'\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+AP$1MV<#&=_3%;M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW&@I/<@B>5=&(:4'^\?.RWXU!;>$+BSLIK*V'AR&TG.98(]#PDA_VE$V#^-
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M-:H0Y484GCG X'I4\FDZ;-<6]Q+I]H\UL,02-"I:(>BG&5_"@#Q^_P!*LX/
M7CJ6)75]&U2?^S2)6_T3:(W'EC/R_,QZ?3I7M,3%HD8\DJ#5#_A'M$,,\/\
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M_EU:*V>Z69Q(8GDD5TW9R 1V'?GKS7K]IHNE:?#)%9Z;:6\<B[72*%5#+Z$
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M+ !=Y'H. #P,5:N+72=(B-FFK?;8;_6+?R;&U*Q6D<Q5F\IC\X$;;=S)SSC
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M^>T"E^.GS8SQV]*H7VGZSJ6MK%<26 T"-HIE15<W$DB'<%;/RA=P4\<\8[T
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M;="W"NN!\P/;;FN1>ZO-"\;ZZUYH6HZEIFMQP/;R6ML9@I6/RVBD!^Z#U^;
MY.>]2LMUI/Q$M;Z32+HV]SH<=FBV4!DCBF25F\LD<(,,,%L+QU% $^O^(FN8
MO">HZ'J;FQU#5HK=]B#;-&0Y(.Y=PY3MCO6[<>*=&M;MK::\VNDZ6SN(G,:2
MMC:C.!M5CN7@D=1ZBO.M,LM1A\"> [:;2M12>RU=);B,VKEHHQYN68 <#YUZ
M^M.\3QZK?VNO6YT/4EFBU>":&*SM2(9H5EB/G%A_K7(4Y&21@<#!- '>S^-/
M#UOJCZ;)J*B\2:.W>)8W8J\G" X&.?7H,C.,BMZN'T:2:U\;^,-2ETS4%BFM
M[5X?]%;,OEQMO53C!8$@8!Y/3-=1HFKQ:[I$&HPP7%NLNX&&YCV21LK%65E[
M$%2* *Z>*=&DOHK1;S,DL[VT;>4_EO*N=R"3&TL,'C/8CL:IR^/?#$/FE]47
M;#<?99F$4A6*3CAR%PH^8#<<#/&>#7#3#5;O^Q)I= U.&YLO$9FN+6WM-EO#
M'F4!DQ@2;MRL7YY+9*@XI^HV-]/X)^(5K'IE^UQ?ZE+):Q_9)-TRLD0!7CD9
M5ORH ]&U76;*QWVTMU+%<&$R_P"CPM*\:=-Y 5L#/=AC@UF?#W4[O5_ &D:C
MJ$[7%U/"7EE(&6.X\X']*R+.XO-&\?ZQ=W>FZC<6.L6UJ;.>"U>3RVC0JT3@
M#*9+%@6P.3DUH_#*WN;/X=Z/:WEI/:7$,11XIT*,#N)Z'ZT 8GB/QQ+J'@#Q
M+J.BRWNGW.FS/%'*UL5+;&56SO7 ));C[PXZ5V-GXGT:_O[JRMKT-<6T?G2(
MT;+F/.-ZD@!UR.JY%>=:G8ZE_P *_P#'&C#2-1>[N-3N98 ELS+,LDH9"A'W
MLC/3ICG'&>I?S&^*EIJ"V=Y]C&B20F;[+(%#F5'"GY>N%/'X=: -#1-=TU=
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M9?,4$9#!-NXK@$[@",=ZT3KVF_8+6]CN?.@NT#V_D1M*TJXSE54%CQ[<5SD
MEC^).N7SV=Y]EDTJ"))OLLA5W5I"R@[>3AEKD=)M-4T/1/!FHW6BZO<VUII\
MUA?6MK'(MQ;LS(P<("&8?)@X[8- 'HG_  FWAS[/93_VK%Y=ZS) =K99ESN4
MC&5(P>#@Y&.M4]3\?Z1:>%;[7;1IKN.UD^SM&MO(KK-P KJ5!3DCD@=>^1G!
MN+!$U#PK/I^@7MG:C5Y;R9# [.JM"Z^9+C.UF8C@G.,$X.<4-9TS4;S1?B'%
M;Z;>M)=7T$]LGV=U,Z(L.XID#<<HW ZXH ]2BN8YK47(WI&06_>QM&P ]58
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M!&TK2* "654!)&".<8Y'J*XQX+@:Y\0I/L%[LO+2%+=A:R$3,L+(0OR_-\Q
M_P#K54T"VU'1=5\+:M=6-\UC_P (['I<Z);.TEK.I5B60#=AL;<@8RH[4 =E
M)XP\/Q:=:7\FJ0K:W<PMX9#G!D)V[3QE2#P<XQWQ4MAXGT;4H[Z2VO0%L#_I
M7G(T1B&-P+!P#@CD'H:\^NM#O[>S^TBPNV2^\7PZFD"6[LT4"NNYV4#*YVEL
M'GD<9R*GU_2=5U/5O'":?9W(ENK2Q-J\D3QI.\+,SH'( YX7KWH [&Y\9Z-;
M0:@[27)FL;;[5+;&UE64Q?WE1E!9<C&X<#N12V'BW3[G1]+O9_.AFOX@\=N+
M>5I&.P.VU0NYE /W@,>]<S''#XDTK5+BT\+ZK9ZBVE3VQEU-75PSKQ$A=CN!
M/.1QP/6H[:[OULO!T3Z'J45O'9M!<7"61-S#(L:+L&1NC1B&!;C[HY YH ZR
M3QGX>CLK"\?4XA!?L5MF"L?,(SD8QD'Y2,''(QUI=(\7Z'KMVMKIUX\T[0_:
M AMY$_=YQN^91QD$?45YWI-EJ%OH/@^TGT;4XY-/\03S3A[5WV1EI\.2,Y'[
MQ.>^<C.#76>.;/4+2\TKQ'HB1MJ=O+]B:-S@313D)@^NU]C_ (-0!U5AJ%MJ
M<#S6CL\:R/$2T;)\RDJP^8#H01]0:M55TVQCTS3;:QB)9((P@9NK8'+'W)Y/
MN:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 445D>(-<71(+0)$)KN^NDM+6(MM#2-DY)P<* &)X
M/2@#16ZMWNI+5+B)KB-0SQ!P74'H2.H!J:O.+.?4-.^(OBRY;3XKF[BTBVDC
MALSM-R0TI'7H2>._3/M6I!XTNCJ6IZ:;>QN;FTTT:@K6]P0A.YE:)C@X8%>H
MSG/04 =G17!6WCC6I8_#-R^C6GV?7X@(0MT0\<IB,@W?+@)P1QDXYQGBKMGX
MLU6:RUN*32(I=5TJ\2V:*WF)B<.$82;F ( 5\GC^$T =A17#_P#"PH[6P\47
M%S##<C0DCD\RS?*7"NFY<9SMYR#R1WJX?%-_9^*%TB^M+,P_V<VI27<<S 1Q
MJ=K*%VG<02.<KD9Z8Q0!UE%<;8^,M0N[[26&BW$FGZDA;S(H)=UKE=R&0E0I
M!Z9!X/J.:L>%/%C^*!#<6_V-K5X6:=(Y#YUI*"H$4BGO@MSQRO3O0!U5%%<9
M9^,[M]?T;3;ZQ@@DU0SJ;82YFM"BEU\P=#N4>V/?K0!UMO=6]T)#;W$4WEN8
MW\MPVUAU4XZ'D<>]35YMX=UBW\-:;XFE6!7>7Q1+:VT"G8'ED,:JN<<#)R3C
M@ \&M^7Q1?:?KTNBWUG;O=263WEE)'*RQS;#AXVR"589!SR"#VZ4 =517":3
MXYU2\'A>[N]*MH;#7AL0I<%I(Y/+,@R-N-IVD=<]#[5+)XYNY!!>Z?I$][I[
MWAMF6&"9I=@<H9@0FP@$$[<].<@\  [:BBN-O?%^HV=UXFM6L+7[1I%LEY;H
MTS 743!CG./E.5*]^?K0!V5%<M;>+UGTRPU3$!L)-,?4KN56),*  @ 8Y)^8
M<X^XU0-XPO+2#0=0O[&&/3=9ECA0QR$R6SRC,6_C# ]"1C:3WZT =A4/VJW^
MU_9/M$7VG9YGD[QOVYQNV]<9(Y]ZXRZ\=7EMX4\0ZP=/@:71M0>S:+S2%E52
M@W XX/S].>E.G:"T^,374FR-5\..\LF,<+.O)^@H [&>ZM[7R_M%Q%#YKB./
MS'"[V/ 49ZD^E35YAXCU.[UZQ\&:P;.WCL;K7+.6#+$S1HS$H3QCYA@D#IQR
M:]/H **X34?&NMV\GBD6NCV3KX?"R2&2[8>;'Y7FG;A/O;>QX![FM9/$\FIZ
MG#IND11?:&T]+^1[@G;&CG"+@<DG#?0#OF@#I:*\XOO&VJ:E8:%)IT,-I/)K
MPTO4()7)*2IN)0,!RIV=<<@CCK7HR;MB[\;\?-MZ9]J %HKC;SQ/XAD\1:SH
MND:-93S:?!#.DD]XR+(K[^,!.&^3 '3J2W0&E;_$*_U:#PV^D:/"[:W%<%1<
M7)3R980=RMA3QN!&1R<=!0!W]%<E!XEU>_34H['3[1[O2D1;N)IVVR7!C#M%
M&P'  (&XCDGIQFH;;QT;ZX\+W-O:QC2->5E2XD<AX9@I81D8QD[6 .>JGVH
MZZYNK>SA\ZZGB@BW!=\KA1DG &3W)('XU(S*B%W8*JC)). !7&>(O$,UOX?N
M;^?2;*^LDU**VC25S\R^<L?F;2I!(?H/]G.:O7VLSZEJ.KZ/IMK;3G3X$-T;
MECM=W4LL8 ']T ECTR.#S@ Z*WN(+N!)[::.:%QE)(V#*P]B.#4E>:>"?$)L
M/ OA32K:/?>3Z8;C<8I)%C12%R50$DDL .@X//0'L_#&L76N:,+J^TR?3KI9
M'BD@E5ADJ<;EW $J1@@X'6@#8J&.[MIIYH(KB)YH<>;&K@LF>FX=1G!Z^E<Q
MXSU35]/U'PW;Z:T"QWNI"";S"P+?NW<#(Z#Y>?R]:YX7VI:+XN\?7NEZ?9S-
M;PVES,LLIC4A8&9@N%)+'!ZX% 'IU%<E)XR-T;2'3+?-Q<:='J!\V.21423.
MQ2(U)R2&YXQCOTK9\.:M/KF@6FHW6G7&G7$RGS+2X4J\; D$<@''&0<#((H
MTR0H))  Y)-5[?4+*[#&VO+>8*VT^7*K8/IP>M<7XMN&U3XB>&?"\^?[,FCF
MO;J+^&X,8^1&]5!Y(Z'C-=3>^'].O;FPNFMXTN+&4202H@#+@$%?H02,?0]J
M -2BN)N?'-PGAJ?Q3;6,4^B6\[HX#GSGB20QM*O&.""0IZ@9R#Q4LWBK6+C7
M=7TO2]-L9#9VD-W#--=,%E63?C("9!^7IT[Y[4 =C3)HS+"\:R/&6& Z8RON
M,@C]*XBQ\=7]W%X8U&72H(=+UUU@3%P6FBD:-G!(V[2N48=<]#QTJO<^._$*
M:=KNHVWA^SEMM#O98+I?MIWR1QJK,8_DY."2<X[ 9H Z[P[H5OX:T.VTBTFG
MEMK9=L9G*E@,YQD 9K4KBM<\<7&GZ9<ZK;6D T^&PCO8'NI=AO=REC'&!T*J
M 22#RPXQS4TWBG59_$T>C:9IEHYGTL:A#/<7+*!EPN& 4D8SVSGCI0!U]%<)
M%X]O)?#WA[6SIT,5EJ%T+2\9YB?LCES'NZ?,I=<9.,9%=38ZA/>:MJ4'E1BT
MM'2)90QW/(5#,,=, ,O/J2.U &E15#6;VZT_29[JRL6O;E !';JP7<20,DGH
M!G)]@:Y=?B##:IXC-ZL$ZZ,D#K-9OE;CSLA%&>C;AMZD<B@#L6NK=+J.U>XB
M6XD!9(BX#L!U('4@5-7GE^]Y!\4_#ESJD-G#_P 2V]=I(&)Q@1%E;(Y"]CWR
M>!WOV7C:]N[C1YTTB>33-3Q^\C@EW6JLNY'D)785(QG!^7/5AS0!V;J'1D.0
M&&#@D'\QTID$$5M D,*!(T&%4=JXRY\;7RZ%8>(+6PMGTN^NX;>)9)667RY)
M BRGC'.<[?0CGM5F;Q;>1?\ "7I]C@,F@1K*O[PXG4Q>;@\?*<<=Z .NHKD+
MWQ9?Q:9:WL5G;002Z8+TSW4N(VD(!$"XY+$9.?IP>U >*=6U7Q!X-:Q2"&PU
M;3Y;UX9';=D(AP2!R )./4C/I0!WU%<3-XYNW6.]T[2)[ZP^VFU9(8)FE*!S
M&TJD)L(!!.W/3G(/ [:@ HKCQXHUN?Q3JNDVNE67D:9);&>>6[89AD!9F V?
M> '3IP>345GXUO;Z?1[B#1YY],U1PNZ."7?;HPRDCDIL*GC.#\N>K4 =4=3T
M\6T]R;ZV%O;L5FE,R[8B.H8YP",CKZU:!! (.0>A%>66=^FA>!_'=ZNEVM]!
M;:U>,]I.=L;IE<C&T@_3'Y5UFI^)YH+^33--MEDNX+1+F3=%*Z#>6")^[4XS
ML;D]..#G@ Z2>XAM8&GN)HX8DY:21@JCZDUCZCI.G>*K>RO8-1F1H&,EK>Z?
M< $9&TX/*L".,$&N2U;6M7U>\\"7*6!L/M=X\DEG>;T=)5AE^5QMZ#J#CG@X
MKO[#3[73;=H;2UAMT=VE=(5VJ78Y8_B: *$-O8>'H6O-2U9W<C8;O49U&!UV
MCA57IG@#.!G.!6O'(DL:R1NKHX#*RG((/0@UP^I/J$_Q;L;,I:R68T>X81RL
MV"K2PJY(QC=CCTQ4<7C!-*\&0>(-/TRW3PQ!)Y2Q1,1*EN)/+\U1C&,\[/[O
M.<\4 =]17()XFUR\\5ZGHUAI-D\5@UJSSR7;#=%+N)(&S[P Z=.#STKKZ "B
MN,N?&=Y9:M86]W8P0I>ZF;!;8R_Z0BG<$F('&UBO3T(Y/2J-[X]UJVTWQ#J"
MZ+9FWT*]:&X!NVW21JJ,2GR?>P^><#H.>P!Z#17.?\)%<Q>-H=$N;:&.TN[1
MKFTN=YS*RD;X\8P" 0W4\5HZ%J%QJFDQWT\4<8F9FA$;$AHLG8W/3<N&QVSB
M@#2HK!\4>)(?#D=@T\D-O'>7/V<W5QD0P?*S N1ZE0HY YZ\54?Q-?VVH^';
M6YL[;&K7$\+/%,6"!%=U=3CY@RJ#VQF@#J:YS6M L3?R:Z^M7NCRB%8IYX;E
M4C=%)*AQ(&7@LW. >35%/&[HNJQSV4?VFUU:/2K9$E.)Y) A4DD?*/GR>N I
MZ]*R?B%/J=SX"\66FJZ9$L5M;));7<;92;/7"GE64C'OD4 =[86,-A;F.)I)
M"[;Y)97+O(V -S'OP /0  # %668*I9B  ,DGM7,Z=XAU ^+AH.HV-O"LU@;
MVVDAF+G:KJC*X*@!OF!XR.O7K72R(DL;)(JNC#!5AD$4 ,M[F"\@6>VGCGA?
M.V2)PRG!QP1QUJ6O(O!WB;5?#7P^\-W4VE6[Z SBVEG2X/G1;Y2HDV;<;-Q
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M!KHM(U"?46OI'BC6VBN7@MW1B3($.UF([?,&7_@.>] &E6%'I&GW/BBXU/\
MM*ZN;B J#9&[W0VS[,!A$/NL5)Z^N>];M<A9:Q<7%]XN@MM,LK2]T^6-3*K9
M^T$Q!@[D*#D*0,<XQC.* .EBU.PGO9+*&]MI+N(9D@252Z#.,E0<CFK5<3\.
M+%;GP7X=U*^M;9[R.Q407 RT@5P"V21U)Y-=M0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/>+O#
MDOB*RLS:78M-0T^[2\M)F3>HD7(PRY&5()!YKH:S-?UVT\-Z/-JNH"7['  9
M7C3<4!(&<=>I'2@#E;_P3KFK7.MW5SK-K;3:IIB61^RP/^[*ECD$OT^8@^H/
M:I5\(:TVKR:E)J&FJTNC_P!F-!#:LD:?,Q4K\QP!N_3''6N@3Q#$T]O')8:A
M"+APB22083)&1D@G&<=ZV* .*@\':C#8^$+;[7:G_A'RI9MC?O\ $1BX_N\'
M/?FH-0\#ZI>#Q T>I6T3:G?6]XBF-F0>4$'ER#(W(P09Z=>]=Y10!YOKVDW^
M@V/BK6;_ %6T$>KV\%NVVR)2!\>4&;+$>6 V3GMD]L%OAT32:@EA]J\,:K9W
M<!M9VTQY&FB@"-MR6=\)G@#(&6XKTH@$$$9!ZBH$CM;) L:0P(S 84!06/3\
M: .6\-^&_$FC00:7=:]!<Z19KLM=MN4N'4#"+(^[&%XZ#)P,G&07:9X2GB\2
M66O7S6:ZA;VKV]Q/9H4-\6V_-(.V-I('S<GJ,8KHX[[S-4N+'[)=)Y,:2?:&
MCQ%)N)^56SRPQR,<9%6Z &R*7C90Q4L"-PZCWK@=+\":W8MX;,NL6+_V)/*P
M9;1@TZR(RLSDO_K#NSGIG).>E>@5%<SBUMI9V1W6-2Q6-<L<>@H XE_ %Q=:
M/K%G<7\4<]WJQU:TN(4)-M-E2H()^8#;[9!/2M5_#U]?:F-7U"2T^W0V4EI;
M)"&\M#)C>Y)Y.=J@#L,\G/&MH>L6VOZ)9ZM9K(MO=QB6,2@!L'U )K0H X>U
M\%ZC;:5X2LOMEJW]@2JY?8W[\"-H\8_AX8GOTJ32?"FO:)>3V-EK< \/2W#S
MK"]N3<0AV+-&CAL!22>2"1GCGFNTHH *Y_5O"\6I^)]*UGSVB-HCQSQJ.+A-
MRNBGV61%;\_6M]VV(S8)P,X R36;X?UVU\1Z0FI6<<R0M))&%F4*P*.4.0">
MZF@#)T;P19Z9H^LZ5+(TUIJ+S*$Z>3 Y8B)?8%W(_P!ZJ]GX0OVTW1=)U6]@
MN;'1YXYHI$0B2?R@1$'!X7'!.,[MO:NQHH \^U3P%JUYIWB32;;5;2+3]8NC
M> O;LTL;MLW+G=@KE,],\XXZULS^&+J\\6'5KNXMY+:32FTV:%$92P9@S,.3
MCTQS]:ZBB@#SR+P-X@CT;1M&;6K%[/1KZ&XM9GM6,KQQ$E4<!P,@8''7V[^A
MCISUHHH XVX\(ZA,WC#%W; >((A&GRM^XQ#Y63_>XY[<\4MIX2U#2]5T_5[&
MZMC>1:<FG7D,@81SHG*.I'*L#GL<@X]Z[&B@#BKCP+,-+LTL[Z%-0AUDZS+-
M+"3'+*Q?<-H8$+A\#G^$?6NS0,L:AV#.  S 8R?7%.HH X"T>^/Q7\4+I[VA
M?^S[(,LY/!_>X;CKCN.,Y'([V[3P/+I=YX7-C=1&WT19_,$J'?<-,/G;CA>2
M6[]<5UR6=K'.9TMH5F;.9 @#'/7FIJ .63PWJ.F:_J^H:/=VZPZOM>:*X1CY
M,P7;YB8^\",94XY'44R\\#6S> [;PS87#VS62QO9W9&7CFC8,LGU+ Y^IKK*
M* .:\2>%Y-5\*P:'I\T=ND4D#!Y06XB=7 XZD[0,^]5F\,:K9^*M0UC2;^TC
MBU:*-;ZWN8F<+(B[5>,@CMP0?3-==35D1W=%=2R'# 'E3C//X&@#SVT\ :UI
M&E>'WTO6K6/6-(MVM"\ELQ@N(6()1UW9X(!!!'TKN-,M[RWL@-0NUNKMR7ED
M1-B9]$7)PH^I]3R:74K[^S;%KD6EU=[65?*M8]\AW,%R!D<#.3[ U;H P/$^
M@W6M-I,]E=0V]SIM\MVAFC+HX",A4@$'H^>O:LY_"FHM>>*I_M=L?[<MHX%R
MC Q;8S'N/KD,3CCT]Z["HY)HXSM+9DV%Q&.68#&<#OU'YB@#A_\ A#-<TZ31
MK_1=6M(-2LM.CTVY6X@9X+F)/NG (96!R>O?&?7L]/MY[:RCBNKDW-P,F27;
MM#,3DX'.!S@#)P .3UJKX?UVU\2:+#JMDDR02M(BK,H5P4=D.0">ZFK$%\9]
M2N[/[)=1_9U0^?)'B*7<"<(V>2,<^F10!D>)?#!UJYT[4[*[%EJ^F2-):W!C
MWKAAAT=<C*L.#@@CM5ZTBUF9XSJ,UI$B')2TW'S#[LW0>P'/KC(.I5'5=6M=
M'M4GNF?]Y(L,4<:EGED;[JJ!U)_H2< 4 <I%X%NH- U#PO'>P_V#=S.ZY4^=
M#$[;GB'8Y);#=L]#BM*'PY>6OB;5M5@EM1#>645I%"58>7Y>[!)[_?/'M6E8
MZ_;WNIOIK6UW;7J1><T5Q%MPF< A@2K<^A/3G%:M '"V_@G4;?0/"FF"]M6.
M@W4=P9-C?OPB.H&/X<ASSSTK-\/V%]K4'CK2[>YMH[2\UFY@EEY,D2M&BOM'
M0DC@9Q@\\]*],K,N9K/2-.NKZST]K@Q##0V$*M*Y!QM &,D>F: .6U+P%?3/
MK5O8:E;0Z?J6F)IZ)- TDELJ(4"HVX *<Y/'6K^F^&=4LO$=IJ\UY:3&#21I
MQ18V3<0P??U.!D 8Y]<]JZP'(!QCZTM 'G<MAI?AKX??\(AXAOX)YKR.Y6VC
MB!62X9G+@(IS\X9U ]\&NP\.:7)HWA^SLIYC/<HFZXF8Y,LK?,[?BQ)K2:.-
MW1V12R9VL1RN?3TJIJ6J6^F)!YV]I;B40P0QC+RN03M ^@)).  "2: */BW1
M+CQ#X<N--M;M;6:1D8.Z;D;:X8HX!&5;&"/0US=_\/;W69-?_M'5;=8]8M;>
M-A;6Q4PRPDE&7+'Y02#@\G':NQT[5K?4I+F&,217-JXCN()0 \9(##."0000
M002/R-7J .,7POKU_KNCZEK.HZ=)]AMKBVFC@MG'GK*$!.2WRD[?P]\\'ASP
MMX@T6&'1[G7(+K0;7Y;=1;E;EHQ]V-WW;=HX' R0,<"NCU?6;71M*OM1G\R2
M*RB,LR0C<ZJ!N/'TYJS9727UC;WD081SQ+*H8<@,,C/OS0!Y5KN@:MX6\'V&
ME7.JVMQI%KJUFMGF$K/L^T*0KMNVG:/0<X[=*Z?5/!^J7&I>)9+'4;6*TUZU
M6*9986:2-UB,8VD'&",9R#BNPGM;>Y %Q!%*%Z"1 V/SJ15"J%4  #  [4 <
M.G@K6(;JSD36+1D31QI<OF6K'9C/[R(;_E+# .<_='TI=/\ !6J6">$W75+4
MSZ';26;G[,VV2)E1?E&[AAY8Y/!R>.U=Q10!Q>E^%->T6^N;.PUN!?#T]P]P
M(7MR;B#>Q9XXW# !22>2"1GCGFNTH)P,FJ5QJ2P/8B.VN+I+R0(LMN@=(P5+
M!W.>%XQGGDB@#*T[P_<VOBK7M4N)H)+754A3R54AD$:E>3WR&/ICWK/\->%_
M$.@+!I3Z[!/H-HV;9?LY%SL!RL;/NV[1P,@9(&.*[*B@#A9O!&HS^%?$^C->
MVH;6[N:Y$H1L0B3&5QGYL8Z\=:LZCX9UU->M]=T+4[.UOFM$M+V"YA:2"95)
M*L,$,&!9N_0_GV-% '+:CX;U*[O_  ]="_AE?2IWN)6F0@SNZ,I Q]P?.<=<
M<#M74TC-M4M@G S@#)K,T#7;7Q'I?]H6<<R1>;)#MF4*P9'*-P">ZF@"C/H5
M[)X[M_$"3V_V>*Q>R,#*=S!W5RV>G&T#&/QK'@\!W,/AJ?PD;R%_#\DQ9"5/
MGI"9-YA]#SD;NP/2NZHH Y[2]!N[#Q?K6L/- UOJ,<$:PJI#1^4& .>ASN/I
MBNAHHH \]'@+6UM[6W_MJS9;36?[4BE>U9I)<LQQ*=_) ? QC@"K%UX(U&YT
M+Q7IIO;4'7KEIQ)L;]R&1$(Q_%P@].M=*NOVK>*'\/\ ESB[6T^V;RF(RFX+
MP<\G)].U:M '!>*HM-\12:?X;74%7Q!:7$,C+:L?,@C*_O6/<*T18?5E]J[M
M$2*-8XU"HH"JH&  .U96M:U8^'VM)KFWE9KZZBLU>&,$AW8*NXY&!DUKT 9>
MM6-W?+"D M);?+"YM;M-R3H1]WO@YP<X/ICFN7C\ W6G:7HJ:3>V\5UI6H37
MD,<R,T"I+O!B4 [@JA\ Y[=.>.\HH X"?X>W]W9ZTD^LQI=7FHQZG:7$-N0;
M>=%0 X+'*_+T]#U-7-5\,^(?$'A+4M,U75;$WE[$( UO Z0Q+G);:6)9C]0!
MV'7/5W5[%:PSR-N=H(_->.,;GV\XX]\'\C4&BZM;Z]HEGJUHLBV]W$LT8D #
M!3R,@$\T 98T&^;QG9:])/;A(-/>R>%0V6W,K%@?J@&/?K71T4U9$=G575F0
M[7 .2IP#@^G!!_&@#BM.\#W</ARQ\-7UY;S:39W"S;HXV62X59/,5&!)"_-C
M)!.0,<9K5T[P]<VWBC7]3N)8);75EA3R54AD$:E>3WR#[8]ZZ*B@#C?#7A?Q
M#H,<.DR:]!/H5H?]& MRMUL!^6-GW;=HX&0N2!C@5GZ=X#UNSCT!)-9LI/['
MO))UD^R-OG5U=69SOY<[^O3/)S7H5% '%Z!X3UOP_(VF6VLVY\.K.TT,1@;[
M3&I;<8@^[;MR3SC."1QU%:Z\"ZE=>&/$ND&^M5;6K][P2[&(A#%"5QGYL;!S
MD=:["UU)+B.\DEM[BTCM9GB9[I @<+R9%.>4/8^QJ[0!0@CU4:L\L]Q;&P-N
MJK D9WK+D[FW9Y7&.,4:S;W]WI%U;:;<QVUW+&4CGD4L(R1C< .I':H9-?M8
M_$\&@-%/]KFMGN4?9^[VJ5!&<]<L.U&O:_:^';.&ZO(YWCEGCMQY*;L,[!5S
MDC R10!2USPQ%J_@>Y\.K%;PB6U%NAP2D1  5AW.T@$?2LJZ\)^('&AZG;ZQ
M:KX@TN%K9YY(&:&[B8#(=<Y!RH;(/7].WHH XW5O">LWDFE:M:ZS"GB#3WD;
MS9(";>5)  \>P-D+A5QR3QGJ<U+?^%=2OFTG5)-3B.NZ=<M<))Y1$!5UV/$%
MR2JE0.<DYY[XKK:* .)UKP/<ZUIGB+S+JWBU'6XH[=Y I:.")!PHZ%CDL2>.
MO3BKNN^&]1U&^T36;&\M[?6-+WKB1&:&9)  Z$ @CH"#V]ZZFJFF7QU*P2Z-
MI=6F\L/)NH]DBX8C)&3UQD>Q% '&W'@?5KK2_%EK-J=EO\0,&RENP$/[M4)^
M\<\+TX]<]JUE\/Z@/%>G:V9[4BTTY[)H0&^<LRL6![<H.,=ZZ&ZG^RV<]QY,
MLWE1L_E0KN=\#.%'<GH!1:3_ &JS@N/)EA\V-7\J9=KID9VL.Q'0B@#S#6=,
MD\-^'-+T*\U;3()+G5I;M+J[A86_WGEVLVX%&W,NTA@3CZUHZ9;ZEK.AZ[H2
M7&@3QWMK(IO],\QD620;#YFYFWO@Y^]GY><9%>@RQ1S1F.6-9$/56&0?PI8X
MTBC$<:*B+P%48 _"@#@_$L=B?"MKX/N-0B'B'[/";!(<^9YJ,!',HZ@!ER?0
M!JVI;;5-)N_#]AI$L)TZ(&*[BEB+2.@48??G"D8).>I-=$8XS*)2B^8!M#8Y
M ],U4N]22VBM)8K>XO([F9(E:U0.$#?\M&YX0=S0!=KE[/P[J%IJ7B>\%Q;,
M=89&C7:P\DK&(^?[W SV]*ZBB@#&\*:1<>'_  OI^CW$T4S64*P"6,$!PHP#
M@]#6S110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7%_%O_DE7B#_ *]Q_P"AK7:5FZ]H5EXDTF72
M]2$KV<V!+''(4W@'."1SU H IVL>M17=E+>WUA)IRQ'S%CMVB8/\NPDL[9'7
MTYQ7+3WNIZ?X^/AZYUJX.G:A+'+;71;YX& 8M:YQC+@ @GG;GOM-=</#-GOM
MFDN=0F6WD61(Y;R1DW+RI(SAL'!Y[@&HKSP?I-_I3Z==+<20O=?;"QG82>:#
MD,'!W#!Z8/&,=.* ,*_N]:U_7?$6D:7=K:S:8D*6[?:3&5=X]XD91&V\9.,'
MCY3QGFDT^]U7Q'J6K:+<ZJ+2]TZPM@);!OD:>5&9IAG!9 0 %/'!SG(QL:IX
M'T;5M3AU*<7D5['$(7GMKN2%YHQ_#(4(W"EU+P/HFIW]M?-%<6MS;PBW62QN
M7MRT(Z1ML(ROM0!FZ?=ZD/'T.DW.J-=0OH FF,8"H\XE"-(H'*YYX!P*Y6&Z
MO];T'X?W=[J5VUQ-K,T4CJX7<!]H ) &"0$ S]?6O1+SPGI5Y?65YLGMYK.$
MV\9M9WA!AX/EMM(RN0./:JL?@308=&L]*BAN8[:RN?M5N4NI%>.3YLE6#94'
M<W P.30!2M9=0N_'?B/1GU2Z%LFGVTEOC:# SF0$K@<_=!YS53PIJU_K%AIV
MEW=Y.-6T^YFCU5PV"WE''Y.6C8?[.['2NIM?#]C9ZY<:O")A=W$20R$RDJ43
M.T;>@QD_G4UIH]C9:G?ZC;VZI=7Y0W,@ZOL7:OY"@#A],O?$OB/3+/Q!I]_;
M6P%ZYF2:Z/E>0LC*T31^7@, /O9SGG..*]!N?^/6;_<;^5<_!X$T*UUR758(
M;B.2:;[1);I<N+=Y>OF&+.TMGGIUYZUTC*&4JPR",$4 >.: VL:%X!\%:W9Z
MQ=21R26EI-ISJGDO%*P3"@+N#C(.<GOVXK7@U#68K?QAK4NN7LZZ!?7)@M-L
M829%MU8(^%SC+=L=^N:Z_3O"&E:6MK% L[V]FQ>TMYIF>.W/(RH/H"<9SC/&
M*L:=X<T_3'U%H5E<:C*9KI)I"ZR.0%)P>!D # XP* .;M!XABFT_6/[9LTTN
M:S=KLW%T95D8Q[TEC'EJ%Q@D@$#;],UF6/B'4]/UG1V:YO+RUNM&N;J9I\!;
MJ2(1L)(TZQ@[C@<<$<<9KI=+^'_A_2$GAMX+E[:6-XEMI[J22*)'!#+&C'"Y
M!(R.<'&:?8^!-#L+C3;B);QY=.1H[9I;R5]J' V'+<J-HPO3B@"EX=_M'5=,
M\.>(O[>8+=0K+?0, T4WF)PB#/R%6( (Y..<FN/T6?4=*\'Z-JMIJES&I\0O
M;-:@+Y3QR7CHP88R3SD'/&!CW[[2/ VB:'=M/IZ7,2[F>*W-R[0V[-G<T<9.
MU2<GD#N<<4+X&T9=(ATM1="SANOMD:?:&R)=^_=G.?O$G'3- &+=W6O^)+_Q
M)::/>1V=SIEPMO:DW)3RV\M'#N@C;>&+$<G&!P <DU=7\0:EI>HB37);FWT^
M5;;R-4TU_,M8'(7S%E7J%9CPQ!^5AC!YKI-2\#:)JFM?VM,EU%>,@CG>VNI(
M1<(.BR!2-P^O;CI5FY\*Z;=R77F^?]GNRAN+42GR9-@55RO88500,9QSF@#;
MKS.SUO4AK/A>2/4[B\@U*]N8+BYP%M[A=DC+Y2')4+M #8&<9RP.:],ZC!KE
M;?X>>'K5+)(8KQ4L9S/:I]LEQ 2""J#=PIW'([]\T <=<:KKT'A76];/B"]>
M?2M>>WAC*QA)(A<)'M<!>?E8],8^M='J>LW'A;QM*^IWEQ+H^HV3O:1DC$5Q
M&"SQK@9)=<%<GJI K4?P-HTFDWNEN+HVE[<F[N$^T-EY2P8MG.1\P!P..*AO
M+6ZU[7+:PO=%=-.TNZ2[2]N)$87#JIV;%!R"&.22!PI'?@ V]$MKNUT:UBOY
MWGO/+!G=CGYSR0/8'@>PKFC<W_B76_%&EVVJ3:=/I9BAM#%CY'>(.)7'\8).
M-IXPI[FNTKGM4\%:-JVLC5IDNH;PQB*5[6ZDA\]!T60(1N'U^E &587]WXA\
M3:SHTNIRQ)IEI:[);,B/SI)49C,.N1P %Y'7.>,847B76W\(:#XIO+N5([*_
M:UU=(@%CGA$K1>=C'&&"L<8&-W:NZN?#.G7&I1ZC$)K2\2#[,9;60QEHNH0@
M<$#MW'8BK#:'IK: ^ABU1=.> VYA'381@C/7//7KGF@#E]8UN]LK-;VWN6$>
MJZO%8VQDDPD47W2P.#C>R-@X/#K65XH;Q7X>\->(KK^V4AA589;%4G\^:'+A
M9%9GC!*'.1W'K7=:AX<TG5/#_P#85Y9I)IWEK$(<D;0N-N".01@8(]*S1X#T
M4Z%<:1,;ZXM[DKY[SWDCRR!3E5+DY"@] ,#\S0!E->ZCH_CC4+"77))+230W
MOS)>!2EO*DFW< H&$P<D>W6JNB:GJC>*M+T\W]^UM?Z+).\TX7,LJM&!-&AS
MY8.\_*0!T^7BNINO">EWVH27UVLT\TMDUA)OE.UX&^\A XY/.>OO5:T\":+9
M7%E<1&^-Q90M!!*][*S+&<?+RW(&T8'0=>M '%Z+J^N_\([X(UVXUR[N)M1U
M!+.Y@<((G1_,YP%SN!4'.?TXKH? ENZZ_P",)'N[J7;K#1A99-PQY,1S^'0>
M@XK5B\#Z-#I>F:;&+I;73)Q<VB?:&_=R#.#G.3C)X.1S5^R\/Z?I^L7VJ6R2
MI<7K!YE\YC&6P%W!,[0Q"@9QGCZT 9'Q%OK[3/"$M[I]Y+:SQW%NNZ,*=RM,
MB,#D'LQZ8-4;P:IJ/Q$U+1EUV^M;$:3%<HL C#([2.ORL5Z?*#SD^^.*Z?7-
M#LO$.FG3]0$K6S.KLL<A0DJP9>1SP0#^%1#PY9#69M7$ER+Z:V%J\GG'F,$D
M#'0<DG/7)H I^ M5N];\":-J-]()+J>V4ROC&YAQG ]<9K*2W=OC1<$W=SL7
M18I1'YGR F9P1CT^4?C74:)HUGX?TF#2]/61;2 $1([ERHZXR>:BNO#NGW6N
MQ:RZS)?1P?9Q)',R!DSN 90<-@DD9'6@#S+P_/J.E>#/#&I6NJ7*))KS6CV@
M"^4T4EY*C9&,EN<@YXKI_M^NR>(?'-C97YDGMK2V;3DGV*D,DB2' . .6 Y;
M/;-:Z>!M&CTBTTM!="SM+K[9"GVALK+O+ALYR?F).#QDU8D\)Z9+=ZK<O]I,
MNJ1K%=$3L-RJ"%Q@_*0"<$8/- &7X-UQ-3U#4+:4ZG:7L$47G:9J/S/ <OET
M?G>C<<@X^7MG%7O&.@P^(M,M;,ZC+I]\ETLUA=1<M'.BL0<=QM#Y'IFM&QT:
MVL;R6]#33WDL2PM/.^Y_+4DJOT!8GU.><TNK:-9ZU';I>"7_ $>83Q-%,T;(
MX5E!#*0>C&@#B=.\4Z[I&IWFE>*].MY=5M=-FN[._M"?+NXDP64KU5LA<CI]
M.,RZ?<^)&L]'\2IJ%M)8R6IFOH6NBXN T>Y?+7RP$8-P #TX.3S766?A^SM+
M^2_=I[J\>+R//N9-Y6/.=BCH 3R<#G SG JAHO@70_#]Z;C3XKE%#,T5N]S(
M\$!;.XQQD[5)R>0.A('6@#.\/_VEK6C>'O$0U]X_M<0EO82 8I/,7B-!T0HQ
M !')QSFN4M9]0TGX+:YJ=CJM[%>175VRRLX<\7+@_>!Y.>3USWKO='\#Z'H5
M^;JPBN(U#M)%;&Y=H(6;.YDC)VJ3D\@<9.,4DG@70Y-*U'3#%<BRU"5I9X1<
MR;<LVY@O/R L<D+C- %5M0GUCQW?Z UU/:VUEI\4X\A]CRO(S#=NZX4*!CID
MG.>*Y>'Q#XAO;/0(9-5FAN%\0SZ1<S11(!<I&),28*\'Y!TXR#P>E=]=>&K&
MZOK;4-]Q#?V\1@6ZAE*R-&>2C'HPSSR.#R,5'+X2TF2+38EBEB339C<6PCE8
M;9#G+GGYB=S9+9SN.>M &=X/NKU=;\3Z/=7T][%IUY&L$MQ@R!9(4D*D@#(!
M8XIGQ MDOK72+*WN);;6I;]3I<\9_P!5*J,S,V>J! ^1WSCO6[I^A6>F:GJ&
MH6_G?:-0=7N2\A8,R@*IP>!@ #BIM2TJTU6.%;E6WP2B:"5&*O$X! 92/8D>
MA!(.0: .8\ W-P]QKEIJ]J8?$4-PC:A*&W1SAEQ$\9XPFU<!>HP<Y))KM*YO
M6O"=OJ.B7UG&T_VF\='DN?M#1N67&TEEYP,?=&!],DUT,2&.)$+LY50"S=6]
MS0!Y7]G==#^*LCW=U+L-T@623<,?9$/Z=!Z#BK,6I:CX;N_#<@U"YO+:]T2X
MFEM) NQ6AAC=/+ &1U(ZG-=?<>#='N9=6D9+A?[639>(EPZH^5"$A<X!*@ D
M#./QJ1?"FFB[TJY/VAI-+B:&UW3$A48 ,"/XL@ <YZ4 <_H1\27_ /PC^NIJ
M5J;&ZB5[Y)+HNLPD4%?+3RP$8,> #TX.3S6YXXNKNP\#ZW>V-U);75M92S12
MH%)#*I(^\".U1:+X%T/P_?&YT^*YC4,SQ6[7,C00,V=QCC)VJ3D\@=R!BI?&
M]K<7W@?6[*S@DGN;JRE@BC0<LS*0.O Z]: .96YUO1?$?A6YDUNYOK36E:&[
MMIU0)&PA,BO'@ J!M.<DY'4YYJ'2]9U,Z_X35=3N;NWU7[4EQ=$!8;G;&SJ\
M49R4 (P#@9'][.:ZG0_#UK'8Z=<727,MQ!:""-+MRWD J Z@>IQC)R<<9Q4%
MI\/= LO[/\E+T?V=(SVFZ]E/DA@057+<+@].A[YH XQH]8U7X>>)]5O/$FI,
MUFNJ0K$A1%=8RX0MM4'(V]B!CC'7.W+/?:5;> HK;4;D07=Q'#<1,5(D4V[-
M@G&>"HZ&NGLO"NEV&D7VE1QRO97S2M<12RL^XR9W\DY&<GI4*^#M*6#2XLW;
M+I<@EM2]T[,KA=H))/S?*<8/&* .:-[XD\1VNJWVCW]M9W%AJ<MO'Y]T5BC2
M&3:RR1B,YW*"V2<C<,$ 5)<Z[>6'BP6NM/?6<-SJ"+I]] V^SE3@>0X'W')#
M#)&2>^.*W)_ FA3Z]+K'DW$<\[!KF**Y=(;AAT,D8.UOQ&#WS5MO"^GO.SR-
M<21-="\-N\I:+S@VX, >F& . <9YQF@#4NY1!9SRF5(0D;-YDGW4P,Y/L*\X
MT_Q!J=CK.A,UU>7MK>Z3<W$SS *MU)$L;"2-.L8.XX&!P1QWKTBYMX;NUFMK
MB,20S(8Y$/1E(P1^5<_8^ ]#T^XTR>);QI=-5DM6EO)7V(P V<MRHVC"].*
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MA')( QU-=!K-[HTWB_Q+I/BC5SI]K?6T(LFD$0CGMS'A@CNC?,)-YP#G)!%
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M75&@$<M_=+";<^6O&&Y95X92N02Q'!R:]6TV"UMM,MH;+ROLR1J(S" $(QU
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M2:5X=\2>%K4WDS>&/LET-/N;YAL-R9 0=V  -F\)G'!XZUN_#*:P9?%,5A)
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M6=C#&2^"Q*CYL=,^N*0V\!))ACRW7Y1S4M% &%>Z+J%]J\6[48DT1 CM8);
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M'46M[6SU**RTLHT5Y;K;@O*AQPCY&SC(S@]:W** *5[I=O?+;1S*/*MY$E5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHJO=WUK81K)=3I$K-M7<>6;K@#J3P>!Z4
M 6**AM;NWOK:.YM9XYX)!E)(V#*P]B*FH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "N6\16FIIXJT#6+.TDO;2T6XAN;>)U#KY@7;(H8@'!4@\
MYPQQWKJ:JW]@FHP&WEFF2%@1(D3[/,![$CY@/H10!ROPWDEN;'7;T1M'9W6M
M7,MHK$']WE02,$C!<.>#CDUVE1V]O#:6\=O;Q)%!$H2..-0JJHX  '05)0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ljb_employmentxageementx010.jpg
<TEXT>
begin 644 ljb_employmentxageementx010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
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M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#9Z'&<=:YW2=,\6:3X*T#21I$^VQNO+OXK>ZB66>'Y_FC;< JY*$\JQ&1QW
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M8A(\ACW)(6\L9.W/7BM+1=<TZ/PQHK:>+Z[2\MPUG%*P>XE0#)9F9@.!C))
MY ZD"J5IIVIV_B_Q;?-ILQMKZVMTM7$D?[UHT<$8W9'+#&<5SD/AK7].\/\
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M$PL2GD @K@ <D\5SJ6GB:]M_!T%SX<FAFT:\0W;_ &B$QLJPO'O3#Y(.0<$
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MV=&X:1F!!4D=&%=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD\^F.* .ZK,U#P_IFJ7L5W>0/)+&AC \YU1D)!*L@(5QD#A@:SO'.M:AX?\
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M$\5^'9='GN3;K*R,9HTRZ%6# KD\'('//>HE\-W/_"16.MS:GYMS:V;V>#
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M1W4J'*YQGOBN4M_ OV;2?#FG)J;&/0IUF@8PC,A564!N>F&/3':NPHH Y/\
MX0:*.VU738+^2+1M4E>:YL_+!*E_]8L;Y^56[C!QDX(J^/#,<7BM-<MKR6W_
M -#2SDM41=CHC,R<D9&-QZ=>*W:* .*^*GS^")(5=EEDO+79L&6&)XV) [X
M)_"M-O#AOKBXU&YOTFO)[(V<,T<.(XHF.6*KN.6;@DYQ\HP.N>BK%\6>(/\
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M3?K'Y2SY.X)_=Z_=SSCIFKDB++&T;9VL,'!(/YB@#QS3)9=,^&&E^)9-4O\
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M>:G?W$ T6TG'EW,L*F1A+EU4-E<X!V@X]0<"H+:]UV]\)>%]62 ZVBZ2&OK
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MV:[EG*%/WB(\$:#@Q@9!SC)R<'K5W7(]5U"_\86<1NYKWRH!H\EI(P%NQCR
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MPXMW-;O,8H5W!,SLPY+Y!"@ XY.5ZUVY\.Z2TU],;-?,OU"7;;FS,HX ;GD
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M'3X;JR3&V*8;MI'0@GD'WIB>&-%BM+.UAT^*"&SS]F$!,9B)ZE2I!!/<YYH
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MK+OVCEMI8-@>F>U06L:S>/M6\16K,-*.D1V\DH4A9Y@[-E?[VU2!D?WL=0<
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M)3MCDC;=O;GY0!R3P>!SP?2H1XIT$VUM<?VQ9"*YD,4+&8#>XZJ!ZCN.W>N
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MK]2>QIDRH^N?$>4P.RW.GPQPOY+$38@=2J''S<D# SSB@#O/[;TS^THM.%]
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M:E9Z;&KW<ZQAL[1@EFQR< <G YXJDWBK0$2T=M9L0MW&TEN?/7]XB@EF'/0
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MY_%&@QBV+:Q8@741F@_?K^\0#)8<\CWKD_$ES%HGCFTU2_MM0;0[K3_LXN+
M2GR)O,+DNL7S8<$<X/*BJL.GV%AXF\#1Z;I=Q9Z?";^18Y5D8Q"1?E+ELE"Q
MR0"<C..#Q0!UP\:^&3;V]Q_;EEY5P_EQL91RV<8/ISQSBKVI:WIFD+F_O(H
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M.ZL!U!W>6PSV!]:U;?4+-_'.H6Z:5-'J\>FQ2/,\HVRQ%VVHN&(X;=R0#^%
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M>097.U<^P)R?8&@#2HKB_AS?W:Z?J'AW5)VGU+0[DVTDKGYI8C\T4A^JG'_
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M0<E&1,*)/E&2Q8\$\#%-N-1\96DGARPO=0@M[F\U&:TED2)',D0C=T=AT5\
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M01N4]2BD_3 P.*O7FE1:7JMSXJW:E>WD=B+8VT"QL98U)8!5P,MN)/4=?PH
MQO#GB'4M;T_1K-[MXM7BGECU<!$RIA^608VX 9VCQC!VMG/%;7B?69M.GT:P
MMY!#+JE\+7SR ?*78SD@'C<=NT9R,G.#C%1^&--C^WZKXA;3I+&YU9XR8I@!
M((T0*N\ D!B=QP#TVYY!J[XB\.6/B?3!97WG((Y5FAF@?9+#(OW71NQ'/YT
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M\[WAIM9;0H%\0"#^TT++*T!&UL$[6P. 2N"1ZYJMXA\(67B&\L[YKN^L-0M
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M![5K>)/#.F:'H%IXITNP07>FW$.HW+C+-/& %ER3GG82V?50>M 'I-5%DO\
M^UWC:&W&G>0I242'S#+DY!7&-N,<YZUYC80E?$FI:/\ 842P\6*M[:[8L!(E
M.V8,>Q,>QQZ-)BM:XAMK3XE:\B3&RA_X1F-FEB_Y98DE&X#M@ =/04 >A @]
M"* 0<X/3K7C\MQJ^@Z7K%@=,M4UB+0WFM-4TGA+J!64%BO59!G(Y(.3BM_P^
MGALZU:Z_I>OV>UK%Q+!9HD<;0CYM\P!."I[G!!.* /0J.E0VEW;7]I%=V=Q%
M<6\J[HY8G#*X]01UK#\:6LU]HL5M:WMM:W3W41@%TA:&9U.X1R ?PMMQ]<4
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M@#V;(SC(SZ4N1G&:\ATS^S=?MVDU36H;+Q!9:M(9%2-1>+(LS;$4D[F1E*J
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ME),<:L22RD EF(Q][ !XKH='\6:7>O%IXN96O5LUN&#P2 2H  S(Q7$@!/\
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MMFMK2QMK>!_O10Q*BGC'( QTK-A\7:),;U1=.KV1VW*/!(K1L2 %(*\L2RX
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MF.<5K&*X_P"$T\+7HLKS[-;:5<13R?9GQ&S"+:IXZ_(W^37=T4 >5Z3HAE\
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M$SB.,1R*6.!ZNM85]8WLL/Q+1-/O"=2BVV?^CO\ OS]E$?R\?WQC]>E>ET4
M>?:0KK\1- 5XY(W3PNZNDB%64B6$$$'W%8-K9ZO!X2\/Z*=!U)KK2M?CFN&$
M("&,7#ON1B<,-I!R.!W(XSZ1I/AZUTF<W N+N[N?+\E9[R;S9%CW%M@8\XR>
M^3P.>!6O0!YG>V-]+:?$M%TZ]+:G%MLQ]G;]\?LHC^7C^^,?KTYIUG+JGASQ
M%#J4NB:E?Z?J.DVMLWV:#?+;31;OE9"00IWGGIG\Z]*HH X::UO[;QOX;U$:
M-*EL-/N+5X[55*VS,\;*K8. ,*<D<9'':G^&=*-W_P )E9:E8SI:ZEJ<KJ)H
MF02PO%&F1D>JM[UVU% '!>'] UNX\(:A8:N_EWZ6<ND6DQ/WHEW*LWJ"_P I
M/^XIJ'PBANFTJWU#P==V>J::NV6[NE!AC(7:6A?<=V[CH. 3D\<^AT4 9/BA
M))?">KPQ122RRV<L<<<:%F9F0@  >Y%<9J6GZFG@OP=>V^E7-V^C>2;S30#'
M*R^0T3[0<99=Q('>O2:* /,O$-C_ &EX#UJ32?#%[9SW\EMB*2 BYN"DBDLZ
M@D@!00-QSP?;.S?6US=_$NSNHK>Z2U;19[8W/D,%21Y$9021P<*3[=.M=I10
M!YEX/LY$M=)T35O!]TNIZ2R*;V9=UJ/+X$T;EN6*] !D$\X&:WO!D5Q#K'BI
MI[2Z@6ZU1KB!I86021^5&N02/53QUKKZ* .4^(%G=W6B6,EI:S736FJ6EU)%
M"NYS&DJLVT=SCM5*Q-[HOCO6M2O+"]>PUBWMI('B@:5H7B4JT3JF2I.=P/3D
M\YKN** .:\ Z)<^'_!UI87:[)@\LIBR"(@\C.$XXX# <<9!KI:** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *Q_$.N+HD-F!&9+B]N1;0*$9OF*LQ)"@D@*C' ZX XSD;%8/BSPX
M_B/3;>.VOGL+^SN$N[.Z5 _ERKD<J?O*0Q!'O0!SVH>.-<TS2=5N)M$#-8W5
MO%'/(DL$=S'*RKN17&=REL$$X[YK7L->U>7Q1J&@7MM917,=E'>VLD+NZ;&=
MDVOD Y!7J,9![55U/PIKFN>&IK#4]<MGO)Y8':2.T*Q(L4@<!4WYR2.6)_#B
MM!= OE\9S>(?MEO^\TY;$0>2W!5V<-NW>K'C'3O0!QGA34VM/!>@W=_;6=YJ
M%WJDT.GNZG<DTDTWF.S') VACQR>G>NBO?&&H:5>ZUI=U:6TU_9:8VJ6SHS1
MQW$*Y# CYBK!AC&3G(Z57M_A]<1>$-.T=]4C^VZ7>_;K*\CMR LOF,_S(6.5
M^<J1D<5H7OA.YU-]4O;NZMUU*]TTZ;&T<1,<$3$EC@MEB2<]1]T#U) *EEXL
MUJ2#26N[&PCDUL0C3UCF9BN8FDE:4$=%"Y !.<@9[U:N/$NJ:5$8-5TY$NIM
M0%G92P[G2X4H7\S8NYUPJME>>1UYR(M0\%W5WX9T.SAU1;;5M$,;VEZD.5+(
MFPAD)Y5ER",TNJ>$=4UK1HOMNN"/6[>Y2[MKNWM]L4$B @ 1ECE2&8')R<^@
M  !H^'-9U+4KO4K74=.D@^R2((;KR)(H[I&&<JKC(((((Y[<\UG1ZAJ\WQ2N
M]+>:W.FQ:9%.L6TY^>1U)/."WR?3'XYV]$LM6MH7DUG48KR[DP/]'A,42*,X
MVJ23DY.23SQTQ5.;P_>#QHWB"TOXHTEL5M)H)("Q.QV=2K;ACEB#P>.F.H .
M)\%:]J6A>#?"X^QVK:7=ZB]@3YC><&DGD"L!C: ",8Z_2N@U#QKJ 2]NM(TN
M6_BLKPVKVT=M,TD^Q@LC(X&P$'=@'.=O49Q4=OX"OK?PQHFC#5;=CI>I+?\
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MN)VLOS90'KCDT 10^.KAM$CN9;2(74VN-HT>&/EAA*4\QN^,*3CUP,\YK/\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"H;&0#@Y&12T4
M%%%% !1110 4444 %%%% ",H92K $'J#0JJBA54*HZ # %+10 4444 %%%%
M!1110 A 8$$ @\$&E  &!P*** "BBB@ HHHH **** "BBB@ HHHH **** &O
M&DB[716'HPS2JJHH55"J.@ P*6B@ HHHH **** "D5510JJ%4= !@4M% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&QFNWM(KRW>Y3EX5E4NOU7.13)-5TZ)PDFH6J,9?)"M,H/F8!V=?O8(XZ\T
M7**** "BBN9OO$-R_C)?#-A-9VMR+(7ADNXVD\P%BH5$#+G&TDG/&1QZ '34
M5CZ9JES]E?\ MP6EE<BY:%%67"R 8VE2V"<@@X[9QVI==U<V>B:K/I]Q:O?6
M-L\_E2'> 54MAE!!&<4 :]%8WA[7(-6TG3VDNK8ZA-90W$UO&XW+O0,3MSD#
M)[U8TZXN&.H->7EE,D5RPC^SY'E1@ A9,D_.,DGIP1Q0!HT56M-0LK^)I;.\
MM[B-#M9X95< ^A(-4[KQ+HMGI-WJ<FIVK6=HI,TD<RL%XZ<'J>PZF@#5HJMI
M]_;ZG8PWEK(DD4JA@48-CCID=Q577-?T[P[9)=:E<I"DDJ0QAF +NS  #/UR
M?0 F@#3HJI/JNG6T$4\]_:Q0R_ZN22955_H2<&K0(8 @@@\@B@!:*S==U[3_
M  YI4FHZE.D4*$*,D NQX"CU)K'D\4/%XYCTY[JQ_L9])DOA<9P0RRHG+[MN
MWYCVH ZJBH&OK1+(7C74"VI4,)S( F#T.[IBG6US!>6Z7%K/'/"XRLD3AE;Z
M$<&@"6BJNHZA;:3IEUJ%Y(([:VB:65SV51DUB:3J'B'6])AU:*.PLX;F,36]
MG/&[R%",KOD# *2,' 5MN>] '2T5EV.K%=!M;[6O(TZ9T'GI)(%6.3NH8]>0
M?K5TWMH(H93=0^7,0(G\P8D)Z!3WS[4 3T50_MO21:FZ_M2R^SB3RC+]H38'
M_NYSC/M4\]]:6O\ Q\74$/R%_P!Y(%^4=3SV'K0!8HJM_:-E]A%]]LM_LA&1
M/YJ^61TSNSBA=1L7M4NDO;=K9V"I,)5*,2<  YP3GB@"S15-=6TYHII5U"U,
M<#;)G$RXC;T8YX/L:?\ VA9>7#)]LM]DYVQ-Y@Q(?13GG\* +-%%<M;>)WA\
M8:[INJW-C;V%C#:R02L?+),OF9#,S8)^08QB@#J:*K?VA9?:EMOM=O\ :&&5
MB\P;R.N0,YJ2&ZM[AI%AGBE:)ML@1PQ0^AQT- $M%<[JNM7UCXU\/Z5&(#9:
MBMR9=R'S%,:!A@YQ@Y].U;"ZE8->FR6]MC=C.8!*N\8Y/RYS0!:HJC_;.E^2
M9O[2L_*#;"_GKM#>F<]:F-]:"3RS=0;S'YNWS!G9_>QZ>] %BBJ]K?V=\K-9
MW<%P%^\89 ^/KBK% !165K'B+2]"DLX]0NXH9+R80PJ[@%CW//8#DG_$5;GU
M.PM6B6XOK:%IO]6))54O],GG\* +5%%9>M>(=-\/QVKZC=1P_:KA+>%68 LS
M,!W[#.2>P% &I17*6WBED\8:O87]U81:7:V=M<P7!;9GS2X^9BV#]T8QCK71
MW-]:6=M]INKJ""#C][+(%7GIR>* +%%,BECGB26*19(W 970Y##U![U5U;4[
M;1M*NM1NW5(;>-I#E@,X!.!GN<4 7:*Y/PUK]]J\UE<S:AHTEG?62S+;PN1/
M#,0&*?>(=0I.3P01TYXF\7^(Y=*\%ZKK.C3V<\]C&6P_[Q,CJ#M88//K0!TU
M%<T-<OQX_M=$86YLI]+DO,A#Y@=9$7&<XQ\Q[5N)J-C)>M9)>V[7:#+0+*I=
M1ZE<YH LT53_ +6TWS)8_P"T+3S(03*OG+E .I89XQWS4&A:_IWB/3A?:9<)
M- 68 JP)P&(!([9QD9[&@#3HHJG'J^FRF<1ZA:.;?_7;9E/E_P"]SQ^- %RB
MJD>IZ?+Y7EWUL_G$B+;,IWD==O//X54TCQ+I.N2WT>GWL,QLYFAD*R Y("DD
M<] 6QGU!H UJ*IPZMIUS!+/!J%K+##_K9$F5E3_>(.!^-.34["266*.^MFDA
M022(LJDHI&0Q&>!CO0!:HK+T+Q#IGB2Q:\TRZCGB$CIE6!/RNRYP.QVDCU%:
MA( ))P!WH **I1:C;:A!/_9E]:3RH,91Q(J,>FX*?ZBN+MO&NKW'@OPEK7EV
M8EU:_M[:Z3RVPJR2%3L^;@@#OF@#T&BJUSJ-C921QW5Y;P/(<(LLJJ7^@)YI
M7U"RBN#;R7=NDX4L8FD ;;C.<9SC% %BBJBZKIS6_P!H6_M3!NV>8)EV[O3.
M<9]J<^HV,5ZEE)>VZ7;C*0-*H=OHN<F@"S17.>-/$?\ PCOAO4;NUNK%-1M[
M9YX8+EL^9M!. H8$]#TK<LIFN+"WF?&^2)7;'3) - $]%1SW$%K"TUQ-'#$O
MWGD8*H^I-1#4;%K+[:+RW-IC/GB5=F/][.* +-%0P75O=>9]GGBF\MS&_EN&
MVL.JG'0CTJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD_$^G6%KJU
MOXD_M*XL=2@@:V MU61[J,G=Y0C8'<=W(QSFNLINQ=^_:-^,;L<XH XOPC O
M@WPXLOB*Y$&H:UJ;3RA_F_TB=OECRHQG  .,#(/:NVI"H;&0#@Y&:6@ HHHH
M **** "O.[&[TZ3XQ>)8I[BV:,Z5;HZR.I!P7+ @^@(S]:]$K%;0[UF+#Q+J
MJY.<".UP/_(- 'E.B?V7:^ _AS=QFTBNO[8B5Y05#XQ*&!/7&-H/X>U2ZMJM
MD? /C_2]9EA373=W,C03D"25<@PL@/+*$"X(Z;:]0_L*^_Z&?5O^_5K_ /&*
M0^'[QFW-XEU4MC&3%:9Q_P!^* .%O=8TN/Q1J-KXAU:2QTW5-,MUL9MB&&>+
M:PDC#,C8;<V< C.1[5+IEAHEK\2-(M-BM%%X;94%]M,I"RILWY_BV#OR!]*[
M5M O7QN\3:JV#D9BM#@_]^*7^PK[.?\ A)]6_P"_=K_\8H \HMQI-O\ "_3[
MF+[&D\/B)?+E!4,BB].,'J $_2MB[@T2?7?B:TJ6+D6,)4L%."8'W$>^<9/K
MBN__ +"OO^AGU;_OU:__ !BC^PK[_H9]6_[]6O\ \8H X:QNK.36_A9.9X&N
M'TV56DW#<W^CH,$]?O9'US5_1Y]+F\4_$))9;1X_,@+!F4C:+90?PR"#[BNJ
M_L*^_P"AGU;_ +]6O_QBC^PK[_H9]6_[]6O_ ,8H \UT/68-'T'X;ZCJ$H71
M(K26&>?K';W!11&S^G'F+GMN-;-YJ'AG3;K09=-BBM;:[U*YN+?4KB1_LR2M
M&=[@%@&W[F51D+G)';/8-H%ZR%&\3:L5/4&*TP?_ "!2G0KX@ ^)]6P.G[JU
MX_\ (% 'E=K=V<?A6Q:6=?)L/&A:>25=@AC,\ARW "#D''&,CI737LJR?$O6
M!HTD*ZA/X7!M]N%+2^8Y3(]?N]>V*Z[^PK[!'_"3ZM@\_P"JM?\ XQ2_V%?9
MS_PD^K9_ZYVO_P 8H \_BDM]5\%^!X=)95URSO;56B!Q- R\7/F#J!C?NSUR
M/45E:G!HW_"%_$R1$LO.CU.7R6 7<O[N(KM]/F!Z=Q7J8T"\5V<>)M5#-U81
M6F3_ .0*7^PK[_H9]6_[]6O_ ,8H LVNMZ=<7\6FQWD<EZUHMV(U.<Q$[=^>
MF,\=:TJAMK<V\"))-)<2*NTS2A0[?7: /R J:@ KA_%]CX5\2:O_ &/KDBV6
MH6L"7-G?+-Y,J;F8?NW]04R1SU!Q7<4QXHY5*R(KJ>H89!H \?NKO59OA=?M
MJUZ=1M]-UN!;?4RO_'Q;1SQ'S3CKCY@6'7:>3UK0U#4K+5/&/BHZ?<1W(N/"
MP6%H3N$Q#39V$<-U XSZ=J]2VJ5VX&W&,8XQ0J*OW5 XQP.U 'DVG:=I5Y;?
M#V;0([3^UK=H7NY;7;O6 0D3"4CU;"_-SN/UJ"7S+#PQXMEM(9!:6WBP2W<=
MM&"PMU\AI,+@@X')&,$ YXKU34;6[EL)H]+N8K*\<@K.\'FJ"""<KD9R,CJ.
MM0:'HJ:-!=CS!+/>73W=Q(%VAI&QG R<   =3TH \UUR72K[1=9\0>&[^]UE
MI5M?[3:(+LD@252R855!?R]^1U"Y!QD5J>(;OPWXB\*^*=5\/A;VZET22*:Y
M@W% JJQ1".F_DG&,@#G'%>D(B1KM155?0# H5%1=J*%'H!B@#,\-WEI?>';"
M>QECE@," /'RI.T9P>_/'US6!\4#''X3@N)=HA@U*SDE=NB()TR2>PQ7:  #
M &!00",$9% ' 6FI6<7Q'UDZM- MA?:;;_V7+.0(GA7?YRJ3QRS D=Q@] *T
MOAK:W5GX(M8;GS!&)9C:K)G<MOYC>4#GG[N,>V*ZMXTD #HK '(R,X-.H XW
MXJ*/^%=ZB[+D1R6[L<9VJ)XR3]  :SI[C1M2^+6FLTEG<6W]@S-'N*E"?.C(
M(SP> Q![CD5Z&0",'D4F!Z"@#Q+1]6BTOPMX2O)KR2WT2UU'4(KF>W57%LS2
MR"!F!5@%P2 <<!A7H_@NVTB*SO[C1+JXNK2\NVN&G<CRY)& W&/  VY]!C.?
M>NF**RE2H*GJ".#0 %    '  H Y_P =:+<>(? VL:5:$?:;BV81 G&YAR!G
MW(Q^-4_"WB[1KCPW9)<7L%G>V\"0W-G<.(Y89%4 J4//4<<<]JZVF&*,RB4Q
MH9 ,!MHR/QH XB_U$VWQ.T>\U,-;Z5/I<L5H]Q\JI<F120<\*S1@8SSU'J*X
MRXL[2 V)G%O_ &7-XS#Z>),;?(*-OV9_Y9E]W3@_B*]K=$D4JZJRGJ&&12X'
MH* /*GM=#/B+XD1O%8;([*$JA"80F!@Q ['(4'WQ5331I%UJOPXEU+['*DWA
M]TD:?:5>14@P&SP2#NX/0^]>P;1Z"N?O_#D][XOTW6_M4"P65O- ;9K<L9!(
M5).[=@8V#L: //+1K#P_;L6BAAT>?Q2\FE7$SE;:UQ&<R<$ IO#A5R%)YSBL
MZZN-.E\,:]!<7$,LB>+XI%,BA#L:2$E@., C<>.HR:]T*J5VE1CTQ1M7G@<^
MU 'GUA9Z1-\3?$.DQQ6GV.[T:V66WBVA9/FE!X'?:1^!%+X+@OY+N/0M2B<I
MX6=H8YW'%P67$#CW6%B#[L*[74[>[N=-GATZ\6RO'7$5R81*(SZ[3@&H]'TU
M],LV2>Y:ZNYG,MQ<,@0RN0!G:.   H [!1UZT :%><3P:"WQ,\2CQ#'8F&73
M;0Q"]"X=1YH?;NZXR <>HKT>FLB.5+(K%3D$C.#0!Y+::7?^&? OACQ/);3F
M\T3>+B%ES*UA(Y^0CKN1"C 'IM(KM8+#Q!;Z#"^F2:?;ZI=3-=7GVV)Y%#/D
ME1L93E?E4'T6KFI:-?ZEJ\+R:MLT=50RZ>MNN99%;<"9,Y"_=RN.<>YK;H X
M#59YH?'_ ($BU2YM#?;+[S?(RB$F-0-JL21GIR:Y0ZWIDW_"-7%M-%9Q0>)Y
M/,LLEYH"WGAC,QR0SMR%XX;'S8S7M. 3G HVK_='7/3O0!Y;K/A^YGUGQ%X/
MM8BEIKRKJD%QLRMO(N!*?J72(C_KH3VJY;W \1^ [_6M?:;2VN;5+)Y0H#0;
M&VN^#V\TOGU5!7H^!G..?6DP,8P,4 >?Z%XF;1Y-=G\47&GLEC';&36K)3Y5
MRC%@@91G$@SR!GAE[8KOH98YX8YH75XI%#(ZG(8$9!%17%G'/9R6RDPHXP3$
M "/7'''UJ2"&*VMXX(4"11*$1%Z*H& * .,^(DMO:W'A.[NVCCMH=<C,LLF
MJ*8I1\Q/09(%9MI=V U;QQ8>)'BC^UE9(1<?+YUF8@J! >N#NR!T9O4UZ20#
MU&::T:.RLR*2IRI(Z?2@# \"P:E;>!-$AU<O]O2T02B3[P.. WN!@'WK+^)3
MPP6&@75R42WM]=LY)I7X6--QR6/8=.:[6@@$8(R* /,Y&T;4/B%XF:Y-G-$-
M#M]@FVD ?O<\'IP1^?O6'HNN1:9I_@>\U74I;/27T0VJWB*CI%<Y3*N65@N5
M7 /'0CUKV?:/04C1HZ%&164]01D4 8/@NQTW3_#J0Z/)<2:<TLDD#S_Q!FR2
M@P,)DG' '<<$5)XRDAB\$ZXT[HJ?8)QER ,^6V.O>MR@C/6@#RMKVPL['X8:
MI-<6\-C -DURS 1QLUFR@,W09/'-9>IZA9R^"/BAY<Z?O+YW0'Y2P:*( @'K
MD@X]:]F9$9=K*I7K@CBEVJ,\#DYZ4 <!<7D4OQ3TT6MU 9G\.SB$[P06,D97
M^1/X&L3PA<:'K5KX;M+S4=0/B+291OT_8B2PS ;96?"!BARQ)+<YZEJ]:P/0
M4@1 Y<*H8\%L<F@#S+PE<RVNMZ+817-IKFC7$,[6-T!MNK)<;F28 D,O1<\'
M=C-:_P );BVD^'NG6\3H9[8/'<(.L;^8WRMZ'VZ\CU%=LL:*Q944,W4@<FG
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MU9"3M)##!!(XZ&FV'@Y+C2O$L.J(JGQ!<22RQ*=WDH4"*,]"P"AB1W/&<9H
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M2:]+>SP+<A#/:22,Y0./NMRN>F0",\U>T'PG=)_PE=AJFG6EOIFKR[T2WEW
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MLK\V5.%!YSS5ZTU7Q3JGBO7--MKK2H;;2KN!-SVKLTD;Q!R/OC!&[KWQT'<
M[6BO-M*\8^))/"EAXBOFTYX[]EM(;6&!@PG>X\M6+%\%0,G;P>!\W.:NW_BK
MQ#X>@U6XU/31+9(D0L+APL1>:1Q'Y;JKMP"P.X8XSWH Z]M7T]-8CT@W4?\
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MB ':NV39DJ5 (PV #C/4UU$G@_4+K4H==MM;N=&U6YM8HM32UC22.=E'97!
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M Q[55LO (L=*\.6$>K3.FA3>?"TD*DR':RX.,?+AF]_>NRI&)"DA2Q X [T
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MH42>X*F:0#E]HP,GO@<4 >:Z,MWXFTFWUT^(H["_M=2?[3B-V="LK+]F9?,
MVD8 &WN#@DY/9>-+N&R\(W\L][<V2$+'YUKCS06<* N<8))"YR,9SD=:F'A+
MP^NOG71H]H-4)S]I$8W9Z;OK[]:T-0T^SU:PFL=0MH[FUF7;)%*N58=>GUH
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M7?QQ!+=(78R@(%+/R6XQD_6J&G^'M)TJ17L;&.$H&6,+DB($Y(0'A >X7 H
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MC55U32=4NS92&]D8((YL*A4G#@CY?FR>0/:O9HXTMX%BAB5(XU"I&@   '
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MJ@S\@/'"X' H \TL]-:;X=^)=:DU/5C?61U6.WD&H3#8JN^T8#<XVCDY/X8
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MYC%C]U.FYL?=7_:/%>?WDUC;>)_$6G>)+#5KFSUATELY+07#Q7,9A2,Q$1'
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M[[>3^Y,IW1M^# 5PR0^(KS4]*\0K:36\GB*V_LZ]MP,&S3;N27ZC$QY_OJ*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4C E2%(#8X)&<&EHH QO#6@#PYI\MFMV]RDEQ+<;G0*0TC%V'';).*V:*
M*  C((SCW%8^@Z"=&25Y]2O-2NY0%:YNRI?8I)51M   W'MDD_3&Q10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!BW/A\W/BRRU[[8RO
M:026Z0",%65RI;)ZYRHQ6U110 53U2REU#3)[2"]GL995PMS;XWQG/49!%7*
M* *6E:;'I5BMLDLL[EB\L\Q!>5SR68@ 9^@  P!@"KM%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.\?>R??O75:YHMIX@TF73;[S/(D*-F-]K*RL&5@?4,H/X54.G1Z*MUK4@O\
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MK6Y,<-T0,9=<=<<'!&:M_P#"*6JW^L7B7=VDFJQ)#.%*;55057:-O& Q'XT
M<QIVOZZTW@?4KC4A+#K\86YLA BQH3;F0,AQOSE><L0<]!4EGK'B?7K"VUO2
M'VQF]<26\S1" VZ2,C G'F!\+G.<9SQBMV/P7910:%"MY>[-#(^QC<G&$*#=
M\O/RDC_Z_-16_@+2[/69[^VN]2A@N)_M$NG)<D6KRDY+%,=SR1G!]* .3U'7
M_$T'A_QAJL>N%6T+4G2"(6L>V6-5C;8^03C#'I@Y/4\ ;L"W4OQAN =1NA N
MBPS+!\A0;IG!497(!V@YSG/?& -";P+I]QI>M:=)>7QM]8G,]V-Z9+$ ':=G
M (51^%7O^$9M?[?M]:^TWGVR*U%JY$@59D#%EW@#G!)/&.O.10!C_%,SI\/[
MY[>[FMV$D 8Q$#>K2HI4Y!X(8],?ED&7^T+V]\8S^&8M2N($LM/2YDN52+S9
MGD=@.J%0JA>R\DCTYW-=T6T\1:+<Z5?>8+>X #&)MK*00P(/J" ?PJE-X4MG
MU"TU**]OH-2MX#;F\1U:2:,G<5<,I5ANY''!Z8H @\$:W>ZUI%VNI!&O=/OY
M[":5%VK,8VQO [9&./7-9-YJOB+6[C7XM E>"XTVZ%M;K^Z\IW"(Y,NX%L$L
M1\N. ,<UU^EZ7:Z18BTM$(3<TC,QRSNQ+,S'N222?K6)?^!=.O=?EUB*]U.Q
MGN55;M+*Z,27048&\ 9SCC((..] &(]_XDU#Q#KVGKK7V%+73+:[C%O!')Y<
MCB3(#,#N7*CJ,D=,5GZK>7OB#P[\.=5FO9H)[W4;5I%A5-H=H)27&Y3SGMR.
M>G>NU7PK:1ZI?ZA#=744M[;):R(A38L: A0HV\8W-^=51X'L5TS1-/6^OU@T
M:5)K0!TR&4%5W'9S@,1^- %&WU'5=?NO$EM8ZI+9OI$HM+<^5&WFR",.7D!4
MY!+8PNW@'N>,6S\3Z_XGG\*?8M1&EIK6EW,TRI;I(8Y8]@W+NSQECP>,?G78
MS^$[5]4O-1MKR]LY[Z)8[P6[J%N HP"P*G# <;EP<?A2CPGI\6J:5?6[SV_]
ME0-;6L$141K&P *D%23D*O?M0!AV5YX@\06>L_V;K*6][IE[]AB$D*&*5HPA
M=I1M)^<EN%(P,8IEUJWB'79==C\/S-#<:=<BVMP/),3L(T<F7<"V&+D?+C@
MCFM6Y\":9/KUSJL=UJ-J;S:;RUMK@I#=$#&77&<XX.",]^])?>!--O->EUB&
M\U.PGN%5+N.RNC%'=!1@;P!U XR"#CO0!T5O)*]C%+.(TE:,,X5LJ&QS@]QG
MO7G^E^(M9;7_  U;2ZD;R'58[H7$J0H+8NB;U: [0Y4=,G(8'J>M>@M;0M:F
MU,:^04\O8.!MQC'Y5RUE\/=-L3I)CU#56.DEQ9[[G/EHR[=F,<KC\> "2.*
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M(LN.NTB-^.TO'<4 >UT YZ5YEKNAV]O<>"UN;=8[F[UAY+I8SMRTD4KNN1U
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M]/19+B&X3#A&^ZRXR&!/ VY.>.M0W'C?2K(:B+N.[MY=.@6ZN(7B^<0G.)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KG_&&OW?AS2H+RUM(KDR7<%NZR2%<"20)D8')Y]1705A
M>+-!G\1Z5#907<=L4NH;DN\1DSY;AP,!AU*B@#)7Q#XFD\1:CH"V.E"\AM8[
MR"8S2>5Y;,R[6&,EMR]1@8.>.A6Q\87FJ^'=!U6"VM[.'48F>XN+E]T=LP&
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M: =H!QD8KOO#6EWFB^';/3+N\BNI+6%($DCA,8VJH5>"QYP,DYZGM7/_ /"
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M[O5].U'5YK2XN;*&6%[B" QR7:.A3;(<G@ Y[Y.",=" 0OXUO;;0](\27%I
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MI4VN48./E/7!!QVK0L?"M_9^(=/U5M2MY3::4=.V?9F7?\RMOSO..5''UYH
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M=1PHMEJW]G2W:HYA5"%(G*]0N&'&>O?'-7+_ ,*Z[J=G82W6NP-J=I>QW?\
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M?:A<6LDFGWSW5O=1P%9_+)8K"6S]T!@">X7H.M &MX9T*+PWH$&E0D-'"\C
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M&,YST&#HV=YK-IK6A^%=:U99FG^UR/<6\I$DJQ[#'$7 4[@KY)&"=H]3D ]
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M&5%8$^8Q)'R<=1GJ*Y?Q!I,UKI.L3Q:_>/9S:/-BV:9F=I5!;SDDW948X*J
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M\X]JV44)&J DA0!ECDGZFN#\:+</\1O :VDL44QDOMKRQF11^XYRH92>/<4
M=;8ZL+V\EM'L;RTFCC63%PJ@,I)'!5B#TY],CUK1K#M[/498]1M-5U-#+<N3
M:RV:F!HXPB E068Y#9/4CD<<XKF/ .IWVH7MQ::MJ,TU[I47EHJNP6_B9F*W
M6#]X,.!C@$'U7 !Z'00",'D5YQH%SX@\0Z5H'B6VU&WMUFG62\5[QWCDC8E6
MA$6S:K D $'.1R3FK7AN>\\4>'=)\2C7)K.>2[+W,62T1CWLGV?9D!3]T!OO
M9&><T =TD4<6?+C5,]=HQFCS8_.\G>OF[=VS/..F<>E>6WNLZI#\/O%-VFI7
M0N=/UV2"VE\P[DC$Z(%SW&UB.<]?6MNPLM_Q>U]OM5VI&FVK*!,Q526E'W3Q
M@8R!C&>>] '7Z;>OJ%F+A[.YLV+NOE7*@/\ *Q&< G@XR/8BK=>6P7>NWGPF
M&LPZC>S:CI]Y<3/B3:US#%<N'C./6-2!CH0,8K5UGQ,\?AS5_%>F73M9I!##
M:L7)CRS+OFQR.!(!TX,;4 =[17+:38:U9^)!/+J$1TJXM<?9'O'N7,H.?,1F
M48&TX(''0\5T5[,]O8W$\:[GCB9U7U(&0* &6VH0W=U<0P;G%NVR20?=#]TS
MW(R,]ATZY%6J\MT[7+G0O@;I6IV\N+JZ\KS+E@#L>>;]Y(<\$@NQYXSBMV[D
MOM'\>:1I5M?7<EAJ]K<B199#*UO)$%(D5GR1G=@CIG'% ':U'/*88'E$3RE1
MG8F-Q^F2!^M<5\,X]0U#PQIFOZCK5_>7%U:%'@E=?*!WG# 8SNP,9SW^F.W?
M_5M]#0!S-EXXM=1T%=<M-*U273FC:03+$G*J2"=N_=V/:NHZBO,/AE;:[+\,
M/#QL[^S2V$BL\1M6\PQ"<EQO\S'(W?P^WO5KQQJ5[H6HV6KV.J2MIMY"T-U"
M'9DMD; %XH7LFX9&<?,,8/- 'HM%<9JM[<1>(-#\-VMPTD%S93SF66]:)[AD
M*  2JI/1F8@8Z#G P<ZTN]9LM;T7PKK.K++]IDO)#/!*1(Z1A&CA9\*=P$F2
M1@D*/4T >B5%,T$*-<S&-%B4LTCX&U1R3GL*X74/[3T*]\.6O]O7%X9==:WD
M).#Y#122+$_)W$87YCR1BL#QE<W5SX;^)=G+>W306+P_9U\YOD#0HS+GJ5)8
M\'CMTH ]3N+UX+^SM5L[F5;DN&GC4&.':N?G.<C/08!YJW7&ZL]WI_C;PCI\
M&H7?V.Z^UK/"\N[S-L1926^\2"?7L*S=.O;^*^UGPE=ZA=R:E]O1K2X:4[S:
M2#>&!]45)%]"P&>M 'HE94VOVT'B6WT.2WNQ-<0F6.?R#Y!(SE-_3?A2<>E<
ME--KGB6Z\1VFEWPL[K3+I;:U<WCIY.(T8.\80B0,2WWB>!@8P2>O:)Y=-6_\
MRV^WK:$)<;B8E8KDL,_PYP<]<"@#3HKA/!VL3RZY_96KIJ=CK45F6GM+J4RP
MW&&4&>%\D8SP0,8W#@8-=Q-(8H)) I8HI;:.IP.E #Z*\Z\/SZ_KNF^'?$L&
MIV\,=PR27RO>.\<R/P8EBV!496( P<Y&"3G-&A:K=OK]MH^OMJ5GJ5PL_ES)
M.7M-03!(:)@<(RKSM &!Z\4 >A12QS(7B=74,RDJ<C()!'X$$?A1++'!$TLK
MJD:C+,QP *\L\)N;3X9>'BNJ7D4M[?%&B5VDEN<22$Q1DL-A;&2V1@ DGO5+
M5[F^O_!'B""]N;L?V?XE@MH%-PQ98S) =C,.7QYC=<]N3@&@#V.BN$O)M0U/
MQ-JOARSN9(A8V,+PL;^2&0M)OS+D*Q<#"C!X]0<\=5H(OUT.T35+J"ZOTCV7
M$\'W)'4X)'3N.??- &C17*^(-4F_X3+P]X?$LD%M?I<S3/&Q1I/+48C##D?>
MW'&#\H[$USUWJNL6>E?$+3%U&Y_XDMO]HL;PD&50\!D$98@YVD=3S@CGO0!Z
M716#X5L;B#38[VYU6]OI;V"&1EN&4I$VP9V  8!SW)Z?6J_CK6KC1-"@DM7,
M3W5];V9GP#Y"R2!6?GC(&<9[D4 =-6-?^)+.QO\ 1[4QS3+JTACMYXMICSL+
M\G.<$ XP#7'^*9+W2M7N]'AO;R33M1T2[G*M<.TEO+"!\RR$[@K;@",XSTQ5
M'[&1H?POBBNKA&EEB;S"^]DS9OG;NR![#H* /5@ H 4  < "EKR[_A(=2T2U
MUS3SJ$TZP:_;V$-U=R_-%%,L;'+X/3<P#$'&1UQ3_%:>)?#_ (9\3W::R;>#
M[(L]G"ETT\T+J0'P[H#L.1[@]",T >G45FZ1ILNG)<--J5Y?-<2>:?M+*1&<
M %4  PO&<<]:TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *H:SHUCK^ES:;J4;RVDPQ)&LK1[AZ$
MJ0<5?KF?&FL7^BV>ESV,L,:S:I;6T_F1[B8Y) K8.< X/7!H GU?P9HFN162
MWT$[2V6?L]PES(DT>>H$@8-@^YINI>"/#^JV%C9W%DRI8DM:R0S/'+$3U(=2
M&Y[Y/)Y/-:6FZYI.LI,^F:G:7B0MME:WF5PA]#@\5'%XBT6?S_*U:R86Z"28
MB=?D0]&//"^_2@"%?"^F1+:"W6XMS:1O'$T-RZG:Y!?<<_,20"2V3GG.:J_\
M(C90ZUHMY91FV32XGBC"3/AD92-A3.#R0Q8Y.5'U&A:>(M%OKU+*TU:RGNI(
MA.D,<ZL[1D A@ <XP0?H:D;6]+745T]M1M1>.Q58#*-Y8#) 'KCG'7% %^J<
M^EV5SJEIJ4UNKW=HLB02GJ@? ;'UVBN0NO%4VK:YK.F:/KNFV$NF"$Q-.4D2
M=BI>3=SG:J@#Y2"#G)[5TFF:E%#X=M+N_P!9L[P,H#7T86.*9B< J,D<], G
M- %FST>QT^UN;:TA\B.YFDGE\MBI9Y"2S9'(.3VK-'@K0ET2RT=;69;*QF$]
MJJW4H>%QG!5PVX?>/?N:DO\ 6;2XL+.?3_$&GVR374<:3.5D6;YP&B7YA\Q^
M[Z@]JNW6N:58W(MKO4;6"8E1LDE"D;CA<YZ9/ ]>U %/_A$M'\_4YA#,KZG$
ML-WMN9 '11M  W87 )'&.M:.G:?;:3IUOI]FK);6\8CB5G9RJ@8 RQ)X%5;K
MQ)H=C.\%WK%A!,C(KQR7"JRECA003P3@X^E,TK4(Y8]3N)-:LKVWANG >':J
MVRA5/ENP8@D9R2<=>E $NJZ#I^LS64UZDKO93">W*3O'LD (#?*1DX)'/J:I
M:WX,T/Q!J,&H7UM*+R%/+6>WN)(7*9SL)0@E?8U?M]=TFZ@N)H-2M9([8XG9
M95Q%QGYO3CUJ>SU&RU%9#9W4,_E-LD\MP=C8S@^AP0<'UH SKCPKI5P9 8IH
MXY;=;66&&=TC>%<@(5!QC#$<<X.,XK!@\.SS?$35KR6SO+73I;"WMH)X+@1J
MVPON7"MD##+@XXQQBNXJA9ZWI6HW!M[/4;6XF">9LBE#$KG&X =1GC/2@#/U
M3P7H&KZ=8V-Q8A(K#'V1K>1HG@XQ\C*01P/7FDOO!.@:AI-IIL]FPAM'\VWD
MCF=98W[L) =VXYY.>>]:=KK&FWUP;>TO[:>8(9/+CD#':"!NQZ9(&>E4M:\4
M:5H-_IMG?7,<4U_*8XP[A0H"EBS$]!QCZD4 -G\(Z+<:7::>]M((+2<7$++<
M2+(LHS\_F!MQ8[CDD\YK;1%C140 *HP .PKC;#QA':>(_$=IK^JV%M:V=S!%
M:/(5A!$D0?&2>3\WZ=JZ>_U;3M+B$M_>V]LA!(:60+D#J>>P[GM0!!=:!IM[
MK5KJ\T+_ &ZV0QQR)*Z90D-M8 @,,@'!!Y%5H?".C6\SM%;NL3W'VHVWG/Y'
MG9SO\O.W.0#TQGG&>:V8I8YX4FAD62)U#(Z'(8'H01U%5/[:TO\ M!;#^T+7
M[8S%1#YHW%@,D >H'..M %ZLB^\-Z=J-Q<S7 N/]*B$%PB7#JDT8S\K*#CN?
M?!QTJPFMZ5+?BQ34;5KLLRB$2C<67[P [D=QU%.76-->^6Q6_MC=,S(L(D&X
MLH)8 =R #D=J ,V^\&:'J%]/=S6TJR7%N+:9(IWCCE0 A0Z*0K8!.,CBH;OP
M%X>O+/3;9[6:,::NRTEANI4EB3&-HD#;L8&,9K6&MZ6VHC3QJ-J;QB0L'FC>
M2.H [D=QVJ:]U&RTV$37UW!;1LP0/-($!8] ,]3[4 9__"+:1]LTVZ6W=)=-
M1DM-D[J(PPPW .#GN3DFK&DZ%8:)]K^P1R)]KG:YFWS/)ND;[S?,3C/M4!\5
M^'ECNY#KFG!+-@MRWVE,1$] W/&>:M/K.F1V4%ZU_;?9KC'DRB0%9<C(VG^+
M@$\4 &L:/8Z]I4^FZE!YUI,!O3<5/!!!!!!!! ((]*S8O!6@Q7%S<&S>:2ZM
MA:W!N)Y)?.C&?O[F.XX8C<><'&<5>_X2'11%:2G5[ 1WAVVS&X0"8YQA.?F.
M?2K:WMJ]Z]DMS";M$$C0!QO53P&*]0/>@#'TCP9H>B6L]M:6TK131&!EN+B2
M;;$?^6:[R=J^PQ2+X*T-+#3K(07'D:=,L]J#>2DQNHPISNR<#@ \ <51U'Q.
M^C^/A9:E?V=KHO\ 9+W9:4!-L@E1!ER>?O' XZ]ZZ)=6TYM-345O[9K*0 I<
M"4%&SP,-T//% %&Z\*:3=WUW>/#*DEX@CNQ#.\:W"@8&]5(#<<9ZXXZ<5*WA
MW3&UB'5A#(EY#;FVC:.9U5(C@E0H.W&0.W857U'7XTT"77=*GAOK2U#23I"P
M?>B_?"D='4 D#N1@XSD:\%W;W-E'>0RJUM)&)4DS\I0C(/TQ0!4T;1+#0+(V
M>G1R1P&1I=KRO)\S$LQRQ)Y))_&GZQI%EKVESZ;J,;2VDXVRQK(R;AZ94@XJ
MGI6J0)HHN[S7+*^C::15NX0J1M\Y 08)!(^[P>2*T[.]M=0MA<6=Q%<0,2!)
M$X920<$9'H01^% &?<^&=,N[W3KR9+AKC3@PM7^U2 IN&T]&Y)'!)S6O7$ZO
MXZM[CPWXHGT"^MC?:-'*1O ?>4C5B0N0=N6VYZ9'>M_1O$&GZHL=I'J-I-J2
M6Z27%O'*I=,@9)4'(Y- %74?!&@:K=ZA<W=I([ZC$(KM5N)%28 ;5+(&"E@.
MAQD5/;>%-)M-0%_!'<)="U%IYGVJ4GR@20.6]23GKDYS5N/6]+FU'^SX]1M7
MO/FQ )07.W[V!WQW]*FN]1LM/\K[9=P6_G2".+S9 N]R<!1GJ23TH Q#X#\/
M?V38Z:EK-'#I\AELWCNI!+ QZ[)-VX ^F<5?TCPYINA37DUA'*LEY())VDG>
M0NV ,G<3S@#GJ:+;Q-H-Y9W-W;:UI\MM;';/,ERA2(_[1S@?C3H?$>B7*7#P
MZM92+;[/.*3J?+W_ '=W/&>WK0!;O[&VU33[BPO8A-:W,;12QDD!E88(XK+;
MPCI#6]A&(IUDT\DVMP+F3SH\C!_>$[B".""2, >@JQ_PDNA?9([HZS8+;R2F
M%)&N$"M(.J D_>]NM6Y-1L89V@EO+=)EB,S1M*H81CJY&?N^_2@!+#3K73+<
MP6D>Q6=I')8LSNQR69CR2?4TW5=+L]:TNXTW4(1-:7";)8R2,CZCD?45%#KF
MEWD-RUKJ=HWD(&E82J1$",AFYX!Z@]#7-ZEKNIZ?I/A2:WU6SOQ?:C!:7-U%
M -LZ/NRR88A?N^_X4 ;D?A;2HM0M;]4N?M5K"T$4K7<K$(QRP.6^8D@$DY.1
M527P'X=GT231Y;%WLWN#=!6N)"R3$DEU8MN4Y)/![GUJW'J<,>L:F9M=L6M;
M:*,O;956M#\V6D;=T;L"!C;4UIXBT6^O8[.TU:RGNI(A.D,<ZL[1D A@ <XP
M0?H: )-(T:RT.R^RV*.$+;W>65I'=NF69B23@ <GH *FU#3[35M/GL+^W2XM
M9T*2Q.,A@:KW&OZ/:3-#<ZI9PR*VPB295PV,[3D]<<XZXYJS<7]G:61O+FZ@
MAM0NXSR2!4 ]=QXQ0!AV/@70=/TNXTZ"&Y,%PHCD+WDK.4'1 Q;(7_9! ]:T
M'\/::^OQ:X8I!J,4'V=95G< QYSM*@[6&>>0:=9^(-&U"_DL+/5;*XO(U#O!
M%.K.JGN5!SW'YTZ'7=)N+O[)#J5I)<88^6LJDG:<-CGG!Z^G>@#-/@7PXVC7
M>D/I^^PNI#*\+S.P5BQ;*9;Y/F)/RXY)I!X&T'^Q7TEX+B2UDD260R7<IDD9
M2"NY]VX@$# S@8J2\\;^&+&VEGEUVP*QQO+MCG5V8)][: <G!XX[U-I_BG1=
M0@L"NIV2SWT8>&W-RA=B1DJ!G)([XH D_P"$<TPZO)JK12O>26WV1W>=V#1<
MG:5)QU)/3O4NBZ)8^']-CT_3HY([:/A%DF>0J.@ +$G ' '059BO;6>YFMH;
MF&2>#'G1(X+1YY&X=1GWJ>@"CJ^D66NZ7-INHPF6UFQO4.5.00P((((((!R/
M2JL7A?2X=434XTN!>);&U64W4I/EDY(.6Y)/.3SGG-;%% '-)X"\/16UA!%;
M7$:V$DDMLR7DRO&9#EP'#;L-W&<4X>!/#J:>;%+*2.#[9]M41W,BF.;).Y&#
M93DGA2!R?6NCHH ;'&L4:QH,(@"J/0"LG5/#&EZQJ5GJ-XEP;NSW?9Y(KJ6+
MRMPPV K <C@UL44 8K>%=+=;H2?;9#<P_9Y&DOIF;R\Y*J2^5![[<9[U)+X;
MTR76;/5FAD%]9P^1#(D[KB/NI .&'U!K6HH YRQ\"^'M-UF35+2R>*>20S&,
M3OY(D/5Q%G8&]\4ZT\$:!8ZU+JMM9O'/+*9VC$[^3YIZR>5G9N]\5T-% ',W
MG@'P[?OJ'VFUF:._D$UQ"+J18VD!!WA V QVC+  _F:T#X;TPZPFK>5*+U8!
M;^8+B0;D&2NX;L,022"<D9ZUK44 9VCZ%I^@Z>;#3XGCMB[/Y;RM)RQ);EB3
MR23^-);:!I=IH"Z'%91#3!$8?LY&5*'.0<]<Y-:5% &'X?\ "&C>&-W]F03+
ME=BF:XDE\M.NQ-Y.U>G ]!Z5N444 <YI?ABWL]$NO#5U:QW.C,9/(5N1Y3L6
M\MAURI) ([ =Q5VS\.V%DV]/M,DHA^SK--<O)(D?]U6)RO09(Y.!DG K6HH
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MF0SGS4:2;:1D#@Y) X&>A!.3X[O4NK/QO90VTUK<8@?RX;=I&O@%3$I;! 0
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MN[\,UR:6EQX:MK'5IK:]A\/#7;VY\NV1@]K!*NV*38!E5SN.,9 DZ=J]EHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$0 <\  ],<GG- '9T45A>(-0O;*ZTZ*">"WMYV=9I2IDFR%RJQ1CER3DG@X
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M?$OQ3%/?K):VT=H$A,6-JLDC  YXY)).#GVH [.BBB@ HHHH **** "BBB@
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M#=AK*0&!;R(2B)FW%0>V:BTCQ!_:NMZWIALWMWTN6.-F9PWF;T#@@#IP1WH
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M(LF-N @&W9MXVXP>^223UU% '+WW@Y]1T1+6ZUFZDU%+J*\34&C3<LL9!7"
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M()R-W3/4"NFHH S]#AO[?0[.'4YS/>I&!+(P +'WQQG&,XXSFM"BB@ HHHH
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MQUBPEL=1M8KJUE&'BE7<IJI;>&=$M-$?1H-+M4TV3.^V\L%'SW.>IX')YX%
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M'H*]#O/#>BZA!9P7>EVLL5F<VR&,8BXQA1V&.,=*B3PEH,/^HTN"!O.:X#0
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MS @;<!F[G)(].0#6TFP_LO2;6Q\Z2<PQJC2RN6:1L<L2><DY-7*** "BBB@
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MF2QWX>/5#BR=(W83'T! X/7@X(P?2N7T07'_  G&DWLNFZA#!'X;^SN\EI(
MLGF(VPG'!PI..O;KQ532= NK[X0+9M%-8:K8W$]Y:-<Q-$8IEGDDC;Y@.""
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MF$TJLZ111/*[*N-S;4!.!D<XQR/6N?\ $_C&"TTC1KC3)WEBU:\MX8[F"%I
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M3B),A92WS;22Q[?+SCDBNFMO%\>IG28=+MA-=ZC8#45CFE\M8H3MY9@&.26
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ML+M77SH1C:1G;@@C@@@Y'6GWW@O3M1TB^T^XGNS_ &A,DUW<!E$LS)MVY.W
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M:'X>M-!TE],@DFGMF>1RMP5;EV+,. ."6)_&FV7AFPTWPJ/#MD98+$0M""K
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M_M]-)TJTFU^\L!<W-V+5#:,=CLTFU0-QSD#&[TPU:SW]G')'&]W KR#=&K2
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MZ^L;'3M*:_12LFJ0+%)+(4AAD!+*\I'51MZ'@G R.H .E2\M9+;[2ES"UO\
M\]5<%?SZ4Z*X@G>1(IHY&B;;(J,"4/H?0UX=JMSI\WA7QS#+=VD[KKEM/&R
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MW4L2?;D=JY:2>?3O$RRPR6>LZ1=ZZ(WA8;;NPNBVTE2/O(,$X."%/I0!Z/\
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MO,.$\QPNX^V>M><ZSJFFP>-WM_$.IBQTR]TB);&>01F!_F?SDW.K ,08SVR
M.O%4;RR72;" ^']1AO8K/1BLNFZWC_2[+>Y#*XP5.%(Z8QLSB@#UD$, 000>
M01WID]Q#;0M-<2QQ1+U>1@H'XFLC1_$.EW?V'3DE%OJ$EA'=BPE/[V.,@=1Z
MCH:RO&NHV%CJOAM+PPQ2R7DC6]U=2%;>!EB;)<9 8D$A02.3G/'(!U:W,#0I
M*L\9BD(".'&&STP>^:2.\M9H7FBN89(D)#.K@JI'7)[8KP]&TN?P_9Q7,MO)
M';>-W1F(">7&\LG'^PI'./2M#Q3HEC9OX^_LFUMX](_L)&GBA0");P;R"H'
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ML/$$.KS1V$D0'GQS"[/EHAZ@8.<#C!)]Z /;YKNVMI(XY[B&)Y#B-7<*7/H
M>M$]W;6NS[1<10[SA?,<+N/H,]:\\MY+&?4_'FG^)S"LKL&3S\#=9^4 A3/8
M,'/'1CZUD*FMVWA_2[J:\LIM8M] 7^T=)U7@7-N2QR&ZK(-I#9R,XS0!ZC)/
M=C5X%2:R&GM [.K$^<7!7!7G&S!.?PJ@/$$>L^'[R]\.WM@\L3/''+=,3""C
ME26VG.WY3@]^M<O:2V5S\2O#=PMLML]WX<E+02X\P M$51^Y(&1^!KEK@Z6?
M@9XBMF^R_:[:[N?-0A=\3?:WV9[@XZ>W2@#VFXN[>TB$EU<10H3C=(X4$^F3
M3VFB39OD1=YPN6 W'T'K7#B[A'Q2NXM7:$VEQI,?]FM-CRV4,WG $\%CE"1U
MV@=JX^WL(%T_P?#?K$]J?$=Q'8>=C)LBLWEKSR4/RX'0@KVQ0![+'>6TMNUQ
M'<0O N<R*X*C'7GIQ2V]S!=1^9;SQS1YQNC<,/S%>5+;V N/&^F6VI0:1$NL
M63V[HJF**8I$PW)P-K2* 177>"+V\N&UJVU&PM+?4+>] N9[)B8+ES$F'7/(
M.T*".Q^M '2S7MK;RQQ3W,,4DAQ&CR!2_P! >M+-=VUN&,]Q%%M7>V]PN%SC
M)SVS7DGQ!U'3I8_'=I&\%M>QV< E$[%Y;DA-Z>2I/RJN>2 ><GC&3K6T.A:O
M\5)I)H[&[AF\.PRL7"NKMYK@N<\$[<<^GM0!Z-)<P0VYN)9HTA R9&8!<>N>
ME8/A7Q!<Z[<:Y'<+;;+"_-M"]N20Z>6C@DD\GY^V!7G'A;5XK73?AP^IW"+H
MWV>YC$LK?NDN0<1!R> 0NX+GN:Z[X=3Z>VK>,HK"6W,9UEI56%@05:*/YACL
M3NY^M '5Q:[IT^NW&C1W,;7MO&DDL88?*'W8'UPI./3'K5N.\MIKB2WBN(7F
MC^_&K@LOU'45YY<LMM\0_%T=KY,>K7&CP-IZD /)*%GY3N><9(_&J/AJ?POK
M,.@WL.LWC:MI]K(C6</EI+!F/$HE 0-M!'5CRV,$DT >F'4[!5G8WUL%@!:8
M^:O[L#J6YXQ[UGQZT=7T6QU+0[FR\FXEB8M=$X,3$9 P>'(/ /<C-<-H/VBW
MF@T>Y&GZS:2:+-_9NJ6BXD,"[/DF3D9SLPPZD'C.:S$FTF7X5^!)8GM&E@U'
M3%=U*Y20,N\$]FP.>_K0![!->VMN',]S#$$ +[Y NW/3.>F<&G"ZMS<"W$\7
MGE=_E[QNV^N.N/>O-FL-%NO'/CU;JWLI%_L^U=ED52 QCEW-@]^G/7GWK*TJ
M/3[;2/A9?Q"W2]FE1);@$>8X-LX8,W4C(48/H!0!ZZUW;)<I;/<1+.XRL1<!
MF'L.II)KVUM]_GW,,6S&[?(%VYZ9STS@XKR9WBO?AOXKM-1P/$D-]<-MSB<W
M&_-L4[\CRPI'88%21:=IUQKGCU=5M[&6Z32;1YMRJ0)3!+O;'8YQSUY]Z /5
MS<P+,(3/&)3T0N-Q_"G1S12LZQRH[(<,%8$J?0^E>7,OV3P+X,\;P)Y]SI%C
M!]L*C<TMJ\:K,/<K]\?[I]:[WPY9O;Z8;JXB\N\OY&N[A2.59^BG_=7:G_ :
M - WMH"X-U"/+.'S(/E[<^E.%U;MY>)XCYGW,./F^GK7GOB3339>,KJVALQ+
M;>+;$V<H"9"7$?&]O;RG<^_EU/X$BGOK6.UU>V7?X=CDTLM(@VRN#@N,]O*6
M/G_IHPH Z+^WTTC2K6;7[RP%Q<78M8S:,=CLTNQ0-QSD#&[TPWI5>W\2R_\
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M4L'"L),-%MR/XL<D9],]JP;2[M+/X?Z5-]NMH+2P\42;89) L3HL\I$9;HH
M.\9XRH]J /9(9X;B)98)4EC;HZ,&!_$4RYO+6S56NKF& ,<*97"Y/H,UQ_@:
MWTFXUSQ%KEA=Z7<2:A<*X2SFCE>! BC#LO0LREB.GUJCXQU#31XHOK&5H+>]
M;0G'FW3%A+&S,/+BCR 7)')Y/W1@]@#T6BN:^'UU'>?#SP])',)L:? CL&S\
MPC4$$^H/!]ZZ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBJ>HZG!ID<)F#O)<2B&&),;I'()VC
M) Z GDC@&@"6*SM89GFBMH8Y7^\Z( S?4]Z=+;03LC30QR-&<H74$J?49Z5C
MMXKL8C9">&[@-Y>&QC$D6,3#/RG!X^Z2#T..M<]X^\1+-X+\5PZ==7EGJ.D(
MGF-&QC9&8!EPP/(*G/% '=-!$[AVB1G'1BH)%-^R6V"/L\6#SC8*PK3QKI-S
MJ\FEE+Z"Z6$SQ+/:2)]HC'5HN,OCT S[54L_B3X?O9-,\LWJV^I.([:[DM76
M!I#G";R,;CCI^'7B@"S#X8<>-+S6I_LDMK/:Q6R6YBR8_+9B&R>,_.>,<5T3
MQ1R%"Z*Q0Y4L,[3ZBL2_\7:9IZW<THN'M+*017=U%'NCMVXR&[G&1D@$#OCF
MIM1\1V>GK*5CGN_)@%S,+5 _EQ'.'/(SG:< 9)P<"@#3^RVYQF"+@DCY!QDY
M_G5#5K#4);,+HEW:Z?=F12TTEKYH*=QMR.OKFLX^.]%>ZM[:U-W>2W-E]N@%
MM;._FQ94?*<<GYA],'.*EM_&6DWFFZ9>6AFG.IN\=I J8D=T#%U(8@*5V-G)
M X^E %Z'1HH=#&F"9V!!\R9E4L[,VYW.1C<6)/3@FKL%M#;6D5K#&JP11B-$
M[!0, ?E531M9M-=T_P"V61?RQ(\3K(NUD=&*LI'J""*T* (Q;P",QB&/8W)7
M:,'\*1K6W>=9V@B:9?NR% 6'T-9FJ>)+/2[MK-H[BXN4MFNWB@0%DA4X+G)'
M?C R3V%5)?&^C1RZ9'&UU.^IVQNK,0VSMYJ  \<=<,..V><"@#HF4,I5@"",
M$'O48MH%4*(8P NP */N^GTK&M?%^DW>B+JB/,L;7!M! \1$WGAMOE;.N[(_
MKTYK'\-:E<WGQ&\46\KWR0PVUF5M;ILB)F\W=M )7! 7D$_I0!V'V2VQC[/%
MCTV"E%M &#"&,%>AVCBGNXC1G()"C)VJ2?P Y-<C#\2_#TR6,P-\MI>3&W2[
M>T=84DW%0KL1A22._MG% '5?9;<*5$$6#U&P<T[R(=RMY4>4!"G:/E!Z@5@?
M\)MI;:W-I,4.H2W5O<1V\_EV;E8BXRK,<?*N/XCQ^&:D3QCI3/9,3.EI?R^1
M:7C1XAFDYPH.<C.#@D -V)R* -P0Q (!&@$?W!M'R]N/2D^SP_:/M'DQ^=MV
M^9M&['IGKBN+\?>(TB\(>(ETY[X7%C;NKW5GP+>7;E5+ YSRN=N< \XK:TS7
M[=[B#2&6=]073DO"I7/F(<+D-G&=W'.* -E+6WCG:=((EE88,@0!B/K3Y(HY
MD*2HKH>JL,@UB6GBW3+[2K"_M#-,+]G2UA6/$DC*3NX.,8VG)) 'KR*S;[Q5
MHFI:;93-=ZE;@ZO'9;;=71UN5D"^5(1P%R0#DX(Z9H ZMK>!R2T,;;CDY4')
MQBA;>%'#K#&&' 8*,BN=OO'.E6-YJEH8=0FGTQ$DN4AM'8JK!CN''( 4G/3T
MS5]_$FGD:<+9GNI=2A,]I%"!NDC"AB_S$ ##+U(Z@4 :*V=LC,RVT*LS%B0@
M!)/!/UJ4*%4*   , "LS0?$.G^([)KO3C.T2N8V,L#QX8$AA\P&2""#C/(JS
MJFIVFC:7<ZE?RB*UMD,DKX)P![#DT 2Q6EO#&T<5O%&C'+*J  GW%21Q1Q+M
MC14&<X48K!/C#3HAJ2W45W;3:=;K=7$+PEG$39PX";LCY6Z=,<XING>--*U/
M4;&RB2[C:_MS<6DDUNR),  S!6/4@$'T]": -\PQ&3S#$AD_O;1G\Z8]K;R1
MM')!$\;$DJR @D]3BN#\<^)A+H4$NE2WZ(-4M[<7EN2L3MYZK(A(.2,;AG&T
MD8SFNJO+K.OP1&<Q6UE;O=W+;MHYRB!O]G E//= : -9$2-%1%"HHP%48 %,
M%K;BX^T""(38QY@0;L?7K6/!XMTV:ZL(76X@745+6,TT6U+C W84]02.0& )
M'3-1:;XUTO5]3^PV4.H2.MQ+;22&S=8XI(QDAV(^7VS_ %&0#=:UMVD:1H(B
M[X#,4&6QR,GVHEMH)V1IH8Y&C.4+J"5/J,]*D9@JECG &>!DUQY^)GAT1Q3L
M;Y;1[DVKW;6<@BAD#%,2,1\N2._MG&: .LGM;>Y $\$4H!R!(@;'YTXPQ-()
M#$A<=&*C(_&N?E\:Z7'K=QI"0ZA->6\L,<RPV<C!/,)VL3C[O'+=.>]/;QCI
M2?9Y6,RV-Q<?9HKXI^X>7)7;NSD D$!B-I/0]* -HVEL96E-O$9&QN?8,G'3
M)]J<((A(9!$@<]6VC)_&LRT\1V=[J>J:=''.MSI@4W"R(% # E<$G!! //2J
M']M:;>^(= !FU."YN[>::VM]K)%*FU23(.A(&"!G(W=.: .A%K;JJJ((@J@J
MH"# !ZBC[-!Y?E^3'LSG;M&,_2N"\:>)A/I^ERZ5+J$<+ZS;6XNX"5BF_?!7
M0D')7AADC:<<$UN)KFE6VO\ B&0W6I--86T+W<#)(T4:X<@QICDG!R5SG ]*
M .ADM;>6-8Y((G12"JL@(!'<"B6UMYV5IH(I&0Y4N@)!]LU@:=XWTC4[W3+:
M%;Q/[3@,UI++;LD<N%WE0Q_B"G/IP>:6[\;Z191O/)]I:S2[^PFYBA,B>?G&
MP!<L?F^7(&,\9H UVTV!]6347&Z:.,QQ\#Y0>ISU)_ESZFK,D4<H D17 (8!
MAG!'0TL;B2-7 8!@" RD'\0>169J7B"UTV]2Q,4]S>/ ]R(+=06$2$!G.2!C
M+ 8SDYX!H I>)_#L^N#2UM9+>!;/48K^02(3YI3/R\>N>O/TJ;Q'H)U?PE?Z
M'9&"T%W T&[9\L888)"C&?TJN_CG1 -(,;W,_P#:\+36?DVSMYBA=Q'3KCMU
M]<5&?'NCKHO]JLEXL"W?V*96@(>";<%VR#^'DCGIR.>: -S3+%;&RCC,<"S;
M%$K0IM#L!C/K^=6%MX4F>988UE<89PH#-]3WJO\ VE%_:RZ;Y<IG:#SR0HVJ
MN<<G/!S^?/H:N4 1"V@'2&,?,7X4?>/4_7WH6V@56588PK?> 48/UK@O'?B8
M2:!'+I4M^BKJ=O;B\MR5B=O/59$)!R1C<,XVDC&<UU&H>)['3Y+Q3'<W L$#
MWC6\>\6ZD9&[G)..<+D@8..10!J_9;?C]Q%QT^0<5C^(-!N-2@MCIEW!93V\
MXFVR6PEBGP"-LB@J2.<C!X(![5/+XCL=MM]D,E_)=0?:88[0!B\7'S\D #D8
MR><\9JII7C/2-:N+2&P>:5KRT:\MSY>!)&K!6Z]"&.,'% #]'T"6UOQJ-_\
MV<;Q8FA3[#:>0H5BI.<LQ8Y4=P/;O6U)!#*09(D<CH64&N>/CO1%TZROF:Z$
M-Y>FQB_T=B?.#%2IP..5/UQQFHF\?Z4JZ@/LFJ&XT\@W-L+-O-1"NX/CIM(R
M<Y[=,T =+);02O&\D$;M&<HS("4/MZ4K01-()&B0N.C%1G\ZS6\163VUG-9B
M6]-[!]IMXK=06>+ ._D@ ?,O4CKCK6;'\0-!F32V@DNIO[3\T6ZQVKL2T8.]
M",<,""-O7\.: .HJ&*TMH"##;Q1D9QL0#KUZ>N!^5<GJ?Q!M8/"TNKV%G=32
M1WJV$D$D6QH)2ZH0X)[;ATSG(^HU[KQ/:VGGAK6\D:V@6XN4CC!:!&W8+#.2
M3M;@9/'- &M]GB222>*&(7#K@OM +>@)ZXK!\(^&G\.Z<UO=-;7$_GS2K/'%
MM8"21G*\Y/!8CK71U0O]7M["XM[4K)/=W(8PV\(!=PN-QY(  R.20.0.I% %
MJ2V@FDCDEAC=XSE&902I]CVHEM;>X96F@BD93E2Z D'VS7/S>.]"@T@:E)+.
M(1=BRD7R&WPS;@I208^4@D=?PSD5KZ5JD>KVC7,5O=VX61HREU T3Y4XSM;G
M![&@"V88C()#$A<?Q%1G\Z0V\+!@T,9#-N(*CD^OUK.USQ%I_AV.TDU!IE6Z
MN$MHS'"SC>QP,X''X_AFJ47C;1VM=7N+AKFS&DA6NTN8&1T5AE6"]2&[=Z -
MR6UMYXECE@BDC4@JKH" ?84YX(I"#)$CD=-R@XK$/B_3HAJ8NHKNVFTV!;FX
MA>$LXB8$AP$W9'RMTZ8YQ5:/Q[H\EQ8Q>5?K]O@\^S8VCXN,*&*I@<L <^GO
M0!T1M;<A@;>(AOO?(.?K3X88K>)8H8TCC7HB* !^ K%L?%NEW^ESWRF>(6]S
M]DE@FB*RK-D 1[>Y.Y<8]13$\9:69+V"83V]Y9R112VDJ 2%I2!%MP2K!B<
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M<G!.&^][5JR:>FL:'=&X\!+:V]P8HIK4>4ES( X)<,C  )U7YLD@\#C/?44
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M^8'KCBFZYH%_?1175EI^IZ?KUKI\4=G?6LB 2. <P3+N*E0W<C&&X/:O2Z*
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MR[F':%*LN[(/R@@@\'L:34_ LNHZ9J48U"&._P!3OH+RZN#;EE_=%"B*NX8
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M97@9)IX7",\J'(!VAF&T \H<D9IH\(ZS8:_?W.B:^MGINI2^?=6LMKYK1R$
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MZ2WQ A *F/R]V=A!.?FSDYST%7=#\/:EI_B;5=;OM1MIWU&&".2&&V9 AB#
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MV&VXSN 7&<]#CIC&KXDG8ZSI%BEY<9F$SM86I*27 "@!C(&&Q$)R>>20.>E
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M(S2[902L?][ ZC/&1WXH ;=>&=+NKJTNA ]O<6D1@AEM9&A98O[F5(RO X/
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MV\L<-G+Y]N\-Q(DL<G.6$@.[)W-DD\Y.:B'@CP^++4[/["Q@U,AKM#/(?,(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ'8$8.#[_2JMQJ_B"RUBWT:XEM[BZOA-<QO:6X!A@01C;AW 9MS_ 'O0'CT
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M<';C(SUS6I0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]@L[>\6!8I7MU'.!SAMH)&>>E64T72XK]K^/3;1;QFWM.L*ARV,9W8SG'&:
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MG0UTNF:+I6C)(FEZ;:622MN=;:%8PQ]3M S4M[IUCJ42Q7]E;W4:MN59XE<
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M&Y33;-;B%=D4H@4.B^BG&0/856'A;P^MP]P-#TT322"5Y/LJ;F?^\3CKR>:
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MZO;[5+LVWFI S9/FL"3L7 (53A0,G' ZXAT'[4OCVPU1].UDVTFA/ \]Q:%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ ZUS-CX)M=.B%K!JNKG35!"V#W(,2K_=!
MV[]OMN]JZ:B@!  JA5  '  [4M%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 445F:]KUAX;TJ74M2>1+:
M/&YHXF<Y)P/N@XY(&3@<T :=%4M3U.#2K7SYDGE);:D5O$9))&ZX51R> 3[
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M6BPR16.19Q3ZN[K; @CY,Q>A(!.2 2!@&@#G;![_ $SX>^.=1M-6O4N[6^U
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MK>CW7B?3(8(;_4UC^R"^1L) GW0^WGDF1QC^^/2@#K)98X(FEFD6.-1EG<X
M'N35&_N[A],2XTFYL"6DCQ+<,3$4+ -@J>N,X]\5Q'B?4-7TJ7P]=>*KJUM[
M!;Z1;BYT^,F*(F/$+.) W\6[DC RIZBLCQ!9^'K7P;<W>E7YO;:;7;6X6XD:
M,Q"4S1^9Y)50,8ZXXSGWH ]9GN[:U*"XN(HBYP@D<+N/H,]:PM7UZ[T[Q?H&
MF*EM]BU$7!ED?.]#''N&.< =.N:Y/Q/J.G6/C+7K:_U'32-2T:*".._N5A$)
M)D P6X*-G)VY(('!XJ$:7H]IJOPUTE9K"]MD@NE9XMICN&$ !? X;+#/?)H
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M!LOF6D_G:==MN)5M_$6T^_1L'V.* .H\+^(!K=C*L\MFVH6DIM[L6DF^+S%
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M9K35(K/[(+9IUO82R D, 596SMP#G.XY]L&K&F>(-,U?2?[3M+N)K,EOWK.
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M [J6)*D[ER,@=#BL_P 7>(5U+P6=2TB[N[9K?58+5]K&)MPN$CD0XZCDCTH
M[G[- +@W AC\\C:9-HW8],]:#;6Y+$P1$M]X[!S]:Y.2\N;?XK3P^?=2VO\
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M#:H7$;*Z_+U.TCJ2<\UL:7HMII=DEND43$.TA81*HW,Q8X ^Z,DX'\^M4O\
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MVN:0MY<:?-I\_F/');2L&*,K$'YEX/3^G:M0@$$'H:;%%'!$L4,:QQJ,*J#
M'X4 <KI5A?Q_$+Q+>364T5E>V]K'!<;DPQC$@;@'(^^,9%87@_1]1TR"QT'4
M?!UHT^G2*JZR5A:*2-#\L@_C$A'&,<'DD5Z510!Y?<^'-=G\#^+M#73'%Q-J
M,]W:NTJ;;A6G$JA><@X&/F P<>^-1%UB\\=_VXV@7L%F^B/:@2/%YBR&7< 5
M#]P#T)[9Q76/KVCQN4?5K%64X*M<H"/UJY;W$%W L]M-'-$V=LD;!E.#C@B@
M#S5]!UL_!+3]!&DSG5(1:H]OOCR/+F1V.[=MQA3WKHH;._;XHR:J;"9+!]'2
MU$[%,>8)6<KC=GHPYQBNLHH Y3QC97]YJ/AB2RL9KE+/5%N;AHV0;(Q'(I/S
M,,\N.![UDZOIM_IOCB^U$^%U\0:;J<,2_)Y1DMI4!7!$A V,"#G/!%>@T4 >
M>I::YX6\5MJ5IX?%[I^HV,,$MMISQH;26(OM #E04PYY&.1G Z4W5].U>S\5
M6^NS>&8=;M;JP2UN;6 QL]I(CNRE?,P&7#E21CIGCI7>WE[:Z=:27=[<16UM
M$,O+,X55'3DG@5.#D9% '"SZ3?KX@\&3P:&EM:V,EU)<Q6GEK';"6-E48R,G
M+#.T$9R:Q-/AN]5\-^.]#M=/EEFOM8OH(I3M\I=^%+,<\;<YZ9..,FO52,@B
ML:QTW2/"L-W*MQ]FBN[DSS/<W!*M,YY.6/!)QP* ,33='U#1_'WFI9RW&GR:
M/;68NPZ (T3/G>"=W(88P#^'6K7Q#L+[5/",MGIUG)=W+W-NXC1E7A)D=CEB
M!T4UU50W=Y;6%L]S>7$5O!&,O+,X15'N3P* .*\5:?J$7BC3?$,&@#6[/[(U
MI=61\OS8LL'61 YVDYR",U6GT_5])U[1?$5AX:7[,L%Q;7.EV1B62W61D97'
M(1FR@W8/?J<9KT*.1)HDEC</&ZAE93D$'H13J /(TT_4=:\,>-H[2R9KU?$J
M7(M=Z[CY8MG*YSC=A3WQGOWK1U70]9\3ZYKS_P!EW%A;:GX?6RAFGDCRDH>0
M@.%8D9W#IG@\X/ [C2M!LM&FOI;/S@U].;B?S)6<-(0 6YZ< #CTK3H \_TJ
M*_O+"4W7@"TLK^WM)5E:00E;ARA'EQ%3G:YZDX&..<Y%6R\+:G;V6NZ9I0OX
MM$N](EB@L=1D#&WN6! 2-LDA,'GDC.,$\X]*JM'J%G->RV45W ]W$H:2!9 7
M0'H2.HS[T >=7.F:U':^%=8/AEK[^SK)K&]TN9HFEVLL?[Q,DKD-'TSD@]N<
M6+S2M5MM3\/>)-/\-I!#9SW!N-*MO+681S(J^8<$(T@*Y(!Z$#/&:[V74+."
M]@LI;N!+J?/DP-( \F 2=J]3@ G\*LT >?6-QK6B7OC'7&\-WDB7,\$]O"9X
M5:11%&C9.X@8P2>W%=W;W'VJQBN8T9/-C$BK(,$9&0#Z4Z:&*XC,<T:R1G&5
M<9!_"I* /*['3?$UQJ7A34=0T*[^W6-Y/]O=KB+8-\3H#$H? C&1T /LQJLV
MC>);7X;S>#SH-U<W=I=QM#=QR1>5<1"Y64-EG!#8SD$=LUZ[10!YX+/7-)UC
MQ7$-&NKVUUM?M%M/"\>8G,(1HY 6&,;1@C(Q4.B:1K5M?> #<:/<1II6ES6M
MXQDB(C=DB5>CY(S&>GJ*])HH \TM=&U'3=7U?2[KP?:ZM#>WTUU::E((FC59
M6+E9@WS?(2>@.1TJQ=Z#J \4#5-&M;W3-0;4$%V%=39WML& ,CKD@-L'& &R
M.F#D>AT4 >>6F@ZA;>+(-2TBUOM+::_D.J6KR!K2>+YOWRC)Q(WR'Y<').1U
M-5O"VC:AI20>']0\'VL\EG/^ZUEUA:)X@^5D/\8D XQCJ,Y KTRB@#R*XT7Q
M);?#O6/!PT.YNKA;EWM;R.2/RKB-[CS<DLP(;D@C';KCFO6XV9XE=HVC8@$H
MV,K['!(_(TZJUUJ%G8M"MW=P0&>011"60*9')P%7/4DD<"@#S2#PUXAC\'Z?
M:)ICK>Z'KC:@D32IMO4\Z5L(0W'R2<;L<BNJL]-N-0\?#Q*]K-:6\.F?8D2<
M /(S2!R2 3@+@#GJ2>PR>JHH Y3QA8ZA-J7AK4+&QDO5T_4#+/%$R*^QHG3(
MW$#@L,\UC7.DZQ+-\0R-*G_XFUJD=EAX\2L+?RR/O<?-ZXXKO;B]M;1X$N;F
M*%KB3RH1(X4R/@G:N>IP#Q[4ZYN;>SMWN+J>."",9>25PJJ/4D\"@#S3^R-6
MTG4M*U.7PL=9M9M(M[&ZM?W336LL6[##>=I4[R#@]LUZ#HUN;728(38V]C@%
MOLMN $BR2=O'&>>2."<FK<$T5S!'/!(LD,JAT=#D,I&00>XQ4E '!^'-/U+P
M-=ZGIG]F7-]H]S>/=V=Q:[6:+?RT3H2#P>C#(.><59\5:?K6K0:3JEI9$2Z7
MJ4=XMBSJ))HPK*XSG:&PQ(&<<<G)P.JBU"SGO)K.&[@DN8 #+"D@+Q@YQN Y
M&<'KZ59H \_UG1+_ %C4=>UR&PN$,V@/I=M;OM629V+,21G"@$J!DC^+MC*Q
M:7JHOOA_(=+N FEV\B7IW1_N2;?RP/O<_-Z9XKOZJ7FIZ?IVS[=?6UKO^YY\
MRIN^F3S0!Y9XAL]0T_PGXLENM/FB%WXCMKNV#,G[U#+;J,88X.4/7':NCUG3
M-8U37KC7]+L?)N+/1Y[6T6["@SSR$$ C/W5V]^"6] 372ZKI6F>*=.^RW,AG
MM1(DA$$Y7+*0ZY*G_=/Y5JJNU%7).!C)/)H \UTW3M9C\66NKOH.HB.30Y;2
M9[BXB>7SBZ-R-Y !VD #CV44RPT/6K?PSX LY-)N!/I-VDEZN^/]TJQ2(3G=
MSRXZ9KTZB@#A=3T*<_$6$VDB#3]5@$VJ0]RUNR^6P_WMRH1W"UVEW]H%E/\
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M,#R"* .5\-V>H0>,_%5[=Z?-;V]_);/;R,R$/LA5&Z$D<@]0,BN3@\.>(8/
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MFQKD<_*3NYZ\9QZUT&H^%M1N+C0]0M=7C_M/3))F::ZMS(DPE7#C8K*5QQM
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M<Y P,+QP.M===Z]>V/CC3M'N([==/U"WE>WGP=YF0 F,\X^Z2P/L1CO61+X
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M/'Y>7_>?>QSD<9[&I;7P+GPEJ_A_4K]9X=1N)KCS8(3$T32.7XRS9*M@CZ4
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MBDO N/,*L1SR>1C!/<@F@ \4Z^OA?PY>:S):2W4=LNYHXF4'&<9R3T_,^U;
M.1FO&_$%P?$OPF\5ZQ>7%P+R*ZGB\I9V58%CE"K&4!Q]T G(Y+9],='>M>^)
M?%'B+0DU#[))9P0BUVSR1L@>/=YRA&&XASCG(&T#N<@'42>($C\7P>'FM)0\
MUF]VMP6780K*I4#.<_,.N/QJ]I]U<W4<[75C)9LD[QHKNK>8@.%<;3P&'.#R
M*XJT\X_$3PV+F]6]F_X1Z</=1KM$Q\R'+@=L]?QK*CAU>^\"^(+BRU'47O\
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MO91@;B2!QG'J34OC-;B3Q7X1M8M0O;6&[N9XIUMIR@=1 [8..^1UZCJ,'!H
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M)G6V;<9VN=IE<H)6R2X3.T-R>0,\U!_PB&A?V>;#[#_HAG^T&+SGV^9G=O\
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M(&.SH&QZ>_0UA>(_$CZ=XET?0UN[?3QJ*2N+NX3<"R;0(DR0-QW9Y[#&"2,
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MJ2(/F RV[L,XQ[C.5<7EO<^%/ATR;\V^H68DWQLI0) RN3D= 2 3TSQ7J=%
M'F<,L=G%X[T?7D)NKZYGGME923=P21*L:Q_WR-NW:.0<4S0+.73O&OAB'5V1
MKRT\,-#/+)@[)M\7!;^]M#>Y )KT^B@#C?A?M7P4D(&TQWEW\A&-JF>1EX[
M@@CV--\02QCXG>$27&(XKT2'LA9(PH)[9P<9ZXKM** .4\53^&-8BNO#NLRN
MTWEB00(LBN<_=,>!\[ C@#//:I= O9]$\.^&]-U^:9]5N8E@)V-(3($W$,PR
M <#DD\FNFHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5:3?V&GWMK--+;ZA<-;V[K;ORZE@<C&5&4;DX%;.1G&>1VKR;PEJNIZ5X/\
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M<>9BXG2WC\N)G^=NF=H.![G@5;KF?&.K:AI)T%K&:.-+K5[>TN%:/<6C=L$
MGIT]/RH Z:DR 0">3TKSS4=7\2R:GXT@M=7AMH]&@BN+;;:*Q.8F?:=Q/!(P
M3U],=TAOK_6/&WA"[-_/!%>:))=O;QA"@8^23U!/.['/(QQCG(!Z+17 66N^
M)M<L[+6M'BD:"2\99+>7R! ;99&0X;/F"0 9],Y&,5%9:GXKOX_$EVNM6L4>
MCZA<P+%]A#"5%A5E!.[(P6!ZG/.>,8 /1**\RM?$7BFTLO!NN7FH6UW9:VUM
M;7-HMJ$,;3)E9%8').>HZ<\ 4L/B;Q%;Z1XAU^[U.WDM=%OKRW^QK:!?M 3Y
M8\OG*88@]^,\^@!Z92 @C(.1[5Q-Q)XKCFN/WUPNFR6$K/<3"W62"<#*F((6
M!4\\,"1QR:H^';S4;7P)X/\ ^)N56\@C,S,@>Y8>3D)"H0[CN )+ D+DY[@
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M=9U;7?\ A)I-+O19MH]R]I;Q&)7661(U=C)D9VDMM&TKP,YYXQ+O4KCQ1?\
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ML_,BDCZ-\TQ!/)SD'.37?44 >;R^&Y+B/7%FTKQ4YUJ%(;QC<V!+!5VY&9,
MD$]..> ,"M#4[*ZU73=-LI]%\2*NGSQ7$<B36 =WC.5+9D(Z^@%=Q51);XZM
M+$]M$+ 0JT<XER[29.Y2N. !CG/>@#C[W3[K43<1W>B>(IK*XN8[E[1Y;$H'
M0J0%/F;@"4!(SZ],FJ%[X9DN6UJ.#2?%%G9ZR'-[9P3V/EO(PPSC=(2I/?!
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M,$9QUP?7I^M;HY% "(NQ%7<6P,9;J?K6+XD\-6_B>VM8+J\N[=+:YCN4^S%
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M]LXQV-% '.OX1A&HW]Y;ZG?VQU&...\2-D/F[$V!@S*65MO!((]>O-22>$[
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MFUFCN=R3Y!R"-NY2I&.ASGCTH U:Y6Y\!V-S:Z[:?VAJ,=KK3M)<0HZ;49P
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MM:G7P_HJHZ+I%@%DB$#J+9,-&.B'CE1Z=*N6UK;V=NEO:P1001C"1Q(%51Z
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M2RMWO(T,:3M$ID53U4-C('M52#PWH5L(Q!HNG1")VDC"6J+L9AAB,#@D<$T
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M7B:WFCD/E1H>H7;L4+T(;ODUMR6%O<_%709=0L;8WDFB32S@QJ?WH>$9^HY
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MI 9?)RI(9@O.W( R >M &%X%\1SWGP^TG6=<OGGN[X'[L(RS;FPJ)&N3PN<
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M.O!]N7M-'T75O"NIKJND&-3<7&\VB&,;?-C<MM)(Z!1G)QP,F@!\_BJ[U/\
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M0#C(SSS@D9SR:\[M66[TCXBZ3'87-U=7FIW44*);LR.SPHJY?&U<'DDD8ZT
M=OJ7C7P[I%W):WNI)'/'&LKHL;N0C' /R@\9JO#XET:PBUW4;G7WGM+6YVS^
M9'\MH=B_NUPN6'?OUK(T+3+G3/B#:QS07,D5OX<@L#>>0_EM*CDL-^,=,'_Z
M]8VJV5]/X?\ B3!%IM^TNH7&;11:29F!AC3*\<_,IH ] L/$^CZIJ<FFV=X)
M+N.+SMAC90T><;E) #C/&5)I(?%.C3WT%FEZ/-N0YMRT;JDX3EO+<C:^!S\I
M/'-<KJUE=ZCXOTXVMO=Q1OH-U:?:3;2*L4DGE[ QQP?E)]L5-X-U"YFTS1])
MU#PQ>VVHZ3"L,L]Q;8BBV)L+Q2?Q;@, +Z\\#D TK#Q5H5CIOVFY\1FYAN+^
M6"*>X3;A]Q_=#"CA>F3Z=:6X\6:=K7AO79=!U1A=V%O(7(B*R0N$+*2DB]#C
MJ1@\XKA)UEL?#^GF[L;N+_BMOM CDMG#/&\SLK*I&6R#G Y_&NBU#39KW7?$
M^O6UG=+;RZ$+!$-NZR7,V7.0A&XX!1<X]?2@#H-#UV-/!^@W>HSRRW=W80RD
M1Q-+)*WEJS,$0$GD\X&!D>M6X?%&CW5G:W5M=FXBN@YA$$3R.P0X;Y%!8;20
M#D<$@'DUP*PZAI$'@_5)]'U:[L8-&73KRWLTD6XMI<1G=Y8(9AE"#CT!]*N7
MVB6<T&F/8V.L>'I\W-Q:7EG"\KPLQCR)XP&SYGWMK?W.2#Q0!Z%9WD&H64%Y
M:R>9;SH)(WP1N4C(.#S6??>)]'TV29;N[*+ RK/((G:.$MC D< JG!!^8C@@
M]Z/"SZG)X7T]]8@C@U Q#SHXUV@'L=O;(P2.Q.*XR"UOM/TKQIH-[IMY<SZC
M=74]E)' SQW"3KA5+@;4*GY3N(P #TH VO$WB,VWB31-#C>\BBOO.>>:VMW=
MMJ1Y4(0ISDL"2,XQSC-;]BDNC:&HU;5?M1MD9I;V95BRH)(+8X&%P">^,UQH
MTV\TKQ!X M9(;NY&EV,UO=W4<#NBL840$L!W*G^M;_C[3;_5O!.HVFEH)+W]
MW+%&3CS"DBN4_P"!!2/QH O6WB72+JYN+9;ORI[>$7$L=Q$\++$<_O,.!E>#
MR.*+7Q+I-W=K:QW3+.\1GC2:%XO,C'5DW@;@,CIGJ*Y+73=^//".KPZ;H-YI
MU_-8&'S=0M_(D9MP;R5)Y*G# G[O(Z\XL7*S^)]9\)W\-A>V;:9))<W9GMGC
M,0,14Q#(&\EB!\N1A2?3(!LP>._#5S):I#J:O]JG-M$PBDV&4,5V%MN%)((
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M ^UEEMG,3A)RIP=C8PWX$\<]*Q(DDN?B9>7DMA>QV4VA1P&22!E7>)'8INZ
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MJ(RPSQ;MP!P0058D@CUI;OPWJCZGH>KQZA!<7^G+.LHGC*I,)MN[;@DH%VC
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M=\4_^2=:E_UTM_\ T?'78UG:YHEEXBTM]-U 2-:R,K.L<A0MM(8<CGJ ?PH
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M;6SW$_F7,# -"T19E\@+QM8': W7(.<YQ6<-<U*+4_#]S!J=Q>0WNLRVD]P
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M/\0V>EF4W=C(=ES" ^QT/5?FW#'7D].UG2WEMO#G@RRCU*[87-BLC64)_?7
M$*8"OD;$0G))(Z@9YP>MMO#FGV_VYI%EN9KZ/RKF:XD+O(@! 3/90">!@<D]
M36>G@/1(XM,2,7J-IH9;:5;V42*C *4W;L[<*HQVP,4 <,MYJ&M^'_ ]S?ZA
M=?:3X@EM9'1PN]4-PJEL#!8"-><>OK6]-<>(?$<_B"WT:^2TNM,NQ:VK/<E
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M+TFQT6U>VL(%AB>:2=E7N[L68_F?P&!0!SGQ5_Y)=XA_Z]3_ #%5[B_U"_\
M$4?ARVD\E8=(BNOEN3 [,S,F00C$A=HXX&6YS6[JWA/2M:U*.^O4E=UA^SO&
M)2(Y8]P?:Z]"-P!_0\<4S7_"&D^(KFUN[Q;B*\M<B&ZM+AX)54]5W*0<'TH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4456AU&RN+V>RANX9+JW"F:%'!:,-G&X#IG!Z^E %FBJ9
MU;3Q?_83>0_:L[?*WC.[&[;]<<XZXYZ5<H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N1TM57XI^(L #.FV)..YWSUUU9L&B6UOKUUK"23&ZNH
MTBERP*E$)*C&.,;F_.@#S!IKC_A2]QJ&6_M8ZT9MW\0N!?A1^. !].*]AK'_
M .$9TW[89]C[#<_;#;[OW7G_ //3;Z]\=,_-C/-;% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
D% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ljb_employmentxageementx011.jpg
<TEXT>
begin 644 ljb_employmentxageementx011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\2ZT?#WA
MZ[U46WVDVX4B+?LW$L%ZX..OI6M7/>.-/O-5\&ZC96$!N+J14\N(,JEB'4XR
MQ ' /4T 1P>)=1M]6LK#7-%6P%\[16UQ#=B>-I I;8WRJ5)"L1P0<5IVGB'1
MK[4)-/M-4LY[R/.Z&.9688X/ /8]?2N>O+?6_%6IZ4MSHT^CV-A<&[>6XGB>
M21PC*BH(V8 9?))(Z8[UDV?A[6KG2?#>@OI;Z<^C9$NI>;&4?$+Q9BVL7.\N
M&.X+CG.30!V4?BKP_,UTL>M6#FU0O/BX4^6H."3ST!X)[&KEUJFGV32K=7MO
M 88O/D$D@79'G&XYZ#/&:\_GT/6M2\%+X='AN&UN+32)+,7<\D9#2;%4"$J2
M0KE<DL%XQWZ3ZGINL>(=0U&^G\-W,5O)ID5O';RWD<<KR+/YAVLC,%(ZJ2<$
MKS@4 =6GB33[N&VFTV[L[N*6Z6V9EN578Q!./=NGR\$YJ2'Q-H5QJ)TZ'5[*
M2]#F/R%G4N6&25 SR1@Y],5QEGH?B&XG@DN(+IK>/5K:XC>^^SB[\M8W5VD:
M([6 )4+U;K[5FZ/+*K> =(^Q0NME>2!;^*XC=;@+;S N@4EP"<%MP7#8'- '
MHMAXFT+5;L6FGZQ8W5P4\P1PSJQ*\<C!Y'(_.J6L>(-0L_$%IHVF:3%?7$]K
M)=%I;OR%54=%(^XV3F05BZ#X:U'3].\!Q262Q2:7'(+T!U_=%H&4]#SER.F?
M6E\8:%+?^+=-U"7PY/K5C#8SPM'#/%&4D:2,J?G=,C"MTSUH Z)=>%A8"X\2
M?8=(D:0JBF\$BL ,\,57GKQCM5NRUK2]1%N;+4+:X%PC20^5*&\Q5(#$8ZX)
M /H37*VFBRS7GAM[?PY-I=II]_-++!<31.5#6[J'&UVSEV ZY'7&.:IW?AS7
MK33KN_TFTC_MBWUBZNK.-I%"RPS94Y.< 88/@\Y04 ===>)]!L88YKK6+&&.
M5G1&>=0&*':^.?X2"#Z=ZC_X22T36;^SG:*&VL[*"\>[>4!"LC2#Z #R\YSS
MFN/N_".H:)JEK+IT>J75HFDQV'_$OE@63S$9F)?SN"K[\D@YR.0>*@_X0O5[
M>%!#8B1+6RTK;;O<JXF:WGED>'<<= RX) !./? !W<?B?09=.?4$UBQ-FCB-
MYO/4*C'HI.>#R.#3X_$>BRZ7+J::K9FQB;;)/YR[$;C@GL>1Q[BO/_$MMJ$M
M[-KTVBR01W-]I4$5A-)'YD[1SL2S;6* G>%&3_#S@5-JWAS6]7O;C78K&[L\
MZA:W"V*2PBX=(HW0ODEHP^9 0">D8Y!Q@ ]#T_4K+5;076GW<-U 25$D3AAD
M=1QW'I7,3^-KDF&&PTA+BZFU:XTQ(Y+KRUS$KL7+;#C(0\8[]:M>#M+N;+^U
M+NZ@O87O;D2 7L\;RN%15W,(QM4G&, G@#)SQ7/OHFN:?<VE]%I$UX;?Q'>7
MQAAFB5FADCE56!=P.KCC.?:@#I+#Q4?MEY8Z[9+I-U:V_P!K8M<"2%X,D%Q)
M@?=(P00,9'K6Y<7D%M8R7LK_ .CQQF1G52WR@9R ,D_A7+6MOK%YX@N_$E[H
MKV_D:<UI::>T\;RSEF#L6(8HN2J*!N/<G%==&28U)382!E3V]J .;T_Q=)JG
MAZZU.TT:\::*[:TCLV&V1F#A 6S]P<Y.?N@'Z4D/BJ]E@U"'^Q'DU6RN8[9[
M6"?S(R9 K*WF;1A0&RQ*Y&.AXS'I]KK>C:3JTEM81SW4FK37,=N\B@RPM)D[
M3G 8KG&['.,XK,TC3M7T?^U[S2O#YMM/N9H"FD2RH)" ")I%VN45F!7 +8.S
MG!- %R?QO=16;*NCH^IQZHFER6WVO]WYCH'#"79R,,/X00<C'%7].\3RR7>I
M6>L:?_9]SI]NEW)Y4WVA&B;?@@A0<_NV^7&>F,UQEYX2U"739A;^')5TMM8M
M[N+1?/B#K$J$2M]_8NYCG:&]^I-;_A#0KG3O$5]>V^B2:%I<ULB-9RW"2-+.
M&/[S",P7"_+UY].* -OPYXEB\0V%[>?99K.*VN9("MR-KX4 [F4_=Z]#R.]4
M-"\;1:WH>IZB+&2W>Q0S""1^983'YD<@.. Z_D01VJA=Z%K4GA[Q!IEO"T<F
MKZLX\U9$S':R% \G7KL#8'7..*@N_"&KZ7J33Z?>7>J0WNF3:=<I<>1'Y2JA
M,! 14! 8LO<_/Z"@"_;>,]2CLM.U+5M 6TTN^,(%S!>B8Q>;@(74HI )902,
MXS5F'Q7=WGB.YTRSTN"2"VN?L[SO?*CG"J798]N2%W$=>2#6(MEXAUKPKI?A
MB?P_/IT,:VJ7=W<W,+ )$49@BQNQ);9@9  SFEU+P_=WMY+:P^%K>TO&U5+M
M=:A,841B0.7)W>9YA4%"N,$GKB@#JO$NN2Z#I\$]O9K=SW%W#:QQ--Y0+2,%
M!+8.!D^E8]SXVNM-MM:&JZ*+>\TS3SJ BBNA*DT?S# ?:"IRA'*_G57Q7X6U
M&XT81BXU#Q IU"VG>RG:!,1))N=4("#D<?,>PK$F\(ZE-9>)!I'AV31K:^T:
M6U%E+=1LUS<G[C85V5<#<,EAG=[4 =;'XHU.TO;"+7-#2RM[Z58(;F"\$ZK*
MPRJN-JE=V, C(S@<9IMIXS>YNK25M,,>D7MV]G:WOG@LTBE@"T>/E5BC ')/
M3(&:JW,6N>)9M(LY]!GTJSL[R&[GGNKB%V?RCN5$6-VZL%R3C !ZU1M-%UF*
MRTC0'TJ40:5J!NS>^;'Y<T2,[QA!NW;V)4$$ ##<],@'0+XN@;QLWAW[,X0(
M5%WO^4SA1(8<8Z^6P;.?6NADD2&)Y9'5(T!9F8X"@=237FA\$:^OAQ-374KI
MM>2[_M?^SLP>3]I)R8]^S=C:3'G?C\*Z+5/"=_J]K<1MXCU!(KIU=K6XBADC
M1=VXQX55)7^$Y8Y&0<YH BM/'T%]H=YJ4&GSDQZ@NGVL+-M:Y=]FQN1\@/F
M\] ,^U)=>-KNT@E@DT9/[7BOK>S:U^U_NSYWW'$FSE3SU4'(/%9$/A7Q';VV
MISSRK>SQZY#J-M"$2+[0J! Q!W$*64$ '&"H[&HM=\/:MK@OM4ET&9UN=0L6
M_LUYHA*UO!DL2=^P$EVP-W0"@#J].\33OJ%_I^L:<-/N;.V6[;RI_M$;1$L,
M@A0<@H>"/IFI_#7B-/$MO?3QV=Q:I;7;6P6X4J[@*K;BI&5SNZ'GUQT&#X2T
M&XT_Q/=WUMH4FA:7+:".2TEN$D:>8-D281F"X7(ZY.[IQ6CINAWXC\0Q/=7&
MG->:HUQ!<6QC9_+V1C(W!@,E6&",T /U'Q'JL7B:;1=*T6&]>&TCNI));WR<
M!W=0 -C9_P!6>XZTT^,HF\%Q>((;&5Y9G$$-DS@,\YD\H(&&1]_^+ICFN<UG
MPM,?%C75_P"';WQ-:G3(;9+@SVZ/YBR2EMP+QCHZ]!BC3O"/B"XAT/3KN:?3
M+'3GN+R-H)8YGA8N5@@RX8-LC9LL01TP>,T =++XPB/A?3-8M+1IY-2DBA@M
MVD"!97.-KM@[=I!!X/(Q@FI+#Q7!-H^I7VH0?8WTRX>VNHU?S1O4*<(P WYW
M*!P#DXQFN2G\)ZU9V]UI+6\^L:(FJ)J!C>2)'NXW5C+%@;5^6;$F"%5@<5:T
MWP;J<R%[>5M"L(=0:[LM,EB2<1_NU&6 ;:/GWN%!(!8'J. #K_#6M?\ "1>'
M[35?LKVOV@,3"[;BF&*X)'TK'M_$VO:C=ZBFF>'K6:WL[N2T\V;4O++LF,G;
MY1P.?6JOAGPMKEMX5L;*^UV]L+F"65F2T2$95GR%;<K@]SD8^]CM6*GAHPZM
MK4NH>!;S5'N=1EGBN8;J!5:-L;>&F4COU% '4ZWXJOM%6YN9-#=K"RCC>[N#
M/M^]U$2E?WFWOROH,GBB^\67$6JW5K8:2;V&RD2*X<7 20N55BL28/F%592>
M5ZX&369XLL]5UNSN+!_#+3N\2OI=VD\:&RF*_>D)?*LC<@H&R!CZY&J^#+[?
MK]N-%74+_59(Y;36 T:_9'\M%+'+!TVNI<; <Y H Z@^)=;NM:U6QTK0;:YB
MTZ=8'FFU#RBS-&DG"^6W&' Z]JL:AXKCT[6M)TE[*>2ZOI5CD9 ?*MR49AER
M,,3L. .<#/'?,LO!%G=^)/$.HZSIRRFXO(WM93(?FC6")2<*>/F5NO\ *MCQ
M%I]U?WGA^2VBWK::FMQ,=P&U!#*N>>O+*,#GF@""Y\1ZC<:K>V&@Z1%?FP*I
M=37%WY""0J&\M"$8LVTJ3P ,CFDU'QA#IG@[^WKK3[N&4HVRPE7;,T@SE/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,O'OW#AMPYC89(Y(]Q7*S:!?GQ7'J^E6=UI5\VH#[:Z7"&UO;4-RSIN/SE,
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M?1_L:7QM=26R-V;.6Y-L0D,@?9\_.0"W' ..,XS6)9Z+K-OI'P_@?2I3)HS
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MHI$"1O/@X4,P8@-D<#IB@#H=-US2KKQ'?R[M2MKF/3H)[B.\W1Q11'<0=C'
M8?-N..W6K$/B_3Y+G3HY8+NVBU,?Z#<31@1SG&X 8)*DKR P4GZ\5AZIX:U'
M6/$_BA&MY+>QU314L(KO>A <>9D[0V['SCMV-,71M8UO2O"VG:CIKV4NCWD%
MS=3F1&C<P*0/+VL2=YQU P,YYX(!MZ9XTL-8U-K&SL=3<I<RVLLQM2(H9(QD
MAV_AST&>_ID9OZQK]MHD^GQW4,["_N5M8I(U!59&^Z&)(QG!_+Z5E>";#4-/
M.OB_L9+7[5J\]W"7=&WQOC'W6.#QT-7O&&BOK_A:^L(&V7902VK]-DZ$/&<]
MOF44 -C\663R:W&;:Z1]&4-=*ZJ#@KO!7YN<KR#_ %JM<>.;&WU233/[-U:6
M^CBBF>"&T+LJ2-M!X/(!!R1Q]:Q8O".K'Q)IVJR-&/[1@_XGR!N"Z.)(@OJ
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M\MTC+97YAE<C[O7C&[O4D?C+5[;P[J<][$L\NF:PVGW5U:6S-M@ 5C-Y62>
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M?7PQX9O-6,0E:$*L<9. SNP103V&YAGVK,N=:U?2/%>DZ1>S6US#J\<RPSI
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MF :<^A^#;74+2PFT31TNKS>;>,V,>9-@RV/E[ U;_P"$1\,_]"[I/_@%'_\
M$UDG6M=L_$7A33;\V9_M."X:[$<+*R21H&PIW$8RV.G;WQ571O&4M_K<EC=W
M<-I>6TLQN],N("DJQ+NV/$Q/S@@*21G.>U '0?\ "(^&?^A=TG_P"C_^)H_X
M1'PS_P!"[I/_ (!1_P#Q-<_I?B+Q-JO]AZI:Z9YNF:B5:XB*(OV>%URKJ_F9
M8CC(V\Y. *[F@#&_X1'PS_T+ND_^ 4?_ ,35BS\/Z+IUP+BQTBPM9@"/,@MD
M1L'J,@9K M-:U[7;-]4T7[$8(]1>V%K.I!DACD,;L7SPW#,!C&, YJ"7Q/J]
M_I/B'5](-JL6CW,\$=M-&6-QY(_>98$;<G<%P., G.<  [>BN#M_%&M:[XBL
M[+2IK*ULK_0TU.*2>W:22(LZC! <!N#[=>^.:T?C76F\%Z!XDD%G';278MM5
M_=,1&GFM$94.[@;@.#GAO:@#T6BN3U;Q+>:<EY<1B*6%KV#3K)/+Y,KLJNQ.
MX!@"Q&..4(SWJG<:CXY2#6DMK&!C!;BXT^>XA \YQG="R)(3GT;@<\T =Q17
M,Z1XBEU^71I=.GA>UGL?M=VQB.X9PJ*/F^4EA)US_JR*Z5MQ4[2 V."1D T
M4]5U?3]$LC>:E=QVUN&"[W/4DX 'J:NUXW?SZG=_"'Q+/J%ZEV_]J/&"8MAR
MEXJ\G)XP!@8X]Z[BRU;6T\:WF@7L]E*'TX7UM+%;LHB/F%"C N=XZ'.5[]*
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M!4?+@\=Z /2Z*XSP=/JEQXE\6?;+])X8-1$*)Y.TJ/)C( .[@#)XQR><UV=
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M&X''RYVYZGO@5LWGB7Q'>IJ4_AW3Q=-87K6J6[(NVXV$"3+EQL/WL<=AG.>
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M4[<DA20!N.<?CD 'HU%9VAW<E_HUO=275K=&4%A/:?ZJ1=QVLO)ZC'&36C0
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M6FG3)[81;5:(DL2#G(.2?P_.H-#\(7VCP+;R^);V_M[>,QV45S$F( 1M!8J
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MK4[ZU'I5YIDUM-);O.LP=7A8*R*0&'.?G'! K7H Y;1_"5SH6C:9IUCJ[;;
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M &16NI8O(DE<EB\?]TY/(]C5:+PGH5O!;0VVG1VZ6N[R# 6C:/=C=AE((R%
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M^4'&<# K2J."&.W@2&(%8T&U1DG _&I* "BBB@ HHHH **** "BBB@ HHHH
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M!;1ER%&2Q'0#W-<WX8N="UW6X]8T_3=66_BM6@FGO_M"F!20?*_>'#'//RY
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MF",^66\X,$SC&=N3CTH Z5=<TM["WOTOH6M+EU2"8'*R,QPH4]\]O6M"O/\
MPKI5[8^()_#LT>=(T.=KJRDSG<LP/E1_]L\S#G_8-=Q?Q3SZ==16TGEW#Q.L
M3_W6((!_ T 54U_29+Y+-+^$SR,R1KNXD9?O*IZ,1@Y .1@US=]XAN=7\5ZC
MX=TK5UTZ>TM8WBE\I9/,G9GRK!@?E 0=,'YCSQ7.16T^J_#GP[X=BM9[?7["
MZM$DC>,AK9H9!OF)QC:5#$-G#;@!DFNFTF0#XK>(7*2".6QM(XY#&P1V0RE@
M&Q@D;AG% '3WLXM-(FFNKZ&T*0G?=. $C;'WL,<8!YP36'_PEVG:8/#MC=ZB
MM[<:G%N6[6/8LBK$6,N!P Q P/\ :]JU?$9 \,ZJ""V;250H!))*D  #J2:X
M&T\VSM/AA>2VMV8K.V:"XV6[NT4AM=@5E R#N&.10!Z$NMZ:]\EDMW&;AW:-
M%YP[J"64'H2 #D \8.:O,RHC.[!549))P *\UTI;S3_$]D-(N9;O3+G4)S<Z
M7>0'S-/8^86FC? (0DG&>#OX/-=YK:PMH&HK<023P&UE$D46=\B[3E5QW(X%
M $/_  DNC>5-*;^)4@B$TC/E0L9Z/R/NG!^;IQ4ZZQIS75I:B]A,]Y&9;=-W
M,R 9)7U&.>*\ZMK76'TW7M$M[QM<TY]"F6RO)8-EQ"[ JMO(<#<2.>0&&.1R
M*+'4!J&L_#YK6VOMMK9W$$\C6<@$4A@1<-E>S#!/3WH ]"_M_2O[02Q^WP_:
M7=HT3=]YUZH#T+#NH.10^OZ5'?I8O?PK</)Y*J6X,F,[,]-V.=N<^U<+X)O8
M&T;2/#6KZ)=/KNE3_.LUHY1&5C_I E(V<@D@YR2<#KFD\(7L,>F6OA;6]%NI
M]<L+]Y0);1VC9O-9Q<B7&T##9SG.<@ DB@#NIM?TFWOX[*:_A2XDD$2JS8!D
M(R$STW8_ASGVI_\ ;>F_;ELOM<?GO(8E7G#. 25!Z%@ 21G(Q7FVE1V$B3^&
M/$6D:O<:O%J,LT2!K@07&9FD28.IV*!N!)..AX)XJ[:K>6'BN%M&N9;FQN=6
MF%YI%Y =UJQ9]]Q$^ 50G+<Y4[\ Y- '>1:WIL]ZMG%=QM.Y9449^<K][:>A
MQCG'3O3!K^DM?)9B_@\]W:)%W<.XZHIZ%A@Y4'(Q7!:+'J%IJ]C:Z+>2W.E7
M1N&:SO8#Y^D2%'.X/@'86.T!NH;@FJ,5I<ZC\+=+\+"VG@\1VEU;QF-HVW0R
M1S M/NQC;M#-OS@[L=3B@#T1_%GA]+];%M9LOM33BW$0F!;S2,A/K[>X]:M6
M>M:;?W @M;M)93'YJJ,_,F0-Z_WER1R.*Y'1HX&\7>/)9K-Y$E>!T)B(\Y4M
MPIV,1SALCCH34/@Q;^PUVUT^VO9-5T(6#F"6Z@V7.GX*8A=L#.1V(W?)Z#D
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M@YJ^C!T5AG##(R"#^1Z5YKIWVO3O$]J=(NI;K3+C49VNM+O83YE@Q\PO/&^
M0A.>N0=_!YH U/"7C.">S^S:[J]K_:4FI7-K K;8RX25D0 #UVX'J?6NENO$
M&DV5V;:YOX8I0R(P8\(S_<#'HI;L#C/:O+FB8?#F\C6UG%RWB8W 00-O*?;
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M61E4 @@\@BN6\:SRSWWBS3DL+J"6;1ML$EM:-(VH'9)\K/M(54)QC@G=U[4
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M[G( .>0#O/\ A,O#7F1QC7+$M)/]G3$P.9,@;<_4@?7BK>HZ[I>D'%_?0V^
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M700QK+,B($4D$A510.2HR3D\=:U*P3XE^>PM%L)1J=ZLKI9R.%,:QG#,[#(
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MW08Z'!/I@9K-D^)T,6FG59- U--*ANWM;N[8QXMV63R\E0Q+#/4KD#/4G(H
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M$C=)AGYH3(&..<G(X'3'UH [RBN!\%>)S;Z/X.T>ZTVZB2_TR-;:[9E*R/'
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M,4ER1NB944KP/O\ R\ 9R2.O2NRU2T?4=&O+-2$>XMWB!;HI92.?SJV5!(R
M<'(SVI: //[?PYX@_L[P5!/:6:OH<J&?R[DMN1(#%E<J.23G'8=ZBOO!NN7C
M^(Y[=[>UN[C4[?4M-D=RZAX50!9 !P#L/3/7VKM-4URQT>:PAO'D5[ZX6V@V
MQ,P:1N@) P.AZGM6C0!C:%-XANE:;7;2SL2%VK;VTYFW'NY8J,>RC/?)/&,B
M\\-7]SXOUBXVP'2]7TQ+.:3S2)(BOF X7&&R).N1C!_'L** ..\+P>,K"TMM
M*U:#3C;6$8C%[!.2]VJC"#RRN$)P,DD]\#G(RX_"6M_\*?N_"K0VPU&5)HU8
M3YCP\K."3C/ ;'2O1:* .4FTK5)?&VCZQ]FC%M:6$UM*/.&[>Y0\#&"!L]1U
MJ;P7I%_HVGZA!J$<2//J-S=IY<F\;)9"X!X'(S@UTM8NK>*=,T9Y5NGF80!&
MN&AA:00*Y(4OM' .#_/I0!M5PFL^$[S5-?34X;.*QU2"\C:#5K>?:7M@REDE
M4??)4,H!R.G(Y%=W10!YMK'A/Q%-8^,])LK>R>VUR0W$-S)<%2C-&B%"FWU3
MKG&#^%7SI'BG1_%$NL:5:Z?>1ZE:PQ7MK-=-&(98@0KH^P[EP>1M!KN0P894
M@C..*6@#A[K1O$^E>*EU[2DLM2-Y9QVNH6\\QMP'0L5D0A6^4;F&W&<>II=0
MTGQ58>([7Q#I:V.HSRV0L]0M)I3 IP[.K1M@XVEV'(Z>]=;J>HVVD:9<ZA>,
MZVUM&9)62-G*J!DG"@FGV5W%?V-O>0$F&XB66,D8)5AD<?0T <AX@\-WGB"U
MB@UC2[6^80EXY[:;RI;2X+$CRW(!V@;1GJ=N=IS@4=9\&ZGJVDVUG?V\5YJ5
MK811VFLQ7!AGAN@"&<MC=LSM/&2>>*]$HH XVRT/6=!\57^JVXCU*+5+:!;D
M-((G2>)-@<9&-K#KW!' -4+'P7J.CW'A$6ZP3II<]U<WK^9MW/.K@A!CD N>
MN. *]!HH *J:JES)I-VEG'#)<M"PB2?_ %;-C@-P>#WXJW2,P498@ =S0!YL
M_@6]ATOQ+:Z-:+IUGJNG&WCTUKG=$EPVX-*N,A%P0,#KZ# K6ET'6I=>\.7T
M<4,2Z=IT]M*YEW%9)%0 J,?, 4[XZUVE% 'FVE>%O$L.J>%]0O+/3OM6G&=;
M^X^UL\ER7CV^:24_$+[XR!3KGPCKEQX'\6Z.(+9;K5[^>XMR9_E5)&!&XXX(
MQV!KT6218HFD8,54$D*I8_@!R?H*Q[7Q3IM[H=EK%K]IFL[R58H6CMW+$E]@
M)7&5&1R3TH MWL=S<:%<1)"/M,ENR",OP&*XZ^GO7'6WAC6H=(\#6AMX#)H4
MB-=$3\,%A:/Y..?O9YQTKT"B@#SO4/!NM:A-XHFB>"TN+R^M;_3I2^\+) J
M"0 < E.V>#[5?OX?'&L^&+V-H[#2M0*(L45O=,XEPZER9-H,>5#*,9(W$D],
M=5J&HPZ;%#),D[B69(%$,32$,QP"0!P/4]!4E[>0Z?8SWEP7$,"%W*(SD*.I
MPH)/X"@#SR?PCKKR>*#;Z;IEK#K.D)9QPQ7!Q#(%D7GY!G_69)]L<]:UTT+5
MCKOA"\:WA6'2K.:"Z_?9.YT105&.0-F><=:ZG3=0M]6TNTU&T8M;7<*3Q%A@
ME6 (X[<&K)8 @$@$G SWH YOQ5IVL7UWI#Z?';W5E#.YO;&>8Q+.I4A22%.0
MK<[2,'\*Y>'P=XA@TZ&T-M88A\2_VLOESD P^87( *\'D #VZBO0K;48;J^O
M;.-)Q):,BR,\3*K;EW#:Q&&XZXZ&K= '*Z=I]UIWC+Q%K-^MO#I]_%:I&[3#
M(,893N!X&2XQR:J^ =#&F?VC+'<^?81W$EMI@QQ%;ARS*#W_ 'A9<]Q&M=5J
M.FV6KV,ECJ-K#=6LN-\,R!E;!R,@^X!J:""*V@C@@B2*&-0J1HH554=  .@H
M XWQZ\T>L^#7MXA+(-8R$+;=W[B7//KC./Z56U?P5J6LOK>K1RQ6.JW,EI)8
MJYWK$;9MZ>81U+,3G&<#'6NQOM'T_4I[>>\M4FEMFWP,Q.8V_O+Z'WJ]0!P^
MJV/B[Q+X-U>PO['3[*ZNK1K:*"*Y,BLS=9&8J-H'91GJ<GIB[K>B2:SI.G6&
MI:);:A9B(BZ@:4"2.0!0KQ-QR/F[J<'\*ZNLZVURQN];O-'A>0WEG&DDRM$R
M@*^=I!(PWW3TS0!QVG^$==T:X\/:JMR-0O+"">SNHIIOFDMY'W(%<CETPHYQ
MNQU%-U;P9JEYI^KSPQP?VAJVJ6MY)&9<)%' 8]J[L<L0ASQC+>@R?1** .0G
MT_6;;QCJOB"WM;8QOI"6T"S7&W,J,[C?QPIW@9SVK>T*]N=2T.TN[VW6WN98
M\R1HVY0?52>H/4>Q%7VV-E&VG(Y4^E.H X;PGH_BKP[;Q>'62Q?2+24F#4?.
M/FM!N+",Q;<;N=N[=@#GDU5A\'ZQ;>$=5\&JL#Z?=2RBVOC)S%!*Y9@R8R77
M<V,<'C)%>AT4 <KI.A7NG^.=0U 01KILUA;VD)\W+@Q%^2,=#N]>U<GH6EW_
M (C\":UH*0)';7FK7D;W9D&$C^TL7^7KOX( Z="2.E>JLH92IS@C!P<53TW2
M;#1X7AT^U2WC=S(R)G!8\DX]3W/>@#FK/0]6\/:]KLVFV\%W8ZLRSQJ\VPV\
MP0(0W!RAPIR.1@C!JII/@R]T'5/",=J(YK'1K*>VGE:3:SO+L)95QTRI.,]^
M]=[10!YIXA\)^)M7BUZ!H-/NGGO8;BQNYKA@T<*/&WDA=AV?<;)!YSR#706&
MDZQ8>-M6U8P6LEIJ-K;[]LY#QR1*X*@%>02PY)'':N@M=1AN[R\M8TG5[1U2
M0R1,JL2H8;21AA@]JMT >:Z;X*UO3_#_ (6D5;;^U] N9I/)\X^7/%*6#J&Q
MPVUN"1U'XU:U[PAJ>M6GBB\2&&*_U>QCL+>!Y>(D7<=SL!U)8\#/ '/)QZ!1
M0!R?]CZI)XUT;5FMXEM;33I;6;]]E@[E#D#'(&SVZU+XDT.^N/$.A^(-,$<M
MQIC2QR6TC[!-#*H#8;LP*@C/![D5K2ZY8PZ_;Z([R"^N(7GC7RFVE%QD[L8[
MCC.:T: /.]>\&:IJFF>*+B"*!=2UQ[55A>;"11PXV[F .6/S$X!Z@<XS7H4;
M,T:LZ;'(Y7.<'TS3J3<-P7(W$9 H \[@\&:O#X)O/ [+"VG22ND%_P";RMN\
MF\ADQGS!D@=CP<CI5_\ X1S5[36/%36L%K)9:M;1K S3E71E@\K:1MZ9P<YZ
M=C7;44 <%:>&M9@3P&KV\'_$AB,=V1-][_1S#E..>3GG'%2>&=*\6^'D7P_L
MT^71X)6-OJ/G'SA 6+!#%MP7YV[L@#KSC![FB@#F?!^DZAI+:Y]OAB07NJ37
ML)CEW_(^,!N!@C'N*K>(=+U^V\56GB/P_%:W;BU-E=V5S*8A)'NWJRN <,"3
MU'0UU]% ''W6D:[>>)?#&J7,=JWV W+W0CEP$\U-JJF1EMO<G&>N.PR+CPAK
MDWA_7[98;9;FZUU=5ME:?Y619(VV,0/E;$9[$<BO1ZJ66HPW[W:1).IM9S _
MFQ,@+  Y7(^9>1R.* ,!M*U:;Q[INMRV]NMM#ITMK,$FR0[NC<9 R!LQGC.>
ME5_#FBR:/X6O-"\1"Q6QDGN$1_/_ ->DLCOR"!M.&QC)Z&NRJEJ>CZ;K4$<&
MJ6%O>0QR"5$GC#JKC.#@]^3^= &!\/=+N+#PS%+=W37<TX CG88+6Z?+#^:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<746M[3=Q2LNW*J%4KM4$$ #'/;/6H8/ EHMY875WJVK7\EC#+;Q?:9EYCD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***X[XAWDEG9Z(')73)M7MXM1;^$0G/#_P"P7V YXP<'
M@T =;-<0V]O)<32I'#&I=Y&.%51R23Z5SU[XI>+5/#$5K;1RV6MLP$[.0Z 0
MM(,+CN ._P"%<EX@TU+;7?%EC8V\0TB7PT]S<VRH/*2Z!<1L%Z!BJD\==H-0
MK:Z9<VOPSMH$MS!(Y\Y("%#,;)BV[;W/&<]0>>M 'K ((R*0$$9!&/6O');E
M?#^D>([6V(M=&MO%$4<ZHF8[>V=(BXVCHFX\@<8)'>E\6:7H\'@OQ==Z9J\-
MVD]O#+)!9!5MX7# !P%) 9AG/KC)H ]CS17G?BSPYI7ABWLO%.F6*1OIM^MW
M>,,LTL+CRY6.<Y(4A_JI/4UEZ/:M'K^I>&YM/2.T\0R1ZK"HBXCM\_O8W]#\
MJ#'8R\4 >FQ27YU6XCEAMQ8"-##(LA,C/D[@RXP .,<U:!!Z$&O.9H+>+QKX
MWB%V=/B?0[<O<)U@R)@7 [8&#^%8UY>ZKH6D>(;.;2;:VU>'2XI?MVD\17-J
MLFUG"C!1PK/_ $/ H ]?!!S@@XI:X'04\-V^N'7M.\061A?3SY\-FJ10>4I#
M"64 _*PSC)P<9'8UW-M<P7EM%<VLT<T$JAXY(V#*ZGH01U% $F1G&1GTI<@$
M#/)KQK5[[37NH=1LYX8G3Q;%')-<R W3$2A) #QLB R ISE>N*T[:X\/ZZWB
M>U\27:0ZG;ZJQB<2!+A(5*M;F ]<$ 8"]2Q[MR >I$@8R>M%>4WU]IFHVOC]
M-<:V_M6T>9+6.Y*[XH1"IA,8/3+9;*\EC]*ET9[6T\4>#IKEH88Y_"S(SR$*
M)"/(."3UP,_A0!Z-J,E_';H=.AMY93*@<3R% (RPW$$ \@9P*MY [UXK"UK-
M\-;%HW1O(\4J$VM]P&^.!CTV_I72PZ#I>K?%7Q(E[;+.(K6PN(T9VP) TI#X
M!ZC _,^IH ]$R,XR,^E&1G&1FO(_#']FZ]9:+?WNMPVWB*UOP;B**-5NVGW%
M7B?)W%#DY&,!0.@7B_H?G:7XGTE+RUM-1L[^YN&T[6;7Y9PS+([1SJ>3QN&0
M>JC(% 'IU8?B_79_#GA/4-9M;:*Z>TB,OER2% 0/< _E^HJEX[N;&#2].BO@
M[+<ZE;Q11^:(XY)-Q8+*2#^[^4Y&#G '>O/KNXA3P1\3K*.YM62.9GCCML+&
MH,498HN3@;B<^^: /2;GQ#<V_B[1M&-K$8-1MIYO/\P[E,80D;<8Q\XYS^%=
M#7$ZH1_PLKP7R/\ CPO_ /T&&I_B3>W%AX42:-G2U-[;+?NA(*VQD'F'(Z#'
M!]B: .O!!Z'-&0>AKSV_TZ&T\?1P:5%''IUYHT[ZC!  L1"E1$Y XW'+ 'N
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MCW(N&!YN"L43)O/\6#TSTH ]/R,XR,^E4-;UJR\/:-=:KJ,ACM;9-SD#)/.
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MKB/!MXWBF>WUF\L1;SZ7;FP:-H\;+G/[_'^R-J $?WF%2>-[IH=:\*6]T/\
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MU_X/TRXL[26T@,.U+>4Y:/:2I7/< @X/<8-;M !1110 4444 %%%% !1110
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MTR7QGH$&CSZK+?%+2WF^SSEH7#129 VNF-RG)'4#J/6@#2&E:<)H9AI]KYL
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MG6,]U'<S6=O)<1?ZN5XE+I]"1D5#_86D>3)%_95CY4K;Y$^SIAV]2,<FK]%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3D@$=!GIP<UDZRUY#:?$71Y=4OKBVM=)2[@:6;]Y&[QRE@&&#M)C''3J.AH
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M,T9"W,"@,!L9A\T>#SR2M 'IE%><>(-0UM[OQ9;13WT5_;10MHB6@8JY*9Y
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M11))&?LDA#Q.4884G@CD5YPEF5\(?"^.*YG1IKFV;S"^]DS9O]W=D#V'0>E
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M/2NJ.K:<)HX3J%J)97*1H9EW.PZ@#/)'I3[G4;&RDBCN[VW@>4XC6655+GT
M)YH Y"7PO>SVJV\NAV,B+=K>[F\071<S+C:Y8PY.-HP"<# J9M U![S4;N30
M-,DEU* 6]WOUNX998P" I4P8'#-T'<UU-WJ-E8;/MEY;V_F'">=*J;C[9/-4
MF\2:4OB,:";R'[?Y/G&/>,J,@ 'W.<@>@^E '.IX7O4BTR,:%8D:8_F6I;7[
MHE&QMR28<M\O'.>..E6]/TC5=,N[^YMM#TP27[^9<^9K4\@D;&,X: @< #CL
M*WM9UBQT#2+G5-1G6&UMT+NS'&?8>I/0#N:<NKZ<=.2_:^MDM7 Q*TRA,^F[
M.,T <CHGA&X\.WC7.F>'=,B;+&.-M<N'CAW?>\M&@*IGV'MTK3U.QUO5U@6\
MT?3BL$JS1B/6YX_G4Y4G; ,X(SS72Q2QSQ)+#(DD;C*NC AAZ@CK69>>)-+L
MM=M=%FO(4O[F-I$C9P,*"!SSW)  [\^E &1KVD:KXETTZ=JNA:7-:EE<QKK4
M\>2#D9*P \'FN5\1:+XCFUN.YE\(RZ@JVR6\,VG>(Y('C4%B1(S!&?)/<''X
MUUWA?Q0^HI?QZO<V,-S%JMQ80*A\OS1&0!A68DD^U=!=:C8V+QI=WMO;O*<1
MK+*J%SZ#)YH X>Q\,:VT%BU_IL,[V4YN+,7/B"X:2V)7&TL(?GQEN23PV.E3
MZSX4NM>U.'4KWP_IHO8D\OSK?7+B%G3.=C%(!N7V-=U5,:MIIEEB&H6ADB!,
MB><N4QUR,\8H Y#5O"-QK-S:7-SX<TN.XM(_)BEM=;N(&$?]S*0#*^U6ET/4
MH]4M]2BT'2XKFWMOLD)CUJ=52+CY H@VXX';L*Z@:C9'R,7EN?/_ -3B5?WG
M^[SS^%<]X<\4M>3ZQ!K%U802VNK26%L%/E^:JI&PP&8DM\YZ4 9O_"(W)T@Z
M5_8%A]B-Q]J,?]OW7^MW;]V?)S][YNN,TFH^#Y]4U@:K=>'=,^V%!'*\>N7$
M8G4=%D"P@./][/ITKK7FNAK\,*W5F+0V[LUNP/GLX888<XV $@\=2*G34;&2
M]:R2]MVNU&6@$JF0#U*YS0!RYT+4_P"T;V_&AZ<MS>PK!.RZ[< ,BYPH AP,
M9.,8ZFJZ^%;I+72K9?#VFK'I6?L>-=N08U(P5SY.2I'!4Y!%=A_:-C]M^Q?;
M;?[7C/D>:N_&,YVYSTJGHWB/2M?:[&FWD4_V:9H6*.#DKC)&.V3C/M0!8L=*
MM-.N+VXMU<27LWGS[I68%]H7@$\# ' Q5MT$D;(2P##&5)!_,4R:Y@MVC6:>
M.-I"0@=P"Q R<9Z\ FJW]MZ2;:.Y_M.R\B1_+27[0FUG_N@YP3[4 0:)X=TW
MP[926FF1RQ02.TC*T[R?,QR2"Q)&3SQ5(^!]!.E/IAM[C[&]S]K:/[7+S+NW
M[L[L_>YZXS6S=ZC8Z?L^VWMO;;_N^=*J;OID\U2N_$NDV6N6FCSWL*7MS&TB
M1F0#"C R>>Y( ]>?2@".;PKI%Q>7]W+#,\U_:_9+EC<2?/%@C;C=@?>/(P>3
M5FQT2SL+MKM/.EN3$(?.GE:1Q&#D*"Q/&3GU/?-1:1XETG7'O5T^]AF%I,T,
MA60')4#)'/W<G&?4&K4.K:;<6TMQ!J%K+!#Q)*DRLJ?4@X'XT ,NM'M+S4[/
M4)A,;BTR82L[JJY&#E0=IR..0:@UGPUI>OS64VH13/)92B:W:.XDC\M_[PVL
M.:OV]Y:W;2+;7,,QB.V01N&V'&<''3BN>F\23V?CV?2;V:SATM-+%Z)G^1E8
MR[,,Q;&./0=: .=O?#EQ<>)-3N+WP]K+RW$X,-YI6K^1&T:JJIO7S4(8!>3M
M/MGBNJTSPM!;SZ?J-])<7&K6EN8!<-=2-\A.2IY ?H,DC)QD\ULRWUI#9B[E
MNH([8@-YS2 )@]#NZ8IHU&Q,$,XO+<PS'$4GFKMD_P!TYP?PH Q;GP+X>NM>
M?69+)Q=RE3,(YW2.<KT,B [7Q[@^]%]X&\/ZCKC:Q/9N+R0*LQCG=$G"]!(B
MD*^/<'T-:LFLZ7%:PW4FI6:6\W^JE:=0C_[IS@_A4UW?V=A$);R[@MXV. \T
M@0$_4F@#//AC2S>ZE>>7.)]2C6*Z87,@WJH(  W87 )'&.M1)X/T:.'284AG
M$>DD&R7[5+^ZP-H_BYX)'.>*;XK\3VWAO0?M_F0-)*\<=NKN '+NJ[NO*C=N
M..PJUHLFJ2?:7OKG3[JV9P;.>S#+O0CG<"2,@Y&03D>E %%/ OAZ/7Y-9CLG
M2ZEE$TB).XB>4=':,'86SSDCKSUYI\G@O0YK'4[*2WG:WU24S7B&ZE_>N0 3
M][C@ <8Z"M;^TK#[=]B^VVWVO_GAYJ^9TS]W.>E-EU73H7VRZA:QMYHAP\R@
M^8>=O7[W(XZT 53X;TLZO:ZJ8I3>VT MTD\]_FC!W .,X?!Y&[.#S6E/!%<P
M203QK)#*I1T<9#*1@@CN,5#?WUM8P;I[RVM6?*QM<.%4M^)&?IFLGP1K=UXC
M\'V&K7JPK<W D+B$$(,2,HQDD] .] "Z'X+T/P\)!I]K(%9#&J33O,L:'JB!
MR0JGN!UP,]*DT[PGI&EFV^S0R^7:LS6L,D[O';D@@[%)(7@D#T!(& :TKC4;
M&TF2&YO;>&5QE4DE56;Z GFD.I6 29S>VVV XE;S5Q&?1N>/QH R)/!&A2Z9
M?Z:]O.UIJ%P;FZC-W+^\D)!+9W9&2 <#CBIY_"NEW,EPTRW$B711KB)KES',
M4"A2RDX/"KGUQSFK\VJ:?;Q^9/?6T2>7YNYYE4;,@;LD],D<].14CWMI'9_;
M'NH5M2H;SC( F#T.[IB@"A_PCFF?VQ=:LL4J7MU&L<SI.ZAPHV@[0<;@"0&Q
MD#O54>"M"71+'2%MIEL["83VH6ZE#PN,X*N&W#[Q[]ZUUU*Q>WBN%O;=H)B%
MBD$JE7)Z!3G!/TJ)M;TE88IFU.R$4N3&YN$VO@X.#GG!H S;[P7H>H7MQ=SV
M\H>YMQ;3I'<2)'*@!"[T!"L0"<$CC\!4@\(:*O\ 916VE4Z4ACM"+F3*(0 4
M)W?,ORCY6R.*T[O4;&P,8O+VWMS(<()I53<?09/-)?WUM8P9GO+:U9\K&UPX
M"EOQ(S],T 8T7@7P]#KTFLQ63QW4LOGR(L[B)Y?^>ACSL+9YSCKSUYJW!X8T
MR"XCE"3.(KA[J**2=W2.5MQ+JI) /S-QT&> *I>$?$K:MX(L==U>6UMGF#F5
M@=D2XD91@L>.@ZFMMM3L$LTO'OK9;5\;)S*H1L],-G!H GEB2>%XI5#QNI5E
M/0@\$5@0^"-"M[;3K>."Y$6FRB:T!O)CY; ;1@EN0%X / '%;\,T5Q$LL,B2
MQM]UT8,#]"*@GU*PM;B.WN+VVAGDQLCDE56;/ P"<F@#-?P?H<RZLD]F9TU;
M!O4FF=UE(  .">" !@C&,#TJ30?#&E^&X7CTZ.8;P SSSO,^T=%#.20HR< <
M<U3_ +:U#_A8;Z#_ */]C.E&\C;8=X?S F"=V".IX ZT_P %:W>:_P"'OMM^
ML*W NKB B!2JXCE9!@$D]%'>@#1UO0]-\1:7+INJVJW%K)@E"2"".001R"/4
M5F#P-H/]C-I3P7$EL\J2R&2[E,DC*05+/NW'! P,X&*V[B_L[3/VF[@APAD/
MFR!<*.K<]AD<^] O[,V\-P+N#R9B!%)Y@VR$] IS@Y]J */_  C>F'5Y=4>*
M5[N:V^R2,\[L&BY.TJ3C&23T[FJD/@C0K>VTZWC@N!%ILHFM ;R4^6P&T<EN
M0%X / '%7!?M=:G8-8ZCITEA+'*70-NDE88 ,9!Q@?-G@U<.HV(O19&\MQ=D
M9$'FKYA[_=SF@"K8>'].TR]O[RVCD$U^X>Y+S.XD8# .&) X ''850T7P/H'
MA^^:ZTVT>%LLR1F=VBA+?>,:$E4SD]!T..E;$FI6$,WDRWMM'+N5-C2J&W-G
M:,9ZG!P.^*L.ZQHSNP5%&69C@ >IH KZEIMIK&FW&G7\*SVERACEC8D;E/N.
M1]:YV\\%V5G:7%[H]J9M92P>TMWO+N5PX(.%D)8[AGUZ=L5TEI?V=^C/9W<%
MRBG:S0R!P#Z'!IL&I6%T[);WMM,R\%8Y58C\C0!P&@^%I8)[(66E>(M&>V>,
MNUUK'FP%%(W($65PP(!'*J!G/&,5V>G^&M*TVVO[:WMV:"_D>6ZCFE>59&?[
MY(8GKWJY%J=A/*(H;VVDD*LP1)5)(4X)P#T!X/H:6TU&QU .;*\M[D1G:YAE
M5]I]#@\4 8^B>"- \/K*MA:/LD0Q;)YWF5(SU10Y(53W Z]Z9H_@70-!,O\
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MS^,O#LAO;&2QF\/2VZQQ#,**&B(B+'.\J,[L],9(6O7L#.<<T@10  H&.G%
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M9[=C7+>*/%L^C:ZVG274.F)+;*UA=7<!:WN)R6!C=\@)C"^GWL^U4;O^U/\
MA97B-M)N+6WG71[5_,GB,HX:8@!0R]?7/'H>P!Z)5"\U33=+NK:"ZN(H+B^E
M$<*'[TKXZ<=>!U]JY>T\4ZEJNB^';Y'MK*/4K(SRLJ&:7SMJD)'$.6'+$GG
M';K6/<:Y/XD\.?#O6+J*..XN=;A:18\[0PCG!QGG'% 'H5KJ^GWVH7EA:W4<
MMU9;1<QH<F,MG:#VSP:NUQWA_P#Y*=XR_P"N-A_Z!)6AKVN7-IK&G:/91L;F
M\BFF+J@<HD>T' +*"277OT!XH Z&BN!O==\::?X2GU:YL+6*;3KIOM,31Y-U
M:*03+&!(0C[<G:2>0?:GZOXIUBT^'-[XJLY;"3=MGLT:(D"!F 4,0_+X()[
M\8/6@#NZ*XDZWXETWQG:Z-J3Z=+!JMM-)92PP./L\L8!*."WSK@CGY23V%9F
MD^,/$<OA72=?O3I[KJWDV]O:P0,&2=Y,;B2^&7:"=O'.!GO0!Z317"W/B#Q7
MI=KJ\USI$D]K;^2]M<I"ID*,X$N8E<EBBY88QG%(WC23_A%Y=:LKV'5+ 7J1
MFZL[9F>WMRJ[VDB!SO5LY&!@$''&" ==J6KZ?H\44NH74=NDLJPQES]YV.
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M?VFGRVE[XFO=100-!;&XB0>2K#;N.T N^.-S'UXY-)%X+,-GX:MEU([- *F
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M>$6[/&2I,8Z)P?NCTK+U#1;Z&TB\/Z'86-OH4\+Q7$C2L&@5N"(X\$'()QR
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M4A$*B0*5:,#C;AMQZFJFKVCS6WQ*F;4-2#Z8?/LMM[*/)<6JR C#?WNQR!V
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M89O[Q&!U]!Z5<71--74O[1%JIO##Y!F9BS&/^X23RO?'KSUH QOAQ!%!\.]
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M^,X1+LA758PIEDSC=!'A<D^IP!]!72>*KR'3_"FJW5Q>S6,4=LY-S"NZ2+C
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MN]8L9+B<RDAW9CO4C.,*V0!_#C [UZ8N@:6E[:W@M%^TVL?E02EF+1IW4'/
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M669IF-Q</,0S8S@L20..GUJ_3401QJBYVJ,#))/YFG4 %%%% !1110 4444
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M;HHX'RCIUQS71W.OZ39WB6ES?PQ3/(L0#-@;VY52>@8\8!.3FO+M+A>#X?>
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MCVESHWV:/6+1[BSE-T')945RKJ%^48;@Y/3D \4ZP\937N@WEZ=,6*_M;[[
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MEL=<\9]JP])\%^(M*T_PQ;>?IDZ:4)DGMY7D,3EVRDJ_+RZ\X!'<X(S7HM%
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M+['?6C2.D9 8NC(^TG*DD<KR#VK3\,Z%_85G>>8ZO=7U[+?7!3[HDD.<+GG
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M;R6&C64UK(TDC+)*9-A+A0I Y3.,]_:NM@TO3[6[EN[>QMHKF;_6S1PJKO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME);WTJ11C]W&=Q8+MQM9&C .,YD'/%1P:YXCDTOQ:;<O?W>G:N(((XHT5_(
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MM79ZYHEIX@TQK"\,JQ^8DJO$^UD=&#*P/J" ><BJI\,6TD=ZUQ=W=Q=WEO\
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MRN[J6YGA3:TLK[W(R< M@;B!@9P,XS6E0 4444 %%%% !1110 4444 %%%%
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M+!;0100K]V.) JCZ 5+110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC)(=0S;2#N(.#Z$^E: TW5-#\5Z3K]KX?'V%["6QGT_3_+#6FZ42*P7(5LX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKS>V\1ZO+X7\)>,+^YFC@6X^S:M%&Y6*1&=HEF([ .%;C@AO0"M'Q7>ZA;^
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M! EU%$+1;)E6[EP\*EL*WS<_>;GJ <9Q3=4\#>']7N[2ZGLWBGM8A!'):SO
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M:*\=GY8=K9P&),F&R0V. <8Q0!:;PQI;7^HWICG%QJ,2PW3"YD&] " ,;L#
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MM+A91<:C8)):(L3-YRBU*$K@8P&!!]*ETA[9_%_@R65 OD^'G1C-&5,;_NL
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M?W=K"L\\<+(-BMG:,L0"S;6P/;DC(R:!JFH:D^I1ZCI\=H]K=M#&8IO-61,
MJV<#!P>1V_2LM=*U/1?'&JZS9VOVZRU>"$2QI(J20S1 JI^8@%"IYP<@CH:
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M#I*J:GJECHVGRW^HW*6UK",O(_0"N4N_%L\/C"31+BZBTV?[3"MG'=0'R[V
M["Y23./,R7 'L.#GB]\2/^2:^(_^P?-_Z": .FCD66-)$.4<!E/J#6/J'A3P
M_J-^=0O=+MI+K: \V-K,!T#$8W >^:P+7Q!JNCZ]96.IRVLVGW.D2WB+!"5>
M P[,KN+'>"&ZX'(Z"I-*USQ1J$VAW\>G"73-00/=+B-?LR,NY&1O,)?&0#E>
M>H Z4 =+HVH:7J-B3I$L,EI [6X\E<(C)P5 QVZ<<4^+6-/GU>;2HKI'OH(Q
M++"N244G )[=:\^T+77T/1-06W5#=ZAXMNK&W,@)17>=OF8#!("ACC(S@#(S
MFM32HKN'XPZDMW<I<'^PX#&ZQ[#M\Z3@C."<YY&.,?6@#NJ*XS7I]3'Q*\-6
MEO?K%:2VUW*T)BW L@09/(R<.0/3WS5.?Q?JUQX1U/Q9IWV8VEC--MLY(SF:
M&%RKDOGY6(5F'&!P"#UH [>^OK73+&:]O9T@MH5+R2.<!0.]/M;F&]M(;JW<
M/!-&LD;@8W*1D'GV-8GB.YCOOA[JUW%GRY]*FD7<.<-$2,_G7+:1K/B#0;7P
M;]L>QN-&U2*"R$44+++;N8<H=Q8AP=ISP,=J /2:JZEJ-II&G3ZA?S"&U@7?
M+(03M'K@<UQUAXE\2ZQ!I.L:7IOGZ=>7 $L++&NRV)(\P.9,EQ@$C;SR !C-
M;/CK5[[0/!6J:MIQ@^TVD)D43QEU/J, C_/:@#1.KZ7;ZE!I7VJ%+N:)IHX!
MP2@Y+>@'/>I-,U:PUFU:YTZY2X@61HBZ9QN4X8?@:YG5CN^*/A-CU-A?'_T3
M6+X=UN71O#\\=O%YES?^)[RTAX!"DRR,3@D9^5&P,CG% 'IM%<%?^)O$V@Z-
MKEWJ.FJ8K:6 6-W(%4.DC!7:1$<X\LG).1D>G)JW'K>O)XIUC2HGLKNWLM/2
M[BD>,H6D</MC=PVU>4SG;]T^V2 =A)(D4;22,%1069B> !WJMI>J66LZ=%?Z
M=<+<6DN[9*N<-ABIQGW!KE?#_B>_N_%EOI%Q/!=0SZ5]M,T4#(JRJZJPC8\/
M&=_!&>G4U)\*_P#DG.F_[]Q_Z/DH ZN[NH;&SGN[F01P01M+(Y!.U5&2>/84
MMM<PWEI#=6[AX)D62-P,;E(R#^1JAXDO;K3?#&J7]D81<VMK).GG(60E5+8(
M!!YQZUS+^(]>FO\ PA:VLMC&-:L))YGD@9C&ZQ(V0 PR,OTXZ=: .KGT:PN=
M5M]4F@+7MNI6&7S&!0'J ,XP<#/KCFEU/1[#6%@6_@\Y8)1-$-[+M<=&&".1
MV/:N'D\6>(X_!.J:HILY;O1-2FMKPK;MB>"-P'=5W?*P0[L9(X-=%>:SJ$B:
MG=:1)93V]K9*\1F.Q'F92XW/G 4(48\?QCD4 ;\TT-I;/--((X8UW,[G@ =R
M:H+XCTA]/T^_6]0VNHRI#:2!6Q*[YV@<=\'K7/Z1XCO+SQ)J&C33)=6ZZ9'>
MQ7 MVB)+,RL!GAD^4$,/S/6L/P[K-_HWPW\ &S,'EWMQ;6<XDC+-L?.2IR #
MQW!ZT >D7U]:Z98S7M[.D%M"I>21S@*!WI]K<PWMI#=6[B2">-9(W QN5AD'
MGV-<+KNL7_B#P]XT%A/#!::9'<66UXMYF=8=TF3D8'S;1CN"3GI73^$_^1-T
M/_L'P?\ HM: -BBL#Q!KDMAJNB:1:[%N]6G>-9)%W+&D<9=VQD9.  !ZG/;!
MYG6O&6MZ-;>*[(FTDO\ 1[1+ZVN&A.R:%@>&4,,,"I&0<'@XH ]%HK*T0:P8
M99=5N;242E7@6WB9/+4J,JQ).XYSSQGT'0<A>^,M:MO!GBK5%-F;O1M3DM8L
MPMLDC4IC<-W7YSR#VZ4 >B45QMYJOB*X\:ZCH-A=:?;Q1:='=Q326S.REG==
MI&\ _<Z\8]#5/2O&U_KNF^'H[>WV7VI:<]].T**WEA&1"%5F Y9\\DX Z'.0
M =]2$A022 !R2:\_;Q%XQMW\/VM]:6-G=WVH36<OF)N#HL;NDJA9#MR%&4)S
MD8R*BO=8UF^\%>.K&\NK8WFDK<0_:8H"HEC-N)!\NX[6^;&<GI0!V5AXBTG4
M[][&TO%DN5B$_EE&4O$3@2+D#<A/\2Y'O6I7!Z3JEW"WAC08Y;?[9=Z9]H:Z
M^SX,4"*@"*,G+%F'/3 /%4M2\;Z[8:5KL(6R.J:+J-M;2.T3>7/%.R;& W?(
MVU^?O#(]^ #TFD=0Z,ASAA@X)!_,=*Y*'4M='B)/#ES?61NW@EOFNH;8J%A#
MJB($+'YLDY)., <9.1%_;OB".?3-$O((%UB>WGN+B2S4.H2-U12BNR\MO4G)
M.,$<YR #IM+TBQT6T^R:=!Y%ON+^6&8@$G)(R3C)))]S1>:QI^GWEG9W5TD5
MQ>/Y=O&<YD;!.!CV!KEX-:\3I8Z>FL06NFS27,T,\H DDE51F-HHE9B2W4CD
M@*>.XYRYUO4O$>D^!]09;>/46UV:'<481[D2XCW%<Y_ASMS[9'6@#T[4=2L]
M(L)KZ_N$M[6%=TDCGA14\,T=Q!'/$VZ.10Z-Z@C(->::QK.L2>'/'GA[7&MI
M[FQTIYX;JVC,:S121OC*$G:P*D=>:V8];OB^G:%IJ.LR:1%=R2K&LA ;Y$ #
M.HQE6SU[=,YH [6BLKPW=:O>:#:S:[8)8ZF01/"CAE!!(!!!/!&#C)QG%,\4
M:G=Z/X?N+^RM9+F6)DW)'&9&$9=0[!1]XJI9L=\4 6M4UC3]&MTGU&Z2WCDD
M6)"V?F9C@  >YJ]7EWB;6UU[X<W5[:ZG::E;_P!JV8MY(E,; >=#\L@ZJV[=
MV'&.*W8]=UZTU[7M(N'L+R>VTU-0LV"&W0%C(NQR6;C*#YLC@F@#L994AB>6
M5PD: LS$X %92^*M#;3["_74HC:ZA,L%I)S^^=FV@*,9Z\5B>'_$U[>>+3H\
M\\5U ^EK?+.D#1C?OV,%)X=#D$,/S-<AI_\ R2+P/_V&[/\ ]*C0![%374.C
M(20&&#M)!_,<BJ.NW5S8Z!J%Y9F(7%O;O+'YJ%ERJDX(!![>M<=I_BO7(KCP
MG<ZG-9/9:Y9-++'# RM RP>=N#;CNS@\8&..O4@'::5I%CHEF+/3H!!;ABPC
M#$@$G)QDG&22?J:NUY]-XSU6W\':=XS86[:=<2Q-/9",[HX)'"*5?/+C<I.1
M@\CCK5[PS/J<_CSQ;'=7ZS6]M/!'''Y6-JF$. #G@ L>QS0!TTVL:?;ZM;:7
M+=(M]=*S0P<[G"C+'V ]ZNUPOC!+Q_'_ (/6PE@BN6COPDDR%U3]VG.T$;OI
MD?6JMMXVUBU-WHNI0V\VM0:K%IR36Z8CE62,RK)L9A@[ WR[L9QS0!Z)17/^
M'KKQ!+?:E;ZS9;+6)D-E=D(K3*1\RLBLV"IXSP"".*R?&'B35M$75YK::UC2
MQL/M=O$(C,\[#<7\P#F./Y0 W')//&* .LOM0M=.B62YD*[VVHJHSNYP3A54
M$L< G '0$UE?\)MX;^QPW@U6)K6;;B958HFYBJ[V PF6!'S8Y!':N=UJ:_OO
M'/@>>"ZB@6X@NI41H2^P^2I.?F&>#@=,>]9UK?3>']5^(6I736UQ;64D+O;B
MWV"5OLZE0#N(49(SP>YH ]2HKA[SQ'XCT![O4-2TXW&C06$MQ+*%CB:*5!D*
M )&)5N@XR#U)K2C;Q0Q@E-S8-:7%DSRNL1#6TV 5V#/SKR>OIGVH Z:BO-?"
M_B+5(?!?A.)Y?M>H:R&*R"(;D4(TCDY8!FX]1US@XP;_ /PDWB.Q\C3=3L8H
M;Z^U,6=A<N%VR0E2YD9%<X90I&,C)(Z#- '76VL:?>:G=Z;;W227EF$:XB7.
M8PV=N>W.T_E5VN&\-1W47Q1\5I=SI.PL['8ZQ["5_?=1G&>O3':IM?GU,?$G
MPS:6]^L5K-!=R-"8MP+($&3R,G#D#T]Z .FTW6-/UA+A]/NDN%MYVMY63.%D
M4 E<]\9'2KM>21ZOK'A[2/&NM:?+:""Q\0322P2PEVG!$(90P8;.#P<'GT[]
M5JNOZW=:EK5AH%ONN-+2,*&C1UEF9/,"MN==JX*C(YR3SQ@@'8T5P3:WXOOO
M$L>C6_\ 9VFSOH\=^R7$+3&&4R;6C)5\,.#R,=>AIR>)?$NJ6T>J:)IWVFV^
MW/";8K&H>!)3&S;S("'^4MTQVP>M '7:;K&GZN+DZ?=)<"VG-O,4SA9  2N>
M_##IZU=KRFTN/$=A#XYU+0YM/5++69[B2"YA9S<;88BRA@PV<#@X.2>W?H;3
MQ9>OXBT1KIH(M#UO3OM-HQC(=)@H<QNV['W"2.!T([4 =K167X?NKR^T>*\O
M2FZX+2Q!8RFV(DF,,"3\VW:3[DUJ4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M6-XHT >)M!FTE[IK:.9D9Y$0,WRL'&,\=5'X5LT4 8<GAPOXK@\0+?S1SK9B
MTGBC1=DRARXZ@E>2>AZ4_P 3:!_PDFE+8-=-;()XIRR(&),;AU'/;*C-;-%
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M"E]NW=COBN/U+X>+J%OKMDNM7<&G:Q-]IEMDC0[)3MW$,1G!V X]?4<5VU%
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M1HI(H_,A4^;O4*Q;&.P&,8QWS0G@R"2?Q";ZZ-U;Z\ +J Q[0H">6-A!R/E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRS>3.5C=A$W'WB <#D?,>.>M<-HUG?Q>%/AO!+I>H)-8W@:Y0VDF85$4BY;
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M]"#4]9GAZR@T_0;6VM=/_LZ! 3':9R8E+$@'D\\\C)P<\FM.@ HHHH ****
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MK+%MY+8^4$,,\9'O0!V=%<$/B2XT=KF70ITOK?5$TN\LO/4F&1V4!E;&'!#
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MWW?.H)PQSC!/IV]37144 >=:[X*\0ZI'XB@2ZTV1-1N(I[:YN"_FQHC1L("
M,*@*$@@GJ>,G(W1HNK_\)Y#KS_86@73#9.HE=6+&0.6 VD8XQC/XUU%% ' #
MP/JMQX=US3Y[JUM;J[U5]5L[FW=I/)D\Q9$# J,X*X)]ZLW_ (<\2^*/#%[I
MWB"]T^TN71?L[:<'9%E5U=9&+X/WE'RCH">3D8[:B@#D_P"R?$^L^'=3T_7[
MG38I;JQEM$%B'9"SKM\QBP!^BCID\GC&SX>M;^QT&SM-1-M]I@B6(_9RQ3"J
M!U8 G.,]!UQVR=.B@#@K[P?K-W8>-+96L%.OL#"QF?\ =#REC^;Y/1<\>N/>
MM,:#JC^+-#U9Q9K#86,MK*@F8L2^SE?DQ@;.^.M=510!SGBG1M4U2XTB;3Y+
M5XK.Y,MQ9W;,L5PI4@9*@\J3N (QD#T%<X/!'B!;*2W-QIDF?$0UE6#2)E?,
M\PKC#8)/'?'J:]&HH Y6"RET3Q7KOB/5+FPMM-NX+:+>]P5,9C+ %BRA>3)C
MKZ=<U6\":+;V,FJWUI<&?3IKJ1=-'&R*'<6<)_LF5GP>X5:ZVZM;>^MGMKNW
MBN()!AXI4#JWU!X-2(B11K'&JHB@!548  [ 4 <_XKT6_P!9ET-K(VP%AJ4=
M[)YTC+N"*PVC"GD[NOM5!O#>K?VKXNNA]B*:S;QPP S/E"D;)EOD[[L\9Z8]
MZ[&B@#@;/PEX@M)-!'GZ;+!8:2NGO%*SLL4HP//C&T;F*C&#MP.AY-,T/P;K
MNF'P<+B73I%T*&:&7RY'!<.@0;<KR1C/..N.V3Z#10!YW/X*UV72=2M VG![
MO7EU93Y[X5 Z/L/R=?DQGW]JNZOX+O-=UG7I;J6WAL]4TR.R5HI&:2)T9F#X
M*@'ENF>WO7;T4 <C96'C.XTFXM-;N=(>06SPQ-:F1?/8KM#R$CY>.<*#D]QC
M%:WA73;K1?"NEZ5>&%I[*UCMV:%BRML4+GD \XZ5L44 <S_8FJ6WCB^UNT>S
M>UO+**"2.5F5U>,N1C (P=_)[8Z&L*S\%:U:^%O"FDE]/:71=02ZE?SGVR*N
M_A?DX)W]_3WX]#HH XC3?#OBG1-1OK+3K_3CH-W=27*/,K_:;7S&+.J ?*PR
M202>,\@]*WO%FEW.N>$]4TFS:%9[VV>!6F8A5W C)P">,ULT4 <D_A_5I/$7
MAG42+(1Z5:S03*)F)<R*@ROR=!L[XSGMBL4^!O$$4<M]9W=A;ZO#K4^J6A9G
M>)TF!5XI/E!'!ZC/X5Z/10!Q>J:'XJU:PL)+FYTQKJ&]2>>P!D%K+$JD;"V"
MS')#9*XR!QQDYD_@?Q!)IFL6?VC2V^W:S%J:,#(FT*T;%2,'_GG@=>N?:O1Z
M* .5;0M6/C#4M:5;+RKG3$LDC,[[@ZL[9/R=/GQ^%95AX.UFSTOP9:%[!FT&
M3=,PF?$H\MHQM^3_ &L\^F/>N_HH \T\0Z7<Z3I'BIM0ETN-/$%]"MMY[LT:
MLP2/$F5&WA"=P/!Z9(&='PT^I67B)8KZST>62\BVM=66HS7,RH@)7>)1D)DD
M<'[S=.2:[:>WANH'@N(8YH7&&CD4,K#W!ZU!8:7I^E1-'IUA:V<;'++;PK&"
M?<*!0!C>(?#]W>ZYHVO:9)"+[3&D7R9V*QSQ2 !U+ $J1@$'!Y'2L76_!&HZ
MKI7B-XWLTU37)+?>&D;RH8X=NT9VY8\,<X'WO;GOJ* &QES&IE55DQ\RJVX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF)*@\X ]: /0**9#-'<P1SPNKQ2*'1U.0RD9!%/H **** "N:7Q%=:MXAO\
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M+H V]VA6+S5)!^5P0O(SU(/>NJ\+:_IL^@>'K?RUTZ>]L]UK8.V6"1J,A3W
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M[1%':R(K[Y' "Y ."<X!YKS'5+6P@OOB;I]C!;QQG0X9%MX54#?Y4P)"CO\
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MFVTZ6L"M-L):3>RJ.%&%&3]/:NB/BS39(].:S\Z]DU&W-U;16Z#<\0 );YB
M/O+P3G)QB@#6:TMFB\IK>(QYW;"@QGUQZTXV\# @PQD%BQ!4=?7ZUQ&O:ZFI
M)X*U;1[^X%G?ZM%&0C,@EC:.0E77ORHX/I5WP_<7+?$/Q=:R7<\MO"EDT,4D
MA98MR.6VCMDB@#J?LUOG/D19QC.P=,8_E0;6W:%H3!$8F^\A0;3]127EW;V%
MG->7<R0V\"&221S@*H&2361#XLTUM0EL;D3V4\=H;[%TFP- #@OG)P!W!P1W
M% &VD:1QB-$5448"J, #TQ4:6EM'#Y*6\2Q9SL5 %SZXK)@\5Z?-?6=K(ES;
MM?1M)9M/%M6X &3MZD''.U@&QVK/7XB:&Z+*JWWV?[8;*2<VCK'#+OV .2/E
MRW'MD9QD4 =6J*BA44*HZ # %,F@AN8S'/%'*AYVNH8?D:S)O$5I%>2VZPW$
MPAN8K6:6) RQ2R;=JMSGI(A) (&>36(/&$5[)XIM;NTO[2STH&*2XA0F0#RP
MS.-N2#A@1@< 9..P!U[PQ2*%>)&5>@*@@4Y45%"HH51T & *X\>+([&X\*:;
M9VM]>0:I;&1+F7YG,:Q;ADDY+G*DGZU?E\::5!I&JZG(MRL&DW#6]X/*^:-E
M"D\9Y&&7D9ZT ;S00O,DSQ1M*F=CE02N?0]J26V@G='EACD:,Y0NH)4^H]*P
M?^$I9O'7_".K87&Q;(733[1@[GVC'/"C#9/K].95\7Z8;VP@;STBU%S'9731
M_N;A@,X5LYY )!( ;L30!MRPQ3!1+$D@5@R[U!P1T(]Z:;:!EVF",C);!0=3
MR3^-2US[>,=*7[/*QF6QN+C[-#?%/W#RY*[=V<@$@@,1M)Z'I0!N+!"CEUB0
M,>I"C-(]M;R6_D/!$T.,>6R K^72N;OO'VCV,NJQ-%J$KZ45^V"*S<^4I7=N
M/'W0O.>XZ9K3NO$%I B&".>]=X/M(CM4#-Y79^2!@]AU.#@'!H TFMX6V[H8
MSM&%RHX'M7/Q>&I#XUO]<N3:S6]S;10+ T9+(8RQ#9/&3O/;BMC2=5LM<TJV
MU/3IQ/:7*;XI ",CZ'H<\8JGJGB2STN\:S:.XN+I+9KMX8$!9(5."YR1WXP,
MD]A0!JO%'(R,Z*Q0Y4D9VGU%-^RVYQF"+CI\@XYS6#+XWT:.73(XVNIWU.V-
MU9B&V=O-0 'CCKAAQVSS@5+:^+])N]$75$>98VN#:"!XB)O/#;?*V==V1_7I
MS0!N&-&<,R*6 (!(YP>HJ(6<$<<RPPQ1-*#O*QCYCZGU_&N0\-:E<WGQ'\46
M\KWR0PVUF5M;ILB)F\W=M )7! 7D$_I6SXQ\0-X6\*7^L):O<O;QDK&O3<>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445B:XGB2XD$.A7%A9JJ;VGNX6FWMDX0*&7 XY8YZC ZT
M;=%<%:>.KZ[\*Z'.]I#!K.JWQT\)RT2.CNLD@YR5 C8@9[@9[UN:/K<\GB35
M/#U^R/=6<<5Q%,B[?.ADR,D9.&#*P/8\'B@#H:*** "BBB@ HHKC;;Q%?:UX
MFUS2;'4+*QN=,D6..TN("[S HK>8WS ["6P-O3&2>0* .RHK)TW5A]BTJ#5Y
M[6VUB[MU9K7S K-(%RX12<D#G\!4C^(=%CMY;AM7L1#%+Y$C_:$PDG]PG/#<
MCCKS0!I45DV_BGP_=W26MOKFG2W#R-$D272%V=?O*!G)(J+7-8M8],O4M_$&
MGZ==0,J-/.R.(&)! 92PY(S@$]Z -NBJ:ZKIS:FVF+?VIOU3>UJ)E\T+Z[<Y
MQ[U&VNZ2D'G'4K0QF5H0RRJ<R#J@P>6&#D=1@T :%%<GXF\13VUAH-]HMY:R
MVM[JEM;22*!()(I'VG:P.!WYY_"NLH **S-1CUJ6]@73KFSMK81L9GGMVE9F
MR-H4!UP,;LGGM7,>#=:\4^)_#.F:X]SI:I<R2+-;K9N"JJ[IE6,OJH.,<C(H
M [JBN-\%>,8-5T+35UC5+$:S=O.%@#K&T@2:11M3.>B_H:Z.ZUO2K*[2UNM1
MM89Y&"K')*%))^Z.>Y[>M %^BF3316\+S32)%$@RSNP55'J2>E9MMXGT&\OH
MK&VUFPFNYH_-CACN%9W3&<@ \C'/TYH U:*RXO$NASWD=I#K%A)<R2-$D27"
MEF=0&90 >2 02.V:EM]<TJ[NC:V^HVLL^TMY:2@DJ#@D#N >"1TH OT5GPZ]
MH]Q9W%Y!JMC+:VQ(GF2X0I$1U#,#@8]ZKVFHQ3ZW?;-;LKBWB@C;[)'MWV^=
MQ+LP/1AC&0.E &Q164^NZ9<6=X;76+*-X8=[2M(I6$-G:[ D?+D<9P#CK3K7
M4K>VT*QNK[5+:<2PQXNUPB7#%<[D&3][D@#/% &G16<=>T=;"*^.J68M)7V1
MS&==CMG&T'/)SQCK2V6NZ1J/VK[%J=G<?9#BX\J96\K_ 'L'CH>OH: -"BJ=
MEJNGZC))'9WD$[Q!6D6-P2H;.TD=@<''KBI+R_M-/C62[N(H$9MJF1@-QZX'
MJ>#Q0!8HKG?$7B[3]&\&WGB"WN;6YBCA=K?;,-DS@'"@@\\CMSP:FT!]0N))
M;I]8M=2TZ:-#"8D4-')SO&Y>"O3'<=R: -RBN,L_$5_KGB#7=-L-0L;*ZTN?
MR8[.X@+O*-JGS&^8'82V!MZ8R2<XK?M=4^S:!87>MR0V=S+!&9U8[0)2N64
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M"OB/1'MHKA=6LC#--Y$;^>N'DSC8.?O9.,=: -.BL63Q=X?32;_5$U:TGM+
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M?I.FWT/E7-G:QV\@#!E8HH&01V..^* *GB#Q'?:7XI\/Z5:Z>]Q%J#S&1U=
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M@&4-E-PZ9'L<'BNFO+9+VQN+1R0D\;1L1U 88_K7'^$[/Q9IEI::-J6FZ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQBD!$85<$Q[_ .(@94,1P>11@L=0AT6UM9-%U56@\8?;&5[=Y#Y'G,V_(SN
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MMLS2QNJN1PO .3G&00":QH](U.3X7:AX'NK"Z;5_.DACF,#&&4/,9%G\W&T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBN7\=ZSJ6B:+;3Z9' TDU];V[M+(5VJ\JJ<84]<XSV
MSGGI0!TV]/,\O<N_&[;GG'KBG5YU/)?6?Q9NIK#28)[^7P_$TD0N!'&6$[\F
M0KD\  ';GIT'37M?'MI?:/HUW!%''<:K \\<-U/Y:QJF ^YP#T9@!@<Y[<X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH P=0\+0WFL/JMMJ>I:==R1K%,UI,H655SM
MW*ZLO&X\@ \UJV-C%I\!BB,CEFWR22N6>1L 98GJ< #V  & !5FB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K \8Z'=:_H2VMC
M)#'=174%S%Y^0C&.17VD@$@'&,X-;]% '+0Z+K"^.)-?E%BT;:6MEY:RN#O#
ML^?NGC+8ZYXS[5S]CX&\1Z/HWAV73+S3EUG1TF@996<V]S#*P8JQ"[E((4C
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MP3''=+.V^3D!BA#\KP?0^M;6E>&EBN-=O-26&2XUIU^TQ(2T:QK&(U0$@%N
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,"ZALEO&E(N-A4MMP.<YS[5H_")'/@AKHHRQ7E_<W,.X8+1M(=IQ[U!9?\G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445ROQ%\07WACP7=Z
MKIHA^UQR0HGG(67YY%4Y ([$]Z .JHKSGQ#K?C?P7I+:YJ5UHFIV$$D:W%O#
M;202E6<+\A+L"<L."*[>+6M/FUN;1DN/^)A#"MP\!1@1&QP&!(P1GC@G% %^
MBL2]\7:'I[ZJEU?!#I4:2WN(G80J_P!W) .2?09-;$,J7$$<T3;HY%#*<8R"
M,B@!]%%% !1110 4444 %%%% !1110!SI_Y*0/\ L$'_ -'"NBKG3_R4@?\
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M!+Y'8+[BNATRUO=!\06GB_5--NVEU>WG%^((6FDM69HV@0JH)("($.!PP]Z
M/3J\N^+?B2ZTS4-#T:U%S<)JBSQW-I:C=),@,9V@ 9!8;T![;B>U>@Z+>W>H
MZ8EW>6+V,DK,4MY#EU3)V[AV8C!([9Q7)ZGJ=@WQDTRWDDA1].T>YGFE8@>6
M)'B4;B>G /\ WU[T 5O"^K7'AW3!/K7AW5+-]0G$]]?.L7E12OA57:LA=8U
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M!*S$Y.%;/NW)-3W/@.28W]G%K=Q!HE_=&YN;!(ERVXYD19.JHYY( SR<$9H
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M.^UC(B;/FPI7[H4CY\9.,9J7?C=;G3&^PP2V\<DGE1M=WG[_ #("-K!1P!@
MR9&W)QB@#V2BO&%O/%RK<&ZMR86FB,VZ^NDV-O?Y6;9E<@@'R_EPJG'(JW/J
M'C^/2[<66C-)8C48I$=-08N4#IB,M*%<QL^?F(^Z?[HY!V/7**\MGO\ QS+?
MZP]]X?58O)C98O[3=8U12V/*,0W%V.20=O &2.!6MIT_C;1[&WTTZ;HT[Q*
M99]6G=W+$\DF$]2#QGCITQ0([RBN2BU'QU-$DL>B: 4=0RG^U)N0?^V%/^V^
M//\ H!Z!_P"#27_XQ0!U5%<I]M\>?] /0/\ P:2__&*/MOCS_H!Z!_X-)?\
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M:M,LD3?WE809!K&.B_%N(!+;6-/6(<*)KOS6_%C;Y-:OEGJW9F2YH:6NCU3
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MC>;QO;RQ*P+QC1D7<,\C/F<9]:Y?QYKMIXH^'%IJ$EO/::;+K-NBR7#>5YD
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M>IK!\?WVM:/IMOJNE:E';PPW$,4]N]L)//$DR)PQ/RX#'L<U>\!?\D\\-_\
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M)%$BQQH JH@P% Z #L*A.G6)OQ?FRMS>!=HN#$OF >F[&<5D:+XQTO7;W['
MEY;W#1>?%'>6KP&:+(&]-P&X<C\Q6AHVM6>O6+7EB9#")7B)DC*'<IP>#[T
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M %%%% !1110 4444 %%%% !7GOQ4N(+23P;<7,T<,$7B*W>221@JHH5\DD\
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MWPU_WU/_ (49\?\ ]WPU_P!]3_X4 =517*Y\??W?#7_?4_\ A1GQ]_=\-?\
M?4_^% '545RN?'W]WPU_WU/_ (49\?\ ]WPU_P!]3_X4 =517*Y\??W?#7_?
M4_\ A1GQ]_=\-?\ ?4_^% '545RN?'W]WPU_WU/_ (5U";MB[\;\?-MZ9]J
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MPL].@\BQM(+6'.[RX(PBY]<"K%<KGQ]_=\-?]]3_ .%&?'W]WPU_WU/_ (4
M=517*Y\?_P!WPU_WU/\ X49\??W?#7_?4_\ A0!U5%<KGQ]_=\-?]]3_ .%&
M?'W]WPU_WU/_ (4 =517*Y\?_P!WPU_WU/\ X49\??W?#7_?4_\ A0!U5%<K
MGQ]_=\-?]]3_ .%&?'W]WPU_WU/_ (4 =517*Y\??W?#7_?4_P#A1GQ]_=\-
M?]]3_P"% '545RN?'_\ =\-?]]3_ .%&?'W]WPU_WU/_ (4 =517*Y\??W?#
M7_?4_P#A1GQ]_=\-?]]3_P"% '545RN?'W]WPU_WU/\ X5JZ,=?_ 'W]N#31
M]WROL)D/KG=O_#&/>@#5HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***K)J-E)J$E@EW"UY&@D>!7!=%/ )'4"@"S15:/4;*6_EL([N%[N)0
M\D"N"Z*>A(ZC/O5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ljb_terminationxemployme001.jpg
<TEXT>
begin 644 ljb_terminationxemployme001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[9QFL[3AKU_XK34->\-7^(IF2Q"W%L;>TC/R^:0)=S2%>IQP"0!U)S[?POJ
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MI*KN;)V@G'7J3754 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52M]
M(TRSO9;RVTZT@NIO];/% JN_^\P&3^-7:* "BBB@ HHHH **** (Y8(IPHFB
M20*P=0Z@X8'((SW![U)110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M03Q-YWR%4;=OQTQG)'.:3X3:'JWACP'#I.KV#V]W!+(VT21N'#,2,%6/ZXH
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M._\ -):&<(#L64<M@E^I/W!^/1_!C4+[6/A];ZEJ5[<WEW--*'DGE9^%8@
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M_P"K7!;=@-\Q('55ZY. #G/A5XPU#Q#!K.EZ[\FM:9?2+-&3T1F) 'LIW+]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\;,JL652,,JAUSR#UP#BI_%?B./PGX?GUF>UEN+> J)%B8!AN8*" < \L.]
M&W162FJWXO+:&XT6XBCG<H9A+&ZQG:6!8 YP<8^I%:U !1110 445#/=06SP
M)-*J-/)Y40/5VP6P/P4G\* )J*J07%W)J5W!+8F*UB5##<^:I\XG.X;1RNW
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MA&NG0HFGG-HJ J(#ZJ!T/7GKS2-X:T=A?!K%"-0_X^P6;]_QCY^?FXXY[<4
M<<M[<>(O$4&BWM]'")-#M[J&.0./.=RXE==CK\RX3'7')&.:KP:=<'Q1X6TJ
M\\07NIQOIMXES/'-)"MR8W102 QP1D@L#EL=<&NSU'P=X=U:SM+34-(MKF"T
M&+=9%R8AZ ]0.!QTX%6CH&E_;+:[%E&D]K'Y-NZ97RDZ;5QT' X'I0!Y6\7V
MSPOHD%W-/.MEXQ^QPO),Y81+<,H!;.20  ">17L<2)'"B1_<50%R<\#W/6LH
M^%-".GRZ>VF0-:33>>\3 E3)G._G^+/.>M:T<:0Q)%&BI&@"JJC 4#H * .&
M\$)]OA\:_; S22Z]=Q2?,02BJBH,CG&P"N2T^TB'PK\ K&\B--JUB799"2"7
M89&<X_"O4K72#IVO7M[:;?L^H%7N8CQME5=HD7ZJ%!'^R#ZU$G@_P]';16\>
MDVT<,4_VF-(UVA9>H<8Z$=CV[8H X+4=1NO"Y\>06-W=+:VGV"2,RS/,;<3'
M;,ZEB6^Z"W7J*ZO0])>Q\2_;8=>BFL[RRR+"%7*.58?OPS2-@X8*<=<@]:W$
MT'2TNKRY%E&TUZGEW3/EO.7& '!Z@ D 'H#BHM$\,:'X;69=&TRVLA,<R&),
M%L=,GT&3QTYH N7^F6.J11Q:A9P74<<BRHLT8<*XZ,,]"/6J=XFF^'K;4]9B
ML84GE423M%&%DN7 PBD]V).!GN:UJJ:AI=EJL*0WUNL\:.LBJQ. P.0>.X/(
M]* /,=7MM4\(W?A_Q5>VEO$+.5K?5[B*X+^;'</EV(VCA9&W 9XZ5U.NR2MX
MWTR&Z$MQI$FGSDV]ON9A,&3$C*O)7:2 ><$]NM='J6DV&KZ>UAJ-LMS:-C=%
M(25;'3/K^-<=XB\'-=ZM;'_A'-+UC28+406\$UP89+9MQ+$':=RD;1C(QMX'
M)H Q9]+U?3?"_A"'4]1U./4+C7(X[DF_D9C$YD(1CN(R%"9QT()'/-7_ + L
MOBB^\'KJ+P6]OI\<MDEU++)(^]Y#)(K>8I)4[0"2=H QCG._H_@K3;;3D@O+
M"%42Y^U6]JD\DD=H^T ;&;!SP3D 8+''OIZUX6T+Q$8#K&EVUZT!S$TR9*^H
MSUQ[=* .)M&NK[7K?PMJ&OQ7HCTA'AN)(W3[8_F2))(-L@RRA4YR>I8=:;#8
M7*>)?"&E7?B&]U-'LKZ*YN(YI(1<>6R!25#'!&2"P.3CKS7;ZOX4T#7;>V@U
M/2;2YBMO]0KQC]V.F%QT' XZ<"ICH&E?:[2Z%E&LUG'Y5LR97R4QC:H'08 &
M!Z4 >5744UKX \17\>HZC]IT36I8-/<WDA\F-;A0%(S\XPQ'S9XXKH[]9_$_
MBGQ/H<FJI8RV<<(M,[P\2-$&\Y-LB\ARP)Y^Z!TXKJV\)Z$UC<V+:=$UK=2^
M=/"2Q663.=S#/)S@Y/4@>E-U3PAX>UN>VGU32+6\FME"Q23)N8 =B3U'L<T
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MWF+G+;B6(.>A.,"K.GW'_"1ZQXGL=4O))FTZTMTM]C-#D/#O:<*#PS,3S_"
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MAMK<M/;,H60O'\IW#@E0W!ZCZT =Q/XBT>VG2&;48$=V1 2WRAF^Z"W0%LC
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MW8RW5RNZ&))@3(/;U]?I7"^'[AI_&/A:\$-\T#:/-;D?8'BAMWS$?*4%>%4
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M/4'TJ^W3ZE_9<L";&:"<.4(/S?,,@XVYSQTH [*BN0@\?1"36+;4=&U"RO\
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M:W<5VI1 Q9XV#*#GMD<_TK9HH 09P,G)[TM%% !1110 4444 %%%% !1110
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MT(!!X.#R%UX+\0OHOB73H;/38UU+4K>\MQ%<$*BH82RXV#&/*(![D]!7J%%
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M)#$LL18,"C ':P([CH:Z/3/MYLE?4_)%TY+-' 24C]%!(!;'J0,G/ ' N44
M<YX\\V;P7J=C;)YEWJ$+65O'W9Y1M'X $L?0 GM5O2K;4--EMM+$$!TFUL(X
MX[CS#YK2K\N"N,;=H!SGK6J88VF69HU,B@A7(Y /7'I3Z "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JZC/<V
MNFW,]G:BZN8XR\<!DV>80/N[L'!/TJU10!YUHWQ0N-=^'NH^*;+0D>33W<36
M/VT[PJ@,QSY?7!SC';K6KHWC>37? ,'B:ST^$RSL$2S-T?OF3RPI?9P=Q'\/
M<<UPFFZ!?Z+\8=>\,VT&="U^%;^;^ZD8?YU^C$O'CT<'M4WPOT/4M%\8>(/"
MTR$Z/I-\+V!F/WFD4B,>XVX;V910!UNI^/;S3?B+I?@\Z-!)-J$'GI<B](5
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M2_V6*^!SYW(R"W<CCD\_-@]*VOAZ8/#W@K2O$U_K#O9?V1Y/V>5UQ&X?(6,
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MQELC'..] 'LU%(@4(H7&W'&/2EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW6@026RF2W8).CJJG(#94C:.>1[4[4/ )O=/GDCU-K?7)-074UOTBX295V*
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M;-QR/O Y;)#'D<8O:9H36VMWVMWDJ3:A=QQP?NU*I%$F2$7)).2S$GOD<<4
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MFHZSX>U33[G4(4GO[5[4-'"?*A5U()"[LLW/4GL.!SFJOA:]&K^&[]K^W/\
M8UK+;E! W[[>JJ3G=\N-@XYZF@#/T[QCY6ARSOIMO;74NM3:;'#;*SJTBNVY
MSM7<W"LQP,G';.:KZUX@UVY\)>+X9+)K9[&RD>"^-O+#'<1F)B2BORKJ1CJ1
MT-3M\/KF30+JR.L"*^_M9]7L[R&#'D3,Y;!4L=P^8CJ,@UHW'A[7=3\+ZIIV
MJ:S;RWFH6S6WF16I2&%"I!(3?DL=Q))/IP,<@%SPM8(FCZ;>W%M:?;18Q0K/
M%'AO*V@A,GG&><=*WJIZ3:36&DVEG/*DLD$2Q%T0J&V@#."3CIZU<H ****
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M<YB!#C'S @XP>* /6?MK_P!KBP^QW.SR/.^U;1Y6=V-F<YW=\8QCO5NN*O\
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M3WO@[3M4U&WUF1[>9;=(;:Z8N;8M*L<DPD8L<8<'!! (]\4 =U6?JNM6>CK
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M00000000#D>E9+> _#\C7C/;7#O>VPM;EVO)BTT8S]XELDX8C<><'&<5TE%
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M R2,LD<F2=X<'=N))).<G)SG)K9HH Q+GPEH][I5YIUU!++!?,&NF:=]\Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;Y-RC?QD!2.?I7':#XW>[T2]U/5;*2U6/4)+2)0\9WL)3&J [OO9').!R3G
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MA+1K);[E#E2I<;F56!(&>O<\4LGCNW:]NK2PTG4;^6&SCO5, C"RPOG:REG
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M9')!89^;"C:I;DC 'KQ5&S\>Z7=I<QB*=;Z"\6Q-F"C.\K#<NTAMI4J"V<C
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MI. 2?K[5JUC^%8+^T\,:=::E;1V]S;6\<#(DOF#Y5"YS@=2#^&*V* "BBB@
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M7,EM'#-$6^T21(K/N((V@EMHQTQDYSB@#J[R^MM/B62YDVAFVHJJ69VP3A5
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M6MBD/V-!F)X-V3,C9.\%\#_9QCDY-6/&PNF\7>"Q9-"ER;NY"/,I9%/V9^2
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M0[QGCUP1@^AK9H XJUT'5-<MM+N-1U1BVF7_ -JM938^2TZA-H\R,GY?O.,
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M\,L:*X.5*,"K<'*L?I5#3_!USI+7#V6O76^;4FU B:)&4LR%65@H7(.<]1C
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M$<P$(_= 1^5\G/\ =]<\\^U;VEV1TW2K2Q,OF_9H5B$FW;N"C )'K@50\/\
MB#^W9=6C-F]LVG7S6;!W#%R$1MW' ^_TYZ5M4 <6WP^'_".S:&FL7 LFO1=Q
M*T2$Q8F\[:#QGY^I.>..*M:GX'M];U/4KK4KHRQ:A8+830I'M 56+JRG)(8,
MQ/<=.*WX;B[?4[JWEL3%:QHAAN?-4^<3G<-HY7;@=>N:MT <_P"'_#U_I)#:
MCX@O-7:)/+@^T1HGEKQR=HR[< ;F)/TR<S^(O#=IXCMK=)I)K>YM9A/:7<!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN[5R"8IER,CH1Z'W% &9X5TR?1TU&REUC^T$%T9(X]C#[(K 'RLLS$@=0">
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M-\07!N@;60O&&:XVG &2/G7D9&3BMG5+.^U/Q+XWM].26*YO=#A@MI&0J&D
MERH;ID;E!YXS0!W-MX@TF\NEMK>_@>9T,D:AL>8HZLAZ,!W(SBJH\9>&S+%&
M-<L6:6;R$VS [I,XVY^O'UXKDG_XJ*R\$1V%O-;WVFWD,UVCQ,C6D<<3+*C9
M'&3A0.^<C(&:Q;V%F^'?C"..TG-Q/XA>:)%MVWR*;E&5U&,D;03D=@: /8)4
M=XF6.0QN1PX ./P-<'X0U3Q9XE\#6NN1ZEIXOI_-VP2V9\HE)&0 E7##.WKS
MC/0UW;7$26_VAG BV[MWM7G'PXUF/0_AGI]M=66I-?0F?-G'92F4DRNRC&W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M444 %%%(S*HRQ &0.3W- "T54348I-5FTX1SB6*)96<Q,(R&)  ?H3QR*MT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB71;C2;R:>.UN!ME$) 9ESG&2#CIVH I6)UMFTP745@-.$6Z4QLS,&"@H?F
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M&Z$X6XMB.!L<#ICC!!X^@P 9T6K^)+'4--T'5;E$FU'4)DM[P>691;)&9 &
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M0(>T3$ *>!R>>!SQ0!U5%4-%L[C3]$LK2[N7N;B&)4DF=MS,0.[=_KWZU?H
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MFWMYF?2-0&$N8R4RR-R%<$  D$8<],\X>@W]EK?B7P_9W-D4T6;PZLFG6MX
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M-A"?+47<42,# 868YP4"@!1R2>YY /58-2M+G4+NQAF5[BT"&=5YV%P2 ??
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M(D;M"2S!1P,D GUK7N-*L="\:>&M4T</$;JSN7U1HG+F>!8@PD?DY(<K@^K
M4 >FY!)&>1UI<CUKQW0KC34\2>!IK.:UBMKZSNE8&4-<2HR*5^T.,!G+<XQP
MV>35.RTZRM_ FBZM%$HOX/$HCBN=Q+HAO64J#V4J3D=#G)H ]NHKS?6(G\)^
M,[I["T5HO%$/V>(B/*Q7J\#=Z(RL6/\ US)[UWVFZ?;Z3IEMI]H@2WMXQ&@]
M@.I]SU- "7SWZ&U^PPV\@:=5N/.D*[8N=S+@'+=, X^M6\@=ZXKX@1Q_:_",
MIX<:_;J#GL5?(_0?E7+:OHNFWES\4FN+9)3:P1S0;R2(I/LF_>H[-NYSUZT
M>O4A( R3@5G>'II+CPUI4\KEY)+.%V<G)8E 2:YSQ3-ID_C#3-/N_(:X%E<3
M 7[#[*D>45F*'[\G8#(PI;F@#M2<#)Z49XSVKQ;PKKEJ=-\!VVMW44FDRV=S
M$3.X,1NE9?+63/&0F[:#Z^PK8N9]#T75/#.GQW(?PK-=7@9YY ]OY^ 8TR?E
MV F0*.@9?5: /4<\9[49&,YX]:\PO!I>FZEX<L-/F,OAFZUBX%UE]\'G-&6C
MB7MY?F$X7H&7'45E>+;+[)I_Q&LK5 FCQ64$\<2<1PW+*2X0#@9&UB/5@>]
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M;VSOYJ# ...3D\CMSG%5+_Q_:)HVD:CIUK<W*:CJ"6.#$5:%O,VN'4X(888
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M,LM\L@FD;R%R[CHQXY8>O6L+_A8F@[&E_P!.\B.\-E-.;20)#+N"8<D?+\Q
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M6DMO+$4>&4E0-X/0?.IXZY%;D_B"WAEBMUM[J6\DB,_V2.,>8L8."S D #/
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M?[F2;D; WJ2" 2,''!-%QXNTNUN(%F,ZV\]S]CCO/+_<F;)&S=]01G&,C&:
M-*72--G:=I=.M)&N,><7A4F3'3=QSCMFA-)TV.>*=-/M%EA7;'((5#(/0''
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MEZ==6 L+BPM9K,  6\D*M'QT^4C%1C1-)%M-;C2[(03A1+%]G3;(  !N&,'
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M'UKC]&N[GQ=K>L^;<ZO8-IVJ+';F!S&BQI'&QC=<E6+%FSN!.",$8%=!XO\
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MO[N&\M]8O9[N14A,93S@ R?>.1@=:C\.>&O$.BPPV%SXB2\TVS7;:(;79*P
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MKF"]M8KFUFCG@E4/'+&P974]"".HH EHJDNL::U\MBM_;&Z9F181(-S,H)8
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M=#^5 %ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH.E;E(VXJ=I ;'!(R ?I0!XE%9Z?JWPMU72+.*%];FU>X%M&B@2B7[4=KCN
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M01IJ3,ZEDEWN^2H/W?F X]#VYH AU759M1\;^!;@65[:P7$T[HTD@VNGV=R
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M'AGQ5=O937=A9W-_9:XMX;V2[P9H S;50;3Y:A64;?5<X))- %RRU=/#NO\
MQ#U"9+JYM;&2WF:-9-[*GV97;;O8=R3C/TKJ/^$FMO[:TO3#;7 ?4K9[F"7"
M[-J!2P/.0?G7MCWKG;CPOJE_)X^B>%($UV!8[21I 0"MN(OF Y'(SWX]^*;;
MZ3XGNM=\,ZA-IMK9KIUC<6TH:Z#E6=8P&X'(RAP/3J1TH V++QE:ZC>:7:M8
MWEO%K"3-92R84N(QDY .Y"5Y'MZ'BN2\)>,8_#?A*$ZAI^IR:<NHW,,VI\/'
M"3<NJ[B6WD= 6 ('3.>*L:7X:\3KJOA;4K_3K0WNGR3KJ%TUYODN-\97S,[?
MN\Y"]LXP *FA\):O-X,O/!]U:HD-S>2O)?+*K)Y#SF4[5^]OP=N",9YSVH O
M6EU%IWQ+\4W%S<.EI#I5K<2&21F6, REB >@PO0>E:-EXWL+O7K+2)(9()K^
M%Y;1FDC<2; "RG:Q*L <X/;OGBLW4?"M[JWB'Q0)HO)L-6TE+".<.I*LOF98
MKG./G&/IVJ[X7'BG_1[?7-*TZT^R)MDN[><2&[(& 57:"@/4Y.>,8YX .LK'
MU#7TM+Z2PM;.>^O(K?[3)#"5&R/)"Y+$<L58 =\'I6Q7&:IIOB'2O&\FOZ)9
M6^HVU]:1VUW:RW'DLC1LQ216(((PY!'6@#3@\6VU\+&.PL[J>[O+3[8MLZB)
MXHL@9?<1M.3@#G)SV!-4G^(.FC3;*]2SOY!<ZA_9KQ+&OF6]QG!21=W48/W<
M]O45$^C:U8^,;7Q*L<=\TVG_ &&^MH7"%"',B-'NP& +%3D@XP>O%9<_@_5(
M;:VEAMTEN9_$JZW=HLH"Q(#C8"<;FVA?8G//2@#=C\<V:6^LO?V5W83:2\2W
M$$YC+$2X\LAE8KALXZ\<YIGB37+5/"FMR:SH]^;.VA'VB.&1098V&=R,'''8
M\@\'BJ4NB:K_ &[XKNSI$%W:ZHEHD<%Q(FV5(\K*K#G&58XZ].<5F2^"M3A\
M(>*=&TN*>.QU")8].T^ZN0_V4E2'.[<<(3C"@G&/>@#K[C6X?M!TFSL[B\N%
MM5GECAD"&*-LA<L6'S-AL<]B21UKE_ 7B*#3OAUH"W#22W=Y]H\J.64*S!97
M+%F<\ 9 /.<D=:NV^E:]H_C&XUFRL([NUU6S@AN87N%C>VEB!"G/(9"&.<<^
MU8FG>$O%.C:'X;N[>RL9]2TDW44U@]Q\MQ#,^XX?;A6!5?4>_:@#?C^)6FRV
M=I/%87\KSZBVEM%&(V,5RH)V$[L'(&01D=,D58F\<"WLKFXFT+4XGLK/[;>0
MR!%:&/+#&=V&;",V >F.<G%4]6TS7]43P_</IMO'+:ZLE]-;PSJ1#$L;)M#$
M#>_S9Z =L\9,7BK0/$&L7^MVXM;:]T^[TTP6)FN-BVDI5PQ*8.YB2N&[8QD<
MT :(\67,_CC3])M;"26PN=+:^$X9 6R\8#8)!"J&.>Y)X'%1Z3XCT6RTS6[^
M*TO+81ZN]O/#*V^2:Z)1<(-Q'S%E  ('?@55TW0]=L_$/A[4WL[8K#HQTVZ0
M7/\ J3OC;<#M^;A",#N>N.:SY/!NLWFBZS&(X[:^/B#^VK#S) 4?:5*J^W.,
M[2#UQD=: .I_X2R*+4KK3+NPNH+^&U-Y'!E&\^('!*-NP2#P02.HZCFJ6F>/
MK74I=#/]EZA;VNM+_HEU,$"%]A?80&+#@'G&"1P2.:;<Z/J&KZ]'KMQ8-;/9
MZ=-;06S2HSR2RXW$D$J% 7 YR<G@8YRK+PUK5OHO@6T>R!DT296NR)DQ@1/'
M\O//+9[<"@#T6N;\3ZM+!J.AZ';2-'<:O<LC2*<,D,:%Y"#V) "@]MV>HKI*
MY#Q;9/%XG\*>(.L&GW4L-P?[B3Q[ Y]@P3/IG- $BZY<_P#">2>%TTV1+&+3
MEF\V.10<,Y4-]X$ ;2..<G..E<YX$\4C2?"6A6UY97\D%W?S68OV*L@E:XDV
M*<MO.<8W8(SWZXZ6?2]4@^(QUNWMHI[&;2TM)#YNUT9)6?@$<Y#8'(Y'.*YR
MV\+:[#X)T#2FL%-U8:RM],!.FWRQ<-+P<\G# 8]0: -_4OB#I.F,995=[%+O
M['+<I(F(WW;"=F[<5#?*3C\".:ZVN!T?2?%&A7EYI$.G:?<Z7-=RW%MJ4DP#
MVZ2.796CVDNP+-C! /&2*[Z@#%\1>)(/#<=B]Q:75PMY=QVB&W56VNYP,@D'
MUZ U0?QK''#LETNZAOQ$TTEC/+#'(B!F5227VDMM;;@G..<4[QII>H:I%HPL
M+83&TU6WO)<R*OR1MD@9ZDYX_F*HZSIFOV'C'^W]&TZUU.WO+2.UN[.><0NC
M(S%'5B",?.P(H T+#QK8:S:6,VC0SWTEY:F[2%=J%(PVT[RQP#N!4#G)![ F
MD3QM8SV-C-!;SBXO8&G2UN"L#HJG:=^\@ [C@=<]N 2,J\TGQ/IOB>S\1Z?9
MV>H236/V*^L1/Y(3$C2(T;D<A=Y4Y )'.,GA=6TGQ/;ZYIWB.RM+'4;K[*]I
M?6#3>6NPOO4QN1U4\9(&1V&> !X\7:#KX\,7HL[V07=\\=JP8(+>=5<,L@#\
M\!NS TZ\^(\%I'JLJZ#K$\.DW!AOGCCCQ" JL7^_\PPV<#)P"2!QEVJZ3K=_
M<>&+E[* 266H&\N8X95V1(8W0(I."Y&\9.!G!Z<"L?2TU"[G^(.FV5B)3=ZC
M)"DS2*$C9K>-27!.< $'Y0<\CB@#>A\6SWGCBUTJTLGFTV;2Q?)<HZ?.'=0K
MX)!"@9]SGIQ76UQ6G^%[_0O%>CSV,<5QIUMHJ:5)(\NQTV.&#XP<Y / [UVM
M &5J6M_8=0M]/@L;B[NYXI)E6/"J$3:#EF( )+  ?R'-8Z?$"PG@T":UT_4+
MA-<1VM?+1,AE0L4;+<'C']WOG S4FOV&M77B;3Y8;6"_T86\B2VLL_EJLQ8%
M9'&#O4 $8P<$YQ7-^'_"OB#3;?P1#=6,/_$DDN/M#17"ME7C=%(SCG+9(].^
M>  =-:>-[&?2+J]GM;JVGM;W^SY+-PIE-P2H5%PQ5MVY<'..>2 #67I5Q<2_
M&#4$FM[FVQHL3&*6;>I)F;YEP2 , #MR#]3FWG@_7KB#5;BW@BBO$\0QZW8I
M+*-DP1%7RW(SM) ;U'(YK<TRPUR?X@/KUYID-G:2:4EH4-T'=7$C/T48/7U]
M/H #L:PKWQ-%;7][9V]G/>36,*37"0L@95?.,*2"W )/Z9/%;M<'XO\ "]WK
MM]<7%MIY@U2%5&F:Q;7 B>$XY67G+(#DXPV03P.I -B7QC:PQ^(F:QO-V@J'
MND&S+J8_,RGS8/R^N*QO$FNSWFJ^$+:#3[B?3M4=YI8<QCSU$#NL9!8=#AB#
MP<#DU#JGA[Q"+SQE%9V=O<PZ]9JL=PTX3RY!;^45*XSR0".W/)JT^B:T+OP1
M*;%&_L='^U^7.I&3 8@$SC/)R>GXT 8>E:3%>Z]XC\/7&FZJ]A8+;_8P+M3)
M:%@\F8W\S*DD@#!Z!0< 5TWASQ#H\7A/0CI%I=B+4 R6%G(^Z4@;BQ9F8X
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M3GK@8QZUHKIGB;1?$VJ2Z;I5CJ.FZM,MT&N;@1/9R[%1MWRMO7Y0<+[_ %H
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M(/0CJ#[4 >CT5S&FZW>Z[97VKZ;=6JZ<H=+6.2$L^],AC)\PVC(^Y@$#J1G
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MG!)S],==10!S,'A.2SU?4]0L]2,"ZE&!<VRP Q-+C!E SD.>_.#QD$\U6M_
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MT#1+;P[HEOI5GN,$&X@G R68L>!P!ECP.E4++PLMOJFNW=S="ZBUK;]IMWB
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M'?S?84M%MTL2JE%8'_6;L;LXXZXK1HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_B%JFI:)X)U#4]
M*N(X+FW56#/$'X+ '&3@'GN#745R/Q-@N+OX?:I:6EM<7-S,J+'%!$TC,=ZG
MHH/8&@#KJ*S[[5DLK>TF%G?7"W,\<(6" EH]QQO<'!51W)Z5H4 %%%% !111
M0 5P'BVY\1:%%IDZ:_,&U#6XK,QK;P[(H)9& "Y0G<%P,DGG/%=_7$?$B&XN
M+?P\EM9W=RT.MVES*+>W>39$C$LQV@XQ0!M17$VA23)JNJS7Z3$-;+]F#3
M?.-D2?,!P<XXW8],M?QOX;CM[*<ZM 8[Y7:V*AF,FP$L, 9!&TC!YR,=>*P?
M%ANM/\7:7KC:=JE_I+V<EI,NG>9YUNY=75RB$,5.,'TP/:J;Z?';Z]X-FL=
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MW,4<#B13MW#Y2 0".=WW<<YP*U](U%-5TJVO421/-C5BKQLA!(R>& ./?O7
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MU$Y2':P0D88Y&..O:@#N+[4VN=*L_L32Q37\R0QEXVC91UD.& ((17(R.PK
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C-X8TYF+&34LDYXU
M.Y'_ +4K9HH Q?\ A%M-_P">FI?^#2Y_^.4?\(MIO_/34O\ P:7/_P <K:HH
M Q?^$6TW_GIJ7_@TN?\ XY1_PBVF_P#/34O_  :7/_QRMJB@#%_X1;3?^>FI
M?^#2Y_\ CE'_  BVF_\ /34O_!I<_P#QRMJB@#%_X1;3?^>FI?\ @TN?_CE'
M_"+:;_STU+_P:7/_ ,<K:HH Q?\ A%M-_P">FI?^#2Y_^.4?\(MIO_/34O\
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MYFU+7+^<9 GN]4F+J#C(&QE ' [<X%:'_"+:;_STU+_P:7/_ ,<K:HH Q?\
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M'\ .30 ^BN=MO'.A7NFG4K66^FL@&/GQZ;<LN%)#<B/L0<_2N@1UDC5T.58
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M75Y;K;R8N[7:J+G;@'N"S>O6J,7AR>'2M&TV/1M8%OH\ZSV@^V6N0R@A<GN
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MI!'4$>AZ@5)I[ZAIIN7C\.7LD]U+YL\TEU!ND;:%!.& X55   &!0!T&H?\
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M8Y!&?F)//K7+WNA:AI'A;4=/L-!UV6VO;H7$Z)>P&2/+AG:(*0<G'W>GMU!
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MRA2&^7DE0!VZ?C530[9=;\1MXJN-%NM-F6S%G"EZ@68C<68E03@= ._WNQ%
M'5@84 DD@=3WKA_&.L:K8OK+6&ILAL]+-U#;VL2.ZR#>2\Q=2H0[0  03A\
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M4F%Y;^5(VQ'\U=K-Z YY/M7E;Z3X=M=2\$6]C-]KL)-3NO*EN2A#QM#(2J8
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M/ ^JMHFXW36$AM/)ZYV';M]_3\* -9+ZTE:98[J!VA_UH60$Q_[WI^-<'?\
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M28V<8B6=YA*6C:,E-S*4*C.<!>,@"@#T?Q/K]OX9T234[H[8$D1'D*,RQAF
MW,%!) SVZ].,YK/E\5O=ZS?Z-I*0R:G;+"ZQ7"NJM$^TF7<!C: Q&!R2IZ5U
M!&1@T8&<]Z .)M/$?B:^\0:]HUO9Z4;C24@;<TD@68RH6 ''&,8[UUD-] [Q
M02RQ1WCQAS;EQO''/'6N,\+7$#_%GQVB31LQ2PP P).(FS^5<YHLNBZQ;0Z=
MK>KW4'B2RU9Y6L8Q$L[7 E8JR93<R%2.<X"]2 * /6OMEL)1%]HA\PL5";QG
M(&2,>H!!^E(E[:22+&EU"TC)YBJL@)*_W@/3WKS'P[HWAV[MO&\\]CI\KVNK
MW9C9T4^2IA0<?W0<M_D5F6-CH_\ PCOPNF,-IYT\D<4S\;I%-LX96/4C(4$'
MCH/:@#UJZNWGTBYGTJYLWF$;^3+*^Z$.!QO*G. >N*E2Z2.WB-U/;K(T>]BK
M84X&6*Y_AKRC4(M-BT?XL6,26J6L2>9' H4(DAM%Y"] =X_,5HO;:5>^./!0
MN(K282Z+/O#A6$F!"5R/XL?,1GTH ])-Y;"U^U&XA%OC=YQ<;,>N>E4M2\0:
M7I6GPWUS>1"">5(865P1([L% 7GGD_D">U>7:3J6E6&BV-K(;=(H_%-Y'9RR
MR[;:UVM*5+@$ C!.U<C)(Y%4FN+%O"FJB2XMY4M/&,<LC[0JQQ-/&2V/X4/)
M]#SUH ]B$]V^LQ+'-9-ISVS/MR3.S[A@KSC9@\]\D592[MI+E[>.XA>>,9>)
M7!9?J.HKSK57C_X6/)+H1M_MTWA2Y^RM%M&]_,3R\>HXX]O:J$;6VH>#? DN
MC,HUJ"]ME8+_ *Y2!BZ$G?&-Y?/4XSSB@#U-[VTC8*]S"K&3RP&D ._&=OUP
M1Q6!?:QKT&LZI9VUEIS6\5B;BUGDN&7$@Q\LW'R@Y8@CLA_#S75;+1QX*^)5
MPD%GY]OJDI@<!<Q'9$1L_NG=GIU(]J]L@=98(Y%8.K*"&!R#QUH P+'Q%<@:
M-_:]JEJ=5C"Q[2<1S[-QC;/J Q4\=,$9QG?EGB@4--*D:DX!=@!G\:X[XE+(
M^GZ D&?M!UZS\G'J')/_ (Z&_#-2?%2(R_#+7 $W[80^,9P%=23^ !- '6B>
M(S-")4,JC+(&&X#Z4Q+VUDF6%+F%I67>J+("Q7U ]/>O/;G4=&U?XI)Y%S9W
M<%QX=GBW*RNDI\Y#MST8XR<5S6CZ3IL_@/P#?:3% -?%[;8GAP9F4'$P<CDH
M$!R#P  * /:'N[:.Y2V>XA6=QE(F<!F^@ZFB:[MK<,9[B*((NYM[A<+G&3GM
MFO*'>"\\!^-;/5=HU^*]N7"GB8RYS:M'WZ>6$QZ8%7[#3K"Z^)<L.N6]E/='
MPW;->+*JE6FWN'8CIG'?TH ]-5@RAE(*D9!!X(I:X[X53>?\,- ;S/,*VVS.
M<XPQ 'X  5V- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %-=%D0HZAE/!5AD&G5@>+O$;>&=+@NDL
MY;EY[J&V 0#"[W"Y/(]>/4X^M &W+;P3[/-ACDV'<F]0=I]1Z4&"(R^88D\S
M^]M&?SKA9]>FT[XEW'F?VI/;/H<=PMA&K2$2&9@2$' .% )_7FNE@\4:=>:9
MI]]8F6[74(S):Q1+\\B@9)P2 ,=R2 "0.I% &G]EM\$>1%SU^0<TOV6W!!\B
M+(Z'8.*IZ)KECX@L&N[%W*I*\,J2*5>*13AD8'H0:R--\8QWFJ>((;JUFM+3
M2) CSR@!<",.6.#QPW ]/RH Z+[);8Q]GBQUQL%*+> -N$,8;&,A1TK#?QEI
MEO=SVMY%>6L\5J;P1RVY+2P@X+(%R3CNO##N*I+\1]#-G#>-%J26LXM_*G:R
MD$;^<<* V,<'@\_G0!U200Q;?+B1-J[5VJ!@>@]J#;PM"T)AC,39RA4;3GKQ
M7.?\)UIIN;VT6SU1KVT59&M19/YKQMG#J/[O!Y..>.I JY!XITZ\M-.N+#S;
MS^T8&N+>.%0&:-=NYL,1C&Y01UR>E &RB)&BI&JHBC 51@ 4C0Q.Q9XT8D;2
M2H.1Z5%87D6HZ?;WL(<13QK(@D7:P!&1D'H?:L>V\9:5=75G%'Y_DWL\MO:W
M)C_=321[MR@YR/N-@D '!P30!M_9;<8_<1<=/D'%+]GA^T?:/)C\[;M\S:-V
M/3/7%<N_Q$T-(IIBM_\ 9[>\^QW$QM'"02;@OSDCY1E@/7VQ5_6]<MX8[ZQB
M%W-<PVQFG^QKEK="#M8G(Y.#@#+<<"@#;DC25=LB*XZX89IL<$,1)CB1">I5
M0*Y[X?75Q>_#W0;JZGDGN);.-Y)96+,[$<DD]34Q\8:4+FSC)G%O>W)M+:[\
MO]S+,,_(#G/\+ '&#C@T ;BPQ)(\B1HLCXWL% +8Z9/>D,$+2>8T2%_[Q49_
M.L.Y\8Z5:(UQ*9A8)<?99+\)F!)=VW!.<XW?*6QM!X)J.^\;Z58WVI61AU">
MYTZ-)9XX+1V(1MQW#CD *>>GIDT =!+;P3,C2PQR,ARA=02I]1Z5)UK';Q)I
M[V^GR6K27;ZE%YUI% HWR1[02_) 4 ,.21R0.I KA](UVW/@W7;G6-1UF.V7
M7Y8(Y8VD\^)1*@1">J#.%.<#DCO0!Z5]CM?^?:'_ +X%*;: [<PQG;PORCCZ
M5@?\)2Q\<S>'OL%QLALEN6G"9#;F(!&#G:-K#IDG]8]%U_1X?#\E]#>W\]N]
M_+"AN]S3-,92OEJIYQNX [ >U '1?9;?G]Q%SU^0<US\7AAO^$TNM:G^R26D
MUI';+;&+)38S,&R>,Y<\8_&GW'C;2;*WU-[U;JVFTR,375N\):18ST<!<AE.
M#\P.!CG%2V/B_3+_ %8:<JW4,KVQNHGN(&C2:,8#,C'KC(_/(R.: -N2&*4@
MR1(Y'3<H.*:]M!),DSPQM+']QV4%E^A[5G:;X@MM4FMTA@N52YMS=6\SH DL
M0*C<""<??4X.#@]*GO\ 58;&YM[7RY9[JX#M%!%C<RIC<?F(&!D=^XH I7FD
M:E?ZXDMQJ<9T:,QRK8K;X=I4.06DS]W<%;&.H';.=F2&*4@R1(Y'3<H.*RO^
M$CM7MK62""ZGFNHFFBMDCQ+L7&XD,0%P2!R1R<=:Q9/B#:3WGAU-+M;B\M]6
MDF4R+'@Q^6CEDVD@APRC([ 'VH ZW[+;DL?(B^;K\@YI'M+:6$0R6\3Q Y",
M@*@^N*H>)-4DT;PWJ.HPPO++;VTDB*JYY"D@GVXYKFO#MY';VVDZK<7>L2WV
MI6:1?V?++O6XD"*[3(K'"<9Y!5<'&,XH [9H(7<.T2,PZ,5!(I!;0!&001A6
M^\NP8/UKGY_'>AVNC76J3R7$<5I<"UN8S WF02D@!7'\/+#G.#D8-4YO'JG7
MM*TVWTC4\7D\\;O/;&(XCCW94-@G)*G/3&>] '7O&DJ[9$5U]&&12&*-HQ&8
MT*#^$J,?E7G>E>+HO#][XL;5I]2N;6UU;:)-CS+;1&*,Y)Z*H)/ ]^.M>B22
MK'"TIW,JKN^12Q(]@.3^% '/:WX?U"ZU*UO=+O;*%88GB:SO+3SH'W$'> K*
M0W&,\\5;TCP_%8F>>Y2SDN[C:)3;VHACPN=H"Y)_B/)))SZ  8^E^+M!TSPQ
MH<R7>IW-IJ$I@M)[F.2:61B6^\<9SP< \D#@5MZ)XAL]=:\CMTN(9[*417$%
MS$8Y$) 8$@]B""#0!HRV\$\/DRPQR1<?(Z@CCIQ2RP0SQ&*:))(SU1U!'Y&N
M?D\2N_CAO#(L;D(+'[0UPH'\3[01SP!ALGUQZ5SO@CQC#:^'-,M]6FU">>ZO
M[BU%Y+&\B>8;B01HTA[D  >G XH ]":WA8KNAC.T87*CCZ4GV6WY_<1<]?D'
M-<]%KFD6VN>))I+Z^5]/@ADO4GW^3"NUR#&I'< DD9S@5KV.JK>W4]J;6YMY
MH421EG4 %7+!2""0?N'OQ0!9>UMY8UCDMXG13N560$ ^H%.:"%WWM$C-_>*@
MFLCQ5=7L.B/:Z6ZIJE\?LMFQ_@=@27_X"H9O^ U!X'U]_$?A*ROK@;+U08+R
M,\%)T.UP1VY&?H10!NBV@"%!#&$;JNP8-2US1\<Z.JV4I%VUK?RM#9W$=NTB
M3N,Y"A<MV8@D $ D9I8O'&DSZI-I\4=^\D%S]FG?[(X2%MF_+L1\JX[GC\.:
M -]+:",R%((U,IS(50#>??UI/LEMC'V>+'IL%9$'BW39=3L[%UN+=K^-I;*2
M>/:EPJC+;3G@@'.& ..::GC#2S>V5NZW,:7ZLUE.T1\NYVC<0F,G..0"!N'3
M- &S):V\L(ADMXGB!R$9 5!^E.F@AN(_+FBCDCZ[74$?D:Y:/XC:#):6=X!?
M+975P;9;EK1Q&D@<H%8XXRRD?EG&:T++Q;IEY-J4+_:+.33HQ-<+>0F(B(@D
M2#/\/RM],<@4 ;;1HX4,BMM.1D9P?6D6&)'+I$BN>K!0":PF\8Z;#>O:745Y
M:SBV:[C26W.9HE^\R!<DD9&5.&&>E0Z=XZT?4[G2X85O%75(C):32V[+'*0N
M\H&/\07)].",Y% '2A54D@ %CDX'4]*8+>%9VG6&,3,,-(%&XCT)K!\+>)W\
M1OJF;">V6TO9+5?,4<[, Y()^;.3CTQ714 -DBCFC,<J*Z'JK#(/X4UK>!PX
M>&-@_P!X%0=W&.?7BI** &111P1+%#&D<:\*J* !^ ILMM!.R--#'(T9RA=0
M2I]1GI4M% $<D$,I!DB1R.A90:DP ,#I110!$+6W&W$$0V_=^0<?2E6W@165
M88PKC# *,$>]244 ,BAB@B6*&-(XUZ(B@ ?@*)(8I<>9&CXZ;E!Q3Z* (W@A
M>$PO$C1$8*%05(^E(;: HB&",J@PH*#"CT%2T4 1FWA9R[0QECQN*C--^R6V
M,?9XL=<;!4U% $7V6W))\B+)Z_(.:/LMOQ^XBXZ?(.*EHH C%O""2(8P2V\G
M:.6]?K[T-!$V_=$AWXW94?-CIGUJ2B@")[6WD@\B2")X?^>;("OY4K00NBHT
M4;*O"@J"!]*DHH C6"%'WK$BM_>"@&D>W@D;=)#&S>K*":EHH 155%"JH51T
M &!3/L\.6/DQY9@Y.T<L.A^M244 -"('9PJAFP"P')Q38;>&W#"&&.,,=S!%
M R?4X[U)10!0U/2XM1^S2;O*NK27SK>8#)C;!!X[@J2I'<'L<$6S"C_-)'&S
ME=K';U'I]*DHH A^RV_'^CQ<=/D'%.^SPFX%QY,?G ;1)M&['IGKBI** "BB
MB@"-;>%'WI#&K?W@H!H^SP_://\ )C\[;M\S:-V/3/7%244 1"V@4,%@C ;J
M @YI/LMO@#[/%QT^0<5-10!%]EM^?W$7S=?D'-'V6WR#Y$61T^0<5+10!#]E
MM]A3[/%M)!QL&,CH:>88BKJ8D*N<N"HPQ]_6GT4 ,\F+S/,\I-_][:,_G34M
MH(YGF2&-97^^ZJ S?4]ZEHH A^R6V"/L\6#U^05*JJBA54*HZ # %+10!0FT
MM+K5K>^N6$@M-QMH\<([#!<^K8) ] 3ZU>(#*00"#P0>]+10!5FLU6SDCM(H
M(I#&8T^7"J/3CMSG%9?A#P[_ ,(UX=L=-E-O+<6L*P&YCCVF11TSW_#)K>HH
M B:V@>=9VAC:9!A9"H+ >QZT&W@9R[0QECU)49-2T4 -CCCB7;&BH.N%&*=1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7+^/M.OM2\.1KI]LUU/;WUK<^2C*&=8Y59@-Q S@'J
M17444 <=#;ZD?B3+K,FE7,=F^BI;;MT9Q*)6<I@-UPPYZ9[]ZY+3_#FNZ1H/
MA.]F\.?V@^F0W-I?:9(T3/LD<,)(\DJ2-H[YP<5Z]10!D^'H/*TYG_L>#21-
M(9!:1J@9<@#+[/E+G&3C/&!DXKCM0\,ZS?/XZTR.T,2ZL\=Q9WCNGE,5B10A
M&=V=R8/&,<Y['T>B@#S^SBO=0TJ\9_ L6D7R64L3.! 6DD9=NR(J?NY.2S$=
MASU$5YH^KR?"_P -:4FE3M?V3Z>)X-\>4$#(7.=V"/E.,'FO1:* .0BM;^/X
MCZEJITZX^Q2Z5#;QR@I\TB/(Q7&[/1QR1BN:TWPK</X+\-:7J^D:G:WEC!,%
MOK&91/92[AC:5;E6!/J/E&0*]4HH R?#$>K1>&M/CUQU?4UB G90!D]LXXSC
M&<<9SBN CTWQ/=W'AV]O]!NWU"QU9Y;MQ<1"+85E4&%=^ @#+G@'_>.:]5HH
M \LOM!UR?P+XOT^/1[@W>H:Q)<VL9>/YXVD1@V=V!PIX/-:T5OK.C^+_ !#<
M#1[J^L=<CBE@EA>/=!(D6PQR!F&!P"",BN]HH YKP%8WNG> M'T_4;62TN[>
MU6&2-F4D$#&<J2*QO!*>(]$TRS\+7NAO_P 2]_+&J>:A@D@#$A@,[]Y7C&.#
MR3VKOJ* /+X?#>LI\.]1\"RV$CRO++%;WV5,+PR2EQ*QSD,NXY7&<CC.<UK0
MZ5J-KXG\43C3KE[6YTRWMK:7<A\UXUD!'WLC[XY..]=U10!Y=HFD:_X=N?"N
MJOH]S<I;Z(-)O;6)XS+ X*L)%!;:P)7!P>F#45SH>OW'@?Q-8C0[E;J^UXWE
MO&9(OFB^T1R9SOP,!#^F,UZM10!R)M-1@^)IU9-.FEL;K2([8S*Z 1.DKN0P
M)ST<8P#S^=<U#X:UY?#EI,FG2)>Z;XCEU06;R(#<0M)(<*0Q4-MDR,D<BO4Z
M* /-?%7A_4O$$VO:O::=<*\^@-I5M;R%%DF=W+EB"V%4<#D]VXZ9T9[#5'\5
M>&[Y-*F,%II=Q!.7*821Q'M4C=D_<.<9%=S10!P'A+0;[1]>MWTV"_T_19;5
MS=Z9>2!X[:?*E1 <D@??S@[>!WP!J>,M&AUF;3XI[&_98A*\>HZ?)LGLY?E"
ME>02&&[/!' R.]=710!Y<^D^)K&?0M:U714\0RK8O97]N!%YJ?O-\<JACM+8
MX8 ]:T[S2=1BU'PIJEGX=2&*SNKAYK"T,2&%98F12>0I.2"V.F>,XR>^HH Q
M_%4%Q=>$M7M;6W>>YN+.6&*)" 69D(')('4URJ:3K%E<^#=:33YY/[-L6L;Z
MS#*9$#H@WKSAL,@S@Y(Z9KT*B@#R_7_#&K7FF>++ZUTZ9[G6KRR>"T#(&6.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-9V,%NT\D[1H%:65LLY Y8GU- %BLG^WX/\ A+!X=-O<"Y-FUX)2%\MD#JF
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M6_6KAEEC ("E3#C&&/0=S5O2K/6]%TZ*PLM&TQ;>( *)-8GD; &!\S0$G
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M#/BE\2Q1+&NE:40HP"VK2L?Q)@R:KZE;:UJ^GS6&H:!HES:S#;)%)J4A!_\
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M%2SM](FE-I*\R2O.S#8KC'W5VEL@\Y(]*Z>L'2/&.B:S!?3VU] (;.=H79I
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M;?2M)N5N+>YDG60W#*A";5'*X+$DGGY1UR<=35.^U;3],A6:]O8+>-@2K2.
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M*+B#['X6\":K;6H-C92VS:D(8OF51"5#N ,D([$D=CSVKU 9VC<03CD@8I:
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M@1T!WJ6Z#<>:Z?PK:N?&7BK5;8_\2J]>V\AE^Y+*L>)'7U!RHW#J5/I78T4
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MK[=#[8S7/ZO%!9WOB_7+334O-'N381D*C-$\ROEYL)RRH"A.WJ01G@X[[7M
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M,5<=6V'&!SR!6F^N:9K?CSP3>:6DKPK!>1OMMG'DY2,!&X^4@\$=OQKTFB@
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M916ETYD\R.$$1L=[?.H/(5OO#/9JWJ** "BBB@ HHHH **** "BBB@ HHHH
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M<'>LBGYCM))&T'=QG%.\4>'Q!H_AVTT:_%OJ^ERPVEG*>7,;+Y<@(]/+!?\
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ME61V!\QCM^<G'<_4]J .M@\61/=VD=SIU[:V]Y;/<P74J@Q[$ 8[\$^6=I!
M/Z'BBU\617-WIJ-IU[%:ZE$\MK=L@*%57=E\',>5Y&[\<'BLO2K#Q3J/A]M
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M.L/W%).=H.!D#.,X&<9P,T 8%OXZLKH>''CLKKR=?7-M*3'MC;:6VO\ -PV
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MA\Q6!./DRLG'7!'.*T]=TWQ)K_AD1R:3:VETUY;3+:1W*N(UBE5V+28&2V,
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M;B:&!XY-\3='5@V" >".H]#5\^,8HR([G3;NTFEE*6J7+1Q^>@4,9 2V HR
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M(SA5.!GJ17/:QXLUG0[KQ%ICM:SW-EI#:O97#PG#QKD,DBAA\P8<$$<'IQR
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M;B^MK/2[N4(N\RG#>8B.?N8)XQNX''6@#LKZ^MM-L+B^O)1%;6\;2RR$$[5
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MI$OKP,8(>=SA02Q]L 'K7.ZOXBOTU[6--MY8+(:=I:WT4DZ;A.Q+YSR/D7:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5B^)_#=OXGTM+2:>>VEAF6XMKJW;$D$J_==?S(^A-;5% '-Q>&+QM-
M>WOM>N;V>9T^TSRPHOFQ*<^5L4 *IR<]SD\^C!X*M/M^N.T['3M:3;=Z>$ C
M+%=I=3U#$=2.O'?FMZ\O[:P6$W,JQ^?,D$0/5W8X 'K_ ( U9H Y72/!;65B
M=/U/6[W5[!(&MH+>Y5%$<;+M(8J 7.TE<D]"?6H]&\*R^&K8"Y\1W][IUE&1
M:6]R$ @&"!N8 ,^ <#)P/3ICKJPM3U^;3_%6A:.+1'AU0S@S^:0T9CC+XVXY
MSQSGUXH Y7X?: ^H^ /#<6I73O;V12?[(T.QUE0DJLA[A3@@8!X&2>_6:5X=
M72-:U6_AOIVAU&;[0]JP78DNU5+ XW<A!QG'7\-NB@#$UOPZNL:EI6H)?3VE
MSILCM&\2J=RNNUU(8$<COVK,N/ PN-/\1V;ZG((]>D,EP1$,QY0(0G/]U1US
M7744 <==> A=3ZB_]M7<2:G8)8WD<<:8D"JRJP)!*\,<@=:LVO@T6FHZ/?QZ
MM=^?I]F;%V*1_P"D1;E;!^7Y>5'(YQW[UOWU_:Z;;K/=RK%&TB1*3W=V"J![
MDD"K- %+3;*XLA=?:-0FO/.N7FC\U5'DH<8C& ,@=B>>:R-0TM[/QI:>)849
MT:T:PO%49*H6#HX'?#;@?9\]C6S9RWTEQ>+=VT4,22[;9DEWF1-H^9A@;3G(
MQSTJ:YN8+*UFNKF58H(4,DDCG 50,DF@#&M=&71M;UK77NI9CJ(B,D"PYV^6
MNU0N.22#SZGTI/"6B2Z-IMT]T +W4;R6_N5!R$>0Y"9[[5"KGOBMN"9+BWCG
MC)*2('4D=B,BI* ..U?P!'JTVO\ _$XO+>VUN-5N;=%0@.J! P8C(& .,]OP
MK0@\,R0^)+;6SJ<LL\%@;';)$N'4L'+'&/FW*.F!CC'>I/#NOS:W<ZU!/:);
MMIM^UG\DI<. B-NS@8^_TK=H QO#6@?\([8W%JMVURLUS+<[G0*0TC%F'';)
M.*AN?#1_X2-]>TV]:SO)X!;W(,8DCF53E25R,,N3@YZ'!!K6CO[674;BPCE5
MKFWC225!U17+!<_78U6: .3D\"V\4>BG2]0N+&XTIYFCG")(9?._UN\$8)8\
MY['MVJ$_#V#^Q=1T[^U[TF[U(:FLS*A,,P<."!MY&5&<_ABNRK"\/:_-K5YK
M=O/:);MIM\;0;)2X<;$?=G Q][I0!6U3PE)J]G?6%YJDD]A?1JEQ%-"K,"
M60C 5CCT(!Q@"BZ\%V]SJNJ78O[J*#5+%;*ZMH]N&"JZJP8@L" YZ'KBNFHH
M Y"Q\#S65]I%\VOWDUQIEJ]I'OAC"M&=N 0 .FP9.<GU%,@\!"VT#1-(35)3
M%I%XMY#(T*[G92Q ;G&,LW3';\>RJHTM\-6CB6VB-@869YS+AUDR,*$QR",G
M.>U '*7GP\6:'7;.TUJZM--UHO)<6BQ(X65Q\[(Q&0&ZD?EBM1/"[QZ_8:L-
M2E>6RLFLD62)3O5BI+-C'.57I@5LV-_:ZE;&YLY5EA\QX]Z]"R,4;_QY2*LT
M <:G@$)X<M=%&JR^3;Z@-060PKN+B4RX/.,;B>W3BN98SS^)-1N#K>JZ7J+7
M;;+230Q=$*N$5HY#&3M8+N #8&[UR3ZQ10!4T[[8^DVO]H!!>F%?/V# #X^;
M R>^>Y^M8UEX3\K4=,OK^^-]<:;;O;V\K1!'97 !,C _,<#M@<DX)KI*PO%.
MOS>'K.SN8K1+A9[V"U?=*4*"1PFX#!SC/3B@#*M_AY;V_A[3]*75+MGTN=9]
M.N2J;[<KG P!AA@D'/4>G%7+SP58ZO;:JFL2-=SZI EO-*B^7L1"2@C'.W#$
MMR3S[8 Z:B@#E(O"%XVBWEAJ/B.]U"2XM7LTGFB0&*)AAL!0-SD8^9L]/KE=
M-\%C2=7L]1L]1DCEBLX[.Y18AMNT3A&D&?O <!AC\N*DU_Q<FF>'&UG3H8KZ
M%+Q;1_WNP F80L1P<X8]..G6NFH R/$7AZW\164$,LLEO/:W"75K<18WPRIT
M89X/4@@]037/^+-%%OX6\3ZG=3_:]4NM(ELU=8]HVA'VQH@).2S$]22<>@%=
MO10!R?A[1/MECX?U"^O3=?8+93:H(@FQS'L+/S\S@;E[ 9/&>D,GP_C?POJO
MA]=6NA8W\TD@4HA, >0R,JG'.6/5L\?G7944 <]<>&7.O1:[9WYMM2%L+6X;
MR@T=Q&#D;DR,$'."#WP<BJS^"+=8M(CMKR2+^SKYM0+,@9IYVW;F<\==[<#'
M48QBNJJKJ,EY#IUQ)I]O'<7BH3#%+)Y:NW8%L''Y4 8*>$KB#5M1U*VUB6*X
MO;J.Z8"$%04C\L+C/*E>O?/((JO<^%KS3[&7^Q-1EM;^[U,7UP\$*".1B I4
MJ<[4PH)Y))'4DUTW]H6Z7\%A+(BWLT+3+"#D[5*AC] 6 _&K5 %74K1[_3I[
M6.YDMGD7:L\6-T9[$9XR*P+KP1;:F-8DU&XWW.JV(L9I8(A%B,;L'&3ELMU/
MH!@5U#9"G: 6QP"<5B>%->E\1:5->36J6TD5W/;-&DF\9C<IG.!G./2@"H_A
M!C<:5J$>JS#5].C:$7;Q*1-&V,HZ# *\ C!!!&<]<Q7_ (!L;_29;=KNXBOW
MOAJ0U"+ D2Y' <#&,!0%V^GOS7644 <G?>#)]4T&33]0UVZN;B:6*6:[>% Q
M\IPZ*JJ JKN&>A)R>:NZ1X9_L;7-0O[6]9;>_<2SV0C B$N,-(O.5+$9/8_7
MFM^JFJ7<MAI5W=PPK-)!$T@C9]@; SC.#CIZ4 9NM^'#JVK:5JD&HW%C=Z<9
M0C1*CATD # A@1GY1@]JXG7?#G_".1^&K"UU2YD'_"1&\#RQJWD*RS$DX ^7
M<^"3Z]17H/A[5&USPWIFK-$(FO;6*X,8;(3>H;&>^,UI4 >=?$#0Q:^!/%-X
M\C7>JZE D1*1XR%/R1QH,G RQZDY).?3HO\ A'SJ4T.HW.I"ZFBM9(+2580%
MC$@ =R,_,Y  SP!S@#)KHZ* .3?P):S>";+PU-?7.VP\LVEY%A)H7C^XXQQD
M=/<4ESX'_M709[#6]:OM0NY61TOMJ1/ R'*&-4  (/.>2<\G&,=;10!R\GA*
MYO/#VHZ;J>O75]/?VYMI+J2*-2D9!!"(H"@G)R3DDX]  Q_!9;4K:^CUBZAD
M33AILXCC3$T0)(/S [6R3DC]*ZNB@#C[/P$EC;>'4BUF]$NAI)%#+LCR\3J%
M*$;<#A5P>M32^!K.]'B.+4+A[BWUUD:>,*%\LJH52A]@JGG/(S[5U5% &!:^
M')A>65[J&HM?75A"\5I(\(7:6 !=@#\SD#&>!@G@9K,A\ B#P]I>C)JLIBTV
M_%]%(85W,XD,@#<XQN8],'&*ZFZO[6SFM89Y522ZE\J%3U=MI; _!2?PIL,M
M\VI74<UM$EDBH;>99<O(3G>&7'RXXQR<YH ;J^GG5=&O-.,QB%U"T+2!<E0P
MP2!ZX)K%OO"'V[PA9>'7U&18K7R,3K$-["%E9,CIU5<^OM73T4 >8^(]]QXS
MN?M.JZCI3Q0Q16^=(%Y#<<%B\9,;;3EMI .3M&<\8Z"QT'4M4N-"U?5-18W>
MEO.8LVHB,ZR IND3/RDIC@8P>H[#KJ* ./E\!1SZ1K%A)J<P_M+4!J7FI&H,
M,P9&&T'(*YC7@^_-6]3\*2ZM9WMA=ZK)-97\*Q7$<T",>!@NA& K'Z$# P!B
MNEHH PK'3]1MO%-S,M].^D&U2-+615V12#;@H?O'C=N)[D8Z'&'XS$C^-_!@
M@G\EXKBY=I?+WK&#"P&X=@Q^7J,YX.:[FD;(4[0"<< G% '+7W@2QU33=1AO
M+F<WM_<)=/?0_NY(Y8P!&8^NT*%  Y[Y))S4-YX(N=4\-WFE:KXBO+V:[58W
MNGAC4I&IW;450%!) R3DG\!C4\*Z]+XBTN>[FM4MI(KR>U:-)-XS&Y3.<#.<
M>E;E &%KWAV37K;38I=0:%K*[BO-\<0_>21G*Y!/"YZC]:C?PP\6OW.M:=J#
M6=U>PI%>J(@Z2E!A7 )^5P"0#DC'4&KFH:W%;6VJ_9!'<W>G0>=+ 9-@&5+!
M2V#@D*3T[CUJ30-3;6O#FF:JT0B:]M(K@Q@Y"%T#8SWQF@#(C\$VUI=^'Y+&
MZ>"'1%D$,10-YID7#ESU)/)XQR2?:IQX8==;UG5$OV$FJ6\=NZ&($1J@8*5Y
MZ_.V<UT-5K2_M;Y[I+:59#;3&"7;T5PH)'X!A^/% '-P^"!!IWARR74Y/+T&
M19+<F$9DVH4 ?G^ZQZ8JK_PKI5MXK5->OTMK;4_[2M8Q'$?*<NSD9*DMRS8S
MZ]Z[>B@#D)_ PGTSQ%8/J<GEZ[*9+AA$,QDJJ$+S_=4=<TZ[\$S/K$.KZ=KU
MWIM^;9+6[D@BC9;E%^Z2K@@,.<-76T4 <EJ/@?S=4M=4T?6KW2;^&W%K)-$J
M2_:(@<@.K@@MDD[NO)KI;*T6QLX[9'DD"#F21LLY/)8GU))/XU8HH YN'PIN
MOM+N;^_:\.E2/):,T060%E*X9P?F4!CQ@=!G.*I)\/;0:!)I#:E>-"EX;VQ<
M! ]G+YC2 H<<G<Q^]GCBM34M?FL/%FB:-]D1X=36<^?YIW(8TW8VXYSD<Y]>
M*W: .=D\)6VHO>S:U*+Z>[LC8.RQ^6JPDDD* 202<$G/4#&,57TGPC>:=8FT
MN/$=[J$<4)@M!<1I^X4C;D[0"[8XRQ]>.37544 <=IG@%-'N-&N+'4Y8I]-M
M?L;.(A_I4(QM64=]N,@C!YKH->T:W\0Z#?:1=,ZP7<31,R'YESW'N#S6C10!
MRUKX0NHM<M=:N-?NKF_@LWM-S0QJC*Q!Y4#U4'@YSWQQ5>W\!"VT'0M)35)#
M%HUVMW [0KN=EW8#<XQ\[=,=OQ[&B@#F6\'132^)C<7LDD?B"(1W"*@7RP(_
M+&P_[OKGG\J?!X;O;:TM8%UIYQ%;&VE6YMD>.9> "5&WD 8'U.<UT=% '*V'
MAR[T34-"M-*U"Z72+"V:">VD52DB[3ABV,[]VW@<  ],@'0\2Z!_PD>GPVAN
MWMEBN8KG<B!B6C8,HY[9 S6U5:]O[73TB>ZE6,33)!'GJSNP50/Q/\Z ,+7O
M"3ZMJEGK%CJ]SI6KVT1@^TVZ*XEB)R49'!!&>1Z&IF\.7"QK'%JLCHT#0W"W
M<*S+<%B278<?-R>!\N#C& ,=!4<[2)!(T**\@4E59MH)]"<''Y&@#FK;P1:Z
M?=Z)/IU]=6W]E61L57"OYT)*G#$C@Y0'(QWQBI]*\+MI6E:K8IJ#2?VA<37!
MD:( QO*27P >1D\9Z>]6?">N-XE\+:?K+VXMVNX_,\H/NV<D8S@9Z>E;- '&
M2?#Y!I.A06>KW5IJ&AQ^59W\4:EO+*A2KJ<JP( _*KM[X/\ MMIIP?5KP7UE
M>"]%Z50O))M*'*[=H&UL  <8%=-10!R,O@>2/7KK4=,\0:AIT-^5:^M80C+.
MP 7<"P)C8@ $KS]#2S^!U35=1O-+U6XT^'4X1%>6R1HZ.578KKN'RMMX..OU
MYK0\-Z_-KDNLQSVB6SZ=J#V6$E,@<*B-NS@==_3%;M &;H&D+H&@6.DI<RW$
M=G"L*22A0Q51@= !T%:5%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %<UXUM;R\TVRAT^XLTN_MB
MM%;WH)ANRJ.QB?'8@%A[J*Z6JU[I]EJ,2Q7UI!<QHX=5FC#A6'1AGH>3S0!Y
M/>G3M4TOPX;C1$L)K?Q4+6ZM9MLBQ.5<NJ-C!C)*D=N@[5O:?%8^(/$GB[3]
M82)H[18%L@2 (;5HLB2(_P .6W'<.X'/ KM9-%TN:P%A+IMG)9AMXMW@5H]V
M<YVD8SGG-%WHNE:A-'->:;:7$D:[$>6%6*KZ D=/:@#S#PSK4U_<^%;+QDZ-
M!=:&\L(O,>7<3^9C+!N&?RMI&?[S>M.UZ.;29O!D/A25]2FMCJ*V;7<V\R8B
M;@-CG'(7MP.<<UZ=J6CZ9K%NMOJ>GVM["C;ECN(5D53Z@$4/H^F2S6TTFG6C
MRVPVP.T"EHAZ*<?+^% &)X7U/PU#X6M]1LKB&UM;A]LLETZQR&<G!20G'S[B
M1C\ ,8K=U2-9M)O(WW;6A<':Q4]#W'-9FI>$-$U#3+FP_LO3XH;I]\^VT3+'
MNPX^_P \,<XK:F@BN('@FB26)QM9'4,K#T(/6@#QRSAM=$^&?A?70QB:^^QV
M^J7DSO(HMSD_.-P&W=M!Z<$@\5MS:)&D&JQ:)XAT_P V]GM94LUBQ8K(&R$(
M5FP)0N& //ISSZ!'I.FPZ<VG1:?:I8L"K6RPJ(R#U!7&*@B\.Z)!IO\ 9T.D
M6$=COW_9EMT$>[^]MQC/O0!Y=JS6E]X<,%]H46FWMEXELEN[8E9(49FBRT;8
MP$9"I(X^\<]:W)] TC5_BC<:?/&9-/\ ["@E6".=ECW"=P" I&,;1TXXKNFT
M;2WT^33WTZT:SD.7MVA4QN<YR5Q@G(%+%H^F0WJWL6G6D=TJ",3K H<*.-N[
M&<>U 'E][?SZ-H_CR>WEG6&+78%G='9GC@98/-*GJ/E+<CIG/:M'Q9IGAIO"
MOBJYTF6&7S]%>1K:W96MUV*2DNT# <YX;N%XZ5Z!#I&FVYN#!IUI$;G/GE(5
M7S<]=V!\WXTRQT/2=,LY;.PTRSM;:7/F0PP*B/D8.0!@\4 >?7%U80:OX;T>
M673+;2+G3':-;F$/;RW/[LD$!E&[:21G^\>Y%1V8M].U[PQX<N-4_M'0Y6O&
MCDE_U4LR[=D.22&5-SX!)Y '517H4WAW1+C2X],FTBPDL(SE+5K=#&A]0N,#
MJ?SI]UHFDWVG1Z?=Z99SV4>-EO) K1ICIA2,#% '*?#N&UM=0\8VMH$6*/6W
MVQH>%'DQ< =@#D8[8Q5+QW%=1:CJ&HK:6NL:;#IZK?6#/LN;1,R'SH&/&2,Y
M'!/EC!XKO++2M/TWS/L-C;6OF$%_(B5-V!@9P.>*9=:+I=[<_:;K3K2>?:$\
MV2%6;:#D#)&<9[4 ><Q/!#XJ\<:KI=I!_:?]E6US8!H@)&E:&8\#KN.!GUI=
ML2Z!X#UO0VSJ-W=VL4\R'+W4;H?/$I_C(PS'.<%>U>E'3K(Z@-0-G;F]">6+
MGRAY@3^[NQG'M45KHNEV5T]S::;:03N26DBA56)/7D#OW]: //M!ET;7]-EN
MM:O3;^(++69/-:.0+<(ZS,(XESSL*;5VC@Y/?)K,6^2V\6Z]#J\*GPU/KVRZ
MG!_U<_DP^4)/2(GJ1WP#QD'U/^P]).K?VM_9EG_:.-OVOR%\W&,??QGIQ3#X
M>T1HKB)M'T\QW+!IU-LF)2#D%ACYCGUH N/;0/:FV,,9@*[?+VC;CTQTQ7D&
ME7D/_"#_  S>2Y3[6=3B1F:3YRN)0P/?&=N??%>PPP16T*0P1)%$@PJ(H55'
MH .E9R>&=!C=W31=.5GF%PQ%L@+2C.'/'WOF//7DT >5ZOIEJWACXCWK&4W.
MGZE)+:2&9R8'6&)@R\\'/?\ "NP=$F^+.G>82ZW'A^<R(S$JW[V(?=Z=":Z@
M^']%:.XC.CZ>4N&W3J;9,2GU88Y/UJ1-&TN.ZBNH]-LTN(D\N.58%#HO]T'&
M0/:@#R[PUIJ2?#6QM]'DTVVU)]3F/D7"?N[K9/.5ADV\XVJ<?[HKKO!FM6']
MG36]Q:QZ+>?VA);26,LZE?/VJQ6$\;E((( ]3Z5OMX?T9HY4;2;$I+-Y\@^S
MIAY/[YXY;D\]:KWWAG3+U+&(V5K'%9W"W,86!=R.&#94_P ))')')&?K0!6\
M=7=I9>"]1EOIKJ&W*K&SVKA),LZJ &/ !) )/0$UP-Z4M[GXA6(>UMD&AQSI
M;6,I5(Y1',>,8RV%7)P,X&17K=U:V][;26UW!%/;RKM>*5 RL/0@\&J(\-Z$
MJ;!HVG!#"+?;]E3'E9SLZ?=SSCI0!P5E:1:3XE\$7-@CBYO])N!<DR$FXV0Q
ML@;)YP>GIVXK%>2PU7X;>'-=N6BDU>36;4W=PY E$OV@;T;N .RG@ #C@5ZV
MNAZ2DMM*NEV2R6HVV[BW0&$>B''R_A4#^%_#\EU-=2:'IKW$S!Y96M4+.P.0
M2<<G/- &?\0K_4-.^'VM7NE%Q=QVQ9'C^\JY&YA[A=Q_"L2]M+2T\5>$9O#R
M1BVU%9H[N.+[ES;>5N#N/XB#MPQY^?&>:] VKMVX&W&,8XQ5.QT;3-+9FL-.
MM+4L,$P0JF1G..!TS0!X_':V$'P5N4MXH(9FU=4D\H!7VC4<+G'/ Z>E;&LB
M;PUXA\7Q^'U>*1O#BWHC1BQ,X>5?,YSEL#KWQ7H;^'=$D29)-'T]UGE\Z56M
MD(DD_OMQRWN>:FCTK3H;W[;'I]JEWL\OSUA4/M_N[L9Q[4 <#86.C7TUMJVF
MZY:,MSI\J/;:>AC-PFW.Z7]XS;E./F.#DX)YK2^%^CV,'@[1M81':_NM.A2:
M9Y68N ,@8)QQGTKI;7PYH=B+D6FCV$ NO^/@16R+YO\ O8'/XU<L[&TTZV6V
ML;6"V@7I%!&$4?@.* /.M8>UUOQAXDT+6=0L+,);PFR-Y%EEB:/YI86+J%8/
MNR0,\+Z4_1KBPO\ Q/>:1X@O([Z"TTJT:Q-^ !<(RMYD^UN"Q(4$]1CMDUW6
MH:'I.K2PRZEIEG>20',3W$"R%#[$CBDU#1].U"6&ZN=,LKNZMOFMWN(E)C;V
M8@E>?2@#RSPU(%TKX9W3R'+WMW$\SMRX*SX4L>N3CKWHU.2"7P9\3UMYQY<-
MX[Q"&7 7]S'TP>F<\=,YKMO"_A%;3P19Z!XBLM.OOL[,Q3'G1$EV8'#J.1NQ
MTK<.@:,T4\3:38M'<$&9#;H1(0,#<,<X &,T <;<V6FO\6-&EN[:U8OH4C;Y
M47YG66+:<GJ1DX^M4X++^R];U3P)Y!-MJEPM[:R[2=MLQS,A/;:4*KW'F)Z5
MZ&VDZ:[VLC:?:,]G_P >S&%28/\ <X^7\*S=#T_6#=MJ7B&2P>_$9@A2Q5_+
MCC+;F.7YRV$SV^04 .DNO$,.M):VVB6!TA61?M)OBLBI@9(B\O''( W<X[5Y
M=)HMK+\/-<UJ!IDURTUB[-A/%,V])?M)"HJYQ\Q(!&.<U[;5!-$TJ._:_33+
M-;QFW-.L"ARW3.[&<X[T >5^.+NWET[Q9>P2JM_8RVJO/<2#?!, A"6P&"J\
MDEL\DMP16KXIFDL=8U'6I+:UUK0UD@6Y,3XN].90A!C)X9#E6*C!^8^]=[<:
M!HUW<SW-SI-C-//'Y4TLENC-(G]UB1DC@<&E.@Z0;D7']EV7GC;B3R%W?+@+
MSCM@8],<4 ><W?V3Q%J'BFPUC6;/3;VSO?W,DL>+FWA"H8WA<N-H/)X'4G.<
MU,LMMK=WXWMM=*RW5A;JELEP-K10>0&$B@_=+.6)8<YP.PKT&ZT/2+[4(-0N
M]+LY[R#'E7$L"M(F.F&(R*2]T'1]2NX[N^TJRN;F)=J2S0*[J/0$C(H S/A^
MRO\ #KPV58'&F6X.#W\M:Y/09=&U_39KG6KTV_B"RUF3S6CD"W".LQ$<2YYV
M%-J[1P<GODUZ3:VEM8VR6UI;Q6\$8PD42!54>P' JL=#TDZM_:QTRS_M'&W[
M7Y"^;C&/OXSTXH \X8QZQX1\;WVI,8]:TZ\N_*GSB6U\L9@\L]57 4C'#9/7
M)J32=+37/%VHP:_ TLLWA^QENK=W;:)F\S?\N<#!''I7HDVBZ7<7POIM-M)+
ML8Q.\*E^.1SC/';TI6T?2WNI;IM-LVN)EV2RF!2[KZ,<9(]C0!Y/I$*Q^%_A
MOKF^5M4N+Z"VENGE9G>)HY 4))^[\HX]J=-H.G:AH7Q!NKJ:X%QIVHW,MI-]
MI?=;NL,;*R\]<\>_2O41X>T0000C1]/\J!M\*?9DVQMZJ,<'W%87AWPDUGJ>
MMWFKV&FS/>ZBUY!(A\QD7:H"G<@Y!7/&>30!RR7#ZWJUQHWBF\L;2Y;1[1XE
MOH<G+1GSGB.]0KA\Y(Y^4>E6+'1[.]\>:98WEY/JMJWAIMTD[L!<@3(H=ES@
MY&#[\&O0=2T/2=8:$ZGIEG>F$[HC<0+)L/MD<4]])TV2]^VOI]HUUL\OSVA4
MOM_N[L9Q[4 >7Z'#J=]X$\.#3Y+.^N;2:]VZ;J+$I=Q1S/&!N.<,B[=I.1S5
MNQU#1M9'AZU2T>!_LMY)]@U&13;P!90DA<8_>,K A<$?+N)(KOAX;T-88X5T
M;3UCB8O&BVR (QZD8'!/J*DET/29Q:";2[*069S;;X%/D'_8X^7H.GI0!Y%H
MZV6IZ+\,YM1^SW;+=7,$DD^'^01S;5).>/E7@^@K:U*ZO=-U;XEW.CL[7<6F
M6<L&&+[6*3$LH/H.0!Z5Z"= T8VB6ATFQ-LDOGK";=-BR9SO Q@-SUZU/%IE
MA!>RWL-C;1W<PQ+.D2AW_P!Y@,G\: .!N8+:VO/ ^H^'<![^80W!B;_CYMFA
M9W>0C[Q4J#N/()Z\US;V%O!X&O\ 5XS+]OL?$S+;3M,Q:)?MJH0,GH5)!]>]
M>O6>B:5ITCR66FVEL[@AFAA5"03DC@=SS47_  CFA_9FMO[&T[R&?S&B^RIM
M+_WB,8S[T 0^+;RVL/"&KW5Y/=06\=K)YDMH<3*",90GHW/!]:X?2+2SD\>S
MZ/(ME#97OAY#):6LH*EO,PK,1@-)M.=P [=<9KTV2WAEMFMI(8W@9-C1,H*E
M<8P1TQCM5.TT+2+"2&2STJRMW@0QQ-#;JAC4G)"D#@$]J /(TNI[#3=(NYK9
M6G\%W1M=5D*']Y"7\M6']X[")<GD'![UU5_'8QQ:(+J%A>ZUJ3W:VS,(X9#Y
M;LJSY!R%3;\H&2X'J37=O96DD=S&]M"R76?/4H")<J%^;U^4 <]@!4=_I>GZ
MK L&HV-M>1*P=4N(ED4,.A (ZT >.ADN/"C6PO 5MO&:01?9I2BQQ&X7A &X
M7DX].U=3%8Z78_$>#PQ);1II(TQ[NTM9F+QRW#S'S#AB<L%Q@=@S8ZUV,GAW
M0Y0XDT;3W$DOG.&MD.Z3^\>.6]^M2ZAHNE:M'%'J.FVEVD+;HEN(5<(?49'%
M 'EN@V<\_A.*VT2:PEFMM>OGCL+UBT-XBO(-A//(!W G/*Y[9KO? ][!>^&4
M:"PET\Q7$\4MI*P;R91*V]0PX*AL@8[8K0_X1W1/*$7]D6'EB0S!1;I@2'JW
M3[W/7K5^WMX+2!(+:&.&%!A8XU"JOT H \UM[/3K?Q-\2&6WMH[@1QF,A5#?
M-:;FQWY.2?7FJ>@V5OIT_P +[RU#)<7MB8;F3>294^R;@K9/(# $#MCBO39M
M&TNYN9;F?3;.6>:/R99'@5F=/[K$C)'L>*8N@Z.AMBNDV(-K_P >^+=/W/\
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MY+>2#2+"-[9=L#);(#$/12!\OX4 >:-!8:Q)XCTO4=8M-+NM-O-EN\J$W5M
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M(QUK(USQ=::IX \0ZGX;U5EN=/MY6+K%M>*1%+89)%R.G<?2N.LEETSP_P"
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M!(!/# ''OWJ]65X:G:?PYI[/;7%NRP(ACN(S&X(4 Y4\CG/7T]*U: "BBB@
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M25/RGC!YZXZU5?QEJ.I:AX+DTFU@%EK44L[K/,5?Y82VPX0@ $@Y&<D#H.2
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M)7CM0!V5%<WI?BIM8U%X;*U@D@AO9;.Y(N?WUN4WC<\>W@,4P/FZ,I]0.DH
MYZY\)POJ]SJ5IJVJ:?+=LK7$=M,OERL%"@E75L': ,KCI6U9VD-C;+! &" D
MY9BS,2<DDGDDDDY-<)\1[C4KB%QHUSY<^AHFJN@./.=6RL1]0464D>NSUKHK
MSQ=I]IX)'BE0\MDUND\:IC<V_ 5?8Y8 ^E '045S \4WR>)Y=!FT=3<I9?;@
M\-T&1DR5Q\RJ<[ACZ$'VK-TWX@SWFAVFLW.B?8]/O8XQ:RO>*2\SOM"$8RH
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M!P4SM7$F<87OGK6;J$EY<?$_P7<7NEP6CO#>;72;S'QY0.Q_E&",]B1R>?4
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MQ.X^ORB@#O**Y"R\<B[U32H/L*M:ZHI,4T$_FO"=NY1,@4!,CC(9L'CWKKZ
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M4DF@C<D*220Q'RL<+DX&<=* ,BY\#ZA'I5M+936C:LFN'6I5E9EAD=MP,88
MD *P .#]W..:@U#P7X@U"V\8I)/IF_Q!'"D>UI (2L80Y^4YZ<>O7C.!Z&"&
M4$9P>>1BEH YO6-&O-7L+.RN]/TN^LS$R7EI<R-M+87:R-L)R,-V'WO:L6#P
M9K.EVWA62QNK:ZN]%-PC)>2N%:*8?=#A6/R *!D<@=J[ZB@#SK_A"O$<>GW<
M2WFFRM-KS:H\#>8L5Q$W6*3@D<X.,,,C!S3+SP/X@N-)\1V0GTL_VKJ$%[&0
M9$";#$2IX/\ SRP/7.>,8KT:.1)8UDC=71AE64Y!'J#6;J>OVFE:EIEC<1SF
M74IC!"R)E0P4M\Q[<*: ,B?P[J-WXQNM6D-K':7&D?V<561F=6W,V[&T CYL
M=>V?:K_@_2]0T3PMI^E:D]J\ME ENK6Q8JRHH4$E@.3C/3CWK<HH R_$NE/K
MOAC5-)CE6)[VUD@61AD*64@$^W-<\/#.MQ:GH>NQR6!U2RM&L;JW\QUAFA.#
MP^TD,&4-]WG./>NUIJR(SLBNI9,;@#R/K0!B^'M"?2KC5;^Y:,WNJ77VB81D
ME$ 4(J D G 7K@9)/ J_K%@=4T2_T\.(S=6TD <C.W<I7/ZU=KF!XWM9+BQ2
MWTK5[JWOB/LUW;6PDB==P4L2&RJC.<L!QR,T 9L/A?7MG@_[0VFEM#;]Z(Y9
M '7R3$-N4Y/);G'I[U7NO VKW<6N.EY:VMY<:M'JNGS(S2".1%50K@J,@A3G
M'][VY]!HH Q]"C\0%&F\02:>LV J0V&\QCU8L^"2>.,<8[YK6==\;)TW BG5
M6O;Z"Q6/S22\SB.*-1EI'P3A1] 3Z  DX - '!6W@?Q%9>%M!M[6_P!.BUC0
M)#]CD(=H9XRI5EDXR-RGL#C'4YXTM8T'Q-K>DV0NY=,^VQ:C;WC1QO(L*+$X
M;:I*EF+$')(';CCG7USQ;IWA^XBM[J*^FFD3?LL[22<JN< ML!QD@XSUP?2M
M%=2@-]'9N'BGEC\V)9!CS%&,X]QD9'4?2@#'O=%U&X\<:5K<8M?LUI:36[HT
MK!R9"AR/EQ@;/7G-8$_@K6YO!FLZ+OT\3W^JM?(_G/M16G$VT_)G/&/QS[5Z
M'10!Q'B/PA?>)+II)X-/AGBGBDL=2BE=;FT "EU&$^;D/C+ '=R!BNWHHH Y
MG5- OAXQLO$VE/;M<):-8W-O<.R++"6W@A@K896]CD''%9.J^![^[\(:_I]O
M+:#4M<NS<SO([".+E<*,*2V%0#.!DY/'2N\HH 9"93$IF1$DQ\RHQ8 ^Q(&?
MRK!\7:)>ZU:Z8VGR6ZW-AJ,-ZJW!(1]F05) )'#'G!KH:* .03P]K"^(/$&I
M,;%UU.PAMHP)74AD#C)&TX!WGN<8[U3L?".L6L/@F-FL6_X1]2LY$S_O<PF+
M*_)Z'//T]Z[NB@#B7\'WEWXGL-:GAL+6^M+MW>_M)&$MS;G<%BD3: >"H))/
MW>.M=JVX*=H!;' )P":6B@#G=)\.@Q74^NZ?IMQJ%Q</*\BKYH*DX1<LH(VH
M%7\,]ZX^;1K[PG\.M7T349]*6QN;EH=-\UV>.%9I/ECDW*  NX_/GCKCBO4J
MY_5_$6GP/<V4VGW6HQ0M''>"" 3+#YGW=ZYR1@@G:&P"": .>T,ZM9:R(I[+
M0[B>\@,*W%KJ<T\J(BLR[_,4D1YXR#]YAP<U)#X(U0?#?2]!^VV]OJVE21S6
MEU'N>/S(VRI8$ X()!'OWZ5V&F:=I=A;YTJRL[:&4!_]%B5%?T/RC!J[0!Q>
MH^'?$OB/P[+#J]_I]EJ<<D4UDU@KO%%+&X<.Q?!;) &,<#UI-2T7Q;K_ (0U
M73=6GTB.[N[5K:-+5I/*&[K(S,NXGT4#CGDYX[6HY)XXL@G+A"X1>6('7 ZG
MJ/SH YB30M5E\4Z!JI6R$6G6<UO*@F8LS2!.5^3H-G?&<^U8I\#:ZNFRR6UY
M8VVK0:W-J]E)N>2(^9NW12?*#@JQ!(KL] URU\2:);ZM9+*MO.7""9=K?*Q4
MY&3CE36E0!Q6LZ#XHU_PY]FOIM+6]:ZMYO+A>00QK%('X8J69F(QG  &...9
M[KPSJ-]XGUB_D>UCM=0T@:<-LC,Z,"YW8V@$?/Z]JZZJ.LZK;Z'H]WJETDK6
M]K$TL@B3<VT#)P/I0!5\*V&H:5X9T_3M2:V:>T@2 &V+%2J*%!RP!R<9Z<9Q
MSC)J>.]#G\1^"]2TVUQ]J=%D@!. 9$8.HS[E0/QK=M+E+VR@NHPPCFC610W4
M C(S^=2&1!(L9=1(P+!<\D#&3CVR/S% '*ZS8W7BBT\/:KI+P)-8WJW9BNMR
MC&QT=&P"58;CQCJ"#BJTGAC6'O/&$Q:P(URVCAA_>N-A6(QY8;#P<YX)]/>N
MS5$0L555+'+$#&3TR?R%.H X"/PIXFTF?1]2T6YTPWL&F1:9?6UTTGDS)'DJ
MZLJ[@P);J.AQ7;6$5U#91I>SK-<\M(Z+M7).<*.P&<#/.!S5FLG5O$$&ES&W
M6VNKV[$#7)MK15:3RE(!;#$9Y(  .3V!P: -:BH+:Z2[L(;R%)-DL0E170H^
M",@$'&#[&L2Q\96.I+=-96>I3BUG>VFV6I.R1.&7W(]J *]EX.6S\?W_ (B2
M?_1KJ)&%KV%R 4:7V.S _P"!-FJ=GX=\4Z-J^I0:5?Z<=$U"ZDN]UPK_ &BU
M>0YD" ?*PSDC)&">_?K[*[BO["WO(-WE7$2RIO4J=K#(R#R#STJ>@#B=5\'W
MFKZU:W\T5A#=VE\LT&IP2,MQY ;)B90H#97*\MC!SCUBN/ ^H7=GXJTU[VWB
MM-6N_MUM/&&,L4V(RNX=,*T8/!.<]J[NB@#B+KPWXE\3^&-0T?Q/>Z;#Y]N8
M8VTY7(9\@B1M^,8*CY1QR>>F"+0O%5[K_AO4]5?2%;2A.DYMY)&,_F(%W %1
MM/&<<X]37;U2N]22VBM)8[>XNTN9DB5K5/,"AOXVYX0=S0!<.=IV@$XX!.*Y
M[2O#P?[9<Z[I^FW%]<W+2F11YH"<!%RR@C:H4>Y!/>NBHH \[L? >J1>#]<\
M-3RV4=G//+<:4T,KLUHQ?S(U.4'"N <CW&*U(?!!A\2Z7JPN\B*V9+]<8^UR
MA_,1R.G#M(WXBMS7=?LO#MM!<7RW'DS3K#OAA:0(3GYFQ]U1CDUJ4 >>>)/!
M6OZR?$\$=UISPZK$BVTUQO,MN%"YB  P$+#=D'J3D&MO3M%U>'QQ<ZY=FR,%
MQI\5JRQ2/N#(S-D KC'SXZ]L^U=134D20L$=6*G:V#G!]#0!YI)X$\20^#KS
MPC:7&EOIOVD2V5S,\@E1//$NQT"D'!S\P;GT'4:OB'P??>(KPRW$6G1W$-Q#
M+8ZG#(Z7-JJA"Z@!?F!(? +8PW/2NXHH *Y/5[!M9\?:"T8S;Z,LUS<-V\QT
MV1I]<%F/H /45UE4I+M+74K:Q2RN&%R)',\468HRN"=[=BV>/7!H NUQ.O\
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MMX[E8UF2,*PC<LN0,<$@?RJS110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6#XJNY+6RLEBOS:-/
M>Q1%8TW2W"G),4?HS8^]V )R.HWJR]<\/V/B"WMXKT3 VTZW$$L$K1O'(N0&
M##GH2/QH \[NO$&OQ>&=>:+4;FWGT_Q##9PF4)(XA=H?D<X.['F-R#GWJ]J%
MUK_A_P 2:EIBZ]>7EM<Z+/J$,LT<1DM9HB <80+L.X<$5-XP\%V]OX=OH=%L
MKZ>YU&_MIYT6=W)V21EWRS<':G7.20*W]3T2*/1=7NH5NKS4;JP>W1Y?FD*E
M3M0# "C+<\#GDGB@#E+:^\0Z=;>!]<?7+F^CUAK:UO;.5$$?[V+<'3"Y!!&2
M23GV'%-6[N[#PG\2KVPNI+6ZMM4NIHY8U4D%8(C_ ! BNE\'^'([;P]X?>_2
M[-WI]I&B07+Y%O+Y85]H[G[P!). 2!@&KI\&Z4=/U>Q)NC;ZO(TMXIF/[QF
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M628M&TB%2IP>>"JG ."1D@U8L_#^GV&LWVJVZS)<7K!IE\YC&6"A=P3.T-@
M9QV^M %C58C/I-W&)9(B8F^>,X8<9XKS+2I[_2/A5X+N;+4[J,SW6GQ2H=A5
MHW=59.5R!@]CFO4[JW6[M9;=W=%D4JQ1L-@]<'M6'_PA6D_V'8:-FZ%C82I+
M;()SE&0Y3YNI /(!H RM0UBZ\.>.IH]0O+B;3-1L'EL8B1\EQ&<O$N!DEE*E
M<GL0*;)<ZO\ V[8^%VO&DG72S>7$OVGR7ED+[3M8(W"G/  ZC.>_5:AHUCJK
MV+WL F:QN%N8"W\,@! /ZFJ7B#PEI?B26UGO!<17=H2;>ZM)VAECSU 92#@^
ME $GAB/6(="A@UZ[MKK48F9)9K<Y# 'Y<\#YMN,\#FL22XDN?C/!9R$F&ST)
MKB%3T\R28(S?7:@'XGUKJK"PM],LHK.U0K#&.-S%F))R26.222223R2:S-3T
MA_\ A(;#Q!9ION;>)[6>,'!E@<@X!/&Y64,/^!#O0!@>,=#U+2SJ/C#0M;O(
M;ZWA\^:RF</:W$<:Y*%<?*2 <$'J?>G_ ! O)8-"T'5H4:.Y@U6TD13][#ML
M9/Q5V!K>'A>Q-_<74DU]*EQ()7M9;IV@W\<["<8XZ=/:FZSI#ZYJ6FQS)ML;
M"Y6\<D_ZV50?+4#T!.XGU50,\X -RO/&U?4](U;Q!X>NM0GGOKD1S:++(1G9
M(1'M& ,^7(<GOM()KT.N6L[>YU[Q+;ZKJ6AO8#2A/%:M.Z.\K.0I==I.%VKW
MZ[O;D S+JXUK5M9UO0M-OFBFTNW@2*9KGRW,CH6$K 1MO&<#' X/'/%+6]4U
MN+3-0+ZOYNI6&B"=X]+P(X+@!R9G9L JQ483!. WR]ZZC6?!6D:WJT6JS_:[
M>^2/RFGL[IX&DCSG8Y0C(IMUX&T*[NIIV@GB$]H+.:*"X>..6)00H95(!P"0
M* .;-WK>N>)=&L4UV[L8-0\/&\D%ND>4EW1#<I*G'WN^>,XQG-2QZY?6/BR+
M3M<GU"U::_*6-XN'M+R/D+"V!A)/7(!+#K@XKH[#P?I>FW]C>V[78FL;7[)"
M7N&?$1()4YZY(!Y]!C&*E7PO8?:%D=[F6);LWJ6\DI:-9RQ;>!U&"20,X!YQ
MF@#8==Z,NXKD$94X(^E>>:;JNJ+]O\*7FIW#Z['J2I%=':'>U?\ >"4 #'$:
MNO3&Y1ZUZ(Y*HS*I8@9"CJ?:N9T*UN-5UMO$NI:*VF78M19PQ3.CRA-Q9R2I
M(P3MP.O!/>@#$ENO$?B-M>71+Z*TN=-OC:VQDN2JIL"$F1/+;>&R>2>A&,$$
MFEXK\0:K9Z?KFI66J/-/8-;%!:8^SVN=A='+?ZPMN)X!(!7[M=5?>!-#O]=D
MU=TNHKF<*MRMO=/%'=!> )54@.,<<]1P<TV_\ :#J4FIM/%=!-3VFYACNI$C
M9P  ^P'&["CGVH S'75]3^(NKZ6GB"]M;*VM;2ZC2%(\AF=\KDK]TA><\^^!
M@]U6/9>&[&PUF75H7N3=2PI!(9)V<,BYV@@]QDG/7DY-;! (P1D&@#S2QUW4
MQKGA9TU.>]M]2N[F&XN-H6WN%"2.OE(>5"[0 W&[&<MG-5!8RHWQ.=-2OD>'
MD,LH!)%HC D@=>W&.*ZRU^'F@6:V*PI>A+"<S6B&]E(AR""JC=PIW'COWK0M
M_"VFV\^JR_OY/[6_X_5DE+++\NSIV^7CC% '):;?7MO9>#M MKAR+_2S<L\M
MQY3-LCB C5@A('SEN!GY>O7,=[)XLTT:!87NOJ)KC6VM&>VV2,UNT3N@<L@_
M>  <@8/!(-='<^ -"NM%LM,D6[V6#![2X%W()X" %&V3.0, #'3@<58;P;I3
M0Z=&6N\V$_VF%S<LSF;!&]V))<X)'.>#B@#5TRSEL--@M9[V>]DC7!N)]N]^
M>IV@#VZ=JY*WMY&^,VH$WEUL71X)1'O^3F60$8QP/E!^M=Q63<>';"YUY=:/
MGQWRV_V??%,RAD!+#<H.&P22,CO0!YGX:GU'2?!O@_4+;5+A8[C6/L4EIM7R
MFBDGE4Y&,[L\YS^%;S7OB7Q';ZO>:+?6UI<6&IRVT7G7)6)%B<!EDC$9SN4$
MYSD;AC&*WX_ VCQ:38:9&;M;2PNA=VR>><I*&+ YZG#$G!XYHG\!Z'<:[+J_
MEW44UP0US%#<O'#<D=#)&#M;\>#WS0!TBG*@G'([&O,=;OKGQ-X-\?737L]N
MFG->64,$1 4+%'\Q<8^8N2>O08Q@\GT^N9OO FBW]WJ4[?:X!J<9CO8K>Y>.
M.?*[=S*#C=COW[YH Y/5M6U"U\-ZA+8:G<--IVA07$,-J HM'$;,7F+</NP,
M)SP#QSFK]L9KOXIV5W)=W0W>'1<F%'^3)E7( QT.!GN>.:V9/AYX?D^TKY=X
ML=U:+:7$8O)=LJ*I5=XW?,0#@$U=A\(Z3!?:?>QK<BXL(/LT3_:9,O'D-M?G
MYQN /- ',:%>>)M?T[0/$EK?VL4%S*LEY%+=$QO"Q(,:IY?RNIP =V21@DYK
MT-CM4G!.!GBN;T[P)H>E:L]_9QW,8:4SBT%R_P!F64]7$6=H/X<=L5TM 'EL
MGB;5I?A?'X\M[V7[6LGGM9\&%HO.V&';CJ%_B^]N'7'%:RV;/\:7?[7=+_Q(
MTEV;AC_CX;Y>GW?;]:W8?!VD0-(D:3+9R7'VIK+S3Y'F[MV[;_O -M^[GG%6
MO^$?LQXC.O![C[>8!;%O,.WR@V[;MZ=><]?>@#5KR_P?#KTNE^,AHUW912'7
MK\1K- S-OR,88. .W4''O7I[#<I )7(QD=17/6/@S3M-6Z6RNM2@%U.]S-LO
M'&^1_O-UX)]J ,OQWJ&HZ%;66OZ3=/+#:3%;G3(R,74>#NVX!(9,%CCLK9Z4
MV\U>ZLM(\,VUKJGVY]9N0C7[R! ZF)Y,(P4[=Q4*."<'KGFNCM/#UC8S6LD)
MGS:V[6\0>4N K$%B<]6) )8\FLS_ (5_X?/AMM >"9]/\WSXD:=MT$F2=T;9
MRG))XXY/J: ,.YO_ !%H%S;Z;J.I0>1JFK0V]K*LOFS6T+H[,K,R*"2T9520
M3\Q[@5)XI;6?#FB:A<P:]+(!?V9M8V ,D,4DJ1NCL<[U.6P2,CUXK<D\#:)/
MH$NCW<=S=PRNLCSW-R\DY=?NMYA.X$=L'C\34A\&:2_A^YT:X^UW,-UM,TUQ
M=/),Q4@J?,)R"I (QP,4 8>LWM^WBOQ#I:ZA<QV@\/B[C5& ,<A>125;&1PH
M_IBLNSN=0TGX??#Z2TU.Y475SIT,Z-M8/'(BY3)7(''8]SUKL;3P=I-IJ4FH
M_P"ESW<MK]DEDGNG<R1Y)^;)PQ^8]>G&,5$G@?1X]*T_35-Y]FT^=+BV!NG8
MHZ?<Y))PHX"]/:@#*N]8O/#WC;4+2^N[BXL]0L?/TN)F Q,AVO"I R68M&1G
MIDT2W&K2>((O"RWSR2V^DI=2S_:?(DFD9V0L"$;A2O3@?,,YKJK_ $:QU.ZL
M+F[@666PF\^W8_POM*Y_)OS /:J&O^$-*\17-K=W8N8+VUR(;JSN&@E53U7<
MI!P?2@!VAV6H7'ANSMO$D]M>:A$V)Y+9CY<C*QP2,#/09&,9!XKF[C7KRQ\7
M"RUF2_LH[C4%33[R+#V<\? $#X^XY.X<\D]\<5W-E90:?9Q6EJFR&(84%BQ]
MR2>22>23R2<FLP^%[!YR\CW,D)NOMOV9Y=T8F#;@P'48;G&<9YQF@#9894@$
M@D=1U%>3Z)J5WH7A&YFAO9WFN_$<M@)+F4$1AKEE+Y*G!(&,D$9(..U>LUSK
M>!] DL-4L9;626TU*5IIX))G9 [-N)09^0[OF^7'/T% '*^*7\6>'O#7B:\_
MMA(8%MEGL56<33Q." XR\8RAR/<'H15S68M;TG6_#T$?B:_D35-2=)E>.+"+
MY#-A?DR "N0"2.><ULKX"T;^PKK2)I+^YM[M52=[B\>21T7HF\G(4>@Q^M:%
MYX=L[^;3)KB2Y:737\RW;S2"'P5W'^\<$CGUH X.YGUR+3O',*^)-0!T M-9
MR8CWL?LZRA9#M^90<C''!.<\8VWU?4I_%7@]!?21V^J:=<33P(J[=ZQQD,,C
M/!<\$D=.*V7\(:9(NLJS71&LC%Z/./[P;=G']WY>.,<4]?"FGK=Z7="2Z$VE
MPM!:-YQ^1& !!'1L@ 9.>@H X&QU?7U\*Z)KTVO7<T[:[]BDB9(Q'+$UV\1#
M +UQC!& ,# ];_B77=3L1J=_9:G/<-::M;0 PJ%MX(V>)6A<'[[G>Q) .,CE
M<8KIE\#:.FCP:4INQ9P77VR-//;(EW[]V>OWB3CIFH[OX?:#>?V@)4O!'?SK
M<S1I=R*GG J?,"@X#$J,F@#-T.TFD^)GC$_VC>+LCLP@WJ0H:.0X ((P"20.
MGKFLO0?%.J7NA>![*ZO9#<:W+<?:KS #E8@[;1QA2Q"C(' !Q@\CMX_#.G0Z
MQ-JL'VF*[F@2&1EN'VL$!"L5)P6 ) )SUJK'X(T6+0;/1TCG%M93>?:/YS>9
M;ODG<K]>I/7/4CIQ0!QOB/7=<T>S\;:;;ZG<?\2RSAOK*[(5I(U?<#$Q(.1E
M3@_>P>O%=!97&IV'Q%M=.FU6XO+6_P!*DN7BF5 L<B2( 4P!@8<C!)Z#DFM>
MZ\(Z7?:7?V%T)Y4U''VR5I2))@!@ L.@ '08'YFIE\.68UJUU8R7+7EK ;:-
MVE./+)!((Z') .>O% "^*=7?0/"NJZM%$)9+.UDF1#T)"DC/MGK7,7>HZGHK
M^$=0CU&>^BU:YBL[R*3!5S+&6$J8'R;2O0<$'IWKNIH8KF"2":-9(I%*.CC(
M92,$$>E8VF^%--TLV8B-Q)%8Y^QQ3S%UML@CY,^Q(!.2 2!@&@# \'6;1>./
M&;F\N9/+O85VNP(?-M'R>.W:M_QCK,OA[PCJ.J0!?-@C&PO]U2S!0Q]AG/X5
M/IOA^STK4K^_MWN#/?N)+GS)"P=@-H.#TP !QCI5Z\L[?4+*>SNX4FMIT,<L
M;C(92,$&@#B[R#Q1IW]H7BZO''I[:;*RJ;@3RK<*"RR1[H@,$ Y7IW %9=I>
M:Z?^$#G/B"\+:Y;>7=J4C*C_ $;S-R#;PV5ZG/7ICBNITWP'H^E6-Q9P/?O%
M-"UN//O))##$>J1[B=@/MSP.>!5A/"&F1KHRJUT!HPQ9#SC^[&W9S_>^7CG/
M% '"WNM:]8Z9K%I!K=RTFG^(K:SBGF1'=X93$2C_ "C.-YY&#[UMVLNKZ1XZ
MO-"N=6N=3T^[TF2^C:Z5/,@D5PC %%4;3N!QCC%1>,_"2KI%PNEVU]<W.HZI
M;75V$D))"2(6<'(VD(N!C'08KK(-"M5:YN6DN);JZA$+W,K?O!&,X4< *.2>
M .3D\T <%X3U:=- ^'?A^*5[>+4K"26:5#AF6*,$(I[9+9)'.%XQFKDT_B6[
M_P"$P\/Z?J=Q]MTDPW&G71"EY!(A?R7R,'E2N>N&!-=,O@O1TTC3M-C2=(],
M</8RK,?-MR!CY6ZXP2,'((ZT^YB;PU837.F:3=:K=7-PK7 25/-D) 7>S.0,
M  #'  Q@ 4 9.F:VWBN*+4-*O[FVLX=-W2;2K'[0_16W C=&%;(_VQZ5SEAJ
M>OOH'@35F\07;3ZO-':W2,D9C*O$[;@-OWP5!!)(SVQQ7=:#H$>G:#-:O$EO
M->RRW-RMN<!9)6+, ?;(4'T45$G@K28M/TFQ0W2V^DRB6S43G]VP! .>^ 2.
M<]: .4G\2:IX=C\6V;:C+=K87ME#;7-V5W0K<",,68+C"EB1D'WS5G75\5:)
MI7B.]75DALTTF2XMD\\3SQW$8))4M&!L(QD<X/3&:Z:3P?H\\NL/<PR7"ZPJ
MK>QRR$K(%&U<#^' X&,?G5:U\!:/:Z/=Z7YE_/!=0FWD:XO))'$)_P"6:EC\
MJ^PQ0!CV=SJMKXK\.VTVLW=S#K.F3O/'($"Q2(L95H\+D??(Y)]\U9^%4+KX
M'@FDNKB=I;BYSYS[L$7$O.>N3U.<\UN+X8L%U#3+[?<M/ID30VQ,IPJ, &!'
M?(5>3SQ4VB^']/\ #\4\6GK,D4LK2^6\S.J%F+$("<*,L3@>M %/Q1=20OI4
M$5\\!N+K:UO N9KI0C'8AR-O(!+9& #R*Y.RUSQ'+X:N9(X;N_:PUVXM;B"*
M15NGM4W856& SJ2O0Y(4\\YKM]:\.V&O/9R7?GI-92F6WFMYFB="1@X92#@@
MX(JC;>"=)LB[637MN[7AO@Z73DK*5*D@,2,$,V000<\YP* )?!^J6VL>'UNK
M:^N+Q/.E4M<ILEB(<_NW7 PR@A??&><YK>JGINEVNE6[PVRD>;*TTKL<M)(Q
MRS$^I/X=AQ5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "LCQ+XAM?#&C/J%RCRDNL4,$?WYI6.%1
M?<G^IK7KA?BE87<^C:1J=K!)<#1M6M]1G@C7<SQ(3NP.Y .?H#0!KWM[XHL=
M'FU VFG7,R1ES91,X9>,D"0YWD>FU<^HK=GO+:U:-;BXAA,AVH)'"[CZ#/6L
M^'Q-HMW9175GJ-O=),/W2P2!GD/]T+G.?;MWQ7)VLUC+XM\:V'B?R566.)H1
M<D!6LO+P=F>P??G'0F@#O9KF"W&9YXXA@GYW"\#DGGTIDE_9Q+NDNX$4E1EI
M !\WW>_?MZUY#I.G)<W_ ,-[7Q+##->RZ;>I/'=*"\B83RUD!ZD+V/?/>KD.
M@^$V\3>/K#4;+3X[2WBMBD;*H$*?9AED'\)R!R.<XH ]5N+JWM(O-N9XH8\X
MWR.%'YFE:>%41VE0(Y 5BPPQ/3'KFO*_"4E_8:[X8MO%&41_#@CM3==!<;\R
M*<_\M/+V9[X!]ZRI[*VBT;38[H0G3/\ A- NF>81@6A8Y"'_ )Y[MV,<$8[8
MH ]C;4[!(HY7OK98Y3B-S*H#GT!SS5>YUW3K76K72);J-;VYC:5(BPSM4@9/
MU) 'KSZ5YYXF&@Z9J>LZ-96]EILBZ$^!(/EF1VD;9!%D#<6R689ZJ,'M%HMY
MIKZ_\/[RXFMV6;P^\0F<@^9,!!\H/=P<C'7.: /5#>6PNQ:FXA%R1N$.\;R/
M7'6LWQ3K\?ACPW>:O+&)%@"@*6V@LS!!D]AEAD]AFO.-$ET76+:#3M;U>[@\
M266K/*UC&(EG-P)6*LF4W,A4CG. O4@"O2/$UYIMEX?N9=8BCETYVCAN%D&5
MV2.J$M[#=D_2@""WOM<CU*PANHK"YLKL,3=6I9?+(0L!M).0<?>R.G3FM@WE
ML+L6IN(?M)&X0[QOQZXZUYII.G-X/\::/I_AC67OM!U,RF;3'F$PM$"%A+&W
M)5,X&#U)[D\4-#ET76;6VT_6]7NX?$MCJK2O8QB)9S<"1B&7*;F0J1DYQMZD
M 4 >M-=VR72VS7$2W#C*Q%P'8>H'6@W=L)A";B(2EM@3>,EL9QCUQS]*\RT#
M4- U"SN-(\1L#XCM]:DF:V+E+B682EHG3!!*[-@!'RA1S@"H]+TFQN9/B!-I
MEG:2ZO:WTSZ>R*I>&4VR[2G]TEB>1U(]J /3Q?V;/,BW<!> 9E42#,8_VO3\
M:J:9X@TS5])&IVEW$UF2W[UG & Q7/7@'&1GL17!^%&\*Z_=>'KRTU6XGU.T
MMGB-BJQ*T2E,2+.H0':"/XC][&,YK'\/:KHMG\._"$$QMA<+J 1I9)-D5M.O
MFD&?!&2 #A"1D[>1UH ]A6[MGMUN%N(F@;&V0."IR<#!Z=:;'J%E*X2.[MW<
MDJ%60$Y'4=:\1NI]-G\)Z]#/<VLKQ>+HI%883:CR0DLHSE0PWG(/(SR>:[?Q
M7H=AX8BT_P 5Z)IMO =(G:6YCM80OFVTG$W ZD##C_=/K0!WB312LZQRH[(<
M,%8$J?0^E,GO+:V:-;BXAB:0X02.%+'T&>M9OART>#36NYXO+O+^0W=PI&"K
M-]U3[JH5/^ UR=M+8S>)?'%AXG,*^8L;1?:" &LO*P-F>P;?G'1CZT =-XC\
M1)HLNF6B20K=:C="WC:4_+&-K,789!(PA'4<D<U-:ZA=Z?H<][XEFL(/LY=G
MN+=F$31 _*^&R5)';)^IKSE(Y8]%^&">(/+.HF["R_:0-Y3R9=H;//=0<]_>
MN_\ &L"R^ M?B$0?_B6W&Q0N>?+;&!0!3NO%DAUGPM'9"V?3M9\WS'<DR1[8
M3(,8.!T&<Y[UTT5S!/;BXAGCDA()\Q'!7 Z\CBO+FET?4+CX:0H]G/;/YH=%
M*E&;[(<@]CS@'WX-9LEW%IFD>(1;L8])L_%JM>):HK"&V*1ECLP1M#X)&,<&
M@#V.WNK>\B\VVGBGCSC?$X89^HK#U/Q')'XCM_#FEPQSZG+ ;J5I6(CMH0=N
M]L<L2> HQGG) JCX1AT&76-6U30]6EU'[8(C<R(T9@#J"!C8H&_'7OTSVK*N
M'3PS\8;C5=3<0Z;K&GQV\-W(<1QS1M_JV;HN1R,]>E '5Q7>M0:S;6=Y;VLU
MI-&Y-Y!N3:XQA"A)QD;CG<>G05II>6TER]LEQ"TZ#+Q*X++]1U%9FJ:I]ITR
M_M]%G2XU$6LK0^2P81OM.S<>@RV,#J?H#CSZ)K?4/!7@:31V4:W!>VRL%/[Y
M6'%T).^,;R^>O?M0!ZF]]:1-MDNH$.\1X:0#YR,A?KSTIR7,$D\D"3QM-'C?
M&K@LN>F1VKQG4;'1G\)?$^3[/9F2"^F:$[5S&WDQ$%?0[AVZD>U=&+?2[?XB
M>%1;1VJ_;M)NUN-@7-P#Y1&_^]D[CSG/- 'H(O;1IDA6ZA,L@)1!(,M@X.!W
MQ@T->VJ72VKW,*W##*Q&0!R/8=:\1T[1]+N?A1HMQID-N/$<>IJMG+%CSED%
MT<KGJ%$>XD= !FKOB?5M,>#66MY[>SDMO$EN\\<S[KAG26)3-DG]W'C@<8QW
M&<4 >PS7MI;[O.NH8]I ;?(!@GIG/KVIQN8!.(#/&)CTCWC=^5>3WEEH=[JG
MQ.DD@LI0ME#*A95.UC;,2P]"3CGKFKUY_P 2[PUX1\=P1FXFT^RACOS&-SS6
MLB*']R5;##Z-ZT >F1S12EA'*CE#A@K [3Z&HWO;6*Y2VDN84G?[D32 ,WT'
M4U0\.V+V6E![B-8[R[=KJZ [2.<E<]]HPH]E%>7>,]5TV2R\5B":"TN+?5K5
MIHYG+7$CH\'[U<G]W&%Z8!S@\C.* /0-7\1S+XA7P_I<]C%?FR>[\V[!:,$,
MJJF%93DEB<YX Z'-7O#?B"WU[1DO%FMC(FY+CR)=\:NI*OM/==P.#W S7-;M
M,NOC-"1]DE\W0#(N0IW$SK@_7'Z5R=M?6UA\/W\M@J6?B&0ZNMNBM)#;_:9#
MEUP> =IP1R >,4 >Q1W]G-;-<QW<#VZYW2K("HQUYZ5)%/%-O\J5)-C%'V,#
MM8=0?0^U>.^+[?PQ<>"_%FK:7JIU(W26S3R[HC LJN I78J@2;<YQSC&<9%>
ML:9IFF:; _\ 9=I;6\4[^:Y@4 2,0!N..IP!S0!A:WXR@A\.>(K[19K6YNM&
M602)(V5+(BNP^4Y.-P'UR.U;^G7\5[;1'S8C<&%))8T893<,\C.0/K7E5Q+I
M]KX5^*5H6MXKP7%VPBX5Q&T$>TXZ[2>G8FM 0VEAXR\+-HZVL-W=Z%=@M'M!
MF;$3)N/\7S9.3[T >EI>6TER]LEQ"UP@RT0<%E'J1U%8?CGQ!<^%?"5[KEK#
M#.UH%9H9<@."P7@CIUST-<1X/E\/:W;^&6DU>\_X2'36P]BHC2=)MNV;S!L#
ME"=Q))Y]2:W_ (QRQQ_"K7 [JI9(PN3C)\U.!0!T2S:['=VHE33Y8)'Q+Y9=
M75<'YAG(/.,^QK&OO%=Y<:GJ]GHLVEA]*,/FB]8XGWKN8*RGY,+CG#<\8%20
MR>'K'5[&]M]:DN+B13:Q6YU%[CS#(R'(5G.,;<DCMG/2L;1ETH^,/B#O6S*Q
MO;GD+A1]F&?IR#GWH V?#OB/4M<MK+6M^F)HES;M+(I9EFMCU3<V2K9'7A<>
M]=0EU;R6WVE)XFM\;O-5P5QZYZ8KQW3KZUTOP%\/KV:;[-HXPM_<PHC".7RB
ML;294C ;(R1P<'J!5J]ET70_[/U2POY[[PU-KOGZG.2C6ZR-&P5EV*!L$FPL
M0,;@.X- 'I.H^(M*TS38[^XO8?L\LJ0Q.D@(D=F"@+SSR?P )[5(US<_VM$5
MN+'^S6MGD8%CYQ<$88<[=F"<^^*\[\6+X;?PU=:GI!AEM)-;LKBZNT?? 7\V
M,.5.=H& -Q''//(.-8-IK_&+3I+4VVV?0)@#'M_>+YT>WIU&,X]J .W%[:F$
MS"YA,0."_F#:#Z9HDO+6*>."2YA2:7_5QLX#/]!WKS[0M.>PU_4/!!M<:9%=
MC58&V?)]F=BXC^HG&,=U!K*N)M$U*]\3Z%XHU>YL;Y]1,D4"B-99HLJ8&A)0
ML3@  *<@@^M 'JM])-%8SR6_E^:B%E\P$J2.<'%<AHGBCQ-K/@VU\1VVDV%P
M)XC,+)+ATD*@GA6*D%N.AP/>NKO9$@T>=YGV*D#%FD(&/E[GI7!?#WQ/HVC_
M  ET22[U"#?%;$>0CAI7;<?D5!R6/H!0!V&A^*-+U[PW;:[;W"Q6<XY,Y"&-
M@<%6ST(((J;4?$&F:5%9R75W$HO9DAM\./WC,>W/0#DGT%>6^'[=?"^G>%X=
M<CBL-2O[V]OHGO)"L%GN7[KKD!G*L  2,$MSQ@T[&XT\>$/#IGFMS#9>+I$F
M>0!5A0R3X#9X0'(.#CJ* /:I;VT@:)9;J&-ICB(/( 7/MZ_A4]>37]WH-[KO
MBG1?%&K/IZ7AB:T!6-1-:F) GE,R$Y#A^%.=QX&<UW>K1ZA%X"O(]*-RVH)I
MKK;&8YF,@C^7./X\X_&@#8CO+::>2"*XA>:/[\:N"R_4=J!=VQF$(N(C*25"
M;QN) R1CU (_.O,@UGJ&C?#ZXT QB_BNX%<1X\Q8-A^TJXZXX^;/\6.YI_@Y
M?"^EIXGUR]33X1IVO76RZ*@FW5MJ@*1]T'<1@=<T >H5SU]K\N@^&M6U?5Y+
M.7[&9GC2T8C<BY*(=W_+3  /;-;L4L-U;)-&Z2P2H&5P<JRD9!]P17CY^P+\
M'/'*)]G\F+4-1$2C;M7]XVS;Z<$8Q0!Z3HEUK-W.\MX^FS:?)"CPR6NY75S]
MY&!+ @<?,"/I6K]LMOM?V7[1#]IQN\G>-^/7'7%0:0+<:1:&U$0B:)6'E ;3
MD#GBO+= ET76;6SL-:U>[A\2V.JM*]B@B6<W D8[E^3<R%3DG.-O4@"@#U@7
MMJ;LV@N8?M(&?)\P;\>NWK22W<()ACN(/M!)1$9QR^,XQUZ<X]*\=NM9TJ1M
M&NK:XMK2.+Q66EMY'W7$9+R*[RL3\@;LN.A')[=)X(TS0I_$?BNZ-I9//::V
MTD+[5S#^YCRR_P!W)+9(]/:@#:\/>(-6U_P3I>L+_9UO=W,X$RR[A&$$I1@O
M.=Q4<9XS7337EM;/&D]Q#$\IVQJ[A2Y]!GK7C5M)9/\ !_PA,[P%HM;@V.Q&
M5_TLYP>W'7VK5U2YT6Z\2>*]#\6:L^GB[,9M@XC FMC$H41,R$E@X<X4YW'(
M&<T >H2W=M VV6XBC;CAW /)P/S/%35Y?IVD:%=?$K4+:^MH;A8]$LY"MZJM
M(75GR[CIY@ 7)ZCZ&O0])U?3]=TZ/4-+NX[JTDR$EC.0<'!_44 3?;+78[_:
M8=J'#-O&%/H?2EDN[>(9DN(D&PR99P/E'5OIR.?>O*]9O+"RG^*EG=3013W-
MHLD$#D!I0;/&Y5ZMR#DCI@YJ33(=&U+QOX6,J65PLGAEBV[:P<JT6,^N,-C/
M3'M0!Z'J/B#2]+BLY+J\B47LR0V^''[QF/4<\@#DGT%)-<:B+^Y\F73VM1:!
MX$);S?,R<EL<;,;<8YSFO)K1]/C\$^%I)7MA9VGBN2,NY79%%YL^ 2> O*^W
M2NMMI;"+XL:P\#6\:R>'X)&*X7/[R3D_\!V_AB@#I/!VM3^(O"&EZQ=1QQSW
MD E=(@0H)[#))JMJOBVW32O$,FDS6UQ>Z/"[R1NV5WJF\KP<G P#Z$XJK\+7
M1_AAX>*,&Q:*#@YP1G(KEI9=/M(_BE;.UO%=E972,X#^6;1.0.NTGOTS0!Z-
MHFJIJ>EV4LDL/VN:UBGEAC;E=R@],Y YXS5P7ELUTUJ+B$W"C<80XW@>N.M>
M86$-A8^(/AU+8+:PW%UIEPLCI@--^XC(W'JWS#OWJMX3ET/6K+P_#J&KWB^)
M=-O TM@HB2X%P"1*6&S>8SEBQS@COF@#UUF5%+,P55&22< "JZZC9/;BX2\M
MVA8[1()5*D^F<XKEOB1>/8:)I]W(TR:=%J4+:@\2!RD'S?,0000'V$\'I60M
MIX+O-/\ $=P-1?5K+51#'<;7B,3SD%46+:JJ)C\N>^=I.* /1%N8'<HD\;.%
MW%0X)QZ_3D4V.]M991%'<PO(4$@19 25/1L>GO7FOAYXXM'\2>'/$ AF\1VU
MH1.\A#_:K<1_NF7@9 '!&.&R>K5EZ9I.F2^'/AM?:-%;C6O.M?-F@P9'A$1$
MX<CDJ ,<].!QG% 'JME<W*QWKZE<6.V.Y=8F@8@)%QM$FX_?YY[<BIY-1L8H
M6FDO+=(E<QL[2J &'52<]?:O&=273!\,_&J#[,L</B5S&%('E_OXONXZ<9Z=
MLUUNJKX=T/Q;I%G:V^GZ;)<6]S<)<R + =WEJX5 0'E8!>_ !ZYQ0!U]_K^F
M:9<Z?;W5W$DM_(4MUWCYL*6)^F!U]QZU+;RWC:M>QS2V;6BI&8$C)\Y2<[C)
MVP2!MQZ&O'M NM-'AWX;W%W-;^1;7US;SRS8VQGRYMJ,3T[8!]JV-2-PFM?$
MU- VKJ+Z;:/&L'#E_+DW$ <[L'ZYQ0!ZC#>6UQ+)%#<0R21'$B(X)0^X'2D^
MVV@D2/[5#O=BBKY@RS#J .Y%>>3G3]1N_ =WX<,'F!]L@AQQ9>4?,60#L&"#
M!Z,1WKES;:1!\.]0OX8[1+FW\3GR)UV[H@+T8"G^$;2>!Q@DT >Y5##>6UQ+
M)%#<0RR1'$BHX8H?<#I6+XW.I'P+K1T;>;\V;^3Y7WLXYVX[XSC'?%<M*UCJ
M%_X"O?#+0B4/AQ 1\MGY1\Q7 [!@@P>C$=Z -M?$FHZOJVH6N@OIKKIUW'!+
M'<EMTZE59V1E/RX#X&5;)!Z5N7FNZ=8ZM9Z7/<QI>789HHRP!VJ,EC[=!]3]
M:Y;P(M@?$OC/[.MOO350%\L+E5\F,<8Z#(/X@T>*6L;;XF>$;B]\B.-X+V/?
M*!AGQ%M7GJ>N!U]* -7PSXEFU-M7CU-K.WEM-6EL(!&Q7S JH1]X\L=QZ?E7
M07%Y;6I07%Q##YAVIYCA=Q]!GJ:\6UB+39?!'Q$OV6V>[@UR5H9S@O&082"I
MZCD'IZ5NZQ?Z/-XO\1:7XHU;[!:7UI"+)Y/*$<]N8\.$=T/S!RQP#GD$=* /
M4JH3:UI=O97-Y)J%L+>V4O-()00@'7.*SI8+2V^'TMO-<WL=E'IC(UQ-_P ?
M"QB,C<>/O@<_6N%D:^&D>)-'U*'3M1E7PY)):ZK8+@3PA6"+(G(5\DD8.#SC
MI0!Z7;:S87.DP:E]JBCM9D5U>215 W#(!.<9YZ5'J&OZ9I<EA'=7<2O?R^5;
MC>/G."21[ #K]/6N!@UG0E7P5'%/8Q2-82&*]FD_T=&\N,2+M! >0YQR1CYO
MH<#1KG35\*> I;J:W\FTUNXAGDFP%B'^D;5;/"_P\'U'M0![3)>6L,L44MS"
MDDO^K1I "_T'>JFNZHNE:5<SI-;+<K$[P)</M$C 9QZG\*\UNKC0M1U+Q1H?
MBG5I[">>\62"';&KS0;4\DPED+$@@C:IR#GC)-3C4+%;_P <Z?XBEC2]:V5;
M5+YE#26OD?*%SPWS[R=O\1H ]!\-:E-K/A;2=4N%1)KRSAN)%C!"AG0,0,DG
M&36I7-_#Z:*?X=>'&BD1PNFVZ$J<X81J"/J",5TE !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8
M'B[Q&WAG2X+J.SEN7GNH;8! ,+O<+D\CUX]3CZT ;$5G:PS/-%;0QRO]YU0!
MF^I[TZ6V@G9&FACD:,Y0NH)4^H]*RK_Q-:Z?%*[VUY*T$ N+B.&(,T$9SRPS
M_LMP,G@\50N?B#H<,T<, O;V26R%_$MI:/)YD)(&5P.>OX8.>>* .E:")Y [
M1(SCHQ4$BN?TOPU):^*=:UB[:UG349(9(T\OYH#&@0<GKD#/;%5[CXB:);VU
M_<&+46AT^?R+MULW_<'"DLP(!"C</?KQ@5HV?BK3KW7!I*+=1SR0M/ \L#)'
M<(I 8QL>N,C\#D9% &O-;PW,?ESPQRIG.V10PS]#0\$,@4/$C!>@90<5%J%_
M:Z7837U[,(;:%=SN><#Z#DGL .36?;^)+2;4VTR6"YMK_P @W$=O.@#31C@E
M""02#C(SD9&0* -8PQ,ZNT:%U!"L5&0#U H$,0" 1H!']P;1\O;CTKA/#$]S
MXKOKV_N+C5K.:PU>=(Q'*4A:*-M@B=,E3D#)XSGH:V]8\3OI?BG1M%2PGF^W
MB5VE100%1>0.>N64GV_0 W_L\/VCS_)C\[&WS-HW8],]<4\@,,$ C.>:\YT7
MQ=#H,GB@ZO/J-S;VVMO%YQ1YEMHBD6-S?PKDG@>YQ77ZKXCM-)%QOAN;C[+"
M)[D6T>_R8^?F;D>A.!DX'2@#2AM+:V9V@MXHF<Y<H@4L??'6G?9X?M'G^3'Y
MV-OF;1NQZ9ZXIEE>6^HV,%[:2K-;7$:RQ2+T92,@_E6+!XRTJXNK2)//\F\N
M9+2VNC'^ZEECW;D!SG^!L$@ [3@F@#=\B'S_ #_*C\[;M\S:-V/3/7%"011,
M6CB1">I50,UR=Q\2_#]M'/,XU#[-;736MS<"RD\NW<$ ^8<?*,G'//MTJUJ'
MCO2-/OKRQ\K4+JZM(DFDBM;-Y"4;.&&!RO!YZ=!G/% '11V\,4DDD<,:/(<N
MRJ 6/N>]!MX&0HT,90MN*E1@GKGZUQ.L:['J=]X'U/1]1F:PU"_*D1.525/)
MD.&7O@J.#T(K6L]:TB+5_$LS7]XIL?*:]6[+"&W 0D>6&Z @9..I]: -]K:!
M\[H8VR<G*@Y/K61JFCZCJ6HPQ_VE%%HGEJ+BR%N"\K!LX\S/"D8!&.F1WXC/
MC+2H;FYM[W[18R6]D=087,6W=;@X+C&>AZJ<-STJK>^)+;4M/U.PA-Y97RZ:
MU[%N&QS$0=KJRD]QC'!'I0!U512VT$[H\L,<C1G*%U!*GU'I7$>#_&]B^C^&
M=-OWOQ>WMA"([NY@<17$WE@LHD/WFZ_7U-3>%]5-G-XODU&^GEM[36#%$9G:
M0HIBBVHHZ\LV HZD^] '9200RD&2)'(XRR@U)CC':LC3O$5GJ&K7.E&.>VU"
MVC65[>X0!C&W =2"01D$<'@]<5+J6MVVFW=I9LDL]Y>;_(MX0"SA!ECR0  "
M.I[B@"[]FM_E_<1?)POR#CZ4JV\*!@D,:AAAL*!GZU@P>-=(N8='FA-PT6KR
MM#;/Y1 \Q<[D;/W2-K=>N#C-2P^+-/F@U>58KH?V2YCND:/#!@ V%&?FX((Q
MUSQF@#:AABMXA%#$D48Z*BA0/P%+)%'-&T<J*Z,,%6&0?PKG[_QII>G-=_:%
MN?+L3$+V18P5M3)@J'YR>""=H.,\TE[XUTNRUF?23!J$][ L;R1V]F[D*[;0
MW Y4$<D<4 ;\%O#;1"*"&.*,=$C4*!^ I$MH(YGF2&-97^^X4!F^I[UP7Q \
M3!O"MQ+I4NH(8KZ&W%[;$K'O$Z*Z%@<D8W*3C;GC.>*[6/4XI-9GTP0W(EAA
M69I&A(B(8D !^A/'(H G^RV^"/(BP>OR#FD:VC5=T4$/F*/D)7&#VJ'5M6M-
M$T][V]<K$K*@"C)9V8*J@>I) _&LBY\<:39:?JUW>)=P'265;R$PEGCW*&4_
M+D$$'KG'KB@!W@WPTWAG0;>PN&M[BX@W@7,<6TLK.SX.<GC=CKVK>-O"S.QA
MC)?&XE1\V.F?7%9%AXJT[4-:?2D6ZAN1!]IC,\#1K-%D LA/4 D?F.U<QXF\
M2_;+OPI-IDFH16MUK,,:W"$I#=18;(X.2"0",@ @9&10!WIM;<EB8(B6^\=@
MYK'O]%O[[58E_M"&+0U5&DL4MAODD5MP_>9X4G;D8YQCN:T]3U"#2=*N]1NB
M1;VL+S2$==J@D_RKE+O4XH_ ,6KZ_=ZA:F_\B9S8,X: NRE(U*_='(4DXW<Y
MZT =K4;6\+L[-#&2X 8E1\P'0'UK$DO-/E\<KIQNM0%^-->3[.&=;<Q;T!?T
M+Y( (.0,TW0-7DEUG6-!NI#)<Z8\;)*W66"1=R$^X(92>^T'O0!NFWA,GF&&
M/?G.[:,_G3A'&-^$4;SEN/O?7UKGM=\3OI'B/0])2PGG_M%Y=TD:@A52-FP.
M1\V=OX9KG-.\6Q>']4\7MJLVI75K::DH#A'F%M$8HR23T502>![\<&@#T!;2
MV2$0K;Q+$IR$" *#]*E5510J@*HZ # %96I>(;33O- BN+MX8!<3):H',<1S
MACR.NUL 9)P< XJ[I]_:ZMIMO?V,PFM;F,212+_$I'!H E:"%RQ:)&+8W94'
M..F:06T"LK"&,%>A"#BO.- \;6N@P:VNM3ZG/!!KES ;MHI)H[:,.%0._11[
M=OQKLM4\3V.E1W,CQW%Q':1":Z>VCWB",@G<W// )P,G'.,8H UEMX4F>9(8
MUE?AG"@,WU/>EDBCE $D:.!TW*#7.R^.='6]-G;+>WMP;-+V-+6U=_-B8_*R
MG&"#Z].V<\5;M_%&G7NEZ??6)ENUU",R6L42_O) !EN"0!CH22 #@=2* -5+
M:"-@R01JPZ$( :3[+;Y)^SQ<]?D'-<3XD\<1R^$4O=%^TEYM0BL)2(]LENWG
M*DB,#RKX) ]SD=JGTH:?IWC.6!-1\0RWDUC)=II]W*[PQ1[D#;=W5MV,?,<9
M(XH [#[-!Y31>3'Y;_>3:,'ZBE$$(@\@1)Y.W;Y>T;<>F/2L+P=XD?Q3H8U%
M[*:UW33*JR 8*K*Z#D$Y.%&?>M&_U>"QN8K01S7%Y*C2);0 %RBXW-R0  2!
MDD<D 4 7!!"(! (D$(&WRPHVX],4>1%Y@D\I-X_BVC/YUBVOB_2M0T_3[NP>
M6Z.H!S;01IB1]AP^0V NT\$D@9P.XJ"7QWH<&D'4I)9UB2[%E*GD-OAFW!=C
MC'R\D<G@Y&,Y% '2;5W%L#<1@G'.*8UO"\R3/#&TJ<(Y4%E^A[5SK^-[#[/K
M+1VE^;G2H!<2VLD!BD>,@E64-C@[3UZ8Y%4K?Q)::G!X2N-0.I65Y?E9(8H0
MRQ2N82Q#D<%,$D G.0#B@#L719%*NH93U##(IJ6\,1S'%&A]54"N7?XB:&D4
M\Q6_^SVUY]CN)OLCA('R%RY(X&6 ]?;%:O\ PD5G_:.I:>(YS=:?"D\T83JC
M;MI4YP?NG\J -1XHY=OF(K[3N7<,X/J/>D,$10H8DVEMQ&T8)SG/US6)'XPT
MRYMM,ELUN+J34K=KJV@B0!VB4 EB&( QN7J<\\9K.N?'ELTWAIM,M+B\M=;=
M]LJ)C:JQNQ&"0=V5''H#[4 =9);PRR1R20QN\9RC,H)4^Q[5)7.66KZ4NO\
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MWR(MN<XV#%*]O!(\;R0QNT9RC,H)4^WI46HZC:Z382WM[+Y<$0&YL$DDG
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M5 R3^5<+X6\66WB">TOM2OYK63469M,L,/%'Y:],O@++(0,E=Q SC'!) .]
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MD$$$@@@\@@@@CVJ_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M )'^4 D[@>..* ,Z\UD>)(/AQK9MQ"]YJ D*9SL)MY<@'TR*U_#*A?B-XWP
M,O9'C_KA5?3_  %?6.D^%[$ZS!(-!N/.5C:$>:-K(%^_QPQYYY_*MS2= N-.
M\4:YJ\EY%+'JAA(A6$J8O+38/FW'.1["@";6M:;3[S2].MT1KW4YFBA\S.Q
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M0"F9HO,V@,#P-PYX]:B?P_>R>,;7Q ;^W_<V#V9@%N?FW,K%MV_CE!QCIWH
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MYCA0729D8'! YY.>/KQ4</BS1YO$E[H8O(5NK.)))-T@7EMY*C/4J$R<=,T
M63X?TMM/N[%[;?!>9^TAY&9ILC!WL3N;@ <GIQTILWAO2;BWLH9+4XL?^/5U
ME=9(1C&%<$,!CC&>G%,TC4HE\/1WMYK=E?1[G!OXML<3_.0 ,$CCA>O)%3C7
M]'.GS7_]J68M(6*RS-,H6-AU#$G@^QH J7\>I:/8VUMX:TFTG#2D2":X,2Q
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M*?2WFGOM6N=4O)!L$]PB(4C!)" ( .IY/4\>@ TK6SBM/-,>XO,_F2NQR7;
M&3^  ^@% '"6ES#IGB/QE9>(AA-0=9K5I%)6Z@,03RT_O,I!&P<_-G'-9>BV
ME_X?O?AVNLI/YL.F75M(PC9]DC>44C. <' Q_P !->K44 >,:DL+^ /'_EH&
MN)]<=X@JY>0;XBC+W8<,01Z&M?4[_3K7Q?X@L_$9U#^S=9BA-C+;)))%<1>4
M$>+]V#SNW''^W[UZA10!YQI6GZ>GQ+@M&LE6"/PU!;)%<?O"A65CY98YRP7&
M1G..:U_B8KGP?YBQNZPWUI-)L4L519T+' YP ":["B@#@TN;.Y^+HO&V^2-
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M$LT+Y>0(JA)%<Y)]=N.!6@]UK,]W;;-&6!0Q\V>2=&98^I50.I8JHY( Z]J
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M>VUJ,M:7,H3:SA-^P@-N!P#R1@XXR.:F\(>(K[Q!)K'VO3WMDM-0EM8SO1@
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MWE[U?(8J5P0>#GKQ5?5-+U_5&\.W,NGV\<EIJ@O9X(9E(AC$;)L#$#>V6SG
M'4=@2QM#U?[1XYD%D"-915L_WR]1;B+YN>.1GOQ[\4 5O#,UG96GA_4FLKS^
MW=4L$B$0G7_2\(LCSO\ -MX_O-\WS8QR!6I=_$&PL=&U.^GL;T3:7<);WMH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[BE%BM@D0*&-(E)*XRI.03G))K=HH Y.+P!8PZ#IFCIJ6I"WTV\6]@;=%O\
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M(BS+&< HWR[67@<$=OK7944 5--T^/3+)+9)9IB"6>:=]TDC'JS'U_0<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1GYB!V$G ]?PH VKGP]H5E;M<74]U!"N-TDNJ3JHR<#),F.I J;_ (132O\
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M&.H)V]P,Y!XIUUXNUE]7UW3],TNQE_LVUANXYI;I@LJ.'/0)D'Y, =.ISVH
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M?*DT\J' +%F.Y0!C+'\ZYW1)/^$C^*'B5]042PZ'Y%M8P.,K&SJ6>3'3<<
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M,8?C# ]"1C!]>M1^"8TB\1^-4C144:LN%48'^HB- '8O(D2[I'5%R!ECCDG
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MG:9J-B(KB>QU".9;"0X%Z2K+Y:_[?S;E[ KGMFF^ +^VUE-9UF"0QM>7F9;
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M@NMB[CF1-+%AMESYCD/O\PL..3Q@#_"NFHH X*'P+J4/A#2=#%]:%[#4EO\
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M;RVMN0;6:%4"L-S'(RG3OZC.!L6VE>)9](O8M8U2QGNYK=K>(6T#1Q+N&"[
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MUK6HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0([>YVAT;IG# ,N,XSCUK8U'P1H>J7M_=7$,X;4+<6]W'%<ND<RA2JEE! )
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M1M0UB&]\ W,^L75TNMV9%W#*%\O(MO,#* ,ALCDY.<FNQ'AFQ,-VDSW,\MW
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !37=8T9W8*BC)9C@
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MGW$46U=[;W"X7.,G/;WJ5'61%=&#*PR&!R"*\OTW3[2X^(]K#KT%G/??\(M
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M@64J&"[44$%FZD\C '>N?^%^EZ,]A>7\%I9M=V^JWT<<R*I>)#*V%4_PKC'
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M4 0W%I;7:JMS;Q3!3D"1 V#^-2[5V[<#;C&,<8I:* (H[6WAA\F*")(NNQ4
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M:1,['*@E?H>U.,4;,69%+%=I)'./3Z4ZB@!J1I&,1HJCKA1BE5550J@!0,
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M 0_9;?\ Y]XO^^!574-)BU(6\$Y'V**196@"\2,IW+G_ &00#CN0.V0="B@
MJ*.V@A:1HX(T,ARY5 -Q]_6I:* &)%'%GRXU3/7:,9I)K>"X1DFACE1L!E=0
MP/US4E% #4C2.,1HBJ@& JC  ],4V&"&WC\N&)(TZ[44 ?D*DHH CB@A@C\N
M&*.-,D[44 <^PH^SPX4>3'A1A1M' ]JDHH C:W@>=)VAC:5!A9"H++]#08(6
M8LT2%CU)49-244 -2-(QA$51UPHQ3J** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ljb_terminationxemployme002.jpg
<TEXT>
begin 644 ljb_terminationxemployme002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[9QFL[3AKU_XK34->\-7^(IF2Q"W%L;>TC/R^:0)=S2%>IQP"0!U)S[?POJ
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MI*KN;)V@G'7J3754 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52M]
M(TRSO9;RVTZT@NIO];/% JN_^\P&3^-7:* "BBB@ HHHH **** (Y8(IPHFB
M20*P=0Z@X8'((SW![U)110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRI*[B7V\$X"CGJ!%XKM[_P 5_":"VT>Q>ZN;R*V<('1-A1T9@V]A@C:1CU%
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MELK%2-PX89'!'48K'\1Z?J%UXP\*WMK8R3VUA//)<R*Z#8'A9!PS GDCIVH
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M\E\-L7G:,RQJ3-&254,-W/3D=<\]" >AU2U+5]/TA(7U"ZCMQ/*L,6\\N['
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MG:3D]L4 :]AX<L;/2+W3W!N$OWEEO'D S,\GWR0. ,< =@ *K6OA6&Q\$?\
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ML\(V >F2"<'TV-4^'JZDNO0+K5W!::Q*D\L"QHVR50HR&(SCY%^7V_"NUHH
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M6>)X/L\NZ($O'S\I)[<D^YYHM_"/A^TE26VTFUBE2 VZR(F'$9ZC=U[GWYH
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M$?#VH75U=7FCV<T]V@2=WC!,@ P,^^.,]<5)_P (QHHE:1=/B7=LWHN51]@
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MB#29-0U!+>+Q'#:6<:3%Y'#B)_(#L<A6)8$D\ GZ5WJ>&-%C6Q5+"-5L"3:
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M6T22V8O VS/E$]=N>GX=.U2P>$O#]MKKZW!H]I'J;DEKE8P&R>I^IYR>IR:
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M* .KHKCK_P >FSFUZ.+0;^<Z'M:[(>)1Y93S-RY;GY>0.OKBNKM+F*]LX+J
MDQ3QK(A(QE6&1^AH FHK+U'6DL]2M=+@A-QJ%TCRQPA@H6-,;G9NPRRCH22>
MG4CE?$OC.6?X>>([S2X9[;4M/66VN(W90]K(%^\#G!&""".N1[T =]16#X>T
M.RL&?48-/-C<W42)-$LF5;;G#%0=NXYZ]?6MZ@ HHHH **** "BBB@ HHHH
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M@9&0&Z9ZCFO2J* .*UC2/%'B/01-*++3-5MKF&[L;=93-&LD9)_>/M!(;)&
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M7(R "/3(ZUV[,%4LQ 4#))[55FU&&#4[6P9)S+<H[HRQ,4 3&=S 84\C&>M
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MMHXI K;AE5 .#W'%:%% '+ZUHE^OC#3/$VF*D[V]O)9W5J[[#)$Y# H3QN#
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MIJ7.+5Y2<EMF,\GDC.#Z8XK:O]*-[>6MW'?7=I-;JZ P%,.K[<A@RL#]T8H
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MYSW]*QX_AQI44%M;I?ZJMO:7WVZUB%R L#DL2J_+G:=[=<D9X(H Y[3M8O=
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MS\N-N%4= >,YSS38_AYID%O;6\-_J:16VHG4HE\Y6VRDL?XE.1EVZ\G/)/%
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MV&IZ6Y:V\A5$)BB1E*$#<<@D')/MCI4^C:OXGURTT'7;(G[)>2*]W;SF$0K
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M1)-7M],GGT1[F<V]NDPCG65$)4MU')X/8D=<$>@-&[VQC\YDD*;?-0#(./O
M$$9[\@BL>'PK9VVOVNKP7%TDMM:&S2+<I0Q$AB#E2Q)(!))SFMR@#QB 7<OP
MAT&XEOYKB>?6[=@UP%8*WVTY/ !.3R<D^V*Z*\\4ZKX9NO%L-Y>_VBNGV=O=
MVKRQ(A1I2Z%6V  J&4'UQGGO6POP^TV/1XM*CO\ 4DLX;M;N%/-4^6RN9%49
M4_*&)/J>Y( J[-X/TZ[U'5+R\DN+D:G:K:7,$A7RVC7. ,*""-S<Y[_2@"#3
M!XDB\1K]ID>;1Y;<AOM9A$J3 \;/*'*D9R#R,=:9\3/^29^(_P#KQD_E5GP]
MX1M_#I&S4M4OA&GEP"^N/,$"?W4&!Z 9.3@8S5_7]$@\1:+<Z3=3SQ6URA24
MP%0S*>HR0<4 9.D-K;6>B"X@L!IPA5IF21F<8CRAPR@ ;@#GKG%9.DV-S+\4
M?%@75[R/%K9'*I">")L#F,\+V_7-= GA@BWMK676]4FM;<QD0,855PA!"L5C
M#$<#(SSWI]OX;BM=>U'68K^]6YOT2.49C* ("$VC9QC<?SYS0!P7A#5+S2/
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M--\AW)@@ #:>0 ,9)SG)JR?#$#ZQI>J27]])<Z=')'$7="'$F-Y;Y<DG Z8
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M8D\8SC=QG(W'D$=><U'I_@FSTV[TJY@U#4&DTRT-G!YDB,/+.W(.5_V5].E
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M8,R0N616QR 2!D59R,9SQ7DNA7):S^&=C?!6TBZTY@RR#,<ER(E\M7SP>-Y
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MG3K0R3(8Y&\A<NI&"I..1CM5F&&*WA2&&-(XHU"HB* J@<  #H*?10 4444
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MBE_X0C0&T&71I;1Y[65A)(TT[O*SCHWF$[@1@8(/':MJTO+6_@$]G<PW$))
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MY%C?4+57:7R54S*"9./D S][D<=>:34]0@L+8F2\M;:9P1";EP%9OID9^@-
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M5#H6LP:IIUD7N;=K^2TBN)H(W&Y-R@YVYR!D]ZN+J-BU\;%;VW-VHR8!*OF
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MN(M/CE1+B9IY \SR9D8Y9OF)QD\G%&IZ#8:M<6MS<QNMU:,6M[B&1HY(\C#
M,IZ$=0>#5B'4K&YF$,%[;2RLI<(DJLQ4-M)P#T!&/KQ45S-=+K-C%'=6:6SI
M)YT,@/G2$ ;3'ST'.>#VH JW/A71[O1VTJ6U8VS3"X)69UD,H;=YGF [MV[G
M.<TL7AC2X=3?4HTN%NWMA:M(+J3_ %0R0/O>I)SUR2<U<_M73O-CB_M"U\R5
MS'&GG+EW'50,\D>E5;;Q)I5WX@N]$AO(6OK1(VDC#C.6W?*/4@)DCL"* ,Z?
MX?\ ANXT.RTAK*1;6P??:%;B020'_8DW;A],XJT?!^BE-.06\P&G2&:V(N9
M5D.<NQW99CDY+9SDUJ1:C8SW4EK#>6\EQ']^%)5+K]0#D5+-/%;0M-/*D42#
M+/(P55'N30!7OM+LM3DLWO+=9FLYQ<P;OX) " WX!C1:Z796=Y?7=O L=Q?.
MKW$@ZN54*/R %.34["2S-XE];-:@X,PE4IGI][.*?!?6EU+-%;W4$TD#;94C
MD#&,^C =#]: ,B'P?H]O;/!!'<QJ]X;XLMW+N$YSEPV[(SDY'0YY%%[X-T+4
M=)GTV]L_/AN)_M,KO(WF--@ 2;\Y#   $'@#'3BM:[O[/3XQ)>W<%M&3@--(
M$!/U-.DO+6&V%S+<PI V")6<!3GISTYH YK4/ NG3^'!H]HL\8\]9_M#7<IE
M60# D+Y+.1Q@$XX'I737-M#>6DUK<1B2"9&CD0]&4C!'Y&HQJ-B;;[2+VW,'
M'[WS5V\].<XYICZOIL=J]T^H6BVZ.8WE,RA%8=5)S@'VH S(/!FB6XTSRX;G
M.EDM:%KN5C&2NWJ6Y^7Y><X''2B3P7H,UGJEI/9--;ZI)YMW'+,[B1^/F&3\
MIX'(QT'I6M+J%E!9B\EN[>.U(!$SR (0>AW9Q2B_LS'#(+N QS_ZEO,&).,_
M*<\\>E %+0O#NG>';=X;!)OGQODGG>9V Z#<Y)P,G Z#)]:=K'A_3==^SM?0
M,9K9B]O/%(T4L+'J5=2&&>_.#WJ3^V])^RK=?VI9?9W?RUE^T)L+_P!T'.,^
MU3WE_9Z?$);V[@MHR<!YI @)],DT 066D6UBQ<-//*5V&6YF:5MO< L3@' R
M!C.!FJ5CX1T?3FA%M;R+#!*9H+=IG:&%SG)1"<#J<>F3C%:DM_9P!3-=P1AD
M,B[Y ,J.2PR>@]:S]3\4:-I5E9WEQ?V_D7D\<%NZRJ1(SL%R#G! SDGL : (
M7\':+):ZK;/!.8=5<O>K]JE_>D@ _P 7'  XQP*E;PWID=[8ZCY-S)<Z;"T5
MJ?M,A*J0,K@MALX'7T%:4MY:PV37LMQ$EJJ>89F<! N,[L],8[U1TKQ%I>L:
M)'J]K=Q?8W4.79P-@/3=S\IQC@^M ',^ _"9M/"]C!K5E<Q75O<RW'V::XWQ
MAS*S(X56*\ @^QYQGFM:[\ ^';U[XS6DQ6^G%Q,BW4JH900?,50P"OE1\PP?
MS-;]M=VU[ )[6XBGA;I)$X93^(IEYJ-EIZHU[>6]LKG"F:54#'T&3S0!F#PC
MHZR:G((9PVIQ+#=XNI/WB*NT#[W& 2.,=:S-3TB>:SA\'VNB%M >WCCDO9KD
M.L<:MS&%8ERVU0 >@R#VKII]0LK4D7%Y;PE8S*?,D"X0$ MR>F2.?>FC5=.9
M[9!?VI>Z&Z!1,N91ZKS\WX4 6E4*H50  , #M7-WW@+P[J,FHO<V<K#4&62Y
MC6YE5'<8PX4, '^4?,!GBMJYU73K,L+J_M8-C*K>;,JX+= <GJ<''TK'O=;O
MK;QYI.C*+<V-[:7$S'8?,#1E,<YQ@[_3M0!83PGI$=S?7*17"RWT"V]PPNI?
MGC4$*/O<8!/(YY/K5>3P-H+VNF0+;SQ?V6-ME+#=2)+"N,%0X;=MQQ@G%;7]
MHV(OA9?;+?[61GR/-7S/7[N<T1ZA932RQ17EN\D.?,195)3'7(SQ0!5T;P_I
MV@)<IIT4D8NIVN)M\SR;I&/+?,3C/M4-_P"%M+U/6(-6N5NOMT"-'%+%=RQ[
M%;J %8#GO6I%/%=V_FVL\4J,#LD0AUS^!YY]ZY#P[K^OZ_!J\WG:5;#3]1N+
M$[[>1@WE'&\GS!C.>G.* -EO"FE/%>1R"\E%XJ),TE[,[,BDD+N+9"\G(& <
M\YJ=O#VFMX@773%(-16#[/YJS. 8\YVE0=I&3GD5):ZBHAM(-1GM8-2EB4R6
MXE&=Y'(4$Y(SG%6$U"RDM7NDN[=K=,[I5D!1<=<G.!0!BZ1X&\/Z%J+7NG6;
MPN69TB\]S%$S?>*1D[5)R>0.A(I=+\$:!HNI/?6%F\3L[2+%Y[F&-V^\R1D[
M5)R>0.];$.H65Q9F\@O+>6U ),R2!D '7Y@<5&FKZ9) DZ:C:-$[^6LBSJ59
MO[H.>3[4 8LOP_\ #LYN!):SF.>Y%V8A=RB-)=VXNBAL(2W)*XK1'AO3%UB?
M5DBF2]GB6*61+B10X4$*2 V-P!(#8SSUJU<:MIUI'<O<7UM&MJF^?=*!Y2^K
M>E9D.O)K.CZ7J6CW]C'#=30E_M)R2C $QC!&)"", Y^E %S3/#^FZ1H:Z+9V
MY73U1D$,DC2#:V<C+$G')XH/A_2G\.KH#V4;Z6(!;_9VY&P# 'KV'/7/-6H]
M0LI998H[RW>2$$RJLJDICKD9X_&F2ZMIL%FMW+J%I';.<+,\RA&/LV<=C0!2
MT#POI7AJ)X].BF&\!2\\[S,%'107)(4>@XHU'PKH^J:LNIW=O(UT(#;,R3N@
MDBR3L=5(#KDDX(/6MA'61%=&#*PR&!R"/6JR:E827K627MLUTN<P+*I<8Z_+
MG- '!ZUX/CL[O2K6T\/ZA>:-8VKQ0-I^I&*YA=F7()>1"R;44#YN,=.!6KIO
M@V"ZTWR-574S:K<I=6MK=:C)++ ZXP3(K'G(R%W,!C.>>.H74;%KPV:WMN;H
M'!A$J[^F?NYSTJIK7B'3- 2U.HW4<)NITMX59@"S,0,\]@#DGL!0!6UWPAHW
MB.6UFU""4W-IGR;B&=XI4!ZC>A!P?2H]4\$:!JUK8V]Q9LGV#/V66WF>*2+/
M7#J0W/?GGKUJKIGBHOXD\0V6IW=A#8V+6PM9MWEAQ*A?DLQ!/0#&,UT=Y?V>
MGPB:]NX+:(G >:0(N?3)H +&QMM-LHK.TB$<$0PJY)]R23R23DDGDDYJQ2(Z
MR(KHP96&0P.012T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5Q?Q/,<?A6WN)MHA@U.RDE=NB()TR
MQ/88KM*" 1@C(H \[:31=1^+DAG:RGMQX>C*"7:5_P!<YR >/NG/T/H:YWPK
MK6G6_A[P%'/-!!<>1=I#?W$A,<."%,87(#2,"  >@!P#G!]EP/04;5X^4<'(
MXH \2T>\LH?"'@F6>9%@LO$4\=Q)*-HAR;G:&R %ZKQQU'M7HWQ!3[1\-?$
MCC+EM.F*KMY^X3TKI]HQC QG/2EH \RO+S1M4\6?#X+-:7%LUO=D#(*,?*3'
ML?F!_$>HK!34(M/T6\N()F32+'QA.]Y]D57\B AMK[<$;!(5;H>F1TKVK:O'
M XZ<4;1@C P>M '*>#H]$FO=7U31-0GOTOGC>XN25\EY%4CY JJ-V,;B!Z9Y
MS6+ILT7A#XG>)&UB5;:RUWR)[*\E.V-G12K1%CP&YR >HKT555%"HH51T &
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MZ#&<UQ]Q=V5I'\4K2:6**Z=9)$C; 8H;1 &^A/&?7CK7JH 4    < "C SG
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MPZYP,8_V3Z5W.E^')K'Q3K6L3W4$Z:DT++"+<J83&FP?,6.<CV%=!@9S@9H
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ML!R:<0",$9% 'DEZ='O]5^)DLWV2;&G0>49-I*_Z,W3/0YV_CBF6^NVMA?\
MAZXUO59+/2[SP[!%;WFU'B,PR949G5@"PV>F=N#7KNT>@I&C1UVLBLN<X(S0
M!B^$+"QTSPM8V>F-=-81JPMVNCERA8D'H..>..F*W*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO<6DUM>G3Y;28IY@GXPH(;:<A@<YQCDGBLF+1M=DN?!,T^FI'_9 <72I<*V
M8#$,=,G)S]/4\50N?".OS6NLS6T,,-]_;ZZQ8I.X:.8!%3RWQG&0&_,<^@!U
MVA>*K/7-1U'34C>"^L"GG1,RL"KC*LK*2"#@^X(Y%8MWJ$^O_$N3PUY\T.F:
M;8K=72PR&-KB5SA$+#!V <X!&3P<BMWP^^KW"27&JZ5;:62 J6T,PF;/=F<
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MJ#*N 0ZX)X.>^#P<BN0U[3?$OB3P/JEG)HEII]W=)''%:QW*OR'#,[O@ #C
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M &D+K?A:\EN]1U?[1_:%U$DZ:E.'15D*KCY\< #J"/7->B('AM5#9FD1 #L
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M_+_,,,#@9/'('%9]OX8UF]\(Z-X5U.V2./39[?S;U)5*2PP,"FP9W!F"J""
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MQV,2W7E>?C+B$812><+[#IGOBK% !1110 4444 %%%% !1110 4444 %%%%
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MKJ&DRWK6QBW*&VQ$\[ADXD(![>AS73>*->?1(=.B@5#=:E?16,!D!*H6R2Q
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M/TR,@@@C@J1@BM6UG^TV<-QMV^;&K[<YQD9Q4M &5::;J&Z,ZGJ@NA$0RI%
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M# '3&P]:KWWBE[3Q5#X?CTN:XN9[9KJ-TE14**P4YR1@Y(H IOX(EBUZ]O\
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MR6_DX22-R"V><@DJ/PJOX<\'7&@-#;OXAO[W3+3BSLIU0"(8P S@;G"@\ G
MXXX&.JHH Q?$/AX:Z=-D6]EL[C3[L74,L:JW.UE((8$8(8UER>")HM>NM1TO
MQ#?Z=!?E6OK6)499F "EU+ F-B ,E>?I7744 8.G^'#IOB/4M7BN\_;H8H3
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M*3W4MT2T84AY&+,.#TR3C^=9.L> 5U6XU\C6+NWMM;A5+F!$1@&5-@8,1D#
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M,.DI=-<QPN[)(Z!6^=RYSCCJQ_#%;-%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<GX\U673;;1
MH_M*VMK>:E';7,[YVHA1R 2"" 65 3D<$UUE5M0TZRU:PEL=0M8KJUE&)(I5
M#*WX4 >9^*M+O-"\-:\T7B&9PUU8S06UL9(Q9AYE1@"7;*OR=IX'/'-:?]C0
MGXF7>C&ZU$Z==:.MW- ;Z7#RB8INSNW#CL" <#BNFA\'>'8-&_LB+2+9-/\
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M1UBA.["D!O3YL\?4UK^-;LSQ>*Y;2ZN)+K3M)24YG,*6+['=6CV\M(W!/08
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MQ:Y+$))IV+1JT4C>6&!&0O SUXQGC%=)\0-5GT?PM%-;2O#%+>6UO/<(V##
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M+,65/[N2>GM0!Q/AZR?5;?PYXAA\3+LN(MEPD0DW7I=/F1CYIPZD$Y !7!Z
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MTX'I0!7TJSGMO ILKG6I=4FAAEB;4$W1.Y4L <AB<C&,YYQGO7!V3OI7P_\
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MKQEAN#8(]#6CXE:YCO[[5- NYAJ!MX4FTNYMS);ZHFWA4XR'^8J<'C R .:
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M<^+YO"J6,L%OYT0F66_;&?)M=RHS_7<ZX]@WH:ZJ:ZM[>U>ZGGCCMT3>TKL
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M44 %%%% !1110 4444 %%%% !1167KFMQ:+!:EHS+<7EREK;0AMN^1NF3V
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MBN 6NUB617+#J0<'Y>!W]JP3K5EXH\3?#O7[6 QFXDO5(D4>8A6!PR$^S T
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MD':?EQCUZXZU13QW?ZU=>#YM&M(EM=5EN!/%<RE'5XHY-T9PIP PSGN5' %
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M<?*2#A>!WYR1WO1>*X]2?3+;2[5;BYU"P&H^7/)Y:Q0,!@L0&Y);  !Z'TH
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MYV7^T8WE0#SCC/X5I_VY8>&= .K:7H,L<%[J:V\EJ (-CF00;]A'&=H./Y4
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M31;>2&X F<ER\83*?)VVYYQUQ[U%I?@^[B\4:?K]S#86=]%#(E_+8R-B_)7
M+IM4#!^;/)R *[:JEGJ,5]-=Q1QSH;6;R7,L3(&. <J3]X<]10!;KSK6?!7B
M+48]>@2ZTR07U[%=6US.7\U41XV$!P,*HV'!!/4\9.:]%I"RJ1D@9.!D]30!
MQH\-ZS_:GBJ\<V#?VQ9PP18E==C)&R$L-AP#OSP3C'?K5*P\(:]HMYH&IZ?)
MI\MY9:3'I%[;S2NL<L:8*NCA"0V03@KT./>NNTW7;'5;[4;.U:4S:?*L5P'B
M9-K%=PQN SP0<].:GEU&*'4[:P:.<RW".ZNL3&-0N,[FZ \\ ]: ,;P=H>HZ
M%9ZE%J,MK(]UJ-Q>(;?=@"1RV#GOS_\ 7-:'B31(O$?AS4-'FD:-+R%HO,49
M*$]&]\'!K4HH XZ#0?$FLZ!<Z/XJN]/-O):O;%[#>7F++M\QMP 4@<[1D9[\
M8IL'AG5[VS\/V.M/9-%HL\=P)H)&+7+Q*5C)4J G4,>6Y&!UKJ--U.RU>S%Y
M87"3VY=T$B="58JWZ@U;H \\N?!6MW'A'Q!I ?3UGU/57OHW\Y]J*TJR;3\F
M<C;C\:O'PWKUAXAUJ]TQ]/DL];C1KB*XD=6MIE39N0A3O4C'!V].HKM:* .!
MT_P=K5G9^"H'DL'.@$^>5D<>8#$T?R_+Z-GG'2I+GPCK)L/&6GP36#6VNO++
M"\C.'C:2)8R&PI&!MSQG.>U=U10!QJ>&=5L=<TK7;)K1[R'31IM[;22LL<D8
M(961PI((;/5>0<<54N?!&H&U@:WDLS>2Z^FM79>1E3*D8C0A23\H49..A..<
M#O:* ./;0-<B\0>(M3M_[.(U*.U2*.61F&(B0RN-G1E9AQG'O5CPGX5'AR_U
M:>&*"RM+YHW33[:1GBA90=SKD#!;(X  ^4?AU%)N7=MR-V,XSSB@"*[M8KVR
MGM)@3%/&T;@'&588/\ZXJU\&ZH_AG3?"^I36DNFV$\3"YC=O-FAB<-&A3;A3
M\J@G<> <=>.[HH YK3]%U*U\=:OK,HM#9WUO!"BK*QD7RM_)&W'._IGC'>NE
MHHH X.Z\'ZTVE^,=,@FL&M]<EEF@>1G#HTD:(0V%(P-N1C.<]JMS>&-1O-=T
M.[N!9BULM/GLKA%F8LWFA 2OR=MG?'7VKL:* .-\+:)XLT6"UT>^U#3IM(L0
M$@N(U<7,L2_<1@?E7 P"03D#'?-=E110!R.K67C&?7_M5BNA/90#_18[N2;<
MK8P7(5<;N<#T&<=3F:70=3;5-(U_S+236+6WDMKM 6CAF1\,54X8C:R@C(.1
MG/7(ZBB@#!\/Z%+H5A?OF*?4+^[EO;@[BJ>8YX4'!.U5"KG'.,XYK,T?PA>0
M?#!O"5_<Q13-:2VOVBU8L,/N^;D _P 73]:[&B@#F(O#UU=ZWHFJ7\-G;SZ5
M%(@:U=F,N]-FWE1M3^+'/./3GIZ** .0NM#UM?B+_P )+:Q:?);C3#IXAEN7
M1C^]\S?D1D#TQ^M1Z_H7B/7[!H9/[,A(O;:>*%9W*JL4@D8EO+!+,>.@  '7
MFNSHH YF+1M5B\<WNO!+,P3:=':)'Y[!MR.[9/R8P=^/PS[5QT6C:GX9N/AO
MI#_8YKVSFNT!65A&X\ASG.W(.">QYKU>JEQIFGW=S#<W-C;37$/^JEDA5FC_
M -TD9'X4 <=K'@K4-4T3Q4%DM$U/7_+1LNWE0QQJ%49VY8X!)X'+8[5HOH&J
MVGBU?$6GBT>2YLEM+ZTEF95)0DHZ.$)R,D8*C(KJZ* .$O-&T/1?!FIZ1KVH
M6Z2ZQ)<W4HWA6DF=MY\E2<L5)0#'.0/6I+OPGJE[\+9M :XB?5[Z#_2KBX8@
M&5R"Y.T'..@]@*Z^>QM+J>">XM8)I;=BT,DD89HR>I4GH?I5B@#EY=%U67QI
MIFME;,0VMA+:R1^>Q8LY1LCY,8&S'XU@IX&U^#2HI;2\L;?6;+5[C4K1BSO"
MZS%MT4GR@@8<C(STKT:B@#B]8T'Q-KNBVT=[+I@O4O[>Z:*)W$,:1.'VJ2I9
MF8CDD #CCCEUYX5U&_UOQ)<R/:QVVKZ4M@A61F>-@)!N(V@$?O/7M[UV5% &
M5X;L[_3_  ]8V6I&V-Q;PI"?LQ8IA5"YRP!.<9Z#KCMDZM%% !1110 4444
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MV'=\O/R@#M^?-5--\ Z7I.I/<V=WJ4=JTQN!IOVD_94D)SN"8]><9QGG' H
MY.?Q#XF@\-:SK9ULL=*UQ[18!:QA9XA.D>USC/W6X*X.>N>W0:1'=/\ %GQ'
MOU*Z:&*SLV6 ["F&\[Y?NY !YX(.3R35V3P'I\NB:AI+WM^;;4+PWL_SIN,A
M<.<'9P-P!Q[5H+X;M4\0OK:W-VMU+;I!,JR!4E";MK, .HW-TP.>E &S15/2
M=.&DZ7!8BZNKL0KM\^[E\R5^<Y9N_6KE !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK+$T:;SNPN0,=..<4 =517+6/Q!T*_O=.MHVNXQJ48>SGFM72*8[=VQ7(P6
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5V)R1V!XK#\0>'-5US6_%2V]K)!'J&DP06MQ+MV-+&SMM(SD [E&2/6O2**
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M.U/5M(O?!UOJT5Y?375IJ3K"\025R^)MQW#82>@.<<5-=Z5JLB_$94TNY/\
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MK6VEN)W$<,2%W=NBJ!DD_A4E9/B#3+O5]/6SMKF&"-I4:X$L1D\V,,"T?##
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M?M?$VBP:M8QSK:3@F)IE"E@"1G )QR#UK3>-),;T5L'(R,XKR3P?JEU:> _
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M"ZN5;6-;:QFG>4N8T-Q,25W9PS;<9]6SUH ]>ICRQQ%!(ZJ9&VH"<;C@G _
M'\JY/3[J]TWXD7&@"XGN-,GTP7T8G<R-;R"385#')*L"#@DX(..*J^-;07/C
M#P6IGN8U>^F4B*9D'_'O(<\'K[]<9'>@#H]+U^WU75=6T^."XBFTR5(IO-
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M/*430/\ >X"JQ/*_(2<8Q71_$ZWFN?ASK,<$3RR"-'V(NXD+(K' ^@)KK:*
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M3-MS:CYDE21L..,'83&3Z#K7J=% 'D5]>:^=%NY;M5U6'3-6M9Y]0TN/:U]
M%^9@HR"Z'83MX^4>E-\4?V!J?@CQ/JVB+>W4E]%;QRW,ZR#SW1QM55<#<57.
M2!Q^>/7Z* .#<VQ^*T?V3R_*?PZ\2F/&TGS5*J".,[<D#TJY\+YU?X=Z-;[9
M4FM;=89DDC9"CC@KR!R*["B@#R;5;?4+FU^)>D:?'.-3NI5F@01L/-B,$8.&
MQCY@K*.>M;-Q/;^)?$7@V^T,X:S:62ZVK@V\)B(,4@_A);:-IYX)[5Z!10!P
MOCN[;2=>\/:M=B\&C0?:(KN:U#,8'<)Y<A"@G'RNN>V[WJC-IGA_4?"MSI>F
M0W*C7+]IK6><NK&? 8W*[L%0I7(Z;B,#[P)](HH \FGOK^[^&U_IJV;S:SI%
M[&VHV\0)-\J3*\DB'^(. 21ZY7TK<O=7T'7]"U_6-)MW>6329();UH'C)^5M
MD7S ;FR3P.G [BN]HH \M2ZAT]OAGJ=T62S@L);>:;82(Y&@C"JV!P258?48
MJK8BWO-*U99;Z]T><^*KB:TOC 0(7*L59PXP4(#*0?4 XKURB@#R;4KV]N_"
M%@VJ0VHN8?$MO_I%JI$=TB3*6N%'8$9R>G!/0UO^)[?4-+\7Z=K6C0M(VJPG
M2[DH,A&(+PS$=PIW@GT-=U10!YSXAFM_"OBW2)[XWT&@#3#917-L'802AP</
MM!(#*%Y]5KJO"5CIVG^'HH=*MKBWL&=Y(4N"VXAF)+8;E0220#V/0=*W*IZG
M:WEW9^78Z@UC.'5A*(EDR <E2K=B..,'WH \JEC9?AWK$R1NT=KXKDGD$:EB
ML:7H+' YP "?H*OW^I6M_P"*/%ES")7M;CPVB12F%@DAS-T)&.=P ]>V:]"T
M;2(-%L#;0$L7FDGE=NKR2.7=OS8\=A@5H4 >4ZO!9Q_!'2C!!$MPT.FHX2/Y
MRR21E@<#.5^<GTYJQXJGGL]9U34=#OXYKEEA6ZT2Z3<FH+M&TPD<A\-CC(R!
MD5Z=10!Y;-J2:=>>/M-UM)$O+]7ELBT3,+B#R JHA .=I#9'N3ZTFFRI]M^%
MA971H;"5)/,C*E";95 ;(XRPP,]3TKU.B@#S#PQJ%@;$^%M?TZ>?7K75)9Q"
M]NY$SF9I$N ^-NW# [B>,?0&M>2+#X>^)^G31RK=337,T2-$WSJ]O&J$'&#E
MA@#J<5ZQ10!YQ:7ATWQEH.IW[A-'GT!;2&Y;_5PW =696/12RA1SC)3%85UI
MWV;2X3/$/[/N_&B7=I%(G"VQ<;GVGHA.YO3# ]Z]DHH XOPZ\0^)WB_85"RP
MV)4CHY5) V/4C*@^G%,FNCH_Q3N+O5G$6G7FF1PV=U(<1(Z.Q>,MT5FW!N>N
M/:NWHH \>NK.72_AJT,JO%!/XB6YL;=E(:.U^UJZ_+U V@M[ UZ9;>(M,N]?
MFT2"X+7T,"W#+L;:8SCE6QAOO+T/<5JU7%G%]N-XVYIMGEJ6/"*<$@#MD@$^
MN!Z"@#E/$>H0VOC?28)89+9I+.<)J*0-*^2R9@0 %0QP&R0>%P!S7$^&# ]A
M\,H;B%@UI<72S+/$5\L^7(%SD?WBH!Z9]Q7M-% 'C5Z\\5KX@GMH9)[*W\70
MWMY#"A8R6JK&78*/O#>N3C^Z:Z;2]3LM3^+LM[8,TUO-H,:B=(6V,PF<XW8Q
MT_PZBN_HH \^\67L:^*[JQ-O+;33:*ZQW<5NTLEUEF_<)P5&#R>"?F'0#-<_
M8ZQ:Z-I_P^U:::2-H-(>VD2X@E$>-D0;YE1BK!@,?+@@-R,#/L-8.J^'[R[U
MF/5=.UJ>PN%@^SNAB2:)TW;ONMT;)Z@C.!GI0!YS,FB#P/HL%E?VVHI_PDD,
M]SY:$+'NG\QUVD9"JK=QTY[UNZ]>6?AWQXMSJ0NK71+W3UB@N;.-C&DPD=G5
M@@."X=3G'.*[G3M.^PK*\MQ)<W4Q!FGD506P,  *   .@_F235Z@#R;=I_A#
M6-&ED@U73_##Z:]M:RCS&:WD,Q?$@P64.I4@'IM .,<=]X2L=/T[PY;V^E6U
MQ;6&YW@CN"V_:S$YPW*@DD@'H#T'2MNB@#QB]E5?A3XDTN2.47::S+OA:)LD
M->!QCCYLK\W&>.:W-;N+:#QSJTT%DM] ?"K(+:'@7!#L1$".Y4]!S@\5Z710
M!Y5X?O8[CQWHES')--#/X?EMXREH\<,;B2(^6N5SA0#]XG&.O:NC^%DP/P[T
MBU*2I/:0"&9)(V0HX)RO(ZBNRHH \RTZ6YT_Q3:)I5ZFI:7<ZI.9=-N8_P#2
M-.D8R%Y48<^7DM]X='&"<UA7-Y';^"+_ $=X[@ZA;^)/-E@6!V*H;T.&X'0J
M01Z]J]JHH \RCU/3[+7O%6A^)[&YF&K7*SVB_99)!>0&)%6-<#@J5(P<8)SZ
MFIT%J/'GBA[B*&,?V);P@-@A<>;O0'OC*Y ]J]&HH YCX=,3\.O#Z-GS([&*
M-U;JK*H!!'8C%=/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7&_%,,OP_OI4DDC>.6W*M'(5ZS
M(#G!Y&">#795S7C[2K[7/!]WING0K+<S/$5#.$4!9%<DD^RG\2* %GO[!?'T
M=H;"[;5%TN66*82 1/$'0% -V-VXCD@?6N<_X2Z/5OAE=:QXBT:\-DT[H\=M
M,H)47#(F&5U;Y2J GC/H1FM^33=0E^(UEK0M"MC'I<EH[-(NY7>1'Z ] %P3
MZG\:YI_"GB'_ (5=J'A?[%;M<FX?[/(MP-LBM<&7<<@;1@@8Y.?2@#M+_P 0
MQVNK/I5M:S7E]':&\DBB*C;'N*CEB,LQ! 'L<D51L?&UMJMAI5S8:=>RG5-Y
MM5<(N41=Q9F#$*.V#SGM6'KW]J7/C=[G0]-%Q<V^FK;W?DWZ03)YC%@C[E93
M@#((P1D\X(I+>TU6YMM"M=-T)+?2=.:6TO=)EO%V[@J^6V\9$B#)R#W/()'
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M ,6Q\4)J7E26=A<3VLTDL4<Z,A&Z/=D,-V5R5(&?QQ63X?\ &]Q?>%8=6O\
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MT>+3]/N=+ENY9[;4GF >!)'+E6CVDNP+-CD \9Q0!I7/CVUM-.UZ\ETK4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *SK?0=*M-8NM7M]/MX]1N@%FN50;W QP3^ _(5H
MT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(GB6,$2C&,-GJ,$\'UI=*\+:%HEG<6>FZ5:VUO<@B:-(QB08(PV>HP3QTY-
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MN[N^MI)[IF82&*1UBC=@RDY ]>2HZUWGA339M(AU"REUC^T56[9XUV,/LJL
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MI\\MY9I/"T;),D[R1\,!PP./HQH ]"EUBPAENHI9]C6BJ\Q9& 4-]WG&"3V
MR:SYO&F@6]M>SW%\T*V)472RV\B/"&^Z60KN"GLV,>]<]KNG:Q?>!5U&&QE?
M5)+VWU2>P20H[*CJWD@C!#*BJ./XEXY-7-$L](\1?;[C_A'M2MH[NT-I<RZJ
MLB2RJ?\ EF Y)(&3STR1C/. #IVU6S2>S@9W$MX"T"^4_P P R<\?+P>^*ML
MP52QS@#/ S7$^ ;/4U23^UV$K:3OTJTFW9\Z-'YE^K 1J1ZQGUKMZ /.-?\
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M!(((."""""#S5VN#\'WDVBZ->"YTK5"USKUP$1+1PRI+,Q60A@,)@Y)[5WE
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M)/)))))/4DU9)P,FLGPUKB^(]"@U(6DUHSEE>"8?,C*2",]QQD'N"*Y=9O\
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M<J,@\Y^7((QB@#MJ*SM)O=0O5N&O]+-@JR8@S.LAE0@'<0/NG)((YZ=36C0
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M9DW@>^MO#NA:9I\MK(]CJB:E<RSNR"1Q(TC!0%;&2Q ST '6N\HH 1=Q4;@
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MYZ<U/J6HQ:79_:9HYY$WHFV")I&RS!1PO.,GD]A0!Q_B#P5?:]!]FN/L4DT
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M*-88Y1M3!"YVK)CDG.&]LU3TKQ+JEW=:YHSZE.;\WL8TR9H8@6MG)Q(H"X8
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M1GO VE7>/.1%*D-%DC8HX/'';%:L7@/3#HMWI>HW6HZM#=1>2\FH7)D=4!R
MI &W! .0,D@9)P*?8^"[:TU73]3FU75;VZL87@A>YG4_(V,AMJC/W1R>3WSQ
M0!L:P)#HM]Y,\EO(('*RQ8W(<'D9!&?PKS_PUJ][:>&_ .CI?S^;K=OO>YD5
M&:)(X-Y5/EP23@9;<<9Z\5Z5+&DT3Q2#<CJ58>H/6N9B\!:7#HMAIJ7-_P#\
M2Z59;&Y,P,ML5& %.,;<<8(((ZYH 3P_JVH?\);KOAV_G-VMDD-Q;73(JN8Y
M WR/M &05." ,CZ5H>*+RXLM+B>VOH;)GN8HVD="[E"PW+&N&W2$<*,'FK6F
MZ/!ILUU<K)+/=W;*T]Q-C?)M&%'R@  #H  .2>I)J'7_  _:^(K."WN9;B%K
M>X2Y@FMWVR12+G# D$=R.0>M '!:CXJ\06OAGQ>\5[+%=:1?0QV\EQ#$9/+D
M$1VL%&W^,X.,],\UOPW&MQ^.;WP_+K4DL=SI/VV&7[/&#;2B380@V\KR#AMQ
MXZU-<?#O2KF#5H9+W4]FJO&]U_I&=S(%P1D'!.Q<_3 P.*OW>D16&K2^*-VH
M7E[;V#6XMX@A,L8._:%P,L6&>HYXZ<4 87A[7]5U;3]-TR>]>/78+V6'5"L<
M?"P_?(&W&UMT6"!G$@.>*[6^NEL;"YNW4LD$32LJ]2%!.!^58/AK3TFU34O$
MTFF2V%SJ8B013@"41HN 7 ) 8DGC/15SS72,H92K $$8(/>@#SF7Q-K5KX-T
M+QA]M,Z7DMNUW8>6GEB.=@NU"%W!E++R6.<'(]+FD6L__"W?$3G4;DJEC9ML
M*QX8%IL(?DS@=L$'U)K7L?!6FV$-O:1SW;Z;;7'VBWL)'4Q0N#N7'R[B QR
M6(!QZ#%RV\/06OB2\UQ+NZ-S=QI%+&Q3RRJ9V@#;D8W'OWYH L:]-<6_A_49
M[2;R;B*VDDCDVAMK*I(X/!Z5P/VK4M7OOAE=3:K=1R7MK)-/Y0C"M)]E+%\%
M2,G<1Z '@"O1=0LTU#3[BRDDDC2>-HV:/&X C!QD$=/:L0^"M/-EH=L+F^0Z
M*-MI,DH60)LV%"0.05X['WS0!C:;XFO&\7Q:1K%W=Z?>M=3^7;30)]FO8 '\
MOR9 N=P&PD%L\-QZ=IJ#W4>FW3V2(]VL+F!9#A2^#M!/IG%947A6U2>T>:[O
M+J*SN6NK:&=D*Q2'=R"%#$#>V 20,^PQKWUI'?V%S9RLZQW$31,4.& 8$'![
M'F@#SNW\6WESH6O,FJ:A::QIVE27$NGW]K&DL,JJ3O7Y-KQDC&>>W3-:BZ_J
M2ZSX*5KHF#5+&:6[B\M<.R0JX(.,CECP#BMI?"ME)---?3W-_--9-8-)<%<B
M!CEE^15ZG&2<GBJ5CX#L+*ZTBY;4=4N9=)5TM3/< @(RA=I 4 @ 8]3W)XP
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M%Q=V<4TNT8&YE!.!]:YWQEK6JZ>=<DL-3*-8Z9]JAM[6)'9' =B\Y=2 AV@
M @D!L XKK-$TB#0=&M=*M9)7M[6,11&4@L%' &0!G%9.I^"--U34=2NY+F_B
M_M.V%M>0P3[$F4*54D8SD!B.#CU!H QUU37-6\86&G0ZL;*TO-!^W,(K=&:.
M3?&,J6!_O'J".O&<$5-$\7ZKJ>F^$].GN@FH:K/>1SWB1J#LMF<$JI&T,V%[
M8&6P.E=-8^#[33]2M+^"^OS/:V/V",R2*_[K(;G*]<@'\,=.*J?\*\TI=(LK
M".ZOXVL+E[JTNTE430.[%GVMMP02QR"".?I0!4\%PS6_C7QO%/<O<N+NU_>N
MJAB/LZ$9V@#@8'3M6AX^U/4-'\-K?:=<^1*MW;1L?+5MRO,B,.>G#'FKVC>&
M;71=3U'48KN]N+G4"C7#7$H8$H@4$   <#_# XJ7Q!H-MXCTT6%W-/%#YJ2G
MR64$LC!EY(/1@#^% '-WEUKU[XXUG1K;7'LK6'38;J$QVT;/&[-(."P((^09
MR#[8JIHGBK5]2E\ S2W(":S:3M>1+&NUG2(,&!QD<\X!Q74CPU -<N]7%[>"
M[NK9;60Y3:$7)&!MZY9C^-4%\!:=%I>C65O>ZA;MH[,;.XBD42HK JRDE2"I
M!QR,^] '-7WB;Q!#X9URY@U,?:;'Q&MA%)) AS"9(EVD  ?QGG&:UY+S6[?Q
M"OALZK=7<S6LE^;F**"*4(9 B( P*X7G)QDY7WS;;X>Z4VG7MBMWJ*PWE\+^
M7]^&/F@JP(+ ]U4^IQR35S7_  ?9>()[*[EN[ZSU"R!$-]93"*8*?O*3@@@X
MZ8^F* +7ADZU_8<*>(# VI1EDE> C#@'Y6(' )7&0.,]*YZY%S_PN*('4;M;
M>/0WF$"["@_?H& !4G!P,GKP,$#BNNTZPATRQCM86D94R2\KEW=B<EF8\DD\
MU2NO#MI=>(K77#-<Q7=O"8/W4FU98RP;:X[C< >,>^1Q0!Q4OBW6?^%<V_CR
M&\+*9%FDT[RT,1@,NS8#MWAPI!W;OO \8.!Z9U%<U;^"-,MH6LXYKK^RS<_:
MAII93 K[M_'R[@N_YMN[;GMCBNEH \<O4NC\-OB/)<:C=76V^O(L3;#]W8 <
MA0<X &,XP. *Z9]:U7P_XI-O>7[7]C)HDVH>0843RGB*<(0,[2&Z,6.1UK5N
M? >F7-IK5H;J_2VUB1I;F%)AM#-C>5!!QNVC/7VQDU=/ABUDUJUU6:ZNI9[>
MU:T"OLV/&V"P8!><E1^5 &'HUYXIOIM"U59A)IMY"'O8YFB" .H*-#M&[@G&
M&)R/?FM_Q;_R)FN_]@^X_P#1;5GZ#X%T[P]<JUG>ZG):Q,6M[&>Z+P6Y.?N+
MCW.,DXSQ717EI#?V5Q9W*;X+B-HI%R1E6&",CV- 'F^F7FO^'[3P1<MJHO-,
MU-;>QEL3;HOD[H=R.C#YN-O.2<^W:[I6L>*-?L-)U[3'VVUQ<[KBWG:(0"WW
M%2%(&\2+@=3@D'C& .CTWPK::>;#?=W=XNG+LLDN60B ;=N1M49.WY06R0">
M>3FI8> =+TS5)+NTN]2CMGG-Q_9HN3]E$I.=P3'KSC.,]N* .2NO$/B:W\->
M(-:_MLEM'UI[:. 6L86:)943:YQGHQP5P<]SVWM0U77M8U/Q#I^AS2V]QI9C
MA@*^3L:1HED!D#@G:=P7Y<< GKTOR^ ].FT74]*DO;\VVI79O+CYTW&0L&.#
MLX!*CCVI=0\#6%_K0U=-0U2RO7B6*YDLKGR?M2KT\P =1ZC!]Z ,.[AU"Y^)
M'A26ZOI;>YDTJY>6.W\MHXW'D[U0LA)4GN<G@8Q69XDU75[SP+\0XY]3E#:?
M=/! \2(A$7E1ML/'0[SD]?>N\D\,6CZY8:JEQ<PRV$#6]O%&4$:QMC(P5)YV
MKW[56;P5ILMCKMG/-=30:V[27:NZCYBH7*X48X5?RH W+*)X+.*.2XEN& YD
ME"AC]=H ]NE<[)JEWJWC74= MKV6PBL+**9I(40O(\A;'WU8;5"CMR3[5T-A
M9BPLHK83SS^6,>;.^YV]R?\ "L^^\-VUWK<6LPW-S9:BD)MVGMBF9(LYV,'5
ME(!Y'&1ZT >>ZQJNH^(? -K)?7+PWEGX@AL+AK=$"3/'=(HD 8''0' .,YSD
M<5ZO!&T4"1O,\S*,&20*&;W.T ?D!6#>>#--N]$MM(66YM[6WN%N1Y+C<\H?
M?O8L#D[_ )CZFN@12J*I<N0,%FQD_EQ0!YSXAU75G;XAV/\ :<L<.GZ3%<VA
MA1%:(M',S#=C)SL SU],'FI+K5]0\.:!X>FEEU.31VLLWEY:01RRV[;4\LLN
MS_5@;\D*3D#)]>FE\)6$]_K-U--<R?VQ;"UNXF90AC"LH P,C =N<]Z;;>%4
MLHK)+;5]41K6 VZN9$<NAV\,&0CC:,8 [^IR :&AW(O= T^Y%['?&2WC8W48
M 68[1EP!TR<G':M"J>E:7::+I5MIMC'Y=K;((XUSG@>I]:N4 %%%% !1110
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MWU^[SUP?>N6_L71[KX9:TUI;V_\ ;L&L7$=@\0'GQ3"Y/E(AZJ.>@XP2?4T
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MPA#]X9)!X[$GUKIM=COO"GB&P\16MH+F?5+9=,ODC7[USC,$AQV+Y0GT8>E
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MVQ#()-J[P,!L<X],UB+XMTT#4UN1/:3::L;7,,R#<H?[A&TD-NP0,'KQ4_\
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M Y[Q)X?N=;U#19XI;=8M.NC<O'*A;S<HR;?88<\\UO10Q0Q+%%&D<:C 15
M_"F7=P+2TEN&CDD6)2Y2)=S$#T'<^U9EGXFL=0TG3=3M4GEM]1<);[4&XY!(
M)&>!A23Z8YH TTM+:.'R4MXEBSG8J #/KBB2TMIHA%+;Q/&.B,@(_*L6Z\8Z
M59I)<2F;[!%<?9I;X)F&.3=M(8YS@-\I;&T'@G@UE6^I36/Q"\3>=<7<]E;:
M;:W(@WEA'DR[BBDX'"CIUQ0!V,EO#-"898HWB(QL905Q]*#;PM&L9AC*+PJE
M1@?05CQ>*],E_L0H9BFM)OLG\LX;]V9,'N#M&>:SS\1-#$<DVV_^SPWALIYS
M:.$@DW!?G)'RC<0/7VH Z22SA>-U6*-6=2N[RP< C'?K186,&FV45I;KB*,8
M&>I).23[DDG\:PH?%@D\8ZGHLEE-%!86T4SW+ ;?FWDD\\+A.OKFI;#QAIFH
M7%M#&EU&;RT:\M&>$XN(1C+(!DY^93M(!Y'% &X((5G:<11B9AM,@4;B/3-(
M;: W N##&9@-HD*C<!Z9ZUR0^)NA-IC:FEOJKV"1/,]RMB_EJJOL;)QU!YQV
M'7H<=&VK0K>V-IY<IEO(VECV@$*JXR6(/'WE'XB@"T88U9I$BC\WG#8P2?K6
M#X3\-/X?M)X[IK:XG>ZGN$GCBVLHE<N5YR>"WKS71US]SXQTJT1[B4S"PCN/
MLLE\$S!'+NVX)SG ;Y2V-H/!- &W+;03NCRPQR-&<HSJ"5/J/2E:")I!(T2%
MQT8J,C\:P+KQKI=MK5QI(AU">\MS%YJ06<C[1(2 W3[HQR>E='0!&UO"S.S0
MQDN &)4?,!TSZTK11LQ9HU+%=I)')'I]*Y9/$NC::_B?47NM3D2PE4WL<L<C
M+"1&#B-,9"D8)/3)SFKEGXPTZ^U,:?%%>+/);&Z@\VW*+<(,9\LG@XW#\\C(
MYH W/L\'E-%Y,?EM]Y-HP?J*1;:!85A6",1+T0(-H_"L>R\6:?J&@KK-M'<O
M;//]G53'B0OYGEXVDY'S\<_RYHO_ !;IVGK>R2)<RV]@P6]N(8]Z6QP#\W.3
M@$$[0< \XH V!;0*P80QAAT(49%.EBCFC:.6-9(V&&5QD'ZBN0U"_F'Q)T'[
M-=SRV5UIEU*8(Y<QR%3%M8#."<,<'WK1A\9Z3/I>E:E&9S::G<BUMW\HC]X6
M*@,.HY4\^U &Y]G@\I8O)C\M?NIM&!]!4BJJ*%4 *.  .E<M>?$'1;(ZGOCU
M!QID@2\,=FY$(VAMS<<+@@Y[]LXJ5_%?_%;VV@164TD4M@;LW*@%3ET52.?N
MC<V3],=Z .@^S0?:!<>3'YX&WS-HW8],]:<T,3DEXT8L,$E0<CTK!M/&>E7M
MU911>?Y5^\L=G<&/]W.T>=X7!R/NMC(&<<9JF/B)H[K</!:ZK/';//'/)'8R
M%8FB&7#''!Z\'GCIR,@'4?9;<$$01?+T^0<4OV>$3F?R8_.*[3)M&XCTSUQ6
M;%XALY[32;J))GCU4J+;:H)(*%P3SP-H)_\ K\5K4 ,CABBSY<2)GKM4#-)-
M!#<Q^7/$DJ9SM=0P_(UAS>,M*@NGB;SS#'>KI\ERJ9C2X;&$/.>K*,XP"<9J
MR_B*T%V\*0W$J1W*VDD\: HDK;<*><_Q+DXQSC.>* --H(78,T2%EZ$J,BD%
MM $9!!&%888!!@CWK-A\16EQ>100PW#QRW,EJERJ QF6/=O4G.1@HPR1C(X)
MK-TSQ#HMMI^OZG]OOC:VE^ZW37@?]U(%3*1J1D+RN% ZDXZT =+Y$1D$GE)O
M'1MHS^=9^L66J3VJ)HE_;Z=.9@\LDEKYP=,$$8R.>AS[51F\::9:WUQ8W<-_
M!=V]M]KDA-H\A$.#\^8PRXX(Z]1BFZ=XXTC4KS3;>%+Q/[2@,]I++;,J2@('
M*@]V"G./8\F@#;TZQBTW3X+.(LR1+MW.<LY[L?4DY)/J:G:-'969%8KG!(SB
MN5?XBZ$EJ]VRWPM(KLV<]P;1PD$@8)\Y(^4;CCU]0*T;'Q5IU[JEUIQ6YMKB
MW@%R1=PF(/#DCS%W?PY&#G&* -7[);8Q]GBQUQL%*;: EB88R678V4'*^GTK
M%3QAIIO[6SDCNX7O(7FLVD@.+E5&6V 9.0#G:0#CM56P^(&B:B=+: 7HM]3D
M,5M<R6S+$TG.$+'^([3C\NO% '3-$K'<%7?M*ABN2!5?3=.@TNT%M;C"[F=C
M@#<S$DG@ #D]!P*Q_#WB=]=U?6K,V$\":?=?9U=U&&PB,2>>"2W ],=^*Z.@
M"+[-!]H^T>3'Y^-OF;1NQZ9ZUD?V1J5QXA-Y?:G'-IL+B6TLTM]I1]FW+OD[
ML98@8')!["KVH:M;:<]M#('DN;IRD$$0R\A R<9P  !DDD >O(K(N/'>B6FC
M7FIW#W$<=E.+>ZB,#&2"0D !P.@.1AL[3D8- '2T50TK5HM7AGEAM[N 0S&$
MBZMVB+8 .Y0PR5.1@U?H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE?']A?:EH%O;Z?9R74RW]K,
MRHRC"1RJ['YB!T!KJJ* .1BM;^/XE7^K'3KC[#)I,5NDH*?-(LDCE<;L]&')
M&*X_3_#FNZ1H'A&\F\.?VC)I<%Q:7VF2-$S[9&5A)'DE204'?)!KUZJ\U_9V
M]U!:S74$=Q<$B&)Y 'D(!)VCJ> 3QZ4 <+?Z7?S/X;N+/PR+&.'6/ML]M;B)
M3%'Y3INDPP!<E@?ESQQSBJ^OB[3QCK;:=I&IW,%W8PVE[+IS0N2V'/(D8;75
M'&.O#9(Z5Z56#=>#](N=4FU%?MMM<SD&=K.^FMQ,0, N$8 G QGK0!QLUE(E
MQH6MZ1X8EU+2K:Q?2I]+N%C%Q;;' 5@'.UB"I4\\CG)K2FTJ_P#[>\)7EOX=
M6SMK6YN9[B"V\H"W62)D7=@@,V2"=N<>^,GN;:VAM+=(+>-8XD&%5>U2T 9&
MF:S/?:UJFFSZ9/:&R*&.5W5EN$?< RX/'*-P?:I]>TYM8\.ZGIB2>4]Y:RVZ
MR?W2Z%<_K4L$U@M]<6D$MO\ :P!-/$C#S &X#,.O., GTJW0!PVB-XAU7P\F
M@:IH<FF2Q6;6EQ>M*C1O^[*!H=K%CDX;D  9')K/AT+6-3\%Z#X7O=.DMKG3
MKBV$]UN4Q>7 P(=&!R2P4 #&06.<8KTFB@#S*_T369_#_P 0;1-)N#-JUP[6
M2[X_WH,*(#][CE3UQQ4GB#0M0OY#?:;8:EIVOP6D:6=[;2*$G('^IG7<5*AL
MY)&,'@G&*])HH XG3K35O#WBK7[F;3YM0M=6\FXBDMBIVRK&$:-@Q& < @],
M=2*R]-\)ZGH,/@&R6U>Z729)Y+V6)EVQ&2-Q@9() 9\<#H*]*HH \QUCPOK>
ML0^/8+>T>W?4I[6>Q>5UVS>2D>5."2,F,CG'!J_*^O:OXN\/ZNGAR\M!;6=W
M%-]IDBQ'(XCV]'R5RIY')':NXNKVUL8EEN[F*WC9UC5I7"@LQPJ@GN3P!4]
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M!Y(S(@+%P "Q78I..N>,CJ+:^%M3?5?#FH7.JVTDFD1RHZI:%1+YB!./G.W
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M>)8F.[>-PPN0,#GOZSCPE=-J?AR[EO[=DTBUEMGC%N?WX=%4G._Y>$''/4T
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MYM9(8;Z.[M9Q 1<6P5E8HKY[D$9XP#C!XK,U+X?ZE>:?XATNWUJ"#3M7NS>
M&T+2QR,R%ANWX*Y3(& >>M &S>:]J=S?:S9Z%;6\T^DHF])R1Y\K)O$2G("_
M*5^8Y&6Z<&F-XAU6_N;^RTJR@CO]/M(IKB&Y;=F:12RP@J0!P.7R1R.#S4$_
MA36;?Q-<ZSHVN06C:C'&FH12V?F([HNT21C>-K;>,$D>N:2Y\(:I:>(CK'A_
M6TM'N;>.VOH[RW\\3>6,)(,,I#@$CT- #KGQ7J,DKV5K8"#4K>QBNKB&6&2X
M"22!L0YB& ?D.6SCI@'G$47C*^OU@M8-.DL=2-BEW<075K+-Y+,S*L9$8R,E
M&^8XXQP<\/OO"&K0ZY#K.@:Z+6[:V2UO!>6_GI<JI)5R RX<;FZ<<XXI-0\(
M:LNL6FM:+KPM]22V^RW;7=OYT=TFXN"5#+M(9F(P>AQP* ':;XMO]9FTW34T
MW^S=5N+)KV[AO48_9D#^6!M^4L6;..1P,^U<UX<\1GPSX:O)[WR+5;CQ+>6\
M]P59X+4EW.XXP=NY0H)(^\":Z:Y\(ZC'KNGZ]IVL(-4AMFM+IKN R1W,3/O^
MZK J0Q)&#P.*;I?A+5M*L[B%=5L[A;C4I[V:*6S(25)=VZ,C>>Y!![8Q@T =
M%HUU<7NF1W%R;9G=GVO;/NCD3<0C*<GJN#U[UR</B/4+#Q5XRGU.XA.E:/;P
M2"-$.Y4\MY..<%CW/? Z8KH/"WAV+PQI+V,++L>XEG"1KMCBWL6V(N3A1T%4
M+CP;]JUO7YY[Q'TW7+9(+JU\GYP51D!5]W PV?NYR!S0!$_BK4-.D\/W&IVM
ML+'6I4MU\DMOM99%W1JQ/#@X() 7![&MGQ+KL?AW19+]X_-?>D,,6[;YDCL$
M49[#)&3V&:R;/PE>-;:)9ZMJ$-W:Z-*DT!2$H\S(I6,N=Q'R@Y..I /'0ZGB
MCP]!XHT"XTN>9X"Y5XIXQEHI%8,K#UP0..] &=)XAU+3O$]MH5_!:RRW]M+-
M8SQ%HT9X\%XW!W$<$$,.O/ K'TKQWK-Y8>%]5N].LH]/UNX%J5CE8RQNP<JW
M(QM^0C'7O[#>30+ZYU6TU;5+NUEO;&VDAM?)A98U:3;OD(+$DD* !G@$\G/&
M3:^ [VU\.^&=)&K6[?V'>)="4VI_?;0X"XW_ "_?///04 .N?&NHR1/?:3I<
MM]:17K6K6\=K,TLB)(8WD5P-G!#';SD#J"<#I?$.MVWASP_?:Q=AFAM(C(RK
MU8]E'N3@?C7/67@_6-*U2]CTWQ (="O;A[F2T:VW2Q,YRZQ2;AM#$D\@XSQS
MS71:]HMKXBT&]TB]W?9[N(QN5/*YZ$>X.#^% &-/XCU/2=:T>RU6VM6BU;='
M#) 6'D3A=PC;.=P(! 8 <C[O-1^$O$.O^(L7<]AI]OIZ37-O*4G=I-\<A12H
MVX*G!SG!]JGM_#5_//I$NLW\%VVD;F@,<!3S9=A02/ECR%)X'<YSVJSX3T"X
M\.:7-93WD5UONIKA72$QX\QRY&"QS@L>: (->U_4M-\2Z'I-E9VTJZGYX\V6
M5E*-''NZ =.G\L=ZYZ?QSXAM_#VMZD^FZ:6T&[>"] F?$ZKM;,8Q\IVL/O$\
MUU&K:!<:CXGT/5X[R*)-+,Q,+0EC+YB;#\VX8P/8UC7'@6]N- \4:6VJVX_M
MZY><R"U/[G<JJ1C?\W"#GCK0!J/KUUJ&O7NCZ.+836-M%//+<ABNZ7<40!2#
MT4DMVR.#VPH_B#?ZA:^'WT_2[<3:G=S64\5Q.0;>:-7+#A>5RG7KCMFM=?#%
M]9>(FUS3KZW2YN;2.VOHI86,<I3[DBX;*D9(QD@@]NM54\"O:G0/L=_&G]EW
MDM[,TL!8W,LH<.>&&T?.V.N./2@".?Q7KBQ7UK%8V\FK:;"AN8889YHYIF3?
MY:,J_+\I7YFSRW3C-=;IUT]_I=K=RVLMJ\\*R/;S##Q$C)5AZCI7-W_A76(O
M%-SK?A_6XK'[>B)?6]Q:^>CE!M61?F7#!>/0X%=3;PFWM8X?->5D0+YDARS$
M#J?<T >7V>JMH/PY\4ZA%86MXD&N7FZWN#A"IN,=,'.,CCCZUTU[XBUYO%6I
MZ%IMCI^ZVL8[N*:XF?#;F<8( ZY3H/KGM52;P%>S^#M:T!M6@!U.]DN_/%J?
MW>^3S"NW?SR, Y%:T?AV_3Q5?:Y]OMBUU81V?D_9VPI0LP;._GESQ].: ,ZQ
M\=-JVFZ&UI!Y-YJ=@UZP,,DZPJI52-J#+99L#H, GT!@/CVZMK32_P"V;1-#
MFNYIX'N+V-_(5H\;<9VD"0'(+$8VD<FHX/A[J6F:7H']E:['!JVC0/:K<-:Y
MBN(6()1TW9Z@'(/4?EN3:%JD]M!%=7]IJ".DJWT%W;9BN"VS;M4-\@7:0!\V
M=QSSS0!M:;-<W&F6TUVD27#QAI%B;<@/^R>X]ZM5E>&M$3PWX=LM(CF:9+5-
MH=AC.23@#)P!G &3@ 5JT %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 445R_C36+C3$T2U@D:$:GJD
M-E+.O5$8,3@]BVW:#VW<<XH ZBL&P\4PZE>VL=KI]])97?FB&_6,-"2A(.2#
ME0<'!( -9-O)>6WQ O?#9NKN;2[C2UOHV>9C);R"385$A.[#=>2<$''%-^$M
MLL/PWT>023,9822'D+!<,WW0>GX4 =!INOP:GK6K:4EO<13Z8T2RF4+M?S%+
M*5P3D8'?'6M:O-ET:XUGQWXWB@UF^TQT%D4DM'"_/Y)P6)!) ]. <G/;$?A;
MQ#JNL:IX.FO;B5?[3T>XENHE8A)'1HPK@=B02>,=: /3:J7]Z]E]FV65S=>=
M.D)\@ ^4&S\[9(^4=\9//2O/++4_$$WAAYK7[3J9M==NXI[9;GR[B:V1Y%"Q
MOD$E3L.,@D+C//+YM>>XT'PQ=Z5JNH^7+X@2UN([D;9=K2.6AES\V5X7KR!S
MF@#TNBO,M2;5;G4_'\8U[4H8],MXI[189%3RV,#/V'3(Z=^^>*M6NMZEXAU'
M3M*:3:TN@V^H-LO'M6DDD)#,"BDD+@<<#Y^0>, 'H=%>:7MYXDT;3=/?6)+C
M6+6VMI8]0GT68I-%('(68H-I<!5((Z AC@TW7=<N[:S@U$W&HW?AV;2HMNJ:
M;(1):2$,3/)$""RD%#SG&T\<F@#TVBL+Q/KKZ1X)U+7+%5G:"S:XA[JWRY4G
MVZ'Z5SUW=WVBW/A"^M-0N;R/5;F.TO(Y9"ZS"2-G$J@\(05)PN!@].E &_J'
MB:WM[JXM8M-O=1%K+%%=FUC63R2^"N5)W-@%2=H. <UMEX8#'$62,R,5C7IN
M."< ?0$_A7$>"K!(?&'C%Q/<L8]0C4!YV8'-O&<D$\GW-.\36BS_ !.\(9GN
M4#PWN5CG91\J(0< ]?F.?44 ='H>OP:ZVI+#;W$#:?>-9RK,%!+JJL2,$\?,
M*UJ\<OVO;#0/B!K5CJ=W:W&GZS)-"D+!49A'#G>,?,".,'BNGOKK5/$/B/7]
M&LKG[-)800_9V6]>!D:1"WFX53O&<#!X^7IS0!WE8=OXH@OS,VEV-[J%M$[1
MO<VZH(RRG#!2[*7P>,J",C'6J^H#5G^'-ZHN([G6/[,E436OW9)_+(W)]6Z5
M!\,WMI/AGX=-H5,8L8U;;_ST P_X[MU &]I.JVVM:<E]:>9Y+LZ#S8RC91RA
MRIY'*G@\U=KD-8U/'C#0?#UO*8+.^%W/.\#[&D>/!,88<@[F9FP0?E^M<KKV
MLZYIVD>,].AU2Z7^Q[NS-G=Y!D,<Y0F)F(R=NX\YW8(R: /6:*X%K2^_X6--
MH?\ ;VJ?8;K2?MD@\X!UD64)\C8^0$-R%QT%8EGJ^N7OAKP6QUN[CFNM7FL+
MB50FZ6-#. 3D<MB-?;/)!H ]9HKRYK[4]#O?%.A3^(KLVL"V<UG>SKYT\9F<
MJT(QC<S;2%],Y[5'J.K:Q:V'Q"@BO+ZS&G64%U9K).)982T;EAO.[J4!QDXY
MP: /5:*X&V:_M?&FBV<FK7US;ZMI,[W$<LO"NGEX:/ &PX<CC\<GFJVBZA?R
M"7P=>:A=OK5KJ6);HRD226F?-67CH&3$?' 8T >CT4=!10 4444 %%%% !11
M10 4444 (RJZ[64,/0C-"JJ+M50H] ,4M% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 P11A]XC4/\ WL<T
M^BB@ I"H88(!'O2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !5+5=(L=;T]['4;<36[D-MR5*L#D,K#!4@\@@Y%7:* ,VUT.RM/M#)Y[3
M7"+'+<23NTK*N<#>3D 9/ QR2>I-.T71+#P]ID6G:9$\5I%D1QM*\FT9S@%B
M3U)K0HH QKKPMI5WJ%S?/'.DUVBQW7DW$D:SJHP ZJ0#@<9ZXXZ4NI>%])U1
M[!YH)(GT\%;9K69X#&I !0%"/E( &.G K8HH Y^V\%Z)90K'9P3VP2Z>\0PW
M,B[97R&(PV "&(V]/:I)O".BSVUM!);2E+:[^VQE;B16\_)/F,0P+-DGKFMR
MB@#%?PII$D^JS-#/YFK(([TBZE'FJ!M ^]\O''&.*J7W@+P]J-IIUO-:3#^S
M4\NTECNI4EB3&-HD#;B,<8)KI:* ,9O"^EYB\E)[?R[?[,!!<21@QY)VD \\
MDG)YY/-,D\):/(K1K#+%"UJEF\,,[I&\*@A4*@XP Q'K@XS6Y10!$UM UJ;5
MH8S;E/+,14;2N,;<=,8XQ67IOA;2M*:V-M%*5M 5M4EG>1;<$8(0,2%XX]AP
M..*V:* ,S3O#^G:3?7M[9QS+/>N)+AGN)'#L!@'#,0. !QZ4NIZ!INL75E=7
ML#//9,S0.DKH5W## [2,J1P0<@UI44 <_)X*T*:PU.RDMIVMM3E,UXANY?WK
MG&2?FXZ#ICH*;JG@?0-8O+:\N[:;[5;Q^2L\5U+'(T?]QF5@6'US7144 ,AA
MCMX8X88UCBC4(B*,!0!@ #TK$C\(:3;W<]Q9B[L_M#F2:*TNY8HW<]6V*P )
M[D8)[UO44 9=_P"'=+U&WM(9K;;]C<26SPN8WA;IE64@CCKZ]\U!=>$M&O=)
MN-,N;>22VN91-/\ Z1('F<$$,SAMQ^ZO?^$#H!6W10!E?\([IQUE=7V3_;UM
MOLHE^TR?ZK.=N-V.O.<9SS7*:_X/2V7PUI^B:;>-86>K?;9S'=G,0*R9(9WW
M9W/G ]Z] HH P[KPCHU[IMW8W5L\T=Y(LL\CROYCNN-K;\[@1M&,$8QQ5=_
M7AV7[=YEI.YOX%M[IFO)B9D7.-QW9)P2,]<'&:Z2B@#%E\.:?#=6NIQ6T\U]
MI]N\5H#=R?=(&5Y;!S@<G/0>E5M L[N\U*?Q#JNE)IU_/;I:I;^:LKQQJ68[
MG7@DLW0=E'<D5T=% %+2=)M-$TR'3K%'2VAW; \C2$98L?F8DGDFKM%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\$!#P,]1[XN>)?"]]KFIRWUKIS6&KQO%]@U:"X5&1,*728 Y8 [QC# CTZT
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M6*"-M0@GWFZ51A=L>W*$\$DGL<#G@ ZC4K^'2],NM0N!(8;:)I7$:EF(49.
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M&OHI[K$R[2B*ZG:<\D[QC..AJ35?"&KZM>>,#&$M3J36<UA.[A@)+?!&\#D
MLH]>,]^* -.7XBZ=;2ZI!/9W'VC3[$Z@T4,D4GF0#(9E(?&5(Y!(/IFK5EXS
MCN]5LK%])O[<W]HUU922[ LX4*64 -E3AA]X"LZZMO%.N^$]8L[[1;'3[FXT
M^:TCBAN1)YLCKMWEL#8@].2<^W+TT753KW@Z[-GMATJSF@NB95R&=$4;1GD
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MF.,X/&P#+Y"G<V3P/?/644 <G9^#[V+2KFQO_$M]J/F6[VL#W$<8\E&&"?E
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MN?KS7644 9OA_2%T#0+'24N9;B.SA6%))0H8JHP.@ Z"M*BB@ HHHH ****
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MV(/F(51@#@8QM]>>35_0O"=CIUE>PS:9IL,5]M\ZQM8O]&&!C[I #$YY.!G
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M/?17TUA:R7<7$=P\*F1/HQ&145SH6D7NHPZA=:79SWL&/*N)8%:1,=,,1D4
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M3]1DEM)#,Y,#K#$P9>>#GO\ A72:U-')XR$>I"*_M)]#_=VAEC4PR%SE\.P
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M!N./F4C\*IV6F+<^']9M=2T_6(4N/$EQ<Q36T$J3P*SEHYT^7) ('8]>1VH
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M"R7*-:N3&BB8%S@'C+KSW[<<T =IH5_?3>/?%6GW%Y)-:VJ6C6\;*H$6]7+
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MV5M-J-I!'-+;&[*NX8$GRAL^<#'7CGC%2>/=7O\ 0? ^K:GIJQ&YMX"RF1B
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M3O"GB"SUJPU(KHT0@TF33Y+>!I-NXNK;@Q7G)7G(XS_%7>HBHBHBA548"@8
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M^'?#OB&\&L)# (X9;%5F$\T1WJL@)>,90[@?4'O76#P5HKZ#=:/=QW%];W0
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M6=OG:-<E5&,;0"2> .3GK0!RJZMJ\&MZYIT=WJ$$*:"M_ UUL:5)0SJ7 .[
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M:Z+"42("AB7RP$8,> #TZY/-1:#J>IW$5SX9O=1N'UNTU0QRW.5#M;?ZU9,
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MG(S@[20 W;/%<GXG\6W>I^%/&R6L5]ITFD;HX;B-MC;EC1LD@Y&2W ],=^*
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MD9&6X/S#N!Q76ZAJUOITMM XDENKIF6"WB +R;1EL9(  '4D@=/44 63:VY
M!@B(&2 4'&>M.2&*-RZ1(K'JP4 FN=G\=:);:/<:G-)<)%;7(M+B,P-O@E+
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ML66XA;4$9[&66/:ER%&3M.<@XYPP!(Z4 ;$MM;SQ"*:".2,8PCH"!CIP:E
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M@G/\!Z#TKESH.N'P!)IW]C7/VPZ]]L$6^+_5?:_.W9WX^[VSG->J4A(52S$
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MY8F#*P]01P10!YU:Z/J.FZOJ^F77@^VU:"]OI;JTU*00M&JRMO*S!OF^4D]
M<CI6QI4&IZ9XG\9:D=(N'BN/)ELP'C'V@QPA2H^;Y26&!G'6NSJ@^J:5-'>(
M]]:,EL-MT#,N(L]GY^7\: $T34VUC1K:_>UDM7E4[X)""8V!((R.#R#@CJ.:
MT*AM);:>R@ELWB>U>-6A:(@HR$?*5QQC&,8J:@ HHHH **** "BBB@ HHHH
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M$51E'EMOX4[B2I![X()S0!+-XFUFZ\4QZ-IEE8A9M*&H13W,K_+EPN&4#WZ
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M4XU3Q L8&RW(-N4C"*<EOF^Z">E=3:0W<>FI#=W*376S#RQ1^6N?9<D@?B:
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M6(SSM';(KF]2^U?V+\2M$GN+J;3]-M#-9R/.^]/,MF=HBV<LJG!PQ/# 'C%
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M(W[T2A=R\_)D-C"X'3BM#X701P_#;061I"9+.-VWRL^#CL"3M'L,"@#7TCQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***H:MK6F:%:"ZU6_M[* MM#SR!03
MZ#/4T 7Z*AM+NVO[2*ZM)XKBWE7='+$P96'J".M34 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !5._-E; :A=(I:%&1&V[F^8C*J.Y8A1@<G@5<
MK'UOPY;:]);/<7>H0&V):/[)=/#AB,9.TC)QD?B?6@"#P=HC:!X>6T=%B>6>
M:Y,"'Y8/,D9_+7'&%# <<<&M^J&D:1!HUHUO!-=3;W,C275PTTC$@#EF)/0
M5?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ljb_terminationxemployme003.jpg
<TEXT>
begin 644 ljb_terminationxemployme003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[9QFL[3AKU_XK34->\-7^(IF2Q"W%L;>TC/R^:0)=S2%>IQP"0!U)S[?POJ
MU+3]FC7]O#I=W)>")[]'MB0K[$MUW9&XL#\X 49 QF@#JK?Q=!<>,Y_#XMG5
M8U94N]_RR3*J.\0&.H613U_O>E9ESXXU*W@UF_7P_'+I6DW$L-Q,+\"4K'RS
M+&4P>.V[FL@>!]>M/#]EJ46IW=QKMM=#5&T\^0L+7#DF9 ^P-@J[J,OCIV%4
M;WPC<SR>($E\%W%U?7E[-/9Z@+R&-8]V/+8GS-XVD9X4F@#T[4=5MM+T6YU:
MY+"UMH&N'('.T+GIZ^U84?BZ\@:X@U+0IX;Q;(WUO;6TOVAYT!"E> ,."R C
MD?-U/-0:OX1U75?#][:S^(;R6XN=/-N;=EB%OYOE[=W";\%AN^]W_"J\S^([
MK4V\01>')8KNPTN2VM[.>XBS<3R/&3AE<@(OECDD$Y/% %N;QK-I9OH=:TG[
M-=V]JEU%%;W G$P=_+50Q5<-O(&",<]3S4H\5WL/VZTN]#E&K6R0R1VEK-YR
MS)*Q16#[1@!@VXD?*!GD5ST6AZQJ.@ZFESHU\FN3F"Z>]OIH-MQ)#*LBPJ(Y
M&\M/E( Q@9)))))O7;>)FO=5\1:=X?E2]:S@L;.SN)H=Y(=V>5L/MP-XP-V3
MM/3- '0Z+KMQJ&HW^F7]BMG?V2Q/(D<_G1LDF[:0VU3_  ,""!T[YJ/Q'XJM
M_#UQIMLT#W%S?W44"QH<>6CR+&9&/9074>Y('J1DZ#HU]-IEU!)'K>BWTLJS
MW&HRR6LDUV^"#T,BJH  "X  P!WJAK_@C7I7-S8ZX]U-+>V+OY]M&76.&5#G
M=E1A<,^T 9);CF@#8O\ QH]G/JDT>EM+I.DRB*^O#.%96VJS%(\?,%#J221W
MP#BK&M^+X-%U_3=+>V:5;K!N)U?"VJLXCC+#'.YSM[=">U<SXH\*7^K7.KV$
M&G7RKJGEJ]U!>JEJ_P BJTLL>X,'7!X4$-A,]\6;GP-J'B%_$-QJ&J7NFG4'
M^SQ6\/D.OV>(8B))1F!+;G^5@1N[&@#;U#Q'JL?B6?1M*T6&]:WM(KF226]\
MGAV=0 -C9_U9[CK6IH&LQZ_H=MJ<4+PK,#F-R"496*L,C@\@\CKUKSV;0M4U
M#6HM3\1>"YM5EETFWMY!#<P 1SH\OF?>E7@[E(QGKZUT7AKPSJ]KHFG176KW
MVG_9I'*V-N\4J+"9"T<3NR,6VIA<@CI^- $MCXU>Z>RNI=,,&D7]RUM:7AG!
M=F&[:6CQ\JMM.#DGD9 S3M*\9R:@^ESSZ6UKINKN4T^Y,X9G.UG7>F!LW*C$
M8+>AQFL"W\*7D^M:?"=,OK*ULM2:];?>K):* 6*^0@;=EB02& "@L![IIWA.
M^DU;24.F7MA;Z9<R7&)[T2VJ_(ZJD"AMVTEP?F V@$#&: -_0/%M_P"( TUM
MI%N+4H[QO_:"F1ASLW(%RH; [\9[U)IGB;5KOQ/_ &)>:#';,MO]HFEBO1*(
M5)P@8;1RQ!P,] 36-HN@7/\ ;6@2Q>%H=!.F++]KFA:+RYPT97RX]C%F4L0^
M7 QM'>MS0M&O4LM:GO'EL]1U.]FD,L;(SQQ@^7#@G<O$:J<$'DG(ZT 7_$FM
M_P!@:0;N.U:[N'EC@M[57VF:1V"JH.#CKDGL :S[WQC##X6TW6K*W%S_ &BT
M201/,(AEQD[F(.W: V>/X36?>^%M8OM:TNWDUK4OL6G))=+J#?9S*]PWR*NW
MR]N%0OSL_C&#D50M_#FIZ/;S:;<:,GB#2[74Q>6QN##YK)(C%RB_*@=)&8X(
M4%7XY% &[+XJO(-/LFETN#[??3,EO E\K1%%7<TC2[<*H /0$].N:D'B+59;
M2S%OX>E:^N))$:-Y]L$83^,S!3E6R-ORY.>@P<<B/!MT+B#5Y?#XDLH]4FN5
MT+=$3'#)"J9P6\LMO3S-N['S'!R*L"R\4Z3H0L=)T:Y@M[Z_GGDCM)H!+I]N
M<;8T#N$#,<G*DA,G&>* .C_X36UC\)W&MW%K+'+!++;-9JP=VG1RAC0CALLI
MP?3DXP<,E\82/:Z5]AT^.:[O[);YHY[H0QP1D+]Z3:>26   YP>F*RIO"=[?
M:5:2::LNB"RM9H(--N8XISN?(,FY7(WL.-Q)/S-ZFJ,/A*]LO^$?O=6T4:^;
M?2!83VH6',+@@J0KL$; W(6SGOT)H Z>;Q5=N^GV5AHTDFKW=N;E[2YF$*VT
M8(4F1P&_B.!M!SSVJO=^+]2LM.S/X?>/4OM\5B('N,0R-)C:Z3;/F7GGY00<
M@@5E:1H6N>%VTC4EL'U%DT\V-W:03)YD*^89(]A<JKA0Q0C(Z C-+XCL?$7B
M31=][H6^!=4MIHM,6:,3>0AR^]]X3<>< -P,<GL ;TVOZOIFD:GJ>LZ-;VMO
M96KSCR+[SFD*C.W'EKC/KS5C0]:O=1AN)[^PM;*&(?ZR*^6<9_B#8 VXKG;;
M2!_9.JVECX#>S:> 9CO[F)HKG##]V=DK$$@G!( ]:KGPA=ZY?W\MM8MX8L+B
MVA@DMS'$QN2CECO2-BNW&$ZY()'3J :UIX_M[W1+_4H+"<B'4%T^UB9@K73N
M(_+89'RAO-!YZ#GVJS'XIOFCO;5M#=M8M)HHFM(9]\9$G*R>9M&$X;)*Y&T\
M'C//1>%/$<%MJ\TTJ7DR:W!J-K"$2+[0(UBW$$,0I8*R@'&"H/0UIPQ:ZM]K
M&OQZ(V;QK:#^SYY8Q,UO&&W,"&*!R9&P"V,+R1G@ WM UM]8CO4GM1;7=C<F
MUN(UE\Q-X56RKX&X8=>P(.016O7*^"])N-,.JN+!],TZYN!)9Z>[JQA&T!VP
MI*KN;)V@G'7J3754 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52M]
M(TRSO9;RVTZT@NIO];/% JN_^\P&3^-7:* "BBB@ HHHH **** (Y8(IPHFB
M20*P=0Z@X8'((SW![U)110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'>+/$TMIKNF^'
M;*2:*>[C>YNKB"!II(;=.#L158EF;Y0<$#DXZ5V-<MJ.DW=KX]L_$UK;M=1-
M8/I]S$C*'1=XD1UW$ C(((SGD'F@#5\/WVF:EI$=SI-W)=6K,0)))'=PP."&
MW_,"".AQBM2N/T+3M2\-VEY/#IC7,VKZT]U-;K,B_98I" 6)/#$!02!U)(!/
M6NPH **** "BBB@ KS6Y\06L7CC5-(\4ZCJ&E22R+_9$Z7+P6[Q;%Z$$*S[]
MV=^>P]J]*KC]52;5;74M+U[PP^J633-]E,;PD.F.,[G4HP.<'TP<YH U;>]D
MT;2=*L+QYM1U1K<)B+:7G9%&]\L0 ,X))(&6 ZD51B\?:3-#8R)#>$7=\=.P
M8U!AN02#')EOE/!]0>QY%<HOA37=#TCPG<BRM]>GTJVFM+RRDE3+1R%6!C9_
ME)38HYQD"NCO] DUWP/?6)L+;2+N<_:+6&$IFWF7!C9F7@MN4$D=CC)QF@#<
MN-?M+2:\2=)E6U\M6DV@J[R$!$7!R6)(&,=QZBLN[\?:5IT>J_;[>^MKC3(5
MN)[9H@[F)NCKL8J5R",YX[XK.UCP]JVI^ U7%JVOFXAU*6&0CRI)E=7\HGNH
M50@/HHJCJEAJNN>"M;@@\(0:3=W5DUM' LL!DD=N^Y2%"#'<Y.>@QR =)'XT
MLY9X;=-/U,3W$IBM8Y+?R_M($?F%T+$*5"]R1SQ7/^)/$T%];>%-9L)K^*%M
M;%M/ F\,VU90\;1J2&(9!Z].*U-:_MR0^'OLVGSS6 W#4K6*XCCF!V )\V\
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MTNUA-Y(EQ_9BW'V9]1"@P))NV')SNV[_ )=VW;GO6_%%'!"D,2!(T4*JJ,
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M"PF=9,*-S MM+@<#L3[5LVMAJN@>--?OX]/FU"PU<0S1M!(@:&5$V%&#L."
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MNH0[K6^0]4GC.U\_4C/T(I)]-GUGQ5(^H65Y#8V<&RSFCNO+$CL?WC?NW#=
M@&1_>]:R=$TB_P##'CG6S!83_P#"-ZA&ERUQ+<HPBN ,.QW.7*L "2><CTH
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M=W.5;)4, 5(SCD'\=?7=)U75?![1V?AJ.QN)KZVF%E"\(=4CE1V9V!"Y(4X
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MI^?Y3ACSSSV&.=B'6]<B\86&FW4MB]OJMC-<P".!@;9XRG!.[]X,/UPO([4
M;'_"(^&?^A=TG_P"C_\ B:/^$1\,_P#0NZ3_ . 4?_Q-<+#XV\5Q^$-,\7W(
MTM].:Y$-Y:10N)-C3&+>KEC@@[?EP?7//&S>>)O$=\FI7'AW3Q=&POFM4MF1
M<3^6P63,A<;3][''89SG@ Z'_A$?#/\ T+ND_P#@%'_\31_PB/AG_H7=)_\
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M?)&TMSCV!.!7,V_C)[Q=*MM.U*POY-8O9(K2[B0A4ACB\QRZ9SY@P1CCD@X
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M8BN$M'O$UZ/1[$K&RH3(L95G&XDXW,3@C.,<4 =DFKZ?)K$FD)=1M?QP^>\
M.65,XR?3FKM<)817D/QDG6\N8[C_ (D"E'6+80//.01DYYSSZ'VR=S7M<EL=
M9T31;38MWJLLH661=RQQQH7<XR,G[H'USSC! -^BO.-;\:ZWHVG^++4_8WU'
M1(8KJ"=H6V3PR9QE0W#@@C.<'@XKM=(35U2X;5KBTE+R;H!;1,GEH0/E8DG<
M0<\\9]!T !I5FQ:%I\.NS:TD<HOYHA#)(9W(* DA=I.W )/;O7,W/BC5X8O'
M2JUH9-!026K&%L.#;B;#C=SR<9&*1?$/B"^\0Z1IEK-I\$>H:,;YI'MV<Q2
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MJJ %]C8*%V!)XR0JDUJ^)/#]IXGT.?2KQI8XY"K++$VUXG4AE=3V((!K6HH
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MSW&>.E36GAF5+C3I]1U)K^73$9;-GA"X9EV[Y,'YGVY&1M')XSR.BHH XQ?
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M@9969V 4]6SDU--H&E7$ME))8Q;K$8M-N5$'&/D X7CCCMQ6B0&!! (/!!H
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M#SE P W/( X [#CI0!P>FM<17OPZU3[=>27>K0%;YI+AV68&U,G*$[1A@",
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MMK4.CLSHJ7<JJP!W#Y0K<$D9'XUK5Q_Q11Y?A_?PQ122RO)!LCB0NS8F1C@
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M9^?$\15K4P\2.3C 4J&P<X;<,9S71>#B]KXD\76<]O<1RRZH;I&:%@C1-%$
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MCKWK6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPLH !)()ZD_>-;-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,%7.!QDD#)P.: -&BJBZC"^K2::$G\Z.%9RQB81E22  ^,$\=.M6Z "BBB@
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ME[67S(FC(D7&X88 \9J;4M1ATJR:[G2=XPR(1!$TC99@H^503C)YH MT444
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M<]*AN=%N+O2K:RET77#+;W:7JWAO[<SF9> Y8L0>.,8QC@ 5.NGW0UZ;5Y-
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M(YZ<,:OZ!X<M?#HOA;7%U,;VY>ZE-Q)N_>-U(P!CH*?XAT&W\2:4VFW<]Q%
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MET+T9/\ I0182HD_O@$G[V:Q;:^CTBTBL9IHK7P_%XIO;20R)OAA4!C$C G
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M* Q7/(!S@X_ _D:=0 4444 %%%% !1110 4444 %%%% !1110 444C,%4LQ
M4#))/ % "T5!:7MKJ%LMS9W,-S Q($L+AU)!(."..""/PJ>@ HHHH **** "
MBBB@ HHHH **9--%;PO--(D<2#+.[ !1ZDGI3;>Y@O+:.YMIHYH)5#QR1L&5
MU/0@C@B@"6BH#>VJWJ637,(NWC,JP%QO* @%@O7 ) S[U/0 4444 %%%% !1
M110 4444 %%%5YKZTMKF"VGNH8I[@E88GD :0@9(4'D\ ]* +%%%% !1110
M44C,J*68A5 R23@ 55L=4T_4_-^P7UM=>4VV3R)5?8?0X/!H MT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !15=[ZTCO8K)[J!;J4%HX#( [@=2
M%ZD"K% !1110 453M-6TW4)Y8+/4+6XFAQYL<,RNR9Z9 /%7* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M([\@5PNE:=8S?%OQ3;RV=N\/]G68\MHE*\[\\8KT*N;T_P -WEGXXU/Q"][
M\5]!% ;<0D%!'G!W;N>ISQ0!S(COM)^(.NQ:#;6A>#1+3:+EV" *TH ^49).
M /\ .#IIXN;44\$WHTNV:+6GSOE;<]LYA9SLX]B,Y'';FM(^'+T>*=5UE+V#
M;?64=HL+0']WL+$,3NY^^>,#M6=9^![VST_PG:#4[=AX??=N^S$>>-C)C[_R
M\,?7F@"SI?BZ35O$$^G026:2VMY+;W-C+E;B.-=VV49/S*Q"G@8 ?J<5UI(
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M@8%0&Y7!X''O5F;POJ$^L^']2FU:.:73'FDF+P']^TJ%#MPV$4 \#GIR3R2
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MNM<M]=L],MX%CL+4"X%XIR\KQ[_*P/NX4KECGDXQQ5WX>?\ )./#?_8-@_\
M0!5)O!VH66M:K=Z/JL,5IJT2K=P74#2E9%38)$8,.2,9SGGGVK;\+Z/-X?\
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M]2M- UN_73[6672]773B/,90ZEHU#@8//[SIGMUI;/P%J&F:-X8@L]5MC?:
M\@BFEM6,<L;J48,@<$'!ZANU-G\ :C/HNMZ<VM0'^U-334#(UH<QE6C;;@.,
M@^6/ID]: +O_  D'B0^*;OP\+'2Q=?8UO;>;SG,:H7*%7&W+-D#I@8/;H>=O
MM=N?$4/P_P!;@L84OIK^=?)>3"!UAF1ANP3MRI/3.*[(:!>CQHWB'[9;X.G"
MQ\CR6ZAR^[=N]3TQT[UC67@.^T_1-!M8M4MWN]%O);J*1K8A)1)ORK+OR.)#
M@@]AQ0 D/CR]LFU73];T^&/5[&XMH8UM79XK@7!Q&R\;AC!R,$_+QGI3-3\;
M:YI.FZ_<2:,)ETZU%U!=/#-;13#HR$."0Z^@."#U%7=2\"+J]GJLEU?M%JM_
M)!,MW;I@6S0G,6Q2>0IR3D\[CTX ;>^%?$&M>%M1TO6->MI;F\@-LLD-F4CC
M4]6*;_F<X'.0!V'7(!T&C3ZO<1S2:K;6D"LP:V%O*SG85!^?( # YZ9%5;[6
MYF\31^'M/$(O#9F]EEG!98X]^Q1M!!)9L]Q@*>O2M>TCEALX8IW1Y40*S(I4
M$@=0"3C\ZP]3\.3R>*;3Q'IEU'#?16S6<\<R%HYX2VX#@@J0W(//4C% '(>*
M_$U[K?PPU\K%':7EC=?V??Q;BPR)$!V'C*LK \CH2*]$LK%());N6WM5O[A5
M6XF@CV^8%SM!)Y. >_J:YC4O LEYX3U32(-0BBNM5NS>7=TT!8%RZMA4W#
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M,A8H\;PLZ2)W!(['.".IKHM>\.2:EJ^E:U8W*VVI::SB,R(6CEC<8=& (/.
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MXQ#M1&#/$$(D#$M]X].!C&2D=_<^*'\5P7%])"-,@2"%;.4HNYH-[2_[0).
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M^.*21Y  CB3=MVX))^X>H%>=2ZA>ZC\/M+;4)FFG@\40V^]VW,52\VJ"<#)
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MM-9MH/,1O+@@0O$C0%,D2-\Q);'&[J"N* .XT[7[?4M=U;28X)XY],\KS6D
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M"0!G&<#V KC?&NJW^DZC<SW2Z@-#-HJ"]TV4EM/FRVZ26,$%E(*'/( 4\<T
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MNYA;HV[@]26.3WS4>HZOJ<'@CX@3QZC=+/I>HRI9R^:=T2B.)@N>XRS=<]:
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M2)IKQ8-J[W6.([A\O!)<_3M@\U%8^(]2AT^RT:74)W:?Q+<:3]MD8&401EF
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQFUF+%B@';86&#GT/% 'I-%<]X%UF;Q#X&T;5;GFXN+93*?[SCY6/XD$UT-
M%6+4[&XOY["&\@DNX%#30HX+Q@]-P'3.#UJ5[F&.>.!I )9<E$ZD@=3CT''/
M3D>HKDM-14^+NN[5"[M)M"<#&3YDW-4=(U>ZGLO'OB!!ON[.ZN;2V4C.U+>/
MY5 ]W+M_P*@#KKCQ!I-K=/;2WT(FC ,J*=QB!Z%\?='UQ4UMJVGW@A:VO(9D
MG+"%XW#+(5)#!2."1@\#T-<Y\+X8X_ASH\ZMYDUW#]JN)2<M)*YW.S'N<G'X
M4OC#38=+^'NLMIRBWDLTEU&W*_\ +.96,V1Z9;/X$CI0!UU%9]CJ$E_X=MM2
MAB4R7%HMPD;-M&60, 3VZ]:Y32/%.JW/B'3=+FN+28W^FRW#216[>7#.A3(1
M]V)4^<C(/;KSB@#NZJ:GJ=EH^GRW^HW,=M:PC<\LAX KS_2O&/B2?1O"VMWC
MZ<;?5+\6,]M% P8;F=0ZN6XP5'RX/&>:;XMUB_\ $7P_\97-G-!#8V8N;-8W
MB+-*(QB1BV1C)W;<#L"<YP #TN.198DD0Y1U#*?4&LK4/%6@:5J46G:AK%E;
M7DN-D,LRJQSTX/3/;/6KNF?\@JS_ .N"?^@BN>\9Z39W?A?4]*ALXI;W6 T4
M:LN2TK# D)ZX0 -GL% '84 =72$A022 !R2:ALK;['86UKYC2>3$L>]NK8 &
M3[\5R=_/JA^+.F6D5^B69TN>;R##D9$L0;G<.2.A[>G)H Z;3-6L-9MWN-.N
MDN84E:%G3H'4X(_"KM>2:=J^L>']!UG5K22S^Q0>)[B.>WDB9GE62Z"'#[@%
M(W9'!Z?A73?VQXDN_&>M:5:W.F0V>FBTGWR6[LS1R;RZ\/UPOWO;ISD ':T5
MYY-XVU2/P1;^-T6W;3'E5Y;+RSO6W:38"'S_ *P9#'C'4>]79_$^K1OXWB5K
M3=H<*36C&%OFS 9<.-W//'&* .VJE?ZOI^ERVD5[=1PR7<RP6ZL>9'/0 5S<
M/B:_OM0\/:<#%:/J>E-?/<F/<#( G[M 3_MECG/ _$<Q?:SJ_B#PGX3U.]6T
M6ZE\1P+$L4;(F%>1 W+,2#MW C'!_&@#UBBN8\-:OJ=SK^OZ-JLMM/+ILD+1
MSP0F(.DJ;@"I9L$$$9SSQ6EXBO;O3]'>XLFM4D$D:M+=/MCB0N SGD9(!) S
MR<"@#5HKS34?'.M6?A_QC/;FW>XT-XC!+<6KIYD<B*V&0D$,-QYZ'CBM>7Q-
MJ>B>*;RSUF2UFL%TB75%-O"R-"(F 9,ECOX.<X'(Z"@#I[W5]/TZXM+>\NHX
MIKR416\;'F1_0"KM>9:S=:KJ<?@'5;R:W$-[JUO/]FCC.8B\,C* ^><*2#D<
MGD8'%>FT 5+34[.^N;RWMIUDELY!%<* ?W;E0P!_ @\5;KSW4/%^N6FB>-[I
M#8&XT.;;;DP-M9/*1_F&_.[YNN<<=*N#Q-JVE>)8[;5Y+2:QN-*FU!1;PLKP
M&(KN7)8[P0W7 Y'04 =J2%!)( '))JGIFK6&LVSW&G727,*2-$73IN4X(_ U
MB:/?^(M2CT/51]A?3M0A\ZYAP5:W5DW1[&R=YY ;(&>HQTKD]+UF]T'PGJ%[
M8^26;Q5/!(LJ%@4DN]AQ@C!&[/>@#U2J4NKZ?#JT&E2748OYT:2*#/S,J]3[
M"N2U[QO=>'=8\01W$<,]I8:=!=6ZJI5VDED:,(S9(QN"\XXR:AOH=3B^*'A/
M[==V\Y:ROMIC@*;7VQ;OXCE>F._7)/8 [73]3L]4BEELIUF2*9X'(!&UT.&'
M/H:MUYQ+XSU^/P=<ZHHT\W=OKATYE\E@C)]H$61\Q*GG.3N^E:<7B/6=-UOQ
M#IVHK;Z@UCIJZE;"TA:)F!\P&+!9LG*#!]Z .THKA+#Q-K=UJOA6*.XL9[?6
MK)KR<K;L3 $5&(4A^%._:"V<$=\X':W<<LME/'!)Y<SQLL;_ -UB.#^= %6+
M7-+GOA917T#7!+*J!OO%?O!3T)'<#D=ZT*\:NKB\M? OA#0IM,O+37K35;2W
M3?$0OF(QW.K]'#(&)()X)S7LM !56^U*UTV)9+J0KN)"*J,[N0"2%502> 3P
M.@-<?-XJU>\T'7M>THVH@TFXGC2UEC)-PL'^L);/RDX;;@<<9SGBI?7MWK'C
MKP3?V5U'%;7EA=7,*20%B@9(B=WS#)PWMCGK0!W>G:C9ZMI\-_I]Q'<6LR[H
MY8SD,.G_ -:F:KJ^GZ)9&\U*[CMK<,%WN>I)P .Y-6EB6*'RX%2,#.T!> ?H
M/>O'KZXU.[^$'B*XU"]2[?\ M5D4F+8<K>JO)R>, 8 ' ]: /9*J:9J=GK&G
M0ZAI\ZSVLP)CD4$!@#COSU!KGK+5M;3QK>^'[V>REWZ<M];2Q6[*(B9"A1@7
M.\< YRO?I6+;>/+X>!O#VNZBJV\%\SB^O+>V:1+4#=M.W)(4D ;CG'XY !Z-
M16=H5W)?Z-;W4EU:W9E#,)[3_52+N.TKR<<8XR:T: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BL;3?$VGZIXAU;1;=R;O3/+\[/0[QGCUP1@^AK9H **** "BBB@ JAJFG
MSZE UJ+U[:VD7;+Y*XE8=PKY^7(XR!GT(/-7Z* ,J71?*TZPL-)NFTNWLY8V
M"01J0\2]8CD< ]SUK5HJ&:Z@@FMX99562X<I$IZNP4L0/P4G\* )J**Q?%/B
M#_A&=$;4S9O=(LL<;*KA=N]U0$D^[#H* -JBBFR,RQLRH78 D*" 2?3F@!U<
M06U:TNK]K#^V42[F:5DFL8Y5B)X_=?.N.F?FW#/..:EC\?+)X1TK7QI4OEW]
MZEIY7G+F+=,8@Q/?D9P!_C794 ><R:)##I6A6>DZ?KMA+HLIDM9_LT<A)965
M]P+8.[>Q/3D\55N/#CSZ5K5@R^(BFK7:7<SO:PDJZ[#\N&'4QKGMCH!7J%%
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M(V\=O!&78#?C?(2O0D%@F<9!1JH>*;&VG^)O@YY@V6BO0Q$K+PL:D=#QU/\
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M]5E$K>6[/ (YB%A*^8 59 HQMYSGD\UW&F>&K#3WM+IHS-J-O:K:_;'9C(R
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVB)KGRY'8J'VQ+M.]MK \XR2!ZXB/C6]NM5GT_2]!>XE73XM0B:>Y$(=)-V
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M[=XX;A<YC<@@-QS^7-:%% ' 67A3Q):ZM;:E$^C6DD6CRZ>(H1(RI(6#*X)
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M&\DK\X:9!@Y!^OX<Y'%=G69KVAVOB+2VT^[>:-#(DJR0MM='1@RL#@\@@=J
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M@5V=W*8 ==NU2IZ#)RO/7+(K[Q,(M*L=6U&*'46MIS/#IJ))/-(K (XWJ45
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M# SN44 >7>-]"UG4?BKX4U>RTJXGL-,/^DS*4 &6SP"P)P/05J?%[1]3\1>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<GXEB_MCQ1HFA3<
MV1$E]<QGI*(]H13ZC<V2/:NLKF+O_DIFF?\ 8+N/_1D=:4M[^3_(SJ;6]#I@
M H    X %+14%[>VVG6,][>3+#;0(9)9'Z*H&2369H3UGV6A:/IMP]Q8Z58V
MLT@P\D%NB,P]R!DU>1UDC5T8,C %2.X-.H STT'1X[.:SCTFQ2UG.Z6!;= D
MA]67&#^-)+H&C3B 3:182"W79"'MD/EKZ+D<#V%:/2B@"D-&TM=0;4!IMF+U
MP0UR(%\P@C'+8STXK%N_ 6B7FN6>J/')&UGY7E6\6U8E\LY0 ;<@ @':"!QR
M*Z>L[2M?TK7&N1IE]#=&V<)+Y9SM)Z?@>Q'!H E_LG3MNW^S[7;L>/'DKC8Y
MRZ].C'DCN>M1'P_HK6<5F=(L#:PMOBA-LFQ&]0N, ^XK1HH I7.D:9>6D5I=
M:=:3VT(Q'#+ K(G&WA2,#@D?0U5'ARP&N6FJ@.'LH&@M8 0(80V-Q50."0 .
MN,=JUZ* (K>V@M(1#;0QPQ DA(U"J"3D\#U))_&I:** "BN2TCQ9+JOQ&U_P
M^BQFTTRW@.\#YC*V2PSZ8('U!KK: "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWYF(E7@@8(()K2NO%8M9[DM82_9(=->_2<N!YP4*=JKU'W@,G'/;O0 ZTO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5%H3)(C3;D>,A?N;2 ,<#&.*NWFEZ#IVOZGI6OMJ\6F7UK FD3QQ2.!"J@&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX;<D 'RTZ+D#WZG&,FN:\8^&K+3_  ;>ZOH<::1J>FVK7<%Q9*(LF-=Q5PN
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M4'CB[ED/1$-FQ/?H(JQ-.U/5;ZW\XZGK)$]FE]9)!]D=IXF.!G,"A&Y4D9(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>May 11, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aquestive Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">30 Technology Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Warren<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3827296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">941-1900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AQST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,450,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001398733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 110,734<span></span>
</td>
<td class="nump">$ 121,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade and other receivables, net</a></td>
<td class="nump">6,867<span></span>
</td>
<td class="nump">17,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">8,066<span></span>
</td>
<td class="nump">6,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,516<span></span>
</td>
<td class="nump">4,168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">130,183<span></span>
</td>
<td class="nump">149,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,839<span></span>
</td>
<td class="nump">3,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">4,468<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">2,635<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">141,125<span></span>
</td>
<td class="nump">160,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">11,889<span></span>
</td>
<td class="nump">29,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,449<span></span>
</td>
<td class="nump">5,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities, current</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">1,092<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent', window );">Liability related to the sale of future revenue, current</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans payable, current</a></td>
<td class="nump">13,661<span></span>
</td>
<td class="nump">9,994<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">31,753<span></span>
</td>
<td class="nump">47,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable, net</a></td>
<td class="nump">25,099<span></span>
</td>
<td class="nump">27,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationLiabilityNoncurrent', window );">Royalty obligations, net</a></td>
<td class="nump">26,914<span></span>
</td>
<td class="nump">25,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent', window );">Liability related to the sale of future revenue, net</a></td>
<td class="nump">62,083<span></span>
</td>
<td class="nump">62,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">4,159<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">19,118<span></span>
</td>
<td class="nump">19,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">6,053<span></span>
</td>
<td class="nump">7,269<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">175,179<span></span>
</td>
<td class="nump">194,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 20)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value. Authorized $250,000,000 shares; 124,284,542 and 122,044,299 shares issued and outstanding at March&#160;31, 2026 and December&#160;31, 2025, respectively</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">420,877<span></span>
</td>
<td class="nump">413,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(455,055)<span></span>
</td>
<td class="num">(446,998)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(34,054)<span></span>
</td>
<td class="num">(33,662)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; deficit</a></td>
<td class="nump">$ 141,125<span></span>
</td>
<td class="nump">$ 160,425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyObligationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligation, Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyObligationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">124,284,542<span></span>
</td>
<td class="nump">122,044,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">124,284,542<span></span>
</td>
<td class="nump">122,044,299<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Manufacture and supply</a></td>
<td class="nump">$ 3,469<span></span>
</td>
<td class="nump">$ 3,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible Enumeration]</a></td>
<td class="text">Manufactured Product, Other [Member]<span></span>
</td>
<td class="text">Manufactured Product, Other [Member]<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 4,204<span></span>
</td>
<td class="nump">$ 5,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">10,977<span></span>
</td>
<td class="nump">19,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">18,650<span></span>
</td>
<td class="nump">28,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(4,204)<span></span>
</td>
<td class="num">(19,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income/(expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(2,903)<span></span>
</td>
<td class="num">(2,782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Interest expense related to royalty obligations</a></td>
<td class="num">(973)<span></span>
</td>
<td class="num">(1,437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InterestExpenseSaleOfFutureRevenues', window );">Interest expense related to the sale of future revenue</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InterestAndOtherIncomeNet', window );">Interest income and other income, net</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (8,057)<span></span>
</td>
<td class="num">$ (22,930)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">122,609,995<span></span>
</td>
<td class="nump">95,497,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">122,609,995<span></span>
</td>
<td class="nump">95,497,056<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InterestAndOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest And Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InterestAndOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InterestExpenseSaleOfFutureRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Sale of Future Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InterestExpenseSaleOfFutureRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Changes in Stockholders' Deficit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Public Equity Offering - ATM</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Public Equity Offering - ATM</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Public Equity Offering - ATM</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,413,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="num">$ (60,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (363,214)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued under public equity offering-ATM (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,457,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued under public equity offering-ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Costs of common stock issued under public equity offering-ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(729)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(729)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">445,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net</a></td>
<td class="num">(702)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(702)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(22,930)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,317,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="num">(60,930)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(386,144)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,044,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="num">(33,662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued under public equity offering-ATM (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,191,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued under public equity offering-ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Costs of common stock issued under public equity offering-ATM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (303)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromExerciseOfWarrantsNet', window );">Warrants issued under the Purchase Agreement</a></td>
<td class="nump">916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">2,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,048,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net</a></td>
<td class="num">(329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercises, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,057)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,284,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2026</a></td>
<td class="num">$ (34,054)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (455,055)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ProceedsFromExerciseOfWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Exercise of Warrants, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ProceedsFromExerciseOfWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (8,057)<span></span>
</td>
<td class="num">$ (22,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, amortization, and impairment</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">2,318<span></span>
</td>
<td class="nump">1,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of warrants</a></td>
<td class="nump">916<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs and discounts</a></td>
<td class="nump">2,286<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Trade and other receivables, net</a></td>
<td class="nump">10,896<span></span>
</td>
<td class="num">(3,129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(1,896)<span></span>
</td>
<td class="num">(1,154)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(340)<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(17,973)<span></span>
</td>
<td class="nump">1,905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(2,803)<span></span>
</td>
<td class="num">(2,776)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(272)<span></span>
</td>
<td class="num">(261)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used for operating activities</a></td>
<td class="num">(14,806)<span></span>
</td>
<td class="num">(23,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises', window );">Proceeds from common stock issued under public equity offering-ATM, net</a></td>
<td class="nump">4,759<span></span>
</td>
<td class="nump">21,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt principal including lease liabilities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_PaymentsForRoyaltyObligations', window );">Payments for royalty obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes on share-based compensation, net</a></td>
<td class="num">(329)<span></span>
</td>
<td class="num">(703)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">4,423<span></span>
</td>
<td class="nump">20,646<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="num">(10,435)<span></span>
</td>
<td class="num">(2,889)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">121,169<span></span>
</td>
<td class="nump">71,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">110,734<span></span>
</td>
<td class="nump">68,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash payments for interest</a></td>
<td class="nump">1,524<span></span>
</td>
<td class="nump">1,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable', window );">Costs associated with public offering-ATM in Accounts Payable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs Associated with At-the-Market Public Equity Offering in Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_PaymentsForRoyaltyObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Royalty Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_PaymentsForRoyaltyObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Overview and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Company Overview and Basis of Presentation</a></td>
<td class="text">Company Overview and Basis of Presentation<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A) Company Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. The worldwide leader in delivering trusted, quality medications on oral film, Aquestive operates as both a developer of its own proprietary products and a Contract Development and Manufacturing Organization (CDMO) for licensees, with its headquarters in New Jersey and U.S.-based manufacturing facilities in Indiana. The Company is the exclusive manufacturer of four commercialized products marketed by its licensees across six continents using proprietary, best-in-class technologies like PharmFilm&#174;. Aquestive's AdrenaVerse&#8482; platform contains a library of more than 20 epinephrine prodrugs enabling the pursuit of various potential allergy and dermatological indications. The Company is advancing Anaphylm&#8482; (dibutepinephrine) sublingual film for the treatment of severe allergic reactions, including anaphylaxis, and AQST-108 (epinephrine) topical gel for various potential dermatological conditions, including alopecia areata, atopic dermatitis, rosacea, and psoriasis. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)&#160;Equity Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ATM Facility</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company established its first ATM facility in September 2019, and since inception to March&#160;31, 2026, the Company has sold 28,506,216 shares of Common Stock under its ATM facility which has generated net cash proceeds of approximately $86,563, net of commissions and estimated other transactions costs of $4,142. On April 3, 2024, the Company filed a new shelf registration statement on Form S-3, the 2024 Registration Statement, which was declared effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement are (i) a base prospectus registering the offer, issuance and sale of up to $250,000 worth of Common Stock, preferred stock, debt securities, warrants, rights and units and (ii) a $100,000 ATM facility prospectus. During the three months ended March 31, 2026, the Company sold 1,191,071 shares of Common Stock pursuant to the ATM prospectus and the Amended Equity Distribution Agreement with Piper Sandler &amp; Co. (successor to Piper Jaffray &amp; Co.), which provided net proceeds of approximately $4,810 after deducting commissions and estimated other transaction costs of $252. For the three months ended March 31, 2025, the Company sold 7,457,627 shares under the ATM facility which provided net proceeds of approximately $21,306 after deducting commissions and other transaction costs of $694. The remaining authorized balance of the ATM facility was approximately $73,000 as of March&#160;31, 2026.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Underwritten Public Offering</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2025, the Company completed the 2025 Underwritten Public Offering of 21,250,000 shares of its common stock at the public offering price of $4.00 per share. Net proceeds from the 2025 Underwritten Public Offering were $79,900, after deducting underwriting discounts of $5,100. In addition to the underwriting discounts related to this offering, the Company incurred professional fees and other costs totaling $440. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">C</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">) </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#8217;s audited financial statements and related notes for the fiscal year ended December&#160;31, 2025 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March&#160;4, 2026 (the &#8220;2025 Annual Report on Form 10-K&#8221;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2025 is derived from the audited financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying condensed financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Adopted as of March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09&#8212;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The ASU modifies the effective tax rate reconciliation table and requires disaggregation of income taxes. The Company adopted ASU 2023-09 for the year ending December&#160;31, 2025 and added the required disclosures on a prospective basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Statements of Operations, and Comprehensive Loss as well as qualitatively describe the remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Company&#8217;s definition of selling expenses. These disclosure requirements will be effective for the Company for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact from the adoption of ASU 2024-03 on disclosures to its financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the FASB issued ASU 2025-06, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Internal-Use Software</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to provide clarification and improvements to the accounting for internal-use software costs under ASC 350-40, Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software. The guidance includes amendments related to capitalization of implementation costs, subsequent measurement, and related presentation and disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on its financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text">Risks and Uncertainties<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company&#8217;s cash requirements for the remainder of 2026 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of March&#160;31, 2026, the Company had $110,734 of cash and cash equivalents.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a history of net losses. The Company&#8217;s accumulated deficits totaled $455,055 as of March&#160;31, 2026. The net losses and accumulated deficits were partially offset by gross margins from sales of commercialized licensed and proprietary products, license fees, milestone and royalty payments from commercial licensees and co-development parties. The Company&#8217;s funding requirements have been met by its cash and cash equivalents, as well as its equity and debt offerings, including the 13.5% Notes as further discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the ATM facility and other equity offerings, including the 2025 Underwritten Public Offering as discussed in Note 1, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company Overview and Basis of Presentation,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Part B, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Transactions.</span></div>While the Company&#8217;s ability to execute its business objectives and achieve profitability over the longer term cannot be assured, the Company&#8217;s on-going business, existing cash and cash equivalents, expense management activities including, but not limited to, the ceasing of certain R&amp;D activities, as well as access to the equity capital markets through its ATM facility, provide near term liquidity for the Company to fund its operating needs for at least the next twelve months as it continues to execute its business strategy.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity for which separate discrete financial information is available for evaluation by the CODM in deciding how to allocate resources and in assessing performance. For the three months ended March 31, 2026 and 2025, the Company has identified one operating and reportable segment. The Company defines its operating segment based on internally reported financial information that is regularly reviewed by the CODM to analyze financial performance, make decisions, and allocate resources. The Company's CEO is the CODM. The Company manages its operations as a single segment for purposes of assessing performance and making operating decisions. This segment encompasses the development and advancement of a product pipeline for the treatment of severe allergic reactions, including anaphylaxis, and the AdrenaVerse epinephrine prodrug pipeline platform. Additionally, the Company served as the exclusive manufacturer for its proprietary product, Libervant, while it had U.S. market access, and four licensed commercialized products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The CODM reviews the segment's profit or loss based on net loss reported on the Condensed Statements of Operations and Comprehensive Loss. The CODM also considers forecast-to-actual variances on a monthly basis for expenses deemed significant. Furthermore, the CODM reviews the segment's assets based on total assets reported on the Condensed Balance Sheets. All long-lived assets are held in the United States. While the Company generated $14,446 and $8,720 in revenues for the three months ended March 31, 2026 and 2025, respectively, management expects the Company to continue to incur significant expenses and operating losses for the foreseeable future as it advances product candidates through all stages of development and clinical trials, ultimately seeking regulatory approval and commencing commercialization activities for Anaphylm, if approved by the FDA. The CODM uses cash forecast models to guide investment decisions and assess entity-wide operating results and performance. Net loss is used to monitor budget and rolling forecasts versus actual results. The CODM views specific categories within R&amp;D expenses, selling expenses, and general and administrative expenses as significant due to their direct correlation with cash burn and profitability.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles reported revenues to net loss under the significant expense principle for the three months ended March&#160;31, 2026 and 2025:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.970%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Manufacture and Supply Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D Project expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Anaphylm project expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AQST-108 project expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D other expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Research and Development Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Selling expenses:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Selling expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">General &amp; Administrative expenses:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">5</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">6</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total General and Administrative Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Selling, General and Administrative Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income/(expenses), net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,565)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 - R&amp;D Personnel costs include payroll expenses,  share-based compensation expenses and severance</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2 - Other R&amp;D expenses include preclinical, consulting, maintenance, and testing fees</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 - Selling Personnel costs include payroll expenses, share-based compensation expenses and severance</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4 - Other Selling expenses include commercialization and other related expenses</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5 - G&amp;A Personnel costs include payroll expenses,  share-based compensation expenses and severance</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 - Other General and Administrative expenses include legal/patent fees, insurance fees, IT expenses, investor relations expenses, regulatory fees, facility and other costs</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues and Trade Receivables, Net</a></td>
<td class="text">Revenues and Trade Receivables, Net<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age while Libervant had U.S. market access through April 2025. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - a performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#8217;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and supply revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenu</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">e &#8211; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research Fees</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#8217;s R&amp;D projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age while Libervant had U.S. market access through April 2025, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Once receivables are collected, allowances are reclassified and treated as accrued liabilities. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once related variable considerations are resolved and uncertainties as to incurred amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of March&#160;31, 2026, and December&#160;31, 2025, such contract assets were $445 and $627, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of March&#160;31, 2026 and December&#160;31, 2025, such contract liabilities were $20,210 and $20,482, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain Contracts</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of March&#160;31, 2026 and December&#160;31, 2025, such costs to obtain contracts were $442 and $449, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Zevra-related royalty revenue of $4,500 recognized during the three months ended March&#160;31, 2026. For additional information, see Note 6, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated net revenue by geographic area: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ex-United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2026, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), Zevra (license and royalty revenue), and Assertio manufacture and supply revenue, license and royalty revenue and co-development and research fees). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Zambon (manufacture and supply revenue, license and royalty revenue, and co-development and research fees) for revenue markets outside of the United States.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2025, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and Assertio (manufacture and supply revenue, license and royalty revenue and co-development and research fees). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Hypera (manufacture and supply revenue, and license and royalty revenue) for revenue markets outside of the United States. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contract and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: sales-related allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into Accrued distribution expenses and sales-related allowances</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,867&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,763&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Contract and other receivables totaled $1,605 and $9,750 as of March&#160;31, 2026 and December&#160;31, 2025, respectively, consisting primarily of contract assets and other receivables. Contract assets consist of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties. Other receivables include the current portion related to the Monetization royalty receivable and other receivables. As of December&#160;31, 2025, other receivables also include an insurance reimbursement. Sales-related allowances as of December&#160;31, 2025 were estimated in relation to revenues recognized for sales of Libervant for patients between two to five years of age while Libervant had U.S. market access.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an allowance for credit losses on accounts receivable, which is recorded as a reduction to accounts receivable. Changes in the allowance are classified as Selling, general and administrative expenses in the Statements of Operations and Comprehensive Loss. The Company assesses collectability by reviewing accounts receivable on a collective basis where similar characteristics exist and on an individual basis when it identifies specific customers with known disputes or collectability issues. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status. It also considers customer-specific information, current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss data. On an ongoing basis, management evaluates the adequacy of these reserves. The allowance for credit losses was $0 as of March&#160;31, 2026 and December&#160;31, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Related Allowances</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, chargebacks, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provides a summary of activity with respect to sales-related allowances:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:70.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payments / credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into Accrued distribution expenses and sales-related allowances</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables as of December&#160;31, 2025 and accruals for wholesaler service fees, co-pay support redemptions and other rebates are reflected as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and accrued expenses were $0 and $902, respectively, as of March&#160;31, 2026, and $0 and $906, respectively, as of December&#160;31, 2025. See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Expenses</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Customers are considered major customers when net revenue exceeds 10% of total revenue for the period or outstanding receivable balances exceed 10% of total receivables. For the three months ended March 31, 2026, Indivior and Zevra, represented approximately 57% and 32%, of total revenue, respectively. As of March&#160;31, 2026, Indivior and Assertio </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">exceeded the 10% threshold for outstanding receivable balances and represented approximately 81% and 15% of total trade and other receivables, respectively. For the three months ended March&#160;31, 2025, Indivior and Hypera exceeded the 10% threshold for revenue and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">represented approximately </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">67% and 17% </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">of total revenue, including the one-time recognition of deferred revenue, respectively. As of December&#160;31, 2025,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Indivior and Hypera exceeded the 10% threshold for outstanding receivable balances and represented 69% and 25% of total trade and other receivables, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Material Agreements</a></td>
<td class="text">Material Agreements<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase and Sale Agreement with RTW Investments LP</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 13, 2025, the Company entered into the Purchase Agreement with funds managed by RTW Investments LP. Under the terms of the Purchase Agreement, in exchange for the Purchaser's payment to the Company of a purchase price of $75,000, upon approval of Anaphylm by the FDA by a specified date, the refinancing of the Company&#8217;s existing 13.5% Notes and certain other customary conditions (the "Closing Conditions"), the Company agreed to a sale of assigned interests to the Purchaser, including a right for the Purchaser to tiered revenue share payments ranging from 1.0% to 7.5% of net sales (as defined in the Purchase Agreement) of Anaphylm (and 9.5% for the subsequent calendar year period if net sales do not achieve specified level in a calendar year period beginning in 2027) in the United States. Revenue share payments commence in the first fiscal quarter in which the first commercial sale of Anaphylm in the United States after the satisfaction of the Closing Conditions. Revenue share payments will cease upon the Purchaser's receipt of $187,500 by December 31, 2035 or $225,000 thereafter. The Purchase Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company&#8217;s ability to, among other things, incur indebtedness (which restrictions are eliminated after the achievement by the Purchaser of a specified return on its investment), and other provisions customary for transactions of this nature, in each case subject to certain exceptions set forth in the Purchase  Agreement. As this financing is contingent on events that have not occurred yet and are outside of the Company's control, the accounting consequences for this transaction as of March&#160;31, 2026 and December&#160;31, 2025 have been limited to capitalized legal fees of approximately $750 and $700, respectively, recorded within Other current assets on the Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, the Company entered into the Amendment No. 1 to the Purchase Agreement. The Amendment extends the Marketing Approval Deadline from its original date in the Purchase Agreement to June 30, 2027. Concurrently, the Company entered into a Warrant Issuance Agreement with funds managed by RTW, pursuant to which the Company agreed to issue a warrant to purchase up to 375,000 shares of the Company's Common Stock at an exercise price of $4.00 per share, expiring on March 3, 2029. For information regarding the RTW Warrants, see Note 14, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, the Company also entered into a Share Purchase Commitment Agreement with certain RTW-affiliated funds, pursuant to which such funds committed to purchase, in the aggregate, not less than $5,000 of Common Stock during the 90-day period following the effective date of the Amendment, at prices determined in accordance with Rule 415(a)(4) under the Securities Act.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Exploitation Agreement with Indivior</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In August 2008, the Company entered into the Indivior License Agreement (with subsequent amendments) with Reckitt Benckiser Pharmaceuticals, Inc. who was later succeeded to in interest by Indivior.&#160;Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#8217;s requirements for Suboxone</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, a sublingual film formulation, both inside and outside the United States on an exclusive basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain API&#160;for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year. The Indivior License Agreement provides for payment by Indivior of an agreed upon purchase price per unit until January 1, 2025 and, thereafter, that is subject to annual adjustments based on changes in an agreed upon price index. In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) outside of the U.S., subject to annual maximum amounts and limited to the life of the related patents. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&#8217;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was seven years from the commencement date. Thereafter, the Indivior License Agreement automatically renewed for successive one-year periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of March 2, 2023, the Company and Indivior entered into the Indivior Amendment to the Indivior License Agreement. The Indivior Amendment was entered into for the primary purpose of amending the Agreement as follows: (i) extending the term of the Agreement until August 16, 2026 and thereafter providing for automatic renewal terms of successive one-year periods unless Indivior delivers notice to the Company, at least twelve months prior to the expiration of the then current term, of Indivior&#8217;s intent not to renew, subject to the earlier termination rights of the parties under the Agreement, and providing that the Agreement will not automatically renew for any renewal term beginning after the expiration of the last to expire of the product patents covered under the Indivior License Agreement; and (ii) agreeing to transfer pricing and payment terms for supplied product under the Indivior License Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreement with Sunovion Pharmaceuticals, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&#8217;s disease patients. Sunovion used this intellectual property to develop its apomorphine product KYNMOBI</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#8217;s obligation to remit a payment of $4,000, due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of FDA approval of the product. This amount was received as of September 30, 2020 and was included in License and royalty revenues for the twelve months ended December 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 16, 2020, the Company entered into the First Amendment. The First Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the EU which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company from January 1, 2020 to April 1, 2020, and (iv) modifying the termination provision to reflect the Company&#8217;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI was not commercialized by January 1, 2020. This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the First Amendment. The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents unless earlier terminated under the termination provisions contained therein. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties' agreement with respect to certain provisions in the Sunovion License Agreement, specifically the date after which Sunovion has the right to terminate the Sunovion License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#8217;s patents covered under the Sunovion License Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $22,000 to date. In addition to the upfront payment of $5,000, the Company has also earned an aggregate of $17,000 in connection with specified regulatory and development milestones in the United States and Europe (the &#8220;Initial Milestone Payments&#8221;), all of which have been received to date. With the Monetization Agreement (defined below) entered into on November 3, 2020 relating to KYNMOBI as described in the paragraph below, the Company is no longer entitled to receive any payments under the Sunovion License Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase and Sale Agreement with an affiliate of Marathon</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold to Marathon all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI. In exchange for the sale of these rights, the Company received an upfront payment from Marathon of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through March&#160;31, 2026 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets; therefore, the Company likely will not receive any of the additional contingent payments under the Monetization Agreement. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on the accounting for the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement to Terminate CLA with Zevra Therapeutics, Inc. (formerly KemPharm)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In March 2012, the Company entered into an agreement with Zevra to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. In March 2026, Zevra sold Azstarys to Commave Therapeutics SA. In accordance with the Company's agreement with Zevra, the Company received a payment out of the proceeds of the Zevra Commave  agreement and recognized royalty revenues of $4,500 during the three months ended March&#160;31, 2026 and will recognize additional $500 royalty revenues as a result of a payment to the Company in April 2026 in accordance with the Company's agreement with Zevra.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Supply Agreement with Atnahs Pharma UK Limited (Pharmanovia)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into the Pharmanovia Agreement, effective as of September 26, 2022, pursuant to which the Company granted Pharmanovia an exclusive license to certain of the Company&#8217;s intellectual property to develop and commercialize Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:700;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (diazepam) buccal film for the treatment of prolonged or acute, convulsive seizures in all ages in the Territory during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and the Company will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. Pursuant to the Pharmanovia Agreement, the Company received $3,500 upon agreement execution and, upon the occurrence of certain conditions set forth in the Pharmanovia Agreement, will receive additional milestone payments and profit shares, as well as manufacturing fees and royalty fees through the expiration of the Pharmanovia Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 27, 2023, the Company amended the Pharmanovia Agreement to expand the scope of territory for the license of Libervant to cover the rest of the world, excluding the U.S., Canada and China. Under the Pharmanovia Amendment, Pharmanovia will be responsible for seeking applicable regulatory approval in the expanded territories, which include Latin America, Africa and Asia Pacific. Pursuant to the terms of the Pharmanovia Amendment, the Company received a non-refundable payment of $2,000 from Pharmanovia in connection with the execution of the Pharmanovia Amendment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2026, the Company entered into a second amendment to the Pharmanovia Agreement relating to the license and supply of Libervant (diazepam) buccal film in territories outside the United States. The Pharmanovia Amendment No. 2 modifies certain commercial and operational terms of the agreement, including subcontracting rights, delivery terms, and minimum volume commitments in certain territories. All other terms and conditions of the Pharmanovia Agreement remain in full force and effect.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with Assertio Holdings, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of October 26, 2022, the Company entered into the Assertio Agreement to license Sympazan</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox&#8208;Gastaut syndrome in patients aged two years of age and older. Under the terms of the Assertio Agreement, the Company granted to Assertio an exclusive, worldwide license of its intellectual property for Sympazan to Assertio during the term of the Assertio Agreement for an upfront payment of $9,000. In addition, Aquestive received a $6,000 milestone payment subsequent to Aquestive&#8217;s receipt of a notice of allowance from the PTO of the Company&#8217;s patent application U.S. Serial No. 16/561,573, and payment by the Company of the related allowance fee. The Company received the notice of allowance from the PTO and paid the related allowance fee on October 27, 2022. Further, under the Assertio Agreement, the Company will receive royalties from Assertio for the sale of the product through the expiration of the Assertio Agreement. The Company also entered into a long-term supply agreement with Assertio for Sympazan pursuant to which the Company is the exclusive sole worldwide manufacturer and supplier of the product and will receive manufacturing fees from Assertio for the product through the expiration of such supply agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 8, 2026, Assertio entered into an Asset Purchase Agreement with Cosette,  a United States-based, branded specialty pharmaceutical company, to divest a portfolio of products, including Sympazan, to Cosette. Under that Asset Purchase Agreement, Assertio assigned and transferred its rights and certain obligations arising post closing to Cosette. Cosette assumed the intellectual property license and rights to commercialize Sympazan and will continue to purchase product and pay royalties and milestones to Aquestive under the Assertio Agreement and the Company's long-term supply agreement with Assertio.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments &#8211; Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments &#8211; Fair Value Measurements</a></td>
<td class="text">Financial Instruments &#8211; Fair Value Measurements<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&#160;Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1 &#8212; Observable quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2 &#8212; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160;methodologies and similar techniques.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the Condensed Balance Sheets for Trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants to purchase up to 4,000,000 shares of Common Stock and Common Stock Warrants to purchase up to 8,850,000 shares of Common Stock in connection with its Securities Purchase Agreements with certain purchasers. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of the remaining warrants to purchase 5,000,000 of the shares of Common Stock. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder new warrants to purchase up to an aggregate of 2,750,000 shares of new warrants at $2.60 per share. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, in connection with the issuance of the 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides the Note Holders:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#8482; (dibutepinephrine) sublingual film for a period of eight years from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (diazepam) buccal film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Those Royalty Agreements were valued based on Level 3 inputs and their&#160;fair value was based primarily on internal management estimates developed based on third-party data and reflect management&#8217;s judgment, current market conditions, and forecasts. The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, in connection with Amendment No.1 to the Purchase and Sale Agreement and the Equity Commitment Agreement with RTW, the Company also entered into the Warrant Issuance Agreement with the RTW investors. Pursuant to this agreement, the Company issued to the RTW Investors the RTW Warrant to purchase up to an aggregate of 375,000 shares of the Company's Common Stock. The RTW Warrant entitles the holders to purchase shares of Common Stock at an exercise price of $4.00 per share. Management estimated the fair value of the RTW Warrants to be $916, and it is presented within Additional Paid-in Capital on the Condensed Balance Sheets as of March&#160;31, 2026, and within Interest income and other income, net on the Condensed Statements of Operations and Comprehensive Loss for the three months ended March&#160;31, 2026. The RTW Warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories, Net</a></td>
<td class="text">Inventories, Net<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of Inventory are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Raw material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Packaging material</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,066&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Useful<br/>Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer, network equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3-7 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,966&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(44,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(44,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,893&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2026 and 2025, total depreciation and amortization related to property and equipment was $113 and $139, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Right-of-Use Assets and Lease Obligations</a></td>
<td class="text">Right-of-Use Assets and Lease Obligations<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all realty used at its production and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these three leases include the characteristics specified in ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, which require classification as financing leases and, accordingly, these leases are accounted for as operating leases. These leases, as amended, provide remaining terms between 2.0 years and 7.5 years, including renewal options expected to be exercised to extend the lease periods. Commitments under finance leases are not significant, and are included in Property and equipment, net, and Notes Payable, net on the Condensed Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize a right-to-use asset and lease liability for short-term leases, which have terms of 12 months or less on its Condensed Balance Sheets. For longer-term lease arrangements that are recognized on the Company&#8217;s Condensed Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#8217;s short-term leases, as well as variable costs relating to the Company&#8217;s lease arrangements, are not material to the Company&#8217;s financial results.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. Measurement of the </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">operating lease liability reflects a range of an estimated discount rate of 14.8% to 15.6% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#8217;s collateralized debt refinancing. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease costs are recorded in manufacture and supply, R&amp;D and selling, general and administrative expenses in its Condensed Statements of Operations and Comprehensive Loss. For the three months ended March&#160;31, 2026, total operating lease expenses totaled $447, including variable lease expenses such as common area maintenance and operating costs of $114. For the three months ended March&#160;31, 2025, total operating lease expenses totaled $427, including variable lease expenses such as common area maintenance and operating costs of $93.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,611)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-current Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Non-current Assets</a></td>
<td class="text">Other Non-current Assets<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of other non-current assets:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the eight $1,000 annual minimum guaranteed royalty payments that are due to the Company. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to determine whether the existing receivable was transferred to Marathon and concluded it was not transferred. As of March&#160;31, 2026 and December&#160;31, 2025, Royalty receivable consists of three annual minimum payments due from Sunovion, the last of which is due in March 2028. The current portion of the royalty receivable is included in Trade and other receivables, net. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on how this receivable relates to the Monetization Agreement transaction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Non-current portion of costs to obtain contracts capitalized under ASC 340, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">is recorded within Other non-current assets on the  Condensed Balance Sheets as of March&#160;31, 2026 and December&#160;31, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and personal property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued distribution expenses and sales returns provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,449&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The reduction in Accrued compensation is mostly related to payments of accrued bonuses during the three months ended March 31, 2026, partially offset by the current year accrual of bonuses. Accrued distribution expenses and sales returns provision mostly represent estimated liabilities for returns, wholesaler service fees, co-pay support redemptions and other </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">rebates related to the proprietary product Libervant and returns and other expenses related to the proprietary product Sympazan (prior to outlicensing to Assertio in October 2022).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">13.5% Senior Secured Notes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company entered into an Indenture Agreement with certain institutional investors (the &#8220;Note Holders&#8221;) and issued $45,000 aggregate principal amount of its 13.5% Notes due 2028. The Company received net proceeds of approximately $4,326 from this transaction after the repayment of the Company's 12.5% Notes and deduction of debt discount, and debt issuance costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> The 13.5% Notes are senior secured obligations of the Company and mature on November 1, 2028. The 13.5% Notes bear interest at a fixed rate of 13.5% per year, payable quarterly commencing on December 30, 2023. On each payment date commencing on June 30, 2026, the Company will pay an installment of principal of the 13.5% Notes pursuant to a fixed amortization schedule, along with the applicable Exit Fee. The Exit Fee totals $2,000.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, at its option, redeem the 13.5% Notes in full or in part:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">if such redemption occurs prior to November 1, 2025, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee, plus an Applicable Premium which is the greater of </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-23.27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">1.0% of the principal redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">the amount, if any, by which the present value of the principal to be redeemed on November 1, 2025, plus all required interest due on such date, computed using a discount rate equal to the Treasury Rate, plus 100 basis points, exceeds the amount of principal to be redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">if such redemption occurs after November 1, 2025, the redemption price is equal to 108.5% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Note Holders may require the Company to repurchase for cash all or any portion of the 13.5% Notes at a change of control repurchase price equal at 108.5% plus the Exit Fee of the remaining principal, plus accrued interest at the election of the Note Holders. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Indenture permits the Company, upon the continuing satisfaction of certain conditions, including that the Company has at least $100,000 of net revenues for the most recently completed twelve calendar month period, to enter into an ABL facility not to exceed $10,000. The ABL Facility may be collateralized only by assets of the Company constituting inventory, accounts receivable, and the proceeds thereof. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2026, the Company entered into a five-year term loan facility of up to $150,000 with funds managed by Oaktree Capital Management, L.P, consisting of a term loan in an aggregate principal amount of $55,000 which was funded on May 12, 2026 and was used by the Company to repay the Company&#8217;s existing 13.5% Notes in the aggregate principal amount of $45,000 plus fees associated with the repayment. See Note 21, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides Note Holders:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#8482; (dibutepinephrine) sublingual film for a period of eight years from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (diazepam) buccal film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Both the 13.5% Notes and Royalty Right Agreements, represent freestanding instruments which were issued in conjunction with each other. They are classified as debt within the scope of ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and are subsequently measured on an amortized cost basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. These inputs are derived using internal management estimates developed based on third-party data and reflect management&#8217;s judgment, current market conditions, and forecasts.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Royalty Right Agreements&#8217; fair value is estimated by applying probability-weighted cash flows for future sales, which are then discounted to present value. Changes to fair value of the Royalty Rights Agreements can result from changes to one or a number of the aforementioned inputs. A significant change in unobservable inputs could result in a material increase or decrease to the effective interest rate of the Royalty Right Agreements liability.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant unobservable inputs used in the fair value measurement of the Royalty Right Agreements:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Methodology</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Input</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (range, if applicable)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Right Agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighted<br/>income approach</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Success</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Projected Years of Payments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2026, there were no changes to the significant unobservable inputs used to recognize the Royalty Right Agreements liability. During the year ended December&#160;31, 2025, the Company updated the probability-weighted cash flows for future sales, which decreased the royalty obligation to $51,886 and decreased the unamortized discount to $25,945. The effective interest rate changed by 2.64%, and the Company updated the projected years of payments to 2035.  </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since the Royalty Right Agreements were issued in connection with the 13.5% Notes, the Company allocated the proceeds to the two instruments based on their relative fair values. The Company allocated approximately $13,856 to the Royalty Right Agreements. The Company determined the allocated fair value by calculating the present value of estimated future royalties to be paid to Note Holders over the life of the arrangement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The excess of future estimated royalty payments over the allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The allocated amounts of $13,856 when combined with the Exit Fee of $2,000, original issue discount of $1,125 and debt issuance costs of $3,517, resulted in a debt discount of $20,498. The debt discount is being amortized over the term of 13.5% Notes using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from the discounts related to the 13.5% Notes and the Royalty Right Agreements for the three months ended March&#160;31, 2026 was $1,254 and $973, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from the discounts related to the 13.5% Notes and the Royalty Right Agreements for the three months ended March&#160;31, 2025 was $1,254 and $1,437, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized discounts totaled $6,376 for the 13.5% Notes and $24,972 for the Royalty obligations as of March&#160;31, 2026. Unamortized discounts totaled $7,630 for the 13.5% Notes and $25,945 for the Royalty obligations as of December&#160;31, 2025, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-term notes and unamortized debt discount balances are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Outstanding notes</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount, including Exit Fee</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13,630)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9,964)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, long-term</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,099&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,519&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Royalty obligations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(24,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(25,945)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, long term</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,914&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments on the 13.5% Notes as of March&#160;31, 2026 are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, the 13.5% Notes were redeemed on May 12, 2026. See Note 21, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued to RTW Investments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2026, in connection with the Amendment No.1 to the Purchase and Sale Agreement and the Equity Commitment Agreement with RTW, the Company also entered into the Warrant Issuance Agreement with the RTW investors. Pursuant to this agreement, the Company issued to the RTW Investors the RTW Warrant to purchase up to an aggregate of 375,000 shares of the Company's Common Stock. The RTW Warrant entitles the holders to purchase shares of Common Stock at an exercise price of $4.00 per share. The Warrant is exercisable at any time from the issuance date through March 3, 2029. Management estimated the fair value of the RTW Warrants to be $916, based on an assessment by an independent third-party appraiser. The fair value was estimated using the Black-Scholes pricing model, which utilized the Company's historical stock price to measure volatility and a holding period of three years based on the time period between the valuation date and the termination date as defined in the Warrant Issuance Agreement. The fair value of the RTW Warrants is presented within Additional Paid-in Capital on the Condensed Balance Sheets as of March&#160;31, 2026 and within Interest income and other income, net on the Condensed Statements of Operations and Comprehensive Loss for the three months ended March&#160;31, 2026.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no warrants exercised as it relates to the RTW Warrants during the three months ended March&#160;31, 2026. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued to 12.5% Senior Secured Noteholders </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Warrants that were issued in conjunction with the Initial Notes (the &#8220;Initial Warrants&#8221;) and Additional Notes (the &#8220;Additional Warrants&#8221;) entitled the noteholders of the Company's 12.5% Notes to purchase up to 2,143,000 shares of Common Stock and included specified registration rights. Management estimated the fair value of the Initial Warrants to be $6,800 and the Additional Warrants to be $735, each based on an assessment by an independent third-party appraiser. The fair value of the respective warrants was treated as a debt discount, amortizable over the term of the respective warrants, with the unamortized 12.5% Notes portion applied to reduce the aggregate principal amount of the 12.5% Notes. The 12.5% Notes were refinanced with the 13.5% Notes on November 1, 2023. Additionally, since the Initial Warrants and Additional Warrants issued do not provide warrant redemption or put rights within the control of the noteholders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the warrants, except in the case of a &#8220;cash change in control&#8221;, the fair value attributed to the warrants is presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets. The Initial Warrants and Additional Warrants expired on June 30, 2025.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no warrants exercised as it relates to the Initial Warrants and the Additional Warrants during the three months ended March&#160;31, 2025.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued Under Securities Purchase Agreements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants and Common Stock warrants to certain purchasers in connection with the Securities Purchase Agreements. The pre-funded warrants entitled purchasers to purchase up to 4,000,000 shares of Common Stock and were exercised in full during the year ended December 31, 2022. The Common Stock warrants expire on June 8, 2027 and entitled the purchasers to purchase up to 8,850,000 shares of Common Stock at an exercise price of $0.96 per share. Management estimated the fair value of the pre-funded warrants and Common Stock warrants to be $5,874 based on an assessment by an independent third-party appraiser. The fair value of the pre-funded and Common Stock warrants is treated as equity and presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets. On June 14, 2023, 3,689,452 Common Stock warrants issued pursuant to the Securities Purchase Agreements were exercised with proceeds of approximately $3,542.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of 5,000,000 of the remaining Common Stock Warrants. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the then current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock. The New Warrants became exercisable after February 2, 2024, expire on February 2, 2029 and are issuable only for cash, subject to exception if the shares of Common </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case, the New Warrants may also be exercised, in whole or in part, at such time by means of a "cashless exercise". The New Warrants have an exercise price of $2.60 per share. Management estimated the fair value of the warrants to be $4,671 based on an assessment by an independent third-party appraiser. The fair value of the New Warrants is treated as equity and is presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were no warrants issued or exercised as it relates to the Warrants issued under Securities Purchase Agreements during the three months ended March&#160;31, 2026 and 2025.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, in addition to the remaining New Warrants to purchase 2,200,000 shares of Common Stock with an exercise price of $2.60 per share and the RTW Warrants to purchase 375,000 shares with an exercise price of $4.00 per share described above, there remain outstanding warrants to purchase 160,548 shares of Common Stock at an exercise price of $0.96.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfFutureRevenueTextBlock', window );">Sale of Future Revenue</a></td>
<td class="text">Sale of Future Revenue<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, an apomorphine film therapy for the treatment of off episodes in Parkinson&#8217;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, the Company received an upfront payment of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through March&#160;31, 2026 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the upfront proceeds of $40,000 and subsequent first milestone of $10,000, reduced by $2,909 of transaction costs, as a liability related to the sale of future revenue that will be amortized using the effective interest method over the life of the Monetization Agreement. As future contingent payments are received, they will increase the balance of the liability related to the sale of future revenue. Although the Company sold all of its rights to receive royalties and milestones, as a result of ongoing obligations related to the generation of these royalties, the Company will account for these royalties as revenue. Its ongoing obligations include the maintenance and defense of the intellectual property and to provide assistance to Marathon in executing a new license agreement for KYNMOBI in the event Sunovion terminates the Sunovion License Agreement in one or more jurisdictions of the licensed territory under the Sunovion License Agreement. The accounting liabilities, as adjusted over time, resulting from this transaction and any non-cash interest expenses associated with those liabilities do not and will not represent any obligation to pay or any potential future use of cash.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the $1,000 annual minimum guaranteed royalty that is due. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As royalties are remitted to Marathon from Sunovion, the collection of the royalty receivable and balance of the liability related to the sale of future revenue will be effectively repaid over the life of the agreement. In order to determine the amortization of the liability related to the sale of future revenue, the Company is required to estimate the total amount of future royalty and milestone payments to Marathon over the life of the Monetization Agreement and contingent milestone payments from Marathon to the Company. The sum of future royalty payments less the $50,000 in proceeds received and future contingent payments has been recorded as interest expense over the life of the Monetization Agreement. At execution, the estimate of this total interest expense resulted in an effective annual interest rate of approximately 24.9%. This estimate contained significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the life of the Monetization Agreement. The Company assesses the estimated royalty and milestone payments to Marathon from Sunovion and contingent milestone payments from Marathon to the Company. To the extent the amount or timing of such payments is materially different from the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. There are a number of factors that could materially affect the amount and timing of royalty and milestone payments to Marathon from Sunovion and, correspondingly, the amount of interest expense recorded by the Company, most of which are not under the Company&#8217;s control. Such factors include, but are not limited to, changing standards of care, the initiation of competing products, manufacturing or other delays, generic competition, intellectual property matters, adverse events that result in government health authority imposed restrictions on the use of products, significant changes in foreign exchange rates as the royalties remitted to Marathon are made in U.S. dollars (USD) while a portion of the underlying sales of KYNMOBI will be made in currencies other than USD, and other events or circumstances that are not </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">currently foreseen. Changes to any of these factors could result in increases or decreases to both royalty revenue and interest expense related to the sale of future revenue. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. Further, the Company discontinued recording interest expense related to the sale of future revenue during the fourth quarter of 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the activity of the liability related to the sale of future revenue:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalties related to the sale of future revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,083&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,023&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfFutureRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Future Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfFutureRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationDisclosureAbstract', window );"><strong>Asset Retirement Obligation Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationDisclosureTextBlock', window );">Other Non-Current Liabilities</a></td>
<td class="text">Other Non-Current Liabilities<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other non-current liabilities at March&#160;31, 2026 and December&#160;31, 2025  consisted of a confidential legal settlement net liability and AROs of  $2,072 and $2,065, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">AROs consists of estimated future spending related to removing certain leasehold improvements at the Company&#8217;s facilities in Portage, Indiana and Warren, New Jersey, and returning all facilities to their original condition. Depreciation expense related to the ARO assets included in overall depreciation expense for the three months ended March&#160;31, 2026 and 2025 was $6 and $7, respectively.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2025</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an asset retirement obligation and the associated long-lived asset. An asset retirement obligation is a legal obligation associated with the disposal or retirement from service of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/410-20/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 20<br> -Topic 410<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss by the weighted-average number of Common Stock.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#8217;s equity compensation plans, warrants and ESPP. As a result of the Company&#8217;s net loss incurred for the three months ended March&#160;31, 2026 and 2025, all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended March&#160;31, 2026 and 2025 as reflected below.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,609,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,497,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss per common share &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended March&#160;31, 2026 and 2025, outstanding stock options of 7,501,729 and 6,977,367 to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three months ended March&#160;31, 2026 and 2025, outstanding restricted stock units of 4,566,190 and 5,167,351 to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended March&#160;31, 2026 and 2025, outstanding warrants of 2,735,548 and 4,594,332 to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation in its Condensed Statements of Operations and Comprehensive Loss during the three months ended March&#160;31, 2026 and 2025 as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation from:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Equity Awards</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the three month period ended March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s awards of service-based and market conditions vesting-based restricted stock units for the three month period ended March&#160;31, 2026:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Service-based:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, $8,931 of total unrecognized compensation expenses related to unvested service-based restricted stock units are expected to be recognized over a remaining weighted average period of 2.24 years. The service-based restricted stock units granted to employees are subject to a three-year graduated vesting schedule and are not subject to performance-based criteria other than continued employment.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, $1,090 of unrecognized compensation expense related to unvested market condition vesting- based restricted stock units are expected to be recognized over a remaining weighted average period of 0.78 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 market conditions vesting-based restricted stock units vest based on a Performance Price measured as the 30-day average of the closing prices of the Common Stock as reported on the Nasdaq Global Market immediately prior to and including the last calendar day of the three-year performance period (which ends on the third anniversary of the grant date). To the extent the Performance Price is less than $1.75, the Vesting Percentage will be zero. To the extent the Performance Price is $1.75, the Vesting Percentage will be 50%. To the extent the Performance Price is $1.76 or greater, but less than $2.50, the Vesting Percentage will be a prorated amount between 50.01% and 99.99%, based on straight-line interpolation. To the extent the Performance Price is $2.50, the Vesting Percentage will be 100%. To the extent the Performance Price is $2.51 or greater, but less than $3.25, the Vesting Percentage will be a prorated amount between 100.01% and 149.99%, based on straight-line interpolation. To the extent the Performance Price is $3.25 or greater, the Vesting Percentage will be 150%. In no event will the Vesting Percentage exceed 150%.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 market conditions vesting-based restricted stock units were measured over a three-year performance period. The performance period is split into two pricing periods. The first pricing period commences on the grant date and ends on the calendar day immediately proceeding the second anniversary of the grant date. The second pricing period commences on the second anniversary of the grant date and ends on the third anniversary of the grant date, The performance price for the first pricing period is calculated based on the 30-day average price observed for the last 30 days of the first pricing period. The performance price for the second pricing period is calculated based on the highest 30-day average for any 30-day period throughout the second pricing period. To the extent the Performance Price is less than $6.00, the Vesting Percentage will be zero. To the extent the Performance Price is $6.00, the Vesting Percentage will be 50%. To the extent the Performance Price is $6.01 or greater, but less than $7.00, the Vesting Percentage will be a prorated amount between 50.01% and 99.99%, based on straight-line interpolation. To the extent the Performance Price is $7.00, the Vesting Percentage will be 100%. To the extent the Performance Price is $7.01 or greater, but less than $8.00, the Vesting Percentage will be a prorated amount between 100.01% and 149.99%, based on straight-line interpolation. To the extent the Performance Price is $8.00 or greater, the Vesting Percentage will be 150%. In no event will the Vesting Percentage exceed 150%.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of the fair value of the 2025 market conditions vesting-based awards at their grant or valuation dates were based on a Monte Carlo simulation and considered various variables and the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock price at grant date</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$2.65</span></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Stock Option Awards:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,342&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.146%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of stock options granted during the three months ended March&#160;31, 2026 was $3.43. During the three months ended March&#160;31, 2026, stock options were granted with a weighted average exercise price of $4.29.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2026, $5,272 of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a remaining weighted average period of 2.04 years.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">2022 Inducement Equity Incentive Plan (number of units in thousands)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Nasdaq Listing Rule 5635(c)(4), the Company adopted the 2022 Equity Inducement Plan approved by the Compensation Committee of the Board of Directors of the Company effective as of July 29, 2022. There were 75  service-based awards and 50 options granted under this Plan during the three months ended March&#160;31, 2026. The options and service-based awards granted under this Plan are included in the tables above. As of March&#160;31, 2026, 775 shares remained available for grant under this Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and R&amp;D credits. Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three months ended March&#160;31, 2026 and 2025, the effective income tax rate was 0%, and the Company recorded no income tax expense from its pretax losses of $8,057 and $22,930, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The primary factors impacting the effective tax rate for the three months ended March&#160;31, 2026 is the anticipated full year pre-tax book loss and a full valuation allowance against any associated net deferred tax assets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 4, 2025, the President signed H.R. 1, the Budget Reconciliation Bill, into law. The legislation includes several changes to federal tax law that generally allow for more favorable deductibility of certain business expenses beginning in 2025, including the restoration of immediate expensing of domestic R&amp;D expenditures, reinstatement of 100% bonus depreciation, and more favorable rules for determining the limitation on business interest expense.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These changes were reflected in the income tax provision for the three months ended March&#160;31, 2026. As the result of the Company maintaining a full valuation allowance against its U.S. federal and state deferred tax assets, the changes introduced by this legislation did not result in a material impact to the Company&#8217;s income tax provision or deferred tax balances for the current reporting period. The Company will continue to monitor the potential future impacts of the legislation, including any changes to its valuation allowance assessment, as further guidance becomes available and as facts and circumstances evolve.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the course of its business, including product liability, intellectual property, securities, civil tort, and commercial litigation, and environmental or other regulatory matters.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California Litigation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis, Inc. v. Aquestive Therapeutics, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, Neurelis, Inc. ("Neurelis") filed a civil tort lawsuit against the Company in the Superior Court of California, County of San Diego. In December 2025, the parties reached a mutual out-of-court settlement agreement resolving all claims related to the matter, the terms of which settlement agreement are confidential. In the settlement agreement, the Company did not concede liability and settled the matter for business reasons. The Company does not consider this settlement material to its financial condition. The settlement of the matter was recorded within Selling, general, and administrative expenses on the Company's Statements of Operations and Comprehensive Loss for the year ended December 31, 2025. The current liability was recorded within Accounts payable and the non-current liability was recorded within Other non-current liabilities on the Company's Balance Sheets as of March&#160;31, 2026 and December 31, 2025. On April 3, 2026 the court signed the Order dismissing the case with prejudice.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neurelis FDA Lawsuit</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis, Inc. v. Califf, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">et al</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, U.S. District Court for the District of Columbia</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In May 2024, Neurelis filed a complaint in the U.S. District Court for the District of Columbia against the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, and certain government officials. The complaint in this matter alleges that the defendants violated the Administrative Procedure Act by approving the Company's NDA for Libervant for ARS patients aged between two and five years, and asked the Court to vacate that approval and enjoin the defendants from approving Libervant for this pediatric patient population until January 10, 2027, the scheduled date for the expiration of the U.S. orphan drug market exclusivity (ODE) granted by the FDA to the Valtoco</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> nasal spray product of Neurelis (the "ODE Expiration"). The Company intervened in this litigation to defend the approval of Libervant for this ARS pediatric patient population. Following submission of briefs and filings of respective motions by the parties for summary judgment, on February 14, 2025, the Court entered a final appealable judgment in favor of Neurelis, and against the FDA's and the Company's cross-motions for summary judgment, and directed the FDA to vacate the approval of Libervant. On February 18, 2025, the Company filed an appeal of the District Court's decision with the U.S. Court of Appeals for the District of Columbia Circuit (the "DC Appellate Court") and, on the same day, filed an emergency motion with the District Court to stay its order pending a decision on the appeal with the DC Appellate Court. The District Court denied the motion for a stay. On March 27, 2025, the DC Appellate Court denied the Company's emergency motion for stay. The FDA filed an appeal of the District Court's decision to the DC Appellate Court and the Company withdrew its appeal. As a result of the District Court's ruling, the FDA converted the approval of Libervant to a "tentative approval" and the Company has ceased marketing activities in the United States for Libervant for these ARS pediatric patients. After a delay of the proceedings at the DC Appellate Court caused by the government shutdown beginning in October 2025, on November 21, 2025, the DC Appellate Court entered a schedule for briefing and oral arguments on the appeal. Subsequently, on February 3, 2026, Congress adopted and the President signed into law legislation that amended the Orphan Drug Act to provide that ODE applies only to the extent a subsequent applicant seeks approval for the same approved use or indication within the designated rare disease or condition to which the ODE applies. As applied, this legislation would confirm the FDA's long-standing interpretation of the Orphan Drug Act and its authority to approve another sponsor&#8217;s orphan drug for a different use or indication than that of an approved drug with ODE, such as the FDA's prior approval of Libervant for ARS patients aged between two and five years. On February 16, 2026, the Company filed a motion with the DC Appellate Court requesting that the DC Appellate Court order all parties to submit simultaneous briefs regarding appropriate next steps regarding this legislation and its intended application to this case, including the possibility of a summary disposition of the matter by the DC Appellate Court. On February 18, 2026, Neurelis </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">filed a brief opposing the Company's motion. On the DC Appellate Court's own motion filed on February 17, 2026, the DC Appellate Court suspended briefing by the parties in this case pending further order from the court. On March 2, 2026, the DC Appellate Court entered an order directing the parties to file motions by March 20, 2026 addressing, among other things, their positions on the effect on the appeal resulting from the recent amendment to the Orphan Drug Act. The court denied pending motioned and entered a briefing scheduling order.  The Company is not able to determine or predict the ultimate outcome of these proceedings or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter or whether the FDA will grant U.S. market access to Libervant for ARS patients aged between two and five years in advance of the ODE Expiration.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suboxone Product Liability Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company was named as a defendant in a multitude of product liability lawsuits, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#174; sublingual film, a prescription drug product for opioid use disorder, caused them dental injuries. On February 2, 2024, this litigation became a MDL consolidated in the U.S District Court for the Northern District of Ohio. One case alleging the same allegations as contained in the MDL has been filed in a state court in the State of New Jersey. The parties to the MDL have agreed to a tolling of unfiled claimants in several states. Indivior has agreed to defend the Company in these litigation matters. Discovery is underway and no trial date has been set in the MDL matter. The Company's motion to dismiss the MDL matter was granted as to all claims against Aquestive by plaintiffs except design defect claims and claims for punitive damages. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company was named as a defendant in three proposed class action lawsuits filed in Canada, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#174; products caused them dental injuries. Two of these cases have been filed in British Columbia, and the plaintiffs in those cases are seeking assignment of a case management judge. The anticipated next step in British Columbia will involve applications by the plaintiffs to determine which of the two cases will proceed towards a certification hearing and which will be stayed. The third case has been filed in Quebec and is proceeding towards an authorization hearing, the date of which has not yet been set. The authorization and certification hearings will determine whether the Courts will allow the cases to proceed as class actions. Pre-discovery and case management proceedings are underway and no trial date has yet been set. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this litigation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Federal Securities Class Action</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2026, a putative securities class action lawsuit was filed against the Company and Daniel Barber in the United States District Court for the District of New Jersey, captioned Modica v. Aquestive Therapeutics, Inc. and Daniel Barber. The complaint purports to seek relief on behalf of a class of investors who purchased or otherwise acquired the Company&#8217;s publicly traded securities between June 16, 2025 and January 8, 2026, and asserts violations of Section 10(b) of the Exchange Act against all defendants and Section 20(a) of the Exchange Act against the individual defendant. The complaint alleges, among other things, that during the proposed class period, defendants made misstatements and/or failed to disclose certain facts regarding the NDA for Anaphylm. The complaint seeks various forms of relief, including monetary damages in an unspecified amount. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Shareholder Derivative Litigation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2026, a shareholder derivative lawsuit was filed by a purported shareholder on behalf of the Company against certain individual directors and officers of the Company, naming the Company as a nominal defendant, in the United States District Court for the District of New Jersey, captioned Wilson v. Brown, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et al</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The complaint asserts claims for violation of Section 14(a) of the Exchange Act against the director defendants, and breach of fiduciary duty, aiding and abetting breach of fiduciary duty, and waste of corporate assets against all individual defendants. The complaint alleges, among other things, that the individual defendants failed to exercise adequate oversight of, and misrepresented and/or failed to disclose certain facts regarding the NDA for Anaphylm. The derivative action has been designated as related to the securities class action described above. The complaint seeks various forms of relief, including monetary damages in an unspecified amount and corporate governance reforms. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On April 20, 2026, the Company entered into a second amendment to the Pharmanovia Agreement relating to the license and supply of Libervant (diazepam) buccal film in territories outside the United States. The Pharmanovia Amendment No. 2 modifies certain commercial and operational terms of the agreement, including subcontracting rights, delivery terms, and minimum volume commitments in certain territories. All other terms and conditions of the Pharmanovia Agreement remain in full force and effect.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 8, 2026, the Company entered into a lease agreement which will serve as the Company&#8217;s corporate headquarters. The lease has an initial term of eleven years, inclusive of an initial rent abatement period of approximately twelve months, commencing on the earlier of the date the Company obtains a certificate of occupancy or September 1, 2026. The lease provides the Company with two successive five-year renewal options at fair market rental value and an option to expand into additional space. The Company expects to account for the lease as an operating lease in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases.</span></div>On May 12, 2026, the Company entered into a five-year term loan facility of up to $150,000 with funds managed by Oaktree Capital Management, L.P. The five year term loan facility consisted of an aggregate principal amount of $55,000, which was funded on May 12, 2026 and was primarily used to repay the Company&#8217;s existing 13.5% Notes in the aggregate principal amount of $45,000 plus fees associated with the repayment. Upon FDA approval of Anaphylm and satisfaction of other customary conditions, an additional $20,000 will be available. A third tranche of $25,000 will be available upon the achievement of specified sales milestones, with the final tranche of up to $50,000 available with the mutual consent of the Lenders and the Company. The Company will pay only interest on the new five-year facility with all principal amounts outstanding due at maturity.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#8217;s audited financial statements and related notes for the fiscal year ended December&#160;31, 2025 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March&#160;4, 2026 (the &#8220;2025 Annual Report on Form 10-K&#8221;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2025 is derived from the audited financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying condensed financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Adopted as of March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09&#8212;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The ASU modifies the effective tax rate reconciliation table and requires disaggregation of income taxes. The Company adopted ASU 2023-09 for the year ending December&#160;31, 2025 and added the required disclosures on a prospective basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of March&#160;31, 2026:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Statements of Operations, and Comprehensive Loss as well as qualitatively describe the remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Company&#8217;s definition of selling expenses. These disclosure requirements will be effective for the Company for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact from the adoption of ASU 2024-03 on disclosures to its financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the FASB issued ASU 2025-06, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Internal-Use Software</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to provide clarification and improvements to the accounting for internal-use software costs under ASC 350-40, Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software. The guidance includes amendments related to capitalization of implementation costs, subsequent measurement, and related presentation and disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on its financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Performance Obligations</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age while Libervant had U.S. market access through April 2025. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - a performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#8217;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and supply revenue</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenu</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">e &#8211; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research Fees</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#8217;s R&amp;D projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age while Libervant had U.S. market access through April 2025, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Once receivables are collected, allowances are reclassified and treated as accrued liabilities. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once related variable considerations are resolved and uncertainties as to incurred amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of March&#160;31, 2026, and December&#160;31, 2025, such contract assets were $445 and $627, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of March&#160;31, 2026 and December&#160;31, 2025, such contract liabilities were $20,210 and $20,482, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to Obtain Contracts</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of March&#160;31, 2026 and December&#160;31, 2025, such costs to obtain contracts were $442 and $449, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles reported revenues to net loss under the significant expense principle for the three months ended March&#160;31, 2026 and 2025:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.970%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Manufacture and Supply Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D Project expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Anaphylm project expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">AQST-108 project expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">R&amp;D other expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Research and Development Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Selling expenses:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Selling expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">General &amp; Administrative expenses:</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personnel costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">5</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline">6</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total General and Administrative Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,116&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Selling, General and Administrative Expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">28,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income/(expenses), net</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,565)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 - R&amp;D Personnel costs include payroll expenses,  share-based compensation expenses and severance</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2 - Other R&amp;D expenses include preclinical, consulting, maintenance, and testing fees</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 - Selling Personnel costs include payroll expenses, share-based compensation expenses and severance</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4 - Other Selling expenses include commercialization and other related expenses</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5 - G&amp;A Personnel costs include payroll expenses,  share-based compensation expenses and severance</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 - Other General and Administrative expenses include legal/patent fees, insurance fees, IT expenses, investor relations expenses, regulatory fees, facility and other costs</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Zevra-related royalty revenue of $4,500 recognized during the three months ended March&#160;31, 2026. For additional information, see Note 6, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated net revenue by geographic area: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,245&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Ex-United States</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,446&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Trade and Other Receivables, Net</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Contract and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: sales-related allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into Accrued distribution expenses and sales-related allowances</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,867&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,763&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock', window );">Schedule of Sales-related Allowances</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provides a summary of activity with respect to sales-related allowances:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:70.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Payments / credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into Accrued distribution expenses and sales-related allowances</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accounts Receivable Allowances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The components of Inventory are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Raw material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Packaging material</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8,066&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,169&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Useful<br/>Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,383&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer, network equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3-7 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,966&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">47,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(44,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(44,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,893&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Liabilities Maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,611)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Non-Current Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of other non-current assets:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,707&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and personal property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued distribution expenses and sales returns provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,449&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock', window );">Schedule of Royalty Right Agreements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant unobservable inputs used in the fair value measurement of the Royalty Right Agreements:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Methodology</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Input</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (range, if applicable)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Right Agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighted<br/>income approach</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Success</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Projected Years of Payments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Term Notes and Unamortized Debt Discount Balances</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Long-term notes and unamortized debt discount balances are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Outstanding notes</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount, including Exit Fee</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,630)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13,630)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9,964)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, long-term</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">24,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,099&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,519&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Royalty obligations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">51,886&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(24,972)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(25,945)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, long term</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,914&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Debt Maturities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments on the 13.5% Notes as of March&#160;31, 2026 are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">20,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationActivityTableTextBlock', window );">Schedule of Royalty Obligation</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the activity of the liability related to the sale of future revenue:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Royalties related to the sale of future revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,083&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,023&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyObligationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligation Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyObligationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationDisclosureAbstract', window );"><strong>Asset Retirement Obligation Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock', window );">Schedule of Liability for Asset Retirement Obligations</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2025</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,045&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accretion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,072&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount of a liability for asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#8217;s equity compensation plans, warrants and ESPP. As a result of the Company&#8217;s net loss incurred for the three months ended March&#160;31, 2026 and 2025, all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended March&#160;31, 2026 and 2025 as reflected below.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(22,930)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,609,995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">95,497,056&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Loss per common share &#8211; basic and diluted</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended March&#160;31, 2026 and 2025, outstanding stock options of 7,501,729 and 6,977,367 to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three months ended March&#160;31, 2026 and 2025, outstanding restricted stock units of 4,566,190 and 5,167,351 to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended March&#160;31, 2026 and 2025, outstanding warrants of 2,735,548 and 4,594,332 to purchase shares of Common Stock, respectively, were anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation in its Condensed Statements of Operations and Comprehensive Loss during the three months ended March&#160;31, 2026 and 2025 as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.823%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation from:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock Units Awards</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s awards of service-based and market conditions vesting-based restricted stock units for the three month period ended March&#160;31, 2026:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Service-based:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,684&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,661&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Stock Option Awards:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,342&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Stock Option Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of the fair value of the 2025 market conditions vesting-based awards at their grant or valuation dates were based on a Monte Carlo simulation and considered various variables and the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91.5%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock price at grant date</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$2.65</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.146%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">98%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.8%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Overview and Basis of Presentation (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">79 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 14, 2025</div></th>
<th class="th"><div>Apr. 23, 2024</div></th>
<th class="th"><div>Apr. 03, 2024</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember', window );">Equity distribution agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,506,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember', window );">Equity distribution agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AmendedEquityDistributionAgreementMember', window );">Amended Equity Distribution Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,191,071<span></span>
</td>
<td class="nump">7,457,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,810<span></span>
</td>
<td class="nump">$ 21,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockMaximumTransactionAmount', window );">Sale of stock, maximum transaction amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts', window );">Underwriting discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">$ 694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares)</a></td>
<td class="nump">21,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on sale of stock</a></td>
<td class="nump">$ 79,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for stock issuance costs</a></td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts', window );">Underwriting discounts</a></td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share)</a></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfStockAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfStockAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Consideration Received on Transaction, Underwriting Discounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfStockMaximumTransactionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Maximum Transaction Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfStockMaximumTransactionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AmendedEquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_AmendedEquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Risks and Uncertainties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Nov. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 110,734<span></span>
</td>
<td class="nump">$ 121,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 455,055<span></span>
</td>
<td class="nump">$ 446,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-18<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues | $</a></td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total Manufacture and Supply Expenses</a></td>
<td class="nump">3,469<span></span>
</td>
<td class="nump">3,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expenses</a></td>
<td class="nump">4,204<span></span>
</td>
<td class="nump">5,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General &amp; Administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Total Selling, General and Administrative Expenses</a></td>
<td class="nump">10,977<span></span>
</td>
<td class="nump">19,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">18,650<span></span>
</td>
<td class="nump">28,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(4,204)<span></span>
</td>
<td class="num">(19,365)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aqst_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">14,446<span></span>
</td>
<td class="nump">8,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total Manufacture and Supply Expenses</a></td>
<td class="nump">3,469<span></span>
</td>
<td class="nump">3,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expenses</a></td>
<td class="nump">4,204<span></span>
</td>
<td class="nump">5,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Total Selling expenses</a></td>
<td class="nump">1,920<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General &amp; Administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total General and Administrative Expenses</a></td>
<td class="nump">9,057<span></span>
</td>
<td class="nump">16,116<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Total Selling, General and Administrative Expenses</a></td>
<td class="nump">10,977<span></span>
</td>
<td class="nump">19,072<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">18,650<span></span>
</td>
<td class="nump">28,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(4,204)<span></span>
</td>
<td class="num">(19,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income/(expenses), net</a></td>
<td class="num">(3,853)<span></span>
</td>
<td class="num">(3,565)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">(8,057)<span></span>
</td>
<td class="num">(22,930)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aqst_ReportableSegmentMember', window );">Reportable Segment | Anaphylm project expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expenses</a></td>
<td class="nump">1,085<span></span>
</td>
<td class="nump">2,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aqst_ReportableSegmentMember', window );">Reportable Segment | AQST-108 project expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expenses</a></td>
<td class="nump">558<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aqst_ReportableSegmentMember', window );">Reportable Segment | Personnel costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expenses</a></td>
<td class="nump">2,242<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Total Selling expenses</a></td>
<td class="nump">1,643<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General &amp; Administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total General and Administrative Expenses</a></td>
<td class="nump">5,509<span></span>
</td>
<td class="nump">4,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aqst_ReportableSegmentMember', window );">Reportable Segment | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and Development Expenses</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingExpense', window );">Total Selling expenses</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">2,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpenseAbstract', window );"><strong>General &amp; Administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total General and Administrative Expenses</a></td>
<td class="nump">$ 3,548<span></span>
</td>
<td class="nump">$ 11,276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized in the period that are directly related to the selling and distribution of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-25<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-19<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-12<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 35<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-35<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=aqst_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=aqst_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_AnaphylmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_AnaphylmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_AQST108Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_AQST108Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_PersonnelCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_PersonnelCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Current and non-current contract assets</a></td>
<td class="nump">$ 445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">20,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized contract cost, net</a></td>
<td class="nump">442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesGrossCurrent', window );">Contract and other receivables</a></td>
<td class="nump">$ 1,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=aqst_IndiviorMember', window );">Indivior | Revenues | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk (as a percent)</a></td>
<td class="nump">57.00%<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=aqst_IndiviorMember', window );">Indivior | Receivables | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk (as a percent)</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=aqst_ZevraMember', window );">Zevra | Revenues | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk (as a percent)</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=aqst_AssertioHoldingsIncMember', window );">Assertio | Receivables | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=aqst_HyperaMember', window );">Hypera | Revenues | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=aqst_HyperaMember', window );">Hypera | Receivables | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember', window );">Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_TradeAccountsReceivableMember', window );">Trade Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_OtherReceivablesAndAccruedExpensesMember', window );">Other Receivables And Accrued Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit loss</a></td>
<td class="nump">$ 902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ResearchAndDevelopmentProjectDuration', window );">Research and development, project duration (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ResearchAndDevelopmentProjectDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development, Project Duration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ResearchAndDevelopmentProjectDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-18<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_IndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_IndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_ZevraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_ZevraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_AssertioHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_AssertioHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_HyperaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_HyperaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_TradeAccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_TradeAccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_OtherReceivablesAndAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_OtherReceivablesAndAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Schedule of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember', window );">Manufacture and supply revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">8,793<span></span>
</td>
<td class="nump">7,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember', window );">License and royalty revenue a</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">5,395<span></span>
</td>
<td class="nump">790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember', window );">License and royalty revenue a | Zevra And Commave Therapeutics Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember', window );">Co-development and research fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">258<span></span>
</td>
<td class="nump">418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_ProprietaryProductRevenueMember', window );">Proprietary product revenue, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_ZevraAndCommaveTherapeuticsAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_ZevraAndCommaveTherapeuticsAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_ProprietaryProductRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_ProprietaryProductRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Schedule of Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">13,245<span></span>
</td>
<td class="nump">5,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Ex-United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,201<span></span>
</td>
<td class="nump">$ 3,519<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Schedule of Trade and Other Receivables, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Trade receivables</a></td>
<td class="nump">$ 5,262<span></span>
</td>
<td class="nump">$ 8,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesGrossCurrent', window );">Contract and other receivables</a></td>
<td class="nump">1,605<span></span>
</td>
<td class="nump">9,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification', window );">Less: sales-related allowances</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(582)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet', window );">Reclassification into Accrued distribution expenses and sales-related allowances</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">582<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Trade and other receivables, net</a></td>
<td class="nump">$ 6,867<span></span>
</td>
<td class="nump">$ 17,763<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowanceForCreditLossPreReclassification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowanceForCreditLossPreReclassification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Schedule of Sales-related Allowances (Details) - Trade Accounts Receivable, Sales Related - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Payments / credits</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AccountsReceivableAllowanceForCreditLossReclassifications', window );">Reclassification into Accrued distribution expenses and sales-related allowances</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowanceForCreditLossReclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Reclassifications</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowanceForCreditLossReclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableSalesRelatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableSalesRelatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">65 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2026</div></th>
<th class="th"><div>Mar. 03, 2026</div></th>
<th class="th"><div>Aug. 13, 2025</div></th>
<th class="th"><div>Mar. 27, 2023</div></th>
<th class="th"><div>Mar. 02, 2023</div></th>
<th class="th"><div>Oct. 26, 2022</div></th>
<th class="th"><div>Sep. 26, 2022</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Oct. 23, 2020</div></th>
<th class="th"><div>May 21, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockSharesCommittedAggregateAmount', window );">Sale of Stock, Shares Committed, Aggregate Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate', window );">Sale of Stock, Share Commitment, Period following Effective Date (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=aqst_AssertioHoldingsIncMember', window );">Assertio Holdings, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Proceeds from collaborators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember', window );">License and royalty revenue a</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,395<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_RTWInvestmentsLPMember', window );">RTW Investments LP | Purchase And Sale Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests', window );">Exchange for the Purchaser&#8217;s payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CollaborativeArrangementRevenueSharingPercentage', window );">Revenue sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen', window );">Revenue share payments year ten</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter', window );">Revenue share payments thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CapitalizedLegalFees', window );">Capitalized Legal Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_RTWInvestmentsLPMember', window );">RTW Investments LP | Purchase And Sale Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CollaborativeArrangementRevenueSharingPercentage', window );">Revenue sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_RTWInvestmentsLPMember', window );">RTW Investments LP | Purchase And Sale Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CollaborativeArrangementRevenueSharingPercentage', window );">Revenue sharing percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_RTWInvestmentsLPMember', window );">RTW Investments LP | Purchase And Sale Agreement | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember', window );">Commercial exploitation agreement with Indivior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LicenseAgreementTerm', window );">License agreement term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AutomaticRenewalPeriodOfAgreement', window );">Automatic renewal period of agreement (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember', window );">License agreement with Sunovion Pharmaceuticals, Inc. upfront</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember', window );">License agreement with Sunovion Pharmaceuticals, Inc milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember', window );">License agreement with Sunovion Pharmaceuticals, Inc milestones | License and royalty revenue a</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember', window );">MAM Pangolin Royalty , LLC | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember', window );">MAM Pangolin Royalty , LLC | Monetization Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet', window );">Additional proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ContingentMonetizationAgreementMilestonePayment', window );">Proceeds from debt, contingent on additional milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_ZevraAndCommaveTherapeuticsAgreementMember', window );">Zevra And Commave Therapeutics Agreement | License and royalty revenue a</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_ZevraAndCommaveTherapeuticsAgreementMember', window );">Zevra And Commave Therapeutics Agreement | License and royalty revenue a | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedMember', window );">Atnahs Pharma UK Limited | License &amp; Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedAmendedAgreementMember', window );">Atnahs Pharma UK Limited, Amended Agreement | License &amp; Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Proceeds From Sale of Future Revenues, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AutomaticRenewalPeriodOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for which the agreement is renewed automatically.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AutomaticRenewalPeriodOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CapitalizedLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Legal Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CapitalizedLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Estimated Revenue Share Payments upon Purchaser&#8217;s Receipt, Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated Revenue Share Payments Upon Purchaser&#8217;s Receipt, Year Ten</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CollaborativeArrangementRevenueSharingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Revenue Sharing Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CollaborativeArrangementRevenueSharingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consideration Receivable From Sale Of Future Revenues Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ContingentMonetizationAgreementMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Monetization Agreement, Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ContingentMonetizationAgreementMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement term period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ProceedsFromSaleOfFutureRevenuesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale of Future Revenues, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ProceedsFromSaleOfFutureRevenuesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Share Commitment, Period following Effective Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfStockSharesCommittedAggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Shares Committed, Aggregate Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfStockSharesCommittedAggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=aqst_AssertioHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=aqst_AssertioHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_RTWInvestmentsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_RTWInvestmentsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_PurchaseAndSaleAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_PurchaseAndSaleAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_ZevraAndCommaveTherapeuticsAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_ZevraAndCommaveTherapeuticsAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_LicenseSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_LicenseSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedAmendedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedAmendedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments &#8211; Fair Value Measurements (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 01, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 03, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationTerm', window );">Royalty payment term (in years)</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,874<span></span>
</td>
<td class="nump">$ 916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationPercentOfNetSales', window );">Royalty interest percent interest (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationPercentOfNetSales', window );">Royalty interest percent interest (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember', window );">Existing Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember', window );">New Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember', window );">Common Stock Warrants | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_SecuritiesPurchaseAgreementMember', window );">Securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants', window );">Shares of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants', window );">Shares of common stock in connection with securities purchase agreements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyObligationPercentOfNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligation, Percent Of Net Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyObligationPercentOfNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyObligationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligation, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyObligationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of Common Stock to be Purchased by Common Stock Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw material</a></td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 3,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InventoryPackingMaterialGross', window );">Packaging material</a></td>
<td class="nump">2,521<span></span>
</td>
<td class="nump">2,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,225<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 8,066<span></span>
</td>
<td class="nump">$ 6,169<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InventoryPackingMaterialGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of packaging materials expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InventoryPackingMaterialGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 47,966<span></span>
</td>
<td class="nump">$ 47,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(44,127)<span></span>
</td>
<td class="num">(44,021)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">3,839<span></span>
</td>
<td class="nump">3,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 20,383<span></span>
</td>
<td class="nump">20,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 769<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 21,419<span></span>
</td>
<td class="nump">21,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, network equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 3,140<span></span>
</td>
<td class="nump">3,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, network equipment and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, network equipment and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,255<span></span>
</td>
<td class="nump">$ 2,203<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_NumberOfOperatingLeases', window );">Number of leases | lease</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Estimated discount rate (as a percent)</a></td>
<td class="nump">14.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term (in years)</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Estimated discount rate (as a percent)</a></td>
<td class="nump">15.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations - Schedule of Operating Lease Liabilities Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2026</a></td>
<td class="nump">$ 991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2027</a></td>
<td class="nump">1,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2028</a></td>
<td class="nump">1,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2029</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter', window );">2030 and thereafter</a></td>
<td class="nump">2,915<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">7,432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(2,611)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 4,821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Non-current Assets - Schedule of Other Non-Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CumulativeRoyaltyReceivable', window );">Royalty receivable</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">635<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other non-current assets</a></td>
<td class="nump">$ 2,635<span></span>
</td>
<td class="nump">$ 2,642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CumulativeRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CumulativeRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-current Assets - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Asset, Acquired, Finite-Lived [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_NumberOfGuaranteedRoyaltyPayments', window );">Number of guaranteed royalty payments | payment</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Asset, Acquired, Finite-Lived [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_MinimumAnnualRoyaltyReceivable', window );">Minimum annual royalty receivable</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_NumberOfAnnualRoyaltyPaymentsReceivable', window );">Number of annual royalty payments receivable | payment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Asset, Acquired, Finite-Lived [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty | License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Asset, Acquired, Finite-Lived [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MinimumAnnualRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MinimumAnnualRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfAnnualRoyaltyPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of annual royalty payments receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfAnnualRoyaltyPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfGuaranteedRoyaltyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Guaranteed Royalty Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfGuaranteedRoyaltyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 805<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478072/944-805-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 2,069<span></span>
</td>
<td class="nump">$ 3,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Real estate and personal property taxes</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 3,449<span></span>
</td>
<td class="nump">$ 5,029<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 12, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jul. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm', window );">Royalty obligation, term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationsGross', window );">Royalty Obligations, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,886,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationPercentOfNetSales', window );">Royalty interest percent interest (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationPercentOfNetSales', window );">Royalty interest percent interest (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Redemption Scenario 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate', window );">Debt instrument, redemption price, basis points above treasury rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,254,000<span></span>
</td>
<td class="nump">$ 1,254,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Repurchase price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective annual interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.64%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Number of equity instruments | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes | Redemption Scenario 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Repurchase price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt instrument, redemption price, percentage of principal amount redeemed (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes | Redemption Scenario 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Repurchase price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentExitFee', window );">Debt instrument, exit fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,856,000<span></span>
</td>
<td class="nump">$ 13,856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount (premium), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred debt issuance cost and deferred debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,498,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,972,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_ABLFacilityMember', window );">ABL Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold', window );">Line of credit facility, accordion feature, net revenue threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Line of credit facility, accordion feature, increase limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TermLoanFacilityMember', window );">Term Loan Facility | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TermLoanFacilityMember', window );">Term Loan Facility | Line of Credit | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyRightAgreementsMember', window );">Royalty Right Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 973,000<span></span>
</td>
<td class="nump">$ 1,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Tiered Royalty Percentage, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentExitFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Exit Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentExitFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Price, Basis Spread On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Net Revenue Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyObligationPercentOfNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligation, Percent Of Net Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyObligationPercentOfNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyObligationsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligations, Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyObligationsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_ABLFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_ABLFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyRightAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_RoyaltyRightAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule Of Royalty Right Agreements (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyAgreementMeasurementInput', window );">Royalty rights agreement, measurement input (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=aqst_MeasurementInputProbabilityOfSuccessMember', window );">Measurement Input, Probability Of Success</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyAgreementMeasurementInput', window );">Royalty rights agreement, measurement input (as a percent)</a></td>
<td class="nump">95.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyAgreementMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Agreement, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyAgreementMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=aqst_MeasurementInputProbabilityOfSuccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=aqst_MeasurementInputProbabilityOfSuccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable, net</a></td>
<td class="nump">$ 25,099<span></span>
</td>
<td class="nump">$ 27,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Outstanding notes/Total Royalty obligations</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount, including Exit Fee</a></td>
<td class="num">(6,376)<span></span>
</td>
<td class="num">(7,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Notes payable, current</a></td>
<td class="num">(13,630)<span></span>
</td>
<td class="num">(9,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Notes payable, long-term</a></td>
<td class="nump">24,994<span></span>
</td>
<td class="nump">27,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable, net</a></td>
<td class="nump">25,099<span></span>
</td>
<td class="nump">27,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Outstanding notes/Total Royalty obligations</a></td>
<td class="nump">51,886<span></span>
</td>
<td class="nump">51,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount, including Exit Fee</a></td>
<td class="num">(24,972)<span></span>
</td>
<td class="num">(25,945)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Notes payable, long-term</a></td>
<td class="nump">$ 26,914<span></span>
</td>
<td class="nump">$ 25,941<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Debt Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2026</a></td>
<td class="nump">$ 9,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2027</a></td>
<td class="nump">14,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2028</a></td>
<td class="nump">20,925<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 45,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 14, 2023</div></th>
<th class="th"><div>Jul. 15, 2019</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 03, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Nov. 01, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsExercised', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued', window );">Fair value of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_A2020AdditionalNotesMember', window );">2020 Additional Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued', window );">Fair value of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,850,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="nump">3,689,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
<td class="nump">$ 3,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember', window );">Common Stock Warrants | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_FirstAdditionalWarrantOfferingMember', window );">First Additional Warrant Offering | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_PreFundedWarrantsMember', window );">Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember', window );">Existing Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember', window );">New Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsExercised', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of fair value of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ClassOfWarrantOrRightWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of class of warrant or right exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ClassOfWarrantOrRightWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_A2020AdditionalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_A2020AdditionalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_FirstAdditionalWarrantOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_FirstAdditionalWarrantOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">65 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,446<span></span>
</td>
<td class="nump">$ 8,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember', window );">MAM Pangolin Royalty , LLC | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_MinimumAnnualRoyaltyReceivable', window );">Minimum annual royalty receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc. | Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember', window );">Monetization Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments for loan acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective annual interest rate (as a percent)</a></td>
<td class="nump">24.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember', window );">Monetization Agreement | MAM Pangolin Royalty , LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ContingentMonetizationAgreementMilestonePayment', window );">Proceeds from debt, contingent on additional milestones</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ContingentMonetizationAgreementMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Monetization Agreement, Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ContingentMonetizationAgreementMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MinimumAnnualRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MinimumAnnualRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ProceedsFromSaleOfFutureRevenuesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale of Future Revenues, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ProceedsFromSaleOfFutureRevenuesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue - Schedule of Royalty Obligation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfFutureRevenueRollForward', window );"><strong>Sale of Future Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LiabilitiesSaleOfFutureRoyalties', window );">Liability related to the sale of future revenue, net at beginning of the period</a></td>
<td class="nump">$ 63,023<span></span>
</td>
<td class="nump">$ 63,718<span></span>
</td>
<td class="nump">$ 63,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Royalties related to the sale of future revenue</a></td>
<td class="num">(14,446)<span></span>
</td>
<td class="num">$ (8,720)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of issuance costs</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LiabilitiesSaleOfFutureRoyalties', window );">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively)</a></td>
<td class="nump">63,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent', window );">Liability related to the sale of future revenue, current</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfFutureRevenueRollForward', window );"><strong>Sale of Future Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Royalties related to the sale of future revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (938)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LiabilitiesSaleOfFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities, Sale of Future Royalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LiabilitiesSaleOfFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities, Sale of Future Royalties, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfFutureRevenueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Future Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfFutureRevenueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Liabilities - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationDisclosureAbstract', window );"><strong>Asset Retirement Obligation Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligation</a></td>
<td class="nump">$ 2,072<span></span>
</td>
<td class="nump">$ 2,045<span></span>
</td>
<td class="nump">$ 2,065<span></span>
</td>
<td class="nump">$ 2,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AssetRetirementObligationsDepreciationExpense', window );">Depreciation expense related to ARO</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AssetRetirementObligationsDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation expense of asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AssetRetirementObligationsDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481999/410-20-25-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Liabilities - Schedule of Liability for Asset Retirement Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward', window );"><strong>Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Balance at beginning of period</a></td>
<td class="nump">$ 2,065<span></span>
</td>
<td class="nump">$ 2,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationLiabilitiesIncurred', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Balance at ending of period</a></td>
<td class="nump">$ 2,072<span></span>
</td>
<td class="nump">$ 2,045<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481999/410-20-25-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481879/410-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset retirement obligations incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (8,057)<span></span>
</td>
<td class="num">$ (22,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares &#8211; basic (in shares)</a></td>
<td class="nump">122,609,995<span></span>
</td>
<td class="nump">95,497,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares &#8211; diluted (in shares)</a></td>
<td class="nump">122,609,995<span></span>
</td>
<td class="nump">95,497,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per common share &#8211; basic (in dollars per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per common share &#8211; diluted (in dollars per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">7,501,729<span></span>
</td>
<td class="nump">6,977,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">4,566,190<span></span>
</td>
<td class="nump">5,167,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants on common shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">2,735,548<span></span>
</td>
<td class="nump">4,594,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Share-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 2,318<span></span>
</td>
<td class="nump">$ 1,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">1,655<span></span>
</td>
<td class="nump">1,102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">663<span></span>
</td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember', window );">Manufacture and supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 2,013<span></span>
</td>
<td class="nump">$ 1,157<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Restricted Stock Units Awards (Details) - Restricted stock units<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Service Based</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at beginning of period (in shares) | shares</a></td>
<td class="nump">2,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1,125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at end of period (in shares) | shares</a></td>
<td class="nump">2,839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares', window );">Expected to vest at end of period (in shares) | shares</a></td>
<td class="nump">2,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">4.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">2.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">4.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">4.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue', window );">Expected to vest at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Market Based</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at beginning of period (in shares) | shares</a></td>
<td class="nump">1,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at end of period (in shares) | shares</a></td>
<td class="nump">1,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares', window );">Expected to vest at end of period (in shares) | shares</a></td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">2.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue', window );">Expected to vest at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_ServiceBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_ServiceBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_MarketBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_MarketBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($) </div>
<div>pricing_period </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=aqst_A2022InducementEquityIncentivePlanMember', window );">2022 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares) | shares</a></td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">150.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Three | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 1.76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">50.01%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Three | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">99.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Four</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Five | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 2.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">100.01%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Five | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">149.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Six</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">150.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Service Based</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs of RSU awards | $</a></td>
<td class="nump">$ 8,931<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period (in years)</a></td>
<td class="text">2 years 2 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Based</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs of RSU awards | $</a></td>
<td class="nump">$ 1,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period (in years)</a></td>
<td class="text">9 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod', window );">Average closing prices period (in days)</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | 2022 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod', window );">Average closing prices period (in days)</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods', window );">Number of pricing periods | pricing_period</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod', window );">Average closing price, number of days utilized in pricing period (in days)</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Vesting Condition Range Seven</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 6.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Vesting Condition Range Eight</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 6.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Vesting Condition Range Ten</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 7.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Vesting Condition Range Twelve</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 8.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">150.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Minimum | Vesting Condition Range Nine</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 6.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">50.01%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Minimum | Vesting Condition Range Eleven</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 7.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">100.01%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">150.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Maximum | Vesting Condition Range Nine</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 7.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">99.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | 2025 Market Based | Maximum | Vesting Condition Range Eleven</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 8.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights (as a percent)</a></td>
<td class="nump">149.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period (in years)</a></td>
<td class="text">2 years 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 3.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 4.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to non-vested stock options | $</a></td>
<td class="nump">$ 5,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | 2022 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Days Utilized in Pricing Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Pricing Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_A2022InducementEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_A2022InducementEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MarketConditionsAxis=aqst_MarketConditionRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MarketConditionsAxis=aqst_MarketConditionRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MarketConditionsAxis=aqst_MarketConditionRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MarketConditionsAxis=aqst_MarketConditionRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MarketConditionsAxis=aqst_MarketConditionRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MarketConditionsAxis=aqst_MarketConditionRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MarketConditionsAxis=aqst_MarketConditionRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MarketConditionsAxis=aqst_MarketConditionRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MarketConditionsAxis=aqst_MarketConditionRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MarketConditionsAxis=aqst_MarketConditionRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MarketConditionsAxis=aqst_MarketConditionRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MarketConditionsAxis=aqst_MarketConditionRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_ServiceBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_ServiceBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_MarketBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_MarketBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_A2025MarketBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_A2025MarketBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeTwelveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeTwelveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price at grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Valuation Technique, Black-Scholes-Merton Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_BlackScholesMertonModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_BlackScholesMertonModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Stock Option Activity (Details) - Stock options<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2026 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">6,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod', window );">Forfeited/expired (in shares) | shares</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares) | shares</a></td>
<td class="nump">7,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested or expected to vest at end of period (in shares) | shares</a></td>
<td class="nump">7,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares) | shares</a></td>
<td class="nump">5,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">4.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">0.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited/expired (in dollars per share) | $ / shares</a></td>
<td class="nump">3.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">5.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested or expected to vest at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">5.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either exercised, forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes (benefit) expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net (loss)/income before income taxes</a></td>
<td class="num">$ (8,057)<span></span>
</td>
<td class="num">$ (22,930)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Details) - Suboxone Produce Liability Litigation - pending_case<br></strong></div></th>
<th class="th"><div>Oct. 15, 2024</div></th>
<th class="th"><div>Feb. 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember', window );">BRITISH COLUMBIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA-BC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA-BC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 12, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 08, 2026 </div>
<div>renewal_option</div>
</th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th">
<div>Nov. 01, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Initial term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod', window );">Initial rent abatement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of renewal options | renewal_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, operating lease, renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Term Loan Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Term Loan Facility | Line of Credit | Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit', window );">Potential increase in available borrowing capacity upon pre determined achievement of milestones</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Term Loan Facility | Line of Credit | Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit', window );">Potential increase in available borrowing capacity upon pre determined achievement of milestones</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Term Loan Facility | Line of Credit | Tranche Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit', window );">Potential increase in available borrowing capacity upon pre determined achievement of milestones</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | 13.5% Senior Secured Notes due November 1, 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="nump">$ 45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LesseeOperatingLeaseInitialRentAbatementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Initial Rent Abatement Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LesseeOperatingLeaseInitialRentAbatementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Available Borrowing Capacity, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentMilestoneTranchesAxis=aqst_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentMilestoneTranchesAxis=aqst_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentMilestoneTranchesAxis=aqst_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentMilestoneTranchesAxis=aqst_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentMilestoneTranchesAxis=aqst_TrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentMilestoneTranchesAxis=aqst_TrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>252</ContextCount>
  <ElementCount>329</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>102</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedBalanceSheets</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Statements of Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit</Role>
      <ShortName>Condensed Statements of Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedStatementsofCashFlows</Role>
      <ShortName>Condensed Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - Company Overview and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CompanyOverviewandBasisofPresentation</Role>
      <ShortName>Company Overview and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RisksandUncertainties</Role>
      <ShortName>Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Revenues and Trade Receivables, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNet</Role>
      <ShortName>Revenues and Trade Receivables, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Material Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreements</Role>
      <ShortName>Material Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Financial Instruments ??? Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements</Role>
      <ShortName>Financial Instruments ??? Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Inventories, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesNet</Role>
      <ShortName>Inventories, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Right-of-Use Assets and Lease Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligations</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Other Non-current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssets</Role>
      <ShortName>Other Non-current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Sale of Future Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenue</Role>
      <ShortName>Sale of Future Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Other Non-Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNonCurrentLiabilities</Role>
      <ShortName>Other Non-Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9952175 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9952176 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://aquestive.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/SegmentReporting</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Revenues and Trade Receivables, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetTables</Role>
      <ShortName>Revenues and Trade Receivables, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/RevenuesandTradeReceivablesNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Inventories, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesNetTables</Role>
      <ShortName>Inventories, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/InventoriesNet</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/RightofUseAssetsandLeaseObligations</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Other Non-current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssetsTables</Role>
      <ShortName>Other Non-current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/OtherNoncurrentAssets</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/AccruedExpenses</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/LongTermDebt</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Sale of Future Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenueTables</Role>
      <ShortName>Sale of Future Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/SaleofFutureRevenue</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Other Non-Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNonCurrentLiabilitiesTables</Role>
      <ShortName>Other Non-Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/OtherNonCurrentLiabilities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/NetLossPerShare</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/ShareBasedCompensation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Company Overview and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails</Role>
      <ShortName>Company Overview and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/CompanyOverviewandBasisofPresentation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Risks and Uncertainties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RisksandUncertaintiesDetails</Role>
      <ShortName>Risks and Uncertainties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/RisksandUncertainties</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails</Role>
      <ShortName>Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Revenues and Trade Receivables, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Schedule of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Schedule of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Trade and Other Receivables, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Schedule of Trade and Other Receivables, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Sales-related Allowances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Schedule of Sales-related Allowances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Material Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreementsDetails</Role>
      <ShortName>Material Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/MaterialAgreements</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Financial Instruments ??? Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails</Role>
      <ShortName>Financial Instruments ??? Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Inventories, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesNetDetails</Role>
      <ShortName>Inventories, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/InventoriesNetTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Property and Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property and Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Right-of-Use Assets and Lease Obligations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Right-of-Use Assets and Lease Obligations - Schedule of Operating Lease Liabilities Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations - Schedule of Operating Lease Liabilities Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Other Non-current Assets - Schedule of Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails</Role>
      <ShortName>Other Non-current Assets - Schedule of Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Other Non-current Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails</Role>
      <ShortName>Other Non-current Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/AccruedExpensesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Long-Term Debt - Schedule Of Royalty Right Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails</Role>
      <ShortName>Long-Term Debt - Schedule Of Royalty Right Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Long-Term Debt - Schedule of Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/WarrantsDetails</Role>
      <ShortName>Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/Warrants</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Sale of Future Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails</Role>
      <ShortName>Sale of Future Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Sale of Future Revenue - Schedule of Royalty Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails</Role>
      <ShortName>Sale of Future Revenue - Schedule of Royalty Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Other Non-Current Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNonCurrentLiabilitiesNarrativeDetails</Role>
      <ShortName>Other Non-Current Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Other Non-Current Liabilities - Schedule of Liability for Asset Retirement Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails</Role>
      <ShortName>Other Non-Current Liabilities - Schedule of Liability for Asset Retirement Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/NetLossPerShareTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Share-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Share-Based Compensation - Schedule of Restricted Stock Units Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Restricted Stock Units Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Share-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/IncomeTaxes</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ContingenciesDetails</Role>
      <ShortName>Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/Contingencies</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="aqst-20260331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/SubsequentEvents</ParentRole>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="aqst-20260331.htm">aqst-20260331.htm</File>
    <File>aqst-20260331.xsd</File>
    <File>aqst-20260331_cal.xml</File>
    <File>aqst-20260331_def.xml</File>
    <File>aqst-20260331_lab.xml</File>
    <File>aqst-20260331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="658">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>112
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aqst-20260331.htm": {
   "nsprefix": "aqst",
   "nsuri": "http://aquestive.com/20260331",
   "dts": {
    "inline": {
     "local": [
      "aqst-20260331.htm"
     ]
    },
    "schema": {
     "local": [
      "aqst-20260331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "aqst-20260331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aqst-20260331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "aqst-20260331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aqst-20260331_pre.xml"
     ]
    }
   },
   "keyStandard": 261,
   "keyCustom": 68,
   "axisStandard": 25,
   "axisCustom": 4,
   "memberStandard": 29,
   "memberCustom": 70,
   "hidden": {
    "total": 7,
    "http://fasb.org/us-gaap/2025": 2,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 252,
   "entityCount": 1,
   "segmentCount": 102,
   "elementCount": 674,
   "unitCount": 11,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 658,
    "http://xbrl.sec.gov/dei/2025": 29,
    "http://xbrl.sec.gov/ecd/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://aquestive.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://aquestive.com/role/CondensedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Balance Sheets",
     "shortName": "Condensed Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://aquestive.com/role/CondensedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Balance Sheets (Parenthetical)",
     "shortName": "Condensed Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Condensed Statements of Operations and Comprehensive Loss",
     "shortName": "Condensed Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseNonoperating",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
     "longName": "9952154 - Statement - Condensed Statements of Changes in Stockholders' Deficit",
     "shortName": "Condensed Statements of Changes in Stockholders' Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://aquestive.com/role/CondensedStatementsofCashFlows",
     "longName": "9952155 - Statement - Condensed Statements of Cash Flows",
     "shortName": "Condensed Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://aquestive.com/role/CompanyOverviewandBasisofPresentation",
     "longName": "9952156 - Disclosure - Company Overview and Basis of Presentation",
     "shortName": "Company Overview and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://aquestive.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952157 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://aquestive.com/role/RisksandUncertainties",
     "longName": "9952158 - Disclosure - Risks and Uncertainties",
     "shortName": "Risks and Uncertainties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://aquestive.com/role/SegmentReporting",
     "longName": "9952159 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNet",
     "longName": "9952160 - Disclosure - Revenues and Trade Receivables, Net",
     "shortName": "Revenues and Trade Receivables, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://aquestive.com/role/MaterialAgreements",
     "longName": "9952161 - Disclosure - Material Agreements",
     "shortName": "Material Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements",
     "longName": "9952162 - Disclosure - Financial Instruments \u2013 Fair Value Measurements",
     "shortName": "Financial Instruments \u2013 Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://aquestive.com/role/InventoriesNet",
     "longName": "9952163 - Disclosure - Inventories, Net",
     "shortName": "Inventories, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNet",
     "longName": "9952164 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligations",
     "longName": "9952165 - Disclosure - Right-of-Use Assets and Lease Obligations",
     "shortName": "Right-of-Use Assets and Lease Obligations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssets",
     "longName": "9952166 - Disclosure - Other Non-current Assets",
     "shortName": "Other Non-current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://aquestive.com/role/AccruedExpenses",
     "longName": "9952167 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://aquestive.com/role/LongTermDebt",
     "longName": "9952168 - Disclosure - Long-Term Debt",
     "shortName": "Long-Term Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://aquestive.com/role/Warrants",
     "longName": "9952169 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://aquestive.com/role/SaleofFutureRevenue",
     "longName": "9952170 - Disclosure - Sale of Future Revenue",
     "shortName": "Sale of Future Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:SaleOfFutureRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:SaleOfFutureRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://aquestive.com/role/OtherNonCurrentLiabilities",
     "longName": "9952171 - Disclosure - Other Non-Current Liabilities",
     "shortName": "Other Non-Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetRetirementObligationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetRetirementObligationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://aquestive.com/role/NetLossPerShare",
     "longName": "9952172 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://aquestive.com/role/ShareBasedCompensation",
     "longName": "9952173 - Disclosure - Share-Based Compensation",
     "shortName": "Share-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://aquestive.com/role/IncomeTaxes",
     "longName": "9952174 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://aquestive.com/role/Contingencies",
     "longName": "9952175 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://aquestive.com/role/SubsequentEvents",
     "longName": "9952176 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrAdoptedFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "ecd:NonRule10b51ArrAdoptedFlag",
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://aquestive.com/role/SegmentReportingTables",
     "longName": "9955512 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables",
     "longName": "9955513 - Disclosure - Revenues and Trade Receivables, Net (Tables)",
     "shortName": "Revenues and Trade Receivables, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://aquestive.com/role/InventoriesNetTables",
     "longName": "9955514 - Disclosure - Inventories, Net (Tables)",
     "shortName": "Inventories, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNetTables",
     "longName": "9955515 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables",
     "longName": "9955516 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)",
     "shortName": "Right-of-Use Assets and Lease Obligations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssetsTables",
     "longName": "9955517 - Disclosure - Other Non-current Assets (Tables)",
     "shortName": "Other Non-current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://aquestive.com/role/AccruedExpensesTables",
     "longName": "9955518 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://aquestive.com/role/LongTermDebtTables",
     "longName": "9955519 - Disclosure - Long-Term Debt (Tables)",
     "shortName": "Long-Term Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://aquestive.com/role/SaleofFutureRevenueTables",
     "longName": "9955520 - Disclosure - Sale of Future Revenue (Tables)",
     "shortName": "Sale of Future Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:RoyaltyObligationActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:RoyaltyObligationActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://aquestive.com/role/OtherNonCurrentLiabilitiesTables",
     "longName": "9955521 - Disclosure - Other Non-Current Liabilities (Tables)",
     "shortName": "Other Non-Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://aquestive.com/role/NetLossPerShareTables",
     "longName": "9955522 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://aquestive.com/role/ShareBasedCompensationTables",
     "longName": "9955523 - Disclosure - Share-Based Compensation (Tables)",
     "shortName": "Share-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
     "longName": "9955524 - Disclosure - Company Overview and Basis of Presentation (Details)",
     "shortName": "Company Overview and Basis of Presentation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-32",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-32",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://aquestive.com/role/RisksandUncertaintiesDetails",
     "longName": "9955525 - Disclosure - Risks and Uncertainties (Details)",
     "shortName": "Risks and Uncertainties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R44": {
     "role": "http://aquestive.com/role/SegmentReportingNarrativeDetails",
     "longName": "9955526 - Disclosure - Segment Reporting - Narrative (Details)",
     "shortName": "Segment Reporting - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails",
     "longName": "9955527 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)",
     "shortName": "Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-41",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
     "longName": "9955528 - Disclosure - Revenues and Trade Receivables, Net - Narrative (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
     "longName": "9955529 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Revenue (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Schedule of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-52",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails",
     "longName": "9955530 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Disaggregation of Revenue (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Schedule of Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-61",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails",
     "longName": "9955531 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Trade and Other Receivables, Net (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Schedule of Trade and Other Receivables, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails",
     "longName": "9955532 - Disclosure - Revenues and Trade Receivables, Net - Schedule of Sales-related Allowances (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Schedule of Sales-related Allowances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-67",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-68",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://aquestive.com/role/MaterialAgreementsDetails",
     "longName": "9955533 - Disclosure - Material Agreements (Details)",
     "shortName": "Material Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-93",
      "name": "aqst:SaleOfStockSharesCommittedAggregateAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
     "longName": "9955534 - Disclosure - Financial Instruments \u2013 Fair Value Measurements (Details)",
     "shortName": "Financial Instruments \u2013 Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-113",
      "name": "aqst:RoyaltyObligationTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://aquestive.com/role/InventoriesNetDetails",
     "longName": "9955535 - Disclosure - Inventories, Net (Details)",
     "shortName": "Inventories, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
     "longName": "9955536 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment (Details)",
     "shortName": "Property and Equipment, Net - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails",
     "longName": "9955537 - Disclosure - Property and Equipment, Net - Narrative (Details)",
     "shortName": "Property and Equipment, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
     "longName": "9955538 - Disclosure - Right-of-Use Assets and Lease Obligations - Narrative (Details)",
     "shortName": "Right-of-Use Assets and Lease Obligations - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "aqst:NumberOfOperatingLeases",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "aqst:NumberOfOperatingLeases",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails",
     "longName": "9955539 - Disclosure - Right-of-Use Assets and Lease Obligations - Schedule of Operating Lease Liabilities Maturities (Details)",
     "shortName": "Right-of-Use Assets and Lease Obligations - Schedule of Operating Lease Liabilities Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails",
     "longName": "9955540 - Disclosure - Other Non-current Assets - Schedule of Other Non-Current Assets (Details)",
     "shortName": "Other Non-current Assets - Schedule of Other Non-Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "aqst:CumulativeRoyaltyReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "aqst:CumulativeRoyaltyReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
     "longName": "9955541 - Disclosure - Other Non-current Assets - Narrative (Details)",
     "shortName": "Other Non-current Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:NumberOfGuaranteedRoyaltyPayments",
      "unitRef": "payment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://aquestive.com/role/AccruedExpensesDetails",
     "longName": "9955542 - Disclosure - Accrued Expenses (Details)",
     "shortName": "Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://aquestive.com/role/LongTermDebtNarrativeDetails",
     "longName": "9955543 - Disclosure - Long-Term Debt - Narrative (Details)",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RepaymentsOfDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-113",
      "name": "aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails",
     "longName": "9955544 - Disclosure - Long-Term Debt - Schedule Of Royalty Right Agreements (Details)",
     "shortName": "Long-Term Debt - Schedule Of Royalty Right Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-149",
      "name": "aqst:RoyaltyAgreementMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aqst:ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-149",
      "name": "aqst:RoyaltyAgreementMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aqst:ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
     "longName": "9955545 - Disclosure - Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)",
     "shortName": "Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtAndCapitalLeaseObligations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-40",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails",
     "longName": "9955546 - Disclosure - Long-Term Debt - Schedule of Debt Maturities (Details)",
     "shortName": "Long-Term Debt - Schedule of Debt Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://aquestive.com/role/WarrantsDetails",
     "longName": "9955547 - Disclosure - Warrants (Details)",
     "shortName": "Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
     "longName": "9955548 - Disclosure - Sale of Future Revenue - Narrative (Details)",
     "shortName": "Sale of Future Revenue - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-175",
      "name": "us-gaap:PaymentsOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails",
     "longName": "9955549 - Disclosure - Sale of Future Revenue - Schedule of Royalty Obligation (Details)",
     "shortName": "Sale of Future Revenue - Schedule of Royalty Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "aqst:LiabilitiesSaleOfFutureRoyalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aqst:RoyaltyObligationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aqst:RoyaltyObligationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://aquestive.com/role/OtherNonCurrentLiabilitiesNarrativeDetails",
     "longName": "9955550 - Disclosure - Other Non-Current Liabilities - Narrative (Details)",
     "shortName": "Other Non-Current Liabilities - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AssetRetirementObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:AssetRetirementObligationsDepreciationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails",
     "longName": "9955551 - Disclosure - Other Non-Current Liabilities - Schedule of Liability for Asset Retirement Obligations (Details)",
     "shortName": "Other Non-Current Liabilities - Schedule of Liability for Asset Retirement Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AssetRetirementObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetRetirementObligationLiabilitiesIncurred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://aquestive.com/role/NetLossPerShareDetails",
     "longName": "9955552 - Disclosure - Net Loss Per Share (Details)",
     "shortName": "Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-181",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
     "longName": "9955553 - Disclosure - Share-Based Compensation - Schedule of Share-Based Compensation Expense (Details)",
     "shortName": "Share-Based Compensation - Schedule of Share-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails",
     "longName": "9955554 - Disclosure - Share-Based Compensation - Schedule of Restricted Stock Units Awards (Details)",
     "shortName": "Share-Based Compensation - Schedule of Restricted Stock Units Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-197",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-197",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
     "longName": "9955555 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-244",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-244",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails",
     "longName": "9955556 - Disclosure - Share-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details)",
     "shortName": "Share-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-196",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-196",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
     "longName": "9955557 - Disclosure - Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "shortName": "Share-Based Compensation - Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-239",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-239",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://aquestive.com/role/IncomeTaxesDetails",
     "longName": "9955558 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://aquestive.com/role/ContingenciesDetails",
     "longName": "9955559 - Disclosure - Contingencies (Details)",
     "shortName": "Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-246",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "unitRef": "pending_case",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-246",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "unitRef": "pending_case",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://aquestive.com/role/SubsequentEventsDetails",
     "longName": "9955560 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RepaymentsOfDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-248",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20260331.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "aqst_A2020AdditionalNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "A2020AdditionalNotesMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2020 Additional Notes",
        "label": "2020 Additional Notes [Member]",
        "documentation": "2020 Additional Notes"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_A2022InducementEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "A2022InducementEquityIncentivePlanMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Inducement Equity Incentive Plan",
        "label": "2022 Inducement Equity Incentive Plan [Member]",
        "documentation": "2022 Inducement Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_A2025MarketBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "A2025MarketBasedMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025 Market Based",
        "label": "2025 Market Based [Member]",
        "documentation": "2025 Market Based"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ABLFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ABLFacilityMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ABL Facility",
        "label": "ABL Facility [Member]",
        "documentation": "ABL Facility"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AQST108Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AQST108Member",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AQST-108 project expenses",
        "label": "AQST-108 [Member]",
        "documentation": "AQST-108"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r964"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable Type [Axis]",
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r48"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/AccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r31",
      "r37",
      "r1011"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r758"
     ]
    },
    "aqst_AccountsReceivableAllowanceForCreditLossPreReclassification": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AccountsReceivableAllowanceForCreditLossPreReclassification",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails": {
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: sales-related allowances",
        "label": "Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification",
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AccountsReceivableAllowanceForCreditLossReclassifications": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AccountsReceivableAllowanceForCreditLossReclassifications",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification into Accrued distribution expenses and sales-related allowances",
        "label": "Accounts Receivable, Allowance for Credit Loss, Reclassifications",
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Reclassifications"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails": {
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reclassification into Accrued distribution expenses and sales-related allowances",
        "label": "Accounts Receivable Allowances and Accruals - Trade and Other Receivables, Net",
        "documentation": "For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails": {
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r220",
      "r221",
      "r462",
      "r1046"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r670",
      "r955"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://aquestive.com/role/AccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesDetails",
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r108",
      "r554"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Asset, Acquired, Finite-Lived [Line Items]",
        "label": "Intangible Asset, Acquired, Finite-Lived [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r592",
      "r683"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r825"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r758",
      "r1078"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r599",
      "r947",
      "r948",
      "r949",
      "r950",
      "r1018",
      "r1080"
     ]
    },
    "aqst_AdditionalProceedsFromSaleOfFutureRevenuesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AdditionalProceedsFromSaleOfFutureRevenuesNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional proceeds from sale of future revenue",
        "label": "Additional Proceeds From Sale of Future Revenues, Net",
        "documentation": "Additional Proceeds From Sale of Future Revenues, Net"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "aqst_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of warrants issued",
        "label": "Adjustments to Additional Paid in Capital, Fair Value of Warrants Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of fair value of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Costs of common stock issued under public equity offering-ATM",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r75"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used for operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r807",
      "r817",
      "r849"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r800",
      "r810",
      "r820",
      "r852"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r845",
      "r853",
      "r857",
      "r865"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation expenses",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r394",
      "r395"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for credit loss",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "terseLabel": "Accrued distribution expenses and sales returns provision",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r222",
      "r226",
      "r227",
      "r230",
      "r1046"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments / credits",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AmendedEquityDistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AmendedEquityDistributionAgreementMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended Equity Distribution Agreement",
        "label": "Amended Equity Distribution Agreement [Member]",
        "documentation": "Amended Equity Distribution Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt discount (premium)",
        "label": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r58",
      "r307",
      "r1030"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r307",
      "r938",
      "r1030"
     ]
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs and discounts",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r725",
      "r726",
      "r938",
      "r1030"
     ]
    },
    "aqst_AnaphylmMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AnaphylmMember",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anaphylm project expenses",
        "label": "Anaphylm [Member]",
        "documentation": "Anaphylm"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "aqst_AssertioHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AssertioHoldingsIncMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assertio",
        "terseLabel": "Assertio Holdings, Inc",
        "label": "Assertio Holdings, Inc [Member]",
        "documentation": "Assertio Holdings, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetRetirementObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligation",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/OtherNonCurrentLiabilitiesNarrativeDetails",
      "http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset retirement obligation",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at ending of period",
        "label": "Asset Retirement Obligation",
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r260"
     ]
    },
    "us-gaap_AssetRetirementObligationAccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligationAccretionExpense",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion",
        "label": "Asset Retirement Obligation, Accretion Expense",
        "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r258",
      "r262"
     ]
    },
    "us-gaap_AssetRetirementObligationDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligationDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Retirement Obligation Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetRetirementObligationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligationDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/OtherNonCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Non-Current Liabilities",
        "label": "Asset Retirement Obligation Disclosure [Text Block]",
        "documentation": "The entire disclosure for an asset retirement obligation and the associated long-lived asset. An asset retirement obligation is a legal obligation associated with the disposal or retirement from service of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r256",
      "r259"
     ]
    },
    "us-gaap_AssetRetirementObligationLiabilitiesIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligationLiabilitiesIncurred",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Asset Retirement Obligation, Liabilities Incurred",
        "documentation": "Amount of asset retirement obligations incurred during the period."
       }
      }
     },
     "auth_ref": [
      "r261"
     ]
    },
    "us-gaap_AssetRetirementObligationRollForwardAnalysisRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligationRollForwardAnalysisRollForward",
     "presentation": [
      "http://aquestive.com/role/OtherNonCurrentLiabilitiesScheduleofLiabilityforAssetRetirementObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]",
        "label": "Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AssetRetirementObligationsDepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AssetRetirementObligationsDepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/OtherNonCurrentLiabilitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation expense related to ARO",
        "label": "Asset Retirement Obligations Depreciation Expense",
        "documentation": "Depreciation expense of asset retirement obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r110",
      "r140",
      "r143",
      "r144",
      "r179",
      "r190",
      "r208",
      "r212",
      "r223",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r425",
      "r427",
      "r468",
      "r540",
      "r541",
      "r548",
      "r627",
      "r714",
      "r715",
      "r727",
      "r758",
      "r775",
      "r776",
      "r788",
      "r977",
      "r978",
      "r1035"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r116",
      "r140",
      "r143",
      "r144",
      "r223",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r425",
      "r427",
      "r468",
      "r758",
      "r977",
      "r978",
      "r1035"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Public Equity Offering - ATM",
        "terseLabel": "At-the-market offering",
        "label": "At The Market Offering [Member]",
        "documentation": "At The Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AtnahsPharmaUKLimitedAmendedAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AtnahsPharmaUKLimitedAmendedAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Atnahs Pharma UK Limited, Amended Agreement",
        "label": "Atnahs Pharma UK Limited, Amended Agreement [Member]",
        "documentation": "Atnahs Pharma UK Limited, Amended Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AtnahsPharmaUKLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AtnahsPharmaUKLimitedMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Atnahs Pharma UK Limited",
        "label": "Atnahs Pharma UK Limited [Member]",
        "documentation": "Atnahs Pharma UK Limited"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AutomaticRenewalPeriodOfAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "AutomaticRenewalPeriodOfAgreement",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Automatic renewal period of agreement (in years)",
        "label": "Automatic Renewal Period of Agreement",
        "documentation": "Period for which the agreement is renewed automatically."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_BlackScholesMertonModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BlackScholesMertonModelMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Technique, Black-Scholes-Merton Model",
        "label": "Valuation Technique, Black-Scholes-Merton Model [Member]",
        "documentation": "Valuation technique estimating price of option using Black-Scholes-Merton model."
       }
      }
     },
     "auth_ref": [
      "r689",
      "r753",
      "r875",
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "stpr_CA-BC": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2025",
     "localname": "CA-BC",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BRITISH COLUMBIA",
        "label": "BRITISH COLUMBIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedContractCostNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalizedContractCostNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized contract cost, net",
        "label": "Capitalized Contract Cost, Net",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "aqst_CapitalizedLegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CapitalizedLegalFees",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized Legal Fees",
        "label": "Capitalized Legal Fees",
        "documentation": "Capitalized Legal Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r106",
      "r690"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r62",
      "r137"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r62"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant exercise price (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r146",
      "r327"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of warrant or right, outstanding (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Table]",
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "aqst_ClassOfWarrantOrRightWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ClassOfWarrantOrRightWarrantsExercised",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in shares)",
        "label": "Class of Warrant or Right, Warrants Exercised",
        "documentation": "The number of class of warrant or right exercised."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ClassOfWarrantOrRightWarrantsIssuedDuringPeriod",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued to purchase common stock (in shares)",
        "label": "Class Of Warrant Or Right Warrants Issued During Period",
        "documentation": "The number of warrants issued during the period."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_CoDevelopmentAndResearchFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CoDevelopmentAndResearchFeesMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-development and research fees",
        "label": "Co-Development and Research Fees [Member]",
        "documentation": "The aggregate revenue generated from Co-development and research fees."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r422",
      "r423"
     ]
    },
    "aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue share payments thereafter",
        "label": "Collaborative Arrangement, Estimated Revenue Share Payments upon Purchaser\u2019s Receipt, Thereafter",
        "documentation": "Collaborative Arrangement, Estimated Revenue Share Payments upon Purchaser\u2019s Receipt, Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue share payments year ten",
        "label": "Collaborative Arrangement, Estimated Revenue Share Payments Upon Purchaser\u2019s Receipt, Year Ten",
        "documentation": "Estimated Revenue Share Payments Upon Purchaser\u2019s Receipt, Year Ten"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_CollaborativeArrangementRevenueSharingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CollaborativeArrangementRevenueSharingPercentage",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue sharing percentage",
        "label": "Collaborative Arrangement, Revenue Sharing Percentage",
        "documentation": "Collaborative Arrangement, Revenue Sharing Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "aqst_CommercialExploitationAgreementWithIndiviorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CommercialExploitationAgreementWithIndiviorMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial exploitation agreement with Indivior",
        "label": "Commercial Exploitation Agreement with Indivior [Member]",
        "documentation": "The commercial exploitation agreement with Indivior."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies (Note 20)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r82",
      "r550",
      "r614"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r266",
      "r267",
      "r671",
      "r966",
      "r971"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r778",
      "r779",
      "r780",
      "r782",
      "r783",
      "r784",
      "r785",
      "r947",
      "r948",
      "r950",
      "r1018",
      "r1077",
      "r1080"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r615"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r41",
      "r615",
      "r633",
      "r1080",
      "r1081"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.001 par value. Authorized $250,000,000 shares; 124,284,542 and 122,044,299 shares issued and outstanding at March\u00a031, 2026 and December\u00a031, 2025, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r319",
      "r324",
      "r551",
      "r758"
     ]
    },
    "aqst_CommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CommonStockWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Warrants",
        "label": "Common Stock Warrants [Member]",
        "documentation": "Common Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r118",
      "r120",
      "r125",
      "r538",
      "r559",
      "r560"
     ]
    },
    "aqst_ComputerNetworkEquipmentAndSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ComputerNetworkEquipmentAndSoftwareMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer, network equipment and software",
        "label": "Computer, Network Equipment and Software [Member]",
        "documentation": "Assets which are related to computer, network equipment and software."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r219",
      "r593",
      "r594",
      "r670",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r219",
      "r593",
      "r594",
      "r670",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r219",
      "r593",
      "r594",
      "r670",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/RisksandUncertainties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks and Uncertainties",
        "label": "Concentration Risk Disclosure [Text Block]",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r184",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r707",
      "r953"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r670",
      "r706",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of risk (as a percent)",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r219",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r670",
      "r706",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r219",
      "r593",
      "r594",
      "r670",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958"
     ]
    },
    "aqst_ConsiderationReceivableFromSaleOfFutureRevenuesInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ConsiderationReceivableFromSaleOfFutureRevenuesInterests",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange for the Purchaser\u2019s payment",
        "label": "Consideration Receivable From Sale Of Future Revenues Interests",
        "documentation": "Consideration Receivable From Sale Of Future Revenues Interests"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ContingentMonetizationAgreementMilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ContingentMonetizationAgreementMilestonePayment",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from debt, contingent on additional milestones",
        "label": "Contingent Monetization Agreement, Milestone Payment",
        "documentation": "Contingent Monetization Agreement, Milestone Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current and non-current contract assets",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r331",
      "r333",
      "r352"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r333",
      "r352"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, current",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r333",
      "r352"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, net of current portion",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r333",
      "r352"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacture and supply",
        "verboseLabel": "Total Manufacture and Supply Expenses",
        "label": "Cost of Product and Service Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54",
      "r502",
      "r696",
      "r704",
      "r744",
      "r929"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSoldAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfGoodsAndServicesSoldAbstract",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and expenses:",
        "label": "Cost of Product and Service Sold [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "aqst_CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs associated with public offering-ATM in Accounts Payable",
        "label": "Costs Associated with At-the-Market Public Equity Offering in Accounts Payable",
        "documentation": "Costs Associated with At-the-Market Public Equity Offering in Accounts Payable"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r140",
      "r148",
      "r149",
      "r289",
      "r326",
      "r494",
      "r500",
      "r547",
      "r692",
      "r693",
      "r694",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r976"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r976"
     ]
    },
    "aqst_CumulativeRoyaltyReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "CumulativeRoyaltyReceivable",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty receivable",
        "label": "Cumulative Royalty Receivable",
        "documentation": "Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer concentration risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r955"
     ]
    },
    "aqst_DebtCovenantRedemptionScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "DebtCovenantRedemptionScenarioAxis",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Covenant, Redemption Scenario [Axis]",
        "label": "Debt Covenant, Redemption Scenario [Axis]",
        "documentation": "Debt Covenant, Redemption Scenario"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtCovenantRedemptionScenarioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "DebtCovenantRedemptionScenarioDomain",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Covenant, Redemption Scenario [Domain]",
        "label": "Debt Covenant, Redemption Scenario [Domain]",
        "documentation": "Debt Covenant, Redemption Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r140",
      "r142",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r274",
      "r275",
      "r285",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r301",
      "r308",
      "r309",
      "r311",
      "r433",
      "r480"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/SubsequentEventsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r30",
      "r31",
      "r80",
      "r81",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r755",
      "r941",
      "r942",
      "r943",
      "r946",
      "r967",
      "r968",
      "r969",
      "r1029",
      "r1031",
      "r1044"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Outstanding notes/Total Royalty obligations",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r81",
      "r312"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of equity instruments",
        "label": "Debt Instrument, Convertible, Number of Equity Instruments",
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r34",
      "r73",
      "r74",
      "r288"
     ]
    },
    "aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "DebtInstrumentCovenantTieredRoyaltyPercentageTerm",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty obligation, term (in years)",
        "label": "Debt Instrument, Covenant, Tiered Royalty Percentage, Term",
        "documentation": "Debt Instrument, Covenant, Tiered Royalty Percentage, Term"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtInstrumentExitFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "DebtInstrumentExitFee",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, exit fee",
        "label": "Debt Instrument, Exit Fee",
        "documentation": "Debt Instrument, Exit Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r480",
      "r481",
      "r723",
      "r724",
      "r755"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective annual interest rate (as a percent)",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r315",
      "r480",
      "r481",
      "r755"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/SubsequentEventsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate (as a percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r287"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r433",
      "r544",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r755",
      "r941",
      "r942",
      "r943",
      "r946",
      "r1029",
      "r1031"
     ]
    },
    "aqst_DebtInstrumentMilestoneTranchesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "DebtInstrumentMilestoneTranchesAxis",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Milestone Tranches [Axis]",
        "label": "Debt Instrument, Milestone Tranches [Axis]",
        "documentation": "Debt Instrument, Milestone Tranches"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtInstrumentMilestoneTranchesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "DebtInstrumentMilestoneTranchesDomain",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Milestone Tranches [Domain]",
        "label": "Debt Instrument, Milestone Tranches [Domain]",
        "documentation": "Debt Instrument, Milestone Tranches [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/SubsequentEventsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r755",
      "r941",
      "r942",
      "r943",
      "r946",
      "r967",
      "r968",
      "r969",
      "r1029",
      "r1031",
      "r1044"
     ]
    },
    "aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, redemption price, basis points above treasury rate",
        "label": "Debt Instrument, Redemption Price, Basis Spread On Variable Rate",
        "documentation": "Debt Instrument, Redemption Price, Basis Spread On Variable Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase price (as a percent)",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, redemption price, percentage of principal amount redeemed (as a percent)",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "documentation": "Percentage of principal amount of debt redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r23",
      "r24",
      "r27",
      "r72",
      "r74",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r297",
      "r298",
      "r299",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r433",
      "r544",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r755",
      "r941",
      "r942",
      "r943",
      "r946",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, term (in years)",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized discount",
        "negatedLabel": "Unamortized discount, including Exit Fee",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r1028",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized deferred debt issuance cost and deferred debt discounts",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r313",
      "r479",
      "r480",
      "r481",
      "r723",
      "r724",
      "r755"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized discount (premium), net",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "documentation": "Amount, after accumulated amortization, of debt discount (premium)."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r1028",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs, net",
        "label": "Debt Issuance Costs, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r1028",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r20",
      "r131",
      "r695",
      "r696",
      "r699",
      "r702"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation, amortization, and impairment",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r20"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r356",
      "r360",
      "r389",
      "r390",
      "r392",
      "r738"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share attributable to common stockholders:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Loss per common share \u2013 basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r126",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r168",
      "r170",
      "r172",
      "r173",
      "r174",
      "r178",
      "r317",
      "r393",
      "r416",
      "r421",
      "r445",
      "r446",
      "r539",
      "r561",
      "r705"
     ]
    },
    "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasicOtherDisclosuresAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding:",
        "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Loss per common share \u2013 diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r126",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r170",
      "r172",
      "r173",
      "r174",
      "r178",
      "r317",
      "r393",
      "r416",
      "r421",
      "r445",
      "r446",
      "r539",
      "r561",
      "r705"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r175",
      "r176",
      "r177"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://aquestive.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r739"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost, recognition period (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation costs of RSU awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense related to non-vested stock options",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r99",
      "r100",
      "r101",
      "r121",
      "r122",
      "r123",
      "r151",
      "r152",
      "r153",
      "r155",
      "r162",
      "r164",
      "r166",
      "r180",
      "r224",
      "r225",
      "r247",
      "r316",
      "r328",
      "r393",
      "r406",
      "r407",
      "r413",
      "r414",
      "r415",
      "r417",
      "r420",
      "r421",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r482",
      "r484",
      "r493",
      "r558",
      "r585",
      "r586",
      "r587",
      "r599",
      "r652"
     ]
    },
    "aqst_EquityDistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "EquityDistributionAgreementMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity distribution agreement",
        "label": "Equity Distribution Agreement [Member]",
        "documentation": "Equity Distribution Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r797",
      "r807",
      "r817",
      "r849"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r804",
      "r814",
      "r846"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "aqst_ExistingWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ExistingWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Existing Warrants",
        "label": "Existing Warrants [Member]",
        "documentation": "Existing Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments \u2013 Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r451",
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r537",
      "r747",
      "r750"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "aqst_FirstAdditionalWarrantOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "FirstAdditionalWarrantOfferingMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Additional Warrant Offering",
        "label": "First Additional Warrant Offering [Member]",
        "documentation": "First Additional Warrant Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r853"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r853"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r853"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r853"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r853"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total General and Administrative Expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r636"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseAbstract",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General &amp; Administrative expenses:",
        "label": "General and Administrative Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "aqst_HyperaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "HyperaMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hypera",
        "label": "Hypera [Member]",
        "documentation": "Hypera"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/IncomeTaxesDetails",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss before income taxes",
        "terseLabel": "Net (loss)/income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r84",
      "r89",
      "r540",
      "r542",
      "r556",
      "r698",
      "r701",
      "r704",
      "r709",
      "r714",
      "r952",
      "r960",
      "r961",
      "r962",
      "r963"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r255",
      "r263",
      "r429",
      "r430",
      "r431",
      "r432",
      "r450",
      "r452",
      "r456",
      "r469",
      "r470",
      "r471",
      "r582",
      "r584",
      "r637",
      "r683",
      "r686",
      "r740",
      "r741",
      "r745",
      "r746",
      "r748",
      "r754",
      "r1012",
      "r1013",
      "r1048"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r263",
      "r429",
      "r430",
      "r431",
      "r432",
      "r450",
      "r452",
      "r456",
      "r469",
      "r470",
      "r471",
      "r582",
      "r584",
      "r637",
      "r683",
      "r686",
      "r740",
      "r741",
      "r745",
      "r746",
      "r748",
      "r754",
      "r1012",
      "r1013",
      "r1048"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r145",
      "r398",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r408",
      "r410",
      "r411",
      "r412",
      "r546",
      "r591",
      "r598",
      "r739"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes (benefit) expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r96",
      "r140",
      "r165",
      "r166",
      "r179",
      "r198",
      "r212",
      "r399",
      "r400",
      "r409",
      "r562",
      "r698",
      "r701",
      "r704",
      "r739"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade and other receivables, net",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r845",
      "r853",
      "r857",
      "r865"
     ]
    },
    "aqst_IndiviorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "IndiviorMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indivior",
        "label": "Indivior [Member]",
        "documentation": "Indivior"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r869"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r869"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r793",
      "r869"
     ]
    },
    "aqst_InterestAndOtherIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "InterestAndOtherIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income and other income, net",
        "label": "Interest And Other Income, Net",
        "documentation": "Interest And Other Income, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r698",
      "r704",
      "r891"
     ]
    },
    "aqst_InterestExpenseSaleOfFutureRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "InterestExpenseSaleOfFutureRevenues",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense related to the sale of future revenue",
        "label": "Interest Expense, Sale of Future Revenues",
        "documentation": "Interest Expense, Sale of Future Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payments for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r135",
      "r136"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "label": "Interest Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory Disclosure [Abstract]",
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/InventoriesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories, Net",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/InventoriesNetDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/InventoriesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Gross",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://aquestive.com/role/InventoriesNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/InventoriesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "totalLabel": "Total inventory",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r691",
      "r758"
     ]
    },
    "aqst_InventoryPackingMaterialGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "InventoryPackingMaterialGross",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/InventoriesNetDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/InventoriesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Packaging material",
        "label": "Inventory Packing Material Gross",
        "documentation": "Amount of packaging materials expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/InventoriesNetDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/InventoriesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw material",
        "label": "Inventory, Raw Materials, Gross",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r491"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r492"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r492"
     ]
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseDiscountRate",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated discount rate (as a percent)",
        "label": "Lessee, Operating Lease, Discount Rate",
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "aqst_LesseeOperatingLeaseInitialRentAbatementPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LesseeOperatingLeaseInitialRentAbatementPeriod",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial rent abatement period",
        "label": "Lessee, Operating Lease, Initial Rent Abatement Period",
        "documentation": "Lessee, Operating Lease, Initial Rent Abatement Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Lease Liabilities Maturities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r942",
      "r946",
      "r1044"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r942",
      "r946",
      "r1044"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r942",
      "r946",
      "r1044"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r942",
      "r946",
      "r1044"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remainder of 2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030 and thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter",
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "aqst_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of renewal options",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining lease term (in years)",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r1032"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, operating lease, renewal term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-Use Assets and Lease Obligations",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r30",
      "r31",
      "r32",
      "r36",
      "r37",
      "r38",
      "r39",
      "r140",
      "r143",
      "r144",
      "r223",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r426",
      "r427",
      "r428",
      "r468",
      "r613",
      "r708",
      "r727",
      "r788",
      "r977",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 deficit",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r83",
      "r553",
      "r758",
      "r775",
      "r776",
      "r941",
      "r945",
      "r965",
      "r1027"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 deficit",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r105",
      "r140",
      "r143",
      "r144",
      "r223",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r426",
      "r427",
      "r428",
      "r468",
      "r758",
      "r977",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LiabilitiesSaleOfFutureRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LiabilitiesSaleOfFutureRoyalties",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Liability related to the sale of future revenue, net at beginning of the period",
        "periodEndLabel": "Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively)",
        "label": "Liabilities, Sale of Future Royalties",
        "documentation": "Liabilities, Sale of Future Royalties"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LiabilitiesSaleOfFutureRoyaltiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability related to the sale of future revenue, current",
        "label": "Liabilities, Sale of Future Royalties, Current",
        "documentation": "Liabilities, Sale of Future Royalties, Current"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LicenseAgreementTerm",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement term (in years)",
        "label": "License Agreement Term",
        "documentation": "License agreement term period."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LicenseAgreementWithSunovionPharmaceuticalsIncMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement with Sunovion Pharmaceuticals, Inc.",
        "label": "License Agreement with Sunovion Pharmaceuticals, Inc. [Member]",
        "documentation": "The license agreement made with sunovion pharmaceuticals, inc."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement with Sunovion Pharmaceuticals, Inc milestones",
        "label": "License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member]",
        "documentation": "The license agreement made with sunovion pharmaceuticals, inc. milestones."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement with Sunovion Pharmaceuticals, Inc. upfront",
        "label": "License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member]",
        "documentation": "The license agreement made with sunovion pharmaceuticals, inc. advance payments."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAndRoyaltyRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LicenseAndRoyaltyRevenueMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and royalty revenue a",
        "label": "License and Royalty Revenue [Member]",
        "documentation": "The aggregate revenue generated from licensing and royalties."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseSupplyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LicenseSupplyAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License &amp; Supply Agreement",
        "label": "License &amp; Supply Agreement [Member]",
        "documentation": "License &amp; Supply Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, accordion feature, increase limit",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LineOfCreditFacilityAccordionFeatureNetRevenueThreshold",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, accordion feature, net revenue threshold",
        "label": "Line of Credit Facility, Accordion Feature, Net Revenue Threshold",
        "documentation": "Line of Credit Facility, Accordion Feature, Net Revenue Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential increase in available borrowing capacity upon pre determined achievement of milestones",
        "label": "Line Of Credit Facility, Available Borrowing Capacity, Increase Limit",
        "documentation": "Line Of Credit Facility, Available Borrowing Capacity, Increase Limit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r941",
      "r943",
      "r976"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility, maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r35"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r35",
      "r275",
      "r941",
      "r943",
      "r976"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LoansPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans payable, current",
        "label": "Loans Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r81",
      "r141",
      "r150",
      "r298",
      "r314",
      "r544",
      "r723",
      "r724",
      "r755",
      "r1045"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      },
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable, net",
        "totalLabel": "Notes payable, net",
        "label": "Long-Term Debt and Lease Obligation",
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r549"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": [
      "r686",
      "r754",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r141",
      "r150",
      "r303",
      "r544"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r141",
      "r150",
      "r303",
      "r544"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r946"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable, long-term",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/SubsequentEventsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r967",
      "r968",
      "r969"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/SubsequentEventsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r22",
      "r967",
      "r968",
      "r969"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r268",
      "r269",
      "r270",
      "r273",
      "r396",
      "r721",
      "r972",
      "r973"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r268",
      "r269",
      "r270",
      "r273",
      "r396",
      "r721",
      "r972",
      "r973"
     ]
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyPendingClaimsNumber",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of cases pending",
        "label": "Loss Contingency, Pending Claims, Number",
        "documentation": "Number of pending claims pertaining to a loss contingency."
       }
      }
     },
     "auth_ref": [
      "r972",
      "r973"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r729",
      "r732",
      "r768",
      "r773",
      "r1047",
      "r1049",
      "r1050",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "aqst_ManufactureAndSupplyRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ManufactureAndSupplyRevenueMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacture and supply revenue",
        "label": "Manufacture and Supply Revenue [Member]",
        "documentation": "The aggregate revenue generated from manufacture and supply."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ManufacturingAndSupplyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ManufacturingAndSupplyMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Manufacture and supply",
        "label": "Manufacturing And Supply [Member]",
        "documentation": "Primary financial statement caption encompassing Manufacturing and supply expense."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarathonPangolinRoyaltyLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarathonPangolinRoyaltyLLCMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAM Pangolin Royalty , LLC",
        "label": "Marathon Pangolin Royalty LLC [Member]",
        "documentation": "Marathon Pangolin Royalty LLC"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketBasedMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Based",
        "label": "Market Based [Member]",
        "documentation": "Market Based"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionRangeFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionRangeFiveMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Five",
        "label": "Market Condition Range Five [Member]",
        "documentation": "Market Condition Range Five"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionRangeFourMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Four",
        "label": "Market Condition Range Four [Member]",
        "documentation": "Market Condition Range Four"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionRangeOneMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range One",
        "label": "Market Condition Range One [Member]",
        "documentation": "Market Condition Range One"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionRangeSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionRangeSixMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Six",
        "label": "Market Condition Range Six [Member]",
        "documentation": "Market Condition Range Six"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionRangeThreeMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Three",
        "label": "Market Condition Range Three [Member]",
        "documentation": "Market Condition Range Three"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionRangeTwoMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Two",
        "label": "Market Condition Range Two [Member]",
        "documentation": "Market Condition Range Two"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionsAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Conditions [Axis]",
        "label": "Market Conditions [Axis]",
        "documentation": "Market Conditions"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketConditionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MarketConditionsDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Conditions [Domain]",
        "label": "Market Conditions [Domain]",
        "documentation": "Market Conditions [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r269",
      "r270",
      "r271",
      "r272",
      "r355",
      "r384",
      "r385",
      "r386",
      "r396",
      "r449",
      "r501",
      "r581",
      "r583",
      "r590",
      "r605",
      "r606",
      "r655",
      "r657",
      "r659",
      "r660",
      "r662",
      "r665",
      "r666",
      "r668",
      "r669",
      "r681",
      "r682",
      "r719",
      "r728",
      "r737",
      "r740",
      "r742",
      "r743",
      "r749",
      "r750",
      "r751",
      "r752",
      "r769",
      "r979",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r740",
      "r742",
      "r743",
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "aqst_MeasurementInputProbabilityOfSuccessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MeasurementInputProbabilityOfSuccessMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Probability Of Success",
        "label": "Measurement Input, Probability Of Success [Member]",
        "documentation": "Measurement Input, Probability Of Success"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r447",
      "r448",
      "r449",
      "r740",
      "r742",
      "r743",
      "r749"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r448",
      "r449",
      "r740",
      "r742",
      "r743",
      "r749"
     ]
    },
    "aqst_MinimumAnnualRoyaltyReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MinimumAnnualRoyaltyReceivable",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum annual royalty receivable",
        "label": "Minimum Annual Royalty Receivable",
        "documentation": "Minimum annual royalty receivable by the entity for the use of its rights and property by another party."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r269",
      "r270",
      "r271",
      "r272",
      "r355",
      "r384",
      "r385",
      "r386",
      "r396",
      "r449",
      "r501",
      "r581",
      "r583",
      "r590",
      "r605",
      "r606",
      "r655",
      "r657",
      "r659",
      "r660",
      "r662",
      "r665",
      "r666",
      "r668",
      "r669",
      "r681",
      "r682",
      "r719",
      "r728",
      "r737",
      "r740",
      "r742",
      "r743",
      "r749",
      "r750",
      "r751",
      "r769",
      "r979",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "aqst_MonetizationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "MonetizationAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monetization Agreement",
        "label": "Monetization Agreement [Member]",
        "documentation": "Monetization Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r219",
      "r729",
      "r732",
      "r768",
      "r773",
      "r1047",
      "r1049",
      "r1050",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used for investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used for operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r65"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/NetLossPerShareDetails",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r65",
      "r85",
      "r101",
      "r103",
      "r117",
      "r119",
      "r123",
      "r140",
      "r143",
      "r144",
      "r147",
      "r154",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r165",
      "r166",
      "r171",
      "r223",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r317",
      "r320",
      "r322",
      "r325",
      "r393",
      "r416",
      "r421",
      "r446",
      "r468",
      "r557",
      "r634",
      "r650",
      "r651",
      "r698",
      "r701",
      "r704",
      "r786",
      "r977"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_NewWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "NewWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Warrants",
        "label": "New Warrants [Member]",
        "documentation": "New Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r801",
      "r811",
      "r821",
      "r845",
      "r853"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonUsMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ex-United States",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1082",
      "r1083",
      "r1084",
      "r1085"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income/(expenses):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Units Awards",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_NotesAndLoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesAndLoansPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Notes payable, current",
        "label": "Notes and Loans Payable, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31"
     ]
    },
    "aqst_NumberOfAnnualRoyaltyPaymentsReceivable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "NumberOfAnnualRoyaltyPaymentsReceivable",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of annual royalty payments receivable",
        "label": "Number of Annual Royalty Payments Receivable",
        "documentation": "Number of annual royalty payments receivable by the entity for the use of its rights and property by another party."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_NumberOfGuaranteedRoyaltyPayments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "NumberOfGuaranteedRoyaltyPayments",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of guaranteed royalty payments",
        "label": "Number Of Guaranteed Royalty Payments",
        "documentation": "Number Of Guaranteed Royalty Payments"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_NumberOfOperatingLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "NumberOfOperatingLeases",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of leases",
        "label": "Number of Operating Leases",
        "documentation": "Number of operating leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r959"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r710",
      "r718",
      "r959"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r698",
      "r704",
      "r709",
      "r952",
      "r960",
      "r961",
      "r962",
      "r963"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r757"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsScheduleofOperatingLeaseLiabilitiesMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Right-of-use assets, net",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Overview and Basis of Presentation",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r877",
      "r939"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Non-current Assets",
        "label": "Other Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/OtherNoncurrentAssetsScheduleofOtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "totalLabel": "Total other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "aqst_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "OtherMember",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other [Member]",
        "documentation": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other, net",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income/(expenses), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r744"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "aqst_OtherReceivablesAndAccruedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "OtherReceivablesAndAccruedExpensesMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Receivables And Accrued Expenses",
        "label": "Other Receivables And Accrued Expenses [Member]",
        "documentation": "Other Receivables And Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivablesGrossCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherReceivablesGrossCurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails": {
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and other receivables",
        "label": "Other Receivables, Gross, Current",
        "documentation": "Amount, before allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r799",
      "r809",
      "r819",
      "r851"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r802",
      "r812",
      "r822",
      "r854"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r802",
      "r812",
      "r822",
      "r854"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_PaymentsForRoyaltyObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "PaymentsForRoyaltyObligations",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments for royalty obligations",
        "label": "Payments for Royalty Obligations",
        "documentation": "Payments for Royalty Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for loan acquisition costs",
        "label": "Payments of Financing Costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for stock issuance costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments for taxes on share-based compensation, net",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r827"
     ]
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Shares",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009"
     ]
    },
    "aqst_PersonnelCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "PersonnelCostsMember",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personnel costs",
        "label": "Personnel Costs [Member]",
        "documentation": "Personnel Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "aqst_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrants",
        "label": "Pre-Funded Warrants [Member]",
        "documentation": "Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_ProceedsFromCollaborators": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromCollaborators",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from collaborators",
        "label": "Proceeds from Collaborators",
        "documentation": "Cash received from collaborators during the current period."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "aqst_ProceedsFromExerciseOfWarrantsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ProceedsFromExerciseOfWarrantsNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued under the Purchase Agreement",
        "label": "Proceeds from Exercise of Warrants, Net",
        "documentation": "Proceeds from Exercise of Warrants, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Issuance of Debt",
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "aqst_ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from common stock issued under public equity offering-ATM, net",
        "label": "Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises",
        "documentation": "Proceeds From Issuance Of Public Offering, Issuance Of Warrants and Warrant Exercises"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ProceedsFromSaleOfFutureRevenuesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ProceedsFromSaleOfFutureRevenuesNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of future revenue",
        "label": "Proceeds From Sale of Future Revenues, Net",
        "documentation": "Proceeds From Sale of Future Revenues, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options, net",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r10"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from warrant exercises",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r215",
      "r502",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r687",
      "r696",
      "r701",
      "r704",
      "r729",
      "r730",
      "r767",
      "r769",
      "r770",
      "r774",
      "r777",
      "r876",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r930",
      "r931",
      "r932",
      "r933",
      "r974",
      "r975",
      "r1047",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r215",
      "r502",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r687",
      "r696",
      "r701",
      "r704",
      "r729",
      "r730",
      "r767",
      "r769",
      "r770",
      "r774",
      "r777",
      "r876",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r930",
      "r931",
      "r932",
      "r933",
      "r974",
      "r975",
      "r1047",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r491"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r92",
      "r94",
      "r95"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r107",
      "r555"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r491",
      "r545",
      "r555",
      "r758"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r491"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful Lives",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ProprietaryProductRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ProprietaryProductRevenueMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proprietary product revenue, net",
        "label": "Proprietary Product Revenue [Member]",
        "documentation": "The aggregate revenue generated from proprietary product sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Provision",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128",
      "r228"
     ]
    },
    "aqst_PurchaseAndSaleAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "PurchaseAndSaleAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase And Sale Agreement",
        "label": "Purchase And Sale Agreement [Member]",
        "documentation": "Purchase And Sale Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "aqst_RTWInvestmentsLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RTWInvestmentsLPMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RTW Investments LP",
        "label": "RTW Investments LP [Member]",
        "documentation": "RTW Investments LP"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r269",
      "r270",
      "r271",
      "r272",
      "r354",
      "r355",
      "r384",
      "r385",
      "r386",
      "r392",
      "r396",
      "r449",
      "r498",
      "r499",
      "r501",
      "r581",
      "r583",
      "r590",
      "r605",
      "r606",
      "r655",
      "r657",
      "r659",
      "r660",
      "r662",
      "r665",
      "r666",
      "r668",
      "r669",
      "r681",
      "r682",
      "r719",
      "r728",
      "r737",
      "r740",
      "r742",
      "r743",
      "r749",
      "r750",
      "r751",
      "r752",
      "r769",
      "r780",
      "r970",
      "r979",
      "r1021",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r269",
      "r270",
      "r271",
      "r272",
      "r354",
      "r355",
      "r384",
      "r385",
      "r386",
      "r392",
      "r396",
      "r449",
      "r498",
      "r499",
      "r501",
      "r581",
      "r583",
      "r590",
      "r605",
      "r606",
      "r655",
      "r657",
      "r659",
      "r660",
      "r662",
      "r665",
      "r666",
      "r668",
      "r669",
      "r681",
      "r682",
      "r719",
      "r728",
      "r737",
      "r740",
      "r742",
      "r743",
      "r749",
      "r750",
      "r751",
      "r752",
      "r769",
      "r780",
      "r970",
      "r979",
      "r1021",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable [Domain]",
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r48"
     ]
    },
    "us-gaap_ReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other receivables, net",
        "totalLabel": "Trade and other receivables, net",
        "label": "Receivables, Net, Current",
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r794",
      "r804",
      "r814",
      "r846"
     ]
    },
    "aqst_RedemptionScenario1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RedemptionScenario1Member",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption Scenario 1",
        "label": "Redemption Scenario 1 [Member]",
        "documentation": "Redemption Scenario 1"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RedemptionScenario2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RedemptionScenario2Member",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption Scenario 2",
        "label": "Redemption Scenario 2 [Member]",
        "documentation": "Redemption Scenario 2"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of debt principal including lease liabilities",
        "terseLabel": "Repayments of debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "aqst_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r140",
      "r148",
      "r149",
      "r289",
      "r326",
      "r494",
      "r500",
      "r547",
      "r692",
      "r693",
      "r694",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "verboseLabel": "Total Research and Development Expenses",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r683",
      "r698",
      "r699",
      "r714",
      "r1043"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ResearchAndDevelopmentProjectDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ResearchAndDevelopmentProjectDuration",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development, project duration (in years)",
        "label": "Research and Development, Project Duration",
        "documentation": "Research and Development, Project Duration"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r795",
      "r805",
      "r815",
      "r847"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r796",
      "r806",
      "r816",
      "r848"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r803",
      "r813",
      "r823",
      "r855"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalentsAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents:",
        "label": "Restricted Cash and Cash Equivalent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r75",
      "r552",
      "r588",
      "r589",
      "r597",
      "r616",
      "r758"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r151",
      "r152",
      "r153",
      "r155",
      "r162",
      "r164",
      "r166",
      "r224",
      "r225",
      "r247",
      "r316",
      "r393",
      "r406",
      "r407",
      "r413",
      "r414",
      "r415",
      "r417",
      "r420",
      "r421",
      "r434",
      "r436",
      "r437",
      "r439",
      "r444",
      "r482",
      "r484",
      "r585",
      "r587",
      "r599",
      "r1080"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails",
      "http://aquestive.com/role/SegmentReportingNarrativeDetails",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "netLabel": "Total revenues",
        "negatedNetLabel": "Royalties related to the sale of future revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r179",
      "r191",
      "r192",
      "r206",
      "r212",
      "r215",
      "r217",
      "r219",
      "r349",
      "r350",
      "r351",
      "r502",
      "r698",
      "r704"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r955",
      "r956"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition and Performance Obligations",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r685"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues and Trade Receivables, Net",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r332",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r351",
      "r353"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate payment",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r124",
      "r140",
      "r143",
      "r144",
      "r179",
      "r191",
      "r192",
      "r206",
      "r212",
      "r215",
      "r217",
      "r219",
      "r223",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r468",
      "r540",
      "r542",
      "r714",
      "r744",
      "r775",
      "r776",
      "r977"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks and Uncertainties [Abstract]",
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyAgreementMeasurementInput": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyAgreementMeasurementInput",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty rights agreement, measurement input (as a percent)",
        "label": "Royalty Agreement, Measurement Input",
        "documentation": "Royalty Agreement, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense related to royalty obligations",
        "label": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_RoyaltyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RoyaltyMember",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty",
        "label": "Royalty [Member]",
        "documentation": "Money for usage-based right to asset."
       }
      }
     },
     "auth_ref": [
      "r982",
      "r983"
     ]
    },
    "aqst_RoyaltyObligationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyObligationActivityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Royalty Obligation",
        "label": "Royalty Obligation Activity [Table Text Block]",
        "documentation": "Royalty Obligation Activity"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyObligationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyObligationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty obligations, net",
        "label": "Royalty Obligation, Liability, Noncurrent",
        "documentation": "Royalty Obligation, Liability, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyObligationPercentOfNetSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyObligationPercentOfNetSales",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty interest percent interest (as a percent)",
        "label": "Royalty Obligation, Percent Of Net Sales",
        "documentation": "Royalty Obligation, Percent Of Net Sales"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyObligationTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyObligationTerm",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty payment term (in years)",
        "label": "Royalty Obligation, Term",
        "documentation": "Royalty Obligation, Term"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyObligationsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyObligationsGross",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty Obligations, Gross",
        "label": "Royalty Obligations, Gross",
        "documentation": "Royalty Obligations, Gross"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyObligationsMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty Obligations",
        "label": "Royalty Obligations [Member]",
        "documentation": "Royalty Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyRightAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "RoyaltyRightAgreementsMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty Right Agreements",
        "label": "Royalty Right Agreements [Member]",
        "documentation": "Royalty Right Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "aqst_SaleOfFutureRevenueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SaleOfFutureRevenueRollForward",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueScheduleofRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Future Revenue [Roll Forward]",
        "label": "Sale of Future Revenue [Roll Forward]",
        "documentation": "Sale of Future Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfFutureRevenueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SaleOfFutureRevenueTextBlock",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Future Revenue",
        "label": "Sale of Future Revenue [Text Block]",
        "documentation": "Sale of Future Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfStockAggregateOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SaleOfStockAggregateOfferingPrice",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate offering price",
        "label": "Sale of Stock, Aggregate Offering Price",
        "documentation": "Sale of Stock, Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration received on sale of stock",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discounts",
        "label": "Sale of Stock, Consideration Received on Transaction, Underwriting Discounts",
        "documentation": "Sale of Stock, Consideration Received on Transaction, Underwriting Discounts"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfStockMaximumTransactionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SaleOfStockMaximumTransactionAmount",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, maximum transaction amount",
        "label": "Sale of Stock, Maximum Transaction Amount",
        "documentation": "Sale of Stock, Maximum Transaction Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfStockShareCommitmentPeriodFollowingEffectiveDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SaleOfStockShareCommitmentPeriodFollowingEffectiveDate",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock, Share Commitment, Period following Effective Date (in days)",
        "label": "Sale of Stock, Share Commitment, Period following Effective Date",
        "documentation": "Sale of Stock, Share Commitment, Period following Effective Date"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfStockSharesCommittedAggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SaleOfStockSharesCommittedAggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock, Shares Committed, Aggregate Amount",
        "label": "Sale of Stock, Shares Committed, Aggregate Amount",
        "documentation": "Sale of Stock, Shares Committed, Aggregate Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts and Financing Receivables [Table]",
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r48",
      "r221",
      "r964"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade and Other Receivables, Net",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r48"
     ]
    },
    "aqst_ScheduleOfAccountsReceivableAllowancesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ScheduleOfAccountsReceivableAllowancesTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Sales-related Allowances",
        "label": "Schedule of Accounts Receivable Allowances [Table Text Block]",
        "documentation": "Schedule of Accounts Receivable Allowances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "documentation": "Disclosure of information about acquired finite-lived intangible asset by major class."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r592",
      "r683"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAssetRetirementObligationsTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/OtherNonCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liability for Asset Retirement Obligations",
        "label": "Schedule of Asset Retirement Obligations [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount of a liability for asset retirement obligations."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Term Notes and Unamortized Debt Discount Balances",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r23",
      "r24",
      "r27",
      "r72",
      "r74",
      "r723",
      "r725",
      "r942",
      "r946",
      "r1029",
      "r1044"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/InventoriesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r49",
      "r50",
      "r51"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt Maturities",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Non-Current Assets",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "documentation": "Tabular disclosure of noncurrent assets."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r491"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r18"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r18"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r392"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r76"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Valuation Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "aqst_ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Royalty Right Agreements",
        "label": "Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement [Table Text Block]",
        "documentation": "Schedule of Significant Unobservable Inputs Used In The Initial Fair Value Measurement Of The Royalty Right Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities purchase agreement",
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90",
      "r179",
      "r187",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r219",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r246",
      "r264",
      "r265",
      "r418",
      "r419",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r711",
      "r714",
      "r715",
      "r720",
      "r772",
      "r1047",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r183",
      "r217",
      "r218",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r540",
      "r541",
      "r542",
      "r543",
      "r602",
      "r603",
      "r604",
      "r656",
      "r658",
      "r661",
      "r663",
      "r665",
      "r667",
      "r668",
      "r669",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r688",
      "r706",
      "r729",
      "r731",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r771",
      "r780",
      "r1047",
      "r1049",
      "r1050",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r179",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r202",
      "r204",
      "r205",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r219",
      "r710",
      "r712",
      "r713",
      "r714",
      "r716",
      "r717",
      "r718"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": "us-gaap_SellingGeneralAndAdministrativeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Selling expenses",
        "label": "Selling Expense",
        "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r130",
      "r697",
      "r700",
      "r703"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "totalLabel": "Total Selling, General and Administrative Expenses",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r696",
      "r698",
      "r699",
      "r704",
      "r929"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpenseAbstract",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling expenses:",
        "label": "Selling, General and Administrative Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/SubsequentEventsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SeniorSecuredNotes13.5DueNovember12028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SeniorSecuredNotes13.5DueNovember12028Member",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/SubsequentEventsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "13.5% Senior Secured Notes due November 1, 2028",
        "label": "Senior Secured Notes, 13.5% due November 1, 2028 [Member]",
        "documentation": "Senior Secured Notes, 13.5% due November 1, 2028"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ServiceBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ServiceBasedMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service Based",
        "label": "Service Based [Member]",
        "documentation": "Service Based"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationAbstract",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation expenses [Abstract]",
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected to vest at end of period (in dollars per share)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value",
        "documentation": "The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected to vest at end of period (in shares)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, in Shares",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested, at beginning of period (in shares)",
        "periodEndLabel": "Unvested, at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Units",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested, at beginning of period (in dollars per share)",
        "periodEndLabel": "Unvested, at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r373"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average closing prices period (in days)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average closing price, number of days utilized in pricing period (in days)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Days Utilized in Pricing Period",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Days Utilized in Pricing Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r392"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of pricing periods",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Pricing Periods",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Pricing Periods"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited/expired (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised, Forfeitures And Expirations In Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited/expired (in dollars per share)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either exercised, forfeited or expired."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested or expected to vest at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested or expected to vest at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance price threshold (in dollars per share)",
        "label": "Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share",
        "documentation": "Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofRestrictedStockUnitsAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock price at grant date",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting rights (as a percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of common stock (in shares)",
        "label": "Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants",
        "documentation": "Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SharesOfCommonStockToBePurchasedByCommonStockWarrants",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of common stock in connection with securities purchase agreements (in shares)",
        "label": "Shares Of Common Stock To Be Purchased By Common Stock Warrants",
        "documentation": "Shares of Common Stock to be Purchased by Common Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://aquestive.com/role/SegmentReportingScheduleofSegmentReportingInformationbySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90",
      "r102",
      "r179",
      "r187",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r219",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r246",
      "r249",
      "r264",
      "r265",
      "r418",
      "r419",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r711",
      "r714",
      "r715",
      "r720",
      "r772",
      "r1047",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r41",
      "r45",
      "r46",
      "r99",
      "r100",
      "r101",
      "r121",
      "r122",
      "r123",
      "r151",
      "r152",
      "r153",
      "r155",
      "r162",
      "r164",
      "r166",
      "r180",
      "r224",
      "r225",
      "r247",
      "r316",
      "r328",
      "r393",
      "r406",
      "r407",
      "r413",
      "r414",
      "r415",
      "r417",
      "r420",
      "r421",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r482",
      "r484",
      "r493",
      "r558",
      "r585",
      "r586",
      "r587",
      "r599",
      "r652"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r183",
      "r217",
      "r218",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r540",
      "r541",
      "r542",
      "r543",
      "r602",
      "r603",
      "r604",
      "r656",
      "r658",
      "r661",
      "r663",
      "r665",
      "r667",
      "r668",
      "r669",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r688",
      "r706",
      "r729",
      "r731",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r771",
      "r780",
      "r1047",
      "r1049",
      "r1050",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r180",
      "r318",
      "r319",
      "r321",
      "r323",
      "r484",
      "r502",
      "r595",
      "r600",
      "r601",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r615",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r635",
      "r636",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r652",
      "r701",
      "r704",
      "r781",
      "r1079"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r180",
      "r220",
      "r318",
      "r319",
      "r321",
      "r323",
      "r484",
      "r502",
      "r595",
      "r600",
      "r601",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r615",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r635",
      "r636",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r652",
      "r701",
      "r704",
      "r781",
      "r1079"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r798",
      "r808",
      "r818",
      "r850"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock issued under public equity offering-ATM (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r75",
      "r596",
      "r652",
      "r664"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested restricted stock units, net (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r75"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercises, net (in shares)",
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r75",
      "r369"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock issued under public equity offering-ATM",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r75",
      "r599",
      "r652",
      "r664",
      "r787"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested restricted stock units, net",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r75"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised, net",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r41",
      "r45",
      "r46",
      "r75"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining authorized amount",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 deficit",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r45",
      "r46",
      "r66",
      "r617",
      "r633",
      "r653",
      "r654",
      "r758",
      "r788",
      "r941",
      "r944",
      "r945",
      "r965",
      "r1027",
      "r1080"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 deficit:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SuboxoneProduceLiabilityLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "SuboxoneProduceLiabilityLitigationMember",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Suboxone Produce Liability Litigation",
        "label": "Suboxone Produce Liability Litigation [Member]",
        "documentation": "Suboxone Produce Liability Litigation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r496"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r496"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r496"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r496"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r496"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://aquestive.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r497"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real estate and personal property taxes",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31"
     ]
    },
    "aqst_TermLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TermLoanFacilityMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan Facility",
        "label": "Term Loan Facility [Member]",
        "documentation": "Term Loan Facility"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "aqst_TradeAccountsReceivableDoubtfulAccountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TradeAccountsReceivableDoubtfulAccountsMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Doubtful Accounts",
        "label": "Trade Accounts Receivable, Doubtful Accounts [Member]",
        "documentation": "Trade Accounts Receivable, Doubtful Accounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradeAccountsReceivableMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Accounts Receivable",
        "label": "Trade Accounts Receivable [Member]",
        "documentation": "Amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TradeAccountsReceivableSalesRelatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TradeAccountsReceivableSalesRelatedMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofSalesrelatedAllowancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Accounts Receivable, Sales Related",
        "label": "Trade Accounts Receivable, Sales Related [Member]",
        "documentation": "Trade Accounts Receivable, Sales Related"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TrancheFourMember",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche Four",
        "label": "Tranche Four [Member]",
        "documentation": "Tranche Four"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TrancheThreeMember",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche Three",
        "label": "Tranche Three [Member]",
        "documentation": "Tranche Three"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TrancheTwoMember",
     "presentation": [
      "http://aquestive.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche Two",
        "label": "Tranche Two [Member]",
        "documentation": "Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability related to the sale of future revenue, current",
        "label": "Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current",
        "documentation": "Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability related to the sale of future revenue, net",
        "label": "Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent",
        "documentation": "Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "TwelvePointFiveSeniorSecuredNotesDueJune302025Member",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior secured notes due 2025",
        "label": "Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]",
        "documentation": "A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost, Product and Service [Extensible Enumeration]",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates type of cost from product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_UnderwrittenPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "UnderwrittenPublicOfferingMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwritten Public Offering",
        "label": "Underwritten Public Offering [Member]",
        "documentation": "Underwritten Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UndistributedEarningsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UndistributedEarningsAbstract",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Undistributed Earnings, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r448",
      "r740",
      "r743",
      "r749",
      "r1022"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationScheduleofStockOptionValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r448",
      "r740",
      "r743",
      "r749",
      "r1022"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease expense",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r757"
     ]
    },
    "aqst_VestingConditionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition [Axis]",
        "label": "Vesting Condition [Axis]",
        "documentation": "Vesting Condition"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition [Domain]",
        "label": "Vesting Condition [Domain]",
        "documentation": "Market Conditions [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionRangeEightMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition Range Eight",
        "label": "Vesting Condition Range Eight [Member]",
        "documentation": "Vesting Condition Range Eight"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeElevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionRangeElevenMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition Range Eleven",
        "label": "Vesting Condition Range Eleven [Member]",
        "documentation": "Vesting Condition Range Eleven"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionRangeNineMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition Range Nine",
        "label": "Vesting Condition Range Nine [Member]",
        "documentation": "Vesting Condition Range Nine"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionRangeSevenMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition Range Seven",
        "label": "Vesting Condition Range Seven [Member]",
        "documentation": "Vesting Condition Range Seven"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionRangeTenMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition Range Ten",
        "label": "Vesting Condition Range Ten [Member]",
        "documentation": "Vesting Condition Range Ten"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeTwelveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "VestingConditionRangeTwelveMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition Range Twelve",
        "label": "Vesting Condition Range Twelve [Member]",
        "documentation": "Vesting Condition Range Twelve"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants on common shares outstanding",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r778",
      "r779",
      "r782",
      "r783",
      "r784",
      "r785"
     ]
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and Rights Note Disclosure [Abstract]",
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and rights outstanding",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period (in years)",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1021",
      "r1022"
     ]
    },
    "aqst_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants Disclosure [Text Block]",
        "documentation": "The entire disclosure for warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "verboseLabel": "Weighted-average number of common shares \u2013 diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r174"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLoss",
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "terseLabel": "Weighted-average number of common shares \u2013 basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r174"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://aquestive.com/role/NetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "aqst_ZevraAndCommaveTherapeuticsAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ZevraAndCommaveTherapeuticsAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetScheduleofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zevra And Commave Therapeutics Agreement",
        "label": "Zevra And Commave Therapeutics Agreement [Member]",
        "documentation": "Zevra And Commave Therapeutics Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ZevraMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20260331",
     "localname": "ZevraMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zevra",
        "label": "Zevra [Member]",
        "documentation": "Zevra"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "20",
   "Topic": "410",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-2"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-35"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2A"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/410-20/tableOfContent"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481999/410-20-25-4"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481879/410-20-45-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480397/718-10-55-16"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-12"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-19"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-25"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-3A"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3G",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-3G"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0001398733-26-000030-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001398733-26-000030-xbrl.zip
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MI^X/YM_WP&T$H&^ >:*$G "6H2QEM"&\-!:!3H[N28E#)PG%T-&=O$LQ;D1
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MX)NZ=]EIR64APQ23,-(OS'D&3/1-G5HANJ(69%=/[4O#A)#QBO-BXDR24\C
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M$2,*CXTX6=JR!>O"T(,0)VPH(3[$/0U[KG/TTD=GPI^P,8)$RLYSH%"6DA<
M^ [8\,V_Z"X-66.AG._4I7X?J 2N.99I1WK_V[?F\6E#WM+[61AZ&&T(E_V6
MT<8AM!&CCR5+B0B[;+4/DQK\QRH;A$SQ$M1=BZ$XYM;SP';-[,\ GMB"]:W*
MIY@?</P04*F@2EN*I]FAAY&GL)&[M:HK(M"P*\))=5?#MVG?"VW?IW]^,P?F
M\0ND* 6I5E#*V]#%PM##Z$+8V&!2Z*(!@PSXYT1%?7F$4:EL'8R<#CV,3H2,
M1C8Q49>Y0X#!Z(X.YAI7[GQ\[G .1B]T2PZ>&WH89H2-]J%B-0V3NB/<E[[O
MM7U'_S&#HC;3 ]?T3>9-MK!/Q$0@0<M;[L/PH7$I86'C>TV+>MY][P^*<@_,
MQ4?SN3\K^5KPT0<VB@8<-_%4Q:P=*99]?ED2-B2W">1W[#5QT):%#9YA*O4M
M+,T-%G1ZF$W-11$S>%*UK!:UZX#=.2_\:3+ *+;^QV)D=JO<[XT)Y<+%Q,Z6
M[;P UO=-L[FA!VD5^7(B3TG%@ CI0<?B;W$#!QL4* :7')L;G2=1I#'FF\FR
MN&YY[% 72J ?"Y]"NL][ 75K2L'F6.""CQXLRKO+M?X,3-YI;M7YW^]4[YLV
M<T>S Y.2-"[+POG@Q]_\21-ZA?7;TX0$83UYP9$0X[$)\(5%0X)@>NPF<&TS
MZN=]8[[AI\34CY:51/CR9U1CR<:N<'&"%.) N"R19. @5ATF;$1C)QQ\8]1C
M?<<R;@=#%V/5+$$MR61%V "'X$B(E1.RJ,1J](XC6</ 9^X=\U\=]\=D()ZS
M=GK^*W43T\!%5K( 15HPG>Q8Q>7A(]EA"R'P$:?.4X6+8.QE>#0=GLR@X[F.
M6QMN?083/#GFGRI<I"$I6(B5%X2+")QSJR\NH KGXI\R'>-80!7.9U]_NF92
M?CT\5G.*Q'3!SLY+I2V3<*08DVM582,*(F/N6/PJ7&0A8<B(5<T+Y_QG6;DK
M)>>9TA=584,&:^FC\\JL%_;@F+9_8[ZP97(!4OF?P&:JA+QT 71R+#DM;'1B
M+>HCL^J^:YG/O*S!P?F% J!7!#%0$BXRPO&-V&B"U+>!R!^9P09#1'H;-#6%
MQ<T2QM)%.2[*R/24$ 0J7-!(& )-.V4(%\@ZE#*43'1=%($*%Q3<2!^-K]_&
MQ1<N%"?"Q13/BY,C'2 K"1N76^]=@J#ZYE![2UC') 2_F3:[[X5E3^)ZHWC%
MCS"PM0VG+PP]C-.%C49F)'@"$IR/G<Q2U6&"+0NKGL;FRTBME+P(;49J:5"L
MPH:/OS/J >7A7;?V,%B!H,41UZ;'^_X^ C02$[_7A(O9;D9 6!YVX?*#ZW1I
MEYLZ][UVH.M)RF;3A M,"KN+\F1[H4K RXG90=>$BR]>J/X5".7)B]BE!N4"
M]-22M>1%#R]RY_Q8*CUY4<M+1V^<06DM>1'!6*1[4H5M\D)MXZ8*O#S:.*'T
M4G5A%IY*@@#5XM2/PD9^Q!:@VO8<JL7(H65AXT1B"=!SH2<+((D70(K3G2@G
M+X 4:XK]09B0:P6I BHG'DP(&]?95%GWQG0]OV$8)G(;M<;C>CU8OOU\*/>=
MYY!HO*A-7DCFW$PVJ_P6<?&.\EL<>ICR2UZHI8%G5Z>L>((PY]F0(VR@9).X
M?'#938"=N4Y2_'VA3=!A<DS8:(=H)?=CA;JP08STE-R/%9]'CU"<;VT58=UY
M(23$PND"@+M<VL:E7QAZD.*L".O2G[7QF C1EHJPSK@XJ#G33D(EL=[YJ=KU
MQ1F5J@CK,*]M_OO=L9EO_L4CCB?M_9N0?O9*;)PHK%<>*VTD54X*ZY8GI+Z2
M%*<U+JZ_?F96F0/XG!@[#.#"N>IQ50-,JC@2+AM %(3LY.+$I[VK1P\0) 40
MPKKA#7B"85J@[W#?1P]<TS>9UWK3K<!@QHWK#,*RVUQ&W_=:U+5-^]E[8&X;
M5"7[.EK]@'DB;PV&EC-BC =<[GF%D<N40%5A??H+Q?.98C=580,$)\'S(_-\
MU]1]9G!,/]FF[SVVGRZ4IX4-3UPPKL_%U\*&&TZ"ZRAT>*%\+&RPXH)P>RZ^
M%3;V<6OKS@ ,(E@:WOG-T<-HQVQ(UPYZ5/<#S)_#7C;!<&A=J(=>%2YD(CB>
MSL5/PD52ML+3C,W"J*OW 4O7[(59#F^=TWH;8MSW,CFK)FPNAO 8.Q./U82-
M"6V%L5^8S5QJ <(:QL"T3? 2*-H?E\UEPL9W$H"S<_&9N+&:5^H:RV>+4A5=
MJ8D;71$).^?B'7'C(:NQDYJ=AIJXT0Q1,',NGA$V%H'-1._H8+8 7K0G_95Z
MS(@K?^W<@O-(I;AJPL8N4H)7(<2NL(&1E!#!<7*0%4G8\,D*O'ZG[@_F7RI:
M8Y39BB1LC"4=:!5 9,/3,AH0A+5CE=C"A75F$-AT[/!4OK>$V\DE?K#UWMX4
M=4L]GH4+$*4<ST+(=.'B4OL01>?5N12B.!;S"Q?E2CF>A6!^80-LL6+G.*38
M=]G!FNA,93EB%2S"!O-23$/'+_06+PT)&PM,,0T=2PZ)H/AD88.4*2:X8PDM
M(0A.N/#I/JB_<0+W4NSO(ZDR6;@8:=H1+03["Q=B38Z^P3JZ2;)OCB58A(O>
M9B24,#=+%B[6FY'017M9PL6<,WJ[:"=+N'#V/IAOFV^78GH?2X\)%W)..9Z%
M8'YA8\@KDI,:O/O'R3*4'IC;<]P!M77&ZQQ<9K%A11$VJIL*$CB2M%>$"YW&
M#.KMM,OO(,Q-^WFB0V9(:?%2J%[8"]MT+NB$]"L0/0D7H<WHZ23T)(2*2EH@
M6 SB:V%Q_D03W[&$6=*BPAD]79 P2UH\60SBNS,/3V'?.Y0L-E4?2THF+1!]
MV82Z50PZG80J7 0[U81Z 1)5"#M!N'A]JJGZ L2O$%0M[(:#T%3=27@4Z4B:
M7Q5V[R*CI@L79&JVP;)7#,F*(R)^H6;GL:1DMG<C%JE>@"UY+%+-=GK$(M4+
MD*I"6 O9CI-8='T!(E@(NLXVL_9RP%Z9=7BF^D4: -FF4TH)2@AQEOJ=I$Q7
M'H^XDK:A<Y*2^7.5=V/4(TG;9S@]L.,K<UQ*6AC^U,".TT(J"1MX_IU: >_Z
MU&%ZWS;_#!:@_M6B^H^VWG<LU%.N#T!W#&;%I5B$:?QQ)OU2$C;,NT;E*[>V
M$>B\7UCKSP F? MFC(T-P?"&(Y-%JH[YE80-JXI(&NF1&,)&)8]!%@*I<.&B
M9NCG?3-]\YGK[R8X83.0;P==Y\VQV8/K(/2_F;1K6C#KZ0U'A7RI("GP7SR0
M%RZ\)#;D9:D@:_% 7KC0"D)^TK#T%^8\NW38-W5J1:$/?^A>-1N%K\W#HBFI
M0*ZPH0T LL? $P&%\0)_EI7]PH!CZQ"M(%7C ;FP 8YKUO5O86EN@#?.$'R'
MN8-O#K5OJ,X)/99(^?S;OIO@6X)CR3HNM6'UL^5$HI]BK(;_S;&??5@4SF&9
MLKZ9-KOO-5UFF)O(*L'D+,>CF#5A0TBBDW,<A84S@HZ?H(4-TPE.T'%6T<WH
M.3YZ%C:Z>#)Z%@?'B\&C62QO"![-#MTV>/3)?+MRF0>,J3,O_-IGU."3-\R7
M^A?XP^G$+&M=M5=6*Z5N5RK)U2[5#4F5>DJOIVH53=/^C5)Q>H_GCRR@EX%I
M%_H,JPM<E91B11OZGU]-P^]?R9+TWSD^M/[%&U*[_J7K?H('A)_#YRP_C;K/
M\$#?&5[ADW )!6J9S_85QHJ8"P_T:==BX_%=QX6E%'3'LNC08U?C#Y\-TQM:
M= 1\8X&D*/";/D=/[SJ^[PSX"UZ8ZZ/;&+V$OR^\'*VB5BM6-147X@/$?&/\
MXFB-15CCI^7?:]5B35I]22K*_/=/_'GN^&($0G7HY_@]L! $U,\Y-;>PUFCV
M\M GGF.9!OE)XO_['%U'V"E+%X?4,$S[^4HB<./D_9\X7%;@817@<3[CZS ]
MQ[T:/[P'Q%;HT8%IC:[^T0&F\\@=>R6/SH#:_\A[0)F]<(QG_L6NY!( GG]]
M#1==@4=P+$5 D!6DG*>[VT[KFK0[C4ZK/4\V8DVTW6H^/=YV;EMMTKB[)JW_
M;?[:N/NE19KWW[_?MMNW]W?GF;VRU>S_H%X?" /T>IY<%YM%HDA:J;8TX_4\
M?*KE5+=:SLW]XW?R!82<[=AWH%1<4R>1+'QD/=Z'.T=LBIK.8.;5M:-SS8-Z
M(,?%8 \&U&6I\!L7E=.G+*_Z79#L?W&U*#RYX--DN:A)X8M72[Y0CBQ>4$M<
M":RZM/:>M1=*%67STU9+4N4]43J6ALKP#>7AK)ZQ6&\9.LXP3DJ6%BBYM$C)
MH>;<F8A_"\!Z8*XU>F1#Q_5SA*>7^:#:W_RKGOG&C (86A,Z!Z/P[S_5*J7R
MY[6D[ALQ03 DK6,"<4D<<"#^]M1X[+0>O_V+/+8>[A\[Y.'IL?W4N.N0SCT!
MP=T!Z4QDE=P_$EG[8'PD]S>D\VN+S,CTB3QO-#MX6:ZII3D K=:DYQ>8&R$4
M"DS')7Z?D3_'Q$-"2Y* @<F,/43I [^]%9JG\S1HP"^% 3RBC[<5##HJC!AU
M"\P>TZ2:JW^GKM[_^T]R6?JLRGF"EN]AHE@@8-\_9N(^$_<QB7N,N7AA&OE:
M>=^CEC<1^*5(X)<N6.!W'AMW[5LNUC.)_[[$]R?T,Q;Y/=<9D'_C_\;S/QT3
M\*F14.X?_>VK >,[\XM/'&:;SF!@>ACP(C<F* ]@[RYSKW90XBT>N,*;PWO'
MHD/# *!<4*M:K;91&Y\"(LIVOOFN*W]DSZ:'C.%C!M-X]>5<O?%G@&=W7ACI
M])E+ARP :>?ER:VM%X4 R)8<]J'U1G6?X.J(TR/3]1+JD?:0Z1C0-8AI$]/W
M2+//C<*/B?1@02$4I5"W[A*[4RK%6DU]-W:W[:/4<K$FK[YEYT?)Q4JMO$U$
M<0\%'A+C(D0'IF%8[/0J?%>>!19T7#" >-H-3PIJ.H'MNZ.F8\P[( 6/Z1AC
M]]G0=5[P.5//HY*K7S.+OE*7'=\Z"BU,893'7F!O&(;+/"_Z!_?CY#$LJ[FZ
M*A%^D@#F_3PBURY(SD6PYG?62]&[FO#QWNTXKQ/DU3".Z;K,CNT=G([NW0>@
M$]/6I[%!*5>_^Y_%M^S[D@<'B-'Z/W,84FKT"AET;472-NC9_8@QV9S>H6^W
MT::CSKE]WDC!3K15!8P4I:+4U@<-)A9\HF3E:J_Q Z=3 A:] R:]2_X3N*9G
MF#JWZD&_S\E&/LQ]IK;Y%__^,1V"[4/D5&Q-;"A?&BZC<URIYNHU3/^;)ZJ/
M.[#^-P?@]-!W[ 7;&ON<UDIR0:Y)TNEX_BQ!C@^WQ<=BNTBB4QHNF6?GR&'Y
MF$AG>XV]'8GZ/ $Q3Y"B"+4-T(T6&R(I1$N>M\7__E-5D2N?/?+@@O(QA]0B
MK3>F!]S_N.\!N)BWITTN $C:L!+7]$UXF,N7S%SP.(:!ZP7HAX 7#B,X.<C*
MA^Y'! V&*QJZ?Y5(/V2_% +P'32E&HOOH*A%57L_&V&'6545Y1 W) (W*H_W
M<QB6+^XLX\X6A#1]B[O7C.I]HEO4\[90M:F C$MQHJ0]&G0=ZX.WC0FR%5S<
M\"47"K9QN(;3$WO3^UCE@X"$?.V;\,M4C.YBY&Z93W02>A1\RR5262-9Z7+>
MGIAN6AAT!4SP Z=Y,J0N>:%6P,C?,/HD8VB=>/W]H@HB8>A<I+\]DB+9$HJ6
M"88P=OM;NW,NZ,<ME\1SNN+BK58DUL+ ^V+4#H7>?, .>U_?4<^@?Y)?+*<+
M-G)8A6@+%RK9+L5.]O/SG/U\WOVU._!W#O9:_A-XX#".3@_V6]M -Y61[HCH
M?:;_(. +_  -S'CD!4'L3CRX*_)!_DCZU",]TP+L4,N"J[A+CTC[,S 198"I
M+HL&P$,G6%,Q4!-N3D>XFT'YF$T0GW@9-Z>) 5?!JL*A0Y?IC-M8LD)XKHU'
M/L#S@*&(%X"QX/4=W-,9[_GZ?>HO3)Z\TOE9XA3#FZ,U?,QS+_:#$JZQ"VP)
MU[O_@17@>#X4;L)91,_!A 6/3X)/DGH^J4G$H".O2*(LM)VCJ,T 0[Y^F/V
MDM^G?N!-Y$,U5_\7\Q;%0<@!)$J$('=.2BB2(PIP-#!]'[#*+,"5Z]BH1JP1
M8:!21N06!1K5>9CAFOHTW$5>H-?I,V9%SF, (TN2%@4R BL,Z+0+'<+C;Y7/
MBJH4HP%^W_1@QG2(>XO')MYPOA.:9-['_2EN!D (GX@ )Q17RRAN%A. 9$HL
MZH*PHKH.%.=2)!M$@HL"9.6O!"!76'G!&P"IPEO<,;\#O@:P_A&*2W@:R!B,
MS3R39]=Y]?OCJT60GHQ/S6 ]T^8)+QY2(4;9%%CEF@GRR_+G\;"E ='U_'C
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ML/;3R3*88DH\FTZ5:K$DO9^1O>VCJD6E\OYIU?V/38D4"=DY )2"]8B5]/D
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MV<(+>6<](>^<?D6K&JCPWA1ZGZARGJN:I</8[Z].PK6MCYTE!@C73 ]+=\W
M03O'_MJY , ;DQR4_Q-)7FR_(Z."<2S3(#AG\4!P(&MOQ/4&KM@=A,F&XHF"
M4N=:<3-P77Z:E+/0U0DCY0+A>,^%[LPIB0=43'J$X+^5,&XEZ.*;U L/9>GX
M@?T9F"_46I5ENLO2)2(XRO]VT.IF5^7B4T59UA?S#7= ;URJ\_22P#;]1PRF
M!9Z1 T*V<>+\![T U&PPW1Q0R_LYA]]L.F XLO!,Z? *Z:)A&_A/:TH4#;])
M77<$D/B=6@'+$0QV4__GG/GF7]G!H& X/*J'CP5N 8@PSC<8">D55"E7EV4I
M7U%+7S[-3W6-M-J'W[9&S^ZJ?Y5 S/CBLOBB= :^D($O%#DOEVN"\$5,QF "
M]!^O+,(5H./WP;5TP<<$K'8MYN6)S=:G5"B[06,EZR>6238HC\<I$.^8'YG>
MNS*%DJN7\]5RY5"6>(<TCZ$JMK&=4TT[&P1L++2C@D"MY"ME51#B.75<:F8[
M('I$ <=?E;DL/CU]8,Z5[3N8N[HA^><]UMC6HDHL:VP0JV,HCH Q=N6(4JY>
MS4OELB &1IPQNU23S 9I>@C):*B ,YOT#!6?7#:DID'8VQ#WL;T9\U2?"V-F
MQND>4C2";BL$+OAR]PC9<&ME3W.CG*N7\II\L'#-3%6Q*&F#<#T")560DN1R
M51!*BC,.+M?$E;@=QZ=6',)UUSW"R^*7#9+W(,ZH@DNG2GFY>K!/M\<^KNCV
M;4KI;8-\/HC>:D!OI5I>B<W^/2J]I<DX=H8PD_ 0*^Y7\CJ26:QV?W,XA"=V
M??#!AFF-0;J[QUB2<G4U7U4/YIC,#A:+A#;:P?&1D,Q)J'9A@=L$R%5>=K/@
M] H!UE[GFG-_H7KQ8;<-0O4>^('ZL/1OC'J,@_:^]P0^(L)U5Y90T"<L'>X3
M9J%;L6AH@U2-E894I*&R(@M"0T>I^2!@_8@$R'T>LR*P[D(66SY<[D\#@'>.
MK>_E>99*N;J2+ZN:("909D6?2-['03L:IYV2(@CMI"M^O%IPQG,DY_)21[=<
M]T6P_E:!\5UYO8P12CDO*P=KBET/AXF89YVQT>6ST5;Q_EW9J )L5);RI02P
M4:1.QS.(X%CC&7TG/MLULT@55F(X 9[OGUOEH<?&3C&U"S\P/&ZY-&ZMX&&!
MNKYC 7R\J&@C<%3/U,U8BO3N>Z0V]OM3<IC5FJ(WEA.MY^+88[%E L(O#9U7
M]?7(D(XPZ3T[=GG9Q\LV>0(1.3R$U+!?[D()<V7D?+4J2NIN=LPRXX,=3?E8
M^*"6JRNU?+5\<#@L2V'?7:VY 9NFL&>["?LI P3BC!&_'Q]H/"^G5,KR<BZ,
M?C8+T7CH1\[5M;RDB$(_Z?$.^-;_K)N7'R>I9VDY!Z?E3/I13[ABB?#Q#+HP
MUD.6>'..Q)LMJ$0%*E$3DEIS03;F->LQ%SMZNNR%V0$[3#9>O+&PJ> 3#,;'
M_&'Z_6;@P7*8NTS[N]D-I5Q=SDLU4;(1,KOS- +T&*2DB45**3)!QX@CO/L(
MB%O?X=V//!IVCN@%?N"R>(3PQ9L>:X0P_=/SKSHNM3U0:?>]&].F-O:)#'>T
MHV 8,VX<M^&U >Y>@U>!OV8NTYUG&R9K[,E79<Y7DB2(]9+9N,<5T><CM(I8
MA)9EH M#UM\<(,?Q_F=FQ!]BQ'-0'K1GHO%S]OER^6!_-C/:Q2*=#49[#*13
MR]5K^5KMX.*^ MKHXB>?Z\LY05D%D]CEZZ%;*67<BI/S%2VK8I+1W):"^6":
MDW/U4B5?EN(Z09Q5,HF%1NX<G\W8O5D!DWUM7ONYP]S!->OZO#+[$)L^\KV;
M^RXLDO<7W?540%G)U14M+]5$V?/.S.!3F<''H"85J*F2UV11J"D]X>M'9T0M
M?T2<*?*RLB9[A:<C2$ZY8+(SL/=QY3(>=2_G:_(%]8/)"&E3^/D8A*1Q=5TK
M95D8PN\/9G;NR?<&]^>K<JY>5O+2X457,S-8+&([WO[@_L16"8E-$878TF,E
M+^499^9Q?.G%^S-$E5>#UR[H&%]&1_LG(.]/1S6D(U4]N)5:9AP?G*(,UB\:
MQ>/=NJ'C(B(R@SCNC.6]F:6"36IK>5D6I0='9O(*D+6\/SG)G)S4VL&);YE1
MNR-M+%<VS0S<&,J;SNQ'[\\5O+FK%%L61&;9"D) V]0XC86 U%R]$F-S%I%,
M6O%SS0Z5H]'B4YKOLWV.V:Y,@>?M*EI>KL2USRQ$=EE,AFU*J6W[[+)=J0V/
MY-5*>:D:5XMVL?+*#F_!??)RC^C"P%R9K6/!QP^88$84Z>.&EMM; &$KS(2,
MN:LH?//,*]NT?L[Y;L"6?;+!P/2QE9"'R3BSRYN081E>N4A_9ZEB>2P@E6(
M4F4MD 2J*2O<_1=3'7:U&FFOKP:[7SG1K!SL1/:/GQT]HH#CK\H\7G*&>K$@
M(1Q\(> [3_[VGO!Y8&Z[3UWVKM&Z(G:&+^#T]$#=>[?M8R;([]0*V/2!D0$A
M3812]7TYN&XJI2-,I9:K2T5)6DX?6OJ!#*E+7O!Q1=((_+[CXJ8W6;L0#]_H
MO;L&Z9TU\ E[TQ=M9Z1-%E:5WH'QZJFIIYJ:C#E;$IX)7GDN>!GRX7P_[PKK
M'1=TZWG![HM1C@WG^\#W?&JC,-EU;BH8ZDHIKU1+>6U%:YAE0&.I\.,2]'Y
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MOWUW/(\A?6:%KLOHCP+MP32OJ/5*1QXB;F8U ],N+$!O<>%KE]?K'6-YX;$
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MV^O65:N[" VZL:E42 8/U#3NV,YA8Q4[GN0UY6"#5)R02<8 E\4 &_NW',8
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MM0L,='0]G'LNHS$]C^)[)CQ=\/>'3PX @AP\5/")&-U<:T4IUHS,_8IEGXG
MX@;5.AV'9UT#D@: ].]_2#*_XOBK\\W^43=:,>B=7;9[C5ZOK->77_,X:_KX
MO<1Q<"A88]@IZ8A#!;VT@30F7$>S =$C\YZ1!1K.(T3I21SEO3!*O:7L-&R6
M8N)Z-HR;RA 9_-%5[0'Z904K>PE'D,D_(V6&CM^BR\S!*1C&V "LT8YB$GQ
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M+KI%?^<>8>]I[-)+C5TZT.".4@X.11%XQCRZ?;J6_WR>7+2-6<>>RXM-E1W
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M7< Q)A,11;!=L(?O9M85O-ZS.JU.OVD9-P,GG01W/ERKOAQ\72BFGIC$=%@
MN!]-@8?"BV';<Q<%WET0.+"5$.1;> \PCNAV)('@]0(<+'L.IC@N8L=JQ8B6
M1(W6=60V"3X)AP%@Q\:^D+W3SP, A04@<6,/WNNB>)W,;/^.;@$>">!V"[N!
M,P8 @9D+1X+?N!&\,D2U&O#.77BH.Q-(SZ-8+*QYX(# AQ_9BX7GPEMHQQ)%
M(^M5^S60*&YAND1%2IZ $)'QT+9RTGTC02))41)-K\-CE8I-!K4%_TN6#T@&
MT$H?L<=1X"5Q]2,&HP"ZB$7X\FSA(@<JX\]9F&H^=Z!:A<+^?FY/89MO;._!
M7D9H0YN,$+A@#GKY@U<>;SI]CN,QVW6 IABWWR3 @4/N _EW>Q^V8<U"E'K_
ML5Z#&0(+)Q\5T/W??[4/<?\HO9&;TO9+T*Y*$(]*!?&(!'&U\.Z4"N]N?>']
M\D2I.#>(Q$Z1V2U$2*Y;5,Z#,>Q4GMS/L$)XMOO:<@20*RK_\EF2'M+##.P7
MW1:O>J\MD*;!A!+=RW^%?+_ZU4K,]E]K^84K/<R$WT Q8-,/6&HL+33+HJF+
MVF/%>LTL<NREKD6+O7%C>/5D@QO]8AST)@7<MCOG;HA?8"16P9[DKE(L2'%(
MA2LB@=(^;,MQT=4%'Z.X-Z2]PA6%Q(0;+FL:&-0@C6DR(5U$X6P2AJCK*95'
M8A'M)XKA>3MTI$UTI;>CM=@BMN(9&*-1>P@L ;I'NM^*@[.B*=4O!Y!6;R>#
MR*LH,-+(K;<;I^"#EXL%_K"14:WL",QFM,;Q0U:=M%X'\$%U-:]G:\6.0,OL
M815!D6Y&0% 7:UYEX;ZR5RM/\B\ 0H855?("\W!*M:0+*5%3S9,:F!:*.[AR
M#S5FP!: /WD-0 D%:@/-<XE8$?-3&?4/EG;GK#2.E_)$J../DPB((,+W(:),
M1$;KUIA4<20^1123NQ=>#EM2P L1$GPL=B_)<^E+*>P1  0F%.C,< L49F)_
M2D"/(6CP9&2\T-&#\/L1LL//J6G)<$M U=>FX*ZX(N%!^RU;*(KXX:]P2:#X
M.]PV0!O"&?,8K" OP2 KG *)+0)S":Y_8M(J\#Q,R;^3!.?B70.[ G0&W6H*
MVW'T8XJ4HF3\;S3\ D0[>$Q^#[_\,[')IR:S^M%?AQ8:/M:TKM2KO"5(7K8;
M%X$K&2Z BUA:88U0_)FXH40^&ZY&<[.&!H<OB($KAS1P"N+DD44@P]<"[SL^
MA/UD."Z^2L<%^Z5VA*Q"8ZORJ6AG#MZ<TON0$9)+/& 7 ,D:\JL8?!710ZV"
MZ*ZX/^$[<G%VVE9Q1S+/Y_82/0/22M=<CRT%DA?\!OR;'8;H,<!M-*V/TZST
M0=F-9@YY&GR@"[D/<Y,H!8,D1EJ\=R,4<*A3K-THB(2,X,5X7?;H^+B G]V[
MXH%U $,8 EE/$Y]HS/;44UEQ%R-9:=A'&0CK$\YPV0F1&KS"HH0%/&Z"<MG8
M#RH<Z;?:@:1_T+0^E&Y)WH@36'X0*Z*&WX6T%=.W!H\SQ +_+J";@:7N0>\2
M>6 U"I=D@(C.HFR'RN/8TDQ@;4H+4%R#-"\#>U,/GV(IR,7L+ ]+N:/T1,(.
MA#]Q68RBR(9WP.\CAE.TG(_14YQ"B;"'&#(LA&IF[ (0[VT/V!PQ7'@1+/-O
M"6#6O=:0 KG'>&'603(P7'?(X%[B"B(0J1DF_.Y"(6GF-IFHG9AOKWAOQF'*
M?MY2URY<C^.X$I=,--%:C<871W@N!M+0W<_8AB=2*@XKW28@G$3CASH.'K%I
M?9&.6H2!("'++D6I^;'+$KZU,3*TU!MX0!U6V"'R-V9W&5322OQ*@))"7\2<
MU3>,;YN+^!!$W$KY\37K?4>*QM2%.4GU'!1)66#_.?%SI:YIC"SX_U/'/P%,
M(3A@V#ABI_Y28TM"C?8TM3+Q>NB=ML<<-P0"%&&,W[KH2^:M$X]2HDT[]^5[
MC7C%S+X7@(MP DUF))M<TN" , [_*DNL9CMT2=22Z"S&15BK70C:MI4L AE(
M(1L3;W_BAI-DCDP1Z3X"^QS3^!0-%Q=L6I^++TDU#Y!$_CE?$A /QOPB9&$L
M7U-.(\/WZ?*OGD^[JJD NDW1W)&J1\ZSW]]=65.7,D>01XV1'/ ?1K3=7B"_
MM3WTPBTP9 97>P^(0.I4-L:#5VR'176MZ$HQ9*RRY[58E:I;"7JQ>4"1LH2,
M/..2694 5D-GF6;0EG$R8HP$$H5S848%A9]"5R S5EH;9KR2J40?(D&'0/5V
M"/P"%2R)T: E8M(KJP E&V4YI86/I@09K%*:LBTY3#P#N,X"S^%#*.:I%=1R
M2C.]2FR,(71"J8*K%Q(CE(QL,DE"*PA7.9LR83I^+(4Z0H!X7NJ/.@ N5Y,D
MKXN!XJ\J4/S!R+_;E1MA;2 ;*5 J,2HNG+GL:>I&B.WH.RIHJ7Y.8G*^\$0L
M[1]@UG<L!,VW*L\""NB,CRW)*7EH2@@[<J7,C>+$,22\"JPJ"X#]9[Y-Q,UZ
M5;0B/# . ]LA35?J:<A.HI1<Z#BF4MD@X"110FIK*JHD>4:38"$]1W&83(Q=
MH. GAF5'AC[:P'\^",_#_[(W#D'W T^:/H<*0\I?%.A+."SF!<PL7Z":BNY%
M#GW;L5HDYX'!Y4 #MM5-&;JY=CVJW%.Y_8@,ZI #Z\A=.''-L^9PIAGQ+=K,
M#]+8 $0K4VKZ.J?&_C.*WR@JN?*==RD&?.$WOY,;S=0'G$=B\@:.\ "' KF2
MYMA<G%TB3Y3)$/FX.L#!0TL=$)N\SR;N&4X Y)&)[_Z9B ;ID  E S-R,@HM
MH?31-'6%4P^F94QS:HDI2HJ)F8*&F;J4K;8(0O:U J'@C464^C%//'U?+DHG
MO/4PB(-XN4#TE#>=TIZD&Y4GC&_Z%<U.K*,X3Q:@#,63F9 V</I[E3!,:($G
MD+\#T*7&F $-Z6<1N(+G1C.IK<-;OS-9Z0T KTD\/IF)WR#0YVX422T MZBQ
M.O=+:45^ ,U#$86IX=N@EL]RS]21,ME4NT,1.E^,S"$%**D&9'H,OGQ$CTP:
M=,\:)EW>B%,[QDC5S%TL)/90-@\P-0Y#9<-!P+Z6"T0H-/AB]AZ3C"%FO00\
MC95"QR++QGP>94M&1)&HA09)ZE/'X-P#FQ:F>9@:#(;J%X>D$>(V_YTX=TCT
MJ!"J]:5S1]E_:0+6"Z5O(0<!\>-'F4/Y9(#.%S'J@8:3G"2^-K/U<=,(JPCG
M_+@! 7X!^D H]Q8V?&^['HK)AB+,2!@0SX"43"R0N"FO"M-,S:9U@PS2^$3Z
M<<C\)K%9N"D/L(1#$/3N4+#'@.(;82*0%3%O(UO]%M1\SPY)AFN/=,56.<.*
MXR,/H&0+O-4TK,S)Q*!4(4C1 P%\&T\FY@LC"4'ERX\96M7PF?(1&4"H#@![
M]55PNG@0"2B.>I1;56KE*/#N)7@RG@O2/0(46 G[JN8&4GAH#]D$\^Q.;0?9
MH529I.A4EZ*6:%I?E"<\4B(P,C'-?!40H73=HA&H5@?<\ /+8R3'2 %&A\(8
MG?>(IV[4W"2G+OO)SYM5UVZ=TNH.)BWM9TVKPV2XLA2YWHJTNM'^9K_7]AY(
MF7L%6D^\PTPLC#*QD+" PR7*9-:Q-M-HDEXEJ2?(\ IQ?$XA0>F)5C[(%U!N
M<F9H%&#0#!5^L(.KXAO2OI"N!;0LM0M)]5+-1 )UW)<R6!P=($#OK@X/R!2B
MC\J ,\\)(I:]FNCS @F%C+ L$:PAW5W*K,DF#*'J&BNM((V I1)0AO6FAO6/
M'^//#:N\(A\1G1V1R+UMO2*A=)%4NY)>&"Z9,=65PD_81X D@SKB;[9'>[J=
M"8'B_HH4U\]HQ#-HN^T&JJ,#UGC>P7IS4&4SW_4;?"WY4SP(.,9_UFD_T%TW
M&Z58I$-$]KN(2QH+M%MGE[U>L3<RG:36OGK;W5?[['+0*;8L08V?<VTPVZ>A
MDL,H)2Z$EX-EL)3%&1R!RB2&Z9"H)!2=)Z13_#*5&TC:C/?H*$3O!*XPX83!
M-+0U%^A[<@-*YD/+3CFN=<;=-/$\;;3A-RD-J+UEG&0IY9C(2:ZH7#9BZGE'
M1?D8W<R27CZE]L A2@M*Z%+>4C(G%FB0Q3G1X=PKIYF)+78^R[=I 3<G?N+Z
M,DR8S1'1GLV)'<WT5J2XT $7*5)8QMBI/TV+*DR;6)EX1,=2:7&TJ[4R)GO,
MS62-YIH9JS G%XSOBL)!YRCHM.(-.7THYC+8MRHIP<C50_-MP25N& _*R;C"
M/L;RE5B6!9^[.FF:&<X*:5-#V)B@>1&)HZAU6;?131N;'+<:G7:QT<V+B*3'
M;[Q+&^^-BA,^LS+K*)ETQ*+SAB+CE@+L_G%J,S$+N2&Y@_!/3KS54R=1?]11
M?D/3+0O$$0^B<(8[E:6:.@<+V1IP<>(+H>9RLL)!IH2JX*3!K5@Q52KB)IP*
M X*\&*9PSI'I_*72/Z)E% ,7BT'1(6>2+.G4F?4ZPIBI<,T7)D@&5EKLFL;"
M>0_LJGLJ\Y)(Q1=A*CY;YV#V@G =(*90%U&Z0C/MH<9<I/+MLZ=:N^KCKB[J
M\9ZBT[!6:X#;R4PXB2=NIN^IN.Q?H%I_])EMPFI&YX#W/T +\FU/<=GHM^47
MJ:!?^<ZMQ*1B%X'VH- O8#V_W)="_[\9)?Z$LJCTAU1O(VEI&J O&;N:;"X3
MS@ZD6]IPT!QUNNN:B>UYN]?51[QH]H>K>YQM_GF_6_Z.NHW7<$_]^GW7NH_M
ML[.KCHWE<UJ?!5$N-H$-QSI>'CJ%1C8\0)NR0CYSMLI[X(?.W\?AKY<DARV0
ML^O;?)T0XL7'T%=UW6P5&V_N+^:A;K?!)6QTV-*)1D<(L'X=<MSZG- 7IM/-
MBD_WG7[77<;&N'E$S:)K'WUOVT'7,>+Z:V;5K^F?]AY+EQ$D5]R(P'E$<^CV
M$!N\#R^*TU(?-\V^#F,]J/$Q)^([-N);X]AY">(;G5T.&^W#(+XMS9G9ZQGD
M9K. 7)=#:]O^Z$&SO\&>2A+N\'K/N\T2!PRFI7(REWV$$]-+\&G_)XO6XDAK
MG+HOP9$NSB[[C>Y%,:FC)D=:,61JC^?9'C%N]9\!MPKHTVF!0+LHAE]W@SQ'
M;@V75%%FJA0/Q1[>B$!+KN;("'3P(@3:/KOL]$=;TC?WP)X[(0\AS_!%D*=S
M=MEK[PORO+0]\L+7OVFYXE%P]^-7OT;/K-I/W1_".?]+A$$9X78QQC7JM#MO
M]T0U.^GUVT*LBQ?A_+VS2[ -]P1YCERO_Q;$5#O,Z3^'PN<W]$V63X[\^::C
M;A,J1\'("L.-7]SWU>F?7;9[C5YOL%UW_),N=[_#9"=J/E%SN5JR>VH>4&"[
M\V1GY(Z)N7SL\:/+/MJC760VV[OIP*B ?XY<Y4V[W6P-\?3_5]R']KEJ"9*/
M\P73>IGX@];N<7UX=MEK]%LE=4]&U8C1RI<[?\F.9-B@S2FKL^ ./49K83=-
MT&]8$:Q 0P\'C:W'1I\PGB"&I6"K5VD)>[%NP1P@5JMJX9T;V7=W..,"87 S
ME7=+?2B*%0B=T2%6(.C" HMK!63=,W675X<'?#'[58VQ4W5P%]J+&<#0#H7]
MQCI5)>RE?7:J2MA7;?-4E7"J2CA5)>P?YIVJ$DY5"2OI] ^?&B_<XOBO8W/7
MGO*@CSX/>K 'GM>+L\MVM]$IZ26UAXG0IRJ$$_5MC_IV7P+4;6'.;Z?5/@3B
M._*LG_<_S@]2G3@E8Q Q[[ZDJ-L&4;H-8CXE^NP9;NV^.*3;.;OL-OJG/*!3
M'M SY0&M#*7^-+KO-F!S%#QO]Y9IM_N2.4&UKGB_3=<3?9_H^P"RA+J]%\P2
M>G;R+LD5RJ<[[&7+V)4Y"1_D8+C-<E8:5L9^SG51!-!3\^JTW3OU1?_H UBP
M!_NK^<H.0]RC?]UTR-<-BS*,K%=>=3N!U[P6HB[V>+;6O7C%4IMMJFGE?0O;
MALV3M\@@^;_V? Q\XRFOV_">J$>_VB&/"XMP[BP.AE)M-C,0.X3VR]NCI?Y^
MT%*&3)X?"0^&3OYKN1#(9#8!\RI&5)\*K&)&W6E\F!P?UCZ-#]OE-D[CPS8:
M']8K'1_6/WMT$V\<5X5S"C$A./H4V#[VYO[@^K:/XTF^ZD$TQ239;O_@DF2K
M9T!19;9JC?]3=.IN-2^&@ZWD>;8[S=Y%O:6>/_F4-C4Z99]N=)[]2D-+4T,Q
M473#++X-$_4.!@AJ2H8)AY\J.8^9M<&BGR\?Y5C=E3^+-W)-\%ZI.*DR\X\P
MB*+:'L<!9=L,BD-@]C#;YI3J=J*OK='7F@2&;=$7-;1NM4\]=7>/'7H 9ZFQ
M5*F._=1Y/FNDT U",261B&CD.@E#4#MKD\H(<\4&K5.SUR/#H36<=JLX='%V
M>=$8]@^DY^ON4Z2.W-[Z)*+HC14!ED2ZPX*-_B\:-/PHEG_TW3LK6+[]9Q27
M:$57"IH?@O":IOY^ O+]$@KXB6='$0XE)W]OC0:!O=;6&@2>6L,^/W*]VH(P
M>#IV%;&H#:9MR0SCU\?>&G87HRKR]V&Y?AQ8<*%A@KU>W"@.W7%"W^!<83_"
MR>88'E['FLL'1OS4^M0C&33&P.A"X#GR0\*_\[H73>3=G$]W3HU<CQ3''LFF
M-\:Q(BYUR[GU7NKMAZX6KXL9[Z33X+$Z5$_]%]=YD;+,X9&F?Z]W=CEHC ;#
M ^^PN.NBB!.Y_O3DNK:V<QODBNV-AXWA8,N1D7WHB'KX50ZK0R56C+6@8*_5
MZDSZ@J&$WJ JE$ 'JK7M%_1>]X95WFO+CC!_KZ3"A ZD\FKR"?.AB!9B@HG-
MWK*A$@&QEV::+0ZK3O1E1Q%F6Y?>>=.ZSOW,R"N4$V&D22_">Q=, =6JT[$H
MH=3"K:!_0+\/\<B:R/*IB!*_'V;N9&8)._1AE[3"!&NI(FMFWPMK+(1OS46,
MV\?2@<"*9BZGI<,F[H+  2B%UC3Q/+@S#XX=R@/.%YY !X/:6P,!^B#@=_!?
M 3"9<_-= \<IC3[=ZH,;SZQXYH:.M;"!%2!$;@J$X?I8!"8HT7+"2& M@I"0
M3#DY8-OX]>< %&WW+_:6I%GP:JVJ6[@B1*BZ\"*I MH&>ELV^F6B)$13#7[E
MSL=)&%%?VJ9U6^&)D:A7_D:N04@!Z,ICXIG@G+I4P>C[B]=,7A]<]9,+2][;
M "7\> $/8@8Q7'3\@'<=/P2XS!1NTEH"5M S]IU / $0I4_/;,?ZHWG;E!4#
MECU!O*E1(/,L+)86V[Q;L+:B"1CL[K30WYEWAQV>/,%.OM= A;:_A"MR_1C^
M'[E%BF=TY@F?V:,S6X!#MG0U&"C=D$S"9:P*D<$ BMKP+^1!$O-*'@0.-K/]
M.Z)2HL#TW38@L?)?\G*WP!N !36L.^&+T/:('&UG[OKHRJ1:D=21*=>C>A1J
M\HQH>H/U,+@=YHIX^E#,X %\%&^U:9E0L;EJ%-FJYP'/ML>NYP)'&%-IC"NH
M!7+)J0A*ZB%<>FP#5P88(6%&+ERC#7"=V<C%X.X (2; \7X@XR8.XS-3P&HA
M)X%SZL?ATQ@$$QP'@1(9[%MS;.*)W_W@P4</[R+!ZB2\Q>P)W"A*D'-]A%\!
M$PX1AK+QMSW'XZC,]!6XT* ?*%B1Y'%P!S,X1Q"B7E: FQT).M["AJ,Z">:N
MVW&"^XB9*::KJ!.=ZS-F6HLK1BYY"SS'+<@C60QE1X&O63;6.P'#IW_#&F("
MKR=\F"94$P4HZP=SEH)JF3B0+P0,0YIE'()/C>,A'"S'CFT0.W1G@7\7(!SI
MPAI8L0F,D62AN+>]A$K%"*J.^#.Q)TL)Y4A0^59X+R0"KJ+ !Z"$>MWGU]10
MF_&<=Z">QR"KB^Y$K1JU4M5H5+,_S9KYE8_?R,7995$_VX["5M(;OEC)AOM8
M7X_31WBMJ[OIE];=#-;5O,A/T);:$\G)NLM7J;M<5421#D]L?E7Z$RFC6FM*
MU>U0I$(0:WWXRSF8L0M[2<P &#-C-<K- !: 14*E!U,!)YH)P)J0G6G -4AD
MW FTMND'8^(GLAX4UE9\#J6N@/<A'R-^8O 7VI[FPTI)C#2[G[,L0VT??T(*
M_9@$,8"/GL&?*8V43J]>H9[%-\3 @6.6VO=@TQ#G5;Q=<O!4066.K971G.(@
M=P8"WH\DDP%3 Q6$F+^ C:D?X7ZR(EQJV9%DL\9+Y6ZEGE!<7IH$@&]X92AW
MR?89TUGB&;S=!ED.>\;PJL^3#D+8 !DWR3SAXE5=-IO7MA-0E\R7/KA@^/@!
MH,L$9%O#(L-+\.82N/X0U;.8=))@XM(1I/DC*D#,VE@4>/?"8:  WYPDTA*
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M\IZ]EV3X?!M;N8TZ(\WVKPSE.O Q3S#46>^?[7]C):<JF#MTT:@/P@63L@
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M9*I.)$A.@RZ;Y__I99&_A%Z0JE!N),V?.VJ'#6O>"WT9U#U;-WQ#<;]4Z3<
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MCH)FTK<=G#WM"+PV !M>$#%3N,YD,FN82^,,:L\E(8V,-J15 <B@](7! XD
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MQ5O0T%NFBE[0T/$&/OJ@Y"2H<JFXQ%>@PUO,+7.^B!"E-XA(K94#C/4U !T
M>A4;_/QBW0H?"?16@*X%-(V8&-4HY=E+G?;&AW/<<S$ ZYC=; L!TG-X?D^
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M>9U?P.N\SR3?K2+Y1[BVGX'B>X^F>%VUL6U$&."E;H )A=HTK*(X[S9+1C$
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MM1@<QQX+N!QJ;..T%;X9%"+_6P1AW-D,8U!WKLX"RZZ%E1POT126&_7UOE
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M>&":I<*RI="X_)9RL^Q%. ^CQ:V'3XY")YW"HO_QOY\_7?_Z8=<@#(-F?Y,
M53%,BVQ_WFV6P'*BC\LA0.##8>_-X^%&K"2V!OG8QE'./)\:9B-[L=2M=.@J
MRT+2<#:SW(47AZ YT4+^8D<_O" VKL8!<8VZ<0&'X'(U.H6)!($XG X&YURW
MY[Y_>RF!-3IL?K>:U@?4/**>5"XE%G(#_@UO8.++$JM^"VBE!;P!EFW4P=:,
MB%0DGTD@FIGG$N$8?W;K M<,.A@5J;"\*1FA/1*-KEM_6\-5[26/L2WL2*K8
MENS%IJ+^Z:T';Y&;HA"7%\6)EB*J@HON&DRPS'WK1)AN!:AYX:L"%8]Q,CAO
M<,W)E+G?6GZ6"_"C=\M_6[/!ALD(K/QO7,WJI-\X0;I#CK]2[S$7I=;T25+I
M%UY$;6( U[O*$\-@^L0EW2G4OF2"="%ZIG/<<Q]&OG./;0>1F/JC.ZZG8.2C
M70UGEP ]N+KUP#9:X3 8/XML;,T6@7[1<Q"G/K<!T#3718@)%7R66?-3\]A7
MA=\>@^\0]*E3?M;/(E)KZD.$)^,8AE*(VU_4GC5BM[5:(\8:YRJG*@Y?+7;;
ME6JQ(7K='$Q[U-Q%11NE*IA3Z)[OJ7,+!-I5&&\:.#)6C]-;&N/6N+R>"MST
M6"QWBH]O<'>C[]D3!O,PK'O3LINQ1QCQL8KF< ^<CXEKZ59&#3WBSF:B^]&3
M !-S%UP>1W=+^M[,7>WO-*W+6+ZY3)G8M"(V-,C<7/*:O& :D:V+CYZ(?(]X
M4\V=PA)\6+8TA:I\KXW]+7G@0EJCY1[<A'AJ9IM7;FFPZVQU4VP\/VMGT_XQ
M:XQVEC#/X\QJ8KVU#S0"HOAZT7]-#\: &R@2.D+<B>/.R!\4QXE_]'V7O4Z0
M7PLW$BH-XW&BP<Z.8P\#=HP@(YU?5%7N3W>:4A66;04@8'WA;2I *]J#<"!E
M;@^7GV@/5>*R"""F%9XKA@X#RG #Q;K6[VGDQ8XWY4TK^IARGA >&WE)&"TW
M\HK9 A8'C_N1=.;)*Z=.:5?2OX?JFXD ORU<+DJ :@YEWV)I 1>?4QN?XB7W
MYP+?C]<9AV P2, 8>$88N^;+9;,C0[X <7"1@4BGTN/UU=.E@4D31O0';4((
MIDCYXG$M1V_*OM7)M1B4,1S/'ZD=)5PXR_&=32Z^X.:&-P')PGKJH5NAY*1Z
M$/H,U=R5B//\&^[["HXS!)OQW4_D6!P 39EYU_EN_ZRM.;K89U)5B2NM5:D!
MD)[ A,$V]Y C\?H;* &Q'JF1%V0U5>9@A>+_Y 7>/)U?!@%('C% \ZMZ<^V]
MX]29*G,&WP 2G-YGW0"1V+!,Q*00&R9EZ%$$C<(C97UGFP3T0';BJH73K$LL
MF POOUU9HT'K@,!,OZ.HFHE"ZF]N=,?X8D\4- ,2<US6!2XX1BYY5*0N9*&O
M)DP![\#+CY@^E5IBRI80)*H://=K%*/&$X[?.P%3R[ 2.-GF)4GN<$A126G8
M$"WQ9  8M==%24"'^C!+3)F;RK3T\9<+VZNP*6VMFS]@1S_)<I-(Z$L"Q\-<
M?LV%Y>O&9?<__4Q6AG'$EAQS'023SS$" 26!>?/X:QC/DHZEU5SR9+I,]>QL
M (,-FCB=ERQ4/8#J_^H+]GV'\[K]ZG >UCI*M]L(6CJK_ X,<$X0+5!Y\5CS
MD[/-:CHZB;2%)5LIRJ%?HF48<GU;[C5L1(IRT<!PO(3B4C^(Q,.R;5]UP4V&
MPRUA0=[)A:U&!ND.P'_M-8ONZY^0(CT-=$D+LPE],09)ZLV\*?8 @=Y,&<1#
M(')X0,[3Q +Q>RLY/J4LEKPZX^1554GAE#,.KV'EU;ID,P#$^EWX++I^M(8L
MR(CBAW-[*)1EPC6<.EA/W@JYB#.N!E9/]+":& [*0T 6R_'@AJFQ1R600O"+
M/0P%RPW&G-I2J%&9(Z7K -J4P$D^@:8H9QX6 H3'_\[?#YTM5@7A_[.8=$EP
MP=6'66P68\4VD:2Y6;I_M=N'7$8C:QTC8(UYJ+,R1A9',%F:5], 9S7FT#%%
M>V6AN'9.\K6N N*E">N![\LC$$Y]PYJDB7J(#WME!==@C!C<.=76V!''(:?P
MU8;@"<3MD(IR"B]UR:P2>5ZX6C _4GP=>U8*UL8!+;J$/U,8@\H9Z*<LZLH#
M"'!)<#I(+0XP6"Q\?G&/.M)]@^P7$"'=NG!5<#HI7$>$NAOX/HP).0ZDD7+R
M.8(@_%B]<E."<&Z3LJB@9L!$,A*>D2U&4&HS!\VE4E,)SWAN.X2Z\UOS6Q,\
M<=^WX29>_?;M[6N\39_0@ 2@EI =1H\ FAMT!S+^(9E%/I4;Z::X@E"8N\!=
M\/2&D500)X?=45XT3><<B!%'*>G@U 55V075.75!'4T7T<OL@MJRJFK_O"0:
M?[E9TXW!@FY:5T+:4L_L4L>WI=K*)S>E.1";]@ WUJ"%5Q:F*M&T&T7^C]VC
M-W"6N@W3. G !IG*V(8'NM-V$,\=#!,[@A50U,J)[/M :1YET9$B(S 0.[ =
M#_8#A_%#8K@!J8=1SB'VO1^NOS1CSYP@T;>]KF:@HJK"\._?IQ'JNNR+":Q3
ME!\*XPJUZG;48/9BS$)\72Y<W&D6RB(WK. 4P<MK%86_1.L73)CRL>0@0I[!
M6'+J!J-!W72J/&K[-KR/1<T$G\"6$9DC&_T]'C='_6[=R=]#^,.H?,+W%I._
M^^U!K4=5?]X=]7>WJ-%#QI'+,6\M'/)6/35RQ;1'-CKW/\:O4#5.]J&8B])N
M5(Y5?;Y[-T'C,MM_8310-DW^96R[7^?:=SX\>95K]EAC.S_6S4/@I!:PZ"8N
M:*! Q+#P^SSC)N=0;#C8]\5-A*VW[V<Q\W55@=U'74J2R<;(V%?M7 Q.+N@V
MP"79T>3IQQOSNJ5H,67NB;M.W-59E>W<.7N-B;V&[6(WZ:&QUS.?SO[5R YL
MH+TKC;I.O1,IE15'RSOMX>B1Z^)* $$T-_5:V DXZK0[;W8TLGQ?.BGWNE(_
MX-E1UJMZI+4&5VDKTBJ24/OL8MPM2N/7^Z:<?7M,>[[[RUPAEQHM2VT.6TG7
MD@,X?!ZHQ0*K&< \TF);2I'2.V!Z%"NLMC,[#L!V/]$(T<AH#=)W72I!*-G>
MKIR_1Q:*,L(/"W6KJ>HQO[5O(_F8XEQNX&0C7-8K4>04*XQIH[IF%Y/ -_+9
MKOC==5VWWJH>A)K])*LB.K)L7S&K[5_2X+%+[EYRG?=A=$E;BR^I7.VMJRL>
MM]U<OVIS#6-4HK]\73-**<A=>*DBZ]8%2>"$*>;PR%-]<5&679[*L]!B#V'G
MVJ0^X CGZ,%*;H?7^$2^YHEO3WQ[+)F)WG!7F8DGYENR&?]"Y2AF16\&P>T!
M('OM;K^[$<S>4^'J#2IQ]2S^/YL59RD'!XVCKV[B151MINNTWGKQU ]CH+EB
MD59O5 2_ZXV*B'O75*/].0S.A6%E&62]%? >O663HJ<GK__*]RUPO3HUNXNS
M,/O8P>"O0CR6Q2'92: 6#X;AIGN$K(?_G'F.Z&CWW1OX7[C9Q.=V.70J=)T9
MS9[]>DWE]SOQ'-924VUQA2"YC=:P9(C8KMR%G:^YWZ(U#\H&O)M>P-&#"Q#I
M"/(C&M(=7L*9C1$NG[N2E<\+QQO>X6=RGJF/Q<TX7QJ[6:+P3N""BX[D//_,
M[*ED%D0 !,_7O@%O^4. =;HV404"M;I!@W;X=VRL67*K2.3"HJAD!$%-C >Q
M)^Y%NI4+H1*H6K<)?+< QU#T!%64T\))R+G6GNRI]KB1%5_EE#U"(1S6 SVG
MONQZG:@KS(M*HH_-;;_C)9?1.DCAD@%9M7FS C=H-VOLG%T,:_,B<]/%_TRB
MOQ15TN9Z]=OTUG52--RJMU%1 @T&2$D)]''4[8X&S?:@LYL2V79ST'U0B>RQ
M9WWD, ^0B/FQPKV'Q)*?D4]9MKMGX1M6U=7LWFKID=72+?:D'V32XM@+9^1P
MG^V2MD=9N+ #>V MU1M^Y8> '*SUHW$,'N@?6B7,,]=LE],I&.5PO*?2A5UR
M@3K6%4;QH,QP/XGZQS7?5'.35>CUV#S4^E(S!2\B%]#=F[TW)'NO5XQ2/2@/
M\'@EU#EH#HYX[;(":H/?&YO,93K,C:JGOQS!EO=+:\NVYRW!GI^<VELP?505
M3#\9Y ?GECY[@WQ;Y?Q MW2\,[?T9+$_OEOZ[(,SVW+!!F[IH%66JSF)^CVZ
MI07DA0V-XO(*H!=9X;;C@WD60F-?%2.#=E7%R(-:@Q]ZB?LL<:M.7=<8,ML[
MZ.JWX0.GRDJR>V=304@LYP87L_"#3K'&;= IUKA]=A/K8QC'UA<<>8_/VJJP
MC1]=\L+CG"C[JQW#)5#5&9Z-GGWMQ1:0_#3E,IH) MG=>50JI+XL$(+Y^6 =
MVUA-<^,:P,?FO.AMD.F*11IY>J#U7P;.6P\A7)V*2HU!M^3*ND4:.<(+%!NW
MWGWYAG>F!OR(RV$@=KP+![^(D(>Q&A/?$,50!-(CT,IIVL\]X2Y78SOC:(%D
MR1#*0<S\L0!K!<>YRDGH^*!WW[Y\H?%9YJBIL@<JFO*$][5M]56#2L?4R" "
M!!?[]A0@?)R=W4[8GK<VH4$FWKGZ 9\=P34#7YPS7TBFP,,2,LZ G)P0.]&$
M*G$O):R%_X\;R^;;5YG1!*T90E;C9;M^>%^C7''OX()@CC1;;)+40A<<-$>=
M[KHJI8-LF=QTB^-F?UBO#JOZ\WZW_!UU*[IP3:OA$S?$NSMPAZ'<X'P40AD?
M']K==Y)(GU@BO4.)1 9K.?[CB2 .XEL;^SJ'2W8;8DNNW^FZ'.*S.*JGQ:/<
M\W[)6[ 3>,TQLVAMC+,Z1+V'Q/H&BWL)>!&?A6%?#A5P$*16;9.>TOP''+6M
M!R"6#]OB$"'X5SZ$ N3Z(0"'W<486.V8;8^&LO:+F9^] XCM 0[@Q -/OZU:
M/% HPWT4'NCC&*;&N%L$CSFAZ.T:9C\(:9CZ,[7TGMJ8>Y'VVK^KTQ133E-0
M=#:V*"C=?E.,Y1Z7I5>G%.8!!0 'I34JE09?[4K;J977%I)@+IE>/A.Y7,]$
MPH6R3_&USB-LID]:6I\,]K/>PD(I959[M<.SBS:HOT%KW!B/B\6>!U^DOF?(
MXA?*4?TGY:C1?M:[(XX:GUV,^XW>> B.5;'3Z^ 9ZN!!2P_U6Z>#.QW<Z>".
MXENG@SL=W$$=W/.8*"?+H4R_^[FXW342:7DLSF<:=ZZY\8-UA5:&I&4]ZDJ7
MO5,9F<Z7M0J7J,1M&+96E_7O>"'"M2DNHWUVT6JVB@FA!P3'ZQ'*X<_2._'W
M\^?O_H[9JK,==V^YC!5BIHO\C?!UQ\3?)[/S(69GMI-I92N$N*ASE%B_M$?K
MFR/.\4L[Y.GQ1LT1KVQ%G?M\<?9X1LU6%_?^?MN.!K-9(<96&M6L$<ZLNBF$
MT>HDPF60>+(!XIMJ%.$I<Z[#4^CFBS01@Y;R H4GM=0-A0Y[]5,A![F/_MG%
ML-%OM1O#3A&FL1R%M_:^.P>X[RU260>Y#YR]T!@/AXWN8 /+%L&E%REPKAV[
M,GF<:WK+@A@WK'LWRG49Y;IV-AN1(.28$#F]3G.(73B+,"9LD%\(_!J>K9MO
M_I3M;1.2O*5_8D_B$&V!RI\4BJ#WW^J&(S$R9V7\[ZV"GUK8-^[Y)'+M'^?V
M#-;YB^W?V\L8M9RITD"?Y8XOO_/*_<UFC[$_5I= G&%$-_T+M=_AMV Y]B$L
MPP+%!<S[7^N;DX&/J!.3%-1?[&-</PY;Q59!6GX)V56U!W=I[D5U\_#:-N%C
M,:TF!V!:#9O]SLY,*Y#4"<A<[*=D*PM5V'8V5O< =5O]Y/AA[F-\=M%K] >#
M1GM<K,3<D8W5.[Q]CU;%_8YI'R >^XWV &RL?OMI;*QG(7ZG!R!^=^K9*N"
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MRO7><J=J-).J/-8_CM^(FF1)W1BQI5^D"9=\B25K!M8U7_K!A2,7%VVBB);
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M$ L\,ZJMQY82[DXRQK2O*@Q(V/N7"+<IYQ6!HX!T$--:0-U)/F?D;O11!7G
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M#,F6:/U0X@V2L>K-T<Z1UFXC0][ 4A,OS)9=R8$.@FL*TV,5>PD;L_J+A$H
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MJ<O+OH6*!#-H7&AG;5AJNQI<!&&D@0H-+Q&8C"F:F8AN9:^C]<MBE&R<2]"
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M*;[^>S!?O'VOIYMQW 4#[2R&L;<M%E@+^CGN5PE"E['1R<<*HT78Q@?(1P5
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MF\^,5Q31O,)^\-_.$=?W$#((%*RN.MCJK.H'ME"06-;?J7]%QHU=-;)HZ9O
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M8..KFR;CY,BTUL4]/?7DX  ._'[WH(5IV+ES&?J#PUY[+CMW+GL]OS<\:C2
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MGZ7.V]O6Q]@:(@]P*&W6P^X=REX;7=^M\SAJC?6G9:R?1I$T'Y)8>VNE;UO
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M!#L(YJ7?]W)P./ W6X+^\;HEN"\]&F[P3F]2*"]/Z*%,C1-8T)<9O,#K5<>
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MD$!@?5&PR-0;_<=;C2L1QC0Q^M';\NN&JUU9Z.3X:[F,)R>=X^$ [Z/ %<O
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MQUEDS!TS#;J%4%DQ%W:KR=N6GAZ GF[ \&@/X6E?:F-OCI/]JC8T!04AE/G
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M00O4WYAJX^=<+=UR^EMS^C">IH$5R34MQQES*LB-AXU!_TA3U-S6=14ABR5
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M+0">0X;P74C<;PL2>) ROKQ'+@J[P]O(50ON6T-PDUH<A)U\/?_I)#7U'EO
M%A<!>=RBGVY8:%$[,D6-LW0DSU[ALUP!O)YP1^P!P4<^%IT"AKB!;W)J&<)D
MPDF+UCOA(B+F!H1%%$JX)%\G92S'2\E:@)9GWB/8[J+E$M U\>_0'",^J  <
MCET95$%X?D,"/LQ L^YER$H+W/LR< EC@5*.M;/A[:3,>P3<+6+?A&MQSUT[
M&@*$0U.<JBFUL'PHPR+YR$Y4X-0C#.[@7 SZMU $X'@[-.LF92*MY8^5#A&S
M<#(>/;+Y+7R F!N5M[LI!1Z\A2Y$#V 60/8%FCET&A8Z/-[M*STA82@[@V3I
MY'C^XG"N/4+HFOM"%(%@/*<P=HJ,4*D@TR(Q*B.1,G$V7'ID^0N$^4J?JW^)
M64AE<(Q= $1_ T$$KR$01C('Q)R;%J>#,DX9;R?'W/F/?_]P,!K]MR-J<60U
M3KZ>'B%YB?F($A**S$>U$HD6D\,R)CD&?1NR;N) ^IJ/WY^_1V@EFINIW>MH
MM0"\+0.0<I+32,:K;UC<BHTSQ+]G<,P8#,4L?<4' 3B9!6@>1[H,W5P]'RU&
M1ZK3R[D.B3_D?)V8L81+LG9RO'N$V"1<0/J%8#>B(K(<6\4(HVI*+2K*TE[R
M<3BC8<(I@:9'(/#5,(V@]_EI)4)29N8OTV@-KRS-$PY.RJ)'!K\B>#Z%8J?8
MS&RB*!!H3:TLMP7Y4- [@D&/#/T54 I,G=:LL-; RJHZ)>V1:>]  (E_$87<
M LDBUBR&44&G,_A[9=DLN(B@7LPG747WR/SI]'<63UI7",Q0@(P#>0WD6C"4
ME?-F"DW8.3E^/<*$.]LB:WH#Z=T"4+/N4*;16E]9#W,.,EGK<!Z.9-(CDTM]
M3[G_+//DW(\PSQ75D&H!4!:_DM%0<G+RK'H$PR7F9H53\&0X_.3+:PVN+'9C
M:D>2]\C(9T1FK" V3JL5*;2&5E:L!?H>6?HNFC'(S8G#SP_&,4^%2&MO92VZ
M8>'$/'IE<Y,4\ ZRRH;9Y:.CD>+XF&>7G9_3__JT:ZZ<KYS*I%:G5&="JL5(
M<8^4A*?S<\RK3T TIRU;P&+$2 N2XD(99$'["%LQ+],"IDI"+2P5CE8QK=-'
M#&IR-"W :.:@147QRAIR/7T$R"!9TV: ,^:F!4YQ[XP30'V$L3*?TP*X)GHM
M5$IRHBXKU$=D2JF>%IA44VK14/(7Y511'U'(IX!:0%!!IK6_DMXHYH_Z:/V*
MK$6;Q4PMM0Z+ \/,1Q\QJ<]A=)@V:IEH$6J7#NDC4*4<1PMTJBFUD!CD2/J(
M0W7&H\TXUL1 BXIQXJ2/V!B=7#J'(4"!:>R_!4,M=DIHP/Q$E/-S4DN?X*P\
M*-,&OD8&6K@J]AY6'KCI)3;ET/(7L7E'6+\-/EHF6HS4[(\2J>835\KV%2EN
M$'']G!<)7[K\YA*+2_2DN+-U\G(;.+O5I,5</9]8@7E:MTPK*>]S]?_BS-99
MB3ZVC^9L1*=^W9*E%G'UZ*-!JJ/O_;X9A$W?3,H]'[ZUK+4X*S$3,YSS?3U;
MRK\B7@L+-S&8SRF, ^4[;0&:JG0MXK#+4<]2BRB*\-I&S("3+WDA&8<I%MI%
M.S&H3MM6E!A2^[82%Q+%X_B3FC]_;3*U&(J@*J,P$'<TCX. /(I;K]JMUYZE
M)FU#42);[1N*E&"8B.!L9.AE U%/CK<!O9Y:"Z02#*LX?MY+1(R/CK<!JC53
M+7Y*0*S3L?1>(ES<G-0&QFI*+59*-$S=U]1#&&JV)6VFJJH";=#:J@(MJ$KX
MK&E;5'$&K"[YV@@V&'4*G9CRTD*K1,F:H>UYK$2_8:U;(*P#7RVR%1>!F6Z)
M>\59B\=F9$UN=L5S622W_8![F1%%[9-1NZE;VU[4J%J+]I(?\C.ADI+Y'1D;
MN5X;UO.!^_OH)9O6[Z/7QF5#XZK<E9L#M+C[*G[=9F3:AK^N@;Q5(KBUNX)+
M[4'9 )9N'GYM ;$E.GDD9IRTJ#;LUU-0[;?+4=J^W0:K&E(M.$I\4]WZW4,@
M\INX.W6=1@9:4)1896D_>-_[2=ZZZ3PP\6_)&@3A6CH5W<++7?AJP50"EPJ8
MV50V\9VDLM@UZGMHN@H/XHLG7T@(X]UZ8"GVZ?P#>J*0L+,X"9Y\1F5K\#M5
MIFT12GBTOD6(/*-X+D5(MA-F0L2E4S'2;\>\-I7<E@+^J]L*O T_+>!*Z+01
M</FHY\N8]'ZW-I"5:;2P*&'/E$,O35YQ9JK;1ET#/EIHE+AES2FLOGM"%<;.
M;:F+?8E-'&5+& TX:X%5OX]0!VQAIU[B%6TJ["7:]6?GMEK?&[#3X7K4$+JI
M.I37]WY;;_I-)TL?KGU"98#D%H8HWL>0"XT^#^!=:]6VBY:'-8O=/I/%X<+$
M02)G(T[Q H<>-J+28<TV+:&&5 NGT4'/'D)1?5 SMPNQ\GT28VLU+3]'15J8
MS4^.EK8ZUA5+!'AM&Q60W7*,*7)#\:U#XGZ[YQ6S\2.@7JNQ??M:M*U"B609
MMHI-U?&7,1U9N1/7_MHD,K-U6VZ9L=*"JP2E&L#MM^^F'8)%&Y^LQ$.Q 56^
MY;Y+M%RU=MB>J2HM^.K16,/Q7G;G6  GD\#)B?#:0IIA&[L<<>[A[JA5E-EK
M6X)Z8+9#2TAK[27XN:NVVVVU5LBT8"E1LOQ%W;TT?N$"[7:W=U00:@%0HED%
M-KU$H'PK=ZN!K896AX/ZE4_E8N]_=2Q^W7MB'\%JA;!/Q)/X-\8DEET^XD]@
M$(=.!%+@.PM_GU* F0_IQ,_.T\2;<9([M:%W(>) \@S;>"F>G$,*73+'(@.9
MA' &#IAQ%Q^XX<G !P&# P>#)3P9/!-WC() '*\[&814?/7F:48#]'$%*2*>
M,,') &$6 E$T?C6+4Z$G Y="#_''C+>'$(61L,6?*8E6)X.X) KA<N"$DDG\
M9$DP;RET?<G?".:#O5KC*6'P+&"UV355:QLS8EM5WPY9 _,\7P6VFO"2*\&'
MES")C0A-)L6$"ZNUCA&M7G$OHK+I*9I[<+9[Q<?)&>[8:Y'?\-2H6T&QA9*[
MA7<<3A?P&M!O,)SXO"%SM^ :+F>0YK6,98Z5;"!HHZ21-EY(A^(_]M$C2X"P
M@3XWE+@0>NR"DN7G)TA=Q'B;2U/F3>@94-K:5/.B7_)5K:ARXM]$?-!V4Y V
MSU.5>#--_DW5K>_)SUB#M48$Z_@ ,*'*I-=@F&8J:_O]&6$<'\8(G[+X+/45
MA8M<SXZ!%4?JN#XIO#B9TQC76>A4:Y-GX6VMY;(-/)DG/X5/X6E W&^U%FFD
MV>&P&::U&.A5,3OK%6LFLD6S;)-LVLHV=V%L+KJ0EXL::-R)F766R'V8Z!X3
MO@RE4H-+O(I"=L]7<I>8]]A+L<@#0=6="!.?OZ_<=-S:D'^@+);@H$P5:2S2
MT';&]);H&X_V?/0+*9K)"C*$FKU- T(;O,XQ_^E!K[.:YO0V:'O/9:6/%(4A
MQ$47L%E+/9T-VL53FLP47(,GM(R6<I'/M1%XR#6\9CK4T%KKV>2D'R?WR\$4
MH1N*W'J/SX#R1]#ZC/OLR(.Q&/&T+D*:.0RS)LP52X\TU"\.GH.UO7:#&!%Z
M!UT^"7ORY,?H\,W1>02_D ?9G4<'^P<?FD>$=CQL&!WB&W>%%,D-N\T*UA:W
M09<Q!JO%.EAJYJ92*2LD_]^[Z6A?T[A*A6R0^P921C"&@5PB-XM?7=8&+61P
MLUGX0A$;9)9W(*HKMG,2S4(_"M(WS5JU9&*#WN7K1\?8*QW"-@#2B-X&;2^Q
MQY=!1-,XRZ5LD/S_X0,%S6(7BM@@L\AT4<[T+R3PN-/"+K&K&9'K"6S0YR]K
M<6-+LPK%,C9(?0L9!-1=\)YY#A]@0.0M:#>4_!VZX7E6?5TDP8SZV16-GZ1$
M!FI> QSY7'[N*7)9[Z+5*E@G$<=FQ P(;8#QBJ^2^'#*14P#62;*Z:ALT.R,
MY%J6D#1I<A=0-_F84-J@H;B(D"*Y<.+_>I$;&H&G);-!-SGK<-N?D>42/, I
M=P? "O)J7&88W&K#P0:-&^+Z%X2>R46U/)8D4AYN !B3P>O&878KGK9N#6E*
M@*1^(C="[#57WH3?Q5[&K+N;;:=YYII%A-PB=!M?O]YI%5+%X$?J3N5V7Q]6
MVX*CK9L/;J=?Q>W3+)2;":YN-%&EFM(VP"U&>;'7 P1\@1@0%._LS 9ZL1G
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M.'?]^X=)'?ZXK(<QO\TO_YP.)C>_W[Y;/%JBD\COEA&:!"]EM#&%2NP0XDR
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M_<.0OB!695=<@<O@]OWS1O]HS*HQ&$A%$&"&(Q^O$-R2W![1G:!>$(GZJ*/
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M'@_"P,XB$IMO!A7)RJ-Q+T6:>\(P]+"3!7TPA$LETA$5<]JF7\NDYSQ^!17
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M_.9MG<@]P^.=)/$PC\>Z8DX XZ-)1H6A2'6J*.DVEWSEV3]-HOXJR9@LL7M
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M;>-R]X1M1G))-,@@ZP+MIN?5;Q\>VOO-<W!:X%D%C!$<: ZAQ9P3:W.G1^Z
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M4/P*!> $=]I#:U2W6^RI%;CEIEI<?ZT"RZRWWZ*D[J9WS4 H14!;(P!RUH7
M)(>A4QALA^96'GJ\ [*7V*L<,LMXRYP!>9A8U0Q$(P-D:AM-&+)$$V>883F4
MM_S09ZB\@V56/ FR:3^A" ,3?P)0LLZ<@MJXW./?SJ>HN5"PH*>8"^2LM!9S
M[<+UDJN:.^MLGVK6?05^[*KF)7R"62 Y]\ @3(7#2L'UB5_/C B'5367YD&K
MG'.[#+_\X8??_$T5I?1N\,UOEM^^F?K_-1UY I.NFH\NPCF0QF, J5/$>DLM
M7LM*V.*R..3I9U;^VEEQU3&EGCNF<!5QP"?7]WKYSO(M)'YEH"+1$I5>:DJ5
M0MWF1V]_QB6H/),$3][58!EH-(F4909XQ;A %'N'NY6V/^.N!@<IOYB4CU $
MW73NP50!!B$'7 HDK/.(\TX7O&=: E_H<M!;U(6REK>4 .Y"]9)KX#MKK'O]
M\[[B/FX-_!(Z;R"06G'@O8GXM I"9)\3_PQJX,MRH%7*1ZN!7UXC"4"AP.)7
MS- 0$%$D=Y>K\ZZ![ZR=3C7P745;H/JU\7Q;C(:<F2U1R'[\6@^'WKWZL0C'
MSO]P(R4[N#2^UNMX)F+!?+ >PMPU+#TAGTEL_$.YK/9"ZCL6^]Y^C^;98.QO
MZH'UC[]\Q(S603LJ@0I! NPHIBK:Y4'E/H0. GKY3,NJJ@(GV0+0U<@](+J>
M3L83/7*#T>U&,I"60 ?F@*8V_D!0)VSNQK]M>"Z*+=D$7^":VX8M50HF?!Y9
MBX'T& -!A0'2.02HH20$JI"&N4NO=F%Z,>386P'%XV3+X]<_3^(_;G/V^J,8
MO 2&2@P4YUY;$1G-RW:#;D-W4:0II)2,?I0'9Z_[[^EX,IMQ^*5Z<OK>Z(%[
M/YH7'S_.VWXZ,=-44^\VD+-X&9"" 8HA-8(31GRW=.U>,"Z"-T?6QM::\$-K
M=)HDLL"W,+LV((IHNAL)0YI(!QGBVB!#.A&FV_,NAQD%Y+M) 5Z. @\4?3--
M]2=QZQM4;MVL2F9VW.T$,$XR$\]3PZSHSX7-![\04O24^"8[1%\[Y::NK/=N
M_"X*:(YRP=SQ.C:<1H&Y0 "6C&DID:<T]^VF#<]%D"2[X#=)(8NX5%IN7YI;
M($7JJ&*5)BHXF'\:^2Y,%T6.K K8)(C*W6KFLTY#J=Y-)],Z_B??_&CJ/R;L
MZ:]ZM)_I\K%]6]+L#3U3FYHW@[&^O:W][7SP_/S9J_P13L67'H9X@570 *VQ
M YHQENQ(8[-/S]J%J?>EN/GS&T/AW-&4&>$ ]H%A0YA@^:_!+7B.U:XF*P\V
M+KRY!'XV+6M6NGLM3<I]D \"PC&1=EP"K.?4&R\#M+D[JVZB.%5J23X%KY]
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M@(VAT'-CI<P]3GTKF!/TF,BJMZJ$T MT2/L4+ZKUP$Z\FT'[/4IY_.GS[UO
MT6@5I*'"6#+K"-%&P]RF6BN@"V-%/N&7&TK6# 91#S3B'!@E%1*!2X$[90[L
MP805 !>F^<.%6R!:\/O(#1(1S30R<7%.7IGQ+-2Q#DZGJH^4&,6#=I(2Q'7V
MR=JM@,Z%"4=V2N134H%3Y*.?O!_9ZLXG'^<Z&"SBD688!\)(;+!5CF>_X*\
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M9Z)AQ7 B@AE1"[6^[D$#O]P9]U<:.9.#EK^%Q2I-<H4/=ULSW1J<"#:"%$:
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MN8-.[L\>U7,[X EF><#HREF?.3$#>F[LZWFL5DTMO!?TI?WO+ 7Q5,'09(G
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MQ^/F,[ =8A&:.,R"6,[SI&:VB35AE.49[MHGJ2=QG8=+SF+I 0%FBQKY#QH
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M.7I3 N76=@5!CNK"UQ% 4)Q>38 -5[Q/F&</HA3LKB'6P>TCPN/9A.'8B/W
M<4/7L&/([:/^Y""; +]N="^& .\&]D67TVI5@8!!ZD'[28T7_@:XUW7'KS_U
MLM?Z!H0ZN<DW](RB UN6K#KQ7$V7X2#QA<Z$L6%%3F(%)D13FFF7T!%$:E)
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MQ9E-&F$)+=_##J/$M ++(:XM;0G!Y&<_J.[X0:S'T-Y&-OF%'4\ $P '6L)
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M8A$%F:^BLKZD=Z*=88@#%CF8L#CR$Y=9MBN5T*;.PLS*NR_#3':D_PH[!U:
M5>[ =EZP@-L^G!'4<2*.4'\0S* T^Q'M(6P9>EFU]?3%[_AJPG6#_UD4RV\?
MY<O[EXYEC=<)U/'2='2IP,"B9XSJ !T?!EXPD^(%Q;;B8YVU^S$G65G7\,A(
M%G-R^SJ0;U[V/Y\KR&$Z$0Z,F.' -:@?A?S/<00JR'$!,W.?^>T(7E#$XQ*L
MY4S;4@@"3P-AX,&O9&J06M=%SDM86?;ZIP;03BZ-ZIA3L=%'\4"R]+^;*F)Y
M5N;KE#:;QQF]Y=]F%T3?)"T_9/V9_Z:Y7B46TW5>-A6,/J</65W6-JM:>3CO
MMWR^F)O=?<7((^,7^@$.?!9BEQ&?)($362'(^"TMP/PG@4\D>T$WSZQX3MG7
M^D[D&U*F==.?OD# YB1+OV<YP_L]OSV8L>Y+LD('LM3OL"^->)4[>=!>(+27
MJ![3DPGMA4*=5)K+FK[V.]'5[V5I]I?M(/-*+^>D)\UK\7%!09$[5J5-_LI-
MM&XK9][EZ_7[O!")@5<96;]P0]O[5;U:T=CU,36HA?DZ97 OW;.Q;=FA'5K,
MM#U0\01%/N8^31%<H3U;:,_7"@DV4,L'ZGA#7_J_ACKTBB]#TI>?'V+@:<QL
MZ*H585''1F?5%@4NEB_SH@[58%V8"Z93KF H$FB;3:Z[M/SCS<NY70B/!)@X
MC&(_<>/8#'S;MT ]_$9HS>XS]R@C05I]LV$,,3G[HPD'X'ZH&@0JA0>GA--7
M;/ LI:4+#$Z)/%!4<'*(FD)_R)[YQ'GQLG>ASH;6)HUQE# ;$]]SDX1Z<>R!
MJG./$9M9I3O2=3?.3PS8 V84)3DMUB4[3(UW5/N1X#Q1GHR FE1YE-2BNBPC
M]+$R2XV!:;-HH/$ISVY9_HGE5\\/8M/G*JZV9+U^$>U]KS:5;"^9B6EF5E-.
M'=^^NT&?^/]U]PP/+SJV[#0=RILNVO)=9Z8P&E=ES?# -%DO,J#6-)(R*[6H
MF9I[L58UDD+V6];(#E%=F>-\PW9['!_;MNTGJ=%UB7#'23 ACH7-T*6NY3HD
M\0W8TCQ";?:U6=#>;UNBCCHP7UH..=GE6A,>,"W?8Y GJ,6EH[U";\BZ;O"H
M+[$:)*ZVU7N,UL++MX38I^NWS" UI;]C(C<QKAC]7'%WX-<LK<J[S[\.)UX3
M+\%A1/G_L,AT$F8%K@O:/!RE-OM!?D<;E8(XV@KJ,$4?1TM.T;5A #V*WXE?
MTT4U8?0#)UW^.$/W'"DQ-2GX.*U%%5Q*[&,%EQND<,-"])EF;)=$])&1DGW:
MBEEODCN6L:]DW98,$*K.3#?FJ[IGASSTMAP<Q<3&;A@GX@)_X@6A]!T+>;IS
MN_<U4;&V%0U9E#=T 5<& "".6X 9H8'9@H:'52_1L&9CA5JX;A+4LM+59YD'
M+L =BWE@4[MEH1$^V)4+. BCERX TRUW[0(NX\'%"X7A\)V/X]CKMZ8"2UM>
M -Q-5W*Z!?)VSL3VS^5/;<VFEB?Y#1!9J*8W0F9 "7I"(0_0#/UZ@?(K;8[(
MTEALDP0H='^S!#I4]0;6NPTK'KBI^5N1?ZT>V^RWX\B)V0D.+,/$B1\;5L!<
MGS"IR&F"SLPVH;V8U)%&#6W4$H?>Q1I&:ESS-<H/TW9%T15N98T*=L'-K.%Y
M%[Z=-2K<Z0VM\<?5MCC^3D1)M3-WR1U"<.@;#O:(X9" &21A4G'.X.PSJV-+
MJT1\ 1+U3?A_ZCJ;_!?;JJQ()BX(P78T#L&1V\%0%AFF@2V9&?8F!@70M!=Q
M./>B>P^#8AWO-0P_I+KX7==?8;UK4=<J+&_V'^))K^TDQ(%M&#BVS,CW[23T
M/:F"5W+DEED*&PZ:+;154_:T1#=0[9,$4'9IU 6+T@JIC(C"4BDCZ 4KYNCT
M"R^<,J*>KI]2HQ0S\<A36I%U^M^B7FG3<O0Z+ZM/[*1]<)@XW-GU71RYOA$;
M;F)&#%0[^SRIN6/@/6$4=XUQ8TZZ;AT,S,,[CY?<,JL'!6",VP-@UQGXN@9@
M+(<)GH4W*9NN)+SSA);-P9L4^"0%;WK$PC7WVXVSGDEI=M9.%GIQQ\!)+$Q#
MWP^"."1>XO[^5!<C_ER1HI*S MKYA*C-,;?2&M2CBDB%(L;#F4S\(T]0,VE=
M*[_QVY<JD"_[YDR+X,BV(NS%D1T8"8T3DK1O[EU&_S3OK>-5]:VQC'Z?[TMN
MY7C5-P!;<#0T&-BU$.BQW9W%? ?= :8P?>TJ_V?Y^W-4ZY^"5UO5_4E""N=(
MC]G#A^R]J,)_5=XDOY55]O"VNDENB^(?Q;M_52]77PM:\E_3#]GU<T'_T97G
ME3U84IQ_;B_[L>[5Q*WJOHT'(O7U\*ZO4]WDH[XN+DH>_X.1HJMI5[^+LM<N
MY#I_9@7_43P$.)=2A5[BH&H!U(%>_6R :]R<TP&=VJ&7*M'E3L$NA.7@6.S2
MN=2"CK<L807_:IJ[U$Q$,N7AUD&38>@&.'0=#U,_,"R#4-<Q/,C6P1DZ,UNT
MMRRJ4%J6VSI;5FP8E H[!N<PDG/Z-$@.LRJUT!\ZH:\;H;7N$DR(I,ES.D=E
M4?]G0M1C+V;J<;@O\B$K4_[D?4&[R@6W11Y_RJLKFC]QRP_.:I&><&;=;/E
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MEU)I6>D"3ZAK*X^FI%LZ"T9 EW( GAX;LU94@<NORUF3)[RLHP4&Y,1)@L\
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MQR[U24R(8\LE *H0G]F"7%&:UN$)S#$&P7>ABW$A*-I\C-5!*>*.E05\C!$
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M_?+I]D.]09AR$$;<7R@:T_L*^H  '@Y-83##GH&<K$J[!!-3+[8O("=B?R=
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MZX]I<G(<S2P+1P'74.I1FUF);?DAM,?/%,VYMSMJ0NAC^@Q=VV7PDE-0S2@
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ME)O](^45=S1[X:>HBMV5KN.X/-"DF0HZTC+)#BB.V'_!U'&3Q P2V[*DIIJ
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M.6>=7BB 7@(^6:U(T6U9)(=X+_!H.$"< _1KRX/.VFYI@775>,\3W+;66QJ
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M+7G$Z:M4(DB@ HA5Z45'L5+AD2)R3-)NNO*C!YK34IBWI@?]]._JSYK"7?*
M3 :_));9+A0F+]-98 SPVH*.=U6GKO?2%KKLXD'2P,.123S#L^S4H_%O=0\V
M=BTJ)>=4].A ?M.7U*1_UC_1ARSG(\111-A?Q'1AU[@IH,PHQ<0S+1R;GNG;
M263:!FV ^I1+MA;5 %-+2SX 5]=SKX"0W-UKD<RPS: F==9(3G,#N2$Y='9Z
M.UM_^Y9L0^(-]DX;?%#A\,;;U)1L*_N_ZE3PZDL>=\YLA'@)CA/3P7X8^3CT
M? ,'AD.,.(B#-+)^>Z%E5$B=VD8)07Z-77+2/\J6,N  ,HU*QV/D4H^AXAHX
MCE/3= +')#:1/LEJP42E,*ZABUK"O*-:K 4?B=.J%JEA=FE88)6CZ;CD@!.I
M%@34#J+ 3P\[6,[*-7F>''][NV/DK 1GI\?YI]4.C9](R0]5U2VM"W,^9KL#
MNR7T8D=1B,,HMG!*#&+;H>LEME2&Y@R=E:U/0T4<A))BM^,=<-C1JCX4 <]$
MDD@9CHU#PW.Q'3N18:<N.T>:<IN71JR4=J^O157#$Q=/3VT=)/KW?PLLT_P+
M2C; 4NZ4J0$?F$UO"2)&L:YCO$(-47UGSAFI-)T\QZAL>OZ<$?7R%#KWN')6
M:=N"])XGN@,S2L_>7=F,'?,J=TU[K\ONW"TSX+S2<P3FW?5+A0?JG:S<Z%?!
MB=ZDTD$AER24GB^X=3+IH#@#B:3#S_W_U7WK;]PXLN_W^U<0N,#%+&">U?MQ
M+G  CY/L"4X2^SJ>/5C,AP$E4D[OM%M>2>V,SU]_23VZU2VUQ*)(.;-89!);
M8E7]J"H6R7HH[/>6%MY^_P<KT@W_W8>\R%C3$*4IP[TIZJ&X$W17GY.<;Y6L
MB.\=:9#AT"9^$H5\MY0%@.(%*[,OI4"+:QVT;##Z5R988 IM%]:>5HD=W@\V
M2^::+OPLUW3A((_(ICY(A*Z;)@R=3'PCAAJI?LR)!VQP?\P/0&W'S%E S^(>
MIGVQ1)4HU\G=\43$CU3M'74STZ(%\Z[N/"#B/1L]1OL=%?]^[KW]G7$GGAT_
MBU0<#6^W_!NB^T*<%HN!"O:<%W4YO+8E"RD1$5="^VTEAL_3IB!Y6@>7DB,K
M_ UQPU2A\IFEFVS35!Q-VXZWHFH^>2P8:ZJLB$8_9%,?XG<]I*L\_;WE%SUS
M,$3#F)KMUDCINHA:_S.9/(!8D9WU3C36Q_CDB.0-R*N=N=P(+(6"B$'O-^7O
M/W/%^O9$BM_'.]"*:@B1[Z<X8W:<$MMV'285N"M+T'@00X\\$O31@0'%GK2S
M$,J=).@$!K;F+\,$?+@@*ZBF4X99<JL>-\@*?W[N(/T>S Q0MOGM*^/KZ:9Z
MM9WD85-MV?D.QA89\<0EF/HD($G(?.I*G5",#6Y8O6L:PBVPG9^2OZ".NIQ"
MCX(QK;Q+180I*E0Z:=6<$F/BE(&_UF@@_\M1\48'6T7)IL3H%&KR&9WA]LTQ
MUGD(( EQ%*0Q3ED8$QJ[KI> >D)/T#*L6E,AY3,G7F#4Y%9,35C =' !#)J"
MZN?. /4%U*]X. @062Z0_NV.#)L6?+>9J&/#MY>-FSY(NN'_PXG-0IS9?D3#
MB/@)BZ5#*#0S9]AT?#D<#3PW9-N=/21D6/=TF#S/6PZR@4.[Z4ZIQREJF6[/
MY-YRBM8X>5L^56K':V\R92L=4TUC:N8LZ@+-/\&!TS1:>DZ59F@ $[VKY^*W
MFVO\\\T@,B>S,6%QB /;)2'+G"1,Y7KS'88TO!+]?/_QX>/7_T0WMY]^^?SS
MQVO)_.VCQ-/+AIH<,&,O+8)\6O: ZXD]GWBX\2C%WWKYU\=!UDFV'C!]R*P>
M_D8QB8%LV6WV55P+= K4!"'7M6KIQYWH+%&2M%Z>SE0A\B),HHABU_;C((E#
M._&E5$&%^&KN6WNSLZE9$)<KU9&)!1'^$)SEMH:FT /Z9:0YKJGYZ"_8#2]-
ML>D:QQX[&C,'%$#0E50 (;UNOH$"*(-4!)4Q%+:@GT;*M%RG*7^?#_R!$7$M
M]'&7BN+,[-/F:5.=;S))'.&8D 2GB94YJ1M'=IQ(;S+!Y$V?0+7UA-*FGE#6
MLG2%2,<4RAJNKKA.-7RAK6 ,L(F!8RZQDS2*)/#\:KPHTQ4Z\(,^="!V+*%/
MQD$$[/6,@JFVFS, *FROIHS)Y&X,/NIZ^RUEB4]V5.JC*)CS#YNBK*YI4XR6
M;-MVA;=9QD3LRWC-@#3R,$E#B@,:6VZ699X;R]<,D*%HV&C7+* C#UV/2]1Q
M 3 K4@!*F&/=L, L\"PB*@E:4M  C*QNB!2#T)0_'ICYA$@[:3&E!EK/2$+D
M.K&+H!?U9'M=*ND;IA0G86;AQ+(S*W5MRTW3)>E>*Q7T/60P-:E+I*J*3;*O
MZF8457[(:Q*;"-&0BA, UON]"*#<%ED'+###-TQ=,E+I=TXP0]E+;U/E=T[8
MN?REA15^:V-QG[^2;?5ZOWG\5ET?(FQ[_@PED8,3CV]&0U>T8*>1BX/0RZ+$
M\3/7DRK0/4O)L#JWI%%-&QV) ];H29PDW!9=TL.T]I+@*E[*) ( [T07$FI>
M"?A3@#DC,L)-.B&3 ZSG?,C(<>)T2+V@8)_>_VO/MW7O-F6S HLKLV[T\4U7
M'')SE04NMES'HE9((]^3/S:;)6?84C7T$>TQ<$Q\ "CK/&P2-DLK&$!WH\&A
M3_NHK"K6:QX0@ G3"HR:'9L$2),QDQ9STJ+-C[*>69.6Z,2VR;^EMIL2AU9[
M;BWOR*O885SO*/])L6>TU]2!4T^W>;DOV+%USWEZAQO@*$L]G#A>8%E6YEH)
MJ!2T(A^&36++@T@[9+M2ME3E4FSE]F$K( :SFQU#J.6HKLC8(=AC"AVYTMQ-
M21,TFC9ZJERLN@]<"-7Y-G'I<"HEV7;D^=OK]FG<)7.#&$>1DV!F!ZX?!L1W
M7*EXBI&Q31N;EAAZ+O)_LK1.'P58G3$P)!PM=1&!UJ&33J6*V*E4D-)ARM(I
MU@MKZ>FJ$#;*_G19L--75JP%-LKK:0&P\4>69,_</HN2P)O=XZ?FJJVQ,J^_
M[/@VIC9%C+[_(^6/7C^)?PW,0VCCR ]$J=3 (R0E<>(F794-.<]%B0^I+_&T
M7 ;P%)F3^G>T>7JNZUUM.'W^L.0N;AG"<MZ+.=069><<&.KR= X\7:$^5ZAA
M"S5\Z<[<481%:TX/E(<WR/91A&D\#TAU,)4,H6,8V&?RQ^9I_]2+^QK8J3H@
MR[$3G'@LPE9"@X!Z06P%4OE_L@0-^S9=1&/91#0^-5R<A(&2:552@U'" =(,
M#LSNG$5ZM@STPSKG3(P:+I 4&;WX**:]+,8)F,,B+_1T7HK$."OFFLA+=9H_
M GA/_1[P-MEN'NO/XF!]OW"AFHZB@_)HQ,4DI $.+!)E<>:'*2"^28;B2O>"
M^8&'\@KM&$31I7"3OQ_4AH;:/>&1_(G7=61!-S+P>T-M""V[/U1'2NE"44IJ
MF8O%Z8%6OV"4DFOLHE'NQ04-4*92]4K)"E"'0D__S<2]**/7+]S!?63=[T5*
MWZ!D2V83'#$[Q%D<4)]:09PP4(GL==DW?2':%=/24B]ZY9F5VX;_N/,%]*,E
MTJ++F;SH0?W)4F18-5)=H4XNU IV>*K.HF::^[:L/B4ZF\*LQ_SZ'6=6GYC1
M=C;K<Z%RS+%/\C_R'1\HI_OT>*3R:5.UR^?XE8WG,!PEEHU=)[2H[;HL"Z5*
M!8*HFC[P:-E +1]'1PT=.8%LZF7!E#GQ,  1T%S+H*-R4R0-$^0 Q !<BJ<@
MBSXJX D(4.KI8Q#9P58\"P'*=WH@ GU9;3/ =Q4OK.2F^9Z)^)^4_ZT^A&F2
MAJ_3:O/"B=85J\8B<QJ7/HHP<3('>X&;,I(&U&6@@@(J3)@VKNDW1O?-B>"1
MJ^9P$/VRVW!7KU[Q@/$Z2G#+^=FF0829WP,W0_3:"@,=1VUM.F0D3&<)*)K\
M52465O4ZEX!T[CLN&DOQ/*-5U=OL1NR?DUQ<LKVPOK]ZO:/B^.3"KWLGS>5H
M:<Q,7.';68R)YP:AZSJ49%)!U^98-&S^3M@\*?Q51]SU_GU;?6-U+?H=.GU)
MJ?*F@;F4/*5XTQF"V=85)@=^I& ,/UW'!OH97/=HP!C @^V_.4KP%F2UD_7P
M]"@B.C]M=NQCQ9[F*F1>?,]@Z*$@AQXV3R*NYQA]6J)?!7%44]?4=FM2,J6^
M6^,CKM9X:U*@?N>MZ0<5CH_$A\H_]@]\5H_G1,S.G!2[8<QW-I2Y./)(BNW$
MI93O-]-,KFK@^/"&%^V6'A($ 0<:0Q0D#G@6R0;3K;Y8*@<V0_D )S.+Y%0[
M@I&:1MA)RT4I)H]4AF^M=W9RD>.30Y++3RW=2GS<B79->?%ZT]RY7CP!:7*3
M@@3';F#AT+?BS ]8XI)(;8,P37C%4X\#(ZH>_ R$4+]<'S# @^0Q3*Y0RX71
MTPNH\-I=Y1FR;^0 RX%QV:V5?%_-A+QC2?5Q5U9%;?EO2%&\<I]P/#7 L6.<
M$-O!@4?C*+.=)+-]B-F8(F;:V<@KLD6W^ZJL^*Y3N+V[O&+E7YN?CX2>P<S(
M)(QRID,7.#!S\2G?/>('5CPA0?\*_:W(2PWE%R!":3(#DZ1657T9H<_57>J=
M-PJ@^INH6 6-GFIJ[G$?(_)8@#,OHX%K4X]:=-7H*7G>#1N@FI$?)7 *,*.2
M?L^/.4] UTEGR%0CT)\S7@H^&3]*L!2 \S]7I!1\2K2'22FPH%C/\.EYF[\R
M=L^V=9KG,5'^9I#Z4"\S)&68N*&'?==B<9B(U0:TS,Q2-+PX=#4ATM[, $L8
MSF(F9\BU(@$SOQUI7#2T^Q4R#AM8C<4-92755>5PEMZZY0YEQ1_4/91^4;55
M7"FN<D1-S_HJ_OVN$ITEZ4-^QS^<;]PX%=Q2W17L@VB+3MN"JN6Y34AB&\<6
M(Y@Y-(I<ZL9A)&43%O)A^LBKB481M?M[94_A'4.6HBUQYKX.A@HN7HEN,]1P
MU<;X='RAAQP=.4,_OW+7C.&&N:YB,KB/FQK T)9MQH%>T)W-%. *7=@6P33?
M<$UM^)5[JRW"8-A&;=EPBD7:MMO\.^'R?LB+=_D^J;+]MJNT=,]2MGD1AZ3\
M;SEW3_G2=+XZ4.YFQ$'@XB1(/3^-LRQF?E?EY %0I W(AY3"G58Y>8 O$JWS
M7J*_MAU>H&7:H.C*^99&P%I6F.U(]@H=V$-97G0-2$3M\2O4\J2A/_A2+'15
M8H.27[<$FR(X@]IKJN.H&:6[(G]F1?5ZQ[^UZGI'1:7*9Z&($N4BDS#%D1]F
M.*%QF)(LBE)?JIJW"G'#/FK'2AW?=^#C"GV1S>57 E3.!IF""69_.BZN4,W'
M*5#FJT&J@*#)\(!(KVIT5$ Y-SA*8^@K]G;/=NP[V8KKO"8TS$]%'3<WQJ'#
M IPD+,11PJR(15Z8.5)-TB7I&38I736R_%"-;-M4(RL:%A ?\W*)024 Y>R)
M1EB %[>7ZK.UU-'#%"):RK"-R&FPX%J?VIN75AL17::(VMAK!FH]=O[_N_W@
M1M;U+9QD68"9Z[J4<&O S<%OE8B"4+<#8X1!!N% 'AC/D>U%6[G&%J#GEKC&
MDHY](-7MP5)X-!F&7F&<*D<)0W=D0U<JU#@B^1JU&?MDW]QF3($!JL X]KYB
M.BVK/N[2_(F);>YP2R+.2!P'1X%CVTX066%((:;B9'3#]H#30MNIT"6X_%'$
MG2?'8YA$,>7_\Y+ !FW)U.57Z"RN07XY"Z<L%<R,"8$:.N@G0>DOZ/JL[]L=
MT7LA."J8KJS:D['739<=$VN0!SOZD&*\V3XIV;_V?&[>OW3AJH/SUY#BV(YB
M;">)37S/C1,&ZHXQ1L3TU=N!)*II*J:,CJ$CIWE+909>E4'%A<<I3<BC*Z!H
MC,2ZD3\30@Y"=*:>A2<C/A3TNBC>__&\*>I+NW>DDJJ0?.E=P_IU)(8$-3FU
MNBCGM$KI$!&F3@\%J</.^_G.LA*#$BZGQ%+*MQP=<+5TRREQ^MF6D\\I1*)T
MMY?7.RJ*_<[TN;-BT8S32G'D$IL$<>1X<JD1$K1,G]:WQ!&GCNJJTO.=R\!P
M36NC9A" 9_&7Y5=)WYP! A#6H0\0M= -E0\#%I$A)^%DU,7,$.M%5LC)<A(]
M(?F*FA=^D]?9)'59@X^[NR+GHY?EN/6*7(J3++;Y3C?,O)1:U))K"25#S+#Y
MZI,6T?;/+7&85SZ)EIQWK@L#F/4Z%[^C.V^ZP.ZZC(":W/9)4JNZ[S)"G[OQ
M4N^H:75=(6?80&X8%]^T!!"5[K+$QBDE$<UL/Z:^ ]'K:7*&-;LF#E/C&7CD
M%%F?T#!5;JH?C;2'-!#\+B>C)FV>(;:J/LL)?J[1DF\9RL^\E)=3__%W5HH;
M@B8IQQY4#G9]G 26A^W8<=S8\T*6P<[9-#)GV%XT18U>&I(BMY+3K /C7QDI
M9./BC4R*Y/'>&T$-/!:42)*<R9%L)JIEN$V/7#'[40'&M=(;(:S]6/F+"J""
M$Q15:"B<_/2"V;MH]?%M$Z'<O?+\&%/&',)8Z$=Q*GWH<Y&,\0U3+P]#(:?E
M,CP2ASQ:A(;ND$;D53G9N2PXX%!'"P!JYSFPB8>=Y,R*-7F(<_GM]<YO9B4X
M.;J9?]IH7DN^W69Y(<S>,+$EP5'D\<U?'/C,"8@?PK9\8 Y,>W6@5 WTJ^ ,
M?6A8 U[-PL&7<^R,0@HSAF;0-)7],D1DW?27'OT?,?]E"(]B LS(0 I^4^N!
MW>0[_OWPA>E>^&WOM^R%76AK8_D4$S=CV(X2RP_M.'!MJ3*$<N0,&Z9N_W)@
M -4<H(8%@%\QCYN$8Z45#9A-F09"Q=.:1P3@<6E%1LWS4OQ48"Z8M)R3KMC\
M*.NY9-(2G;AF\F]ISO+[P@:%:7PWQDGH>3BB=DA3VTD=V,7:%#'3<0']+#YV
MS.*3[LBK I@7>Z)J1R1:N\=^&@:V)>("Y6..M0&FFI+PO IL<HZG+C!@Z\%D
M<N-T%JB^3,:>A*8S%P6I'R-3L2>T=&9B_QT%I^]:X/29%+^SJCZ7&_?T_%AT
MI*$>MNTT)%[B>XDEWYM\G(9A\R=HHH8HJJD"_)<+H$BX<<M%A>GJ0$H5=^V"
MN  ?;;G8:HZ9_"3#?+%I>28=L NOKN=U3?-^XFK-/*IX'<H>Q43>L^>\$([<
MQQW?FSZUS<6[CBKG;D/HXB2V;9RPF 29&S":$- UIP11PP:G90$=>$ ])N0:
MLZCC*>=/Z$8)9JLT  2_3 1(K.N24(;DNI=_ ! &EWJ0=U53'*YI_JR6X-!_
MT_1!=DM**;GA1,)I95TN'$PMQQ(;Y&152&L8$VE!4L/)<"NG-(R),DQH&'U*
MP4]O5NG30Y&OFS]Z[GI(*<%!&EDXC!U1)\1EV*)>9OEN;%MA)NVN3Y(RK&2M
M+W=^T,;) _S9::PDO'AM", T\;+P*E[]- H YUX;&FH^OL(G 7/VI>2;]/FG
M1UC/]9>2Y&0'(/<&?%T7$4#7:;4GV^VK*%/Q]_*0H7RL^"6YTLN,93[FIA<H
MU_)2U]] +^6_H6.NN[Q?((70O*>@&QR8Q9+&17,A-*CD2BZ&%('5G Z(N'TW
M!/2>2IYED:>,T?(#YU9D0=UF'^JB/O?BPF;/RI%+ N)9F/@I=U2<R&$.M4*:
M6?+)EO,$S=^LU!P@,4.H)$VSMK:64=&P <DXE$!0PFG1C OXSJ"!1%!OD@TY
M) T#J., 4$%2&AA(/J9>@!23,I<#!<S1E)=Z.E%38IP5LS7EI3I-V02\IYRW
M614DK?Y[4WV[V9<5M[/%=5FRL=M2.Q'Y79&-LY"0,,P2A[E2URHRQ$R[1&U#
M2G$[N,MW.&W_G;8L(2+X@*=Q7@9/[HQ3%R101ZB5^CLGBSJZ5ZBF?(5(5HG4
ML$MQ>EIS/&>EUY?C>9G4VCF>LT*/Y'C.OZ/@#OWGJZCY-GZ+&EI4U(BV<. F
M=L:LD'FV?+Y!?V3#NMV0 JS4)U)+^"JJLL"4LJ&B<G9R(@_ Q5"52\V7F)DF
MF)\PQOJD0W#RPGHK_QB?)TO\Z ,P3:9L\UO=!Z-KV7NX_OC*IV@_N+X,0X(3
M-^/[QY0$(0O=C%B)C&+/$3*LYPWI0V_IX\5<0UU.86;!FK8'.B& F0=5Z:7U
M2E:TB=,)/D2S%O._')?@V8%744=9\3KME'Y>7T5E4:A9=+=IUOKSFNIQY/+U
M.&$XHK$=IK[O9AZH'_8\2<,*_'&WJ3;:JJ>?H27G;^O% *;!%TLEUPVQ<]&S
MJF'!;)7D<7$-UD<^(_CFE9'' 9"IB7SA39@%* MQD?'/O.@<^?+ZC\U@D29!
M@J,PLW'DD#AP_,2AD92VCP]O?'O=T$*_"F*2ONL%(*85>;EXP*VRI&32JCDM
MP)0:\C=[*LC_=52_"X.NHFK3 G5J-?,4_,ZN3L,O;[8Y5\O\\^YY(YJ>-/5M
M)6_J+H]@6%L:PJBF+*IH/6R>ZA+3G[_<?>RUXY'T:&? F%8G?3C U$H6 GUE
M@.4D5;IZFQAVM0NW>='ZUVP23RM6#.O6R\N%[ED:X2A@%HZ#R'$MRV*)GT*2
M;D9H@!06GFM39R?7UV=M1Z!\!SPJ'L-%SF-=*"U,+8^NZ4DQ?(V5P"Y+HZO\
MUPB%=6M^719Q4.AKXE'%;>5FQ[B'6A_6#XYUZRI]6>IC0HF''3_UW#CP(S>P
M0=O( 0G#RZ4@6&^/:I+ C>,0#\F-XB(I@1O#$P$-U-*\+(RN;=^0P+K;O(L"
M#K9UEY]4T[A[5A$^)GU/BAW7Y/(Z3?=/^[I9_3N6;=+-,$U75.^.' NSD)+(
M90%EJ=3%BCQ)TP[LD2"B#4686BJ %G*S%5L!#EV7VS&/N$$2=BV45X7MM%_R
MCP><G'W3^PW![%U'&W7$T4]]8%KZ&KT.>6$UV4,)@JO:1WD SNTEX$W%!+ST
M&Z-[$=O2#\^\R<OJ0UX,*_ =TSY*$:"0UD_?9N/5_,0HHAT\__KJS<W%?LA>
MRK<C*0EPEJ5!()+ZX@S4?.M-I#!LY3N9A&MRL0[G^S_$WR4#"-]VSN4,XP\_
MDS!;.UH8]<CT%1(\B0JJ@JGVM 49:0/]IL#JRI9\$QG63;]\RVD:Y'.^*3.Z
MJI)]'2U*5N_&/6;AQ.%;<M^U'(LF/M\*R >7SU$SO$!<*C3U54=)LJ\:*I(I
M0@&SL),H:*M']E5C.3)%6/16(YO^2#04(QN1$EZ+[.N/4XIL1)[Y2F1C+RGZ
MZ7S>:]-ZFWW8[,@NW9#M75[6I*Z3\A"RTG>KXS##<49L',?,)I'ONZD3@]QJ
M":*FO>".A3KSH6,"=5R@7SL^H(4R9/"4=%DUHP3T,)<#!/<E 1+K<OUD2*[K
MJ0% &#A6D'?AE_/_*-[OZ(?B[V1[F[W_5_5Z_;V@Y=^*744_[FY>"OJ/XG9?
ME73W>+VCO^Q>RJJKXB1Y=:\ZOF%;\0]&"LQV%'T@FP)Q[O;UYEE4/ZM>47OG
M_3=1OYOOQC8[OB:^L(+_5;R'JF^D0MQ118+UBNSJ,A<B7X4+P$V[;$FP1?!/
MVYNUD(?9'[.@:[R-T0&?4GR",M'5HA>6PM*/;5@\%MS<O?^#I?MJ\\)NN%5]
MS(O7.I!-TI:-OFS84!UHHH[HO\M;EW%IYTW'8D%A=F$HH[88OEEIE-1T?,35
M='!2H+Z"33^H>HOZW)SAE+?9.Y8T.XF 4A_'EA\V.PD2>@E.;#L*?2]T:'2X
M_GN 7)V>TE&X\7N J]N!JEB8*">+GHL-][F>N9_,_[O=U\O.5H08H^VQX1OT
M:G ((;,SQ\5Q$/@X])P0DRA+L)\2)XVH:\4$%/BAA)VZC3J2ZU!;B(?LQ:BZ
ME-!KT+Z [Z8$5+CQ')="V_WFV? KWV:."S>\N[SPG$I%LWS'JLW_-$W"IKNS
M!YF+B>UR;<N<Q,\LSZ:9E*+-$3*L<'W*2EW9IS"2.,+5)#E,"<>%5JI@-B$]
MI'Z9'A04JY?!/@%@Y;)YR:;KEDV\OV+5LGDI3FN623P/S_=M<Q(_;,J4;,5.
MEN]YZFJ=9_=+)&,X"3R&P]"C3ABQ,,ND3F"GB!BV0UV*:T.WV:=SRH!*II,(
M35LB77+#K)"2R*#,WCF9E+)Z+PZZ6D;OG%C];-[99Q4;$C@?=W2?UGK='#I]
MY&SOQ 9)W"V/USP-:(!)$H?83>PD))2XA,K?^\I2-:RH@@MT9*,[<CLP4L>4
M "O[2X$IX4R8@ BFTU+HJ#9 D(()V!)!-US*31(6?%3PQ@D0J6=;*4@-MFYS
M!8A\@W8+H)<5S.=7ENZ+^JSCCG\.WTC)+N^M:G^FSHBFE&';M=PDL?G_J%3#
M43ERIN^2#_31<\L (@H;K7G8)"RD5C!@IK&'0T=[V=YK'A" +=0*C)H1G 1(
MD_&3%G/2ZLV/LIZYDY;HQ,[)OZ48.".B#Y/Y1O/)>:-Y<9]97V=>E^7^J:[+
M7XIPZ[0YA'ZRSXUCDMHX"1T7VPGQ4YLD;A8%H' ;8ZP:O\]J:-6E9=!/K]RY
MG\A:77N:Y Z>?PSP@8;\4EI OSU'\HI&H] %[U?]6_L>_U?H,*4/4]6"X)%#
MQE'6%6]DCM%UHY2, SZ(;3)/47$EV"<E^]=>.-,O_(\'/LJ[_(EL=L.2XZ+X
M#V/8<]*,AAYUO4"JK,DL)=,.[H$NJ@DC01G]VM"&!DA>1$O2GNK  &@.U<2'
M&[$YT739H(MTUC4A<^(.+,#L"PHQ/ETHT<?=U_W34_$JC$M9[1Z2[8>\N'[>
M)MM_%+ H1L"0AO7V^I&[O"*ZH0F4J\^=)^+IT/53OA?WUDU-Q":N3HA BM=3
M/Z#.K &$%@% GK8"!O&%V02ST&H.3U1 3"W4"4!GO0 HN/ G85$*KR]-F;Y.
MT_IK^9)7K/R4DUUYO:-M0/?N\9ZE;/-R*?&YWC(&GH.)XWB8A DCS(ILUX9M
M&=5Y,>V+]-*71== 5L?UWE;?6(&.W$#:?.C 7])W60=5H'?3 [1CBZ,G&+M"
M-6LUP@?F>BBOE%BL#);V]& X)V^4Y*L,V>547?4AU<PAW\+5FLRI<-+%GFS+
M2PEIW I@0E,'Q['GIG&297$$:F$R0<NP.>LHUSK6T5;./IO"3,Y$:4("9H*4
M00 ;%0GQ-!F-*4JK&@4)D<^57N:5!:?F@YS]X2'.S^>'.%_VPL-JD_[+ZQ>R
MV0H6N0M6^]_G@1BIG^*860ZFGF431A,_IB"+8(I1T]Y13161CFS=Y.>QWJ'\
MQ'<<9?UKE2-T$W,&.$!_XYE8_?B\X?U0HJ=$UR<S6@N@^?3<(,0ZS\Y-L+G^
MR;E!L$?/S4W26WDEZ")6^'JT;[( Q-[OX1O9W39G^U_R-LGSO]GF\1O_[_4+
M*\@CJ[D6YS2'"X'[?"LV\6+48047&R?,]7$:,C\D+G=O0U!;CA],/L/K3L<*
M:GD9/Q5;:=TQ](487J[>?MY77^4.08 'F=N#G(I+C6Z[.^.#X%=([CLS4YSB
MQYS8MUY;#4GWYUB2S4ZMMI7<,)N*/04$#YQP?EHMO:T\.3CBL3.<Q"'#?L87
M9!9;U+5 ::[3Y POCXU5V]04__H3:VB6?[E".^@A]0QJ<FN4/BQ@2T8#0Y_P
MH2%!2UMG3P(I(76U)Y@FMFZG BG!!TT+Y-Y:6&6L:5YSIMMNYF/BV!:V/9)%
M<9)%S)/*FAD?WO01RZ$PUEP3&QDH))U*90&!/IVT;.JUO>8:\RRJXK5B>YYI
MP2Y6YM+1CN>:_G-?5O5*_I#?,\'H9LN^L.K8<.0AOR'EM[LB?]E01G]^_86[
M!!]WA\XDUVFU>:FCHR_=J3"^ 2:I[V'BAEPW660E :AVM@DF3<?+'%D67:N*
MCFFQ3*.MZ!;$?RK^GG*VT5[L:,1IW'$U(P>.)0OO&)U1.=ORUO,$LU!';L5<
M'-@5M_V=+\%_+MA%';]B$_J38)D[8'_IM>ELV7XULELTB:HFHVF$Q55-KTF0
MSPVX45IJR\ -WXN1)!>CO[#>-O#8:.]B9P3'%RU(O0C'?&.5N0EE5B"5<*=
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M;Z*+TOE'_B0J@-2S4':S\'P^"YM=^F^]3_W?--EI/8!-FO:%)-9;#?1@<;*
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MRAPKLB,;5+U(@J9AFU>'BGS:O'#U?. _W]2E,<2MM^+F1 9%.:NF&1N8V5H
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MC,H@=("J3@8A5*O?I!5*6(4F12PF:S%!QUROZI*BM"?UE53'6!H3>UY>OC[
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MLJBABW[M* -3#RXB)6D4-<@/M&TJHL,-TXQ<NNS+)3+KFHD980?:/O>\:LK
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MNB%%\<IIUF?@YX=D46;AQ&49SL(T2XB;4A* ,A.EJ)J^W.+$ZR3%5/R%'=F
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MX)5>?%!Q<326!?AW5E:,?MPU,5Z#&LBIB^,T\+"5$"_P0RNTL^BW77T_2Q\
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M7/!R62=QK6_@$J2C#I;S SZH HIB#2B74E.%%)4A0UAP?/5VT"@^%9E!M$5
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M;O7T?WE=-Y264PJ!1LH IR##P5HH>#^GLVGE=I@H.*F91:2%5.L_,O$F?N?
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MH0Q!Y&Y.T4!*_\SX5S];^C=Q4QZKQGK]W4Z7:<.D\M3X/_=9?S_@WG*@.%/
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MUIR;:*RY I1#+IR(D2=#3R'4T(:EQ6+CNC_#H&4001>&G^WHM+74CHPVTL0
MA6G\*P^6(X>ELNV:]S0N,:Y_<P&L]!-J$>[-UN/?7@Y.9LLHK\<K\Q<^5+5?
M_]YG_=W/7W^/PHNZF\QT??\V^HZKW@CI6K%:)2RVLCG8+%$*FG,2C2VWBG"#
M+<G],&I =L;MY3.T>U4&"DH()/WB1!1L--!!(V"4]U&P$B*<.^'YA(!Q03=(
M@-A9O@6 XTGMT(/-OPY'ZB4XU\!@I8#73@I&A>!D@ KA)G+&[0$U!'!RR;X
M&&W?KVX+Y1L3OB:&LH((X**AU)(X;$3N'%43+>.V>!H"0%FD7H#+ML_'"SV?
MV(.W%NG-,_0.I&D!DMOT]CFW^3E*R+A9J#PZ/@.<YPN\0-2\FDR7B\/:>$Y2
M*P9N 7021\]1"V+\P+C9D#)N&NHBR.DB] *QL]H J[CWU61NI]5\63??6M)
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M8L;N09;//<XB[A)P\TC^>WT;OUP-"XPA9]3)\<TE-04:IJ8>D%OHA#6,9G_
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M.<QI179[#G-*JB58GK.5^10QH$S*0!E-#/).X/P/[[H]AAGIR>;SSJA^ BX
M(N_](OEX'^KJZR3&#"_N_XA!QMO9PR2VJ[BCODX6D^:N9\Q8H"4D@$).I12(
M"YJ[N=+SJ2S$#>J(B\-TX)!**@.&S=WXG93 \/@'T9Y**X)"+G=OBPZ9YJ'
M,[2VGS,(X:3H"\#-D[JD5%0TLY.I?\+2YZJG-%&((:X/.CH.Q$F.I>3[Q9)Y
M*]4R\3'R.+7+HGAT(!2P&5[YN+*=K%4\<U>W5;V8_'/UUT//-<TE% 1$GU4:
M#4V(^SLSID^0,ZZ!'1\KU3"**P"#VZZY3XM #WI-(@BD,!!8YI4/+OY$9K^Z
M.4K)N$:Q..1E4%<1;1^V3SBV>:*9VY;BOZGJ3>7Q_+I^.=63C2^>QB8 9*&(
M[,5H3R'CT]RG&, K93G)[5\^B\!QGS06!]+AE%N P=PU]M?AS606.8TB7+U%
MBIRFMN/5<K8X],PM!9$7 8+24G""A->Y36A;VL9]!%D<7@=1:0%07?7!3],5
MHRR?S'X\J"_Q""@%5YTUB6-&X6!R7Y@V$C/N,\?BP)A':47,*S^L?7D0VN8)
M4I/$##+ 6,^!U1Q:PJ@Q*O=S\?;4C?M$LCB$#J36 @SF(6=7=FWZM_.:H_S]
MY&NZASB\UT0*2,(A8"3Z,U)Q8FWNJYEG$5A:CZ \*#D+QEPJ*]2$OIU]C=*O
MZLDA.]!AH(S%( C,F N6,9[[#==)@DIK)G0AQ'552:$(^U#[.SUQKS84;>>%
M;[;3U7SN#UUA(6+4YC4'A%))@_<!^MSMA;I16EJ[H0MA,KL2"P7KUMI_T/='
MJP,,!E(1!)CAR,<PC>],C1_\4-X055K/H0L?Q%U44ZHS6"\C'1-M)M.U/[W9
M3P\2W?G9@8^M+- 66Q"#M1!];&XURYZU[$ES:2V'+H?4H11;))"WI\)''QV7
MY6%_84: A,&!N"4I\2@0F#U5>9:HTOH270B*?513Q,U.^SJ"?=[2 S?I' 0R
M4**(C)%9]MK&]M2-ZS=>OJ9H"*5U-WY5W&%#PC&%;/-V@DPO=R6"$$#$M7&!
MFB!S1]7/I[*0DMQW0]9+YE)2 6=P](&WS;CL/Y:3VD=>X^9:W'^8ZMDB>AOI
MO>9=^I6#?:Q]JN@S@%&OI*?12<X^\KD]=4566F;#2741I1412;<7Y3YO1&J@
M< B &!8<549 D[MM:GOJBBR:' J0 RFMW&/ZX2[^O" %IT [@H!#$4Z2!<IM
M;COY?"H+&2,SZ#&=2TEC/\[;;1'[6,+T86FF$[M]5_;X_6U)TV-UT[9MT$-)
MDP**(1XW'\= .>D!12:ZRHA@2^Q3:+;HWMN+I"+/[6S :6KT>SDMEN!B[C#>
MW,TJ&&X 5"I$F08"-.$LQ6^(2(NQX3:W9WF.J"+/[]S '$9%!6#NH[_;^,C7
MX94WBTWK*Q</%<AXNE':-&/7Z1$OPD%(G]M7W*>AR,3-4(CJI8!2NN%O.'A3
MU1^K>SU=W%]'8WVS4MFVF9KC ".;>K-[!HQ+#9&<T)PA2X/ [<[24\N,>T5W
MT?,QF[3'A\]^H/[13U<?7'W6W_\V67Q)O;"B^%+5>:MW$U(Y8 *W@#D4D,08
MTI#;7'6E==RKN4L?E)=0:#GX;2_=@X9NS@/%)0+&>**=#L;H 9Y:MZ1NW#N[
M"V-T(*45D(Q);*7_I_3F5SU=;\1MT_'T@Q@M/?W&SF^N>^H>7FS:Z3)MW=??
M[1<]N_$?XPYZ'<.Q(Q=7U$6?U]DH'42@E#QZP;D3.9?E<%SG(G,2J&!P%+!U
M#D2Q)X FR\,Q!D90"F!@T9CH:!=([H:,;6D;U]/(#-=!%%) Y-UK&QZTVM($
M&(0I"!+J525\(+E;@_<B>-STY3 8RFE7GZ708B;99F79<!$- HNA*H;)U3=:
MNMQ=7X;'\&"9SA\/PR<56DK3\^7=W71U6NGIMO7NVUFHZMNU8IOBC)4#@QV@
MG"DAC5;(YV[!UI*T<4.VS(?]$.HHX*Q_.XN?%;=-FMZWG53Y)&K%0 =F@.0J
MW5@ASU!NR[='PMBM9@=0\T%E;G>9CWV1O6Y<,)]7J461=REQMM,B=7T5NIX/
M\' A>NZQAC 2J#1%S"(7V=80Z_TBR(:T>P9B1JYU'!!MHZ@K&SSSSGBXO=.S
M^^NOJ3V,_Z9G[H6>3^95^+#SZ4\Y:#OJH<T'YYCX\&P&,@U^N*YO]&S3ON1E
M-9M7TXG;MB;;7?RAM4D:IKV=2M$(7T*!HL$"IUTPTB.ALO=8RD)X[R8I?8A(
MK6&FU7Q9IY>5GR8WLTF8V%0;NMZ>:<18_#P[\?//4=DOXKI_'H1J(CHXT30
M%X@(QL2?9/<%+\WCN.[!Y??#00^7DC%5I/G_M+R]U?5]%4XRW,7^M_SD_@=
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M6RURS'=.?JT@S  3L ><:&4QQQJ:W)=63RGH:YK>^2@^_]C]??7AQT"^XL]
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MD1\6Y,#!04/*+((OP'?:,K(63PI>FC@Q@0-I/ 3:6JDT$SR0W&V;FZD9^67
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M:;<_CBQ/,Z &>@I+).6!4C8%% "FJ^FT^J:CF-Y4]7YI_2.+!P_5D(MNH,
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MM12@-$L PV!-NXXJYQ#31,!X5WR9%%OEEO*(4%D5B];W?__CTS[%,@0@@[8
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M]JW!O&Y9@2@-*-,"(".IM<HCLW^]V#1$\N0Z)6&BBQ*K820Z-CA^KV9^L2E
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M9_G8VN-69A9RKF51S-AI7'^WK=_9WL;OL[2__]9,0<:!<BH *@*W009#$,J
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MR'X8&!*)L("#9)N)YYS4Q_G$^OW;]9$MRR504>/QD$1(*!@,)>-:T =)*RD
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MF ,EJ 2<<P6Y98+CU*WUCQ*4>2+#*$93.@WD/I4>'.$G'WAWU^R)20@@A<5
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MD60!5]+!8;8-'NIAHF8-:2(#QH)033M-KSBSE+>LP=#C&#&#Y5T@9@[L)<6
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M(4S]*'P@R066L_5$3Q=@CJ3*4I'[YH>?V\G"?YQ/K'_ZRR<>T2Z3CDJ@0I
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M0:AM@$[(U#6 ;71D3F0/U.U1J/00=.Y(P!_5S"\G_[N1?]Q,OHZ>-<J,'OG
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M%3#AH:V7T28H$;I."#EKX2*32PGP-*;\"[CN/CZ-CMR,N8^LOJH6RSV!D6"
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MKK-..V?NN@JX #M]/[?4(-[$GZ2@&@3H/&+<! T[Y75?6N:NLT)/9NZZ2K<
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MP3VS/7,?IWJV4_'<D &V#D@5G7(3! R1"4Y@ZO%M8_"1N1BR/ZQVXQRY=5P
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ME^K\S2+\QV&5(<)_5,<%X/RL(#''#L@0&'#**1J@\$3\BO!?$"]#(OQ'E5<
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MDHD7HOA*_;]AP<YR,5%$UY\+G",[C977$GL=[]VW>C+_4T]7_LB9R*4$VK,
ML&<Z.(JTE1>OE[RL"*[40;R:E,1H<'S1 9KNXML[ V7TIWT\ P./OQJMJ$H^
M *8$OE]\IF.\C5/@(7 6BO]V69*SQ4<A!D9&WP;!X%0PQ B7>H)>,<Q?J9W]
MMSH)QL3SBS8$MH/G9PO..58/[*Z?H2,4C*-&JNLI;CB3^2LUY?]6!\&8>'[1
M!\%#S'X547VVU!#E0 8% 82&2XH-YNQZ?()S.'_QR:47< 2,AN07O?_[^U*!
M.6 4I\!!;!334AEYA67$:?;^-2>S7L#>'PG%?X=$V)O%<G)?Y\]/RXHK#S1G
M'%@?)84,1H[9(G)C1YBXTJO["M)EJ9!S5>W$/NCYIJM^\IYA>U\>JS'8<1;*
MZ?X5O3(-N)40"&D5T- )X#'6E!**!+*);8V7U/VK(3I#!5#<U6]^'15&.>WL
MK]E\K8?U!3$[;O>OKNHOP+/9;PHDG/> 0,. <!"!^ <8>&FA(T8@D;QNX,5V
M_^H,@I/=O[IJI  X]1?<B4X_#1D$X8 6RH(@1-S7)" 2+EZJ^0*Z?W6&U:6Z
M?W75<0$X/]U JLE,8,! C4']QT22R)A)7>G_=^S^U1DO9W?_ZJJ\ I#XT<]#
M-;_7,^LWU9.[;+!@%! Z&""#"( ;JR"'S!*!$V/P "F%)_(OC;X4"BL =\='
ME*P9L2+R(!15P A+@(K;A\<]) A)[0 -FRN3+W=\:>RE45H!Z&OIS/8DD7A$
M ZU"/+&-$UII*GAR^_"E]CSLZ[3TUD=!6&K?7]!!H* RP-O J?26.97ZU71)
M?D)_37;I>=A-K+D;X!WLW_=$O@XVWLXR_B2%B,(PF,J= JQK[GG844V=>AYV
MDUENE1_JX/=DCR%)@#9< L,DEIABZ[#HI/%KZ'G80^'#))9;WS?U(7R2!4L\
M4%[0:(0CYC2&#N%NC2[;OY_7'$VE^02R*T']^-W,K>S:,GK,N-KX\^2[KP75
M8,H0&%FQ)AI%+.C(% H@4!D4"Y)PK3H#HLN*>?/E*2&27+ZY0;.!_*MJYB;K
M-/RVB;1!/47U' 4L 0V:<0&A%[MSDHY>$]M??TGM2<]U+=*(O#3,[&ZL#0O,
M4*!<%$W BD./M#;J'.-B]_MY3,I$&CNF_Q[B*PP!G^HM<SOS!Z)^)IZ$AE)
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M%\LV@7"#@5+<18%P*IU4T";OQ3,Z4R^BKT@1NV@P9$K90\U:]R?*D8N4.QL
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M0B,!*8&T"[WR'CBJC]M==F2(>X(K"A2DP2-DA36I1WN=(*FH0-YXEUU?)12
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MY4Z[Z*A0"E#6R8FKBT,C5Y\YFKF/4SUK--1)J_-12,Q:ZML.AG-GX0[03 '
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M(%Y/$X')"WMMIDWZ<40.,CWZWN\R3+R*H,^Q"^;9$8$Q=(R0GE035"40(YL
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M<2AZ#JAB V_9"!YS_O",OD_1(R!;1VC4CI"JW=S?N@I3-,[O'3-TXS6<>!+
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M1N#W,UC:L:)<LA\1DLE@%YB:0]4S(A:PH:*$/1C8,(N-'<V!2-501J4M HE
MRQ$DN90K,4Y["5 396B Z=!0ZA'\03Y?IS@I" =.-3 \S"@R<(#FD<>T?WR1
M'(&E,H7&1@)(0-T%8,QROI]MT&*$C(DEAIX/NA7CY*M1U FV=@0N1J\AB._H
M_G$T1UXW[D"4@@I"""-+A;(Y;UY2-;DX<N2!=$RM1/S)NEPCG3T$.@/#WDE<
M"S= 8U5;EQ6_#^!H(I0-D_TUP\_3Y&=WF_R V"L<O>#(A**T8.54%K_U21^?
M&XGYNIM2DD^=F&:S$%TC7K%IZ$S0C?-A"ECLAGRSEY@WT51JS6,"YES^)3-7
MET8>K[B39,?)P$;N^"C(/"BU+*3'7A-,AQ" G+1.F #3?<<Z2@)N(>(FITTY
M-)FDPX@ZS7(Z@4CJDN9Y=)J\,70^8L=?4"&,PTA_313JP9^)0CV8HE /O@0*
M]>"NL-TW"UY!Y++$ZC>V@Q<R5[MY4&LL) TVGMS(3$IB=IR+B!'T]#Y&[G,9
M!@L85,9SL,)3 G'B55*F5-WQ+[P^7'AKHUXP@RX<\+;B1WSI^J#>-$L(WEYO
M+*OW1LZ/L3P8'N)9<T(NUAP1=FQGJ1-8@R\ *ND CA*%TT@M3P85J73A%Y<F
MV^86SKI-$Y\A.\K6@(/88QJ9_.09)6?B-W8?T4&KQX'S?@LFUF;[R0MF&/
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M$7<WL!9]Z 2K*0<8\,Z=R8+*J"J*O0>&A,/,/9WHD?F@K)?WU!FZ 74GMG<
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MG=T_.7\$1'3O$?[UA/[ZLL[>Z/]>O'GU+_S_[Z]_^O';_P%02P,$%     @
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M>T_A&$F6[GIS[<"Q3N,RE1:Q8.(N0.<:GSW'0D#=Z92<DW@>:C=!7L^RC%J
M<YN5GEBNX&5MX;E-"S3R$A.Q!,1@E(-(*5CU(&Q-,.L0]I#78[=3B@9R3#&N
MRO$MDCMU+_+DU+0I-_V>U-1.[TO1WJCN'WXISI_8*FZ,=89O2N,(B&M2X-C9
MF9AZ#6N,TOW>&L,.'L.BGKJQ!1FHKDF12\P,TD_Q.() EB3A7WH59!\>9%7=
M(?;<\- L1#HA<>G-J\1:4QU*?*Z.I?4GM<H$;*FY%C.U3Q)C_7>E6+8^PJ5I
MIN%!3&4!IXY*D1ODYCX8[=IR)^LV8PB/#Q8M$?$&[V\3>'R T%)D9JO )B?'
M2@Q))/1C9A,SEKH!6XJ\JHGL*#43+=P046E15E37.8XS6?2(8-%R25*M?Z ;
ME@XKF'23PAYI,ZC/P=!#&3U9CL0'&62P!HQ,V1YKB@]ZZA-@-7NB?BZ=\8D)
M11(U_W.-F8FK1YJ(%$Z 3X87+B??DVN9YX:JS:2XH^YV5B!KU %9VCFQF!4R
M>1E (J?ZWJMMS!LQ0JU#(!=?&U&HDU5J=+PK J;<P+U2/X/SL*A1>V+FA ;!
M18(O(V1GL<E38/VB4&-,B.($>*I4S+RNQ!CS3!NE8;<1B%&)\7E95!&/M37-
MGJ3@Z2IW=>R#XI$:J_C^'J=8!J&3?6GIG=V)Y T3ECI3UGS@FB99HKN4W# ;
MML)"^B?ROS'02(,R1.FP1;&Q+AH ["A.],:^\**GSHW J0#'B3KS5*J)MRR'
M8691RDK?0;UX]#TV' 5DM;!5O5P/*C731 5A:>['(<!JM*5]<UBLJ)-"G/(O
M8Z=UXH38-8<!7T]>5[1WL!ZI[Y!(YSE""P26(C_0Q[M<49>(A-Y;YR,UTPO2
MMK -C#$M=BLI'-0UP@J-9M9#A$9!QUR<\X0_*QU4/EH5#8%(BTH/K:%*FGV(
MR%&-'M44H5X;)@CAS!E0=D'&L/;P%+!QR"%&H#-,5V@XM6"?BR@6<1N64TZ"
MWR(2A&C'X(BG6J(CC&Y0-4"CFM1\*^MU<YMBJ\_IB:S57.K:IZ*N+I%0C 0<
MC7.IZ42+-(&O4XZF>BK 1ZXQ(NL $FX6;0:2$5"]*0(.JA,WC##N\/?R9@Z!
M0W1S/ S7=P:A'7QG,#0%PH#@-\B&)K>U\UB% &'R*Z5VR$N5R5'&+W0YTP4E
M;EK)^9)@CTR&L2P:D0"K#_*10$]5!(6IO7:.6LVP8H3J124$' W!&:WE<0.+
M#$!='C$'D)CDQ14+-$4/95!'6^*"3:*J16*/;%>C*_IK *<NJ1L0H>#.0MZ3
M)J(0_E?L1?&+6$6A5V7&J,J7--Z05QCDB<AB;#B-&@F8F<8V'J4-"1NCHD(W
MPPE1)!18H'E],RKIZG1M'Q1R"+T,TBBD(PI@.!9I]V+%$!S"1,=3X(J;U-4)
M=;IHIU!H+2]357:U#?U(90 \<JF +:,W$,W(11CCB2]W:S5-&J_R<3*+:V0;
M8[:9-K(1H0VR!5\C=FO6'0]UPPM,&9MT1%D=H8ISL75MSM\4X&\7<B,92(H@
M77$1M$.@ M]*]K4U9\O;@O_72<7!GSFI.%B=5!S\%9.* ]+W436QDR*2)W7<
MEC.TM["\?OD7/&/==+U.MU-(.3B9BM1#7/S-<JQ#<6&G_I*W<2;E]W%4Z7(-
M3 >767LP&? A!&<4N@V:;R;B9NOJE]8TNVK-EP(+CY<<[=DCC8O+&:%[3!5K
M>X)+U2E!-;][)# V7@1=+T"T(D'4%'%<W'"])Y\E4*G*(?"R5P\FWH'F#".-
M@0]WI^'N<H_=G= Z&94[P"J)IQ55?>T%<9KBB)@13KH +&]VL8HA+*IJO[H!
M634^<_]C#[-%R2L1<?S:M""O5C#)-)"?E?Q! KM(LSM2%;H&G;>Z&21'N0@9
M,Q.,(-3Z" OBD MD=:&_4JZU$V C5M.;JHY@YZY2G,?4I%KYA85YA:8HW=R@
M-<4$7=\/9O)A9+^_?;$3$;T^4G2VG$Q#G8D]!Y>>KS8W:)Z/D9A;>>_5[7.5
MNKJI/GJ1KQQNWZY[W2T->ZUH8B6!E "9':[K+;Y^GT ? =%:?H<U-EAC*#VR
M]"&$Y&!63/,9$_[]]J0_M?IM#[T:_^<O@SLF1)\=G'T8(-6+NPA%O AOCQ?'
M3SJ!7K]D!E)UKMV(<N$'1 G$S?#6^6)P^[^<6Y;^H8_K^%L[^ICO/U!+ P04
M    "  /@:U< ?GE;^@'  !H*0  #P   '$Q,C R-F5X,S$Q+FAT;>U:77/;
MMA)][Z] G;FI,R/9I&1%MNQX)DUR9_+0-DTST\<.2"Y-7(,$ X"2U5]_=Q>D
M/BPY4=+8H[KU@RP2BX_%'IP]@'!1^%)?7A0@L\OO+K[O]\5KDS8E5%ZD%J2'
M3#1.55?B]PS<M>CW6ZM7IIY;=55X,8@&S\7OQEZKJ0SE7GD-EUT[%\?A^>*8
M.[E(3#:_O,C45*CLQ8$ZC<8R&9U%Z>DH/QG *)$1/,^&<CP^@4$V2/Z(#[ J
MFH<ZSL\UO#@H5=4O@/J?G R.QJ/:G\]4YHM)'$7_.6#3RXO<5![[LU@_? W-
M;#8F[16VYTT]B:DE#S>^+[6ZJB8I.@ 6&_0RT=!52(S-P/93H[6L'4RZ+^>9
M<K66\XFJM*J@SY7.V^83X[TI)]3!%*Q7J=1M)]Q?*&Z].#L[.AT-R1&/H_=9
MUW'KXQ'[>.RSS;*STZ.SZ.[BZ"A>E!USV[8S:*=S6/L#KH=.N5I6+PZ&![?\
MYHFJO7!&JTP\B?COO)99AD"91"+F)I9]'/,\;)GXE8EF+!V$F'7%. )C)UW[
M5-+/9:GT?/+#!U6"$S_#3+PWI:Q^Z#FP*@\V3OT)B .<9WZ<!;_&V 0'I?4S
M'M LO;DI5**\&,9'\3I*/H6@[2XLL/+ /KPB-.6()Z],)4PNWEE5I:J66KRY
M@;3Q:@KBEQPMP%+QRX\-.'[YH0 K:T"+U/7$VRH]VF<_WS76-1*[]$;\!BE[
M.XP&Y)(O0/PF;2(K</U?;C3,Q<O44\D@B@9_-;#_:W"Z\OE]>GRRU>.W/?%:
M5@JT^!&= ]L3*<=ZC@Y+__3)Z/3\JWQKEVI?0XX+_GE'>:K*,+23?GQ:W^M2
MW.YLO #?@W9\OC89<70T(N??BD+B K$P53##'.@+Y<2OC;2(?#T7[Z$V%O%5
MB?\:6XHXZO_ZN96%T3I[1-$:[%.T?I0.8X31*.?BNC(S#=D5]$+0; A59K#W
MRJ"JP1ZDJH2LYJ*IO&THJZ/.8<F#,92BQ">KD#US21R"G%DJ)AVVVS"H( 7G
MI)V322FO@=EHT:;#=QD.!KO4K)=:NDJ517V$9A56QY%@8A6S0J6%< U]+.O/
MP$+;"#E0*J=12)$FFRE?H(.N1C:DWJG=&H=F*'NCR,!)2>:KT_#(0#C\6X 0
M"'.LE5A.YZK"F!-\EC'N(1RQ+MK:E7)5Y<@N(:UC1M=-AM411RL![2$&%3%2
MC3 @!!.RM5Y"M$6'XW$LF\8198H:[JT/#LT;C=8(4H-(XKX=#V[-+)6N$+DV
M,]?!V<*5<MY2>I;T,GB$X^^MH-)UP]SPXY$!\V2?@/EA+3Q/GYP.XO&Y:]'6
M"@IB$]-*1 K<6R$M,'@P[(JV/AA*@<D-E;QR!9F368E,2FQ*S[CW2;5QC66\
M>XO;![:IK4DAP]=.'"(T,D 4AOB_N4D+65T!:[7WC4:+>"C[\>@0GG'5>)2%
MI_"H2'=6 ;W4OB".6P%U@!*-9>>.\K6.<NR(_+P-:+0@.?"-!-?H9#] *O<"
MI+B9'9/WK\&AUL9X<?K[/)AZE)E3V;C=JU"*3 "!T?84DJYI< O<($%-E6-"
M1"NHN!U2V4LJ7:5C"UHRTMJLNT1+KZ5J*E3(I&N\Z9K$J4Q)J\@!%;0!9XN*
M6FH<Y6M>F(Z3.Y.D<8 #\DC75*F6=';0:$FLCV[Q()9Y'VL$%;$J?O!; F2(
M](OU(?M&=+LO2$[V LDMW:X#>6?.VL#S[FRW,ZQQ*4Q51FB5SE1\HB4=(ITT
M*$%8VJR#$P)<R41IY>>4XK=U2XN+D<>@6IP^;-,W(7O<M [5C:T1U([%2IH:
MF_$ 6,U>086R0R.VL01J6C1D@DH]X)=/-I# 'QF"T[U <,?%;Z92-TQ8%%_(
M<SIMF6)DW!:]MQ 4.Q!P>-PN 1FQ6!')TP75F9C&WSV"75*$7%@#Z>O\\SLD
MD70RGA<AA)G \3#@J(/' [IL+T#7T68(YR8L:*/>RC<NV8J]+R!+RNDF31M+
MP5])H%M:+8WS^)X./+$MEV)#'\,9D#B\HTJ.*$8:NV7=#ARW3<!G#'3\4#6+
M<3T+HRJD6Z@-(D!&/62<&7@^6M:>"ZVN0;<'#K?L>W]YBKXATO=E/S;:)Z1_
MW7Z,SR.S;I'TECQ%M+D*U"5E$=2^0']L2-G%T"3*66^L6Z1\?H%-EJ7R'AC3
M6ZHE!@4%E64*Q\8-'"*4D7\=\3O^)T'=K3_XV"@<.J^UIN+C???LWRW7/:;Y
MEQHU&FI&_O$(AT,[YE0! J--U8NMSPSD->7>H-DX^[+:Y-/1[ISHB^#6[E+"
M*<,67I,95G2PH+4[H=EJ5*R"&$,IV0L"P&'V=TU9XE;K3V!GVG2R]7CM$2;W
MO=H3O<0<GEMDC1[&'9CH$#E\FMU"K!=2H*JF1D^!\F EK]I#>=MR(Y2U-G/
MTEEA B'*-0 CX+Z)2-C\&?13,'CPT+[&.6-B%#_)^=,G\?/H/![V^"+&G1A=
MN>,P"K_P/_2%AG$T_IH+#2>[7VBXIV;;>Q)W78KH[CT,ZANZ^;!Z>X36P,;<
MF/I!R8"=#"!9@*/U^&_KS FN9OY<_WE\S;]_4M1VNI>SSY[^&\:O<"80[+WX
MPXU-E,>.TAT\?&=1#9+88:'UJE"0;UX]HMQY^(FK2<\VX[YQ<6P7-7;K6F!M
M'/_0.0E']E/8N"BX7$6<SZ)E%9G@4FK\9I7/W"UL/\--QV.^8?E_4$L#!!0
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MC^EQ?ZO'[P-QT1:7!KURXEJ[+! _FD#$'/\9>BW=RQ>#X>D7.=@LWU8.*9+
MZSD-JC+!^(Y:X;!ZU.6YW>-P@< G[?AT;3+"3GM SK\7F<158F"B8(IYT67*
MBE]J:1#^^4Q<0:4-@JP4WVM3B+#3^N5SRPNC=?*,HM7=IVA])RW&"*-1S,1-
MJ:<Y)&,(?-",#U6BL?=2H]+!'J0JD21G @G2U)3I4?NP#,(82E'@DR$>3241
M"1)GH9AYN-Y&A1)BL%::&54IY TP)2UL6OPMP<%@ESEKJ(:S8F50,V&U$IOC
M2##9BFFFXDS8FCZ6[:=@H#%"#A3*YBBNB-FGRF7HH*V0$JEWLEOAT#1E=!0>
M."G1;'4:GAD(>W\)$ )ACO432^QTD:>7,0XX9R/+(PB6Y:I,D5U\JL<LG]<)
M-D<<K00T0 PJ8J0*84 ()F3G^1*B#3HLCV-I&D>4*#(<K \.J]<YUD:0:D02
M]VUY<&O58FDSD>9Z:N=P-C!6UAG*T9)^]![A^(,55-KY,#?\>&; [.\3,*_7
MPO/RQ; ;'I_:!FV-H" VT8U.I,"]%]( @P?#KF@[A*$4F-Q0W2N;476J5B"3
M$IO2,^Z'XES;VC#>G<$M!=>IC(XAP9^M.$1H)( H]/&_O(TS68Z!!=M5G6.-
ML"=;X> 07G'3<)#X)_^H2'R6'KUD7Q#'K8#:0XG&LG-'Z5I'*79$?MX%--8@
M.?"5!->@OQ\@E7L!4MS@'I/W[\"BX,9X<?K[/)@"RLRQK.WN32A%1H# :'KR
M25?7N"VND: FRC(A8BTHV0ZI["65KM*Q@5PRTIJLNT1+T% U%2IDTC7>M'5D
M5:*D4>2 \MJ LT5)EFI+^9H7IN7DSB2I+>" '-(U-:HDG2?4N2361[=X$,N\
MCRV\BE@5/_@M JJ(](OM(?E*=+LO2([V LD-W:X#>6?.VL#S[FRW,ZQQ*4Q4
M0FB55I=\RB4M(ITT*$%8FF0.)P2XDI'*E9M1BM_6+2TN1AZ#:G$BL4W?^.QQ
MVSA4U:9"4%L6*W&L3<(#8#4[AA)E1X[8QA*H:-'(Y5%&Y4\[D,"?&8+CO4#P
MG(LO)S*OF; HOI"F=.0RP<C8+7IO(2AV(&#_N%T",F*Q(9*G]:HSTK6[?P2[
MI BYJ VDK]//[Y!$-)?QO C!SP2.AP%''3P?T"5[ ;HY;?IP;L*"-NJ-?..2
MK=A[ %E23M=Q7!L*_DH"W6*UT-;A[W3JB;9LC(8^^3,@<7A/DQ11C#1VIW8S
M<-PV 9\QT/%#62_&]<J/*I-VH3:( !GUD'!FX/EH6'LF<G4#>7/@<*=^\*>G
MZ"LB?5_V8X-]0OJ7[<?X/#*9+Y)@R5-$FZM 75(60>T!^F-#RBZ&)E'..FWL
M(N7S#VBR*)1SP)C>TBS2*"BH+%$X-C9PB%!&_K7$[_B?!/5\_<&G6N'0>:W5
M)9_QVU?_;+D>,<U?Y*C14#/R"R4<#NV88P4(C"95+[8^4Y WE'N]9N/LRVJ3
M3T?GYT0/@ENS2_&G#%MX32;8T,*"UNZ%9J-1L0EB#*5DX 6 Q>QOZZ+ K=;O
MP,XTZ63K\=HS3.Y[M2>ZP!R>&F2- .,.3'2('#[-;B 6^!2HRHG.)T!YL)3C
MYE#>--P(197K&6#I--.>$.4:@!%P7T4D;+X+_2,8/'EHW^&<,3&*_\C9RQ?A
MZ\YIV OX<L:]&%VY]S#P;_V?^I+#<>?X2RXY]'>_Y/!(9IN[$_==E)C?A>A6
MMW0;8O5&":V!C;G1U9.2 3OI0;( 1^/Q7]:9/JYF_N1WY%<_77Z\%M<?KG\(
MQ(]7[34O_TZQV^G&SH,\W6-9SU-S\7_(<9V[.6[8[K+S=^YJW,DA?SLT/M 9
MGRT>Q1\V-E(..XIW\/!MIB!=N4W57)^BU'^X[;954_YJDW<V[L+M(B;OW'2L
MM.7WM"/_QF$"&W<?E\N?TW%GV41&R &UVVSRF>N2S:>_O'G$ET;_!U!+ P04
M    "  /@:U<7Q=HQ(@%   A&   #P   '$Q,C R-F5X,S(Q+FAT;>U96V_;
M-A1^WZ_@'*QU <N1Y+OL!NB2%MC#UDM2]'&@2,KB2HLJ2<71?OT.*<FR[+;)
M4C1KM^4AB'@YU^^0WV%6J=F(LU7*,#W[8?6CYZ$+28H-RPPBBF'#*"HTS];H
M'67Z/?*\>M6YS$O%UZE!H1].T3NIWO-K7,T;;@0[:^2L3JOOU:E3LHHE+<]6
ME%\C3I_V.&'SZ932^1A/P_&8Q3@,0Q(FR60ZGB6,XM^#'FR%Y=4>;4K!GO8V
M//-29O5'XW XF^1FN>74I%'@^S_UW-*S52(S _H4[*_^K,0<"\-J#?*,S*/
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M<[SEED?Q^G?U1'_J_C7P%U!+ P04    "  /@:U<Z<+>9;(%  !>&   #P
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MB*N[;#M@ZZNN9]ET(M!B*"9L/SRP+4@N#:(,>@4*-2/TFET7L=6[VXIOTQY
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M,S,Q+FAT;5!+ 0(4 Q0    (  ^!K5QE<QM&D!<  #L= 0 1
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M;G1X+FAT;5!+ 0(4 Q0    (  ^!K5Q1/5=A)PT  -,G   <
M  "  1]+! !L:F)?=&5R;6EN871I;VYX96UP;&]Y;64N:'1M4$L! A0#%
M  @ #X&M7 'YY6_H!P  :"D   \              ( !@%@$ '$Q,C R-F5X
M,S$Q+FAT;5!+ 0(4 Q0    (  ^!K5Q2L?OI%P@  #LJ   /
M  "  95@! !Q,3(P,C9E>#,Q,BYH=&U02P$"% ,4    "  /@:U<7Q=HQ(@%
M   A&   #P              @ '9: 0 <3$R,#(V97@S,C$N:'1M4$L! A0#
M%     @ #X&M7.G"WF6R!0  7A@   \              ( !CFX$ '$Q,C R
@-F5X,S(R+FAT;5!+!08     #  , !(#  !M= 0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>aqst-20260331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aqst="http://aquestive.com/20260331"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aqst-20260331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2026-05-11</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-03</startDate>
            <endDate>2024-04-03</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-14</startDate>
            <endDate>2025-08-14</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-14</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AnaphylmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AnaphylmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AQST108Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:AQST108Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:PersonnelCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:PersonnelCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aqst:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ProprietaryProductRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:ZevraAndCommaveTherapeuticsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:ZevraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:AssertioHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:HyperaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:HyperaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-13</startDate>
            <endDate>2025-08-13</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-13</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-13</startDate>
            <endDate>2025-08-13</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-13</startDate>
            <endDate>2025-08-13</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-13</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:PurchaseAndSaleAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:RTWInvestmentsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2026-03-03</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-03</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2026-03-03</startDate>
            <endDate>2026-03-03</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-02</startDate>
            <endDate>2023-03-02</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-23</startDate>
            <endDate>2020-10-23</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-23</startDate>
            <endDate>2020-10-23</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-23</startDate>
            <endDate>2020-10-23</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:ZevraAndCommaveTherapeuticsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-30</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AtnahsPharmaUKLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-26</startDate>
            <endDate>2022-09-26</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AtnahsPharmaUKLimitedAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-27</startDate>
            <endDate>2023-03-27</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:AssertioHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-26</startDate>
            <endDate>2022-10-26</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-03</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-03</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-12</startDate>
            <endDate>2026-05-12</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-12</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-12</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-12</startDate>
            <endDate>2026-05-12</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">aqst:MeasurementInputProbabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyRightAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyRightAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-15</startDate>
            <endDate>2019-07-15</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:A2020AdditionalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-15</startDate>
            <endDate>2019-07-15</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-14</startDate>
            <endDate>2023-06-14</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:ServiceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:ServiceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:ServiceBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:MarketConditionsAxis">aqst:MarketConditionRangeSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeNineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeElevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwelveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2025MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:BlackScholesMertonModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-02</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-15</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA-BC</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-15</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-08</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtInstrumentMilestoneTranchesAxis">aqst:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-12</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtInstrumentMilestoneTranchesAxis">aqst:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-12</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtInstrumentMilestoneTranchesAxis">aqst:TrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-12</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-12</startDate>
            <endDate>2026-05-12</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>aqst:segment</measure>
    </unit>
    <unit id="lease">
        <measure>aqst:lease</measure>
    </unit>
    <unit id="payment">
        <measure>aqst:payment</measure>
    </unit>
    <unit id="instrument">
        <measure>aqst:instrument</measure>
    </unit>
    <unit id="pricing_period">
        <measure>aqst:pricing_period</measure>
    </unit>
    <unit id="pending_case">
        <measure>aqst:pending_case</measure>
    </unit>
    <unit id="renewal_option">
        <measure>aqst:renewal_option</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001398733</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="c-1" id="f-98">http://fasb.org/us-gaap/2025#ManufacturedProductOtherMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="c-5" id="f-99">http://fasb.org/us-gaap/2025#ManufacturedProductOtherMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38599</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Aquestive Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">30 Technology Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Warren</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">07059</dei:EntityAddressPostalZipCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-12">82-3827296</dei:EntityTaxIdentificationNumber>
    <dei:CityAreaCode contextRef="c-1" id="f-13">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">941-1900</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">AQST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="0" id="f-24" unitRef="shares">125450119</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">110734000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">121169000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">6867000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">17763000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">8066000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">6169000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">4516000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">4168000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">130183000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">149269000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">3839000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">3893000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">4468000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">4621000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">2635000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">2642000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">141125000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">160425000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">11889000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">29862000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">3449000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">5029000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">662000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">631000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">1092000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">1092000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent contextRef="c-3" decimals="-3" id="f-56" unitRef="usd">1000000</aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent>
    <aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">1000000</aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent>
    <us-gaap:LoansPayableCurrent contextRef="c-3" decimals="-3" id="f-58" unitRef="usd">13661000</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">9994000</us-gaap:LoansPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-60" unitRef="usd">31753000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">47608000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-3" decimals="-3" id="f-62" unitRef="usd">25099000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">27519000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <aqst:RoyaltyObligationLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-64" unitRef="usd">26914000</aqst:RoyaltyObligationLiabilityNoncurrent>
    <aqst:RoyaltyObligationLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">25941000</aqst:RoyaltyObligationLiabilityNoncurrent>
    <aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent contextRef="c-3" decimals="-3" id="f-66" unitRef="usd">62083000</aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent>
    <aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">62023000</aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-68" unitRef="usd">4159000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">4337000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-70" unitRef="usd">19118000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">19390000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-72" unitRef="usd">6053000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">7269000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-74" unitRef="usd">175179000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">194087000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-76" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-77" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="3"
      id="f-78"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="3"
      id="f-79"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="0" id="f-80" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="0" id="f-81" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="0" id="f-82" unitRef="shares">124284542</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="0" id="f-83" unitRef="shares">124284542</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="0" id="f-84" unitRef="shares">122044299</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="0" id="f-85" unitRef="shares">122044299</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-86" unitRef="usd">124000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">122000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-88" unitRef="usd">420877000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">413214000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-90" unitRef="usd">-455055000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">-446998000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-92" unitRef="usd">-34054000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">-33662000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-94" unitRef="usd">141125000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-95" unitRef="usd">160425000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-96" unitRef="usd">14446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-97" unitRef="usd">8720000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-100" unitRef="usd">3469000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-3" id="f-101" unitRef="usd">3652000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-102" unitRef="usd">4204000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-103" unitRef="usd">5361000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-104" unitRef="usd">10977000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-105" unitRef="usd">19072000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-106" unitRef="usd">18650000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="-3" id="f-107" unitRef="usd">28085000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-108" unitRef="usd">-4204000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">-19365000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-110" unitRef="usd">2903000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-111" unitRef="usd">2782000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:RoyaltyExpense contextRef="c-1" decimals="-3" id="f-112" unitRef="usd">973000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="c-5" decimals="-3" id="f-113" unitRef="usd">1437000</us-gaap:RoyaltyExpense>
    <aqst:InterestExpenseSaleOfFutureRevenues contextRef="c-1" decimals="-3" id="f-114" unitRef="usd">60000</aqst:InterestExpenseSaleOfFutureRevenues>
    <aqst:InterestExpenseSaleOfFutureRevenues contextRef="c-5" decimals="-3" id="f-115" unitRef="usd">59000</aqst:InterestExpenseSaleOfFutureRevenues>
    <aqst:InterestAndOtherIncomeNet contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">83000</aqst:InterestAndOtherIncomeNet>
    <aqst:InterestAndOtherIncomeNet contextRef="c-5" decimals="-3" id="f-117" unitRef="usd">713000</aqst:InterestAndOtherIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-118" unitRef="usd">-8057000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-119" unitRef="usd">-22930000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-120" unitRef="usd">-8057000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">-22930000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-122" unitRef="usd">-8057000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-123" unitRef="usd">-22930000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-124"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-125"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-126"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-127"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-128" unitRef="shares">122609995</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-129" unitRef="shares">122609995</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-130" unitRef="shares">95497056</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-131" unitRef="shares">95497056</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="c-6" decimals="0" id="f-132" unitRef="shares">122044299</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-133" unitRef="usd">122000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-134" unitRef="usd">413214000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-135" unitRef="usd">-446998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-136" unitRef="usd">-33662000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-9" decimals="0" id="f-137" unitRef="shares">1191071</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-9" decimals="-3" id="f-138" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-10" decimals="-3" id="f-139" unitRef="usd">5061000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-11" decimals="-3" id="f-140" unitRef="usd">5062000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-10" decimals="-3" id="f-141" unitRef="usd">303000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-11" decimals="-3" id="f-142" unitRef="usd">303000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <aqst:ProceedsFromExerciseOfWarrantsNet contextRef="c-12" decimals="-3" id="f-143" unitRef="usd">916000</aqst:ProceedsFromExerciseOfWarrantsNet>
    <aqst:ProceedsFromExerciseOfWarrantsNet contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">916000</aqst:ProceedsFromExerciseOfWarrantsNet>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-12" decimals="-3" id="f-145" unitRef="usd">2318000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-146" unitRef="usd">2318000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-13" decimals="0" id="f-147" unitRef="shares">1048422</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-13" decimals="-3" id="f-148" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-12" decimals="-3" id="f-149" unitRef="usd">-330000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-1" decimals="-3" id="f-150" unitRef="usd">-329000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-13" decimals="0" id="f-151" unitRef="shares">750</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-12" decimals="-3" id="f-152" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-153" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-154" unitRef="usd">-8057000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">-8057000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-15" decimals="0" id="f-156" unitRef="shares">124284542</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-3" id="f-157" unitRef="usd">124000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-158" unitRef="usd">420877000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-159" unitRef="usd">-455055000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-160" unitRef="usd">-34054000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c-18" decimals="0" id="f-161" unitRef="shares">91413742</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-162" unitRef="usd">91000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-163" unitRef="usd">302967000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-164" unitRef="usd">-363214000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-165" unitRef="usd">-60156000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-22" decimals="0" id="f-166" unitRef="shares">7457627</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-22" decimals="-3" id="f-167" unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-23" decimals="-3" id="f-168" unitRef="usd">21992000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-24" decimals="-3" id="f-169" unitRef="usd">22000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-23" decimals="-3" id="f-170" unitRef="usd">729000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-24" decimals="-3" id="f-171" unitRef="usd">729000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-25" decimals="-3" id="f-172" unitRef="usd">1587000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-173" unitRef="usd">1587000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-26" decimals="0" id="f-174" unitRef="shares">445784</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-25" decimals="-3" id="f-175" unitRef="usd">-702000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-5" decimals="-3" id="f-176" unitRef="usd">-702000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:NetIncomeLoss contextRef="c-27" decimals="-3" id="f-177" unitRef="usd">-22930000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-178" unitRef="usd">-22930000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-28" decimals="0" id="f-179" unitRef="shares">99317153</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-180" unitRef="usd">99000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-181" unitRef="usd">325115000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-182" unitRef="usd">-386144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-183" unitRef="usd">-60930000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-184" unitRef="usd">-8057000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-185" unitRef="usd">-22930000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-186" unitRef="usd">113000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-187" unitRef="usd">139000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-188" unitRef="usd">2318000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-5" decimals="-3" id="f-189" unitRef="usd">1587000</us-gaap:ShareBasedCompensation>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-1" decimals="-3" id="f-190" unitRef="usd">916000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-5" decimals="-3" id="f-191" unitRef="usd">0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-1" decimals="-3" id="f-192" unitRef="usd">2286000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-5" decimals="-3" id="f-193" unitRef="usd">2750000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-194" unitRef="usd">-6000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-5" decimals="-3" id="f-195" unitRef="usd">-46000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-1" decimals="-3" id="f-196" unitRef="usd">-10896000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-5" decimals="-3" id="f-197" unitRef="usd">3129000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-3" id="f-198" unitRef="usd">1896000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-5" decimals="-3" id="f-199" unitRef="usd">1154000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-200" unitRef="usd">340000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-5" decimals="-3" id="f-201" unitRef="usd">-423000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-202" unitRef="usd">-17973000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-5" decimals="-3" id="f-203" unitRef="usd">1905000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-204" unitRef="usd">-2803000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-5" decimals="-3" id="f-205" unitRef="usd">-2776000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-1" decimals="-3" id="f-206" unitRef="usd">-272000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-5" decimals="-3" id="f-207" unitRef="usd">-261000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-208" unitRef="usd">-14806000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="-3" id="f-209" unitRef="usd">-23400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-210" unitRef="usd">52000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-211" unitRef="usd">135000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-212" unitRef="usd">-52000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="-3" id="f-213" unitRef="usd">-135000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <aqst:ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises contextRef="c-1" decimals="-3" id="f-214" unitRef="usd">4759000</aqst:ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises>
    <aqst:ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises contextRef="c-5" decimals="-3" id="f-215" unitRef="usd">21360000</aqst:ProceedsFromIssuanceOfPublicOfferingIssuanceOfWarrantsAndWarrantExercises>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-216" unitRef="usd">1000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-5" decimals="-3" id="f-217" unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:RepaymentsOfDebt contextRef="c-1" decimals="-3" id="f-218" unitRef="usd">8000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-5" decimals="-3" id="f-219" unitRef="usd">6000</us-gaap:RepaymentsOfDebt>
    <aqst:PaymentsForRoyaltyObligations contextRef="c-1" decimals="-3" id="f-220" unitRef="usd">0</aqst:PaymentsForRoyaltyObligations>
    <aqst:PaymentsForRoyaltyObligations contextRef="c-5" decimals="-3" id="f-221" unitRef="usd">5000</aqst:PaymentsForRoyaltyObligations>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-222" unitRef="usd">329000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-5" decimals="-3" id="f-223" unitRef="usd">703000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-224" unitRef="usd">4423000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="-3" id="f-225" unitRef="usd">20646000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-226" unitRef="usd">-10435000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="-3" id="f-227" unitRef="usd">-2889000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-228" unitRef="usd">121169000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-21" decimals="-3" id="f-229" unitRef="usd">71546000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-230" unitRef="usd">110734000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-31" decimals="-3" id="f-231" unitRef="usd">68657000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-232" unitRef="usd">1524000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-5" decimals="-3" id="f-233" unitRef="usd">1525000</us-gaap:InterestPaidNet>
    <aqst:CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable contextRef="c-1" decimals="-3" id="f-234" unitRef="usd">0</aqst:CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable>
    <aqst:CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable contextRef="c-5" decimals="-3" id="f-235" unitRef="usd">89000</aqst:CostsAssociatedWithAtTheMarketPublicEquityOfferingInAccountsPayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-236">Company Overview and Basis of Presentation&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(A) Company Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. The worldwide leader in delivering trusted, quality medications on oral film, Aquestive operates as both a developer of its own proprietary products and a Contract Development and Manufacturing Organization (CDMO) for licensees, with its headquarters in New Jersey and U.S.-based manufacturing facilities in Indiana. The Company is the exclusive manufacturer of four commercialized products marketed by its licensees across six continents using proprietary, best-in-class technologies like PharmFilm&#xae;. Aquestive's AdrenaVerse&#x2122; platform contains a library of more than 20 epinephrine prodrugs enabling the pursuit of various potential allergy and dermatological indications. The Company is advancing Anaphylm&#x2122; (dibutepinephrine) sublingual film for the treatment of severe allergic reactions, including anaphylaxis, and AQST-108 (epinephrine) topical gel for various potential dermatological conditions, including alopecia areata, atopic dermatitis, rosacea, and psoriasis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(B)&#160;Equity Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ATM Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company established its first ATM facility in September 2019, and since inception to March&#160;31, 2026, the Company has sold 28,506,216 shares of Common Stock under its ATM facility which has generated net cash proceeds of approximately $86,563, net of commissions and estimated other transactions costs of $4,142. On April 3, 2024, the Company filed a new shelf registration statement on Form S-3, the 2024 Registration Statement, which was declared effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement are (i) a base prospectus registering the offer, issuance and sale of up to $250,000 worth of Common Stock, preferred stock, debt securities, warrants, rights and units and (ii) a $100,000 ATM facility prospectus. During the three months ended March 31, 2026, the Company sold 1,191,071 shares of Common Stock pursuant to the ATM prospectus and the Amended Equity Distribution Agreement with Piper Sandler &amp;amp; Co. (successor to Piper Jaffray &amp;amp; Co.), which provided net proceeds of approximately $4,810 after deducting commissions and estimated other transaction costs of $252. For the three months ended March 31, 2025, the Company sold 7,457,627 shares under the ATM facility which provided net proceeds of approximately $21,306 after deducting commissions and other transaction costs of $694. The remaining authorized balance of the ATM facility was approximately $73,000 as of March&#160;31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2025 Underwritten Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 14, 2025, the Company completed the 2025 Underwritten Public Offering of 21,250,000 shares of its common stock at the public offering price of $4.00 per share. Net proceeds from the 2025 Underwritten Public Offering were $79,900, after deducting underwriting discounts of $5,100. In addition to the underwriting discounts related to this offering, the Company incurred professional fees and other costs totaling $440. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;C&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#x2019;s audited financial statements and related notes for the fiscal year ended December&#160;31, 2025 included in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March&#160;4, 2026 (the &#x201c;2025 Annual Report on Form 10-K&#x201d;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2025 is derived from the audited financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-32" decimals="0" id="f-237" unitRef="shares">28506216</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-32" decimals="-3" id="f-238" unitRef="usd">86563000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-32" decimals="-3" id="f-239" unitRef="usd">4142000</us-gaap:PaymentsOfStockIssuanceCosts>
    <aqst:SaleOfStockMaximumTransactionAmount contextRef="c-33" decimals="-3" id="f-240" unitRef="usd">250000</aqst:SaleOfStockMaximumTransactionAmount>
    <aqst:SaleOfStockAggregateOfferingPrice contextRef="c-34" decimals="-6" id="f-241" unitRef="usd">100000000</aqst:SaleOfStockAggregateOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-35" decimals="0" id="f-242" unitRef="shares">1191071</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-35" decimals="-3" id="f-243" unitRef="usd">4810000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts contextRef="c-35" decimals="-3" id="f-244" unitRef="usd">252000</aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-36" decimals="0" id="f-245" unitRef="shares">7457627</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-36" decimals="-3" id="f-246" unitRef="usd">21306000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts contextRef="c-36" decimals="-3" id="f-247" unitRef="usd">694000</aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-37" decimals="-3" id="f-248" unitRef="usd">73000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-38" decimals="0" id="f-249" unitRef="shares">21250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-39"
      decimals="2"
      id="f-250"
      unitRef="usdPerShare">4.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-38" decimals="-3" id="f-251" unitRef="usd">79900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts contextRef="c-38" decimals="-3" id="f-252" unitRef="usd">5100000</aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-38" decimals="-3" id="f-253" unitRef="usd">440000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-254">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#x2019;s audited financial statements and related notes for the fiscal year ended December&#160;31, 2025 included in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March&#160;4, 2026 (the &#x201c;2025 Annual Report on Form 10-K&#x201d;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2025 is derived from the audited financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-255">Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Adopted as of March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&#x2014;Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ASU modifies the effective tax rate reconciliation table and requires disaggregation of income taxes. The Company adopted ASU 2023-09 for the year ending December&#160;31, 2025 and added the required disclosures on a prospective basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Not Adopted as of March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Statements of Operations, and Comprehensive Loss as well as qualitatively describe the remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Company&#x2019;s definition of selling expenses. These disclosure requirements will be effective for the Company for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact from the adoption of ASU 2024-03 on disclosures to its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the FASB issued ASU 2025-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Internal-Use Software&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to provide clarification and improvements to the accounting for internal-use software costs under ASC 350-40, Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software. The guidance includes amendments related to capitalization of implementation costs, subsequent measurement, and related presentation and disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-256">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Adopted as of March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&#x2014;Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ASU modifies the effective tax rate reconciliation table and requires disaggregation of income taxes. The Company adopted ASU 2023-09 for the year ending December&#160;31, 2025 and added the required disclosures on a prospective basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Not Adopted as of March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, included in certain expense captions in the Statements of Operations, and Comprehensive Loss as well as qualitatively describe the remaining amounts included in those captions. ASU 2024-03 will also require the Company to disclose both the amount and the Company&#x2019;s definition of selling expenses. These disclosure requirements will be effective for the Company for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact from the adoption of ASU 2024-03 on disclosures to its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the FASB issued ASU 2025-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Internal-Use Software&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to provide clarification and improvements to the accounting for internal-use software costs under ASC 350-40, Intangibles &#x2013; Goodwill and Other &#x2013; Internal-Use Software. The guidance includes amendments related to capitalization of implementation costs, subsequent measurement, and related presentation and disclosure requirements. This ASU will be effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact this ASU will have on its financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c-1" id="f-257">Risks and Uncertainties&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company&#x2019;s cash requirements for the remainder of 2026 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of March&#160;31, 2026, the Company had $110,734 of cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has experienced a history of net losses. The Company&#x2019;s accumulated deficits totaled $455,055 as of March&#160;31, 2026. The net losses and accumulated deficits were partially offset by gross margins from sales of commercialized licensed and proprietary products, license fees, milestone and royalty payments from commercial licensees and co-development parties. The Company&#x2019;s funding requirements have been met by its cash and cash equivalents, as well as its equity and debt offerings, including the 13.5% Notes as further discussed in Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the ATM facility and other equity offerings, including the 2025 Underwritten Public Offering as discussed in Note 1, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Company Overview and Basis of Presentation,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Part B, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Transactions.&lt;/span&gt;&lt;/div&gt;While the Company&#x2019;s ability to execute its business objectives and achieve profitability over the longer term cannot be assured, the Company&#x2019;s on-going business, existing cash and cash equivalents, expense management activities including, but not limited to, the ceasing of certain R&amp;amp;D activities, as well as access to the equity capital markets through its ATM facility, provide near term liquidity for the Company to fund its operating needs for at least the next twelve months as it continues to execute its business strategy.</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-258" unitRef="usd">110734000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-259" unitRef="usd">-455055000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-260" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-261">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an entity for which separate discrete financial information is available for evaluation by the CODM in deciding how to allocate resources and in assessing performance. For the three months ended March 31, 2026 and 2025, the Company has identified one operating and reportable segment. The Company defines its operating segment based on internally reported financial information that is regularly reviewed by the CODM to analyze financial performance, make decisions, and allocate resources. The Company's CEO is the CODM. The Company manages its operations as a single segment for purposes of assessing performance and making operating decisions. This segment encompasses the development and advancement of a product pipeline for the treatment of severe allergic reactions, including anaphylaxis, and the AdrenaVerse epinephrine prodrug pipeline platform. Additionally, the Company served as the exclusive manufacturer for its proprietary product, Libervant, while it had U.S. market access, and four licensed commercialized products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CODM reviews the segment's profit or loss based on net loss reported on the Condensed Statements of Operations and Comprehensive Loss. The CODM also considers forecast-to-actual variances on a monthly basis for expenses deemed significant. Furthermore, the CODM reviews the segment's assets based on total assets reported on the Condensed Balance Sheets. All long-lived assets are held in the United States. While the Company generated $14,446 and $8,720 in revenues for the three months ended March 31, 2026 and 2025, respectively, management expects the Company to continue to incur significant expenses and operating losses for the foreseeable future as it advances product candidates through all stages of development and clinical trials, ultimately seeking regulatory approval and commencing commercialization activities for Anaphylm, if approved by the FDA. The CODM uses cash forecast models to guide investment decisions and assess entity-wide operating results and performance. Net loss is used to monitor budget and rolling forecasts versus actual results. The CODM views specific categories within R&amp;amp;D expenses, selling expenses, and general and administrative expenses as significant due to their direct correlation with cash burn and profitability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles reported revenues to net loss under the significant expense principle for the three months ended March&#160;31, 2026 and 2025:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.970%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.574%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Manufacture and Supply Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D Project expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anaphylm project expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AQST-108 project expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D other expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personnel costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selling expenses:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personnel costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Selling expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General &amp;amp; Administrative expenses:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personnel costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Selling, General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income/(expenses), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.952%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 - R&amp;amp;D Personnel costs include payroll expenses,  share-based compensation expenses and severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - Other R&amp;amp;D expenses include preclinical, consulting, maintenance, and testing fees&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - Selling Personnel costs include payroll expenses, share-based compensation expenses and severance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 - Other Selling expenses include commercialization and other related expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - G&amp;amp;A Personnel costs include payroll expenses,  share-based compensation expenses and severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 - Other General and Administrative expenses include legal/patent fees, insurance fees, IT expenses, investor relations expenses, regulatory fees, facility and other costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-5"
      decimals="INF"
      id="f-262"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-263"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-264" unitRef="usd">14446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-265" unitRef="usd">8720000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-266">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles reported revenues to net loss under the significant expense principle for the three months ended March&#160;31, 2026 and 2025:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.970%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.574%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs and expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Manufacture and Supply Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D Project expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anaphylm project expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AQST-108 project expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;R&amp;amp;D other expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personnel costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Research and Development Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selling expenses:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personnel costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Selling expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;General &amp;amp; Administrative expenses:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personnel costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:1.41pt;vertical-align:baseline"&gt;6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Selling, General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income/(expenses), net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.952%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1 - R&amp;amp;D Personnel costs include payroll expenses,  share-based compensation expenses and severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 - Other R&amp;amp;D expenses include preclinical, consulting, maintenance, and testing fees&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - Selling Personnel costs include payroll expenses, share-based compensation expenses and severance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4 - Other Selling expenses include commercialization and other related expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - G&amp;amp;A Personnel costs include payroll expenses,  share-based compensation expenses and severance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6 - Other General and Administrative expenses include legal/patent fees, insurance fees, IT expenses, investor relations expenses, regulatory fees, facility and other costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-41" decimals="-3" id="f-267" unitRef="usd">14446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-42" decimals="-3" id="f-268" unitRef="usd">8720000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-41" decimals="-3" id="f-269" unitRef="usd">3469000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-42" decimals="-3" id="f-270" unitRef="usd">3652000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-43" decimals="-3" id="f-271" unitRef="usd">1085000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-44" decimals="-3" id="f-272" unitRef="usd">2488000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-45" decimals="-3" id="f-273" unitRef="usd">558000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-46" decimals="-3" id="f-274" unitRef="usd">195000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-47" decimals="-3" id="f-275" unitRef="usd">2242000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-48" decimals="-3" id="f-276" unitRef="usd">2132000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-49" decimals="-3" id="f-277" unitRef="usd">319000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-50" decimals="-3" id="f-278" unitRef="usd">546000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-41" decimals="-3" id="f-279" unitRef="usd">4204000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-42" decimals="-3" id="f-280" unitRef="usd">5361000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingExpense contextRef="c-47" decimals="-3" id="f-281" unitRef="usd">1643000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense contextRef="c-48" decimals="-3" id="f-282" unitRef="usd">694000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense contextRef="c-49" decimals="-3" id="f-283" unitRef="usd">277000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense contextRef="c-50" decimals="-3" id="f-284" unitRef="usd">2262000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense contextRef="c-41" decimals="-3" id="f-285" unitRef="usd">1920000</us-gaap:SellingExpense>
    <us-gaap:SellingExpense contextRef="c-42" decimals="-3" id="f-286" unitRef="usd">2956000</us-gaap:SellingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-47" decimals="-3" id="f-287" unitRef="usd">5509000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-48" decimals="-3" id="f-288" unitRef="usd">4840000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-49" decimals="-3" id="f-289" unitRef="usd">3548000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-50" decimals="-3" id="f-290" unitRef="usd">11276000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-41" decimals="-3" id="f-291" unitRef="usd">9057000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-42" decimals="-3" id="f-292" unitRef="usd">16116000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-41" decimals="-3" id="f-293" unitRef="usd">10977000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-42" decimals="-3" id="f-294" unitRef="usd">19072000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-41" decimals="-3" id="f-295" unitRef="usd">18650000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-42" decimals="-3" id="f-296" unitRef="usd">28085000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-41" decimals="-3" id="f-297" unitRef="usd">-4204000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-42" decimals="-3" id="f-298" unitRef="usd">-19365000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-41" decimals="-3" id="f-299" unitRef="usd">-3853000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-42" decimals="-3" id="f-300" unitRef="usd">-3565000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-41" decimals="-3" id="f-301" unitRef="usd">-8057000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-302" unitRef="usd">-22930000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-41" decimals="-3" id="f-303" unitRef="usd">-8057000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-42" decimals="-3" id="f-304" unitRef="usd">-22930000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-41" decimals="-3" id="f-305" unitRef="usd">-8057000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-42" decimals="-3" id="f-306" unitRef="usd">-22930000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-307">Revenues and Trade Receivables, Net&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age while Libervant had U.S. market access through April 2025. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - a performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#x2019;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;License and Royalty Revenu&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e &#x2013; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;i.e.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Co-development and Research Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#x2019;s R&amp;amp;D projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age while Libervant had U.S. market access through April 2025, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Once receivables are collected, allowances are reclassified and treated as accrued liabilities. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once related variable considerations are resolved and uncertainties as to incurred amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of March&#160;31, 2026, and December&#160;31, 2025, such contract assets were $445 and $627, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#x2019;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of March&#160;31, 2026 and December&#160;31, 2025, such contract liabilities were $20,210 and $20,482, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs to Obtain Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of March&#160;31, 2026 and December&#160;31, 2025, such costs to obtain contracts were $442 and $449, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License and royalty revenue &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Co-development and research fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;Zevra-related royalty revenue of $4,500 recognized during the three months ended March&#160;31, 2026. For additional information, see Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Material Agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides disaggregated net revenue by geographic area: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ex-United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2026, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), Zevra (license and royalty revenue), and Assertio manufacture and supply revenue, license and royalty revenue and co-development and research fees). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Zambon (manufacture and supply revenue, license and royalty revenue, and co-development and research fees) for revenue markets outside of the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2025, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and Assertio (manufacture and supply revenue, license and royalty revenue and co-development and research fees). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Hypera (manufacture and supply revenue, and license and royalty revenue) for revenue markets outside of the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade and other receivables, net consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sales-related allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into Accrued distribution expenses and sales-related allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract and other receivables totaled $1,605 and $9,750 as of March&#160;31, 2026 and December&#160;31, 2025, respectively, consisting primarily of contract assets and other receivables. Contract assets consist of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties. Other receivables include the current portion related to the Monetization royalty receivable and other receivables. As of December&#160;31, 2025, other receivables also include an insurance reimbursement. Sales-related allowances as of December&#160;31, 2025 were estimated in relation to revenues recognized for sales of Libervant for patients between two to five years of age while Libervant had U.S. market access.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains an allowance for credit losses on accounts receivable, which is recorded as a reduction to accounts receivable. Changes in the allowance are classified as Selling, general and administrative expenses in the Statements of Operations and Comprehensive Loss. The Company assesses collectability by reviewing accounts receivable on a collective basis where similar characteristics exist and on an individual basis when it identifies specific customers with known disputes or collectability issues. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status. It also considers customer-specific information, current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss data. On an ongoing basis, management evaluates the adequacy of these reserves. The allowance for credit losses was $0 as of March&#160;31, 2026 and December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales-Related Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, chargebacks, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on no less than a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provides a summary of activity with respect to sales-related allowances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.793%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments / credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into Accrued distribution expenses and sales-related allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables as of December&#160;31, 2025 and accruals for wholesaler service fees, co-pay support redemptions and other rebates are reflected as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and accrued expenses were $0 and $902, respectively, as of March&#160;31, 2026, and $0 and $906, respectively, as of December&#160;31, 2025. See Note 12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers are considered major customers when net revenue exceeds 10% of total revenue for the period or outstanding receivable balances exceed 10% of total receivables. For the three months ended March 31, 2026, Indivior and Zevra, represented approximately 57% and 32%, of total revenue, respectively. As of March&#160;31, 2026, Indivior and Assertio &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;exceeded the 10% threshold for outstanding receivable balances and represented approximately 81% and 15% of total trade and other receivables, respectively. For the three months ended March&#160;31, 2025, Indivior and Hypera exceeded the 10% threshold for revenue and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represented approximately &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;67% and 17% &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of total revenue, including the one-time recognition of deferred revenue, respectively. As of December&#160;31, 2025,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Indivior and Hypera exceeded the 10% threshold for outstanding receivable balances and represented 69% and 25% of total trade and other receivables, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-308">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age while Libervant had U.S. market access through April 2025. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - a performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#x2019;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;License and Royalty Revenu&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e &#x2013; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;i.e.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Co-development and Research Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#x2019;s R&amp;amp;D projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age while Libervant had U.S. market access through April 2025, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Once receivables are collected, allowances are reclassified and treated as accrued liabilities. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once related variable considerations are resolved and uncertainties as to incurred amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of March&#160;31, 2026, and December&#160;31, 2025, such contract assets were $445 and $627, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#x2019;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of March&#160;31, 2026 and December&#160;31, 2025, such contract liabilities were $20,210 and $20,482, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs to Obtain Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of March&#160;31, 2026 and December&#160;31, 2025, such costs to obtain contracts were $442 and $449, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <aqst:ResearchAndDevelopmentProjectDuration contextRef="c-51" id="f-309">P3Y</aqst:ResearchAndDevelopmentProjectDuration>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-3" decimals="-3" id="f-310" unitRef="usd">445000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-4" decimals="-3" id="f-311" unitRef="usd">627000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability contextRef="c-3" decimals="-3" id="f-312" unitRef="usd">20210000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-3" id="f-313" unitRef="usd">20482000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:CapitalizedContractCostNet contextRef="c-3" decimals="-3" id="f-314" unitRef="usd">442000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet contextRef="c-4" decimals="-3" id="f-315" unitRef="usd">449000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="c-1" id="f-316">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License and royalty revenue &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;a&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Co-development and research fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;Zevra-related royalty revenue of $4,500 recognized during the three months ended March&#160;31, 2026. For additional information, see Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Material Agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-52" decimals="-3" id="f-317" unitRef="usd">8793000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-53" decimals="-3" id="f-318" unitRef="usd">7193000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-54" decimals="-3" id="f-319" unitRef="usd">5395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-55" decimals="-3" id="f-320" unitRef="usd">790000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-56" decimals="-3" id="f-321" unitRef="usd">258000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-57" decimals="-3" id="f-322" unitRef="usd">418000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-58" decimals="-3" id="f-323" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-59" decimals="-3" id="f-324" unitRef="usd">319000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">14446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-326" unitRef="usd">8720000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-60" decimals="-3" id="f-327" unitRef="usd">4500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-328">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides disaggregated net revenue by geographic area: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ex-United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-61" decimals="-3" id="f-329" unitRef="usd">13245000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-62" decimals="-3" id="f-330" unitRef="usd">5201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-63" decimals="-3" id="f-331" unitRef="usd">1201000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-64" decimals="-3" id="f-332" unitRef="usd">3519000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">14446000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-334" unitRef="usd">8720000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-335">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade and other receivables, net consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sales-related allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into Accrued distribution expenses and sales-related allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross contextRef="c-3" decimals="-3" id="f-336" unitRef="usd">5262000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-4" decimals="-3" id="f-337" unitRef="usd">8013000</us-gaap:AccountsReceivableGross>
    <us-gaap:OtherReceivablesGrossCurrent contextRef="c-3" decimals="-3" id="f-338" unitRef="usd">1605000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:OtherReceivablesGrossCurrent contextRef="c-4" decimals="-3" id="f-339" unitRef="usd">9750000</us-gaap:OtherReceivablesGrossCurrent>
    <aqst:AccountsReceivableAllowanceForCreditLossPreReclassification contextRef="c-3" decimals="-3" id="f-340" unitRef="usd">0</aqst:AccountsReceivableAllowanceForCreditLossPreReclassification>
    <aqst:AccountsReceivableAllowanceForCreditLossPreReclassification contextRef="c-4" decimals="-3" id="f-341" unitRef="usd">582000</aqst:AccountsReceivableAllowanceForCreditLossPreReclassification>
    <aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet contextRef="c-3" decimals="-3" id="f-342" unitRef="usd">0</aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet>
    <aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet contextRef="c-4" decimals="-3" id="f-343" unitRef="usd">582000</aqst:AccountsReceivableAllowancesAndAccrualsTradeAndOtherReceivablesNet>
    <us-gaap:ReceivablesNetCurrent contextRef="c-3" decimals="-3" id="f-344" unitRef="usd">6867000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-345" unitRef="usd">17763000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherReceivablesGrossCurrent contextRef="c-3" decimals="-3" id="f-346" unitRef="usd">1605000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:OtherReceivablesGrossCurrent contextRef="c-4" decimals="-3" id="f-347" unitRef="usd">9750000</us-gaap:OtherReceivablesGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-65" decimals="-3" id="f-348" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-66" decimals="-3" id="f-349" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <aqst:ScheduleOfAccountsReceivableAllowancesTableTextBlock contextRef="c-1" id="f-350">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provides a summary of activity with respect to sales-related allowances:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.793%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments / credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into Accrued distribution expenses and sales-related allowances&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</aqst:ScheduleOfAccountsReceivableAllowancesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-67" decimals="-3" id="f-351" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-68" decimals="-3" id="f-352" unitRef="usd">48000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-69" decimals="-3" id="f-353" unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-70" decimals="-3" id="f-354" unitRef="usd">568000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries contextRef="c-69" decimals="-3" id="f-355" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries contextRef="c-70" decimals="-3" id="f-356" unitRef="usd">34000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <aqst:AccountsReceivableAllowanceForCreditLossReclassifications contextRef="c-69" decimals="-3" id="f-357" unitRef="usd">0</aqst:AccountsReceivableAllowanceForCreditLossReclassifications>
    <aqst:AccountsReceivableAllowanceForCreditLossReclassifications contextRef="c-70" decimals="-3" id="f-358" unitRef="usd">-582000</aqst:AccountsReceivableAllowanceForCreditLossReclassifications>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-71" decimals="-3" id="f-359" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-67" decimals="-3" id="f-360" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-72" decimals="-3" id="f-361" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-73" decimals="-3" id="f-362" unitRef="usd">902000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-74" decimals="-3" id="f-363" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-75" decimals="-3" id="f-364" unitRef="usd">906000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-76" decimals="2" id="f-365" unitRef="number">0.57</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-77" decimals="2" id="f-366" unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-78" decimals="2" id="f-367" unitRef="number">0.81</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-79" decimals="2" id="f-368" unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-80" decimals="2" id="f-369" unitRef="number">0.67</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-81" decimals="2" id="f-370" unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-82" decimals="2" id="f-371" unitRef="number">0.69</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-83" decimals="2" id="f-372" unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-373">Material Agreements&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase and Sale Agreement with RTW Investments LP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 13, 2025, the Company entered into the Purchase Agreement with funds managed by RTW Investments LP. Under the terms of the Purchase Agreement, in exchange for the Purchaser's payment to the Company of a purchase price of $75,000, upon approval of Anaphylm by the FDA by a specified date, the refinancing of the Company&#x2019;s existing 13.5% Notes and certain other customary conditions (the "Closing Conditions"), the Company agreed to a sale of assigned interests to the Purchaser, including a right for the Purchaser to tiered revenue share payments ranging from 1.0% to 7.5% of net sales (as defined in the Purchase Agreement) of Anaphylm (and 9.5% for the subsequent calendar year period if net sales do not achieve specified level in a calendar year period beginning in 2027) in the United States. Revenue share payments commence in the first fiscal quarter in which the first commercial sale of Anaphylm in the United States after the satisfaction of the Closing Conditions. Revenue share payments will cease upon the Purchaser's receipt of $187,500 by December 31, 2035 or $225,000 thereafter. The Purchase Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company&#x2019;s ability to, among other things, incur indebtedness (which restrictions are eliminated after the achievement by the Purchaser of a specified return on its investment), and other provisions customary for transactions of this nature, in each case subject to certain exceptions set forth in the Purchase  Agreement. As this financing is contingent on events that have not occurred yet and are outside of the Company's control, the accounting consequences for this transaction as of March&#160;31, 2026 and December&#160;31, 2025 have been limited to capitalized legal fees of approximately $750 and $700, respectively, recorded within Other current assets on the Condensed Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2026, the Company entered into the Amendment No. 1 to the Purchase Agreement. The Amendment extends the Marketing Approval Deadline from its original date in the Purchase Agreement to June 30, 2027. Concurrently, the Company entered into a Warrant Issuance Agreement with funds managed by RTW, pursuant to which the Company agreed to issue a warrant to purchase up to 375,000 shares of the Company's Common Stock at an exercise price of $4.00 per share, expiring on March 3, 2029. For information regarding the RTW Warrants, see Note 14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrants. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2026, the Company also entered into a Share Purchase Commitment Agreement with certain RTW-affiliated funds, pursuant to which such funds committed to purchase, in the aggregate, not less than $5,000 of Common Stock during the 90-day period following the effective date of the Amendment, at prices determined in accordance with Rule 415(a)(4) under the Securities Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial Exploitation Agreement with Indivior&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2008, the Company entered into the Indivior License Agreement (with subsequent amendments) with Reckitt Benckiser Pharmaceuticals, Inc. who was later succeeded to in interest by Indivior.&#160;Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#x2019;s requirements for Suboxone&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a sublingual film formulation, both inside and outside the United States on an exclusive basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain API&#160;for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year. The Indivior License Agreement provides for payment by Indivior of an agreed upon purchase price per unit until January 1, 2025 and, thereafter, that is subject to annual adjustments based on changes in an agreed upon price index. In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) outside of the U.S., subject to annual maximum amounts and limited to the life of the related patents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&#x2019;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was seven years from the commencement date. Thereafter, the Indivior License Agreement automatically renewed for successive one-year periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective as of March 2, 2023, the Company and Indivior entered into the Indivior Amendment to the Indivior License Agreement. The Indivior Amendment was entered into for the primary purpose of amending the Agreement as follows: (i) extending the term of the Agreement until August 16, 2026 and thereafter providing for automatic renewal terms of successive one-year periods unless Indivior delivers notice to the Company, at least twelve months prior to the expiration of the then current term, of Indivior&#x2019;s intent not to renew, subject to the earlier termination rights of the parties under the Agreement, and providing that the Agreement will not automatically renew for any renewal term beginning after the expiration of the last to expire of the product patents covered under the Indivior License Agreement; and (ii) agreeing to transfer pricing and payment terms for supplied product under the Indivior License Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License Agreement with Sunovion Pharmaceuticals, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&#x2019;s disease patients. Sunovion used this intellectual property to develop its apomorphine product KYNMOBI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#x2019;s obligation to remit a payment of $4,000, due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of FDA approval of the product. This amount was received as of September 30, 2020 and was included in License and royalty revenues for the twelve months ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective March 16, 2020, the Company entered into the First Amendment. The First Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the EU which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company from January 1, 2020 to April 1, 2020, and (iv) modifying the termination provision to reflect the Company&#x2019;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI was not commercialized by January 1, 2020. This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the First Amendment. The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents unless earlier terminated under the termination provisions contained therein. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties' agreement with respect to certain provisions in the Sunovion License Agreement, specifically the date after which Sunovion has the right to terminate the Sunovion License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#x2019;s patents covered under the Sunovion License Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration of the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $22,000 to date. In addition to the upfront payment of $5,000, the Company has also earned an aggregate of $17,000 in connection with specified regulatory and development milestones in the United States and Europe (the &#x201c;Initial Milestone Payments&#x201d;), all of which have been received to date. With the Monetization Agreement (defined below) entered into on November 3, 2020 relating to KYNMOBI as described in the paragraph below, the Company is no longer entitled to receive any payments under the Sunovion License Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase and Sale Agreement with an affiliate of Marathon&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold to Marathon all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#x2019;s apomorphine product, KYNMOBI. In exchange for the sale of these rights, the Company received an upfront payment from Marathon of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through March&#160;31, 2026 under the Monetization Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets; therefore, the Company likely will not receive any of the additional contingent payments under the Monetization Agreement. See Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale of Future Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details on the accounting for the Monetization Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Agreement to Terminate CLA with Zevra Therapeutics, Inc. (formerly KemPharm)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2012, the Company entered into an agreement with Zevra to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In March 2026, Zevra sold Azstarys to Commave Therapeutics SA. In accordance with the Company's agreement with Zevra, the Company received a payment out of the proceeds of the Zevra Commave  agreement and recognized royalty revenues of $4,500 during the three months ended March&#160;31, 2026 and will recognize additional $500 royalty revenues as a result of a payment to the Company in April 2026 in accordance with the Company's agreement with Zevra.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensing and Supply Agreement with Atnahs Pharma UK Limited (Pharmanovia)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into the Pharmanovia Agreement, effective as of September 26, 2022, pursuant to which the Company granted Pharmanovia an exclusive license to certain of the Company&#x2019;s intellectual property to develop and commercialize Libervant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.15pt;font-weight:700;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (diazepam) buccal film for the treatment of prolonged or acute, convulsive seizures in all ages in the Territory during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and the Company will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. Pursuant to the Pharmanovia Agreement, the Company received $3,500 upon agreement execution and, upon the occurrence of certain conditions set forth in the Pharmanovia Agreement, will receive additional milestone payments and profit shares, as well as manufacturing fees and royalty fees through the expiration of the Pharmanovia Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective March 27, 2023, the Company amended the Pharmanovia Agreement to expand the scope of territory for the license of Libervant to cover the rest of the world, excluding the U.S., Canada and China. Under the Pharmanovia Amendment, Pharmanovia will be responsible for seeking applicable regulatory approval in the expanded territories, which include Latin America, Africa and Asia Pacific. Pursuant to the terms of the Pharmanovia Amendment, the Company received a non-refundable payment of $2,000 from Pharmanovia in connection with the execution of the Pharmanovia Amendment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 20, 2026, the Company entered into a second amendment to the Pharmanovia Agreement relating to the license and supply of Libervant (diazepam) buccal film in territories outside the United States. The Pharmanovia Amendment No. 2 modifies certain commercial and operational terms of the agreement, including subcontracting rights, delivery terms, and minimum volume commitments in certain territories. All other terms and conditions of the Pharmanovia Agreement remain in full force and effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensing Agreement with Assertio Holdings, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective as of October 26, 2022, the Company entered into the Assertio Agreement to license Sympazan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox&#x2010;Gastaut syndrome in patients aged two years of age and older. Under the terms of the Assertio Agreement, the Company granted to Assertio an exclusive, worldwide license of its intellectual property for Sympazan to Assertio during the term of the Assertio Agreement for an upfront payment of $9,000. In addition, Aquestive received a $6,000 milestone payment subsequent to Aquestive&#x2019;s receipt of a notice of allowance from the PTO of the Company&#x2019;s patent application U.S. Serial No. 16/561,573, and payment by the Company of the related allowance fee. The Company received the notice of allowance from the PTO and paid the related allowance fee on October 27, 2022. Further, under the Assertio Agreement, the Company will receive royalties from Assertio for the sale of the product through the expiration of the Assertio Agreement. The Company also entered into a long-term supply agreement with Assertio for Sympazan pursuant to which the Company is the exclusive sole worldwide manufacturer and supplier of the product and will receive manufacturing fees from Assertio for the product through the expiration of such supply agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 8, 2026, Assertio entered into an Asset Purchase Agreement with Cosette,  a United States-based, branded specialty pharmaceutical company, to divest a portfolio of products, including Sympazan, to Cosette. Under that Asset Purchase Agreement, Assertio assigned and transferred its rights and certain obligations arising post closing to Cosette. Cosette assumed the intellectual property license and rights to commercialize Sympazan and will continue to purchase product and pay royalties and milestones to Aquestive under the Assertio Agreement and the Company's long-term supply agreement with Assertio.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <aqst:ConsiderationReceivableFromSaleOfFutureRevenuesInterests contextRef="c-84" decimals="-3" id="f-374" unitRef="usd">75000</aqst:ConsiderationReceivableFromSaleOfFutureRevenuesInterests>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-85" decimals="3" id="f-375" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:CollaborativeArrangementRevenueSharingPercentage contextRef="c-86" decimals="3" id="f-376" unitRef="number">0.010</aqst:CollaborativeArrangementRevenueSharingPercentage>
    <aqst:CollaborativeArrangementRevenueSharingPercentage contextRef="c-87" decimals="3" id="f-377" unitRef="number">0.075</aqst:CollaborativeArrangementRevenueSharingPercentage>
    <aqst:CollaborativeArrangementRevenueSharingPercentage contextRef="c-84" decimals="3" id="f-378" unitRef="number">0.095</aqst:CollaborativeArrangementRevenueSharingPercentage>
    <aqst:CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen contextRef="c-88" decimals="-3" id="f-379" unitRef="usd">187500000</aqst:CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptYearTen>
    <aqst:CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter contextRef="c-88" decimals="-3" id="f-380" unitRef="usd">225000</aqst:CollaborativeArrangementEstimatedRevenueSharePaymentsUponPurchasersReceiptThereafter>
    <aqst:CapitalizedLegalFees contextRef="c-89" decimals="-3" id="f-381" unitRef="usd">750000</aqst:CapitalizedLegalFees>
    <aqst:CapitalizedLegalFees contextRef="c-90" decimals="-3" id="f-382" unitRef="usd">700000</aqst:CapitalizedLegalFees>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-91" decimals="0" id="f-383" unitRef="shares">375000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-92"
      decimals="2"
      id="f-384"
      unitRef="usdPerShare">4.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <aqst:SaleOfStockSharesCommittedAggregateAmount contextRef="c-93" decimals="-3" id="f-385" unitRef="usd">5000000</aqst:SaleOfStockSharesCommittedAggregateAmount>
    <aqst:SaleOfStockShareCommitmentPeriodFollowingEffectiveDate contextRef="c-93" id="f-386">P90D</aqst:SaleOfStockShareCommitmentPeriodFollowingEffectiveDate>
    <aqst:LicenseAgreementTerm contextRef="c-94" id="f-387">P7Y</aqst:LicenseAgreementTerm>
    <aqst:AutomaticRenewalPeriodOfAgreement contextRef="c-94" id="f-388">P1Y</aqst:AutomaticRenewalPeriodOfAgreement>
    <aqst:AutomaticRenewalPeriodOfAgreement contextRef="c-95" id="f-389">P1Y</aqst:AutomaticRenewalPeriodOfAgreement>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-96" decimals="-3" id="f-390" unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-97" decimals="-3" id="f-391" unitRef="usd">22000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-98" decimals="-3" id="f-392" unitRef="usd">5000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-99" decimals="-3" id="f-393" unitRef="usd">17000000</us-gaap:Revenues>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-100" decimals="-3" id="f-394" unitRef="usd">40000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:AdditionalProceedsFromSaleOfFutureRevenuesNet contextRef="c-100" decimals="-3" id="f-395" unitRef="usd">10000000</aqst:AdditionalProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-101" decimals="-3" id="f-396" unitRef="usd">50000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ContingentMonetizationAgreementMilestonePayment contextRef="c-100" decimals="-3" id="f-397" unitRef="usd">75000000</aqst:ContingentMonetizationAgreementMilestonePayment>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-102" decimals="-3" id="f-398" unitRef="usd">125000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-60" decimals="-3" id="f-399" unitRef="usd">4500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-103" decimals="-3" id="f-400" unitRef="usd">500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-104" decimals="-3" id="f-401" unitRef="usd">3500000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-105" decimals="-3" id="f-402" unitRef="usd">2000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:ProceedsFromCollaborators contextRef="c-106" decimals="-3" id="f-403" unitRef="usd">9000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-106" decimals="-3" id="f-404" unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-405">Financial Instruments &#x2013; Fair Value Measurements&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&#160;Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 1 &#x2014; Observable quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 2 &#x2014; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160;methodologies and similar techniques.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the Condensed Balance Sheets for Trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company issued pre-funded warrants to purchase up to 4,000,000 shares of Common Stock and Common Stock Warrants to purchase up to 8,850,000 shares of Common Stock in connection with its Securities Purchase Agreements with certain purchasers. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide. See Note 14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on these warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of the remaining warrants to purchase 5,000,000 of the shares of Common Stock. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder new warrants to purchase up to an aggregate of 2,750,000 shares of new warrants at $2.60 per share. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide. See Note 14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on these warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, in connection with the issuance of the 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides the Note Holders:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#x2122; (dibutepinephrine) sublingual film for a period of eight years from the first sale of Anaphylm on a global basis, and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (diazepam) buccal film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Those Royalty Agreements were valued based on Level 3 inputs and their&#160;fair value was based primarily on internal management estimates developed based on third-party data and reflect management&#x2019;s judgment, current market conditions, and forecasts. The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2026, in connection with Amendment No.1 to the Purchase and Sale Agreement and the Equity Commitment Agreement with RTW, the Company also entered into the Warrant Issuance Agreement with the RTW investors. Pursuant to this agreement, the Company issued to the RTW Investors the RTW Warrant to purchase up to an aggregate of 375,000 shares of the Company's Common Stock. The RTW Warrant entitles the holders to purchase shares of Common Stock at an exercise price of $4.00 per share. Management estimated the fair value of the RTW Warrants to be $916, and it is presented within Additional Paid-in Capital on the Condensed Balance Sheets as of March&#160;31, 2026, and within Interest income and other income, net on the Condensed Statements of Operations and Comprehensive Loss for the three months ended March&#160;31, 2026. The RTW Warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide. See Note 14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on these warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <aqst:SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants contextRef="c-107" decimals="0" id="f-406" unitRef="shares">4000000</aqst:SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants>
    <aqst:SharesOfCommonStockToBePurchasedByCommonStockWarrants contextRef="c-107" decimals="0" id="f-407" unitRef="shares">8850000</aqst:SharesOfCommonStockToBePurchasedByCommonStockWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-108" decimals="0" id="f-408" unitRef="shares">5000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-108"
      decimals="2"
      id="f-409"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-109" decimals="0" id="f-410" unitRef="shares">2750000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-109"
      decimals="2"
      id="f-411"
      unitRef="usdPerShare">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-110" decimals="3" id="f-412" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-111" decimals="3" id="f-413" unitRef="number">0.010</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-112" decimals="3" id="f-414" unitRef="number">0.020</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:RoyaltyObligationTerm contextRef="c-113" id="f-415">P8Y</aqst:RoyaltyObligationTerm>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-111" decimals="3" id="f-416" unitRef="number">0.010</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-112" decimals="3" id="f-417" unitRef="number">0.020</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:RoyaltyObligationTerm contextRef="c-113" id="f-418">P8Y</aqst:RoyaltyObligationTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-114" decimals="0" id="f-419" unitRef="shares">375000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-115"
      decimals="2"
      id="f-420"
      unitRef="usdPerShare">4.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-3" decimals="-3" id="f-421" unitRef="usd">916000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c-1" id="f-422">Inventories, Net&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Inventory are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw material&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging material&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-423">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Inventory are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw material&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging material&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="c-3" decimals="-3" id="f-424" unitRef="usd">4320000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="c-4" decimals="-3" id="f-425" unitRef="usd">3143000</us-gaap:InventoryRawMaterials>
    <aqst:InventoryPackingMaterialGross contextRef="c-3" decimals="-3" id="f-426" unitRef="usd">2521000</aqst:InventoryPackingMaterialGross>
    <aqst:InventoryPackingMaterialGross contextRef="c-4" decimals="-3" id="f-427" unitRef="usd">2362000</aqst:InventoryPackingMaterialGross>
    <us-gaap:InventoryFinishedGoods contextRef="c-3" decimals="-3" id="f-428" unitRef="usd">1225000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c-4" decimals="-3" id="f-429" unitRef="usd">664000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-3" id="f-430" unitRef="usd">8066000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-3" id="f-431" unitRef="usd">6169000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-432">Property and Equipment, Net&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful&lt;br/&gt;Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer, network equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2026 and 2025, total depreciation and amortization related to property and equipment was $113 and $139, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-433">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful&lt;br/&gt;Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer, network equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-116" id="f-434">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-117" id="f-435">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-118" decimals="-3" id="f-436" unitRef="usd">20383000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-119" decimals="-3" id="f-437" unitRef="usd">20383000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-120" id="f-438">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-121" id="f-439">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-122" decimals="-3" id="f-440" unitRef="usd">769000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-123" decimals="-3" id="f-441" unitRef="usd">769000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-124" decimals="-3" id="f-442" unitRef="usd">21419000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-125" decimals="-3" id="f-443" unitRef="usd">21419000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-126" id="f-444">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-127" id="f-445">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-128" decimals="-3" id="f-446" unitRef="usd">3140000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-129" decimals="-3" id="f-447" unitRef="usd">3140000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-130" decimals="-3" id="f-448" unitRef="usd">2255000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-131" decimals="-3" id="f-449" unitRef="usd">2203000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-450" unitRef="usd">47966000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-451" unitRef="usd">47914000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-452" unitRef="usd">44127000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-453" unitRef="usd">44021000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-454" unitRef="usd">3839000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-455" unitRef="usd">3893000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-456" unitRef="usd">113000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="-3" id="f-457" unitRef="usd">139000</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-458">Right-of-Use Assets and Lease Obligations&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases all realty used at its production and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these three leases include the characteristics specified in ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which require classification as financing leases and, accordingly, these leases are accounted for as operating leases. These leases, as amended, provide remaining terms between 2.0 years and 7.5 years, including renewal options expected to be exercised to extend the lease periods. Commitments under finance leases are not significant, and are included in Property and equipment, net, and Notes Payable, net on the Condensed Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize a right-to-use asset and lease liability for short-term leases, which have terms of 12 months or less on its Condensed Balance Sheets. For longer-term lease arrangements that are recognized on the Company&#x2019;s Condensed Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#x2019;s short-term leases, as well as variable costs relating to the Company&#x2019;s lease arrangements, are not material to the Company&#x2019;s financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The implicit interest rates of the Company&#x2019;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. Measurement of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;operating lease liability reflects a range of an estimated discount rate of 14.8% to 15.6% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#x2019;s collateralized debt refinancing. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease costs are recorded in manufacture and supply, R&amp;amp;D and selling, general and administrative expenses in its Condensed Statements of Operations and Comprehensive Loss. For the three months ended March&#160;31, 2026, total operating lease expenses totaled $447, including variable lease expenses such as common area maintenance and operating costs of $114. For the three months ended March&#160;31, 2025, total operating lease expenses totaled $427, including variable lease expenses such as common area maintenance and operating costs of $93.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payments due under its operating leases are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <aqst:NumberOfOperatingLeases contextRef="c-3" decimals="INF" id="f-459" unitRef="lease">3</aqst:NumberOfOperatingLeases>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-132" id="f-460">P2Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-133" id="f-461">P7Y6M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c-132" decimals="3" id="f-462" unitRef="number">0.148</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c-133" decimals="3" id="f-463" unitRef="number">0.156</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-464" unitRef="usd">447000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-465" unitRef="usd">114000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-3" id="f-466" unitRef="usd">427000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-5" decimals="-3" id="f-467" unitRef="usd">93000</us-gaap:VariableLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-468">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payments due under its operating leases are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-469" unitRef="usd">991000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-470" unitRef="usd">1346000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-471" unitRef="usd">1180000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-472" unitRef="usd">1000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <aqst:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter contextRef="c-3" decimals="-3" id="f-473" unitRef="usd">2915000</aqst:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-474" unitRef="usd">7432000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-475" unitRef="usd">2611000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-476" unitRef="usd">4821000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="c-1" id="f-477">Other Non-current Assets&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of other non-current assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the eight $1,000 annual minimum guaranteed royalty payments that are due to the Company. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfer and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to determine whether the existing receivable was transferred to Marathon and concluded it was not transferred. As of March&#160;31, 2026 and December&#160;31, 2025, Royalty receivable consists of three annual minimum payments due from Sunovion, the last of which is due in March 2028. The current portion of the royalty receivable is included in Trade and other receivables, net. See Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale of Future Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details on how this receivable relates to the Monetization Agreement transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-current portion of costs to obtain contracts capitalized under ASC 340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is recorded within Other non-current assets on the  Condensed Balance Sheets as of March&#160;31, 2026 and December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock contextRef="c-1" id="f-478">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of other non-current assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <aqst:CumulativeRoyaltyReceivable contextRef="c-3" decimals="-3" id="f-479" unitRef="usd">2000000</aqst:CumulativeRoyaltyReceivable>
    <aqst:CumulativeRoyaltyReceivable contextRef="c-4" decimals="-3" id="f-480" unitRef="usd">2000000</aqst:CumulativeRoyaltyReceivable>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-3" decimals="-3" id="f-481" unitRef="usd">635000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-4" decimals="-3" id="f-482" unitRef="usd">642000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-483" unitRef="usd">2635000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-484" unitRef="usd">2642000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-134" decimals="-3" id="f-485" unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <aqst:NumberOfGuaranteedRoyaltyPayments
      contextRef="c-1"
      decimals="INF"
      id="f-486"
      unitRef="payment">8</aqst:NumberOfGuaranteedRoyaltyPayments>
    <aqst:MinimumAnnualRoyaltyReceivable contextRef="c-135" decimals="-3" id="f-487" unitRef="usd">1000000</aqst:MinimumAnnualRoyaltyReceivable>
    <aqst:NumberOfAnnualRoyaltyPaymentsReceivable
      contextRef="c-135"
      decimals="INF"
      id="f-488"
      unitRef="payment">3</aqst:NumberOfAnnualRoyaltyPaymentsReceivable>
    <aqst:NumberOfAnnualRoyaltyPaymentsReceivable
      contextRef="c-136"
      decimals="INF"
      id="f-489"
      unitRef="payment">3</aqst:NumberOfAnnualRoyaltyPaymentsReceivable>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-490">Accrued Expenses&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate and personal property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued distribution expenses and sales returns provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reduction in Accrued compensation is mostly related to payments of accrued bonuses during the three months ended March 31, 2026, partially offset by the current year accrual of bonuses. Accrued distribution expenses and sales returns provision mostly represent estimated liabilities for returns, wholesaler service fees, co-pay support redemptions and other &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rebates related to the proprietary product Libervant and returns and other expenses related to the proprietary product Sympazan (prior to outlicensing to Assertio in October 2022).&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-491">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate and personal property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued distribution expenses and sales returns provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-492" unitRef="usd">2069000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-493" unitRef="usd">3707000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-3" decimals="-3" id="f-494" unitRef="usd">408000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-4" decimals="-3" id="f-495" unitRef="usd">349000</us-gaap:TaxesPayableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-73" decimals="-3" id="f-496" unitRef="usd">902000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-75" decimals="-3" id="f-497" unitRef="usd">906000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InterestPayableCurrent contextRef="c-3" decimals="-3" id="f-498" unitRef="usd">17000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-4" decimals="-3" id="f-499" unitRef="usd">17000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-500" unitRef="usd">53000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-501" unitRef="usd">50000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-502" unitRef="usd">3449000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-503" unitRef="usd">5029000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-504">Long-Term Debt&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;13.5% Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, the Company entered into an Indenture Agreement with certain institutional investors (the &#x201c;Note Holders&#x201d;) and issued $45,000 aggregate principal amount of its 13.5% Notes due 2028. The Company received net proceeds of approximately $4,326 from this transaction after the repayment of the Company's 12.5% Notes and deduction of debt discount, and debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The 13.5% Notes are senior secured obligations of the Company and mature on November 1, 2028. The 13.5% Notes bear interest at a fixed rate of 13.5% per year, payable quarterly commencing on December 30, 2023. On each payment date commencing on June 30, 2026, the Company will pay an installment of principal of the 13.5% Notes pursuant to a fixed amortization schedule, along with the applicable Exit Fee. The Exit Fee totals $2,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may, at its option, redeem the 13.5% Notes in full or in part:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;if such redemption occurs prior to November 1, 2025, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee, plus an Applicable Premium which is the greater of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-23.27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt"&gt;1.0% of the principal redeemed; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt"&gt;the amount, if any, by which the present value of the principal to be redeemed on November 1, 2025, plus all required interest due on such date, computed using a discount rate equal to the Treasury Rate, plus 100 basis points, exceeds the amount of principal to be redeemed; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;if such redemption occurs after November 1, 2025, the redemption price is equal to 108.5% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company undergoes a change of control, the Note Holders may require the Company to repurchase for cash all or any portion of the 13.5% Notes at a change of control repurchase price equal at 108.5% plus the Exit Fee of the remaining principal, plus accrued interest at the election of the Note Holders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Indenture permits the Company, upon the continuing satisfaction of certain conditions, including that the Company has at least $100,000 of net revenues for the most recently completed twelve calendar month period, to enter into an ABL facility not to exceed $10,000. The ABL Facility may be collateralized only by assets of the Company constituting inventory, accounts receivable, and the proceeds thereof. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 12, 2026, the Company entered into a five-year term loan facility of up to $150,000 with funds managed by Oaktree Capital Management, L.P, consisting of a term loan in an aggregate principal amount of $55,000 which was funded on May 12, 2026 and was used by the Company to repay the Company&#x2019;s existing 13.5% Notes in the aggregate principal amount of $45,000 plus fees associated with the repayment. See Note 21, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides Note Holders:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#x2122; (dibutepinephrine) sublingual film for a period of eight years from the first sale of Anaphylm on a global basis, and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (diazepam) buccal film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Both the 13.5% Notes and Royalty Right Agreements, represent freestanding instruments which were issued in conjunction with each other. They are classified as debt within the scope of ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and are subsequently measured on an amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. These inputs are derived using internal management estimates developed based on third-party data and reflect management&#x2019;s judgment, current market conditions, and forecasts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Royalty Right Agreements&#x2019; fair value is estimated by applying probability-weighted cash flows for future sales, which are then discounted to present value. Changes to fair value of the Royalty Rights Agreements can result from changes to one or a number of the aforementioned inputs. A significant change in unobservable inputs could result in a material increase or decrease to the effective interest rate of the Royalty Right Agreements liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant unobservable inputs used in the fair value measurement of the Royalty Right Agreements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Methodology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (range, if applicable)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty Right Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighted&lt;br/&gt;income approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Years of Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2026, there were no changes to the significant unobservable inputs used to recognize the Royalty Right Agreements liability. During the year ended December&#160;31, 2025, the Company updated the probability-weighted cash flows for future sales, which decreased the royalty obligation to $51,886 and decreased the unamortized discount to $25,945. The effective interest rate changed by 2.64%, and the Company updated the projected years of payments to 2035.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the Royalty Right Agreements were issued in connection with the 13.5% Notes, the Company allocated the proceeds to the two instruments based on their relative fair values. The Company allocated approximately $13,856 to the Royalty Right Agreements. The Company determined the allocated fair value by calculating the present value of estimated future royalties to be paid to Note Holders over the life of the arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of future estimated royalty payments over the allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allocated amounts of $13,856 when combined with the Exit Fee of $2,000, original issue discount of $1,125 and debt issuance costs of $3,517, resulted in a debt discount of $20,498. The debt discount is being amortized over the term of 13.5% Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense arising from the discounts related to the 13.5% Notes and the Royalty Right Agreements for the three months ended March&#160;31, 2026 was $1,254 and $973, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense arising from the discounts related to the 13.5% Notes and the Royalty Right Agreements for the three months ended March&#160;31, 2025 was $1,254 and $1,437, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized discounts totaled $6,376 for the 13.5% Notes and $24,972 for the Royalty obligations as of March&#160;31, 2026. Unamortized discounts totaled $7,630 for the 13.5% Notes and $25,945 for the Royalty obligations as of December&#160;31, 2025, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term notes and unamortized debt discount balances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Outstanding notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount, including Exit Fee&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, long-term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Royalty obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty obligations, long term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled principal payments on the 13.5% Notes as of March&#160;31, 2026 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted above, the 13.5% Notes were redeemed on May 12, 2026. See Note 21, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-505" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-110" decimals="-3" id="f-506" unitRef="usd">45000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-507" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-137" decimals="-3" id="f-508" unitRef="usd">4326000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-138" decimals="3" id="f-509" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-510" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-511" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-512" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-513" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:DebtInstrumentExitFee contextRef="c-139" decimals="-3" id="f-514" unitRef="usd">2000000</aqst:DebtInstrumentExitFee>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-515" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-140" decimals="2" id="f-516" unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="c-140" decimals="3" id="f-517" unitRef="number">0.010</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <aqst:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate contextRef="c-141" decimals="4" id="f-518" unitRef="number">0.0100</aqst:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-142" decimals="3" id="f-519" unitRef="number">1.085</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-520" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-137" decimals="3" id="f-521" unitRef="number">1.085</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <aqst:LineOfCreditFacilityAccordionFeatureNetRevenueThreshold contextRef="c-143" decimals="-3" id="f-522" unitRef="usd">100000</aqst:LineOfCreditFacilityAccordionFeatureNetRevenueThreshold>
    <aqst:LineOfCreditFacilityAccordionFeatureIncreaseLimit contextRef="c-144" decimals="-3" id="f-523" unitRef="usd">10000</aqst:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentTerm contextRef="c-145" id="f-524">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-146" decimals="INF" id="f-525" unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-146" decimals="INF" id="f-526" unitRef="usd">55000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-147" decimals="3" id="f-527" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt contextRef="c-148" decimals="-3" id="f-528" unitRef="usd">45000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-529" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-111" decimals="3" id="f-530" unitRef="number">0.010</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-112" decimals="3" id="f-531" unitRef="number">0.020</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm contextRef="c-113" id="f-532">P8Y</aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-111" decimals="3" id="f-533" unitRef="number">0.010</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:RoyaltyObligationPercentOfNetSales contextRef="c-112" decimals="3" id="f-534" unitRef="number">0.020</aqst:RoyaltyObligationPercentOfNetSales>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm contextRef="c-113" id="f-535">P8Y</aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-536" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock contextRef="c-1" id="f-537">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant unobservable inputs used in the fair value measurement of the Royalty Right Agreements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Methodology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (range, if applicable)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty Right Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighted&lt;br/&gt;income approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Years of Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aqst:ScheduleOfSignificantUnobservableInputsUsedInTheInitialFairValueMeasurementOfTheRoyaltyRightAgreementTableTextBlock>
    <aqst:RoyaltyAgreementMeasurementInput contextRef="c-149" decimals="2" id="f-538" unitRef="number">0.15</aqst:RoyaltyAgreementMeasurementInput>
    <aqst:RoyaltyAgreementMeasurementInput contextRef="c-150" decimals="2" id="f-539" unitRef="number">0.95</aqst:RoyaltyAgreementMeasurementInput>
    <aqst:RoyaltyObligationsGross contextRef="c-4" decimals="-3" id="f-540" unitRef="usd">51886000</aqst:RoyaltyObligationsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-151" decimals="-3" id="f-541" unitRef="usd">25945000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-152" decimals="4" id="f-542" unitRef="number">0.0264</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-543" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="c-153"
      decimals="INF"
      id="f-544"
      unitRef="instrument">2</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:LongTermDebtFairValue contextRef="c-154" decimals="-3" id="f-545" unitRef="usd">13856000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="c-155" decimals="-3" id="f-546" unitRef="usd">13856000</us-gaap:LongTermDebtFairValue>
    <aqst:DebtInstrumentExitFee contextRef="c-139" decimals="-3" id="f-547" unitRef="usd">2000000</aqst:DebtInstrumentExitFee>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="c-155" decimals="-3" id="f-548" unitRef="usd">1125000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-155" decimals="-3" id="f-549" unitRef="usd">3517000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-155" decimals="-3" id="f-550" unitRef="usd">20498000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-551" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-552" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-156" decimals="-3" id="f-553" unitRef="usd">1254000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-157" decimals="-3" id="f-554" unitRef="usd">973000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-158" decimals="3" id="f-555" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-159" decimals="-3" id="f-556" unitRef="usd">1254000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-160" decimals="-3" id="f-557" unitRef="usd">1437000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-40" decimals="-3" id="f-558" unitRef="usd">6376000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-559" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-161" decimals="-3" id="f-560" unitRef="usd">24972000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-152" decimals="-3" id="f-561" unitRef="usd">7630000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-152" decimals="3" id="f-562" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-151" decimals="-3" id="f-563" unitRef="usd">25945000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-564">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term notes and unamortized debt discount balances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Outstanding notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount, including Exit Fee&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, long-term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Royalty obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty obligations, long term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-40" decimals="-3" id="f-565" unitRef="usd">45000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-152" decimals="-3" id="f-566" unitRef="usd">45000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-40" decimals="-3" id="f-567" unitRef="usd">6376000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-152" decimals="-3" id="f-568" unitRef="usd">7630000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="c-40" decimals="-3" id="f-569" unitRef="usd">13630000</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:NotesAndLoansPayableCurrent contextRef="c-152" decimals="-3" id="f-570" unitRef="usd">9964000</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-40" decimals="-3" id="f-571" unitRef="usd">24994000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-152" decimals="-3" id="f-572" unitRef="usd">27406000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-40" decimals="-3" id="f-573" unitRef="usd">105000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-152" decimals="-3" id="f-574" unitRef="usd">113000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-40" decimals="-3" id="f-575" unitRef="usd">25099000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-152" decimals="-3" id="f-576" unitRef="usd">27519000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-161" decimals="-3" id="f-577" unitRef="usd">51886000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-151" decimals="-3" id="f-578" unitRef="usd">51886000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-161" decimals="-3" id="f-579" unitRef="usd">24972000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-151" decimals="-3" id="f-580" unitRef="usd">25945000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-161" decimals="-3" id="f-581" unitRef="usd">26914000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-151" decimals="-3" id="f-582" unitRef="usd">25941000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-583">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled principal payments on the 13.5% Notes as of March&#160;31, 2026 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-584" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-585" unitRef="usd">9540000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-3" decimals="-3" id="f-586" unitRef="usd">14535000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-3" decimals="-3" id="f-587" unitRef="usd">20925000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-3" id="f-588" unitRef="usd">45000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-589" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:WarrantsDisclosureTextBlock contextRef="c-1" id="f-590">Warrants&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants Issued to RTW Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2026, in connection with the Amendment No.1 to the Purchase and Sale Agreement and the Equity Commitment Agreement with RTW, the Company also entered into the Warrant Issuance Agreement with the RTW investors. Pursuant to this agreement, the Company issued to the RTW Investors the RTW Warrant to purchase up to an aggregate of 375,000 shares of the Company's Common Stock. The RTW Warrant entitles the holders to purchase shares of Common Stock at an exercise price of $4.00 per share. The Warrant is exercisable at any time from the issuance date through March 3, 2029. Management estimated the fair value of the RTW Warrants to be $916, based on an assessment by an independent third-party appraiser. The fair value was estimated using the Black-Scholes pricing model, which utilized the Company's historical stock price to measure volatility and a holding period of three years based on the time period between the valuation date and the termination date as defined in the Warrant Issuance Agreement. The fair value of the RTW Warrants is presented within Additional Paid-in Capital on the Condensed Balance Sheets as of March&#160;31, 2026 and within Interest income and other income, net on the Condensed Statements of Operations and Comprehensive Loss for the three months ended March&#160;31, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no warrants exercised as it relates to the RTW Warrants during the three months ended March&#160;31, 2026. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants Issued to 12.5% Senior Secured Noteholders &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrants that were issued in conjunction with the Initial Notes (the &#x201c;Initial Warrants&#x201d;) and Additional Notes (the &#x201c;Additional Warrants&#x201d;) entitled the noteholders of the Company's 12.5% Notes to purchase up to 2,143,000 shares of Common Stock and included specified registration rights. Management estimated the fair value of the Initial Warrants to be $6,800 and the Additional Warrants to be $735, each based on an assessment by an independent third-party appraiser. The fair value of the respective warrants was treated as a debt discount, amortizable over the term of the respective warrants, with the unamortized 12.5% Notes portion applied to reduce the aggregate principal amount of the 12.5% Notes. The 12.5% Notes were refinanced with the 13.5% Notes on November 1, 2023. Additionally, since the Initial Warrants and Additional Warrants issued do not provide warrant redemption or put rights within the control of the noteholders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the warrants, except in the case of a &#x201c;cash change in control&#x201d;, the fair value attributed to the warrants is presented in Additional Paid-in Capital in the Company&#x2019;s Condensed Balance Sheets. The Initial Warrants and Additional Warrants expired on June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no warrants exercised as it relates to the Initial Warrants and the Additional Warrants during the three months ended March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants Issued Under Securities Purchase Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company issued pre-funded warrants and Common Stock warrants to certain purchasers in connection with the Securities Purchase Agreements. The pre-funded warrants entitled purchasers to purchase up to 4,000,000 shares of Common Stock and were exercised in full during the year ended December 31, 2022. The Common Stock warrants expire on June 8, 2027 and entitled the purchasers to purchase up to 8,850,000 shares of Common Stock at an exercise price of $0.96 per share. Management estimated the fair value of the pre-funded warrants and Common Stock warrants to be $5,874 based on an assessment by an independent third-party appraiser. The fair value of the pre-funded and Common Stock warrants is treated as equity and presented in Additional Paid-in Capital in the Company&#x2019;s Condensed Balance Sheets. On June 14, 2023, 3,689,452 Common Stock warrants issued pursuant to the Securities Purchase Agreements were exercised with proceeds of approximately $3,542.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of 5,000,000 of the remaining Common Stock Warrants. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the then current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock. The New Warrants became exercisable after February 2, 2024, expire on February 2, 2029 and are issuable only for cash, subject to exception if the shares of Common &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case, the New Warrants may also be exercised, in whole or in part, at such time by means of a "cashless exercise". The New Warrants have an exercise price of $2.60 per share. Management estimated the fair value of the warrants to be $4,671 based on an assessment by an independent third-party appraiser. The fair value of the New Warrants is treated as equity and is presented in Additional Paid-in Capital in the Company&#x2019;s Condensed Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no warrants issued or exercised as it relates to the Warrants issued under Securities Purchase Agreements during the three months ended March&#160;31, 2026 and 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, in addition to the remaining New Warrants to purchase 2,200,000 shares of Common Stock with an exercise price of $2.60 per share and the RTW Warrants to purchase 375,000 shares with an exercise price of $4.00 per share described above, there remain outstanding warrants to purchase 160,548 shares of Common Stock at an exercise price of $0.96.&lt;/span&gt;&lt;/div&gt;</aqst:WarrantsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-114" decimals="0" id="f-591" unitRef="shares">375000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-115"
      decimals="2"
      id="f-592"
      unitRef="usdPerShare">4.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-3" decimals="-3" id="f-593" unitRef="usd">916000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-3" id="f-594">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-162" decimals="3" id="f-595" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-162" decimals="3" id="f-596" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-163" decimals="0" id="f-597" unitRef="shares">2143000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <aqst:AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued contextRef="c-164" decimals="-3" id="f-598" unitRef="usd">6800000</aqst:AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued>
    <aqst:AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued contextRef="c-165" decimals="-3" id="f-599" unitRef="usd">735000</aqst:AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssued>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-162" decimals="3" id="f-600" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-162" decimals="3" id="f-601" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-162" decimals="3" id="f-602" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-40" decimals="3" id="f-603" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:ClassOfWarrantOrRightWarrantsExercised contextRef="c-5" decimals="0" id="f-604" unitRef="shares">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-166" decimals="0" id="f-605" unitRef="shares">4000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-167" decimals="0" id="f-606" unitRef="shares">8850000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-168"
      decimals="2"
      id="f-607"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-169" decimals="-3" id="f-608" unitRef="usd">5874000</us-gaap:WarrantsAndRightsOutstanding>
    <aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod contextRef="c-170" decimals="0" id="f-609" unitRef="shares">3689452</aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-170" decimals="-3" id="f-610" unitRef="usd">3542000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-108" decimals="0" id="f-611" unitRef="shares">5000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-108"
      decimals="2"
      id="f-612"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-109" decimals="0" id="f-613" unitRef="shares">2750000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-109"
      decimals="2"
      id="f-614"
      unitRef="usdPerShare">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-109" decimals="-3" id="f-615" unitRef="usd">4671000</us-gaap:WarrantsAndRightsOutstanding>
    <aqst:ClassOfWarrantOrRightWarrantsExercised
      contextRef="c-171"
      decimals="-3"
      id="f-616"
      unitRef="shares">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
    <aqst:ClassOfWarrantOrRightWarrantsExercised
      contextRef="c-172"
      decimals="-3"
      id="f-617"
      unitRef="shares">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-173"
      decimals="-3"
      id="f-618"
      unitRef="shares">2200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-109"
      decimals="2"
      id="f-619"
      unitRef="usdPerShare">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-114" decimals="0" id="f-620" unitRef="shares">375000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-115"
      decimals="2"
      id="f-621"
      unitRef="usdPerShare">4.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod contextRef="c-172" decimals="0" id="f-622" unitRef="shares">160548</aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-173"
      decimals="2"
      id="f-623"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <aqst:SaleOfFutureRevenueTextBlock contextRef="c-1" id="f-624">Sale of Future Revenue&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#x2019;s apomorphine product, KYNMOBI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an apomorphine film therapy for the treatment of off episodes in Parkinson&#x2019;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, the Company received an upfront payment of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through March&#160;31, 2026 under the Monetization Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded the upfront proceeds of $40,000 and subsequent first milestone of $10,000, reduced by $2,909 of transaction costs, as a liability related to the sale of future revenue that will be amortized using the effective interest method over the life of the Monetization Agreement. As future contingent payments are received, they will increase the balance of the liability related to the sale of future revenue. Although the Company sold all of its rights to receive royalties and milestones, as a result of ongoing obligations related to the generation of these royalties, the Company will account for these royalties as revenue. Its ongoing obligations include the maintenance and defense of the intellectual property and to provide assistance to Marathon in executing a new license agreement for KYNMOBI in the event Sunovion terminates the Sunovion License Agreement in one or more jurisdictions of the licensed territory under the Sunovion License Agreement. The accounting liabilities, as adjusted over time, resulting from this transaction and any non-cash interest expenses associated with those liabilities do not and will not represent any obligation to pay or any potential future use of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the $1,000 annual minimum guaranteed royalty that is due. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfer and Servicing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As royalties are remitted to Marathon from Sunovion, the collection of the royalty receivable and balance of the liability related to the sale of future revenue will be effectively repaid over the life of the agreement. In order to determine the amortization of the liability related to the sale of future revenue, the Company is required to estimate the total amount of future royalty and milestone payments to Marathon over the life of the Monetization Agreement and contingent milestone payments from Marathon to the Company. The sum of future royalty payments less the $50,000 in proceeds received and future contingent payments has been recorded as interest expense over the life of the Monetization Agreement. At execution, the estimate of this total interest expense resulted in an effective annual interest rate of approximately 24.9%. This estimate contained significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the life of the Monetization Agreement. The Company assesses the estimated royalty and milestone payments to Marathon from Sunovion and contingent milestone payments from Marathon to the Company. To the extent the amount or timing of such payments is materially different from the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. There are a number of factors that could materially affect the amount and timing of royalty and milestone payments to Marathon from Sunovion and, correspondingly, the amount of interest expense recorded by the Company, most of which are not under the Company&#x2019;s control. Such factors include, but are not limited to, changing standards of care, the initiation of competing products, manufacturing or other delays, generic competition, intellectual property matters, adverse events that result in government health authority imposed restrictions on the use of products, significant changes in foreign exchange rates as the royalties remitted to Marathon are made in U.S. dollars (USD) while a portion of the underlying sales of KYNMOBI will be made in currencies other than USD, and other events or circumstances that are not &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;currently foreseen. Changes to any of these factors could result in increases or decreases to both royalty revenue and interest expense related to the sale of future revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. Further, the Company discontinued recording interest expense related to the sale of future revenue during the fourth quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the activity of the liability related to the sale of future revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at beginning of the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties related to the sale of future revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aqst:SaleOfFutureRevenueTextBlock>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-100" decimals="-3" id="f-625" unitRef="usd">40000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-174" decimals="-3" id="f-626" unitRef="usd">10000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-101" decimals="-3" id="f-627" unitRef="usd">50000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ContingentMonetizationAgreementMilestonePayment contextRef="c-100" decimals="-3" id="f-628" unitRef="usd">75000000</aqst:ContingentMonetizationAgreementMilestonePayment>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-102" decimals="-3" id="f-629" unitRef="usd">125000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-100" decimals="-3" id="f-630" unitRef="usd">40000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-174" decimals="-3" id="f-631" unitRef="usd">10000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-175" decimals="-3" id="f-632" unitRef="usd">2909000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-134" decimals="-3" id="f-633" unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <aqst:MinimumAnnualRoyaltyReceivable contextRef="c-176" decimals="-3" id="f-634" unitRef="usd">1000000</aqst:MinimumAnnualRoyaltyReceivable>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-101" decimals="-3" id="f-635" unitRef="usd">50000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-177" decimals="3" id="f-636" unitRef="number">0.249</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <aqst:RoyaltyObligationActivityTableTextBlock contextRef="c-1" id="f-637">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the activity of the liability related to the sale of future revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at beginning of the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties related to the sale of future revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $1,000, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aqst:RoyaltyObligationActivityTableTextBlock>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-4" decimals="-3" id="f-638" unitRef="usd">63023000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-21" decimals="-3" id="f-639" unitRef="usd">63718000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-178" decimals="-3" id="f-640" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-179" decimals="-3" id="f-641" unitRef="usd">938000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-642" unitRef="usd">60000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-180" decimals="-3" id="f-643" unitRef="usd">243000</us-gaap:AmortizationOfFinancingCosts>
    <aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent contextRef="c-3" decimals="-3" id="f-644" unitRef="usd">1000000</aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent>
    <aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent contextRef="c-4" decimals="-3" id="f-645" unitRef="usd">1000000</aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedCurrent>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-3" decimals="-3" id="f-646" unitRef="usd">63083000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-4" decimals="-3" id="f-647" unitRef="usd">63023000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <us-gaap:AssetRetirementObligationDisclosureTextBlock contextRef="c-1" id="f-648">Other Non-Current Liabilities&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s other non-current liabilities at March&#160;31, 2026 and December&#160;31, 2025  consisted of a confidential legal settlement net liability and AROs of  $2,072 and $2,065, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AROs consists of estimated future spending related to removing certain leasehold improvements at the Company&#x2019;s facilities in Portage, Indiana and Warren, New Jersey, and returning all facilities to their original condition. Depreciation expense related to the ARO assets included in overall depreciation expense for the three months ended March&#160;31, 2026 and 2025 was $6 and $7, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AssetRetirementObligationDisclosureTextBlock>
    <us-gaap:AssetRetirementObligation contextRef="c-3" decimals="-3" id="f-649" unitRef="usd">2072000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="c-4" decimals="-3" id="f-650" unitRef="usd">2065000</us-gaap:AssetRetirementObligation>
    <aqst:AssetRetirementObligationsDepreciationExpense contextRef="c-1" decimals="-3" id="f-651" unitRef="usd">6000</aqst:AssetRetirementObligationsDepreciationExpense>
    <aqst:AssetRetirementObligationsDepreciationExpense contextRef="c-5" decimals="-3" id="f-652" unitRef="usd">7000</aqst:AssetRetirementObligationsDepreciationExpense>
    <us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock contextRef="c-1" id="f-653">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.162%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.638%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock>
    <us-gaap:AssetRetirementObligation contextRef="c-21" decimals="-3" id="f-654" unitRef="usd">2039000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligationLiabilitiesIncurred contextRef="c-5" decimals="-3" id="f-655" unitRef="usd">0</us-gaap:AssetRetirementObligationLiabilitiesIncurred>
    <us-gaap:AssetRetirementObligationAccretionExpense contextRef="c-5" decimals="-3" id="f-656" unitRef="usd">6000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligation contextRef="c-31" decimals="-3" id="f-657" unitRef="usd">2045000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="c-4" decimals="-3" id="f-658" unitRef="usd">2065000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligationLiabilitiesIncurred contextRef="c-1" decimals="-3" id="f-659" unitRef="usd">0</us-gaap:AssetRetirementObligationLiabilitiesIncurred>
    <us-gaap:AssetRetirementObligationAccretionExpense contextRef="c-1" decimals="-3" id="f-660" unitRef="usd">7000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligation contextRef="c-3" decimals="-3" id="f-661" unitRef="usd">2072000</us-gaap:AssetRetirementObligation>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-662">Net Loss Per Share&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing net loss by the weighted-average number of Common Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#x2019;s equity compensation plans, warrants and ESPP. As a result of the Company&#x2019;s net loss incurred for the three months ended March&#160;31, 2026 and 2025, all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended March&#160;31, 2026 and 2025 as reflected below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,609,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,497,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per common share &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended March&#160;31, 2026 and 2025, outstanding stock options of 7,501,729 and 6,977,367 to purchase shares of Common Stock, respectively, were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the three months ended March&#160;31, 2026 and 2025, outstanding restricted stock units of 4,566,190 and 5,167,351 to purchase shares of Common Stock, respectively, were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended March&#160;31, 2026 and 2025, outstanding warrants of 2,735,548 and 4,594,332 to purchase shares of Common Stock, respectively, were anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-663">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#x2019;s equity compensation plans, warrants and ESPP. As a result of the Company&#x2019;s net loss incurred for the three months ended March&#160;31, 2026 and 2025, all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended March&#160;31, 2026 and 2025 as reflected below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,930)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,609,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,497,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss per common share &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.07)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended March&#160;31, 2026 and 2025, outstanding stock options of 7,501,729 and 6,977,367 to purchase shares of Common Stock, respectively, were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the three months ended March&#160;31, 2026 and 2025, outstanding restricted stock units of 4,566,190 and 5,167,351 to purchase shares of Common Stock, respectively, were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended March&#160;31, 2026 and 2025, outstanding warrants of 2,735,548 and 4,594,332 to purchase shares of Common Stock, respectively, were anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-664" unitRef="usd">-8057000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-665" unitRef="usd">-22930000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-666" unitRef="shares">122609995</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-667" unitRef="shares">122609995</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-668" unitRef="shares">95497056</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-669" unitRef="shares">95497056</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-670"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-671"
      unitRef="usdPerShare">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-672"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-673"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-181" decimals="0" id="f-674" unitRef="shares">7501729</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-181" decimals="0" id="f-675" unitRef="shares">7501729</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-182" decimals="0" id="f-676" unitRef="shares">6977367</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-182" decimals="0" id="f-677" unitRef="shares">6977367</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-183" decimals="0" id="f-678" unitRef="shares">4566190</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-183" decimals="0" id="f-679" unitRef="shares">4566190</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-184" decimals="0" id="f-680" unitRef="shares">5167351</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-184" decimals="0" id="f-681" unitRef="shares">5167351</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-185" decimals="0" id="f-682" unitRef="shares">2735548</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-185" decimals="0" id="f-683" unitRef="shares">2735548</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-186" decimals="0" id="f-684" unitRef="shares">4594332</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-186" decimals="0" id="f-685" unitRef="shares">4594332</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-686">Share-Based Compensation&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized share-based compensation in its Condensed Statements of Operations and Comprehensive Loss during the three months ended March&#160;31, 2026 and 2025 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation Equity Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information about the Company&#x2019;s restricted stock unit and stock option activity during the three month period ended March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s awards of service-based and market conditions vesting-based restricted stock units for the three month period ended March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Service-based:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, $8,931 of total unrecognized compensation expenses related to unvested service-based restricted stock units are expected to be recognized over a remaining weighted average period of 2.24 years. The service-based restricted stock units granted to employees are subject to a three-year graduated vesting schedule and are not subject to performance-based criteria other than continued employment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, $1,090 of unrecognized compensation expense related to unvested market condition vesting- based restricted stock units are expected to be recognized over a remaining weighted average period of 0.78 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2023 market conditions vesting-based restricted stock units vest based on a Performance Price measured as the 30-day average of the closing prices of the Common Stock as reported on the Nasdaq Global Market immediately prior to and including the last calendar day of the three-year performance period (which ends on the third anniversary of the grant date). To the extent the Performance Price is less than $1.75, the Vesting Percentage will be zero. To the extent the Performance Price is $1.75, the Vesting Percentage will be 50%. To the extent the Performance Price is $1.76 or greater, but less than $2.50, the Vesting Percentage will be a prorated amount between 50.01% and 99.99%, based on straight-line interpolation. To the extent the Performance Price is $2.50, the Vesting Percentage will be 100%. To the extent the Performance Price is $2.51 or greater, but less than $3.25, the Vesting Percentage will be a prorated amount between 100.01% and 149.99%, based on straight-line interpolation. To the extent the Performance Price is $3.25 or greater, the Vesting Percentage will be 150%. In no event will the Vesting Percentage exceed 150%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2025 market conditions vesting-based restricted stock units were measured over a three-year performance period. The performance period is split into two pricing periods. The first pricing period commences on the grant date and ends on the calendar day immediately proceeding the second anniversary of the grant date. The second pricing period commences on the second anniversary of the grant date and ends on the third anniversary of the grant date, The performance price for the first pricing period is calculated based on the 30-day average price observed for the last 30 days of the first pricing period. The performance price for the second pricing period is calculated based on the highest 30-day average for any 30-day period throughout the second pricing period. To the extent the Performance Price is less than $6.00, the Vesting Percentage will be zero. To the extent the Performance Price is $6.00, the Vesting Percentage will be 50%. To the extent the Performance Price is $6.01 or greater, but less than $7.00, the Vesting Percentage will be a prorated amount between 50.01% and 99.99%, based on straight-line interpolation. To the extent the Performance Price is $7.00, the Vesting Percentage will be 100%. To the extent the Performance Price is $7.01 or greater, but less than $8.00, the Vesting Percentage will be a prorated amount between 100.01% and 149.99%, based on straight-line interpolation. To the extent the Performance Price is $8.00 or greater, the Vesting Percentage will be 150%. In no event will the Vesting Percentage exceed 150%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of the fair value of the 2025 market conditions vesting-based awards at their grant or valuation dates were based on a Monte Carlo simulation and considered various variables and the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price at grant date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.65&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Stock Option Awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.654%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.146%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of stock options granted during the three months ended March&#160;31, 2026 was $3.43. During the three months ended March&#160;31, 2026, stock options were granted with a weighted average exercise price of $4.29.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2026, $5,272 of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a remaining weighted average period of 2.04 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;2022 Inducement Equity Incentive Plan (number of units in thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Nasdaq Listing Rule 5635(c)(4), the Company adopted the 2022 Equity Inducement Plan approved by the Compensation Committee of the Board of Directors of the Company effective as of July 29, 2022. There were 75  service-based awards and 50 options granted under this Plan during the three months ended March&#160;31, 2026. The options and service-based awards granted under this Plan are included in the tables above. As of March&#160;31, 2026, 775 shares remained available for grant under this Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="c-1" id="f-687">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized share-based compensation in its Condensed Statements of Operations and Comprehensive Loss during the three months ended March&#160;31, 2026 and 2025 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.575%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-187" decimals="-3" id="f-688" unitRef="usd">69000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-188" decimals="-3" id="f-689" unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-189" decimals="-3" id="f-690" unitRef="usd">236000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-190" decimals="-3" id="f-691" unitRef="usd">330000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-191" decimals="-3" id="f-692" unitRef="usd">2013000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-192" decimals="-3" id="f-693" unitRef="usd">1157000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-694" unitRef="usd">2318000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-695" unitRef="usd">1587000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-193" decimals="-3" id="f-696" unitRef="usd">1655000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-194" decimals="-3" id="f-697" unitRef="usd">1102000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-195" decimals="-3" id="f-698" unitRef="usd">663000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-196" decimals="-3" id="f-699" unitRef="usd">485000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-700" unitRef="usd">2318000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-701" unitRef="usd">1587000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-702">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s awards of service-based and market conditions vesting-based restricted stock units for the three month period ended March&#160;31, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Service-based:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-197"
      decimals="-3"
      id="f-703"
      unitRef="shares">2684000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-197"
      decimals="2"
      id="f-704"
      unitRef="usdPerShare">3.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-198"
      decimals="-3"
      id="f-705"
      unitRef="shares">1282000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-198"
      decimals="2"
      id="f-706"
      unitRef="usdPerShare">4.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-198"
      decimals="-3"
      id="f-707"
      unitRef="shares">1125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-198"
      decimals="2"
      id="f-708"
      unitRef="usdPerShare">2.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-198"
      decimals="-3"
      id="f-709"
      unitRef="shares">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-198"
      decimals="2"
      id="f-710"
      unitRef="usdPerShare">4.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-199"
      decimals="-3"
      id="f-711"
      unitRef="shares">2839000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-199"
      decimals="2"
      id="f-712"
      unitRef="usdPerShare">4.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares
      contextRef="c-199"
      decimals="-3"
      id="f-713"
      unitRef="shares">2597000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue
      contextRef="c-199"
      decimals="2"
      id="f-714"
      unitRef="usdPerShare">4.08</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-199" decimals="-3" id="f-715" unitRef="usd">8931000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-198" id="f-716">P2Y2M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-198" id="f-717">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-718">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Stock Option Awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-200"
      decimals="-3"
      id="f-719"
      unitRef="shares">1728000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-200"
      decimals="2"
      id="f-720"
      unitRef="usdPerShare">2.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-201"
      decimals="-3"
      id="f-721"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-201"
      decimals="2"
      id="f-722"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-201"
      decimals="-3"
      id="f-723"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-201"
      decimals="2"
      id="f-724"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-201"
      decimals="-3"
      id="f-725"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-201"
      decimals="2"
      id="f-726"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-202"
      decimals="-3"
      id="f-727"
      unitRef="shares">1728000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-202"
      decimals="2"
      id="f-728"
      unitRef="usdPerShare">2.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares
      contextRef="c-202"
      decimals="-3"
      id="f-729"
      unitRef="shares">1661000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue
      contextRef="c-202"
      decimals="2"
      id="f-730"
      unitRef="usdPerShare">2.54</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-202" decimals="-3" id="f-731" unitRef="usd">1090000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-201" id="f-732">P0Y9M10D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod contextRef="c-202" id="f-733">P30D</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-201" id="f-734">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-203"
      decimals="2"
      id="f-735"
      unitRef="usdPerShare">1.75</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-204" decimals="2" id="f-736" unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-205"
      decimals="2"
      id="f-737"
      unitRef="usdPerShare">1.75</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-206" decimals="2" id="f-738" unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-207"
      decimals="2"
      id="f-739"
      unitRef="usdPerShare">1.76</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-208"
      decimals="2"
      id="f-740"
      unitRef="usdPerShare">2.50</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-209" decimals="4" id="f-741" unitRef="number">0.5001</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-210" decimals="4" id="f-742" unitRef="number">0.9999</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-211"
      decimals="2"
      id="f-743"
      unitRef="usdPerShare">2.50</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-212" decimals="2" id="f-744" unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-213"
      decimals="2"
      id="f-745"
      unitRef="usdPerShare">2.51</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-214"
      decimals="2"
      id="f-746"
      unitRef="usdPerShare">3.25</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-215" decimals="4" id="f-747" unitRef="number">1.0001</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-216" decimals="4" id="f-748" unitRef="number">1.4999</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-217"
      decimals="2"
      id="f-749"
      unitRef="usdPerShare">3.25</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-218" decimals="2" id="f-750" unitRef="number">1.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-193" decimals="2" id="f-751" unitRef="number">1.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-219" id="f-752">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods
      contextRef="c-219"
      decimals="INF"
      id="f-753"
      unitRef="pricing_period">2</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPricingPeriods>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod contextRef="c-220" id="f-754">P30D</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod contextRef="c-220" id="f-755">P30D</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod contextRef="c-220" id="f-756">P30D</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod contextRef="c-220" id="f-757">P30D</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDaysUtilizedInPricingPeriod>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-221"
      decimals="2"
      id="f-758"
      unitRef="usdPerShare">6.00</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-222" decimals="2" id="f-759" unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-223"
      decimals="2"
      id="f-760"
      unitRef="usdPerShare">6.00</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-224" decimals="2" id="f-761" unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-225"
      decimals="2"
      id="f-762"
      unitRef="usdPerShare">6.01</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-226"
      decimals="2"
      id="f-763"
      unitRef="usdPerShare">7.00</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-227" decimals="4" id="f-764" unitRef="number">0.5001</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-228" decimals="4" id="f-765" unitRef="number">0.9999</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-229"
      decimals="2"
      id="f-766"
      unitRef="usdPerShare">7.00</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-230" decimals="2" id="f-767" unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-231"
      decimals="2"
      id="f-768"
      unitRef="usdPerShare">7.01</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-232"
      decimals="2"
      id="f-769"
      unitRef="usdPerShare">8.00</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-233" decimals="4" id="f-770" unitRef="number">1.0001</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-234" decimals="4" id="f-771" unitRef="number">1.4999</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-235"
      decimals="2"
      id="f-772"
      unitRef="usdPerShare">8.00</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-236" decimals="2" id="f-773" unitRef="number">1.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-237" decimals="2" id="f-774" unitRef="number">1.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-775">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of the fair value of the 2025 market conditions vesting-based awards at their grant or valuation dates were based on a Monte Carlo simulation and considered various variables and the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.285%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price at grant date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.65&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.654%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.146%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-196" decimals="3" id="f-776" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-196" decimals="3" id="f-777" unitRef="number">0.915</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-196" decimals="3" id="f-778" unitRef="number">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharePrice
      contextRef="c-238"
      decimals="2"
      id="f-779"
      unitRef="usdPerShare">2.65</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-239"
      decimals="-3"
      id="f-780"
      unitRef="shares">6558000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-239"
      decimals="2"
      id="f-781"
      unitRef="usdPerShare">5.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-195"
      decimals="-3"
      id="f-782"
      unitRef="shares">946000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-195"
      decimals="2"
      id="f-783"
      unitRef="usdPerShare">4.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-195"
      decimals="-3"
      id="f-784"
      unitRef="shares">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-195"
      decimals="2"
      id="f-785"
      unitRef="usdPerShare">0.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod
      contextRef="c-195"
      decimals="-3"
      id="f-786"
      unitRef="shares">1000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-195"
      decimals="2"
      id="f-787"
      unitRef="usdPerShare">3.84</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-240"
      decimals="-3"
      id="f-788"
      unitRef="shares">7502000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-240"
      decimals="2"
      id="f-789"
      unitRef="usdPerShare">5.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-240"
      decimals="-3"
      id="f-790"
      unitRef="shares">7342000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-240"
      decimals="2"
      id="f-791"
      unitRef="usdPerShare">5.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-240"
      decimals="-3"
      id="f-792"
      unitRef="shares">5441000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-240"
      decimals="2"
      id="f-793"
      unitRef="usdPerShare">5.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-241" decimals="2" id="f-794" unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c-241" decimals="2" id="f-795" unitRef="number">0.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-241" id="f-796">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-241" decimals="3" id="f-797" unitRef="number">0.038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-195"
      decimals="2"
      id="f-798"
      unitRef="usdPerShare">3.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-195"
      decimals="2"
      id="f-799"
      unitRef="usdPerShare">4.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-240" decimals="-3" id="f-800" unitRef="usd">5272000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-195" id="f-801">P2Y14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-242"
      decimals="-3"
      id="f-802"
      unitRef="shares">75000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-243"
      decimals="-3"
      id="f-803"
      unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-244"
      decimals="-3"
      id="f-804"
      unitRef="shares">775000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-805">Income Taxes&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and R&amp;amp;D credits. Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three months ended March&#160;31, 2026 and 2025, the effective income tax rate was 0%, and the Company recorded no income tax expense from its pretax losses of $8,057 and $22,930, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary factors impacting the effective tax rate for the three months ended March&#160;31, 2026 is the anticipated full year pre-tax book loss and a full valuation allowance against any associated net deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 4, 2025, the President signed H.R. 1, the Budget Reconciliation Bill, into law. The legislation includes several changes to federal tax law that generally allow for more favorable deductibility of certain business expenses beginning in 2025, including the restoration of immediate expensing of domestic R&amp;amp;D expenditures, reinstatement of 100% bonus depreciation, and more favorable rules for determining the limitation on business interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These changes were reflected in the income tax provision for the three months ended March&#160;31, 2026. As the result of the Company maintaining a full valuation allowance against its U.S. federal and state deferred tax assets, the changes introduced by this legislation did not result in a material impact to the Company&#x2019;s income tax provision or deferred tax balances for the current reporting period. The Company will continue to monitor the potential future impacts of the legislation, including any changes to its valuation allowance assessment, as further guidance becomes available and as facts and circumstances evolve.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="2" id="f-806" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="2" id="f-807" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-808" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-809" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-810" unitRef="usd">-8057000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-811" unitRef="usd">-22930000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-812">Contingencies&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has been and may again become involved in legal proceedings arising in the course of its business, including product liability, intellectual property, securities, civil tort, and commercial litigation, and environmental or other regulatory matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;California Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Neurelis, Inc. v. Aquestive Therapeutics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 5, 2019, Neurelis, Inc. ("Neurelis") filed a civil tort lawsuit against the Company in the Superior Court of California, County of San Diego. In December 2025, the parties reached a mutual out-of-court settlement agreement resolving all claims related to the matter, the terms of which settlement agreement are confidential. In the settlement agreement, the Company did not concede liability and settled the matter for business reasons. The Company does not consider this settlement material to its financial condition. The settlement of the matter was recorded within Selling, general, and administrative expenses on the Company's Statements of Operations and Comprehensive Loss for the year ended December 31, 2025. The current liability was recorded within Accounts payable and the non-current liability was recorded within Other non-current liabilities on the Company's Balance Sheets as of March&#160;31, 2026 and December 31, 2025. On April 3, 2026 the court signed the Order dismissing the case with prejudice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Neurelis FDA Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Neurelis, Inc. v. Califf, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, U.S. District Court for the District of Columbia&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2024, Neurelis filed a complaint in the U.S. District Court for the District of Columbia against the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, and certain government officials. The complaint in this matter alleges that the defendants violated the Administrative Procedure Act by approving the Company's NDA for Libervant for ARS patients aged between two and five years, and asked the Court to vacate that approval and enjoin the defendants from approving Libervant for this pediatric patient population until January 10, 2027, the scheduled date for the expiration of the U.S. orphan drug market exclusivity (ODE) granted by the FDA to the Valtoco&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; nasal spray product of Neurelis (the "ODE Expiration"). The Company intervened in this litigation to defend the approval of Libervant for this ARS pediatric patient population. Following submission of briefs and filings of respective motions by the parties for summary judgment, on February 14, 2025, the Court entered a final appealable judgment in favor of Neurelis, and against the FDA's and the Company's cross-motions for summary judgment, and directed the FDA to vacate the approval of Libervant. On February 18, 2025, the Company filed an appeal of the District Court's decision with the U.S. Court of Appeals for the District of Columbia Circuit (the "DC Appellate Court") and, on the same day, filed an emergency motion with the District Court to stay its order pending a decision on the appeal with the DC Appellate Court. The District Court denied the motion for a stay. On March 27, 2025, the DC Appellate Court denied the Company's emergency motion for stay. The FDA filed an appeal of the District Court's decision to the DC Appellate Court and the Company withdrew its appeal. As a result of the District Court's ruling, the FDA converted the approval of Libervant to a "tentative approval" and the Company has ceased marketing activities in the United States for Libervant for these ARS pediatric patients. After a delay of the proceedings at the DC Appellate Court caused by the government shutdown beginning in October 2025, on November 21, 2025, the DC Appellate Court entered a schedule for briefing and oral arguments on the appeal. Subsequently, on February 3, 2026, Congress adopted and the President signed into law legislation that amended the Orphan Drug Act to provide that ODE applies only to the extent a subsequent applicant seeks approval for the same approved use or indication within the designated rare disease or condition to which the ODE applies. As applied, this legislation would confirm the FDA's long-standing interpretation of the Orphan Drug Act and its authority to approve another sponsor&#x2019;s orphan drug for a different use or indication than that of an approved drug with ODE, such as the FDA's prior approval of Libervant for ARS patients aged between two and five years. On February 16, 2026, the Company filed a motion with the DC Appellate Court requesting that the DC Appellate Court order all parties to submit simultaneous briefs regarding appropriate next steps regarding this legislation and its intended application to this case, including the possibility of a summary disposition of the matter by the DC Appellate Court. On February 18, 2026, Neurelis &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;filed a brief opposing the Company's motion. On the DC Appellate Court's own motion filed on February 17, 2026, the DC Appellate Court suspended briefing by the parties in this case pending further order from the court. On March 2, 2026, the DC Appellate Court entered an order directing the parties to file motions by March 20, 2026 addressing, among other things, their positions on the effect on the appeal resulting from the recent amendment to the Orphan Drug Act. The court denied pending motioned and entered a briefing scheduling order.  The Company is not able to determine or predict the ultimate outcome of these proceedings or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter or whether the FDA will grant U.S. market access to Libervant for ARS patients aged between two and five years in advance of the ODE Expiration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Suboxone Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was named as a defendant in a multitude of product liability lawsuits, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#xae; sublingual film, a prescription drug product for opioid use disorder, caused them dental injuries. On February 2, 2024, this litigation became a MDL consolidated in the U.S District Court for the Northern District of Ohio. One case alleging the same allegations as contained in the MDL has been filed in a state court in the State of New Jersey. The parties to the MDL have agreed to a tolling of unfiled claimants in several states. Indivior has agreed to defend the Company in these litigation matters. Discovery is underway and no trial date has been set in the MDL matter. The Company's motion to dismiss the MDL matter was granted as to all claims against Aquestive by plaintiffs except design defect claims and claims for punitive damages. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was named as a defendant in three proposed class action lawsuits filed in Canada, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#xae; products caused them dental injuries. Two of these cases have been filed in British Columbia, and the plaintiffs in those cases are seeking assignment of a case management judge. The anticipated next step in British Columbia will involve applications by the plaintiffs to determine which of the two cases will proceed towards a certification hearing and which will be stayed. The third case has been filed in Quebec and is proceeding towards an authorization hearing, the date of which has not yet been set. The authorization and certification hearings will determine whether the Courts will allow the cases to proceed as class actions. Pre-discovery and case management proceedings are underway and no trial date has yet been set. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Federal Securities Class Action&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 5, 2026, a putative securities class action lawsuit was filed against the Company and Daniel Barber in the United States District Court for the District of New Jersey, captioned Modica v. Aquestive Therapeutics, Inc. and Daniel Barber. The complaint purports to seek relief on behalf of a class of investors who purchased or otherwise acquired the Company&#x2019;s publicly traded securities between June 16, 2025 and January 8, 2026, and asserts violations of Section 10(b) of the Exchange Act against all defendants and Section 20(a) of the Exchange Act against the individual defendant. The complaint alleges, among other things, that during the proposed class period, defendants made misstatements and/or failed to disclose certain facts regarding the NDA for Anaphylm. The complaint seeks various forms of relief, including monetary damages in an unspecified amount. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Shareholder Derivative Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 15, 2026, a shareholder derivative lawsuit was filed by a purported shareholder on behalf of the Company against certain individual directors and officers of the Company, naming the Company as a nominal defendant, in the United States District Court for the District of New Jersey, captioned Wilson v. Brown, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The complaint asserts claims for violation of Section 14(a) of the Exchange Act against the director defendants, and breach of fiduciary duty, aiding and abetting breach of fiduciary duty, and waste of corporate assets against all individual defendants. The complaint alleges, among other things, that the individual defendants failed to exercise adequate oversight of, and misrepresented and/or failed to disclose certain facts regarding the NDA for Anaphylm. The derivative action has been designated as related to the securities class action described above. The complaint seeks various forms of relief, including monetary damages in an unspecified amount and corporate governance reforms. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-245"
      decimals="INF"
      id="f-813"
      unitRef="pending_case">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-246"
      decimals="INF"
      id="f-814"
      unitRef="pending_case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-247"
      decimals="INF"
      id="f-815"
      unitRef="pending_case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-247"
      decimals="INF"
      id="f-816"
      unitRef="pending_case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-817">Subsequent Events&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 20, 2026, the Company entered into a second amendment to the Pharmanovia Agreement relating to the license and supply of Libervant (diazepam) buccal film in territories outside the United States. The Pharmanovia Amendment No. 2 modifies certain commercial and operational terms of the agreement, including subcontracting rights, delivery terms, and minimum volume commitments in certain territories. All other terms and conditions of the Pharmanovia Agreement remain in full force and effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 8, 2026, the Company entered into a lease agreement which will serve as the Company&#x2019;s corporate headquarters. The lease has an initial term of eleven years, inclusive of an initial rent abatement period of approximately twelve months, commencing on the earlier of the date the Company obtains a certificate of occupancy or September 1, 2026. The lease provides the Company with two successive five-year renewal options at fair market rental value and an option to expand into additional space. The Company expects to account for the lease as an operating lease in accordance with ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases.&lt;/span&gt;&lt;/div&gt;On May 12, 2026, the Company entered into a five-year term loan facility of up to $150,000 with funds managed by Oaktree Capital Management, L.P. The five year term loan facility consisted of an aggregate principal amount of $55,000, which was funded on May 12, 2026 and was primarily used to repay the Company&#x2019;s existing 13.5% Notes in the aggregate principal amount of $45,000 plus fees associated with the repayment. Upon FDA approval of Anaphylm and satisfaction of other customary conditions, an additional $20,000 will be available. A third tranche of $25,000 will be available upon the achievement of specified sales milestones, with the final tranche of up to $50,000 available with the mutual consent of the Lenders and the Company. The Company will pay only interest on the new five-year facility with all principal amounts outstanding due at maturity.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-248" id="f-818">P11Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <aqst:LesseeOperatingLeaseInitialRentAbatementPeriod contextRef="c-248" id="f-819">P12M</aqst:LesseeOperatingLeaseInitialRentAbatementPeriod>
    <aqst:LesseeOperatingLeaseNumberOfRenewalOptions
      contextRef="c-248"
      decimals="INF"
      id="f-820"
      unitRef="renewal_option">2</aqst:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-248" id="f-821">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-145" id="f-822">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-146" decimals="INF" id="f-823" unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm contextRef="c-145" id="f-824">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-146" decimals="INF" id="f-825" unitRef="usd">55000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-147" decimals="3" id="f-826" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt contextRef="c-148" decimals="-3" id="f-827" unitRef="usd">45000000</us-gaap:RepaymentsOfDebt>
    <aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit contextRef="c-249" decimals="-3" id="f-828" unitRef="usd">20000000</aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit>
    <aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit contextRef="c-250" decimals="-3" id="f-829" unitRef="usd">25000000</aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit>
    <aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit contextRef="c-251" decimals="-3" id="f-830" unitRef="usd">50000000</aqst:LineOfCreditFacilityAvailableBorrowingCapacityIncreaseLimit>
    <us-gaap:DebtInstrumentTerm contextRef="c-252" id="f-831">P5Y</us-gaap:DebtInstrumentTerm>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-832">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-833">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-834">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-1" id="f-835">false</ecd:Rule10b51ArrAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
